[
    {
        "uniprot_canonical_ac": "Q9EQ86-1",
        "uniprot_id": "Q9EQ86_MOUSE",
        "mass": 35176.0,
        "length": 311,
        "protein_name": "Olfactory receptor family 10 subfamily D member 1",
        "gene_name": "Or10d1",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 10 subfamily D member 1",
        "refseq_ac": "NP_666719",
        "gene_names_uniprotkb": "Or10d1; Olfr959",
        "gene_names_refseq": "M34; MOR224-3; ORL583; Olfr959; Or10d1",
        "protein_names_uniprotkb": "Olfactory receptor family 10 subfamily D member 1",
        "protein_names_refseq": "GA_x6K02T2PVTD-33270211-33269276; odorant receptor; olfactory receptor 959; olfactory receptor MOR224-3; olfactory receptor family 10 subfamily D member 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258501)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9EQ86-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A1W2P7U0-1",
        "uniprot_id": "A0A1W2P7U0_MOUSE",
        "mass": 20416.0,
        "length": 201,
        "protein_name": "Keratin associated protein 10-24",
        "gene_name": "Krtap10-24",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein LOC100041351",
        "refseq_ac": "NP_001095101",
        "gene_names_uniprotkb": "Krtap10-24; Gm3285",
        "gene_names_refseq": "100041351; Gm3285; Krtap10-24",
        "protein_names_uniprotkb": "Keratin associated protein 10-24",
        "protein_names_refseq": "uncharacterized protein LOC100041351",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100041351);  (R-MMU-6805567)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005829 cytosol;GO:0045095 keratin filament",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A1W2P7U0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2A4U6-1",
        "uniprot_id": "A2A4U6_MOUSE",
        "mass": 78258.0,
        "length": 679,
        "protein_name": "Zinc finger protein 334",
        "gene_name": "Zfp334",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 334",
        "refseq_ac": "NP_848498",
        "gene_names_uniprotkb": "Zfp334",
        "gene_names_refseq": "D2Ertd535e; Zfp334",
        "protein_names_uniprotkb": "Zinc finger protein 334",
        "protein_names_refseq": "zinc finger protein 334",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:228876);  (R-MMU-212436)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A2A4U6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2ADW8-1",
        "uniprot_id": "A2ADW8_MOUSE",
        "mass": 52845.0,
        "length": 449,
        "protein_name": "Predicted gene 15128",
        "gene_name": "Gm15128",
        "organism": "Mouse",
        "refseq_name": "histidine-rich glycoprotein",
        "refseq_ac": "XP_006529068",
        "gene_names_uniprotkb": "Gm15128",
        "gene_names_refseq": "Gm15128",
        "protein_names_uniprotkb": "Predicted gene 15128",
        "protein_names_refseq": "histidine-rich glycoprotein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:434863)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A2ADW8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "D3Z622-1",
        "uniprot_id": "D3Z622_MOUSE",
        "mass": 6698.0,
        "length": 58,
        "protein_name": "RIKEN cDNA 4930455H04 gene",
        "gene_name": "4930455H04Rik",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "4930455H04Rik",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "RIKEN cDNA 4930455H04 gene",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "D3Z622-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "J3QNM7-1",
        "uniprot_id": "J3QNM7_MOUSE",
        "mass": 11422.0,
        "length": 103,
        "protein_name": "ATP synthase F(0) complex subunit g, mitochondrial",
        "gene_name": "Atg5lrt",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Atg5lrt; Gm5426",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "ATP synthase F(0) complex subunit g, mitochondrial; ATPase subunit g",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "Alzheimer's disease (Disease Ontology:DOID:10652)",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Subunit g, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel. These two domains are linked by a central stalk rotating inside the F(1) region and a stationary peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. In vivo, can only synthesize ATP although its ATP hydrolase activity can be activated artificially in vitro. Part of the complex F(0) domain., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0015078 proton transmembrane transporter activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0031966 mitochondrial membrane;GO:0045259 proton-transporting ATP synthase complex",
        "go_biological_process": "GO:0015986 proton motive force-driven ATP synthesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "J3QNM7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "K7N641-1",
        "uniprot_id": "K7N641_MOUSE",
        "mass": 34932.0,
        "length": 315,
        "protein_name": "Olfactory receptor family 2 subfamily AG member 1B",
        "gene_name": "Or2ag1b",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 694",
        "refseq_ac": "NP_666663",
        "gene_names_uniprotkb": "Or2ag1b; Olfr694; Olfr698; Olfr706",
        "gene_names_refseq": "MOR283-9; Olfr694; Or2ag1b",
        "protein_names_uniprotkb": "Olfactory receptor family 2 subfamily AG member 1B",
        "protein_names_refseq": "GA_x6K02T2PBJ9-9067220-9066273; olfactory receptor 694; olfactory receptor MOR283-9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258444)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "F6VBP6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "K7N641-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRU7-1",
        "uniprot_id": "Q7TRU7_MOUSE",
        "mass": 35577.0,
        "length": 318,
        "protein_name": "Olfactory receptor family 56 subfamily B member 1B",
        "gene_name": "Or56b1b",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 56 subfamily B member 1B",
        "refseq_ac": "NP_001011858",
        "gene_names_uniprotkb": "Or56b1b; Olfr504",
        "gene_names_refseq": "MOR40-15; MOR40-7P; Olfr504; Or56b1b",
        "protein_names_uniprotkb": "Olfactory receptor family 56 subfamily B member 1B",
        "protein_names_refseq": "GA_x6K02T2PBJ9-10895499-10894543; olfactory receptor 504; olfactory receptor MOR40-7P; olfactory receptor family 56 subfamily B member 1B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258163)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0071396 cellular response to lipid",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRU7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFD7-1",
        "uniprot_id": "Q8VFD7_MOUSE",
        "mass": 35424.0,
        "length": 314,
        "protein_name": "Olfactory receptor family 8 subfamily G member 33",
        "gene_name": "Or8g33",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 952",
        "refseq_ac": "NP_666714",
        "gene_names_uniprotkb": "Or8g33; Olfr952",
        "gene_names_refseq": "MOR171-21; Olfr952; Or8g33",
        "protein_names_uniprotkb": "Olfactory receptor family 8 subfamily G member 33",
        "protein_names_refseq": "GA_x6K02T2PVTD-33124064-33123120; olfactory receptor 952; olfactory receptor MOR171-21",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:235248)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFD7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFQ7-1",
        "uniprot_id": "Q8VFQ7_MOUSE",
        "mass": 35704.0,
        "length": 311,
        "protein_name": "Olfactory receptor family 5 subfamily W member 17",
        "gene_name": "Or5w17",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 5 subfamily W member 17",
        "refseq_ac": "NP_666848",
        "gene_names_uniprotkb": "Or5w17; Olfr1141",
        "gene_names_refseq": "MOR177-10; Olfr1141; Or5w17",
        "protein_names_uniprotkb": "Olfactory receptor family 5 subfamily W member 17",
        "protein_names_refseq": "GA_x6K02T2Q125-49257818-49256883; olfactory receptor 1141; olfactory receptor MOR177-10; olfactory receptor family 5 subfamily W member 17",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258630)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFQ7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFW3-1",
        "uniprot_id": "Q8VFW3_MOUSE",
        "mass": 34905.0,
        "length": 307,
        "protein_name": "Olfactory receptor family 5 subfamily B member 108",
        "gene_name": "Or5b108",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 5 subfamily B member 108",
        "refseq_ac": "NP_666904",
        "gene_names_uniprotkb": "Or5b108; Olfr1462",
        "gene_names_refseq": "MOR202-13; Olfr1462; Or5b108",
        "protein_names_uniprotkb": "Olfactory receptor family 5 subfamily B member 108",
        "protein_names_refseq": "GA_x6K02T2RE5P-3517488-3518411; olfactory receptor 1462; olfactory receptor MOR202-13; olfactory receptor family 5 subfamily B member 108",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258688)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFW3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VGB1-1",
        "uniprot_id": "Q8VGB1_MOUSE",
        "mass": 35502.0,
        "length": 315,
        "protein_name": "Olfactory receptor family 13 subfamily P member 5",
        "gene_name": "Or13p5",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 1339",
        "refseq_ac": "NP_667063",
        "gene_names_uniprotkb": "Or13p5; Olfr1339; Olfr62",
        "gene_names_refseq": "MOR258-2; Olfr1339; Or13p5",
        "protein_names_uniprotkb": "Olfactory receptor family 13 subfamily P member 5",
        "protein_names_refseq": "GA_x6K02T2QD9B-18815145-18814198; olfactory receptor 1339; olfactory receptor MOR258-2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258851)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VGB1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VGL2-1",
        "uniprot_id": "Q8VGL2_MOUSE",
        "mass": 33626.0,
        "length": 304,
        "protein_name": "Olfactory receptor family 2 subfamily J member 6",
        "gene_name": "Or2j6",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 2 subfamily J member 6",
        "refseq_ac": "NP_667164",
        "gene_names_uniprotkb": "Or2j6; Olfr531",
        "gene_names_refseq": "MOR251-3; Olfr531; Or2j6",
        "protein_names_uniprotkb": "Olfactory receptor family 2 subfamily J member 6",
        "protein_names_refseq": "GA_x6K02T2PBJ9-42551260-42550346; olfactory receptor 531; olfactory receptor MOR251-3; olfactory receptor family 2 subfamily J member 6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258955)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]; Possible taste receptor., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VGL2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A0G2JDX6-1",
        "uniprot_id": "A0A0G2JDX6_MOUSE",
        "mass": 2291.0,
        "length": 20,
        "protein_name": "T cell receptor alpha joining 19",
        "gene_name": "Traj19",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Traj19",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "T cell receptor alpha joining 19",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A0G2JDX6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "D3Z623-1",
        "uniprot_id": "D3Z623_MOUSE",
        "mass": 73957.0,
        "length": 648,
        "protein_name": "RIKEN cDNA 9330159F19 gene",
        "gene_name": "9330159F19Rik",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein KIAA0408 homolog",
        "refseq_ac": "NP_001156009",
        "gene_names_uniprotkb": "9330159F19Rik",
        "gene_names_refseq": "9330159F19Rik",
        "protein_names_uniprotkb": "RIKEN cDNA 9330159F19 gene",
        "protein_names_refseq": "uncharacterized protein KIAA0408 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:212448)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "D3Z623-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B1AXP3-1",
        "uniprot_id": "B1AXP3_MOUSE",
        "mass": 54784.0,
        "length": 476,
        "protein_name": "Stabilizer of axonemal microtubules 1",
        "gene_name": "Saxo1",
        "organism": "Mouse",
        "refseq_name": "stabilizer of axonemal microtubules 1",
        "refseq_ac": "NP_001074565",
        "gene_names_uniprotkb": "Saxo1",
        "gene_names_refseq": "4930500O09Rik; Fam154a; Saxo1",
        "protein_names_uniprotkb": "Stabilizer of axonemal microtubules 1",
        "protein_names_refseq": "family with sequence similarity 154, member A; likely ortholog of H. sapiens chromosome 9 open reading frame 138 (C9orf138); stabilizer of axonemal microtubules 1; stablizer of axonemal microtubules 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:75811)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008017 microtubule binding",
        "go_cellular_component": "GO:0097229 sperm end piece;GO:0005856 cytoskeleton;GO:0031514 motile cilium;GO:0036126 sperm flagellum;GO:0005814 centriole",
        "go_biological_process": "GO:0070417 cellular response to cold;GO:0050821 protein stabilization;GO:0009631 cold acclimation;GO:0045724 positive regulation of cilium assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "B1AXP3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B1B0N6-1",
        "uniprot_id": "B1B0N6_MOUSE",
        "mass": 10439.0,
        "length": 92,
        "protein_name": "Secretoglobin, family 1B, member 24",
        "gene_name": "Scgb1b24",
        "organism": "Mouse",
        "refseq_name": "secretoglobin, family 1B, member 24 protein precursor",
        "refseq_ac": "NP_001092799",
        "gene_names_uniprotkb": "Scgb1b24",
        "gene_names_refseq": "Abpa24; Gm12769; Scgb1b24",
        "protein_names_uniprotkb": "Secretoglobin, family 1B, member 24",
        "protein_names_refseq": "androgen-binding protein; novel androgen binding protein (Abp) family member; secretoglobin, family 1B, member 24 protein precursor",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100043860)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005496 steroid binding",
        "go_cellular_component": "GO:0005576 extracellular region",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "B1B0N6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9PWU0-1",
        "uniprot_id": "E9PWU0_MOUSE",
        "mass": 35514.0,
        "length": 318,
        "protein_name": "Olfactory receptor family 10 subfamily G member 1B",
        "gene_name": "Or10g1b",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 1511",
        "refseq_ac": "NP_666383",
        "gene_names_uniprotkb": "Or10g1b; Olfr1511",
        "gene_names_refseq": "MOR223-9; MOR29B; Olfr1511; Or10g1b",
        "protein_names_uniprotkb": "Olfactory receptor family 10 subfamily G member 1B",
        "protein_names_refseq": "GA_x6K02T2RJGY-608749-609705; olfactory receptor 1511; olfactory receptor MOR223-9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258268)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "E9PWU0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9Q550-1",
        "uniprot_id": "E9Q550_MOUSE",
        "mass": 35598.0,
        "length": 322,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or51d1",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 557",
        "refseq_ac": "NP_666473",
        "gene_names_uniprotkb": "Or51d1; Olfr557",
        "gene_names_refseq": "MOR18-3; Olfr557; Or51d1",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PBJ9-5414934-5415902; olfactory receptor 557; olfactory receptor MOR18-3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258358);  (R-MMU-381753)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0071396 cellular response to lipid",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "E9Q550-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9Q9T3-1",
        "uniprot_id": "E9Q9T3_MOUSE",
        "mass": 36521.0,
        "length": 319,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or5k15",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 178",
        "refseq_ac": "NP_667208",
        "gene_names_uniprotkb": "Or5k15; Olfr178",
        "gene_names_refseq": "MOR184-6; Olfr178; Or5k15",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x54KRFPKG5P-55108059-55107100; olfactory receptor 178; olfactory receptor MOR184-6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258999)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "E9Q9T3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRB9-1",
        "uniprot_id": "Q7TRB9_MOUSE",
        "mass": 35899.0,
        "length": 317,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or8b56",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 923",
        "refseq_ac": "NP_667027",
        "gene_names_uniprotkb": "Or8b56; Olfr923",
        "gene_names_refseq": "MOR164-2; Olfr923; Or8b56",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PVTD-32530445-32531380; olfactory receptor 923; olfactory receptor MOR164-2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258812);  (R-MMU-381753)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB, UniProtKB]; Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRB9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "F8VQ26-1",
        "uniprot_id": "F8VQ26_MOUSE",
        "mass": 35357.0,
        "length": 312,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or52e19",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 596",
        "refseq_ac": "NP_001177310",
        "gene_names_uniprotkb": "Or52e19; Olfr596; Olfr603",
        "gene_names_refseq": "Gm15117; Olfr596-ps1; Olfr596; Or52e19",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PBJ9-6019769-6019943; olfactory receptor 596, pseudogene 1; olfactory receptor 596",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100041187)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "F8VQ26-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "G3X8R7-1",
        "uniprot_id": "G3X8R7_MOUSE",
        "mass": 55435.0,
        "length": 492,
        "protein_name": "Zinc finger protein 212",
        "gene_name": "Zfp212",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 212 isoform 1",
        "refseq_ac": "NP_663551",
        "gene_names_uniprotkb": "Zfp212",
        "gene_names_refseq": "Zfp212; Znf212; mKIAA3011",
        "protein_names_uniprotkb": "Zinc finger protein 212",
        "protein_names_refseq": "Zinc finger protein C2H2-150; zinc finger protein 212 isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (R-MMU-212436)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;34815492",
        "class_list": "",
        "function": "Loss of zinc-finger protein 212 leads to Purkinje cell death and locomotive abnormalities with phospholipase D3 downregulation. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003700 DNA-binding transcription factor activity;GO:0008270 zinc ion binding;GO:0042802 identical protein binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm",
        "go_biological_process": "GO:0097305 response to alcohol;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0016358 dendrite development;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "G3X8R7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "J3QK00-1",
        "uniprot_id": "J3QK00_MOUSE",
        "mass": 19468.0,
        "length": 171,
        "protein_name": "2 cell stage variable group member 2B",
        "gene_name": "Tcstv2b",
        "organism": "Mouse",
        "refseq_name": "2-cell-stage, variable group-like",
        "refseq_ac": "NP_001297561",
        "gene_names_uniprotkb": "Tcstv2b; Gm21761",
        "gene_names_refseq": "Gm21761; Tcstv2b",
        "protein_names_uniprotkb": "2 cell stage variable group member 2B",
        "protein_names_refseq": "2-cell-stage, variable group-like",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:106029237)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "J3QK00-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "K7N6T9-1",
        "uniprot_id": "K7N6T9_MOUSE",
        "mass": 34420.0,
        "length": 304,
        "protein_name": "Vomeronasal type-1 receptor",
        "gene_name": "Vmn1r175",
        "organism": "Mouse",
        "refseq_name": "vomeronasal 1 receptor 175",
        "refseq_ac": "NP_001160199",
        "gene_names_uniprotkb": "Vmn1r175",
        "gene_names_refseq": "EG622222; Gm6299; Vmn1r175",
        "protein_names_uniprotkb": "Vomeronasal type-1 receptor",
        "protein_names_refseq": "vomernasal 1 receptor Vmn1r175; vomeronasal 1 receptor 175",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:622222)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005550 pheromone binding;GO:0016503 pheromone receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0019236 response to pheromone;GO:0007606 sensory perception of chemical stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "K7N6T9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TQR3-1",
        "uniprot_id": "Q7TQR3_MOUSE",
        "mass": 34901.0,
        "length": 310,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or5b109",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 5 subfamily B member 109",
        "refseq_ac": "NP_001011840",
        "gene_names_uniprotkb": "Or5b109; Olfr1457; Olfr1463",
        "gene_names_refseq": "MOR202-29P; Olfr1463; Or5b109",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2RE5P-3560863-3561795; olfactory receptor 1463; olfactory receptor MOR202-29P; olfactory receptor family 5 subfamily B member 109",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258120)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TQR3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TQT4-1",
        "uniprot_id": "Q7TQT4_MOUSE",
        "mass": 34718.0,
        "length": 311,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or2y11",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 1381",
        "refseq_ac": "NP_666680",
        "gene_names_uniprotkb": "Or2y11; Olfr1381",
        "gene_names_refseq": "MOR256-26; Olfr1381; Or2y11",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2QP88-5884501-5883566; olfactory receptor 1381; olfactory receptor MOR256-26",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258461)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TQT4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TR13-1",
        "uniprot_id": "Q7TR13_MOUSE",
        "mass": 36016.0,
        "length": 314,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or4a27",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 1197",
        "refseq_ac": "NP_001005225",
        "gene_names_uniprotkb": "Or4a27; Olfr1197",
        "gene_names_refseq": "MOR225-10P; MOR225-14; Olfr1197; Or4a27",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2Q125-50202854-50201910; olfactory receptor 1197",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:433449)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TR13-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TR63-1",
        "uniprot_id": "Q7TR63_MOUSE",
        "mass": 35371.0,
        "length": 313,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or8k3b",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 1087",
        "refseq_ac": "NP_667057",
        "gene_names_uniprotkb": "Or8k3b; Olfr1087",
        "gene_names_refseq": "MOR188-5; Olfr1087; Or8k3b",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2Q125-48182406-48181465; olfactory receptor 1087; olfactory receptor MOR188-5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258843)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TR63-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TR70-1",
        "uniprot_id": "Q7TR70_MOUSE",
        "mass": 35544.0,
        "length": 313,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or8k27",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 1065",
        "refseq_ac": "NP_666520",
        "gene_names_uniprotkb": "Or8k27; Olfr1065",
        "gene_names_refseq": "MOR190-1; Olfr1065; Or8k27",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2Q125-47915274-47914333; odorant receptor B1; olfactory receptor 1065; olfactory receptor MOR190-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258403)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB]; Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TR70-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRA1-1",
        "uniprot_id": "Q7TRA1_MOUSE",
        "mass": 34654.0,
        "length": 309,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or5ak20",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 5 subfamily AK member 20",
        "refseq_ac": "NP_001011534",
        "gene_names_uniprotkb": "Or5ak20; Olfr988",
        "gene_names_refseq": "MOR203-5P; Olfr988; Or5ak20",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2Q125-46830591-46829662; olfactory receptor 988; olfactory receptor MOR203-5P; olfactory receptor family 5 subfamily AK member 20",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258166)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRA1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRF0-1",
        "uniprot_id": "Q7TRF0_MOUSE",
        "mass": 35006.0,
        "length": 311,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or7h8",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 871",
        "refseq_ac": "NP_667114",
        "gene_names_uniprotkb": "Or7h8; Olfr871",
        "gene_names_refseq": "MOR141-2; Olfr871; Or7h8",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PVTD-13952555-13953490; olfactory receptor 871; olfactory receptor MOR141-2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258905)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007165 signal transduction;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRF0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRG2-1",
        "uniprot_id": "Q7TRG2_MOUSE",
        "mass": 34597.0,
        "length": 312,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or7g27",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 845",
        "refseq_ac": "NP_997028",
        "gene_names_uniprotkb": "Or7g27; Olfr845",
        "gene_names_refseq": "GA_x5J8B7W6RL5-13522154-13521822; MOR150-1P; MOR150-1; MOR150-2; Olfr1522-ps1; Olfr845; Or7g27",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PVTD-13076685-13077623; olfactory receptor 1522, pseudogene 1; olfactory receptor 845; olfactory receptor GA_x5J8B7W6RL5-13522154-13521822; olfactory receptor MOR150-1P; olfactory receptor MOR150-2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258249);  (R-MMU-381753)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007165 signal transduction;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRG2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRJ8-1",
        "uniprot_id": "Q7TRJ8_MOUSE",
        "mass": 34697.0,
        "length": 310,
        "protein_name": "Olfactory receptor family 14 subfamily J member 4",
        "gene_name": "Or14j4",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Or14j4; Olfr115",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Olfactory receptor family 14 subfamily J member 4",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRJ8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRT5-1",
        "uniprot_id": "Q7TRT5_MOUSE",
        "mass": 34122.0,
        "length": 310,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or13a24",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 13 subfamily A member 24",
        "refseq_ac": "NP_001011867",
        "gene_names_uniprotkb": "Or13a24; Olfr538",
        "gene_names_refseq": "MOR253-10P; MOR253-12P; MOR253-13P; Olfr1523-ps1; Olfr1553-ps1; Olfr538; Or13a24",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PBJ9-42723314-42724246; olfactory receptor 1523, pseudogene 1; olfactory receptor 1553, pseudogene 1; olfactory receptor 538; olfactory receptor MOR253-10P; olfactory receptor MOR253-12P; olfactory receptor MOR253-13P; olfactory receptor family 13 subfamily A member 24",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258201)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]; Possible taste receptor., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRT5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRX3-1",
        "uniprot_id": "Q7TRX3_MOUSE",
        "mass": 34032.0,
        "length": 311,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or3a4",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 399",
        "refseq_ac": "NP_667215",
        "gene_names_uniprotkb": "Or3a4; Olfr399",
        "gene_names_refseq": "MOR255-1; Olfr399; Or3a4",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2P1NL-4211516-4210581; olfactory receptor 399; olfactory receptor MOR255-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:259006)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007165 signal transduction;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRX3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R293-1",
        "uniprot_id": "Q8R293_MOUSE",
        "mass": 34662.0,
        "length": 303,
        "protein_name": "Vomeronasal type-1 receptor",
        "gene_name": "Vmn1r73",
        "organism": "Mouse",
        "refseq_name": "vomeronasal 1 receptor 73",
        "refseq_ac": "NP_598964",
        "gene_names_uniprotkb": "Vmn1r73; Vmn1r80",
        "gene_names_refseq": "V1rg2; Vmn1r73",
        "protein_names_uniprotkb": "Vomeronasal type-1 receptor",
        "protein_names_refseq": "vomernasal 1 receptor Vmn1r73; vomeronasal 1 receptor 73; vomeronasal 1 receptor, G2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:171237)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9Q311",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005550 pheromone binding;GO:0016503 pheromone receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0019236 response to pheromone;GO:0007606 sensory perception of chemical stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8R293-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VF55-1",
        "uniprot_id": "Q8VF55_MOUSE",
        "mass": 34747.0,
        "length": 309,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or10v1",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 10 subfamily V member 1",
        "refseq_ac": "NP_666522",
        "gene_names_uniprotkb": "Or10v1; Olfr1420",
        "gene_names_refseq": "MOR266-4; Olfr1420; Or10v1",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2RE5P-2247227-2248156; olfactory receptor 1420; olfactory receptor MOR266-4; olfactory receptor family 10 subfamily V member 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258405)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;32061665",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]; This odorant receptor, Olfr1420, responds to the odorants bourgeonal and undecanal in both in vivo and in vitro assays., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8VF55-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFE4-1",
        "uniprot_id": "Q8VFE4_MOUSE",
        "mass": 33615.0,
        "length": 305,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or1o4",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 99",
        "refseq_ac": "NP_666726",
        "gene_names_uniprotkb": "Or1o4; Olfr99",
        "gene_names_refseq": "MOR156-1; Olfr99; Or1o4",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PSCP-1720261-1719344; olfactory receptor 99; olfactory receptor MOR156-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258508)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB]; Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007165 signal transduction;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFE4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFM8-1",
        "uniprot_id": "Q8VFM8_MOUSE",
        "mass": 34684.0,
        "length": 312,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or7g16",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 7 subfamily G member 16",
        "refseq_ac": "NP_666816",
        "gene_names_uniprotkb": "Or7g16; Olfr828",
        "gene_names_refseq": "MOR149-1; Olfr828; Or7g16",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PVTD-12559294-12558356; olfactory receptor 828; olfactory receptor MOR149-1; olfactory receptor family 7 subfamily G member 16",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258598)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007165 signal transduction;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFM8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFV0-1",
        "uniprot_id": "Q8VFV0_MOUSE",
        "mass": 35102.0,
        "length": 310,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or4d11",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 4 subfamily D member 11",
        "refseq_ac": "NP_666891",
        "gene_names_uniprotkb": "Or4d11; Olfr1423; Olfr1427",
        "gene_names_refseq": "MOR239-3; Olfr1423; Or4d11",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2RE5P-2393361-2392429; olfactory receptor 1423; olfactory receptor MOR239-3; olfactory receptor family 4 subfamily D member 11",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258675)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFV0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VG26-1",
        "uniprot_id": "Q8VG26_MOUSE",
        "mass": 35536.0,
        "length": 313,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or52e5",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 52 subfamily E member 5",
        "refseq_ac": "NP_666969",
        "gene_names_uniprotkb": "Or52e5; Olfr678",
        "gene_names_refseq": "MOR32-5; Olfr678; Or52e5",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PBJ9-7698491-7699432; olfactory receptor 678; olfactory receptor MOR32-5; olfactory receptor family 52 subfamily E member 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258753)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB]; Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VG26-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VG37-1",
        "uniprot_id": "Q8VG37_MOUSE",
        "mass": 34939.0,
        "length": 312,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or8h9",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 8 subfamily H member 9",
        "refseq_ac": "NP_666979",
        "gene_names_uniprotkb": "Or8h9; Olfr1099",
        "gene_names_refseq": "MOR206-3; Olfr1099; Or8h9",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2Q125-48446067-48445129; olfactory receptor 1099; olfactory receptor MOR206-3; olfactory receptor family 8 subfamily H member 9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258764)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;32061665",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]; This odorant receptor, Olfr1099, responds to the odorant bourgeonal in vivo., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8VG37-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VGA6-1",
        "uniprot_id": "Q8VGA6_MOUSE",
        "mass": 35612.0,
        "length": 313,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or8k40",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 8 subfamily K member 40",
        "refseq_ac": "NP_667058",
        "gene_names_uniprotkb": "Or8k40; Olfr1090",
        "gene_names_refseq": "MOR188-4; Olfr1090; Or8k40",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2Q125-48247345-48246404; olfactory receptor 1090; olfactory receptor MOR188-4; olfactory receptor family 8 subfamily K member 40",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258844)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VGA6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VHH8-1",
        "uniprot_id": "IL25_MOUSE",
        "mass": 19210.0,
        "length": 169,
        "protein_name": "Interleukin-25",
        "gene_name": "Il25",
        "organism": "Mouse",
        "refseq_name": "interleukin-25 precursor",
        "refseq_ac": "NP_542767",
        "gene_names_uniprotkb": "Il25; Il17e",
        "gene_names_refseq": "IL-17e; IL-25; Il17e; Il25",
        "protein_names_uniprotkb": "Interleukin-25; IL-17E; IL-25; Interleukin-17E",
        "protein_names_refseq": "interleukin 17E; interleukin-25 precursor",
        "tax_id": 10090,
        "disease": "gastric ulcer (Disease Ontology:DOID:10808); diffuse scleroderma (Disease Ontology:DOID:1580); atopic dermatitis (Disease Ontology:DOID:3310); allergic rhinitis (Disease Ontology:DOID:4481); psoriasis (Disease Ontology:DOID:8893)",
        "pathway": " (mmu:140806)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "11754819;12077275;18768888;35615348;39397451",
        "class_list": "",
        "function": "Cytokine produced by various cells such as eosinophils, T-helper type 2 (Th2) cells or epithelial cells that plays a role in internal safety of adaptive immune responses by regulating cytokine production (PubMed:11754819, PubMed:35615348). Promotes and augments T-helper type 2 responses locally or systemically (PubMed:35615348). Exerts its activity via its receptor composed of IL17RA and IL17RB for signal transduction (PubMed:18768888). In turn, stimulates the JAK2-STAT5A pathway and promotes the secretion of type-2 associated cytokines including IL4, IL9 and IL13. Also induces the release of IL8, and IL6 from eosinophils through the combined activation of MAPK and NF-kappa-B pathways. Inhibits the differentiation of T-helper (Th17) cells via the production of IL4, IL5 and IL13., [UniProtKB, PubMed, UniProtKB, PubMed]; Intranasal administration of IL-25 promotes Th2 cell-mediated production of IL-4, IL-5, IL-13, and eotaxin mRNA in lung, eosinophilia in bronchoalveolar lavage and lung, epithelial cell hyperplasia, increased mucus secretion, and airway hyperreactivity., [RefSeq, PubMed]; [The role and its regulatory significance of interleukin-25 in ovalbumin induced atopic dermatitis of mice]., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030380 interleukin-17E receptor binding;GO:0005125 cytokine activity",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0030222 eosinophil differentiation;GO:0006954 inflammatory response;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0002437 inflammatory response to antigenic stimulus;GO:0009620 response to fungus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q8VHH8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91WD8-1",
        "uniprot_id": "NCKX1_MOUSE",
        "mass": 124667.0,
        "length": 1130,
        "protein_name": "Sodium/potassium/calcium exchanger 1",
        "gene_name": "Slc24a1",
        "organism": "Mouse",
        "refseq_name": "sodium/potassium/calcium exchanger 1 isoform 1",
        "refseq_ac": "NP_659062",
        "gene_names_uniprotkb": "Slc24a1; Nckx1",
        "gene_names_refseq": "Slc24a1",
        "protein_names_uniprotkb": "Sodium/potassium/calcium exchanger 1; Na(+)/K(+)/Ca(2+)-exchange protein 1; Retinal rod Na-Ca+K exchanger; Solute carrier family 24 member 1",
        "protein_names_refseq": "Na(+)/K(+)/Ca(2+)-exchange protein 1; retinal rod Na-Ca+K exchanger; sodium/potassium/calcium exchanger 1 isoform 1; sodium/potassium/calcium exchanger 1; solute carrier family 24 member 1",
        "tax_id": 10090,
        "disease": "congenital stationary night blindness 1D (Disease Ontology:DOID:0110868)",
        "pathway": " (mmu:214111);  (R-MMU-425561)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "26246500",
        "class_list": "",
        "function": "Calcium, potassium:sodium antiporter that transports 1 Ca(2+) and 1 K(+) in exchange for 4 Na(+). Critical component of the visual transduction cascade, controlling the calcium concentration of outer segments during light and darkness. Light causes a rapid lowering of cytosolic free calcium in the outer segment of both retinal rod and cone photoreceptors and the light-induced lowering of calcium is caused by extrusion via this protein which plays a key role in the process of light adaptation., [UniProtKB, UniProtKB]; The deletion of NCKX1 in mice results in malformed outer segment disks, suppressed expression and function of rod cGMP-gated channels and a subsequent 100-fold reduction in rod responses, while preserving normal cone responses., [RefSeq, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005262 calcium channel activity;GO:0015293 symporter activity;GO:0008273 calcium, potassium:sodium antiporter activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009986 cell surface",
        "go_biological_process": "GO:0006874 intracellular calcium ion homeostasis;GO:0060292 long-term synaptic depression;GO:0007601 visual perception;GO:0035725 sodium ion transmembrane transport;GO:0070588 calcium ion transmembrane transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q91WD8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QZ20-1",
        "uniprot_id": "Q9QZ20_MOUSE",
        "mass": 34839.0,
        "length": 318,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or13c7c",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 157",
        "refseq_ac": "NP_062348",
        "gene_names_uniprotkb": "Or13c7c; Olfr157",
        "gene_names_refseq": "Mor262-12; Olfr157; Olfr37c; Or13c7c; Or37c",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2N78B-16110014-16110970; olfactory receptor 157; olfactory receptor 37c; olfactory receptor MOR262-12",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100040268)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB]; Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9QZ20-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z0L6-1",
        "uniprot_id": "PTHY_MOUSE",
        "mass": 12825.0,
        "length": 115,
        "protein_name": "Parathyroid hormone",
        "gene_name": "Pth",
        "organism": "Mouse",
        "refseq_name": "parathyroid hormone precursor",
        "refseq_ac": "NP_065648",
        "gene_names_uniprotkb": "Pth",
        "gene_names_refseq": "Pthp; Pth",
        "protein_names_uniprotkb": "Parathyroid hormone; PTH",
        "protein_names_refseq": "parathyroid hormone precursor",
        "tax_id": 10090,
        "disease": "hyperphosphatemia (Disease Ontology:DOID:0050459); stroke (Disease Ontology:DOID:0051061); atrial fibrillation (Disease Ontology:DOID:0060224); familial isolated hypoparathyroidism 1 (Disease Ontology:DOID:0061150); calcium oxalate nephrolithiasis (Disease Ontology:DOID:0080652); autosomal dominant hypocalcemia (Disease Ontology:DOID:0090109); familial isolated hypoparathyroidism (Disease Ontology:DOID:0111387); otitis media (Disease Ontology:DOID:10754); hypertension (Disease Ontology:DOID:10763); primary hyperparathyroidism (Disease Ontology:DOID:11202); osteoporosis (Disease Ontology:DOID:11476); secondary hyperparathyroidism (Disease Ontology:DOID:12466); hypercalcemia (Disease Ontology:DOID:12678); nephrocalcinosis (Disease Ontology:DOID:12679); renal osteodystrophy (Disease Ontology:DOID:13068); osteosarcoma (Disease Ontology:DOID:3347); coronary artery disease (Disease Ontology:DOID:3393); uremia (Disease Ontology:DOID:4676); congestive heart failure (Disease Ontology:DOID:6000); end stage renal disease (Disease Ontology:DOID:783); chronic kidney disease (Disease Ontology:DOID:784); atrophic gastritis (Disease Ontology:DOID:8929); type 2 diabetes mellitus (Disease Ontology:DOID:9352); type 1 diabetes mellitus (Disease Ontology:DOID:9744)",
        "pathway": " (mmu:19226);  (R-MMU-373080);  (R-MMU-418555)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "11606467;11994406;12370121;12671051;19968565;38316249;38386045",
        "class_list": "",
        "function": "A novel mouse model for familial hypocalciuric hypercalcemia (FHH1) reveals PTH-dependent and independent CaSR defects., [RefSeq, PubMed]; PTH 1-34 reduced apoptosis of MLO-Y4 osteocyte-like cells by activating autophagy and inhibiting ER stress under RPM conditions., [RefSeq, PubMed]; Parathyroid hormone elevates calcium level by dissolving the salts in bone and preventing their renal excretion (PubMed:11606467, PubMed:19968565). Acts by binding to its receptor, PTH1R, activating G protein-coupled receptor signaling (By similarity). Stimulates [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblastic cells (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 24,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005179 hormone activity;GO:0051428 peptide hormone receptor binding;GO:0048018 receptor ligand activity;GO:0031857 type 1 parathyroid hormone receptor binding;GO:0031856 parathyroid hormone receptor binding",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:1900158 negative regulation of bone mineralization involved in bone maturation;GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway;GO:0007267 cell-cell signaling;GO:0010288 response to lead ion;GO:0010628 positive regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9Z0L6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A087WRK3-1",
        "uniprot_id": "A0A087WRK3_MOUSE",
        "mass": 25590.0,
        "length": 222,
        "protein_name": "Predicted gene 28553; Predicted gene, 20817; Predicted gene, 21173; Predicted gene, 21497",
        "gene_name": "Gm21173; Gm28553",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Gm21173; Gm28553; Gm20817; Gm21173; Gm21497; Gm28553",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Predicted gene 28553; Predicted gene, 20817; Predicted gene, 21173; Predicted gene, 21497",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "spermatogenic failure 4 (Disease Ontology:DOID:0070176)",
        "pathway": " (mmu:108168590)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0000795 synaptonemal complex",
        "go_biological_process": "GO:0007286 spermatid development;GO:0051321 meiotic cell cycle;GO:0035092 sperm DNA condensation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A087WRK3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A0A0MQA4-1",
        "uniprot_id": "A0A0A0MQA4_MOUSE",
        "mass": 12148.0,
        "length": 119,
        "protein_name": "Keratin associated protein 12-22",
        "gene_name": "Krtap12-22",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein LOC100009614",
        "refseq_ac": "NP_001074921",
        "gene_names_uniprotkb": "Krtap12-22; Gm10024",
        "gene_names_refseq": "Gm10024; Krtap12-22",
        "protein_names_uniprotkb": "Keratin associated protein 12-22",
        "protein_names_refseq": "keratin associated protein LOC100009614; uncharacterized protein LOC100009614",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100009614);  (R-MMU-6805567)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005829 cytosol;GO:0045095 keratin filament",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A0A0MQA4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A0G2JFN0-1",
        "uniprot_id": "A0A0G2JFN0_MOUSE",
        "mass": 2081.0,
        "length": 21,
        "protein_name": "T cell receptor alpha joining 42",
        "gene_name": "Traj42",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Traj42",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "T cell receptor alpha joining 42",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 2,
        "publication_id_list": "21750661;30059200",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "A0A0G2JFN0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A0G2JH15-1",
        "uniprot_id": "A0A0G2JH15_MOUSE",
        "mass": 2172.0,
        "length": 20,
        "protein_name": "T cell receptor alpha joining 40",
        "gene_name": "Traj40",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Traj40",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "T cell receptor alpha joining 40",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A0G2JH15-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2BED8-1",
        "uniprot_id": "A2BED8_MOUSE",
        "mass": 26912.0,
        "length": 237,
        "protein_name": "Predicted gene, 58953; Spermatogenesis associated multipass transmembrane protein 1c; Spermatogenesis associated multipass transmembrane protein 1",
        "gene_name": "Samt1",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein LOC667256",
        "refseq_ac": "NP_001188287",
        "gene_names_uniprotkb": "Samt1; 4921511M17Rik; Gm10057; Gm58953; Samt1b; Samt1c",
        "gene_names_refseq": "4921511M17Rik; Samt1b",
        "protein_names_uniprotkb": "Predicted gene, 58953; Spermatogenesis associated multipass transmembrane protein 1c; Spermatogenesis associated multipass transmembrane protein 1",
        "protein_names_refseq": "uncharacterized protein LOC667256",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:625650);  (mmu:667256);  (mmu:78092)",
        "pathway_count": 3,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0005923 bicellular tight junction",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A2BED8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B1AUV7-1",
        "uniprot_id": "B1AUV7_MOUSE",
        "mass": 18845.0,
        "length": 164,
        "protein_name": "PRAME like 62",
        "gene_name": "Prame62",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein LOC381536",
        "refseq_ac": "NP_001078989",
        "gene_names_uniprotkb": "Prame62",
        "gene_names_refseq": "Gm12789; Prame62",
        "protein_names_uniprotkb": "PRAME like 62",
        "protein_names_refseq": "uncharacterized protein LOC381536",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:381536)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "B1AUV7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9PXX8-1",
        "uniprot_id": "E9PXX8_MOUSE",
        "mass": 96836.0,
        "length": 851,
        "protein_name": "Metastasis-associated in colon cancer protein 1",
        "gene_name": "Macc1",
        "organism": "Mouse",
        "refseq_name": "metastasis-associated in colon cancer protein 1",
        "refseq_ac": "NP_001156608",
        "gene_names_uniprotkb": "Macc1",
        "gene_names_refseq": "4732474O15Rik; Gm267; Macc1",
        "protein_names_uniprotkb": "Metastasis-associated in colon cancer protein 1; SH3 domain-containing protein 7a5",
        "protein_names_refseq": "metastasis-associated in colon cancer protein 1",
        "tax_id": 10090,
        "disease": "cervical cancer (Disease Ontology:DOID:4362)",
        "pathway": " (mmu:238455)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "19098908;21750661;22484916;24469707;25444928",
        "class_list": "",
        "function": "Data suggest a critical role for MACC1 in lymphatic dissemination of GC, providing evidence that MACC1 upregulated VEGF-C/VEGF-D secretion to promote lymphangiogenesis via c-Met signaling., [RefSeq, PubMed]; HGF, MACC1 and C-met genes involve into malignant cervical tumors occurrence, development and prognosis, and might become potential molecular target therapy site of cervical cancer, [RefSeq, PubMed]; MACC1 has a role in colorectal cancer and can be used for imaging in xenografts, [RefSeq, PubMed]; MACC1 will be useful for the identification of poor prognosis subjects with colorectal cancer and is a promising new target for intervention in metastasis formation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "E9PXX8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9Q407-1",
        "uniprot_id": "E9Q407_MOUSE",
        "mass": 35319.0,
        "length": 322,
        "protein_name": "Olfactory receptor family 51 subfamily S member 1",
        "gene_name": "Or51s1",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 571",
        "refseq_ac": "NP_667296",
        "gene_names_uniprotkb": "Or51s1; Olfr571",
        "gene_names_refseq": "MOR21-1; Olfr571; Or51s1",
        "protein_names_uniprotkb": "Olfactory receptor family 51 subfamily S member 1",
        "protein_names_refseq": "GA_x6K02T2PBJ9-5620890-5619922; olfactory receptor 571; olfactory receptor MOR21-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:259089)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0071396 cellular response to lipid",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "E9Q407-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "G3UW82-1",
        "uniprot_id": "MYH2_MOUSE",
        "mass": 223219.0,
        "length": 1942,
        "protein_name": "Myosin-2",
        "gene_name": "Myh2",
        "organism": "Mouse",
        "refseq_name": "myosin-2",
        "refseq_ac": "NP_001034634",
        "gene_names_uniprotkb": "Myh2",
        "gene_names_refseq": "MHC2A; MyHC-2a; MyHC-IIa; Myh2a; Myh2; Myhs-f1; Myhs-f; Myhsf1",
        "protein_names_uniprotkb": "Myosin-2; MyHC-2a; MyHC-IIa; Myosin heavy chain 2a; Myosin heavy chain 2; Myosin heavy chain IIa; Myosin heavy chain, skeletal muscle, adult 2",
        "protein_names_refseq": "myosin heavy chain 2A; myosin heavy chain IIa; myosin heavy chain, skeletal muscle, adult 2; myosin-2; skeletal muscle myosin heavy chain II-a",
        "tax_id": 10090,
        "disease": "distal arthrogryposis (Disease Ontology:DOID:0050646); cardiomyopathy (Disease Ontology:DOID:0050700); familial hypertrophic cardiomyopathy (Disease Ontology:DOID:0080326); congenital myopathy 6 (Disease Ontology:DOID:0080719); dilated cardiomyopathy 1S (Disease Ontology:DOID:0110454); autosomal dominant hyaline body myopathy (Disease Ontology:DOID:0111269); distal arthrogryposis type 1 (Disease Ontology:DOID:0111596); distal arthrogryposis type 2B3 (Disease Ontology:DOID:0111602); distal arthrogryposis type 2A (Disease Ontology:DOID:0111605); distal myopathy (Disease Ontology:DOID:11720); dilated cardiomyopathy (Disease Ontology:DOID:12930); myotonia congenita (Disease Ontology:DOID:2106); inclusion body myositis (Disease Ontology:DOID:3429); restrictive cardiomyopathy (Disease Ontology:DOID:397); myopathy (Disease Ontology:DOID:423)",
        "pathway": " (mmu:17882);  (R-MMU-2029482)",
        "pathway_count": 2,
        "publication_count": 2,
        "publication_id_list": "10.1101/2023.09.13.557529;39927985",
        "class_list": "",
        "function": "Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 35,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 15,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0051015 actin filament binding;GO:0000146 microfilament motor activity",
        "go_cellular_component": "GO:0005859 muscle myosin complex;GO:0005737 cytoplasm;GO:0005911 cell-cell junction;GO:0032982 myosin filament;GO:0030016 myofibril",
        "go_biological_process": "GO:0006936 muscle contraction;GO:0014850 response to muscle activity",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "G3UW82-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "G3X9G9-1",
        "uniprot_id": "G3X9G9_MOUSE",
        "mass": 28028.0,
        "length": 244,
        "protein_name": "Thiol methyltransferase 1A3",
        "gene_name": "Tmt1a3",
        "organism": "Mouse",
        "refseq_name": "UbiE3 protein",
        "refseq_ac": "NP_001074940",
        "gene_names_uniprotkb": "Tmt1a3",
        "gene_names_refseq": "Gm10035; Mettl7a3; Tmt1a3; Ubie3",
        "protein_names_uniprotkb": "Thiol methyltransferase 1A3",
        "protein_names_refseq": "UbiE3 protein; methyltransferase like 7A3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:668178)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001734 mRNA m(6)A methyltransferase activity;GO:0008168 methyltransferase activity;GO:0008173 RNA methyltransferase activity;GO:0018708 thiol S-methyltransferase activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005811 lipid droplet",
        "go_biological_process": "GO:0042476 odontogenesis;GO:0001649 osteoblast differentiation;GO:0180035 lncRNA processing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "G3X9G9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "J3QN17-1",
        "uniprot_id": "J3QN17_MOUSE",
        "mass": 25885.0,
        "length": 227,
        "protein_name": "Predicted gene, 20918",
        "gene_name": "Gm20918",
        "organism": "Mouse",
        "refseq_name": "Y-linked testis-specific protein 1",
        "refseq_ac": "XP_017174340",
        "gene_names_uniprotkb": "Gm20918",
        "gene_names_refseq": "Gm20918",
        "protein_names_uniprotkb": "Predicted gene, 20918",
        "protein_names_refseq": "Y-linked testis-specific protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:108168642)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0006355 regulation of DNA-templated transcription;GO:0007276 gamete generation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "J3QN17-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "J3QPM5-1",
        "uniprot_id": "J3QPM5_MOUSE",
        "mass": 14430.0,
        "length": 127,
        "protein_name": "Predicted gene 3629",
        "gene_name": "Gm3629",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Gm3629",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Predicted gene 3629",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "J3QPM5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "K7N692-1",
        "uniprot_id": "K7N692_MOUSE",
        "mass": 24257.0,
        "length": 204,
        "protein_name": "Predicted gene 10338",
        "gene_name": "Gm10338",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Gm10338",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Predicted gene 10338",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "K7N692-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O89006-1",
        "uniprot_id": "O89006_MOUSE",
        "mass": 36096.0,
        "length": 320,
        "protein_name": "MAGE family member A1",
        "gene_name": "Magea1",
        "organism": "Mouse",
        "refseq_name": "melanoma antigen family A, 1",
        "refseq_ac": "NP_064399",
        "gene_names_uniprotkb": "Magea1",
        "gene_names_refseq": "Mage-a1; Magea1",
        "protein_names_uniprotkb": "MAGE family member A1",
        "protein_names_refseq": "melanoma antigen family A, 1; melanoma antigen, family A, 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:17137)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;24314011;29749485",
        "class_list": "",
        "function": "HSP70MAGEA1 delivered via microbubbles clearly inhibited and delayed the growth of MAGEA1expressing B16 melanomas in mice and improved the survival times of these animals compared with the fusion protein alone., [RefSeq, PubMed]; Results indicate that the fusion of Hsp70 to Mage-a1 can enhance immune responses and anti-tumor effects against Mage-a1-expressing tumors Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "O89006-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TR44-1",
        "uniprot_id": "Q7TR44_MOUSE",
        "mass": 35074.0,
        "length": 313,
        "protein_name": "Olfactory receptor family 5 subfamily W member 1B",
        "gene_name": "Or5w1b",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 1133",
        "refseq_ac": "NP_666463",
        "gene_names_uniprotkb": "Or5w1b; Olfr1133",
        "gene_names_refseq": "MOR176-2; Olfr1133; Or5w1b",
        "protein_names_uniprotkb": "Olfactory receptor family 5 subfamily W member 1B",
        "protein_names_refseq": "GA_x6K02T2Q125-49151278-49150337; olfactory receptor 1133; olfactory receptor MOR176-2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258348)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB]; Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TR44-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRE0-1",
        "uniprot_id": "Q7TRE0_MOUSE",
        "mass": 34398.0,
        "length": 309,
        "protein_name": "Olfactory receptor family 8 subfamily B member 38",
        "gene_name": "Or8b38",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 8 subfamily B member 38",
        "refseq_ac": "NP_001011739",
        "gene_names_uniprotkb": "Or8b38; Olfr885",
        "gene_names_refseq": "MOR162-12; Olfr885; Or8b38",
        "protein_names_uniprotkb": "Olfactory receptor family 8 subfamily B member 38",
        "protein_names_refseq": "GA_x6K02T2PVTD-31740639-31741568; olfactory receptor 885; olfactory receptor MOR162-12; olfactory receptor family 8 subfamily B member 38",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:257885)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRE0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRV1-1",
        "uniprot_id": "Q7TRV1_MOUSE",
        "mass": 36884.0,
        "length": 327,
        "protein_name": "Olfactory receptor family 10 subfamily AB member 4",
        "gene_name": "Or10ab4",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 10 subfamily AB member 4",
        "refseq_ac": "NP_001011742",
        "gene_names_uniprotkb": "Or10ab4; Olfr479",
        "gene_names_refseq": "MOR267-15; Olfr479; Or10ab4",
        "protein_names_uniprotkb": "Olfactory receptor family 10 subfamily AB member 4",
        "protein_names_refseq": "GA_x6K02T2PBJ9-10384085-10385068; olfactory receptor 479; olfactory receptor MOR267-15; olfactory receptor family 10 subfamily AB member 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:257891)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRV1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFR3-1",
        "uniprot_id": "Q8VFR3_MOUSE",
        "mass": 35425.0,
        "length": 314,
        "protein_name": "Olfactory receptor family 5 subfamily D member 16",
        "gene_name": "Or5d16",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 1155",
        "refseq_ac": "NP_666854",
        "gene_names_uniprotkb": "Or5d16; Olfr1155",
        "gene_names_refseq": "MOR174-10; Olfr1155; Or5d16",
        "protein_names_uniprotkb": "Olfactory receptor family 5 subfamily D member 16",
        "protein_names_refseq": "GA_x6K02T2Q125-49426894-49425950; olfactory receptor 1155; olfactory receptor MOR174-10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258636)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFR3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91Z40-1",
        "uniprot_id": "GBP7_MOUSE",
        "mass": 72721.0,
        "length": 638,
        "protein_name": "Guanylate-binding protein 7",
        "gene_name": "Gbp7",
        "organism": "Mouse",
        "refseq_name": "guanylate-binding protein 7",
        "refseq_ac": "NP_001076781",
        "gene_names_uniprotkb": "Gbp7; Gbp4l",
        "gene_names_refseq": "9830147J24Rik; GBP-7; Gbp7",
        "protein_names_uniprotkb": "Guanylate-binding protein 7; 3.6.1.-; 3.6.5.-; GBP-7; GTP-binding protein 7; Guanine nucleotide-binding protein 7; Guanylate-binding protein 4-like",
        "protein_names_refseq": "GTP-binding protein 7; guanine nucleotide-binding protein 7; guanylate-binding protein 4-like; guanylate-binding protein 7",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:229900)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "18025219;21551061;24739961;31689351;31964735;33408175",
        "class_list": "",
        "function": "Findings show that at least 4 IFN-gamma-inducible Gbps--Gbp1, Gbp6, Gbp7, and Gbp10--conferred cell-autonomous immunity to listerial or mycobacterial infection within macrophages and gene-deficient animals, [RefSeq, PubMed]; Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-kappaB and JAK-STAT Signaling Pathways. Publication Status: Online-Only, [RefSeq, PubMed]; Interferon (IFN)-inducible GTPase that plays important roles in innate immunity against a diverse range of bacterial, viral and protozoan pathogens (PubMed:18025219, PubMed:21551061, PubMed:24739961, PubMed:31964735). Hydrolyzes GTP to GMP in two consecutive cleavage reactions and predominantly uses GTP and not GDP or GMP as the substrate (PubMed:21551061, PubMed:31689351). Following infection, recruited to the pathogen-containing vacuoles or vacuole-escaped bacteria and acts as a positive regulator of inflammasome assembly by promoting the release of inflammasome ligands from bacteria (PubMed:24739961). Acts by promoting lysis of pathogen-containing vacuoles, releasing pathogens into the cytosol (PubMed:24739961). Following pathogen release in the cytosol, promotes recruitment of proteins that mediate bacterial cytolysis, such as Gm12250/Irgb10: this liberates ligands that are detected by inflammasomes, such as lipopolysaccharide (LPS) that activates the non-canonical CASP4/CASP11 inflammasome or double-stranded DNA (dsDNA) that activates the AIM2 inflammasome (PubMed:24739961). Also promotes IFN-gamma-mediated host defense against bacterial infections by regulating oxidative responses and bacteriolytic peptide generation (PubMed:21551061). May help to assemble NADPH oxidase on phagosomal membranes by acting as a bridging protein between NADPH oxidase cytosolic subunits NCF2-NCF4 and the membrane subunits CYBA-CYBB (PubMed:21551061). Participates along with GBP1 in trafficking monoubiquitinated protein cargo to autolysosomes for generating ubiquitin-derived antimicrobial peptides (PubMed:21551061). Facilitates influenza A virus replication by inhibiting the activation of NF-kappaB and JAK-STAT signaling pathways and the expression of type I, type III interferons and pro-inflammatory cytokines (By similarity). Confers protection to several pathogens, including the bacterial pathogens Listeria monocytogenes and Mycobacterium bovis BCG as well as the protozoan pathogen Toxoplasma gondii (PubMed:18025219, PubMed:21551061, PubMed:31964735). Required for disruption of the parasitophorous vacuole formed following T.gondii infection and subsequent killing of the parasite (PubMed:31964735)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6KAN1;Q78UK8;Q8BU48",
        "ec_number_list": "3.6.5.-;3.6.5.2;3.6.5.3;3.6.1.5;3.6.5.4;3.6.5.5;3.6.1.-;3.6.1.15;3.6.1.6;2.7.11.1;3.6.-.-;3.6.1.42",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005794 Golgi apparatus;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0044406 adhesion of symbiont to host;GO:0050830 defense response to Gram-positive bacterium;GO:0051607 defense response to virus;GO:0042742 defense response to bacterium;GO:0071346 cellular response to type II interferon",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q91Z40-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EPF7-1",
        "uniprot_id": "Q9EPF7_MOUSE",
        "mass": 35252.0,
        "length": 316,
        "protein_name": "Olfactory receptor family 2 subfamily AG member 1",
        "gene_name": "Or2ag1",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 705",
        "refseq_ac": "NP_667243",
        "gene_names_uniprotkb": "Or2ag1; Olfr705",
        "gene_names_refseq": "MOR283-2; Olfr705; Or2ag1",
        "protein_names_uniprotkb": "Olfactory receptor family 2 subfamily AG member 1",
        "protein_names_refseq": "GA_x6K02T2PBJ9-9256348-9255398; T2 olfactory receptor; olfactory receptor 705; olfactory receptor MOR283-2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:259034)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9EPF7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EQ87-1",
        "uniprot_id": "Q9EQ87_MOUSE",
        "mass": 34966.0,
        "length": 310,
        "protein_name": "Olfactory receptor family 10 subfamily D member 1C",
        "gene_name": "Or10d1c",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 10 subfamily D member 1C",
        "refseq_ac": "NP_666653",
        "gene_names_uniprotkb": "Or10d1c; Olfr934",
        "gene_names_refseq": "MOR224-6; Olfr934; Or10d1c",
        "protein_names_uniprotkb": "Olfactory receptor family 10 subfamily D member 1C",
        "protein_names_refseq": "GA_x6K02T2PVTD-32678895-32677963; olfactory receptor 934; olfactory receptor MOR224-6; olfactory receptor family 10 subfamily D member 1C",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258434)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9EQ87-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "V9GXK1-1",
        "uniprot_id": "PIRC2_MOUSE",
        "mass": 13714.0,
        "length": 122,
        "protein_name": "Piercer of microtubule wall 2 protein",
        "gene_name": "Pierce2",
        "organism": "Mouse",
        "refseq_name": "piercer of microtubule wall 2 protein",
        "refseq_ac": "NP_001185718",
        "gene_names_uniprotkb": "Pierce2; Ccpg1os",
        "gene_names_refseq": "Ccpg1os; EG546143; Gm5918; Pierce2",
        "protein_names_uniprotkb": "Piercer of microtubule wall 2 protein",
        "protein_names_refseq": "cell cycle progression 1, opposite strand; piercer of microtubule wall 2 protein; uncharacterized protein C15orf65 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:546143)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21750661;34715025;37295417;37865089;37989994",
        "class_list": "",
        "function": "Microtubule inner protein involved in the attachment of outer dynein arms (ODAs) to dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating., [UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0036126 sperm flagellum;GO:0005879 axonemal microtubule;GO:0160111 axonemal A tubule inner sheath",
        "go_biological_process": "GO:0030317 flagellated sperm motility;GO:0007368 determination of left/right symmetry;GO:0003341 cilium movement;GO:0035082 axoneme assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "V9GXK1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A087WSG3-1",
        "uniprot_id": "A0A087WSG3_MOUSE",
        "mass": 13857.0,
        "length": 125,
        "protein_name": "Predicted gene 28269",
        "gene_name": "Gm28269",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Gm28269",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Predicted gene 28269",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A087WSG3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A0B4J1P6-1",
        "uniprot_id": "A0A0B4J1P6_MOUSE",
        "mass": 1715.0,
        "length": 16,
        "protein_name": "T cell receptor beta joining 2-3",
        "gene_name": "Trbj2-3",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Trbj2-3",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "T cell receptor beta joining 2-3",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A0B4J1P6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CGR4-1",
        "uniprot_id": "Q8CGR4_MOUSE",
        "mass": 28042.0,
        "length": 254,
        "protein_name": "Kallikrein related-peptidase 15",
        "gene_name": "Klk15",
        "organism": "Mouse",
        "refseq_name": "kallikrein-15 precursor",
        "refseq_ac": "NP_777354",
        "gene_names_uniprotkb": "Klk15",
        "gene_names_refseq": "Klk15",
        "protein_names_uniprotkb": "Kallikrein related-peptidase 15",
        "protein_names_refseq": "kallikrein 15; kallikrein-15 precursor",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:317652)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004252 serine-type endopeptidase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0030141 secretory granule",
        "go_biological_process": "GO:0006508 proteolysis;GO:0051604 protein maturation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8CGR4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A0G2JDE1-1",
        "uniprot_id": "A0A0G2JDE1_MOUSE",
        "mass": 13263.0,
        "length": 119,
        "protein_name": "Immunoglobulin heavy variable V8-12",
        "gene_name": "Ighv8-12",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Ighv8-12",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Immunoglobulin heavy variable V8-12",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (R-MMU-173623);  (R-MMU-198933);  (R-MMU-202733);  (R-MMU-2029481);  (R-MMU-2029482);  (R-MMU-2029485);  (R-MMU-2168880);  (R-MMU-2454202);  (R-MMU-2730905);  (R-MMU-2871796);  (R-MMU-2871809);  (R-MMU-2871837);  (R-MMU-5690714);  (R-MMU-977606);  (R-MMU-983695)",
        "pathway_count": 15,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003823 antigen binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0019814 immunoglobulin complex",
        "go_biological_process": "GO:0016064 immunoglobulin mediated immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A0G2JDE1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D350-1",
        "uniprot_id": "OBOX1_MOUSE",
        "mass": 22875.0,
        "length": 204,
        "protein_name": "Oocyte-specific homeobox protein 1",
        "gene_name": "Obox1",
        "organism": "Mouse",
        "refseq_name": "oocyte-specific homeobox protein 1",
        "refseq_ac": "NP_082078",
        "gene_names_uniprotkb": "Obox1",
        "gene_names_refseq": "7420700M11Rik; Obox1",
        "protein_names_uniprotkb": "Oocyte-specific homeobox protein 1",
        "protein_names_refseq": "oocyte-specific homeobox protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71468)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "11991721;21750661;29033306;37459895",
        "class_list": "",
        "function": "Obox1 serves as a strong activator for somatic cell reprogramming through promoting the mesenchymal-to-epithelial transition and mitigating cell hyperproliferation., [RefSeq, PubMed]; Transcription factor required for zygotic genome activation (ZGA), a critical event in early embryonic development during which the developmental control passes from maternally provided mRNAs to the expression of the zygotic genome after fertilization (PubMed:37459895). Together with other Obox family members, required in early two-cell stage embryos to kick-start the major ZGA wave by facilitating RNA Polymerase II 'pre-configuration', during which RNA Polymerase II relocates from the initial one-cell stage binding targets to ZGA gene promoters and distal enhancers (PubMed:37459895). Mechanistically, promotes recruitment of RNA Polymerase II from (CG-rich) non-ZGA genes to (CG-poor) ZGA genes at the two-cell stage (PubMed:37459895). Binds to regulatory DNA sequences containing a 5'-ACNCCTTTAATCCCAG-3' sequence motif (PubMed:37459895). Most maternal and zygotic Obox family proteins can compensate for one another (PubMed:37459895). In addition to its role in ZGA, promotes embryonic stem cell pluripotency (PubMed:29033306)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "G3UX03",
        "ec_number_list": "",
        "go_molecular_function": "GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0030154 cell differentiation;GO:0019827 stem cell population maintenance;GO:0048706 embryonic skeletal system development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9D350-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3T9X0-1",
        "uniprot_id": "GTR9_MOUSE",
        "mass": 58621.0,
        "length": 538,
        "protein_name": "Solute carrier family 2, facilitated glucose transporter member 9",
        "gene_name": "Slc2a9",
        "organism": "Mouse",
        "refseq_name": "solute carrier family 2, facilitated glucose transporter member 9 isoform 3",
        "refseq_ac": "NP_001095885",
        "gene_names_uniprotkb": "Slc2a9; Glut9",
        "gene_names_refseq": "GLUT-9; Glut9; SLC2A9B; SLC2a9A; Slc2a9",
        "protein_names_uniprotkb": "Solute carrier family 2, facilitated glucose transporter member 9; GLUT-9; Glucose transporter type 9; Urate transporter",
        "protein_names_refseq": "facilitated glucose transporter, type 9; glucose transporter type 9; solute carrier family 2, facilitated glucose transporter member 9 isoform 3; solute carrier family 2, facilitated glucose transporter member 9; urate transporter",
        "tax_id": 10090,
        "disease": "abdominal obesity-metabolic syndrome (Disease Ontology:DOID:0060611); hyperuricemia (Disease Ontology:DOID:1920)",
        "pathway": " (mmu:117591);  (R-MMU-189200)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "14657010;16293642;17913964;18842065;19587147;21750661;25100214;34428180;35203284;36006548;39393275",
        "class_list": "glycogene",
        "function": "Blocking GLUT9 expression during preimplantation development had no effect on glucose transport or apoptosis but transfer of these embryos resulted in increased pregnancy loss, suggesting that GLUT9 is critical for early preimplantation development., [RefSeq, PubMed]; Glucose Transporter 9 (GLUT9) Plays an Important Role in the Placental Uric Acid Transport System. Publication Status: Online-Only, [RefSeq, PubMed]; Glucose uptake via GLUT9a and GLUT9b likely affects normal spermatogenesis, steroidogenesis, and sperm function in the mouse., [RefSeq, PubMed]; High-capacity urate transporter, which may play a role in the urate reabsorption by proximal tubules. May have a residual high-affinity, low-capacity glucose and fructose transporter activity. Transports urate at rates 45- to 60-fold faster than glucose. Does not transport galactose. May mediate small uptake of adenine but not of other nucleobases., [UniProtKB, UniProtKB]; METTL14 downregulates GLUT9 through m6A methylation and attenuates hyperuricemia-induced fibrosis in mouse renal tubular epithelial cells., [RefSeq, PubMed]; MGLUT9 protein expression was significantly increased in the kidney and liver from streptozotocin-induced diabetic mice compared with nondiabetic animals, [RefSeq, PubMed]; The regulation effect of GLUT9/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 33,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A0J9YUW8;B7ZNE4;B9EHN5;D3Z1X2;D6REU9;Q5ERC7;Q7TSK9;Q7TSP0;Q8BZR3;Q99JJ2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005353 fructose transmembrane transporter activity;GO:0015143 urate transmembrane transporter activity;GO:0055056 D-glucose transmembrane transporter activity;GO:0015149 hexose transmembrane transporter activity;GO:0022857 transmembrane transporter activity",
        "go_cellular_component": "GO:0005635 nuclear envelope;GO:0005886 plasma membrane;GO:0016323 basolateral plasma membrane;GO:0016324 apical plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0070837 dehydroascorbic acid transport;GO:1904659 D-glucose transmembrane transport;GO:0046415 urate metabolic process;GO:0015755 fructose transmembrane transport;GO:0015747 urate transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q3T9X0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C5Y2-1",
        "uniprot_id": "MISFA_MOUSE",
        "mass": 6174.0,
        "length": 53,
        "protein_name": "Mitochondrial sheath formation-associated protein",
        "gene_name": "Misfa",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Misfa; Gm9999",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Mitochondrial sheath formation-associated protein",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "35228556",
        "class_list": "",
        "function": "Regulates sperm development. May be involved in mitochondrial sheath formation., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A0N4SVS5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005741 mitochondrial outer membrane",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0030154 cell differentiation;GO:0120317 sperm mitochondrial sheath assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8C5Y2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A140LIE7-1",
        "uniprot_id": "A0A140LIE7_MOUSE",
        "mass": 35206.0,
        "length": 315,
        "protein_name": "Olfactory receptor family 10 subfamily H member 5",
        "gene_name": "Or10h5",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Or10h5; Gm4461; Olfr1564",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Olfactory receptor family 10 subfamily H member 5",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100043474);  (R-MMU-381753)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A140LIE7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A087WRT9-1",
        "uniprot_id": "A0A087WRT9_MOUSE",
        "mass": 25715.0,
        "length": 222,
        "protein_name": "Predicted gene 28490; Predicted gene 29582",
        "gene_name": "Gm29582",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Gm29582; Gm28490",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Predicted gene 28490; Predicted gene 29582",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "spermatogenic failure 4 (Disease Ontology:DOID:0070176)",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0000795 synaptonemal complex",
        "go_biological_process": "GO:0007286 spermatid development;GO:0051321 meiotic cell cycle;GO:0035092 sperm DNA condensation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A087WRT9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A1W2P709-1",
        "uniprot_id": "A0A1W2P709_MOUSE",
        "mass": 24364.0,
        "length": 240,
        "protein_name": "Predicted gene, 49918",
        "gene_name": "Krtap10-20",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein LOC100040299",
        "refseq_ac": "NP_001191938",
        "gene_names_uniprotkb": "Krtap10-20; Gm49918; Krtap10-36",
        "gene_names_refseq": "100040299; Gm2696; Krtap10-20",
        "protein_names_uniprotkb": "Predicted gene, 49918",
        "protein_names_refseq": "uncharacterized protein LOC100040299",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100040299)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005829 cytosol;GO:0045095 keratin filament",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A1W2P709-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFE9-1",
        "uniprot_id": "Q8VFE9_MOUSE",
        "mass": 34040.0,
        "length": 307,
        "protein_name": "Olfactory receptor family 12 subfamily J member 5",
        "gene_name": "Or12j5",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 12 subfamily J member 5",
        "refseq_ac": "NP_666731",
        "gene_names_uniprotkb": "Or12j5; Olfr536",
        "gene_names_refseq": "MOR252-1; MOR252-4; Olfr536; Or12j5",
        "protein_names_uniprotkb": "Olfactory receptor family 12 subfamily J member 5",
        "protein_names_refseq": "GA_x6K02T2PBJ9-42653501-42652578; olfactory receptor 536; olfactory receptor MOR252-1; olfactory receptor family 12 subfamily J member 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258513)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]; Possible taste receptor., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80XD6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFE9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CZP3-1",
        "uniprot_id": "ZN655_MOUSE",
        "mass": 63373.0,
        "length": 541,
        "protein_name": "Zinc finger protein 655",
        "gene_name": "Zfp655; Znf655",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 655 isoform a",
        "refseq_ac": "NP_082574",
        "gene_names_uniprotkb": "Zfp655; Znf655; Kiaa4222; Zfp655",
        "gene_names_refseq": "2700038I16Rik; 9030409O18Rik; Zfp655; Znf655",
        "protein_names_uniprotkb": "Zinc finger protein 655",
        "protein_names_refseq": "zinc finger protein 655 isoform a",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72611);  (R-MMU-212436)",
        "pathway_count": 2,
        "publication_count": 2,
        "publication_id_list": "21750661;28528544",
        "class_list": "",
        "function": "Probable transcription factor., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A0G2JE56;A0A0G2JEF7;A0A0G2JEM1;Q5DTG8;Q6P8W7;Q6P9P9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006357 regulation of transcription by RNA polymerase II;GO:2000134 negative regulation of G1/S transition of mitotic cell cycle",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9CZP3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "G3UY09-1",
        "uniprot_id": "G3UY09_MOUSE",
        "mass": 78742.0,
        "length": 685,
        "protein_name": "Zinc finger protein 141",
        "gene_name": "Zfp141",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 141 isoform 1",
        "refseq_ac": "NP_001296317",
        "gene_names_uniprotkb": "Zfp141",
        "gene_names_refseq": "Zfp141",
        "protein_names_uniprotkb": "Zinc finger protein 141",
        "protein_names_refseq": "zinc finger protein 141 isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:434178);  (R-MMU-212436);  (R-MMU-9843940)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661",
        "class_list": "",
        "function": "May be involved in transcriptional regulation., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 9562,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006355 regulation of DNA-templated transcription;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "G3UY09-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VGW8-1",
        "uniprot_id": "Q8VGW8_MOUSE",
        "mass": 35329.0,
        "length": 311,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or6b1",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 449",
        "refseq_ac": "NP_001343339",
        "gene_names_uniprotkb": "Or6b1; Olfr449",
        "gene_names_refseq": "GA_x6K02T2P3E9-4722003-4721068; MOR103-1; Olfr449; Or6b1",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "olfactory receptor 449; olfactory receptor MOR103-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:259067)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VGW8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2A761-1",
        "uniprot_id": "ZFP69_MOUSE",
        "mass": 65725.0,
        "length": 587,
        "protein_name": "Zinc finger protein 69",
        "gene_name": "Zfp69",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 69 isoform 1",
        "refseq_ac": "NP_001005788",
        "gene_names_uniprotkb": "Zfp69; Znf642",
        "gene_names_refseq": "Gm1029; Krab2; Zfp63; Zfp69",
        "protein_names_uniprotkb": "Zinc finger protein 69; Zinc finger protein 642",
        "protein_names_refseq": "Zfp63p; zinc finger protein 642; zinc finger protein 69 isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:381549);  (R-MMU-212436)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "19578398;20865372;21750661;26232096",
        "class_list": "",
        "function": "Putative transcription factor that appears to regulate lipid metabolism., [UniProtKB, PubMed, PubMed]; Zfp69 is the most likely candidate for the diabetogenic effect of Nidd/SJL locus., [RefSeq, PubMed]; Zfp69 mRNA-expression was significantly higher in diabetic subjects than in unaffected controls. Review article, [RefSeq, PubMed]; Zfp69 mediates hyperlipidaemia, liver fat accumulation and mild insulin resistance. However, it does not induce type 2 diabetes, suggesting that the diabetogenic effect of the Zfp69 locus requires synergy with other as yet unidentified genes., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0006629 lipid metabolic process;GO:0019216 regulation of lipid metabolic process;GO:0006355 regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "A2A761-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5NCD0-1",
        "uniprot_id": "Q5NCD0_MOUSE",
        "mass": 36339.0,
        "length": 323,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or11l3",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 323",
        "refseq_ac": "NP_666488",
        "gene_names_uniprotkb": "Or11l3; Olfr323",
        "gene_names_refseq": "MOR107-1; Olfr323; Or11l3",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2NKPP-794386-795357; olfactory receptor 323; olfactory receptor MOR107-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258373)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q5NCD0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A075B614-1",
        "uniprot_id": "A0A075B614_MOUSE",
        "mass": 10260.0,
        "length": 92,
        "protein_name": "T cell receptor alpha variable 3D-3; T cell receptor alpha variable 3N-3",
        "gene_name": "Trav3d-3; Trav3n-3",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Trav3d-3; Trav3n-3; Trav3d-3; Trav3n-3",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "T cell receptor alpha variable 3D-3; T cell receptor alpha variable 3N-3",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0042101 T cell receptor complex",
        "go_biological_process": "GO:0002250 adaptive immune response;GO:0009617 response to bacterium",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A075B614-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VEU8-1",
        "uniprot_id": "Q8VEU8_MOUSE",
        "mass": 35213.0,
        "length": 314,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or5w18",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 1143",
        "refseq_ac": "NP_666405",
        "gene_names_uniprotkb": "Or5w18; Olfr1143",
        "gene_names_refseq": "MOR177-14; Olfr1143; Or5w18",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2Q125-49303473-49304405; olfactory receptor 1143; olfactory receptor MOR177-14",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258290)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VEU8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VGW0-1",
        "uniprot_id": "Q8VGW0_MOUSE",
        "mass": 35988.0,
        "length": 319,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or52r1c",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 52 subfamily R member 1C",
        "refseq_ac": "NP_667265",
        "gene_names_uniprotkb": "Or52r1c; Olfr584",
        "gene_names_refseq": "MOR30-2; Olfr584; Or52r1c",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PBJ9-5796876-5797820; olfactory receptor 584; olfactory receptor MOR30-2; olfactory receptor family 52 subfamily R member 1C",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:259056)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB, UniProtKB]; Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VGW0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A087WNP5-1",
        "uniprot_id": "A0A087WNP5_MOUSE",
        "mass": 58051.0,
        "length": 499,
        "protein_name": "Predicted gene 10778; Predicted gene 4767",
        "gene_name": "Gm10778",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein LOC100233208",
        "refseq_ac": "NP_001136435",
        "gene_names_uniprotkb": "Gm10778; Gm4767",
        "gene_names_refseq": "Gm10778",
        "protein_names_uniprotkb": "Predicted gene 10778; Predicted gene 4767",
        "protein_names_refseq": "uncharacterized protein LOC100233208; zinc finger protein LOC100233208",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100233208)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "May be involved in transcriptional regulation., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0006355 regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A087WNP5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFQ2-1",
        "uniprot_id": "Q8VFQ2_MOUSE",
        "mass": 36724.0,
        "length": 330,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or10al4",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 10 subfamily AL member 4",
        "refseq_ac": "NP_666842",
        "gene_names_uniprotkb": "Or10al4; Olfr120",
        "gene_names_refseq": "MOR263-3; Olfr120; Or10al4",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PSCP-2184981-2185946; olfactory receptor 120; olfactory receptor MOR263-3; olfactory receptor family 10 subfamily AL member 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258624)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFQ2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VFF1-1",
        "uniprot_id": "Q8VFF1_MOUSE",
        "mass": 35455.0,
        "length": 315,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or7g34",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 7 subfamily G member 34",
        "refseq_ac": "NP_666733",
        "gene_names_uniprotkb": "Or7g34; Olfr854",
        "gene_names_refseq": "MOR147-3; Olfr854; Or7g34",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PVTD-13313295-13312357; olfactory receptor 854; olfactory receptor MOR147-3; olfactory receptor family 7 subfamily G member 34",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258515)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007165 signal transduction;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VFF1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VGL9-1",
        "uniprot_id": "Q8VGL9_MOUSE",
        "mass": 35327.0,
        "length": 319,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or13a25",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 13 subfamily A member 25",
        "refseq_ac": "NP_667172",
        "gene_names_uniprotkb": "Or13a25; Olfr539",
        "gene_names_refseq": "MOR253-4; Olfr539; Or13a25",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "GA_x6K02T2PBJ9-42813436-42814368; olfactory receptor 539; olfactory receptor MOR253-4; olfactory receptor family 13 subfamily A member 25",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258963)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]; Possible taste receptor., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VGL9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A075B6A1-1",
        "uniprot_id": "A0A075B6A1_MOUSE",
        "mass": 12943.0,
        "length": 113,
        "protein_name": "T cell receptor alpha variable 14D-1; T cell receptor alpha variable 14N-1",
        "gene_name": "Trav14d-1; Trav14n-1",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Trav14d-1; Trav14n-1; Trav14d-1; Trav14n-1",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "T cell receptor alpha variable 14D-1; T cell receptor alpha variable 14N-1",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042605 peptide antigen binding",
        "go_cellular_component": "GO:0042101 T cell receptor complex",
        "go_biological_process": "GO:0002250 adaptive immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A075B6A1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O08546-1",
        "uniprot_id": "U9ORF_MOUSE",
        "mass": 9927.0,
        "length": 87,
        "protein_name": "Endotoxic shock protective protein U9-ORF",
        "gene_name": "U90926",
        "organism": "Mouse",
        "refseq_name": "endotoxic shock protective protein U9-ORF precursor",
        "refseq_ac": "NP_001403482",
        "gene_names_uniprotkb": "U90926",
        "gene_names_refseq": "U90926",
        "protein_names_uniprotkb": "Endotoxic shock protective protein U9-ORF",
        "protein_names_refseq": "U9-ORF protein; endotoxic shock protective protein U9-ORF precursor; endotoxic shock protective protein U9-ORF; putative TNF-resistance related protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:57425)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "33895326;36705532;37346046",
        "class_list": "",
        "function": "Cryptosporidium parvum hijacks a host's long noncoding RNA U90926 to evade intestinal epithelial cell-autonomous antiparasitic defense. Publication Status: Online-Only, [RefSeq, PubMed]; Long Noncoding RNA U90926 Is Induced in Activated Macrophages, Is Protective in Endotoxic Shock, and Encodes a Novel Secreted Protein., [RefSeq, PubMed]; Microglial lnc-U90926 facilitates neutrophil infiltration in ischemic stroke via MDH2/CXCL2 axis., [RefSeq, PubMed]; Plays a protective role during endotoxic shock., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0045087 innate immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "O08546-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2ASP7-1",
        "uniprot_id": "A2ASP7_MOUSE",
        "mass": 21561.0,
        "length": 199,
        "protein_name": "RIKEN cDNA 9430015G10 gene",
        "gene_name": "9430015G10Rik",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein C1orf159 homolog precursor",
        "refseq_ac": "NP_663532",
        "gene_names_uniprotkb": "9430015G10Rik",
        "gene_names_refseq": "9430015G10Rik",
        "protein_names_uniprotkb": "RIKEN cDNA 9430015G10 gene",
        "protein_names_refseq": "uncharacterized protein C1orf159 homolog precursor",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:230996)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "A2ASP7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TS12-1",
        "uniprot_id": "Q7TS12_MOUSE",
        "mass": 35263.0,
        "length": 315,
        "protein_name": "Olfactory receptor",
        "gene_name": "Or5ae2",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Or5ae2; Olfr291",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Olfactory receptor",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258410)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TS12-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VI33-1",
        "uniprot_id": "TAF9_MOUSE",
        "mass": 28979.0,
        "length": 264,
        "protein_name": "Transcription initiation factor TFIID subunit 9",
        "gene_name": "Taf9",
        "organism": "Mouse",
        "refseq_name": "transcription initiation factor TFIID subunit 9",
        "refseq_ac": "NP_001015889",
        "gene_names_uniprotkb": "Taf9; Taf2g",
        "gene_names_refseq": "2310012M09Rik; TAFII31; TAFII32; Taf2g; Taf9",
        "protein_names_uniprotkb": "Transcription initiation factor TFIID subunit 9; RNA polymerase II TBP-associated factor subunit G; TAFII-31; TAFII-32; TAFII31; TAFII32; Transcription initiation factor TFIID 31 kDa subunit; Transcription initiation factor TFIID 32 kDa subunit",
        "protein_names_refseq": "RNA polymerase II TBP-associated factor subunit G; TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32 kDa; transcription initiation factor TFIID 31 kDa subunit; transcription initiation factor TFIID 32 kDa subunit; transcription initiation factor TFIID subunit 9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:108143);  (R-MMU-674695);  (R-MMU-6804756);  (R-MMU-6807505);  (R-MMU-73776);  (R-MMU-73779);  (R-MMU-75953);  (R-MMU-76042)",
        "pathway_count": 8,
        "publication_count": 11,
        "publication_id_list": "17242355;21183079;21750661;32782141;32848054;34428180;35822049;36852467;40021952;40885482;40997131",
        "class_list": "",
        "function": "The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription. TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC). The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13. TAF9 is also a component of the TBP-free TAFII complex (TFTC), the PCAF histone acetylase complex and the STAGA transcription coactivator-HAT complex. TAF9 and its paralog TAF9B are involved in transcriptional activation as well as repression of distinct but overlapping sets of genes. Essential for cell viability. May have a role in gene regulation associated with apoptosis., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q32P09;Q80XS3;Q9CV61",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003713 transcription coactivator activity;GO:0046982 protein heterodimerization activity;GO:0051117 ATPase binding;GO:0000976 transcription cis-regulatory region binding",
        "go_cellular_component": "GO:0033276 transcription factor TFTC complex;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0071339 MLL1 complex;GO:0070761 pre-snoRNP complex",
        "go_biological_process": "GO:0060261 positive regulation of transcription initiation by RNA polymerase II;GO:0060760 positive regulation of response to cytokine stimulus;GO:0006338 chromatin remodeling;GO:0006357 regulation of transcription by RNA polymerase II;GO:0043066 negative regulation of apoptotic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q8VI33-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80VI1-1",
        "uniprot_id": "TRI56_MOUSE",
        "mass": 79513.0,
        "length": 734,
        "protein_name": "E3 ubiquitin-protein ligase TRIM56",
        "gene_name": "Trim56",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase TRIM56",
        "refseq_ac": "NP_958761",
        "gene_names_uniprotkb": "Trim56",
        "gene_names_refseq": "A130009K11Rik; Gm452; RNF109; Trim56",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase TRIM56; 2.3.2.27; Tripartite motif-containing protein 56",
        "protein_names_refseq": "E3 ubiquitin-protein ligase TRIM56; RING-type E3 ubiquitin transferase TRIM56; tripartite motif-containing protein 56",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:384309);  (R-MMU-3134975)",
        "pathway_count": 2,
        "publication_count": 13,
        "publication_id_list": "19224205;20173027;21074459;21750661;25428506;29426904;30084848;30779550;34203471;34428180;35820727;38206764;38556084",
        "class_list": "",
        "function": "E3 ubiquitin-protein ligase that plays a key role in innate antiviral immunity by mediating ubiquitination of CGAS and STING1 (PubMed:21074459, PubMed:29426904). In response to pathogen- and host-derived double-stranded DNA (dsDNA), targets STING1 to 'Lys-63'-linked ubiquitination, thereby promoting its homodimerization, a step required for the production of type I interferon IFN-beta (PubMed:21074459). Also mediates monoubiquitination of CGAS, thereby promoting CGAS oligomerization and subsequent activation (PubMed:29426904). Independently of its E3 ubiquitin ligase activity, positive regulator of TLR3 signaling (By similarity). Potentiates extracellular double stranded RNA (dsRNA)-induced expression of IFNB1 and interferon-stimulated genes ISG15, IFIT1/ISG56, CXCL10, OASL and CCL5/RANTES (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; Key roles for phosphorylation and the Coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF-dependent innate immunity., [RefSeq, PubMed]; TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CAY0",
        "ec_number_list": "2.3.2.27",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0061630 ubiquitin protein ligase activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0044790 suppression of viral release by host;GO:0045087 innate immune response;GO:0051607 defense response to virus;GO:1901224 positive regulation of non-canonical NF-kappaB signal transduction;GO:0070534 protein K63-linked ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q80VI1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A4Q9F4-1",
        "uniprot_id": "TTL11_MOUSE",
        "mass": 82361.0,
        "length": 727,
        "protein_name": "Tubulin polyglutamylase TTLL11",
        "gene_name": "Ttll11",
        "organism": "Mouse",
        "refseq_name": "tubulin polyglutamylase TTLL11",
        "refseq_ac": "NP_084050",
        "gene_names_uniprotkb": "Ttll11",
        "gene_names_refseq": "4932702F08Rik; 4933424A20Rik; D2Ertd624e; Ttll11",
        "protein_names_uniprotkb": "Tubulin polyglutamylase TTLL11; 6.3.2.-; Tubulin--tyrosine ligase-like protein 11",
        "protein_names_refseq": "polyglutamylase; tubulin polyglutamylase TTLL11; tubulin--tyrosine ligase-like protein 11",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74410);  (R-MMU-8955332)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "17499049;20530212;21750661;23897886;34428180",
        "class_list": "",
        "function": "Polyglutamylase which modifies tubulin, generating polyglutamate side chains of variable lengths on the gamma-carboxyl group of specific glutamate residues within the C-terminal tail of tubulin (PubMed:17499049, PubMed:20530212). Preferentially mediates ATP-dependent polyglutamate long side-chain elongation over the initiation step of the polyglutamylation reaction (PubMed:17499049, PubMed:20530212). Preferentially modifies the alpha-tubulin tail over a beta-tail (PubMed:17499049). Required for CCSAP localization to both spindle and cilia microtubules (By similarity). Promotes tubulin polyglutamylation which stimulates spastin/SPAST-mediated microtubule severing, thereby regulating microtubule functions (PubMed:20530212)., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q1LZJ9;Q9D4E7",
        "ec_number_list": "6.3.2.-;6.-.-.-;3.6.5.-",
        "go_molecular_function": "GO:0070740 tubulin-glutamic acid ligase activity;GO:0005524 ATP binding;GO:0046872 metal ion binding;GO:0015631 tubulin binding;GO:0106437 protein-glutamic acid ligase activity, initiating",
        "go_cellular_component": "GO:0005874 microtubule;GO:0036064 ciliary basal body",
        "go_biological_process": "GO:0051013 microtubule severing;GO:0000226 microtubule cytoskeleton organization;GO:0018095 protein polyglutamylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "A4Q9F4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A4Q9F6-1",
        "uniprot_id": "TTL13_MOUSE",
        "mass": 93463.0,
        "length": 804,
        "protein_name": "Tubulin polyglutamylase TTLL13",
        "gene_name": "Ttll13",
        "organism": "Mouse",
        "refseq_name": "tubulin polyglutamylase TTLL13 isoform 2",
        "refseq_ac": "NP_808433",
        "gene_names_uniprotkb": "Ttll13",
        "gene_names_refseq": "1700111A04Rik; 4921538O11; Ttll13",
        "protein_names_uniprotkb": "Tubulin polyglutamylase TTLL13; 6.3.2.-; Tubulin--tyrosine ligase-like protein 13",
        "protein_names_refseq": "tubulin polyglutamylase TTLL13 isoform 2; tubulin polyglutamylase TTLL13; tubulin--tyrosine ligase-like protein 13",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:269954);  (R-MMU-8955332)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "17499049;23897886;40593606",
        "class_list": "",
        "function": "Polyglutamylase which modifies tubulin, generating polyglutamate side chains of variable lengths on the gamma-carboxyl group of specific glutamate residues within the C-terminal tail of tubulin (PubMed:17499049). Mediates ATP-dependent polyglutamate side-chain elongation of the polyglutamylation reaction but not the initiation step (PubMed:17499049). Preferentially modifies the alpha-tubulin tail over a beta-tail (PubMed:17499049). Mediates spindle-pole microtubule glutamylation in a CFAP100-dependent manner, a modification necessary for maintaining spindle-pole integrity and ensuring proper spindle assembly (PubMed:40593606)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C0W9",
        "ec_number_list": "6.3.2.-;6.-.-.-;3.6.5.-",
        "go_molecular_function": "GO:0070740 tubulin-glutamic acid ligase activity;GO:0005524 ATP binding;GO:0046872 metal ion binding;GO:0015631 tubulin binding;GO:0106438 protein-glutamic acid ligase activity, elongating",
        "go_cellular_component": "GO:0005874 microtubule;GO:0036064 ciliary basal body",
        "go_biological_process": "GO:0001578 microtubule bundle formation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "A4Q9F6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BGE7-1",
        "uniprot_id": "TRIM6_MOUSE",
        "mass": 56152.0,
        "length": 488,
        "protein_name": "Tripartite motif-containing protein 6",
        "gene_name": "Trim6",
        "organism": "Mouse",
        "refseq_name": "tripartite motif-containing protein 6",
        "refseq_ac": "NP_001013637",
        "gene_names_uniprotkb": "Trim6",
        "gene_names_refseq": "C430046K18Rik; D7Ertd684e; Trim6",
        "protein_names_uniprotkb": "Tripartite motif-containing protein 6; 2.3.2.27; RING-type E3 ubiquitin transferase TRIM6",
        "protein_names_refseq": "RING-type E3 ubiquitin transferase TRIM6; tripartite motif protein 6; tripartite motif-containing protein 6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:94088)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "11331580;21750661;22328504;24882218;31171760;36654781;37236551",
        "class_list": "",
        "function": "E3 ubiquitin ligase that plays a crucial role in the activation of the IKBKE-dependent branch of the type I interferon signaling pathway (PubMed:24882218). In concert with the ubiquitin-conjugating E2 enzyme UBE2K, synthesizes unanchored 'Lys-48'-linked polyubiquitin chains that promote the oligomerization and autophosphorylation of IKBKE leading to stimulation of an antiviral response (PubMed:24882218). Also ubiquitinates MYC and inhibits its transcription activation activity, maintaining the pluripotency of embryonic stem cells (PubMed:22328504). Promotes the association of unanchored 'Lys-48'-polyubiquitin chains with DHX16 leading to enhancement of RIGI-mediated innate antiviral immune response (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB]; TRIM6 Reduces Ferroptosis and Chemosensitivity by Targeting SLC1A5 in Lung Cancer. Publication Status: Online-Only, [RefSeq, PubMed]; TRIM6 regulates the transcriptional activity of Myc during the maintenance of cell pluripotency, suggesting that TRIM6 functions as a novel regulator for Myc-mediated transcription in embryonic stem cells., [RefSeq, PubMed]; TRIM6 silencing for inhibiting growth and angiogenesis of gliomas by regulating VEGFA., [RefSeq, PubMed]; These results suggest that TRIM6 aggravates MI/R injury through promoting IKKepsilon/STAT1 activation-dependent cardiomyocyte apoptosis, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RSQ8;Q99PQ6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0019901 protein kinase binding;GO:0030674 protein-macromolecule adaptor activity;GO:0042802 identical protein binding;GO:0061630 ubiquitin protein ligase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0010628 positive regulation of gene expression;GO:0010629 negative regulation of gene expression;GO:0010800 positive regulation of peptidyl-threonine phosphorylation;GO:0032496 response to lipopolysaccharide;GO:0033138 positive regulation of peptidyl-serine phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8BGE7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91YD4-1",
        "uniprot_id": "TRPM2_MOUSE",
        "mass": 172202.0,
        "length": 1506,
        "protein_name": "Transient receptor potential cation channel subfamily M member 2",
        "gene_name": "Trpm2",
        "organism": "Mouse",
        "refseq_name": "transient receptor potential cation channel subfamily M member 2",
        "refseq_ac": "NP_612174",
        "gene_names_uniprotkb": "Trpm2; Ltrpc2; Trpc7",
        "gene_names_refseq": "9830168K16Rik; LTRPC2; TRPC7; Trp7; Trpm2; Trrp7",
        "protein_names_uniprotkb": "Transient receptor potential cation channel subfamily M member 2; LTrpC-2; LTrpC2; Long transient receptor potential channel 2; Transient receptor potential channel 7; TrpC7",
        "protein_names_refseq": "LTrpC-2; long transient receptor potential channel 2; transient receptor potential cation channel subfamily M member 2; transient receptor potential channel 7; transient receptor protein 7",
        "tax_id": 10090,
        "disease": "transient cerebral ischemia (Disease Ontology:DOID:224)",
        "pathway": " (mmu:28240);  (R-MMU-3295583);  (R-MMU-6798695)",
        "pathway_count": 3,
        "publication_count": 19,
        "publication_id_list": "11804595;15708008;16260005;16601673;19454650;20921208;21709234;21750661;21753080;22493272;25562606;25817999;26495903;26740625;27533035;27562954;34428180;36042566;38649091",
        "class_list": "",
        "function": "Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model., [RefSeq, PubMed]; Nonselective, voltage-independent cation channel that mediates Na(+) and Ca(2+) influx, leading to increased cytoplasmic Ca(2+) levels (PubMed:11804595, PubMed:19454650, PubMed:21753080, PubMed:22493272). Functions as a ligand-gated ion channel, gated by intracellular adenosine diphosphate ribose (ADP-ribose), Ca(2+), warm temperature, and oxidative stress. The precise physiological activators are under debate; the true, physiological activators may be ADP-ribose and ADP-ribose-2'-phosphate (By similarity). Binding of ADP-ribose to the cytoplasmic Nudix domain causes a conformation change; the channel is primed but still requires Ca(2+) binding to trigger channel opening. Extracellular Ca(2+) passes through the channel and increases channel activity (By similarity). Also contributes to Ca(2+) release from intracellular stores in response to ADP-ribose (PubMed:21753080). Plays a role in numerous processes that involve signaling via intracellular Ca(2+) levels (PubMed:21753080). Besides, mediates the release of lysosomal Zn(2+) stores in response to reactive oxygen species, leading to increased cytosolic Zn(2+) levels (By similarity). Plays a role in mediating behavorial and physiological responses to moderate heat and thereby contributes to body temperature homeostasis (PubMed:27533035, PubMed:27562954). Plays a role in insulin secretion, a process that requires increased cytoplasmic Ca(2+) levels (PubMed:20921208, PubMed:25817999). Required for normal IFNG and cytokine secretion and normal innate immune immunity in response to bacterial infection (PubMed:21709234). Required for normal phagocytosis and cytokine release by macrophages exposed to zymosan (in vitro) (PubMed:22493272). Plays a role in dendritic cell differentiation and maturation, and in dendritic cell chemotaxis via its role in regulating cytoplasmic Ca(2+) levels (PubMed:21753080). Plays a role in the regulation of the reorganization of the actin cytoskeleton and filopodia formation in response to reactive oxygen species via its function in increasing cytoplasmic Ca(2+) and Zn(2+) levels (By similarity). Confers susceptibility to cell death following oxidative stress (PubMed:25562606)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5KTC0",
        "ec_number_list": "1.8.-.-;2.7.11.1",
        "go_molecular_function": "GO:0005509 calcium ion binding;GO:0005261 monoatomic cation channel activity;GO:0005272 sodium channel activity;GO:0015278 intracellularly gated calcium channel activity;GO:0005384 manganese ion transmembrane transporter activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0043025 neuronal cell body;GO:0043204 perikaryon;GO:0005764 lysosome;GO:0005765 lysosomal membrane",
        "go_biological_process": "GO:0071577 zinc ion transmembrane transport;GO:0001659 temperature homeostasis;GO:0014074 response to purine-containing compound;GO:0032024 positive regulation of insulin secretion;GO:0032956 regulation of actin cytoskeleton organization",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "Q91YD4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EPK8-1",
        "uniprot_id": "TRPV4_MOUSE",
        "mass": 98027.0,
        "length": 871,
        "protein_name": "Transient receptor potential cation channel subfamily V member 4",
        "gene_name": "Trpv4",
        "organism": "Mouse",
        "refseq_name": "transient receptor potential cation channel subfamily V member 4",
        "refseq_ac": "NP_071300",
        "gene_names_uniprotkb": "Trpv4; Trp12; Vrl2; Vroac",
        "gene_names_refseq": "0610033B08Rik; OTRPC4; Trp12; Trpv4; VR-OAC; VRL-2; VROAC",
        "protein_names_uniprotkb": "Transient receptor potential cation channel subfamily V member 4; OTRPC4; Osm-9-like TRP channel 4; TRP12; Transient receptor potential protein 12; TrpV4; VR-OAC; Vanilloid receptor-like channel 2; Vanilloid receptor-like protein 2; Vanilloid receptor-related osmotically-activated channel",
        "protein_names_refseq": "osm-9-like TRP channel 4; osmosensitive transient receptor potential channel 4; transient receptor potential cation channel subfamily V member 4; transient receptor potential protein 12; trpv4 channel; vanilloid receptor-like channel 2; vanilloid receptor-like protein 2; vanilloid receptor-related osmotically-activated channel",
        "tax_id": 10090,
        "disease": "Charcot-Marie-Tooth disease axonal type 2C (Disease Ontology:DOID:0110182); autosomal dominant nonsyndromic deafness 25 (Disease Ontology:DOID:0110555); autosomal dominant distal hereditary motor neuronopathy 8 (Disease Ontology:DOID:0111215); metatropic dysplasia (Disease Ontology:DOID:0111514); parastremmatic dwarfism (Disease Ontology:DOID:0111539); scapuloperoneal spinal muscular atrophy (Disease Ontology:DOID:0111552); spondyloepiphyseal dysplasia Maroteaux type (Disease Ontology:DOID:0111553); spondylometaphyseal dysplasia Kozlowski type (Disease Ontology:DOID:0111554); osteonecrosis (Disease Ontology:DOID:10159); pulmonary hypertension (Disease Ontology:DOID:6432)",
        "pathway": " (mmu:63873);  (R-MMU-3295583);  (R-MMU-9856530)",
        "pathway_count": 3,
        "publication_count": 24,
        "publication_id_list": "11025659;11081638;11094154;11827975;12093812;12538589;12692122;14517216;14691263;16368742;16571723;16627472;18174177;18695040;19033444;20043876;20413591;21750661;23021218;24509911;27252474;27861175;34428180;36210013",
        "class_list": "",
        "function": "Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives., [RefSeq, PubMed]; Non-selective calcium permeant cation channel involved in osmotic sensitivity and mechanosensitivity (PubMed:11094154, PubMed:12093812, PubMed:12538589). Activation by exposure to hypotonicity within the physiological range exhibits an outward rectification (PubMed:12093812, PubMed:14691263, PubMed:16368742, PubMed:16571723). Also activated by heat, low pH, citrate and phorbol esters (PubMed:14691263). Increase of intracellular Ca(2+) potentiates currents. Channel activity seems to be regulated by a calmodulin-dependent mechanism with a negative feedback mechanism (By similarity). Acts as a regulator of intracellular Ca(2+) in synoviocytes (By similarity). Plays an obligatory role as a molecular component in the nonselective cation channel activation induced by 4-alpha-phorbol 12,13-didecanoate and hypotonic stimulation in synoviocytes and also regulates production of IL-8 (By similarity). Together with PKD2, forms mechano- and thermosensitive channels in cilium (PubMed:18695040). Promotes cell-cell junction formation in skin keratinocytes and plays an important role in the formation and/or maintenance of functional intercellular barriers (PubMed:20413591). Negatively regulates expression of PPARGC1A, UCP1, oxidative metabolism and respiration in adipocytes (PubMed:23021218). Regulates expression of chemokines and cytokines related to pro-inflammatory pathway in adipocytes (PubMed:23021218). Together with AQP5, controls regulatory volume decrease in salivary epithelial cells (PubMed:16571723). Required for normal development and maintenance of bone and cartilage (By similarity). In its inactive state, may sequester DDX3X at the plasma membrane. When activated, the interaction between both proteins is affected and DDX3X relocalizes to the nucleus (By similarity). In neurons of the central nervous system, could play a role in triggering voluntary water intake in response to increased sodium concentration in body fluid (PubMed:27252474)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 14,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 10,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0JNY0;Q91XR5;Q9EQZ4;Q9ERZ7;Q9ES76",
        "ec_number_list": "2.7.11.1",
        "go_molecular_function": "GO:0003779 actin binding;GO:0005262 calcium channel activity;GO:0005516 calmodulin binding;GO:0005524 ATP binding;GO:0008017 microtubule binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0005912 adherens junction;GO:0005925 focal adhesion;GO:0005929 cilium;GO:0009986 cell surface",
        "go_biological_process": "GO:0071476 cellular hypotonic response;GO:0046785 microtubule polymerization;GO:0031117 positive regulation of microtubule depolymerization;GO:0007231 osmosensory signaling pathway;GO:0000122 negative regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 2.6,
        "record_id": "Q9EPK8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P17751-1",
        "uniprot_id": "TPIS_MOUSE",
        "mass": 26713.0,
        "length": 249,
        "protein_name": "Triosephosphate isomerase",
        "gene_name": "Tpi1",
        "organism": "Mouse",
        "refseq_name": "triosephosphate isomerase",
        "refseq_ac": "NP_033441",
        "gene_names_uniprotkb": "Tpi1; Tpi",
        "gene_names_refseq": "TIM; Tpi-1; Tpi1; Tpi",
        "protein_names_uniprotkb": "Triosephosphate isomerase; 4.2.3.3; 5.3.1.1; Methylglyoxal synthase; TIM; Triose-phosphate isomerase",
        "protein_names_refseq": "methylglyoxal synthase; triose-phosphate isomerase; triosephosphate isomerase",
        "tax_id": 10090,
        "disease": "triosephosphate isomerase deficiency (Disease Ontology:DOID:0050884); neurodegenerative disease (Disease Ontology:DOID:1289); cancer (Disease Ontology:DOID:162); carbohydrate metabolic disorder (Disease Ontology:DOID:2978); ocular hypertension (Disease Ontology:DOID:9282)",
        "pathway": " (mmu:21991);  (R-MMU-70171);  (R-MMU-70263)",
        "pathway_count": 3,
        "publication_count": 21,
        "publication_id_list": "16800626;17242355;21183079;21540332;21750661;22645316;2377473;23806337;24788674;25153642;25428506;28135057;34428180;36064721;36288343;37453647;37507081;39627609;39927985;7739600;9445485",
        "class_list": "glycogene",
        "function": "It is also responsible for the non-negligible production of methylglyoxal a reactive cytotoxic side-product that modifies and can alter proteins, DNA and lipids., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Triosephosphate isomerase is an extremely efficient metabolic enzyme that catalyzes the interconversion between dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde-3-phosphate (G3P) in glycolysis and gluconeogenesis., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 24,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TJH2;Q3UC04;Q3UKG9;Q64513;Q9CVF9;Q9CWE7",
        "ec_number_list": "5.3.1.1;4.2.3.3",
        "go_molecular_function": "GO:0004807 triose-phosphate isomerase activity;GO:0042803 protein homodimerization activity;GO:0031625 ubiquitin protein ligase binding;GO:0016853 isomerase activity;GO:0008929 methylglyoxal synthase activity",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0019682 glyceraldehyde-3-phosphate metabolic process;GO:0019563 glycerol catabolic process;GO:0006094 gluconeogenesis;GO:0006006 glucose metabolic process;GO:0006096 glycolytic process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "P17751-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P70399-1",
        "uniprot_id": "TP53B_MOUSE",
        "mass": 212735.0,
        "length": 1969,
        "protein_name": "TP53-binding protein 1",
        "gene_name": "Tp53bp1; Trp53bp1",
        "organism": "Mouse",
        "refseq_name": "TP53-binding protein 1 isoform b",
        "refseq_ac": "NP_001277759",
        "gene_names_uniprotkb": "Tp53bp1; Trp53bp1; Trp53bp1",
        "gene_names_refseq": "53BP1; Tp53bp1; Trp53bp1; m53BP1; p53BP1",
        "protein_names_uniprotkb": "TP53-binding protein 1; 53BP1; p53-binding protein 1; p53BP1",
        "protein_names_refseq": "TP53-binding protein 1 isoform b; TP53-binding protein 1; murine p53-binding protein; tumor suppressor p53-binding protein 1",
        "tax_id": 10090,
        "disease": "pulmonary hypertension (Disease Ontology:DOID:6432)",
        "pathway": " (mmu:27223);  (R-MMU-3232118);  (R-MMU-5693565);  (R-MMU-5693571);  (R-MMU-5693607);  (R-MMU-69473)",
        "pathway_count": 6,
        "publication_count": 32,
        "publication_id_list": "10.1101/2023.09.13.557529;11673449;11801725;12578828;12640136;15077110;15159415;15341721;19131326;19144319;20362325;20453858;21183079;21750661;23209566;23306439;23333305;24129315;24788674;25428506;26308889;28528544;29328365;30084848;30297459;30779550;34203471;34428180;35820727;39083600;40885482;8910340",
        "class_list": "",
        "function": "ATM and 53BP1 regulate alternative end joining-mediated V(D)J recombination., [RefSeq, PubMed]; Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:15077110, PubMed:15159415, PubMed:20362325, PubMed:20453858, PubMed:23333305, PubMed:26308889). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:20362325, PubMed:23333305, PubMed:30297459). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites. Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites. Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:15077110, PubMed:15159415). Participates in the repair and the orientation of the broken DNA ends during CSR (PubMed:26308889). In contrast, it is not required for classic NHEJ and V(D)J recombination (PubMed:15159415). Promotes NHEJ of dysfunctional telomeres (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; M53BP1(tr/tr) mice are sensitive to ionizing radiation and cells from these animals exhibit chromosomal abnormalities consistent with defects in DNA repair, indicating that 53BP1 is a critical element in the DNA damage response., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 66,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 4,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 8,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AU89;A2AU91;Q68FD0;Q8CI97;Q91YC9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0061649 ubiquitin-modified histone reader activity;GO:0003677 DNA binding;GO:0003713 transcription coactivator activity;GO:0042393 histone binding;GO:0002039 p53 binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0016604 nuclear body;GO:0000776 kinetochore;GO:0035861 site of double-strand break",
        "go_biological_process": "GO:1990166 protein localization to site of double-strand break;GO:0097680 double-strand break repair via classical nonhomologous end joining;GO:2000042 negative regulation of double-strand break repair via homologous recombination;GO:0006351 DNA-templated transcription;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 4.0,
        "record_id": "P70399-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5I043-1",
        "uniprot_id": "UBP28_MOUSE",
        "mass": 119318.0,
        "length": 1051,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 28",
        "gene_name": "Usp28",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 28 isoform 1",
        "refseq_ac": "NP_780691",
        "gene_names_uniprotkb": "Usp28; Kiaa1515",
        "gene_names_refseq": "9830148O20Rik; Usp28; mKIAA1515",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 28; 3.4.19.12; Deubiquitinating enzyme 28; Ubiquitin thioesterase 28; Ubiquitin-specific-processing protease 28",
        "protein_names_refseq": "deubiquitinating enzyme 28; ubiquitin carboxyl-terminal hydrolase 28 isoform 1; ubiquitin carboxyl-terminal hydrolase 28; ubiquitin specific protease 28; ubiquitin thioesterase 28; ubiquitin thiolesterase 28; ubiquitin-specific-processing protease 28",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:235323);  (R-MMU-5689880)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "21183079;21750661;24960159;25437563;31219806;34203471;34428180;36210013;36442624;39076972",
        "class_list": "",
        "function": "Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome (APC/C). In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with FBXW7 (FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBXW7) complex. Deubiquitinates ZNF304, hence preventing ZNF304 degradation by the proteasome and leading to the activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) in a subset of colorectal cancers (CRC) cells., [UniProtKB, UniProtKB]; Dual regulation of Fbw7 activity by Usp28 is a safeguard mechanism for maintaining physiological levels of proto-oncogenic Fbw7 substrates, which is equivalently disrupted by loss or overexpression of Usp28., [RefSeq, PubMed]; Identified Usp28 as a c-MYC target gene highly expressed in colorectal cancers, which indicates that USP28 and c-MYC form a positive feedback loop that maintains high c-MYC protein levels in tumors, [RefSeq, PubMed]; Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease., [RefSeq, PubMed]; USP28 protects development of inflammation in mouse intestine by regulating STAT5 phosphorylation and IL22 production in T lymphocytes. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6NZP3;Q6ZPP1;Q8BWI1",
        "ec_number_list": "3.4.19.12",
        "go_molecular_function": "GO:0004843 cysteine-type deubiquitinase activity;GO:0101005 deubiquitinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0016604 nuclear body;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006281 DNA repair;GO:0008283 cell population proliferation;GO:0016579 protein deubiquitination;GO:0006974 DNA damage response;GO:0042771 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q5I043-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BUM9-1",
        "uniprot_id": "UBP43_MOUSE",
        "mass": 123874.0,
        "length": 1132,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 43",
        "gene_name": "Usp43",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 43 isoform 2",
        "refseq_ac": "NP_001277978",
        "gene_names_uniprotkb": "Usp43",
        "gene_names_refseq": "Usp43",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 43; 3.4.19.12; Deubiquitinating enzyme 43; Ubiquitin thioesterase 43; Ubiquitin-specific-processing protease 43",
        "protein_names_refseq": "deubiquitinating enzyme 43; ubiquitin carboxyl-terminal hydrolase 43 isoform 2; ubiquitin carboxyl-terminal hydrolase 43; ubiquitin thioesterase 43; ubiquitin thiolesterase 43; ubiquitin-specific-processing protease 43",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:216835);  (R-MMU-5656169)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "21183079;21750661;24129315;34418053;35820727",
        "class_list": "",
        "function": "May recognize and hydrolyze the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of poly-ubiquitin precursors as well as that of ubiquitinated proteins (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8VDP5",
        "ec_number_list": "3.4.19.12",
        "go_molecular_function": "GO:0004843 cysteine-type deubiquitinase activity",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006508 proteolysis;GO:0016579 protein deubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q8BUM9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CC21-1",
        "uniprot_id": "TTC19_MOUSE",
        "mass": 41234.0,
        "length": 365,
        "protein_name": "Tetratricopeptide repeat protein 19, mitochondrial",
        "gene_name": "Ttc19",
        "organism": "Mouse",
        "refseq_name": "tetratricopeptide repeat protein 19, mitochondrial isoform 1",
        "refseq_ac": "NP_082636",
        "gene_names_uniprotkb": "Ttc19",
        "gene_names_refseq": "2010204O13Rik; 2810460C24Rik; Ttc19",
        "protein_names_uniprotkb": "Tetratricopeptide repeat protein 19, mitochondrial; TPR repeat protein 19",
        "protein_names_refseq": "TPR repeat protein 19; tetratricopeptide repeat protein 19, mitochondrial isoform 1; tetratricopeptide repeat protein 19, mitochondrial",
        "tax_id": 10090,
        "disease": "mitochondrial complex III deficiency nuclear type 2 (Disease Ontology:DOID:0060351)",
        "pathway": " (mmu:72795);  (R-MMU-9865881)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "19892989;21278747;21750661;22872234;25428506;28673544;30084848;30779550;34203471;34428180",
        "class_list": "",
        "function": "Required for the preservation of the structural and functional integrity of mitochondrial respiratory complex III by allowing the physiological turnover of the Rieske protein UQCRFS1 (PubMed:21278747, PubMed:28673544). Involved in the clearance of UQCRFS1 N-terminal fragments, which are produced upon incorporation into the complex III and whose presence is detrimental for its catalytic activity (PubMed:28673544)., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB]; UQCRFS1 produces N-terminal polypeptides, which remain bound to holocomplex III. We show that, in normal conditions, these UQCRFS1 fragments are rapidly removed, but when TTC19 is absent they accumulate within complex III, causing its structural and functional impairment., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5NCZ3;Q5NCZ4;Q8K1X2;Q8R0G6;Q9CYS5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane",
        "go_biological_process": "GO:0022904 respiratory electron transport chain;GO:0034551 mitochondrial respiratory chain complex III assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q8CC21-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JLV2-1",
        "uniprot_id": "TP4AP_MOUSE",
        "mass": 90727.0,
        "length": 797,
        "protein_name": "Short transient receptor potential channel 4-associated protein",
        "gene_name": "Trpc4ap",
        "organism": "Mouse",
        "refseq_name": "short transient receptor potential channel 4-associated protein isoform 1",
        "refseq_ac": "NP_001156924",
        "gene_names_uniprotkb": "Trpc4ap; Trrp4ap",
        "gene_names_refseq": "4833429F06Rik; D2Ertd113e; Trpc4ap; Trrp4ap; mFLJ00177; truss",
        "protein_names_uniprotkb": "Short transient receptor potential channel 4-associated protein; Protein TAP1; Protein TRUSS; Rabex-5/Rin2-interacting protein; TNF-receptor ubiquitous scaffolding/signaling protein; Trp4-associated protein; Trpc4-associated protein",
        "protein_names_refseq": "TNF-receptor ubiquitous scaffolding/signaling protein; Trp4-associated protein TAP1; rabex-5/Rin2-interacting protein; short transient receptor potential channel 4-associated protein isoform 1; short transient receptor potential channel 4-associated protein; transient receptor protein 4, associated protein; trpc4-associated protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56407);  (R-MMU-3295583)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "14585990;16876162;20458742;22872234;25428506;29704259;30084848;30765221;31219806;34428180",
        "class_list": "",
        "function": "Cloning and characterization of tumor necrosis factor receptor 1 (TNF-R1)-associated ubiquitous scaffolding and signaling protein (TRUSS), [RefSeq, PubMed]; Hepatocyte TRUSS promotes pathological stimuli-induced non alcoholic fatty liver disease and metabolic disorders, through activation of NF-kappaB by promoting ubiquitination and degradation of IkappaBalpha, [RefSeq, PubMed]; Substrate-recognition component of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex required for cell cycle control. The DCX(TRPC4AP) complex specifically mediates the polyubiquitination and subsequent degradation of MYC as part of the DesCEND (destruction via C-end degrons) pathway. The DesCEND (destruction via C-end degrons) pathway recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation. The DCX(TRPC4AP) complex specifically recognizes proteins with an arginine at the minus 3 position (R-3 motif) at the C-terminus, such as MYC, leading to their ubiquitination and degradation (By similarity). Also participates in the activation of NFKB1 in response to ligation of TNFRSF1A, possibly by linking TNFRSF1A to the IKK signalosome (PubMed:14585990). Involved in JNK activation via its interaction with TRAF2 (PubMed:16876162). Also involved in elevation of endoplasmic reticulum Ca(2+) storage reduction in response to CHRM1 (PubMed:20458742)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; TRUSS ablation alleviates high fat diet -induced cognitive impairments and metabolic disorder., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q920J6;Q99L03",
        "ec_number_list": "",
        "go_molecular_function": "GO:1990756 ubiquitin-like ligase-substrate adaptor activity;GO:0019902 phosphatase binding",
        "go_cellular_component": "GO:0031464 Cul4A-RING E3 ubiquitin ligase complex;GO:0005829 cytosol;GO:0048471 perinuclear region of cytoplasm;GO:0080008 Cul4-RING E3 ubiquitin ligase complex",
        "go_biological_process": "GO:0048820 hair follicle maturation;GO:0016567 protein ubiquitination;GO:0006511 ubiquitin-dependent protein catabolic process;GO:0140627 ubiquitin-dependent protein catabolic process via the C-end degron rule pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9JLV2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z2W1-1",
        "uniprot_id": "STK25_MOUSE",
        "mass": 48158.0,
        "length": 426,
        "protein_name": "Serine/threonine-protein kinase 25",
        "gene_name": "Stk25",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase 25",
        "refseq_ac": "NP_067512",
        "gene_names_uniprotkb": "Stk25; Sok1",
        "gene_names_refseq": "1500019J11Rik; Ste20-like; Stk25; Ysk1",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase 25; 2.7.11.1; SOK-1; Ste20-like kinase; Ste20/oxidant stress response kinase 1; Sterile 20/oxidant stress-response kinase 1",
        "protein_names_refseq": "SOK-1; Ste20-like kinase; Yeast Sps1/Ste20-related kinase 1; serine/threonine kinase 25 (Ste20, yeast homolog); serine/threonine-protein kinase 25; ste20/oxidant stress response kinase 1; sterile 20/oxidant stress-response kinase 1",
        "tax_id": 10090,
        "disease": "cerebral cavernous malformation (Disease Ontology:DOID:0060669)",
        "pathway": " (mmu:59041)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "21183079;21750661;30084848;30576769;30779550;34428180;35130716;35977512;36692953",
        "class_list": "",
        "function": "GCKIII (Germinal Center Kinase III) Kinases STK24 and STK25 (Serine/Threonine Kinase 24 and 25) Inhibit Cavernoma Development., [RefSeq, PubMed]; Oxidant stress-activated serine/threonine kinase that plays a role in metabolic homeostasis, neuronal polarization, cell migration, Golgi organization, apoptosis or innate immunity. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration. Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation. Functions as an inhibitor of the PKA pathway by affecting phosphorylation of the PRKAR1A regulatory subunit, which in turn suppresses the kinase activity of the catalytic subunit (PubMed:35977512). Positively regulates the TLR signaling by directly phosphorylating the transcription factor IRF5., [UniProtKB, UniProtKB, PubMed]; Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation. Publication Status: Online-Only, [RefSeq, PubMed]; STK25 inhibits PKA signaling by phosphorylating PRKAR1A., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6IR17",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0042803 protein homodimerization activity;GO:0046872 metal ion binding;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005737 cytoplasm;GO:0005794 Golgi apparatus;GO:0090443 FAR/SIN/STRIPAK complex",
        "go_biological_process": "GO:0006468 protein phosphorylation;GO:0035556 intracellular signal transduction;GO:0046777 protein autophosphorylation;GO:0034599 cellular response to oxidative stress;GO:0051683 establishment of Golgi localization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q9Z2W1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R0N7-1",
        "uniprot_id": "SYT7_MOUSE",
        "mass": 45472.0,
        "length": 403,
        "protein_name": "Synaptotagmin-7",
        "gene_name": "Syt7",
        "organism": "Mouse",
        "refseq_name": "synaptotagmin-7 isoform alpha",
        "refseq_ac": "NP_061271",
        "gene_names_uniprotkb": "Syt7",
        "gene_names_refseq": "B230112P13Rik; Syt7",
        "protein_names_uniprotkb": "Synaptotagmin-7; Synaptotagmin VII; SytVII",
        "protein_names_refseq": "synaptotagmin-7 isoform alpha; synaptotagmin-7; sytVII",
        "tax_id": 10090,
        "disease": "type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:54525)",
        "pathway_count": 1,
        "publication_count": 23,
        "publication_id_list": "10531343;10871604;11395007;12071850;12925704;16982801;17720139;18308938;18539119;19171650;20824061;20956309;21041449;21183079;21750661;22645316;24129315;24569478;25860611;26738595;30429473;34678516;39000085",
        "class_list": "",
        "function": "Ca(2+) sensor involved in Ca(2+)-dependent exocytosis of secretory and synaptic vesicles through Ca(2+) and phospholipid binding to the C2 domain. Ca(2+) induces binding of the C2-domains to phospholipid membranes and to assembled SNARE-complexes; both actions contribute to triggering exocytosis. SYT7 binds Ca(2+) with high affinity and slow kinetics compared to other synaptotagmins (PubMed:26738595). Involved in Ca(2+)-triggered lysosomal exocytosis, a major component of the plasma membrane repair (By similarity). Ca(2+)-regulated delivery of lysosomal membranes to the cell surface is also involved in the phagocytic uptake of particles by macrophages (PubMed:16982801, PubMed:21041449). Ca(2+)-triggered lysosomal exocytosis also plays a role in bone remodeling by regulating secretory pathways in osteoclasts and osteoblasts (PubMed:18539119). Involved in cholesterol transport from lysosome to peroxisome by promoting membrane contacts between lysosomes and peroxisomes: probably acts by promoting vesicle fusion by binding phosphatidylinositol-4,5-bisphosphate on peroxisomal membranes (PubMed:25860611). Acts as a key mediator of synaptic facilitation, a process also named short-term synaptic potentiation: synaptic facilitation takes place at synapses with a low initial release probability and is caused by influx of Ca(2+) into the axon terminal after spike generation, increasing the release probability of neurotransmitters (PubMed:24569478, PubMed:26738595). Probably mediates synaptic facilitation by directly increasing the probability of release (PubMed:26738595). May also contribute to synaptic facilitation by regulating synaptic vesicle replenishment, a process required to ensure that synaptic vesicles are ready for the arrival of the next action potential: SYT7 is required for synaptic vesicle replenishment by acting as a sensor for Ca(2+) and by forming a complex with calmodulin (PubMed:24569478). Also acts as a regulator of Ca(2+)-dependent insulin and glucagon secretion in beta-cells (PubMed:18308938, PubMed:19171650). Triggers exocytosis by promoting fusion pore opening and fusion pore expansion in chromaffin cells (PubMed:20956309). Also regulates the secretion of some non-synaptic secretory granules of specialized cells (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; Identified the conserved alternative splicing events in the spacer domain of Syt VII; also shown that Syt VIIa-GFP is mainly localized in the perinuclear region and tips of neurites (dense-core vesicles), and not in the plasma membrane, [RefSeq, PubMed]; Region-Related Differences in Short-Term Synaptic Plasticity and Synaptotagmin-7 in the Male and Female Hippocampus of a Rat Model of Fragile X Syndrome. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 5,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A4QPF1;E9PZA8;Q0D2K7;Q8CF95;Q8CF96",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005516 calmodulin binding;GO:0005546 phosphatidylinositol-4,5-bisphosphate binding;GO:0005509 calcium ion binding;GO:0019905 syntaxin binding;GO:0005544 calcium-dependent phospholipid binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0098982 GABA-ergic synapse;GO:0005777 peroxisome;GO:0005778 peroxisomal membrane;GO:0005829 cytosol",
        "go_biological_process": "GO:0001778 plasma membrane repair;GO:0006909 phagocytosis;GO:0014059 regulation of dopamine secretion;GO:0050796 regulation of insulin secretion;GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 2.6,
        "record_id": "Q9R0N7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60610-1",
        "uniprot_id": "TIAM1_MOUSE",
        "mass": 177533.0,
        "length": 1591,
        "protein_name": "Rho guanine nucleotide exchange factor TIAM1",
        "gene_name": "Tiam1",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Tiam1; Tiam-1",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Rho guanine nucleotide exchange factor TIAM1; T-lymphoma invasion and metastasis-inducing protein 1; TIAM-1",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "cataract 48 (Disease Ontology:DOID:0070354); neurodevelopmental disorder with language delay and seizures (Disease Ontology:DOID:0070444)",
        "pathway": " (mmu:21844);  (R-MMU-193648);  (R-MMU-3928662);  (R-MMU-3928665);  (R-MMU-416482);  (R-MMU-8980692);  (R-MMU-9013148);  (R-MMU-9013149);  (R-MMU-9013404);  (R-MMU-9013423);  (R-MMU-9958810)",
        "pathway_count": 11,
        "publication_count": 13,
        "publication_id_list": "11130063;15592455;16452087;16801538;17339315;17947660;19893486;20496116;21183079;21750661;31219806;34428180;7999144",
        "class_list": "",
        "function": "Guanyl-nucleotide exchange factor that activates RHO-like proteins and connects extracellular signals to cytoskeletal activities. Activates RAC1, CDC42, and to a lesser extent RHOA and their downstream signaling to regulate processes like cell adhesion and cell migration., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 7,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005543 phospholipid binding;GO:0008017 microtubule binding;GO:0046875 ephrin receptor binding;GO:0019900 kinase binding;GO:0005085 guanyl-nucleotide exchange factor activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0005874 microtubule;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0010717 regulation of epithelial to mesenchymal transition;GO:0008284 positive regulation of cell population proliferation;GO:0010976 positive regulation of neuron projection development;GO:0016477 cell migration;GO:0030335 positive regulation of cell migration",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q60610-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q69ZM6-1",
        "uniprot_id": "STK36_MOUSE",
        "mass": 144180.0,
        "length": 1316,
        "protein_name": "Serine/threonine-protein kinase 36",
        "gene_name": "Stk36",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase 36 isoform 1",
        "refseq_ac": "NP_778196",
        "gene_names_uniprotkb": "Stk36; Kiaa1278",
        "gene_names_refseq": "1700112N14Rik; B930045J24; FU; Fused; Stk36; mKIAA1278",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase 36; 2.7.11.1; Fused homolog",
        "protein_names_refseq": "fused homolog; serine/threonine kinase 36 (fused homolog, Drosophila); serine/threonine-protein kinase 36 isoform 1; serine/threonine-protein kinase 36",
        "tax_id": 10090,
        "disease": "hydrocephalus (Disease Ontology:DOID:10908); primary ciliary dyskinesia (Disease Ontology:DOID:9562)",
        "pathway": " (mmu:269209)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10806483;16055717;18600476;19305393;21750661;36989043;38096226",
        "class_list": "",
        "function": "Serine/threonine protein kinase which plays an important role in the smoothened pathway by regulating the activity of GLI transcription factors (PubMed:18600476, PubMed:38096226). Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization (PubMed:38096226). Acts by mediating phosphorylation of GLI proteins, promoting their dissociation from SUFU (PubMed:38096226). Also catalyzes phosphorylation of ULK4 adapter (By similarity). GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur (By similarity). Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function (PubMed:16055717). Essential for construction of the central pair apparatus of motile cilia (PubMed:19305393)., [UniProtKB, PubMed, PubMed, UniProtKB, PubMed, PubMed]; ULK4 and Fused/STK36 interact to mediate assembly of a motile flagellum., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6PDI0;Q80XQ6",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0046872 metal ion binding;GO:0001222 transcription corepressor binding;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005930 axoneme",
        "go_biological_process": "GO:0045880 positive regulation of smoothened signaling pathway;GO:0003351 epithelial cilium movement involved in extracellular fluid movement;GO:0007420 brain development;GO:0009791 post-embryonic development;GO:0060271 cilium assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q69ZM6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EQN3-1",
        "uniprot_id": "T22D4_MOUSE",
        "mass": 39979.0,
        "length": 387,
        "protein_name": "TSC22 domain family protein 4",
        "gene_name": "Tsc22d4",
        "organism": "Mouse",
        "refseq_name": "TSC22 domain family protein 4",
        "refseq_ac": "NP_076399",
        "gene_names_uniprotkb": "Tsc22d4; Thg1-pit",
        "gene_names_refseq": "0610009M14Rik; 1700023B23Rik; AI415410; Spacdr; Thg-1pit; Tilz2; Tsc22d4",
        "protein_names_uniprotkb": "TSC22 domain family protein 4; TSC22-related-inducible leucine zipper protein 2",
        "protein_names_refseq": "TSC22 domain family 4; TSC22 domain family protein 4; TSC22-related inducible leucine zipper 2; TSC22-related-inducible leucine zipper protein 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:78829)",
        "pathway_count": 1,
        "publication_count": 13,
        "publication_id_list": "10.1101/2023.09.13.557529;11707329;15895388;17147695;17690703;20878296;21183079;21750661;23305244;23307490;27827363;34428180;36269831",
        "class_list": "",
        "function": "Binds DNA and acts as a transcriptional repressor (PubMed:27827363). Involved in the regulation of systematic glucose homeostasis and insulin sensitivity, via transcriptional repression of downstream insulin signaling targets such as OBP2A/LCN13 (PubMed:27827363). Acts as a negative regulator of lipogenic gene expression in hepatocytes and thereby mediates the control of very low-density lipoprotein release (PubMed:23307490). May play a role in neurite elongation and survival (PubMed:20878296)., [UniProtKB, PubMed, PubMed, PubMed]; TSC-22 is a potential tumor suppressor that is upregulated by Flt3-D835V but not Flt3-ITD, [RefSeq, PubMed]; TSC22D4 interacts with Akt1 to regulate glucose metabolism., [RefSeq, PubMed]; TSC22D4 is stably upregulated by hyperosmolality in mIMCD3 cells and increased in renal papilla compared with cortex., [RefSeq, PubMed]; Thg-1 pit is relevant to specification, proliferation/migration, differentiation, and mature function of granule/interneuron cells in different brain districts [Thg-1 pit], [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 12,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q99PD5;Q9D2V9",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0030425 dendrite;GO:0045202 synapse",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0006970 response to osmotic stress;GO:0070050 neuron cellular homeostasis;GO:0042593 glucose homeostasis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q9EQN3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D6K5-1",
        "uniprot_id": "SYJ2B_MOUSE",
        "mass": 15815.0,
        "length": 145,
        "protein_name": "Synaptojanin-2-binding protein",
        "gene_name": "S2bpcox16; Synj2bp",
        "organism": "Mouse",
        "refseq_name": "synaptojanin-2-binding protein isoform 2",
        "refseq_ac": "NP_001296743",
        "gene_names_uniprotkb": "S2bpcox16; Synj2bp; Arip2; Omp25; Synj2bp",
        "gene_names_refseq": "ARIP2; ActRIP4; D12Wsu118e; OMP25; Synj2bp",
        "protein_names_uniprotkb": "Synaptojanin-2-binding protein; Activin receptor-interacting protein 2; Activin receptor-interacting protein 4; Mitochondrial outer membrane protein 25",
        "protein_names_refseq": "activin receptor interacting protein 2; activin receptor-interacting protein 4; mitochondrial outer membrane protein 25; outer membrane protein 25; synaptojanin-2-binding protein isoform 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:105940408);  (mmu:24071)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;11882656;15451561;16648306;17907296;21750661;34428180;36457006",
        "class_list": "",
        "function": "Expression of Synj2bp in mouse liver regulates the extent of wrappER-mitochondria contact to maintain hepatic lipid homeostasis. Publication Status: Online-Only, [RefSeq, PubMed]; Isoform 1 regulates endocytosis of activin type 2 receptor kinases through the Ral/RALBP1-dependent pathway and may be involved in suppression of activin-induced signal transduction. Isoform 2 and isoform 3 show a stimulatory affect on activin-induced signal transduction and enhance activin type 2 expression at the cell surface., [UniProtKB, PubMed, PubMed]; Overexpression of ARIP2 enhances endocytosis of ActRIIAs; data indicate that ARIP2 is a novel factor regulating cell surface ActRIIA expression and activin function., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9409,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q2TTN6;Q6YNE6;Q78HT9;Q8K4F3;Q9D8G4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0070699 type II activin receptor binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0009986 cell surface;GO:0048471 perinuclear region of cytoplasm;GO:0005743 mitochondrial inner membrane",
        "go_biological_process": "GO:0006897 endocytosis;GO:0030100 regulation of endocytosis;GO:2000010 positive regulation of protein localization to cell surface;GO:0006605 protein targeting;GO:0007266 Rho protein signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9D6K5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QZ47-1",
        "uniprot_id": "TNNT3_MOUSE",
        "mass": 32241.0,
        "length": 272,
        "protein_name": "Troponin T, fast skeletal muscle",
        "gene_name": "Tnnt3",
        "organism": "Mouse",
        "refseq_name": "troponin T, fast skeletal muscle isoform 2",
        "refseq_ac": "NP_001157137",
        "gene_names_uniprotkb": "Tnnt3",
        "gene_names_refseq": "Tnnt3; fTnT",
        "protein_names_uniprotkb": "Troponin T, fast skeletal muscle; Fast skeletal muscle troponin T; TnTf; fTnT",
        "protein_names_refseq": "fast skeletal muscle troponin T3; skeletal muscle fast-twitch TnT; tnTf; troponin T, fast skeletal muscle isoform 2; troponin T, fast skeletal muscle",
        "tax_id": 10090,
        "disease": "cardiomyopathy (Disease Ontology:DOID:0050700); intrinsic cardiomyopathy (Disease Ontology:DOID:0060036); distal arthrogryposis type 2B (Disease Ontology:DOID:0111599); distal arthrogryposis type 2B2 (Disease Ontology:DOID:0111601); nemaline myopathy (Disease Ontology:DOID:3191)",
        "pathway": " (mmu:21957);  (R-MMU-390522)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "21183079;21750661;39927985;9107680;9249073",
        "class_list": "",
        "function": "Troponin T is the tropomyosin-binding subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2A6H7;A2A6H8;A2A6H9;A2A6I1;A2A6I2;A2A6I4;A2A6I6;A2A6I7;A2A6I9;O35575;O35576;O35577;O35578;O35579;O35580;O35581;O35582;O35583;O35584;O35585;P97456;Q99L89;Q9QZ46",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030172 troponin C binding;GO:0048306 calcium-dependent protein binding;GO:0005523 tropomyosin binding;GO:0031013 troponin I binding;GO:0003779 actin binding",
        "go_cellular_component": "GO:0005861 troponin complex",
        "go_biological_process": "GO:0003009 skeletal muscle contraction;GO:0045214 sarcomere organization;GO:0006942 regulation of striated muscle contraction;GO:0043462 regulation of ATP-dependent activity;GO:1903612 positive regulation of calcium-dependent ATPase activity",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9QZ47-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "F7ACM4-1",
        "uniprot_id": "F7ACM4_MOUSE",
        "mass": 28441.0,
        "length": 249,
        "protein_name": "Predicted gene 14296; RIKEN cDNA 2210418O10 gene",
        "gene_name": "2210418O10Rik; Gm14296; Gm14393",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "2210418O10Rik; Gm14296; Gm14393; 2210418O10Rik; Gm14296",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Predicted gene 14296; RIKEN cDNA 2210418O10 gene",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100504263);  (mmu:102639598);  (mmu:664987)",
        "pathway_count": 3,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006355 regulation of DNA-templated transcription;GO:0006351 DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "F7ACM4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P29037-1",
        "uniprot_id": "TBP_MOUSE",
        "mass": 34709.0,
        "length": 316,
        "protein_name": "TATA-box-binding protein",
        "gene_name": "Tbp",
        "organism": "Mouse",
        "refseq_name": "TATA-box-binding protein",
        "refseq_ac": "NP_038712",
        "gene_names_uniprotkb": "Tbp; Tfiid",
        "gene_names_refseq": "GTF2D1; Gtf2d; SCA17; TFIID; Tbp",
        "protein_names_uniprotkb": "TATA-box-binding protein; TATA sequence-binding protein; TATA-binding factor; TATA-box factor; Transcription initiation factor TFIID TBP subunit",
        "protein_names_refseq": "TATA sequence-binding protein; TATA-binding factor; TATA-binding protein; TATA-box factor; TATA-box-binding protein; TFIID core protein; transcription initiation factor TFIID TBP subunit",
        "tax_id": 10090,
        "disease": "sleep apnea (Disease Ontology:DOID:0050847); spinocerebellar ataxia 17 (Disease Ontology:DOID:0050967); late onset Parkinson's disease (Disease Ontology:DOID:0060892); Alzheimer's disease (Disease Ontology:DOID:10652); Huntington's disease (Disease Ontology:DOID:12858); neurodegenerative disease (Disease Ontology:DOID:1289); schizophrenia (Disease Ontology:DOID:5419); type 1 diabetes mellitus (Disease Ontology:DOID:9744)",
        "pathway": " (mmu:21374);  (R-MMU-5250924);  (R-MMU-674695);  (R-MMU-6804756);  (R-MMU-6807505);  (R-MMU-73762);  (R-MMU-73772);  (R-MMU-73776);  (R-MMU-73779);  (R-MMU-73863);  (R-MMU-75953);  (R-MMU-76042);  (R-MMU-76061);  (R-MMU-76066);  (R-MMU-76071);  (R-MMU-9018519)",
        "pathway_count": 16,
        "publication_count": 16,
        "publication_id_list": "10215616;10593900;14612417;16412700;1861978;21750661;26961175;36995326;38861834;39352809;40128797;8332475;8769130;9050847;9286694;9524124",
        "class_list": "glycogene",
        "function": "General transcription factor that functions at the core of the DNA-binding multiprotein factor TFIID. Binding of TFIID to the TATA box is the initial transcriptional step of the pre-initiation complex (PIC), playing a role in the activation of eukaryotic genes transcribed by RNA polymerase II. Component of a BRF2-containing transcription factor complex that regulates transcription mediated by RNA polymerase III. Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (pre-initiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1 with the rDNA promoter. SL1 is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA., [UniProtKB, UniProtKB]; RNA Polymerase II transcription independent of TBP in murine embryonic stem cells. Publication Status: Online-Only, [RefSeq, PubMed]; RNA polymerase II transcription initiation in holo-TFIID-depleted mouse embryonic stem cells., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 16,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 8,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O09169;Q80UL8;Q8C3S1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001093 TFIIB-class transcription factor binding;GO:0003677 DNA binding;GO:0019899 enzyme binding;GO:0017162 aryl hydrocarbon receptor binding;GO:0000976 transcription cis-regulatory region binding",
        "go_cellular_component": "GO:0005668 RNA polymerase transcription factor SL1 complex;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0060261 positive regulation of transcription initiation by RNA polymerase II;GO:0006355 regulation of DNA-templated transcription;GO:0045893 positive regulation of DNA-templated transcription;GO:0006366 transcription by RNA polymerase II;GO:0045945 positive regulation of transcription by RNA polymerase III",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "P29037-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P80318-1",
        "uniprot_id": "TCPG_MOUSE",
        "mass": 60630.0,
        "length": 545,
        "protein_name": "T-complex protein 1 subunit gamma",
        "gene_name": "Cct3",
        "organism": "Mouse",
        "refseq_name": "T-complex protein 1 subunit gamma",
        "refseq_ac": "NP_033966",
        "gene_names_uniprotkb": "Cct3; Cctg",
        "gene_names_refseq": "Cct3; Cctg; Tcp1-rs3; TriC-P5",
        "protein_names_uniprotkb": "T-complex protein 1 subunit gamma; 3.6.1.-; CCT-gamma; Matricin; TCP-1-gamma; mTRiC-P5",
        "protein_names_refseq": "CCT-gamma; T-complex protein 1 subunit gamma; TCP-1-gamma; chaperonin containing Tcp1, subunit 3 (gamma); chaperonin subunit 3 (gamma); matricin",
        "tax_id": 10090,
        "disease": "intrinsic cardiomyopathy (Disease Ontology:DOID:0060036)",
        "pathway": " (mmu:12462);  (R-MMU-390471);  (R-MMU-5620922);  (R-MMU-6814122)",
        "pathway_count": 4,
        "publication_count": 19,
        "publication_id_list": "10.1101/2023.09.13.557529;12083524;21183079;21750661;23872636;25428506;30084848;30779550;33300544;34203471;34428180;34887587;35820727;37453647;37507081;37828378;39627609;7953530;8110840",
        "class_list": "",
        "function": "Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of actin, tubulin and other proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 8,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.6.4.13;3.6.4.10;3.6.4.-;5.6.2.3;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;7.6.2.1;3.6.1.5;3.4.24.-;3.6.-.-;3.1.3.1;3.9.1.1;3.6.1.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;3.6.4.6;3.6.5.-;3.6.1.15;3.1.4.-;5.6.2.-;7.2.2.-;7.6.2.16;3.4.21.53;2.7.7.7;2.7.7.49;2.7.1.91;2.3.1.-;2.7.11.1;2.7.4.3",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0046872 metal ion binding;GO:0051082 unfolded protein binding;GO:0016887 ATP hydrolysis activity;GO:0044183 protein folding chaperone",
        "go_cellular_component": "GO:0005874 microtubule;GO:0043209 myelin sheath;GO:0044297 cell body;GO:0005832 chaperonin-containing T-complex;GO:0002199 zona pellucida receptor complex",
        "go_biological_process": "GO:0007339 binding of sperm to zona pellucida;GO:0032212 positive regulation of telomere maintenance via telomerase;GO:0050821 protein stabilization;GO:0006457 protein folding",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "P80318-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P80315-1",
        "uniprot_id": "TCPD_MOUSE",
        "mass": 58066.0,
        "length": 539,
        "protein_name": "T-complex protein 1 subunit delta",
        "gene_name": "Cct4",
        "organism": "Mouse",
        "refseq_name": "T-complex protein 1 subunit delta",
        "refseq_ac": "NP_033967",
        "gene_names_uniprotkb": "Cct4; Cctd",
        "gene_names_refseq": "2610204B21Rik; A45; Cct4; Cctd",
        "protein_names_uniprotkb": "T-complex protein 1 subunit delta; 3.6.1.-; A45; CCT-delta; TCP-1-delta",
        "protein_names_refseq": "CCT-delta; T complex protein 1, delta; T-complex protein 1 subunit delta; TCP-1-delta; chaperonin containing Tcp1, subunit 4 (delta); chaperonin subunit 4 (delta)",
        "tax_id": 10090,
        "disease": "hereditary sensory and autonomic neuropathy (Disease Ontology:DOID:0050548); intrinsic cardiomyopathy (Disease Ontology:DOID:0060036)",
        "pathway": " (mmu:12464);  (R-MMU-390471);  (R-MMU-5620922);  (R-MMU-6814122)",
        "pathway_count": 4,
        "publication_count": 24,
        "publication_id_list": "10336634;21750661;23806337;23807208;23872636;25428506;26740625;30084848;30779550;31219806;33300544;33725478;34203471;34428180;34655026;34887587;36288343;37453647;37507081;37828378;39627609;39927985;7919332;7953530",
        "class_list": "",
        "function": "Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of actin, tubulin and other proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Functional assessment of the V390F mutation in the CCTdelta subunit of chaperonin containing tailless complex polypeptide 1., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.6.4.13;3.6.4.10;3.6.4.-;5.6.2.3;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;7.6.2.1;3.6.1.5;3.4.24.-;3.6.-.-;3.1.3.1;3.9.1.1;3.6.1.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;3.6.4.6;3.6.5.-;3.6.1.15;3.1.4.-;5.6.2.-;7.2.2.-;7.6.2.16;3.4.21.53;2.7.7.7;2.7.7.49;2.7.1.91;2.3.1.-;2.7.11.1;2.7.4.3",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0046872 metal ion binding;GO:0051082 unfolded protein binding;GO:0016887 ATP hydrolysis activity;GO:0044183 protein folding chaperone",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005813 centrosome;GO:0005829 cytosol;GO:0005874 microtubule;GO:0042470 melanosome",
        "go_biological_process": "GO:0090666 scaRNA localization to Cajal body;GO:0007339 binding of sperm to zona pellucida;GO:0032212 positive regulation of telomere maintenance via telomerase;GO:0050821 protein stabilization;GO:0006457 protein folding",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "P80315-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "D3YX67-1",
        "uniprot_id": "D3YX67_MOUSE",
        "mass": 47150.0,
        "length": 415,
        "protein_name": "RIKEN cDNA 1700017N19 gene",
        "gene_name": "1700017N19Rik",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein C12orf50 homolog",
        "refseq_ac": "NP_001074715",
        "gene_names_uniprotkb": "1700017N19Rik",
        "gene_names_refseq": "1700017N19Rik; Zc3h11d",
        "protein_names_uniprotkb": "RIKEN cDNA 1700017N19 gene",
        "protein_names_refseq": "uncharacterized protein C12orf50 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66605)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0003729 mRNA binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0016973 poly(A)+ mRNA export from nucleus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "D3YX67-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q921F2-1",
        "uniprot_id": "TADBP_MOUSE",
        "mass": 44548.0,
        "length": 414,
        "protein_name": "TAR DNA-binding protein 43",
        "gene_name": "Tardbp",
        "organism": "Mouse",
        "refseq_name": "TAR DNA-binding protein 43 isoform 3",
        "refseq_ac": "NP_001003899",
        "gene_names_uniprotkb": "Tardbp; Tdp43",
        "gene_names_refseq": "1190002A23Rik; TDP-43; Tardbp; Tdp43",
        "protein_names_uniprotkb": "TAR DNA-binding protein 43; TDP-43",
        "protein_names_refseq": "TAR DNA-binding protein 43 isoform 3; TAR DNA-binding protein 43",
        "tax_id": 10090,
        "disease": "obstructive sleep apnea (Disease Ontology:DOID:0050848); amyotrophic lateral sclerosis type 10 (Disease Ontology:DOID:0060201); frontotemporal dementia 2 (Disease Ontology:DOID:0060672); Alzheimer's disease (Disease Ontology:DOID:10652); Pick's disease (Disease Ontology:DOID:11870); Lewy body dementia (Disease Ontology:DOID:12217); neurodegenerative disease (Disease Ontology:DOID:1289); Parkinson's disease (Disease Ontology:DOID:14330); motor neuron disease (Disease Ontology:DOID:231); amyotrophic lateral sclerosis (Disease Ontology:DOID:332); progressive supranuclear palsy (Disease Ontology:DOID:678); frontotemporal dementia (Disease Ontology:DOID:9255)",
        "pathway": " (mmu:230908)",
        "pathway_count": 1,
        "publication_count": 28,
        "publication_id_list": "19174564;21183079;21750661;22198567;22570411;22645316;23449777;23666556;24129315;24788674;25153642;25428506;25605945;25678563;26102026;27123980;28409281;29125738;30464263;32081878;32562018;33228809;33649389;34428180;35820727;37453647;37507081;39627609",
        "class_list": "",
        "function": "RNA-binding protein that is involved in various steps of RNA biogenesis and processing. Preferentially binds, via its two RNA recognition motifs RRM1 and RRM2, to GU-repeats on RNA molecules predominantly localized within long introns and in the 3'UTR of mRNAs. In turn, regulates the splicing of many non-coding and protein-coding RNAs including proteins involved in neuronal survival, as well as mRNAs that encode proteins relevant for neurodegenerative diseases. Plays a role in maintaining mitochondrial homeostasis by regulating the processing of mitochondrial transcripts. Also regulates mRNA stability by recruiting CNOT7/CAF1 deadenylase on mRNA 3'UTR leading to poly(A) tail deadenylation and thus shortening. In response to oxidative insult, associates with stalled ribosomes localized to stress granules (SGs) and contributes to cell survival (By similarity). Also participates in the normal skeletal muscle formation and regeneration, forming cytoplasmic myo-granules and binding mRNAs that encode sarcomeric proteins (PubMed:30464263). Plays a role in the maintenance of the circadian clock periodicity via stabilization of the CRY1 and CRY2 proteins in a FBXL3-dependent manner (PubMed:27123980). Negatively regulates the expression of CDK6 (By similarity). Regulates the expression of HDAC6, ATG7 and VCP in a PPIA/CYPA-dependent manner (PubMed:25678563)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 12,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U591;Q3V0E7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0097157 pre-mRNA intronic binding;GO:0003677 DNA binding;GO:0003723 RNA binding;GO:0042802 identical protein binding;GO:0008289 lipid binding",
        "go_cellular_component": "GO:0005726 perichromatin fibrils;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0016607 nuclear speck",
        "go_biological_process": "GO:0042307 positive regulation of protein import into nucleus;GO:0006351 DNA-templated transcription;GO:0006397 mRNA processing;GO:0010629 negative regulation of gene expression;GO:0032024 positive regulation of insulin secretion",
        "synthesized_glycan_count": 0,
        "hit_score": 3.1,
        "record_id": "Q921F2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99MR6-1",
        "uniprot_id": "SRRT_MOUSE",
        "mass": 100452.0,
        "length": 875,
        "protein_name": "Serrate RNA effector molecule homolog",
        "gene_name": "Srrt",
        "organism": "Mouse",
        "refseq_name": "serrate RNA effector molecule homolog isoform 2",
        "refseq_ac": "NP_001103379",
        "gene_names_uniprotkb": "Srrt; Ars2; Asr2",
        "gene_names_refseq": "2810019G02Rik; ASR2A; ASR2B; ASR2C; ASR2D; Ars2; Asr2; Srrt",
        "protein_names_uniprotkb": "Serrate RNA effector molecule homolog; Arsenite-resistance protein 2",
        "protein_names_refseq": "arsenate resistance protein 2; arsenite-resistance protein 2; serrate RNA effector molecule homolog isoform 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:83701);  (R-MMU-6807505);  (R-MMU-72163);  (R-MMU-9770562);  (R-MMU-9930044)",
        "pathway_count": 5,
        "publication_count": 18,
        "publication_id_list": "11239002;15345747;18086880;19131326;19632182;21183079;21750661;22198669;22645316;25428506;25605945;26303529;30673303;31219806;31969356;34428180;34887587;39627609",
        "class_list": "",
        "function": "ARS2 plays a central role in RNA recognition and processing through multiple protein and RNA interactions., [RefSeq, PubMed]; Acts as a mediator between the cap-binding complex (CBC) and the primary microRNAs (miRNAs) processing machinery during cell proliferation. Contributes to the stability and delivery of capped primary miRNA transcripts to the primary miRNA processing complex containing DGCR8 and DROSHA, thereby playing a role in RNA-mediated gene silencing (RNAi) by miRNAs. Binds capped RNAs (m7GpppG-capped RNA); however interaction is probably mediated via its interaction with NCBP1/CBP80 component of the CBC complex. Involved in cell cycle progression at S phase. Does not directly confer arsenite resistance but rather modulates arsenic sensitivity. Independently of its activity on miRNAs, necessary and sufficient to promote neural stem cell self-renewal. Does so by directly binding SOX2 promoter and positively regulating its transcription., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB]; Ars2 is an essential neural regulator that interacts dynamically with DNA and controls neural lineage development. Publication Status: Online-Only, [RefSeq, PubMed]; Findings reveal Ars2 as a new transcription factor that controls the multipotent progenitor state of NSCs through direct activation of the pluripotency factor Sox2 Publication Status: Online-Only, [RefSeq, PubMed]; The Arsenic-resistance protein 2 (ARS2, also known as SRRT) is a component of the nuclear cap-binding complex involved in RNA Polymerase II transcription, and is required for cell cycle progression., [RefSeq, PubMed]; These data indicate ARS2 is essential for early mammalian development and is likely involved in an essential cellular process., [RefSeq, PubMed]; These findings provide evidence for a role for Ars2 in RNA interference regulation during cell proliferation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 11,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UD04;Q5D042;Q8VEE6;Q99MR4;Q99MR5;Q99MR7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0030674 protein-macromolecule adaptor activity;GO:0140262 mRNA cap binding complex binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0016604 nuclear body;GO:0032991 protein-containing complex;GO:1990904 ribonucleoprotein complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006355 regulation of DNA-templated transcription;GO:0097150 neuronal stem cell population maintenance;GO:0050769 positive regulation of neurogenesis;GO:0031053 primary miRNA processing",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "Q99MR6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A0J9YV76-1",
        "uniprot_id": "A0A0J9YV76_MOUSE",
        "mass": 45299.0,
        "length": 386,
        "protein_name": "2'-5' oligoadenylate synthetase 1E",
        "gene_name": "Oas1e",
        "organism": "Mouse",
        "refseq_name": "2'-5' oligoadenylate synthetase 1E isoform 1",
        "refseq_ac": "NP_001334379",
        "gene_names_uniprotkb": "Oas1e",
        "gene_names_refseq": "Oas1e; oasl7",
        "protein_names_uniprotkb": "2'-5' oligoadenylate synthetase 1E",
        "protein_names_refseq": "2'-5' oligoadenylate synthetase 1E isoform 1; 2'-5' oligoadenylate synthetase-like 7; 2'-5'olygoadenylate synthetase 1E; 2,5-oligoadenylate synthetase-like 7",
        "tax_id": 10090,
        "disease": "immunodeficiency 100 (Disease Ontology:DOID:0061070)",
        "pathway": " (mmu:231699)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003725 double-stranded RNA binding;GO:0001730 2'-5'-oligoadenylate synthetase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol",
        "go_biological_process": "GO:0071360 cellular response to exogenous dsRNA;GO:0070106 interleukin-27-mediated signaling pathway;GO:2000342 negative regulation of chemokine (C-X-C motif) ligand 2 production;GO:0035457 cellular response to interferon-alpha;GO:0043129 surfactant homeostasis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A0J9YV76-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5SW75-1",
        "uniprot_id": "SSH2_MOUSE",
        "mass": 158230.0,
        "length": 1423,
        "protein_name": "Protein phosphatase Slingshot homolog 2",
        "gene_name": "Ssh2",
        "organism": "Mouse",
        "refseq_name": "protein phosphatase Slingshot homolog 2 isoform 2",
        "refseq_ac": "NP_001278119",
        "gene_names_uniprotkb": "Ssh2; Kiaa1725; Ssh2l",
        "gene_names_refseq": "SSH-2L; SSH-2; Ssh2; mSSH-2L",
        "protein_names_uniprotkb": "Protein phosphatase Slingshot homolog 2; 3.1.3.16; 3.1.3.48; SSH-2L; SSH-like protein 2; mSSH-2L",
        "protein_names_refseq": "SSH-like protein 2; protein phosphatase Slingshot homolog 2 isoform 2; protein phosphatase Slingshot homolog 2; slingshot 2L; slingshot homolog 2; slingshot-like 2",
        "tax_id": 10090,
        "disease": "alcohol use disorder (Disease Ontology:DOID:1574)",
        "pathway": " (mmu:237860)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "14531860;15345747;21183079;21750661;22172670;34203471;34428180;36210013;36942942",
        "class_list": "",
        "function": "A PLCbeta/PI3Kgamma-GSK3 signaling pathway regulates cofilin phosphatase slingshot2 and neutrophil polarization and chemotaxis., [RefSeq, PubMed]; Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein (PubMed:14531860). Required for spermatogenesis (PubMed:36942942). Involved in acrosome biogenesis, probably by regulating cofilin-mediated actin cytoskeleton remodeling during proacrosomal vesicle fusion and/or Golgi to perinuclear vesicle trafficking (PubMed:36942942)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 10,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B9EJ94;Q3TDK8;Q3TYP8;Q3U2K3;Q5F268;Q5SW74;Q69ZC3;Q76I78",
        "ec_number_list": "3.1.3.48;3.1.3.2;3.1.3.67;3.1.3.-;3.1.3.16;3.1.3.74;3.1.3.53;3.1.3.27;3.1.3.52;3.1.3.5;3.1.3.21;3.1.3.18;3.1.3.86;3.1.3.36",
        "go_molecular_function": "GO:0003779 actin binding;GO:0004722 protein serine/threonine phosphatase activity;GO:0004721 phosphoprotein phosphatase activity;GO:0004725 protein tyrosine phosphatase activity;GO:0016791 phosphatase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005856 cytoskeleton;GO:0005925 focal adhesion;GO:0001669 acrosomal vesicle",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0030154 cell differentiation;GO:0030335 positive regulation of cell migration;GO:0030036 actin cytoskeleton organization;GO:0006470 protein dephosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q5SW75-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35638-1",
        "uniprot_id": "STAG2_MOUSE",
        "mass": 141281.0,
        "length": 1231,
        "protein_name": "Cohesin subunit SA-2",
        "gene_name": "Stag2",
        "organism": "Mouse",
        "refseq_name": "cohesin subunit SA-2 isoform 1",
        "refseq_ac": "NP_001071180",
        "gene_names_uniprotkb": "Stag2; Sa2; Sap2",
        "gene_names_refseq": "9230105L23Rik; B230112I07Rik; SA-2; SAP2; Stag2",
        "protein_names_uniprotkb": "Cohesin subunit SA-2; SCC3 homolog 2; Stromal antigen 2",
        "protein_names_refseq": "SCC3 homolog 2; cohesin subunit SA-2 isoform 1; cohesin subunit SA-2; nuclear protein SA2; stromal antigen 2",
        "tax_id": 10090,
        "disease": "Holoprosencephaly 13, X-linked (Disease Ontology:DOID:0060954); Mullegama-Klein-Martinez syndrome (Disease Ontology:DOID:0111845)",
        "pathway": " (mmu:20843);  (R-MMU-2467813);  (R-MMU-2468052);  (R-MMU-2470946);  (R-MMU-2500257);  (R-MMU-3108214)",
        "pathway_count": 6,
        "publication_count": 10,
        "publication_id_list": "12034751;17242355;21183079;21750661;25428506;30084848;34428180;35959892;37479689;39627609",
        "class_list": "",
        "function": "A cohesin complex containing Rad21 and STAG2 cooperates with a STAG3-specific complex to maintain sister chromatid cohesion during the diplotene stage of meiosis, [RefSeq, PubMed]; Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis (By similarity)., [UniProtKB, UniProtKB, UniProtKB]; STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells. Publication Status: Online-Only, [RefSeq, PubMed]; STAG2 promotes the myelination transcriptional program in oligodendrocytes. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AFF5;Q6NZN7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003682 chromatin binding",
        "go_cellular_component": "GO:0030892 mitotic cohesin complex;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0001650 fibrillar center",
        "go_biological_process": "GO:0051301 cell division;GO:0090307 mitotic spindle assembly;GO:0019827 stem cell population maintenance;GO:0051321 meiotic cell cycle;GO:0007062 sister chromatid cohesion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "O35638-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60988-1",
        "uniprot_id": "STIL_MOUSE",
        "mass": 138730.0,
        "length": 1262,
        "protein_name": "SCL-interrupting locus protein homolog",
        "gene_name": "Stil",
        "organism": "Mouse",
        "refseq_name": "SCL-interrupting locus protein homolog isoform 1",
        "refseq_ac": "NP_033211",
        "gene_names_uniprotkb": "Stil; Sil",
        "gene_names_refseq": "Sil; Stil",
        "protein_names_uniprotkb": "SCL-interrupting locus protein homolog",
        "protein_names_refseq": "SCL-interrupting locus protein homolog isoform 1; SCL-interrupting locus protein homolog; Tal1 interrupting locus",
        "tax_id": 10090,
        "disease": "primary autosomal recessive microcephaly 7 (Disease Ontology:DOID:0070278); microcephaly (Disease Ontology:DOID:10907)",
        "pathway": " (mmu:20460)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10385121;11156618;11668681;16024801;1922059;21245198;21750661;25486474;39466849;8825637",
        "class_list": "",
        "function": "Immediate-early gene. Plays an important role in embryonic development as well as in cellular growth and proliferation; its long-term silencing affects cell survival and cell cycle distribution as well as decreases CDK1 activity correlated with reduced phosphorylation of CDK1. Plays a role as a positive regulator of the sonic hedgehog pathway, acting downstream of PTCH1. Plays an important role in the regulation of centriole duplication. Required for the onset of procentriole formation and proper mitotic progression. During procentriole formation, is essential for the correct loading of SASS6 and CPAP to the base of the procentriole to initiate procentriole assembly (By similarity). In complex with STIL acts as a modulator of PLK4-driven cytoskeletal rearrangements and directional cell motility (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB, PubMed]; STIL overexpression shortens lifespan and reduces tumor formation in mice. Publication Status: Online-Only, [RefSeq, PubMed]; STIL(-/-) mouse embryos do not contain centrioles or primary cilia, suggesting that these organelles are not essential for mammalian development until mid gestation., [RefSeq, PubMed]; Stil protein regulates centrosome integrity and mitosis through suppression of Chfr., [RefSeq, PubMed]; This gene encodes a centrosomal protein ubiquitously expressed in proliferating cells and during early embryonic development. Mice lacking the encoded protein die in utero with marked growth retardation, defects in the developing neural fold and randomization of left-right asymmetry. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Feb 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 7,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AD39;Q80VK7;Q8C7U6;Q8CEL7;Q99KL4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005813 centrosome;GO:0005829 cytosol;GO:0005938 cell cortex",
        "go_biological_process": "GO:0046601 positive regulation of centriole replication;GO:0000578 embryonic axis specification;GO:1905832 positive regulation of spindle assembly;GO:0001701 in utero embryonic development;GO:0030900 forebrain development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q60988-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WUM5-1",
        "uniprot_id": "SUCA_MOUSE",
        "mass": 36155.0,
        "length": 346,
        "protein_name": "Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial",
        "gene_name": "Suclg1",
        "organism": "Mouse",
        "refseq_name": "succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial precursor",
        "refseq_ac": "NP_063932",
        "gene_names_uniprotkb": "Suclg1",
        "gene_names_refseq": "1500000I01Rik; Sucla1; Suclg1",
        "protein_names_uniprotkb": "Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial; 6.2.1.-; 6.2.1.4; 6.2.1.5; 6.2.1.9; Itaconyl--CoA ligase [ADP/GDP-forming] subunit alpha; Malyl--CoA ligase [ADP/GDP-forming] subunit alpha; SCS-alpha; Succinyl-CoA synthetase subunit alpha",
        "protein_names_refseq": "SCS-alpha; itaconyl--CoA ligase [ADP/GDP-forming] subunit alpha; malyl--CoA ligase [ADP/GDP-forming] subunit alpha; succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial precursor; succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial; succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial; succinyl-CoA ligase [GDP-forming] subunit alpha, mitochondrial; succinyl-CoA synthetase subunit alpha",
        "tax_id": 10090,
        "disease": "mitochondrial DNA depletion syndrome 9 (Disease Ontology:DOID:0080128)",
        "pathway": " (mmu:56451);  (R-MMU-71403)",
        "pathway_count": 2,
        "publication_count": 15,
        "publication_id_list": "15234968;21750661;23576753;23806337;30084848;31219806;33300544;34428180;36210013;36288343;37453647;37507081;37828378;38649537;39927985",
        "class_list": "",
        "function": "ADP and GDP succinyl-CoA synthetases have different expression patterns and specificity, [RefSeq, PubMed]; SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression., [RefSeq, PubMed]; Succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of either ATP or GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The alpha subunit of the enzyme binds the substrates coenzyme A and phosphate, while succinate binding and specificity for either ATP or GTP is provided by different beta subunits. Also able to act as an itaconyl- and malyl-CoA synthetase., [UniProtKB, HAMAP]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C2C3;Q9DBA3;Q9DCI8",
        "ec_number_list": "6.2.1.-;6.2.1.4;6.2.1.5;6.2.1.9",
        "go_molecular_function": "GO:0044877 protein-containing complex binding;GO:0019003 GDP binding;GO:0004775 succinate-CoA ligase (ADP-forming) activity;GO:0004776 succinate-CoA ligase (GDP-forming) activity;GO:0050074 malate-CoA ligase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005759 mitochondrial matrix;GO:0032991 protein-containing complex;GO:1902494 catalytic complex",
        "go_biological_process": "GO:0006099 tricarboxylic acid cycle;GO:0006104 succinyl-CoA metabolic process;GO:0006105 succinate metabolic process;GO:0006108 malate metabolic process;GO:0110052 toxic metabolite repair",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q9WUM5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q704Y3-1",
        "uniprot_id": "TRPV1_MOUSE",
        "mass": 94976.0,
        "length": 839,
        "protein_name": "Transient receptor potential cation channel subfamily V member 1",
        "gene_name": "Trpv1",
        "organism": "Mouse",
        "refseq_name": "transient receptor potential cation channel subfamily V member 1",
        "refseq_ac": "NP_001001445",
        "gene_names_uniprotkb": "Trpv1",
        "gene_names_refseq": "OTRPC1; TRPV1alpha; TRPV1beta; Trpv1; VR-1; Vr1",
        "protein_names_uniprotkb": "Transient receptor potential cation channel subfamily V member 1; OTRPC1; Osm-9-like TRP channel 1; TrpV1; Vanilloid receptor 1",
        "protein_names_refseq": "capsaicin receptor; cation channel; deltaN-TRPv1; osm-9-like TRP channel 1; transient receptor potential cation channel V1; transient receptor potential cation channel subfamily V member 1; vanilloid receptor 1; vanilloid receptor subtype 1",
        "tax_id": 10090,
        "disease": "overactive bladder syndrome (Disease Ontology:DOID:0070355); gastric ulcer (Disease Ontology:DOID:10808); sciatic neuropathy (Disease Ontology:DOID:11446); reflex epilepsy (Disease Ontology:DOID:2548); myocardial infarction (Disease Ontology:DOID:5844); migraine (Disease Ontology:DOID:6364); cocaine abuse (Disease Ontology:DOID:809); diabetic neuropathy (Disease Ontology:DOID:9743); cocaine dependence (Disease Ontology:DOID:9975)",
        "pathway": " (mmu:193034);  (R-MMU-3295583)",
        "pathway_count": 2,
        "publication_count": 12,
        "publication_id_list": "10764638;15194687;15489017;17194758;18455988;21750661;23668392;25640077;26420335;26902776;35726573;40021952",
        "class_list": "",
        "function": "Non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli (PubMed:15194687, PubMed:15489017). Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. Involved in mediation of inflammatory pain and hyperalgesia (PubMed:10764638). Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Activation by vanilloids, like capsaicin, and temperatures higher than 42 degrees Celsius (By similarity). Upon activation, exhibits a time- and Ca(2+)-dependent outward rectification, followed by a long-lasting refractory state. Mild extracellular acidic pH (6.5) potentiates channel activation by noxious heat and vanilloids, whereas acidic conditions (pH <6) directly activate the channel. Can be activated by endogenous compounds, including 12-hydroperoxytetraenoic acid and bradykinin. Acts as ionotropic endocannabinoid receptor with central neuromodulatory effects. Triggers a form of long-term depression (TRPV1-LTD) mediated by the endocannabinoid anandamine in the hippocampus and nucleus accumbens by affecting AMPA receptors endocytosis (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 9,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 9,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SSE1;Q5SSE2;Q5SSE4;Q5WPV5;Q68SW0",
        "ec_number_list": "1.8.-.-;2.7.11.1",
        "go_molecular_function": "GO:0004888 transmembrane signaling receptor activity;GO:0005216 monoatomic ion channel activity;GO:0005262 calcium channel activity;GO:0005516 calmodulin binding;GO:0005524 ATP binding",
        "go_cellular_component": "GO:0098982 GABA-ergic synapse;GO:0005634 nucleus;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0030425 dendrite",
        "go_biological_process": "GO:0050954 sensory perception of mechanical stimulus;GO:0001660 fever generation;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0001659 temperature homeostasis;GO:0001774 microglial cell activation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q704Y3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DAG5-1",
        "uniprot_id": "STPG4_MOUSE",
        "mass": 27632.0,
        "length": 247,
        "protein_name": "Protein STPG4",
        "gene_name": "Stpg4",
        "organism": "Mouse",
        "refseq_name": "protein STPG4",
        "refseq_ac": "NP_083574",
        "gene_names_uniprotkb": "Stpg4; 1700011E24Rik",
        "gene_names_refseq": "1700011E24Rik; GSE; Stpg4",
        "protein_names_uniprotkb": "Protein STPG4; GSE; Gonad-specific expression gene protein; Sperm-tail PG-rich repeat-containing protein 4",
        "protein_names_refseq": "gonad-specific expression gene protein; protein STPG4; sperm-tail PG-rich repeat-containing protein 4; uncharacterized protein C2orf61 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:75467)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "16571911;21750661;23560077;28930672",
        "class_list": "",
        "function": "Findings suggest that GSE protein may play a role in the establishment of nuclear totipotency and may be associated with early lineage specification., [RefSeq, PubMed]; GSE is a maternal factor involved in active DNA demethylation in zygotes., [RefSeq, PubMed]; Maternal factor that plays a role in epigenetic chromatin reprogramming during early development of the zygote (PubMed:23560077, PubMed:28930672). Involved in the regulation of gametic DNA demethylation by inducing the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) (PubMed:23560077, PubMed:28930672)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003682 chromatin binding;GO:0042393 histone binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0001939 female pronucleus;GO:0001940 male pronucleus",
        "go_biological_process": "GO:0044727 epigenetic programing of male pronucleus;GO:0072529 pyrimidine-containing compound catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9DAG5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3ULF4-1",
        "uniprot_id": "SPG7_MOUSE",
        "mass": 85996.0,
        "length": 781,
        "protein_name": "Mitochondrial inner membrane m-AAA protease component paraplegin",
        "gene_name": "Spg7",
        "organism": "Mouse",
        "refseq_name": "mitochondrial inner membrane m-AAA protease component paraplegin isoform 1 preproprotein",
        "refseq_ac": "NP_694816",
        "gene_names_uniprotkb": "Spg7",
        "gene_names_refseq": "Cmar; PGN; Spg7",
        "protein_names_uniprotkb": "Mitochondrial inner membrane m-AAA protease component paraplegin; 3.4.24.-; 3.6.-.-; Paraplegin; Spastic paraplegia 7 protein",
        "protein_names_refseq": "cell matrix adhesion regulator; mitochondrial inner membrane m-AAA protease component paraplegin isoform 1 preproprotein; mitochondrial inner membrane m-AAA protease component paraplegin; paraplegin; spastic paraplegia 7 homolog; spastic paraplegia 7 protein",
        "tax_id": 10090,
        "disease": "hereditary spastic paraplegia 7 (Disease Ontology:DOID:0110816)",
        "pathway": " (mmu:234847);  (R-MMU-8949664);  (R-MMU-9837999)",
        "pathway_count": 3,
        "publication_count": 12,
        "publication_id_list": "14722615;16239145;16800626;17101804;19656850;21750661;22563492;25428506;31219806;33045469;34428180;37086482",
        "class_list": "",
        "function": "Catalytic component of the m-AAA protease, a protease that plays a key role in proteostasis of inner mitochondrial membrane proteins, and which is essential for axonal and neuron development (PubMed:16239145). SPG7 possesses both ATPase and protease activities: the ATPase activity is required to unfold substrates, threading them into the internal proteolytic cavity for hydrolysis into small peptide fragments (By similarity). The m-AAA protease exerts a dual role in the mitochondrial inner membrane: it mediates the processing of specific regulatory proteins and ensures protein quality control by degrading misfolded polypeptides (By similarity). Mediates protein maturation of the mitochondrial ribosomal subunit MRPL32/bL32m by catalyzing the cleavage of the presequence of MRPL32/bL32m prior to assembly into the mitochondrial ribosome (PubMed:16239145). Acts as a regulator of calcium in neurons by mediating degradation of SMDT1/EMRE before its assembly with the uniporter complex, limiting the availability of SMDT1/EMRE for MCU assembly and promoting efficient assembly of gatekeeper subunits with MCU (By similarity). Also regulates mitochondrial calcium by catalyzing degradation of MCU (By similarity). Plays a role in the formation and regulation of the mitochondrial permeability transition pore (mPTP) and its proteolytic activity is dispensable for this function (By similarity)., [UniProtKB, UniProtKB, UniProtKB, PubMed]; Impaired flickering of the permeability transition pore causes SPG7 spastic paraplegia., [RefSeq, PubMed]; SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency., [RefSeq, PubMed]; Studies indicate that both mouse and human SPG7 ESTs containing alternative first exons., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RQY8;D3Z1Z1;Q4V9T9;Q7TNG0;Q80X42;Q811Y5;Q8K414;Q8R1A1;Q8R1K2",
        "ec_number_list": "3.6.4.13;3.6.4.10;3.6.4.-;5.6.2.3;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;7.6.2.1;3.6.1.5;3.4.24.-;3.6.-.-;3.1.3.1;3.9.1.1;3.6.1.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;3.6.4.6;3.6.5.-;3.6.1.15;3.1.4.-;5.6.2.-;7.2.2.-;7.6.2.16;3.4.21.53;2.7.7.7;2.7.7.49;2.7.11.1;2.7.4.3;3.4.24.64",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0005524 ATP binding;GO:0008270 zinc ion binding;GO:0016887 ATP hydrolysis activity;GO:0004176 ATP-dependent peptidase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:1904115 axon cytoplasm;GO:0005745 m-AAA complex;GO:0005757 mitochondrial permeability transition pore complex",
        "go_biological_process": "GO:1902686 mitochondrial outer membrane permeabilization involved in programmed cell death;GO:0007155 cell adhesion;GO:0030155 regulation of cell adhesion;GO:0046902 regulation of mitochondrial membrane permeability;GO:0008089 anterograde axonal transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q3ULF4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q922B9-1",
        "uniprot_id": "ITPI2_MOUSE",
        "mass": 136947.0,
        "length": 1252,
        "protein_name": "Protein ITPRID2",
        "gene_name": "Itprid2",
        "organism": "Mouse",
        "refseq_name": "protein ITPRID2",
        "refseq_ac": "NP_542125",
        "gene_names_uniprotkb": "Itprid2; Kiaa1927; Krap; Ssfa2",
        "gene_names_refseq": "5730488C15Rik; CS-1; CS1; Itprid2; KRAP; SPAG13; Ssfa2; mKIAA1927",
        "protein_names_uniprotkb": "Protein ITPRID2; ITPR-interacting domain-containing protein 2; Ki-ras-induced actin-interacting protein; Sperm-specific antigen 2 homolog",
        "protein_names_refseq": "ITPR-interacting domain-containing protein 2; ki-ras-induced actin-interacting protein; protein ITPRID2; sperm specific antigen 2; sperm-specific antigen 2 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:70599)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "14673706;17242355;19144319;21160370;21183079;21420385;21457704;21750661;21873152;22992961;34428180",
        "class_list": "",
        "function": "KRAP is involved in the proper regulation of IP3R-mediated Ca2+ release., [RefSeq, PubMed]; KRAP physically associates with IP3 receptors and regulates their proper localization in the mucous cells and the chief cells of the stomach and in the proximal tubular cells of the kidneys., [RefSeq, PubMed]; KRAP-deficient mice show altered whole-body energy metabolism & resistance to diet-induced obesity and diabetes. Review. Review article, [RefSeq, PubMed]; The lack and/or decrease in Ki-ras-induced actin-interacting protein level in the pancreas may promote the pancreatic growth and hypertrophy., [RefSeq, PubMed]; These findings demonstrate that KRAP physically associates with IP(3)R and regulates the proper localization of IP(3)R in the epithelial cells in vivo and cultured cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 24,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AQD4;A5D8Z6;Q08E80;Q14BJ9;Q544I3;Q68FN1;Q75WU7;Q8CH96;Q8VEF7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005102 signaling receptor binding;GO:0051015 actin filament binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q922B9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BGJ9-1",
        "uniprot_id": "U2AF4_MOUSE",
        "mass": 25836.0,
        "length": 220,
        "protein_name": "Splicing factor U2AF 26 kDa subunit",
        "gene_name": "Gm49396; U2af1l4",
        "organism": "Mouse",
        "refseq_name": "splicing factor U2AF 26 kDa subunit",
        "refseq_ac": "NP_739566",
        "gene_names_uniprotkb": "Gm49396; U2af1l4; U2af26",
        "gene_names_refseq": "U2af1l4; U2af26",
        "protein_names_uniprotkb": "Splicing factor U2AF 26 kDa subunit; U2 auxiliary factor 26; U2 small nuclear RNA auxiliary factor 1-like protein 4; U2AF1-like 4",
        "protein_names_refseq": "U2 auxiliary factor 26; U2 small nuclear RNA auxiliary factor 1-like protein 4; U2AF1-like 4; splicing factor U2AF 26 kDa subunit",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:233073);  (R-MMU-159236);  (R-MMU-72163);  (R-MMU-72187);  (R-MMU-9770562)",
        "pathway_count": 5,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;11739736;16819553;18460468;21750661;24837677;33300544",
        "class_list": "",
        "function": "Data suggest light-induced U2af26 alternative splicing to be a buffering mechanism that limits PERIOD1 induction, thus stabilizing the circadian clock against abnormal changes in light:dark conditions., [RefSeq, PubMed]; Differential isoform expression and interaction with the P32 regulatory protein controls the subcellular localization of the splicing factor U2AF26, [RefSeq, PubMed]; RNA-binding protein that function as a pre-mRNA splicing factor. Plays a critical role in both constitutive and enhancer-dependent splicing by mediating protein-protein interactions and protein-RNA interactions required for accurate 3'-splice site selection. It can functionally substitute for U2AF1 in constitutive splicing and enhancer-dependent splicing. Acts by enhancing the binding of U2AF2 to weak pyrimidine tracts. Also participates in the regulation of alternative pre-mRNA splicing. Activates exon 5 skipping of PTPRC during T-cell activation; an event reversed by GFI1. Binds to RNA at the AG dinucleotide at the 3'-splice site. Shows a preference for AGC or AGA (PubMed:11739736, PubMed:16819553, PubMed:18460468). Alternative splicing of U2AF1L4 may play a role in connecting the circadian rhythm to changing external cues: may provide a circadian buffering system in central and periphery clocks that allows synchronized adaption to clock-resetting stimuli in order to prevent potentially pathogenic desynchronization (PubMed:24837677)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0030628 pre-mRNA 3'-splice site binding;GO:0003723 RNA binding;GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0016607 nuclear speck;GO:0005681 spliceosomal complex;GO:0089701 U2AF complex",
        "go_biological_process": "GO:0048511 rhythmic process;GO:0000398 mRNA splicing, via spliceosome",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8BGJ9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6ZQ93-1",
        "uniprot_id": "UBP34_MOUSE",
        "mass": 408214.0,
        "length": 3582,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 34",
        "gene_name": "Usp34",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 34",
        "refseq_ac": "NP_001177330",
        "gene_names_uniprotkb": "Usp34; Kiaa0570; Murr2",
        "gene_names_refseq": "A530081C03Rik; Murr2; Usp34",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 34; 3.4.19.12; Deubiquitinating enzyme 34; Ubiquitin thioesterase 34; Ubiquitin-specific-processing protease 34",
        "protein_names_refseq": "U2af1-rs1 region 2; deubiquitinating enzyme 34; ubiquitin carboxyl-terminal hydrolase 34; ubiquitin specific protease 34; ubiquitin thioesterase 34; ubiquitin thiolesterase 34; ubiquitin-specific-processing protease 34",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:17847);  (R-MMU-201681);  (R-MMU-5689880)",
        "pathway_count": 3,
        "publication_count": 18,
        "publication_id_list": "10.1101/2023.09.13.557529;15345747;16479539;21183079;21750661;25428506;25605945;28499884;30084848;30181118;30779550;31219806;32212276;33300544;34203471;34428180;36210013;9001233",
        "class_list": "",
        "function": "Data indicate that USP34 is required for osteogenic differentiation and bone formation. Erratum:[EMBO J. 2020 Oct 15;39(20):e105578. doi: 10.15252/embj.2020105578. PMID: 33058248], [RefSeq, PubMed]; Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes., [UniProtKB, UniProtKB]; The role of USP34 on epithelial-mesenchymal (EMT) induction and its effects on mammary epithelial stem cells, was investigated., [RefSeq, PubMed]; Ubiquitin hydrolase that can remove conjugated ubiquitin from AXIN1 and AXIN2, thereby acting as a regulator of Wnt signaling pathway. Acts as an activator of the Wnt signaling pathway downstream of the beta-catenin destruction complex by deubiquitinating and stabilizing AXIN1 and AXIN2, leading to promote nuclear accumulation of AXIN1 and AXIN2 and positively regulate beta-catenin (CTNBB1)-mediated transcription. Recognizes and hydrolyzes the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of poly-ubiquitin precursors as well as that of ubiquitinated proteins., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Ubiquitin-Specific Protease 34 Inhibits Osteoclast Differentiation by Regulating NF-kappaB Signaling., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 12,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AF26;A2AF27;A2AF77;Q3UF93;Q3UPN0;Q6P563;Q7TMJ6;Q8CCH0",
        "ec_number_list": "2.4.2.-;2.4.2.30;3.4.19.12;2.3.2.27",
        "go_molecular_function": "GO:0004197 cysteine-type endopeptidase activity;GO:0004843 cysteine-type deubiquitinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol",
        "go_biological_process": "GO:0006508 proteolysis;GO:0031647 regulation of protein stability;GO:0016055 Wnt signaling pathway;GO:0090263 positive regulation of canonical Wnt signaling pathway;GO:0071108 protein K48-linked deubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 2.5,
        "record_id": "Q6ZQ93-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80UV9-1",
        "uniprot_id": "TAF1_MOUSE",
        "mass": 214419.0,
        "length": 1891,
        "protein_name": "Transcription initiation factor TFIID subunit 1",
        "gene_name": "Taf1",
        "organism": "Mouse",
        "refseq_name": "transcription initiation factor TFIID subunit 1 isoform 2",
        "refseq_ac": "NP_001392888",
        "gene_names_uniprotkb": "Taf1; Ccg1",
        "gene_names_refseq": "B430306D02Rik; Ccg-1; Ccg1; KAT4; N-TAF1; TAFII250; Taf1; Taf2a; p250",
        "protein_names_uniprotkb": "Transcription initiation factor TFIID subunit 1; 2.3.1.48; 2.7.11.1; Cell cycle gene 1 protein; TAF(II)250; TAFII-250; TAFII250; TBP-associated factor 250 kDa; Transcription initiation factor TFIID 250 kDa subunit; p250",
        "protein_names_refseq": "TBP-associated factor 250 kDa; cell cycle gene 1 protein; cell cycle, G1 phase defect; transcription initiation factor TFIID 250 kDa subunit; transcription initiation factor TFIID subunit 1 isoform 2; transcription initiation factor TFIID subunit 1",
        "tax_id": 10090,
        "disease": "syndromic X-linked intellectual disability (Disease Ontology:DOID:0060309); X-linked dystonia-parkinsonism (Disease Ontology:DOID:0090057)",
        "pathway": " (mmu:270627);  (R-MMU-674695);  (R-MMU-6804756);  (R-MMU-73776);  (R-MMU-73779);  (R-MMU-75953);  (R-MMU-76042)",
        "pathway_count": 7,
        "publication_count": 15,
        "publication_id_list": "10070062;10438527;19144319;21183079;21750661;23806337;25428506;30084848;30779550;31219806;34203471;34403156;34418053;34428180;9751712",
        "class_list": "",
        "function": "Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 Isoforms., [RefSeq, PubMed]; The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription (By similarity). TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) (By similarity). The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (By similarity). TAF1 is the largest component and core scaffold of the TFIID complex, involved in nucleating complex assembly (PubMed:10438527). TAF1 forms a promoter DNA binding subcomplex of TFIID, together with TAF7 and TAF2 (By similarity). Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors (By similarity). Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53 (By similarity). Phosphorylates GTF2A1 and GTF2F1 on Ser residues (By similarity). Possesses DNA-binding activity (By similarity). Exhibits histone acetyltransferase activity towards histones H3 and H4 (By similarity). Essential for progression of the G1 phase of the cell cycle (By similarity)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AM32;A2AM33;O35361;Q3UPF3;Q3V223;Q505F9;Q8BQH8;Q8BQQ7;Q8BR59;Q8C7N8;Q9WTW9;Q9WTX0;Q9WTX1",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.3.1.48;2.3.1.-;5.6.2.3;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;3.1.13.-;2.7.7.48;2.7.7.6;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;5.6.2.4;2.7.1.40;2.7.11.21;2.7.11.39;2.7.11.31;3.6.5.-;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;2.3.1.259;3.1.26.-;2.7.11.34;2.3.1.57;2.7.1.154;2.7.11.8;2.3.1.80;4.2.1.-;2.7.1.150",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0004672 protein kinase activity;GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0046982 protein heterodimerization activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005667 transcription regulator complex;GO:0000785 chromatin;GO:0071339 MLL1 complex",
        "go_biological_process": "GO:0060261 positive regulation of transcription initiation by RNA polymerase II;GO:0042789 mRNA transcription by RNA polymerase II;GO:0051123 RNA polymerase II preinitiation complex assembly;GO:0006352 DNA-templated transcription initiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "Q80UV9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6P8M1-1",
        "uniprot_id": "TATD1_MOUSE",
        "mass": 33365.0,
        "length": 295,
        "protein_name": "Deoxyribonuclease TATDN1",
        "gene_name": "Tatdn1",
        "organism": "Mouse",
        "refseq_name": "deoxyribonuclease TATDN1 isoform 2",
        "refseq_ac": "NP_780360",
        "gene_names_uniprotkb": "Tatdn1",
        "gene_names_refseq": "2310079P03Rik; CDA11; Tatdn1",
        "protein_names_uniprotkb": "Deoxyribonuclease TATDN1; 3.1.11.-; 3.1.21.-; DNA-(apurinic or apyrimidinic site) endonuclease TATDN1",
        "protein_names_refseq": "DNA-(apurinic or apyrimidinic site) endonuclease TATDN1; deoxyribonuclease TATDN1 isoform 2; putative deoxyribonuclease TATDN1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69694)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;23806337;25428506",
        "class_list": "",
        "function": "Exhibits 3'-5' exonuclease and apurinic/apyrimidinic (AP) endonuclease activities (in vitro). Shows preferential AP endonuclease activity on dsDNA substrates and 3'-5'exonuclease activity on ssDNA (By similarity). Catalyzes decatenation of catenated kinetoplast DNA to produce separated linear DNA in vitro. Plays an important role in chromosomal segregation and cell cycle progression during eye development probably via its DNA decatenation activity (By similarity)., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BY37",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008296 3'-5'-DNA exonuclease activity;GO:0046872 metal ion binding;GO:0004520 DNA endonuclease activity;GO:0016788 hydrolase activity, acting on ester bonds;GO:0004518 nuclease activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005634 nucleus",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q6P8M1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q0KL02-1",
        "uniprot_id": "TRIO_MOUSE",
        "mass": 347861.0,
        "length": 3102,
        "protein_name": "Triple functional domain protein",
        "gene_name": "Trio",
        "organism": "Mouse",
        "refseq_name": "triple functional domain protein",
        "refseq_ac": "NP_001074771",
        "gene_names_uniprotkb": "Trio",
        "gene_names_refseq": "6720464I07Rik; Solo; Trio",
        "protein_names_uniprotkb": "Triple functional domain protein; 2.7.11.1",
        "protein_names_refseq": "triple functional domain protein",
        "tax_id": 10090,
        "disease": "autosomal dominant intellectual developmental disorder 63 with macrocephaly (Disease Ontology:DOID:0061036); autosomal dominant intellectual developmental disorder 44 (Disease Ontology:DOID:0070074); epilepsy (Disease Ontology:DOID:1826)",
        "pathway": " (mmu:223435);  (R-MMU-193648);  (R-MMU-416476);  (R-MMU-416482);  (R-MMU-418885);  (R-MMU-8980692);  (R-MMU-9013148);  (R-MMU-9013149);  (R-MMU-9013404);  (R-MMU-9013408);  (R-MMU-9013409);  (R-MMU-9013423)",
        "pathway_count": 12,
        "publication_count": 16,
        "publication_id_list": "10.1101/2023.09.13.557529;16943433;17332503;19131326;21183079;21750661;22155786;22645316;22666460;25428506;30084848;31219806;31599954;33300544;34428180;40885482",
        "class_list": "",
        "function": "Guanine nucleotide exchange factor (GEF) for RHOA and RAC1 GTPases. Involved in coordinating actin remodeling, which is necessary for cell migration and growth (By similarity). Plays a key role in the regulation of neurite outgrowth and lamellipodia formation (By similarity). In developing hippocampal neurons, limits dendrite formation, without affecting the establishment of axon polarity. Once dendrites are formed, involved in the control of synaptic function by regulating the endocytosis of AMPA-selective glutamate receptors (AMPARs) at CA1 excitatory synapses (By similarity). May act as a regulator of adipogenesis (PubMed:22666460)., [UniProtKB, UniProtKB, UniProtKB, PubMed]; M-cadherin-dependent adhesion can activate Rac1 via the Rho-GEF Trio at the time of myoblast fusion., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 8,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 3,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U522;Q6P9K6;Q80W23",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;3.6.5.-;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;3.6.5.2;2.7.11.39;2.3.1.-;2.7.11.31;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0019899 enzyme binding;GO:0005085 guanyl-nucleotide exchange factor activity;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005737 cytoplasm;GO:0005769 early endosome;GO:0005829 cytosol;GO:0048786 presynaptic active zone",
        "go_biological_process": "GO:0048812 neuron projection morphogenesis;GO:0050804 modulation of chemical synaptic transmission;GO:0045599 negative regulation of fat cell differentiation;GO:0007411 axon guidance;GO:0099170 postsynaptic modulation of chemical synaptic transmission",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q0KL02-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JI10-1",
        "uniprot_id": "STK3_MOUSE",
        "mass": 56855.0,
        "length": 497,
        "protein_name": "Serine/threonine-protein kinase 3",
        "gene_name": "Stk3",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase 3 isoform 1",
        "refseq_ac": "NP_062609",
        "gene_names_uniprotkb": "Stk3; Mess1; Mst2",
        "gene_names_refseq": "0610042I06Rik; MST; Mst2; Mst3; Ste20; Stk3; mess1",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase 3; 2.7.11.1; MST-2; Mammalian STE20-like protein kinase 2; STE20-like kinase MST2",
        "protein_names_refseq": "MST-2; STE20-like kinase MST2; mammalian STE20-like protein kinase 2; protein kinase homolog; serine/threonine-protein kinase 3 isoform 1; serine/threonine-protein kinase 3",
        "tax_id": 10090,
        "disease": "neurodegenerative disease (Disease Ontology:DOID:1289); cancer (Disease Ontology:DOID:162); carcinoma (Disease Ontology:DOID:305); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:56274);  (R-MMU-2028269)",
        "pathway_count": 2,
        "publication_count": 18,
        "publication_id_list": "11278283;11805089;15618521;17242355;18328708;19144319;20080689;21145499;21183079;21750661;28087714;28135057;28528544;29187734;31219806;34203471;34428180;36210013",
        "class_list": "",
        "function": "MST1 and MST2 are activated in mitosis and catalyze the mitotic phosphorylation of MOBKL1A/MOBKL1B, which is sufficient to inhibit proliferation through actions at several points in the cell cycle., [RefSeq, PubMed]; Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST)., [RefSeq, PubMed]; Proteomic analysis of Raf-1 signaling complexes was used to show that Raf-1 counteracts apoptosis by suppressing the activation of mammalian sterile 20-like kinase (MST2), [RefSeq, PubMed]; Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1. Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259'. Phosphorylates MOBKL1A and RASSF2. Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38 (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 9,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q60877;Q80UG4;Q8CI58",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;3.4.22.56;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0004672 protein kinase activity;GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005813 centrosome;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0046621 negative regulation of organ growth;GO:0060706 cell differentiation involved in embryonic placenta development;GO:0006468 protein phosphorylation;GO:0008285 negative regulation of cell population proliferation;GO:0035556 intracellular signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "Q9JI10-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TNE1-1",
        "uniprot_id": "SUCHY_MOUSE",
        "mass": 47690.0,
        "length": 436,
        "protein_name": "Succinyl-CoA:glutarate CoA-transferase",
        "gene_name": "Sugct",
        "organism": "Mouse",
        "refseq_name": "succinyl-CoA:glutarate CoA-transferase",
        "refseq_ac": "NP_619595",
        "gene_names_uniprotkb": "Sugct",
        "gene_names_refseq": "5033411D12Rik; Sugct",
        "protein_names_uniprotkb": "Succinyl-CoA:glutarate CoA-transferase; 2.8.3.-; 2.8.3.13; Dicarboxyl-CoA:dicarboxylic acid coenzyme A transferase SUGCT; Succinate--hydroxymethylglutarate CoA-transferase",
        "protein_names_refseq": "dicarboxyl-CoA:dicarboxylic acid coenzyme A transferase SUGCT; succinate--hydroxymethylglutarate CoA-transferase; succinyl-CoA:glutarate CoA-transferase; succinylCoA:glutarate-CoA transferase",
        "tax_id": 10090,
        "disease": "glutaric acidemia type 3 (Disease Ontology:DOID:0112246)",
        "pathway": " (mmu:192136)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21750661;23576753;31722069;33483254;34428180",
        "class_list": "",
        "function": "Coenzyme A (CoA) transferase that reversibly catalyzes the transfer of a CoA moiety from a dicarboxyl-CoA to a dicarboxylate in a metabolite recycling process. Displays preference for succinyl-CoA and glutarate-CoA as dicarboxyl-CoA donors and glutarate, succinate, adipate/hexanedioate, itaconate and 3-hydroxy-3-methylglutarate as dicarboxylate acceptors (By similarity). Acts on intermediates or end products of lysine and tryptophan degradation pathway, in particular catalyzes succinyl-CoA-dependent reesterification of free glutarate into glutaryl-CoA to prevent renal excretion of glutarate (By similarity). Upon inflammation, may convert macrophage-derived itaconate to itaconyl-CoA in erythroid precursors where it negatively regulates the TCA cycle and heme synthesis to limit erythroid differentiation in the context of stress erythropoiesis (By similarity)., [UniProtKB, UniProtKB]; Glutaric aciduria type 3 is a naturally occurring biochemical trait in inbred mice of 129 substrains., [RefSeq, PubMed]; Knockout of the non-essential gene SUGCT creates diet-linked, age-related microbiome disbalance with a diabetes-like metabolic syndrome phenotype., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "G3X9F8",
        "ec_number_list": "2.8.3.13;2.8.3.-",
        "go_molecular_function": "GO:0047369 succinate-hydroxymethylglutarate CoA-transferase activity",
        "go_cellular_component": "GO:0005739 mitochondrion",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q7TNE1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z2R6-1",
        "uniprot_id": "U119A_MOUSE",
        "mass": 27010.0,
        "length": 240,
        "protein_name": "Protein unc-119 homolog A",
        "gene_name": "Unc119",
        "organism": "Mouse",
        "refseq_name": "protein unc-119 homolog A isoform 2",
        "refseq_ac": "NP_035806",
        "gene_names_uniprotkb": "Unc119; Unc119h",
        "gene_names_refseq": "D11Bhm52; HRG4; MRG4; Rg4; Rtg4; Unc119h; Unc119",
        "protein_names_uniprotkb": "Protein unc-119 homolog A; Retinal protein 4; mRG4",
        "protein_names_refseq": "protein unc-119 homolog A isoform 2; protein unc-119 homolog A; retinal gene 4; retinal protein 4",
        "tax_id": 10090,
        "disease": "cone-rod dystrophy 24 (Disease Ontology:DOID:0081449); immunodeficiency 13 (Disease Ontology:DOID:0111987)",
        "pathway": " (mmu:22248)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "17174953;17242355;18296658;19781630;20173027;21183079;21642972;21750661;31696965;37175812;9761287",
        "class_list": "",
        "function": "A Novel Role for UNC119 as an Enhancer of Synaptic Transmission. Publication Status: Online-Only, [RefSeq, PubMed]; Involved in synaptic functions in photoreceptor cells, the signal transduction in immune cells as a Src family kinase activator, endosome recycling, the uptake of bacteria and endocytosis, protein trafficking in sensory neurons and as lipid-binding chaperone with specificity for a diverse subset of myristoylated proteins. Specifically binds the myristoyl moiety of a subset of N-terminally myristoylated proteins and is required for their localization. Binds myristoylated GNAT1 and is required for G-protein localization and trafficking in sensory neurons. Probably plays a role in trafficking proteins in photoreceptor cells. Plays important roles in mediating Src family kinase signals for the completion of cytokinesis via RAB11A., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, PubMed, UniProtKB, PubMed, PubMed]; The protein encoded by this gene is multifunctional, affecting trafficking of transducin in rod photoreceptors, interacting with src-type tyrosine kinases through SH2 and SH3 interacting domains, and aiding the uptake of bacteria through endocytosis. In addition, the encoded protein acts as a lipid-binding chaperone to help localize some myristoylated proteins correctly. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008289 lipid binding",
        "go_cellular_component": "GO:0000922 spindle pole;GO:0005813 centrosome;GO:0051233 spindle midzone;GO:0045171 intercellular bridge",
        "go_biological_process": "GO:0006897 endocytosis;GO:0007399 nervous system development;GO:0042953 lipoprotein transport;GO:0061098 positive regulation of protein tyrosine kinase activity;GO:0007601 visual perception",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q9Z2R6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q569Z6-1",
        "uniprot_id": "TR150_MOUSE",
        "mass": 108178.0,
        "length": 951,
        "protein_name": "Thyroid hormone receptor-associated protein 3",
        "gene_name": "Thrap3",
        "organism": "Mouse",
        "refseq_name": "thyroid hormone receptor-associated protein 3",
        "refseq_ac": "NP_666265",
        "gene_names_uniprotkb": "Thrap3; Trap150",
        "gene_names_refseq": "9330151F09Rik; B230333E16Rik; Thrap3; Trap150",
        "protein_names_uniprotkb": "Thyroid hormone receptor-associated protein 3; Thyroid hormone receptor-associated protein complex 150 kDa component; Trap150",
        "protein_names_refseq": "thyroid hormone receptor-associated protein 3; thyroid hormone receptor-associated protein complex 150 kDa component",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:230753)",
        "pathway_count": 1,
        "publication_count": 23,
        "publication_id_list": "10.1101/2023.09.13.557529;16452087;17242355;18630941;19131326;19144319;21183079;21750661;23525231;23806337;24043798;24129315;28770354;33725478;34418053;34428180;34526909;34887587;35820727;37524868;37549548;39627609;40021952",
        "class_list": "",
        "function": "Involved in pre-mRNA splicing. Remains associated with spliced mRNA after splicing which probably involves interactions with the exon junction complex (EJC). Can trigger mRNA decay which seems to be independent of nonsense-mediated decay involving premature stop codons (PTC) recognition. May be involved in nuclear mRNA decay. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45 is proposed to sequester phosphorylated SFPQ from PTPRC/CD45 pre-mRNA in resting T-cells. Involved in cyclin-D1/CCND1 mRNA stability probably by acting as component of the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in response to DNA damage. Is excluced from DNA damage sites in a manner that parallels transcription inhibition; the function may involve the SNARP complex. Initially thought to play a role in transcriptional coactivation through its association with the TRAP complex; however, it is not regarded as a stable Mediator complex subunit. Cooperatively with HELZ2, enhances the transcriptional activation mediated by PPARG, maybe through the stabilization of the PPARG binding to DNA in presence of ligand. May play a role in the terminal stage of adipocyte differentiation. Plays a role in the positive regulation of the circadian clock. Acts as a coactivator of the CLOCK-BMAL1 heterodimer and promotes its transcriptional activator activity and binding to circadian target genes (PubMed:24043798)., [UniProtKB, PubMed, PubMed]; LncRNA RP4-639F20.1 interacts with THRAP3 to attenuate atherosclerosis by regulating c-FOS in vascular smooth muscle cells proliferation and migration., [RefSeq, PubMed]; These results indicate that THRAP3 negatively regulates SOX9 transcriptional activity as a cofactor of a SOX9 transcriptional complex during chondrogenesis., [RefSeq, PubMed]; Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 33,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003713 transcription coactivator activity;GO:0005524 ATP binding;GO:0051219 phosphoprotein binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0016607 nuclear speck;GO:0016592 mediator complex;GO:0035145 exon-exon junction complex",
        "go_biological_process": "GO:0048026 positive regulation of mRNA splicing, via spliceosome;GO:0006397 mRNA processing;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0048255 mRNA stabilization;GO:0045893 positive regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 2.9,
        "record_id": "Q569Z6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35618-1",
        "uniprot_id": "MDM4_MOUSE",
        "mass": 54963.0,
        "length": 489,
        "protein_name": "Protein Mdm4",
        "gene_name": "Mdm4",
        "organism": "Mouse",
        "refseq_name": "protein Mdm4 isoform 1",
        "refseq_ac": "NP_001289730",
        "gene_names_uniprotkb": "Mdm4; Mdmx",
        "gene_names_refseq": "4933417N07Rik; Mdm4; Mdmx",
        "protein_names_uniprotkb": "Protein Mdm4; Double minute 4 protein; Mdm2-like p53-binding protein; Protein Mdmx; p53-binding protein Mdm4",
        "protein_names_refseq": "double minute 4 protein; mdm2-like p53-binding protein; p53-binding protein Mdm4; protein Mdm4 isoform 1; protein Mdm4; protein Mdmx; transformed mouse 3T3 cell double minute 4",
        "tax_id": 10090,
        "disease": "Alzheimer's disease (Disease Ontology:DOID:10652); dilated cardiomyopathy (Disease Ontology:DOID:12930)",
        "pathway": " (mmu:17248);  (R-MMU-2559580);  (R-MMU-2559585);  (R-MMU-5689880);  (R-MMU-6804756);  (R-MMU-6804757);  (R-MMU-6804760);  (R-MMU-69541)",
        "pathway_count": 8,
        "publication_count": 10,
        "publication_id_list": "10075736;16511560;17823617;21750661;22556425;24013503;25826083;29262653;29348869;8895579",
        "class_list": "",
        "function": "Acts as a more potent inhibitor of TP53 activity than the long isoform., [UniProtKB, PubMed]; Contributes to p53/TP53 regulation. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding their transcriptional activation domains. Inhibits degradation of MDM2. Can reverse MDM2-targeted degradation of TP53 while maintaining suppression of TP53 transactivation and apoptotic functions., [UniProtKB, UniProtKB, PubMed]; Identify Mdm4 as one of these key mRNAs that senses the defects in the spliceosomal machinery and transduces the signal to activate the p53 response, [RefSeq, PubMed]; This gene encodes a protein that has been shown to negatively regulate the activity of the tumor suppressor protein p53. Homozygous knockout mice exhibit embryonic lethality as a result of p53-dependent apoptosis and cell cycle arrest. Amplification of this gene or overexpression of the encoded protein has been linked to a range of human cancers. A pseudogene has been identified on the X chromosome. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Nov 2014]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CYG1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008047 enzyme activator activity;GO:0008270 zinc ion binding;GO:0019899 enzyme binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0017053 transcription repressor complex;GO:0005634 nucleus",
        "go_biological_process": "GO:0003170 heart valve development;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0008284 positive regulation of cell population proliferation;GO:0045892 negative regulation of DNA-templated transcription;GO:0050821 protein stabilization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "O35618-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VIG6-1",
        "uniprot_id": "TRAIP_MOUSE",
        "mass": 53149.0,
        "length": 470,
        "protein_name": "E3 ubiquitin-protein ligase TRAIP",
        "gene_name": "Traip",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase TRAIP isoform 1",
        "refseq_ac": "NP_035764",
        "gene_names_uniprotkb": "Traip; Trip",
        "gene_names_refseq": "Traip; Trip",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase TRAIP; 2.3.2.27; TRAF-interacting protein",
        "protein_names_refseq": "E3 ubiquitin-protein ligase TRAIP isoform 1; E3 ubiquitin-protein ligase TRAIP; RING-type E3 ubiquitin transferase TRAIP",
        "tax_id": 10090,
        "disease": "Seckel syndrome 9 (Disease Ontology:DOID:0070005)",
        "pathway": " (mmu:22036);  (R-MMU-983168)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "11801660;17544371;17927961;21750661;22945920;25428506;27405720;33590678;35820727;38100027;9104814",
        "class_list": "",
        "function": "E3 ubiquitin ligase required to protect genome stability in response to replication stress (PubMed:33590678). Acts as a key regulator of interstrand cross-link repair, which takes place when both strands of duplex DNA are covalently tethered together, thereby blocking replication and transcription (By similarity). During mitosis, controls the choice between the two pathways of replication-coupled interstrand-cross-link repair by mediating ubiquitination of MCM7 subunit of the CMG helicase complex (PubMed:33590678). Short ubiquitin chains on MCM7 promote recruitment of DNA glycosylase NEIL3 (By similarity). If the interstrand cross-link cannot be cleaved by NEIL3, the ubiquitin chains continue to grow on MCM7, promoting the unloading of the CMG helicase complex by the VCP/p97 ATPase, enabling the Fanconi anemia DNA repair pathway (By similarity). Only catalyzes ubiquitination of MCM7 when forks converge (By similarity). Also involved in the repair of covalent DNA-protein cross-links (DPCs) during DNA synthesis: promotes ubiquitination of DPCs, leading to their degradation by the proteasome (By similarity). Has also been proposed to play a role in promoting translesion synthesis by mediating the assembly of 'Lys-63'-linked poly-ubiquitin chains on the Y-family polymerase POLN in order to facilitate bypass of DNA lesions and preserve genomic integrity (By similarity). The function in translesion synthesis is however controversial (By similarity). Acts as a regulator of the spindle assembly checkpoint (By similarity). Also acts as a negative regulator of innate immune signaling by inhibiting activation of NF-kappa-B mediated by TNF (PubMed:17544371, PubMed:22945920). Negatively regulates TLR3/4- and RIG-I-mediated IRF3 activation and subsequent IFNB1 production and cellular antiviral response by promoting 'Lys-48'-linked polyubiquitination of TNK1 leading to its proteasomal degradation (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, UniProtKB]; TRAIP suppressed apoptosis and cell cycle to promote prostate cancer proliferation via TRAF2-PI3K-AKT pathway activation., [RefSeq, PubMed]; TRIP as a negative regulator in TLR3/4- and RIG-I-triggered antiviral responses and suggested TRIP as a potential target for the intervention of diseases with uncontrolled IFN-beta production., [RefSeq, PubMed]; Taken together, these data indicate that TRAIP plays important roles in oocyte meiosis regulation. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O08854;Q922M8;Q9CPP4",
        "ec_number_list": "2.3.2.26;2.3.2.31;2.3.2.27;2.3.2.-;3.6.4.-;2.3.2.24;2.3.2.23;2.3.2.34;2.3.2.32;2.7.11.1;2.3.2.36;2.3.2.25;6.2.1.-",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0042802 identical protein binding;GO:0061630 ubiquitin protein ligase activity;GO:0004842 ubiquitin-protein transferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005886 plasma membrane;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0007165 signal transduction;GO:0006974 DNA damage response;GO:0043124 negative regulation of canonical NF-kappaB signal transduction;GO:0016567 protein ubiquitination;GO:0010804 negative regulation of tumor necrosis factor-mediated signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8VIG6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "D3YV92-1",
        "uniprot_id": "GAR2_MOUSE",
        "mass": 50108.0,
        "length": 440,
        "protein_name": "Golgi-associated RAB2 interactor protein 2",
        "gene_name": "Garin2",
        "organism": "Mouse",
        "refseq_name": "Golgi-associated RAB2 interactor protein 2 isoform 1",
        "refseq_ac": "NP_083345",
        "gene_names_uniprotkb": "Garin2; Fam71d",
        "gene_names_refseq": "4921509E07Rik; 4930516C23Rik; Fam71d; GARI-L2; Garin2",
        "protein_names_uniprotkb": "Golgi-associated RAB2 interactor protein 2",
        "protein_names_refseq": "Golgi associated RAB2 interactor protein 2; Golgi-associated RAB2 interactor protein 2 isoform 1; Golgi-associated Rab2B interactor-like 2; family with sequence similarity 71, member D; protein FAM71D",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:70897)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;29025071",
        "class_list": "",
        "function": "Seems to play a role in sperm motility., [UniProtKB, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0061827 sperm head;GO:0097225 sperm midpiece",
        "go_biological_process": "GO:0030317 flagellated sperm motility;GO:0000902 cell morphogenesis;GO:0007286 spermatid development;GO:0007341 penetration of zona pellucida",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "D3YV92-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C5W3-1",
        "uniprot_id": "TBCEL_MOUSE",
        "mass": 48032.0,
        "length": 424,
        "protein_name": "Tubulin-specific chaperone cofactor E-like protein",
        "gene_name": "Tbcel",
        "organism": "Mouse",
        "refseq_name": "tubulin-specific chaperone cofactor E-like protein isoform b",
        "refseq_ac": "NP_766626",
        "gene_names_uniprotkb": "Tbcel; Lrrc35",
        "gene_names_refseq": "D330014K23; E130107N23Rik; Lrrc35; Tbcel",
        "protein_names_uniprotkb": "Tubulin-specific chaperone cofactor E-like protein; Leucine-rich repeat-containing protein 35",
        "protein_names_refseq": "leucine-rich repeat-containing protein 35; tubulin-specific chaperone cofactor E-like protein isoform b; tubulin-specific chaperone cofactor E-like protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:272589)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "17242355;21183079;21750661;34428180;36210013",
        "class_list": "",
        "function": "Acts as a regulator of tubulin stability., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B9EID8;Q8C7A5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0043014 alpha-tubulin binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005856 cytoskeleton",
        "go_biological_process": "GO:0000226 microtubule cytoskeleton organization;GO:0007021 tubulin complex assembly;GO:0007023 post-chaperonin tubulin folding pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q8C5W3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BZ60-1",
        "uniprot_id": "STON2_MOUSE",
        "mass": 99611.0,
        "length": 895,
        "protein_name": "Stonin-2",
        "gene_name": "Ston2",
        "organism": "Mouse",
        "refseq_name": "stonin-2 isoform 1",
        "refseq_ac": "NP_780576",
        "gene_names_uniprotkb": "Ston2; Stn2; Stnb",
        "gene_names_refseq": "4933401N24Rik; EG666955; Gm8378; Ston2",
        "protein_names_uniprotkb": "Stonin-2; Stoned B",
        "protein_names_refseq": "stoned B; stonin-2 isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:108800);  (R-MMU-8856825);  (R-MMU-8856828)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "21183079;21750661;23345427;34428180;36210013;38402028;40885482",
        "class_list": "",
        "function": "Adapter protein involved in endocytic machinery. Involved in the synaptic vesicle recycling. May facilitate clathrin-coated vesicle uncoating (By similarity)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Loss of Stn2 leads to selective missorting of synaptotagmin 1 to the neuronal surface, an elevated synaptic vesicle (SV) pool size, and accelerated SV protein endocytosis., [RefSeq, PubMed]; STON2 variations are involved in synaptic dysfunction and schizophrenia-like behaviors by regulating Syt1 trafficking., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2RTJ7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0035615 clathrin adaptor activity",
        "go_cellular_component": "GO:0005730 nucleolus;GO:0005829 cytosol;GO:0030136 clathrin-coated vesicle;GO:0043005 neuron projection;GO:0030122 AP-2 adaptor complex",
        "go_biological_process": "GO:0030100 regulation of endocytosis;GO:0007268 chemical synaptic transmission;GO:0072583 clathrin-dependent endocytosis;GO:0002244 hematopoietic progenitor cell differentiation;GO:0048488 synaptic vesicle endocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q8BZ60-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TN58-1",
        "uniprot_id": "TMC8_MOUSE",
        "mass": 82329.0,
        "length": 722,
        "protein_name": "Transmembrane channel-like protein 8",
        "gene_name": "Tmc8",
        "organism": "Mouse",
        "refseq_name": "transmembrane channel-like protein 8 isoform D",
        "refseq_ac": "NP_001182019",
        "gene_names_uniprotkb": "Tmc8; Ever2",
        "gene_names_refseq": "EVIN2; Ever2; Tmc8; mFLJ00400",
        "protein_names_uniprotkb": "Transmembrane channel-like protein 8; Epidermodysplasia verruciformis protein 2 homolog",
        "protein_names_refseq": "epidermodysplasia verruciformis 2; epidermodysplasia verruciformis protein 2 homolog; transmembrane channel-like 8; transmembrane channel-like protein 8 isoform D; transmembrane channel-like protein 8",
        "tax_id": 10090,
        "disease": "epidermodysplasia verruciformis (Disease Ontology:DOID:13777)",
        "pathway": " (mmu:217356)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "12812529;12906855;17242355;21183079;21750661;32917726;34428180;38869286",
        "class_list": "",
        "function": "Acts as a regulatory protein involved in the regulation of numerous cellular processes (PubMed:32917726). Together with its homolog TMC6/EVER1, forms a complex with calcium-binding protein CIB1 in lymphocytes and keratynocytes where TMC6 and TMC8 stabilize CIB1 levels and reciprocally (PubMed:32917726). Together with TMC6, also forms a complex with and activates zinc transporter ZNT1 at the ER membrane of keratynocytes, thereby facilitating zinc uptake into the ER (By similarity). Also inhibits receptor-mediated calcium release from ER stores and calcium activated and volume regulated chloride channels (By similarity). Down-regulates the activity of transcription factors induced by zinc and cytokines (By similarity). Also sequesters TRADD which impairs the recruitment of TRAF2 and RIPK1 in the pro-survival complex I and promotes proapoptotic complex II formation, and may therefore be involved in TNF-induced cell death/survival decisions (By similarity)., [UniProtKB, UniProtKB, PubMed]; Deficiency in Ever2 does not increase susceptibility of mice to pathogenesis by the mouse papillomavirus, MmuPV1., [RefSeq, PubMed]; Expression of a TMC6-TMC8-CIB1 heterotrimeric complex in lymphocytes is regulated by each of the components., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TAL0;Q3UWI0;Q7TQ67",
        "ec_number_list": "",
        "go_molecular_function": "GO:0043120 tumor necrosis factor binding;GO:0008381 mechanosensitive monoatomic ion channel activity;GO:0140311 protein sequestering activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0043065 positive regulation of apoptotic process;GO:0043123 positive regulation of canonical NF-kappaB signal transduction;GO:0050821 protein stabilization;GO:0043124 negative regulation of canonical NF-kappaB signal transduction;GO:0031333 negative regulation of protein-containing complex assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q7TN58-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P68368-1",
        "uniprot_id": "TBA4A_MOUSE",
        "mass": 49924.0,
        "length": 448,
        "protein_name": "Tubulin alpha-4A chain",
        "gene_name": "Tuba4a",
        "organism": "Mouse",
        "refseq_name": "tubulin alpha-4A chain isoform 1",
        "refseq_ac": "NP_033473",
        "gene_names_uniprotkb": "Tuba4a; Tuba4",
        "gene_names_refseq": "M[a]4; Tuba4a; Tuba4",
        "protein_names_uniprotkb": "Tubulin alpha-4A chain; 3.6.5.-; Alpha-tubulin 4; Alpha-tubulin isotype M-alpha-4; Tubulin alpha-4 chain",
        "protein_names_refseq": "alpha-tubulin isotype M-alpha-4; tubulin alpha-4 chain; tubulin alpha-4A chain isoform 1; tubulin alpha-4A chain",
        "tax_id": 10090,
        "disease": "lissencephaly (Disease Ontology:DOID:0050453); amyotrophic lateral sclerosis type 22 (Disease Ontology:DOID:0060355); polymicrogyria (Disease Ontology:DOID:0080918); lissencephaly 3 (Disease Ontology:DOID:0112232); microlissencephaly (Disease Ontology:DOID:0112234)",
        "pathway": " (mmu:22145);  (R-MMU-114608);  (R-MMU-190840);  (R-MMU-2132295);  (R-MMU-2467813);  (R-MMU-2500257);  (R-MMU-2565942);  (R-MMU-3371497);  (R-MMU-380259);  (R-MMU-380270);  (R-MMU-380284);  (R-MMU-380320);  (R-MMU-437239);  (R-MMU-5610787);  (R-MMU-5620912);  (R-MMU-5620920);  (R-MMU-5620924);  (R-MMU-5626467);  (R-MMU-5663220);  (R-MMU-6807878);  (R-MMU-6811434);  (R-MMU-6811436);  (R-MMU-68877);  (R-MMU-8852276);  (R-MMU-8854518);  (R-MMU-8955332);  (R-MMU-9646399);  (R-MMU-9648025);  (R-MMU-9668328);  (R-MMU-983189);  (R-MMU-9833482)",
        "pathway_count": 31,
        "publication_count": 23,
        "publication_id_list": "15890843;16800626;19524510;20665223;21750661;22645316;23897886;25605945;27965440;33300544;33414192;33725478;34203471;34428180;34678516;36064721;36288343;37453647;37507081;3785200;39627609;39927985;40684658",
        "class_list": "",
        "function": "Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P05215;Q3TY31",
        "ec_number_list": "3.6.5.-;6.3.2.-;6.-.-.-;3.6.5.2;3.6.5.3;2.7.11.1;2.4.1.41;3.6.1.5;2.7.11.11;3.6.4.10;1.8.-.-;1.15.1.1;2.7.11.22;2.7.11.23;3.6.5.4;5.6.1.6;3.6.4.-;5.2.1.8;5.6.1.3;3.6.5.5;3.4.22.49;3.1.3.16;3.6.1.-;2.7.10.2;2.7.11.21;3.6.1.15;3.4.21.-;3.6.4.12;3.1.30.-;3.6.-.-;2.3.1.108;3.1.2.-;3.5.1.-;3.5.1.124;2.3.1.-;2.7.11.26;2.3.2.-;3.1.11.-;5.6.1.1;5.3.99.3",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0005525 GTP binding;GO:0016787 hydrolase activity;GO:0019899 enzyme binding;GO:0019901 protein kinase binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005856 cytoskeleton;GO:0005874 microtubule;GO:0005929 cilium;GO:0015630 microtubule cytoskeleton",
        "go_biological_process": "GO:0000278 mitotic cell cycle;GO:0030182 neuron differentiation;GO:0000226 microtubule cytoskeleton organization;GO:0007017 microtubule-based process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.8,
        "record_id": "P68368-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D2G5-1",
        "uniprot_id": "SYNJ2_MOUSE",
        "mass": 158480.0,
        "length": 1434,
        "protein_name": "Polyphosphatidylinositol phosphatase SYNJ2",
        "gene_name": "Synj2",
        "organism": "Mouse",
        "refseq_name": "synaptojanin-2 isoform d",
        "refseq_ac": "NP_001106822",
        "gene_names_uniprotkb": "Synj2; Kiaa0348",
        "gene_names_refseq": "SJ2; Synj2; mKIAA0348",
        "protein_names_uniprotkb": "Polyphosphatidylinositol phosphatase SYNJ2; 3.1.3.-; 3.1.3.95; Phosphatidylinositol-3,5-bisphosphate 3-phosphatase SYNJ2; Phosphatidylinositol-4-phosphatase SYNJ2; Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 2; Synaptojanin-2",
        "protein_names_refseq": "synaptic inositol-1,4,5-trisphosphate 5-phosphatase 2; synaptojanin-2 isoform d",
        "tax_id": 10090,
        "disease": "early-onset Parkinson's disease (Disease Ontology:DOID:0060894); Down syndrome (Disease Ontology:DOID:14250); Parkinson's disease (Disease Ontology:DOID:14330)",
        "pathway": " (mmu:20975);  (R-MMU-1660499);  (R-MMU-8856828)",
        "pathway_count": 3,
        "publication_count": 10,
        "publication_id_list": "15722415;21750661;25428506;27878645;30084848;31219806;32848054;34428180;9442075;9636665",
        "class_list": "",
        "function": "Inositol 5-phosphatase which may be involved in distinct membrane trafficking and signal transduction pathways. May mediate the inhibitory effect of Rac1 on endocytosis., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Phosphatase that hydrolyzes phosphate groups from the inositol ring of phosphoinositides and inositol phosphates, in a domain-specific manner (PubMed:9442075). The 5-PPase domain catalyzes removal of the 5-phosphate from substrates such as phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2), phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3), inositol-1,4,5-trisphosphate (Ins(1,4,5)P3) and inositol-1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4) (PubMed:9442075). The SAC domain hydrolyzes phosphates at the 3- and 4-positions of the inositol ring, targeting phosphatidylinositol-3-phosphate (PI(3)P), phosphatidylinositol-4-phosphate (PI(4)P), and phosphatidylinositol-3,5-bisphosphate (PI(3,5)P2) (By similarity). Plays a role in the phosphatidylinositol metabolic process during the early stage of clathrin-coated-pit formation (By similarity). During EGF activation, plays a role in receptor-mediated endocytosis (RME) by converting PtdIns(4,5)P2 to PtdIns(4)P through the H2O2-dependent oxidation of the 4-phosphatase domain (By similarity). May play a role in tumor cell invadopodia formation (By similarity)., [UniProtKB, UniProtKB, PubMed, UniProtKB]; Report showing expression, location and isoforms of Synj1 and Synj2 in the small and large intestine and that they might participate in intestinal pathology., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O35404;O88399;O88400;O88401;O88402;O88403;O88404",
        "ec_number_list": "3.1.3.67;3.1.3.86;3.1.3.95;3.1.3.36;3.1.3.56;3.1.3.-;3.1.3.16;3.1.3.64",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0017124 SH3 domain binding;GO:0030165 PDZ domain binding;GO:0004438 phosphatidylinositol-3-phosphate phosphatase activity;GO:0043812 phosphatidylinositol-4-phosphate phosphatase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0016020 membrane;GO:0043679 axon terminus;GO:0045121 membrane raft;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0006898 receptor-mediated endocytosis;GO:0048268 clathrin coat assembly;GO:0046856 phosphatidylinositol dephosphorylation;GO:0046488 phosphatidylinositol metabolic process;GO:0048488 synaptic vesicle endocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q9D2G5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q62393-1",
        "uniprot_id": "TPD52_MOUSE",
        "mass": 24313.0,
        "length": 224,
        "protein_name": "Tumor protein D52",
        "gene_name": "Tpd52",
        "organism": "Mouse",
        "refseq_name": "tumor protein D52 isoform 2",
        "refseq_ac": "NP_001020433",
        "gene_names_uniprotkb": "Tpd52",
        "gene_names_refseq": "Tpd52; mD52",
        "protein_names_uniprotkb": "Tumor protein D52; mD52",
        "protein_names_refseq": "tumor protein D52 isoform 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:21985);  (R-MMU-432722)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "17314271;21183079;21750661;26183179;28798933;30084848;34428180;8632896;8812487",
        "class_list": "",
        "function": "Findings uncover a new isoform-specific role for TPD52 in promoting intracellular lipid storage, which might be relevant to TPD52 overexpression in cancer., [RefSeq, PubMed]; The important roles of TPD52 and TPD54, which work oppositely, in the terminal differentiation of chondrocytes during endochondral ossification., [RefSeq, PubMed]; Together, these data suggest that mD52 expression in 3T3 cells initiated cellular transformation, tumorigenesis, and progression to metastasis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q545M5;Q8CCU1;Q8K564;Q99KP8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0005509 calcium ion binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0045202 synapse;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0008284 positive regulation of cell population proliferation;GO:0030183 B cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q62393-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q924X7-1",
        "uniprot_id": "STK33_MOUSE",
        "mass": 54459.0,
        "length": 491,
        "protein_name": "Serine/threonine-protein kinase 33",
        "gene_name": "Stk33",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase 33 isoform 1",
        "refseq_ac": "NP_473444",
        "gene_names_uniprotkb": "Stk33",
        "gene_names_refseq": "4921505G21Rik; Stk33",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase 33; 2.7.11.1",
        "protein_names_refseq": "serine/threonine-protein kinase 33 isoform 1; serine/threonine-protein kinase 33",
        "tax_id": 10090,
        "disease": "spermatogenic failure 93 (Disease Ontology:DOID:0070592); depressive disorder (Disease Ontology:DOID:1596); colorectal cancer (Disease Ontology:DOID:9256)",
        "pathway": " (mmu:117229)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "11528127;11738831;16176263;18811945;21183079;21750661;29155043;30256516;37146716;38781365",
        "class_list": "",
        "function": "He findings from this work indicate that STK33 decreases the sensitivity to the apoptosis dependent on mitochondrial apoptotic pathway by regulating ROS generation after gentamicin treatment, which provides a new potential target for protection from the aminoglycoside-induced ototoxicity., [RefSeq, PubMed]; STK33 Phosphorylates Fibrous Sheath Protein AKAP3/4 to Regulate Sperm Flagella Assembly in Spermiogenesis., [RefSeq, PubMed]; STK33/Stk33 expression pattern resembles those of some related members of the calcium/calmodulin dependent kinase group, [RefSeq, PubMed]; Serine/threonine protein kinase required for spermatid differentiation and male fertility (PubMed:29155043, PubMed:37146716, PubMed:38781365). Promotes sperm flagella assembly during spermatogenesis by mediating phosphorylation of fibrous sheath proteins AKAP3 and AKAP4 (PubMed:37146716). Also phosphorylates vimentin/VIM, thereby regulating the dynamic behavior of the intermediate filament cytoskeleton (PubMed:18811945)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; Serine/threonine protein kinase required for spermatid differentiation and male fertility. Promotes sperm flagella assembly during spermatogenesis by mediating phosphorylation of fibrous sheath proteins AKAP3 and AKAP4. Also phosphorylates vimentin/VIM, thereby regulating the dynamic behavior of the intermediate filament cytoskeleton., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q4A1D4",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0048471 perinuclear region of cytoplasm;GO:0002177 manchette",
        "go_biological_process": "GO:0044773 mitotic DNA damage checkpoint signaling;GO:0007283 spermatogenesis;GO:0046777 protein autophosphorylation;GO:0032435 negative regulation of proteasomal ubiquitin-dependent protein catabolic process;GO:1905198 manchette assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q924X7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99LQ4-1",
        "uniprot_id": "SVBP_MOUSE",
        "mass": 7836.0,
        "length": 66,
        "protein_name": "Small vasohibin-binding protein",
        "gene_name": "Svbp",
        "organism": "Mouse",
        "refseq_name": "small vasohibin-binding protein isoform b",
        "refseq_ac": "NP_077782",
        "gene_names_uniprotkb": "Svbp; Ccdc23",
        "gene_names_refseq": "2410005K17Rik; Ccdc23; Svbp",
        "protein_names_uniprotkb": "Small vasohibin-binding protein; Coiled coil domain-containing protein 23",
        "protein_names_refseq": "coiled-coil domain containing 23; coiled-coil domain-containing protein 23; small vasohibin-binding protein isoform b",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69216)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "20736312;21750661;29146868;31235911;31324789;31363758;35482892",
        "class_list": "",
        "function": "Enhances the tyrosine carboxypeptidase activity of VASH1 and VASH2, thereby promoting the removal of the C-terminal tyrosine residue of alpha-tubulin (PubMed:29146868, PubMed:31363758, PubMed:35482892). Also required to enhance the solubility and secretion of VASH1 and VASH2 (By similarity). Plays a role in axon and excitatory synapse formation (PubMed:31235911)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008017 microtubule binding;GO:0016504 peptidase activator activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0005856 cytoskeleton;GO:0045177 apical part of cell",
        "go_biological_process": "GO:0006508 proteolysis;GO:0007420 brain development;GO:0010596 negative regulation of endothelial cell migration;GO:0009306 protein secretion;GO:0031397 negative regulation of protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q99LQ4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CHC4-1",
        "uniprot_id": "SYNJ1_MOUSE",
        "mass": 172617.0,
        "length": 1574,
        "protein_name": "Polyphosphatidylinositol phosphatase SYNJ1",
        "gene_name": "Synj1",
        "organism": "Mouse",
        "refseq_name": "synaptojanin-1 isoform b",
        "refseq_ac": "NP_001038980",
        "gene_names_uniprotkb": "Synj1; Kiaa0910",
        "gene_names_refseq": "A930006D20Rik; Synj1; mKIAA0910",
        "protein_names_uniprotkb": "Polyphosphatidylinositol phosphatase SYNJ1; 3.1.3.-; 3.1.3.95; Inositol polyphosphate-5-phosphatase G; Phosphatidylinositol-3,5-bisphosphate 3-phosphatase SYNJ1; Phosphatidylinositol-4-phosphatase SYNJ1; Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1; Synaptojanin-1",
        "protein_names_refseq": "synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1; synaptojanin-1 isoform b",
        "tax_id": 10090,
        "disease": "early-onset Parkinson's disease (Disease Ontology:DOID:0060894); Parkinson's disease 20 (Disease Ontology:DOID:0060898); developmental and epileptic encephalopathy 53 (Disease Ontology:DOID:0080464); Down syndrome (Disease Ontology:DOID:14250); Parkinson's disease (Disease Ontology:DOID:14330)",
        "pathway": " (mmu:104015);  (R-MMU-1660499);  (R-MMU-1855183);  (R-MMU-1855204);  (R-MMU-8856828)",
        "pathway_count": 5,
        "publication_count": 28,
        "publication_id_list": "10.1101/2023.09.13.557529;10535736;11082044;17114649;17242355;18034455;18093523;21183079;21750661;22517741;22645316;24129315;25428506;26740625;29953872;30084848;31599954;32782141;32848054;33300544;34428180;35820727;36852467;37072173;37419331;38635628;40021952;40885482",
        "class_list": "",
        "function": "Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons., [RefSeq, PubMed]; Phosphatase that acts on various phosphoinositides, including phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate. Has a role in clathrin-mediated endocytosis. Hydrolyzes PIP2 bound to actin regulatory proteins resulting in the rearrangement of actin filaments downstream of tyrosine kinase and ASH/GRB2., [UniProtKB, UniProtKB, UniProtKB]; Phosphatase that hydrolyzes phosphate groups from the inositol ring of phosphoinositides and inositol phosphates, in a domain-specific manner (PubMed:10535736). The 5-PPase domain catalyzes removal of the 5-phosphate from substrates such as phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2), phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3), inositol-1,4,5-trisphosphate (Ins(1,4,5)P3) and inositol-1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4) (PubMed:10535736). The SAC domain hydrolyzes phosphates at the 3- and 4-positions of the inositol ring, targeting phosphatidylinositol-3-phosphate (PI(3)P), phosphatidylinositol-4-phosphate (PI(4)P), phosphatidylinositol-3,5-bisphosphate (PI(3,5)P2) and their derived compounds (By similarity). Participes in the phosphatidylinositol metabolic process during an unconventional endocytic mechanism, the ultrafast endocytosis where participates in the rapide neck formation of the newly generated synaptic vesicle through its phosphoinositide 5-phosphatase activity (PubMed:10535736, PubMed:18093523, PubMed:29953872). Also, participates in the clathrin uncoating of synaptc vesicle formed via budding from synaptic endosomes after ultrafast endocytosis through combined activity of its phosphatase domains (PubMed:10535736, PubMed:18093523, PubMed:29953872). Additionally, regulates actin filament rearrangement by hydrolyzing PIP2 bound to actin regulatory proteins (By similarity)., [UniProtKB, UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; SYNJ1 rescues motor functions in hereditary and sporadic Parkinson's disease mice by upregulating TSP-1 expression., [RefSeq, PubMed]; Synaptojanin1 Modifies Endolysosomal Parameters in Cultured Ventral Midbrain Neurons. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 10,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 10,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 10,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 9,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 5,
        "glyco_site_count": 13,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9Q7S0",
        "ec_number_list": "3.1.3.67;3.1.3.86;3.1.3.95;3.1.3.36;3.1.3.56;3.1.3.16;3.1.3.27;3.1.3.48;3.1.3.-;3.1.3.64",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0017124 SH3 domain binding;GO:0044877 protein-containing complex binding;GO:0034595 phosphatidylinositol phosphate 5-phosphatase activity;GO:1990175 EH domain binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0030118 clathrin coat;GO:0005737 cytoplasm;GO:0005874 microtubule;GO:0016020 membrane",
        "go_biological_process": "GO:0031161 phosphatidylinositol catabolic process;GO:0007612 learning;GO:0032526 response to retinoic acid;GO:0034097 response to cytokine;GO:0048015 phosphatidylinositol-mediated signaling",
        "synthesized_glycan_count": 0,
        "hit_score": 4.2,
        "record_id": "Q8CHC4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WTK7-1",
        "uniprot_id": "STK11_MOUSE",
        "mass": 49267.0,
        "length": 436,
        "protein_name": "Serine/threonine-protein kinase STK11",
        "gene_name": "Stk11",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase STK11 isoform S",
        "refseq_ac": "NP_001288782",
        "gene_names_uniprotkb": "Stk11; Lkb1",
        "gene_names_refseq": "Lkb1; Par-4; Stk11",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase STK11; 2.7.11.1; LKB1; Liver kinase B1 homolog; mLKB1",
        "protein_names_refseq": "liver kinase B1 homolog; serine/threonine-protein kinase 11; serine/threonine-protein kinase LKB1; serine/threonine-protein kinase STK11 isoform S; serine/threonine-protein kinase STK11",
        "tax_id": 10090,
        "disease": "endometrial cancer (Disease Ontology:DOID:1380); pancreatic cancer (Disease Ontology:DOID:1793); breast carcinoma (Disease Ontology:DOID:3459); cervical mucinous adenocarcinoma (Disease Ontology:DOID:3701); Peutz-Jeghers syndrome (Disease Ontology:DOID:3852); ovarian carcinoma (Disease Ontology:DOID:4001); familial melanoma (Disease Ontology:DOID:6846); hyperthyroidism (Disease Ontology:DOID:7998); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:20869);  (R-MMU-380972);  (R-MMU-6804756)",
        "pathway_count": 3,
        "publication_count": 38,
        "publication_id_list": "10381580;10400995;10642527;11297520;11509733;11853558;11956081;12060709;12218179;12226664;12234250;15345747;15480979;16308421;17482548;17482549;18687677;18774945;18854309;19144319;20142099;20864035;21183079;21487392;21750661;22611470;24093678;24295069;24586906;25002183;25329316;27849007;29777910;31219806;32841502;34428180;36210013;37828378",
        "class_list": "",
        "function": "Has a role in spermiogenesis., [UniProtKB, PubMed]; LKB1(S) is a novel form in which last 63 residues are replaced by unique 39-residue sequence lacking known phosphorylation & farnesylation sites. Both isoforms are widely expressed in rodent & human, LKB1(S) is particularly abundant in haploid spermatids., [RefSeq, PubMed]; The physiological significance of the different forms of LKB1 is not related directly to differences in the C-terminal sequences but may be due to their differential patterns of tissue distribution., [RefSeq, PubMed]; This gene encodes a member of the serine/threonine kinase family. The encoded protein, a known tumor suppressor, activates (via phosphorylation) adenine monophosphate-activated protein kinase (AMPK) and AMPK-related kinase proteins. This upstream regulation of the AMPK pathway is thought to regulate a number of different processes, including cell metabolism, cell polarity, apoptosis and DNA damage response. Mutations in a similar gene in human have been associated with Peutz-Jeghers syndrome. Alternative splicing results in multiple transcript variants, including the S isoform which plays a potential role in spermiogenesis. [provided by RefSeq, Sep 2014]., [RefSeq]; Tumor suppressor serine/threonine-protein kinase that controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response (PubMed:16308421). Acts by phosphorylating the T-loop of AMPK family proteins, thus promoting their activity: phosphorylates PRKAA1, PRKAA2, BRSK1, BRSK2, MARK1, MARK2, MARK3, MARK4, NUAK1, NUAK2, SIK1, SIK2, SIK3 and SNRK but not MELK (PubMed:24093678, PubMed:25002183). Also phosphorylates non-AMPK family proteins such as STRADA, PTEN and possibly p53/TP53 (By similarity). Acts as a key upstream regulator of AMPK by mediating phosphorylation and activation of AMPK catalytic subunits PRKAA1 and PRKAA2 and thereby regulates processes including: inhibition of signaling pathways that promote cell growth and proliferation when energy levels are low, glucose homeostasis in liver, activation of autophagy when cells undergo nutrient deprivation, and B-cell differentiation in the germinal center in response to DNA damage (PubMed:20864035, PubMed:24093678, PubMed:25002183). Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton (By similarity). Required for cortical neuron polarization by mediating phosphorylation and activation of BRSK1 and BRSK2, leading to axon initiation and specification (PubMed:17482548, PubMed:17482549). Involved in DNA damage response: interacts with p53/TP53 and recruited to the CDKN1A/WAF1 promoter to participate in transcription activation (By similarity). Able to phosphorylate p53/TP53; the relevance of such result in vivo is however unclear and phosphorylation may be indirect and mediated by downstream STK11/LKB1 kinase NUAK1 (By similarity). Also acts as a mediator of p53/TP53-dependent apoptosis via interaction with p53/TP53: translocates to the mitochondrion during apoptosis and regulates p53/TP53-dependent apoptosis pathways (By similarity). Regulates UV radiation-induced DNA damage response mediated by CDKN1A (PubMed:25329316). In association with NUAK1, phosphorylates CDKN1A in response to UV radiation and contributes to its degradation which is necessary for optimal DNA repair (PubMed:25329316)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 14,
        "reported_mutagensis": 8,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 9,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A2L1DGD8;B3VBP0;Q3TAE0",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0030295 protein kinase activator activity;GO:0044877 protein-containing complex binding",
        "go_cellular_component": "GO:1902554 serine/threonine protein kinase complex;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion",
        "go_biological_process": "GO:0051896 regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;GO:0060770 negative regulation of epithelial cell proliferation involved in prostate gland development;GO:0071493 cellular response to UV-B;GO:0006468 protein phosphorylation;GO:0007165 signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 3.9,
        "record_id": "Q9WTK7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DBG3-1",
        "uniprot_id": "AP2B1_MOUSE",
        "mass": 104583.0,
        "length": 937,
        "protein_name": "AP-2 complex subunit beta",
        "gene_name": "Ap2b1",
        "organism": "Mouse",
        "refseq_name": "AP-2 complex subunit beta isoform a",
        "refseq_ac": "NP_001030931",
        "gene_names_uniprotkb": "Ap2b1; Clapb1",
        "gene_names_refseq": "1300012O03Rik; AP105B; Ap2b1",
        "protein_names_uniprotkb": "AP-2 complex subunit beta; AP105B; Adaptor protein complex AP-2 subunit beta; Adaptor-related protein complex 2 subunit beta; Beta-2-adaptin; Beta-adaptin; Clathrin assembly protein complex 2 beta large chain; Plasma membrane adaptor HA2/AP2 adaptin beta subunit",
        "protein_names_refseq": "AP-2 complex subunit beta isoform a; AP-2 complex subunit beta; adapter-related protein complex 2 beta subunit; adapter-related protein complex 2 subunit beta; adaptor protein complex AP-2 subunit beta; adaptor-related protein complex 2 subunit beta; beta-2-adaptin; beta-adaptin; beta2-adaptin; clathrin assembly protein complex 2 beta large chain; plasma membrane adaptor HA2/AP2 adaptin beta subunit",
        "tax_id": 10090,
        "disease": "middle cerebral artery infarction (Disease Ontology:DOID:3525)",
        "pathway": " (mmu:71770);  (R-MMU-177504);  (R-MMU-2132295);  (R-MMU-416993);  (R-MMU-437239);  (R-MMU-5099900);  (R-MMU-5140745);  (R-MMU-8856825);  (R-MMU-8856828);  (R-MMU-8866427);  (R-MMU-8964038)",
        "pathway_count": 11,
        "publication_count": 24,
        "publication_id_list": "10.1101/2023.09.13.557529;14745134;15473838;21750661;23676497;25428506;26495903;26740625;28011936;28935714;29262337;30084848;30779550;31219806;33300544;34105348;34428180;34887587;35984892;37453647;37507081;37828378;39627609;40997131",
        "class_list": "",
        "function": "Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. During long-term potentiation in hippocampal neurons, AP-2 is responsible for the endocytosis of ADAM10 (PubMed:23676497). The AP-2 beta subunit acts via its C-terminal appendage domain as a scaffolding platform for endocytic accessory proteins; at least some clathrin-associated sorting proteins (CLASPs) are recognized by their [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif. The AP-2 beta subunit binds to clathrin heavy chain, promoting clathrin lattice assembly; clathrin displaces at least some CLASPs from AP2B1 which probably then can be positioned for further coat assembly (By similarity)., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80XJ4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0044877 protein-containing complex binding;GO:0030276 clathrin binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0030118 clathrin coat;GO:0045202 synapse;GO:0009898 cytoplasmic side of plasma membrane;GO:0030122 AP-2 adaptor complex",
        "go_biological_process": "GO:0098884 postsynaptic neurotransmitter receptor internalization;GO:0006886 intracellular protein transport;GO:0007507 heart development;GO:0001822 kidney development;GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 3.1,
        "record_id": "Q9DBG3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P32233-1",
        "uniprot_id": "DRG1_MOUSE",
        "mass": 40512.0,
        "length": 367,
        "protein_name": "Developmentally-regulated GTP-binding protein 1",
        "gene_name": "Drg1",
        "organism": "Mouse",
        "refseq_name": "developmentally-regulated GTP-binding protein 1",
        "refseq_ac": "NP_031905",
        "gene_names_uniprotkb": "Drg1; Drg; Nedd-3; Nedd3",
        "gene_names_refseq": "DRG-1; Drg1; NEDD-3; Nedd3",
        "protein_names_uniprotkb": "Developmentally-regulated GTP-binding protein 1; 3.6.5.-; DRG-1; NEDD-3; Neural precursor cell expressed developmentally down-regulated protein 3; TRAFAC GTPase DRG1; Translation factor GTPase DRG1",
        "protein_names_refseq": "GTP-binding protein; TRAFAC GTPase DRG1; developmentally-regulated GTP-binding protein 1; neural precursor cell expressed developmentally down-regulated protein 3; translation factor GTPase DRG1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13494);  (R-MMU-9629569)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "1280421;1449490;15676025;19224205;20173027;21750661;25428506;25605945;29187734;30084848;30779550;34428180;37179472;37453647",
        "class_list": "",
        "function": "Catalyzes the conversion of GTP to GDP through hydrolysis of the gamma-phosphate bond in GTP. Appears to have an intrinsic GTPase activity that is stimulated by ZC3H15/DFRP1 binding likely by increasing the affinity for the potassium ions. When hydroxylated at C-3 of 'Lys-22' by JMJD7, may bind to RNA and play a role in translation. Binds to microtubules and promotes microtubule polymerization and bundling that are required for mitotic spindle assembly during prophase to anaphase transition. GTPase activity is not necessary for these microtubule-related functions., [UniProtKB, UniProtKB]; Inactivation of DRG1, encoding a translation factor GTPase, causes a recessive neurodevelopmental disorder., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.6.5.-;3.6.5.2;3.6.5.3;3.6.1.5;3.4.-.-;1.14.11.63;3.6.5.4;3.6.5.5;3.6.1.-;3.6.1.15;2.7.11.1;3.6.-.-",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0008017 microtubule binding;GO:0042802 identical protein binding;GO:0030955 potassium ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016604 nuclear body",
        "go_biological_process": "GO:0031116 positive regulation of microtubule polymerization;GO:1901673 regulation of mitotic spindle assembly;GO:0002181 cytoplasmic translation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "P32233-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P70663-1",
        "uniprot_id": "SPRL1_MOUSE",
        "mass": 72287.0,
        "length": 650,
        "protein_name": "SPARC-like protein 1",
        "gene_name": "Sparcl1",
        "organism": "Mouse",
        "refseq_name": "SPARC-like protein 1 precursor",
        "refseq_ac": "NP_034227",
        "gene_names_uniprotkb": "Sparcl1; Ecm2; Sc1",
        "gene_names_refseq": "Ecm2; Sc1; Sparcl1; hevin; mast9",
        "protein_names_uniprotkb": "SPARC-like protein 1; Extracellular matrix protein 2; Matrix glycoprotein Sc1",
        "protein_names_refseq": "SPARC-like 1 (mast9, hevin); SPARC-like protein 1 precursor; SPARC-like protein 1; extracellular matrix protein 2; matrix glycoprotein Sc1",
        "tax_id": 10090,
        "disease": "cardiomyopathy (Disease Ontology:DOID:0050700)",
        "pathway": " (mmu:13602);  (R-MMU-381426);  (R-MMU-8957275)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;21183079;21750661;22826440;26495903;30899004;34428180;8938431;9199668",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 8,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 11,
        "disease_count": 1,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QPH2;P97810;Q99L82",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005509 calcium ion binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005615 extracellular space;GO:0031012 extracellular matrix;GO:0098965 extracellular matrix of synaptic cleft",
        "go_biological_process": "GO:0007165 signal transduction;GO:0099560 synaptic membrane adhesion;GO:0050807 regulation of synapse organization",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "P70663-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q923Q2-1",
        "uniprot_id": "STA13_MOUSE",
        "mass": 125060.0,
        "length": 1113,
        "protein_name": "StAR-related lipid transfer protein 13",
        "gene_name": "Stard13",
        "organism": "Mouse",
        "refseq_name": "stAR-related lipid transfer protein 13 isoform 2",
        "refseq_ac": "NP_666370",
        "gene_names_uniprotkb": "Stard13",
        "gene_names_refseq": "DLC2; GT650; Stard13",
        "protein_names_uniprotkb": "StAR-related lipid transfer protein 13; START domain-containing protein 13; StARD13",
        "protein_names_refseq": "START domain-containing protein 13; StAR-related lipid transfer (START) domain containing 13; serologically defined colon cancer antigen 13; serologically defined colon cancer antigen 28; stAR-related lipid transfer protein 13 isoform 2; stAR-related lipid transfer protein 13",
        "tax_id": 10090,
        "disease": "gonadal dysgenesis (Disease Ontology:DOID:14447)",
        "pathway": " (mmu:243362);  (R-MMU-8980692);  (R-MMU-9013026);  (R-MMU-9013106);  (R-MMU-9013148)",
        "pathway_count": 5,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;16217026;19250640;21183079;21750661;25428506;31323253",
        "class_list": "",
        "function": "May function as a GTPase-activating protein., [UniProtKB]; Results suggest that DLC2 exhibits its tumor suppressor functions in vivo as a GAP specific for RhoA, exerting its effects in suppression of cytoskeleton reorganization, cell growth, cell migration, and transformation., [RefSeq, PubMed]; Role of DLC2 and RhoA/ROCK pathway in formalin induced inflammatory pain in mice., [RefSeq, PubMed]; START-GAP2 is localized in focal adhesions through a 'FAT (focal adhesion targeting)' region in the N-terminal half., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9753,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9PUB5;Q8K369",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0008289 lipid binding",
        "go_cellular_component": "GO:0005811 lipid droplet;GO:0031966 mitochondrial membrane",
        "go_biological_process": "GO:0090051 negative regulation of cell migration involved in sprouting angiogenesis;GO:0097498 endothelial tube lumen extension;GO:0007165 signal transduction;GO:0030036 actin cytoskeleton organization;GO:0035023 regulation of Rho protein signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q923Q2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P70302-1",
        "uniprot_id": "STIM1_MOUSE",
        "mass": 77567.0,
        "length": 685,
        "protein_name": "Stromal interaction molecule 1",
        "gene_name": "Stim1",
        "organism": "Mouse",
        "refseq_name": "stromal interaction molecule 1 isoform 1 precursor",
        "refseq_ac": "NP_033313",
        "gene_names_uniprotkb": "Stim1; Sim",
        "gene_names_refseq": "SIM; Stim1",
        "protein_names_uniprotkb": "Stromal interaction molecule 1",
        "protein_names_refseq": "stromal interaction molecule 1 isoform 1 precursor",
        "tax_id": 10090,
        "disease": "Stormorken syndrome (Disease Ontology:DOID:0060354); tubular aggregate myopathy 1 (Disease Ontology:DOID:0080089); immunodeficiency 10 (Disease Ontology:DOID:0111970); stomach cancer (Disease Ontology:DOID:10534); hypertrophic cardiomyopathy (Disease Ontology:DOID:11984); nephrogenic diabetes insipidus (Disease Ontology:DOID:12387); dilated cardiomyopathy (Disease Ontology:DOID:12930); lung cancer (Disease Ontology:DOID:1324); lung non-small cell carcinoma (Disease Ontology:DOID:3908); hepatocellular carcinoma (Disease Ontology:DOID:684); gastrointestinal stromal tumor (Disease Ontology:DOID:9253); colorectal cancer (Disease Ontology:DOID:9256); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:20866);  (R-MMU-5578775);  (R-MMU-983695)",
        "pathway_count": 3,
        "publication_count": 23,
        "publication_id_list": "10.1101/2023.09.13.557529;17208939;17242355;21183079;21750661;24621671;26495903;26644563;28218251;29243589;30059200;30084848;30520731;30899004;31064875;31346090;33023909;33730587;34428180;36852467;39627609;39927985;8707854",
        "class_list": "",
        "function": "A short isoform of STIM1 confers frequency-dependent synaptic enhancement., [RefSeq, PubMed]; Acts as a Ca(2+) sensor that gates two major inward rectifying Ca(2+) channels at the plasma membrane: Ca(2+) release-activated Ca(2+) (CRAC) channels and arachidonate-regulated Ca(2+)-selective (ARC) channels. Plays a role in mediating store-operated Ca(2+) entry (SOCE), a Ca(2+) influx following depletion of intracellular Ca(2+) stores. Upon Ca(2+) depletion, translocates from the endoplasmic reticulum to the plasma membrane where it activates CRAC channel pore-forming subunits ORA1, ORA2 and ORAI3 to generate sustained and oscillatory Ca(2+) entry. Involved in enamel formation. Plays a role in regulating the type I interferon response by retaining the signaling adapter STING at the endoplasmic reticulum., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 21,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 8,
        "disease_count": 13,
        "glyco_site_count": 8,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8K1E1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0002020 protease binding;GO:0042802 identical protein binding;GO:0005246 calcium channel regulator activity;GO:0005509 calcium ion binding;GO:0051010 microtubule plus-end binding",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005874 microtubule;GO:0005886 plasma membrane;GO:0030426 growth cone;GO:0044853 plasma membrane raft",
        "go_biological_process": "GO:0007207 phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway;GO:0006874 intracellular calcium ion homeostasis;GO:0045766 positive regulation of angiogenesis;GO:0051924 regulation of calcium ion transport;GO:0006812 monoatomic cation transport",
        "synthesized_glycan_count": 0,
        "hit_score": 3.9,
        "record_id": "P70302-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P70452-1",
        "uniprot_id": "STX4_MOUSE",
        "mass": 34165.0,
        "length": 298,
        "protein_name": "Syntaxin-4",
        "gene_name": "Stx4a; Stx4",
        "organism": "Mouse",
        "refseq_name": "syntaxin-4 isoform 1",
        "refseq_ac": "NP_033320",
        "gene_names_uniprotkb": "Stx4a; Stx4; Stx4a",
        "gene_names_refseq": "Stx4a; Stx4; Syn-4; Syn4",
        "protein_names_uniprotkb": "Syntaxin-4",
        "protein_names_refseq": "syntaxin-4 isoform 1; syntaxin-4",
        "tax_id": 10090,
        "disease": "autosomal recessive nonsyndromic deafness (Disease Ontology:DOID:0050565)",
        "pathway": " (mmu:20909);  (R-MMU-114516);  (R-MMU-199992);  (R-MMU-449836)",
        "pathway_count": 4,
        "publication_count": 21,
        "publication_id_list": "10394363;11809830;12877659;15363411;17242355;17548353;18827011;19033398;19131326;19144319;21183079;21750661;21998599;30516436;31219806;34428180;36355422;37638825;38136609;38565851;9045631",
        "class_list": "",
        "function": "Involution of brown adipose tissue through a Syntaxin 4 dependent pyroptosis pathway. Publication Status: Online-Only, [RefSeq, PubMed]; Phosphorylation of Syntaxin 4 by the Insulin Receptor Drives Exocytic SNARE Complex Formation to Deliver GLUT4 to the Cell Surface. Publication Status: Online-Only, [RefSeq, PubMed]; Plasma membrane t-SNARE that mediates docking of transport vesicles. Necessary for the translocation of SLC2A4 from intracellular vesicles to the plasma membrane. In neurons, recruited at neurite tips to membrane domains rich in the phospholipid 1-oleoyl-2-palmitoyl-PC (OPPC) which promotes neurite tip surface expression of the dopamine transporter SLC6A3/DAT by facilitating fusion of SLC6A3-containing transport vesicles with the plasma membrane (By similarity). Together with STXB3 and VAMP2, may also play a role in docking/fusion of intracellular GLUT4-containing vesicles with the cell surface in adipocytes and in docking of synaptic vesicles at presynaptic active zones. Required for normal hearing (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB, PubMed]; Sec22b and Stx4 Depletion Has No Major Effect on Cross-Presentation of PLGA Microsphere-Encapsulated Antigen and a Synthetic Long Peptide In Vitro., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TSL5;Q3UKQ8;Q80WT8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0016230 sphingomyelin phosphodiesterase activator activity;GO:0000149 SNARE binding;GO:0005484 SNAP receptor activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0032589 neuron projection membrane;GO:0005615 extracellular space;GO:0005768 endosome;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0008284 positive regulation of cell population proliferation;GO:0030335 positive regulation of cell migration;GO:0045785 positive regulation of cell adhesion;GO:2000010 positive regulation of protein localization to cell surface",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "P70452-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64310-1",
        "uniprot_id": "SURF4_MOUSE",
        "mass": 30381.0,
        "length": 269,
        "protein_name": "Surfeit locus protein 4",
        "gene_name": "Surf4",
        "organism": "Mouse",
        "refseq_name": "surfeit locus protein 4 isoform 1",
        "refseq_ac": "NP_035642",
        "gene_names_uniprotkb": "Surf4; Surf-4",
        "gene_names_refseq": "Surf-4; Surf4",
        "protein_names_uniprotkb": "Surfeit locus protein 4",
        "protein_names_refseq": "surfeit locus protein 4 isoform 1; surfeit locus protein 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:20932);  (R-MMU-6798695);  (R-MMU-6811434)",
        "pathway_count": 3,
        "publication_count": 17,
        "publication_id_list": "20173027;21750661;21976701;2300057;25428506;26740625;27802388;30084848;30779550;31599954;31978056;33186557;33300544;34428180;35820727;38042368;7540914",
        "class_list": "",
        "function": "Endoplasmic reticulum cargo receptor that mediates the export of lipoproteins by recruiting cargos into COPII vesicles to facilitate their secretion. Acts as a cargo receptor for lipoproteins bearing both APOB and APOA1, thereby regulating lipoprotein delivery and the maintenance of lipid homeostasis. Synergizes with the GTPase SAR1B to mediate transport of circulating lipoproteins (PubMed:33186557). Promotes the secretion of PCSK9. Also mediates the efficient secretion of erythropoietin (EPO). May also play a role in the maintenance of the architecture of the endoplasmic reticulum-Golgi intermediate compartment and of the Golgi., [UniProtKB, UniProtKB, PubMed]; Intestinal SURF4 is essential for apolipoprotein transport and lipoprotein secretion., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0038024 cargo receptor activity;GO:0097020 COPII receptor activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0005829 cytosol;GO:0030134 COPII-coated ER to Golgi transport vesicle",
        "go_biological_process": "GO:0032368 regulation of lipid transport;GO:0090110 COPII-coated vesicle cargo loading;GO:0042953 lipoprotein transport;GO:0055088 lipid homeostasis;GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "Q64310-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P13609-1",
        "uniprot_id": "SRGN_MOUSE",
        "mass": 16711.0,
        "length": 152,
        "protein_name": "Serglycin",
        "gene_name": "Srgn",
        "organism": "Mouse",
        "refseq_name": "serglycin isoform b precursor",
        "refseq_ac": "NP_035287",
        "gene_names_uniprotkb": "Srgn; Prg1; Prg",
        "gene_names_refseq": "Prg1; Prg; Sgc; Srgn",
        "protein_names_uniprotkb": "Serglycin; Mastocytoma proteoglycan core protein; Secretory granule proteoglycan core protein; gp600",
        "protein_names_refseq": "gp600; mastocytoma proteoglycan core protein; proteoglycan 1, secretory granule; proteoglycan, secretory granule; secretory granule proteoglycan core protein; serglycin isoform b precursor",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:19073);  (R-MMU-114608)",
        "pathway_count": 2,
        "publication_count": 16,
        "publication_id_list": "15231821;16046402;16807245;17010166;17081126;17147513;17272511;2121613;21750661;2532501;2726751;2777804;34872979;38287411;7535771;8502243",
        "class_list": "glycogene",
        "function": "Plays a role in formation of mast cell secretory granules and mediates storage of various compounds in secretory vesicles. Required for storage of some proteases in both connective tissue and mucosal mast cells and for storage of granzyme B in T-lymphocytes. Plays a role in localizing neutrophil elastase in azurophil granules of neutrophils. Mediates processing of MMP2. Plays a role in cytotoxic cell granule-mediated apoptosis by forming a complex with granzyme B which is delivered to cells by perforin to induce apoptosis. Regulates the secretion of TNF and may also regulate protease secretion. Inhibits bone mineralization., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; SRGN amplifies microglia-mediated neuroinflammation and exacerbates ischemic brain injury. Publication Status: Online-Only, [RefSeq, PubMed]; Serglycin Is Involved in Adipose Tissue Inflammation in Obesity., [RefSeq, PubMed]",
        "predicted_glycosites": 8,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 8,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 11,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 8,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TZD4;Q8C2U2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005518 collagen binding",
        "go_cellular_component": "GO:0042588 zymogen granule;GO:0000139 Golgi membrane;GO:0005615 extracellular space;GO:0005794 Golgi apparatus;GO:0030141 secretory granule",
        "go_biological_process": "GO:0016485 protein processing;GO:0006915 apoptotic process;GO:0031214 biomineral tissue development;GO:0033363 secretory granule organization;GO:0033371 T cell secretory granule organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "P13609-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O55106-1",
        "uniprot_id": "STRN_MOUSE",
        "mass": 85966.0,
        "length": 780,
        "protein_name": "Striatin",
        "gene_name": "Strn",
        "organism": "Mouse",
        "refseq_name": "striatin isoform 1",
        "refseq_ac": "NP_035630",
        "gene_names_uniprotkb": "Strn",
        "gene_names_refseq": "D130055P19; Strn",
        "protein_names_uniprotkb": "Striatin",
        "protein_names_refseq": "striatin isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:268980);  (R-MMU-1257604);  (R-MMU-6811558);  (R-MMU-9009391)",
        "pathway_count": 4,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;10748158;17242355;21183079;21750661;22089104;22645316;31219806;32782141;34428180",
        "class_list": "",
        "function": "Calmodulin-binding scaffolding protein which is the center of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; These results provide evidence that increased striatin levels is a component of MR activation in the vasculature and suggest that regulation of striatin by ALDO may modulate estrogen's nongenomic effects., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RWV9;Q5BKR9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005516 calmodulin binding;GO:0019904 protein domain specific binding;GO:0030674 protein-macromolecule adaptor activity;GO:0044877 protein-containing complex binding;GO:0051721 protein phosphatase 2A binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005737 cytoplasm;GO:0005923 bicellular tight junction;GO:0014069 postsynaptic density;GO:0030425 dendrite",
        "go_biological_process": "GO:0007626 locomotory behavior;GO:0008285 negative regulation of cell population proliferation;GO:0016358 dendrite development;GO:0016055 Wnt signaling pathway;GO:0009966 regulation of signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "O55106-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O70439-1",
        "uniprot_id": "STX7_MOUSE",
        "mass": 29821.0,
        "length": 261,
        "protein_name": "Syntaxin-7",
        "gene_name": "Stx7",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Stx7; Syn7",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Syntaxin-7",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "cancer (Disease Ontology:DOID:162); carcinoma (Disease Ontology:DOID:305)",
        "pathway": " (mmu:53331)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "11786915;15345747;15363411;16393994;17242355;19144319;21183079;21750661;26495903;26740625;28855648",
        "class_list": "",
        "function": "May be involved in protein trafficking from the plasma membrane to the early endosome (EE) as well as in homotypic fusion of endocytic organelles. Mediates the endocytic trafficking from early endosomes to late endosomes and lysosomes (By similarity)., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 8,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019869 chloride channel inhibitor activity;GO:0044877 protein-containing complex binding;GO:0019905 syntaxin binding;GO:0000149 SNARE binding;GO:0005484 SNAP receptor activity",
        "go_cellular_component": "GO:0005768 endosome;GO:0005769 early endosome;GO:0005886 plasma membrane;GO:0048471 perinuclear region of cytoplasm;GO:0055037 recycling endosome",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0008333 endosome to lysosome transport;GO:0001916 positive regulation of T cell mediated cytotoxicity;GO:0016192 vesicle-mediated transport;GO:1903076 regulation of protein localization to plasma membrane",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "O70439-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q05738-1",
        "uniprot_id": "SRY_MOUSE",
        "mass": 49124.0,
        "length": 392,
        "protein_name": "Sex-determining region Y protein",
        "gene_name": "Sry",
        "organism": "Mouse",
        "refseq_name": "sex-determining region Y protein",
        "refseq_ac": "NP_035694",
        "gene_names_uniprotkb": "Sry; Tdf; Tdy",
        "gene_names_refseq": "Sry; Tdf; Tdy",
        "protein_names_uniprotkb": "Sex-determining region Y protein; Testis-determining factor",
        "protein_names_refseq": "sex-determining region Y protein; testis determining-Y; testis-determining factor",
        "tax_id": 10090,
        "disease": "46,XX sex reversal 1 (Disease Ontology:DOID:0111761); 46,XY sex reversal 1 (Disease Ontology:DOID:0111778); 46,XY complete gonadal dysgenesis (Disease Ontology:DOID:14448)",
        "pathway": " (mmu:21674);  (R-MMU-3769402)",
        "pathway_count": 2,
        "publication_count": 21,
        "publication_id_list": "11085593;11535586;11784049;15170344;1518820;15297880;15469996;16166090;16414182;16488877;16904257;16996051;19349578;2374589;33004521;7600978;7670499;8012385;8159753;8190643;8355784",
        "class_list": "",
        "function": "Constitutes a minor isoform, which is unstable due to the presence of a degron at the C-terminus that promotes its degradation (PubMed:33004521). Not necessary and sufficient for initiating male sex determination (PubMed:33004521)., [UniProtKB, PubMed]; Constitutes the major isoform, which is necessary and sufficient for initiating male sex determination., [UniProtKB, PubMed]; Transcriptional regulator that controls a genetic switch in male development (PubMed:33004521). It is necessary and sufficient for initiating male sex determination by directing the development of supporting cell precursors (pre-Sertoli cells) as Sertoli rather than granulosa cells (PubMed:33004521). Involved in different aspects of gene regulation including promoter activation or repression (PubMed:15170344, PubMed:8159753, PubMed:8190643). Binds to the DNA consensus sequence 5'-[AT]AACAA[AT]-3' (PubMed:15170344, PubMed:8159753, PubMed:8190643). SRY HMG box recognizes DNA by partial intercalation in the minor groove and promotes DNA bending (PubMed:15170344, PubMed:8159753, PubMed:8190643). Also involved in pre-mRNA splicing (By similarity). In male adult brain involved in the maintenance of motor functions of dopaminergic neurons (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008301 DNA binding, bending;GO:0003677 DNA binding;GO:0005516 calmodulin binding;GO:0019899 enzyme binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0016607 nuclear speck;GO:0005667 transcription regulator complex",
        "go_biological_process": "GO:0007530 sex determination;GO:2000020 positive regulation of male gonad development;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0007283 spermatogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "Q05738-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q4FZF2-1",
        "uniprot_id": "SPT46_MOUSE",
        "mass": 22997.0,
        "length": 204,
        "protein_name": "Spermatogenesis-associated protein 46",
        "gene_name": "Spata46",
        "organism": "Mouse",
        "refseq_name": "spermatogenesis-associated protein 46",
        "refseq_ac": "NP_001034682",
        "gene_names_uniprotkb": "Spata46",
        "gene_names_refseq": "1700015E13Rik; Spata46",
        "protein_names_uniprotkb": "Spermatogenesis-associated protein 46",
        "protein_names_refseq": "spermatogenesis-associated protein 46; uncharacterized protein C1orf111 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76925)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "27488028;35820727",
        "class_list": "",
        "function": "In the present study, we demonstrated that deletion of Spata46, a gene encoding a novel protein of unknown function found in mouse testis, was responsible for male subfertility, and the cause of subfertility was characterized as abnormal sperm head shape and a failure of sperm-egg fusion., [RefSeq, PubMed]; Plays a role in spermiogenesis and fertilization., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0031965 nuclear membrane",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0007342 fusion of sperm to egg plasma membrane involved in single fertilization;GO:0009566 fertilization;GO:0030154 cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q4FZF2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z0G2-1",
        "uniprot_id": "SRPK3_MOUSE",
        "mass": 62365.0,
        "length": 565,
        "protein_name": "SRSF protein kinase 3",
        "gene_name": "Srpk3",
        "organism": "Mouse",
        "refseq_name": "SRSF protein kinase 3 isoform 2",
        "refseq_ac": "NP_062658",
        "gene_names_uniprotkb": "Srpk3; Mssk1; Stk23",
        "gene_names_refseq": "Mssk1; Srpk3; Stk23",
        "protein_names_uniprotkb": "SRSF protein kinase 3; 2.7.11.1; MSSK-1; Muscle-specific serine kinase 1; SR-protein-specific kinase 3; Serine/arginine-rich protein-specific kinase 3; Serine/threonine-protein kinase 23",
        "protein_names_refseq": "SR-protein-specific kinase 3; SRSF protein kinase 3 isoform 2; SRSF protein kinase 3; muscle-specific serine kinase 1; serine/threonine kinase 23, muscle-specific serine kinase 1 70; serine/threonine-protein kinase 23; serine/threonine-protein kinase SRPK3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56504)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "16140986;21183079;30059200;34428180;34502283;36369636",
        "class_list": "",
        "function": "Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model., [RefSeq, PubMed]; Normal muscle growth and homeostasis require MEF2-dependent signaling by Srpk3, [RefSeq, PubMed]; Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains. Phosphorylates the SR splicing factor SRSF1 and the lamin-B receptor (LBR) in vitro. Required for normal muscle development., [UniProtKB, PubMed]; Srpk3 Decrease Associated with Alpha-Synuclein Increase in Muscles of MPTP-Induced Parkinson's Disease Mice. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006468 protein phosphorylation;GO:0030154 cell differentiation;GO:0035556 intracellular signal transduction;GO:0000245 spliceosomal complex assembly;GO:0060537 muscle tissue development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q9Z0G2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O70306-1",
        "uniprot_id": "TBX15_MOUSE",
        "mass": 65802.0,
        "length": 602,
        "protein_name": "T-box transcription factor TBX15",
        "gene_name": "Tbx15",
        "organism": "Mouse",
        "refseq_name": "T-box transcription factor TBX15 isoform 1",
        "refseq_ac": "NP_033349",
        "gene_names_uniprotkb": "Tbx15; Tbx14; Tbx8",
        "gene_names_refseq": "Tbx14; Tbx15; Tbx8; de; mmTBx8",
        "protein_names_uniprotkb": "T-box transcription factor TBX15; MmTBx8; T-box protein 14; T-box protein 15; T-box transcription factor TBX14",
        "protein_names_refseq": "T-box 14; T-box protein 14; T-box protein 15; T-box transcription factor TBX14; T-box transcription factor TBX15 isoform 1; T-box transcription factor TBX15; droopy ear",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:21384)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "15652702;17584735;21750661;25428506;30084848;34203471;34428180;9503012;9693034",
        "class_list": "",
        "function": "Probable transcriptional regulator involved in the development of the skeleton of the limb, vertebral column and head. Acts by controlling the number of mesenchymal precursor cells and chondrocytes., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O54840;Q5GBG1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:1990837 sequence-specific double-stranded DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0000785 chromatin;GO:0090571 RNA polymerase II transcription repressor complex",
        "go_biological_process": "GO:0001708 cell fate specification;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045893 positive regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "O70306-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q62209-1",
        "uniprot_id": "SYCP1_MOUSE",
        "mass": 115935.0,
        "length": 993,
        "protein_name": "Synaptonemal complex protein 1",
        "gene_name": "Sycp1",
        "organism": "Mouse",
        "refseq_name": "synaptonemal complex protein 1",
        "refseq_ac": "NP_035646",
        "gene_names_uniprotkb": "Sycp1; Scp1",
        "gene_names_refseq": "SCP1; Sycp1",
        "protein_names_uniprotkb": "Synaptonemal complex protein 1; SCP-1",
        "protein_names_refseq": "SCP-1; synaptonemal complex protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:20957)",
        "pathway_count": 1,
        "publication_count": 14,
        "publication_id_list": "15937223;15944401;16717126;16968740;21183079;21750661;22761579;25428506;27932493;30272023;30746471;30949703;35820727;7548215",
        "class_list": "",
        "function": "Major component of the transverse filaments of synaptonemal complexes, formed between homologous chromosomes during meiotic prophase (PubMed:16717126). Required for normal assembly of the central element of the synaptonemal complexes (PubMed:15937223). Required for normal centromere pairing during meiosis (PubMed:22761579). Required for normal meiotic chromosome synapsis during oocyte and spermatocyte development and for normal male and female fertility (PubMed:15937223)., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RQK2;E9QP17;O09205;P70192;Q62329",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003690 double-stranded DNA binding",
        "go_cellular_component": "GO:0000801 central element;GO:0000794 condensed nuclear chromosome;GO:0005654 nucleoplasm;GO:0000775 chromosome, centromeric region;GO:0001673 male germ cell nucleus",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0051289 protein homotetramerization;GO:0051301 cell division;GO:0032880 regulation of protein localization;GO:0007130 synaptonemal complex assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q62209-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99MN1-1",
        "uniprot_id": "SYK_MOUSE",
        "mass": 67840.0,
        "length": 595,
        "protein_name": "Lysine--tRNA ligase",
        "gene_name": "Kars1",
        "organism": "Mouse",
        "refseq_name": "lysine--tRNA ligase isoform 2",
        "refseq_ac": "NP_444322",
        "gene_names_uniprotkb": "Kars1; Kars",
        "gene_names_refseq": "D8Ertd698e; D8Wsu108e; Kars1; Kars; LysRS; mKIAA0070",
        "protein_names_uniprotkb": "Lysine--tRNA ligase; 2.7.7.-; 6.1.1.6; LysRS; Lysyl-tRNA synthetase",
        "protein_names_refseq": "lysine--tRNA ligase isoform 2; lysine--tRNA ligase",
        "tax_id": 10090,
        "disease": "hypomyelinating leukoencephalopathy (Disease Ontology:DOID:0050987); Charcot-Marie-Tooth disease recessive intermediate B (Disease Ontology:DOID:0110204); autosomal recessive nonsyndromic deafness 89 (Disease Ontology:DOID:0110534); sciatic neuropathy (Disease Ontology:DOID:11446)",
        "pathway": " (mmu:85305);  (R-MMU-9856649)",
        "pathway_count": 2,
        "publication_count": 13,
        "publication_id_list": "11331948;12060739;14659874;14975237;17242355;21183079;21750661;25605945;26740625;30275047;34428180;35820727;39087379",
        "class_list": "",
        "function": "Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. When secreted, acts as a signaling molecule that induces immune response through the activation of monocyte/macrophages. Catalyzes the synthesis of the signaling molecule diadenosine tetraphosphate (Ap4A), and thereby mediates disruption of the complex between HINT1 and MITF and the concomitant activation of MITF transcriptional activity., [UniProtKB, UniProtKB]; KARS Mutations Impair Brain Myelination by Inducing Oligodendrocyte Deficiency: One Potential Mechanism and Improvement by Melatonin., [RefSeq, PubMed]; These results indicated that KRS effectively induced the maturation and activation of dendritic cells, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.7.10.1;2.7.11.24;3.4.22.-;3.9.1.-;6.1.1.10;6.1.1.4;6.1.1.18;6.1.1.5;6.1.1.12;2.7.7.-;6.1.1.6;6.1.1.19",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0016597 amino acid binding;GO:0000049 tRNA binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol",
        "go_biological_process": "GO:0043032 positive regulation of macrophage activation;GO:0015966 diadenosine tetraphosphate biosynthetic process;GO:0045893 positive regulation of DNA-templated transcription;GO:0070371 ERK1 and ERK2 cascade;GO:0010165 response to X-ray",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q99MN1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R0A5-1",
        "uniprot_id": "TCAL3_MOUSE",
        "mass": 22468.0,
        "length": 200,
        "protein_name": "Transcription elongation factor A protein-like 3",
        "gene_name": "Tceal3",
        "organism": "Mouse",
        "refseq_name": "transcription elongation factor A protein-like 3",
        "refseq_ac": "NP_001025149",
        "gene_names_uniprotkb": "Tceal3",
        "gene_names_refseq": "1100001D19Rik; Tceal3",
        "protein_names_uniprotkb": "Transcription elongation factor A protein-like 3; TCEA-like protein 3; Transcription elongation factor S-II protein-like 3",
        "protein_names_refseq": "TCEA-like protein 3; transcription elongation factor A protein-like 3; transcription elongation factor S-II protein-like 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:594844)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21183079;21750661;30059200;34560191",
        "class_list": "",
        "function": "Developmentally upregulated transcriptional elongation factor a like 3 suppresses axon regeneration after optic nerve injury., [RefSeq, PubMed]; May be involved in transcriptional regulation., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AEC3;Q9CYK5;Q9D1S4",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q8R0A5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P40749-1",
        "uniprot_id": "SYT4_MOUSE",
        "mass": 47659.0,
        "length": 425,
        "protein_name": "Synaptotagmin-4",
        "gene_name": "Syt4",
        "organism": "Mouse",
        "refseq_name": "synaptotagmin-4",
        "refseq_ac": "NP_033334",
        "gene_names_uniprotkb": "Syt4; Syt3",
        "gene_names_refseq": "Syt4; SytIV",
        "protein_names_uniprotkb": "Synaptotagmin-4; Synaptotagmin IV; SytIV",
        "protein_names_refseq": "synaptotagmin-4",
        "tax_id": 10090,
        "disease": "type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:20983)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21183079;29166604;30084848;8058779",
        "class_list": "",
        "function": "Synaptotagmin family member which does not bind Ca(2+) (By similarity). Involved in neuronal dense core vesicles (DCVs) mobility through its interaction with KIF1A. Upon increased neuronal activity, phosphorylation by MAPK8/JNK1 destabilizes the interaction with KIF1A and captures DCVs to synapses (PubMed:29166604). Plays a role in dendrite formation by melanocytes (By similarity)., [UniProtKB, UniProtKB, UniProtKB, PubMed]; Synaptotagmin family member which does not bind Ca(2+). Plays a role in dendrite formation by melanocytes (By similarity)., [UniProtKB, UniProtKB, UniProtKB]; The protein encoded by this gene belongs to the synaptotagmin family. Members of this family are multi-domained, integral membrane proteins of synaptic vesicles, and are thought to serve as Ca2+ sensors in the process of vesicular trafficking and exocytosis. This gene is primarily expressed in the nervous tissues. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UFC1;Q8BGH3;Q8BRL6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0046982 protein heterodimerization activity;GO:0005509 calcium ion binding;GO:0019905 syntaxin binding;GO:0005544 calcium-dependent phospholipid binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0098992 neuronal dense core vesicle;GO:0005794 Golgi apparatus;GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:2000301 negative regulation of synaptic vesicle exocytosis;GO:1903861 positive regulation of dendrite extension;GO:0050709 negative regulation of protein secretion;GO:0007613 memory;GO:0030100 regulation of endocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P40749-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q69ZR9-1",
        "uniprot_id": "TASOR_MOUSE",
        "mass": 181396.0,
        "length": 1610,
        "protein_name": "Protein TASOR",
        "gene_name": "Tasor",
        "organism": "Mouse",
        "refseq_name": "protein TASOR isoform 1",
        "refseq_ac": "NP_001108351",
        "gene_names_uniprotkb": "Tasor; D14Abb1e; Fam208a; Kiaa1105",
        "gene_names_refseq": "4732418E12; 4933409E02Rik; D14Abb1e; Fam208a; MommeD6; Tasor",
        "protein_names_uniprotkb": "Protein TASOR; Transgene activation suppressor protein",
        "protein_names_refseq": "family with sequence similarity 208, member A; protein FAM208A; protein TASOR isoform 1; protein TASOR; retinoblastoma-associated protein 140; transgene activation suppressor protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:218850)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "21183079;21750661;24781204;28839193;30084848;31112734;34418053;34428180",
        "class_list": "",
        "function": "Core component of the HUSH complex, a multiprotein complex that specifically mediates epigenetic repression of mobile genetic elements, such as retroviruses and transposable elements (By similarity). The HUSH complex represses LINE-1 (L1) retrotransposons that are still capable of transposition (By similarity). Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression (By similarity). The HUSH complex also represses exogenous retroviruses and synthetic transgenes (By similarity). Mediates silencing of unintegrated retroviral DNA following recruitment by ZNF638: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (By similarity). The HUSH complex is recruited to genomic loci rich in H3K9me3 and is required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3, as well as MORC2, a chromatin remodeler that compacts chromatin (By similarity). Within the HUSH complex, TASOR acts as the central scaffold which recruits MPHOSPH8 and PPHLN1 to mobile genetic elements and mediates association with SETDB1 and MORC2 (By similarity). The ability to silence mobile genetic elements plays a crucial role in early embryonic development: it is required to maintain epiblast cell fitness and cell division (PubMed:24781204, PubMed:28839193)., [UniProtKB, PubMed, UniProtKB, PubMed]; D14Abb1e is localised to the nucleus and is expressed in skin and testes., [RefSeq, PubMed]; This data demonstrates a new in vivo function of Fam208a in maintaining epiblast fitness, establishing it as an important factor at the onset of gastrulation when cells are exiting pluripotency. Erratum:[Sci Rep. 2018 Apr 5;8(1):5762. doi: 10.1038/s41598-018-22650-w. PMID: 29622773] Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 10,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9PUH2;Q9CUD3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003682 chromatin binding;GO:0030674 protein-macromolecule adaptor activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0000792 heterochromatin;GO:0140283 HUSH complex",
        "go_biological_process": "GO:0060809 mesodermal to mesenchymal transition involved in gastrulation;GO:0006351 DNA-templated transcription;GO:0045814 negative regulation of gene expression, epigenetic;GO:0008595 anterior/posterior axis specification, embryo;GO:0097355 protein localization to heterochromatin",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q69ZR9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6SJ95-1",
        "uniprot_id": "TBPL2_MOUSE",
        "mass": 38967.0,
        "length": 350,
        "protein_name": "TATA box-binding protein-like 2",
        "gene_name": "Tbpl2",
        "organism": "Mouse",
        "refseq_name": "TATA box-binding protein-like 2 isoform 2",
        "refseq_ac": "NP_001276618",
        "gene_names_uniprotkb": "Tbpl2; Tbp2; Trf3",
        "gene_names_refseq": "Gm348; Tbpl2; Trf3",
        "protein_names_uniprotkb": "TATA box-binding protein-like 2; TATA box-binding protein-related factor 3; TBP-like 2; TBP-related factor 3",
        "protein_names_refseq": "TATA box-binding protein-like 2 isoform 2; TATA box-binding protein-like protein 2; TATA box-binding protein-related factor 3; TBP-like 2; TBP-like protein 2; TBP-related factor 3 (Trf3)",
        "tax_id": 10090,
        "disease": "neurodegenerative disease (Disease Ontology:DOID:1289)",
        "pathway": " (mmu:227606)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "14634207;15062100;16412700;16721357;17570761;17704303;18851836;19759265;21750661;33353944;34203471",
        "class_list": "",
        "function": "Data suggest that TRF3 plays a role in early mouse development, and may also be involved in Pol I transcription., [RefSeq, PubMed]; Properties of a TAF3/TRF3 complex in directing transcription initiation at the Myogenin promoter, [RefSeq, PubMed]; TBP2 binds to promoters of misregulated genes, suggesting that TBP2 directly regulates their expression, [RefSeq, PubMed]; TBPL2/TFIIA complex establishes the maternal transcriptome through oocyte-specific promoter usage. Publication Status: Online-Only, [RefSeq, PubMed]; TRF3 is a nuclear protein that is present in all human and mouse tissues and cell lines examined, [RefSeq, PubMed]; Transcription factor required in complex with TAF3 for the differentiation of myoblasts into myocytes. The complex replaces TFIID at specific promoters at an early stage in the differentiation process., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AQK6;Q498A1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0016251 RNA polymerase II general transcription initiation factor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0001674 female germ cell nucleus",
        "go_biological_process": "GO:0006352 DNA-templated transcription initiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q6SJ95-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DBX3-1",
        "uniprot_id": "SUSD2_MOUSE",
        "mass": 90641.0,
        "length": 820,
        "protein_name": "Sushi domain-containing protein 2",
        "gene_name": "Susd2",
        "organism": "Mouse",
        "refseq_name": "sushi domain-containing protein 2 isoform 2 precursor",
        "refseq_ac": "NP_001156385",
        "gene_names_uniprotkb": "Susd2",
        "gene_names_refseq": "1200011D11Rik; Susd2",
        "protein_names_uniprotkb": "Sushi domain-containing protein 2",
        "protein_names_refseq": "sushi domain-containing protein 2 isoform 2 precursor; sushi domain-containing protein 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71733)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;19349973;23131994;33300544;34428180;36210013;36266363",
        "class_list": "",
        "function": "May be a cytokine receptor for GPR15LG. May be a tumor suppressor; together with GPR15LG has a growth inhibitory effect on colon cancer cells which includes G1 cell cycle arrest (By similarity). May play a role in breast tumorigenesis (PubMed:23131994)., [UniProtKB, UniProtKB, PubMed]; SUSD2 suppresses CD8<sup>+</sup> T cell antitumor immunity by targeting IL-2 receptor signaling., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 4,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 4,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 4,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 17,
        "disease_count": 0,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BY19;Q8BYN0;Q8BYZ3;Q8BYZ9;Q8BZQ4;Q8C179",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0051782 negative regulation of cell division;GO:1902807 negative regulation of cell cycle G1/S phase transition",
        "synthesized_glycan_count": 0,
        "hit_score": 3.0,
        "record_id": "Q9DBX3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R0Q1-1",
        "uniprot_id": "SYTL4_MOUSE",
        "mass": 76021.0,
        "length": 673,
        "protein_name": "Synaptotagmin-like protein 4",
        "gene_name": "Sytl4",
        "organism": "Mouse",
        "refseq_name": "synaptotagmin-like protein 4 isoform 2",
        "refseq_ac": "NP_001277646",
        "gene_names_uniprotkb": "Sytl4; Slp4",
        "gene_names_refseq": "Gph; Slp4; Sytl4",
        "protein_names_uniprotkb": "Synaptotagmin-like protein 4; Exophilin-2; Granuphilin",
        "protein_names_refseq": "exophilin-2; granuphilin-a; granuphilin-b; synaptotagmin-like protein 4 isoform 2; synaptotagmin-like protein 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:27359);  (R-MMU-114608)",
        "pathway_count": 2,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;10497219;11773082;11956164;12101244;12590134;17242355;21183079;21750661;23798443;25428506;35820727",
        "class_list": "",
        "function": "Modulates exocytosis of dense-core granules and secretion of hormones in the pancreas and the pituitary. Interacts with vesicles containing negatively charged phospholipids in a Ca(2+)-independent manner., [UniProtKB, PubMed]; Synaptotagmin-like protein 4 (Slp4)/granuphilin-a contains an N-terminal Slp homology domain (SHD) (PMID: 11327731). The SHD of Slp4 specifically and directly binds the GTP-bound form of Rab3A, Rab8, and Rab27A., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 6,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9803,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AVI8;B1AVI9;Q8R321;Q9R0Q0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005543 phospholipid binding;GO:0008270 zinc ion binding;GO:0031267 small GTPase binding;GO:0042043 neurexin family protein binding",
        "go_cellular_component": "GO:0005768 endosome;GO:0005886 plasma membrane;GO:0030141 secretory granule;GO:0016324 apical plasma membrane;GO:0030658 transport vesicle membrane",
        "go_biological_process": "GO:0001778 plasma membrane repair;GO:0071985 multivesicular body sorting pathway;GO:0006886 intracellular protein transport;GO:0050714 positive regulation of protein secretion;GO:0046676 negative regulation of insulin secretion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9R0Q1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z0P7-1",
        "uniprot_id": "SUFU_MOUSE",
        "mass": 53957.0,
        "length": 484,
        "protein_name": "Suppressor of fused homolog",
        "gene_name": "Sufu",
        "organism": "Mouse",
        "refseq_name": "suppressor of fused homolog isoform 2",
        "refseq_ac": "NP_001020562",
        "gene_names_uniprotkb": "Sufu",
        "gene_names_refseq": "Su(fu); Sufu",
        "protein_names_uniprotkb": "Suppressor of fused homolog",
        "protein_names_refseq": "suppressor of fused homolog isoform 2; suppressor of fused homolog",
        "tax_id": 10090,
        "disease": "medulloblastoma (Disease Ontology:DOID:0050902); pre-malignant neoplasm (Disease Ontology:DOID:0060071); nevoid basal cell carcinoma syndrome 2 (Disease Ontology:DOID:0070366); Joubert syndrome 32 (Disease Ontology:DOID:0080278); nevoid basal cell carcinoma syndrome (Disease Ontology:DOID:2512); brain glioblastoma multiforme (Disease Ontology:DOID:3073); familial meningioma (Disease Ontology:DOID:4586)",
        "pathway": " (mmu:24069);  (R-MMU-5610780);  (R-MMU-5610785);  (R-MMU-5610787);  (R-MMU-5632684)",
        "pathway_count": 5,
        "publication_count": 16,
        "publication_id_list": "10531011;11252182;11477086;11557033;11960000;16155214;16459298;19592253;19622347;20360384;20956384;21183079;21750661;23034632;31219806;38261656",
        "class_list": "",
        "function": "Negative regulator in the hedgehog signaling pathway. Down-regulates GLI1-mediated transactivation of target genes. Part of a corepressor complex that acts on DNA-bound GLI1. May also act by linking GLI1 to BTRC and thereby targeting GLI1 to degradation by the proteasome. Sequesters GLI1, GLI2 and GLI3 in the cytoplasm, this effect is overcome by binding of STK36 to both SUFU and a GLI protein. Negative regulator of beta-catenin signaling. Regulates the formation of either the repressor form (GLI3R) or the activator form (GLI3A) of the full-length form of GLI3 (GLI3FL). GLI3FL is complexed with SUFU in the cytoplasm and is maintained in a neutral state. Without the Hh signal, the SUFU-GLI3 complex is recruited to cilia, leading to the efficient processing of GLI3FL into GLI3R. When Hh signaling is initiated, SUFU dissociates from GLI3FL and the latter translocates to the nucleus, where it is phosphorylated, destabilized, and converted to a transcriptional activator (GLI3A)., [UniProtKB, UniProtKB]; Negative regulator in the hedgehog/smoothened signaling pathway that acts by sequestering the GLI (GI1, GLI2 and GLI3) transcription factors in the cytoplasm (PubMed:10531011, PubMed:11960000, PubMed:16155214, PubMed:16459298, PubMed:19622347, PubMed:20360384, PubMed:20956384). When smoothened signaling is initiated, GLI transcription factors dissociate from SUFU, translocate to the nucleus and activate expression of target genes (PubMed:10531011, PubMed:11960000, PubMed:16155214, PubMed:16459298, PubMed:19622347, PubMed:20360384, PubMed:20956384). In absence of smoothened signaling, the SUFU-GLI3 complex is recruited to cilia, leading to the efficient processing of full-length GLI3 into transcription repressor GLI3R: SUFU participates to GLI3 processing by promoting recruitment of GSK3B to GLI3 (PubMed:10531011, PubMed:19622347, PubMed:20360384). May also act as a negative regulator of beta-catenin signaling (PubMed:11477086). Required for normal embryonic development (PubMed:16155214, PubMed:16459298). Required for the proper formation of hair follicles and the control of epidermal differentiation (PubMed:16155214, PubMed:16459298, PubMed:23034632)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 7,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C8B4;Q99JG0;Q9D521;Q9JLU1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019901 protein kinase binding;GO:0008013 beta-catenin binding;GO:0140311 protein sequestering activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005929 cilium",
        "go_biological_process": "GO:0021513 spinal cord dorsal/ventral patterning;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006355 regulation of DNA-templated transcription;GO:0007286 spermatid development;GO:0001843 neural tube closure",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q9Z0P7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35526-1",
        "uniprot_id": "STX1A_MOUSE",
        "mass": 33054.0,
        "length": 288,
        "protein_name": "Syntaxin-1A",
        "gene_name": "Stx1a",
        "organism": "Mouse",
        "refseq_name": "syntaxin-1A isoform 1",
        "refseq_ac": "NP_058081",
        "gene_names_uniprotkb": "Stx1a",
        "gene_names_refseq": "HPC-1; Stx1a",
        "protein_names_uniprotkb": "Syntaxin-1A; Neuron-specific antigen HPC-1",
        "protein_names_refseq": "neuron-specific antigen HPC-1; syntaxin 1 a; syntaxin-1A isoform 1; syntaxin-1A",
        "tax_id": 10090,
        "disease": "Hirschsprung's disease (Disease Ontology:DOID:10487); Creutzfeldt-Jakob disease (Disease Ontology:DOID:11949); disease of mental health (Disease Ontology:DOID:150); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:20907);  (R-MMU-181429);  (R-MMU-181430);  (R-MMU-210500);  (R-MMU-212676);  (R-MMU-264642);  (R-MMU-449836);  (R-MMU-5682910);  (R-MMU-888590);  (R-MMU-9609523)",
        "pathway_count": 10,
        "publication_count": 21,
        "publication_id_list": "10.1101/2023.09.13.557529;12101244;15774481;16452087;17055430;17296554;17502420;18760330;19196426;21183079;21445306;21750661;21998599;23341457;28031464;28596237;28821673;29056747;33300544;38512129;38613786",
        "class_list": "",
        "function": "Activator of KAT3 histone acetyltransferase family ameliorates a neurodevelopmental disorder phenotype in the syntaxin 1A ablated mouse model., [RefSeq, PubMed]; Plays an essential role in hormone and neurotransmitter calcium-dependent exocytosis and endocytosis (PubMed:17502420, PubMed:28031464, PubMed:28596237). Part of the SNARE (Soluble NSF Attachment Receptor) complex composed of SNAP25, STX1A and VAMP2 which mediates the fusion of synaptic vesicles with the presynaptic plasma membrane. STX1A and SNAP25 are localized on the plasma membrane while VAMP2 resides in synaptic vesicles. The pairing of the three SNAREs from the N-terminal SNARE motifs to the C-terminal anchors leads to the formation of the SNARE complex, which brings membranes into close proximity and results in final fusion. Participates in the calcium-dependent regulation of acrosomal exocytosis in sperm (PubMed:12101244). Also plays an important role in the exocytosis of hormones such as insulin or glucagon-like peptide 1 (GLP-1) (PubMed:17502420, PubMed:28031464, PubMed:28596237)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, UniProtKB, UniProtKB]; The stability of the primed pool of synaptic vesicles and the clamping of spontaneous neurotransmitter release rely on the integrity of the C-terminal half of the SNARE domain of syntaxin-1A. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 4,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019869 chloride channel inhibitor activity;GO:0030674 protein-macromolecule adaptor activity;GO:0042802 identical protein binding;GO:0048306 calcium-dependent protein binding;GO:0044325 transmembrane transporter binding",
        "go_cellular_component": "GO:0070032 synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex;GO:0098978 glutamatergic synapse;GO:0048787 presynaptic active zone membrane;GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0035494 SNARE complex disassembly;GO:0010701 positive regulation of norepinephrine secretion;GO:0006886 intracellular protein transport;GO:0016925 protein sumoylation;GO:0032940 secretion by cell",
        "synthesized_glycan_count": 0,
        "hit_score": 2.9,
        "record_id": "O35526-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P32921-1",
        "uniprot_id": "SYWC_MOUSE",
        "mass": 54358.0,
        "length": 481,
        "protein_name": "Tryptophan--tRNA ligase, cytoplasmic",
        "gene_name": "Wars1",
        "organism": "Mouse",
        "refseq_name": "tryptophan--tRNA ligase, cytoplasmic isoform 2",
        "refseq_ac": "NP_001157786",
        "gene_names_uniprotkb": "Wars1; Wars; Wrs",
        "gene_names_refseq": "TrpRS; WRS; Wars1; Wars",
        "protein_names_uniprotkb": "Tryptophan--tRNA ligase, cytoplasmic; 6.1.1.2; TrpRS; Tryptophanyl-tRNA synthetase",
        "protein_names_refseq": "tryptophan--tRNA ligase, cytoplasmic isoform 2; tryptophan--tRNA ligase, cytoplasmic; tryptophanyl-tRNA synthetase, cytoplasmic",
        "tax_id": 10090,
        "disease": "autosomal dominant distal hereditary motor neuronopathy 9 (Disease Ontology:DOID:0111212)",
        "pathway": " (mmu:22375)",
        "pathway_count": 1,
        "publication_count": 25,
        "publication_id_list": "17114825;18299400;20484733;21750661;21952136;22645316;23806337;24788674;25153642;25428506;25605945;28528544;30084848;30779550;31219806;31599954;33300544;34203471;34428180;35820727;37507081;38177528;38856632;39627609;7932716",
        "class_list": "",
        "function": "Catalyzes the attachment of tryptophan to tRNA(Trp) in a two-step reaction: tryptophan is first activated by ATP to form Trp-AMP and then transferred to the acceptor end of the tRNA(Trp). Could also possess an angiostatic activity., [UniProtKB, UniProtKB]; Highly secreted tryptophanyl tRNA synthetase 1 as a potential theranostic target for hypercytokinemic severe sepsis. Erratum:[EMBO Mol Med. 2024 Mar;16(3):665. doi: 10.1038/s44321-024-00030-4. PMID: 38316935], [RefSeq, PubMed]; Single-Cell RNA Sequencing Identifies WARS1+ Mesenchymal Stem Cells with Enhanced Immunomodulatory Capacity and Improved Therapeutic Efficacy., [RefSeq, PubMed]; TrpRS plays a role in protecting against neurodegeneration is suggested, providing an insight into the pathogenesis and a possible treatment of neurodegenerative diseases., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80ZY4;Q99J58;Q9DC65",
        "ec_number_list": "6.1.1.2",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0019901 protein kinase binding;GO:0019904 protein domain specific binding;GO:0030674 protein-macromolecule adaptor activity;GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0001525 angiogenesis;GO:0010628 positive regulation of gene expression;GO:0035556 intracellular signal transduction;GO:0031334 positive regulation of protein-containing complex assembly;GO:0045765 regulation of angiogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 2.8,
        "record_id": "P32921-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q920N7-1",
        "uniprot_id": "SYT12_MOUSE",
        "mass": 46680.0,
        "length": 421,
        "protein_name": "Synaptotagmin-12",
        "gene_name": "Syt12",
        "organism": "Mouse",
        "refseq_name": "synaptotagmin-12",
        "refseq_ac": "NP_598925",
        "gene_names_uniprotkb": "Syt12",
        "gene_names_refseq": "Syt12",
        "protein_names_uniprotkb": "Synaptotagmin-12; Synaptotagmin XII; SytXII",
        "protein_names_refseq": "synaptotagmin-12; sytXII",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:171180)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;11514560;17190793;21183079;23739973;34428180;36210013",
        "class_list": "",
        "function": "Synaptic vesicle phosphoprotein that enhances spontaneous neurotransmitter release but does not effect induced neurotransmitter release (By similarity). Unlike other synaptotagmins, it does not bind Ca(2+) or phospholipids (By similarity). Essential for mossy-fiber long-term potentiation in the hippocampus (PubMed:23739973)., [UniProtKB, UniProtKB, PubMed]; Synaptotagmin-12 is essential for cyclic AMP-dependent protein kinase presynaptic long term potentiation at mossy-fiber synapses., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005544 calcium-dependent phospholipid binding;GO:0000149 SNARE binding;GO:0061891 calcium ion sensor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030672 synaptic vesicle membrane;GO:0008021 synaptic vesicle;GO:0070382 exocytic vesicle;GO:0098793 presynapse",
        "go_biological_process": "GO:0016192 vesicle-mediated transport;GO:0060291 long-term synaptic potentiation;GO:0017158 regulation of calcium ion-dependent exocytosis;GO:0048792 spontaneous exocytosis of neurotransmitter;GO:0099171 presynaptic modulation of chemical synaptic transmission",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q920N7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3TMP8-1",
        "uniprot_id": "TM38A_MOUSE",
        "mass": 33309.0,
        "length": 298,
        "protein_name": "Trimeric intracellular cation channel type A",
        "gene_name": "Tmem38a",
        "organism": "Mouse",
        "refseq_name": "trimeric intracellular cation channel type A isoform 1",
        "refseq_ac": "NP_653117",
        "gene_names_uniprotkb": "Tmem38a",
        "gene_names_refseq": "1110001E17Rik; SPR-27; TRIC-A; Tmem38a; mg33a",
        "protein_names_uniprotkb": "Trimeric intracellular cation channel type A; 27 kDa sarcoplasmic reticulum protein; Mitsugumin-33A; SPR-27; TRIC-A; TRICA; Transmembrane protein 38A",
        "protein_names_refseq": "27 kDa sarcoplasmic reticulum protein; mitsugumin-33A; trimeric intracellular cation channel type A isoform 1; trimeric intracellular cation channel type A",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74166)",
        "pathway_count": 1,
        "publication_count": 12,
        "publication_id_list": "17611541;20858894;21750661;21803293;24526676;27264872;30907436;31805819;33300544;33347504;36288343;37507081",
        "class_list": "",
        "function": "Absence of TRIC-A leads to instability of Ca(2+) movement across the sarcoplasmic reticulum membrane., [RefSeq, PubMed]; Data suggest a function for TRIC-A protein (TRIC-A) as an accessory protein that interacts with ryanodine receptor calcium release channel (RyR2) to modulate intracellular Ca2+ signaling., [RefSeq, PubMed]; Decreased cardiac pacemaking and attenuated beta-adrenergic response in TRIC-A knockout mice. Publication Status: Online-Only, [RefSeq, PubMed]; Intracellular monovalent cation channel required for maintenance of rapid intracellular calcium release. Acts as a potassium counter-ion channel that functions in synchronization with calcium release from intracellular stores. Opened by a change of voltage within the sarcoplasmic reticulum lumen., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; TRIC channels are likely to act as counter-ion channels that function in synchronization with Ca2+ release from intracellular stores, [RefSeq, PubMed]; TRIC-A and TRIC-B seem to have differential functions in Ca(2+) signaling in excitable and nonexcitable cells. Review article Erratum:[Circ Res. 2020 May 8;126(10):e119. doi: 10.1161/RES.0000000000000350. PMID: 32379571], [RefSeq, PubMed]; TRIC-A channels contribute to maintaining blood pressure, while TRIC-A SNPs could provide biomarkers for constitutional diagnosis and personalized medical treatment of essential hypertension., [RefSeq, PubMed]; The role of TRIC-A and TRIC-B channels in skeletal muscle sarcoplasmic reticulum channels is reported., [RefSeq, PubMed]; Three muscle-specific nuclear membrane proteins, NET39, Tmem38A, and WFS1, direct specific myogenic genes to the nuclear periphery to facilitate their repression during myogenesis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A5A6S4;A7LBB7;Q3TZB9;Q91WL2",
        "ec_number_list": "1.8.-.-",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0046872 metal ion binding;GO:0005267 potassium channel activity;GO:0015269 calcium-activated potassium channel activity",
        "go_cellular_component": "GO:0031965 nuclear membrane;GO:0016529 sarcoplasmic reticulum;GO:0033017 sarcoplasmic reticulum membrane",
        "go_biological_process": "GO:0055085 transmembrane transport;GO:0010881 regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;GO:0051279 regulation of release of sequestered calcium ion into cytosol;GO:0007029 endoplasmic reticulum organization;GO:0071805 potassium ion transmembrane transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q3TMP8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P10639-1",
        "uniprot_id": "THIO_MOUSE",
        "mass": 11675.0,
        "length": 105,
        "protein_name": "Thioredoxin",
        "gene_name": "Txn",
        "organism": "Mouse",
        "refseq_name": "thioredoxin",
        "refseq_ac": "NP_035790",
        "gene_names_uniprotkb": "Txn; Txn1",
        "gene_names_refseq": "ADF; Trx1; Txn1; Txn",
        "protein_names_uniprotkb": "Thioredoxin; ADF; ATL-derived factor; Trx",
        "protein_names_refseq": "ATL-derived factor; thioredoxin; trx",
        "tax_id": 10090,
        "disease": "dilated cardiomyopathy (Disease Ontology:DOID:12930); glaucoma (Disease Ontology:DOID:1686); myocardial infarction (Disease Ontology:DOID:5844); myocarditis (Disease Ontology:DOID:820); intermediate coronary syndrome (Disease Ontology:DOID:8805); steatotic liver disease (Disease Ontology:DOID:9452)",
        "pathway": " (mmu:22166);  (R-MMU-2559580);  (R-MMU-3299685);  (R-MMU-499943);  (R-MMU-5628897);  (R-MMU-5676934);  (R-MMU-844456)",
        "pathway_count": 7,
        "publication_count": 23,
        "publication_id_list": "10843682;23747528;23806337;25428506;26495903;26740625;2785919;28011936;30084848;30779550;31599954;32152506;34428180;36288343;37453647;37507081;37641878;37771783;37828378;38171410;38976128;39059206;7835695",
        "class_list": "",
        "function": "ADF augments the expression of the interleukin-2 receptor TAC (IL2R/P55)., [UniProtKB]; Middle-age abolishes cardioprotection conferred by thioredoxin-1 in mice., [RefSeq, PubMed]; Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6/STAT3 signaling axis through interaction with STAT3. Publication Status: Online-Only, [RefSeq, PubMed]; Participates in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyzes dithiol-disulfide exchange reactions (By similarity). Plays a role in the reversible S-nitrosylation of cysteine residues in target proteins, and thereby contributes to the response to intracellular nitric oxide. Nitrosylates the active site Cys of CASP3 in response to nitric oxide (NO), and thereby inhibits caspase-3 activity. Induces the FOS/JUN AP-1 DNA binding activity in ionizing radiation (IR) cells through its oxidation/reduction status and stimulates AP-1 transcriptional activity (By similarity)., [UniProtKB]; The cold-inducible RNA-binding protein-Thioredoxin 1 pathway ameliorates mitochondrial dysfunction and mitochondrial dynamin-related protein 1 level in the hippocampus of aged mice with perioperative neurocognitive dysfunction., [RefSeq, PubMed]; Thioredoxin-1 Protects Neurons Through Inhibiting NLRP1-Mediated Neuronal Pyroptosis in Models of Alzheimer's Disease. Erratum:[Mol Neurobiol. 2025 May;62(5):6626. doi: 10.1007/s12035-024-04523-8. PMID: 39333348], [RefSeq, PubMed]; TrxR1 is involved in the activation of Caspase-11 by regulating the oxidative-reductive status of Trx-1., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 6,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q52KC4;Q9D8R0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0047134 protein-disulfide reductase [NAD(P)H] activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005654 nucleoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;GO:0045454 cell redox homeostasis;GO:0009314 response to radiation;GO:0043388 positive regulation of DNA binding",
        "synthesized_glycan_count": 0,
        "hit_score": 2.6,
        "record_id": "P10639-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P41047-1",
        "uniprot_id": "TNFL6_MOUSE",
        "mass": 31442.0,
        "length": 279,
        "protein_name": "Tumor necrosis factor ligand superfamily member 6",
        "gene_name": "Faslg",
        "organism": "Mouse",
        "refseq_name": "tumor necrosis factor ligand superfamily member 6 isoform 1",
        "refseq_ac": "NP_034307",
        "gene_names_uniprotkb": "Faslg; Apt1lg1; Cd95l; Fasl; Tnfsf6; gld",
        "gene_names_refseq": "APT1LG1; CD178; CD95-L; CD95L; Fas-L; Faslg; Fasl; Tnfsf6; Tnlg1a; gld",
        "protein_names_uniprotkb": "Tumor necrosis factor ligand superfamily member 6; CD95 ligand; CD95-L; Fas antigen ligand; Fas ligand; FasL; Receptor-binding FasL ectodomain; SPA; SPPL2A-processed FasL form; Soluble Fas ligand; sFasL",
        "protein_names_refseq": "CD95 ligand; Fas antigen ligand; Fas ligand (TNF superfamily, member 6); generalized lymphoproliferative disease; tumor necrosis factor ligand 1a; tumor necrosis factor ligand superfamily member 6 isoform 1; tumor necrosis factor ligand superfamily member 6",
        "tax_id": 10090,
        "disease": "biliary tract benign neoplasm (Disease Ontology:DOID:0050625); myelodysplastic syndrome (Disease Ontology:DOID:0050908); brain glioma (Disease Ontology:DOID:0060108); graft-versus-host disease (Disease Ontology:DOID:0081267); pre-eclampsia (Disease Ontology:DOID:10591); gastric ulcer (Disease Ontology:DOID:10808); urinary bladder cancer (Disease Ontology:DOID:11054); diabetic angiopathy (Disease Ontology:DOID:11713); leiomyoma (Disease Ontology:DOID:127); Huntington's disease (Disease Ontology:DOID:12858); HELLP syndrome (Disease Ontology:DOID:13133); lung cancer (Disease Ontology:DOID:1324); clonorchiasis (Disease Ontology:DOID:13767); Parkinson's disease (Disease Ontology:DOID:14330); cystic fibrosis (Disease Ontology:DOID:1485); pancreatic cancer (Disease Ontology:DOID:1793); melanoma (Disease Ontology:DOID:1909); hepatitis B (Disease Ontology:DOID:2043); brain ischemia (Disease Ontology:DOID:2316); multiple sclerosis (Disease Ontology:DOID:2377); transitional cell carcinoma (Disease Ontology:DOID:2671); substance-related disorder (Disease Ontology:DOID:303); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); invasive lobular carcinoma (Disease Ontology:DOID:3457); pancreatic ductal carcinoma (Disease Ontology:DOID:3587); liver disease (Disease Ontology:DOID:409); seminoma (Disease Ontology:DOID:4440); intrahepatic cholangiocarcinoma (Disease Ontology:DOID:4928); cholangiocarcinoma (Disease Ontology:DOID:4947); congestive heart failure (Disease Ontology:DOID:6000); autoimmune lymphoproliferative syndrome (Disease Ontology:DOID:6688); hepatocellular carcinoma (Disease Ontology:DOID:684); abdominal aortic aneurysm (Disease Ontology:DOID:7693); chronic myeloid leukemia (Disease Ontology:DOID:8552); infectious mononucleosis (Disease Ontology:DOID:8568); ulcerative colitis (Disease Ontology:DOID:8577); cervix uteri carcinoma in situ (Disease Ontology:DOID:8991); type 2 diabetes mellitus (Disease Ontology:DOID:9352); multiple myeloma (Disease Ontology:DOID:9538); type 1 diabetes mellitus (Disease Ontology:DOID:9744)",
        "pathway": " (mmu:14103);  (R-MMU-3371378);  (R-MMU-5218900);  (R-MMU-69416);  (R-MMU-75157)",
        "pathway_count": 5,
        "publication_count": 12,
        "publication_id_list": "10552956;10779162;19794494;37013690;38514848;39339840;7495745;7511063;7532682;7544870;7889405;9108079",
        "class_list": "",
        "function": "Ambivalent role of FasL in murine acute graft-versus-host-disease., [RefSeq, PubMed]; Cytokine that binds to TNFRSF6/FAS, a receptor that transduces the apoptotic signal into cells (PubMed:7511063). Involved in cytotoxic T-cell-mediated apoptosis, natural killer cell-mediated apoptosis and in T-cell development (PubMed:19794494, PubMed:7532682). Initiates fratricidal/suicidal activation-induced cell death (AICD) in antigen-activated T-cells contributing to the termination of immune responses (PubMed:19794494). TNFRSF6/FAS-mediated apoptosis also has a role in the induction of peripheral tolerance (PubMed:10779162). Binds to TNFRSF6B/DcR3, a decoy receptor that blocks apoptosis (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB, PubMed]; Cytoplasmic form induces gene transcription inhibition., [UniProtKB, UniProtKB]; Fas/FasL-Mediated Apoptosis and Inflammation Contribute to Recovery from HSV-2-Mediated Spinal Cord Infection. Publication Status: Online-Only, [RefSeq, PubMed]; Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality., [RefSeq, PubMed]; Induces FAS-mediated activation of NF-kappa-B, initiating non-apoptotic signaling pathways (PubMed:19794494). Can induce apoptosis but does not appear to be essential for this process (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 5,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 40,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q61217;Q9R1F2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005125 cytokine activity;GO:0005123 death receptor binding;GO:0005164 tumor necrosis factor receptor binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005634 nucleus;GO:0009986 cell surface;GO:0048471 perinuclear region of cytoplasm;GO:0070062 extracellular exosome",
        "go_biological_process": "GO:0030644 intracellular chloride ion homeostasis;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0008284 positive regulation of cell population proliferation;GO:0032496 response to lipopolysaccharide",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "P41047-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R0J4-1",
        "uniprot_id": "TM134_MOUSE",
        "mass": 21637.0,
        "length": 195,
        "protein_name": "Transmembrane protein 134",
        "gene_name": "Tmem134",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 134 isoform a",
        "refseq_ac": "NP_001072117",
        "gene_names_uniprotkb": "Tmem134",
        "gene_names_refseq": "2410001H17Rik; Tmem134",
        "protein_names_uniprotkb": "Transmembrane protein 134",
        "protein_names_refseq": "transmembrane protein 134 isoform a",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66990)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21183079;21750661;34428180",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TLG9;Q8C1M3;Q9CR66",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005829 cytosol;GO:0016020 membrane;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8R0J4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EQU3-1",
        "uniprot_id": "TLR9_MOUSE",
        "mass": 116412.0,
        "length": 1032,
        "protein_name": "Toll-like receptor 9",
        "gene_name": "Tlr9",
        "organism": "Mouse",
        "refseq_name": "toll-like receptor 9 precursor",
        "refseq_ac": "NP_112455",
        "gene_names_uniprotkb": "Tlr9",
        "gene_names_refseq": "Tlr9",
        "protein_names_uniprotkb": "Toll-like receptor 9",
        "protein_names_refseq": "toll-like receptor 9 precursor",
        "tax_id": 10090,
        "disease": "sinusitis (Disease Ontology:DOID:0050127); lupus nephritis (Disease Ontology:DOID:0080162); metabolic dysfunction-associated steatotic liver disease (Disease Ontology:DOID:0080208); acute necrotizing pancreatitis (Disease Ontology:DOID:0080998); dermatomyositis (Disease Ontology:DOID:10223); viral pneumonia (Disease Ontology:DOID:10533); mastitis (Disease Ontology:DOID:10690); Human papillomavirus infectious disease (Disease Ontology:DOID:11166); anogenital venereal wart (Disease Ontology:DOID:11168); allergic conjunctivitis (Disease Ontology:DOID:11204); primary biliary cholangitis (Disease Ontology:DOID:12236); cardiovascular system disease (Disease Ontology:DOID:1287); allergic bronchopulmonary aspergillosis (Disease Ontology:DOID:13166); alcoholic liver cirrhosis (Disease Ontology:DOID:14018); cystic fibrosis (Disease Ontology:DOID:1485); alcohol use disorder (Disease Ontology:DOID:1574); breast cancer (Disease Ontology:DOID:1612); squamous cell carcinoma (Disease Ontology:DOID:1749); hepatitis C (Disease Ontology:DOID:1883); hepatitis B (Disease Ontology:DOID:2043); bronchiolitis obliterans (Disease Ontology:DOID:2799); asthma (Disease Ontology:DOID:2841); pulmonary tuberculosis (Disease Ontology:DOID:2957); IgA glomerulonephritis (Disease Ontology:DOID:2986); interstitial lung disease (Disease Ontology:DOID:3082); chronic granulomatous disease (Disease Ontology:DOID:3265); pulmonary fibrosis (Disease Ontology:DOID:3770); lung non-small cell carcinoma (Disease Ontology:DOID:3908); renal cell carcinoma (Disease Ontology:DOID:4450); allergic rhinitis (Disease Ontology:DOID:4481); proteinuria (Disease Ontology:DOID:576); hepatocellular carcinoma (Disease Ontology:DOID:684); chronic kidney disease (Disease Ontology:DOID:784); perinatal necrotizing enterocolitis (Disease Ontology:DOID:8677); cervix uteri carcinoma in situ (Disease Ontology:DOID:8991); systemic lupus erythematosus (Disease Ontology:DOID:9074); cutaneous leishmaniasis (Disease Ontology:DOID:9111)",
        "pathway": " (mmu:81897);  (R-MMU-109704);  (R-MMU-1679131);  (R-MMU-168138)",
        "pathway_count": 4,
        "publication_count": 31,
        "publication_id_list": "10.1101/2023.09.13.557529;11130078;11470918;11867692;11923871;14993594;17452530;17474149;18305481;18780723;18820679;18931679;20173027;20484733;20865800;21402738;21940676;25428506;25686612;25917084;26095358;26740625;28011936;29187734;30024926;30084848;31408613;31599954;32152506;34428180;40419769",
        "class_list": "",
        "function": "Key component of innate and adaptive immunity (PubMed:31408613). TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms (PubMed:31408613). TLR9 is a nucleotide-sensing TLR which is activated by unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides (PubMed:31408613). Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:14993594, PubMed:17474149, PubMed:18820679, PubMed:18931679, PubMed:21402738, PubMed:25686612). Also acts via ADCY7, leading to cyclic di-AMP (c-di-AMP) synthesis and activation of the NLRP3 inflammasome (PubMed:40419769). Plays a role in defense against systemic mouse cytomegalovirus infection (PubMed:14993594). Controls lymphocyte response to Helicobacter infection (PubMed:17474149). Upon CpG stimulation, induces B-cell proliferation, activation, survival and antibody production (By similarity)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed]; Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4., [RefSeq, PubMed]; TLR9 acts at the cell surface and engages an intracellular signaling pathway that includes MyD88, IRAK, and TRAF6, [RefSeq, PubMed]",
        "predicted_glycosites": 8,
        "predicted_n_glycosites": 6,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 12,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 6,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 12,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 12,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 12,
        "reported_glycation": 0,
        "reported_snv": 6,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 6,
        "disease_count": 37,
        "glyco_site_count": 20,
        "binding_glycan_count": 0,
        "secondary_ac_list": "F8VPN5;Q4L0K3;Q4L0K4;Q99MF2;Q99MQ8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0035197 siRNA binding;GO:0045322 unmethylated CpG binding;GO:0005149 interleukin-1 receptor binding;GO:0038187 pattern recognition receptor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005768 endosome;GO:0005783 endoplasmic reticulum;GO:0005886 plasma membrane;GO:0016323 basolateral plasma membrane",
        "go_biological_process": "GO:0045577 regulation of B cell differentiation;GO:0032727 positive regulation of interferon-alpha production;GO:0032741 positive regulation of interleukin-18 production;GO:1901895 negative regulation of ATPase-coupled calcium transmembrane transporter activity;GO:0002730 regulation of dendritic cell cytokine production",
        "synthesized_glycan_count": 0,
        "hit_score": 5.1,
        "record_id": "Q9EQU3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P58682-1",
        "uniprot_id": "TLR8_MOUSE",
        "mass": 119358.0,
        "length": 1032,
        "protein_name": "Toll-like receptor 8",
        "gene_name": "Tlr8",
        "organism": "Mouse",
        "refseq_name": "toll-like receptor 8 isoform 2 precursor",
        "refseq_ac": "NP_001300689",
        "gene_names_uniprotkb": "Tlr8",
        "gene_names_refseq": "Tlr8",
        "protein_names_uniprotkb": "Toll-like receptor 8",
        "protein_names_refseq": "toll-like receptor 8 isoform 2 precursor",
        "tax_id": 10090,
        "disease": "immunodeficiency 98 (Disease Ontology:DOID:0061068); COVID-19 (Disease Ontology:DOID:0080600); severe COVID-19 (Disease Ontology:DOID:0081013); anogenital venereal wart (Disease Ontology:DOID:11168); respiratory syncytial virus infectious disease (Disease Ontology:DOID:1273); alcohol use disorder (Disease Ontology:DOID:1574); asthma (Disease Ontology:DOID:2841); pulmonary tuberculosis (Disease Ontology:DOID:2957); atopic dermatitis (Disease Ontology:DOID:3310); allergic rhinitis (Disease Ontology:DOID:4481); rhinitis (Disease Ontology:DOID:4483)",
        "pathway": " (mmu:170744);  (R-MMU-1679131)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "10.1101/2023.09.13.557529;16737960;19451267;21750661;26095358;29237092;30084848;31219806;34428180;35507634;37395441;37462944;38202845;38631842",
        "class_list": "",
        "function": "CD8 T Cell-Derived Exosomal miR-186-5p Elicits Renal Inflammation via Activating Tubular TLR7/8 Signal Axis., [RefSeq, PubMed]; Endosomal receptor that plays a key role in innate and adaptive immunity. Controls host immune response against pathogens through recognition of RNA degradation products specific to microorganisms that are initially processed by RNASET2. Upon binding to agonists, undergoes dimerization that brings TIR domains from the two molecules into direct contact, leading to the recruitment of TIR-containing downstream adapter MYD88 through homotypic interaction. In turn, the Myddosome signaling complex is formed involving IRAK4, IRAK1, TRAF6, TRAF3 leading to activation of downstream transcription factors NF-kappa-B and IRF7 to induce pro-inflammatory cytokines and interferons, respectively., [UniProtKB, UniProtKB]; Expression of toll like receptor 8 (TLR8) in specific groups of mouse hippocampal interneurons. Publication Status: Online-Only, [RefSeq, PubMed]; Gender Control of Mouse Embryos by Activation of TLR7/8 on X Sperm via Ligands dsRNA-40 and dsRNA-DR. Publication Status: Online-Only, [RefSeq, PubMed]; TLR7/8 stress response drives histiocytosis in SLC29A3 disorders., [RefSeq, PubMed]; TLR8-activating miR-146a-3p is an intermediate signal contributing to fetal membrane inflammation in response to bacterial LPS., [RefSeq, PubMed]; TLR8-mediated MEKK3-dependent IKKgamma phosphorylation might play an important role in the activation of IKK complex, leading to IkappaBalpha phosphorylation, [RefSeq, PubMed]",
        "predicted_glycosites": 18,
        "predicted_n_glycosites": 18,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 11,
        "glyco_site_count": 22,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AHI9;Q91XI7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0042802 identical protein binding;GO:0003725 double-stranded RNA binding;GO:0003727 single-stranded RNA binding;GO:0038187 pattern recognition receptor activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005886 plasma membrane;GO:0005764 lysosome;GO:0009897 external side of plasma membrane;GO:0010008 endosome membrane",
        "go_biological_process": "GO:0032727 positive regulation of interferon-alpha production;GO:0002718 regulation of cytokine production involved in immune response;GO:0006954 inflammatory response;GO:0045087 innate immune response;GO:0051607 defense response to virus",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "P58682-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B2RWJ3-1",
        "uniprot_id": "TM240_MOUSE",
        "mass": 20005.0,
        "length": 173,
        "protein_name": "Transmembrane protein 240",
        "gene_name": "Tmem240",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 240",
        "refseq_ac": "NP_001094976",
        "gene_names_uniprotkb": "Tmem240; Gm5151",
        "gene_names_refseq": "EG381582; Gm5151; Tmem240",
        "protein_names_uniprotkb": "Transmembrane protein 240",
        "protein_names_refseq": "transmembrane protein 240",
        "tax_id": 10090,
        "disease": "spinocerebellar ataxia 21 (Disease Ontology:DOID:0050972)",
        "pathway": " (mmu:381582)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "22645316;32535204",
        "class_list": "",
        "function": "Neural-specific distribution of transmembrane protein TMEM240 and formation of TMEM240-Body., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0097060 synaptic membrane;GO:0098839 postsynaptic density membrane;GO:0098688 parallel fiber to Purkinje cell synapse;GO:0150053 cerebellar climbing fiber to Purkinje cell synapse;GO:0160045 TMEM240-body",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "B2RWJ3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P39429-1",
        "uniprot_id": "TRAF2_MOUSE",
        "mass": 56026.0,
        "length": 501,
        "protein_name": "TNF receptor-associated factor 2",
        "gene_name": "Traf2",
        "organism": "Mouse",
        "refseq_name": "TNF receptor-associated factor 2 isoform a",
        "refseq_ac": "NP_001277342",
        "gene_names_uniprotkb": "Traf2",
        "gene_names_refseq": "Traf2",
        "protein_names_uniprotkb": "TNF receptor-associated factor 2; 2.3.2.27; E3 ubiquitin-protein ligase TRAF2; RING-type E3 ubiquitin transferase TRAF2",
        "protein_names_refseq": "E3 ubiquitin-protein ligase TRAF2; RING-type E3 ubiquitin transferase TRAF2; TNF receptor-associated factor 2 isoform a",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22030);  (R-MMU-3371378);  (R-MMU-5218900);  (R-MMU-5357786);  (R-MMU-5357905);  (R-MMU-5357956);  (R-MMU-5668541);  (R-MMU-5675482);  (R-MMU-5676594);  (R-MMU-5689880);  (R-MMU-69416);  (R-MMU-75893);  (R-MMU-9758274)",
        "pathway_count": 13,
        "publication_count": 36,
        "publication_id_list": "10514016;11275257;11340079;11435475;11804591;11909853;15121867;15175328;16876162;17188031;18281285;18849341;18997792;18997794;19150425;19409903;19506082;19815541;20185725;21307340;22424771;23542741;25026888;25428506;28489822;34428180;38043870;38062811;38363556;8069916;8565075;8692885;9104814;9390694;9461607;9500555",
        "class_list": "",
        "function": "E3 ubiquitin-protein ligase that regulates activation of NF-kappa-B and JNK and plays a central role in the regulation of cell survival and apoptosis (PubMed:15121867, PubMed:18997792, PubMed:19150425, PubMed:19409903, PubMed:19815541, PubMed:9390694). Catalyzes 'Lys-63'-linked ubiquitination of target proteins, such as BIRC3, IKBKE, MLST8, RIPK1 and TICAM1 (PubMed:15175328, PubMed:28489822). Is an essential constituent of several E3 ubiquitin-protein ligase complexes, where it promotes the ubiquitination of target proteins by bringing them into contact with other E3 ubiquitin ligases (By similarity). Regulates BIRC2 and BIRC3 protein levels by inhibiting their autoubiquitination and subsequent degradation; this does not depend on the TRAF2 RING-type zinc finger domain (PubMed:18997794). Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR (By similarity). In complex with BIRC2 or BIRC3, promotes ubiquitination of IKBKE (By similarity). Acts as a regulator of mTORC1 and mTORC2 assembly by mediating 'Lys-63'-linked ubiquitination of MLST8, thereby inhibiting formation of the mTORC2 complex, while facilitating assembly of the mTORC1 complex (PubMed:28489822). Required for normal antibody isotype switching from IgM to IgG (PubMed:10514016)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; Silencing of CPNE1-TRAF2 Axis Restrains the Development of Pancreatic Cancer., [RefSeq, PubMed]; TRAF2 decrease promotes the TGF-beta-mTORC1 signal in MAFLD-HCC through enhancing AXIN1-mediated Smad7 degradation., [RefSeq, PubMed]; TRAF2 inhibits senescence in hepatocellular carcinoma cells via regulating the ROMO1/ NAD[+]/SIRT3/SOD2 axis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 6,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AJA3;O54896",
        "ec_number_list": "3.4.19.12;2.3.2.27;3.4.25.1;2.7.11.1;2.7.11.10;3.4.22.61;2.3.2.24;2.3.2.23;2.3.2.-;2.7.11.25;2.3.2.31",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0019899 enzyme binding;GO:0019901 protein kinase binding;GO:0030674 protein-macromolecule adaptor activity;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:1990604 IRE1-TRAF2-ASK1 complex;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005938 cell cortex;GO:0045121 membrane raft",
        "go_biological_process": "GO:0002637 regulation of immunoglobulin production;GO:0023035 CD40 signaling pathway;GO:0007165 signal transduction;GO:0043066 negative regulation of apoptotic process;GO:0045087 innate immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 3.7,
        "record_id": "P39429-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q01320-1",
        "uniprot_id": "TOP2A_MOUSE",
        "mass": 172790.0,
        "length": 1528,
        "protein_name": "DNA topoisomerase 2-alpha",
        "gene_name": "Top2a",
        "organism": "Mouse",
        "refseq_name": "DNA topoisomerase 2-alpha",
        "refseq_ac": "NP_035753",
        "gene_names_uniprotkb": "Top2a; Top-2; Top2",
        "gene_names_refseq": "Top-2; Top2a",
        "protein_names_uniprotkb": "DNA topoisomerase 2-alpha; 5.6.2.2; DNA topoisomerase II, alpha isozyme",
        "protein_names_refseq": "DNA Topoisomerase II alpha; DNA topoisomerase 2-alpha; DNA topoisomerase II, alpha isozyme",
        "tax_id": 10090,
        "disease": "ductal carcinoma in situ (Disease Ontology:DOID:0060074); prostate cancer (Disease Ontology:DOID:10283); urinary bladder cancer (Disease Ontology:DOID:11054); penile benign neoplasm (Disease Ontology:DOID:11624); limited scleroderma (Disease Ontology:DOID:1577); diffuse scleroderma (Disease Ontology:DOID:1580); cancer (Disease Ontology:DOID:162); B cell deficiency (Disease Ontology:DOID:2115); nephroblastoma (Disease Ontology:DOID:2154); pulmonary fibrosis (Disease Ontology:DOID:3770); lung non-small cell carcinoma (Disease Ontology:DOID:3908); cervix uteri carcinoma in situ (Disease Ontology:DOID:8991); acute myeloid leukemia (Disease Ontology:DOID:9119)",
        "pathway": " (mmu:21973);  (R-MMU-4615885)",
        "pathway_count": 2,
        "publication_count": 19,
        "publication_id_list": "10.1101/2023.09.13.557529;1331984;21183079;22645316;23806337;24321095;25428506;30084848;30779550;31219806;31599954;31839538;34203471;34428180;34887587;35820727;38445610;39627609;8261398",
        "class_list": "",
        "function": "Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand (PubMed:1331984). May play a role in regulating the period length of BMAL1 transcriptional oscillation (PubMed:24321095)., [UniProtKB, PubMed, PubMed]; TOP2A modulates signaling via the AKT/mTOR pathway to promote ovarian cancer cell proliferation., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 22,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 13,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9PX08",
        "ec_number_list": "2.3.2.-;5.6.2.2;2.3.2.27",
        "go_molecular_function": "GO:0008301 DNA binding, bending;GO:0003918 DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity;GO:0000287 magnesium ion binding;GO:0003677 DNA binding;GO:0003682 chromatin binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0000775 chromosome, centromeric region",
        "go_biological_process": "GO:0000712 resolution of meiotic recombination intermediates;GO:0007059 chromosome segregation;GO:0043065 positive regulation of apoptotic process;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0006974 DNA damage response",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "Q01320-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6PD31-1",
        "uniprot_id": "TRAK1_MOUSE",
        "mass": 104467.0,
        "length": 939,
        "protein_name": "Trafficking kinesin-binding protein 1",
        "gene_name": "Trak1",
        "organism": "Mouse",
        "refseq_name": "trafficking kinesin-binding protein 1 isoform 1",
        "refseq_ac": "NP_780323",
        "gene_names_uniprotkb": "Trak1",
        "gene_names_refseq": "2310001H13Rik; Trak1; hyrt; mKIAA1042",
        "protein_names_uniprotkb": "Trafficking kinesin-binding protein 1; Protein Milton",
        "protein_names_refseq": "protein Milton; trafficking kinesin-binding protein 1 isoform 1; trafficking kinesin-binding protein 1",
        "tax_id": 10090,
        "disease": "developmental and epileptic encephalopathy 68 (Disease Ontology:DOID:0112204); neurodegenerative disease (Disease Ontology:DOID:1289); Stiff-Person syndrome (Disease Ontology:DOID:13366)",
        "pathway": " (mmu:67095);  (R-MMU-9013419);  (R-MMU-9013425)",
        "pathway_count": 3,
        "publication_count": 12,
        "publication_id_list": "16380713;21183079;21750661;21952136;22645316;24995978;31219806;32848054;34428180;34678516;40021952;40885482",
        "class_list": "",
        "function": "Involved in the regulation of endosome-to-lysosome trafficking, including endocytic trafficking of EGF-EGFR complexes and GABA-A receptors (By similarity). Involved in mitochondrial motility (PubMed:24995978). When O-glycosylated, abolishes mitochondrial motility. Crucial for recruiting OGT to the mitochondrial surface of neuronal processes (By similarity). TRAK1 and RHOT form an essential protein complex that links KIF5 to mitochondria for light chain-independent, anterograde transport of mitochondria (By similarity)., [UniProtKB, UniProtKB, PubMed, UniProtKB]; Our data implicate Trak1 as a crucial regulator of GABA(A) receptor homeostasis and underscore the importance of hyrt mice as a model for studying the molecular etiology of hypertonia associated with human neurological diseases. Erratum:[Nat Genet. 2006 Mar;38(3):389. Anderson, Jeffrey R [added]], [RefSeq, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 4,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 1,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 11,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 11,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 11,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 15,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BYA3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030911 TPR domain binding;GO:0017022 myosin binding;GO:0050811 GABA receptor binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005769 early endosome;GO:0005938 cell cortex",
        "go_biological_process": "GO:0006605 protein targeting;GO:0008333 endosome to lysosome transport;GO:0048813 dendrite morphogenesis;GO:0050772 positive regulation of axonogenesis;GO:0022008 neurogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 2.5,
        "record_id": "Q6PD31-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R310-1",
        "uniprot_id": "TMCC3_MOUSE",
        "mass": 53722.0,
        "length": 477,
        "protein_name": "Transmembrane and coiled-coil domain protein 3",
        "gene_name": "Tmcc3",
        "organism": "Mouse",
        "refseq_name": "transmembrane and coiled-coil domain protein 3 isoform b",
        "refseq_ac": "NP_001162155",
        "gene_names_uniprotkb": "Tmcc3",
        "gene_names_refseq": "A230066D03Rik; C630016B22Rik; Gm1556; Tmcc1; Tmcc3",
        "protein_names_uniprotkb": "Transmembrane and coiled-coil domain protein 3",
        "protein_names_refseq": "transmembrane and coiled coil domains 1; transmembrane and coiled-coil domain protein 3 isoform b; transmembrane and coiled-coil domain protein 3; transmembrane and coiled-coil domains protein 3",
        "tax_id": 10090,
        "disease": "alcohol-related neurodevelopmental disorder (Disease Ontology:DOID:0050667)",
        "pathway": " (mmu:319880)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "17242355;21183079;21750661;27697108;30084848",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q501N6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0071889 14-3-3 protein binding",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane;GO:0012505 endomembrane system;GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q8R310-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CQN1-1",
        "uniprot_id": "TRAP1_MOUSE",
        "mass": 80209.0,
        "length": 706,
        "protein_name": "Heat shock protein 75 kDa, mitochondrial",
        "gene_name": "Trap1",
        "organism": "Mouse",
        "refseq_name": "heat shock protein 75 kDa, mitochondrial precursor",
        "refseq_ac": "NP_080784",
        "gene_names_uniprotkb": "Trap1; Hsp75; Hspc5",
        "gene_names_refseq": "2410002K23Rik; HSP75; Trap1",
        "protein_names_uniprotkb": "Heat shock protein 75 kDa, mitochondrial; HSP 75; TNFR-associated protein 1; TRAP-1; Tumor necrosis factor type 1 receptor-associated protein",
        "protein_names_refseq": "HSP 75; TNFR-associated protein 1; TRAP-1; heat shock protein 75 kDa, mitochondrial precursor; heat shock protein 75 kDa, mitochondrial; tumor necrosis factor type 1 receptor-associated protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68015);  (R-MMU-71403)",
        "pathway_count": 2,
        "publication_count": 16,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;22872234;23576753;25428506;25605945;26740625;28135057;30084848;34203471;34428180;35820727;37453647;37507081;37983591;39627609",
        "class_list": "",
        "function": "Chaperone that expresses an ATPase activity. Involved in maintaining mitochondrial function and polarization, downstream of PINK1 and mitochondrial complex I. Is a negative regulator of mitochondrial respiration able to modulate the balance between oxidative phosphorylation and aerobic glycolysis. The impact of TRAP1 on mitochondrial respiration is probably mediated by modulation of mitochondrial SRC and inhibition of SDHA., [UniProtKB]; Targeting the Mitochondrial Chaperone TRAP1 Alleviates Vascular Pathologies in Ischemic Retinopathy., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q542I4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0005524 ATP binding;GO:0019901 protein kinase binding;GO:0051082 unfolded protein binding;GO:0016887 ATP hydrolysis activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005758 mitochondrial intermembrane space;GO:0005759 mitochondrial matrix",
        "go_biological_process": "GO:1903751 negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide;GO:0006457 protein folding;GO:0009386 translational attenuation;GO:1901856 negative regulation of cellular respiration",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q9CQN1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CYG7-1",
        "uniprot_id": "TOM34_MOUSE",
        "mass": 34278.0,
        "length": 309,
        "protein_name": "Mitochondrial import receptor subunit TOM34",
        "gene_name": "Tomm34",
        "organism": "Mouse",
        "refseq_name": "mitochondrial import receptor subunit TOM34 isoform a",
        "refseq_ac": "NP_001278084",
        "gene_names_uniprotkb": "Tomm34",
        "gene_names_refseq": "2610100K07Rik; TOM34; Tomm34",
        "protein_names_uniprotkb": "Mitochondrial import receptor subunit TOM34; Translocase of outer membrane 34 kDa subunit",
        "protein_names_refseq": "mitochondrial import receptor subunit TOM34 isoform a; mitochondrial import receptor subunit TOM34; translocase of outer membrane 34 kDa subunit",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:67145)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "12801914;21183079;26495903;31219806;31599954;35820727",
        "class_list": "",
        "function": "Plays a role in the import of cytosolically synthesized preproteins into mitochondria. Binds the mature portion of precursor proteins. Interacts with cellular components, and possesses weak ATPase activity. May be a chaperone-like protein that helps to keep newly synthesized precursors in an unfolded import compatible state (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2A5N5;A2A5N6;Q3THD0;Q812F1;Q812F2;Q9D059",
        "ec_number_list": "",
        "go_molecular_function": "GO:0031072 heat shock protein binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0005829 cytosol",
        "go_biological_process": "GO:0006626 protein targeting to mitochondrion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9CYG7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D9S2-1",
        "uniprot_id": "TM225_MOUSE",
        "mass": 26483.0,
        "length": 230,
        "protein_name": "Transmembrane protein 225",
        "gene_name": "Tmem225",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 225 isoform 1",
        "refseq_ac": "NP_083655",
        "gene_names_uniprotkb": "Tmem225; Pmp22cd",
        "gene_names_refseq": "1700030E15Rik; Tmem225; Tnen225",
        "protein_names_uniprotkb": "Transmembrane protein 225",
        "protein_names_refseq": "transmembrane protein 225 isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:75667)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;25605614;38246484",
        "class_list": "",
        "function": "Probably inhibits protein phosphatase 1 (PP1) in sperm via binding to catalytic subunit PPP1CC., [UniProtKB, PubMed]; TMEM225 Is Essential for Sperm Maturation and Male Fertility by Modifying Protein Distribution of Sperm in Mice., [RefSeq, PubMed]; TMEM225 is involved in the differentiation and function of spermatozoa through the regulation of PP1gamma2 activity., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008157 protein phosphatase 1 binding;GO:0004864 protein phosphatase inhibitor activity",
        "go_cellular_component": "GO:0002079 inner acrosomal membrane;GO:0002081 outer acrosomal membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0010923 negative regulation of phosphatase activity",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9D9S2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EPW9-1",
        "uniprot_id": "TLR6_MOUSE",
        "mass": 91116.0,
        "length": 795,
        "protein_name": "Toll-like receptor 6",
        "gene_name": "Tlr6",
        "organism": "Mouse",
        "refseq_name": "toll-like receptor 6 precursor",
        "refseq_ac": "NP_001346109",
        "gene_names_uniprotkb": "Tlr6",
        "gene_names_refseq": "Tlr6",
        "protein_names_uniprotkb": "Toll-like receptor 6",
        "protein_names_refseq": "toll-like receptor 6 precursor",
        "tax_id": 10090,
        "disease": "infective endocarditis (Disease Ontology:DOID:0060000); aspergillosis (Disease Ontology:DOID:13564); alcohol use disorder (Disease Ontology:DOID:1574); asthma (Disease Ontology:DOID:2841); pulmonary tuberculosis (Disease Ontology:DOID:2957); tuberculosis (Disease Ontology:DOID:399); glucose metabolism disease (Disease Ontology:DOID:4194); rhinitis (Disease Ontology:DOID:4483); primary immunodeficiency disease (Disease Ontology:DOID:612); collagen disease (Disease Ontology:DOID:854); perinatal necrotizing enterocolitis (Disease Ontology:DOID:8677); bacterial pneumonia (Disease Ontology:DOID:874)",
        "pathway": " (mmu:21899);  (R-MMU-5686938)",
        "pathway_count": 2,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;10231569;11095740;19931471;20037584;21750661;23812099;25428506;30084848;32652111;33011801;34428180",
        "class_list": "",
        "function": "Clostridioides difficile Binary Toxin Is Recognized by the Toll-Like Receptor 2/6 Heterodimer to Induce a Nuclear Factor-kappaB Response., [RefSeq, PubMed]; Participates in the innate immune response to Gram-positive bacteria and fungi. Specifically recognizes diacylated and, to a lesser extent, triacylated lipopeptides (PubMed:19931471). In response to diacylated lipopeptides, forms the activation cluster TLR2:TLR6:CD14:CD36, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Recognizes mycoplasmal macrophage-activating lipopeptide-2kD (MALP-2), soluble tuberculosis factor (STF), phenol-soluble modulin (PSM) and B.burgdorferi outer surface protein A lipoprotein (OspA-L) cooperatively with TLR2. In complex with TLR4, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion (PubMed:20037584, PubMed:23812099)., [UniProtKB, PubMed, PubMed, PubMed]; TLR2/6 signaling promotes the expansion of premalignant hematopoietic stem and progenitor cells in the NUP98-HOXD13 mouse model of MDS., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 8,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 8,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 8,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 9696,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 12,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9WTQ4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004888 transmembrane signaling receptor activity;GO:0005102 signaling receptor binding;GO:0042802 identical protein binding;GO:0046982 protein heterodimerization activity;GO:0071723 lipopeptide binding",
        "go_cellular_component": "GO:0005794 Golgi apparatus;GO:0005886 plasma membrane;GO:0043235 receptor complex;GO:0045121 membrane raft;GO:0030670 phagocytic vesicle membrane",
        "go_biological_process": "GO:0046209 nitric oxide metabolic process;GO:0043032 positive regulation of macrophage activation;GO:0034136 negative regulation of toll-like receptor 2 signaling pathway;GO:0042496 detection of diacyl bacterial lipopeptide;GO:0001774 microglial cell activation",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q9EPW9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UHC0-1",
        "uniprot_id": "TNR6C_MOUSE",
        "mass": 175775.0,
        "length": 1690,
        "protein_name": "Trinucleotide repeat-containing gene 6C protein",
        "gene_name": "Tnrc6c",
        "organism": "Mouse",
        "refseq_name": "trinucleotide repeat-containing gene 6C protein isoform 1",
        "refseq_ac": "NP_932139",
        "gene_names_uniprotkb": "Tnrc6c; Kiaa1582",
        "gene_names_refseq": "9930033H14Rik; Tnrc6c; mKIAA1582",
        "protein_names_uniprotkb": "Trinucleotide repeat-containing gene 6C protein",
        "protein_names_refseq": "trinucleotide repeat-containing gene 6C protein isoform 1; trinucleotide repeat-containing gene 6C protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:217351);  (R-MMU-426496)",
        "pathway_count": 2,
        "publication_count": 22,
        "publication_id_list": "17242355;18299400;21183079;21750661;22517741;22645316;22872234;24129315;25428506;28811219;30084848;30779550;31219806;32782141;32848054;34428180;34678516;35820727;36084651;36852467;40021952;40885482",
        "class_list": "",
        "function": "Plays a role in RNA-mediated gene silencing by micro-RNAs (miRNAs). Required for miRNA-dependent translational repression of complementary mRNAs by argonaute family proteins As scaffoldng protein associates with argonaute proteins bound to partially complementary mRNAs and simultaneously can recruit CCR4-NOT and PAN deadenylase complexes (By similarity)., [UniProtKB]; These results imply a complex and indirect mode of regulation of sacculation by TNRC6c, mediated in part by dynamic transcriptional repression of an inhibitor of TGFbeta family gene expression., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 27,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 27,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 27,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 26,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UZ61;Q80TB6;Q8BXF9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0000932 P-body",
        "go_biological_process": "GO:0035162 embryonic hemopoiesis;GO:0006417 regulation of translation;GO:0060964 regulation of miRNA-mediated gene silencing;GO:0007179 transforming growth factor beta receptor signaling pathway;GO:0060213 positive regulation of nuclear-transcribed mRNA poly(A) tail shortening",
        "synthesized_glycan_count": 0,
        "hit_score": 5.1,
        "record_id": "Q3UHC0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5S248-1",
        "uniprot_id": "TM11E_MOUSE",
        "mass": 48065.0,
        "length": 423,
        "protein_name": "Transmembrane protease serine 11E",
        "gene_name": "Tmprss11e",
        "organism": "Mouse",
        "refseq_name": "transmembrane protease serine 11E",
        "refseq_ac": "NP_766468",
        "gene_names_uniprotkb": "Tmprss11e; Desc1",
        "gene_names_refseq": "A030012E10; DESC1; TTSP; Tmprss11e",
        "protein_names_uniprotkb": "Transmembrane protease serine 11E; 3.4.21.-; Serine protease DESC1",
        "protein_names_refseq": "serine protease DESC1; transmembrane protease serine 11E; type II transmembrane serine protease",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:243084)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "15328353;36413750",
        "class_list": "",
        "function": "Increased Expression of TMPRSS11E Is Involved in LPS- or Poly(I:C)-mediated Inflammation., [RefSeq, PubMed]; Mouse DESC1 encodes a functional cell surface serine protease that may have important functions in the epidermis, oral, and reproductive epithelium, [RefSeq, PubMed]; Serine protease which possesses both gelatinolytic and caseinolytic activities. Shows a preference for Arg in the P1 position., [UniProtKB, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A4FUP5;Q8BM10",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004252 serine-type endopeptidase activity;GO:0008236 serine-type peptidase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006508 proteolysis;GO:0016485 protein processing;GO:0050890 cognition;GO:0046718 symbiont entry into host cell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q5S248-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C996-1",
        "uniprot_id": "TM163_MOUSE",
        "mass": 31193.0,
        "length": 288,
        "protein_name": "Transmembrane protein 163",
        "gene_name": "Tmem163",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 163",
        "refseq_ac": "NP_082411",
        "gene_names_uniprotkb": "Tmem163; Sv31",
        "gene_names_refseq": "2610024A01Rik; A-cre; Act-Cre; SV31; Tg(ACTB-cre)2Mrt; Tmem163; actin-cre; cre<actin>",
        "protein_names_uniprotkb": "Transmembrane protein 163; Synaptic vesicle membrane protein of 31 kDa",
        "protein_names_refseq": "TgN(ACTB-cre)2Mrt; beta-actin-cre; synaptic vesicle membrane protein of 31 kDa; transmembrane protein 163",
        "tax_id": 10090,
        "disease": "hypomyelinating leukodystrophy 25 (Disease Ontology:DOID:0070401); proteinuria (Disease Ontology:DOID:576)",
        "pathway": " (mmu:72160)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;17114649;17623043;21183079;25130899;26495903;28011936;31697912;40885482",
        "class_list": "",
        "function": "Zinc ion transporter that mediates zinc efflux and plays a crucial role in intracellular zinc homeostasis (By similarity). Binds the divalent cations Zn(2+), Ni(2+), and to a minor extent Cu(2+) (By similarity). Is a functional modulator of P2X purinoceptors, including P2RX1, P2RX3, P2RX4 and P2RX7 (By similarity). Plays a role in central nervous system development and is required for myelination, and survival and proliferation of oligodendrocytes (By similarity)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C8I2;Q9D0E0",
        "ec_number_list": "2.7.11.1",
        "go_molecular_function": "GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0097708 intracellular vesicle;GO:0005886 plasma membrane;GO:0005765 lysosomal membrane;GO:0031902 late endosome membrane;GO:0031901 early endosome membrane",
        "go_biological_process": "GO:0042552 myelination;GO:0006882 intracellular zinc ion homeostasis;GO:0099180 zinc ion import into synaptic vesicle;GO:0140882 zinc export across plasma membrane",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q8C996-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R4P4-1",
        "uniprot_id": "TMC2_MOUSE",
        "mass": 101134.0,
        "length": 888,
        "protein_name": "Transmembrane channel-like protein 2",
        "gene_name": "Tmc2",
        "organism": "Mouse",
        "refseq_name": "transmembrane channel-like protein 2",
        "refseq_ac": "NP_619596",
        "gene_names_uniprotkb": "Tmc2",
        "gene_names_refseq": "CWEA2; Tmc2",
        "protein_names_uniprotkb": "Transmembrane channel-like protein 2; Transmembrane cochlear-expressed protein 2",
        "protein_names_refseq": "transmembrane channel-like protein 2; transmembrane cochlear-expressed protein 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:192140)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "11850618;12812529;22105175;23871232;25114259;28663585;30138589;37507081;38228630",
        "class_list": "",
        "function": "Pore-forming subunit of the mechanotransducer (MET) non-selective cation channel complex located at the tips of stereocilia of cochlear hair cells and that mediates sensory transduction in the auditory system (PubMed:11850618, PubMed:23871232). The MET complex is composed of two dimeric pore-forming ion-conducting transmembrane TMC (TMC1 or TMC2) subunits, several auxiliary proteins including LHFPL5, TMIE, CIB2/3 and TOMT, the tip-link PCDH15, and possibly the PIEZO subunits (By similarity). MET channel is activated by tension in the tip-link extending from the side wall of one stereocilium to the tip of the adjacent shorter stereocilium, where the channel is located (By similarity). TMC2 MET channel is highly permeable to calcium and likely transports monovalent cations (PubMed:23871232). Also involved in vestibular hair cell transduction current of the mammalian inner ear (PubMed:23871232)., [UniProtKB, PubMed, PubMed, UniProtKB]; Tmc1 is expressed in mouse vestibular & cochlear hair cells near the stereocilia tips. Deletion of Tmc1 & Tmc2 causes deafness. Deletion of only Tmc2 does not., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TQB1",
        "ec_number_list": "2.7.11.1",
        "go_molecular_function": "GO:0005262 calcium channel activity;GO:0008381 mechanosensitive monoatomic ion channel activity;GO:0005245 voltage-gated calcium channel activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0032437 cuticular plate;GO:0032426 stereocilium tip;GO:0032420 stereocilium",
        "go_biological_process": "GO:0060005 vestibular reflex;GO:0050910 detection of mechanical stimulus involved in sensory perception of sound;GO:0070588 calcium ion transmembrane transport;GO:1903169 regulation of calcium ion transmembrane transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8R4P4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VD26-1",
        "uniprot_id": "TM143_MOUSE",
        "mass": 51596.0,
        "length": 458,
        "protein_name": "Transmembrane protein 143",
        "gene_name": "Tmem143",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 143",
        "refseq_ac": "NP_659050",
        "gene_names_uniprotkb": "Tmem143",
        "gene_names_refseq": "2310076O21Rik; Tmem143",
        "protein_names_uniprotkb": "Transmembrane protein 143",
        "protein_names_refseq": "transmembrane protein 143",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:70209)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21183079;21750661;31219806",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BHU3;Q8BI00;Q8BI09",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0016020 membrane",
        "go_biological_process": "GO:0002244 hematopoietic progenitor cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8VD26-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WUU8-1",
        "uniprot_id": "TNIP1_MOUSE",
        "mass": 73050.0,
        "length": 647,
        "protein_name": "TNFAIP3-interacting protein 1",
        "gene_name": "Tnip1",
        "organism": "Mouse",
        "refseq_name": "TNFAIP3-interacting protein 1 isoform 2",
        "refseq_ac": "NP_001186205",
        "gene_names_uniprotkb": "Tnip1; Abin; Naf1",
        "gene_names_refseq": "ABIN-1; ABIN1; ABIN; Naf1; Nef; Tnip1; VAN",
        "protein_names_uniprotkb": "TNFAIP3-interacting protein 1; A20-binding inhibitor of NF-kappa-B activation 1; ABIN-1; ABIN; Naf1; Nef-associated factor 1; VAN; Virion-associated nuclear shuttling protein; mVAN",
        "protein_names_refseq": "A20-binding inhibitor of NF-kappa B activation; Nef-associated factor 1; TNFAIP3-interacting protein 1 isoform 2; virion-associated nuclear shuttling protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:57783);  (R-MMU-5689896)",
        "pathway_count": 2,
        "publication_count": 21,
        "publication_id_list": "10.1101/2023.09.13.557529;10385526;11090181;11389905;12586352;15722346;16075062;18212736;21606507;21750661;22011580;22517741;22645316;24129315;26495903;30016717;32782141;36034412;36852467;38009796;40021952",
        "class_list": "",
        "function": "ABIN1 (Q478) is Required to Prevent Hematopoietic Deficiencies through Regulating Type I IFNs Expression., [RefSeq, PubMed]; ABIN1 Inhibits Inflammation through Necroptosis-Dependent Pathway in Ulcerative Colitis. Publication Status: Online-Only, [RefSeq, PubMed]; Inhibits NF-kappa-B activation and TNF-induced NF-kappa-B-dependent gene expression by regulating TAX1BP1 and A20/TNFAIP3-mediated deubiquitination of IKBKG; proposed to link A20/TNFAIP3 to ubiquitinated IKBKG (By similarity). Involved in regulation of EGF-induced ERK1/ERK2 signaling pathway; blocks MAPK3/MAPK1 nuclear translocation and MAPK1-dependent transcription. Increases cell surface CD4(T4) antigen expression. Involved in the anti-inflammatory response of macrophages and positively regulates TLR-induced activation of CEBPB. Involved in the prevention of autoimmunity; this function implicates binding to polyubiquitin. Involved in leukocyte integrin activation during inflammation; this function is mediated by association with SELPLG and dependent on phosphorylation by SRC-family kinases., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed]; Using a murine model of allergen-induced asthma, we have demonstrated that adenovirus-mediated delivery of ABIN-1 to the lung epithelium results in a reduction of allergen-induced eosinophil infiltration into the lungs., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 9,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 9,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 9,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 4,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q922A9;Q922F7;Q9EPP8;Q9R0X3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0031593 polyubiquitin modification-dependent protein binding;GO:0042802 identical protein binding;GO:0051019 mitogen-activated protein kinase binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005634 nucleus",
        "go_biological_process": "GO:0006357 regulation of transcription by RNA polymerase II;GO:0006954 inflammatory response;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0009101 glycoprotein biosynthetic process;GO:0071222 cellular response to lipopolysaccharide",
        "synthesized_glycan_count": 0,
        "hit_score": 3.4,
        "record_id": "Q9WUU8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6PFR5-1",
        "uniprot_id": "TRA2A_MOUSE",
        "mass": 32316.0,
        "length": 281,
        "protein_name": "Transformer-2 protein homolog alpha",
        "gene_name": "Tra2a",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Tra2a",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Transformer-2 protein homolog alpha; TRA-2 alpha; TRA2-alpha; Transformer-2 protein homolog A",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:101214)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "18630941;21750661;24129315;28785060;34428180",
        "class_list": "",
        "function": "Sequence-specific RNA-binding protein which participates in the control of pre-mRNA splicing., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 12,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0003729 mRNA binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005681 spliceosomal complex",
        "go_biological_process": "GO:0048026 positive regulation of mRNA splicing, via spliceosome;GO:0000398 mRNA splicing, via spliceosome;GO:0006397 mRNA processing;GO:0008380 RNA splicing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q6PFR5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B2RQC2-1",
        "uniprot_id": "UBP42_MOUSE",
        "mass": 146223.0,
        "length": 1324,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 42",
        "gene_name": "Usp42",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 42",
        "refseq_ac": "NP_084025",
        "gene_names_uniprotkb": "Usp42",
        "gene_names_refseq": "2410140K03Rik; 3110031A07Rik; A630018G05Rik; D5Ertd591e; Usp42",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 42; 3.4.19.12; Deubiquitinating enzyme 42; Ubiquitin thioesterase 42; Ubiquitin-specific-processing protease 42",
        "protein_names_refseq": "deubiquitinating enzyme 42; ubiquitin carboxyl-terminal hydrolase 42; ubiquitin specific protease 42; ubiquitin thioesterase 42; ubiquitin thiolesterase 42; ubiquitin-specific-processing protease 42",
        "tax_id": 10090,
        "disease": "congenital heart disease (Disease Ontology:DOID:1682); primary ovarian insufficiency (Disease Ontology:DOID:5426)",
        "pathway": " (mmu:76800);  (R-MMU-5689880)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "16904385;21183079;25428506;30084848;30779550",
        "class_list": "",
        "function": "Deubiquitinating enzyme which may play an important role during spermatogenesis., [UniProtKB, PubMed]; Northern blot analysis revealed that Usp42 is expressed mainly in brain, lung, thymus and testis, and at E10.5 the most during embryonic development., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.4.19.12",
        "go_molecular_function": "GO:0004843 cysteine-type deubiquitinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol",
        "go_biological_process": "GO:0006508 proteolysis;GO:0007283 spermatogenesis;GO:0016579 protein deubiquitination;GO:0030154 cell differentiation;GO:0031647 regulation of protein stability",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "B2RQC2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P56399-1",
        "uniprot_id": "UBP5_MOUSE",
        "mass": 95833.0,
        "length": 858,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 5",
        "gene_name": "Usp5",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 5 isoform 2",
        "refseq_ac": "NP_001313523",
        "gene_names_uniprotkb": "Usp5; Isot",
        "gene_names_refseq": "ISOT-1; ISOT; Ucht; Usp5",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 5; 3.4.19.12; Deubiquitinating enzyme 5; Isopeptidase T; Ubiquitin thioesterase 5; Ubiquitin-specific-processing protease 5",
        "protein_names_refseq": "deubiquitinating enzyme 5; isopeptidase T; ubiquitin carboxy terminal hydrolase T; ubiquitin carboxyl-terminal hydrolase 5 isoform 2; ubiquitin carboxyl-terminal hydrolase 5; ubiquitin specific protease 5; ubiquitin thioesterase 5; ubiquitin thiolesterase 5; ubiquitin-specific-processing protease 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22225);  (R-MMU-5689880);  (R-MMU-8866652)",
        "pathway_count": 3,
        "publication_count": 16,
        "publication_id_list": "15345747;19156909;21183079;21750661;31455361;33300544;34428180;36288343;37208329;37507081;37828378;38772301;39189428;39627609;39927985;40684658",
        "class_list": "",
        "function": "Deubiquitinating enzyme that participates in a wide range of cellular processes by specifically cleaving isopeptide bonds between ubiquitin and substrate proteins or ubiquitin itself. Affects thereby important cellular signaling pathways such as NF-kappa-B, Wnt/beta-catenin, and cytokine production by regulating ubiquitin-dependent protein degradation. Participates in the activation of the Wnt signaling pathway by promoting FOXM1 deubiquitination and stabilization that induces the recruitment of beta-catenin to Wnt target gene promoter. Regulates the assembly and disassembly of heat-induced stress granules by mediating the hydrolysis of unanchored ubiquitin chains. Promotes lipopolysaccharide-induced apoptosis and inflammatory response by stabilizing the TXNIP protein. Affects T-cell biology by stabilizing the inhibitory receptor on T-cells PDC1 (PubMed:37208329). Acts as a negative regulator of autophagy by regulating ULK1 at both protein and mRNA levels. Acts also as a negative regulator of type I interferon production by simultaneously removing both 'Lys-48'-linked unanchored and 'Lys-63'-linked anchored polyubiquitin chains on the transcription factor IRF3. Modulates the stability of DNA mismatch repair protein MLH1 and counteracts the effect of the ubiquitin ligase UBR4. Upon activation by insulin, it gets phosphorylated through mTORC1-mediated phosphorylation to enhance YTHDF1 stability by removing 'Lys-11'-linked polyubiquitination (By similarity). May also deubiquitinate other substrates such as the calcium channel CACNA1H (PubMed:31455361)., [UniProtKB, UniProtKB, PubMed, PubMed]; ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Erratum:[Nat Commun. 2025 Jun 20;16(1):5357. doi: 10.1038/s41467-025-61049-w. PMID: 40541949] Publication Status: Online-Only, [RefSeq, PubMed]; Hydrogen sulfide inhibits skeletal muscle ageing by up-regulating autophagy through promoting deubiquitination of adenosine 5'-monophosphate (AMP)-activated protein kinase alpha1 via ubiquitin specific peptidase 5., [RefSeq, PubMed]; USP5 negatively regulates the activation of NLRP3 inflammasomes and participates in the pathological and physiological processes of Sjogren's syndrome., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.4.19.12",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0043130 ubiquitin binding;GO:0004843 cysteine-type deubiquitinase activity;GO:0101005 deubiquitinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0010494 cytoplasmic stress granule;GO:0098793 presynapse",
        "go_biological_process": "GO:0006508 proteolysis;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0007346 regulation of mitotic cell cycle;GO:0031647 regulation of protein stability;GO:0045727 positive regulation of translation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "P56399-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9Q9K5-1",
        "uniprot_id": "TRDN_MOUSE",
        "mass": 77844.0,
        "length": 693,
        "protein_name": "Triadin",
        "gene_name": "Trdn",
        "organism": "Mouse",
        "refseq_name": "triadin isoform 1",
        "refseq_ac": "NP_084002",
        "gene_names_uniprotkb": "Trdn",
        "gene_names_refseq": "2310045H21Rik; EG432451; TDN; Trdn",
        "protein_names_uniprotkb": "Triadin",
        "protein_names_refseq": "cardiac triadin; triadin isoform 1",
        "tax_id": 10090,
        "disease": "catecholaminergic polymorphic ventricular tachycardia (Disease Ontology:DOID:0060674); catecholaminergic polymorphic ventricular tachycardia 5 (Disease Ontology:DOID:0060679); dilated cardiomyopathy (Disease Ontology:DOID:12930)",
        "pathway": " (mmu:76757);  (R-MMU-2672351);  (R-MMU-5578775)",
        "pathway_count": 3,
        "publication_count": 17,
        "publication_id_list": "10.1101/2023.09.13.557529;11707337;12234783;17408688;17526652;19383796;19843516;21750661;22768324;29126880;31877066;34428180;34736417;35213584;35862102;36288343;39927985",
        "class_list": "",
        "function": "Association of decreased triadin expression level with apoptosis of dopaminergic cells in Parkinson's disease mouse model. Publication Status: Online-Only, [RefSeq, PubMed]; Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the Heart., [RefSeq, PubMed]; Contributes to the regulation of lumenal Ca2+ release via the sarcoplasmic reticulum calcium release channels RYR1 and RYR2, a key step in triggering skeletal and heart muscle contraction. Required for normal organization of the triad junction, where T-tubules and the sarcoplasmic reticulum terminal cisternae are in close contact. Required for normal skeletal muscle strength (PubMed:19843516). Plays a role in excitation-contraction coupling in the heart and in regulating the rate of heart beats., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, UniProtKB]; Dynamics of triadin, a muscle-specific triad protein, within sarcoplasmic reticulum subdomains., [RefSeq, PubMed]; Histidine-rich Ca-binding protein may play a key role in the regulation of SR Ca cycling through its direct interactions with SERCA2 and triadin, mediating a fine cross talk between SR Ca uptake and release in the heart., [RefSeq, PubMed]; Quantification of the calcium signaling deficit in muscles devoid of triadin. Publication Status: Online-Only, [RefSeq, PubMed]; The lncRNA TRDN-AS regulates the balance between cardiac and skeletal isoforms of triadin., [RefSeq, PubMed]; Triadin 1 overexpression triggered time-dependent alterations in SR protein expression, Ca(2+) homeostasis, and contractility, indicating for the first time an inhibitory function of triadin 1 on SR-Ca(2+) release in vivo., [RefSeq, PubMed]; Triadin(TRD)xjunctin(JCN) mice were studied to compensate the down-regulation of junctin expression in triadin-expressing mice; exercise or stress provoked repetitive ventricular tachycardia in freely roaming TRDxJCN mice., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 3,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8VIN7;Q8VIN8;Q8VIN9;Q9CV36",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005102 signaling receptor binding;GO:0030674 protein-macromolecule adaptor activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0014701 junctional sarcoplasmic reticulum membrane",
        "go_biological_process": "GO:0051280 negative regulation of release of sequestered calcium ion into cytosol;GO:0090158 endoplasmic reticulum membrane organization;GO:0006874 intracellular calcium ion homeostasis;GO:0060047 heart contraction;GO:0009617 response to bacterium",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "E9Q9K5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R117-1",
        "uniprot_id": "TYK2_MOUSE",
        "mass": 133315.0,
        "length": 1184,
        "protein_name": "Non-receptor tyrosine-protein kinase TYK2",
        "gene_name": "Tyk2",
        "organism": "Mouse",
        "refseq_name": "non-receptor tyrosine-protein kinase TYK2 isoform 2",
        "refseq_ac": "NP_061263",
        "gene_names_uniprotkb": "Tyk2",
        "gene_names_refseq": "JTK1; Tyk2",
        "protein_names_uniprotkb": "Non-receptor tyrosine-protein kinase TYK2; 2.7.10.2",
        "protein_names_refseq": "non-receptor tyrosine-protein kinase TYK2 isoform 2; non-receptor tyrosine-protein kinase TYK2; tyrosine kinase TYK2",
        "tax_id": 10090,
        "disease": "immunodeficiency 35 (Disease Ontology:DOID:0111989); disease of cellular proliferation (Disease Ontology:DOID:14566); cancer (Disease Ontology:DOID:162); hematologic cancer (Disease Ontology:DOID:2531); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:54721);  (R-MMU-1059683);  (R-MMU-110056);  (R-MMU-112411);  (R-MMU-6783783);  (R-MMU-6785807);  (R-MMU-6788467);  (R-MMU-8854691);  (R-MMU-8984722);  (R-MMU-9020591);  (R-MMU-9020933);  (R-MMU-9020956);  (R-MMU-909733);  (R-MMU-912694);  (R-MMU-9674555);  (R-MMU-9705462);  (R-MMU-9958825)",
        "pathway_count": 17,
        "publication_count": 13,
        "publication_id_list": "11070173;11070174;17947660;21183079;21750661;22859374;22872234;22995073;31219806;34428180;36210013;38683377;39084258",
        "class_list": "",
        "function": "Augmentative effects of leukemia inhibitory factor reveal a critical role for TYK2 signaling in vascular calcification., [RefSeq, PubMed]; Non-membrane spanning protein tyrosine kinase involved in numerous cytokines and interferons signaling, which regulates cell growth, development, cell migration, innate and adaptive immunity (PubMed:11070174). Plays both structural and catalytic roles in numerous interleukins and interferons (IFN-alpha/beta) signaling (By similarity). Associates with heterodimeric cytokine receptor complexes and activates STAT family members including STAT1, STAT3, STAT4 or STAT6 (PubMed:22859374). The heterodimeric cytokine receptor complexes are composed of (1) a TYK2-associated receptor chain (IFNAR1, IL12RB1, IL10RB or IL13RA1), and (2) a second receptor chain associated either with JAK1 or JAK2 (By similarity). In response to cytokine-binding to receptors, phosphorylates and activates receptors (IFNAR1, IL12RB1, IL10RB or IL13RA1), creating docking sites for STAT members (By similarity). In turn, recruited STATs are phosphorylated by TYK2 (or JAK1/JAK2 on the second receptor chain), form homo- and heterodimers, translocate to the nucleus, and regulate cytokine/growth factor responsive genes (By similarity). Negatively regulates STAT3 activity by promototing phosphorylation at a specific tyrosine that differs from the site used for signaling (By similarity). Involved in the oncostatin-M-mediated signaling pathway through both type I OSM receptor complex (heterodimers composed of LIFR and IL6ST) and type II OSM receptor complex (heterodimers composed of OSMR and IL6ST) (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling. Erratum:[Cell Mol Life Sci. 2024 Nov 15;81(1):455. doi: 10.1007/s00018-024-05482-y. PMID: 39545991] Publication Status: Online-Only, [RefSeq, PubMed]; Tyrosine kinase of the non-receptor type involved in numerous cytokines and interferons signaling, which regulates cell growth, development, cell migration, innate and adaptive immunity. Plays both structural and catalytic roles in numerous interleukins and interferons (IFN-alpha/beta) signaling. Associates with heterodimeric cytokine receptor complexes and activates STAT family members including STAT1, STAT3, STAT4 or STAT6. The heterodimeric cytokine receptor complexes are composed of (1) a TYK2-associated receptor chain (IFNAR1, IL12RB1, IL10RB or IL13RA1), and (2) a second receptor chain associated either with JAK1 or JAK2. In response to cytokine-binding to receptors, phosphorylates and activates receptors (IFNAR1, IL12RB1, IL10RB or IL13RA1), creating docking sites for STAT members. In turn, recruited STATs are phosphorylated by TYK2 (or JAK1/JAK2 on the second receptor chain), form homo- and heterodimers, translocate to the nucleus, and regulate cytokine/growth factor responsive genes. Negatively regulates STAT3 activity by promototing phosphorylation at a specific tyrosine that differs from the site used for signaling. Involved in the oncostatin-M-mediated signaling pathway through both type I OSM receptor complex (heterodimers composed of LIFR and IL6ST) and type II OSM receptor complex (heterodimers composed of OSMR and IL6ST)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O88431;Q3TXE3;Q52KQ2;Q8VE41",
        "ec_number_list": "2.7.12.2;2.7.10.1;2.7.12.1;2.7.1.32;2.7.1.82;2.7.10.2;2.7.11.1;2.3.2.27;2.7.11.13;3.1.3.48;3.6.5.2;2.7.10.4;2.7.1.40;2.3.2.24;2.3.2.23;2.7.11.24;2.7.11.23;2.3.2.32",
        "go_molecular_function": "GO:0004713 protein tyrosine kinase activity;GO:0004715 non-membrane spanning protein tyrosine kinase activity;GO:0005524 ATP binding;GO:0031702 type 1 angiotensin receptor binding;GO:0005131 growth hormone receptor binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0043235 receptor complex",
        "go_biological_process": "GO:0051142 positive regulation of NK T cell proliferation;GO:0032740 positive regulation of interleukin-17 production;GO:0006357 regulation of transcription by RNA polymerase II;GO:0006955 immune response;GO:0008283 cell population proliferation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q9R117-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35857-1",
        "uniprot_id": "TIM44_MOUSE",
        "mass": 51091.0,
        "length": 452,
        "protein_name": "Mitochondrial import inner membrane translocase subunit TIM44",
        "gene_name": "Timm44",
        "organism": "Mouse",
        "refseq_name": "mitochondrial import inner membrane translocase subunit TIM44",
        "refseq_ac": "NP_035722",
        "gene_names_uniprotkb": "Timm44; Mimt44; Tim44",
        "gene_names_refseq": "0710005E20Rik; D8Ertd118e; Mimt44; Tim44; Timm44",
        "protein_names_uniprotkb": "Mitochondrial import inner membrane translocase subunit TIM44",
        "protein_names_refseq": "DNA segment, Chr 8, ERATO Doi 118, expressed; mitochondrial import inner membrane translocase subunit TIM44; translocator of inner mitochondrial membrane 44",
        "tax_id": 10090,
        "disease": "proliferative diabetic retinopathy (Disease Ontology:DOID:13207); oncocytic carcinoma of the thyroid (Disease Ontology:DOID:8161); diabetic retinopathy (Disease Ontology:DOID:8947)",
        "pathway": " (mmu:21856)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "23806337;31618756;35820727;36288343;36438483;37147302;37453647;37507081;9419343",
        "class_list": "",
        "function": "Essential component of the PAM complex, a complex required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner (PubMed:31618756). Recruits mitochondrial HSP70 to drive protein translocation into the matrix using ATP as an energy source (By similarity)., [UniProtKB, UniProtKB, PubMed]; TIMM44 is a potential therapeutic target of human glioma. Publication Status: Online-Only, [RefSeq, PubMed]; The mitochondrial protein TIMM44 is required for angiogenesis in vitro and in vivo. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q2NLC5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0019899 enzyme binding;GO:0051087 protein-folding chaperone binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005759 mitochondrial matrix;GO:0001650 fibrillar center;GO:0005744 TIM23 mitochondrial import inner membrane translocase complex",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0030150 protein import into mitochondrial matrix",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "O35857-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BH18-1",
        "uniprot_id": "TM117_MOUSE",
        "mass": 60356.0,
        "length": 514,
        "protein_name": "Transmembrane protein 117",
        "gene_name": "Tmem117",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 117",
        "refseq_ac": "NP_848904",
        "gene_names_uniprotkb": "Tmem117",
        "gene_names_refseq": "B930062P21Rik; Tmem117",
        "protein_names_uniprotkb": "Transmembrane protein 117",
        "protein_names_refseq": "transmembrane protein 117",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:320709)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21183079;37314252;37488300",
        "class_list": "",
        "function": "Involved in endoplasmic reticulum (ER) stress-induced cell death pathway., [UniProtKB, UniProtKB]; Tmem117 in AVP neurons regulates the counterregulatory response to hypoglycemia., [RefSeq, PubMed]; Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C6X8",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0070059 intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8BH18-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C0E3-1",
        "uniprot_id": "TRI47_MOUSE",
        "mass": 69912.0,
        "length": 641,
        "protein_name": "E3 ubiquitin-protein ligase TRIM47",
        "gene_name": "Trim47",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase TRIM47 isoform 2",
        "refseq_ac": "NP_766158",
        "gene_names_uniprotkb": "Trim47",
        "gene_names_refseq": "2210023F24Rik; Trim47",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase TRIM47; 2.3.2.27; Tripartite motif-containing protein 47",
        "protein_names_refseq": "E3 ubiquitin-protein ligase TRIM47 isoform 2; E3 ubiquitin-protein ligase TRIM47; tripartite motif protein 47; tripartite motif-containing protein 47",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:217333)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21183079;29291351;31219806;35513381",
        "class_list": "",
        "function": "E3 ubiquitin-protein ligase that mediates the ubiquitination and proteasomal degradation of CYLD., [UniProtKB, PubMed]; TRIM47 is a novel endothelial activation factor that aggravates lipopolysaccharide-induced acute lung injury in mice via K63-linked ubiquitination of TRAF2. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2A862;Q6P249;Q811J7;Q8BVZ8;Q8R1K0;Q8R3Y1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0061630 ubiquitin protein ligase activity;GO:0004842 ubiquitin-protein transferase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005634 nucleus;GO:0005829 cytosol;GO:0098794 postsynapse",
        "go_biological_process": "GO:0016567 protein ubiquitination;GO:0150052 regulation of postsynapse assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q8C0E3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99PP7-1",
        "uniprot_id": "TRI33_MOUSE",
        "mass": 123843.0,
        "length": 1142,
        "protein_name": "E3 ubiquitin-protein ligase TRIM33",
        "gene_name": "Trim33",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase TRIM33 isoform 2",
        "refseq_ac": "NP_001073299",
        "gene_names_uniprotkb": "Trim33; Kiaa1113",
        "gene_names_refseq": "8030451N04Rik; Ecto; Tif1g; Trim33",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase TRIM33; 2.3.2.27; Ectodermin homolog; RING-type E3 ubiquitin transferase TRIM33; TIF1-gamma; Transcription intermediary factor 1-gamma; Tripartite motif-containing protein 33",
        "protein_names_refseq": "E3 ubiquitin-protein ligase TRIM33 isoform 2; E3 ubiquitin-protein ligase TRIM33; RING-type E3 ubiquitin transferase TRIM33; TIF1-gamma; ectodermin homolog; transcription intermediary factor 1-gamma; tripartite motif-containing protein 33",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:94093);  (R-MMU-2173795)",
        "pathway_count": 2,
        "publication_count": 19,
        "publication_id_list": "10.1101/2023.09.13.557529;11331580;15256250;15314655;16751102;21183079;21606357;21750661;22645316;23213215;23806337;24129315;32782141;34428180;36852467;37482091;38608038;40885482;40997131",
        "class_list": "",
        "function": "Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4 ubiquitination, nuclear exclusion and degradation via the ubiquitin proteasome pathway (By similarity). May act as a transcriptional repressor (By similarity). Inhibits the transcriptional response to TGF-beta/BMP signaling cascade (By similarity). Plays a role in the control of cell proliferation (By similarity). Its association with SMAD2 and SMAD3 stimulates erythroid differentiation of hematopoietic stem/progenitor. Monoubiquitinates SMAD4 and acts as an inhibitor of SMAD4-dependent TGF-beta/BMP signaling cascade (Monoubiquitination of SMAD4 hampers its ability to form a stable complex with activated SMAD2/3 resulting in inhibition of TGF-beta/BMP signaling cascade) (By similarity)., [UniProtKB, PubMed]; Genome-wide screening identifies Trim33 as an essential regulator of dendritic cell differentiation., [RefSeq, PubMed]; Tubular cell transcriptional intermediary factor 1gamma deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosis., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 5,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 5,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 5,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6SI71;Q6ZPX5",
        "ec_number_list": "2.3.2.27",
        "go_molecular_function": "GO:0070410 co-SMAD binding;GO:0003677 DNA binding;GO:0008270 zinc ion binding;GO:0061630 ubiquitin protein ligase activity;GO:0070412 R-SMAD binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0000785 chromatin",
        "go_biological_process": "GO:0017015 regulation of transforming growth factor beta receptor signaling pathway;GO:0006351 DNA-templated transcription;GO:0030514 negative regulation of BMP signaling pathway;GO:0016567 protein ubiquitination;GO:0010467 gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 2.8,
        "record_id": "Q99PP7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P20065-1",
        "uniprot_id": "TYB4_MOUSE",
        "mass": 5679.0,
        "length": 50,
        "protein_name": "Thymosin beta-4",
        "gene_name": "Tmsb4x",
        "organism": "Mouse",
        "refseq_name": "thymosin beta-4",
        "refseq_ac": "NP_067253",
        "gene_names_uniprotkb": "Tmsb4x; Ptmb4; Tmsb4",
        "gene_names_refseq": "Ptmb4; Tb4; Tbeta4; Tmsb4x",
        "protein_names_uniprotkb": "Thymosin beta-4; AcSDKP; N-acetyl-SDKP; Seraspenide; T beta 4",
        "protein_names_refseq": "prothymosin beta 4; t beta 4; thymosin beta-4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:19241);  (R-MMU-114608)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "11303049;21183079;2226839;2351831;26495903;26740625;34428180;37371128;37724952;38049080;8838802",
        "class_list": "",
        "function": "Plays an important role in the organization of the cytoskeleton. Binds to and sequesters actin monomers (G actin) and therefore inhibits actin polymerization., [UniProtKB, UniProtKB]; Potent inhibitor of bone marrow derived stem cell differentiation (By similarity). Acts by inhibits the entry of hematopoietic pluripotent stem cells into the S-phase (By similarity)., [UniProtKB, UniProtKB]; Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model. Publication Status: Online-Only, [RefSeq, PubMed]; Thymosin beta4 preserves vascular smooth muscle phenotype in atherosclerosis via regulation of low density lipoprotein related protein 1 (LRP1)., [RefSeq, PubMed]; Upregulated Tbeta4 expression in inflammatory bowel disease impairs the intestinal mucus barrier by inhibiting autophagy in mice., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003785 actin monomer binding;GO:0019899 enzyme binding;GO:0140311 protein sequestering activity;GO:0003788 actin monomer sequestering activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005856 cytoskeleton",
        "go_biological_process": "GO:2001171 positive regulation of ATP biosynthetic process;GO:2001028 positive regulation of endothelial cell chemotaxis;GO:1902037 negative regulation of hematopoietic stem cell differentiation;GO:0007015 actin filament organization;GO:0050728 negative regulation of inflammatory response",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "P20065-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9PZ19-1",
        "uniprot_id": "TUTLB_MOUSE",
        "mass": 144951.0,
        "length": 1328,
        "protein_name": "Protein turtle homolog B",
        "gene_name": "Igsf9b",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Igsf9b; Kiaa1030",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Protein turtle homolog B; Immunoglobulin superfamily member 9B",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "depressive disorder (Disease Ontology:DOID:1596)",
        "pathway": " (mmu:235086)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;16452087;21183079;21750661;23751499;24129315;25428506;32641624;34678516",
        "class_list": "",
        "function": "Transmembrane protein which is abundantly expressed in interneurons, where it may regulate inhibitory synapse development (By similarity). May mediate homophilic cell adhesion (PubMed:23751499). Is involved in the organization and maintenance of axon initial segment (AIS) architecture, likely cooperating with PRICKLE2 to regulate ANK3/ANKG localization to AIS (PubMed:32641624)., [UniProtKB, UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 1,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5DU06",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019900 kinase binding",
        "go_cellular_component": "GO:0098982 GABA-ergic synapse;GO:0014069 postsynaptic density;GO:0030424 axon;GO:0030425 dendrite;GO:0043025 neuronal cell body",
        "go_biological_process": "GO:0007399 nervous system development;GO:0007156 homophilic cell adhesion via plasma membrane adhesion molecules;GO:0099560 synaptic membrane adhesion;GO:0097151 positive regulation of inhibitory postsynaptic potential",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "E9PZ19-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80U87-1",
        "uniprot_id": "UBP8_MOUSE",
        "mass": 122611.0,
        "length": 1080,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 8",
        "gene_name": "Usp8",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 8 isoform 2",
        "refseq_ac": "NP_062703",
        "gene_names_uniprotkb": "Usp8; Kiaa0055; Ubpy",
        "gene_names_refseq": "Ubpy; Usp8; mKIAA0055",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 8; 3.4.19.12; Deubiquitinating enzyme 8; Ubiquitin isopeptidase Y; Ubiquitin thioesterase 8; Ubiquitin-specific-processing protease 8; mUBPy",
        "protein_names_refseq": "deubiquitinating enzyme 8; putative deubiquitinating enzyme; ubiquitin carboxyl-terminal hydrolase 8 isoform 2; ubiquitin carboxyl-terminal hydrolase 8; ubiquitin isopeptidase Y; ubiquitin thioesterase 8; ubiquitin thiolesterase 8; ubiquitin-specific-processing protease 8",
        "tax_id": 10090,
        "disease": "ACTH-secreting pituitary adenoma (Disease Ontology:DOID:7004)",
        "pathway": " (mmu:84092);  (R-MMU-1358803);  (R-MMU-4641263);  (R-MMU-5689880);  (R-MMU-6807004)",
        "pathway_count": 5,
        "publication_count": 35,
        "publication_id_list": "10982817;11500497;12485825;14661020;15314180;15342353;15345747;16120644;16771824;16944949;17121848;17210635;17452457;17720156;18250455;19144319;20130268;21750661;22645316;25428506;26495903;26740625;28011936;30084848;30779550;31219806;31599954;34203471;34428180;36210013;37293711;37704159;37828378;38174929;38598341",
        "class_list": "",
        "function": "Brucella targets the host ubiquitin-specific protease, Usp8, through the effector protein, TcpB, for facilitating infection of macrophages., [RefSeq, PubMed]; Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension., [RefSeq, PubMed]; Deubiquitinating enzyme specifically expressed in testis, associates with the acrosome and centrosome in mouse germ cells, [RefSeq, PubMed]; Hydrolase that can remove conjugated ubiquitin from proteins and therefore plays an important regulatory role at the level of protein turnover by preventing degradation. Converts both 'Lys-48' an 'Lys-63'-linked ubiquitin chains. Catalytic activity is enhanced in the M phase. Involved in cell proliferation. Required to enter into S phase in response to serum stimulation. May regulate T-cell anergy mediated by RNF128 via the formation of a complex containing RNF128 and OTUB1. Probably regulates the stability of STAM2 and RASGRF1. Regulates endosomal ubiquitin dynamics, cargo sorting, membrane traffic at early endosomes, and maintenance of ESCRT-0 stability. The level of protein ubiquitination on endosomes is essential for maintaining the morphology of the organelle. Deubiquitinates EPS15 and controls tyrosine kinase stability. Removes conjugated ubiquitin from EGFR thus regulating EGFR degradation and downstream MAPK signaling. Involved in acrosome biogenesis through interaction with the spermatid ESCRT-0 complex and microtubules. Deubiquitinates BIRC6/bruce and KIF23/MKLP1 (By similarity). Deubiquitinates BACE1 which inhibits BACE1 lysosomal degradation and modulates BACE-mediated APP cleavage and amyloid-beta formation (By similarity)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; USP8 mitigates cognitive dysfunction of mice with sepsis-associated encephalopathy., [RefSeq, PubMed]; USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Erratum:[Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2409669121. doi: 10.1073/pnas.2409669121. PMID: 38843252], [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 12,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AI53;Q80YP2;Q8R0D3;Q9EQU1;Q9WVP5",
        "ec_number_list": "2.7.10.1;2.7.11.1;3.4.19.12;2.3.2.27",
        "go_molecular_function": "GO:0017124 SH3 domain binding;GO:0004843 cysteine-type deubiquitinase activity;GO:0061578 K63-linked deubiquitinase activity;GO:1990380 K48-linked deubiquitinase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005769 early endosome;GO:0005829 cytosol",
        "go_biological_process": "GO:0006508 proteolysis;GO:0016579 protein deubiquitination;GO:0070536 protein K63-linked deubiquitination;GO:1905908 positive regulation of amyloid fibril formation;GO:1990090 cellular response to nerve growth factor stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 3.9,
        "record_id": "Q80U87-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P62069-1",
        "uniprot_id": "UBP46_MOUSE",
        "mass": 42442.0,
        "length": 366,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 46",
        "gene_name": "Usp46",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 46 isoform 1",
        "refseq_ac": "NP_808229",
        "gene_names_uniprotkb": "Usp46",
        "gene_names_refseq": "1190009E20Rik; 2410018I08Rik; Usp46",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 46; 3.4.19.12; Deubiquitinating enzyme 46; Ubiquitin thioesterase 46; Ubiquitin-specific-processing protease 46",
        "protein_names_refseq": "deubiquitinating enzyme 46; ubiquitin carboxyl-terminal hydrolase 46 isoform 1; ubiquitin carboxyl-terminal hydrolase 46; ubiquitin specific protease 46; ubiquitin thioesterase 46; ubiquitin thiolesterase 46; ubiquitin-specific-processing protease 46",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69727)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;19465912;21750661;22043315;23472206;26284364",
        "class_list": "",
        "function": "Deubiquitinating enzyme that plays a role in behavior, possibly by regulating GABA action. May act by mediating the deubiquitination of GAD1/GAD67 (PubMed:19465912). Has almost no deubiquitinating activity by itself and requires the interaction with WDR48 to have a high activity. Not involved in deubiquitination of monoubiquitinated FANCD2 (By similarity)., [UniProtKB, PubMed, UniProtKB]; Results suggest that the Lys 92 deletion of USP46 could influence enzyme activity and thereby provide a molecular clue how the enzyme regulating the pathogenesis of mental illnesses., [RefSeq, PubMed]; Usp46 mutation is associated with Impaired Maternal Behavior. Publication Status: Online-Only, [RefSeq, PubMed]; Usp46 regulates a wide range of behavioral phenotypes that might be related to mental disorders, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9737,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3ULU5;Q80V95;Q9H7U4;Q9H9T8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0004843 cysteine-type deubiquitinase activity;GO:0101005 deubiquitinase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0045202 synapse",
        "go_biological_process": "GO:0006508 proteolysis;GO:0016579 protein deubiquitination;GO:0048149 behavioral response to ethanol;GO:0050862 positive regulation of T cell receptor signaling pathway;GO:0008343 adult feeding behavior",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P62069-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5ND28-1",
        "uniprot_id": "SREC_MOUSE",
        "mass": 87464.0,
        "length": 820,
        "protein_name": "Scavenger receptor class F member 1",
        "gene_name": "Scarf1",
        "organism": "Mouse",
        "refseq_name": "scavenger receptor class F member 1 precursor",
        "refseq_ac": "NP_001004157",
        "gene_names_uniprotkb": "Scarf1; Kiaa0149; Srec",
        "gene_names_refseq": "SREC-I; SREC; Scarf1; mKIAA0149",
        "protein_names_uniprotkb": "Scavenger receptor class F member 1; Acetyl LDL receptor; SREC-I; Scavenger receptor expressed by endothelial cells 1 protein",
        "protein_names_refseq": "acetyl LDL receptor; scavenger receptor class F member 1 precursor; scavenger receptor expressed by endothelial cells 1 protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:380713)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "15247299;17586471;19144319;21183079;21750661;23892722;25836976;35082161;8590280",
        "class_list": "",
        "function": "Interaction of SREC-I and advillin are involved in the development of dorsal root ganglion neurons by inducing the described morphological changes., [RefSeq, PubMed]; Mediates the binding and degradation of acetylated low density lipoprotein (Ac-LDL). Mediates heterophilic interactions, suggesting a function as adhesion protein (By similarity). Plays a role in the regulation of neurite-like outgrowth., [UniProtKB, PubMed, UniProtKB, UniProtKB]; Our system may be useful for the elucidation of the mechanism of morphological maturation of neuronal cells such as dorsal root ganglion neurons that express SREC-I during early development., [RefSeq, PubMed]; SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus., [RefSeq, PubMed]; SREC-I became associated with TLR4 on binding bacterial lipopolysaccharides in RAW 264.7. Publication Status: Online-Only, [RefSeq, PubMed]; The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3V029;Q571H4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005044 scavenger receptor activity;GO:0030169 low-density lipoprotein particle binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0048680 positive regulation of axon regeneration;GO:0010976 positive regulation of neuron projection development;GO:0016322 neuron remodeling;GO:0016358 dendrite development;GO:0007157 heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q5ND28-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K400-1",
        "uniprot_id": "STXB5_MOUSE",
        "mass": 127651.0,
        "length": 1152,
        "protein_name": "Syntaxin-binding protein 5",
        "gene_name": "Stxbp5",
        "organism": "Mouse",
        "refseq_name": "syntaxin-binding protein 5 isoform 2",
        "refseq_ac": "NP_001394992",
        "gene_names_uniprotkb": "Stxbp5; Kiaa4253; Llgl3",
        "gene_names_refseq": "0710001E20Rik; 4930565N16Rik; LGL3; Stxbp5; mKIAA1006",
        "protein_names_uniprotkb": "Syntaxin-binding protein 5; Lethal(2) giant larvae protein homolog 3; Tomosyn-1",
        "protein_names_refseq": "lethal(2) giant larvae protein homolog 3; syntaxin-binding protein 5 isoform 2; syntaxin-binding protein 5; tomosyn-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:78808)",
        "pathway_count": 1,
        "publication_count": 13,
        "publication_id_list": "12832401;15659226;15690082;16452087;16505218;17242355;19144319;21183079;21750661;28746398;31219806;37432648;37695731",
        "class_list": "",
        "function": "Data indicate that bidirectional moving tomosyn-1 (Stxbp5) and tomosyn-2 (Stxbp5l) puncta were observed. Publication Status: Online-Only, [RefSeq, PubMed]; Genetic ablation of synaptotagmin-9 alters tomosyn-1 function to increase insulin secretion from pancreatic beta-cells improving glucose clearance., [RefSeq, PubMed]; In the pancreatic beta-cell, tomosyn negatively regulates insulin exocytosis., [RefSeq, PubMed]; Interacts with SNAP23 and Syntaxin4 and plays a role in Insulin-stimulated GLUT4 translocacion., [RefSeq, PubMed]; Plays a regulatory role in calcium-dependent exocytosis and neurotransmitter release (By similarity). Inhibits membrane fusion between transport vesicles and the plasma membrane. May modulate the assembly of trans-SNARE complexes between transport vesicles and the plasma membrane. Competes with STXBP1 for STX1 binding. Inhibits translocation of GLUT4 from intracellular vesicles to the plasma membrane., [UniProtKB, PubMed]; The interaction between syntaxin4 and Munc18c in adipocytes results in enhancement of insulin-stimulated GLUT4 externalization., [RefSeq, PubMed]; Tomosyn affects dense core vesicle composition but not exocytosis in mammalian neurons. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 12,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QLY8;Q80TM5;Q8K401;Q9D2F3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0045159 myosin II binding;GO:0005096 GTPase activator activity;GO:0019905 syntaxin binding;GO:0017075 syntaxin-1 binding",
        "go_cellular_component": "GO:0098888 extrinsic component of presynaptic membrane;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0005892 acetylcholine-gated channel complex",
        "go_biological_process": "GO:0099504 synaptic vesicle cycle;GO:0007409 axonogenesis;GO:0015031 protein transport;GO:0006887 exocytosis;GO:0010807 regulation of synaptic vesicle priming",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q8K400-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6NZL6-1",
        "uniprot_id": "TONSL_MOUSE",
        "mass": 151108.0,
        "length": 1363,
        "protein_name": "Tonsoku-like protein",
        "gene_name": "Tonsl",
        "organism": "Mouse",
        "refseq_name": "tonsoku-like protein",
        "refseq_ac": "NP_898914",
        "gene_names_uniprotkb": "Tonsl; Ikbr; Nfkbil2",
        "gene_names_refseq": "2810439M11Rik; Nfkbil2; Tonsl",
        "protein_names_uniprotkb": "Tonsoku-like protein; I-kappa-B-related protein; IkappaBR; Inhibitor of kappa B-related protein; NF-kappa-B inhibitor-like protein 2; Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2",
        "protein_names_refseq": "I-kappa-B-related protein; NF-kappa-B inhibitor-like protein 2; ikappaBR; inhibitor of kappa B-related protein; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2; tonsoku-like protein",
        "tax_id": 10090,
        "disease": "spondyloepimetaphyseal dysplasia, Sponastrime type (Disease Ontology:DOID:5684)",
        "pathway": " (mmu:72749)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "21750661;22872234;24129315;25428506;30084848;30773278;30779550;31219806;34428180;35298257;37828378",
        "class_list": "",
        "function": "Component of the MMS22L-TONSL complex, a complex that promotes homologous recombination-mediated repair of double-strand breaks (DSBs) at stalled or collapsed replication forks. The MMS22L-TONSL complex is required to maintain genome integrity during DNA replication. It mediates the assembly of RAD51 filaments on single-stranded DNA (ssDNA): the MMS22L-TONSL complex is recruited to DSBs following histone replacement by histone chaperones and eviction of the replication protein A complex (RPA/RP-A) from DSBs. Following recruitment to DSBs, the TONSL-MMS22L complex promotes recruitment of RAD51 filaments and subsequent homologous recombination. Within the complex, TONSL acts as a histone reader, which recognizes and binds newly synthesized histones following their replacement by histone chaperones. Specifically binds histone H4 lacking methylation at 'Lys-20' (H4K20me0) and histone H3.1., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BT74;Q9ER45",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042393 histone binding;GO:0140566 histone reader activity",
        "go_cellular_component": "GO:0043596 nuclear replication fork;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0016604 nuclear body;GO:0035861 site of double-strand break",
        "go_biological_process": "GO:0000724 double-strand break repair via homologous recombination;GO:0031297 replication fork processing;GO:0071168 protein localization to chromatin",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q6NZL6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P16546-1",
        "uniprot_id": "SPTN1_MOUSE",
        "mass": 284597.0,
        "length": 2472,
        "protein_name": "Spectrin alpha chain, non-erythrocytic 1",
        "gene_name": "Sptan1",
        "organism": "Mouse",
        "refseq_name": "spectrin alpha chain, non-erythrocytic 1 isoform 5",
        "refseq_ac": "NP_001356254",
        "gene_names_uniprotkb": "Sptan1; Spna2; Spta2",
        "gene_names_refseq": "2610027H02Rik; Spna-2; Spna2; Sptan1",
        "protein_names_uniprotkb": "Spectrin alpha chain, non-erythrocytic 1; Alpha-II spectrin; Fodrin alpha chain",
        "protein_names_refseq": "alpha-II spectrin; alpha-spectrin 2, brain; alphaII-spectrin; fodrin alpha chain; spectrin alpha chain, brain; spectrin alpha chain, non-erythrocytic 1 isoform 5; spectrin alpha chain, non-erythrocytic 1; spectrin, non-erythroid alpha chain",
        "tax_id": 10090,
        "disease": "hereditary spastic paraplegia 91 (Disease Ontology:DOID:0070643); developmental and epileptic encephalopathy 5 (Disease Ontology:DOID:0080438); autosomal dominant distal hereditary motor neuronopathy 11 (Disease Ontology:DOID:0081400)",
        "pathway": " (mmu:20740);  (R-MMU-264870);  (R-MMU-375165);  (R-MMU-445095);  (R-MMU-5673001);  (R-MMU-6798695);  (R-MMU-6807878);  (R-MMU-9013420);  (R-MMU-9013424)",
        "pathway_count": 9,
        "publication_count": 28,
        "publication_id_list": "10.1101/2023.09.13.557529;10870971;16452087;17114649;17242355;19224205;20173027;2111175;21183079;21750661;22645316;23806337;25428507;25605945;2926814;30899004;33300544;33649389;33725478;34203471;34428180;35820727;35984892;36064721;36210013;36288343;37507081;37828378",
        "class_list": "",
        "function": "Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 5,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 5,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 5,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 22,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 7,
        "disease_count": 3,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A3KGU6;A3KGU8;Q8K380;Q9CT05",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005516 calmodulin binding;GO:0051015 actin filament binding;GO:0005509 calcium ion binding;GO:0030507 spectrin binding;GO:0044877 protein-containing complex binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0030054 cell junction",
        "go_biological_process": "GO:0030036 actin cytoskeleton organization;GO:0051693 actin filament capping",
        "synthesized_glycan_count": 0,
        "hit_score": 4.4,
        "record_id": "P16546-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O08736-1",
        "uniprot_id": "CASPC_MOUSE",
        "mass": 47854.0,
        "length": 419,
        "protein_name": "Caspase-12",
        "gene_name": "Casp12",
        "organism": "Mouse",
        "refseq_name": "caspase-12",
        "refseq_ac": "NP_033938",
        "gene_names_uniprotkb": "Casp12",
        "gene_names_refseq": "Casp12",
        "protein_names_uniprotkb": "Caspase-12; 3.4.22.-; CASP-12",
        "protein_names_refseq": "CASP-12; caspase-12",
        "tax_id": 10090,
        "disease": "Alzheimer's disease (Disease Ontology:DOID:10652); heart disease (Disease Ontology:DOID:114); sciatic neuropathy (Disease Ontology:DOID:11446); post-traumatic stress disorder (Disease Ontology:DOID:2055); brain ischemia (Disease Ontology:DOID:2316); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); amyotrophic lateral sclerosis (Disease Ontology:DOID:332); pancreatitis (Disease Ontology:DOID:4989); ureteral obstruction (Disease Ontology:DOID:5199); congestive heart failure (Disease Ontology:DOID:6000); type 2 diabetes mellitus (Disease Ontology:DOID:9352); type 1 diabetes mellitus (Disease Ontology:DOID:9744)",
        "pathway": " (mmu:12364)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "11278723;21750661;9038361",
        "class_list": "",
        "function": "Involved in the activation cascade of caspases responsible for apoptosis execution., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 12,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TT82",
        "ec_number_list": "",
        "go_molecular_function": "GO:0002020 protease binding;GO:0004175 endopeptidase activity;GO:0004197 cysteine-type endopeptidase activity;GO:0008234 cysteine-type peptidase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol;GO:0072558 NLRP1 inflammasome complex",
        "go_biological_process": "GO:0006915 apoptotic process;GO:0050729 positive regulation of inflammatory response;GO:0043525 positive regulation of neuron apoptotic process;GO:0097193 intrinsic apoptotic signaling pathway;GO:0030968 endoplasmic reticulum unfolded protein response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "O08736-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BIJ6-1",
        "uniprot_id": "SYIM_MOUSE",
        "mass": 112804.0,
        "length": 1012,
        "protein_name": "Isoleucine--tRNA ligase, mitochondrial",
        "gene_name": "Iars2",
        "organism": "Mouse",
        "refseq_name": "isoleucine--tRNA ligase, mitochondrial precursor",
        "refseq_ac": "NP_941055",
        "gene_names_uniprotkb": "Iars2",
        "gene_names_refseq": "2010002H18Rik; Iars2",
        "protein_names_uniprotkb": "Isoleucine--tRNA ligase, mitochondrial; 6.1.1.5; IleRS; Isoleucyl-tRNA synthetase",
        "protein_names_refseq": "ileRS; isoleucine--tRNA ligase, mitochondrial precursor; isoleucine--tRNA ligase, mitochondrial; isoleucyl-tRNA synthetase, mitochondrial",
        "tax_id": 10090,
        "disease": "mitochondrial metabolism disease (Disease Ontology:DOID:700)",
        "pathway": " (mmu:381314);  (R-MMU-9837999)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;22645316;23576753;23806337;34428180;36288343;37507081",
        "class_list": "",
        "function": "Aminoacyl-tRNA synthetase that catalyzes the specific attachment of isoleucine to its cognate tRNA (tRNA(Ile))., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TKT8;Q8BIJ0;Q8BIP3",
        "ec_number_list": "3.5.3.1;1.1.1.35;1.1.1.62;1.1.1.239;1.1.1.178;1.1.1.53;1.1.1.159;5.3.3.21;3.1.2.-;3.1.2.2;1.1.1.37;4.98.1.1;1.4.1.3;3.6.4.10;5.3.3.8;1.2.1.3;2.3.1.168;2.3.3.10;7.1.2.2;5.6.1.7;4.2.1.2;1.2.4.2;2.7.11.2;6.1.1.5;2.7.1.23;3.4.21.53;5.6.2.3;2.3.1.9;7.1.1.2;1.1.1.38;4.2.1.3;6.4.1.3;1.2.1.36;1.7.1.-;1.2.1.28;2.3.3.1;1.2.4.1;2.8.3.5;2.3.1.41;1.3.8.5;1.3.8.1",
        "go_molecular_function": "GO:0002161 aminoacyl-tRNA deacylase activity;GO:0004822 isoleucine-tRNA ligase activity;GO:0005524 ATP binding;GO:0000049 tRNA binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005759 mitochondrial matrix",
        "go_biological_process": "GO:0006428 isoleucyl-tRNA aminoacylation;GO:0032543 mitochondrial translation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q8BIJ6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0A1B0GS05-1",
        "uniprot_id": "A0A1B0GS05_MOUSE",
        "mass": 20516.0,
        "length": 176,
        "protein_name": "Coiled-coil domain containing 196",
        "gene_name": "Ccdc196",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Ccdc196",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Coiled-coil domain containing 196",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A0A1B0GS05-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D9U9-1",
        "uniprot_id": "CFA45_MOUSE",
        "mass": 65826.0,
        "length": 551,
        "protein_name": "Cilia- and flagella-associated protein 45",
        "gene_name": "Cfap45",
        "organism": "Mouse",
        "refseq_name": "cilia- and flagella-associated protein 45",
        "refseq_ac": "NP_082248",
        "gene_names_uniprotkb": "Cfap45; Ccdc19; Nesg1",
        "gene_names_refseq": "1700028D05Rik; Ccdc19; Cfap45; Nesg1",
        "protein_names_uniprotkb": "Cilia- and flagella-associated protein 45; Coiled-coil domain-containing protein 19; Nasopharyngeal epithelium-specific protein 1",
        "protein_names_refseq": "cilia- and flagella-associated protein 45; coiled-coil domain containing 19; coiled-coil domain-containing protein 19; nasopharyngeal epithelium specific protein 1",
        "tax_id": 10090,
        "disease": "visceral heterotaxy 11 (Disease Ontology:DOID:0051025)",
        "pathway": " (mmu:71870)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21750661;33139725;37295417;37865089;37989994",
        "class_list": "",
        "function": "CFAP45 deficiency causes situs abnormalities and asthenospermia by disrupting an axonemal adenine nucleotide homeostasis module. Publication Status: Online-Only, [RefSeq, PubMed]; Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating (PubMed:37295417, PubMed:37865089, PubMed:37989994). It is an AMP-binding protein that may facilitate dynein ATPase-dependent ciliary and flagellar beating via adenine nucleotide homeostasis (By similarity). May function as a donor of AMP to AK8 and hence promote ADP production (PubMed:33139725)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0016208 AMP binding",
        "go_cellular_component": "GO:0097229 sperm end piece;GO:0005576 extracellular region;GO:0005929 cilium;GO:0036126 sperm flagellum;GO:0097228 sperm principal piece",
        "go_biological_process": "GO:0030317 flagellated sperm motility;GO:0060296 regulation of cilium beat frequency involved in ciliary motility;GO:0060287 epithelial cilium movement involved in determination of left/right asymmetry;GO:0090660 cerebrospinal fluid circulation;GO:0061966 establishment of left/right asymmetry",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q9D9U9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CI66-1",
        "uniprot_id": "STML1_MOUSE",
        "mass": 42926.0,
        "length": 399,
        "protein_name": "Stomatin-like protein 1",
        "gene_name": "Stoml1",
        "organism": "Mouse",
        "refseq_name": "stomatin-like protein 1",
        "refseq_ac": "NP_081218",
        "gene_names_uniprotkb": "Stoml1",
        "gene_names_refseq": "1810015E19Rik; SLP1; STORP; Stoml1; UNC24; WPB72",
        "protein_names_uniprotkb": "Stomatin-like protein 1; SLP-1",
        "protein_names_refseq": "stomatin-like protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69106)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;24247984",
        "class_list": "",
        "function": "May play a role in cholesterol transfer to late endosomes (By similarity). May play a role in modulating membrane acid-sensing ion channels. Can specifically inhibit proton-gated current of ASIC1 isoform 1. Can increase inactivation speed of ASIC3. May be involved in regulation of proton sensing in dorsal root ganglions (PubMed:24247984)., [UniProtKB, UniProtKB, PubMed]; STOML1 modulates ASIC1a and ASIC3 in DRG neurons., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BLA3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008200 ion channel inhibitor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0045121 membrane raft;GO:0031410 cytoplasmic vesicle;GO:0031902 late endosome membrane",
        "go_biological_process": "GO:0006869 lipid transport;GO:1990830 cellular response to leukemia inhibitory factor",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8CI66-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "G3UW36-1",
        "uniprot_id": "C97D2_MOUSE",
        "mass": 11800.0,
        "length": 98,
        "protein_name": "Uncharacterized protein CFAP97D2",
        "gene_name": "Cfap97d2",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein CFAP97D2",
        "refseq_ac": "NP_001094989",
        "gene_names_uniprotkb": "Cfap97d2",
        "gene_names_refseq": "4932443I19Rik; A230061C02Rik; Cfap97d2; Gm1106",
        "protein_names_uniprotkb": "Uncharacterized protein CFAP97D2; CFAP97 domain-containing protein 2",
        "protein_names_refseq": "CFAP97 domain-containing protein 2; uncharacterized protein CFAP97D2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:403185)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;32785227",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "G3UW36-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80VJ2-1",
        "uniprot_id": "SRA1_MOUSE",
        "mass": 24325.0,
        "length": 220,
        "protein_name": "Steroid receptor RNA activator 1",
        "gene_name": "Sra1",
        "organism": "Mouse",
        "refseq_name": "steroid receptor RNA activator 1 isoform b",
        "refseq_ac": "NP_001157878",
        "gene_names_uniprotkb": "Sra1",
        "gene_names_refseq": "Sra1; Srap; Sra; Straa1; Strra1",
        "protein_names_uniprotkb": "Steroid receptor RNA activator 1; SRAP; Steroid receptor RNA activator protein",
        "protein_names_refseq": "steroid receptor RNA activator 1 isoform b; steroid receptor RNA activator protein",
        "tax_id": 10090,
        "disease": "congestive heart failure (Disease Ontology:DOID:6000)",
        "pathway": " (mmu:24068)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "14517287;15327771;21750661;31945347;36288343;40885482",
        "class_list": "",
        "function": "Functional RNA which acts as a transcriptional coactivator that selectively enhances steroid receptor-mediated transactivation ligand-independently through a mechanism involving the modulating N-terminal domain (AF-1) of steroid receptors. Also mediates transcriptional coactivation of steroid receptors ligand-dependently through the steroid-binding domain (AF-2). Enhances cellular proliferation and differentiation and promotes apoptosis in vivo. May play a role in tumorigenesis (By similarity)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Results identify a pseudouridine synthase, mPus1p, as a coactivator for retinoic acid receptor (mRAR)gamma when coexpressed with steroid receptor RNA activator., [RefSeq, PubMed]; Steroid Receptor RNA Activator, a Long Noncoding RNA, Activates p38, Facilitates Epithelial-Mesenchymal Transformation, and Mediates Experimental Melanoma Metastasis., [RefSeq, PubMed]; Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QM44;Q8R0S3;Q9CWU7;Q9D973",
        "ec_number_list": "",
        "go_molecular_function": "GO:0002153 steroid receptor RNA activator RNA binding;GO:0003713 transcription coactivator activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0006915 apoptotic process;GO:0045662 negative regulation of myoblast differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q80VJ2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q924W7-1",
        "uniprot_id": "DEN2B_MOUSE",
        "mass": 126861.0,
        "length": 1134,
        "protein_name": "DENN domain-containing protein 2B",
        "gene_name": "Dennd2b",
        "organism": "Mouse",
        "refseq_name": "DENN domain-containing protein 2B isoform 1",
        "refseq_ac": "NP_001001326",
        "gene_names_uniprotkb": "Dennd2b; Denn2b; St5",
        "gene_names_refseq": "2010004M01Rik; 2610305K15Rik; Denn2b; Dennd2b; St5",
        "protein_names_uniprotkb": "DENN domain-containing protein 2B; HeLa tumor suppression 1; Suppression of tumorigenicity 5 protein",
        "protein_names_refseq": "DENN domain-containing protein 2B isoform 1; DENN domain-containing protein 2B; heLa tumor suppression 1; suppression of tumorigenicity 5 protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76954);  (R-MMU-8876198)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "11528127;21183079;21750661;29650351;30084848;34428180;34887587;35820727",
        "class_list": "",
        "function": "Guanine nucleotide exchange factor (GEF) which may activate RAB9A and RAB9B. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form., [UniProtKB, UniProtKB]; May be involved in cytoskeletal organization and tumorogenicity. Seems to be involved in a signaling transduction pathway leading to activation of MAPK1/ERK2. Plays a role in EGFR trafficking from recycling endosomes back to the cell membrane., [UniProtKB, UniProtKB]; May block ERK2 activation stimulated by ABL1. May alter cell morphology and cell growth., [UniProtKB, UniProtKB]; ST5 overexpression has no mitogenic effect on the adult beta-cell under basal and metabolically challenged states., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q05BD9;Q78H54;Q8K2P3;Q924W8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005085 guanyl-nucleotide exchange factor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0005938 cell cortex;GO:0055037 recycling endosome",
        "go_biological_process": "GO:0070374 positive regulation of ERK1 and ERK2 cascade",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q924W7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q921T2-1",
        "uniprot_id": "TOIP1_MOUSE",
        "mass": 66781.0,
        "length": 595,
        "protein_name": "Torsin-1A-interacting protein 1",
        "gene_name": "Tor1aip1",
        "organism": "Mouse",
        "refseq_name": "torsin-1A-interacting protein 1 isoform 1",
        "refseq_ac": "NP_001153490",
        "gene_names_uniprotkb": "Tor1aip1",
        "gene_names_refseq": "LAP1; Lap1B; Tor1aip1",
        "protein_names_uniprotkb": "Torsin-1A-interacting protein 1; LAP1B; Lamina-associated polypeptide 1B",
        "protein_names_refseq": "lamina-associated polypeptide 1B; torsin-1A-interacting protein 1 isoform 1; torsin-1A-interacting protein 1",
        "tax_id": 10090,
        "disease": "autosomal recessive limb-girdle muscular dystrophy type 2Y (Disease Ontology:DOID:0110289)",
        "pathway": " (mmu:208263);  (R-MMU-9035034)",
        "pathway_count": 2,
        "publication_count": 19,
        "publication_id_list": "10.1101/2023.09.13.557529;16364897;17242355;19144319;20457914;21183079;21750661;22872234;25428506;26495903;30084848;30899004;31219806;31408437;31599954;34428180;36210013;36288343;36362402",
        "class_list": "",
        "function": "Loss of the Nuclear Envelope Protein LAP1B Disrupts the Myogenic Differentiation of Patient-Derived Fibroblasts. Publication Status: Online-Only, [RefSeq, PubMed]; Required for nuclear membrane integrity. Induces TOR1A and TOR1B ATPase activity and is required for their location on the nuclear membrane. Binds to A- and B-type lamins. Possible role in membrane attachment and assembly of the nuclear lamina., [UniProtKB, PubMed, UniProtKB, UniProtKB]; Results establish an essential role for the nuclear envelope-localized torsinA-LAP1 complex in hepatic VLDL secretion and suggest that the torsinA pathway participates in the pathophysiology of nonalcoholic fatty liver disease. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 12,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 6,
        "disease_count": 1,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QLK1;Q1EQW1;Q3U7A4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051117 ATPase binding;GO:0008092 cytoskeletal protein binding;GO:0001671 ATPase activator activity;GO:0005521 lamin binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005635 nuclear envelope;GO:0005654 nucleoplasm;GO:0031965 nuclear membrane;GO:0005637 nuclear inner membrane",
        "go_biological_process": "GO:0090435 protein localization to nuclear envelope;GO:0032781 positive regulation of ATP-dependent activity;GO:0071763 nuclear membrane organization",
        "synthesized_glycan_count": 0,
        "hit_score": 2.9,
        "record_id": "Q921T2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P25118-1",
        "uniprot_id": "TNR1A_MOUSE",
        "mass": 50130.0,
        "length": 454,
        "protein_name": "Tumor necrosis factor receptor superfamily member 1A",
        "gene_name": "Tnfrsf1a",
        "organism": "Mouse",
        "refseq_name": "tumor necrosis factor receptor superfamily member 1A precursor",
        "refseq_ac": "NP_035739",
        "gene_names_uniprotkb": "Tnfrsf1a; Tnfr-1; Tnfr1",
        "gene_names_refseq": "CD120a; FPF; TNF-R-I; TNF-R1; TNF-R55; TNF-R; TNF-alphaR1; TNFAR; TNFR60; TNFRI; TNFRp55; TNFalpha-R1; Tnfr-2; Tnfr1; Tnfrsf1a; p55-R; p55",
        "protein_names_uniprotkb": "Tumor necrosis factor receptor superfamily member 1A; TNF-R1; TNF-RI; TNFR-I; Tumor necrosis factor receptor 1; Tumor necrosis factor receptor type I; p55; p60",
        "protein_names_refseq": "TNF receptor alpha chain; TNF-RI; TNF-alpha-R1; TNFR-I; p60; tumor necrosis factor receptor 1; tumor necrosis factor receptor superfamily member 1A precursor; tumor necrosis factor receptor type I",
        "tax_id": 10090,
        "disease": "cryptogenic organizing pneumonia (Disease Ontology:DOID:0050157); obstructive sleep apnea (Disease Ontology:DOID:0050848); colorectal adenoma (Disease Ontology:DOID:0050860); lupus nephritis (Disease Ontology:DOID:0080162); polymyositis (Disease Ontology:DOID:0080745); TNF receptorassociated periodic syndrome (Disease Ontology:DOID:0090018); Alzheimer's disease (Disease Ontology:DOID:10652); adult respiratory distress syndrome (Disease Ontology:DOID:11394); sciatic neuropathy (Disease Ontology:DOID:11446); uveitis (Disease Ontology:DOID:13141); allergic bronchopulmonary aspergillosis (Disease Ontology:DOID:13166); Behcet's disease (Disease Ontology:DOID:13241); endometrial cancer (Disease Ontology:DOID:1380); root resorption (Disease Ontology:DOID:14550); cystic fibrosis (Disease Ontology:DOID:1485); colon carcinoma (Disease Ontology:DOID:1520); transient cerebral ischemia (Disease Ontology:DOID:224); brain ischemia (Disease Ontology:DOID:2316); anemia (Disease Ontology:DOID:2355); multiple sclerosis (Disease Ontology:DOID:2377); ovarian cancer (Disease Ontology:DOID:2394); glomerulonephritis (Disease Ontology:DOID:2921); IgA glomerulonephritis (Disease Ontology:DOID:2986); acute kidney failure (Disease Ontology:DOID:3021); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); ischemia (Disease Ontology:DOID:326); fibrosarcoma (Disease Ontology:DOID:3355); coronary artery disease (Disease Ontology:DOID:3393); middle cerebral artery infarction (Disease Ontology:DOID:3525); lung non-small cell carcinoma (Disease Ontology:DOID:3908); renal cell carcinoma (Disease Ontology:DOID:4450); ureteral obstruction (Disease Ontology:DOID:5199); kidney disease (Disease Ontology:DOID:557); myocardial infarction (Disease Ontology:DOID:5844); acquired immunodeficiency syndrome (Disease Ontology:DOID:635); acne (Disease Ontology:DOID:6543); rheumatoid arthritis (Disease Ontology:DOID:7148); end stage renal disease (Disease Ontology:DOID:783); extrinsic allergic alveolitis (Disease Ontology:DOID:841); Crohn's disease (Disease Ontology:DOID:8778); psoriasis (Disease Ontology:DOID:8893); systemic lupus erythematosus (Disease Ontology:DOID:9074); amyloidosis (Disease Ontology:DOID:9120); type 2 diabetes mellitus (Disease Ontology:DOID:9352); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:21937);  (R-MMU-5357786);  (R-MMU-5357905);  (R-MMU-5357956);  (R-MMU-5626978);  (R-MMU-5669034);  (R-MMU-75893)",
        "pathway_count": 7,
        "publication_count": 12,
        "publication_id_list": "11278441;1645445;1647956;1657766;1849278;21750661;24440909;30902834;31219806;31599954;8188324;8381516",
        "class_list": "",
        "function": "Receptor for TNFSF2/TNF and homotrimeric TNFSF1/lymphotoxin-alpha. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis (By similarity)., [UniProtKB]; This gene encodes a member of the TNF receptor superfamily of proteins. The encoded receptor is found in membrane-bound and soluble forms that interact with membrane-bound and soluble forms, respectively, of its ligand, tumor necrosis factor alpha. Binding of membrane-bound tumor necrosis factor alpha to the membrane-bound receptor induces receptor trimerization and activation, which plays a role in cell survival, apoptosis, and inflammation. Proteolytic processing of the encoded receptor results in release of the soluble form of the receptor, which can interact with free tumor necrosis factor alpha to inhibit inflammation. Mice lacking a functional copy of this gene exhibit impaired immune function. [provided by RefSeq, Sep 2016]., [RefSeq]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 45,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0002020 protease binding;GO:0042802 identical protein binding;GO:0043120 tumor necrosis factor binding;GO:0044877 protein-containing complex binding;GO:0005031 tumor necrosis factor receptor activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005615 extracellular space;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0030424 axon",
        "go_biological_process": "GO:0042307 positive regulation of protein import into nucleus;GO:1903140 regulation of establishment of endothelial barrier;GO:0006952 defense response;GO:0006954 inflammatory response;GO:0007166 cell surface receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "P25118-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JI11-1",
        "uniprot_id": "STK4_MOUSE",
        "mass": 55541.0,
        "length": 487,
        "protein_name": "Serine/threonine-protein kinase 4",
        "gene_name": "Stk4",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase 4 precursor",
        "refseq_ac": "NP_067395",
        "gene_names_uniprotkb": "Stk4; Mst1",
        "gene_names_refseq": "Kas-2; Mst1; Stk4; Ysk3",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase 4; 2.7.11.1; MST-1; Mammalian STE20-like protein kinase 1; STE20-like kinase MST1",
        "protein_names_refseq": "STE20-like kinase MST1; Sps1/Ste20-related kinase 3; mammalian STE20-like protein kinase 1; serine/threonine-protein kinase 4 precursor; serine/threonine-protein kinase 4; sterile 20-like kinase 1",
        "tax_id": 10090,
        "disease": "neurodegenerative disease (Disease Ontology:DOID:1289); cancer (Disease Ontology:DOID:162); carcinoma (Disease Ontology:DOID:305); primary immunodeficiency disease (Disease Ontology:DOID:612); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:58231);  (R-MMU-2028269)",
        "pathway_count": 2,
        "publication_count": 13,
        "publication_id_list": "11278283;11864565;15345747;17947660;20080689;21183079;21750661;25605945;28087714;30084848;31219806;34428180;39627609",
        "class_list": "",
        "function": "MST1 is a phylogenetically conserved partner of the NORE/RASSF polypeptide family, and the NORE-MST1 complex is a novel Ras effector unit that mediates the apoptotic effect of Ki-RasG12V, [RefSeq, PubMed]; Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 9,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;3.4.22.56;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0004672 protein kinase activity;GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016604 nuclear body",
        "go_biological_process": "GO:0046621 negative regulation of organ growth;GO:0060706 cell differentiation involved in embryonic placenta development;GO:1904237 positive regulation of substrate-dependent cell migration, cell attachment to substrate;GO:0001934 positive regulation of protein phosphorylation;GO:0006468 protein phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q9JI11-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CYZ2-1",
        "uniprot_id": "TPD54_MOUSE",
        "mass": 24043.0,
        "length": 220,
        "protein_name": "Tumor protein D54",
        "gene_name": "Tpd52l2",
        "organism": "Mouse",
        "refseq_name": "tumor protein D54 isoform a",
        "refseq_ac": "NP_001278126",
        "gene_names_uniprotkb": "Tpd52l2",
        "gene_names_refseq": "2810411G23Rik; D54; Tpd52l2",
        "protein_names_uniprotkb": "Tumor protein D54; Tumor protein D52-like 2",
        "protein_names_refseq": "tumor protein D54 isoform a; tumor protein D54",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66314)",
        "pathway_count": 1,
        "publication_count": 15,
        "publication_id_list": "15345747;18630941;19131326;21183079;21750661;22645316;28657654;32782141;32848054;34428180;34678516;35822049;36852467;37507081;40885482",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 5,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 5,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 5,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 12,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TVY1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0005975 carbohydrate metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "Q9CYZ2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q76I79-1",
        "uniprot_id": "SSH1_MOUSE",
        "mass": 115297.0,
        "length": 1042,
        "protein_name": "Protein phosphatase Slingshot homolog 1",
        "gene_name": "Ssh1",
        "organism": "Mouse",
        "refseq_name": "protein phosphatase Slingshot homolog 1 isoform 1",
        "refseq_ac": "NP_932777",
        "gene_names_uniprotkb": "Ssh1; Kiaa1298; Ssh1l",
        "gene_names_refseq": "Gm1394; Gm1395; SSH-1L; SSH-1; Ssh1",
        "protein_names_uniprotkb": "Protein phosphatase Slingshot homolog 1; 3.1.3.16; 3.1.3.48; SSH-1L; SSH-like protein 1; mSSH-1L",
        "protein_names_refseq": "SSH-like protein 1; protein phosphatase Slingshot homolog 1 isoform 1; protein phosphatase Slingshot homolog 1; slingshot 1L; slingshot-like 1",
        "tax_id": 10090,
        "disease": "alcohol use disorder (Disease Ontology:DOID:1574)",
        "pathway": " (mmu:231637)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;14531860;15660133;17535256;21183079;21750661;21857021;34428180;37837551",
        "class_list": "",
        "function": "Dysregulated expression of slingshot protein phosphatase 1 (SSH1) disrupts circadian rhythm and WNT signaling associated to hepatocellular carcinoma pathogenesis., [RefSeq, PubMed]; Knockdown of SSH1 expression by RNA interference significantly suppressed stress fiber formation in C2C12 myoblast cells, indicating a role for SSH1 in stress fiber formation or stabilization in cells., [RefSeq, PubMed]; PDGF activates SSH1L in VSMC by a mechanism that involves Nox1-mediated oxidation of 14-3-3 and Ser-834 SSH1L auto-dephosphorylation. Erratum:[J Biol Chem. 2020 Jun 12;295(24):8348. doi: 10.1074/jbc.AAC120.014380. PMID: 32532854], [RefSeq, PubMed]; Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein., [UniProtKB, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 9641,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TDG3;Q69ZM4;Q811E5",
        "ec_number_list": "3.1.3.48;3.1.3.2;3.1.3.67;3.1.3.-;3.1.3.16;3.1.3.74;3.1.3.53;3.1.3.27;3.1.3.52;3.1.3.5;3.1.3.21;3.1.3.18;3.1.3.86;3.1.3.36",
        "go_molecular_function": "GO:0003779 actin binding;GO:0004722 protein serine/threonine phosphatase activity;GO:0004721 phosphoprotein phosphatase activity;GO:0004725 protein tyrosine phosphatase activity;GO:0016791 phosphatase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005856 cytoskeleton;GO:0005886 plasma membrane;GO:0030426 growth cone;GO:0031252 cell leading edge",
        "go_biological_process": "GO:0098976 excitatory chemical synaptic transmission;GO:2000463 positive regulation of excitatory postsynaptic potential;GO:0000902 cell morphogenesis;GO:0030036 actin cytoskeleton organization;GO:0006470 protein dephosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q76I79-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64511-1",
        "uniprot_id": "TOP2B_MOUSE",
        "mass": 181909.0,
        "length": 1612,
        "protein_name": "DNA topoisomerase 2-beta",
        "gene_name": "Top2b",
        "organism": "Mouse",
        "refseq_name": "DNA topoisomerase 2-beta",
        "refseq_ac": "NP_033435",
        "gene_names_uniprotkb": "Top2b",
        "gene_names_refseq": "D230016L12Rik; Top-2; Top2b",
        "protein_names_uniprotkb": "DNA topoisomerase 2-beta; 5.6.2.2; DNA topoisomerase II, beta isozyme",
        "protein_names_refseq": "DNA topoisomerase 2-beta; DNA topoisomerase II, beta isozyme",
        "tax_id": 10090,
        "disease": "cancer (Disease Ontology:DOID:162); B cell deficiency (Disease Ontology:DOID:2115); acute myeloid leukemia (Disease Ontology:DOID:9119)",
        "pathway": " (mmu:21974);  (R-MMU-4615885)",
        "pathway_count": 2,
        "publication_count": 22,
        "publication_id_list": "10.1101/2023.09.13.557529;16452087;17242355;19131326;19144319;19224205;20173027;21183079;21750661;22872234;23806337;25428506;28203736;30084848;31409799;34428180;34887587;35820727;36210013;37507081;38377005;39627609",
        "class_list": "",
        "function": "Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand. Plays a role in B-cell differentiation., [UniProtKB, PubMed]; Mapping catalytically engaged TOP2B in neurons reveals the principles of topoisomerase action within the genome., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 31,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 3,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TQG4",
        "ec_number_list": "2.3.2.-;5.6.2.2",
        "go_molecular_function": "GO:0003918 DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity;GO:0003677 DNA binding;GO:0003682 chromatin binding;GO:0005524 ATP binding;GO:0043021 ribonucleoprotein complex binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005829 cytosol;GO:1990904 ribonucleoprotein complex",
        "go_biological_process": "GO:0000712 resolution of meiotic recombination intermediates;GO:2001034 positive regulation of double-strand break repair via nonhomologous end joining;GO:0007409 axonogenesis;GO:0030900 forebrain development;GO:0001764 neuron migration",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "Q64511-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BYC6-1",
        "uniprot_id": "TAOK3_MOUSE",
        "mass": 105336.0,
        "length": 898,
        "protein_name": "Serine/threonine-protein kinase TAO3",
        "gene_name": "Taok3",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase TAO3",
        "refseq_ac": "NP_001074777",
        "gene_names_uniprotkb": "Taok3",
        "gene_names_refseq": "2900006A08Rik; A130052D22; A430105I05Rik; Taok3",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase TAO3; 2.7.11.1; Thousand and one amino acid protein 3",
        "protein_names_refseq": "serine/threonine-protein kinase TAO3; thousand and one amino acid protein 3",
        "tax_id": 10090,
        "disease": "autism spectrum disorder (Disease Ontology:DOID:0060041); chromosome 16p11.2 deletion syndrome, 593-kb (Disease Ontology:DOID:0070515); cancer (Disease Ontology:DOID:162); central nervous system disease (Disease Ontology:DOID:331)",
        "pathway": " (mmu:330177);  (R-MMU-9013149);  (R-MMU-9013404);  (R-MMU-9013423)",
        "pathway_count": 4,
        "publication_count": 15,
        "publication_id_list": "17242355;19144319;21183079;21750661;23806337;28068307;32807497;33214146;34428180;34506849;34634521;37347461;37400834;37864157;38166031",
        "class_list": "",
        "function": "Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice. Publication Status: Online-Only, [RefSeq, PubMed]; STE20 kinase TAOK3 regulates type 2 immunity and metabolism in obesity., [RefSeq, PubMed]; Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade (By similarity). In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases (By similarity). Inhibits basal activity of the MAPK8/JNK cascade and diminishes its activation in response to epidermal growth factor (EGF) (By similarity). Positively regulates canonical T cell receptor (TCR) signaling by preventing early PTPN6/SHP1-mediated inactivation of LCK, ensuring sustained TCR signaling that is required for optimal activation and differentiation of T cells (By similarity). Phosphorylates PTPN6/SHP1 on 'Thr-394', leading to its polyubiquitination and subsequent proteasomal degradation (By similarity). Required for cell surface expression of metalloprotease ADAM10 on type 1 transitional B cells which is necessary for their NOTCH-mediated development into marginal zone B cells (PubMed:28068307). Also required for the NOTCH-mediated terminal differentiation of splenic conventional type 2 dendritic cells (PubMed:33214146). Positively regulates osteoblast differentiation by acting as an upstream activator of the JNK pathway (PubMed:32807497). Promotes JNK signaling in hepatocytes and positively regulates hepatocyte lipid storage by inhibiting beta-oxidation and triacylglycerol secretion while enhancing lipid synthesis (By similarity). Restricts age-associated inflammation by negatively regulating differentiation of macrophages and their production of pro-inflammatory cytokines (PubMed:37400834). Plays a role in negatively regulating the abundance of regulatory T cells in white adipose tissue (PubMed:37347461)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]; The induction of SHP-1 degradation by TAOK3 ensures the responsiveness of T cells to TCR stimulation., [RefSeq, PubMed]; This study shows that during positive selection in the spleen, B-cell receptor signaling causes immature type 1 transitional B cells to become receptive to Notch ligands via Taok3-mediated surface expression of ADAM10, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 7,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RY27;Q3V3B3",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;3.6.5.2;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;3.1.4.4;2.7.10.1;2.7.11.31;3.6.5.-;1.6.3.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0016740 transferase activity;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005811 lipid droplet;GO:0005886 plasma membrane;GO:0045121 membrane raft",
        "go_biological_process": "GO:0006281 DNA repair;GO:0006468 protein phosphorylation;GO:0046330 positive regulation of JNK cascade;GO:0000165 MAPK cascade;GO:0048812 neuron projection morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q8BYC6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3TA38-1",
        "uniprot_id": "T120B_MOUSE",
        "mass": 40407.0,
        "length": 339,
        "protein_name": "Transmembrane protein 120B",
        "gene_name": "Tmem120b",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 120B isoform 1",
        "refseq_ac": "NP_001034812",
        "gene_names_uniprotkb": "Tmem120b",
        "gene_names_refseq": "Tmem120b",
        "protein_names_uniprotkb": "Transmembrane protein 120B",
        "protein_names_refseq": "transmembrane protein 120B isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:330189)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;26024229;32084332",
        "class_list": "",
        "function": "It is possible that the TMEM120A and B fat-specific nuclear envelope transmembrane proteins may play a contributory role in the tissue-specific pathology of this disorder or in the wider problem of obesity. Publication Status: Online-Only, [RefSeq, PubMed]; Necessary for efficient adipogenesis (PubMed:26024229). Does not show ion channel activity (PubMed:32084332)., [UniProtKB, PubMed, PubMed]; Necessary for efficient adipogenesis. Does not show ion channel activity., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q14BK6;Q8R243",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005637 nuclear inner membrane",
        "go_biological_process": "GO:0051291 protein heterooligomerization;GO:0045444 fat cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q3TA38-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z2I8-1",
        "uniprot_id": "SUCB2_MOUSE",
        "mass": 46840.0,
        "length": 433,
        "protein_name": "Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial",
        "gene_name": "Suclg2",
        "organism": "Mouse",
        "refseq_name": "succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial isoform 2",
        "refseq_ac": "NP_001313487",
        "gene_names_uniprotkb": "Suclg2",
        "gene_names_refseq": "D6Wsu120e; G-SCS; GTPSCS; SCS-betaG; Suclg2",
        "protein_names_uniprotkb": "Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial; 6.2.1.-; 6.2.1.4; G-SCS; GTP-specific succinyl-CoA synthetase subunit beta; GTPSCS; Itaconyl--CoA ligase [GDP-forming] subunit beta; Malyl--CoA ligase [GDP-forming] subunit beta; SCS-betaG; Succinyl-CoA synthetase beta-G chain",
        "protein_names_refseq": "GTP-specific succinyl-CoA synthetase beta subunit; itaconyl--CoA ligase [GDP-forming] subunit beta; malyl--CoA ligase [GDP-forming] subunit beta; succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial isoform 2; succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial; succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial; succinyl-CoA synthetase beta-G chain",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:20917);  (R-MMU-71403);  (R-MMU-9837999)",
        "pathway_count": 3,
        "publication_count": 10,
        "publication_id_list": "21183079;21750661;23576753;23806337;30779550;34428180;36288343;37453647;37507081;9765291",
        "class_list": "",
        "function": "GTP-specific succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The beta subunit provides nucleotide specificity of the enzyme and binds the substrate succinate, while the binding sites for coenzyme A and phosphate are found in the alpha subunit. Also able to act as a GTP-specific itaconyl- and malyl-CoA synthetase., [UniProtKB, HAMAP]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3T9B8;Q3TJQ5;Q3TK63;Q66JT3;Q7TMY3;Q80VV1;Q8K2K9",
        "ec_number_list": "3.5.3.1;1.8.1.4;5.3.3.21;3.1.2.-;3.1.2.2;3.4.21.92;1.1.1.37;4.98.1.1;1.2.4.1;3.6.4.10;5.3.3.8;1.2.1.3;1.1.1.42;7.1.2.2;5.6.1.7;4.2.1.2;1.2.4.2;1.1.1.35;1.1.1.30;2.7.11.2;2.3.1.9;2.3.1.37;7.1.1.2;1.1.1.38;4.2.1.3;1.2.1.36;1.7.1.-;1.2.1.28;2.3.3.1;2.8.3.5;2.3.1.41;1.1.1.41;1.3.8.5;6.2.1.-;6.2.1.4;6.2.1.5;6.2.1.9",
        "go_molecular_function": "GO:0004777 succinate-semialdehyde dehydrogenase (NAD+) activity;GO:0000287 magnesium ion binding;GO:0005524 ATP binding;GO:0005525 GTP binding;GO:0044877 protein-containing complex binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005759 mitochondrial matrix;GO:0005886 plasma membrane;GO:0032991 protein-containing complex;GO:0045244 succinate-CoA ligase complex (GDP-forming)",
        "go_biological_process": "GO:0006099 tricarboxylic acid cycle;GO:0006104 succinyl-CoA metabolic process;GO:0006105 succinate metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q9Z2I8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WTS4-1",
        "uniprot_id": "TEN1_MOUSE",
        "mass": 305795.0,
        "length": 2731,
        "protein_name": "Teneurin-1",
        "gene_name": "Tenm1",
        "organism": "Mouse",
        "refseq_name": "teneurin-1",
        "refseq_ac": "NP_035985",
        "gene_names_uniprotkb": "Tenm1; Odz1; Tnm1",
        "gene_names_refseq": "Odz1; Odz2; TCAP-1; Ten-m1; Tenm1; ten-1",
        "protein_names_uniprotkb": "Teneurin-1; Protein Odd Oz/ten-m homolog 1; Ten-1 ECD; Ten-1 extracellular domain; Ten-1; Ten-m1; Tenascin-M1; Teneurin transmembrane protein 1",
        "protein_names_refseq": "protein Odd Oz/ten-m homolog 1; tenascin-M1; teneurin-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:23963)",
        "pathway_count": 1,
        "publication_count": 31,
        "publication_id_list": "10.1101/2023.09.13.557529;10225957;12000766;12915301;15710242;15777793;17174479;17644218;17900539;18082275;19428634;20883474;21183079;21411044;21750661;22209827;22517741;22645316;22698694;23026563;24788674;25428506;30084848;30779550;30899004;31088288;31219806;33300544;34428180;35820727;40885482",
        "class_list": "",
        "function": "Induces gene transcription activation., [UniProtKB, UniProtKB, UniProtKB]; Involved in neural development, regulating the establishment of proper connectivity within the nervous system. May function as a cellular signal transducer (By similarity)., [UniProtKB, UniProtKB, UniProtKB]; Plays a role in the regulation of neuroplasticity in the limbic system. Mediates a rapid reorganization of actin- and tubulin-based cytoskeleton elements with an increase in dendritic arborization and spine density formation of neurons in the hippocampus and amygdala. Induces BDNF transcription inhibition in neurons. Activates the mitogen-activated protein (MAP) kinase 2 (MEK2) and extracellular signal-regulated kinase (ERK) cascade. Also acts as a bioactive neuroprotective peptide on limbic neurons of the brain and regulates stress-induced behavior: attenuates alkalosis-associated necrotic cell death and the effects of corticotropin-releasing factor (CRF) on c-fos/FOS induction and on the reinstatement of cocaine seeking., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 5,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 9,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 9,
        "reported_o_glycosites_with_glycan": 5,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 9,
        "total_reported_o_glycosites": 5,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 9,
        "total_o_glycosites": 5,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 9,
        "disease_count": 0,
        "glyco_site_count": 20,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CAT1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0046982 protein heterodimerization activity;GO:0050839 cell adhesion molecule binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0007218 neuropeptide signaling pathway;GO:0090316 positive regulation of intracellular protein transport;GO:0048666 neuron development",
        "synthesized_glycan_count": 0,
        "hit_score": 5.5,
        "record_id": "Q9WTS4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B1AZI6-1",
        "uniprot_id": "THOC2_MOUSE",
        "mass": 182773.0,
        "length": 1594,
        "protein_name": "THO complex subunit 2",
        "gene_name": "Thoc2",
        "organism": "Mouse",
        "refseq_name": "THO complex subunit 2",
        "refseq_ac": "NP_001028594",
        "gene_names_uniprotkb": "Thoc2",
        "gene_names_refseq": "6330441O12Rik; D130005M13Rik; Gm1139; Gm1793; Tho2; Thoc2",
        "protein_names_uniprotkb": "THO complex subunit 2; Tho2",
        "protein_names_refseq": "THO complex subunit 2; transcription/export complex subunit 2",
        "tax_id": 10090,
        "disease": "X-linked intellectual disability-short stature-overweight syndrome (Disease Ontology:DOID:0112056)",
        "pathway": " (mmu:331401);  (R-MMU-159236);  (R-MMU-72187)",
        "pathway_count": 3,
        "publication_count": 17,
        "publication_id_list": "10.1101/2023.09.13.557529;16479539;17242355;21183079;21750661;25428506;25605945;26166480;31219806;31599954;34203471;34428180;34887587;36210013;37252988;38331934;39627609",
        "class_list": "",
        "function": "Component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. Required for efficient export of polyadenylated RNA and spliced mRNA. The THOC1-THOC2-THOC3 core complex alone is sufficient to bind export factor NXF1-NXT1 and promote ATPase activity of DDX39B; in the complex THOC2 is the only component that directly interacts with DDX39B. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NXF1 pathway. Required for NXF1 localization to the nuclear rim. THOC2 (and probably the THO complex) is involved in releasing mRNA from nuclear speckle domains. Plays a role for proper neuronal development., [UniProtKB, UniProtKB]; Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopment. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 8,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003729 mRNA binding",
        "go_cellular_component": "GO:0000347 THO complex;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0016607 nuclear speck;GO:0000445 THO complex part of transcription export complex",
        "go_biological_process": "GO:0016973 poly(A)+ mRNA export from nucleus;GO:0006397 mRNA processing;GO:0006406 mRNA export from nucleus;GO:0000902 cell morphogenesis;GO:0010977 negative regulation of neuron projection development",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "B1AZI6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6ZQ29-1",
        "uniprot_id": "TAOK2_MOUSE",
        "mass": 139297.0,
        "length": 1240,
        "protein_name": "Serine/threonine-protein kinase TAO2",
        "gene_name": "Taok2",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase TAO2 isoform 1",
        "refseq_ac": "NP_001157246",
        "gene_names_uniprotkb": "Taok2; Kiaa0881",
        "gene_names_refseq": "1110033K02Rik; B230344N16; MAP3K17; PSK1; PSK; TAO1; TAO2; Taok2; mKIAA0881",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase TAO2; 2.7.11.1; Thousand and one amino acid protein 2",
        "protein_names_refseq": "TAO kinase 2TAO kinase 2; serine/threonine-protein kinase TAO2 isoform 1; serine/threonine-protein kinase TAO2; thousand and one amino acid protein 2",
        "tax_id": 10090,
        "disease": "autism spectrum disorder (Disease Ontology:DOID:0060041); chromosome 16p11.2 deletion syndrome, 593-kb (Disease Ontology:DOID:0070515); cancer (Disease Ontology:DOID:162); central nervous system disease (Disease Ontology:DOID:331)",
        "pathway": " (mmu:381921)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "21183079;21750661;22872234;22883308;24129315;29467497;31219806;34428180;36210013",
        "class_list": "",
        "function": "Disruption of the Taok2 gene alters behavioral response to ethanol., [RefSeq, PubMed]; Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. May affect microtubule organization and stability. May play a role in the osmotic stress-MAPK8 pathway. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14/p38 MAPK activation (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 8,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TSS8",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0031434 mitogen-activated protein kinase kinase binding;GO:0038191 neuropilin binding;GO:0004709 MAP kinase kinase kinase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0007409 axonogenesis;GO:0032956 regulation of actin cytoskeleton organization;GO:0043410 positive regulation of MAPK cascade;GO:0046330 positive regulation of JNK cascade;GO:0000165 MAPK cascade",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q6ZQ29-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3V0Q6-1",
        "uniprot_id": "SPAG8_MOUSE",
        "mass": 50541.0,
        "length": 470,
        "protein_name": "Sperm-associated antigen 8",
        "gene_name": "Spag8",
        "organism": "Mouse",
        "refseq_name": "sperm-associated antigen 8 isoform 2",
        "refseq_ac": "NP_001007464",
        "gene_names_uniprotkb": "Spag8",
        "gene_names_refseq": "MH-SPAG8; SMP-1; Spag8",
        "protein_names_uniprotkb": "Sperm-associated antigen 8; SMP-1; Sperm membrane protein 1; Sperm membrane protein BS-84",
        "protein_names_refseq": "sperm associated antigen 8-like protein; sperm membrane protein 1; sperm membrane protein BS-84; sperm-associated antigen 8 isoform 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:433700)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "17187156;20488182;21750661;37295417;37865089;37989994",
        "class_list": "",
        "function": "Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating (PubMed:37295417, PubMed:37865089, PubMed:37989994). Plays a role in spermatogenesis by enhancing the binding of CREM isoform tau to its coactivator FHL5 and increasing the FHL5-regulated transcriptional activation of CREM isoform tau (PubMed:20488182). Involved in the acrosome reaction and in binding of sperm to the zona pellucida (PubMed:17187156). Plays a role in regulation of the cell cycle by controlling progression through the G2/M phase, possibly by delaying the activation of CDK1 which is required for entry into mitosis (By similarity). May play a role in fertility and microtubule formation through interaction with RANBP9 (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]; Results indicate that SPAG8 acts as a regulator of ACT and plays an important role in CREM-ACT-mediated gene transcription during spermatogenesis., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B9EKF1;Q5UAV3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008017 microtubule binding",
        "go_cellular_component": "GO:0097229 sperm end piece;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005819 spindle",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0030154 cell differentiation;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0030317 flagellated sperm motility;GO:0007338 single fertilization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q3V0Q6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CDY7-1",
        "uniprot_id": "DYLT4_MOUSE",
        "mass": 23451.0,
        "length": 219,
        "protein_name": "Dynein light chain Tctex-type 4",
        "gene_name": "Dynlt4",
        "organism": "Mouse",
        "refseq_name": "dynein light chain Tctex-type 4",
        "refseq_ac": "NP_778195",
        "gene_names_uniprotkb": "Dynlt4; Tctex1d4",
        "gene_names_refseq": "4833401D15Rik; Dynlt4; Tctex1d4",
        "protein_names_uniprotkb": "Dynein light chain Tctex-type 4; Tctex1 domain-containing protein 4",
        "protein_names_refseq": "Tctex1 domain containing 4; dynein light chain Tctex-type 4; tctex1 domain-containing protein 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:242646)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21183079;21750661;23789093",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AE79;A2AE80;Q14C28",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008157 protein phosphatase 1 binding;GO:0045505 dynein intermediate chain binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0001669 acrosomal vesicle;GO:0005815 microtubule organizing center",
        "go_biological_process": "GO:0007018 microtubule-based movement",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8CDY7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C7M3-1",
        "uniprot_id": "TRIM9_MOUSE",
        "mass": 90870.0,
        "length": 817,
        "protein_name": "E3 ubiquitin-protein ligase TRIM9",
        "gene_name": "Trim9",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase TRIM9 isoform 2",
        "refseq_ac": "NP_001103672",
        "gene_names_uniprotkb": "Trim9; Kiaa0282",
        "gene_names_refseq": "Trim9",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase TRIM9; 2.3.2.27; RING-type E3 ubiquitin transferase TRIM9; Tripartite motif-containing protein 9",
        "protein_names_refseq": "E3 ubiquitin-protein ligase TRIM9 isoform 2; E3 ubiquitin-protein ligase TRIM9; RING-type E3 ubiquitin transferase TRIM9; tripartite motif-containing protein 9",
        "tax_id": 10090,
        "disease": "Opitz GBBB syndrome (Disease Ontology:DOID:0080697)",
        "pathway": " (mmu:94090);  (R-MMU-983168)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "11331580;11960705;20085810;21183079;21750661;33378226;38507236",
        "class_list": "",
        "function": "E3 ubiquitin-protein ligase which ubiquitinates itself in cooperation with an E2 enzyme UBE2D2/UBC4 and serves as a targeting signal for proteasomal degradation. May play a role in regulation of neuronal functions. May act as a regulator of synaptic vesicle exocytosis by controlling the availability of SNAP25 for the SNARE complex formation., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; TRIM9 is expressed in the mouse embryonic and adult nervous system, [RefSeq, PubMed]; The E3 ubiquitin ligase TRIM9 regulates synaptic function and actin dynamics in response to netrin-1., [RefSeq, PubMed]; The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6ZQE5;Q80WT6;Q8C7Z4;Q8CC32;Q8CEG2;Q99PQ3",
        "ec_number_list": "2.3.2.26;2.3.2.31;2.3.2.27;2.3.2.-;3.6.4.-;2.3.2.24;2.3.2.23;2.3.2.34;2.3.2.32;2.7.11.1;2.3.2.36;2.3.2.25;6.2.1.-",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0019904 protein domain specific binding;GO:0042803 protein homodimerization activity;GO:0061630 ubiquitin protein ligase activity;GO:0000149 SNARE binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005856 cytoskeleton;GO:0030425 dendrite;GO:0045202 synapse;GO:0008021 synaptic vesicle",
        "go_biological_process": "GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0045955 negative regulation of calcium ion-dependent exocytosis;GO:0016567 protein ubiquitination;GO:0035544 negative regulation of SNARE complex assembly;GO:0016079 synaptic vesicle exocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8C7M3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B6A8R8-1",
        "uniprot_id": "TARM1_MOUSE",
        "mass": 31392.0,
        "length": 288,
        "protein_name": "T-cell-interacting, activating receptor on myeloid cells protein 1",
        "gene_name": "Tarm1",
        "organism": "Mouse",
        "refseq_name": "T-cell-interacting, activating receptor on myeloid cells protein 1 isoform 1 precursor",
        "refseq_ac": "NP_796337",
        "gene_names_uniprotkb": "Tarm1; Gm9904",
        "gene_names_refseq": "9930022N03Rik; Gm9904; OLT-2; Tarm1",
        "protein_names_uniprotkb": "T-cell-interacting, activating receptor on myeloid cells protein 1; OLT-2; OSCAR-like transcript-2 protein",
        "protein_names_refseq": "OSCAR-like transcript-2 protein; T-cell-interacting, activating receptor on myeloid cells protein 1 isoform 1 precursor; T-cell-interacting, activating receptor on myeloid cells protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:245126);  (R-MMU-6798695)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "21750661;26311901;33397982",
        "class_list": "",
        "function": "May act as receptor. Negatively regulates TCR-mediated CD4(+) T cell proliferation and activation, possibly by binding an unknown ligand on the T cell surface. Enhances Toll-like receptor-mediated production of pro-inflammatory cytokines by macrophages and neutrophils., [UniProtKB, PubMed]; TARM1 contributes to development of arthritis by activating dendritic cells through recognition of collagens. Publication Status: Online-Only, [RefSeq, PubMed]; The results suggest a putative T cell ligand can interact with TARM1 receptor, resulting in bidirectional signaling and raising the T cell activation threshold while costimulating the release of proinflammatory cytokines by macrophages and neutrophils., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0034987 immunoglobulin receptor binding;GO:0004888 transmembrane signaling receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0007165 signal transduction;GO:0045087 innate immune response;GO:0002250 adaptive immune response;GO:2000562 negative regulation of CD4-positive, alpha-beta T cell proliferation;GO:1900017 positive regulation of cytokine production involved in inflammatory response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "B6A8R8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60769-1",
        "uniprot_id": "TNAP3_MOUSE",
        "mass": 87654.0,
        "length": 775,
        "protein_name": "Tumor necrosis factor alpha-induced protein 3",
        "gene_name": "Tnfaip3",
        "organism": "Mouse",
        "refseq_name": "tumor necrosis factor alpha-induced protein 3 isoform 1",
        "refseq_ac": "NP_033423",
        "gene_names_uniprotkb": "Tnfaip3; Tnfip3",
        "gene_names_refseq": "A20; Tnfaip3; Tnfip3",
        "protein_names_uniprotkb": "Tumor necrosis factor alpha-induced protein 3; 2.3.2.-; 3.4.19.12; Putative DNA-binding protein A20; TNF alpha-induced protein 3; Zinc finger protein A20",
        "protein_names_refseq": "TNF alpha-induced protein 3; putative DNA-binding protein A20; tumor necrosis factor alpha-induced protein 3 isoform 1; tumor necrosis factor induced protein 3; zinc finger protein A20",
        "tax_id": 10090,
        "disease": "familial Behcet-like autoinflammatory syndrome (Disease Ontology:DOID:0080944); breast cancer (Disease Ontology:DOID:1612); colon cancer (Disease Ontology:DOID:219); esophagus squamous cell carcinoma (Disease Ontology:DOID:3748); cholangiocarcinoma (Disease Ontology:DOID:4947); esophageal cancer (Disease Ontology:DOID:5041); stomach carcinoma (Disease Ontology:DOID:5517); hepatocellular carcinoma (Disease Ontology:DOID:684); ulcerative colitis (Disease Ontology:DOID:8577); colorectal cancer (Disease Ontology:DOID:9256); nasopharynx carcinoma (Disease Ontology:DOID:9261)",
        "pathway": " (mmu:21929);  (R-MMU-168638);  (R-MMU-5357786);  (R-MMU-5357905);  (R-MMU-5357956);  (R-MMU-5689896);  (R-MMU-936440)",
        "pathway_count": 7,
        "publication_count": 16,
        "publication_id_list": "10.1101/2023.09.13.557529;10385526;11389905;15334086;18342009;19131965;20185725;21151899;21750661;23609450;29203883;30084848;30779550;34428180;35820727;7836754",
        "class_list": "",
        "function": "Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of pro-inflammatory cytokines and IFN beta in LPS-tolerized macrophages., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 11,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U968",
        "ec_number_list": "3.4.19.12;2.3.2.27;2.7.11.10;2.7.11.1;2.7.10.2;2.3.2.-;2.7.11.25;2.3.2.31",
        "go_molecular_function": "GO:0002020 protease binding;GO:0003677 DNA binding;GO:0008270 zinc ion binding;GO:0042802 identical protein binding;GO:0019900 kinase binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005764 lysosome",
        "go_biological_process": "GO:2000347 positive regulation of hepatocyte proliferation;GO:0002677 negative regulation of chronic inflammatory response;GO:0002637 regulation of immunoglobulin production;GO:0032703 negative regulation of interleukin-2 production;GO:0072573 tolerance induction to lipopolysaccharide",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q60769-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9ERK0-1",
        "uniprot_id": "RIPK4_MOUSE",
        "mass": 86613.0,
        "length": 786,
        "protein_name": "Receptor-interacting serine/threonine-protein kinase 4",
        "gene_name": "Ripk4",
        "organism": "Mouse",
        "refseq_name": "receptor-interacting serine/threonine-protein kinase 4",
        "refseq_ac": "NP_076152",
        "gene_names_uniprotkb": "Ripk4; Ankrd3; Pkk",
        "gene_names_refseq": "2310069J12Rik; ANKK2; Ankrd3; DIk; PKK; RIP4; Ripk4",
        "protein_names_uniprotkb": "Receptor-interacting serine/threonine-protein kinase 4; 2.7.11.1; Ankyrin repeat domain-containing protein 3; PKC-associated protein kinase; PKC-regulated protein kinase",
        "protein_names_refseq": "PKC-associated protein kinase; PKC-regulated protein kinase; ankyrin repeat domain-containing protein 3; receptor-interacting serine/threonine-protein kinase 4",
        "tax_id": 10090,
        "disease": "popliteal pterygium syndrome (Disease Ontology:DOID:0060055)",
        "pathway": " (mmu:72388)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "11278382;12091384;12194825;12446564;12676934;22197488;28507225;34428180;36210013;37871667",
        "class_list": "",
        "function": "A member of the RICK/RIP family of kinases, which is involved in a PKC-activated NF-kappa B signaling pathway that is independent of Bcl10 and IKK gamma, [RefSeq, PubMed]; Data show that RIP4 is a critical component of a novel pathway that controls keratinocyte differentiation., [RefSeq, PubMed]; RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/beta-catenin signaling in melanoma cells and tumor growth in vivo., [RefSeq, PubMed]; Serine/threonine protein kinase (PubMed:28507225). Required for embryonic skin development and correct skin homeostasis in adults, via phosphorylation of PKP1 and subsequent promotion of keratinocyte differentiation and cell adhesion (PubMed:28507225). It is a direct transcriptional target of TP63 (PubMed:22197488). Plays a role in NF-kappa-B activation (PubMed:12446564)., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UM04",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0043588 skin development;GO:0002009 morphogenesis of an epithelium",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9ERK0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91ZR2-1",
        "uniprot_id": "SNX18_MOUSE",
        "mass": 67904.0,
        "length": 614,
        "protein_name": "Sorting nexin-18",
        "gene_name": "Snx18",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Snx18; Snag1",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Sorting nexin-18; Sorting nexin-associated Golgi protein 1",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "colorectal cancer (Disease Ontology:DOID:9256)",
        "pathway": " (R-MMU-8856828)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "26495903;26567222;28528544;31219806;34887587",
        "class_list": "",
        "function": "Involved in endocytosis and intracellular vesicle trafficking, both during interphase and at the end of mitosis. Required for efficient progress through mitosis and cytokinesis. Required for normal formation of the cleavage furrow at the end of mitosis. Plays a role in endocytosis via clathrin-coated pits, but also clathrin-independent, actin-dependent fluid-phase endocytosis. Plays a role in macropinocytosis. Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate and promotes membrane tubulation. Stimulates the GTPase activity of DNM2. Promotes DNM2 location at the plasma membrane. Together with DNM2, involved in autophagosome assembly by regulating trafficking from recycling endosomes of phospholipid scramblase ATG9A., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005546 phosphatidylinositol-4,5-bisphosphate binding;GO:0035091 phosphatidylinositol binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030426 growth cone;GO:0043025 neuronal cell body;GO:0070062 extracellular exosome;GO:0031410 cytoplasmic vesicle",
        "go_biological_process": "GO:0006897 endocytosis;GO:0015031 protein transport;GO:0043547 positive regulation of GTPase activity;GO:0016197 endosomal transport;GO:0000281 mitotic cytokinesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q91ZR2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C7E7-1",
        "uniprot_id": "STBD1_MOUSE",
        "mass": 36127.0,
        "length": 338,
        "protein_name": "Starch-binding domain-containing protein 1",
        "gene_name": "Stbd1",
        "organism": "Mouse",
        "refseq_name": "starch-binding domain-containing protein 1",
        "refseq_ac": "NP_780305",
        "gene_names_uniprotkb": "Stbd1; D5Ertd593e",
        "gene_names_refseq": "D530019K15Rik; D5Ertd593e; Stbd1",
        "protein_names_uniprotkb": "Starch-binding domain-containing protein 1; Genethonin-1; Glycophagy cargo receptor stbd1",
        "protein_names_refseq": "genethonin 1; glycophagy cargo receptor stbd1; starch-binding domain-containing protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:52331);  (R-MMU-6798695);  (R-MMU-8980692);  (R-MMU-9013404);  (R-MMU-9013408);  (R-MMU-9013423)",
        "pathway_count": 6,
        "publication_count": 11,
        "publication_id_list": "17242355;18630941;20810658;21183079;21750661;23726947;27358407;28137759;30772465;34428180;39927985",
        "class_list": "glycogene",
        "function": "AMPK-dependent phosphorylation of Gapex-5 (also known as GTPase-activating protein and VPS9 domain-containing protein 1 (GAPVD1)) on Ser902 in hepatocytes and starch-binding domain 1 (STBD1) on Ser175 in multiple cells/tissues, [RefSeq, PubMed]; Acts as a cargo receptor for glycogen. Delivers its cargo to an autophagic pathway called glycophagy, resulting in the transport of glycogen to lysosomes., [UniProtKB, UniProtKB, PubMed]; Mouse Stbd1 is a transmembrane endoplasmic reticulum (ER)-resident protein with the capacity to induce the formation of organized ER structures., [RefSeq, PubMed]; Results demonstrate that Stbd1 plays a dominant role in glycogen transport to lysosomes in liver and that the N-terminal transmembrane region and the C-terminal CBM20 domain are critical for this function., [RefSeq, PubMed]; Stbd1 is highly elevated in skeletal muscle of Pompe disease mice but suppression of its expression does not affect lysosomal glycogen accumulation., [RefSeq, PubMed]; Stbd1 is involved in glycogen metabolism by binding to glycogen and anchoring it to membranes, thereby affecting its cellular localization and its intracellular trafficking to lysosomes. Erratum:[J Biol Chem. 2011 Nov 11;286(45):39673], [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 11,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 21,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q147T8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030247 polysaccharide binding;GO:0019899 enzyme binding;GO:2001070 starch binding;GO:2001069 glycogen binding;GO:0038024 cargo receptor activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0048471 perinuclear region of cytoplasm;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0007041 lysosomal transport;GO:0061723 glycophagy;GO:0061753 substrate localization to autophagosome;GO:0005980 glycogen catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q8C7E7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6P6N5-1",
        "uniprot_id": "SPRE3_MOUSE",
        "mass": 42794.0,
        "length": 408,
        "protein_name": "Sprouty-related, EVH1 domain-containing protein 3",
        "gene_name": "Spred3",
        "organism": "Mouse",
        "refseq_name": "sprouty-related, EVH1 domain-containing protein 3",
        "refseq_ac": "NP_891557",
        "gene_names_uniprotkb": "Spred3",
        "gene_names_refseq": "D130060H24Rik; Spred-3; Spred3",
        "protein_names_uniprotkb": "Sprouty-related, EVH1 domain-containing protein 3; Spred-3",
        "protein_names_refseq": "Sprouty-related EVH1 domain-containing protein; sprouty-related, EVH1 domain-containing protein 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:101809);  (R-MMU-5658442)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "12646235;21750661;24129315;24705354;25576668;29501879;34678516",
        "class_list": "",
        "function": "The finding of Spred-3 revealed the presence of a novel family of regulators for the Ras/MAP kinase pathway, each member of which may have different specificities for extracellular signals. [Spred-3], [RefSeq, PubMed]; Tyrosine kinase substrate that inhibits growth-factor-mediated activation of MAP kinase (PubMed:12646235). Inhibits fibroblast growth factor (FGF)-induced retinal lens fiber differentiation, probably by inhibiting FGF-mediated phosphorylation of ERK1/2 (PubMed:29501879). Inhibits TGFB-induced epithelial-to-mesenchymal transition in lens epithelial cells (PubMed:25576668)., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TNJ8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019901 protein kinase binding",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0070373 negative regulation of ERK1 and ERK2 cascade;GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway;GO:0043409 negative regulation of MAPK cascade;GO:0010719 negative regulation of epithelial to mesenchymal transition;GO:1902747 negative regulation of lens fiber cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q6P6N5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K031-1",
        "uniprot_id": "STAR8_MOUSE",
        "mass": 113021.0,
        "length": 1019,
        "protein_name": "StAR-related lipid transfer protein 8",
        "gene_name": "Stard8",
        "organism": "Mouse",
        "refseq_name": "stAR-related lipid transfer protein 8",
        "refseq_ac": "NP_950183",
        "gene_names_uniprotkb": "Stard8; Kiaa0189",
        "gene_names_refseq": "Dlc3; Stard8; mKIAA0189",
        "protein_names_uniprotkb": "StAR-related lipid transfer protein 8; START domain-containing protein 8; StARD8",
        "protein_names_refseq": "START domain containing 8; START domain-containing protein 8; stAR-related lipid transfer protein 8",
        "tax_id": 10090,
        "disease": "gonadal dysgenesis (Disease Ontology:DOID:14447)",
        "pathway": " (mmu:236920);  (R-MMU-8980692);  (R-MMU-9013026);  (R-MMU-9013148)",
        "pathway_count": 4,
        "publication_count": 7,
        "publication_id_list": "17976533;21183079;21750661;24129315;30084848;34428180;35820727",
        "class_list": "",
        "function": "Accelerates GTPase activity of RHOA and CDC42, but not RAC1. Stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLCD1 (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AZJ2;Q3UZC7;Q6A0A8;Q6P5E0;Q8R3X8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0008289 lipid binding",
        "go_cellular_component": "GO:0005925 focal adhesion",
        "go_biological_process": "GO:0007165 signal transduction;GO:0030036 actin cytoskeleton organization;GO:0035023 regulation of Rho protein signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8K031-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B2RQL2-1",
        "uniprot_id": "STOX1_MOUSE",
        "mass": 108902.0,
        "length": 990,
        "protein_name": "Storkhead-box protein 1",
        "gene_name": "Stox1",
        "organism": "Mouse",
        "refseq_name": "storkhead-box protein 1 isoform 1",
        "refseq_ac": "NP_001028432",
        "gene_names_uniprotkb": "Stox1",
        "gene_names_refseq": "4732470K04Rik; Gm63; Stox1",
        "protein_names_uniprotkb": "Storkhead-box protein 1",
        "protein_names_refseq": "storkhead-box protein 1 isoform 1; storkhead-box protein 1",
        "tax_id": 10090,
        "disease": "pre-eclampsia (Disease Ontology:DOID:10591); Alzheimer's disease (Disease Ontology:DOID:10652)",
        "pathway": " (mmu:216021)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "21750661;24738702;25677106;27564589;29465714;31189914;31417152;33301424;34203471;34418053",
        "class_list": "",
        "function": "Alpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model. Publication Status: Online-Only, [RefSeq, PubMed]; Involved in regulating the levels of reactive oxidative species and reactive nitrogen species and in mitochondrial homeostasis in the placenta (By similarity). Required for regulation of inner ear epithelial cell proliferation via the AKT signaling pathway (PubMed:25677106). Involved in cell cycle regulation by binding to the CCNB1 promoter, up-regulating its expression and promoting mitotic entry (By similarity). Induces phosphorylation of MAPT/tau (By similarity)., [UniProtKB, UniProtKB, PubMed]; Long-term cardiovascular disorders in the STOX1 mouse model of preeclampsia. Publication Status: Online-Only, [RefSeq, PubMed]; Our data posit STOX1 as a genetic switch in the ROS/RNS balance and suggest an explanation for elevated blood pressure in pre-eclampsia., [RefSeq, PubMed]; STOX1 deficiency is associated with renin-mediated gestational hypertension and placental defects. Publication Status: Online-Only, [RefSeq, PubMed]; STOX1 is a novel stimulatory factor for inner ear epithelial cell proliferation and might be an important target to be considered in regeneration or repair of inner ear epithelium., [RefSeq, PubMed]; Studied association of overexpression of storkhead box 1 (STOX1) protein, preeclampsia, intrauterine growth restriction and fetal imaging pathology in mice., [RefSeq, PubMed]; This study illustrates a SHH-Stox1-Math1 regulatory axis in normal cerebellar development and medulloblastoma formation., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UZS9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005813 centrosome;GO:0005829 cytosol",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0010628 positive regulation of gene expression;GO:0010629 negative regulation of gene expression;GO:0010800 positive regulation of peptidyl-threonine phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "B2RQL2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BFT9-1",
        "uniprot_id": "SVOP_MOUSE",
        "mass": 60769.0,
        "length": 548,
        "protein_name": "Synaptic vesicle 2-related protein",
        "gene_name": "Svop",
        "organism": "Mouse",
        "refseq_name": "synaptic vesicle 2-related protein isoform 1",
        "refseq_ac": "NP_081081",
        "gene_names_uniprotkb": "Svop",
        "gene_names_refseq": "1110030H18Rik; Svop; msvop",
        "protein_names_uniprotkb": "Synaptic vesicle 2-related protein; SV2-related protein",
        "protein_names_refseq": "synaptic vesicle 2-related protein isoform 1; synaptic vesicle 2-related protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68666)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "19013223;21183079;21750661",
        "class_list": "glycogene",
        "function": "These results indicate that msvop is a central nervous system-specific gene and could be utilized for elucidating gene regulation in neuronal cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 19,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6PB56;Q8BKY9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0022857 transmembrane transporter activity",
        "go_cellular_component": "GO:0030672 synaptic vesicle membrane;GO:0008021 synaptic vesicle;GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8BFT9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CYR0-1",
        "uniprot_id": "SSBP_MOUSE",
        "mass": 17319.0,
        "length": 152,
        "protein_name": "Single-stranded DNA-binding protein, mitochondrial",
        "gene_name": "Ssbp1",
        "organism": "Mouse",
        "refseq_name": "single-stranded DNA-binding protein, mitochondrial isoform 2",
        "refseq_ac": "NP_082634",
        "gene_names_uniprotkb": "Ssbp1",
        "gene_names_refseq": "2810480P10Rik; G630031O20Rik; MtSSB; Ssbp1; mtDBP",
        "protein_names_uniprotkb": "Single-stranded DNA-binding protein, mitochondrial; Mt-SSB; MtSSB",
        "protein_names_refseq": "single-stranded DNA-binding protein, mitochondrial isoform 2; single-stranded DNA-binding protein, mitochondrial",
        "tax_id": 10090,
        "disease": "optic atrophy (Disease Ontology:DOID:5723)",
        "pathway": " (mmu:381760);  (R-MMU-9837999);  (R-MMU-9913635)",
        "pathway_count": 3,
        "publication_count": 8,
        "publication_id_list": "16860483;21048415;21183079;21750661;23806337;30369577;31298765;36288343",
        "class_list": "",
        "function": "Binds preferentially and cooperatively to pyrimidine rich single-stranded DNA (ss-DNA). In vitro, required to maintain the copy number of mitochondrial DNA (mtDNA) and plays a crucial role during mtDNA replication by stimulating the activity of the replisome components POLG and TWNK at the replication fork. Promotes the activity of the gamma complex polymerase POLG, largely by organizing the template DNA and eliminating secondary structures to favor ss-DNA conformations that facilitate POLG activity. In addition it is able to promote the 5'-3' unwinding activity of the mtDNA helicase TWNK. May also function in mtDNA repair., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Overexpression of Mitogenin I or mitochondrial single-stranded DNA-binding protein increased elongated or fragmented mitochondria in mouse C2C12 myoblast cells, respectively., [RefSeq, PubMed]; Plays a role in the regulation of mitochondrial morphology. (review), [RefSeq, PubMed]; SSBP1 was down-regulated by Angiotensin II and implicated in cardiac fibrosis through fibroblast proliferation and collagen expression partly via the p53 protein., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003682 chromatin binding;GO:0008047 enzyme activator activity;GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0003697 single-stranded DNA binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0042645 mitochondrial nucleoid;GO:0097228 sperm principal piece;GO:0120238 sperm glycocalyx",
        "go_biological_process": "GO:0090297 positive regulation of mitochondrial DNA replication;GO:0051289 protein homotetramerization;GO:0006260 DNA replication;GO:0007005 mitochondrion organization;GO:0051096 positive regulation of helicase activity",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9CYR0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R1R3-1",
        "uniprot_id": "STAR7_MOUSE",
        "mass": 43144.0,
        "length": 373,
        "protein_name": "StAR-related lipid transfer protein 7, mitochondrial",
        "gene_name": "Stard7",
        "organism": "Mouse",
        "refseq_name": "stAR-related lipid transfer protein 7, mitochondrial isoform 1 precursor",
        "refseq_ac": "NP_647469",
        "gene_names_uniprotkb": "Stard7",
        "gene_names_refseq": "Stard7",
        "protein_names_uniprotkb": "StAR-related lipid transfer protein 7, mitochondrial; STARD7, mitochodrial; START domain-containing protein 7; StARD7",
        "protein_names_refseq": "START domain containing 7; START domain-containing protein 7; stAR-related lipid transfer protein 7, mitochondrial isoform 1 precursor; stAR-related lipid transfer protein 7, mitochondrial",
        "tax_id": 10090,
        "disease": "familial adult myoclonic epilepsy 2 (Disease Ontology:DOID:0111692)",
        "pathway": " (mmu:99138);  (R-MMU-1483191);  (R-MMU-2142789)",
        "pathway_count": 3,
        "publication_count": 8,
        "publication_id_list": "21750661;25980009;27694445;28401922;32071354;34428180;36658222;37846201",
        "class_list": "",
        "function": "May play a protective role in mucosal tissues by preventing exaggerated allergic responses., [UniProtKB, UniProtKB]; Mediates non-vesicular transfer of phosphatidylcholine to mitochondria, thereby maintaining mitochondrial membrane lipid composition, cristae organization, and respiratory function across diverse tissues., [UniProtKB, PubMed, PubMed]; Phosphatidylcholine (PC) transfer protein that operates in two distinct forms: a cytosolic form and a mitochondrial intermembrane space (IMM) form. Both mature forms facilitate non-vesicular PC transport by transiently associating with mitochondrial membranes. The mitochondrial intermembrane space (IMM) form supports lipid exchange between the outer and inner mitochondrial membranes. Through this activity, the protein is essential for maintaining mitochondrial lipid homeostasis, preserving normal cristae architecture, and ensuring optimal respiratory chain function (PubMed:32071354). Mediates intracellular distribution of coenzyme Q (ubiquinone), the intermembrane space form supports mitochondrial coenzyme Q biosynthesis and the cytosolic form transfers coenzyme Q to extramitochondrial membranes, enhancing antioxidant protection and limiting ferroptosis sensitivity (PubMed:36658222)., [UniProtKB, PubMed, PubMed]; StarD7 deficiency switches on glycolysis and promotes mitophagy flux in C2C12 myoblasts., [RefSeq, PubMed]; Stard7 deficiency was associated with altered mitochondrial size and membrane organization both in vitro and in vivo. Publication Status: Online-Only, [RefSeq, PubMed]; The phosphatidylcholine transfer protein StarD7 is important for myogenic differentiation in mouse myoblast C2C12 cells and human primary skeletal myoblasts. Publication Status: Online-Only, [RefSeq, PubMed]; These data suggest that Stard7 is an important component of a novel protective pathway in tissues exposed to the extracellular environment., [RefSeq, PubMed]; Transfers phosphatidylcholine (PC) from the endoplasmic reticulum to the mitochondrial outer membrane at ER-mitochondria contact sites, thereby maintaining mitochondrial PC content, respiratory complex stability and mitochondrial cristae morphology., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2ARG0",
        "ec_number_list": "3.1.-.-",
        "go_molecular_function": "GO:0008289 lipid binding;GO:0120019 phosphatidylcholine transfer activity;GO:0140104 molecular carrier activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0005741 mitochondrial outer membrane;GO:0005758 mitochondrial intermembrane space;GO:0005829 cytosol",
        "go_biological_process": "GO:0043457 regulation of cellular respiration;GO:0006954 inflammatory response;GO:0061436 establishment of skin barrier;GO:0001773 myeloid dendritic cell activation;GO:0042092 type 2 immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q8R1R3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P10856-1",
        "uniprot_id": "STP1_MOUSE",
        "mass": 6407.0,
        "length": 55,
        "protein_name": "Spermatid nuclear transition protein 1",
        "gene_name": "Tnp1",
        "organism": "Mouse",
        "refseq_name": "spermatid nuclear transition protein 1",
        "refseq_ac": "NP_033433",
        "gene_names_uniprotkb": "Tnp1",
        "gene_names_refseq": "Stp-1; TP1; Tnp1; Tp-1",
        "protein_names_uniprotkb": "Spermatid nuclear transition protein 1; STP-1; TP-1",
        "protein_names_refseq": "spermatid nuclear transition protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:21958)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "10781074;15083521;15163613;15189834;1685480;28366643;29397043;30084848;3382664",
        "class_list": "",
        "function": "Plays a key role in the replacement of histones to protamine in the elongating spermatids of mammals (PubMed:10781074, PubMed:15083521, PubMed:15163613, PubMed:15189834, PubMed:28366643). In condensing spermatids, loaded onto the nucleosomes, where it promotes the recruitment and processing of protamines, which are responsible for histone eviction (PubMed:28366643). The histone H2AB1-H2BC1/TH2B dimer is required for loading of TNP1 onto chromatin (PubMed:28366643)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]; Tnp1, Tekt1, and Plzf have essential roles in spermatogenesis and can be expressed during organ culture of testis; with this system, genes can be induced only at the molecular level and not beyond meiosis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0001673 male germ cell nucleus;GO:0000786 nucleosome",
        "go_biological_process": "GO:0019953 sexual reproduction;GO:0006338 chromatin remodeling;GO:0007283 spermatogenesis;GO:0030317 flagellated sperm motility;GO:0045892 negative regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "P10856-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P33242-1",
        "uniprot_id": "STF1_MOUSE",
        "mass": 52077.0,
        "length": 462,
        "protein_name": "Steroidogenic factor 1",
        "gene_name": "Nr5a1",
        "organism": "Mouse",
        "refseq_name": "steroidogenic factor 1",
        "refseq_ac": "NP_001303616",
        "gene_names_uniprotkb": "Nr5a1; Ftzf1",
        "gene_names_refseq": "Ad4BP; ELP-3; ELP; Ftz-F1; Ftzf1; Nr5a1; SF-1; SF1; STF-1",
        "protein_names_uniprotkb": "Steroidogenic factor 1; Adrenal 4-binding protein; ELP; Embryonal LTR-binding protein; Embryonal long terminal repeat-binding protein; Fushi tarazu factor homolog 1; Nuclear receptor subfamily 5 group A member 1; SF-1; STF-1; Steroid hormone receptor Ad4BP; Steroid hydroxylase positive regulator",
        "protein_names_refseq": "adrenal 4-binding protein; embryonal LTR-binding protein; embryonal long terminal repeat-binding protein; fushi tarazu 1 factor homolog; fushi tarazu factor homolog 1; steroid hormone receptor Ad4BP; steroid hydroxylase positive regulator; steroidogenic factor 1",
        "tax_id": 10090,
        "disease": "spermatogenic failure 8 (Disease Ontology:DOID:0070169); primary ovarian insufficiency 7 (Disease Ontology:DOID:0080864); hypogonadotropic hypogonadism (Disease Ontology:DOID:0090070); 46,XX sex reversal 4 (Disease Ontology:DOID:0111764); 46,XY sex reversal 3 (Disease Ontology:DOID:0111772); gonadal dysgenesis (Disease Ontology:DOID:14447); Zellweger syndrome (Disease Ontology:DOID:905)",
        "pathway": " (mmu:26423);  (R-MMU-383280);  (R-MMU-4090294)",
        "pathway_count": 3,
        "publication_count": 11,
        "publication_id_list": "11196480;12239114;1545809;15707893;15721253;17210646;18988706;24232453;34428180;8395013;8413309",
        "class_list": "",
        "function": "Transcriptional activator. Seems to be essential for sexual differentiation and formation of the primary steroidogenic tissues. Binds to the Ad4 site found in the promoter region of steroidogenic P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences for the recognition by NR5A1. The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity (By similarity). Transcription repressor of the Moloney leukemia virus long terminal repeat in undifferentiated murine embryonal carcinoma cells. Binds phosphatidylcholine and phospholipids with a phosphatidylinositol (PI) headgroup, in particular phosphatidyl(3,4)bisphosphate, phosphatidyl(3,5)bisphosphate and phosphatidyl(3,4,5)triphosphate. Activated by the phosphorylation of NR5A1 by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 11,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 7,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q812G5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003682 chromatin binding;GO:0003700 DNA-binding transcription factor activity;GO:0005543 phospholipid binding;GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0090575 RNA polymerase II transcription regulator complex",
        "go_biological_process": "GO:0007530 sex determination;GO:2000020 positive regulation of male gonad development;GO:0097720 calcineurin-mediated signaling;GO:0006357 regulation of transcription by RNA polymerase II;GO:0010628 positive regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "P33242-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60864-1",
        "uniprot_id": "STIP1_MOUSE",
        "mass": 62582.0,
        "length": 543,
        "protein_name": "Stress-induced-phosphoprotein 1",
        "gene_name": "Stip1",
        "organism": "Mouse",
        "refseq_name": "stress-induced-phosphoprotein 1",
        "refseq_ac": "NP_058017",
        "gene_names_uniprotkb": "Stip1",
        "gene_names_refseq": "Hop; Sti1; Stip1; p60",
        "protein_names_uniprotkb": "Stress-induced-phosphoprotein 1; Hop; Hsc70/Hsp90-organizing protein; STI1; mSTI1",
        "protein_names_refseq": "Hsp70/Hsp90 organizing protein; IEF SSP 3521; hsc70/Hsp90-organizing protein; mSTI1; stress-induced-phosphoprotein 1; stress-inducible protein",
        "tax_id": 10090,
        "disease": "childhood-onset asthma (Disease Ontology:DOID:0080815)",
        "pathway": " (mmu:20867);  (R-MMU-3371497);  (R-MMU-9696273)",
        "pathway_count": 3,
        "publication_count": 19,
        "publication_id_list": "11154072;23386199;23806337;25428506;30084848;31219806;31562773;31588228;33908654;34428180;34887587;36121476;36288343;37453647;37507081;37828378;39927985;8999875;9272871",
        "class_list": "",
        "function": "Acts as a co-chaperone for HSP90AA1. Mediates the association of the molecular chaperones HSPA8/HSC70 and HSP90., [UniProtKB, UniProtKB, UniProtKB]; Hsp90 and its co-chaperone Sti1 control TDP-43 misfolding and toxicity., [RefSeq, PubMed]; Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co-chaperone STI1., [RefSeq, PubMed]; Role of FOXC1 in regulating APSCs self-renewal via STI-1/PrP(C) signaling. Publication Status: Online-Only, [RefSeq, PubMed]; Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of alpha-synuclein in vivo., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TT16;Q8BPH3;Q99L66",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051087 protein-folding chaperone binding;GO:0051879 Hsp90 protein binding;GO:0030544 Hsp70 protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol;GO:0043209 myelin sheath;GO:0032991 protein-containing complex;GO:0101031 protein folding chaperone complex",
        "go_biological_process": "GO:0098761 cellular response to interleukin-7",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "Q60864-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61542-1",
        "uniprot_id": "STAR3_MOUSE",
        "mass": 50470.0,
        "length": 446,
        "protein_name": "StAR-related lipid transfer protein 3",
        "gene_name": "Stard3",
        "organism": "Mouse",
        "refseq_name": "stAR-related lipid transfer protein 3 isoform 1",
        "refseq_ac": "NP_067522",
        "gene_names_uniprotkb": "Stard3; Es64; Mln64",
        "gene_names_refseq": "Mln64; Stard3; es64",
        "protein_names_uniprotkb": "StAR-related lipid transfer protein 3; Protein ES 64; Protein MLN 64; START domain-containing protein 3; StARD3",
        "protein_names_refseq": "START domain containing 3; START domain-containing protein 3; protein ES 64; protein MLN 64; stAR-related lipid transfer protein 3 isoform 1; stAR-related lipid transfer protein 3; steroidogenic acute regulatory protein related",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:59045);  (R-MMU-196108)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "21183079;26740625;29908180;30084848;30322615;33771709;34418053;34428180;7490069",
        "class_list": "",
        "function": "Overexpression of STARD3 attenuates oxidized LDL-induced oxidative stress and inflammation in retinal pigment epithelial cells., [RefSeq, PubMed]; Stard3 is an essential factor for the 3T3-L1 cells' differentiation, [RefSeq, PubMed]; Sterol-binding protein that mediates cholesterol transport from the endoplasmic reticulum to endosomes. The sterol transport mechanism is triggered by phosphorylation of FFAT motif that leads to membrane tethering between the endoplasmic reticulum and late endosomes via interaction with VAPA and VAPB. Acts as a lipid transfer protein that redirects sterol to the endosome at the expense of the cell membrane and favors membrane formation inside endosomes. May also mediate cholesterol transport between other membranes, such as mitochondria membrane or cell membrane. However, such results need additional experimental evidences; probably mainly mediates cholesterol transport from the endoplasmic reticulum to endosomes. Does not activate transcriptional cholesterol sensing. Able to bind other lipids, such as lutein, a xanthophyll carotenoids that form the macular pigment of the retina., [UniProtKB, UniProtKB]; The results suggested that MLN64 played a critical role in the meditation of osteoclastic differentiation, and its suppression alleviated diabetic osteoporosis in streptozotocin-induced mice., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0015485 cholesterol binding;GO:0120020 cholesterol transfer activity",
        "go_cellular_component": "GO:0044232 organelle membrane contact site;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005768 endosome",
        "go_biological_process": "GO:0006701 progesterone biosynthetic process;GO:0030301 cholesterol transport;GO:0099044 vesicle tethering to endoplasmic reticulum",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q61542-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64HY3-1",
        "uniprot_id": "SP9_MOUSE",
        "mass": 48959.0,
        "length": 484,
        "protein_name": "Transcription factor Sp9",
        "gene_name": "Sp9",
        "organism": "Mouse",
        "refseq_name": "transcription factor Sp9",
        "refseq_ac": "NP_001005343",
        "gene_names_uniprotkb": "Sp9",
        "gene_names_refseq": "Sp9",
        "protein_names_uniprotkb": "Transcription factor Sp9",
        "protein_names_refseq": "buttonhead-like zinc finger transcription factor Sp9; transcription factor Sp9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:381373)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "15358670;21183079;25428506",
        "class_list": "",
        "function": "Sp8 and Sp9, via Fgf8, are involved in mediating the actions of Fgf10 and Wnt/beta-catenin signaling during vertebrate limb outgrowth., [RefSeq, PubMed]; Transcription factor which plays a key role in limb development. Positively regulates FGF8 expression in the apical ectodermal ridge (AER) and contributes to limb outgrowth in embryos., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5QR89",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:1990837 sequence-specific double-stranded DNA binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0030326 embryonic limb morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q64HY3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D939-1",
        "uniprot_id": "ST1C2_MOUSE",
        "mass": 34953.0,
        "length": 296,
        "protein_name": "Sulfotransferase 1C2",
        "gene_name": "Sult1c2",
        "organism": "Mouse",
        "refseq_name": "sulfotransferase 1C2",
        "refseq_ac": "NP_081211",
        "gene_names_uniprotkb": "Sult1c2; Sult1c1",
        "gene_names_refseq": "1810008N17Rik; ST1C1; ST1C2; Sult1c1; Sult1c2",
        "protein_names_uniprotkb": "Sulfotransferase 1C2; 2.8.2.1; ST1C2",
        "protein_names_refseq": "sulfotransferase 1C2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69083);  (R-MMU-156584)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "12164856;21183079;30084848;40885482",
        "class_list": "",
        "function": "Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) to catalyze the sulfate conjugation of phenolic compounds (PubMed:12164856). Does not transfer sulfate to steroids, dopamine, acetaminophen, or alpha-naphthol (PubMed:12164856). Except in mitochondria, where it can add sulfate to cholesterol producing cholesterol sulfate, which alters mitochondrial membrane organization, and impacts protein complex mobility increasing state-III respiration, thereby modulating mitochondrial respiration (By similarity). Catalyzes the sulfation of the carcinogenic N-hydroxy-2-acetylaminofluorene leading to highly reactive intermediates capable of forming DNA adducts, potentially resulting in mutagenesis (By similarity)., [UniProtKB, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UNA9;Q8R210",
        "ec_number_list": "2.8.2.-;2.8.2.2;2.8.2.n2;2.8.2.4;2.8.2.1",
        "go_molecular_function": "GO:0008146 sulfotransferase activity;GO:0004062 aryl sulfotransferase activity;GO:0051922 cholesterol sulfotransferase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005764 lysosome",
        "go_biological_process": "GO:0051923 sulfation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9D939-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BG39-1",
        "uniprot_id": "SV2B_MOUSE",
        "mass": 77457.0,
        "length": 683,
        "protein_name": "Synaptic vesicle glycoprotein 2B",
        "gene_name": "Sv2b",
        "organism": "Mouse",
        "refseq_name": "synaptic vesicle glycoprotein 2B",
        "refseq_ac": "NP_001103223",
        "gene_names_uniprotkb": "Sv2b; Kiaa0735",
        "gene_names_refseq": "A830038F04Rik; Sv2b; mKIAA0735",
        "protein_names_uniprotkb": "Synaptic vesicle glycoprotein 2B; Synaptic vesicle protein 2B",
        "protein_names_refseq": "synaptic vesicle glycoprotein 2 b; synaptic vesicle glycoprotein 2B; synaptic vesicle protein 2B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:64176)",
        "pathway_count": 1,
        "publication_count": 15,
        "publication_id_list": "10.1101/2023.09.13.557529;10611374;10624962;12687700;15466855;16543415;18034455;18815274;21183079;21483489;21632541;21750661;25428506;33300544;37682518",
        "class_list": "",
        "function": "(Microbial infection) Possible receptor for C.botulinum neurotoxin type D (BoNT/D, botD) (PubMed:21483489). Not a receptor for C.botulinum neurotoxin type D (BoNT/D, botD) (PubMed:21632541)., [UniProtKB, PubMed]; (Microbial infection) Receptor for C.botulinum neurotoxin type A (BoNT/A, botA); the toxin probably binds via extracellular loop 4 (PubMed:16543415)., [UniProtKB, PubMed]; (Microbial infection) Receptor for C.botulinum neurotoxin type E (BoNT/E); the toxin probably binds via extracellular loop 4 (PubMed:18815274). It probably requires glycosylation of Asn-516 (PubMed:18815274)., [UniProtKB, PubMed]; Probably plays a role in the control of regulated secretion in neural and endocrine cells., [UniProtKB, PubMed]; SV2B defines a subpopulation of synaptic vesicles., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80TT1;Q9ES95",
        "ec_number_list": "",
        "go_molecular_function": "GO:0022857 transmembrane transporter activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0001669 acrosomal vesicle;GO:0030672 synaptic vesicle membrane;GO:0008021 synaptic vesicle",
        "go_biological_process": "GO:0007268 chemical synaptic transmission;GO:0099509 regulation of presynaptic cytosolic calcium ion concentration;GO:0006836 neurotransmitter transport;GO:2000300 regulation of synaptic vesicle exocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "Q8BG39-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JIA7-1",
        "uniprot_id": "SPHK2_MOUSE",
        "mass": 65618.0,
        "length": 617,
        "protein_name": "Sphingosine kinase 2",
        "gene_name": "Sphk2",
        "organism": "Mouse",
        "refseq_name": "sphingosine kinase 2",
        "refseq_ac": "NP_001166032",
        "gene_names_uniprotkb": "Sphk2",
        "gene_names_refseq": "Sk2; Sphk2; Spk2",
        "protein_names_uniprotkb": "Sphingosine kinase 2; 2.7.1.91; SK 2; SPK 2",
        "protein_names_refseq": "sphingosine kinase 2",
        "tax_id": 10090,
        "disease": "cardiomyopathy (Disease Ontology:DOID:0050700); metabolic dysfunction-associated steatohepatitis (Disease Ontology:DOID:0080547); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:56632);  (R-MMU-1660661)",
        "pathway_count": 2,
        "publication_count": 17,
        "publication_id_list": "10751414;12835323;12874225;12954646;16118219;16314531;17346996;20959514;21084291;21183079;21750661;25637806;30593892;35820727;38925249;39062926;39207053",
        "class_list": "glycogene",
        "function": "A functional nuclear localization signal is mapped to the N-terminal region of SPHK2, [RefSeq, PubMed]; Catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions (PubMed:16118219, PubMed:17346996, PubMed:21084291). Also acts on D-erythro-dihydrosphingosine, D-erythro-sphingosine and L-threo-dihydrosphingosine. Binds phosphoinositides (PubMed:10751414, PubMed:16118219). In contrast to prosurvival SPHK1, has a positive effect on intracellular ceramide levels, inhibits cells growth and enhances apoptosis (PubMed:16118219). In mitochondria, is important for cytochrome-c oxidase assembly and mitochondrial respiration. The SPP produced in mitochondria binds PHB2 and modulates the regulation via PHB2 of complex IV assembly and respiration (PubMed:20959514). In nucleus, plays a role in epigenetic regulation of gene expression. Interacts with HDAC1 and HDAC2 and, through SPP production, inhibits their enzymatic activity, preventing the removal of acetyl groups from lysine residues with histones. Up-regulates acetylation of histone H3-K9, histone H4-K5 and histone H2B-K12. In nucleus, may have an inhibitory effect on DNA synthesis and cell cycle (By similarity). In mast cells, is the main regulator of SPP production which mediates calcium influx, NF-kappa-B activation, cytokine production, such as TNF and IL6, and degranulation of mast cells (PubMed:17346996). In dopaminergic neurons, is involved in promoting mitochondrial functions regulating ATP and ROS levels (PubMed:25637806). Also involved in the regulation of glucose and lipid metabolism (PubMed:30593892)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; Deletion of Sphingosine Kinase 2 Attenuates Acute Kidney Injury in Mice with Hemolytic-Uremic Syndrome. Publication Status: Online-Only, [RefSeq, PubMed]; SPHK2 associates with the interleukin (IL)-12 receptor beta 1 cytoplasmic region and appears to be involved in the positive modulation of IL-12 signaling, especially IL-12-induced interferon-gamma production., [RefSeq, PubMed]; Sphingosine Kinase 2 Regulates Aryl Hydrocarbon Receptor Nuclear Translocation and Target Gene Activation., [RefSeq, PubMed]; Sphingosine kinase 2 and p62 regulation are determinants of sexual dimorphism in hepatocellular carcinoma., [RefSeq, PubMed]; The apoptotic effect of SphK2 might be because of its putative BH3 domain, [RefSeq, PubMed]; This gene encodes a kinase that phosphorylates sphingosine into sphingosine-1-phosphate, which is involved in cell differentiation, motility, and apoptosis. The encoded protein plays a role in maintaining cellular levels of sphingosine-1-phosphate. The gene product also enhances apoptosis in different cell types and suppresses cellular proliferation. In mast cells, the encoded protein is necessary for influx of calcium, protein kinase C activation, and cytokine production and degranulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 31,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q91VA9;Q9DBH6",
        "ec_number_list": "2.7.1.91;2.3.1.-",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0042393 histone binding;GO:0038036 sphingosine-1-phosphate receptor activity;GO:0008481 sphingosine kinase activity;GO:0016301 kinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane",
        "go_biological_process": "GO:0032736 positive regulation of interleukin-13 production;GO:0006670 sphingosine metabolic process;GO:0008284 positive regulation of cell population proliferation;GO:0035556 intracellular signal transduction;GO:0043065 positive regulation of apoptotic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q9JIA7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91YU8-1",
        "uniprot_id": "SSF1_MOUSE",
        "mass": 52756.0,
        "length": 470,
        "protein_name": "Suppressor of SWI4 1 homolog",
        "gene_name": "Ppan",
        "organism": "Mouse",
        "refseq_name": "suppressor of SWI4 1 homolog",
        "refseq_ac": "NP_663585",
        "gene_names_uniprotkb": "Ppan; Ssf1",
        "gene_names_refseq": "A230087P06Rik; Ppan; SSF1",
        "protein_names_uniprotkb": "Suppressor of SWI4 1 homolog; Peter Pan homolog; Ssf-1",
        "protein_names_refseq": "second-step splicing factor 1; ssf-1; suppressor of SWI4 1 homolog; suppressor of sterile four 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:235036)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "21183079;21750661;23806337;25428506;30084848;31219806",
        "class_list": "",
        "function": "May have a role in cell growth., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BYM4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019843 rRNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005730 nucleolus;GO:0030687 preribosome, large subunit precursor",
        "go_biological_process": "GO:0001560 regulation of cell growth by extracellular stimulus;GO:0000463 maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);GO:0006364 rRNA processing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q91YU8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C0C7-1",
        "uniprot_id": "SYFA_MOUSE",
        "mass": 57599.0,
        "length": 508,
        "protein_name": "Phenylalanine--tRNA ligase alpha subunit",
        "gene_name": "Farsa",
        "organism": "Mouse",
        "refseq_name": "phenylalanine--tRNA ligase alpha subunit",
        "refseq_ac": "NP_079924",
        "gene_names_uniprotkb": "Farsa; Farsla",
        "gene_names_refseq": "0610012A19Rik; Farsa; Farsla; pheRS",
        "protein_names_uniprotkb": "Phenylalanine--tRNA ligase alpha subunit; 6.1.1.20; PheRS; Phenylalanyl-tRNA synthetase alpha subunit",
        "protein_names_refseq": "phenylalanine--tRNA ligase alpha chain; phenylalanine--tRNA ligase alpha subunit; phenylalanine-tRNA synthetase-like, alpha subunit; phenylalanyl-tRNA synthetase alpha chain",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66590)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "21183079;21750661;29187734;33300544;34203471;34428180",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U3Q9;Q91WR4;Q922S1",
        "ec_number_list": "6.1.1.20",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0005524 ATP binding;GO:0000049 tRNA binding;GO:0004826 phenylalanine-tRNA ligase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0009328 phenylalanine-tRNA ligase complex;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0051290 protein heterotetramerization;GO:0006432 phenylalanyl-tRNA aminoacylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q8C0C7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P83093-1",
        "uniprot_id": "STIM2_MOUSE",
        "mass": 83925.0,
        "length": 746,
        "protein_name": "Stromal interaction molecule 2",
        "gene_name": "Stim2",
        "organism": "Mouse",
        "refseq_name": "stromal interaction molecule 2 isoform 2 precursor",
        "refseq_ac": "NP_001074572",
        "gene_names_uniprotkb": "Stim2; Kiaa1482",
        "gene_names_refseq": "Stim2",
        "protein_names_uniprotkb": "Stromal interaction molecule 2",
        "protein_names_refseq": "stromal interaction molecule 2 isoform 2 precursor",
        "tax_id": 10090,
        "disease": "hypertrophic cardiomyopathy (Disease Ontology:DOID:11984); dilated cardiomyopathy (Disease Ontology:DOID:12930); brain disease (Disease Ontology:DOID:936); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:116873)",
        "pathway_count": 1,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;11463338;17242355;18327260;19111578;19144319;19843959;21183079;21750661;25605945;28528544;32848054",
        "class_list": "",
        "function": "Data demonstrate that cellular levels of STIM1 and STIM2, which are key players in capacitative Ca2+ entry, depend on presenilins., [RefSeq, PubMed]; Plays a role in mediating store-operated Ca(2+) entry (SOCE), a Ca(2+) influx following depletion of intracellular Ca(2+) stores. Functions as a highly sensitive Ca(2+) sensor in the endoplasmic reticulum which activates both store-operated and store-independent Ca(2+)-influx. Regulates basal cytosolic and endoplasmic reticulum Ca(2+) concentrations. Upon mild variations of the endoplasmic reticulum Ca(2+) concentration, translocates from the endoplasmic reticulum to the plasma membrane where it probably activates the Ca(2+) release-activated Ca(2+) (CRAC) channels ORAI1, ORAI2 and ORAI3. May inhibit STIM1-mediated Ca(2+) influx (By similarity)., [UniProtKB]; Promote store-operated entry of calcium ions into T cells; required for the development and function of regulatory T cells., [RefSeq, PubMed]; Show that STIM2, but not STIM1, is essential for capacitive Ca(2+) entry and ischemia-induced cytosolic Ca(2+) accumulation in neurons. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 4,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q69ZI3;Q80VF4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005246 calcium channel regulator activity;GO:0005509 calcium ion binding;GO:0015279 store-operated calcium channel activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006874 intracellular calcium ion homeostasis;GO:0030163 protein catabolic process;GO:0051928 positive regulation of calcium ion transport;GO:0032237 activation of store-operated calcium channel activity;GO:0010467 gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "P83093-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80TF6-1",
        "uniprot_id": "STAR9_MOUSE",
        "mass": 500243.0,
        "length": 4561,
        "protein_name": "StAR-related lipid transfer protein 9",
        "gene_name": "Stard9",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Stard9; Kiaa1300; Kif16a",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "StAR-related lipid transfer protein 9; Kinesin-like protein Kif16a; START domain-containing protein 9; StARD9",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 8,
        "publication_id_list": "21183079;21750661;31219806;34203471;34418053;34428180;35820727;9275178",
        "class_list": "",
        "function": "Microtubule-dependent motor protein required for spindle pole assembly during mitosis. Required to stabilize the pericentriolar material (PCM) (By similarity)., [UniProtKB]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 4,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 6,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O35058;Q8C121;Q8CFL0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0008017 microtubule binding;GO:0008289 lipid binding;GO:0003777 microtubule motor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005814 centriole;GO:0005874 microtubule",
        "go_biological_process": "GO:0007018 microtubule-based movement;GO:0051225 spindle assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q80TF6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O70166-1",
        "uniprot_id": "STMN3_MOUSE",
        "mass": 20954.0,
        "length": 180,
        "protein_name": "Stathmin-3",
        "gene_name": "Stmn3",
        "organism": "Mouse",
        "refseq_name": "stathmin-3",
        "refseq_ac": "NP_033159",
        "gene_names_uniprotkb": "Stmn3; Sclip",
        "gene_names_refseq": "9330161A03Rik; Sclip; Stmn3",
        "protein_names_uniprotkb": "Stathmin-3; Hippocampus abundant transcript 3; SCG10-like protein; SCG10-related protein HiAT3",
        "protein_names_refseq": "SCG10-like protein; SCG10-related protein HiAT3; Scgn10 like-protein; hippocampus abundant transcript 3; stathmin-3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:20262)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;15345747;16401721;21183079;21705344;22872234;34203471;34428180;9603203;9714847",
        "class_list": "",
        "function": "Exhibits microtubule-destabilizing activity, which is antagonized by STAT3., [UniProtKB, PubMed]; The determined the genomic and promoter structures of the SCLIP gene, and found that the gene retained an NRS-like element that functioned as a negative regulator in non-neuronal cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019904 protein domain specific binding;GO:0051087 protein-folding chaperone binding;GO:0015631 tubulin binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005794 Golgi apparatus;GO:0005829 cytosol;GO:0030426 growth cone;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0031110 regulation of microtubule polymerization or depolymerization;GO:0031175 neuron projection development;GO:0010977 negative regulation of neuron projection development;GO:0051493 regulation of cytoskeleton organization;GO:0035021 negative regulation of Rac protein signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "O70166-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P11378-1",
        "uniprot_id": "STP2_MOUSE",
        "mass": 13117.0,
        "length": 117,
        "protein_name": "Nuclear transition protein 2",
        "gene_name": "Tnp2",
        "organism": "Mouse",
        "refseq_name": "nuclear transition protein 2",
        "refseq_ac": "NP_038722",
        "gene_names_uniprotkb": "Tnp2",
        "gene_names_refseq": "TP2; Tnp2; Tp-2",
        "protein_names_uniprotkb": "Nuclear transition protein 2; TP-2; TP2",
        "protein_names_refseq": "nuclear transition protein 2; transition protein 2 (alt.)",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:21959)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "15083521;15163613;15189834;2249785;28366643;28743739;32726616;3693351;8720108",
        "class_list": "",
        "function": "Juvenile spermatids from Ip6k1(-/-) mice display premature expression of the transition protein TNP2 and the protamine PRM2 due to translational derepression., [RefSeq, PubMed]; Plays a key role in the replacement of histones to protamine in the elongating spermatids of mammals (PubMed:15083521, PubMed:15163613, PubMed:15189834, PubMed:28366643). In condensing spermatids, loaded onto the nucleosomes, where it promotes the recruitment and processing of protamines, which are responsible for histone eviction (PubMed:28366643). The histone H2AB1-H2BC1/TH2B dimer is required for loading of TNP2 onto chromatin (PubMed:28366643)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q91XK4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0001673 male germ cell nucleus;GO:0000786 nucleosome",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0007339 binding of sperm to zona pellucida;GO:0030317 flagellated sperm motility;GO:0010954 positive regulation of protein processing;GO:0007340 acrosome reaction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "P11378-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P54116-1",
        "uniprot_id": "STOM_MOUSE",
        "mass": 31375.0,
        "length": 284,
        "protein_name": "Stomatin",
        "gene_name": "Stom",
        "organism": "Mouse",
        "refseq_name": "stomatin",
        "refseq_ac": "NP_038543",
        "gene_names_uniprotkb": "Stom; Epb7.2; Epb72",
        "gene_names_refseq": "Epb7.2; Stom",
        "protein_names_uniprotkb": "Stomatin; Erythrocyte band 7 integral membrane protein; Erythrocyte membrane protein band 7.2; Protein 7.2b",
        "protein_names_refseq": "erythrocyte band 7 integral membrane protein; erythrocyte membrane protein band 7.2; erythrocyte protein band 7.2; protein 7.2b; stomatin",
        "tax_id": 10090,
        "disease": "nephrotic syndrome (Disease Ontology:DOID:1184); kidney disease (Disease Ontology:DOID:557)",
        "pathway": " (mmu:13830);  (R-MMU-2672351);  (R-MMU-6798695);  (R-MMU-8980692);  (R-MMU-9013026);  (R-MMU-9013106);  (R-MMU-9013406);  (R-MMU-9013407)",
        "pathway_count": 8,
        "publication_count": 18,
        "publication_id_list": "10.1101/2023.09.13.557529;10383825;15471860;19144319;21183079;22850675;26495903;26740625;29187734;31219806;34203471;34428180;36210013;36288343;38185615;7540886;8786142;8921901",
        "class_list": "",
        "function": "Regulates ion channel activity and transmembrane ion transport. Regulates ASIC2 and ASIC3 channel activity., [UniProtKB, PubMed, PubMed]; Stomatin promotes neutrophil degranulation and vascular leakage in the early stage after severe burn via enhancement of the intracellular binding of neutrophil primary granules to F-actin., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O88988;Q3UP81;Q60744;Q62455",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0008200 ion channel inhibitor activity;GO:0070063 RNA polymerase binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol;GO:0005856 cytoskeleton",
        "go_biological_process": "GO:0044829 host-mediated activation of viral genome replication;GO:0090314 positive regulation of protein targeting to membrane;GO:0034765 regulation of monoatomic ion transmembrane transport;GO:0048524 positive regulation of viral process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "P54116-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5DQR4-1",
        "uniprot_id": "STB5L_MOUSE",
        "mass": 131844.0,
        "length": 1185,
        "protein_name": "Syntaxin-binding protein 5-like",
        "gene_name": "Stxbp5l",
        "organism": "Mouse",
        "refseq_name": "syntaxin-binding protein 5-like isoform s",
        "refseq_ac": "NP_001108083",
        "gene_names_uniprotkb": "Stxbp5l; Llgl4",
        "gene_names_refseq": "9430094L02; A830015P08Rik; LLGL4; Stxbp5l; T2dm1; t2md1; tomosyn-2",
        "protein_names_uniprotkb": "Syntaxin-binding protein 5-like; Lethal(2) giant larvae protein homolog 4; Tomosyn-2",
        "protein_names_refseq": "insulin level locus 1; lethal(2) giant larvae protein homolog 4; syntaxin-binding protein 5-like isoform s; tomosyn 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:207227)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "15659226;21183079;21998599;24129315;24744148;25002582;25428506;28746398;34428180;35820727;40885482",
        "class_list": "",
        "function": "Data indicate that bidirectional moving tomosyn-1 (Stxbp5) and tomosyn-2 (Stxbp5l) puncta were observed. Publication Status: Online-Only, [RefSeq, PubMed]; Data indicate that glucose induces phosphorylation, ubiquitination, and degradation of tomosyn-2., [RefSeq, PubMed]; Plays a role in vesicle trafficking and exocytosis inhibition (PubMed:25002582). In pancreatic beta-cells, inhibits insulin secretion probably by interacting with and regulating STX1A and STX4, key t-SNARE proteins involved in the fusion of insulin granules to the plasma membrane (PubMed:21998599). Also plays a role in neurotransmitter release by inhibiting basal acetylcholine release from axon terminals and by preventing synaptic fatigue upon repetitive stimulation (PubMed:24744148). Promotes as well axonal outgrowth (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 18,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TSM3;Q3UVG2;Q5DQR1;Q5DQR2;Q5DQR3;Q8BS52",
        "ec_number_list": "",
        "go_molecular_function": "GO:0045159 myosin II binding;GO:0005096 GTPase activator activity;GO:0019905 syntaxin binding",
        "go_cellular_component": "GO:0098992 neuronal dense core vesicle;GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0031594 neuromuscular junction",
        "go_biological_process": "GO:0015031 protein transport;GO:0050714 positive regulation of protein secretion;GO:0042593 glucose homeostasis;GO:0046676 negative regulation of insulin secretion;GO:0006887 exocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q5DQR4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6PE84-1",
        "uniprot_id": "STML3_MOUSE",
        "mass": 31591.0,
        "length": 287,
        "protein_name": "Stomatin-like protein 3",
        "gene_name": "Stoml3",
        "organism": "Mouse",
        "refseq_name": "stomatin-like protein 3",
        "refseq_ac": "NP_694796",
        "gene_names_uniprotkb": "Stoml3; Sro",
        "gene_names_refseq": "Epb7.2l; SLP3; Stoml3; sro",
        "protein_names_uniprotkb": "Stomatin-like protein 3; SLP-3; Stomatin-related olfactory protein",
        "protein_names_refseq": "SLP-3; stomatin related olfactory protein SRO; stomatin-like protein 3; stomatin-related olfactory protein",
        "tax_id": 10090,
        "disease": "nephrotic syndrome (Disease Ontology:DOID:1184)",
        "pathway": " (mmu:229277);  (R-MMU-2672351)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "12122055;12239636;17167420;21501885;24662763;27810912;27941788;33637538;34428180;36858824",
        "class_list": "",
        "function": "A Conserved Role for Stomatin Domain Genes in Olfactory Behavior. Publication Status: Online-Only, [RefSeq, PubMed]; A Role for STOML3 in Olfactory Sensory Transduction. Publication Status: Online-Only, [RefSeq, PubMed]; Characterization of an olfactory neuronal protein, SLP3, which shares extensive homology with the stomatin family of membrane proteins; expressed selectively in the receptor neurons of the olfactory epithelium, [RefSeq, PubMed]; PI3K-dependent formation of a kinesin-1/Slp3/Rab27b complex is critical for the microtubule-dependent movement of secretory granules required for mast cell degranulation., [RefSeq, PubMed]; Required for the function of many mechanoreceptors. Modulate mechanotransduction channels and acid-sensing ion channels (ASIC) proteins. Potentiates PIEZO1 and PIEZO2 function by increasing their sensitivity to mechanical stimulations., [UniProtKB, PubMed]; SLP3 is therefore indispensable for the function of a subset of cutaneous mechanoreceptors, and our data support the idea that this protein is an essential subunit of a mammalian mechanotransducer, [RefSeq, PubMed]; STOML3 inhibitors in the skin also reversibly attenuate fine touch perception in normal mice., [RefSeq, PubMed]; [review] Generation of stoml3-deficient mice demonstrates that murine STOML3 is functionally orthologous to the MEC-2 memrane protein. Review article, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q66JM3;Q8K4P4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008200 ion channel inhibitor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0005929 cilium;GO:0045121 membrane raft",
        "go_biological_process": "GO:0007165 signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q6PE84-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BHS8-1",
        "uniprot_id": "SYBU_MOUSE",
        "mass": 73024.0,
        "length": 665,
        "protein_name": "Syntabulin",
        "gene_name": "Sybu",
        "organism": "Mouse",
        "refseq_name": "syntabulin isoform b",
        "refseq_ac": "NP_001027899",
        "gene_names_uniprotkb": "Sybu; Golsyn; Kiaa1472",
        "gene_names_refseq": "Golsyn; Sybu",
        "protein_names_uniprotkb": "Syntabulin; Golgi-localized syntaphilin-related protein; Syntaxin-1-binding protein; m-Golsyn",
        "protein_names_refseq": "Golgi-localized syntaphilin-related protein; Golsyn/Syntabulin; syntabulin isoform b; syntaxin-1-binding protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:319613)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;15345747;15656992;16750881;21183079;21750661;22975310;25428506;31219806",
        "class_list": "",
        "function": "Part of a kinesin motor-adapter complex that is critical for the anterograde axonal transport of active zone components and contributes to activity-dependent presynaptic assembly during neuronal development., [UniProtKB]; Results may indicate a significant role for this protein in neuronal cells and other types of cells such as those of the choroid plexus and ciliary body, [RefSeq, PubMed]; Syntabulin could be a novel effector of Epac2 and play a critical role in cAMP-enhanced insulin secretion, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9630,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TQN7;Q401F3;Q401F4;Q571C1;Q6P1J2;Q80XH0;Q8BHS7;Q8BI27",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008017 microtubule binding",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005874 microtubule;GO:0031982 vesicle;GO:0097433 dense body;GO:1904115 axon cytoplasm",
        "go_biological_process": "GO:0035774 positive regulation of insulin secretion involved in cellular response to glucose stimulus;GO:0061178 regulation of insulin secretion involved in cellular response to glucose stimulus;GO:1990048 anterograde neuronal dense core vesicle transport;GO:0060074 synapse maturation;GO:0019896 axonal transport of mitochondrion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8BHS8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JIS5-1",
        "uniprot_id": "SV2A_MOUSE",
        "mass": 82647.0,
        "length": 742,
        "protein_name": "Synaptic vesicle glycoprotein 2A",
        "gene_name": "Sv2a",
        "organism": "Mouse",
        "refseq_name": "synaptic vesicle glycoprotein 2A",
        "refseq_ac": "NP_071313",
        "gene_names_uniprotkb": "Sv2a; Kiaa0736; Sv2",
        "gene_names_refseq": "Sv2a; mKIAA0736",
        "protein_names_uniprotkb": "Synaptic vesicle glycoprotein 2A; Calcium regulator SV2A; Synaptic vesicle protein 2A; Synaptic vesicle protein 2",
        "protein_names_refseq": "calcium regulator SV2A; synaptic vesicle glycoprotein 2 a; synaptic vesicle glycoprotein 2A; synaptic vesicle protein 2A; synaptic vesicle protein 2",
        "tax_id": 10090,
        "disease": "developmental and epileptic encephalopathy (Disease Ontology:DOID:0112202); epilepsy (Disease Ontology:DOID:1826)",
        "pathway": " (mmu:64051)",
        "pathway_count": 1,
        "publication_count": 14,
        "publication_id_list": "10.1101/2023.09.13.557529;10611374;10624962;11483953;12209837;12687700;16436618;16543415;18034455;18815274;21183079;21483489;30899004;33300544",
        "class_list": "",
        "function": "(Microbial infection) Possible receptor for C.botulinum neurotoxin type D (BoNT/D, botD); BoNT/D does not bind to extracellular loop 4 as do BoNT/A and BoNT/E (PubMed:21483489)., [UniProtKB, PubMed]; (Microbial infection) Receptor for C.botulinum neurotoxin type A (BoNT/A, botA); the toxin probably binds via extracellular loop 4 (PubMed:16543415)., [UniProtKB, PubMed]; (Microbial infection) Receptor for C.botulinum neurotoxin type E (BoNT/E); the toxin probably binds via extracellular loop 4 (PubMed:18815274). It probably requires glycosylation of Asn-573 (PubMed:18815274)., [UniProtKB, PubMed]; Plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 12,
        "disease_count": 2,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80TT0;Q8R0R5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019901 protein kinase binding;GO:0022857 transmembrane transporter activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0098982 GABA-ergic synapse;GO:0005783 endoplasmic reticulum;GO:0005911 cell-cell junction;GO:0030425 dendrite",
        "go_biological_process": "GO:0098828 modulation of inhibitory postsynaptic potential;GO:0006874 intracellular calcium ion homeostasis;GO:0007268 chemical synaptic transmission;GO:0035418 protein localization to synapse;GO:0014052 regulation of gamma-aminobutyric acid secretion",
        "synthesized_glycan_count": 0,
        "hit_score": 3.1,
        "record_id": "Q9JIS5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WVL2-1",
        "uniprot_id": "STAT2_MOUSE",
        "mass": 105417.0,
        "length": 923,
        "protein_name": "Signal transducer and activator of transcription 2",
        "gene_name": "Stat2",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Stat2",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Signal transducer and activator of transcription 2",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "Zika fever (Disease Ontology:DOID:0060478); immunodeficiency 44 (Disease Ontology:DOID:0111975); neutropenia (Disease Ontology:DOID:1227); hepatitis C (Disease Ontology:DOID:1883)",
        "pathway": " (R-MMU-8854691);  (R-MMU-909733);  (R-MMU-912694)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "17332413;18234692;25428506;31219806;31599954;34428180;8601453",
        "class_list": "",
        "function": "Signal transducer and activator of transcription that mediates signaling by type I interferons (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with IRF9/ISGF3G to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state. In addition, also has a negative feedback regulatory role in the type I interferon signaling by recruiting USP18 to the type I IFN receptor subunit IFNAR2 thereby mitigating the response to type I IFNs. Acts as a regulator of mitochondrial fission by modulating the phosphorylation of DNM1L at 'Ser-616' and 'Ser-637' which activate and inactivate the GTPase activity of DNM1L respectively., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q64188;Q64189;Q64250",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003700 DNA-binding transcription factor activity;GO:0042802 identical protein binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0044389 ubiquitin-like protein ligase binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0097228 sperm principal piece",
        "go_biological_process": "GO:0090140 regulation of mitochondrial fission;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0006952 defense response;GO:0042127 regulation of cell population proliferation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9WVL2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P05213-1",
        "uniprot_id": "TBA1B_MOUSE",
        "mass": 50152.0,
        "length": 451,
        "protein_name": "Tubulin alpha-1B chain",
        "gene_name": "Tuba1b",
        "organism": "Mouse",
        "refseq_name": "tubulin alpha-1B chain",
        "refseq_ac": "NP_035784",
        "gene_names_uniprotkb": "Tuba1b; Tuba2",
        "gene_names_refseq": "Tuba1b; Tuba2",
        "protein_names_uniprotkb": "Tubulin alpha-1B chain; 3.6.5.-; Alpha-tubulin 2; Alpha-tubulin isotype M-alpha-2; Tubulin alpha-2 chain",
        "protein_names_refseq": "alpha-tubulin 2; alpha-tubulin isotype M-alpha-2; tubulin alpha-1B chain; tubulin alpha-2 chain; tubulin, alpha 2",
        "tax_id": 10090,
        "disease": "lissencephaly (Disease Ontology:DOID:0050453); polymicrogyria (Disease Ontology:DOID:0080918); lissencephaly 3 (Disease Ontology:DOID:0112232); microlissencephaly (Disease Ontology:DOID:0112234)",
        "pathway": " (mmu:22143);  (R-MMU-190840);  (R-MMU-2132295);  (R-MMU-2467813);  (R-MMU-2500257);  (R-MMU-3371497);  (R-MMU-380320);  (R-MMU-437239);  (R-MMU-5610787);  (R-MMU-5620920);  (R-MMU-5620924);  (R-MMU-5626467);  (R-MMU-5663220);  (R-MMU-6807878);  (R-MMU-6811434);  (R-MMU-6811436);  (R-MMU-68877);  (R-MMU-8852276);  (R-MMU-8955332);  (R-MMU-9013407);  (R-MMU-9646399);  (R-MMU-9648025);  (R-MMU-9668328);  (R-MMU-983189);  (R-MMU-9833482)",
        "pathway_count": 25,
        "publication_count": 22,
        "publication_id_list": "15890843;16954346;18299400;19524510;19564401;1967194;20665223;23897886;26446751;26740625;27102488;29146868;29187734;31219806;33300544;33414192;34887587;36288343;37507081;3785200;3839797;39627609",
        "class_list": "",
        "function": "Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (By similarity). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms (By similarity). Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TY23;Q3U8B1;Q3UAW8;Q4KMW2",
        "ec_number_list": "3.6.5.-;6.3.2.-;6.-.-.-;2.1.1.13;3.6.5.2;3.6.5.3;2.7.11.1;2.4.1.41;3.6.1.5;2.7.11.11;2.7.10.2;3.6.4.10;2.7.11.22;2.7.11.23;3.6.5.4;5.6.1.6;3.6.4.-;5.2.1.8;5.6.1.3;3.6.5.5;2.7.10.4;2.3.1.168;3.4.22.49;3.1.3.16;2.7.11.39;3.6.1.-;3.6.4.6;2.7.11.21;3.6.1.15;3.4.21.-;3.6.4.12;3.6.-.-;2.3.1.108;3.1.2.-;3.5.1.-;3.5.1.124;2.3.1.-;2.7.11.26;2.3.2.-;3.1.11.-;5.6.1.1;5.3.99.3",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005200 structural constituent of cytoskeleton;GO:0005525 GTP binding;GO:0046872 metal ion binding;GO:0031625 ubiquitin protein ligase binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005874 microtubule;GO:0005929 cilium;GO:0043209 myelin sheath",
        "go_biological_process": "GO:0000278 mitotic cell cycle;GO:0030182 neuron differentiation;GO:0000226 microtubule cytoskeleton organization;GO:0071353 cellular response to interleukin-4",
        "synthesized_glycan_count": 0,
        "hit_score": 2.5,
        "record_id": "P05213-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P68373-1",
        "uniprot_id": "TBA1C_MOUSE",
        "mass": 49909.0,
        "length": 449,
        "protein_name": "Tubulin alpha-1C chain",
        "gene_name": "Tuba1c",
        "organism": "Mouse",
        "refseq_name": "tubulin alpha-1C chain",
        "refseq_ac": "NP_033474",
        "gene_names_uniprotkb": "Tuba1c; Tuba6",
        "gene_names_refseq": "M[a]6; Tuba1c; Tuba6",
        "protein_names_uniprotkb": "Tubulin alpha-1C chain; 3.6.5.-; Alpha-tubulin 6; Alpha-tubulin isotype M-alpha-6; Tubulin alpha-6 chain",
        "protein_names_refseq": "alpha-tubulin 6; alpha-tubulin isotype M-alpha-6; tubulin alpha-1C chain; tubulin alpha-6 chain; tubulin, alpha 6",
        "tax_id": 10090,
        "disease": "lissencephaly (Disease Ontology:DOID:0050453); polymicrogyria (Disease Ontology:DOID:0080918); lissencephaly 3 (Disease Ontology:DOID:0112232); microlissencephaly (Disease Ontology:DOID:0112234)",
        "pathway": " (mmu:22146);  (R-MMU-190840);  (R-MMU-2132295);  (R-MMU-2467813);  (R-MMU-2500257);  (R-MMU-3371497);  (R-MMU-380320);  (R-MMU-437239);  (R-MMU-5610787);  (R-MMU-5620920);  (R-MMU-5620924);  (R-MMU-5626467);  (R-MMU-5663220);  (R-MMU-6807878);  (R-MMU-6811434);  (R-MMU-6811436);  (R-MMU-68877);  (R-MMU-8852276);  (R-MMU-8955332);  (R-MMU-9646399);  (R-MMU-9648025);  (R-MMU-9668328);  (R-MMU-983189);  (R-MMU-9833482)",
        "pathway_count": 24,
        "publication_count": 22,
        "publication_id_list": "10.1101/2023.09.13.557529;15890843;16800626;16954346;19524510;19564401;20665223;21183079;23897886;25428506;26446751;27102488;28011936;29146868;30031227;30779550;33414192;34428180;35820727;37453647;37828378;3785200",
        "class_list": "",
        "function": "Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 4,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P05216;Q9CSE9",
        "ec_number_list": "3.6.5.-;6.3.2.-;6.-.-.-;3.6.5.2;3.6.5.3;2.7.11.1;2.4.1.41;3.6.1.5;2.7.11.11;3.6.4.10;2.7.11.22;2.7.11.23;3.6.5.4;5.6.1.6;3.6.4.-;5.2.1.8;5.6.1.3;3.6.5.5;3.4.22.49;3.1.3.16;3.6.1.-;2.7.10.2;2.7.11.21;3.6.1.15;3.4.21.-;3.6.4.12;3.6.-.-;2.3.1.108;3.1.2.-;3.5.1.-;3.5.1.124;2.3.1.-;2.7.11.26;2.3.2.-;3.1.11.-;5.6.1.1;5.3.99.3",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0005525 GTP binding;GO:0016787 hydrolase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005874 microtubule;GO:0005929 cilium;GO:0045121 membrane raft",
        "go_biological_process": "GO:0000278 mitotic cell cycle;GO:0030182 neuron differentiation;GO:0000226 microtubule cytoskeleton organization",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "P68373-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R5A6-1",
        "uniprot_id": "TB22A_MOUSE",
        "mass": 59362.0,
        "length": 516,
        "protein_name": "TBC1 domain family member 22A",
        "gene_name": "Tbc1d22a",
        "organism": "Mouse",
        "refseq_name": "TBC1 domain family member 22A isoform 1",
        "refseq_ac": "NP_663451",
        "gene_names_uniprotkb": "Tbc1d22a; D15Ertd781e",
        "gene_names_refseq": "D15Ertd781e; Tbc1d22a",
        "protein_names_uniprotkb": "TBC1 domain family member 22A",
        "protein_names_refseq": "TBC1 domain family member 22A isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:223754)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "17242355;21183079;21750661;22872234;31219806;34203471;34428180",
        "class_list": "",
        "function": "May act as a GTPase-activating protein for Rab family protein(s)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U268;Q3U3T0;Q8CA49",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0042803 protein homodimerization activity;GO:0071889 14-3-3 protein binding",
        "go_cellular_component": "GO:0005794 Golgi apparatus",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8R5A6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CXF4-1",
        "uniprot_id": "TBC15_MOUSE",
        "mass": 76527.0,
        "length": 671,
        "protein_name": "TBC1 domain family member 15",
        "gene_name": "Tbc1d15",
        "organism": "Mouse",
        "refseq_name": "TBC1 domain family member 15 isoform 2",
        "refseq_ac": "NP_079982",
        "gene_names_uniprotkb": "Tbc1d15",
        "gene_names_refseq": "4432405K22Rik; Ly6dl; Rab7-GAP; Tbc1d15",
        "protein_names_uniprotkb": "TBC1 domain family member 15; GAP for RAB7; GTPase-activating protein RAB7; Rab7-GAP",
        "protein_names_refseq": "GAP for RAB7; GTPase-activating protein RAB7; TBC1 domain family member 15 isoform 2; lymphocyte antigen 6, locus D ligand",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66687);  (R-MMU-8854214)",
        "pathway_count": 2,
        "publication_count": 17,
        "publication_id_list": "10.1101/2023.09.13.557529;15345747;16055087;20173027;20363736;21183079;25153642;25428506;26495903;28135057;28528544;28729291;30084848;30779550;31219806;33042281;34428180",
        "class_list": "",
        "function": "Acts as a GTPase activating protein for RAB7A. Does not act on RAB4, RAB5 or RAB6., [UniProtKB, PubMed, PubMed]; Nigericin-induced mitochondria fission was rescued by knockdown of either dynamin-related protein 1 or TBC1 domain family member 15 (TBC1D15), which are two distinct mitochondria fission regulators, only TBC1D15 restored the activity of the STING pathway, which indicates that inflammasome-activating signals curtail STING pathway activation via TBC1D15., [RefSeq, PubMed]; TBC1D15/RAB7-regulated mitochondria-lysosome interaction confers cardioprotection against acute myocardial infarction-induced cardiac injury. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 8,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UI41",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol",
        "go_biological_process": "GO:0043087 regulation of GTPase activity",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "Q9CXF4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K1H1-1",
        "uniprot_id": "TDRD7_MOUSE",
        "mass": 122174.0,
        "length": 1086,
        "protein_name": "Tudor domain-containing protein 7",
        "gene_name": "Tdrd7",
        "organism": "Mouse",
        "refseq_name": "tudor domain-containing protein 7 isoform 1",
        "refseq_ac": "NP_001277404",
        "gene_names_uniprotkb": "Tdrd7; Pctaire2bp",
        "gene_names_refseq": "5730495N10Rik; PCTAIRE2BP; Tdrd7",
        "protein_names_uniprotkb": "Tudor domain-containing protein 7; PCTAIRE2-binding protein; Trap; Tudor repeat associator with PCTAIRE-2",
        "protein_names_refseq": "PCTAIRE2-binding protein; trap; tudor domain-containing protein 7 isoform 1; tudor domain-containing protein 7; tudor repeat associator with PCTAIRE 2",
        "tax_id": 10090,
        "disease": "cataract 36 (Disease Ontology:DOID:0110247)",
        "pathway": " (mmu:100121)",
        "pathway_count": 1,
        "publication_count": 15,
        "publication_id_list": "11527406;17141210;19584108;21183079;21436445;21670278;21750661;25428506;25605945;27802388;30084848;32273341;32420594;34428180;37712680",
        "class_list": "",
        "function": "Component of specific cytoplasmic RNA granules involved in post-transcriptional regulation of specific genes: probably acts by binding to specific mRNAs and regulating their translation. Required for lens transparency during lens development, by regulating translation of genes such as CRYBB3 and HSPB1 in the developing lens. Also required during spermatogenesis., [UniProtKB, PubMed, UniProtKB, UniProtKB]; Interferon-stimulated gene TDRD7 interacts with AMPK and inhibits its activation to suppress viral replication and pathogenesis., [RefSeq, PubMed]; Results identify TRPC3 as a pivotal signaling gateway in Ca(2+)-dependent control of cardiac gene expression, [RefSeq, PubMed]; The Tudor-domain protein TDRD7, mutated in congenital cataract, controls the heat shock protein HSPB1 (HSP27) and lens fiber cell morphology., [RefSeq, PubMed]; The interferon-inducible protein TDRD7 inhibits AMP-activated protein kinase and thereby restricts autophagy-independent virus replication., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AWG7;B1AWH5;Q8R181",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003729 mRNA binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0036464 cytoplasmic ribonucleoprotein granule;GO:1990904 ribonucleoprotein complex;GO:0033391 chromatoid body;GO:0035770 ribonucleoprotein granule",
        "go_biological_process": "GO:0030719 P granule organization;GO:0007283 spermatogenesis;GO:0010608 post-transcriptional regulation of gene expression;GO:0007281 germ cell development;GO:0034587 piRNA processing",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q8K1H1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P99024-1",
        "uniprot_id": "TBB5_MOUSE",
        "mass": 49671.0,
        "length": 444,
        "protein_name": "Tubulin beta-5 chain",
        "gene_name": "Tubb5",
        "organism": "Mouse",
        "refseq_name": "tubulin beta-5 chain",
        "refseq_ac": "NP_035785",
        "gene_names_uniprotkb": "Tubb5",
        "gene_names_refseq": "B130022C14Rik; M(beta)5; Tubb5",
        "protein_names_uniprotkb": "Tubulin beta-5 chain",
        "protein_names_refseq": "tubulin beta-5 chain",
        "tax_id": 10090,
        "disease": "cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome (Disease Ontology:DOID:0050997); ptosis (Disease Ontology:DOID:0060260); complex cortical dysplasia with other brain malformations 7 (Disease Ontology:DOID:0090132); complex cortical dysplasia with other brain malformations 6 (Disease Ontology:DOID:0090136); tubulinopathy (Disease Ontology:DOID:0112227); congenital symmetric circumferential skin creases 1 (Disease Ontology:DOID:0112242); microcephaly (Disease Ontology:DOID:10907); facial paralysis (Disease Ontology:DOID:13934)",
        "pathway": " (mmu:22154);  (R-MMU-2565942);  (R-MMU-380259);  (R-MMU-380270);  (R-MMU-380284);  (R-MMU-380320);  (R-MMU-5620912);  (R-MMU-6798695);  (R-MMU-8854518)",
        "pathway_count": 9,
        "publication_count": 33,
        "publication_id_list": "10.1101/2023.09.13.557529;15890843;16371510;18347012;19524510;20643351;21183079;21540332;21750661;22645316;23246003;23806337;23897886;24788674;25605945;26637975;27965440;29187734;31219806;33300544;33414192;33725478;34418053;34428180;34887587;35820727;37453647;37507081;37601086;3782288;3839797;39627609;40684658",
        "class_list": "",
        "function": "Effects of Venlafaxine on the Size of Brain and Expression of SHANK3, TUBB5 and DDC Genes in BALB/c Mice., [RefSeq, PubMed]; Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 5,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 8,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1B178;P05218;Q3TFB6;Q3THH9;Q3TIL1;Q3UAV4;Q3UF52;Q8WUC1;Q9CY33",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005200 structural constituent of cytoskeleton;GO:0005525 GTP binding;GO:0019904 protein domain specific binding;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0097229 sperm end piece;GO:0005634 nucleus;GO:0005641 nuclear envelope lumen;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0000278 mitotic cell cycle;GO:0000226 microtubule cytoskeleton organization;GO:0051225 spindle assembly;GO:0050807 regulation of synapse organization;GO:0007017 microtubule-based process",
        "synthesized_glycan_count": 0,
        "hit_score": 3.8,
        "record_id": "P99024-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P83887-1",
        "uniprot_id": "TBG1_MOUSE",
        "mass": 51101.0,
        "length": 451,
        "protein_name": "Tubulin gamma-1 chain",
        "gene_name": "Tubg1",
        "organism": "Mouse",
        "refseq_name": "tubulin gamma-1 chain",
        "refseq_ac": "NP_598785",
        "gene_names_uniprotkb": "Tubg1; Tubg",
        "gene_names_refseq": "1500010O08Rik; GCP-1; Tubg1; Tubg",
        "protein_names_uniprotkb": "Tubulin gamma-1 chain; GCP-1; Gamma-1-tubulin; Gamma-tubulin complex component 1",
        "protein_names_refseq": "gamma-tubulin complex component 1; tubulin gamma-1 chain; tubulin, gamma polypeptide",
        "tax_id": 10090,
        "disease": "muscular disease (Disease Ontology:DOID:0080000); complex cortical dysplasia with other brain malformations 4 (Disease Ontology:DOID:0090138); inclusion body myositis (Disease Ontology:DOID:3429)",
        "pathway": " (mmu:103733);  (R-MMU-2565942);  (R-MMU-380259);  (R-MMU-380270);  (R-MMU-380284);  (R-MMU-380320);  (R-MMU-5620912);  (R-MMU-8854518)",
        "pathway_count": 8,
        "publication_count": 7,
        "publication_id_list": "18287022;19648910;20643351;30084848;34428180;36210013;38870534",
        "class_list": "",
        "function": "Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (By similarity). Gamma-tubulin is a key component of the gamma-tubulin ring complex (gTuRC) which mediates microtubule nucleation (By similarity). The gTuRC regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments, a critical step in centrosome duplication and spindle formation (By similarity). Plays a role in sperm morphological development during late stage spermiogenesis, particularly the anchoring of the sperm head to the tail (PubMed:38870534)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9Z310",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0005525 GTP binding;GO:0042802 identical protein binding;GO:0140490 microtubule nucleator activity",
        "go_cellular_component": "GO:0000794 condensed nuclear chromosome;GO:0000922 spindle pole;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005813 centrosome",
        "go_biological_process": "GO:0000278 mitotic cell cycle;GO:0007020 microtubule nucleation;GO:0007088 regulation of mitotic nuclear division;GO:0007052 mitotic spindle organization;GO:0000070 mitotic sister chromatid segregation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "P83887-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q70IV5-1",
        "uniprot_id": "SYNEM_MOUSE",
        "mass": 173209.0,
        "length": 1561,
        "protein_name": "Synemin",
        "gene_name": "Synm",
        "organism": "Mouse",
        "refseq_name": "synemin isoform L",
        "refseq_ac": "NP_899135",
        "gene_names_uniprotkb": "Synm; Dmn; Kiaa0353",
        "gene_names_refseq": "4930412K21Rik; Dmn; E130104F11; Synemin; Synm; Syn",
        "protein_names_uniprotkb": "Synemin; Desmuslin",
        "protein_names_refseq": "synemin isoform L",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:233335)",
        "pathway_count": 1,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;15265691;16817202;17356066;19124017;21183079;21750661;24129315;30084848;31461342;34428180;35820727",
        "class_list": "",
        "function": "Dmn is expressed in reactive astrocytes in neurotrauma and interacts differentially with Vim and Gfap., [RefSeq, PubMed]; Synemin gene encodes proteins belonging to the intermediate filament which confer resistance to mechanical stress and modulate cell shape., [RefSeq, PubMed]; Synemin is a target of myocardin family coactivators., [RefSeq, PubMed]; Type-VI intermediate filament (IF) which plays an important cytoskeletal role within the muscle cell cytoskeleton. It forms heteromeric IFs with desmin and/or vimentin, and via its interaction with cytoskeletal proteins alpha-dystrobrevin, dystrophin, talin-1, utrophin and vinculin, is able to link these heteromeric IFs to adherens-type junctions, such as to the costameres, neuromuscular junctions, and myotendinous junctions within striated muscle cells (By similarity)., [UniProtKB, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 11,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9624,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UPZ4;Q6A081;Q70IV3;Q70IV4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0030674 protein-macromolecule adaptor activity;GO:0008307 structural constituent of muscle;GO:0017166 vinculin binding;GO:0019215 intermediate filament binding",
        "go_cellular_component": "GO:0005912 adherens junction;GO:0016020 membrane;GO:0005882 intermediate filament;GO:0042383 sarcolemma;GO:0030018 Z disc",
        "go_biological_process": "GO:0045104 intermediate filament cytoskeleton organization;GO:0031443 fast-twitch skeletal muscle fiber contraction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q70IV5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "G5E8X2-1",
        "uniprot_id": "G5E8X2_MOUSE",
        "mass": 41936.0,
        "length": 370,
        "protein_name": "Polyadenylate-binding protein 5",
        "gene_name": "Pabpc4l",
        "organism": "Mouse",
        "refseq_name": "polyadenylate-binding protein 4-like",
        "refseq_ac": "NP_001094949",
        "gene_names_uniprotkb": "Pabpc4l",
        "gene_names_refseq": "C330050A14Rik; EG241989; Pabpc4l",
        "protein_names_uniprotkb": "Polyadenylate-binding protein 5",
        "protein_names_refseq": "polyadenylate-binding protein 4-like",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:241989)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Binds the poly(A) tail of mRNA. May be involved in cytoplasmic regulatory processes of mRNA metabolism. Can probably bind to cytoplasmic RNA sequences other than poly(A) in vivo., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0003730 mRNA 3'-UTR binding;GO:0008143 poly(A) binding;GO:0008266 poly(U) RNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol;GO:0010494 cytoplasmic stress granule;GO:1990904 ribonucleoprotein complex",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "G5E8X2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q920M7-1",
        "uniprot_id": "SYT17_MOUSE",
        "mass": 53293.0,
        "length": 470,
        "protein_name": "Synaptotagmin-17",
        "gene_name": "Syt17",
        "organism": "Mouse",
        "refseq_name": "synaptotagmin-17 isoform 1",
        "refseq_ac": "NP_619590",
        "gene_names_uniprotkb": "Syt17; Bk",
        "gene_names_refseq": "Bk; Syt17; sytXVII",
        "protein_names_uniprotkb": "Synaptotagmin-17; Protein B/K; Synaptotagmin XVII; SytXVII",
        "protein_names_refseq": "B/K protein; brain and kidney protein; synaptotagmin-17 isoform 1; synaptotagmin-17",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:110058)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "11716773;21183079;21750661;25428506;31219806;31387992;36332665",
        "class_list": "",
        "function": "Circadian expression and specific localization of synaptotagmin17 in the suprachiasmatic nucleus, the master circadian oscillator in mammals., [RefSeq, PubMed]; Plays a role in dendrite formation by melanocytes., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Study localized syt-17 in primary hippocampal neurons to two compartments: the Golgi complex in the soma and Rab5-positive early endosomes in neurites and concluded that syt-17 is a multifunctional regulator of intracellular protein trafficking in excitatory hippocampal neurons, modulating both neural development and synaptic physiology. Publication Status: Online-Only, [RefSeq, PubMed]; The N-terminal domain of B/K protein contains a novel cysteine-based motif that allows B/K protein to localize in the trans-Golgi network., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UXZ2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005544 calcium-dependent phospholipid binding;GO:0000149 SNARE binding;GO:0061891 calcium ion sensor activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005886 plasma membrane;GO:0098794 postsynapse;GO:0005802 trans-Golgi network;GO:0070382 exocytic vesicle",
        "go_biological_process": "GO:1903861 positive regulation of dendrite extension;GO:0030154 cell differentiation;GO:0016192 vesicle-mediated transport;GO:0017158 regulation of calcium ion-dependent exocytosis;GO:0099149 regulation of postsynaptic neurotransmitter receptor internalization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q920M7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QXN3-1",
        "uniprot_id": "TRIP4_MOUSE",
        "mass": 66197.0,
        "length": 581,
        "protein_name": "Activating signal cointegrator 1",
        "gene_name": "Trip4",
        "organism": "Mouse",
        "refseq_name": "activating signal cointegrator 1 isoform 2",
        "refseq_ac": "NP_001164378",
        "gene_names_uniprotkb": "Trip4",
        "gene_names_refseq": "4930558E03Rik; ASC-1; Asc1; Trip4",
        "protein_names_uniprotkb": "Activating signal cointegrator 1; ASC-1; TR-interacting protein 4; TRIP-4; Thyroid receptor-interacting protein 4",
        "protein_names_refseq": "TR-interacting protein 4; TRIP-4; activating signal cointegrator 1 isoform 2; activating signal cointegrator 1; thyroid receptor-interacting protein 4; transcription coactivator Asc1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56404);  (R-MMU-9954716)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "12077347;12390891;17947660;21494687;21750661;25428506;26924529;27008887;30084848;30779550;34428180",
        "class_list": "",
        "function": "ASC-1 exists as a steady-state complex associated with three polypeptides, P200, P100, and P50, in HeLa nuclei., [RefSeq, PubMed]; Homozygous and compound-heterozygous nonsense and frameshift TRIP4 and ASCC1 mutations that cosegregated with the Prenatal Spinal Muscular Atrophy and Congenital Bone Fracture phenotype, [RefSeq, PubMed]; Transcription coactivator which associates with nuclear receptors, transcriptional coactivators including EP300, CREBBP and NCOA1, and basal transcription factors like TBP and TFIIA to facilitate nuclear receptors-mediated transcription. May thereby play an important role in establishing distinct coactivator complexes under different cellular conditions. Plays a role in thyroid hormone receptor and estrogen receptor transactivation (By similarity). Also involved in androgen receptor transactivation (PubMed:12077347). Plays a pivotal role in the transactivation of NF-kappa-B, SRF and AP1. Acts as a mediator of transrepression between nuclear receptor and either AP1 or NF-kappa-B. May play a role in the development of neuromuscular junction (By similarity). May play a role in late myogenic differentiation (PubMed:27008887). Also functions as part of the RQC trigger (RQT) complex that activates the ribosome quality control (RQC) pathway, a pathway that degrades nascent peptide chains during problematic translation (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QK64;Q8CAD5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0002020 protease binding;GO:0003713 transcription coactivator activity;GO:0008270 zinc ion binding;GO:0019901 protein kinase binding;GO:0030331 nuclear estrogen receptor binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005813 centrosome;GO:0005829 cytosol",
        "go_biological_process": "GO:0072344 rescue of stalled ribosome;GO:0032790 ribosome disassembly;GO:0006351 DNA-templated transcription;GO:0006355 regulation of DNA-templated transcription;GO:0045893 positive regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q9QXN3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2A8Q4-1",
        "uniprot_id": "A2A8Q4_MOUSE",
        "mass": 43300.0,
        "length": 368,
        "protein_name": "Zinc finger protein 982",
        "gene_name": "Zfp982",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein LOC195531",
        "refseq_ac": "NP_001034298",
        "gene_names_uniprotkb": "Zfp982",
        "gene_names_refseq": "Gm13152; Zfp982",
        "protein_names_uniprotkb": "Zinc finger protein 982",
        "protein_names_refseq": "uncharacterized protein LOC195531",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:195531);  (R-MMU-212436);  (R-MMU-9843940)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "21750661;38342310",
        "class_list": "",
        "function": "May be involved in transcriptional regulation., [UniProtKB, UniProtKB]; ZFP982 confers mouse embryonic stem cell characteristics by regulating expression of Nanog, Zfp42, and Dppa3., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005730 nucleolus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0045892 negative regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "A2A8Q4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2ANA3-1",
        "uniprot_id": "A2ANA3_MOUSE",
        "mass": 23480.0,
        "length": 212,
        "protein_name": "Claudin 34C4",
        "gene_name": "Cldn34c4",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein LOC73934",
        "refseq_ac": "NP_001268466",
        "gene_names_uniprotkb": "Cldn34c4",
        "gene_names_refseq": "4930412D23Rik; Cldn34c4",
        "protein_names_uniprotkb": "Claudin 34C4",
        "protein_names_refseq": "uncharacterized protein LOC73934",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:73934)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005198 structural molecule activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0005923 bicellular tight junction",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A2ANA3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "D3YV94-1",
        "uniprot_id": "D3YV94_MOUSE",
        "mass": 8894.0,
        "length": 81,
        "protein_name": "Late cornified envelope 6A",
        "gene_name": "Lce6a",
        "organism": "Mouse",
        "refseq_name": "late cornified envelope protein 6A",
        "refseq_ac": "NP_001159644",
        "gene_names_uniprotkb": "Lce6a",
        "gene_names_refseq": "2210420J11Rik; Lce6a",
        "protein_names_uniprotkb": "Late cornified envelope 6A",
        "protein_names_refseq": "late cornified envelope protein 6A",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:78382)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;25428506",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "D3YV94-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9Q546-1",
        "uniprot_id": "E9Q546_MOUSE",
        "mass": 34985.0,
        "length": 317,
        "protein_name": "Olfactory receptor family 52 subfamily M member 1",
        "gene_name": "Or52m1",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 554",
        "refseq_ac": "NP_666437",
        "gene_names_uniprotkb": "Or52m1; Olfr554",
        "gene_names_refseq": "MOR25-1; Olfr554; Or52m1",
        "protein_names_uniprotkb": "Olfactory receptor family 52 subfamily M member 1",
        "protein_names_refseq": "GA_x6K02T2PBJ9-5356887-5357840; olfactory receptor 554; olfactory receptor MOR25-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258322)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB]; Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "E9Q546-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9Q848-1",
        "uniprot_id": "E9Q848_MOUSE",
        "mass": 35207.0,
        "length": 314,
        "protein_name": "Olfactory receptor family 10 subfamily K member 2",
        "gene_name": "Or10k2",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 370",
        "refseq_ac": "NP_666382",
        "gene_names_uniprotkb": "Or10k2; Olfr370",
        "gene_names_refseq": "MOR267-16; MOR26716; Olfr370; Or10k2",
        "protein_names_uniprotkb": "Olfactory receptor family 10 subfamily K member 2",
        "protein_names_refseq": "olfactory receptor 370",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258267)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Odorant receptor., [UniProtKB, UniProtKB]; Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "E9Q848-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "J3QNZ6-1",
        "uniprot_id": "J3QNZ6_MOUSE",
        "mass": 26707.0,
        "length": 232,
        "protein_name": "Predicted gene, 21874",
        "gene_name": "Gm21874",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Gm21874",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Predicted gene, 21874",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0006355 regulation of DNA-templated transcription;GO:0007276 gamete generation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "J3QNZ6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "J3QPM6-1",
        "uniprot_id": "J3QPM6_MOUSE",
        "mass": 8891.0,
        "length": 83,
        "protein_name": "RIKEN cDNA D430019H16 gene",
        "gene_name": "D430019H16Rik",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein C14orf132 homolog",
        "refseq_ac": "NP_001239437",
        "gene_names_uniprotkb": "D430019H16Rik",
        "gene_names_refseq": "D430019H16Rik",
        "protein_names_uniprotkb": "RIKEN cDNA D430019H16 gene",
        "protein_names_refseq": "uncharacterized protein C14orf132 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:268595)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;25428506",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "J3QPM6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "K9J7E2-1",
        "uniprot_id": "K9J7E2_MOUSE",
        "mass": 32673.0,
        "length": 286,
        "protein_name": "Aly/REF export factor family member 12; Aly/REF export factor family member 4; Aly/REF export factor family member 9",
        "gene_name": "Alyreffm4",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Alyreffm4; Alyreffm12; Alyreffm9; Gm4301; Gm4308; Gm4312",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Aly/REF export factor family member 12; Aly/REF export factor family member 4; Aly/REF export factor family member 9",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "alcohol use disorder (Disease Ontology:DOID:1574)",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003729 mRNA binding;GO:0003697 single-stranded DNA binding;GO:0062153 C5-methylcytidine-containing RNA reader activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0071013 catalytic step 2 spliceosome;GO:0000346 transcription export complex;GO:0035145 exon-exon junction complex",
        "go_biological_process": "GO:0016071 mRNA metabolic process;GO:0006406 mRNA export from nucleus;GO:0006405 RNA export from nucleus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "K9J7E2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3TS39-1",
        "uniprot_id": "SIM33_MOUSE",
        "mass": 13926.0,
        "length": 127,
        "protein_name": "Small integral membrane protein 33",
        "gene_name": "Smim33",
        "organism": "Mouse",
        "refseq_name": "small integral membrane protein 33",
        "refseq_ac": "NP_001028340",
        "gene_names_uniprotkb": "Smim33",
        "gene_names_refseq": "1700066B19Rik; Smim33",
        "protein_names_uniprotkb": "Small integral membrane protein 33",
        "protein_names_refseq": "small integral membrane protein 33",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:73449)",
        "pathway_count": 1,
        "publication_count": 0,
        "publication_id_list": "",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.1,
        "record_id": "Q3TS39-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5SQ27-1",
        "uniprot_id": "Q5SQ27_MOUSE",
        "mass": 46084.0,
        "length": 401,
        "protein_name": "SEC14-like lipid binding 3",
        "gene_name": "Sec14l3",
        "organism": "Mouse",
        "refseq_name": "SEC14-like protein 3",
        "refseq_ac": "NP_001025108",
        "gene_names_uniprotkb": "Sec14l3",
        "gene_names_refseq": "1110069O07Rik; Sec14l3",
        "protein_names_uniprotkb": "SEC14-like lipid binding 3",
        "protein_names_refseq": "SEC14-like protein 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:380683)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21750661;21796385;25428506;28383034;37507081",
        "class_list": "",
        "function": "Creb1/Crtc1-3 and Sec14l3 could be important for early responses of the bronchial epithelium to Th2-stimuli. Publication Status: Online-Only, [RefSeq, PubMed]; Study demonstrated that the ciliated cells in the lung selectively express Sec14l3 mRNA; levels of the Sec14l3 mRNA correlated with the differentiation of ciliated cells, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008289 lipid binding",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q5SQ27-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TRA9-1",
        "uniprot_id": "Q7TRA9_MOUSE",
        "mass": 34347.0,
        "length": 311,
        "protein_name": "Olfactory receptor family 10 subfamily D member 4",
        "gene_name": "Or10d4",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 10 subfamily D member 4",
        "refseq_ac": "NP_001011827",
        "gene_names_uniprotkb": "Or10d4; Olfr963",
        "gene_names_refseq": "MOR224-13; MOR224-7P; Olfr963; Or10d4",
        "protein_names_uniprotkb": "Olfactory receptor family 10 subfamily D member 4",
        "protein_names_refseq": "GA_x6K02T2PVTD-33365879-33366814; olfactory receptor 963; olfactory receptor MOR224-7P; olfactory receptor family 10 subfamily D member 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258087)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q7TRA9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C0X7-1",
        "uniprot_id": "SO6C1_MOUSE",
        "mass": 78986.0,
        "length": 706,
        "protein_name": "Solute carrier organic anion transporter family member 6C1",
        "gene_name": "Slco6c1",
        "organism": "Mouse",
        "refseq_name": "solute carrier organic anion transporter family member 6C1",
        "refseq_ac": "NP_083218",
        "gene_names_uniprotkb": "Slco6c1",
        "gene_names_refseq": "4933404A18Rik; Slco6c1",
        "protein_names_uniprotkb": "Solute carrier organic anion transporter family member 6C1",
        "protein_names_refseq": "solute carrier organic anion transporter family member 6C1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74441)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "25428506;34225353",
        "class_list": "",
        "function": "Auxiliary component of the CatSper complex, a complex involved in sperm cell hyperactivation., [UniProtKB, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3V161;Q9D4B7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0022857 transmembrane transporter activity",
        "go_cellular_component": "GO:0036128 CatSper complex;GO:0005886 plasma membrane;GO:0016323 basolateral plasma membrane;GO:0097228 sperm principal piece",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0030317 flagellated sperm motility;GO:0048240 sperm capacitation;GO:0015711 organic anion transport;GO:0043252 sodium-independent organic anion transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8C0X7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VF15-1",
        "uniprot_id": "Q8VF15_MOUSE",
        "mass": 36613.0,
        "length": 326,
        "protein_name": "Olfactory receptor family 10 subfamily D member 5J",
        "gene_name": "Or10d5j",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 976 isoform 2",
        "refseq_ac": "NP_666479",
        "gene_names_uniprotkb": "Or10d5j; Olfr976",
        "gene_names_refseq": "MOR224-10; Olfr976; Or10d5j",
        "protein_names_uniprotkb": "Olfactory receptor family 10 subfamily D member 5J",
        "protein_names_refseq": "GA_x6K02T2PVTD-33657378-33656440; olfactory receptor 976 isoform 2; olfactory receptor 976; olfactory receptor MOR224-10",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VF15-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VF89-1",
        "uniprot_id": "Q8VF89_MOUSE",
        "mass": 35153.0,
        "length": 316,
        "protein_name": "Olfactory receptor family 2 subfamily AG member 12",
        "gene_name": "Or2ag12",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 693",
        "refseq_ac": "NP_666664",
        "gene_names_uniprotkb": "Or2ag12; Olfr693",
        "gene_names_refseq": "MOR283-8; Olfr693; Or2ag12",
        "protein_names_uniprotkb": "Olfactory receptor family 2 subfamily AG member 12",
        "protein_names_refseq": "GA_x6K02T2PBJ9-9055944-9054994; olfactory receptor 693; olfactory receptor MOR283-8",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258445)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0050911 detection of chemical stimulus involved in sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VF89-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VG58-1",
        "uniprot_id": "Q8VG58_MOUSE",
        "mass": 33961.0,
        "length": 305,
        "protein_name": "Olfactory receptor family 4 subfamily C member 123",
        "gene_name": "Or4c123",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 4 subfamily C member 123",
        "refseq_ac": "NP_667000",
        "gene_names_uniprotkb": "Or4c123; Olfr1230",
        "gene_names_refseq": "MOR237-1; Olfr1230; Or4c123",
        "protein_names_uniprotkb": "Olfactory receptor family 4 subfamily C member 123",
        "protein_names_refseq": "GA_x6K02T2Q125-50741934-50741017; olfactory receptor 1230; olfactory receptor MOR237-1; olfactory receptor family 4 subfamily C member 123",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258785)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VG58-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VGC7-1",
        "uniprot_id": "Q8VGC7_MOUSE",
        "mass": 35435.0,
        "length": 313,
        "protein_name": "Olfactory receptor family 8 subfamily K member 16",
        "gene_name": "Or8k16",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 8 subfamily K member 16",
        "refseq_ac": "NP_667077",
        "gene_names_uniprotkb": "Or8k16; Olfr1008",
        "gene_names_refseq": "MOR187-3; Olfr1008; Or8k16",
        "protein_names_uniprotkb": "Olfactory receptor family 8 subfamily K member 16",
        "protein_names_refseq": "GA_x6K02T2Q125-47170431-47171372; olfactory receptor 1008; olfactory receptor MOR187-3; olfactory receptor family 8 subfamily K member 16",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258866)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VGC7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VGZ3-1",
        "uniprot_id": "Q8VGZ3_MOUSE",
        "mass": 35594.0,
        "length": 318,
        "protein_name": "Olfactory receptor family 51 subfamily H member 5",
        "gene_name": "Or51h5",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor 572",
        "refseq_ac": "NP_667300",
        "gene_names_uniprotkb": "Or51h5; Olfr572",
        "gene_names_refseq": "MOR10-2; Olfr572; Or51h5",
        "protein_names_uniprotkb": "Olfactory receptor family 51 subfamily H member 5",
        "protein_names_refseq": "GA_x6K02T2PBJ9-5638785-5639741; olfactory receptor 572; olfactory receptor MOR10-2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:259093)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell;GO:0071396 cellular response to lipid",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VGZ3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VH09-1",
        "uniprot_id": "Q8VH09_MOUSE",
        "mass": 34668.0,
        "length": 310,
        "protein_name": "Olfactory receptor family 8 subfamily D member 6",
        "gene_name": "Or8d6",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 8 subfamily D member 6",
        "refseq_ac": "NP_667318",
        "gene_names_uniprotkb": "Or8d6; Olfr974",
        "gene_names_refseq": "MOR171-1; Olfr974; Or8d6",
        "protein_names_uniprotkb": "Olfactory receptor family 8 subfamily D member 6",
        "protein_names_refseq": "GA_x6K02T2PVTD-33640290-33641222; olfactory receptor 974; olfactory receptor MOR171-1; olfactory receptor family 8 subfamily D member 6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:259111)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8VH09-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EQ99-1",
        "uniprot_id": "Q9EQ99_MOUSE",
        "mass": 34328.0,
        "length": 308,
        "protein_name": "Olfactory receptor family 8 subfamily D member 23",
        "gene_name": "Or8d23",
        "organism": "Mouse",
        "refseq_name": "olfactory receptor family 8 subfamily D member 23",
        "refseq_ac": "NP_666384",
        "gene_names_uniprotkb": "Or8d23; Olfr930",
        "gene_names_refseq": "MOR171-46; Olfr930; Or8d23",
        "protein_names_uniprotkb": "Olfactory receptor family 8 subfamily D member 23",
        "protein_names_refseq": "GA_x6K02T2PVTD-32626123-32627049; olfactory receptor 930; olfactory receptor MOR171-46; olfactory receptor family 8 subfamily D member 23",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:258269);  (R-MMU-381753)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0004984 olfactory receptor activity;GO:0005549 odorant binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007608 sensory perception of smell",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9EQ99-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P54763-3",
        "uniprot_id": "EPHB2_MOUSE",
        "mass": 109899.0,
        "length": 986,
        "protein_name": "Ephrin type-B receptor 2",
        "gene_name": "Ephb2",
        "organism": "Mouse",
        "refseq_name": "ephrin type-B receptor 2 isoform 1 precursor",
        "refseq_ac": "NP_001277682",
        "gene_names_uniprotkb": "Ephb2; Epth3; Nuk; Sek3",
        "gene_names_refseq": "Cek5; Drt; ETECK; Ephb2; Erk; Hek5; Nuk; Prkm5; Qek5; Sek3; Tyro5",
        "protein_names_uniprotkb": "Ephrin type-B receptor 2; 2.7.10.1; Neural kinase; Nuk receptor tyrosine kinase; Tyrosine-protein kinase receptor EPH-3; Tyrosine-protein kinase receptor SEK-3",
        "protein_names_refseq": "ephrin type-B receptor 2 isoform 1 precursor; ephrin type-B receptor 2; neural kinase; nuk receptor tyrosine kinase; tyrosine-protein kinase receptor EPH-3; tyrosine-protein kinase receptor SEK-3",
        "tax_id": 10090,
        "disease": "cognitive disorder (Disease Ontology:DOID:1561); blood platelet disease (Disease Ontology:DOID:2218); middle cerebral artery infarction (Disease Ontology:DOID:3525); human immunodeficiency virus infectious disease (Disease Ontology:DOID:526); ulcerative colitis (Disease Ontology:DOID:8577); irritable bowel syndrome (Disease Ontology:DOID:9778)",
        "pathway": " (mmu:13844);  (R-MMU-2682334);  (R-MMU-3928662);  (R-MMU-3928664);  (R-MMU-3928665)",
        "pathway_count": 5,
        "publication_count": 25,
        "publication_id_list": "10.1101/2023.09.13.557529;10542222;10704386;10839360;11780069;14691139;15107857;15223334;16977320;17428795;19349973;19656770;21029865;27446912;28931592;38758791;38913115;38925462;7947319;8134103;8689685;8947026;9853759;9883737;9990854",
        "class_list": "",
        "function": "EphB2 activation in neural stem cells in the basolateral amygdala facilitates neurogenesis and enhances long-term memory. Publication Status: Online-Only, [RefSeq, PubMed]; Ephrin-B2 promotes nociceptive plasticity and hyperalgesic priming through EphB2-MNK-eIF4E signaling in both mice and humans., [RefSeq, PubMed]; Phosphorylation of Doc2 by EphB2 modulates Munc13-mediated SNARE complex assembly and neurotransmitter release., [RefSeq, PubMed]; Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Functions in axon guidance during development. Involved in the guidance of commissural axons, that form a major interhemispheric connection between the 2 temporal lobes of the cerebral cortex. Also involved in guidance of contralateral inner ear efferent growth cones at the midline and of retinal ganglion cell axons to the optic disk. In addition to axon guidance, also regulates dendritic spines development and maturation and stimulates the formation of excitatory synapses. Upon activation by EFNB1, abolishes the ARHGEF15-mediated negative regulation on excitatory synapse formation. Controls other aspects of development including angiogenesis, palate development and in inner ear development through regulation of endolymph production. Forward and reverse signaling through the EFNB2/EPHB2 complex regulate movement and adhesion of cells that tubularize the urethra and septate the cloaca. May function as a tumor suppressor. May be involved in the regulation of platelet activation and blood coagulation (By similarity)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed, PubMed, PubMed]; This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors consist of an N-terminal glycosylated ligand-binding domain, a transmembrane region and an intracellular kinase domain. The encoded receptor preferentially binds membrane-bound ephrin-B ligands and is involved in nervous system and vascular development. This gene is used as a marker of intestinal stem cells. Homozygous knockout mice for this gene exhibit impaired axon guidance and vestibular function. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9753,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 6,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A3KG00;A3KG01;A3KG02;A3KG89;A3KG90;Q62213;Q6GTQ7;Q6P5F1;Q9QVY4",
        "ec_number_list": "2.7.11.1;2.7.12.2;2.7.10.1;2.7.12.1;2.7.1.32;2.7.1.82;2.7.10.2;2.7.11.13;3.4.24.24;2.7.10.4;3.4.24.35;3.4.23.-;2.7.1.40;3.6.4.-;3.6.5.2;2.7.11.23",
        "go_molecular_function": "GO:0004713 protein tyrosine kinase activity;GO:0005102 signaling receptor binding;GO:0005524 ATP binding;GO:0042802 identical protein binding;GO:0001540 amyloid-beta binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005654 nucleoplasm;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0030424 axon",
        "go_biological_process": "GO:0050770 regulation of axonogenesis;GO:0046580 negative regulation of Ras protein signal transduction;GO:0021934 hindbrain tangential cell migration;GO:0120192 tight junction assembly;GO:0046425 regulation of receptor signaling pathway via JAK-STAT",
        "synthesized_glycan_count": 0,
        "hit_score": 3.1,
        "record_id": "P54763-3",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UHA3-1",
        "uniprot_id": "SPTCS_MOUSE",
        "mass": 273934.0,
        "length": 2430,
        "protein_name": "Spatacsin",
        "gene_name": "Spg11",
        "organism": "Mouse",
        "refseq_name": "spatacsin",
        "refseq_ac": "NP_663506",
        "gene_names_uniprotkb": "Spg11; Kiaa1840",
        "gene_names_refseq": "6030465E24Rik; A330015I11; C530005A01Rik; Spg11",
        "protein_names_uniprotkb": "Spatacsin; Spastic paraplegia 11 protein homolog",
        "protein_names_refseq": "spastic paraplegia 11 protein homolog; spatacsin",
        "tax_id": 10090,
        "disease": "amyotrophic lateral sclerosis type 5 (Disease Ontology:DOID:0060197); Charcot-Marie-Tooth disease axonal type 2X (Disease Ontology:DOID:0110176); hereditary spastic paraplegia 11 (Disease Ontology:DOID:0110764)",
        "pathway": " (mmu:214585)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "17322883;20173027;21183079;24794856;25428506;25605945;30084848;34428180;35820727;37828378;38876323",
        "class_list": "",
        "function": "Decreasing ganglioside synthesis delays motor and cognitive symptom onset in Spg11 knockout mice., [RefSeq, PubMed]; May play a role in neurite plasticity by maintaining cytoskeleton stability and regulating synaptic vesicle transport., [UniProtKB, PubMed]; Study provides evidence that SPG11 is implicated in axonal maintenance and cargo trafficking., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2ARM0;Q6ZPH3;Q8BHQ1;Q8C7R3;Q8C7U2;Q8CA88;Q8VEA5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019901 protein kinase binding",
        "go_cellular_component": "GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0007409 axonogenesis;GO:0007528 neuromuscular junction development;GO:0007613 memory;GO:0008088 axo-dendritic transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q3UHA3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q62383-1",
        "uniprot_id": "SPT6H_MOUSE",
        "mass": 199086.0,
        "length": 1726,
        "protein_name": "Transcription elongation factor SPT6",
        "gene_name": "Supt6h",
        "organism": "Mouse",
        "refseq_name": "transcription elongation factor SPT6",
        "refseq_ac": "NP_033323",
        "gene_names_uniprotkb": "Supt6h; Kiaa0162; Supt6",
        "gene_names_refseq": "5131400N11Rik; SPT6; Supt6h; Supt6; mKIAA0162",
        "protein_names_uniprotkb": "Transcription elongation factor SPT6",
        "protein_names_refseq": "suppressor of Ty 6 homolog; transcription elongation factor SPT6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:20926);  (R-MMU-112382);  (R-MMU-674695);  (R-MMU-75955)",
        "pathway_count": 4,
        "publication_count": 18,
        "publication_id_list": "10.1101/2023.09.13.557529;17234882;19141475;21183079;21518874;22843687;23503590;25428506;29237092;30084848;30208029;30846735;31219806;32782141;34428180;36852467;39627609;8786132",
        "class_list": "",
        "function": "Histone H3-H4 chaperone that plays a key role in the regulation of transcription elongation and mRNA processing. Enhances the transcription elongation by RNA polymerase II (RNAPII) and is also required for the efficient activation of transcriptional elongation by the HIV-1 nuclear transcriptional activator, Tat. Besides chaperoning histones in transcription, acts to transport and splice mRNA by forming a complex with IWS1 and the C-terminal domain (CTD) of the RNAPII subunit RPB1 (POLR2A). The SUPT6H:IWS1:CTD complex recruits mRNA export factors (ALYREF/THOC4, EXOSC10) as well as histone modifying enzymes (such as SETD2), to ensure proper mRNA splicing, efficient mRNA export and elongation-coupled H3K36 methylation, a signature chromatin mark of active transcription. SUPT6H via its association with SETD1A, regulates both class-switch recombination and somatic hypermutation through formation of H3K4me3 epigenetic marks on activation-induced cytidine deaminase (AICDA) target loci. Promotes the activation of the myogenic gene program by entailing erasure of the repressive H3K27me3 epigenetic mark through stabilization of the chromatin interaction of the H3K27 demethylase KDM6A., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; Iws1 and Spt6 Regulate Trimethylation of Histone H3 on Lysine 36 through Akt Signaling and are Essential for Mouse Embryonic Genome Activation. Publication Status: Online-Only, [RefSeq, PubMed]; Iws1 is expressed in all adult organs and it is an essential gene for mouse embryonic development. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 19,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SYM0;Q6GQS3;Q6ZQI0;Q8BQY6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0042393 histone binding;GO:0031491 nucleosome binding",
        "go_cellular_component": "GO:0008023 transcription elongation factor complex",
        "go_biological_process": "GO:0034728 nucleosome organization;GO:0006397 mRNA processing;GO:0008380 RNA splicing;GO:0045191 regulation of isotype switching;GO:0006368 transcription elongation by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 2.5,
        "record_id": "Q62383-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D9D3-1",
        "uniprot_id": "TBC21_MOUSE",
        "mass": 39261.0,
        "length": 336,
        "protein_name": "TBC1 domain family member 21",
        "gene_name": "Tbc1d21",
        "organism": "Mouse",
        "refseq_name": "TBC1 domain family member 21 isoform 1",
        "refseq_ac": "NP_083130",
        "gene_names_uniprotkb": "Tbc1d21; MgcRabGAP",
        "gene_names_refseq": "1700095K08Rik; MgcRabGAP; Tbc1d21",
        "protein_names_uniprotkb": "TBC1 domain family member 21; Male germ cell Rab GTPase-activating protein",
        "protein_names_refseq": "TBC1 domain family member 21 isoform 1; male germ cell Rab GTPase-activating protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74286)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "21128978;21750661;30360518;32976492;33536340;35403672",
        "class_list": "",
        "function": "ARMC12 regulates spatiotemporal mitochondrial dynamics during spermiogenesis and is required for male fertility., [RefSeq, PubMed]; Acts as a GTPase-activating protein for Rab family protein (s) (PubMed:30360518). Essential for the establishment of male fertility, and is required for both the production of normal sperm number and sperm function (PubMed:32976492). Plays an important role in the formation of intact mitochondria, outer dense fibers and axoneme within the sperm tail (PubMed:32976492). Essential for sperm mitochondrial sheath formation and for the interactions of ARMC12 with VDAC2 and VDAC3 (PubMed:33536340). May be involved in acrosome formation and cytoskeletal reorganization during spermiogenesis, possibly by regulating RAB3A activity (PubMed:21128978)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; Deficiency of the Tbc1d21 gene causes male infertility with morphological abnormalities of the sperm mitochondria and flagellum in mice. Publication Status: Online-Only, [RefSeq, PubMed]; MgcRabGAP is involved in acrosome/acroplaxome formation and cytoskeletal reorganization via Rab activity during mammalian spermiogenesis, [RefSeq, PubMed]; TBC1D21 is an essential factor for sperm mitochondrial sheath assembly and male fertilitydouble dagger., [RefSeq, PubMed]; TBC1D21 may interact with and potentially regulate Rap1 during murine spermatogenesis. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B7ZNH3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003779 actin binding;GO:0005096 GTPase activator activity;GO:0031267 small GTPase binding",
        "go_cellular_component": "GO:0005856 cytoskeleton;GO:0031410 cytoplasmic vesicle;GO:0001669 acrosomal vesicle;GO:0097225 sperm midpiece",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0030317 flagellated sperm motility;GO:0007288 sperm axoneme assembly;GO:0048227 plasma membrane to endosome transport;GO:0120317 sperm mitochondrial sheath assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9D9D3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A1A5B6-1",
        "uniprot_id": "TBC25_MOUSE",
        "mass": 82575.0,
        "length": 742,
        "protein_name": "TBC1 domain family member 25",
        "gene_name": "Tbc1d25",
        "organism": "Mouse",
        "refseq_name": "TBC1 domain family member 25 isoform 2",
        "refseq_ac": "NP_001159909",
        "gene_names_uniprotkb": "Tbc1d25",
        "gene_names_refseq": "6330576A08Rik; DXHXS7927e; Oatl1; Tbc1d25",
        "protein_names_uniprotkb": "TBC1 domain family member 25",
        "protein_names_refseq": "TBC1 domain family member 25 isoform 2; ornithine aminotransferase-like 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:209815);  (R-MMU-8854214)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "21183079;21383079;21750661;32210723;36710714",
        "class_list": "",
        "function": "Acts as a GTPase-activating protein specific for RAB33B. Involved in the regulation of autophagosome maturation, the process in which autophagosomes fuse with endosomes and lysosomes., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; OATL1 has a role in autophagy., [RefSeq, PubMed]; TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway. Publication Status: Online-Only, [RefSeq, PubMed]; TBC1D25 alleviates nonalcoholic steatohepatitis by inhibiting abnormal lipid accumulation and inflammation., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BIM6;Q8BIW8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0008483 transaminase activity",
        "go_cellular_component": "GO:0031410 cytoplasmic vesicle;GO:0005776 autophagosome",
        "go_biological_process": "GO:0006914 autophagy;GO:1901096 regulation of autophagosome maturation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "A1A5B6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99JT2-1",
        "uniprot_id": "STK26_MOUSE",
        "mass": 46614.0,
        "length": 416,
        "protein_name": "Serine/threonine-protein kinase 26",
        "gene_name": "Stk26",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase 26 isoform 2",
        "refseq_ac": "NP_001300673",
        "gene_names_uniprotkb": "Stk26; 2610018G03Rik; Mst4",
        "gene_names_refseq": "2610018G03Rik; Mst4; Stk26",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase 26; 2.7.11.1; MST-4; Mammalian STE20-like protein kinase 4; STE20-like kinase MST4; Serine/threonine-protein kinase MST4",
        "protein_names_refseq": "Mst3 and SOK1-related kinase; STE20-like kinase MST4; mammalian STE20-like protein kinase 4; serine/threonine-protein kinase 26 isoform 2; serine/threonine-protein kinase 26; serine/threonine-protein kinase MST4",
        "tax_id": 10090,
        "disease": "cerebral cavernous malformation (Disease Ontology:DOID:0060669); nervous system disease (Disease Ontology:DOID:863)",
        "pathway": " (mmu:70415);  (R-MMU-111465)",
        "pathway_count": 2,
        "publication_count": 6,
        "publication_id_list": "21183079;21750661;25642822;31722252;37833401;38579991",
        "class_list": "",
        "function": "Findings reveal a mechanism by which TRAF6 is regulated and highlight a role for MST4 in limiting inflammatory responses., [RefSeq, PubMed]; MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages. Erratum:[Cell Mol Immunol. 2023 Dec;20(12):1533. doi: 10.1038/s41423-023-01094-x. PMID: 37907780], [RefSeq, PubMed]; MST4 modulates the neuro-inflammatory response by regulating IkappaBalpha signaling pathway and affects the early outcome of experimental ischemic stroke in mice., [RefSeq, PubMed]; Mst4, a novel cardiac STRIPAK complex-associated kinase, regulates cardiomyocyte growth and survival and is upregulated in human cardiomyopathy., [RefSeq, PubMed]; Serine/threonine-protein kinase that acts as a mediator of cell growth. Modulates apoptosis. In association with STK24 negatively regulates Golgi reorientation in polarized cell migration upon RHO activation. Phosphorylates ATG4B at 'Ser-383', thereby increasing autophagic flux. Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 9,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;3.4.22.56;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0004672 protein kinase activity;GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005737 cytoplasm;GO:0005794 Golgi apparatus;GO:0005798 Golgi-associated vesicle;GO:0005829 cytosol",
        "go_biological_process": "GO:0006468 protein phosphorylation;GO:0035556 intracellular signal transduction;GO:0006915 apoptotic process;GO:0030336 negative regulation of cell migration;GO:0046777 protein autophosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q99JT2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CUU3-1",
        "uniprot_id": "SYCP2_MOUSE",
        "mass": 172123.0,
        "length": 1500,
        "protein_name": "Synaptonemal complex protein 2",
        "gene_name": "Sycp2",
        "organism": "Mouse",
        "refseq_name": "synaptonemal complex protein 2",
        "refseq_ac": "NP_796165",
        "gene_names_uniprotkb": "Sycp2; Scp2",
        "gene_names_refseq": "3830402K23Rik; 4930518F03Rik; Sycp2",
        "protein_names_uniprotkb": "Synaptonemal complex protein 2; SCP-2; Synaptonemal complex lateral element protein",
        "protein_names_refseq": "SCP-2; synaptonemal complex lateral element protein; synaptonemal complex protein 2",
        "tax_id": 10090,
        "disease": "spermatogenic failure 1 (Disease Ontology:DOID:0070188)",
        "pathway": " (mmu:320558)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "11463847;15237206;15870106;16717126;18316482;21183079;21750661;22346761",
        "class_list": "",
        "function": "Major component of the axial/lateral elements of synaptonemal complexes (SCS) during meiotic prophase. Plays a role in the assembly of synaptonemal complexes (PubMed:16717126). Required for normal meiotic chromosome synapsis during oocyte and spermatocyte development and for normal male and female fertility (PubMed:16717126). Required for insertion of SYCP3 into synaptonemal complexes (PubMed:16717126). May be involved in the organization of chromatin by temporarily binding to DNA scaffold attachment regions. Requires SYCP3, but not SYCP1, in order to be incorporated into the axial/lateral elements., [UniProtKB, PubMed, PubMed]; SYCP2 and SYCP3 proteins function in the specificity of chromatin attachment to the chromosome core, [RefSeq, PubMed]; SYCP2 are not required for centromere cohesion at the metaphase-I stage in male germ cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 33,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AJW2;Q1G7B6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0000779 condensed chromosome, centromeric region;GO:0000800 lateral element;GO:0000795 synaptonemal complex",
        "go_biological_process": "GO:0009566 fertilization;GO:0043066 negative regulation of apoptotic process;GO:0051301 cell division;GO:0009887 animal organ morphogenesis;GO:0007143 female meiotic nuclear division",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q9CUU3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C1E7-1",
        "uniprot_id": "TACAN_MOUSE",
        "mass": 40751.0,
        "length": 343,
        "protein_name": "Transmembrane protein 120A",
        "gene_name": "Tmem120a",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 120A",
        "refseq_ac": "NP_766129",
        "gene_names_uniprotkb": "Tmem120a; Net29; Tacan",
        "gene_names_refseq": "2010310D06Rik; Tmem120a; Tmpit",
        "protein_names_uniprotkb": "Transmembrane protein 120A; Ion channel TACAN",
        "protein_names_refseq": "ion channel TACAN; transmembrane protein 120A; transmembrane protein induced by tumor necrosis factor alpha",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:215210)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "20091084;21750661;26024229;32084332;34374644;34409941;34731626;35013224;35027552;35819364;39147733",
        "class_list": "",
        "function": "Genomic loci mispositioning in Tmem120a knockout mice yields latent lipodystrophy. Publication Status: Online-Only, [RefSeq, PubMed]; It is possible that the TMEM120A and B fat-specific nuclear envelope transmembrane proteins may play a contributory role in the tissue-specific pathology of this disorder or in the wider problem of obesity. Publication Status: Online-Only, [RefSeq, PubMed]; Multifunctional protein involved in mechanosensation, and plays an essential role in lipid metabolism and adipocyte differentiation (PubMed:26024229, PubMed:32084332, PubMed:34731626, PubMed:35027552, PubMed:39147733). May function as a potential ion channel involved in sensing mechanical stimuli (By similarity). Mediates the mechanosensitivity of the PKD2-TMEM120A channel complex through direct physical interaction (By similarity). TMEM120A seems to affect mechanosensation by inhibiting PIEZO2 channels, possibly by altering cellular lipid content (PubMed:35819364, PubMed:39147733). TMEM120A is structurally similar to a lipid-modifying enzyme, ELOVL7, and contains a bound coenzyme A molecule, which suggests it might function as an enzyme in lipid metabolism (PubMed:34374644)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed]; TACAN Is an Ion Channel Involved in Sensing Mechanical Pain., [RefSeq, PubMed]; TMEM120A contains a specific coenzyme A-binding site and might not mediate poking- or stretch-induced channel activities in cells. Publication Status: Online-Only, [RefSeq, PubMed]; TMEM120A/TACAN inhibits mechanically activated PIEZO2 channels., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BWP7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0120225 coenzyme A binding;GO:0005216 monoatomic ion channel activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0005637 nuclear inner membrane",
        "go_biological_process": "GO:0051260 protein homooligomerization;GO:0051291 protein heterooligomerization;GO:0034220 monoatomic ion transmembrane transport;GO:0045444 fat cell differentiation;GO:0050966 detection of mechanical stimulus involved in sensory perception of pain",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8C1E7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R3D1-1",
        "uniprot_id": "TBC13_MOUSE",
        "mass": 46453.0,
        "length": 400,
        "protein_name": "TBC1 domain family member 13",
        "gene_name": "Tbc1d13",
        "organism": "Mouse",
        "refseq_name": "TBC1 domain family member 13",
        "refseq_ac": "NP_666364",
        "gene_names_uniprotkb": "Tbc1d13",
        "gene_names_refseq": "2600014A06Rik; Tbc1d13",
        "protein_names_uniprotkb": "TBC1 domain family member 13",
        "protein_names_refseq": "TBC1 domain family member 13",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:70296);  (R-MMU-8854214)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "21750661;22762500;34428180",
        "class_list": "",
        "function": "Acts as a GTPase-activating protein for RAB35. Together with RAB35 may be involved in regulation of insulin-induced glucose transporter SLC2A4/GLUT4 translocation to the plasma membrane in adipocytes., [UniProtKB, PubMed]; TBC1D13 is a potent inhibitor of insulin-stimulated GLUT4 translocation in adipocytes., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0031267 small GTPase binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016020 membrane",
        "go_biological_process": "GO:0006886 intracellular protein transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8R3D1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P05214-1",
        "uniprot_id": "TBA3_MOUSE",
        "mass": 49960.0,
        "length": 450,
        "protein_name": "Tubulin alpha-3 chain",
        "gene_name": "Tuba3a; Tuba3b",
        "organism": "Mouse",
        "refseq_name": "tubulin alpha-3 chain",
        "refseq_ac": "NP_033472",
        "gene_names_uniprotkb": "Tuba3a; Tuba3b; Tuba3; Tuba7",
        "gene_names_refseq": "M[a]3; Tuba3a; Tuba3",
        "protein_names_uniprotkb": "Tubulin alpha-3 chain; 3.6.5.-; Alpha-tubulin 3/7; Alpha-tubulin isotype M-alpha-3/7; Tubulin alpha-3/alpha-7 chain",
        "protein_names_refseq": "alpha-tubulin 3/7; alpha-tubulin isotype M-alpha-3/7; tubulin alpha-3 chain; tubulin, alpha 3",
        "tax_id": 10090,
        "disease": "lissencephaly (Disease Ontology:DOID:0050453); polymicrogyria (Disease Ontology:DOID:0080918); lissencephaly 3 (Disease Ontology:DOID:0112232); microlissencephaly (Disease Ontology:DOID:0112234); keratoconus (Disease Ontology:DOID:10126)",
        "pathway": " (mmu:22144);  (mmu:22147);  (R-MMU-190840);  (R-MMU-2132295);  (R-MMU-2467813);  (R-MMU-2500257);  (R-MMU-3371497);  (R-MMU-380320);  (R-MMU-437239);  (R-MMU-5610787);  (R-MMU-5620920);  (R-MMU-5620924);  (R-MMU-5626467);  (R-MMU-5663220);  (R-MMU-6807878);  (R-MMU-6811434);  (R-MMU-6811436);  (R-MMU-68877);  (R-MMU-8852276);  (R-MMU-8955332);  (R-MMU-9646399);  (R-MMU-9648025);  (R-MMU-9668328);  (R-MMU-983189);  (R-MMU-9833482)",
        "pathway_count": 25,
        "publication_count": 17,
        "publication_id_list": "15890843;16954346;19524510;19564401;23897886;26446751;27102488;29146868;33300544;33414192;35820727;37295417;37828378;3785200;37989994;39627609;39927985",
        "class_list": "",
        "function": "Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.6.5.-;6.3.2.-;6.-.-.-;3.6.5.2;3.6.5.3;2.7.11.1;2.4.1.41;3.6.1.5;2.7.11.11;3.6.4.10;2.7.11.22;2.7.11.23;3.6.5.4;5.6.1.6;3.6.4.-;5.2.1.8;5.6.1.3;3.6.5.5;3.4.22.49;3.1.3.16;3.6.1.-;2.7.10.2;2.7.11.21;3.6.1.15;3.4.21.-;3.6.4.12;3.6.-.-;2.3.1.108;3.1.2.-;3.5.1.-;3.5.1.124;2.3.1.-;2.7.11.26;2.3.2.-;3.1.11.-;5.6.1.1;5.3.99.3",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0005525 GTP binding;GO:0016787 hydrolase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005874 microtubule;GO:0005929 cilium;GO:0015630 microtubule cytoskeleton;GO:0036126 sperm flagellum",
        "go_biological_process": "GO:0000278 mitotic cell cycle;GO:0030317 flagellated sperm motility;GO:0000226 microtubule cytoskeleton organization;GO:0036098 male germ-line stem cell population maintenance",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "P05214-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P68369-1",
        "uniprot_id": "TBA1A_MOUSE",
        "mass": 50136.0,
        "length": 451,
        "protein_name": "Tubulin alpha-1A chain",
        "gene_name": "Tuba1a",
        "organism": "Mouse",
        "refseq_name": "tubulin alpha-1A chain",
        "refseq_ac": "NP_035783",
        "gene_names_uniprotkb": "Tuba1a; Tuba1",
        "gene_names_refseq": "Tuba-1; Tuba1a; Tuba1",
        "protein_names_uniprotkb": "Tubulin alpha-1A chain; 3.6.5.-; Alpha-tubulin 1; Alpha-tubulin isotype M-alpha-1; Tubulin alpha-1 chain",
        "protein_names_refseq": "Talpha1 alpha-tubulin; alpha-tubulin 1; alpha-tubulin isotype M-alpha-1; tubulin alpha-1 chain; tubulin alpha-1A chain; tubulin, alpha 1",
        "tax_id": 10090,
        "disease": "lissencephaly (Disease Ontology:DOID:0050453); polymicrogyria (Disease Ontology:DOID:0080918); lissencephaly 3 (Disease Ontology:DOID:0112232); microlissencephaly (Disease Ontology:DOID:0112234); microcephaly (Disease Ontology:DOID:10907); Down syndrome (Disease Ontology:DOID:14250); congenital nervous system abnormality (Disease Ontology:DOID:2490)",
        "pathway": " (mmu:22142);  (R-MMU-190840);  (R-MMU-2132295);  (R-MMU-2467813);  (R-MMU-2500257);  (R-MMU-2565942);  (R-MMU-3371497);  (R-MMU-380259);  (R-MMU-380270);  (R-MMU-380284);  (R-MMU-380320);  (R-MMU-437239);  (R-MMU-5610787);  (R-MMU-5620912);  (R-MMU-5620920);  (R-MMU-5620924);  (R-MMU-5626467);  (R-MMU-5663220);  (R-MMU-6807878);  (R-MMU-6811434);  (R-MMU-6811436);  (R-MMU-68877);  (R-MMU-8852276);  (R-MMU-8854518);  (R-MMU-8955332);  (R-MMU-9646399);  (R-MMU-9648025);  (R-MMU-9668328);  (R-MMU-983189);  (R-MMU-9833482)",
        "pathway_count": 30,
        "publication_count": 31,
        "publication_id_list": "10.1101/2023.09.13.557529;11465105;15890843;16954346;18250455;19224205;19524510;19564401;1967194;20173027;20665223;22645316;23897886;24788674;25605945;26446751;26495903;26740625;27102488;29146868;33300544;33414192;33725478;34428180;34887587;35984892;36210013;3785200;37865089;37873730;3839797",
        "class_list": "",
        "function": "TUBA1A licenses APC/C-mediated mitotic progression to drive glioblastoma growth by inhibiting PLK3., [RefSeq, PubMed]; Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (By similarity). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms (By similarity). Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 7,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P02551;P05210;P05212;Q3TGF0;Q3TIW2;Q3TPJ1;Q3ULN1;Q5XJF8",
        "ec_number_list": "3.6.5.-;6.3.2.-;6.-.-.-;3.6.5.2;3.6.5.3;2.7.11.1;2.4.1.41;3.6.1.5;2.7.11.11;3.6.4.10;2.7.11.22;2.7.11.23;3.6.5.4;5.6.1.6;3.6.4.-;5.2.1.8;5.6.1.3;3.6.5.5;3.4.22.49;3.1.3.16;3.6.1.-;2.7.10.2;2.7.11.21;3.6.1.15;3.4.21.-;3.6.4.12;3.6.-.-;2.3.1.108;3.1.2.-;3.5.1.-;3.5.1.124;2.3.1.-;2.7.11.26;2.3.2.-;3.1.11.-;5.6.1.1;5.3.99.3",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0005525 GTP binding;GO:0008017 microtubule binding;GO:0016787 hydrolase activity;GO:0019904 protein domain specific binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005874 microtubule;GO:0005886 plasma membrane;GO:0005929 cilium",
        "go_biological_process": "GO:0046785 microtubule polymerization;GO:0021696 cerebellar cortex morphogenesis;GO:0001964 startle response;GO:0000278 mitotic cell cycle;GO:0006886 intracellular protein transport",
        "synthesized_glycan_count": 0,
        "hit_score": 3.6,
        "record_id": "P68369-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3TBT3-1",
        "uniprot_id": "STING_MOUSE",
        "mass": 42830.0,
        "length": 378,
        "protein_name": "Stimulator of interferon genes protein",
        "gene_name": "Sting1",
        "organism": "Mouse",
        "refseq_name": "stimulator of interferon genes protein isoform 2",
        "refseq_ac": "NP_001276520",
        "gene_names_uniprotkb": "Sting1; Eris; Mita; Mpys; Sting; Tmem173",
        "gene_names_refseq": "2610307O08Rik; ERIS; MPYS; Mita; STING-beta; STING; Sting1; Tmem173",
        "protein_names_uniprotkb": "Stimulator of interferon genes protein; ERIS; Endoplasmic reticulum interferon stimulator; MMITA; Mediator of IRF3 activation; Transmembrane protein 173; mSTING",
        "protein_names_refseq": "endoplasmic reticulum interferon stimulator; mitochondrial mediator of IRF3 activation; stimulator of interferon genes protein isoform 2; stimulator of interferon genes protein; stimulator of interferon protein; transmembrane protein 173",
        "tax_id": 10090,
        "disease": "STING-associated vasculopathy with onset in infancy (Disease Ontology:DOID:0111457); human immunodeficiency virus infectious disease (Disease Ontology:DOID:526)",
        "pathway": " (mmu:72512);  (R-MMU-1834941);  (R-MMU-3134975);  (R-MMU-3249367);  (R-MMU-3270619);  (R-MMU-6798695)",
        "pathway_count": 6,
        "publication_count": 31,
        "publication_id_list": "18559423;18724357;18818105;19433799;19776740;21750661;21892174;21947006;23258412;23519410;23722158;23910378;25636800;26229117;26300263;26669264;26740625;27324217;27637147;28529930;28930687;29056340;29496741;29973723;30568238;31346090;31992625;32999453;33397928;37832545;37916870",
        "class_list": "",
        "function": "A novel plasma membrane tetraspanner (MPYS) that is associated with type II major histocompatibility complex and mediates its transduction of death signals, is described., [RefSeq, PubMed]; Facilitator of innate immune signaling that acts as a sensor of cytosolic DNA from bacteria and viruses and promotes the production of type I interferon (IFN-alpha and IFN-beta) (PubMed:18818105, PubMed:19433799, PubMed:19776740, PubMed:26229117, PubMed:26669264, PubMed:27324217, PubMed:28529930, PubMed:29973723, PubMed:31346090). Innate immune response is triggered in response to non-CpG double-stranded DNA from viruses and bacteria delivered to the cytoplasm (PubMed:18818105, PubMed:19433799, PubMed:19776740, PubMed:26229117, PubMed:26669264). Acts by binding cyclic dinucleotides: recognizes and binds cyclic di-GMP (c-di-GMP), a second messenger produced by bacteria, cyclic UMP-AMP (2',3'-cUAMP), and cyclic GMP-AMP (cGAMP), a messenger produced by CGAS in response to DNA virus in the cytosol (PubMed:21947006, PubMed:23258412, PubMed:23519410, PubMed:23722158, PubMed:23910378). Upon binding to c-di-GMP, cUAMP or cGAMP, STING1 oligomerizes, translocates from the endoplasmic reticulum and is phosphorylated by TBK1 on the pLxIS motif, leading to recruitment and subsequent activation of the transcription factor IRF3 to induce expression of type I interferon and exert a potent anti-viral state (PubMed:25636800, PubMed:27324217, PubMed:29973723). Exhibits 2',3' phosphodiester linkage-specific ligand recognition: can bind both 2'-3' linked cGAMP (2'-3'-cGAMP) and 3'-3' linked cGAMP but is preferentially activated by 2'-3' linked cGAMP (PubMed:26300263). The preference for 2'-3'-cGAMP, compared to other linkage isomers is probably due to the ligand itself, which adopts an organized free-ligand conformation that resembles the STING1-bound conformation and pays low energy costs in changing into the active conformation (By similarity). In addition to promote the production of type I interferons, plays a direct role in autophagy (PubMed:30568238). Following cGAMP-binding, STING1 buds from the endoplasmic reticulum into COPII vesicles, which then form the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) (By similarity). The ERGIC serves as the membrane source for WIPI2 recruitment and LC3 lipidation, leading to formation of autophagosomes that target cytosolic DNA or DNA viruses for degradation by the lysosome (By similarity). Promotes autophagy by acting as a proton channel that directs proton efflux from the Golgi to facilitate MAP1LC3B/LC3B lipidation (By similarity). The autophagy- and interferon-inducing activities can be uncoupled and autophagy induction is independent of TBK1 phosphorylation (By similarity). Autophagy is also triggered upon infection by bacteria: following c-di-GMP-binding, which is produced by live Gram-positive bacteria, promotes reticulophagy (PubMed:29056340). May be involved in translocon function, the translocon possibly being able to influence the induction of type I interferons (By similarity). May be involved in transduction of apoptotic signals via its association with the major histocompatibility complex class II (MHC-II) (PubMed:18559423). Involved in intercellular immune signaling. Cross-activated by 2',3'-cGAMP previously generated in virus-infected cells, triggers type I interferon signaling in macrophages and uninfected neighboring cells to propagate and amplify the antiviral immune response., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; Identification, following expression cloning, of a molecule (STING; stimulator of interferon genes) that appears essential for effective innate immune signalling processes GeneRIF: STING (TMEM173) is an endoplasmic reticulum adaptor protein that facilitates innate immune signaling Erratum:[Nature. 2008 Nov 13;456(7219):274], [RefSeq, PubMed]; STING is essential for host defence against DNA pathogens such as HSV-1 and facilitates the adjuvant activity of DNA-based vaccines, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 20,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A7YGY9;Q3TAV5;Q3TYP5;Q3TZY8;Q3UJW3;Q8C227;Q8C5Q3;Q8K393;Q9CZY7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003713 transcription coactivator activity;GO:0019901 protein kinase binding;GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0031625 ubiquitin protein ligase binding",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0000421 autophagosome membrane;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005741 mitochondrial outer membrane",
        "go_biological_process": "GO:0071360 cellular response to exogenous dsRNA;GO:0002221 pattern recognition receptor signaling pathway;GO:0000045 autophagosome assembly;GO:0045087 innate immune response;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 3.2,
        "record_id": "Q3TBT3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5SVR0-1",
        "uniprot_id": "TBC9B_MOUSE",
        "mass": 141779.0,
        "length": 1263,
        "protein_name": "TBC1 domain family member 9B",
        "gene_name": "Tbc1d9b",
        "organism": "Mouse",
        "refseq_name": "TBC1 domain family member 9B isoform 2",
        "refseq_ac": "NP_001277688",
        "gene_names_uniprotkb": "Tbc1d9b; Kiaa0676",
        "gene_names_refseq": "Tbc1d9b",
        "protein_names_uniprotkb": "TBC1 domain family member 9B",
        "protein_names_refseq": "TBC1 domain family member 9B isoform 2",
        "tax_id": 10090,
        "disease": "nephrotic syndrome type 20 (Disease Ontology:DOID:0070357)",
        "pathway": " (mmu:76795)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;21183079;22645316;25428506;26495903;30084848;30779550;34428180",
        "class_list": "",
        "function": "May act as a GTPase-activating protein for Rab family protein(s)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UGF5;Q6A019;Q6P1G9;Q6PDP2;Q80ZU6;Q8C7K9;Q8CBR7;Q8CCW2;Q9CSQ2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0005509 calcium ion binding",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "GO:0003008 system process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q5SVR0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80T23-1",
        "uniprot_id": "SYTL5_MOUSE",
        "mass": 84089.0,
        "length": 753,
        "protein_name": "Synaptotagmin-like protein 5",
        "gene_name": "Sytl5",
        "organism": "Mouse",
        "refseq_name": "synaptotagmin-like protein 5 isoform 2",
        "refseq_ac": "NP_001277657",
        "gene_names_uniprotkb": "Sytl5; Slp5",
        "gene_names_refseq": "Sytl5; slp5",
        "protein_names_uniprotkb": "Synaptotagmin-like protein 5",
        "protein_names_refseq": "synaptotagmin-like protein 5 isoform 2; synaptotagmin-like protein 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:236643)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "12590134;21183079",
        "class_list": "",
        "function": "May act as Rab effector protein and play a role in vesicle trafficking. Binds phospholipids (By similarity)., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AF59;Q812E5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005543 phospholipid binding;GO:0008270 zinc ion binding;GO:0031267 small GTPase binding;GO:0042043 neurexin family protein binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0070382 exocytic vesicle",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0006887 exocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q80T23-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BP47-1",
        "uniprot_id": "SYNC_MOUSE",
        "mass": 64279.0,
        "length": 559,
        "protein_name": "Asparagine--tRNA ligase, cytoplasmic",
        "gene_name": "Nars1",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Nars1; Nars",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Asparagine--tRNA ligase, cytoplasmic; 6.1.1.22; AsnRS; Asparaginyl-tRNA synthetase 1; Asparaginyl-tRNA synthetase",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "autosomal dominant distal hereditary motor neuronopathy (Disease Ontology:DOID:0111198); Charcot-Marie-Tooth disease (Disease Ontology:DOID:10595)",
        "pathway": " (mmu:70223)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "21183079;21750661;23806337;33300544;35820727;37453647;37828378",
        "class_list": "",
        "function": "Catalyzes the attachment of asparagine to tRNA(Asn) in a two-step reaction: asparagine is first activated by ATP to form Asn-AMP and then transferred to the acceptor end of tRNA(Asn). In addition to its essential role in protein synthesis, acts as a signaling molecule that induced migration of CCR3-expressing cells. Has an essential role in the development of the cerebral cortex, being required for proper proliferation of radial glial cells., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3T9A7;Q7TPX0;Q9CRY5",
        "ec_number_list": "6.1.1.22",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0046983 protein dimerization activity;GO:0003676 nucleic acid binding;GO:0031728 CCR3 chemokine receptor binding;GO:0004816 asparagine-tRNA ligase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol",
        "go_biological_process": "GO:0016477 cell migration;GO:0021987 cerebral cortex development;GO:0006421 asparaginyl-tRNA aminoacylation;GO:0006412 translation;GO:0006418 tRNA aminoacylation for protein translation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q8BP47-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K0F1-1",
        "uniprot_id": "TBC23_MOUSE",
        "mass": 76426.0,
        "length": 684,
        "protein_name": "TBC1 domain family member 23",
        "gene_name": "Tbc1d23",
        "organism": "Mouse",
        "refseq_name": "TBC1 domain family member 23 isoform 2",
        "refseq_ac": "NP_080530",
        "gene_names_uniprotkb": "Tbc1d23",
        "gene_names_refseq": "4930451A13Rik; D030022P07Rik; Tbc1d23",
        "protein_names_uniprotkb": "TBC1 domain family member 23",
        "protein_names_refseq": "TBC1 domain family member 23 isoform 2",
        "tax_id": 10090,
        "disease": "pontocerebellar hypoplasia (Disease Ontology:DOID:0060264); pontocerebellar hypoplasia type 11 (Disease Ontology:DOID:0112324)",
        "pathway": " (mmu:67581)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "21183079;21750661;22312129;22645316;28823707;29084197;31219806;34428180;35820727;36210013",
        "class_list": "",
        "function": "Homozygous Truncating Variants in TBC1D23 gene are associated with Pontocerebellar Hypoplasia and Alter Cortical Development., [RefSeq, PubMed]; Putative Rab GTPase-activating protein which plays a role in vesicular trafficking. Involved in endosome-to-Golgi trafficking. Acts as a bridging protein by binding simultaneously to golgins, including GOLGA1 and GOLGA4, located at the trans-Golgi, and to the WASH complex, located on endosome-derived vesicles (PubMed:29084197). Together with WDR11 complex facilitates the golgin-mediated capture of vesicles generated using AP-1 (By similarity). Plays a role in brain development, including in cortical neuron positioning. May also be important for neurite outgrowth, possibly through its involvement in membrane trafficking and cargo delivery, 2 processes which are essential for axonal and dendritic growth (PubMed:28823707). May act as a general inhibitor of innate immunity signaling, strongly inhibiting multiple TLR and dectin/CLEC7A-signaling pathways. Does not alter initial activation events, but instead affects maintenance of inflammatory gene expression several hours after bacterial lipopolysaccharide (LPS) challenge (PubMed:22312129)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; We now show that Tbc1d23 is a general inhibitor of innate immunity signaling, strongly inhibiting multiple TLR and dectin-signaling pathways, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TAW9;Q8VE48",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005794 Golgi apparatus;GO:0005829 cytosol;GO:0031410 cytoplasmic vesicle;GO:0005802 trans-Golgi network;GO:0071203 WASH complex",
        "go_biological_process": "GO:0031175 neuron projection development;GO:0032755 positive regulation of interleukin-6 production;GO:0007420 brain development;GO:0050727 regulation of inflammatory response;GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q8K0F1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91VJ4-1",
        "uniprot_id": "STK38_MOUSE",
        "mass": 54174.0,
        "length": 465,
        "protein_name": "Serine/threonine-protein kinase 38",
        "gene_name": "Stk38",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase 38",
        "refseq_ac": "NP_598876",
        "gene_names_uniprotkb": "Stk38; Ndr1",
        "gene_names_refseq": "5830476G13Rik; 9530097A09Rik; Ndr1; Stk38",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase 38; 2.7.11.1; NDR1 protein kinase; Nuclear Dbf2-related kinase 1",
        "protein_names_refseq": "NDR1 protein kinase; nuclear Dbf2-related kinase 1; serine/threonine-protein kinase 38",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:106504);  (R-MMU-9013418);  (R-MMU-9013422)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "15037617;20551432;21183079;21730291;21750661;34699306;37028764",
        "class_list": "",
        "function": "Diet-induced induction of hepatic serine/threonine kinase STK38 triggers proinflammation and hepatic lipid accumulation., [RefSeq, PubMed]; Findings show a biological role for MICAL-1 in apoptosis and define a novel negative regulatory mechanism of MST-NDR signaling., [RefSeq, PubMed]; Molecular Mechanism of Biofilm Locator Protein Kinase Dbf2p-related kinase 1 in Regulating Innate Immune Response to Interleukin 17-induced Viral Pneumonia., [RefSeq, PubMed]; Reduction in the abundances of the NDR proteins NDR1 and NDR2 results in defective responses to proapoptotic stimuli, thereby facilitating the development of tumors Publication Status: Online-Only, [RefSeq, PubMed]; Serine/threonine-protein kinase that acts as a negative regulator of MAP3K1/2 signaling (PubMed:21730291). Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2 (By similarity). Acts as an ufmylation 'reader' in a kinase-independent manner: specifically recognizes and binds mono-ufmylated histone H4 in response to DNA damage, promoting the recruitment of SUV39H1 to the double-strand breaks, resulting in ATM activation (By similarity)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;3.6.4.-;2.7.11.39;2.3.1.-;3.6.1.-;2.3.2.27;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;3.1.4.-;3.1.4.35;2.7.11.38;3.6.5.2;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;3.6.4.13;2.7.1.150",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0031435 mitogen-activated protein kinase kinase kinase binding;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0035861 site of double-strand break",
        "go_biological_process": "GO:0006468 protein phosphorylation;GO:0035556 intracellular signal transduction;GO:0006974 DNA damage response;GO:0043407 negative regulation of MAP kinase activity;GO:0000077 DNA damage checkpoint signaling",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q91VJ4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P37804-1",
        "uniprot_id": "TAGL_MOUSE",
        "mass": 22576.0,
        "length": 201,
        "protein_name": "Transgelin",
        "gene_name": "Tagln",
        "organism": "Mouse",
        "refseq_name": "transgelin",
        "refseq_ac": "NP_035656",
        "gene_names_uniprotkb": "Tagln; Sm22a; Sm22",
        "gene_names_refseq": "Sm22a; Sm22; Tagln; Ws310",
        "protein_names_uniprotkb": "Transgelin; Actin-associated protein p27; SM22-alpha; Smooth muscle protein 22-alpha",
        "protein_names_refseq": "SM22-alpha; Sm22alpha; actin-associated protein p27; smooth muscle protein 22-alpha; transgelin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:21345)",
        "pathway_count": 1,
        "publication_count": 12,
        "publication_id_list": "18378184;21750661;23806337;24129315;26495903;28011936;2924801;30084848;34428180;37507081;7768949;8575061",
        "class_list": "",
        "function": "Actin cross-linking/gelling protein., [UniProtKB]; Involved in calcium-independent smooth muscle contraction Review article, [RefSeq, PubMed]; This gene encodes a smooth muscle cell-specific cytoskeletal protein. The encoded protein is structurally similar to calponin, an actin-binding protein. In mouse models of atherosclerosis the gene product may be involved in plaque cell and atherosclerotic lesion formation during atherogenesis. [provided by RefSeq, Mar 2010]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q545W0",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0030855 epithelial cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "P37804-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P61166-1",
        "uniprot_id": "TM258_MOUSE",
        "mass": 9079.0,
        "length": 79,
        "protein_name": "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258",
        "gene_name": "Tmem258",
        "organism": "Mouse",
        "refseq_name": "dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258 isoform 1",
        "refseq_ac": "NP_081195",
        "gene_names_uniprotkb": "Tmem258; 1810006K21Rik",
        "gene_names_refseq": "1810006K21Rik; Tmem258",
        "protein_names_uniprotkb": "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258; Oligosaccharyl transferase subunit TMEM258; Transmembrane protein 258",
        "protein_names_refseq": "UPF0197 transmembrane protein C11orf10 homolog; dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258 isoform 1; dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258; oligosaccharyl transferase subunit TMEM258",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69038);  (R-MMU-9768727);  (R-MMU-9931295)",
        "pathway_count": 3,
        "publication_count": 6,
        "publication_id_list": "21750661;25428506;27974209;30084848;30779550;34428180",
        "class_list": "",
        "function": "Subunit of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation (By similarity). N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits are required for a maximal enzyme activity. Involved in ER homeostasis in the colonic epithelium., [UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB]; We identify TMEM258 within this locus as a central regulator of intestinal inflammation. Strikingly, Tmem258 haploinsufficient mice exhibit severe intestinal inflammation in a model of colitis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D953;Q9Y2Q7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0062062 oligosaccharyltransferase complex binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0016020 membrane;GO:0005789 endoplasmic reticulum membrane;GO:0008250 oligosaccharyltransferase complex",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0006487 protein N-linked glycosylation;GO:0009306 protein secretion;GO:0034976 response to endoplasmic reticulum stress;GO:1904019 epithelial cell apoptotic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "P61166-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6A039-1",
        "uniprot_id": "TBC12_MOUSE",
        "mass": 76810.0,
        "length": 696,
        "protein_name": "TBC1 domain family member 12",
        "gene_name": "Tbc1d12",
        "organism": "Mouse",
        "refseq_name": "TBC1 domain family member 12 isoform 1",
        "refseq_ac": "NP_666064",
        "gene_names_uniprotkb": "Tbc1d12; Kiaa0608",
        "gene_names_refseq": "Tbc1d12",
        "protein_names_uniprotkb": "TBC1 domain family member 12",
        "protein_names_refseq": "TBC1 domain family member 12 isoform 1; TBC1 domain family member 12",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:209478)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "19144319;21183079;21750661;28384198;31219806;34428180;40885482",
        "class_list": "",
        "function": "RAB11A-binding protein that plays a role in neurite outgrowth., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RQS2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0019899 enzyme binding",
        "go_cellular_component": "GO:0055037 recycling endosome;GO:0005776 autophagosome;GO:0031410 cytoplasmic vesicle;GO:0005773 vacuole",
        "go_biological_process": "GO:0016192 vesicle-mediated transport;GO:2000785 regulation of autophagosome assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q6A039-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60707-1",
        "uniprot_id": "TBX2_MOUSE",
        "mass": 75081.0,
        "length": 711,
        "protein_name": "T-box transcription factor TBX2",
        "gene_name": "Tbx2",
        "organism": "Mouse",
        "refseq_name": "T-box transcription factor TBX2",
        "refseq_ac": "NP_033350",
        "gene_names_uniprotkb": "Tbx2",
        "gene_names_refseq": "Tbx2",
        "protein_names_uniprotkb": "T-box transcription factor TBX2; T-box protein 2",
        "protein_names_refseq": "T-box protein 2; T-box transcription factor TBX2",
        "tax_id": 10090,
        "disease": "vertebral anomalies and variable endocrine and T-cell dysfunction (Disease Ontology:DOID:0070345); depressive disorder (Disease Ontology:DOID:1596); cancer (Disease Ontology:DOID:162); heart septal defect (Disease Ontology:DOID:1681); atrial heart septal defect (Disease Ontology:DOID:1882)",
        "pathway": " (mmu:21385)",
        "pathway_count": 1,
        "publication_count": 19,
        "publication_id_list": "10770922;11867218;12023302;15459098;16222716;18025091;20485683;21183079;22186728;26486273;26971330;27720610;28910203;30599067;33731112;33795231;7920656;8853987;9710594",
        "class_list": "",
        "function": "Transcription factor which acts as a transcriptional repressor (PubMed:11867218, PubMed:12023302, PubMed:18025091, PubMed:22186728). May also function as a transcriptional activator (PubMed:11867218, PubMed:22186728, PubMed:26486273). Binds to the palindromic T site 5'-TTCACACCTAGGTGTGAA-3' DNA sequence, or a half-site, which are present in the regulatory region of several genes (PubMed:12023302, PubMed:26971330, PubMed:27720610, PubMed:33731112, PubMed:9710594). Required for cardiac atrioventricular canal formation (PubMed:15459098). May cooperate with NKX2.5 to negatively modulate expression of NPPA/ANF in the atrioventricular canal (PubMed:12023302). May play a role as a positive regulator of TGFB2 expression, perhaps acting in concert with GATA4 in the developing outflow tract myocardium (PubMed:22186728). Plays a role in limb pattern formation (PubMed:15459098). Acts as a transcriptional repressor of ADAM10 gene expression, perhaps in concert with histone deacetylase HDAC1 as cofactor (PubMed:30599067). Involved in branching morphogenesis in both developing lungs and adult mammary glands, via negative modulation of target genes; acting redundantly with TBX3 (PubMed:16222716, PubMed:27720610). Required, together with TBX3, to maintain cell proliferation in the embryonic lung mesenchyme; perhaps acting downstream of SHH, BMP and TGFbeta signaling (PubMed:27720610). Involved in modulating early inner ear development, acting independently of, and also redundantly with TBX3, in different subregions of the developing ear (PubMed:33795231). Acts as a negative regulator of PML function in cellular senescence (By similarity). Acts as a negative regulator of expression of CDKN1A/p21, IL33 and CCN4; repression of CDKN1A is enhanced in response to UV-induced stress, perhaps as a result of phosphorylation by p38 MAPK (PubMed:18025091, PubMed:33731112). Negatively modulates expression of CDKN2A/p19ARF and CDH1/E-cadherin (By similarity). Plays a role in induction of the epithelial-mesenchymal transition (EMT) (By similarity). Plays a role in melanocyte proliferation, perhaps via regulation of cyclin CCND1 (PubMed:26486273). Involved in melanogenesis, acting via negative modulation of expression of DHICA oxidase/TYRP1 and P protein/OCA2 (PubMed:26971330, PubMed:9710594). Involved in regulating retinal pigment epithelium (RPE) cell proliferation, perhaps via negatively modulating transcription of the transcription factor CEBPD (PubMed:28910203)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 7,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SSP7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0042826 histone deacetylase binding;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005667 transcription regulator complex;GO:0000785 chromatin",
        "go_biological_process": "GO:0001708 cell fate specification;GO:0036302 atrioventricular canal development;GO:0060379 cardiac muscle cell myoblast differentiation;GO:0097325 melanocyte proliferation;GO:0000122 negative regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "Q60707-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6U7R4-1",
        "uniprot_id": "TIMD4_MOUSE",
        "mass": 37548.0,
        "length": 343,
        "protein_name": "T-cell immunoglobulin and mucin domain-containing protein 4",
        "gene_name": "Timd4",
        "organism": "Mouse",
        "refseq_name": "T-cell immunoglobulin and mucin domain-containing protein 4 precursor",
        "refseq_ac": "NP_848874",
        "gene_names_uniprotkb": "Timd4; Tim4",
        "gene_names_refseq": "B430010N18Rik; TIM-4; Tim4; Timd4",
        "protein_names_uniprotkb": "T-cell immunoglobulin and mucin domain-containing protein 4; SMUCKLER; Spleen, mucin-containing, knockout of lymphotoxin protein; T-cell immunoglobulin mucin receptor 4; T-cell membrane protein 4; TIM-4; TIMD-4",
        "protein_names_refseq": "T-cell immunoglobulin and mucin domain-containing protein 4 precursor; T-cell immunoglobulin and mucin domain-containing protein 4; T-cell immunoglobulin mucin receptor 4; T-cell membrane protein 4; TIMD-4; smuckler; spleen, mucin-containing, knockout of lymphotoxin protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:276891)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "14768054;15793576;17513880;17960135;18083575;18354194;18367551;20368430;21183079;31263038;39036980",
        "class_list": "",
        "function": "Phosphatidylserine receptor that plays different role in immune response including phagocytosis of apoptotic cells and T-cell regulation (PubMed:17960135, PubMed:18354194, PubMed:18367551, PubMed:20368430). Involved in efferocytosis, the process by which apoptotic cells are removed by phagocytic cells by promoting the engulfment of apoptotic cells or exogenous particles (PubMed:17960135, PubMed:20368430). Mechanistically, acts by securing apoptotic cells to phagocytes through direct binding to phosphatidylserine present on apoptotic cells, while other engulfment receptors such as MERTK efficiently recognize apoptotic cells and mediate their ingestion (PubMed:17960135). Controls T-cell activation in a bimodal fashion, decreasing the activation of naive T-cells by inducing cell cycle arrest, while increasing proliferation of activated T-cells by activating AKT1 and ERK1/2 phosphorylations and subsequent signaling pathways (PubMed:18354194, PubMed:18367551). Also promotes autophagy process by suppressing NLRP3 inflammasome activity via activation of LKB1/PRKAA1 pathway in a phosphatidylserine-dependent mechanism (PubMed:31263038)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]; TIM-1-TIM-4 interaction is involved in regulating T cell proliferation., [RefSeq, PubMed]; The Ig domains of murine TIM1, 3 and 4 display calcium-dependent binding to carbohydrate ligands expressed by murine splenocytes and non-murine cell lines. Both homo- and heterotypic interactions were observed for binding between the TIM proteins., [RefSeq, PubMed]; Tim-4 alleviates acute hepatic injury by modulating homeostasis and function of NKT cells., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6U7R3;Q8CIC7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001786 phosphatidylserine binding",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "GO:0043277 apoptotic cell clearance;GO:0060097 cytoskeletal rearrangement involved in phagocytosis, engulfment",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q6U7R4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VCK3-1",
        "uniprot_id": "TBG2_MOUSE",
        "mass": 51122.0,
        "length": 451,
        "protein_name": "Tubulin gamma-2 chain",
        "gene_name": "Tubg2",
        "organism": "Mouse",
        "refseq_name": "tubulin gamma-2 chain",
        "refseq_ac": "NP_598789",
        "gene_names_uniprotkb": "Tubg2",
        "gene_names_refseq": "Tubg2; Tubgl",
        "protein_names_uniprotkb": "Tubulin gamma-2 chain; Gamma-2-tubulin",
        "protein_names_refseq": "gamma-2-tubulin; tubulin gamma-2 chain",
        "tax_id": 10090,
        "disease": "complex cortical dysplasia with other brain malformations 4 (Disease Ontology:DOID:0090138)",
        "pathway": " (mmu:103768);  (R-MMU-380270);  (R-MMU-380320)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "19648910;31219806",
        "class_list": "",
        "function": "Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (By similarity). Gamma-tubulin is a key component of the gamma-tubulin ring complex (gTuRC) which mediates microtubule nucleation (By similarity). The gTuRC regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments, a critical step in centrosome duplication and spindle formation (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005525 GTP binding;GO:0140490 microtubule nucleator activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005813 centrosome;GO:0005819 spindle;GO:0005874 microtubule",
        "go_biological_process": "GO:0000278 mitotic cell cycle;GO:0007020 microtubule nucleation;GO:0007052 mitotic spindle organization;GO:0000070 mitotic sister chromatid segregation;GO:0031122 cytoplasmic microtubule organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8VCK3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99MX7-1",
        "uniprot_id": "T121B_MOUSE",
        "mass": 58158.0,
        "length": 572,
        "protein_name": "Transmembrane protein 121B",
        "gene_name": "Tmem121b",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 121B",
        "refseq_ac": "NP_291045",
        "gene_names_uniprotkb": "Tmem121b; Cecr6",
        "gene_names_refseq": "Cecr6; Tmem121b",
        "protein_names_uniprotkb": "Transmembrane protein 121B; Cat eye syndrome critical region protein 6 homolog",
        "protein_names_refseq": "cat eye syndrome chromosome region, candidate 6 homolog; cat eye syndrome critical region protein 6 homolog; transmembrane protein 121B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:94047)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "11381032;17114649;21183079;33300544",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q99MX7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D915-1",
        "uniprot_id": "TCIM_MOUSE",
        "mass": 12215.0,
        "length": 106,
        "protein_name": "Transcriptional and immune response regulator",
        "gene_name": "Tcim",
        "organism": "Mouse",
        "refseq_name": "transcriptional and immune response regulator",
        "refseq_ac": "NP_081207",
        "gene_names_uniprotkb": "Tcim; Tc1",
        "gene_names_refseq": "1110065B09Rik; 1810011O10Rik; Tcim",
        "protein_names_uniprotkb": "Transcriptional and immune response regulator",
        "protein_names_refseq": "protein C8orf4 homolog; thyroid cancer-1; transcriptional and immune response regulator",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69068)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "18959821;24937306;25558895;25985737;27775060",
        "class_list": "",
        "function": "Seems to be involved in the regulation of cell growth an differentiation, may play different and opposite roles depending on the tissue or cell type. May enhance the WNT-CTNNB1 pathway by relieving antagonistic activity of CBY1. Enhances the proliferation of follicular dendritic cells. Plays a role in the mitogen-activated MAPK2/3 signaling pathway, positively regulates G1-to-S-phase transition of the cell cycle. In endothelial cells, enhances key inflammatory mediators and inflammatory response through the modulation of NF-kappaB transcriptional regulatory activity. Involved in the regulation of heat shock response, seems to play a positive feedback with HSF1 to modulate heat-shock downstream gene expression (By similarity). Plays a role in the regulation of hematopoiesis even if the mechanisms are unknown (PubMed:24937306). In cancers such as thyroid or lung cancer, it has been described as promoter of cell proliferation, G1-to-S-phase transition and inhibitor of apoptosis. However, it negatively regulates self-renewal of liver cancer cells via suppresion of NOTCH2 signaling (By similarity)., [UniProtKB, PubMed, UniProtKB]; TC1 was involved in the mitogen-activated ERK1/2 signaling pathway and positively regulated G(1)- to S-phase transition of the cell cycle.[TC1], [RefSeq, PubMed]; Tc1 mice express sleep-related phenotypes that are comparable with those seen in Down syndrome patients, [RefSeq, PubMed]; These data support that Tc1 is a novel regulator for adipose stem cells. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005112 Notch binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0043066 negative regulation of apoptotic process;GO:1901224 positive regulation of non-canonical NF-kappaB signal transduction;GO:0006355 regulation of DNA-templated transcription;GO:0006915 apoptotic process;GO:0034605 cellular response to heat",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q9D915-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99KF1-1",
        "uniprot_id": "TMED9_MOUSE",
        "mass": 27127.0,
        "length": 235,
        "protein_name": "Transmembrane emp24 domain-containing protein 9",
        "gene_name": "Tmed9",
        "organism": "Mouse",
        "refseq_name": "transmembrane emp24 domain-containing protein 9 precursor",
        "refseq_ac": "NP_080487",
        "gene_names_uniprotkb": "Tmed9; Gp25l2",
        "gene_names_refseq": "2400003B06Rik; Tmed9",
        "protein_names_uniprotkb": "Transmembrane emp24 domain-containing protein 9; Glycoprotein 25L2; p24 family protein alpha-2; p24alpha2",
        "protein_names_refseq": "glycoprotein 25L2; p24 family protein alpha-2; p24alpha2; transmembrane emp24 domain-containing protein 9 precursor; transmembrane emp24 domain-containing protein 9; transmembrane emp24 protein transport domain containing 9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:67511);  (R-MMU-6807878);  (R-MMU-6811434)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;18299400;21750661;23806337;26495903;28011936;30899004;34428180;37828378",
        "class_list": "",
        "function": "Appears to be involved in vesicular protein trafficking, mainly in the early secretory pathway. In COPI vesicle-mediated retrograde transport involved in the coatomer recruitment to membranes of the early secretory pathway. Increases coatomer-dependent activity of ARFGAP2. Thought to play a crucial role in the specific retention of p24 complexes in cis-Golgi membranes; specifically contributes to the coupled localization of TMED2 and TMED10 in the cis-Golgi network. May be involved in organization of intracellular membranes, such as of the ER-Golgi intermediate compartment and the Golgi apparatus. Involved in ER localization of PTPN2 (By similarity)., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 8621,
        "biomarker_type": "",
        "glycan_count": 22,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CX02",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019905 syntaxin binding",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0030134 COPII-coated ER to Golgi transport vesicle;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0048205 COPI coating of Golgi vesicle;GO:0006886 intracellular protein transport;GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport;GO:0010638 positive regulation of organelle organization;GO:0007030 Golgi organization",
        "synthesized_glycan_count": 0,
        "hit_score": 3.3,
        "record_id": "Q99KF1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A1Y9I9-1",
        "uniprot_id": "TOMT_MOUSE",
        "mass": 28846.0,
        "length": 258,
        "protein_name": "Transmembrane O-methyltransferase homolog",
        "gene_name": "Tomt",
        "organism": "Mouse",
        "refseq_name": "transmembrane O-methyltransferase homolog",
        "refseq_ac": "NP_001075148",
        "gene_names_uniprotkb": "Tomt; Comt2",
        "gene_names_refseq": "Comt2; F930017I19Rik; Tomt",
        "protein_names_uniprotkb": "Transmembrane O-methyltransferase homolog; 2.1.1.6; Catechol O-methyltransferase 2; mTOMT",
        "protein_names_refseq": "catechol O-methyltransferase 2; transmembrane O-methyltransferase homolog",
        "tax_id": 10090,
        "disease": "autosomal recessive nonsyndromic deafness 63 (Disease Ontology:DOID:0110515)",
        "pathway": " (mmu:791260);  (R-MMU-379397)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "18794526;18953341;28504928;28534737",
        "class_list": "",
        "function": "Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones (PubMed:18794526). Required for auditory function (PubMed:18794526, PubMed:28504928). Component of the cochlear hair cell's mechanotransduction (MET) machinery. Involved in the assembly of the asymmetric tip-link MET complex. Required for transportation of TMC1 and TMC2 proteins into the mechanically sensitive stereocilia of the hair cells. The function in MET is independent of the enzymatic activity (PubMed:28504928)., [UniProtKB, PubMed, PubMed]; Mice homozygous for a missense mutation in Comt2 show vestibular impairment, profound sensorineuronal deafness, and progressive degeneration of the organ of Corti, [RefSeq, PubMed]; These studies thus suggest functional diversification between mCOMT and mTOMT, where mTOMT is critical for the assembly of the mechanotransduction machinery of hair cells. Erratum:[Elife. 2017 Nov 08;6:e33307. doi: 10.7554/eLife.33307. PMID: 29116042] Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.1.1.6",
        "go_molecular_function": "GO:0016206 catechol O-methyltransferase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0045177 apical part of cell",
        "go_biological_process": "GO:1904591 positive regulation of protein import;GO:0032502 developmental process;GO:0007605 sensory perception of sound;GO:0042417 dopamine metabolic process;GO:0032259 methylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "A1Y9I9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9ESG4-1",
        "uniprot_id": "CLTRN_MOUSE",
        "mass": 25070.0,
        "length": 222,
        "protein_name": "Collectrin",
        "gene_name": "Cltrn",
        "organism": "Mouse",
        "refseq_name": "collectrin isoform 2",
        "refseq_ac": "NP_001300648",
        "gene_names_uniprotkb": "Cltrn; Nx17; Tmem27",
        "gene_names_refseq": "0610008J07Rik; Cltrn; NX-17; NX17; Tmem27",
        "protein_names_uniprotkb": "Collectrin; Transmembrane protein 27",
        "protein_names_refseq": "collectrin isoform 2; collectrin; kidney-specific membrane protein; transmembrane protein 27",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:57394)",
        "pathway_count": 1,
        "publication_count": 12,
        "publication_id_list": "10432394;11278314;16330323;16330324;16985211;17167413;19478081;19715677;21183079;21750661;21907142;31520464",
        "class_list": "",
        "function": "Plays an important role in amino acid transport by acting as binding partner of amino acid transporters SLC6A18 and SLC6A19, regulating their trafficking on the cell surface and their activity (PubMed:16985211, PubMed:17167413). May also play a role in trafficking of amino acid transporters SLC3A1 and SLC7A9 to the renal cortical cell membrane (PubMed:16985211). Regulator of SNARE complex function (PubMed:16330323). Stimulator of beta cell replication (PubMed:16330324)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; Tmem27 is a pancreatic beta cell transmembrane protein that regulates cell growth of pancreatic islets, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UFF6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0141109 transporter activator activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0031526 brush border membrane",
        "go_biological_process": "GO:0035493 SNARE complex assembly;GO:0051957 positive regulation of amino acid transport;GO:0089718 amino acid import across plasma membrane;GO:1905737 positive regulation of L-proline import across plasma membrane",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q9ESG4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B9EKI3-1",
        "uniprot_id": "TMF1_MOUSE",
        "mass": 121803.0,
        "length": 1091,
        "protein_name": "TATA element modulatory factor",
        "gene_name": "Tmf1",
        "organism": "Mouse",
        "refseq_name": "TATA element modulatory factor",
        "refseq_ac": "NP_001074580",
        "gene_names_uniprotkb": "Tmf1; Ara160; Gm153",
        "gene_names_refseq": "7030402D04Rik; Gm153; Tmf1`; Tmf1",
        "protein_names_uniprotkb": "TATA element modulatory factor; Androgen receptor coactivator 160 kDa protein; Androgen receptor-associated protein of 160 kDa; TMF",
        "protein_names_refseq": "TATA element modulatory factor; TMF; androgen receptor coactivator 160 kDa protein; androgen receptor-associated protein of 160 kDa",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:232286);  (R-MMU-6811440)",
        "pathway_count": 2,
        "publication_count": 16,
        "publication_id_list": "10.1101/2023.09.13.557529;15467733;16792503;17242355;20691678;21183079;21750661;22553199;23000399;24639530;25428506;26701263;30779550;33475194;34428180;9742951",
        "class_list": "",
        "function": "Absence of TMF/ARA160 renders the colonic mucus refractory to bacterial colonization and the large intestine less susceptible to the onset of colitis., [RefSeq, PubMed]; Altered mucus secretion in TMF(-/-) mouse colons is accompanied by a reprogrammed intestinal microbiota, leading to a transmissible reduced sensitivity to induced colitis., [RefSeq, PubMed]; Data from knockout mice suggest that TMF/ARA160 participates in control of serum testosterone levels in males, and its absence results in major testicular and epididymal defects and abnormal spermatogenesis and Leydig cell proliferation., [RefSeq, PubMed]; Potential coactivator of the androgen receptor. May play critical roles in two RAB6-dependent retrograde transport processes: one from endosomes to the Golgi and the other from the Golgi to the ER (By similarity). Mediates STAT3 degradation., [UniProtKB, PubMed]; TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3, [RefSeq, PubMed]; TMF/ARA160 is a key regulator which is essential for the onset of key events in the differentiation and maturation of mammalian sperm and whose absence severely compromises their ability to fertilize ova., [RefSeq, PubMed]; TMF1 is upregulated by insulin and is required for a sustained glucose homeostasis., [RefSeq, PubMed]; The microtubule interacting domain (MIT) domain in TMF, along with microtubule integrity, are required for stable association of TMF with the Golgi apparatus. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 17,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9803,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QPJ3;Q3UMH8;Q3UMR3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003713 transcription coactivator activity;GO:0050681 nuclear androgen receptor binding",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005634 nucleus;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0032275 luteinizing hormone secretion;GO:0006351 DNA-templated transcription;GO:0010629 negative regulation of gene expression;GO:0043066 negative regulation of apoptotic process;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "B9EKI3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q4VAE3-1",
        "uniprot_id": "TMM65_MOUSE",
        "mass": 24918.0,
        "length": 234,
        "protein_name": "Transmembrane protein 65",
        "gene_name": "Tmem65",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 65",
        "refseq_ac": "NP_780421",
        "gene_names_uniprotkb": "Tmem65",
        "gene_names_refseq": "2610029O13Rik; 4930438D12Rik; Tmem65",
        "protein_names_uniprotkb": "Transmembrane protein 65",
        "protein_names_refseq": "transmembrane protein 65",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74868)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "26403541;36257954;40200126",
        "class_list": "",
        "function": "Mitochondrial protein that plays a critical role in the sodium-dependent calcium efflux from mitochondrion (PubMed:40200126). The precise role of TMEM65 in mitochondrial sodium/calcium exchange is however unclear: TMEM65 associates with the SLC8B1/NCLX antiporter and probably promotes the sodium/calcium exchange mediated by SLC8B1/NCLX (By similarity). According to another report, TMEM65 functions as the mitochondrial sodium/calcium antiporter itself: homodimerization drives formation of a pocket capable of binding calcium (By similarity). Essential for maintaining proper cardiac intercalated disk (ICD) structure and function as well as cardiac conduction velocity in the heart (PubMed:36257954). Its association with SCN1B is required for stabilizing the perinexus in the ICD and for localization of GJA1 and SCN5A to the ICD (PubMed:26403541, PubMed:36257954)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; Tmem65 is an intercalated disc protein that interacts with and functionally regulates ventricular Cx43. Publication Status: Online-Only, [RefSeq, PubMed]; Tmem65 is critical for the structure and function of the intercalated discs in mouse hearts. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q810S8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005432 calcium:sodium antiporter activity",
        "go_cellular_component": "GO:0005730 nucleolus;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005886 plasma membrane;GO:0014704 intercalated disc",
        "go_biological_process": "GO:0003231 cardiac ventricle development;GO:1903779 regulation of cardiac conduction;GO:0061337 cardiac conduction;GO:0099093 calcium export from the mitochondrion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q4VAE3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64127-1",
        "uniprot_id": "TIF1A_MOUSE",
        "mass": 116657.0,
        "length": 1051,
        "protein_name": "Transcription intermediary factor 1-alpha",
        "gene_name": "Trim24",
        "organism": "Mouse",
        "refseq_name": "transcription intermediary factor 1-alpha isoform 2",
        "refseq_ac": "NP_001258993",
        "gene_names_uniprotkb": "Trim24; Tif1a; Tif1",
        "gene_names_refseq": "A130082H20Rik; D430004I05Rik; TIF1-alpha; TIF1alpha; TIF1; Tif1a; Trim24",
        "protein_names_uniprotkb": "Transcription intermediary factor 1-alpha; 2.3.2.27; E3 ubiquitin-protein ligase Trim24; RING-type E3 ubiquitin transferase TIF1-alpha; TIF1-alpha; Tripartite motif-containing protein 24",
        "protein_names_refseq": "E3 ubiquitin-protein ligase Trim24; RING-type E3 ubiquitin transferase TIF1-alpha; transcription intermediary factor 1-alpha isoform 2; transcription intermediary factor 1-alpha; transcriptional intermediary factor 1, alpha; tripartite motif-containing protein 24",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:21848)",
        "pathway_count": 1,
        "publication_count": 24,
        "publication_id_list": "10.1101/2023.09.13.557529;10610177;11313457;16322096;16880268;17242355;17412818;18026104;18287084;19556538;19909775;21183079;21750661;24129315;34428180;34508101;34678516;35653796;35803934;36852467;37326695;40997131;7744009;8978696",
        "class_list": "",
        "function": "Decrease in Tripartite Motif Containing 24 suppresses hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/mammalian target of rapamycin complex 1 pathway., [RefSeq, PubMed]; Loss of TRIM24 promotes IL-10 expression via CBP/p300-dependent IFNbeta1 transcription during macrophage activation., [RefSeq, PubMed]; Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer. Publication Status: Online-Only, [RefSeq, PubMed]; TRIM24 is an insulin-responsive regulator of P-bodies. Publication Status: Online-Only, [RefSeq, PubMed]; The protein encoded by this gene is part of the tripartite-motif containing family (TRIM), which are typified by the RING, B-box type 1, B-box type 2, and coiled-coil region domains. This protein, which also contains a PHD/TTC finger and bromodomain important for regulating nuclear receptors and binding chromatin, has important roles in differentiation, development, and tissue homeostasis. This protein has been reported to regulate the activity of the tumor suppressor p53 and of the retinoic acid receptor. A translocation event between this gene and Braf transforming gene, which results in the fusion protein T18, has been reported in hepatocellular carcinomas. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jan 2013]., [RefSeq]; Transcriptional coactivator that interacts with numerous nuclear receptors and coactivators and modulates the transcription of target genes. Interacts with chromatin depending on histone H3 modifications, having the highest affinity for histone H3 that is both unmodified at 'Lys-4' (H3K4me0) and acetylated at 'Lys-23' (H3K23ac) (By similarity). Has E3 protein-ubiquitin ligase activity. Promotes ubiquitination and proteasomal degradation of p53/TP53. Plays a role in the regulation of cell proliferation and apoptosis via its effects on p53/TP53 levels. Up-regulates ligand-dependent transcription activation by AR, GCR/NR3C1, thyroid hormone receptor (TR) and ESR1. Modulates transcription activation by retinoic acid (RA) receptors, such as RARA. Plays a role in regulating retinoic acid-dependent proliferation of hepatocytes. Required for normal transition from proliferating neonatal hepatocytes to quiescent adult hepatocytes., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 13,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 0,
        "glyco_site_count": 8,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q64126",
        "ec_number_list": "",
        "go_molecular_function": "GO:0034056 estrogen response element binding;GO:0003682 chromatin binding;GO:0003713 transcription coactivator activity;GO:0004672 protein kinase activity;GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005726 perichromatin fibrils;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0000785 chromatin",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006468 protein phosphorylation;GO:0008285 negative regulation of cell population proliferation;GO:0010628 positive regulation of gene expression;GO:0045892 negative regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 3.6,
        "record_id": "Q64127-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BXJ2-1",
        "uniprot_id": "TREF1_MOUSE",
        "mass": 132402.0,
        "length": 1205,
        "protein_name": "Transcriptional-regulating factor 1",
        "gene_name": "Trerf1",
        "organism": "Mouse",
        "refseq_name": "transcriptional-regulating factor 1 isoform 1",
        "refseq_ac": "NP_001091092",
        "gene_names_uniprotkb": "Trerf1",
        "gene_names_refseq": "9430096I18Rik; B830015H24; RAPA; Trep-132; Trep132; Trerf1",
        "protein_names_uniprotkb": "Transcriptional-regulating factor 1; Transcriptional-regulating protein 132; Zinc finger transcription factor TReP-132",
        "protein_names_refseq": "transcriptional regulating protein 132; transcriptional-regulating factor 1 isoform 1; zinc finger transcription factor TReP-132",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:224829)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "12556907;20173027;21183079;23806337;31219806;35820727",
        "class_list": "",
        "function": "Binds DNA and activates transcription of CYP11A1. Interaction with CREBBP and EP300 results in a synergistic transcriptional activation of CYP11A1., [UniProtKB, UniProtKB]; Cloning and characterization; expression of both mTReP-132 and P450scc provides anatomical evidence that mTReP-132 may regulate this key steroidogenic enzyme within specific regions of the brain involved in behavioral and psychiatric disorders, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q32NY5;Q6PCQ4;Q80X25;Q810H8;Q8BY31",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003713 transcription coactivator activity;GO:0008270 zinc ion binding;GO:0003714 transcription corepressor activity;GO:0033142 nuclear progesterone receptor binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0001650 fibrillar center;GO:0005667 transcription regulator complex",
        "go_biological_process": "GO:0071393 cellular response to progesterone stimulus;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0045892 negative regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q8BXJ2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C0V0-1",
        "uniprot_id": "TLK1_MOUSE",
        "mass": 86624.0,
        "length": 766,
        "protein_name": "Serine/threonine-protein kinase tousled-like 1",
        "gene_name": "Tlk1",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase tousled-like 1 isoform 1",
        "refseq_ac": "NP_766252",
        "gene_names_uniprotkb": "Tlk1",
        "gene_names_refseq": "4930545J15Rik; Tlk1",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase tousled-like 1; 2.7.11.1; Tousled-like kinase 1",
        "protein_names_refseq": "serine/threonine-protein kinase tousled-like 1 isoform 1; serine/threonine-protein kinase tousled-like 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:228012)",
        "pathway_count": 1,
        "publication_count": 14,
        "publication_id_list": "10.1101/2023.09.13.557529;10523312;16156902;21183079;25153642;25605945;28135057;31219806;32445866;34428180;37462140;38111505;38498343;39927985",
        "class_list": "",
        "function": "CircTLK1 alleviates oxygen-glucose deprivation/reperfusion induced apoptosis in HK-2 cells through miR-136-5p/Bcl2 signal axis., [RefSeq, PubMed]; CircTLK1: A novel regulator involved in VSMC phenotypic switching and the developmental process of atherosclerosis., [RefSeq, PubMed]; Rapidly and transiently inhibited by phosphorylation following the generation of DNA double-stranded breaks during S-phase. This is cell cycle checkpoint and ATM-pathway dependent and appears to regulate processes involved in chromatin assembly (By similarity). Isoform 3 protects the cells from the ionizing radiation by facilitating the repair of DSBs. In vitro, phosphorylates histone H3 at 'Ser-10' (By similarity)., [UniProtKB, PubMed]; The circular RNA TLK1 exacerbates myocardial ischemia/reperfusion injury via targeting miR-214/RIPK1 through TNF signaling pathway. Erratum:[Free Radic Biol Med. 2022 Feb 1;179:435-436. doi: 10.1016/j.freeradbiomed.2021.03.012. PMID: 33985875], [RefSeq, PubMed]; Tousled-like kinase 1 promotes gastric cancer progression by regulating the tumor growth factor-beta signaling pathway., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 9,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm",
        "go_biological_process": "GO:0006468 protein phosphorylation;GO:0006886 intracellular protein transport;GO:0007059 chromosome segregation;GO:0035556 intracellular signal transduction;GO:0006974 DNA damage response",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "Q8C0V0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R4P5-1",
        "uniprot_id": "TMC1_MOUSE",
        "mass": 87264.0,
        "length": 757,
        "protein_name": "Transmembrane channel-like protein 1",
        "gene_name": "Tmc1",
        "organism": "Mouse",
        "refseq_name": "transmembrane channel-like protein 1 isoform 2",
        "refseq_ac": "NP_083229",
        "gene_names_uniprotkb": "Tmc1; Bth; dn",
        "gene_names_refseq": "4933416G09Rik; Beethoven; Bth; CWEA1; TMC1ex1; Tmc1; dn",
        "protein_names_uniprotkb": "Transmembrane channel-like protein 1; Beethoven protein; Deafness protein; Transmembrane cochlear-expressed protein 1",
        "protein_names_refseq": "deafness protein; transmembrane channel-like protein 1 isoform 2; transmembrane channel-like protein 1; transmembrane cochlear-expressed protein 1; transmembrane, cochlear expressed 1",
        "tax_id": 10090,
        "disease": "autosomal recessive nonsyndromic deafness 7 (Disease Ontology:DOID:0110520); autosomal dominant nonsyndromic deafness 36 (Disease Ontology:DOID:0110563); sensorineural hearing loss (Disease Ontology:DOID:10003)",
        "pathway": " (mmu:13409)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "11850618;11850623;12812529;21750661;23871232;25114259;28663585;30138589;34089643;36191207;38228630",
        "class_list": "",
        "function": "Pore-forming subunit of the mechanotransducer (MET) non-selective cation channel complex located at the tips of stereocilia of cochlear hair cells and that mediates sensory transduction in the auditory system (PubMed:11850618, PubMed:23871232, PubMed:30138589, PubMed:36191207). The MET complex is composed of two dimeric pore-forming ion-conducting transmembrane TMC (TMC1 or TMC2) subunits, several auxiliary proteins including LHFPL5, TMIE, CIB2/3 and TOMT, the tip-link PCDH15, and possibly the PIEZO subunits (PubMed:30138589, PubMed:36191207). MET channel is activated by tension in the tip-link extending from the side wall of one stereocilium to the tip of the adjacent shorter stereocilium, where the channel is located (PubMed:30138589, PubMed:36191207). TMC1 MET channel is highly permeable to calcium and likely transports monovalent cations (PubMed:23871232, PubMed:30138589, PubMed:36191207). Also involved in vestibular hair cells transduction current (PubMed:23871232)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 16,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TQB2;Q9D435",
        "ec_number_list": "2.7.11.1",
        "go_molecular_function": "GO:0005262 calcium channel activity;GO:0008381 mechanosensitive monoatomic ion channel activity;GO:0005245 voltage-gated calcium channel activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009897 external side of plasma membrane;GO:0032426 stereocilium tip;GO:0032420 stereocilium",
        "go_biological_process": "GO:0060005 vestibular reflex;GO:0050910 detection of mechanical stimulus involved in sensory perception of sound;GO:0070588 calcium ion transmembrane transport;GO:1903169 regulation of calcium ion transmembrane transport;GO:0060117 auditory receptor cell development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8R4P5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91ZE0-1",
        "uniprot_id": "TMLH_MOUSE",
        "mass": 49610.0,
        "length": 421,
        "protein_name": "Trimethyllysine dioxygenase, mitochondrial",
        "gene_name": "Tmlhe",
        "organism": "Mouse",
        "refseq_name": "trimethyllysine dioxygenase, mitochondrial precursor",
        "refseq_ac": "NP_620097",
        "gene_names_uniprotkb": "Tmlhe; Tmlh",
        "gene_names_refseq": "Bbox2; D430017M14Rik; TMLD; TMLH; Tmlhe",
        "protein_names_uniprotkb": "Trimethyllysine dioxygenase, mitochondrial; 1.14.11.8; Epsilon-trimethyllysine 2-oxoglutarate dioxygenase; TML dioxygenase; TML hydroxylase; TML-alpha-ketoglutarate dioxygenase; TMLD",
        "protein_names_refseq": "TML dioxygenase; TML hydroxylase; TML-alpha-ketoglutarate dioxygenase; butyrobetaine (gamma), 2-oxoglutarate dioxygenase 2 (gamma-butyrobetaine hydroxylase); epsilon-trimethyllysine 2-oxoglutarate dioxygenase; trimethyllysine dioxygenase, mitochondrial precursor; trimethyllysine dioxygenase, mitochondrial",
        "tax_id": 10090,
        "disease": "autistic disorder (Disease Ontology:DOID:12849)",
        "pathway": " (mmu:192289)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "11431483;15754339;17408883;22645316;23576753;37553674",
        "class_list": "",
        "function": "C-terminal region of TMLH contains the main determinants for its enzymatic activity including a key H389 residue, [RefSeq, PubMed]; Converts trimethyllysine (TML) into hydroxytrimethyllysine (HTML) in the carnitine biosynthesis pathway., [UniProtKB, PubMed]; Knockout of Tmlhe in mice is not associated with autism spectrum disorder phenotypes or motor dysfunction despite low carnitine levels. Publication Status: Online-Only, [RefSeq, PubMed]; TMLH expression is present at E12.5 dpc in the liver, lung and brain, and is then maintained in the postnatal brain with a specific neuronal pattern., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TSX6;Q3UMX1;Q91XH1",
        "ec_number_list": "1.14.11.8",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0016702 oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;GO:0050353 trimethyllysine dioxygenase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005759 mitochondrial matrix",
        "go_biological_process": "GO:0045329 carnitine biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q91ZE0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99NH8-1",
        "uniprot_id": "TREM2_MOUSE",
        "mass": 24527.0,
        "length": 227,
        "protein_name": "Triggering receptor expressed on myeloid cells 2",
        "gene_name": "Trem2",
        "organism": "Mouse",
        "refseq_name": "triggering receptor expressed on myeloid cells 2 isoform 2 precursor",
        "refseq_ac": "NP_001259007",
        "gene_names_uniprotkb": "Trem2; Trem2a; Trem2b; Trem2c",
        "gene_names_refseq": "TREM-2; Trem2a; Trem2b; Trem2c; Trem2",
        "protein_names_uniprotkb": "Triggering receptor expressed on myeloid cells 2; TREM-2; Triggering receptor expressed on monocytes 2",
        "protein_names_refseq": "triggering receptor expressed on monocytes 2; triggering receptor expressed on myeloid cells 2 isoform 2 precursor; triggering receptor expressed on myeloid cells 2a; triggering receptor expressed on myeloid cells 2b; triggering receptor expressed on myeloid cells 2c",
        "tax_id": 10090,
        "disease": "Alzheimer's disease 17 (Disease Ontology:DOID:0110049); syphilis (Disease Ontology:DOID:4166); frontotemporal dementia (Disease Ontology:DOID:9255)",
        "pathway": " (mmu:83433);  (R-MMU-198933);  (R-MMU-2172127);  (R-MMU-2424491);  (R-MMU-416700)",
        "pathway_count": 5,
        "publication_count": 26,
        "publication_id_list": "10799849;11241283;12472885;12847223;15728241;16418779;16715077;18957693;24990881;25631124;27477018;28077724;28483841;28559417;28592261;28802038;28855301;29518356;29663649;29752066;29794134;29859094;30084848;30232263;30548312;30779550",
        "class_list": "",
        "function": "Forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:11241283). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia (PubMed:27477018, PubMed:29518356). Binding to amyloid-beta 42 mediates microglial activation, proliferation, migration, apoptosis and expression of pro-inflammatory cytokines, such as IL6R and CCL3, and the anti-inflammatory cytokine ARG1 (PubMed:27477018, PubMed:29518356). Acts as a receptor for lipoprotein particles such as LDL, VLDL, and HDL and for apolipoproteins such as APOA1, APOA2, APOB, APOE, APOE2, APOE3, APOE4, and CLU and enhances their uptake in microglia (PubMed:27477018). Binds phospholipids (preferably anionic lipids) such as phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol and sphingomyelin (By similarity). Regulates microglial proliferation by acting as an upstream regulator of the Wnt/beta-catenin signaling cascade (PubMed:28077724). Required for microglial phagocytosis of apoptotic neurons (PubMed:24990881). Also required for microglial activation and phagocytosis of myelin debris after neuronal injury and of neuronal synapses during synapse elimination in the developing brain (PubMed:15728241, PubMed:25631124, PubMed:28592261, PubMed:29752066). Regulates microglial chemotaxis and process outgrowth, and also the microglial response to oxidative stress and lipopolysaccharide (PubMed:28483841, PubMed:29663649, PubMed:29859094, PubMed:30232263). It suppresses PI3K and NF-kappa-B signaling in response to lipopolysaccharide; thus promoting phagocytosis, suppressing pro-inflammatory cytokine and nitric oxide production, inhibiting apoptosis and increasing expression of IL10 and TGFB (PubMed:29663649). During oxidative stress, it promotes anti-apoptotic NF-kappa-B signaling and ERK signaling (PubMed:28592261). Plays a role in microglial MTOR activation and metabolism (PubMed:28802038). Regulates age-related changes in microglial numbers (PubMed:25631124, PubMed:29752066, PubMed:30548312). Triggers activation of the immune responses in macrophages and dendritic cells. Mediates cytokine-induced formation of multinucleated giant cells which are formed by the fusion of macrophages (PubMed:18957693). In dendritic cells, receptor of SEMA6D with PLEXNA1 as coreceptor and mediates up-regulation of chemokine receptor CCR7 and dendritic cell maturation and survival (PubMed:16715077). Involved in the positive regulation of osteoclast differentiation (PubMed:16418779)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; TREM-2a and TREM-2b binding to both Gram-positive and Gram-negative bacteria is disrupted by anionic bacterial products or other anionic carbohydrates and suggests that TREM-2 recognizes pathogens via charged carbohydrates expressed on pathogen surface., [RefSeq, PubMed]; The protein encoded by this gene is part of the immunoglobulin and lectin-like superfamily and functions as part of the innate immune system. This gene forms part of a cluster of genes on mouse chromosome 17 thought to be involved in innate immunity. This protein associates with the adaptor protein Dap-12 and recruits several factors, such as kinases and phospholipase C-gamma, to form a receptor signaling complex that activates myeloid cells, including dendritic cells and microglia. In humans homozygous loss-of-function mutations in this gene cause Nasu-Hakola disease and mutations in this gene may be risk factors to the development of Alzheimer's disease. In mouse mutations of this gene serve as a pathophysiological model for polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (Nasu-Hakola disease) and for inflammatory bowel disease. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jan 2013]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CGK4;Q8CIA6;Q99NH9;Q9JL34",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019209 kinase activator activity;GO:0042834 peptidoglycan binding;GO:0004888 transmembrane signaling receptor activity;GO:0005543 phospholipid binding;GO:0030215 semaphorin receptor binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0044853 plasma membrane raft",
        "go_biological_process": "GO:0030316 osteoclast differentiation;GO:1904141 positive regulation of microglial cell migration;GO:1903376 regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;GO:0070345 negative regulation of fat cell proliferation;GO:2001171 positive regulation of ATP biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "Q99NH8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D3H0-1",
        "uniprot_id": "TMM80_MOUSE",
        "mass": 13473.0,
        "length": 123,
        "protein_name": "Transmembrane protein 80",
        "gene_name": "Tmem80",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 80 isoform 1",
        "refseq_ac": "NP_001135422",
        "gene_names_uniprotkb": "Tmem80",
        "gene_names_refseq": "5530601I19Rik; Tmem80",
        "protein_names_uniprotkb": "Transmembrane protein 80",
        "protein_names_refseq": "transmembrane protein 80 isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71448)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "26982032",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BQL4",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0016020 membrane;GO:0035869 ciliary transition zone",
        "go_biological_process": "GO:1905515 non-motile cilium assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9D3H0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DAV9-1",
        "uniprot_id": "TM38B_MOUSE",
        "mass": 32640.0,
        "length": 292,
        "protein_name": "Trimeric intracellular cation channel type B",
        "gene_name": "Tmem38b",
        "organism": "Mouse",
        "refseq_name": "trimeric intracellular cation channel type B",
        "refseq_ac": "NP_082329",
        "gene_names_uniprotkb": "Tmem38b; D4Ertd89e; Mg33b",
        "gene_names_refseq": "1600017F22Rik; D4Ertd89e; TRIC-B; Tmem38b; mg33b",
        "protein_names_uniprotkb": "Trimeric intracellular cation channel type B; Mitsugumin-33B; TRIC-B; TRICB; Transmembrane protein 38B",
        "protein_names_refseq": "Mitsugumin33B; TRICB; mitsugumin-33B; trimeric intracellular cation channel type B",
        "tax_id": 10090,
        "disease": "osteogenesis imperfecta type 14 (Disease Ontology:DOID:0110343)",
        "pathway": " (mmu:52076)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "17611541;19515693;21750661;23467973;24526676;25428506;30907436;31219806;37178987;37348683;38123563",
        "class_list": "",
        "function": "Absence of TRIC-B from type XIV Osteogenesis Imperfecta osteoblasts alters cell adhesion and mitochondrial function - A multi-omics study., [RefSeq, PubMed]; Atypical cell death and insufficient matrix organization in long-bone growth plates from Tric-b-knockout mice. Publication Status: Online-Only, [RefSeq, PubMed]; CaMKII inhibition due to TRIC-B loss-of-function dysregulates SMAD signaling in osteogenesis imperfecta., [RefSeq, PubMed]; Intracellular monovalent cation channel required for maintenance of rapid intracellular calcium release. Acts as a potassium counter-ion channel that functions in synchronization with calcium release from intracellular stores. Activated by increased cytosolic Ca(2+) levels., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Rapid transitions between TRIC-B sub-conductance states prevented development of reliable gating models., [RefSeq, PubMed]; TRIC channels are likely to act as counter-ion channels that function in synchronization with Ca2+ release from intracellular stores, [RefSeq, PubMed]; TRIC-A and TRIC-B seem to have differential functions in Ca(2+) signaling in excitable and nonexcitable cells. Review article Erratum:[Circ Res. 2020 May 8;126(10):e119. doi: 10.1161/RES.0000000000000350. PMID: 32379571], [RefSeq, PubMed]; TRIC-B-knockout neonates were cyanotic owing to respiratory failure and died shortly after birth. In mutant neonates, the deflated lungs exhibited severe histological defects, and alveolar type II epithelial cells displayed ultrastructural abnormalities., [RefSeq, PubMed]; The role of TRIC-A and TRIC-B channels in skeletal muscle sarcoplasmic reticulum channels is reported., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AQG4;Q3U6M4;Q3UBM6;Q3UWS8",
        "ec_number_list": "1.8.-.-",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0005267 potassium channel activity",
        "go_cellular_component": "GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0048286 lung alveolus development;GO:0051209 release of sequestered calcium ion into cytosol;GO:0060348 bone development;GO:0001503 ossification;GO:0010881 regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q9DAV9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EPQ1-1",
        "uniprot_id": "TLR1_MOUSE",
        "mass": 90673.0,
        "length": 795,
        "protein_name": "Toll-like receptor 1",
        "gene_name": "Tlr1",
        "organism": "Mouse",
        "refseq_name": "toll-like receptor 1 precursor",
        "refseq_ac": "NP_001263374",
        "gene_names_uniprotkb": "Tlr1",
        "gene_names_refseq": "Tlr1",
        "protein_names_uniprotkb": "Toll-like receptor 1; TIL; Toll/interleukin-1 receptor-like protein",
        "protein_names_refseq": "TIL; toll-like receptor 1 precursor; toll/interleukin-1 receptor-like protein",
        "tax_id": 10090,
        "disease": "leprosy (Disease Ontology:DOID:1024); pyelonephritis (Disease Ontology:DOID:11400); aspergillosis (Disease Ontology:DOID:13564); asthma (Disease Ontology:DOID:2841); pulmonary tuberculosis (Disease Ontology:DOID:2957); IgA glomerulonephritis (Disease Ontology:DOID:2986); tuberculosis (Disease Ontology:DOID:399); glucose metabolism disease (Disease Ontology:DOID:4194); primary immunodeficiency disease (Disease Ontology:DOID:612); collagen disease (Disease Ontology:DOID:854); perinatal necrotizing enterocolitis (Disease Ontology:DOID:8677)",
        "pathway": " (mmu:21897);  (R-MMU-1461957);  (R-MMU-5686938)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;11095740;11123271;17998391;19362712;26740625;34428180;36398889;38378891",
        "class_list": "",
        "function": "Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206[+] macrophages[IL-10] activation., [RefSeq, PubMed]; Participates in the innate immune response to microbial agents. Specifically recognizes diacylated and triacylated lipopeptides. Cooperates with TLR2 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Forms the activation cluster TLR2:TLR1:CD14 in response to triacylated lipopeptides, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). Acts as a coreceptor for M.tuberculosis lipoproteins LprG, LpqH and PhoS1 (pstS1), in conjunction with TLR2 and for some but not all lipoproteins CD14 and/or CD36. The lipoproteins act as agonists to modulate antigen presenting cell functions in response to the pathogen (PubMed:19362712)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 8,
        "predicted_n_glycosites": 8,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 11,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9EPW5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042497 triacyl lipopeptide binding;GO:0004888 transmembrane signaling receptor activity;GO:0042802 identical protein binding;GO:0071723 lipopeptide binding;GO:0038023 signaling receptor activity",
        "go_cellular_component": "GO:0005794 Golgi apparatus;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0043235 receptor complex;GO:0044853 plasma membrane raft",
        "go_biological_process": "GO:0001774 microglial cell activation;GO:0006952 defense response;GO:0006954 inflammatory response;GO:0045087 innate immune response;GO:0032755 positive regulation of interleukin-6 production",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q9EPQ1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JJG6-1",
        "uniprot_id": "TMM47_MOUSE",
        "mass": 19995.0,
        "length": 181,
        "protein_name": "Transmembrane protein 47",
        "gene_name": "Tmem47",
        "organism": "Mouse",
        "refseq_name": "transmembrane protein 47",
        "refseq_ac": "NP_620090",
        "gene_names_uniprotkb": "Tmem47; MNCb-0941; Tm4sf10",
        "gene_names_refseq": "3010015F07Rik; BCMP1; Tm4sf10; Tmem47",
        "protein_names_uniprotkb": "Transmembrane protein 47; Transmembrane 4 superfamily member 10",
        "protein_names_refseq": "transmembrane 4 superfamily member 10; transmembrane protein 47",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:192216)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "17195181;21881001;25428506;26990309",
        "class_list": "",
        "function": "Regulates cell junction organization in epithelial cells. May play a role in the transition from adherens junction to tight junction assembly. May regulate F-actin polymerization required for tight junctional localization dynamics and affect the junctional localization of PARD6B (PubMed:26990309). During podocyte differentiation may negatively regulate activity of FYN and subsequently the abundance of nephrin (PubMed:21881001)., [UniProtKB, PubMed, PubMed]; TM4SF10 functions during differentiation of podocytes and may participate in the maturation of cell junctions from simple adherens junctions to elaborate slit diaphragms., [RefSeq, PubMed]; TM4SF10, possibly through ADAP, may regulate Fyn activity, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AUN5;Q3TS34;Q3UZL4;Q8C0H5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0005911 cell-cell junction;GO:0005912 adherens junction",
        "go_biological_process": "GO:0098609 cell-cell adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9JJG6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WVA2-1",
        "uniprot_id": "TIM8A_MOUSE",
        "mass": 11042.0,
        "length": 97,
        "protein_name": "Mitochondrial import inner membrane translocase subunit Tim8 A",
        "gene_name": "Timm8a1",
        "organism": "Mouse",
        "refseq_name": "mitochondrial import inner membrane translocase subunit Tim8 A",
        "refseq_ac": "NP_038926",
        "gene_names_uniprotkb": "Timm8a1; Ddp1; Tim8a; Timm8a",
        "gene_names_refseq": "DXHXS1274E; Ddp1; Fci-12; Tim8a; Timm8a1; Timm8a",
        "protein_names_uniprotkb": "Mitochondrial import inner membrane translocase subunit Tim8 A; Deafness dystonia protein 1 homolog",
        "protein_names_refseq": "deafness dystonia protein 1 homolog; mitochondrial import inner membrane translocase subunit Tim8 A; translocase of inner mitochondrial membrane 8 homolog a1; translocase of inner mitochondrial membrane 8 homolog a",
        "tax_id": 10090,
        "disease": "deafness-dystonia-optic neuronopathy syndrome (Disease Ontology:DOID:0050757); dystonia (Disease Ontology:DOID:543)",
        "pathway": " (mmu:30058)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10611480;10873677;11875042;15254020;17242355;21183079;32820032",
        "class_list": "",
        "function": "Frameshift mutation of Timm8a1 gene in mouse leads to an abnormal mitochondrial structure in the brain, correlating with hearing and memory impairment., [RefSeq, PubMed]; Human deafness dystonia syndrome is caused by a defect in assembly of this protein complex. The defect is caused by a point mutation (a missense mutation)., [RefSeq, PubMed]; Mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. Also required for the transfer of beta-barrel precursors from the TOM complex to the sorting and assembly machinery (SAM complex) of the outer membrane. Acts as a chaperone-like protein that protects the hydrophobic precursors from aggregation and guide them through the mitochondrial intermembrane space. The TIMM8-TIMM13 complex mediates the import of proteins such as TIMM23, SLC25A12/ARALAR1 and SLC25A13/ARALAR2, while the predominant TIMM9-TIMM10 70 kDa complex mediates the import of much more proteins (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q542E5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0042719 mitochondrial intermembrane space chaperone complex;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005758 mitochondrial intermembrane space",
        "go_biological_process": "GO:0015031 protein transport;GO:0045039 protein insertion into mitochondrial inner membrane;GO:0006626 protein targeting to mitochondrion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9WVA2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z1Y4-1",
        "uniprot_id": "TRIP6_MOUSE",
        "mass": 50934.0,
        "length": 480,
        "protein_name": "Thyroid receptor-interacting protein 6",
        "gene_name": "Trip6",
        "organism": "Mouse",
        "refseq_name": "thyroid receptor-interacting protein 6 isoform 1",
        "refseq_ac": "NP_035769",
        "gene_names_uniprotkb": "Trip6; Zrp1",
        "gene_names_refseq": "Trip6",
        "protein_names_uniprotkb": "Thyroid receptor-interacting protein 6; TR-interacting protein 6; TRIP-6; ZRP-1; Zyxin-related protein 1",
        "protein_names_refseq": "TR-interacting protein 6; TRIP-6; ZRP-1; thyroid receptor-interacting protein 6 isoform 1; thyroid receptor-interacting protein 6; zyxin-related protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22051)",
        "pathway_count": 1,
        "publication_count": 20,
        "publication_id_list": "10395914;10826496;11239002;14688263;15988003;17095609;19131326;21540332;21750661;24129315;28135057;28528544;31599954;32782141;34145356;34428180;34620853;35820727;37827326;38411462",
        "class_list": "",
        "function": "Relays signals from the cell surface to the nucleus to weaken adherens junction and promote actin cytoskeleton reorganization and cell invasiveness. Involved in lysophosphatidic acid-induced cell adhesion and migration. Acts as a transcriptional coactivator for NF-kappa-B and JUN, and mediates the transrepression of these transcription factors induced by glucocorticoid receptor (By similarity)., [UniProtKB]; TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer., [RefSeq, PubMed]; TRIP6 functions at a point of convergence between the activated LPA(2) receptor and downstream signals involved in cell adhesion and migration, [RefSeq, PubMed]; TRIP6 functions in brain ciliogenesis. Publication Status: Online-Only, [RefSeq, PubMed]; TRIP6 in lysophosphatidic acid signaling is regulated by c-Src-mediated phosphorylation of TRIP6 at the Tyr-55 residue., [RefSeq, PubMed]; TRIP6 promotes neural stem cell maintenance through YAP-mediated Sonic Hedgehog activation., [RefSeq, PubMed]; The LIM domain protein nTRIP6 modulates the dynamics of myogenic differentiation. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 2,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 5,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 5,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 5,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TX74",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0019900 kinase binding;GO:0005149 interleukin-1 receptor binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005856 cytoskeleton;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0007155 cell adhesion;GO:0007165 signal transduction;GO:0030335 positive regulation of cell migration;GO:1901224 positive regulation of non-canonical NF-kappaB signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "Q9Z1Y4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P39428-1",
        "uniprot_id": "TRAF1_MOUSE",
        "mass": 45465.0,
        "length": 409,
        "protein_name": "TNF receptor-associated factor 1",
        "gene_name": "Traf1",
        "organism": "Mouse",
        "refseq_name": "TNF receptor-associated factor 1",
        "refseq_ac": "NP_001313530",
        "gene_names_uniprotkb": "Traf1",
        "gene_names_refseq": "4732496E14Rik; Traf1",
        "protein_names_uniprotkb": "TNF receptor-associated factor 1",
        "protein_names_refseq": "TNF receptor-associated factor 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22029);  (R-MMU-5357905);  (R-MMU-5357956)",
        "pathway_count": 3,
        "publication_count": 22,
        "publication_id_list": "11672546;11804591;16352630;18429822;18849341;19144319;21750661;22424771;22570473;23376065;23542741;26860405;30867239;32093731;34428180;35815528;35820727;36637223;37419425;39863932;8069916;9104814",
        "class_list": "",
        "function": "Adapter molecule that is involved in multiple signaling pathways including the NF-kappa-B and MAPK pathways and thus influences inflammatory and apoptotic responses (PubMed:26860405). Plays a critical role in regulating T-cell activation both through restricting the costimulation-independent activation of NIK in activated T-cells and by promoting the TNFRSF9-induced classical NF-kappa-B pathway (PubMed:22570473, PubMed:23376065). Forms a heterotrimer with TRAF2 as part of an E3 ubiquitin-protein ligase complex that mediates ubiquitination of target proteins such as MAP3K14 and gasdermin D/GSDMD (By similarity). This complex also recruits the antiapoptotic E3 ligases BIRC2 and BIRC3 to TNFRSF1B/TNFR2. Acts downstream of MAVS within the RIG-I/MAVS antiviral pathway to enhance type I interferon signaling (By similarity). Regulates osteoclastogenesis by preventing ubiquitination and degradation of MLST8, thereby promoting PI3K-AKT signaling and enhancing oxidative phosphorylation in osteoclasts (PubMed:39863932)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; Cutting Edge: Negative Regulation of Inflammasome Activation by TRAF1 Can Limit Gout., [RefSeq, PubMed]; LINC00313 alleviates osteoarthritis progression in mice through promoting TRAF1 promoter methylation and inhibiting the ASK1/JNK signaling pathway., [RefSeq, PubMed]; TRAF1 improves cisplatin-induced acute kidney injury via inhibition of inflammation and metabolic disorders., [RefSeq, PubMed]; TRAF1 suppresses antifungal immunity through CXCL1-mediated neutrophil recruitment during Candida albicans intradermal infection. Publication Status: Online-Only, [RefSeq, PubMed]; These data point to an important role for 4-1BB, TRAF1, and mTOR in the persistence of CD8 effector T cells in the lung parenchyma, thereby allowing the transition to Trm., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CE28",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0042802 identical protein binding;GO:0031625 ubiquitin protein ligase binding;GO:0031996 thioesterase binding;GO:0035591 signaling adaptor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0009898 cytoplasmic side of plasma membrane;GO:0035631 CD40 receptor complex",
        "go_biological_process": "GO:0006915 apoptotic process;GO:0043123 positive regulation of canonical NF-kappaB signal transduction;GO:1901223 negative regulation of non-canonical NF-kappaB signal transduction;GO:2001236 regulation of extrinsic apoptotic signaling pathway;GO:0033209 tumor necrosis factor-mediated signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "P39428-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3U0V2-1",
        "uniprot_id": "TRADD_MOUSE",
        "mass": 34577.0,
        "length": 310,
        "protein_name": "Tumor necrosis factor receptor type 1-associated DEATH domain protein",
        "gene_name": "Tradd",
        "organism": "Mouse",
        "refseq_name": "tumor necrosis factor receptor type 1-associated DEATH domain protein",
        "refseq_ac": "NP_001028333",
        "gene_names_uniprotkb": "Tradd",
        "gene_names_refseq": "9130005N23Rik; Tradd",
        "protein_names_uniprotkb": "Tumor necrosis factor receptor type 1-associated DEATH domain protein; TNFR1-associated DEATH domain protein; TNFRSF1A-associated via death domain",
        "protein_names_refseq": "TNF receptor 1 associated signal transducer; TNFR1-associated DEATH domain protein; tumor necrosis factor receptor type 1-associated DEATH domain protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71609);  (R-MMU-3371378);  (R-MMU-5218900);  (R-MMU-5357786);  (R-MMU-5357905);  (R-MMU-5357956);  (R-MMU-5675482);  (R-MMU-69416);  (R-MMU-75893)",
        "pathway_count": 9,
        "publication_count": 12,
        "publication_id_list": "14585990;16702408;21750661;22561347;28135057;28528544;30185824;30902834;31219806;31783009;32968279;34428180",
        "class_list": "",
        "function": "Adapter molecule for TNFRSF1A/TNFR1 that specifically associates with the cytoplasmic domain of activated TNFRSF1A/TNFR1 mediating its interaction with FADD (By similarity). Overexpression of TRADD leads to two major TNF-induced responses, apoptosis and activation of NF-kappa-B (By similarity). The nuclear form acts as a tumor suppressor by preventing ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A by TRIP12: acts by interacting with TRIP12, leading to disrupt interaction between TRIP12 and isoform p19ARF/ARF of CDKN2A (PubMed:22561347)., [UniProtKB, PubMed, UniProtKB]; High TRADD expression promotes liver inflammatory response and liver carcinogenesis., [RefSeq, PubMed]; Modulating TRADD to restore cellular homeostasis and inhibit apoptosis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0070513 death domain binding;GO:0030674 protein-macromolecule adaptor activity;GO:0042802 identical protein binding;GO:0019900 kinase binding;GO:0044877 protein-containing complex binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005856 cytoskeleton;GO:0005886 plasma membrane;GO:0043235 receptor complex",
        "go_biological_process": "GO:0030335 positive regulation of cell migration;GO:0097190 apoptotic signaling pathway;GO:0043123 positive regulation of canonical NF-kappaB signal transduction;GO:0050729 positive regulation of inflammatory response;GO:0097191 extrinsic apoptotic signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q3U0V2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P29812-1",
        "uniprot_id": "TYRP2_MOUSE",
        "mass": 58510.0,
        "length": 517,
        "protein_name": "L-dopachrome tautomerase",
        "gene_name": "Dct",
        "organism": "Mouse",
        "refseq_name": "L-dopachrome tautomerase precursor",
        "refseq_ac": "NP_034154",
        "gene_names_uniprotkb": "Dct; Tyrp-2; Tyrp2",
        "gene_names_refseq": "DT; Dct; TRP-2; TRP2; Tyrp-2; Tyrp2; slaty; slt",
        "protein_names_uniprotkb": "L-dopachrome tautomerase; 5.3.3.12; DCT; DOPAchrome conversion factor; DOPAchrome isomerase; DOPAchrome oxidoreductase; DT; L-dopachrome Delta-isomerase; SLATY locus protein; TRP-2; TRP2; Tyrosinase-related protein 2",
        "protein_names_refseq": "DOPAchrome conversion factor; DOPAchrome isomerase; DOPAchrome oxidoreductase; L-dopachrome Delta-isomerase; L-dopachrome tautomerase precursor; L-dopachrome tautomerase; SLATY locus protein; tyrosinase-related protein 2",
        "tax_id": 10090,
        "disease": "oculocutaneous albinism (Disease Ontology:DOID:0050632)",
        "pathway": " (mmu:13190);  (R-MMU-5662702)",
        "pathway_count": 2,
        "publication_count": 19,
        "publication_id_list": "1537333;1537334;25363716;26451316;26620560;30005865;30084848;30764534;31156619;33100333;34103348;34428180;35766157;35820727;36593402;37161052;7980602;8530099;8573077",
        "class_list": "",
        "function": "Plays a role in melanin biosynthesis (PubMed:33100333). Catalyzes the conversion of L-dopachrome into 5,6-dihydroxyindole-2-carboxylic acid (DHICA) (PubMed:1537333, PubMed:1537334)., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 7,
        "predicted_n_glycosites": 7,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 5,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6NXI2",
        "ec_number_list": "5.3.3.12;5.3.2.1",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0016491 oxidoreductase activity;GO:0004167 dopachrome isomerase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0042470 melanosome;GO:0033162 melanosome membrane",
        "go_biological_process": "GO:0043473 pigmentation;GO:0048468 cell development;GO:0002052 positive regulation of neuroblast proliferation;GO:0042438 melanin biosynthetic process;GO:0048066 developmental pigmentation",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "P29812-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P43488-1",
        "uniprot_id": "TNFL4_MOUSE",
        "mass": 22255.0,
        "length": 198,
        "protein_name": "Tumor necrosis factor ligand superfamily member 4",
        "gene_name": "Tnfsf4",
        "organism": "Mouse",
        "refseq_name": "tumor necrosis factor ligand superfamily member 4",
        "refseq_ac": "NP_033478",
        "gene_names_uniprotkb": "Tnfsf4; Ox40l; Txgp1l",
        "gene_names_refseq": "Ath-1; Ath1; CD134L; OX-40L; Ox40l; TXGP1; Tnfsf4; Tnlg2b; Txgp1l; gp34",
        "protein_names_uniprotkb": "Tumor necrosis factor ligand superfamily member 4; OX40 ligand; OX40L",
        "protein_names_refseq": "OX40 ligand; atherosclerosis 1; tax-transcriptionally activated glycoprotein 1 ligand; tumor necrosis factor ligand 2b; tumor necrosis factor ligand superfamily member 4",
        "tax_id": 10090,
        "disease": "primary pulmonary hypertension (Disease Ontology:DOID:14557); cervical squamous cell carcinoma (Disease Ontology:DOID:3744); myocardial infarction (Disease Ontology:DOID:5844); type 1 diabetes mellitus (Disease Ontology:DOID:9744)",
        "pathway": " (mmu:22164);  (R-MMU-5669034)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "16905106;34093535;36345699;36450532;8076595",
        "class_list": "",
        "function": "Cytokine that binds to TNFRSF4. Co-stimulates T-cell proliferation and cytokine production., [UniProtKB]; IL-10(-/-) Enhances DCs Immunity Against Chlamydia psittaci Infection via OX40L/NLRP3 and IDO/Treg Pathways. Publication Status: Online-Only, [RefSeq, PubMed]; OX40 Ligand-Mannose-Binding Lectin Fusion Protein Induces Potent OX40 Cosignaling in CD4[+] T Cells., [RefSeq, PubMed]; OX40L enhances the immunogenicity of dendritic cells and inhibits tumor metastasis in mice., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005125 cytokine activity;GO:0048018 receptor ligand activity;GO:0032813 tumor necrosis factor receptor superfamily binding;GO:0005164 tumor necrosis factor receptor binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0009986 cell surface;GO:0016020 membrane",
        "go_biological_process": "GO:0032736 positive regulation of interleukin-13 production;GO:0032700 negative regulation of interleukin-17 production;GO:0045626 negative regulation of T-helper 1 cell differentiation;GO:2000570 positive regulation of T-helper 2 cell activation;GO:0000122 negative regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "P43488-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P50284-1",
        "uniprot_id": "TNR3_MOUSE",
        "mass": 44956.0,
        "length": 415,
        "protein_name": "Tumor necrosis factor receptor superfamily member 3",
        "gene_name": "Ltbr",
        "organism": "Mouse",
        "refseq_name": "tumor necrosis factor receptor superfamily member 3 precursor",
        "refseq_ac": "NP_034866",
        "gene_names_uniprotkb": "Ltbr; Tnfcr; Tnfrsf3",
        "gene_names_refseq": "LTbetaR; Ltar; Ltbr; TNF-R-III; TNFCR; TNFR-RP; TNFR2-RP; TNFRrp; Tnfbr; Tnfrsf3",
        "protein_names_uniprotkb": "Tumor necrosis factor receptor superfamily member 3; Lymphotoxin-beta receptor",
        "protein_names_refseq": "LT-beta receptor; TNF receptor-related protein; lymphotoxin-beta receptor; tumor necrosis factor receptor superfamily member 3 precursor; tumor necrosis factor receptor superfamily member 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:17000);  (R-MMU-5668541);  (R-MMU-5676594)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "29507355;7594541;8586432;8663299",
        "class_list": "",
        "function": "(Microbial infection) Plays a role in host defense against Zika virus infection., [UniProtKB, PubMed]; Receptor for the heterotrimeric lymphotoxin containing LTA and LTB, and for TNFS14/LIGHT. Activates NF-kappa-B signaling upon stimulation with lymphotoxin. Promotes apoptosis via TRAF3 and TRAF5. May play a role in the development of lymphoid organs., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0031625 ubiquitin protein ligase binding",
        "go_cellular_component": "GO:0005794 Golgi apparatus;GO:0005886 plasma membrane;GO:0002947 tumor necrosis factor receptor superfamily complex",
        "go_biological_process": "GO:0006955 immune response;GO:0046330 positive regulation of JNK cascade;GO:0006915 apoptotic process;GO:0043123 positive regulation of canonical NF-kappaB signal transduction;GO:2001238 positive regulation of extrinsic apoptotic signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P50284-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P70196-1",
        "uniprot_id": "TRAF6_MOUSE",
        "mass": 60070.0,
        "length": 530,
        "protein_name": "TNF receptor-associated factor 6",
        "gene_name": "Traf6",
        "organism": "Mouse",
        "refseq_name": "TNF receptor-associated factor 6",
        "refseq_ac": "NP_001290202",
        "gene_names_uniprotkb": "Traf6",
        "gene_names_refseq": "2310003F17Rik; C630032O20Rik; Traf6",
        "protein_names_uniprotkb": "TNF receptor-associated factor 6; 2.3.2.27; E3 ubiquitin-protein ligase TRAF6; RING-type E3 ubiquitin transferase TRAF6",
        "protein_names_refseq": "E3 ubiquitin-protein ligase TRAF6; RING-type E3 ubiquitin transferase TRAF6; TNF receptor-associated factor 6",
        "tax_id": 10090,
        "disease": "intrinsic cardiomyopathy (Disease Ontology:DOID:0060036); hypohidrotic ectodermal dysplasia (Disease Ontology:DOID:14793); laryngeal carcinoma (Disease Ontology:DOID:2600)",
        "pathway": " (mmu:22034)",
        "pathway_count": 1,
        "publication_count": 26,
        "publication_id_list": "10215628;10421844;10747026;10748240;11244088;12060722;12881420;14499111;15322147;15705807;16079148;16951688;17092936;17633018;18849341;21435586;22424771;23542741;25026888;26553469;27330028;29563609;38908751;38995476;39162488;8910514",
        "class_list": "",
        "function": "14-3-3zeta suppresses RANKL signaling by destabilizing TRAF6., [RefSeq, PubMed]; ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiota., [RefSeq, PubMed]; E3 ubiquitin ligase that, together with UBE2N and UBE2V1, mediates the synthesis of 'Lys-63'-linked-polyubiquitin chains conjugated to proteins, such as ECSIT, IKBKG, IRAK1, AKT1 and AKT2 (PubMed:15322147, PubMed:17633018). Also mediates ubiquitination of free/unanchored polyubiquitin chain that leads to MAP3K7 activation (By similarity). Leads to the activation of NF-kappa-B and JUN. Seems to also play a role in dendritic cells (DCs) maturation and/or activation (PubMed:14499111). Represses c-Myb-mediated transactivation, in B-lymphocytes (By similarity). Adapter protein that seems to play a role in signal transduction initiated via TNF receptor, IL-1 receptor and IL-17 receptor (PubMed:10215628, PubMed:10421844). Regulates osteoclast differentiation by mediating the activation of adapter protein complex 1 (AP-1) and NF-kappa-B, in response to RANK-L stimulation (PubMed:10421844, PubMed:17092936). Together with MAP3K8, mediates CD40 signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production (PubMed:12881420). Acts as a regulator of the JNK and NF-kappa-B signaling pathways by initiating assembly of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains that are then recognized by TAB2: TRAF6 catalyzes initial 'Lys-63'-linked-polyubiquitin chains that are then branched via 'Lys-48'-linked polyubiquitin by HUWE1 (By similarity). 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains protect 'Lys-63'-linkages from CYLD deubiquitination (By similarity). Also participates in the TCR signaling by ubiquitinating LAT (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; TRAF6 promotes spinal microglial M1 polarization to aggravate neuropathic pain by activating the c-JUN/NF-kB signaling pathway. Publication Status: Online-Only, [RefSeq, PubMed]; This gene encodes a member of the TNF receptor associated factor (TRAF) family of adaptor proteins that mediate signaling events from members of the TNF receptor and Toll/IL-1 receptor families to activate transcription factors such as NF-kappa-B and AP-1. The product of this gene is essential for perinatal and postnatal survival. Mice deficient in this protein exhibit osteopetrosis and defective in development of epidermal appendixes, normal B cell differentiation, lymph node organogenesis, interleukin-1 signaling, lipopolysaccharide signaling and neural tube closure. This protein possesses ubiquitin ligase activity. Alternate splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2014]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6P9M0;Q8BLV2",
        "ec_number_list": "2.7.11.25;2.3.2.27",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0030674 protein-macromolecule adaptor activity;GO:0042802 identical protein binding;GO:0042826 histone deacetylase binding;GO:0061630 ubiquitin protein ligase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005811 lipid droplet;GO:0005829 cytosol",
        "go_biological_process": "GO:0030316 osteoclast differentiation;GO:0070498 interleukin-1-mediated signaling pathway;GO:0002637 regulation of immunoglobulin production;GO:1904996 positive regulation of leukocyte adhesion to vascular endothelial cell;GO:0023035 CD40 signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "P70196-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80Z37-1",
        "uniprot_id": "TOPRS_MOUSE",
        "mass": 117082.0,
        "length": 1033,
        "protein_name": "E3 ubiquitin-protein ligase Topors",
        "gene_name": "Topors",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase Topors isoform 1",
        "refseq_ac": "NP_598858",
        "gene_names_uniprotkb": "Topors",
        "gene_names_refseq": "LUN; TP53BPL; Topors; p53BP3/LUN; p53BP3",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase Topors; 2.3.2.27; RING-type E3 ubiquitin transferase Topors; SUMO1-protein E3 ligase Topors; Topoisomerase I-binding RING finger protein; Topoisomerase I-binding arginine/serine-rich protein; Tumor suppressor p53-binding protein 3; p53-binding protein 3; p53BP3",
        "protein_names_refseq": "E3 ubiquitin-protein ligase Topors isoform 1; E3 ubiquitin-protein ligase Topors; RING-type E3 ubiquitin transferase Topors; SUMO1-protein E3 ligase Topors; p53-binding protein 3; topoisomerase 1-binding RING finger; topoisomerase I-binding RING finger protein; topoisomerase I-binding arginine/serine-rich protein; tumor suppressor p53-binding protein 3",
        "tax_id": 10090,
        "disease": "retinitis pigmentosa 31 (Disease Ontology:DOID:0110391)",
        "pathway": " (mmu:106021);  (R-MMU-3899300);  (R-MMU-4085377);  (R-MMU-4755510)",
        "pathway_count": 4,
        "publication_count": 8,
        "publication_id_list": "15703819;15735665;17242355;18077445;21183079;30059200;31219806;32113985",
        "class_list": "",
        "function": "Functions as an E3 ubiquitin-protein ligase and as a E3 SUMO1-protein ligase. Probable tumor suppressor involved in cell growth, cell proliferation and apoptosis that regulates p53/TP53 stability through ubiquitin-dependent degradation. May regulate chromatin modification through sumoylation of several chromatin modification-associated proteins. May be involved in DNA-damage-induced cell death through IKBKE sumoylation., [UniProtKB, PubMed, PubMed]; NKX3.1 can be ubiquitinated by TOPORS in vitro and in vivo, and overexpression of TOPORS leads to NKX3.1 proteasomal degradation in prostate cancer cells, [RefSeq, PubMed]; TOPORS regulates chromatin architecture partially by interacting with PML., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 13,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U5B5;Q3UPZ1;Q3USN3;Q3UZ55;Q8BXP2;Q8CFF5;Q8CGC8;Q920L3",
        "ec_number_list": "2.3.2.-;2.3.2.27;2.7.11.10",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0008270 zinc ion binding;GO:0061630 ubiquitin protein ligase activity;GO:0004842 ubiquitin-protein transferase activity;GO:0019789 SUMO transferase activity",
        "go_cellular_component": "GO:0000922 spindle pole;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0016607 nuclear speck;GO:0005814 centriole",
        "go_biological_process": "GO:0016925 protein sumoylation;GO:0042127 regulation of cell population proliferation;GO:0006974 DNA damage response;GO:0042771 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q80Z37-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BLA8-1",
        "uniprot_id": "TRPA1_MOUSE",
        "mass": 128467.0,
        "length": 1125,
        "protein_name": "Transient receptor potential cation channel subfamily A member 1",
        "gene_name": "Trpa1",
        "organism": "Mouse",
        "refseq_name": "transient receptor potential cation channel subfamily A member 1 isoform 2",
        "refseq_ac": "NP_001335217",
        "gene_names_uniprotkb": "Trpa1; Anktm1",
        "gene_names_refseq": "Anktm1; TRPA1b; Trpa1",
        "protein_names_uniprotkb": "Transient receptor potential cation channel subfamily A member 1; Ankyrin-like with transmembrane domains protein 1; Wasabi receptor",
        "protein_names_refseq": "ankyrin-like with transmembrane domains protein 1; transient receptor potential cation channel subfamily A member 1 isoform 2; wasabi receptor",
        "tax_id": 10090,
        "disease": "overactive bladder syndrome (Disease Ontology:DOID:0070355); familial episodic pain syndrome 1 (Disease Ontology:DOID:0111729); asthma (Disease Ontology:DOID:2841); diabetic neuropathy (Disease Ontology:DOID:9743)",
        "pathway": " (mmu:277328);  (R-MMU-3295583)",
        "pathway_count": 2,
        "publication_count": 20,
        "publication_id_list": "12654248;12815418;15046718;15194861;15483558;15843607;16564016;17237762;17567811;21873995;21908607;22207754;24140646;25428506;25640077;29352128;29703838;31447178;34428180;37828378",
        "class_list": "",
        "function": "Functional comparison with Drosophila protein homologue, [RefSeq, PubMed]; Inhibition of TRPA1 protein expression in zebrafish and mouse inner ears inhibits receptor cell function [TRPA1], [RefSeq, PubMed]; Ligand-activated Ca(2+)-permeable, nonselective cation channel (By similarity). Involved in pain detection and possibly also in cold perception, oxygen concentration perception, cough, itch, and inner ear function (PubMed:12654248, PubMed:15843607, PubMed:16564016, PubMed:24140646). Has a relatively high Ca(2+) selectivity, with a preference for divalent over monovalent cations (Ca(2+) > Ba(2+) > Mg(2+) > NH4(+) > Li(+) > K(+)), the influx of cation into the cytoplasm, leads to membrane depolarization. Has a central role in the pain response to endogenous inflammatory mediators, such as bradykinin and to a diverse array of irritants (PubMed:15046718). Activated by a large variety of structurally unrelated electrophilic and non-electrophilic chemical compounds, such as allylthiocyanate (AITC) from mustard oil or wasabi, cinnamaldehyde, diallyl disulfide (DADS) from garlic, and acrolein, an environmental irritant. Electrophilic ligands activate TRPA1 by interacting with critical N-terminal Cys residues in a covalent manner. Non-electrophile agonists bind at distinct sites in the transmembrane domain to promote channel activation. Also acts as an ionotropic cannabinoid receptor by being activated by delta(9)-tetrahydrocannabinol (THC), the psychoactive component of marijuana (By similarity). May be a component for the mechanosensitive transduction channel of hair cells in inner ear, thereby participating in the perception of sounds (PubMed:15483558)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]; TRPA1 activation elicits a painful sensation and provide a potential molecular model for why noxious cold can paradoxically be perceived as burning pain., [RefSeq, PubMed]; This protein was found only in dorsal root ganglia and responds to cold temperatures., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q0VBN5",
        "ec_number_list": "1.8.-.-;2.7.11.1",
        "go_molecular_function": "GO:0097604 temperature-gated cation channel activity;GO:0005216 monoatomic ion channel activity;GO:0005262 calcium channel activity;GO:0042802 identical protein binding;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane;GO:0030424 axon;GO:0016324 apical plasma membrane;GO:0032421 stereocilium bundle",
        "go_biological_process": "GO:0070417 cellular response to cold;GO:0071240 cellular response to food;GO:0007166 cell surface receptor signaling pathway;GO:0009409 response to cold;GO:0051289 protein homotetramerization",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "Q8BLA8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z0W1-1",
        "uniprot_id": "TNR16_MOUSE",
        "mass": 45647.0,
        "length": 427,
        "protein_name": "Tumor necrosis factor receptor superfamily member 16",
        "gene_name": "Ngfr",
        "organism": "Mouse",
        "refseq_name": "tumor necrosis factor receptor superfamily member 16 precursor",
        "refseq_ac": "NP_150086",
        "gene_names_uniprotkb": "Ngfr; Tnfrsf16",
        "gene_names_refseq": "LNGFR; Ngfr; Tnfrsf16; p75NGFR; p75NTR; p75",
        "protein_names_uniprotkb": "Tumor necrosis factor receptor superfamily member 16; Low affinity neurotrophin receptor p75NTR; Low-affinity nerve growth factor receptor p75NGFR; Low-affinity nerve growth factor receptor p75NGR; Low-affinity nerve growth factor receptor; NGF receptor",
        "protein_names_refseq": "NGF receptor; low affinity neurotrophin receptor p75NTR; low-affinity nerve growth factor receptor p75NGFR; low-affinity nerve growth factor receptor p75NGR; low-affinity nerve growth factor receptor; p75 neurotrophin receptor; tumor necrosis factor receptor superfamily member 16 precursor; tumor necrosis factor receptor superfamily member 16",
        "tax_id": 10090,
        "disease": "congenital hypothyroidism (Disease Ontology:DOID:0050328); alcohol dependence (Disease Ontology:DOID:0050741); diabetic encephalopathy (Disease Ontology:DOID:0050850); chronic pancreatitis (Disease Ontology:DOID:0051065); Parkinsonism (Disease Ontology:DOID:0080855); Hirschsprung's disease (Disease Ontology:DOID:10487); Alzheimer's disease (Disease Ontology:DOID:10652); portal hypertension (Disease Ontology:DOID:10762); hypertension (Disease Ontology:DOID:10763); sciatic neuropathy (Disease Ontology:DOID:11446); polycystic ovary syndrome (Disease Ontology:DOID:11612); Lewy body dementia (Disease Ontology:DOID:12217); respiratory syncytial virus infectious disease (Disease Ontology:DOID:1273); Huntington's disease (Disease Ontology:DOID:12858); dementia (Disease Ontology:DOID:1307); Parkinson's disease (Disease Ontology:DOID:14330); urticaria (Disease Ontology:DOID:1555); depressive disorder (Disease Ontology:DOID:1596); cystitis (Disease Ontology:DOID:1679); glaucoma (Disease Ontology:DOID:1686); pancreatic cancer (Disease Ontology:DOID:1793); atherosclerosis (Disease Ontology:DOID:1936); transient cerebral ischemia (Disease Ontology:DOID:224); multiple sclerosis (Disease Ontology:DOID:2377); atopic dermatitis (Disease Ontology:DOID:3310); coronary artery disease (Disease Ontology:DOID:3393); middle cerebral artery infarction (Disease Ontology:DOID:3525); rhinitis (Disease Ontology:DOID:4483); congestive heart failure (Disease Ontology:DOID:6000); degenerative disc disease (Disease Ontology:DOID:90); diabetic neuropathy (Disease Ontology:DOID:9743)",
        "pathway": " (mmu:18053);  (R-MMU-193634);  (R-MMU-193692);  (R-MMU-205017);  (R-MMU-205025);  (R-MMU-205043);  (R-MMU-209543);  (R-MMU-209560);  (R-MMU-209563)",
        "pathway_count": 9,
        "publication_count": 12,
        "publication_id_list": "11559852;11830582;1317267;22155786;22460790;22923615;23785138;24908487;27457814;29909994;34428180;9857182",
        "class_list": "",
        "function": "(Microbial infection) Cell surface receptor for rabies virus glycoprotein Gs., [UniProtKB, PubMed]; Does not bind NGF, BDNF, NTF3, and NTF4., [UniProtKB, PubMed]; Low affinity neurotrophin receptor which can bind to mature NGF, BDNF, NTF3, and NTF4 (PubMed:11559852, PubMed:1317267). Forms a heterodimeric receptor with SORCS2 that binds the precursor forms of NGF (proNGF), BDNF (proBDNF) and NTF3 (proNT3) with high affinity, and has much lower affinity for mature NGF and BDNF (PubMed:22155786, PubMed:24908487, PubMed:27457814). Plays an important role in differentiation and survival of specific neuronal populations during development (PubMed:11559852, PubMed:1317267). Can mediate cell survival as well as cell death of neural cells (PubMed:11559852, PubMed:1317267, PubMed:24908487). The heterodimeric receptor formed with SORCS2 plays a role in proBDNF-dependent synaptic plasticity, in hippocampal long term depression (LTD) and long term potentiation (LTP) (PubMed:27457814). Plays a role in the inactivation of RHOA (By similarity). Plays a role in the regulation of the translocation of GLUT4 to the cell surface in adipocytes and skeletal muscle cells in response to insulin, probably by regulating RAB31 activity, and thereby contributes to the regulation of insulin-dependent glucose uptake (PubMed:22460790). Necessary for the circadian oscillation of the clock genes BMAL1, PER1, PER2 and NR1D1 in the suprachiasmatic nucleus (SCN) of the brain and in liver and of the genes involved in glucose and lipid metabolism in the liver (PubMed:23785138)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 31,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CFT3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0048406 nerve growth factor binding;GO:0043121 neurotrophin binding;GO:0005516 calmodulin binding;GO:0015026 coreceptor activity;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005635 nuclear envelope;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0042488 positive regulation of odontogenesis of dentin-containing tooth;GO:0032224 positive regulation of synaptic transmission, cholinergic;GO:1903588 negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;GO:0006886 intracellular protein transport;GO:0010976 positive regulation of neuron projection development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q9Z0W1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9ERZ6-1",
        "uniprot_id": "FIGN_MOUSE",
        "mass": 82098.0,
        "length": 759,
        "protein_name": "Fidgetin",
        "gene_name": "Fign",
        "organism": "Mouse",
        "refseq_name": "fidgetin isoform 2",
        "refseq_ac": "NP_001254775",
        "gene_names_uniprotkb": "Fign",
        "gene_names_refseq": "Fgn; Fign; fidget; fi",
        "protein_names_uniprotkb": "Fidgetin",
        "protein_names_refseq": "fidgetin isoform 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:60344)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "11017077;15707573;16751186;21750661;30647150;35820727",
        "class_list": "",
        "function": "ATP-dependent microtubule severing protein. Severs microtubules along their length and depolymerizes their ends, primarily the minus-end, suppressing microtubule growth from and attachment to centrosomes. Microtubule severing may promote rapid reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. Microtubule release from the mitotic spindle poles may allow depolymerization of the microtubule end proximal to the spindle pole, leading to poleward microtubule flux and poleward motion of chromosome (By similarity)., [UniProtKB]; Knockdown of fidgetin improves regeneration of injured axons by a microtubule-based mechanism., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TPB0;Q3UP57;Q6PCM0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008568 microtubule severing ATPase activity;GO:0005524 ATP binding;GO:0016887 ATP hydrolysis activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005813 centrosome;GO:0005874 microtubule;GO:0016363 nuclear matrix",
        "go_biological_process": "GO:0051013 microtubule severing;GO:0051301 cell division",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9ERZ6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D8C2-1",
        "uniprot_id": "TSN13_MOUSE",
        "mass": 22219.0,
        "length": 204,
        "protein_name": "Tetraspanin-13",
        "gene_name": "Tspan13",
        "organism": "Mouse",
        "refseq_name": "tetraspanin-13",
        "refseq_ac": "NP_079635",
        "gene_names_uniprotkb": "Tspan13; Tm4sf13",
        "gene_names_refseq": "1100001I23Rik; NET-6; Tm4sf13; Tspan13",
        "protein_names_uniprotkb": "Tetraspanin-13; Transmembrane 4 superfamily member 13; Tspan-13",
        "protein_names_refseq": "tetraspanin-13; transmembrane 4 superfamily member 13; tspan-13",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66109)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;17965585;21183079;21750661;26495903;30899004;31219806",
        "class_list": "",
        "function": "Down-regulated in pre-osteoclasts during cell differentiation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A7NSH9;Q3TMS0;Q8BTH3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005246 calcium channel regulator activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:1903169 regulation of calcium ion transmembrane transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q9D8C2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P52483-1",
        "uniprot_id": "UB2E3_MOUSE",
        "mass": 22913.0,
        "length": 207,
        "protein_name": "Ubiquitin-conjugating enzyme E2 E3",
        "gene_name": "Ube2e3",
        "organism": "Mouse",
        "refseq_name": "ubiquitin-conjugating enzyme E2 E3 isoform a",
        "refseq_ac": "NP_033480",
        "gene_names_uniprotkb": "Ube2e3; Ubce4; Ubcm2",
        "gene_names_refseq": "Ubce4; Ube2e3; ubcM2",
        "protein_names_uniprotkb": "Ubiquitin-conjugating enzyme E2 E3; 2.3.2.23; E2 ubiquitin-conjugating enzyme E3; UbcM2; Ubiquitin carrier protein E3; Ubiquitin-conjugating enzyme E2-23 kDa; Ubiquitin-protein ligase E3",
        "protein_names_refseq": "E2 ubiquitin-conjugating enzyme E3; ubiquitin carrier protein E3; ubiquitin-conjugating enzyme 4; ubiquitin-conjugating enzyme E2 E3 isoform a; ubiquitin-conjugating enzyme E2-23 kDa; ubiquitin-conjugating enzyme E2E 3, UBC4/5 homolog; ubiquitin-protein ligase E3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22193);  (R-MMU-8866652);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "11032817;14993279;15545318;16024774;21750661;8576256;9872334",
        "class_list": "",
        "function": "Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'- and 'Lys-48'-, as well as 'Lys-63'-linked polyubiquitination (By similarity). Participates in the regulation of transepithelial sodium transport in renal cells., [UniProtKB, UniProtKB, PubMed]; UBC4-testis isoform plays a role in early maturation of the testis, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O09180;Q3TI00;Q91X63",
        "ec_number_list": "2.3.2.26;2.3.2.31;2.3.2.27;2.3.2.-;3.6.4.-;2.3.2.24;2.3.2.23;2.3.2.34;2.3.2.32;6.2.1.45;2.7.11.1;6.2.1.64;2.3.2.36;2.3.2.25;6.2.1.-",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0004842 ubiquitin-protein transferase activity;GO:0061631 ubiquitin conjugating enzyme activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0010629 negative regulation of gene expression;GO:0070979 protein K11-linked ubiquitination;GO:0070936 protein K48-linked ubiquitination;GO:0070534 protein K63-linked ubiquitination;GO:0006513 protein monoubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "P52483-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BGB2-1",
        "uniprot_id": "TTC7A_MOUSE",
        "mass": 96156.0,
        "length": 858,
        "protein_name": "Tetratricopeptide repeat protein 7A",
        "gene_name": "Ttc7a; Ttc7",
        "organism": "Mouse",
        "refseq_name": "tetratricopeptide repeat protein 7A isoform 2",
        "refseq_ac": "NP_082915",
        "gene_names_uniprotkb": "Ttc7a; Ttc7; Ttc7",
        "gene_names_refseq": "1110035E02Rik; 1700007L07Rik; Ttc7a; Ttc7; fsn; hea",
        "protein_names_uniprotkb": "Tetratricopeptide repeat protein 7A; TPR repeat protein 7A",
        "protein_names_refseq": "TPR repeat protein 7A; tetratricopeptide repeat protein 7A isoform 2; tetratricopeptide repeat protein 7A",
        "tax_id": 10090,
        "disease": "multiple intestinal atresia (Disease Ontology:DOID:14671); psoriasis (Disease Ontology:DOID:8893)",
        "pathway": " (mmu:225049)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "19144319;21183079;21750661;29775636;31004027;31219806;34428180;36210013;37390900",
        "class_list": "",
        "function": "Actin dynamics regulation by TTC7A/PI4KIIIalpha limits DNA damage and cell death under confinement., [RefSeq, PubMed]; Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane. The complex acts as a regulator of phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis (By similarity). In the complex, plays a central role in bridging PI4KA to EFR3B and HYCC1, via direct interactions (By similarity)., [UniProtKB, UniProtKB, UniProtKB]; Epithelial proliferation in inflammatory skin disease is regulated by tetratricopeptide repeat domain 7 (Ttc7) in fibroblasts and lymphocytes., [RefSeq, PubMed]; Ttc7a regulates hematopoietic stem cell functions while controlling the stress-induced response., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80XT5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0072659 protein localization to plasma membrane;GO:0046854 phosphatidylinositol phosphate biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q8BGB2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9Q735-1",
        "uniprot_id": "UBE4A_MOUSE",
        "mass": 118198.0,
        "length": 1028,
        "protein_name": "Ubiquitin conjugation factor E4 A",
        "gene_name": "Ube4a",
        "organism": "Mouse",
        "refseq_name": "ubiquitin conjugation factor E4 A isoform 1",
        "refseq_ac": "NP_663375",
        "gene_names_uniprotkb": "Ube4a; Ufd2b",
        "gene_names_refseq": "4732444G18Rik; 9930123J21Rik; UFD2b; Ube4a",
        "protein_names_uniprotkb": "Ubiquitin conjugation factor E4 A; 2.3.2.27",
        "protein_names_refseq": "ubiquitin conjugation factor E4 A isoform 1; ubiquitin conjugation factor E4 A; ubiquitination factor E4A, UFD2 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:140630);  (R-MMU-983168)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;11435423;21750661;33300544;35820727;36210013;36442857;37429524;39627609",
        "class_list": "",
        "function": "Loss of FoxOs in muscle increases strength and mitochondrial function during aging., [RefSeq, PubMed]; Ube4A maintains metabolic homeostasis and facilitates insulin signaling in vivo., [RefSeq, PubMed]; Ubiquitin-protein ligase that probably functions as an E3 ligase in conjunction with specific E1 and E2 ligases. Also functions as an E4 ligase mediating the assembly of polyubiquitin chains on substrates ubiquitinated by another E3 ubiquitin ligase. Mediates 'Lys-48'-linked polyubiquitination of substrates., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.3.2.26;2.3.2.31;2.3.2.27;2.3.2.-;3.6.4.-;2.3.2.24;2.3.2.23;2.3.2.34;2.3.2.32;2.7.11.1;2.3.2.36;2.3.2.25;6.2.1.-",
        "go_molecular_function": "GO:0061630 ubiquitin protein ligase activity;GO:0034450 ubiquitin-ubiquitin ligase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0000151 ubiquitin ligase complex",
        "go_biological_process": "GO:0000209 protein polyubiquitination;GO:0006511 ubiquitin-dependent protein catabolic process;GO:0036503 ERAD pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "E9Q735-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88623-3",
        "uniprot_id": "UBP2_MOUSE",
        "mass": 69525.0,
        "length": 619,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 2",
        "gene_name": "Usp2",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 2 isoform Usp2-69",
        "refseq_ac": "NP_058088",
        "gene_names_uniprotkb": "Usp2; MNCb-0190; Ubp41",
        "gene_names_refseq": "B930035K21Rik; Ubp41; Usp2",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 2; 3.4.19.12; 41 kDa ubiquitin-specific protease; Deubiquitinating enzyme 2; Ubiquitin thioesterase 2; Ubiquitin-specific-processing protease 2",
        "protein_names_refseq": "41 kDa ubiquitin-specific protease; deubiquitinating enzyme 2; ubiquitin carboxyl-terminal hydrolase 2 isoform Usp2-69; ubiquitin carboxyl-terminal hydrolase 2; ubiquitin specific protease 2; ubiquitin thioesterase 2; ubiquitin thiolesterase 2; ubiquitin-specific-processing protease 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:53376);  (R-MMU-5357786);  (R-MMU-5357905);  (R-MMU-5357956);  (R-MMU-5689880);  (R-MMU-6804757)",
        "pathway_count": 6,
        "publication_count": 5,
        "publication_id_list": "14686789;23213472;25238854;26756164;31219806",
        "class_list": "",
        "function": "Circadian clock output effector that regulates Ca(2+) absorption in the small intestine. Probably functions by regulating protein levels of the membrane scaffold protein NHERF4 in a rhythmic manner, and is therefore likely to control Ca(2+) membrane permeability mediated by the Ca(2+) channel TRPV6 in the intestine., [UniProtKB, PubMed]; Hydrolase that deubiquitinates polyubiquitinated target proteins such as MDM2, MDM4 and CCND1 (By similarity). Isoform 1 and isoform 2 possess both ubiquitin-specific peptidase and isopeptidase activities (By similarity). Deubiquitinates MDM2 without reversing MDM2-mediated p53/TP53 ubiquitination and thus indirectly promotes p53/TP53 degradation and limits p53 activity (By similarity). Has no deubiquitinase activity against p53/TP53 (By similarity). Prevents MDM2-mediated degradation of MDM4 (By similarity). Plays a role in the G1/S cell-cycle progression in normal and cancer cells (By similarity). Plays a role in the regulation of myogenic differentiation of embryonic muscle cells (By similarity). Regulates the circadian clock by modulating its intrinsic circadian rhythm and its capacity to respond to external cues (PubMed:23213472, PubMed:25238854, PubMed:26756164). Associates with clock proteins and deubiquitinates core clock component PER1 but does not affect its overall stability (PubMed:23213472). Regulates the nucleocytoplasmic shuttling and nuclear retention of PER1 and its repressive role on the clock transcription factors CLOCK and BMAL1 (PubMed:25238854)., [UniProtKB, UniProtKB, PubMed, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6X4T9;Q6X4U1;Q8VD74;Q9JJ87",
        "ec_number_list": "3.4.19.12;2.3.2.27;2.7.11.10;2.7.11.1;2.3.2.-;2.7.11.25;2.3.2.31",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0046872 metal ion binding;GO:0031625 ubiquitin protein ligase binding;GO:0004843 cysteine-type deubiquitinase activity;GO:0030332 cyclin binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005813 centrosome;GO:0005829 cytosol;GO:0005938 cell cortex",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006508 proteolysis;GO:0016579 protein deubiquitination;GO:0045931 positive regulation of mitotic cell cycle;GO:0007517 muscle organ development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "O88623-3",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q692V3-1",
        "uniprot_id": "TTC41_MOUSE",
        "mass": 150823.0,
        "length": 1318,
        "protein_name": "Tetratricopeptide repeat protein 41",
        "gene_name": "Ttc41",
        "organism": "Mouse",
        "refseq_name": "tetratricopeptide repeat protein 41 isoform 3",
        "refseq_ac": "NP_001003910",
        "gene_names_uniprotkb": "Ttc41; BC030307; GNN",
        "gene_names_refseq": "Gnn; Ttc41",
        "protein_names_uniprotkb": "Tetratricopeptide repeat protein 41; Grp94-neighboring nucleotidase; TPR repeat protein 41",
        "protein_names_refseq": "TPR repeat protein 41; TPR repeat protein GNN; grp94-neighboring nucleotidase; tetratricopeptide repeat protein 41 isoform 3; tetratricopeptide repeat protein 41; tetratricopeptide repeat protein GNN",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:103220)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "15827139;21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TLE1;Q692V4;Q692V5;Q8K0V5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q692V3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6P4T2-1",
        "uniprot_id": "U520_MOUSE",
        "mass": 244547.0,
        "length": 2136,
        "protein_name": "U5 small nuclear ribonucleoprotein 200 kDa helicase",
        "gene_name": "Snrnp200",
        "organism": "Mouse",
        "refseq_name": "U5 small nuclear ribonucleoprotein 200 kDa helicase",
        "refseq_ac": "NP_796188",
        "gene_names_uniprotkb": "Snrnp200; Kiaa0788",
        "gene_names_refseq": "A330064G03Rik; Ascc3l1; HELIC2; Snrnp200; U5-200-KD; U5-200KD",
        "protein_names_uniprotkb": "U5 small nuclear ribonucleoprotein 200 kDa helicase; 3.6.4.13; BRR2 homolog; U5 snRNP-specific 200 kDa protein; U5-200KD",
        "protein_names_refseq": "BRR2 homolog; U5 small nuclear ribonucleoprotein 200 kDa helicase; U5 snRNP-specific protein, 200 kDa (DEXH RNA helicase family); activating signal cointegrator 1 complex subunit 3-like 1",
        "tax_id": 10090,
        "disease": "retinitis pigmentosa 33 (Disease Ontology:DOID:0110366); retinitis pigmentosa (Disease Ontology:DOID:10584)",
        "pathway": " (mmu:320632);  (R-MMU-72163);  (R-MMU-72165)",
        "pathway_count": 3,
        "publication_count": 16,
        "publication_id_list": "17242355;17525332;18630941;19144319;21183079;25428506;25605945;29187734;30779550;31219806;33300544;34203471;34428180;36084651;37507081;39627609",
        "class_list": "",
        "function": "Catalyzes the ATP-dependent unwinding of U4/U6 RNA duplices, an essential step in the assembly of a catalytically active spliceosome. Plays a role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (By similarity). Involved in spliceosome assembly, activation and disassembly. Mediates changes in the dynamic network of RNA-RNA interactions in the spliceosome., [UniProtKB, UniProtKB]; On February 19, 2002, this locus was switched from human to mouse. The source accession, Z70200.1, is almost identical to the mouse BAC clone AC074224, and it matches the mouse cDNA accession BC011390 as well. The human gene is LocusID 23020. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 11,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q69ZZ3",
        "ec_number_list": "3.6.4.13;3.6.4.10;3.6.4.-;5.6.2.3;5.2.1.8;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;7.6.2.1;3.6.1.5;3.4.24.-;3.6.-.-;3.1.13.-;2.7.7.48;2.7.7.6;3.1.3.1;3.9.1.1;3.6.1.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;3.6.4.6;3.6.5.-;3.6.1.15;3.1.4.-;5.6.2.-;3.4.19.12;7.2.2.-;7.6.2.16;2.7.11.1;3.4.21.53;2.7.7.7;2.7.7.49;2.7.4.3",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0005524 ATP binding;GO:0042802 identical protein binding;GO:0016887 ATP hydrolysis activity;GO:0004386 helicase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005886 plasma membrane;GO:0005929 cilium;GO:0005681 spliceosomal complex",
        "go_biological_process": "GO:0000398 mRNA splicing, via spliceosome;GO:0000388 spliceosome conformational change to release U4 (or U4atac) and U1 (or U11)",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "Q6P4T2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TSS2-1",
        "uniprot_id": "UB2Q1_MOUSE",
        "mass": 46173.0,
        "length": 422,
        "protein_name": "Ubiquitin-conjugating enzyme E2 Q1",
        "gene_name": "Ube2q1",
        "organism": "Mouse",
        "refseq_name": "ubiquitin-conjugating enzyme E2 Q1",
        "refseq_ac": "NP_081591",
        "gene_names_uniprotkb": "Ube2q1; Ube2q",
        "gene_names_refseq": "1110002C01Rik; 2310012M18Rik; Gtap; NICE-5; PRO3094; Ube2q1; Ube2q",
        "protein_names_uniprotkb": "Ubiquitin-conjugating enzyme E2 Q1; 2.3.2.23; E2 ubiquitin-conjugating enzyme Q1; GTAP; Galactosyl transferase-associated protein; Ubiquitin carrier protein Q1; Ubiquitin-protein ligase Q1",
        "protein_names_refseq": "E2 ubiquitin-conjugating enzyme Q1; galactosyl transferase-associated protein; ubiquitin carrier protein Q1; ubiquitin-conjugating enzyme E2 Q1; ubiquitin-conjugating enzyme E2Q (putative) 1; ubiquitin-protein ligase Q1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:70093);  (R-MMU-983168)",
        "pathway_count": 2,
        "publication_count": 6,
        "publication_id_list": "18511602;20173027;23108111;25428506;30779550;34428180",
        "class_list": "",
        "function": "Catalyzes the covalent attachment of ubiquitin to other proteins (By similarity). Involved in female fertility and embryo implantation (PubMed:23108111). May be involved in hormonal homeostasis in females (PubMed:23108111). Involved in regulation of B4GALT1 cell surface expression, B4GALT1-mediated cell adhesion to laminin and embryoid body formation (PubMed:18511602)., [UniProtKB, PubMed, UniProtKB, PubMed]; GTAP functions as an evolutionarily conserved E2 enzyme, which may participate in intercellular adhesion and embryonic development., [RefSeq, PubMed]; Ube2q1 is not expressed in the uterus of non-pregnant females but its expression is up-regulated during pregnancy. Ube2q1 is involved in different aspects of female fertility. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q29ST1;Q3UIY3;Q6P913;Q80UT5;Q8K2T0;Q9D7E1",
        "ec_number_list": "2.3.2.26;2.3.2.31;2.3.2.27;2.3.2.-;3.6.4.-;2.3.2.24;2.3.2.23;2.3.2.34;2.3.2.32;6.2.1.45;2.7.11.1;6.2.1.64;2.3.2.36;2.3.2.25;6.2.1.-",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0061631 ubiquitin conjugating enzyme activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol;GO:0030175 filopodium",
        "go_biological_process": "GO:0001967 suckling behavior;GO:0007617 mating behavior;GO:0009566 fertilization;GO:0000209 protein polyubiquitination;GO:0070459 prolactin secretion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q7TSS2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VCF5-1",
        "uniprot_id": "TSN10_MOUSE",
        "mass": 35313.0,
        "length": 332,
        "protein_name": "Tetraspanin-10",
        "gene_name": "Tspan10",
        "organism": "Mouse",
        "refseq_name": "tetraspanin-10",
        "refseq_ac": "NP_663338",
        "gene_names_uniprotkb": "Tspan10; Ocsp",
        "gene_names_refseq": "Ocsp; Tspan10",
        "protein_names_uniprotkb": "Tetraspanin-10; Oculospanin; Tspan-10",
        "protein_names_refseq": "oculospanin; tetraspanin-10; tspan-10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:208634)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "23035126;24935633;26668317",
        "class_list": "",
        "function": "Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10. This interaction is required for ADAM10 exit from the endoplasmic reticulum and for enzymatic maturation and trafficking to the cell surface as well as substrate specificity. Different TspanC8/ADAM10 complexes have distinct substrates., [UniProtKB, PubMed, PubMed]; Tspan-5 and Tspan-10, are up-regulated during osteoclast differentiation and knockdown of their expression dramatically inhibits osteoclastogenesis, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UFN9;Q3UFS7;Q3UGA5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019899 enzyme binding",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0072594 establishment of protein localization to organelle;GO:0051604 protein maturation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8VCF5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D3A9-1",
        "uniprot_id": "TTYH1_MOUSE",
        "mass": 49032.0,
        "length": 450,
        "protein_name": "Protein tweety homolog 1",
        "gene_name": "Ttyh1",
        "organism": "Mouse",
        "refseq_name": "protein tweety homolog 1 isoform 1",
        "refseq_ac": "NP_001001454",
        "gene_names_uniprotkb": "Ttyh1",
        "gene_names_refseq": "4930459B04Rik; 6330408P11Rik; TTY1; Ttyh1; mTTY1; tty",
        "protein_names_uniprotkb": "Protein tweety homolog 1; Volume-regulated anion channel subunit Ttyh1; mTTY1",
        "protein_names_refseq": "protein tweety homolog 1 isoform 1; protein tweety homolog 1; volume-regulated anion channel subunit Ttyh1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:57776);  (R-MMU-2672351)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "10.1101/2023.09.13.557529;10950931;15010458;17114649;17116230;20568244;21183079;21750661;31138989;34428180;36042377",
        "class_list": "",
        "function": "Calcium-independent, swelling-dependent volume-regulated anion channel (VRAC-swell) which plays a pivotal role in the process of regulatory volume decrease (RVD) in the brain through the efflux of anions like chloride and organic osmolytes like glutamate., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, PubMed]; Probable chloride channel., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; This gene encodes a member of the Tweety family of membrane proteins. Members of this family contain five predicted transmembrane regions that are arranged in a characteristic pattern. In mouse, the protein is predominantly localized to the endoplasmic reticulum and displays calcium binding activity. Targeted knock out of this gene results in early embryonic lethality prior to the blastocyst stage. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]., [RefSeq]; Ttyh1 plays an indispensable role during mitosis in early embryogenesis, possibly by maintaining Ca(2+) homeostasis in the ER., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9737,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6L751;Q6P0A7;Q8BRL4;Q8C7M4;Q9D5D1;Q9EQN7;Q9ESC3",
        "ec_number_list": "5.6.1.6;1.8.-.-;1.8.5.1",
        "go_molecular_function": "GO:0072320 volume-sensitive chloride channel activity;GO:0005509 calcium ion binding;GO:0005229 intracellularly calcium-gated chloride channel activity;GO:0005254 chloride channel activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane;GO:0030424 axon;GO:0045202 synapse;GO:0030868 smooth endoplasmic reticulum membrane",
        "go_biological_process": "GO:0000278 mitotic cell cycle;GO:0007219 Notch signaling pathway;GO:0046847 filopodium assembly;GO:0048863 stem cell differentiation;GO:0000902 cell morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q9D3A9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JMI7-1",
        "uniprot_id": "TX101_MOUSE",
        "mass": 26998.0,
        "length": 250,
        "protein_name": "Testis-expressed protein 101",
        "gene_name": "Tex101",
        "organism": "Mouse",
        "refseq_name": "testis-expressed protein 101 precursor",
        "refseq_ac": "NP_064365",
        "gene_names_uniprotkb": "Tex101",
        "gene_names_refseq": "1700008H15Rik; TES101RP; Tex101",
        "protein_names_uniprotkb": "Testis-expressed protein 101; TES101-reactive protein; TES101RP",
        "protein_names_refseq": "TES101-reactive protein; testis-expressed protein 101 precursor; testis-expressed protein 101; testis-expressed sequence 101 protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56746);  (R-MMU-163125)",
        "pathway_count": 2,
        "publication_count": 15,
        "publication_id_list": "11207211;15689535;15917346;16388701;16678124;16822331;18503752;18620756;21724266;23633567;23969891;24501175;27005865;32927778;33649997",
        "class_list": "",
        "function": "Cooperation-based sperm clusters mediate sperm oviduct entry and fertilization., [RefSeq, PubMed]; From these results we concluded that cellubrevin-dependent membrane trafficking is involved in TEX101-transport to the surface of male germ cells., [RefSeq, PubMed]; May play an important physiological role in germ cell development, [RefSeq, PubMed]; Plays a role in fertilization by controlling binding of sperm to zona pellucida and migration of spermatozoa into the oviduct probably through molecule adhesion ADAM3 (PubMed:23633567, PubMed:23969891). May play a role in signal transduction and promote protein tyrosine phosphorylation (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; Role of the Glycosylphosphatidylinositol-Anchored Protein TEX101 and Its Related Molecules in Spermatogenesis. Review article Publication Status: Online-Only, [RefSeq, PubMed]; Study demonstrated that both TEX101 and Ly6k contribute mutually for their protein expression in the testicular germ cells, suggesting that the expression-balance of these two proteins is essential for fertile sperm formation. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0044853 plasma membrane raft;GO:0001669 acrosomal vesicle",
        "go_biological_process": "GO:0007339 binding of sperm to zona pellucida;GO:0009566 fertilization;GO:0030317 flagellated sperm motility;GO:0051480 regulation of cytosolic calcium ion concentration;GO:0045575 basophil activation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q9JMI7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CGF6-1",
        "uniprot_id": "WDR47_MOUSE",
        "mass": 102312.0,
        "length": 920,
        "protein_name": "WD repeat-containing protein 47",
        "gene_name": "Wdr47",
        "organism": "Mouse",
        "refseq_name": "WD repeat-containing protein 47 isoform 1",
        "refseq_ac": "NP_852065",
        "gene_names_uniprotkb": "Wdr47; Kiaa0893",
        "gene_names_refseq": "1810073M12Rik; Wdr47; mKIAA0893",
        "protein_names_uniprotkb": "WD repeat-containing protein 47; Nemitin; Neuronal enriched MAP interacting protein",
        "protein_names_refseq": "WD repeat-containing protein 47 isoform 1; WD repeat-containing protein 47; nemitin; neuronal enriched MAP interacting protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:99512)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;21183079;21750661;22523538;34428180;34608154",
        "class_list": "",
        "function": "Wdr47, Camsaps, and Katanin cooperate to generate ciliary central microtubules. Publication Status: Online-Only, [RefSeq, PubMed]; We identify a novel LisH/WD40 repeat protein, tentatively named nemitin (neuronal enriched MAP interacting protein), as a potential regulator of MAP8-associated microtubule function, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 4,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 4,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 4,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9606,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AGC7;Q80TP4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0044877 protein-containing complex binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005874 microtubule;GO:0030424 axon;GO:0030425 dendrite;GO:0030426 growth cone",
        "go_biological_process": "GO:0007626 locomotory behavior;GO:0008344 adult locomotory behavior;GO:0031175 neuron projection development;GO:0021987 cerebral cortex development;GO:0007420 brain development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q8CGF6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K1S2-1",
        "uniprot_id": "UNC5D_MOUSE",
        "mass": 106352.0,
        "length": 956,
        "protein_name": "Netrin receptor UNC5D",
        "gene_name": "Unc5d",
        "organism": "Mouse",
        "refseq_name": "netrin receptor UNC5D isoform 1 precursor",
        "refseq_ac": "NP_694775",
        "gene_names_uniprotkb": "Unc5d; Unc5h4",
        "gene_names_refseq": "D930029E11Rik; Unc5d; Unc5h4; mKIAA1777",
        "protein_names_uniprotkb": "Netrin receptor UNC5D; Protein unc-5 homolog 4; Protein unc-5 homolog D",
        "protein_names_refseq": "netrin receptor UNC5D isoform 1 precursor; netrin receptor UNC5D; protein unc-5 homolog 4; protein unc-5 homolog D; unc5 homolog 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:210801)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;12351186;18547816;19492039;21216843;21673655;21750661;25374360;26235030;35820727",
        "class_list": "",
        "function": "Receptor for netrin required for axon guidance. Mediates axon repulsion of neuronal growth cones in the developing nervous system upon ligand binding., [UniProtKB, UniProtKB]; Receptor for the netrin NTN4 that promotes neuronal cell survival (PubMed:21216843). Plays a role in cell-cell adhesion and cell guidance. Receptor for netrin involved in cell migration (By similarity). Plays a role in the regulation of neuronal cell migration in the developing brain via its interaction with FLRT2 (PubMed:21673655). Plays a role in axon guidance by mediating axon repulsion of neuronal growth cones in the developing nervous system upon ligand binding (PubMed:21673655). May play a role in apoptosis in response to DNA damage. It also acts as a dependence receptor required for apoptosis induction when not associated with netrin ligand (By similarity). Mediates cell-cell adhesion via its interaction with FLRT3 on an adjacent cell (PubMed:26235030)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; Unc5h4 was cloned; its expression is in the developing limb and mammary gland in developing mouse, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9545,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B9EHC0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005042 netrin receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009986 cell surface",
        "go_biological_process": "GO:0006915 apoptotic process;GO:0098609 cell-cell adhesion;GO:0007411 axon guidance;GO:2001222 regulation of neuron migration;GO:0021859 pyramidal neuron differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q8K1S2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60930-1",
        "uniprot_id": "VDAC2_MOUSE",
        "mass": 31733.0,
        "length": 295,
        "protein_name": "Non-selective voltage-gated ion channel VDAC2",
        "gene_name": "Vdac2",
        "organism": "Mouse",
        "refseq_name": "non-selective voltage-gated ion channel VDAC2",
        "refseq_ac": "NP_035825",
        "gene_names_uniprotkb": "Vdac2; Vdac6",
        "gene_names_refseq": "Vdac2; Vdac6; mVDAC2; mVDAC6",
        "protein_names_uniprotkb": "Non-selective voltage-gated ion channel VDAC2; Outer mitochondrial membrane protein porin 2; VDAC-2; VDAC-6; Voltage-dependent anion-selective channel protein 6; mVDAC2; mVDAC6",
        "protein_names_refseq": "VDAC-2; VDAC-6; non-selective voltage-gated ion channel VDAC2; outer mitochondrial membrane protein porin 2; voltage-dependent anion-selective channel protein 2; voltage-dependent anion-selective channel protein 6",
        "tax_id": 10090,
        "disease": "neurodegenerative disease (Disease Ontology:DOID:1289); temporal lobe epilepsy (Disease Ontology:DOID:3328); myocardial infarction (Disease Ontology:DOID:5844); retinal degeneration (Disease Ontology:DOID:8466)",
        "pathway": " (mmu:22334);  (R-MMU-5205685);  (R-MMU-5689880)",
        "pathway_count": 3,
        "publication_count": 30,
        "publication_id_list": "10.1101/2023.09.13.557529;10430654;11465105;18250455;21540332;21750661;22561200;22645316;23576753;23806337;26495903;27802388;28011936;28135057;28935714;32069316;32152506;33087875;33300544;34203471;34321484;34428180;34799735;35984892;36288343;37453647;37507081;37828378;39927985;8660977",
        "class_list": "",
        "function": "Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis. Publication Status: Online-Only, [RefSeq, PubMed]; Catalyzes the scrambling of phospholipids across the outer mitochondrial membrane; the mechanism is unrelated to channel activity and is capable of translocating both anionic and zwitterionic phospholipids., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Non-selective voltage-gated ion channel that mediates the transport of anions and cations through the mitochondrion outer membrane and plasma membrane (PubMed:10430654). The channel adopts an open conformation at zero mV and a closed conformation at both positive and negative potentials (By similarity). There are two populations of channels; the main that functions in a lower open-state conductance with lower ion selectivity, that switch, in a voltage-dependent manner, from the open to a low-conducting 'closed' state and the other that has a normal ion selectivity in the typical high conductance, 'open' state (PubMed:10430654). Binds various lipids, including the sphingolipid ceramide, the phospholipid phosphatidylcholine, and the sterols cholesterol and oxysterol (PubMed:34799735). Binding of ceramide promotes the mitochondrial outer membrane permeabilization (MOMP) apoptotic pathway (By similarity). Associates with the translocase of the outer mitochondrial membrane (TOM) complex and PINK1 kinase at depolarized mitochondria, this interaction stabilizes PINK1 at the outer mitochondrial membrane and triggers downstream mitophagy by the recruitment of the E3 ubiquitin ligase PRKN (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 4,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q78MH6;Q99L98",
        "ec_number_list": "5.6.1.6;1.6.5.5;1.8.-.-;3.1.-.-;1.8.5.1",
        "go_molecular_function": "GO:0008142 oxysterol binding;GO:0005524 ATP binding;GO:0015485 cholesterol binding;GO:0031210 phosphatidylcholine binding;GO:0005244 voltage-gated monoatomic ion channel activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0005743 mitochondrial inner membrane;GO:0016020 membrane;GO:0031966 mitochondrial membrane",
        "go_biological_process": "GO:0007339 binding of sperm to zona pellucida;GO:0045332 phospholipid translocation;GO:0006820 monoatomic anion transport;GO:2001243 negative regulation of intrinsic apoptotic signaling pathway;GO:0097345 mitochondrial outer membrane permeabilization",
        "synthesized_glycan_count": 0,
        "hit_score": 3.9,
        "record_id": "Q60930-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P63044-1",
        "uniprot_id": "VAMP2_MOUSE",
        "mass": 12691.0,
        "length": 116,
        "protein_name": "Vesicle-associated membrane protein 2",
        "gene_name": "Vamp2",
        "organism": "Mouse",
        "refseq_name": "vesicle-associated membrane protein 2 isoform 1",
        "refseq_ac": "NP_033523",
        "gene_names_uniprotkb": "Vamp2; Syb2",
        "gene_names_refseq": "Syb-2; Syb2; Vamp-2; Vamp2; sybII",
        "protein_names_uniprotkb": "Vesicle-associated membrane protein 2; Synaptobrevin-2; VAMP-2",
        "protein_names_refseq": "synaptobrevin II; synaptobrevin-2; vesicle-associated membrane 2; vesicle-associated membrane protein 2 isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22318);  (R-MMU-181429);  (R-MMU-181430);  (R-MMU-199992);  (R-MMU-210500);  (R-MMU-212676);  (R-MMU-264642);  (R-MMU-432720);  (R-MMU-432722);  (R-MMU-449836);  (R-MMU-8856825);  (R-MMU-8856828);  (R-MMU-888590);  (R-MMU-9609523)",
        "pathway_count": 14,
        "publication_count": 17,
        "publication_id_list": "10.1101/2023.09.13.557529;10413679;15475946;17114649;17313651;17548353;19196426;20057356;20798282;21750661;26406599;28821673;32848054;33300544;38810653;40885482;9430681",
        "class_list": "",
        "function": "SNAREs (soluble N-ethylmaleimide-sensitive factor-attachment protein receptors) are essential proteins for intracellular membrane fusion. SNAREs localized on opposing membranes assemble to form a trans-SNARE complex, an extended, parallel four-helix bundle whose assembly releases energy that drives membrane fusion. The core SNARE complex typically consists of four alpha-helical domains, three from target membrane SNAREs (t-SNAREs) and one from a vesicle SNARE (v-SNARE) (PubMed:15475946, PubMed:28821673, PubMed:9430681). VAMP2 is a v-SNARE assembling into a SNARE complex with the t-SNAREs SNAP25 and STX1A to mediate the fusion of synaptic vesicles with the presynaptic plasma membrane in neurotransmitter release (PubMed:15475946). Also functions in compensatory endocytosis for synaptic vesicle recycling (PubMed:15475946). In adipocytes, it is involved in the insulin-dependent exocytosis of GLUT4 storage vesicles (PubMed:17548353, PubMed:9430681). Independently of its SNARE activity, it could modulate the gating characteristics of the delayed rectifier voltage-dependent potassium channel KCNB1 (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed]; VAMP2 controls murine epidermal differentiation and carcinogenesis by regulation of nucleophagy., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q64357",
        "ec_number_list": "",
        "go_molecular_function": "GO:0060090 molecular adaptor activity;GO:0005516 calmodulin binding;GO:0005543 phospholipid binding;GO:0042802 identical protein binding;GO:0048306 calcium-dependent protein binding",
        "go_cellular_component": "GO:0070032 synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex;GO:0098978 glutamatergic synapse;GO:0060203 clathrin-sculpted glutamate transport vesicle membrane;GO:0005737 cytoplasm;GO:0005886 plasma membrane",
        "go_biological_process": "GO:1902259 regulation of delayed rectifier potassium channel activity;GO:0015031 protein transport;GO:0032869 cellular response to insulin stimulus;GO:0045055 regulated exocytosis;GO:0090316 positive regulation of intracellular protein transport",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "P63044-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35426-1",
        "uniprot_id": "XBP1_MOUSE",
        "mass": 29619.0,
        "length": 267,
        "protein_name": "X-box-binding protein 1",
        "gene_name": "Xbp1",
        "organism": "Mouse",
        "refseq_name": "X-box-binding protein 1 isoform XBP1(S)",
        "refseq_ac": "NP_001258659",
        "gene_names_uniprotkb": "Xbp1; Treb5",
        "gene_names_refseq": "D11Ertd39e; TREB-5; TREB5; XBP-1; Xbp1",
        "protein_names_uniprotkb": "X-box-binding protein 1; TREB-5; Tax-responsive element-binding protein 5; XBP-1",
        "protein_names_refseq": "X-box-binding protein 1 isoform XBP1(S); tax-responsive element-binding protein 5 homolog",
        "tax_id": 10090,
        "disease": "inflammatory bowel disease (Disease Ontology:DOID:0050589); metabolic dysfunction-associated steatotic liver disease (Disease Ontology:DOID:0080208); borna disease (Disease Ontology:DOID:5154)",
        "pathway": " (mmu:22433)",
        "pathway_count": 1,
        "publication_count": 28,
        "publication_id_list": "10425189;10652269;10907849;11780124;11850408;12612580;12902539;14559994;15486293;16332684;16362047;17213183;17612490;18556558;18775308;19416856;20348926;20955178;21317886;21750661;21892182;23184933;23529610;23623498;24753614;25223794;38139429;7693055",
        "class_list": "",
        "function": "Functions as a stress-inducible potent transcriptional activator during endoplasmic reticulum (ER) stress by inducing unfolded protein response (UPR) target genes via binding to the UPR element (UPRE). Up-regulates target genes encoding ER chaperones and ER-associated degradation (ERAD) components to enhance the capacity of productive folding and degradation mechanism, respectively, in order to maintain the homeostasis of the ER under ER stress (PubMed:11850408, PubMed:14559994). Plays a role in the production of immunoglobulins and interleukin-6 in the presence of stimuli required for plasma cell differentiation, and promotes as well membrane phospholipid biosynthesis necessary for ER expansion (PubMed:12612580, PubMed:17213183). Contributes to the VEGF-induced endothelial cell (EC) growth and proliferation in a Akt/GSK-dependent and/or -independent signaling pathway, respectively, leading to beta-catenin nuclear translocation and E2F2 gene expression. Promotes umbilical vein EC apoptosis and atherosclerotisis development in a caspase-dependent signaling pathway, and contributes to VEGF-induced EC proliferation and angiogenesis in adult tissues under ischemic conditions. Involved in the regulation of endostatin-induced autophagy in EC through BECN1 transcriptional activation. Plays a role as an oncogene by promoting tumor progression: stimulates zinc finger protein SNAI1 transcription to induce epithelial-to-mesenchymal (EMT) transition, cell migration and invasion of breast cancer cells (By similarity). Involved in adipocyte differentiation by regulating lipogenic gene expression during lactation (PubMed:23623498, PubMed:25223794). Plays a role in the survival of both dopaminergic neurons of the substantia nigra pars compacta (SNpc), by maintaining protein homeostasis and of myeloma cells (PubMed:12902539, PubMed:24753614). Increases insulin sensitivity in the liver as a response to a high carbohydrate diet, resulting in improved glucose tolerance (PubMed:20348926). Also improves glucose homeostasis in an ER stress- and/or insulin-independent manner through both binding and proteasome-induced degradation of the transcription factor FOXO1, hence resulting in suppression of gluconeogenic genes expression and in a reduction of blood glucose levels (PubMed:21317886). Controls the induction of de novo fatty acid synthesis in hepatocytes by regulating the expression of a subset of lipogenic genes in an ER stress- and UPR-independent manner (PubMed:18556558). Binds to the 5'-CCACG-3' motif in the PPARG promoter (PubMed:25223794). Associates preferentially to the HDAC3 gene promoter region in a disturbed flow-dependent manner. Binds to the BECN1 gene promoter region. Binds to the CDH5/VE-cadherin gene promoter region. Binds to the ER stress response element (ERSE) upon ER stress (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; Functions as a transcription factor during endoplasmic reticulum stress by regulating the unfolded protein response (UPR). Required for cardiac myogenesis and hepatogenesis during embryonic development and the development of secretory tissues such as exocrine pancreas and salivary gland (PubMed:10425189, PubMed:10652269, PubMed:16362047, PubMed:17612490). Involved in differentiation of B lymphocytes to plasma cells and production of immunoglobulins. Modulates the cellular response to ER stress in a PIK3R-dependent manner. Binds to the cis-acting X box present in the promoter regions of major histocompatibility complex class II genes (By similarity). Involved in VEGF-induced endothelial cell (EC) proliferation and retinal blood vessel formation during embryonic development but also for angiogenesis in adult tissues under ischemic conditions (PubMed:23529610). Also functions as a major regulator of the UPR in obesity-induced insulin resistance and type 2 diabetes for the management of obesity and diabetes prevention (PubMed:15486293)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]; Plays a role in the unconventional cytoplasmic splicing processing of its own mRNA triggered by the endoplasmic reticulum (ER) transmembrane endoribonuclease ERN1: upon ER stress, the emerging XBP1 polypeptide chain, as part of a mRNA-ribosome-nascent chain (R-RNC) complex, cotranslationally recruits its own unprocessed mRNA through transient docking to the ER membrane and translational pausing, therefore facilitating efficient IRE1-mediated XBP1 mRNA isoform 2 production. In endothelial cells (EC), associated with KDR, promotes IRE1-mediated XBP1 mRNA isoform 2 production in a vascular endothelial growth factor (VEGF)-dependent manner, leading to EC proliferation and angiogenesis (By similarity). Functions as a negative feed-back regulator of the potent transcription factor XBP1 isoform 2 protein levels through proteasome-mediated degradation, thus preventing the constitutive activation of the ER stress response signaling pathway (PubMed:16332684). Inhibits the transactivation activity of XBP1 isoform 2 in myeloma cells (PubMed:12902539). Acts as a weak transcriptional factor. Together with HDAC3, contributes to the activation of NFE2L2-mediated HMOX1 transcription factor gene expression in a PI(3)K/mTORC2/Akt-dependent signaling pathway leading to EC survival under disturbed flow/oxidative stress. Binds to the ER stress response element (ERSE) upon ER stress. Binds to the consensus 5'-GATGACGTG[TG]N(3)[AT]T-3' sequence related to cAMP responsive element (CRE)-like sequences. Binds the Tax-responsive element (TRE) present in the long terminal repeat (LTR) of T-cell leukemia virus type 1 (HTLV-I) and to the TPA response elements (TRE). Associates preferentially to the HDAC3 gene promoter region in a static flow-dependent manner. Binds to the CDH5/VE-cadherin gene promoter region (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8VHM0;Q922G5;Q9ESS3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0002020 protease binding;GO:0003700 DNA-binding transcription factor activity;GO:0019901 protein kinase binding;GO:0042802 identical protein binding;GO:0046982 protein heterodimerization activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0042307 positive regulation of protein import into nucleus;GO:2000347 positive regulation of hepatocyte proliferation;GO:0031670 cellular response to nutrient;GO:1901985 positive regulation of protein acetylation;GO:1900102 negative regulation of endoplasmic reticulum unfolded protein response",
        "synthesized_glycan_count": 0,
        "hit_score": 3.1,
        "record_id": "O35426-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80VW5-1",
        "uniprot_id": "WHRN_MOUSE",
        "mass": 98012.0,
        "length": 918,
        "protein_name": "Whirlin",
        "gene_name": "Whrn",
        "organism": "Mouse",
        "refseq_name": "whirlin isoform 2",
        "refseq_ac": "NP_001008791",
        "gene_names_uniprotkb": "Whrn; Dfnb31; Kiaa1526",
        "gene_names_refseq": "1110035G07Rik; C430046P22Rik; Dfnb31; Ush2d; Whrn; wi",
        "protein_names_uniprotkb": "Whirlin",
        "protein_names_refseq": "whirler; whirlin isoform 2",
        "tax_id": 10090,
        "disease": "autosomal recessive nonsyndromic deafness 31 (Disease Ontology:DOID:0110490); Usher syndrome type 2D (Disease Ontology:DOID:0110840); sensorineural hearing loss (Disease Ontology:DOID:10003)",
        "pathway": " (mmu:73750)",
        "pathway_count": 1,
        "publication_count": 21,
        "publication_id_list": "12124769;12833159;15590698;15590699;15654330;16301217;16434480;16829577;17326148;17567809;17584769;20502675;21236676;21750661;22323458;23055499;24334608;25406310;30053338;33009420;37066759",
        "class_list": "",
        "function": "Deafness-Associated ADGRV1 Mutation Impairs USH2A Stability through Improper Phosphorylation of WHRN and WDSUB1 Recruitment., [RefSeq, PubMed]; Interaction of protocadherin-15 with the scaffold protein whirlin supports its anchoring of hair-bundle lateral links in cochlear hair cells. Publication Status: Online-Only, [RefSeq, PubMed]; Involved in hearing and vision as member of the USH2 complex (PubMed:20502675). Necessary for elongation and maintenance of inner and outer hair cell stereocilia in the organ of Corti in the inner ear (PubMed:15590699). Involved in the maintenance of the hair bundle ankle region, which connects stereocilia in cochlear hair cells of the inner ear (PubMed:20502675, PubMed:24334608). In retina photoreceptors, required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport (PubMed:20502675)., [UniProtKB, PubMed, PubMed, PubMed]; This gene encodes a protein required for elongation and actin polymerization in the hair cell stereocilia. The encoded protein is localized to the cytoplasm and co-localizes with the growing end of actin filaments. Mutations in this gene have been linked to deafness. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2013]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AGD2;I6MML6;I6MML7;Q3TZC8;Q5MLF1;Q5MLF2;Q5MLF3;Q5MLF4;Q5MLF5;Q5MLF6;Q5MLF7;Q5MLF8;Q5MLF9;Q80TC2;Q80VW4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019904 protein domain specific binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005884 actin filament;GO:0005886 plasma membrane;GO:0005929 cilium",
        "go_biological_process": "GO:0010628 positive regulation of gene expression;GO:0050910 detection of mechanical stimulus involved in sensory perception of sound;GO:0001895 retina homeostasis;GO:0045184 establishment of protein localization;GO:0007605 sensory perception of sound",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "Q80VW5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P97441-1",
        "uniprot_id": "ZNT3_MOUSE",
        "mass": 41824.0,
        "length": 388,
        "protein_name": "Probable proton-coupled zinc antiporter SLC30A3",
        "gene_name": "Slc30a3",
        "organism": "Mouse",
        "refseq_name": "probable proton-coupled zinc antiporter SLC30A3 isoform 1",
        "refseq_ac": "NP_035903",
        "gene_names_uniprotkb": "Slc30a3; Znt3",
        "gene_names_refseq": "Slc30a3; Znt3",
        "protein_names_uniprotkb": "Probable proton-coupled zinc antiporter SLC30A3; Solute carrier family 30 member 3; Zinc transporter 3; ZnT-3",
        "protein_names_refseq": "probable proton-coupled zinc antiporter SLC30A3 isoform 1; probable proton-coupled zinc antiporter SLC30A3; solute carrier family 30 member 3; zinc transporter 3; znT-3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22784)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "17114649;19521526;21750661;21998198;33300544;38830758;39048372;8962159;9356509;9990090",
        "class_list": "",
        "function": "Probable proton-coupled zinc ion antiporter mediating the import of zinc from cytoplasm into synaptic vesicles and participating to cellular zinc ion homeostasis in the brain., [UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Trans-synaptic Association of Vesicular Zinc Transporter 3 and Shank3 Supports Synapse-Specific Dendritic Spine Structure and Function in the Mouse Auditory Cortex. Publication Status: Online-Only, [RefSeq, PubMed]; Zinc transporter ZnT3/Slc30a3 has a potential role in zinc ion influx in mouse oocytes., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P97511",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005385 zinc ion transmembrane transporter activity;GO:0046872 metal ion binding;GO:0015297 antiporter activity;GO:0008324 monoatomic cation transmembrane transporter activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0097457 hippocampal mossy fiber;GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0005765 lysosomal membrane",
        "go_biological_process": "GO:0010312 detoxification of zinc ion;GO:0071577 zinc ion transmembrane transport;GO:0010043 response to zinc ion;GO:0051050 positive regulation of transport;GO:0099180 zinc ion import into synaptic vesicle",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "P97441-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q68FE8-1",
        "uniprot_id": "Z280D_MOUSE",
        "mass": 107836.0,
        "length": 974,
        "protein_name": "Zinc finger protein 280D",
        "gene_name": "Zfp280d; Znf280d",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 280D isoform 2",
        "refseq_ac": "NP_001298034",
        "gene_names_uniprotkb": "Zfp280d; Znf280d; Suhw4; Zfp280d",
        "gene_names_refseq": "A930005F02Rik; Suhw4; ZNF634; Zfp280d; Znf280d",
        "protein_names_uniprotkb": "Zinc finger protein 280D; Suppressor of hairy wing homolog 4",
        "protein_names_refseq": "suppressor of hairy wing homolog 4; zinc finger protein 280D isoform 2",
        "tax_id": 10090,
        "disease": "autism spectrum disorder (Disease Ontology:DOID:0060041); intellectual disability (Disease Ontology:DOID:1059)",
        "pathway": " (mmu:235469)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "10.1101/2023.09.13.557529;21183079;21750661",
        "class_list": "",
        "function": "May function as a transcription factor., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9507,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3T9B1;Q8BI82",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006355 regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q68FE8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80TN5-1",
        "uniprot_id": "ZDH17_MOUSE",
        "mass": 72621.0,
        "length": 632,
        "protein_name": "Palmitoyltransferase ZDHHC17",
        "gene_name": "Zdhhc17",
        "organism": "Mouse",
        "refseq_name": "palmitoyltransferase ZDHHC17 isoform 1",
        "refseq_ac": "NP_766142",
        "gene_names_uniprotkb": "Zdhhc17; Hip14; Kiaa0946",
        "gene_names_refseq": "A230053P19Rik; D130071N24Rik; DHHC-17; Hip14; Zdhhc17",
        "protein_names_uniprotkb": "Palmitoyltransferase ZDHHC17; 2.3.1.-; 2.3.1.225; Acyltransferase ZDHHC17; DHHC domain-containing cysteine-rich protein 17; DHHC-17; Huntingtin-interacting protein 14; Zinc finger DHHC domain-containing protein 17",
        "protein_names_refseq": "DHHC domain-containing cysteine-rich protein 17; acyltransferase ZDHHC17; acyltransferase ZDHHC7; huntingtin interacting protein 14; palmitoyltransferase ZDHHC17 isoform 1; palmitoyltransferase ZDHHC17; zinc finger DHHC domain-containing protein 17",
        "tax_id": 10090,
        "disease": "Huntington's disease (Disease Ontology:DOID:12858)",
        "pathway": " (mmu:320150)",
        "pathway_count": 1,
        "publication_count": 17,
        "publication_id_list": "10.1101/2023.09.13.557529;12393793;15489887;15603741;18596047;18794299;21750661;24705354;25253725;26198635;26232532;27911442;28167757;28882895;33207199;34428180;36442513",
        "class_list": "",
        "function": "Coupled Control of Distal Axon Integrity and Somal Responses to Axonal Damage by the Palmitoyl Acyltransferase ZDHHC17., [RefSeq, PubMed]; Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates and is involved in a variety of cellular processes (PubMed:15489887, PubMed:15603741, PubMed:25253725, PubMed:27911442). Has no stringent fatty acid selectivity and in addition to palmitate can also transfer onto target proteins myristate from tetradecanoyl-CoA and stearate from octadecanoyl-CoA (PubMed:28167757). Palmitoyltransferase specific for a subset of neuronal proteins, including SNAP25, DLG4/PSD95, GAD2, SYT1 and HTT (PubMed:15489887, PubMed:15603741, PubMed:25253725). Also palmitoylates neuronal protein GPM6A as well as SPRED1 and SPRED3 (By similarity). Could also play a role in axonogenesis through the regulation of NTRK1 and the downstream ERK1/ERK2 signaling cascade (PubMed:26232532). May be involved in the sorting or targeting of critical proteins involved in the initiating events of endocytosis at the plasma membrane (By similarity). May play a role in Mg(2+) transport (By similarity). Could also palmitoylate DNAJC5 and regulate its localization to the Golgi membrane (PubMed:18596047). Palmitoylates CASP6, thereby preventing its dimerization and subsequent activation (PubMed:27911442)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed]; S-acylation of Sprouty and SPRED proteins by the S-acyltransferase zDHHC17 involves a novel mode of enzyme-substrate interaction., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9718,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BJ08;Q8BYQ2;Q8BYQ6",
        "ec_number_list": "2.3.1.225;6.3.1.2;2.3.1.-",
        "go_molecular_function": "GO:0005102 signaling receptor binding;GO:0042802 identical protein binding;GO:0019706 protein-cysteine S-palmitoyltransferase activity;GO:0016409 palmitoyltransferase activity;GO:0019705 protein-cysteine S-myristoyltransferase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0000139 Golgi membrane;GO:0005794 Golgi apparatus;GO:0042734 presynaptic membrane;GO:0030660 Golgi-associated vesicle membrane",
        "go_biological_process": "GO:0007409 axonogenesis;GO:0042953 lipoprotein transport;GO:0070372 regulation of ERK1 and ERK2 cascade;GO:0043067 regulation of programmed cell death;GO:0018345 protein palmitoylation",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "Q80TN5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BHZ4-1",
        "uniprot_id": "ZN592_MOUSE",
        "mass": 137514.0,
        "length": 1262,
        "protein_name": "Zinc finger protein 592",
        "gene_name": "Znf592",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 592",
        "refseq_ac": "NP_848822",
        "gene_names_uniprotkb": "Znf592; Kiaa0211; Zfp592",
        "gene_names_refseq": "A730014M16Rik; Zfp592; Znf592",
        "protein_names_uniprotkb": "Zinc finger protein 592; Zfp-592",
        "protein_names_refseq": "zinc finger protein 592",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:233410);  (R-MMU-9940951)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "20531441;21183079;25428506;30084848;34428180",
        "class_list": "",
        "function": "May be involved in transcriptional regulation., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80XM1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q8BHZ4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CHP0-1",
        "uniprot_id": "ZC3H3_MOUSE",
        "mass": 103224.0,
        "length": 950,
        "protein_name": "Zinc finger CCCH domain-containing protein 3",
        "gene_name": "Zc3h3",
        "organism": "Mouse",
        "refseq_name": "zinc finger CCCH domain-containing protein 3 isoform 1",
        "refseq_ac": "NP_742119",
        "gene_names_uniprotkb": "Zc3h3; Kiaa0150; Smicl; Zc3hdc3; Zfp623",
        "gene_names_refseq": "Kiaa0150; Smicl; Zc3h3; Zc3hdc3",
        "protein_names_uniprotkb": "Zinc finger CCCH domain-containing protein 3; Smad-interacting CPSF-like factor",
        "protein_names_refseq": "smad-interacting CPSF-like factor; zinc finger CCCH domain-containing protein 3 isoform 1; zinc finger CCCH domain-containing protein 3; zinc finger CCCH type domain containing 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:223642);  (R-MMU-9930044)",
        "pathway_count": 2,
        "publication_count": 2,
        "publication_id_list": "16115198;21183079",
        "class_list": "",
        "function": "Required for the export of polyadenylated mRNAs from the nucleus (By similarity). Enhances ACVR1B-induced SMAD-dependent transcription. Binds to single-stranded DNA but not to double-stranded DNA in vitro. Involved in RNA cleavage (PubMed:16115198)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80X78",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0008270 zinc ion binding;GO:0046332 SMAD binding;GO:0070412 R-SMAD binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005847 mRNA cleavage and polyadenylation specificity factor complex",
        "go_biological_process": "GO:0032927 positive regulation of activin receptor signaling pathway;GO:0051028 mRNA transport;GO:0031124 mRNA 3'-end processing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8CHP0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JJ48-1",
        "uniprot_id": "ZC3H8_MOUSE",
        "mass": 34913.0,
        "length": 305,
        "protein_name": "Zinc finger CCCH domain-containing protein 8",
        "gene_name": "Zc3h8",
        "organism": "Mouse",
        "refseq_name": "zinc finger CCCH domain-containing protein 8",
        "refseq_ac": "NP_065619",
        "gene_names_uniprotkb": "Zc3h8; Fliz1; Zc3hdc8",
        "gene_names_refseq": "E130108N08Rik; Fliz1; Zc3h8; Zc3hdc8",
        "protein_names_uniprotkb": "Zinc finger CCCH domain-containing protein 8; Fetal liver zinc finger protein 1",
        "protein_names_refseq": "fetal liver zinc finger 1; fetal liver zinc finger protein 1; putative zinc finger protein FLIZ1; zinc finger CCCH domain-containing protein 8; zinc finger CCCH type domain containing 8",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:57432);  (R-MMU-6807505)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "11318609;12077251;21183079;30041613",
        "class_list": "",
        "function": "Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III. Acts as a transcriptional repressor of the GATA3 promoter. Induces thymocyte apoptosis when overexpressed, which may indicate a role in regulation of thymocyte homeostasis (By similarity). Sequence-specific DNA-binding factor that binds to the 5'-AGGTCTC-3' sequence within the negative cis-acting element intronic regulatory region (IRR) of the GATA3 gene., [UniProtKB]; Fliz1 binds specifically to a negative cis-acting element in the intronic regulatory region of GATA-3 and, when overexpressed, can function as a transcriptional repressor of the GATA-3 promoter in vitro and in vivo., [RefSeq, PubMed]; Using RNA silencing to decrease expression of ZC3H8 in a mouse tumor cell line in vitro, then studied phenotype and cell behavior of the tumor cell line, and further studied ability of those cells to form tumors in mice in vivo. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80X92",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0008270 zinc ion binding;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0001162 RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0008023 transcription elongation factor complex;GO:0016604 nuclear body;GO:0015030 Cajal body",
        "go_biological_process": "GO:0032785 negative regulation of DNA-templated transcription, elongation;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006915 apoptotic process;GO:0045892 negative regulation of DNA-templated transcription;GO:0070245 positive regulation of thymocyte apoptotic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9JJ48-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9ESG8-1",
        "uniprot_id": "ZDH16_MOUSE",
        "mass": 41794.0,
        "length": 361,
        "protein_name": "Palmitoyltransferase ZDHHC16",
        "gene_name": "Zdhhc16",
        "organism": "Mouse",
        "refseq_name": "palmitoyltransferase ZDHHC16 isoform 2",
        "refseq_ac": "NP_076229",
        "gene_names_uniprotkb": "Zdhhc16; Aph2",
        "gene_names_refseq": "1500015N03Rik; Aph2; Zdhhc16",
        "protein_names_uniprotkb": "Palmitoyltransferase ZDHHC16; 2.3.1.225; Abl-philin 2; DHHC-16; Zinc finger DHHC domain-containing protein 16",
        "protein_names_refseq": "Abl-philin 2; ablphilin-2; palmitoyltransferase ZDHHC16 isoform 2; probable palmitoyltransferase ZDHHC16; zinc finger DHHC domain-containing protein 16",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74168)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "12021275;21750661;26644582;27159997;30084848",
        "class_list": "",
        "function": "Aph2 as a critical in vivo regulator of cardiac function and reveal roles for protein palmitoylation in the development of other organs including eyes., [RefSeq, PubMed]; Aph2 may be involved in ER stress-induced apoptosis in which c-Abl plays an important role, [RefSeq, PubMed]; Knockout of zDHHC16, a palmitoyltransferase gene is identified as an interacting protein for c-Abl, a non-receptor tyrosine kinase involved in DNA damage response, reproduced most of the defects in DNA damage responses produced by the inhibition of protein palmitoylation. Publication Status: Online-Only, [RefSeq, PubMed]; Palmitoyl acyltransferase that mediates palmitoylation of proteins such as PLN and ZDHHC6 (PubMed:26644582). Required during embryonic heart development and cardiac function, possibly by mediating palmitoylation of PLN, thereby affecting PLN phosphorylation and homooligomerization (PubMed:26644582). Also required for eye development (PubMed:26644582). Palmitoylates ZDHHC6, affecting the quaternary assembly of ZDHHC6, its localization, stability and function (By similarity). May play a role in DNA damage response (PubMed:27159997). May be involved in apoptosis regulation (PubMed:12021275). Involved in the proliferation of neural stem cells by regulating the FGF/ERK pathway (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TI22;Q3UA59;Q91XC5",
        "ec_number_list": "2.3.1.225;6.3.1.2;2.3.1.-",
        "go_molecular_function": "GO:0019706 protein-cysteine S-palmitoyltransferase activity;GO:0016409 palmitoyltransferase activity",
        "go_cellular_component": "GO:0005794 Golgi apparatus;GO:0005789 endoplasmic reticulum membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007507 heart development;GO:0006915 apoptotic process;GO:0006974 DNA damage response;GO:0001654 eye development;GO:0021537 telencephalon development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q9ESG8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5F293-1",
        "uniprot_id": "ZBTB4_MOUSE",
        "mass": 102663.0,
        "length": 982,
        "protein_name": "Zinc finger and BTB domain-containing protein 4",
        "gene_name": "Zbtb4",
        "organism": "Mouse",
        "refseq_name": "zinc finger and BTB domain-containing protein 4",
        "refseq_ac": "NP_083624",
        "gene_names_uniprotkb": "Zbtb4; Kiaa1538",
        "gene_names_refseq": "2310026P19Rik; 9230111I22Rik; Zbtb4; mKIAA1538",
        "protein_names_uniprotkb": "Zinc finger and BTB domain-containing protein 4",
        "protein_names_refseq": "zinc finger and BTB domain-containing protein 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:75580)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21750661;27446912;34428180;38641154;40021952",
        "class_list": "",
        "function": "MSC-derived exosomes deliver ZBTB4 to mediate transcriptional repression of ITIH3 in astrocytes in spinal cord injury., [RefSeq, PubMed]; Transcriptional repressor with bimodal DNA-binding specificity. Represses transcription in a methyl-CpG-dependent manner. Binds with a higher affinity to methylated CpG dinucleotides in the consensus sequence 5'-CGCG-3' but can also bind to the non-methylated consensus sequence 5'-CTGCNA-3' also known as the consensus kaiso binding site (KBS). Can also bind specifically to a single methyl-CpG pair and can bind hemimethylated DNA but with a lower affinity compared to methylated DNA. Plays a role in postnatal myogenesis, may be involved in the regulation of satellite cells self-renewal (PubMed:27446912)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UHT8;Q69ZH0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0019901 protein kinase binding;GO:0042803 protein homodimerization activity;GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0016604 nuclear body;GO:0005694 chromosome",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0006355 regulation of DNA-templated transcription;GO:0045892 negative regulation of DNA-templated transcription;GO:0006974 DNA damage response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q5F293-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3U3W5-1",
        "uniprot_id": "ANM9_MOUSE",
        "mass": 94220.0,
        "length": 846,
        "protein_name": "Protein arginine N-methyltransferase 9",
        "gene_name": "Prmt9",
        "organism": "Mouse",
        "refseq_name": "protein arginine N-methyltransferase 9 isoform 1",
        "refseq_ac": "NP_001074709",
        "gene_names_uniprotkb": "Prmt9; Prmt10",
        "gene_names_refseq": "Prmt10; Prmt9",
        "protein_names_uniprotkb": "Protein arginine N-methyltransferase 9; 2.1.1.320; Protein arginine N-methyltransferase 10",
        "protein_names_refseq": "protein arginine N-methyltransferase 9 isoform 1; protein arginine methyltransferase 10 (putative); putative protein arginine N-methyltransferase 10; putative protein arginine N-methyltransferase 9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:102182)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;38561334",
        "class_list": "",
        "function": "Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA). Specifically mediates the symmetrical dimethylation of SF3B2. Involved in the regulation of alternative splicing of pre-mRNA., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "D3YU52;Q8BLF8;Q8BLG1",
        "ec_number_list": "2.1.1.320",
        "go_molecular_function": "GO:0016274 protein-arginine N-methyltransferase activity;GO:0042054 histone methyltransferase activity;GO:0035243 protein-arginine omega-N symmetric methyltransferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006338 chromatin remodeling;GO:0006397 mRNA processing;GO:0006355 regulation of DNA-templated transcription;GO:0032259 methylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q3U3W5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BXQ6-1",
        "uniprot_id": "AMPO_MOUSE",
        "mass": 93579.0,
        "length": 823,
        "protein_name": "Aminopeptidase O",
        "gene_name": "Aopep",
        "organism": "Mouse",
        "refseq_name": "aminopeptidase O",
        "refseq_ac": "NP_001276853",
        "gene_names_uniprotkb": "Aopep; 2010111I01Rik; Onpep",
        "gene_names_refseq": "2010111I01Rik; 2300006M17Rik; AP-O; Aopep; ApO; mir-23b; mir-24-1; mir-27b",
        "protein_names_uniprotkb": "Aminopeptidase O; 3.4.11.-; AP-O",
        "protein_names_refseq": "aminopeptidase O",
        "tax_id": 10090,
        "disease": "dystonia 31 (Disease Ontology:DOID:0060938)",
        "pathway": " (mmu:72061)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "15687497;17803194;21750661;25187367;29275848;33430468",
        "class_list": "",
        "function": "Alternative splicing predictably produces protein products with or without the catalytic domain and/or a nucleolar localisation signal and represents mechanism in regulating activity of APO., [RefSeq, PubMed]; Aminopeptidase which catalyzes the hydrolysis of amino acid residues from the N-terminus of peptide or protein substrates., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Loss of miR-23b/27b/24-1 Cluster Impairs Glucose Tolerance via Glycolysis Pathway in Mice. Publication Status: Online-Only, [RefSeq, PubMed]; Our results characterize a novel aspect of miR-23b function in leukocyte migration, and they identify miR-23b as a potential therapeutic target in the amelioration of MS and likely other autoimmune diseases., [RefSeq, PubMed]; These results indicate that miR-27b functions as a central target of glucocorticoids and as an upstream regulator of Prdm16., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UQZ7;Q6P0W6;Q6P394;Q8BHX5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0070006 metalloaminopeptidase activity",
        "go_cellular_component": "GO:0005730 nucleolus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006508 proteolysis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q8BXQ6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P58459-1",
        "uniprot_id": "ATS10_MOUSE",
        "mass": 121086.0,
        "length": 1104,
        "protein_name": "A disintegrin and metalloproteinase with thrombospondin motifs 10",
        "gene_name": "Adamts10",
        "organism": "Mouse",
        "refseq_name": "A disintegrin and metalloproteinase with thrombospondin motifs 10 isoform 1 preproprotein",
        "refseq_ac": "NP_766207",
        "gene_names_uniprotkb": "Adamts10",
        "gene_names_refseq": "9430006O18; Adam-ts10; Adamts-10; Adamts10; Znmp",
        "protein_names_uniprotkb": "A disintegrin and metalloproteinase with thrombospondin motifs 10; 3.4.24.-; ADAM-TS 10; ADAM-TS10; ADAMTS-10",
        "protein_names_refseq": "A disintegrin and metalloproteinase with thrombospondin motifs 10 isoform 1 preproprotein; a disintegrin and metalloproteinase with thrombospondin motifs 10; a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 10; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 10; zinc metalloendopeptidase",
        "tax_id": 10090,
        "disease": "Weill-Marchesani syndrome (Disease Ontology:DOID:0050475)",
        "pathway": " (mmu:224697);  (R-MMU-5173214)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;15112104;15355968;21750661;22458710;24103556;34424262;36216203",
        "class_list": "",
        "function": "ADAMTS10 is a functional metalloprotease as demonstrated by cleavage of alpha2-macroglobulin, [RefSeq, PubMed]; Altered Ocular Fibrillin Microfibril Composition in Mice With a Glaucoma-Causing Mutation of Adamts10., [RefSeq, PubMed]; Metalloprotease that participate in microfibrils assembly. Microfibrils are extracellular matrix components occurring independently or along with elastin in the formation of elastic tissues (By similarity)., [UniProtKB]; Optic neuropathy associated with TGFbeta dysregulation in mice with a glaucoma-causative mutation of ADAMTS10., [RefSeq, PubMed]; TGF-beta stimulation of renal cells results in a significant up-regulation of Adams 10, 17, 12, and 19, [RefSeq, PubMed]; These studies support the notion that sperm-oocyte interactions involve considerable functional redundancy and identify ADAMTS10 as a novel candidate in the mediation of these fundamentally important events., [RefSeq, PubMed]; This gene encodes a member of 'a disintegrin and metalloproteinase with thrombospondin motifs' (ADAMTS) family of multi-domain matrix-associated metalloendopeptidases that have diverse roles in tissue morphogenesis and pathophysiological remodeling, in inflammation and in vascular biology. The encoded preproprotein undergoes proteolytic processing to generate a functional, zinc-dependent metallopeptidase enzyme. [provided by RefSeq, Jul 2016]., [RefSeq]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q497H1;Q78TI1;Q8CG28",
        "ec_number_list": "3.4.24.-;3.4.24.87;2.4.1.-;3.4.24.82;3.4.24.14;2.4.1.221",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0046872 metal ion binding;GO:0008237 metallopeptidase activity",
        "go_cellular_component": "GO:0031012 extracellular matrix;GO:0001527 microfibril",
        "go_biological_process": "GO:0006508 proteolysis;GO:0030198 extracellular matrix organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "P58459-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91YE9-1",
        "uniprot_id": "5NT1B_MOUSE",
        "mass": 65002.0,
        "length": 573,
        "protein_name": "Cytosolic 5'-nucleotidase 1B",
        "gene_name": "Nt5c1b",
        "organism": "Mouse",
        "refseq_name": "cytosolic 5'-nucleotidase 1B isoform 1",
        "refseq_ac": "NP_081864",
        "gene_names_uniprotkb": "Nt5c1b; Airp",
        "gene_names_refseq": "4921514H13Rik; AIRP; CN-IB; Nt5c1b; cN1B",
        "protein_names_uniprotkb": "Cytosolic 5'-nucleotidase 1B; 3.1.3.5; Autoimmune infertility-related protein; Cytosolic 5'-nucleotidase IB; cN-IB; cN1B",
        "protein_names_refseq": "5'nucleotidase; autoimmune infertility-related protein; cytosolic 5'-nucleotidase 1B isoform 1; cytosolic 5'-nucleotidase 1B; cytosolic 5'-nucleotidase IB",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:70881);  (R-MMU-74259)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "11690631;21750661;26917036",
        "class_list": "",
        "function": "Catalyzes the hydrolysis of nucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside, AMP is the major substrate., [UniProtKB, PubMed]; Ecto-5'-nucleotidase mRNA levels were found to be diminished in both MT1 and MT1/2 knockout mice., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QNH2;Q91Y48",
        "ec_number_list": "3.1.3.5;3.1.3.89;3.1.3.99;3.1.3.1;3.9.1.1;3.1.3.91;2.7.1.77;3.1.3.35;3.6.1.-;3.1.4.1;3.6.1.9;3.1.3.2;3.1.3.48",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0000166 nucleotide binding;GO:0008253 5'-nucleotidase activity",
        "go_cellular_component": "GO:0005829 cytosol;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0046085 adenosine metabolic process;GO:0006196 AMP catabolic process;GO:0009116 nucleoside metabolic process;GO:0009117 nucleotide metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q91YE9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99MD6-1",
        "uniprot_id": "TRXR3_MOUSE",
        "mass": 71319.0,
        "length": 652,
        "protein_name": "Thioredoxin reductase 3",
        "gene_name": "Txnrd3",
        "organism": "Mouse",
        "refseq_name": "thioredoxin reductase 3 isoform 1",
        "refseq_ac": "NP_001171529",
        "gene_names_uniprotkb": "Txnrd3; Tgr; Trxr3",
        "gene_names_refseq": "TGR; TR2; Txnrd3",
        "protein_names_uniprotkb": "Thioredoxin reductase 3; 1.8.1.9; Thioredoxin and glutathione reductase; Thioredoxin reductase TR2",
        "protein_names_refseq": "thioredoxin and glutathione reductase; thioredoxin reductase 3 isoform 1; thioredoxin reductase TR2",
        "tax_id": 10090,
        "disease": "colorectal adenoma (Disease Ontology:DOID:0050860); colorectal carcinoma (Disease Ontology:DOID:0080199)",
        "pathway": " (mmu:232223)",
        "pathway_count": 1,
        "publication_count": 14,
        "publication_id_list": "10455115;11259642;15901730;16262253;20018845;21540332;21750661;22645316;23806337;24129315;34428180;35094204;35753352;36421005",
        "class_list": "",
        "function": "Decreased thioredoxin reductase 3 expression promotes nickel-induced damage to cardiac tissue via activating oxidative stress-induced apoptosis and inflammation., [RefSeq, PubMed]; Displays thioredoxin reductase, glutaredoxin and glutathione reductase activities. Catalyzes disulfide bond isomerization. Promotes disulfide bond formation between GPX4 and various sperm proteins and may play a role in sperm maturation by promoting formation of sperm structural components., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB]; Selenoprotein TXNRD3 supports male fertility via the redox regulation of spermatogenesis., [RefSeq, PubMed]; Study shows that CUG codon is used as an inefficient start codon to generate protein Thioredoxin/glutathione reductase isoforms in mouse., [RefSeq, PubMed]; The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes the third TrxR, which unlike the other two isozymes, contains an additional N-terminal glutaredoxin (Grx) domain, and shows highest expression in testis. The Grx domain allows this isozyme to participate in both Trx and glutathione systems. It functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. There is evidence for additional isoforms resulting from the use of a non-AUG (CUG), and an in-frame downstream AUG as translation initiation codons (PMID:20018845). [provided by RefSeq, Aug 2017]., [RefSeq]; Thioredoxin reductase 3 suppression promotes colitis and carcinogenesis via activating pyroptosis and necrosis. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CZE5",
        "ec_number_list": "1.8.1.9;1.11.1.2",
        "go_molecular_function": "GO:0004791 thioredoxin-disulfide reductase (NADPH) activity;GO:0050660 flavin adenine dinucleotide binding;GO:0016668 oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0030154 cell differentiation;GO:0045454 cell redox homeostasis;GO:0001825 blastocyst formation;GO:0006749 glutathione metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q99MD6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CX30-1",
        "uniprot_id": "YIF1B_MOUSE",
        "mass": 33983.0,
        "length": 311,
        "protein_name": "Protein YIF1B",
        "gene_name": "Yif1b",
        "organism": "Mouse",
        "refseq_name": "protein YIF1B isoform 2",
        "refseq_ac": "NP_001103671",
        "gene_names_uniprotkb": "Yif1b",
        "gene_names_refseq": "9430029K10Rik; Yif1b; Yip1b",
        "protein_names_uniprotkb": "Protein YIF1B; YIP1-interacting factor homolog B",
        "protein_names_refseq": "YIP1-interacting factor homolog B; protein YIF1B isoform 2; protein YIF1B",
        "tax_id": 10090,
        "disease": "Parkinson's disease (Disease Ontology:DOID:14330)",
        "pathway": " (mmu:77254)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "17242355;21750661;22645316;25605945;26077767;32782141;33103737;34428180;36852467;40885482",
        "class_list": "",
        "function": "Functions in endoplasmic reticulum to Golgi vesicle-mediated transport and regulates the proper organization of the endoplasmic reticulum and the Golgi (PubMed:26077767, PubMed:33103737). Plays a key role in targeting to neuronal dendrites receptors such as HTR1A (By similarity). Also plays a role in primary cilium and sperm flagellum assembly probably through protein transport to these compartments (PubMed:33103737)., [UniProtKB, UniProtKB, PubMed, PubMed]; Has a role in transport between endoplasmic reticulum and Golgi., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; If1B depletion disorganizes Golgi architecture and anterograde traffic., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q32M25;Q3UXJ5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0030134 COPII-coated ER to Golgi transport vesicle;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0015031 protein transport;GO:0006612 protein targeting to membrane;GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport;GO:0060271 cilium assembly;GO:0120316 sperm flagellum assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9CX30-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UHH1-1",
        "uniprot_id": "ZSWM8_MOUSE",
        "mass": 197061.0,
        "length": 1832,
        "protein_name": "Zinc finger SWIM domain-containing protein 8",
        "gene_name": "Zswim8",
        "organism": "Mouse",
        "refseq_name": "zinc finger SWIM domain-containing protein 8 isoform 2",
        "refseq_ac": "NP_001239010",
        "gene_names_uniprotkb": "Zswim8; Kiaa0913",
        "gene_names_refseq": "2310021P13Rik; 4832404P21Rik; Kiaa0913; Zswim8; mKIAA0913",
        "protein_names_uniprotkb": "Zinc finger SWIM domain-containing protein 8",
        "protein_names_refseq": "zinc finger SWIM domain-containing protein 8 isoform 2; zinc finger SWIM domain-containing protein 8",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:268721)",
        "pathway_count": 1,
        "publication_count": 17,
        "publication_id_list": "10.1101/2023.09.13.557529;17242355;21183079;21750661;24012004;24129315;25605945;29187734;31219806;32782141;33184237;34203471;34428180;35820727;35989311;37532519;40885482",
        "class_list": "",
        "function": "Substrate recognition component of a SCF-like E3 ubiquitin-protein ligase complex that promotes target-directed microRNA degradation (TDMD), a process that mediates degradation of microRNAs (miRNAs) (PubMed:33184237, PubMed:37532519). The SCF-like E3 ubiquitin-protein ligase complex acts by catalyzing ubiquitination and subsequent degradation of AGO proteins (AGO1, AGO2, AGO3 and/or AGO4), thereby exposing miRNAs for degradation (By similarity). Specifically recognizes and binds AGO proteins when they are engaged with a TDMD target (By similarity). May also acts as a regulator of axon guidance: specifically recognizes misfolded ROBO3 and promotes its ubiquitination and subsequent degradation (By similarity). Plays an essential role for proper embryonic development of heart and lung (PubMed:37532519). Controls protein quality of DAB1, a key signal molecule for brain development, thus protecting its signaling strength. Mechanistically, recognizes intrinsically disordered regions of DAB1 and eliminates misfolded DAB1 that cannot be properly phosphorylated (PubMed:35989311)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; ZSWIM8 destabilizes many murine microRNAs and is required for proper embryonic growth and development., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 1,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 11,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 8,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RX90;Q5U4B9;Q6PCY6;Q80Y41;Q8CE12;Q8CHC3;Q9D789",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:1990756 ubiquitin-like ligase-substrate adaptor activity",
        "go_cellular_component": "GO:0005829 cytosol;GO:0031462 Cul2-RING ubiquitin ligase complex;GO:0031463 Cul3-RING ubiquitin ligase complex;GO:0031461 cullin-RING ubiquitin ligase complex",
        "go_biological_process": "GO:0060337 type I interferon-mediated signaling pathway;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination;GO:2000627 positive regulation of miRNA catabolic process;GO:0006515 protein quality control for misfolded or incompletely synthesized proteins",
        "synthesized_glycan_count": 0,
        "hit_score": 2.5,
        "record_id": "Q3UHH1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P97467-1",
        "uniprot_id": "AMD_MOUSE",
        "mass": 108963.0,
        "length": 979,
        "protein_name": "Peptidyl-glycine alpha-amidating monooxygenase",
        "gene_name": "Pam",
        "organism": "Mouse",
        "refseq_name": "peptidyl-glycine alpha-amidating monooxygenase isoform 1 precursor",
        "refseq_ac": "NP_038654",
        "gene_names_uniprotkb": "Pam",
        "gene_names_refseq": "PHM; Pam",
        "protein_names_uniprotkb": "Peptidyl-glycine alpha-amidating monooxygenase; PAL; PAM; Peptidylamidoglycolate lyase",
        "protein_names_refseq": "PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE PRECURSOR (PAM); peptidyl-glycine alpha-amidating monooxygenase isoform 1 precursor",
        "tax_id": 10090,
        "disease": "hypothyroidism (Disease Ontology:DOID:1459); prostate adenocarcinoma (Disease Ontology:DOID:2526)",
        "pathway": " (mmu:18484)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "16225857;21183079;21750661;25428506;27016726;30084848;31599954;32902163;35820727;37828378;9562574",
        "class_list": "",
        "function": "Bifunctional enzyme that catalyzes amidation of the C-terminus of proteins (PubMed:9562574, PubMed:16225857). Alpha-amidation is present at the C-terminus of many endocrine hormones and neuropeptides and is required for their activity (PubMed:9562574). C-terminal amidation also takes place in response to protein fragmentation triggered by oxidative stress, promoting degradation of amidated protein fragments by the proteasome (By similarity). Alpha-amidation involves two sequential reactions, both of which are catalyzed by separate catalytic domains of the enzyme (By similarity). The first step, catalyzed by peptidyl alpha-hydroxylating monooxygenase (PHM) domain, is the copper-, ascorbate-, and O2- dependent stereospecific hydroxylation (with S stereochemistry) at the alpha-carbon (C-alpha) of the C-terminal glycine of the peptidylglycine substrate (By similarity). The second step, catalyzed by the peptidylglycine amidoglycolate lyase (PAL) domain, is the zinc-dependent cleavage of the N-C-alpha bond, producing the alpha-amidated peptide and glyoxylate (By similarity). Similarly, catalyzes the two-step conversion of an N-fatty acylglycine to a primary fatty acid amide and glyoxylate (PubMed:27016726)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; Cell-type specific knockout of peptidylglycine alpha-amidating monooxygenase reveals specific behavioral roles in excitatory forebrain neurons and cardiomyocytes., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QL07",
        "ec_number_list": "1.14.17.3;4.3.2.5",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0019901 protein kinase binding;GO:0042802 identical protein binding;GO:0005509 calcium ion binding;GO:0004504 peptidylglycine monooxygenase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0009986 cell surface",
        "go_biological_process": "GO:0001676 long-chain fatty acid metabolic process;GO:0006357 regulation of transcription by RNA polymerase II;GO:0010043 response to zinc ion;GO:0032956 regulation of actin cytoskeleton organization;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "P97467-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D659-1",
        "uniprot_id": "VISTA_MOUSE",
        "mass": 33559.0,
        "length": 308,
        "protein_name": "V-type immunoglobulin domain-containing suppressor of T-cell activation",
        "gene_name": "Vsir",
        "organism": "Mouse",
        "refseq_name": "V-type immunoglobulin domain-containing suppressor of T-cell activation isoform 2 precursor",
        "refseq_ac": "NP_001153044",
        "gene_names_uniprotkb": "Vsir; 4632428N05Rik; Dies1; PD-1H; VISTA",
        "gene_names_refseq": "4632428N05Rik; Dies1; PD-1H; VISTA; Vsir",
        "protein_names_uniprotkb": "V-type immunoglobulin domain-containing suppressor of T-cell activation; Platelet receptor Gi24; V-set domain-containing immunoregulatory receptor; V-set immunoregulatory receptor",
        "protein_names_refseq": "V-set domain-containing immunoregulatory receptor; V-type immunoglobulin domain-containing suppressor of T-cell activation isoform 2 precursor; V-type immunoglobulin domain-containing suppressor of T-cell activation; differentiation of ESCs 1; platelet receptor Gi24",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74048)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;20042595;21383057;21750661;21768399;24743150;25267631;30084848;34428180;38925679",
        "class_list": "",
        "function": "Expression of VISTA regulated via IFN-gamma governs endogenous T-cell function and exhibits correlation with the efficacy of CD19 CAR-T cell treated B-malignant mice. Publication Status: Online-Only, [RefSeq, PubMed]; Immunoregulatory receptor which inhibits the T-cell response (PubMed:21383057, PubMed:24743150, PubMed:25267631). May promote differentiation of embryonic stem cells, by inhibiting BMP4 signaling (PubMed:20042595). May stimulate MMP14-mediated MMP2 activation (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB, PubMed, PubMed]; Results demonstrate that Dies1 is required for BMP4/Smad1 signaling cascade. GeneRIF: Dies1 is a necessary factor of BMP4 signaling and its suppression sustains mESC self-renewal., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9545,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A3RLQ7;E9PUF5;Q6KAT9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019899 enzyme binding;GO:0042802 identical protein binding;GO:0061133 endopeptidase activator activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009897 external side of plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0032693 negative regulation of interleukin-10 production;GO:0002725 negative regulation of T cell cytokine production;GO:0032700 negative regulation of interleukin-17 production;GO:0010628 positive regulation of gene expression;GO:0030335 positive regulation of cell migration",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q9D659-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60722-1",
        "uniprot_id": "ITF2_MOUSE",
        "mass": 71625.0,
        "length": 670,
        "protein_name": "Transcription factor 4",
        "gene_name": "Tcf4",
        "organism": "Mouse",
        "refseq_name": "transcription factor 4 isoform b",
        "refseq_ac": "NP_001077436",
        "gene_names_uniprotkb": "Tcf4; Itf2; Sef2",
        "gene_names_refseq": "5730422P05Rik; ASP-I2; E2-2; E2.2; ITF-2b; ITF-2; ITF2; ME2; MITF-2A; MITF-2B; SEF-2; SEF2-1; SEF2; TFE; Tcf-4; Tcf4; bHLHb19",
        "protein_names_uniprotkb": "Transcription factor 4; Class A helix-loop-helix transcription factor ME2; ITF-2; Immunoglobulin transcription factor 2; MITF-2; SEF-2; SL3-3 enhancer factor 2; TCF-4",
        "protein_names_refseq": "MITF-2; SL3-3 enhancer factor 2; Transcription factor 4 (Immunoglobulin transcription factor 2) (ITF-2) (MITF-2) (SL3-3 enhancer factor 2) (SEF-2) (Class A helix-loop-helix transcription factor ME2); class A helix-loop-helix transcription factor ME2; immunoglobulin transcription factor-2; transcription factor 4 isoform b",
        "tax_id": 10090,
        "disease": "developmental disorder of mental health (Disease Ontology:DOID:0060037); Pitt-Hopkins syndrome (Disease Ontology:DOID:0060488); Fuchs' endothelial dystrophy (Disease Ontology:DOID:11555); Lynch syndrome (Disease Ontology:DOID:3883); schizophrenia (Disease Ontology:DOID:5419); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:21413);  (R-MMU-525793)",
        "pathway_count": 2,
        "publication_count": 12,
        "publication_id_list": "10207097;18214987;21183079;21750661;30084848;31219806;32782141;34428180;40885482;7984047;8631961;8978694",
        "class_list": "",
        "function": "Transcription factor that binds to the immunoglobulin enhancer Mu-E5/KE5-motif. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3'). Isoform 2 inhibits MYOD1 activation of the cardiac alpha-actin promoter. Binds to the E-box present in the somatostatin receptor 2 initiator element (SSTR2-INR) to activate transcription. May have a regulatory function in developmental processes as well as during neuronal plasticity., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 6,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q60721;Q62211;Q64072;Q80UE8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001093 TFIIB-class transcription factor binding;GO:0003677 DNA binding;GO:0003682 chromatin binding;GO:0003700 DNA-binding transcription factor activity;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005667 transcription regulator complex;GO:0000785 chromatin;GO:1990907 beta-catenin-TCF complex",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0007399 nervous system development;GO:0010629 negative regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q60722-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80V03-1",
        "uniprot_id": "ADCK5_MOUSE",
        "mass": 66654.0,
        "length": 582,
        "protein_name": "Uncharacterized aarF domain-containing protein kinase 5",
        "gene_name": "Adck5",
        "organism": "Mouse",
        "refseq_name": "uncharacterized aarF domain-containing protein kinase 5",
        "refseq_ac": "NP_766548",
        "gene_names_uniprotkb": "Adck5",
        "gene_names_refseq": "A230108P17; Adck5",
        "protein_names_uniprotkb": "Uncharacterized aarF domain-containing protein kinase 5; 2.7.11.-",
        "protein_names_refseq": "uncharacterized aarF domain-containing protein kinase 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:268822)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21750661;31219806;34428180;35820727",
        "class_list": "",
        "function": "The function of this protein is not yet clear. It is not known if it has protein kinase activity and what type of substrate it would phosphorylate (Ser, Thr or Tyr)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CAA3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q80V03-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2CG63-1",
        "uniprot_id": "ARI4B_MOUSE",
        "mass": 147643.0,
        "length": 1314,
        "protein_name": "AT-rich interactive domain-containing protein 4B",
        "gene_name": "Arid4b",
        "organism": "Mouse",
        "refseq_name": "AT-rich interactive domain-containing protein 4B isoform 1",
        "refseq_ac": "NP_919238",
        "gene_names_uniprotkb": "Arid4b; Sap180",
        "gene_names_refseq": "Arid4b; BCAA; BRCAA1; RBBP1L1; Rbp1l1; SAP180",
        "protein_names_uniprotkb": "AT-rich interactive domain-containing protein 4B; 180 kDa Sin3-associated polypeptide; ARID domain-containing protein 4B; Histone deacetylase complex subunit SAP180; Sin3-associated polypeptide p180",
        "protein_names_refseq": "180 kDa Sin3-associated polypeptide; ARID domain-containing protein 4B; AT rich interactive domain 4B (RBP1-like); AT-rich interactive domain-containing protein 4B isoform 1; AT-rich interactive domain-containing protein 4B; breast cancer-associated antigen; histone deacetylase complex subunit SAP180; retinoblastoma binding protein 1-like 1; sin3-associated polypeptide p180",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:94246);  (R-MMU-3214815)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;17043311;18728284;21183079;21750661;23487765;31219806;33454011;34428180;34818550",
        "class_list": "",
        "function": "ARID4B is critical for mouse embryonic stem cell differentiation towards mesoderm and endoderm, linking epigenetics to pluripotency exit., [RefSeq, PubMed]; Acts as a transcriptional repressor. May function in the assembly and/or enzymatic activity of the Sin3A corepressor complex or in mediating interactions between the complex and other regulatory complexes (By similarity). Plays a role in the regulation of epigenetic modifications at the PWS/AS imprinting center near the SNRPN promoter, where it might function as part of a complex with RB1 and ARID4A (PubMed:17043311). Involved in spermatogenesis, together with ARID4A, where it functions as a transcriptional coactivator for AR (androgen receptor) and enhances expression of genes required for sperm maturation. Regulates expression of the tight junction protein CLDN3 in the testis, which is important for integrity of the blood-testis barrier (PubMed:23487765). Plays a role in myeloid homeostasis where it regulates the histone methylation state of bone marrow cells and expression of various genes involved in hematopoiesis. May function as a leukemia suppressor (PubMed:18728284)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB]; Differentiation of fetal hematopoietic stem cells requires ARID4B to restrict autocrine KITLG/KIT-Src signaling., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 19,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9462,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2CG61;A2CG62;A2CG64;B2RQ67;Q8BMI8;Q8BYA5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0000976 transcription cis-regulatory region binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol",
        "go_biological_process": "GO:1902459 positive regulation of stem cell population maintenance;GO:1902455 negative regulation of stem cell population maintenance;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006357 regulation of transcription by RNA polymerase II;GO:0007283 spermatogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "A2CG63-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P07147-1",
        "uniprot_id": "TYRP1_MOUSE",
        "mass": 60761.0,
        "length": 537,
        "protein_name": "5,6-dihydroxyindole-2-carboxylic acid oxidase",
        "gene_name": "Tyrp1",
        "organism": "Mouse",
        "refseq_name": "5,6-dihydroxyindole-2-carboxylic acid oxidase precursor",
        "refseq_ac": "NP_001268943",
        "gene_names_uniprotkb": "Tyrp1; Tyrp-1",
        "gene_names_refseq": "Oca3; TRP-1; TRP1; Tyrp1; Tyrp; brown; b; isa",
        "protein_names_uniprotkb": "5,6-dihydroxyindole-2-carboxylic acid oxidase; 1.14.18.-; Brown locus protein; Catalase B; DHICA oxidase; TRP-1; TRP1; TRP; Tyrosinase-related protein 1",
        "protein_names_refseq": "5,6-dihydroxyindole-2-carboxylic acid oxidase precursor; 5,6-dihydroxyindole-2-carboxylic acid oxidase; DHICA oxidase; brown locus protein; catalase B; iris stromal atrophy",
        "tax_id": 10090,
        "disease": "oculocutaneous albinism (Disease Ontology:DOID:0050632); oculocutaneous albinism type III (Disease Ontology:DOID:0070097); pigmentation disease (Disease Ontology:DOID:10123)",
        "pathway": " (mmu:22178);  (R-MMU-5662702)",
        "pathway_count": 2,
        "publication_count": 15,
        "publication_id_list": "1537333;1693779;17182842;18650808;21750661;2245916;26451316;26620560;3008090;30084848;30352798;3132713;35820727;7813420;8270621",
        "class_list": "",
        "function": "Plays a role in melanin biosynthesis (PubMed:2245916). Catalyzes the oxidation of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) into indole-5,6-quinone-2-carboxylic acid (PubMed:7813420). May regulate or influence the type of melanin synthesized (PubMed:2245916, PubMed:7813420). Also to a lower extent, capable of hydroxylating tyrosine and producing melanin (PubMed:1537333)., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 6,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.14.18.-;1.14.18.1",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0046872 metal ion binding;GO:0004503 tyrosinase activity;GO:0004497 monooxygenase activity",
        "go_cellular_component": "GO:0097708 intracellular vesicle;GO:0005737 cytoplasm;GO:0030669 clathrin-coated endocytic vesicle membrane;GO:0042470 melanosome;GO:0010008 endosome membrane",
        "go_biological_process": "GO:0032438 melanosome organization;GO:0043473 pigmentation;GO:0048023 positive regulation of melanin biosynthetic process;GO:0006582 melanin metabolic process;GO:0030318 melanocyte differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "P07147-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CJG1-1",
        "uniprot_id": "AGO1_MOUSE",
        "mass": 97214.0,
        "length": 857,
        "protein_name": "Protein argonaute-1",
        "gene_name": "Ago1",
        "organism": "Mouse",
        "refseq_name": "protein argonaute-1 isoform 1x",
        "refseq_ac": "NP_001304102",
        "gene_names_uniprotkb": "Ago1; Eif2c1",
        "gene_names_refseq": "Ago1; Eif2c1",
        "protein_names_uniprotkb": "Protein argonaute-1; Argonaute RISC catalytic component 1; Argonaute1; Eukaryotic translation initiation factor 2C 1; Piwi/argonaute family protein meIF2C1; eIF-2C 1; eIF2C 1; mAgo1",
        "protein_names_refseq": "Piwi/Argonaute family protein meIF2C1; argonaute 1; argonaute RISC catalytic component 1; argonaute1; eIF-2C 1; eIF2C 1; eukaryotic translation initiation factor 2C, 1; mAgo1; protein argonaute-1 isoform 1x; protein argonaute-1",
        "tax_id": 10090,
        "disease": "alcohol dependence (Disease Ontology:DOID:0050741)",
        "pathway": " (mmu:236511);  (R-MMU-203927);  (R-MMU-426486);  (R-MMU-426496)",
        "pathway_count": 4,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;10512872;12526743;19174539;21750661;31219806;34203471;34428180;35236760;35820727;36210013;38458189",
        "class_list": "",
        "function": "AGO1 controls protein folding in mouse embryonic stem cell fate decisions., [RefSeq, PubMed]; AGO1 regulates pericentromeric regions in mouse embryonic stem cells. Publication Status: Online-Only, [RefSeq, PubMed]; Describes cloning rat sequence and used RNA interference to show that the GERp95 orthologue in C. elegans is important for maturation of germ-line stem cells in the gonad., [RefSeq, PubMed]; Required for RNA-mediated gene silencing (RNAi). Binds to short RNAs such as microRNAs (miRNAs) or short interfering RNAs (siRNAs), and represses the translation of mRNAs which are complementary to them. Lacks endonuclease activity and does not appear to cleave target mRNAs. May also be required for transcriptional gene silencing (TGS) of promoter regions which are complementary to bound short antigene RNAs (agRNAs)., [UniProtKB, PubMed]; This gene encodes a member of the argonaute family of proteins, which associate with small RNAs and have important roles in RNA interference (RNAi) and RNA silencing. This protein binds to microRNAs (miRNAs) or small interfering RNAs (siRNAs) and represses translation of mRNAs that are complementary to them. It is also involved in transcriptional gene silencing (TGS) of promoter regions that are complementary to bound short antigene RNAs (agRNAs), as well as in the degradation of miRNA-bound mRNA targets. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A recent study showed this gene to be an authentic stop codon readthrough target, and that its mRNA could give rise to an additional C-terminally extended isoform by use of an alternative in-frame translation termination codon. [provided by RefSeq, Nov 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A1L365",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0003725 double-stranded RNA binding;GO:0003727 single-stranded RNA binding;GO:0000976 transcription cis-regulatory region binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0000932 P-body;GO:0036464 cytoplasmic ribonucleoprotein granule",
        "go_biological_process": "GO:0070922 RISC complex assembly;GO:0006351 DNA-templated transcription;GO:0010628 positive regulation of gene expression;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:1901224 positive regulation of non-canonical NF-kappaB signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q8CJG1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P63280-1",
        "uniprot_id": "UBC9_MOUSE",
        "mass": 18007.0,
        "length": 158,
        "protein_name": "SUMO-conjugating enzyme UBC9",
        "gene_name": "Ube2i",
        "organism": "Mouse",
        "refseq_name": "SUMO-conjugating enzyme UBC9",
        "refseq_ac": "NP_001171080",
        "gene_names_uniprotkb": "Ube2i; Ubc9; Ubce2i; Ubce9",
        "gene_names_refseq": "5830467E05Rik; UBC9; Ubce2i; Ubce9; Ube2i",
        "protein_names_uniprotkb": "SUMO-conjugating enzyme UBC9; 2.3.2.-; RING-type E3 SUMO transferase UBC9; SUMO-protein ligase; Ubiquitin carrier protein 9; Ubiquitin carrier protein I; Ubiquitin-conjugating enzyme E2 I; Ubiquitin-protein ligase I; mUBC9",
        "protein_names_refseq": "RING-type E3 SUMO transferase UBC9; SUMO-conjugating enzyme UBC9; SUMO-protein ligase; ubiquitin carrier protein 9; ubiquitin carrier protein I; ubiquitin-protein ligase I",
        "tax_id": 10090,
        "disease": "urinary bladder cancer (Disease Ontology:DOID:11054); dilated cardiomyopathy (Disease Ontology:DOID:12930); cancer (Disease Ontology:DOID:162); ovarian cancer (Disease Ontology:DOID:2394); hematologic cancer (Disease Ontology:DOID:2531)",
        "pathway": " (mmu:22196);  (R-MMU-196791);  (R-MMU-3065678);  (R-MMU-3108214);  (R-MMU-3232118);  (R-MMU-3232142);  (R-MMU-3899300);  (R-MMU-4085377);  (R-MMU-4090294);  (R-MMU-4551638);  (R-MMU-4570464);  (R-MMU-4615885);  (R-MMU-4655427);  (R-MMU-4755510);  (R-MMU-5693565);  (R-MMU-5693607);  (R-MMU-5696395);  (R-MMU-8866904);  (R-MMU-9615933);  (R-MMU-9793242);  (R-MMU-9856649);  (R-MMU-9937850)",
        "pathway_count": 22,
        "publication_count": 17,
        "publication_id_list": "10535925;12633878;16326389;16352559;17187077;18681895;21750661;22214662;26074071;36626227;37957143;8610150;8824223;8839844;9223278;9261152;9409784",
        "class_list": "",
        "function": "Accepts the ubiquitin-like proteins SUMO1, SUMO2 and SUMO3 from the UBLE1A-UBLE1B E1 complex and catalyzes their covalent attachment to other proteins with the help of an E3 ligase such as RANBP2, CBX4 and ZNF451. Can catalyze the formation of poly-SUMO chains. Essential for nuclear architecture, chromosome segregation and embryonic viability. Necessary for sumoylation of FOXL2 and KAT5 (By similarity). Sumoylates p53/TP53 at 'Lys-386'. Mediates sumoylation of ERCC6 which is essential for its transcription-coupled nucleotide excision repair activity (By similarity). Sumoylates SHMT1 at 'Lys-32' or 'Lys-33' leading to RAN-dependent nuclear import of SHMT1 (By similarity). Also sumoylates TYMS and DHFR (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed]; UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer. Publication Status: Online-Only, [RefSeq, PubMed]; Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation. Erratum:[Cell Death Dis. 2026 Jan 28;17(1):145. doi: 10.1038/s41419-025-08382-6. PMID: 41605886] Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P50550;Q15698;Q6RUT3;Q86VB3",
        "ec_number_list": "2.3.1.48;2.3.1.-;5.6.2.3;3.5.1.-;3.5.1.98;2.3.2.27;2.3.2.-;2.7.11.1;2.1.1.37;2.1.1.-;2.4.2.-;2.4.2.30;5.6.2.4;1.1.1.-;3.4.19.-;1.14.11.-;3.2.2.29;2.3.2.23;2.3.2.32;3.6.-.-;5.6.2.2;5.6.2.1;2.3.2.26;3.6.4.13;3.1.-.-;3.4.21.-;2.1.1.357;1.14.11.69;1.14.11.66;3.1.2.-;3.5.1.124;3.6.4.-;2.7.11.10",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0019899 enzyme binding;GO:0004842 ubiquitin-protein transferase activity;GO:0019789 SUMO transferase activity;GO:0043425 bHLH transcription factor binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:1990234 transferase complex;GO:0005634 nucleus;GO:0005635 nuclear envelope;GO:0005654 nucleoplasm",
        "go_biological_process": "GO:0036211 protein modification process;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0007059 chromosome segregation;GO:0016925 protein sumoylation;GO:0030335 positive regulation of cell migration",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "P63280-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VHH5-1",
        "uniprot_id": "AGAP3_MOUSE",
        "mass": 97965.0,
        "length": 910,
        "protein_name": "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3",
        "gene_name": "Agap3",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Agap3; Centg3",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3; AGAP-3; CRAG; CRAM-associated GTPase; Centaurin-gamma-3; Cnt-g3; MR1-interacting protein; MRIP-1",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "syndromic intellectual disability (Disease Ontology:DOID:0050888); autism spectrum disorder (Disease Ontology:DOID:0060041)",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 12,
        "publication_id_list": "15381706;16461359;21183079;21750661;22645316;28528544;31219806;32848054;34428180;35822049;40021952;40885482",
        "class_list": "",
        "function": "GTPase-activating protein for the ADP ribosylation factor family (Potential). GTPase which may be involved in the degradation of expanded polyglutamine proteins through the ubiquitin-proteasome pathway., [UniProtKB, PubMed]; GTPase-activating protein for the ADP ribosylation factor family. GTPase which may be involved in the degradation of expanded polyglutamine proteins through the ubiquitin-proteasome pathway., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q812F7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005096 GTPase activator activity;GO:0005525 GTP binding;GO:0008270 zinc ion binding;GO:0031593 polyubiquitin modification-dependent protein binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0014069 postsynaptic density;GO:0071944 cell periphery",
        "go_biological_process": "GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0034614 cellular response to reactive oxygen species;GO:0006606 protein import into nucleus;GO:0099072 regulation of postsynaptic membrane neurotransmitter receptor levels",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q8VHH5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JLT4-1",
        "uniprot_id": "TRXR2_MOUSE",
        "mass": 56603.0,
        "length": 524,
        "protein_name": "Thioredoxin reductase 2, mitochondrial",
        "gene_name": "Txnrd2",
        "organism": "Mouse",
        "refseq_name": "thioredoxin reductase 2, mitochondrial isoform 1 precursor",
        "refseq_ac": "NP_038739",
        "gene_names_uniprotkb": "Txnrd2; Trxr2",
        "gene_names_refseq": "ESTM573010; TGR; Tr3; Trxr2; Trxrd2; Txnrd2",
        "protein_names_uniprotkb": "Thioredoxin reductase 2, mitochondrial; 1.8.1.9; Thioredoxin reductase TR3",
        "protein_names_refseq": "TR beta; thioredoxin reductase 2, mitochondrial isoform 1 precursor; thioredoxin reductase 2, mitochondrial; thioredoxin reductase TR3",
        "tax_id": 10090,
        "disease": "chromosome 22q11.2 deletion syndrome, distal (Disease Ontology:DOID:0060413); familial glucocorticoid deficiency (Disease Ontology:DOID:0080620)",
        "pathway": " (mmu:26462);  (R-MMU-3299685)",
        "pathway_count": 2,
        "publication_count": 15,
        "publication_id_list": "10455115;10500251;10721726;11060283;12132591;21750661;23806337;26495903;26740625;31079872;32671444;33579817;34428180;35577894;37507081",
        "class_list": "",
        "function": "Genomic organization and identification of a novel alternative splicing variant of mouse mitochondrial TrxR2 gene, [RefSeq, PubMed]; Involved in the control of reactive oxygen species levels and the regulation of mitochondrial redox homeostasis (By similarity). Maintains thioredoxin in a reduced state. May play a role in redox-regulated cell signaling (By similarity)., [UniProtKB, UniProtKB, UniProtKB]; Mitochondrial TrxR2 regulates metabolism and protects from metabolic disease through enhanced TCA and ETC function. Publication Status: Online-Only, [RefSeq, PubMed]; Study identified a causal molecular mechanism that reflects diminished dosage of a single 22q11 gene-the mitochondrial enzyme thioredoxin-reductase 2 (Txnrd2)-essential for catabolism of reactive oxygen species underlies reduced long-distance projections, limited axon and dendrite growth, and disrupted mitochondrial and synaptic integrity in layer 2/3 in DiGeorge syndrome., [RefSeq, PubMed]; The mitochondrial thioredoxin reductase system (TrxR2) in vascular endothelium controls peroxynitrite levels and tissue integrity., [RefSeq, PubMed]; The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes a mitochondrial form important for scavenging reactive oxygen species in mitochondria. It functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jun 2017]., [RefSeq]; Wogonin induces cellular senescence in breast cancer via suppressing TXNRD2 expression., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6KG49;Q80VZ4;Q91YX4;Q9JHA7;Q9JMH5",
        "ec_number_list": "1.8.1.9;1.11.1.2",
        "go_molecular_function": "GO:0004791 thioredoxin-disulfide reductase (NADPH) activity;GO:0042803 protein homodimerization activity;GO:0050660 flavin adenine dinucleotide binding;GO:0044877 protein-containing complex binding;GO:0016668 oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol;GO:0030424 axon;GO:0030425 dendrite",
        "go_biological_process": "GO:0007507 heart development;GO:0030097 hemopoiesis;GO:0045454 cell redox homeostasis;GO:0000305 response to oxygen radical;GO:0006979 response to oxidative stress",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q9JLT4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P24721-1",
        "uniprot_id": "ASGR2_MOUSE",
        "mass": 34907.0,
        "length": 301,
        "protein_name": "Asialoglycoprotein receptor 2",
        "gene_name": "Asgr2",
        "organism": "Mouse",
        "refseq_name": "asialoglycoprotein receptor 2 isoform a",
        "refseq_ac": "NP_001300854",
        "gene_names_uniprotkb": "Asgr2; Asgr-2",
        "gene_names_refseq": "ASGPR2; Asgr-2; Asgr2; Asgr; HL-2",
        "protein_names_uniprotkb": "Asialoglycoprotein receptor 2; ASGP-R 2; ASGPR 2; HL-2; Hepatic lectin 2; mHL-2",
        "protein_names_refseq": "asialoglycoprotein receptor 2 isoform a; hepatic lectin 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:11890);  (R-MMU-446203)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "21750661;2223888;27405760;34428180;35547772",
        "class_list": "glycogene",
        "function": "Enhanced ASGR2 by microplastic exposure leads to resistance to therapy in gastric cancer. Publication Status: Online-Only, [RefSeq, PubMed]; Mediates the endocytosis of plasma glycoproteins to which the terminal sialic acid residue on their complex carbohydrate moieties has been removed. The receptor recognizes terminal galactose and N-acetylgalactosamine units. After ligand binding to the receptor, the resulting complex is internalized and transported to a sorting organelle, where receptor and ligand are disassociated. The receptor then returns to the cell membrane surface., [UniProtKB]; The key roles of the ManR and ASGR in controlling circulating levels of numerous glycoproteins critical for regulating reproductive hormones and blood coagulation., [RefSeq, PubMed]; This gene encodes a subunit of the asialoglycoprotein receptor. This receptor is a transmembrane protein that plays a critical role in serum glycoprotein homeostasis by mediating the endocytosis and lysosomal degradation of glycoproteins with exposed terminal galactose or N-acetylgalactosamine residues. The asialoglycoprotein receptor is a hetero-oligomeric protein composed of major and minor subunits, which are encoded by different genes. The protein encoded by this gene is the less abundant minor subunit. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene [provided by RefSeq, Sep 2015]., [RefSeq]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 11,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005537 D-mannose binding;GO:0042806 fucose binding;GO:0038187 pattern recognition receptor activity;GO:0030246 carbohydrate binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0048471 perinuclear region of cytoplasm;GO:0009897 external side of plasma membrane;GO:0044322 endoplasmic reticulum quality control compartment",
        "go_biological_process": "GO:0006897 endocytosis;GO:0006955 immune response;GO:0055088 lipid homeostasis;GO:0031647 regulation of protein stability;GO:0009100 glycoprotein metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P24721-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6A4J8-1",
        "uniprot_id": "UBP7_MOUSE",
        "mass": 128475.0,
        "length": 1103,
        "protein_name": "Ubiquitin C-terminal hydrolase 7",
        "gene_name": "Usp7",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 7",
        "refseq_ac": "NP_001003918",
        "gene_names_uniprotkb": "Usp7; Hausp",
        "gene_names_refseq": "2210010O09Rik; Hausp; Usp7",
        "protein_names_uniprotkb": "Ubiquitin C-terminal hydrolase 7; 3.4.19.12; Deubiquitinating enzyme 7; Herpesvirus-associated ubiquitin-specific protease; Ubiquitin thioesterase 7; Ubiquitin-specific-processing protease 7; mHAUSP",
        "protein_names_refseq": "deubiquitinating enzyme 7; herpesvirus-associated ubiquitin-specific protease; mHAUSP; ubiquitin carboxyl-terminal hydrolase 7; ubiquitin specific protease 7; ubiquitin thioesterase 7; ubiquitin thiolesterase 7; ubiquitin-specific-processing protease 7",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:252870);  (R-MMU-5689880);  (R-MMU-6781823);  (R-MMU-6782135);  (R-MMU-6782210);  (R-MMU-6804757);  (R-MMU-8866652);  (R-MMU-8948747)",
        "pathway_count": 8,
        "publication_count": 23,
        "publication_id_list": "10.1101/2023.09.13.557529;12413694;14719112;19144319;19946331;21183079;21268065;21750661;23973222;26365382;27123980;27863226;30899004;31219806;33300544;34887587;35820727;36210013;38735043;38815879;39190377;39627609;39868537",
        "class_list": "",
        "function": "Hydrolase that deubiquitinates target proteins such as ARMC5, FOXO4, DEPTOR, KAT5, p53/TP53, MDM2, ERCC6, DNMT1, UHRF1, PTEN, KMT2E/MLL5 and DAXX (PubMed:14719112, PubMed:19946331, PubMed:21268065). Together with DAXX, prevents MDM2 self-ubiquitination and enhances the E3 ligase activity of MDM2 towards p53/TP53, thereby promoting p53/TP53 ubiquitination and proteasomal degradation. Deubiquitinates p53/TP53, preventing degradation of p53/TP53, and enhances p53/TP53-dependent transcription regulation, cell growth repression and apoptosis. Deubiquitinates p53/TP53 and MDM2 and strongly stabilizes p53/TP53 even in the presence of excess MDM2, and also induces p53/TP53-dependent cell growth repression and apoptosis. Deubiquitination of FOXO4 in presence of hydrogen peroxide is not dependent on p53/TP53 and inhibits FOXO4-induced transcriptional activity. In association with DAXX, is involved in the deubiquitination and translocation of PTEN from the nucleus to the cytoplasm, both processes that are counteracted by PML. Deubiquitinates KMT2E preventing KMT2E proteasomal-mediated degradation (By similarity). Involved in cell proliferation during early embryonic development. Involved in transcription-coupled nucleotide excision repair (TC-NER) in response to UV damage: recruited to DNA damage sites following interaction with KIAA1530/UVSSA and promotes deubiquitination of ERCC6, preventing UV-induced degradation of ERCC6 (By similarity). Involved in maintenance of DNA methylation via its interaction with UHRF1 and DNMT1: acts by mediating deubiquitination of UHRF1 and DNMT1, preventing their degradation and promoting DNA methylation by DNMT1. Deubiquitinates alkylation repair enzyme ALKBH3. OTUD4 recruits USP7 and USP9X to stabilize ALKBH3, thereby promoting the repair of alkylated DNA lesions (By similarity). Acts as a chromatin regulator via its association with the Polycomb group (PcG) multiprotein PRC1-like complex; may act by deubiquitinating components of the PRC1-like complex (By similarity). Able to mediate deubiquitination of histone H2B; it is however unsure whether this activity takes place in vivo (PubMed:27863226). Exhibits a preference towards 'Lys-48'-linked ubiquitin chains. Increases regulatory T-cells (Treg) suppressive capacity by deubiquitinating and stabilizing the transcription factor FOXP3 which is crucial for Treg cell function (PubMed:23973222). Plays a role in the maintenance of the circadian clock periodicity via deubiquitination and stabilization of the CRY1 and CRY2 proteins (PubMed:27123980). Deubiquitinates REST, thereby stabilizing REST and promoting the maintenance of neural progenitor cells (By similarity). Deubiquitinates SIRT7, inhibiting SIRT7 histone deacetylase activity and regulating gluconeogenesis (By similarity). Involved in the regulation of WASH-dependent actin polymerization at the surface of endosomes and the regulation of endosomal protein recycling (By similarity). It maintains optimal WASH complex activity and precise F-actin levels via deubiquitination of TRIM27 and WASHC1 (By similarity). Mediates the deubiquitination of phosphorylated DEPTOR, promoting its stability and leading to decreased mTORC1 signaling (By similarity). Deubiquitinates H2AB1, H2BC4 and H2BC22 (PubMed:39868537)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed]; MHAUSP functions as a deubiquitinating enzyme for p53, [RefSeq, PubMed]; USP7 (HAUSP) is proteolytically processed upon dexamethasone-, gamma-irradiation-, and antigen-induced cell death. Such processing of HAUSP does not occur in caspase 3-/- thymocytes., [RefSeq, PubMed]; USP7 Promotes TGF-beta1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis., [RefSeq, PubMed]; USP7 promotes IgA class switching through stabilizing RUNX3 for germline transcription activation. Erratum:[Cell Rep. 2024 Jun 25;43(6):114315. doi: 10.1016/j.celrep.2024.114315. PMID: 38795349], [RefSeq, PubMed]; USP7 promotes cardiometabolic disorders and mitochondrial homeostasis dysfunction in diabetic mice via stabilizing PGC1beta., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 5,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UX92;Q496Y5;Q8BW01",
        "ec_number_list": "3.6.4.-;3.1.3.67;3.1.3.-;3.1.3.16;3.1.3.48;5.6.2.3;3.1.13.-;2.7.7.48;2.7.7.6;2.3.2.27;3.1.-.-;6.5.1.1;5.6.2.4;2.7.7.7;3.1.11.-;2.3.2.32;3.4.19.12;2.7.11.22;2.7.11.23;2.7.11.24;3.6.4.13;5.2.1.8",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0002039 p53 binding;GO:0004197 cysteine-type endopeptidase activity;GO:0004843 cysteine-type deubiquitinase activity;GO:1990380 K48-linked deubiquitinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016604 nuclear body",
        "go_biological_process": "GO:0000045 autophagosome assembly;GO:0006508 proteolysis;GO:0016579 protein deubiquitination;GO:0043065 positive regulation of apoptotic process;GO:0006307 DNA alkylation repair",
        "synthesized_glycan_count": 0,
        "hit_score": 3.3,
        "record_id": "Q6A4J8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P05064-1",
        "uniprot_id": "ALDOA_MOUSE",
        "mass": 39356.0,
        "length": 364,
        "protein_name": "Fructose-bisphosphate aldolase A",
        "gene_name": "Aldoa",
        "organism": "Mouse",
        "refseq_name": "fructose-bisphosphate aldolase A isoform 2",
        "refseq_ac": "NP_001170779",
        "gene_names_uniprotkb": "Aldoa; Aldo1",
        "gene_names_refseq": "Aldo-1; Aldo1; Aldoa",
        "protein_names_uniprotkb": "Fructose-bisphosphate aldolase A; 4.1.2.13; Aldolase 1; Muscle-type aldolase",
        "protein_names_refseq": "fructose-bisphosphate aldolase A isoform 2; fructose-bisphosphate aldolase A; muscle-type aldolase",
        "tax_id": 10090,
        "disease": "chromosome 16p11.2 deletion syndrome, 593-kb (Disease Ontology:DOID:0070515)",
        "pathway": " (mmu:11674);  (R-MMU-114608);  (R-MMU-6798695);  (R-MMU-70171);  (R-MMU-70263)",
        "pathway_count": 5,
        "publication_count": 29,
        "publication_id_list": "21750661;22645316;2365699;25428506;26740625;28723898;29125738;30084848;3009179;30779550;31204282;31219806;32848054;33300544;33725478;34428180;35820727;35984892;36288343;3697100;37453647;37507081;39227156;39627609;39927985;40021952;40446798;40684658;40885482",
        "class_list": "glycogene",
        "function": "Beyond Glycolysis: Aldolase A Is a Novel Effector in Reelin-Mediated Dendritic Development. Publication Status: Online-Only, [RefSeq, PubMed]; Catalyzes the reversible conversion of beta-D-fructose 1,6-bisphosphate (FBP) into two triose phosphate and plays a key role in glycolysis and gluconeogenesis (PubMed:40446798). In addition, also functions as a scaffolding protein (PubMed:28723898, PubMed:31204282). In response to glucose deprivation, FBP dissociates from aldolase and acts as an adapter that promotes AMP-activated protein kinase (AMPK) activity: mechanistically, associates with transient receptor potential channels TrpV (TRPV1-TRPV4), promoting inhibition of the V-ATPase complex on lysosomes and AMPK activation via the AXIN1-STK11/LKB1 axis (PubMed:28723898, PubMed:31204282)., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 30,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.4.1.25;3.2.1.33;3.5.4.6;1.11.1.24;3.4.22.52;3.4.19.12;3.4.24.34;3.4.22.27;1.1.1.42;3.4.21.46;4.1.2.13;5.3.1.9;5.1.3.-;3.4.21.4;3.6.4.10;2.4.2.7;3.4.21.-;3.2.1.17;1.16.3.1;3.6.5.-;4.2.1.24;3.4.22.1;3.2.1.31;2.7.1.11;2.7.10.2;5.2.1.8;3.4.23.5;2.5.1.18;4.2.99.18;5.6.2.4;2.4.2.1;3.2.1.23;1.11.1.6;3.3.2.6;3.4.11.4;1.1.1.205;3.1.3.48;5.3.2.1;5.3.3.12;3.4.24.35;3.6.1.-;2.7.11.24;1.13.11.-;1.13.11.34;1.11.1.7;3.1.6.12;2.7.11.1;2.7.1.40;3.5.4.5;3.4.25.1;2.7.11.39;2.7.4.6;2.7.13.3;3.6.4.6;2.7.1.1;2.7.1.-;3.1.1.47;3.6.4.13;2.7.11.22;2.7.11.23;2.3.2.26;5.4.2.2;5.4.2.7;2.3.2.27;3.1.6.14;2.3.2.13;1.8.3.2;1.8.3.5;2.7.1.35;1.-.-.-;3.4.19.1;3.6.1.6;2.3.3.8;4.1.2.4;2.3.2.5;3.2.1.14;5.4.2.11;5.4.2.4;2.4.1.1;3.5.1.3;2.4.1.186;3.4.18.1;3.5.1.23;3.5.1.-;3.4.19.9",
        "go_molecular_function": "GO:0002020 protease binding;GO:0042802 identical protein binding;GO:0008092 cytoskeletal protein binding;GO:0004332 fructose-bisphosphate aldolase activity;GO:0070061 fructose binding",
        "go_cellular_component": "GO:0061827 sperm head;GO:0005615 extracellular space;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0007339 binding of sperm to zona pellucida;GO:0030335 positive regulation of cell migration;GO:0046716 muscle cell cellular homeostasis;GO:0051289 protein homotetramerization;GO:0006754 ATP biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 3.3,
        "record_id": "P05064-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C6M1-1",
        "uniprot_id": "UBP20_MOUSE",
        "mass": 102140.0,
        "length": 916,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 20",
        "gene_name": "Usp20",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 20",
        "refseq_ac": "NP_083122",
        "gene_names_uniprotkb": "Usp20; Kiaa1003; Vdu2",
        "gene_names_refseq": "1700055M05Rik; Usp20; Vdu2",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 20; 3.4.19.12; Deubiquitinating enzyme 20; Ubiquitin thioesterase 20; Ubiquitin-specific-processing protease 20; VHL-interacting deubiquitinating enzyme 2",
        "protein_names_refseq": "VHL-interacting deubiquitinating enzyme 2; deubiquitinating enzyme 20; ubiquitin carboxyl-terminal hydrolase 20; ubiquitin specific protease 20; ubiquitin thioesterase 20; ubiquitin thiolesterase 20; ubiquitin-specific-processing protease 20",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74270);  (R-MMU-5689880)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "12056827;15345747;17242355;21183079;21750661;26839314;30354204;30814308;31219806;33177714;34428180;36636478;37311534;38321831",
        "class_list": "",
        "function": "A novel PDIA3/FTO/USP20 positive feedback regulatory loop induces osteogenic differentiation of preosteoblast in osteoporosis., [RefSeq, PubMed]; Deubiquitinating enzyme that plays a role in many cellular processes including autophagy, cellular antiviral response or membrane protein biogenesis. Attenuates TLR4-mediated NF-kappa-B signaling by cooperating with beta-arrestin-2/ARRB2 and inhibiting TRAF6 autoubiquitination. Promotes cellular antiviral responses by deconjugating 'Lys-33' and 'Lys-48'-linked ubiquitination of STING1 leading to its stabilization. Plays an essential role in autophagy induction by regulating the ULK1 stability through deubiquitination of ULK1. Acts as a positive regulator for NF-kappa-B activation by TNF through deubiquitinating 'Lys-48'-linked polyubiquitination of SQSTM1, leading to its increased stability. Acts as a regulator of G protein coupled receptor (GPCR) signaling by mediating the deubiquitination beta-2 adrenergic receptor (ADRB2). Plays a central role in ADRB2 recycling and resensitization after prolonged agonist stimulation by constitutively binding ADRB2, mediating deubiquitination of ADRB2 and inhibiting lysosomal trafficking of ADRB2. Upon dissociation, it is probably transferred to the translocated beta-arrestins, possibly leading to beta-arrestins deubiquitination and disengagement from ADRB2. This suggests the existence of a dynamic exchange between the ADRB2 and beta-arrestins. Deubiquitinates DIO2, thereby regulating thyroid hormone regulation. Deubiquitinates HIF1A, leading to stabilize HIF1A and enhance HIF1A-mediated activity. Deubiquitinates MCL1, a pivotal member of the anti-apoptotic Bcl-2 protein family to regulate its stability. Within the endoplasmic reticulum, participates with USP33 in the rescue of post-translationally targeted membrane proteins that are inappropriately ubiquitinated by the cytosolic protein quality control in the cytosol., [UniProtKB, UniProtKB]; Phosphorylation of USP20 on Ser334 by IRAK1 promotes IL-1beta-evoked signaling in vascular smooth muscle cells and vascular inflammation., [RefSeq, PubMed]; Sleeve gastrectomy improves lipid dysmetabolism by downregulating the USP20-HSPA2 axis in diet-induced obese mice. Publication Status: Online-Only, [RefSeq, PubMed]; That pro- and anti-inflammatory activities of beta-arrestin2 are determined by beta-arrestin2 ubiquitination and that changes in USP20 expression and/or activity can therefore regulate inflammatory responses, [RefSeq, PubMed]; USP20 attenuates TNF- and IL-1beta-evoked atherogenic signaling in smooth muscle cells, by deubiquitinating RIPK1, among other signaling intermediates., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 9,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q69ZT5;Q8CJ72",
        "ec_number_list": "3.4.19.12",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0001664 G protein-coupled receptor binding;GO:0004197 cysteine-type endopeptidase activity;GO:0004843 cysteine-type deubiquitinase activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005813 centrosome;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0006508 proteolysis;GO:0006897 endocytosis;GO:0007399 nervous system development;GO:0016579 protein deubiquitination;GO:0070536 protein K63-linked deubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q8C6M1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P63115-1",
        "uniprot_id": "AAA1_MOUSE",
        "mass": 57549.0,
        "length": 530,
        "protein_name": "Asc-type amino acid transporter 1",
        "gene_name": "Slc7a10",
        "organism": "Mouse",
        "refseq_name": "asc-type amino acid transporter 1",
        "refseq_ac": "NP_059090",
        "gene_names_uniprotkb": "Slc7a10; Asc1",
        "gene_names_refseq": "Asc-1; D7Bwg0847e; Slc7a10",
        "protein_names_uniprotkb": "Asc-type amino acid transporter 1; Asc-1; D-serine transporter; Solute carrier family 7 member 10",
        "protein_names_refseq": "D-serine transporter; asc-type amino acid transporter 1; solute carrier family 7 member 10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:53896);  (R-MMU-210991);  (R-MMU-352230)",
        "pathway_count": 3,
        "publication_count": 12,
        "publication_id_list": "10734121;16026768;21750661;25755256;27759100;30084848;33707431;34428180;34749773;35820727;36403747;36916878",
        "class_list": "",
        "function": "Amino acid transporter Asc-1 (SLC7A10) expression is altered in basal ganglia in experimental Parkinsonism and L-dopa-induced dyskinesia model mice., [RefSeq, PubMed]; Asc-1 regulates white versus beige adipocyte fate in a subcutaneous stromal cell population. Publication Status: Online-Only, [RefSeq, PubMed]; Associates with SLC3A2/4F2hc to form a functional heterodimeric complex that translocates small neutral L- and D-amino acids across the plasma membrane. Preferentially mediates exchange transport, but can also operate via facilitated diffusion (By similarity) (PubMed:10734121). Acts as a major transporter for glycine, L- and D-serine in the central nervous system. At the spinal cord and brainstem regulates glycine metabolism and glycinergic inhibitory neurotransmission by providing for glycine de novo synthesis from L-serine and glycine recycling from astrocytes to glycinergic motor neurons (PubMed:25755256, PubMed:27759100). At Schaffer collateral-CA1 synapses mediates D-serine and glycine release that modulates post-synaptic activation of NMDA receptors and excitatory glutamatergic transmission (By similarity). May regulate D-serine release from mesenchymal progenitors located in developing subcutaneous adipose tissue, favoring white adipocyte over thermogenic beige adipocyte lineage commitment (PubMed:33707431)., [UniProtKB, PubMed, PubMed, UniProtKB, PubMed, PubMed]; Impaired Adipocyte SLC7A10 Promotes Lipid Storage in Association With Insulin Resistance and Altered BCAA Metabolism., [RefSeq, PubMed]; Lack of the alanine-serine-cysteine transporter 1 causes tremors, seizures, and early postnatal death in mice., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CW25;Q9JMH8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0015179 L-amino acid transmembrane transporter activity;GO:0015175 neutral L-amino acid transmembrane transporter activity;GO:0022857 transmembrane transporter activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0043025 neuronal cell body;GO:0097440 apical dendrite;GO:0016020 membrane",
        "go_biological_process": "GO:0015816 glycine transport;GO:0015804 neutral amino acid transport;GO:0042941 D-alanine transmembrane transport;GO:0042942 D-serine transmembrane transport;GO:1903444 negative regulation of brown fat cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "P63115-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q01063-1",
        "uniprot_id": "PDE4D_MOUSE",
        "mass": 84563.0,
        "length": 747,
        "protein_name": "3',5'-cyclic-AMP phosphodiesterase 4D",
        "gene_name": "Pde4d",
        "organism": "Mouse",
        "refseq_name": "3',5'-cyclic-AMP phosphodiesterase 4D isoform 1",
        "refseq_ac": "NP_035186",
        "gene_names_uniprotkb": "Pde4d",
        "gene_names_refseq": "9630011N22Rik; Dpde3; Pde4d",
        "protein_names_uniprotkb": "3',5'-cyclic-AMP phosphodiesterase 4D; 3.1.4.53; DPDE3; cAMP-specific phosphodiesterase 4D",
        "protein_names_refseq": "3',5'-cyclic-AMP phosphodiesterase 4D isoform 1; 3',5'-cyclic-AMP phosphodiesterase 4D; cAMP-specific 3',5'-cyclic phosphodiesterase 4D; cAMP-specific phosphodiesterase 4D; cyclic AMP specific phosphodiesterase PDE4D5A; dunce",
        "tax_id": 10090,
        "disease": "stroke (Disease Ontology:DOID:0051061); acrodysostosis (Disease Ontology:DOID:14669); depressive disorder (Disease Ontology:DOID:1596); transient cerebral ischemia (Disease Ontology:DOID:224); asthma (Disease Ontology:DOID:2841); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083)",
        "pathway": " (mmu:238871);  (R-MMU-180024);  (R-MMU-418555);  (R-MMU-9860927)",
        "pathway_count": 4,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;12834813;1326532;16452087;17244609;18268335;21750661;33300544;36976866;37072403;37306762;37643895",
        "class_list": "",
        "function": "Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-beta pathology. Publication Status: Online-Only, [RefSeq, PubMed]; Arrestin-dependent nuclear export of phosphodiesterase 4D promotes GPCR-induced nuclear cAMP signaling required for learning and memory., [RefSeq, PubMed]; Genetic deletion of phosphodiesterase 4D in the liver improves kidney damage in high-fat fed mice: liver-kidney crosstalk. Publication Status: Online-Only, [RefSeq, PubMed]; Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes., [UniProtKB]; PDE4D mediates impaired beta-adrenergic receptor signalling in the sinoatrial node in mice with hypertensive heart disease., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 6,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2KF58;Q6TRH9;Q8C4Q7;Q8CG05",
        "ec_number_list": "3.1.4.-;3.1.4.53;3.1.4.1;3.6.1.9;3.1.4.35;3.1.3.16;3.1.4.17;3.6.1.25;3.6.1.14",
        "go_molecular_function": "GO:0031698 beta-2 adrenergic receptor binding;GO:0019899 enzyme binding;GO:0046872 metal ion binding;GO:0051117 ATPase binding;GO:0005246 calcium channel regulator activity",
        "go_cellular_component": "GO:0034705 potassium channel complex;GO:0005654 nucleoplasm;GO:0005813 centrosome;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0022409 positive regulation of cell-cell adhesion;GO:0032754 positive regulation of interleukin-5 production;GO:0061028 establishment of endothelial barrier;GO:1901898 negative regulation of relaxation of cardiac muscle;GO:0001934 positive regulation of protein phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q01063-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q0P678-1",
        "uniprot_id": "ZCH18_MOUSE",
        "mass": 105694.0,
        "length": 948,
        "protein_name": "Zinc finger CCCH domain-containing protein 18",
        "gene_name": "Zc3h18",
        "organism": "Mouse",
        "refseq_name": "zinc finger CCCH domain-containing protein 18 isoform a",
        "refseq_ac": "NP_001025164",
        "gene_names_uniprotkb": "Zc3h18; Nhn1",
        "gene_names_refseq": "1190001B23Rik; 5830416A07Rik; Nhn1; Zc3h18",
        "protein_names_uniprotkb": "Zinc finger CCCH domain-containing protein 18; Nuclear protein NHN1",
        "protein_names_refseq": "conserved nuclear protein Nhn1; nuclear protein NHN1; zinc finger CCCH domain-containing protein 18 isoform a; zinc finger CCCH domain-containing protein 18",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76014);  (R-MMU-9930044)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "10.1101/2023.09.13.557529;17242355;19131326;19144319;21183079;21750661;23806337;24129315;32782141;34418053;34428180;34887587;36852467;39627609",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 22,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TKW3;Q52KI3;Q6KAL8;Q9CU64",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0030674 protein-macromolecule adaptor activity;GO:0140262 mRNA cap binding complex binding",
        "go_cellular_component": "GO:0016607 nuclear speck;GO:0032991 protein-containing complex;GO:1990904 ribonucleoprotein complex",
        "go_biological_process": "GO:0050779 RNA destabilization",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q0P678-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O54950-1",
        "uniprot_id": "AAKG1_MOUSE",
        "mass": 37520.0,
        "length": 330,
        "protein_name": "5'-AMP-activated protein kinase subunit gamma-1",
        "gene_name": "Prkag1",
        "organism": "Mouse",
        "refseq_name": "5'-AMP-activated protein kinase subunit gamma-1 isoform 1",
        "refseq_ac": "NP_058061",
        "gene_names_uniprotkb": "Prkag1; Prkaac",
        "gene_names_refseq": "Prkaac; Prkag1",
        "protein_names_uniprotkb": "5'-AMP-activated protein kinase subunit gamma-1; AMPK gamma1; AMPK subunit gamma-1; AMPKg",
        "protein_names_refseq": "5'-AMP-activated protein kinase subunit gamma-1 isoform 1; 5'-AMP-activated protein kinase subunit gamma-1; AMPK gamma1; AMPK subunit gamma-1; AMPKg",
        "tax_id": 10090,
        "disease": "lethal congenital glycogen storage disease of heart (Disease Ontology:DOID:0090101); neurodegenerative disease (Disease Ontology:DOID:1289); Wolff-Parkinson-White syndrome (Disease Ontology:DOID:384)",
        "pathway": " (mmu:19082);  (R-MMU-1632852);  (R-MMU-380972);  (R-MMU-5628897);  (R-MMU-6804756);  (R-MMU-9931269)",
        "pathway_count": 6,
        "publication_count": 13,
        "publication_id_list": "11306812;21460634;21750661;25428506;25605945;26740625;28355557;30084848;30779550;32591547;33300544;34428180;38177907",
        "class_list": "",
        "function": "AMP/ATP-binding subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Gamma non-catalytic subunit mediates binding to AMP, ADP and ATP, leading to activate or inhibit AMPK: AMP-binding results in allosteric activation of alpha catalytic subunit (PRKAA1 or PRKAA2) both by inducing phosphorylation and preventing dephosphorylation of catalytic subunits. ADP also stimulates phosphorylation, without stimulating already phosphorylated catalytic subunit. ATP promotes dephosphorylation of catalytic subunit, rendering the AMPK enzyme inactive., [UniProtKB, UniProtKB]; S-nitrosylation of AMPKgamma impairs coronary collateral circulation and disrupts VSMC reprogramming., [RefSeq, PubMed]; The importance of the AMPK gamma 1 subunit in metformin suppression of liver glucose production. Publication Status: Online-Only, [RefSeq, PubMed]; These results emphasize the clinical relevance of activating AMPK in the liver to combat non-alcoholic fatty liver disease., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5PRE8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0019901 protein kinase binding;GO:0004679 AMP-activated protein kinase activity;GO:0016208 AMP binding;GO:0043531 ADP binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0031588 nucleotide-activated protein kinase complex",
        "go_biological_process": "GO:0006110 regulation of glycolytic process;GO:0006633 fatty acid biosynthetic process;GO:0050790 regulation of catalytic activity;GO:0031669 cellular response to nutrient levels;GO:0042149 cellular response to glucose starvation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "O54950-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91WF3-1",
        "uniprot_id": "ADCY4_MOUSE",
        "mass": 120380.0,
        "length": 1077,
        "protein_name": "Adenylate cyclase type 4",
        "gene_name": "Adcy4",
        "organism": "Mouse",
        "refseq_name": "adenylate cyclase type 4",
        "refseq_ac": "NP_536683",
        "gene_names_uniprotkb": "Adcy4",
        "gene_names_refseq": "Adcy4; mKIAA4004",
        "protein_names_uniprotkb": "Adenylate cyclase type 4; 4.6.1.1; ATP pyrophosphate-lyase 4; Adenylate cyclase type IV; Adenylyl cyclase 4",
        "protein_names_refseq": "ATP pyrophosphate-lyase 4; adenylate cyclase type 4; adenylate cyclase type IV; adenylyl cyclase 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:104110);  (R-MMU-163615);  (R-MMU-170660);  (R-MMU-170670);  (R-MMU-418597);  (R-MMU-5610787)",
        "pathway_count": 6,
        "publication_count": 3,
        "publication_id_list": "21750661;34428180;35114419",
        "class_list": "",
        "function": "Catalyzes the formation of the signaling molecule cAMP in response to G protein signaling., [UniProtKB, UniProtKB]; In Vivo Cardiac-specific Expression of Adenylyl Cyclase 4 Gene Protects against Klotho Deficiency-induced Heart Failure., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.6.5.-;4.6.1.1;2.7.7.85",
        "go_molecular_function": "GO:0004016 adenylate cyclase activity;GO:0005524 ATP binding;GO:0046872 metal ion binding;GO:0031683 G-protein beta/gamma-subunit complex binding;GO:0005080 protein kinase C binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0030425 dendrite;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006171 cAMP biosynthetic process;GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway;GO:0007190 activation of adenylate cyclase activity;GO:0035556 intracellular signal transduction;GO:0007188 adenylate cyclase-modulating G protein-coupled receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q91WF3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BJ63-1",
        "uniprot_id": "AP5M1_MOUSE",
        "mass": 54337.0,
        "length": 490,
        "protein_name": "AP-5 complex subunit mu-1",
        "gene_name": "Ap5m1",
        "organism": "Mouse",
        "refseq_name": "AP-5 complex subunit mu-1",
        "refseq_ac": "NP_653118",
        "gene_names_uniprotkb": "Ap5m1; Mudeng",
        "gene_names_refseq": "4932432K03Rik; Ap5m1; Mu5; Mudeng",
        "protein_names_uniprotkb": "AP-5 complex subunit mu-1; Adaptor-related protein complex 5 subunit mu-1; Mu-2-related death-inducing protein; Mu5; MuD",
        "protein_names_refseq": "AP-5 complex subunit mu-1; MHD domain-containing death-inducing protein; MU-2/AP1M2 domain containing, death-inducing; adapter-related protein complex 5 mu subunit; adapter-related protein complex 5 subunit mu-1; adaptor-related protein complex 5 subunit mu-1; mu-2-related death-inducing protein; muD",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74385)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "18395520;21750661",
        "class_list": "",
        "function": "As part of AP-5, a probable fifth adaptor protein complex it may be involved in endosomal transport., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TDF2;Q3TPT5;Q8BII2;Q8BJ31;Q8BJ58;Q8BY11;Q8R5B1",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005829 cytosol;GO:0016020 membrane;GO:0005764 lysosome;GO:0005765 lysosomal membrane;GO:0031902 late endosome membrane",
        "go_biological_process": "GO:0015031 protein transport;GO:0016197 endosomal transport;GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8BJ63-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q505D1-1",
        "uniprot_id": "ANR28_MOUSE",
        "mass": 112898.0,
        "length": 1053,
        "protein_name": "Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A",
        "gene_name": "Ankrd28",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A isoform 1",
        "refseq_ac": "NP_001019775",
        "gene_names_uniprotkb": "Ankrd28",
        "gene_names_refseq": "Ankrd28; E430019N21Rik; mKIAA0379",
        "protein_names_uniprotkb": "Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A; Ankyrin repeat domain-containing protein 28; PITK; PP6-ARS-A; Phosphatase interactor targeting protein hnRNP K; Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A",
        "protein_names_refseq": "PITK; PP6-ARS-A; ankyrin repeat domain-containing protein 28; phosphatase interactor targeting protein hnRNP K; serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A isoform 1; serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A; serine/threonine-protein phosphatase 6 regulatory subunit ARS-A",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:105522);  (R-MMU-171319);  (R-MMU-204005)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "16564677;21183079;21750661;22645316;25428506;34428180;40885482",
        "class_list": "",
        "function": "Putative regulatory subunit of protein phosphatase 6 (PP6) that may be involved in the recognition of phosphoprotein substrates. Involved in the PP6-mediated dephosphorylation of NFKBIE opposing its degradation in response to TNF. Selectively inhibits the phosphatase activity of PPP1C. Targets PPP1C to modulate HNRPK phosphorylation (By similarity). Involved in the PP6-mediated dephosphorylation of MOB1 and induced focal adhesion assembly during cell migration (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019888 protein phosphatase regulator activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0030027 lamellipodium;GO:0008287 protein serine/threonine phosphatase complex",
        "go_biological_process": "GO:0051894 positive regulation of focal adhesion assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q505D1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BH43-1",
        "uniprot_id": "WASF2_MOUSE",
        "mass": 54074.0,
        "length": 497,
        "protein_name": "Actin-binding protein WASF2",
        "gene_name": "Wasf2",
        "organism": "Mouse",
        "refseq_name": "actin-binding protein WASF2",
        "refseq_ac": "NP_700472",
        "gene_names_uniprotkb": "Wasf2; Wave2",
        "gene_names_refseq": "D4Ertd13e; WAVE2; Wasf2",
        "protein_names_uniprotkb": "Actin-binding protein WASF2; Protein WAVE-2; WASP family protein member 2; Wiskott-Aldrich syndrome protein family member 2",
        "protein_names_refseq": "WAS protein family, member 2; WASP family protein member 2; actin-binding protein WASF2; protein WAVE-2; wiskott-Aldrich syndrome protein family member 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:242687);  (R-MMU-2029482);  (R-MMU-4420097);  (R-MMU-5663213);  (R-MMU-9013149);  (R-MMU-9013404);  (R-MMU-9013423)",
        "pathway_count": 7,
        "publication_count": 11,
        "publication_id_list": "10.1101/2023.09.13.557529;12589062;12856283;14765121;21750661;29187734;29760073;31219806;31361958;35477411;38201213",
        "class_list": "",
        "function": "Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation. The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex (By similarity)., [UniProtKB, UniProtKB]; Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma. Publication Status: Online-Only, [RefSeq, PubMed]; Scar2 and the Arp2/3 complex appear to be involved in the establishment and maintenance of Golgi polarity during directed migration, [RefSeq, PubMed]; WAVE2 Is a Vital Regulator in Myogenic Differentiation of Progenitor Cells through the Mechanosensitive MRTFA-SRF Axis. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003779 actin binding;GO:0017124 SH3 domain binding;GO:0034237 protein kinase A regulatory subunit binding;GO:0051018 protein kinase A binding;GO:0071933 Arp2/3 complex binding",
        "go_cellular_component": "GO:0005769 early endosome;GO:0005856 cytoskeleton;GO:0005911 cell-cell junction;GO:0016323 basolateral plasma membrane;GO:0030027 lamellipodium",
        "go_biological_process": "GO:0001525 angiogenesis;GO:0006897 endocytosis;GO:0001764 neuron migration;GO:0030036 actin cytoskeleton organization;GO:0016601 Rac protein signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q8BH43-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q0KK55-1",
        "uniprot_id": "KNDC1_MOUSE",
        "mass": 191313.0,
        "length": 1742,
        "protein_name": "Kinase non-catalytic C-lobe domain-containing protein 1",
        "gene_name": "Kndc1",
        "organism": "Mouse",
        "refseq_name": "kinase non-catalytic C-lobe domain-containing protein 1",
        "refseq_ac": "NP_796235",
        "gene_names_uniprotkb": "Kndc1; Kiaa1768; Rasgef2; Vkind",
        "gene_names_refseq": "2410012C07Rik; B830014K08Rik; Kndc1; VKIND; v-KIND; very-kind",
        "protein_names_uniprotkb": "Kinase non-catalytic C-lobe domain-containing protein 1; KIND domain-containing protein 1; Protein very KIND; Ras-GEF domain-containing family member 2; v-KIND",
        "protein_names_refseq": "KIND domain-containing protein 1; kinase non-catalytic C-lobe domain-containing protein 1; protein very KIND; ras-GEF domain-containing family member 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76484)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "16099729;16807365;17114649;17984326;21183079;21385318;21750661;28264072;30084848",
        "class_list": "",
        "function": "During mouse embryogenesis the VKIND gene was specifically expressed in the developing nervous system., [RefSeq, PubMed]; Our results suggest that v-KIND is required for compact dendritic growth and proper excitatory synaptic connections in cerebellar granule cells, which are necessary for normal motor coordination and balance. Publication Status: Online-Only, [RefSeq, PubMed]; RAS-Guanine nucleotide exchange factor (GEF) that controls the negative regulation of neuronal dendrite growth by mediating a signaling pathway linking RAS and MAP2 (PubMed:17984326, PubMed:21385318). May be involved in cellular senescence (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB]; Results demonstrate the structural and functional determinant underlying the v-KIND-MAP2 interaction that controls dendrite arborization patterns, [RefSeq, PubMed]; V-KIND mediates a signaling pathway that links Ras and MAP2 to control dendrite growth, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q0KK50;Q3TF27;Q3UGX9;Q3UGZ3;Q3UHK4;Q7TNH0;Q8BTH5;Q8BXJ3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005085 guanyl-nucleotide exchange factor activity",
        "go_cellular_component": "GO:0030425 dendrite;GO:0043025 neuronal cell body;GO:0043204 perikaryon;GO:0032045 guanyl-nucleotide exchange factor complex",
        "go_biological_process": "GO:0001934 positive regulation of protein phosphorylation;GO:0048814 regulation of dendrite morphogenesis;GO:0007264 small GTPase-mediated signal transduction;GO:0050773 regulation of dendrite development;GO:0021707 cerebellar granule cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q0KK55-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5GH67-1",
        "uniprot_id": "XKR4_MOUSE",
        "mass": 71503.0,
        "length": 647,
        "protein_name": "XK-related protein 4",
        "gene_name": "Xkr4",
        "organism": "Mouse",
        "refseq_name": "XK-related protein 4",
        "refseq_ac": "NP_001011874",
        "gene_names_uniprotkb": "Xkr4; Xrg4",
        "gene_names_refseq": "Gm210; XRG4; Xkr4; mKIAA1889",
        "protein_names_uniprotkb": "XK-related protein 4",
        "protein_names_refseq": "X Kell blood group precursor related family member 4; XK-related protein 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:497097)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "17114649;21183079;25231987;33725486;37696806",
        "class_list": "",
        "function": "Caspase cleavage releases a nuclear protein fragment that stimulates phospholipid scrambling at the plasma membrane., [RefSeq, PubMed]; Phospholipid scramblase that promotes phosphatidylserine exposure on apoptotic cell surface (PubMed:25231987, PubMed:33725486, PubMed:37696806). Phosphatidylserine is a specific marker only present at the surface of apoptotic cells and acts as a specific signal for engulfment (PubMed:25231987, PubMed:33725486, PubMed:37696806)., [UniProtKB, PubMed, PubMed, PubMed]; Unlike Xkr8, which is ubiquitously expressed, Xkr4 and Xkr9 expression is tissue-specific., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 10,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.6.5.5;3.1.-.-",
        "go_molecular_function": "GO:0017128 phospholipid scramblase activity",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0043652 engulfment of apoptotic cell;GO:0070782 phosphatidylserine exposure on apoptotic cell surface;GO:1902742 apoptotic process involved in development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q5GH67-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6J1H4-1",
        "uniprot_id": "UTF1_MOUSE",
        "mass": 36408.0,
        "length": 339,
        "protein_name": "Undifferentiated embryonic cell transcription factor 1",
        "gene_name": "Utf1",
        "organism": "Mouse",
        "refseq_name": "undifferentiated embryonic cell transcription factor 1",
        "refseq_ac": "NP_033508",
        "gene_names_uniprotkb": "Utf1",
        "gene_names_refseq": "Utf1",
        "protein_names_uniprotkb": "Undifferentiated embryonic cell transcription factor 1",
        "protein_names_refseq": "undifferentiated embryonic cell transcription factor 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22286)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10329418;11467843;21183079;33517544;34428180;36852467;9524124",
        "class_list": "glycogene",
        "function": "Acts as a transcriptional coactivator of ATF2., [UniProtKB, PubMed]; An Insight into the Role of UTF1 in Development, Stem Cells, and Cancer. Review article, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 18,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O70530",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003713 transcription coactivator activity;GO:0071837 HMG box domain binding;GO:0017025 TBP-class protein binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q6J1H4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C190-1",
        "uniprot_id": "VP9D1_MOUSE",
        "mass": 71284.0,
        "length": 649,
        "protein_name": "VPS9 domain-containing protein 1",
        "gene_name": "Vps9d1",
        "organism": "Mouse",
        "refseq_name": "VPS9 domain-containing protein 1 isoform 1",
        "refseq_ac": "NP_001297590",
        "gene_names_uniprotkb": "Vps9d1; 1300018I17Rik",
        "gene_names_refseq": "1300018I17Rik; 2410004N05Rik; 5DOS1; Vps9d1; Vsp9d1",
        "protein_names_uniprotkb": "VPS9 domain-containing protein 1; 5-day ovary-specific transcript 1 protein",
        "protein_names_refseq": "5-day ovary-specific transcript 1 protein; VPS9 domain-containing protein 1 isoform 1; VPS9 domain-containing protein 1; VSP9 domain containing 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72325)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21183079;21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6PFD1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0005085 guanyl-nucleotide exchange factor activity;GO:0031267 small GTPase binding",
        "go_cellular_component": "GO:0005829 cytosol;GO:0030139 endocytic vesicle",
        "go_biological_process": "GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8C190-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91YD9-1",
        "uniprot_id": "WASL_MOUSE",
        "mass": 54274.0,
        "length": 501,
        "protein_name": "Actin nucleation-promoting factor WASL",
        "gene_name": "Wasl",
        "organism": "Mouse",
        "refseq_name": "actin nucleation-promoting factor WASL isoform 1",
        "refseq_ac": "NP_082735",
        "gene_names_uniprotkb": "Wasl",
        "gene_names_refseq": "2900021I12Rik; 3110031I02Rik; N-WASP; Wasl",
        "protein_names_uniprotkb": "Actin nucleation-promoting factor WASL; N-WASP; Neural Wiskott-Aldrich syndrome protein",
        "protein_names_refseq": "Wiskott-Aldrich syndrome-like; actin nucleation-promoting factor WASL isoform 1; actin nucleation-promoting factor WASL; neural Wiskott-Aldrich syndrome protein",
        "tax_id": 10090,
        "disease": "atopic dermatitis (Disease Ontology:DOID:3310)",
        "pathway": " (mmu:73178)",
        "pathway_count": 1,
        "publication_count": 21,
        "publication_id_list": "10.1101/2023.09.13.557529;11082044;11559594;12871950;14506234;14676198;14697212;16199863;18034455;19131326;19144319;21183079;23437151;25428506;25851601;29650963;29887380;30084848;31219806;34428180;38560567",
        "class_list": "",
        "function": "Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via activation of LOXL2. Publication Status: Online-Only, [RefSeq, PubMed]; Regulates actin polymerization by stimulating the actin-nucleating activity of the Arp2/3 complex. Involved in various processes, such as mitosis and cytokinesis, via its role in the regulation of actin polymerization. Together with CDC42, involved in the extension and maintenance of the formation of thin, actin-rich surface projections called filopodia. In addition to its role in the cytoplasm, also plays a role in the nucleus by regulating gene transcription, probably by promoting nuclear actin polymerization (By similarity). Binds to HSF1/HSTF1 and forms a complex on heat shock promoter elements (HSE) that negatively regulates HSP90 expression (PubMed:12871950). Plays a role in dendrite spine morphogenesis (PubMed:25851601)., [UniProtKB, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003779 actin binding;GO:0042802 identical protein binding;GO:0008092 cytoskeletal protein binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0000139 Golgi membrane;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0010324 membrane invagination;GO:0006351 DNA-templated transcription;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0051301 cell division;GO:0009617 response to bacterium",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "Q91YD9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z0U0-1",
        "uniprot_id": "S53A1_MOUSE",
        "mass": 81751.0,
        "length": 695,
        "protein_name": "Solute carrier family 53 member 1",
        "gene_name": "Xpr1",
        "organism": "Mouse",
        "refseq_name": "solute carrier family 53 member 1",
        "refseq_ac": "NP_035403",
        "gene_names_uniprotkb": "Xpr1; Syg1",
        "gene_names_refseq": "Rmc-1; Rmc1; Sxv; Syg1; XR; Xpr1",
        "protein_names_uniprotkb": "Solute carrier family 53 member 1; Phosphate exporter SLC53A1; Protein SYG1 homolog; Rmc-1; Xenotropic and polytropic retrovirus receptor 1",
        "protein_names_refseq": "phosphate exporter SLC53A1; receptor for MCF virus 1; solute carrier family 53 member 1; suppressor of yeast G<a> deletion; susceptibility to xenotropic virus; xenotropic and polytropic murine leukemia virus receptor; xenotropic and polytropic retrovirus receptor 1 homolog",
        "tax_id": 10090,
        "disease": "basal ganglia calcification (Disease Ontology:DOID:0060230)",
        "pathway": " (mmu:19775)",
        "pathway_count": 1,
        "publication_count": 19,
        "publication_id_list": "10516044;17634227;19144319;21183079;21750661;22090134;22872234;25428506;26740625;28011936;30084848;30779550;32826297;34428180;34578445;35112184;39019040;39927985;9988277",
        "class_list": "",
        "function": "(Microbial infection) Receptor for xenotropic and polytropic murine leukemia (X- and P-MLV) retroviruses. Confers susceptibility to X- or P-MLV infection in vitro., [UniProtKB, PubMed, PubMed]; Astrocytes modulate brain phosphate homeostasis via polarized distribution of phosphate uptake transporter PiT2 and exporter XPR1., [RefSeq, PubMed]; Inorganic ion transporter that mediates phosphate ion export across the plasma membrane (PubMed:32826297). Plays a major role in phosphate homeostasis, preventing intracellular phosphate accumulation and possible calcium phosphate precipitation, ultimately preserving calcium signaling (By similarity). Binds inositol hexakisphosphate (Ins6P) and similar inositol polyphosphates, such as 5-diphospho-inositol pentakisphosphate (5-InsP7), which are important intracellular signaling molecules involved in regulation of phosphate flux (By similarity)., [UniProtKB, UniProtKB, PubMed]; Inorganic ion transporter that mediates phosphate ion export across the plasma membrane. Plays a major role in phosphate homeostasis, preventing intracellular phosphate accumulation and possible calcium phosphate precipitation, ultimately preserving calcium signaling. Binds inositol hexakisphosphate (Ins6P) and similar inositol polyphosphates, such as 5-diphospho-inositol pentakisphosphate (5-InsP7), which are important intracellular signaling molecules involved in regulation of phosphate flux., [UniProtKB, UniProtKB]; Patterns of Coevolutionary Adaptations across Time and Space in Mouse Gammaretroviruses and Three Restrictive Host Factors. Publication Status: Online-Only, [RefSeq, PubMed]; Protective Roles of Xenotropic and Polytropic Retrovirus Receptor 1 (XPR1) in Uremic Vascular Calcification., [RefSeq, PubMed]; Results indicate that Xpr1 is a novel, atypical G-protein-coupled receptor (GPCR) and that xenotropic or polytropic retrovirus binding can disrupt the cAMP-mediated signaling function of Xpr1, leading to the apoptosis of infected cells, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UHG6;Q3UR99;Q8CCC8;Q8CCT2;Q9QZ72;Q9R034;Q9R036",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001618 virus receptor activity;GO:0015562 efflux transmembrane transporter activity;GO:0005315 phosphate transmembrane transporter activity;GO:0000822 inositol hexakisphosphate binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0009615 response to virus;GO:0006817 phosphate ion transport;GO:0016036 cellular response to phosphate starvation;GO:0035435 phosphate ion transmembrane transport;GO:0030643 intracellular phosphate ion homeostasis",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "Q9Z0U0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99JW2-1",
        "uniprot_id": "ACY1_MOUSE",
        "mass": 45781.0,
        "length": 408,
        "protein_name": "Aminoacylase-1",
        "gene_name": "Acy1",
        "organism": "Mouse",
        "refseq_name": "aminoacylase-1",
        "refseq_ac": "NP_001263371",
        "gene_names_uniprotkb": "Acy1",
        "gene_names_refseq": "1110014J22Rik; Acy-1; Acy1",
        "protein_names_uniprotkb": "Aminoacylase-1; 3.5.1.14; ACY-1; N-acyl-L-amino-acid amidohydrolase",
        "protein_names_refseq": "N-acyl-L-amino-acid amidohydrolase; aminoacylase-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:109652);  (R-MMU-5423646);  (R-MMU-9753281)",
        "pathway_count": 3,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;15196915;21750661;31587987;34916608;37507081",
        "class_list": "",
        "function": "Aminoacylase involved in the hydrolysis of N-acetylated and N-formylated amino acids. May act sequentially with APEH in the degradation of N-acylated peptides: APEH first cleaves N-acylaminoacids from N-acylated peptides, then ACY1 further hydrolyzes the N-acylaminoacid into free aminoacid and a carboxylate., [UniProtKB, PubMed, UniProtKB]; Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CR15",
        "ec_number_list": "3.1.-.-;3.5.1.114;3.5.1.14",
        "go_molecular_function": "GO:0004046 aminoacylase activity;GO:0042802 identical protein binding;GO:0046872 metal ion binding;GO:0008463 formylmethionine deformylase activity;GO:0016787 hydrolase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0070062 extracellular exosome",
        "go_biological_process": "GO:0006520 amino acid metabolic process;GO:0030163 protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q99JW2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P61967-1",
        "uniprot_id": "AP1S1_MOUSE",
        "mass": 18733.0,
        "length": 158,
        "protein_name": "AP-1 complex subunit sigma-1A",
        "gene_name": "Ap1s1",
        "organism": "Mouse",
        "refseq_name": "AP-1 complex subunit sigma-1A isoform 1",
        "refseq_ac": "NP_031483",
        "gene_names_uniprotkb": "Ap1s1; Ap19",
        "gene_names_refseq": "AP19; Ap1s1",
        "protein_names_uniprotkb": "AP-1 complex subunit sigma-1A; Adaptor protein complex AP-1 subunit sigma-1A; Adaptor-related protein complex 1 subunit sigma-1A; Clathrin assembly protein complex 1 sigma-1A small chain; Clathrin coat assembly protein AP19; Golgi adaptor HA1/AP1 adaptin sigma-1A subunit; HA1 19 kDa subunit; Sigma 1a subunit of AP-1 clathrin; Sigma-adaptin 1A; Sigma1A-adaptin",
        "protein_names_refseq": "AP-1 complex subunit sigma-1A isoform 1; AP-1 complex subunit sigma-1A; HA1 19 kDa subunit; adapter-related protein complex 1 sigma-1A subunit; adapter-related protein complex 1 subunit sigma-1A; adaptor protein complex AP-1 sigma-1A subunit; adaptor protein complex AP-1 subunit sigma-1A; adaptor-related protein complex 1 subunit sigma-1A; adaptor-related protein complex AP-1, sigma 1; clathrin assembly protein complex 1 sigma-1A small chain; clathrin coat assembly protein AP19; golgi adaptor HA1/AP1 adaptin sigma-1A subunit; sigma 1a subunit of AP-1 clathrin; sigma-adaptin 1A; sigma1A-adaptin",
        "tax_id": 10090,
        "disease": "MEDNIK syndrome (Disease Ontology:DOID:0060483)",
        "pathway": " (mmu:11769);  (R-MMU-2132295);  (R-MMU-432720);  (R-MMU-432722)",
        "pathway_count": 4,
        "publication_count": 7,
        "publication_id_list": "17114649;2040623;21183079;21750661;22872234;27411398;31219806",
        "class_list": "",
        "function": "AP-1/sigma1A-ArfGAP1-Rabex-5 complex formation leads to more endosomal Rabex-5 and enhanced, Rab5(GTP)-stimulated Vps34 PI3-kinase activity, which is essential for multivesicular body endosome formation. Publication Status: Online-Only, [RefSeq, PubMed]; Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P82267;Q00382;Q9BTN4;Q9UDW9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0035615 clathrin adaptor activity",
        "go_cellular_component": "GO:0005769 early endosome;GO:0005794 Golgi apparatus;GO:0005829 cytosol;GO:0005905 clathrin-coated pit;GO:0032588 trans-Golgi network membrane",
        "go_biological_process": "GO:1903232 melanosome assembly;GO:0006886 intracellular protein transport;GO:0009615 response to virus;GO:0060155 platelet dense granule organization;GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "P61967-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CGB3-1",
        "uniprot_id": "UACA_MOUSE",
        "mass": 160813.0,
        "length": 1411,
        "protein_name": "Uveal autoantigen with coiled-coil domains and ankyrin repeats",
        "gene_name": "Uaca",
        "organism": "Mouse",
        "refseq_name": "uveal autoantigen with coiled-coil domains and ankyrin repeats isoform 1",
        "refseq_ac": "NP_082559",
        "gene_names_uniprotkb": "Uaca; Kiaa1561",
        "gene_names_refseq": "2700059D02Rik; Uaca; nucling",
        "protein_names_uniprotkb": "Uveal autoantigen with coiled-coil domains and ankyrin repeats; Nuclear membrane-binding protein; Nucling",
        "protein_names_refseq": "nuclear membrane binding protein NUCLING; nuclear membrane-binding protein; uveal autoantigen with coiled-coil domains and ankyrin repeats isoform 1",
        "tax_id": 10090,
        "disease": "hepatocellular carcinoma (Disease Ontology:DOID:684)",
        "pathway": " (mmu:72565);  (R-MMU-9013407)",
        "pathway_count": 2,
        "publication_count": 17,
        "publication_id_list": "12761289;14961764;15271982;19144319;20702393;21183079;21750661;23071121;23624502;25428506;26269594;29187734;30084848;31219806;34428180;34887587;36210013",
        "class_list": "",
        "function": "Data from knockout mice suggest that nucling plays important role in induction of apoptosis in liver/hepatocytes damaged by cytotoxic stressors; nucling acts through modulation of NFkappaB signaling., [RefSeq, PubMed]; Expressed specifically in cardiomuscular tissue and up-regulated during cardiac differentiation in the developing embryo, [RefSeq, PubMed]; Findings indicate that UACA functions as a Rab39A effector in the retinoic acid-induced differentiation of Neuro2A cells., [RefSeq, PubMed]; Modulates isoactin dynamics to regulate the morphological alterations required for cell growth and motility. Interaction with ARF6 may modulate cell shape and motility after injury (By similarity). May be involved in multiple neurite formation (PubMed:23624502)., [UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Nucling expression is induced by canonical NF-kappaB signalling pathway, whereas Nucling is undergoing proteasome degradation, as well as being cleaved by caspase system under stress conditions, [RefSeq, PubMed]; Nucling plays an important role in mammary gland involution by regulating NF-kappaB and STAT3 signaling pathways, [RefSeq, PubMed]; Nucling recruits and transports the apoptosome complex during stress-induced apoptosis, [RefSeq, PubMed]; Nucling was shown to interfere with NF-kappaB activation via the nuclear translocation process of NF-kappaB/p65, thus inhibiting the expression of galectin-3., [RefSeq, PubMed]; Regulates APAF1 expression and plays an important role in the regulation of stress-induced apoptosis. Promotes apoptosis by regulating three pathways, apoptosome up-regulation, LGALS3/galectin-3 down-regulation and NF-kappa-B inactivation. Regulates the redistribution of APAF1 into the nucleus after proapoptotic stress. Down-regulates the expression of LGALS3 by inhibiting NFKB1., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q69ZG3;Q7TN77;Q8BJC8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003779 actin binding;GO:0140416 transcription regulator inhibitor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005635 nuclear envelope;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0042307 positive regulation of protein import into nucleus;GO:0043065 positive regulation of apoptotic process;GO:0050728 negative regulation of inflammatory response;GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage;GO:0009411 response to UV",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "Q8CGB3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3V384-1",
        "uniprot_id": "AFG1L_MOUSE",
        "mass": 54313.0,
        "length": 480,
        "protein_name": "AFG1-like ATPase",
        "gene_name": "Afg1l",
        "organism": "Mouse",
        "refseq_name": "AFG1-like ATPase isoform 1",
        "refseq_ac": "NP_665686",
        "gene_names_uniprotkb": "Afg1l; Lace1",
        "gene_names_refseq": "Afg1l; CG8520; Lace1",
        "protein_names_uniprotkb": "AFG1-like ATPase; 3.6.-.-; Lactation elevated protein 1",
        "protein_names_refseq": "AFG1-like ATPase isoform 1; lactation elevated 1; lactation elevated protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:215951)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "12079282;21750661",
        "class_list": "",
        "function": "Putative mitochondrial ATPase. Plays a role in mitochondrial morphology and mitochondrial protein metabolism. Promotes degradation of excess nuclear-encoded complex IV subunits (COX4I1, COX5A and COX6A1) and normal activity of complexes III and IV of the respiratory chain. Mediates mitochondrial translocation of TP53 and its transcription-independent apoptosis in response to genotoxic stress., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5EBH5;Q8K1E9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0016887 ATP hydrolysis activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0031966 mitochondrial membrane",
        "go_biological_process": "GO:0007005 mitochondrion organization;GO:0035694 mitochondrial protein catabolic process;GO:0141164 mitochondrial protein quality control",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q3V384-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C7N7-1",
        "uniprot_id": "APH1B_MOUSE",
        "mass": 28703.0,
        "length": 257,
        "protein_name": "Gamma-secretase subunit APH-1B",
        "gene_name": "Aph1b",
        "organism": "Mouse",
        "refseq_name": "gamma-secretase subunit APH-1B",
        "refseq_ac": "NP_808251",
        "gene_names_uniprotkb": "Aph1b",
        "gene_names_refseq": "APH-1b; Aph1b; aph-1beta",
        "protein_names_uniprotkb": "Gamma-secretase subunit APH-1B; APH-1b; Aph-1beta",
        "protein_names_refseq": "APH1B homolog; anterior pharynx defective 1b homolog; anterior pharynx defective 1c homolog; gamma-secretase subunit APH-1B",
        "tax_id": 10090,
        "disease": "coronary artery disease (Disease Ontology:DOID:3393)",
        "pathway": " (mmu:208117);  (R-MMU-1251985);  (R-MMU-193692);  (R-MMU-205043);  (R-MMU-3928665);  (R-MMU-9013507);  (R-MMU-9017802);  (R-MMU-9839383)",
        "pathway_count": 8,
        "publication_count": 2,
        "publication_id_list": "21750661;27240539",
        "class_list": "",
        "function": "Potential subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral proteins such as Notch receptors., [UniProtKB, UniProtKB]; Probable subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral proteins such as Notch receptors and APP (amyloid-beta precursor protein). It probably represents a stabilizing cofactor for the presenilin homodimer that promotes the formation of a stable complex. Probably present in a minority of gamma-secretase complexes compared to APH1A (By similarity)., [UniProtKB]; Prostaglandin I2 accumulation in neuronal cells activates PKA/CREB and JNK/c-Jun signaling pathways by phosphorylation, which results in APH-1alpha/1beta expression., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U3B5;Q8CEC9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030674 protein-macromolecule adaptor activity;GO:0061133 endopeptidase activator activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005783 endoplasmic reticulum;GO:0005886 plasma membrane;GO:0045202 synapse;GO:0030133 transport vesicle",
        "go_biological_process": "GO:0006509 membrane protein ectodomain proteolysis;GO:0007219 Notch signaling pathway;GO:0007220 Notch receptor processing;GO:0016485 protein processing;GO:0001963 synaptic transmission, dopaminergic",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8C7N7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R3P0-1",
        "uniprot_id": "ACY2_MOUSE",
        "mass": 35345.0,
        "length": 312,
        "protein_name": "Aspartoacylase",
        "gene_name": "Aspa",
        "organism": "Mouse",
        "refseq_name": "aspartoacylase isoform 1",
        "refseq_ac": "NP_075602",
        "gene_names_uniprotkb": "Aspa",
        "gene_names_refseq": "Acy-2; Acy2; Aspa; nur7",
        "protein_names_uniprotkb": "Aspartoacylase; 3.5.1.15; ACY-2; Aminoacylase-2",
        "protein_names_refseq": "aminoacylase-2; aspartoacylase (aminoacylase) 2; aspartoacylase isoform 1",
        "tax_id": 10090,
        "disease": "Canavan disease (Disease Ontology:DOID:3613)",
        "pathway": " (mmu:11484);  (R-MMU-8963693)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "10837925;18987190;21750661",
        "class_list": "",
        "function": "Catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids., [UniProtKB, UniProtKB]; Nur7( Q193X) is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS., [RefSeq, PubMed]; This gene encodes an enzyme that deacteylates N-acetyl-L-aspartic acid (NAA) in the brain to yield acetate and L-aspartate. In humans, alterations in neuronal NAA concentration are associated with many neurodegenerative diseases (decrease associated with epilepsy, multiple sclerosis, myotrophic lateral sclerosis, and Alzheimer's disease; increase associated with Canavan disease). In mouse, mutations in this gene, which cause accumulation of NAA, result in demyelination and spongy degeneration in the CNS and serve as a pathophysiological model for Canavan disease. [provided by RefSeq, Dec 2012]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SV07;Q9D876;Q9DCE2;Q9JIN8",
        "ec_number_list": "3.5.1.15",
        "go_molecular_function": "GO:0004046 aminoacylase activity;GO:0016788 hydrolase activity, acting on ester bonds;GO:0019807 aspartoacylase activity;GO:0042802 identical protein binding;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006083 acetate metabolic process;GO:0048714 positive regulation of oligodendrocyte differentiation;GO:0006531 aspartate metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8R3P0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P83741-1",
        "uniprot_id": "WNK1_MOUSE",
        "mass": 250934.0,
        "length": 2377,
        "protein_name": "Serine/threonine-protein kinase WNK1",
        "gene_name": "Wnk1",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase WNK1 isoform 2",
        "refseq_ac": "NP_001171949",
        "gene_names_uniprotkb": "Wnk1; Hsn2; Prkwnk1",
        "gene_names_refseq": "6430573H23Rik; EG406236; Hsn2; Prkwnk1; Wnk1; mKIAA0344",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase WNK1; 2.7.11.1; Protein kinase lysine-deficient 1; Protein kinase with no lysine 1",
        "protein_names_refseq": "protein kinase lysine-deficient 1; protein kinase with no lysine 1; serine/threonine-protein kinase WNK1 isoform 2; serine/threonine-protein kinase Wnk1",
        "tax_id": 10090,
        "disease": "hereditary sensory and autonomic neuropathy (Disease Ontology:DOID:0050548); hereditary sensory and autonomic neuropathy type 2A (Disease Ontology:DOID:0070155); hypertension (Disease Ontology:DOID:10763); transient cerebral ischemia (Disease Ontology:DOID:224); pseudohypoaldosteronism (Disease Ontology:DOID:4479)",
        "pathway": " (mmu:232341)",
        "pathway_count": 1,
        "publication_count": 49,
        "publication_id_list": "10.1101/2023.09.13.557529;11498583;12522152;12671053;14514722;14610273;15060842;16204408;17242355;18521183;19644017;21131289;21183079;21317537;21750661;21952136;22517741;22645316;22826440;23443134;23542070;25428506;26192747;26495903;27669760;29202451;30016717;30059200;30779550;32782141;32848054;33300544;33649389;34203471;34428180;34678516;34887587;35820727;35822049;36064721;36288343;36852467;37828378;38885324;38961847;39627609;39927985;40021952;40885482",
        "class_list": "",
        "function": "Deletion of KS-WNK1 promotes NCC activation by increasing WNK1/4 abundance., [RefSeq, PubMed]; Findings suggest that WNK1 plays a general role in the regulation of epithelial Cl(-) flux [WNK1], [RefSeq, PubMed]; Kinase-defective isoform specifically expressed in kidney, which acts as a dominant-negative regulator of the longer isoform 1 (PubMed:21131289). Does not directly inhibit WNK4 and has no direct effect on sodium and chloride ion transport (By similarity). Down-regulates sodium-chloride cotransporter activity indirectly by inhibiting isoform 1, it associates with isoform 1 and attenuates its kinase activity (By similarity). In kidney, may play an important role regulating sodium and potassium balance (By similarity)., [UniProtKB, UniProtKB, PubMed]; Serine/threonine-protein kinase component of the WNK1-SPAK/OSR1 kinase cascade, which acts as a key regulator of blood pressure and regulatory volume increase by promoting ion influx (PubMed:12671053, PubMed:14610273). WNK1 mediates regulatory volume increase in response to hyperosmotic stress by acting as a molecular crowding sensor, which senses cell shrinkage and mediates formation of a membraneless compartment by undergoing liquid-liquid phase separation (By similarity). The membraneless compartment concentrates WNK1 with its substrates, OXSR1/OSR1 and STK39/SPAK, promoting WNK1-dependent phosphorylation and activation of downstream kinases OXSR1/OSR1 and STK39/SPAK (By similarity). Following activation, OXSR1/OSR1 and STK39/SPAK catalyze phosphorylation of ion cotransporters SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A5/KCC2 and SLC12A6/KCC3, regulating their activity (By similarity). Phosphorylation of Na-K-Cl cotransporters SLC12A2/NKCC1 and SLC12A2/NKCC1 promote their activation and ion influx; simultaneously, phosphorylation of K-Cl cotransporters SLC12A5/KCC2 and SLC12A6/KCC3 inhibit their activity, blocking ion efflux (By similarity). Also acts as a regulator of angiogenesis in endothelial cells (PubMed:19644017). Also acts independently of the WNK1-SPAK/OSR1 kinase cascade by catalyzing phosphorylation of other substrates, such as SYT2, PCF11 and NEDD4L (By similarity). Mediates phosphorylation of SYT2, regulating SYT2 association with phospholipids and membrane-binding (By similarity). Regulates mRNA export in the nucleus by mediating phosphorylation of PCF11, thereby decreasing the association between PCF11 and POLR2A/RNA polymerase II and promoting mRNA export to the cytoplasm (By similarity). Acts as a negative regulator of autophagy (By similarity). Required for the abscission step during mitosis, independently of the WNK1-SPAK/OSR1 kinase cascade (By similarity). WNK1 may also play a role in actin cytoskeletal reorganization (By similarity). Also acts as a scaffold protein independently of its protein kinase activity: negatively regulates cell membrane localization of various transporters and channels, such as SLC4A4, SLC26A6, SLC26A9, TRPV4 and CFTR (PubMed:21317537, PubMed:23542070). Involved in the regulation of epithelial Na(+) channel (ENaC) by promoting activation of SGK1 in a kinase-independent manner: probably acts as a scaffold protein that promotes the recruitment of SGK1 to the mTORC2 complex in response to chloride, leading to mTORC2-dependent phosphorylation and activation of SGK1 (By similarity). Acts as an assembly factor for the ER membrane protein complex independently of its protein kinase activity: associates with EMC2 in the cytoplasm via its amphipathic alpha-helix, and prevents EMC2 ubiquitination and subsequent degradation, thereby promoting EMC2 stabilization (By similarity)., [UniProtKB, UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]; Several WNK1 transcript classes are demonstrated, showing tissue-, developmental-, and nephron-segment-specific expression., [RefSeq, PubMed]; WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 48,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 48,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 48,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 19,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 5,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 5,
        "glyco_site_count": 52,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A6H6V1;B2RRJ7;B7ZNJ4;Q3UZP3;Q6A083;Q6IFS6;Q6VYA0",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0019870 potassium channel inhibitor activity;GO:0000287 magnesium ion binding;GO:0004672 protein kinase activity;GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding",
        "go_cellular_component": "GO:0098982 GABA-ergic synapse;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016020 membrane",
        "go_biological_process": "GO:1990869 cellular response to chemokine;GO:0030644 intracellular chloride ion homeostasis;GO:0033633 negative regulation of cell-cell adhesion mediated by integrin;GO:0006468 protein phosphorylation;GO:0006811 monoatomic ion transport",
        "synthesized_glycan_count": 0,
        "hit_score": 10.1,
        "record_id": "P83741-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z0F8-1",
        "uniprot_id": "ADA17_MOUSE",
        "mass": 93056.0,
        "length": 827,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 17",
        "gene_name": "Adam17",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 17 isoform 2 precursor",
        "refseq_ac": "NP_001264195",
        "gene_names_uniprotkb": "Adam17; Tace",
        "gene_names_refseq": "Adam17; CD156b; Tace",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 17; 3.4.24.86; ADAM 17; TNF-alpha convertase; TNF-alpha-converting enzyme",
        "protein_names_refseq": "TNF-alpha convertase; TNF-alpha converting enzyme; disintegrin and metalloproteinase domain-containing protein 17 isoform 2 precursor; disintegrin and metalloproteinase domain-containing protein 17",
        "tax_id": 10090,
        "disease": "renal fibrosis (Disease Ontology:DOID:0050855); neonatal inflammatory skin and bowel disease 1 (Disease Ontology:DOID:0061192); Alzheimer's disease (Disease Ontology:DOID:10652); thoracic aortic aneurysm (Disease Ontology:DOID:14004); atopic dermatitis (Disease Ontology:DOID:3310); congestive heart failure (Disease Ontology:DOID:6000); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:11491);  (R-MMU-193692);  (R-MMU-75893)",
        "pathway_count": 3,
        "publication_count": 17,
        "publication_id_list": "10.1101/2023.09.13.557529;10375622;10433800;10799547;10882063;11108241;12907434;17245433;19144319;21183079;21750661;23868980;25428506;30084848;30355783;34428180;9755855",
        "class_list": "",
        "function": "Cleaves the membrane-bound precursor of TNF to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Plays a role in the proteolytic processing of ACE2 (By similarity). Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein (PubMed:10799547, PubMed:11108241). Acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called notch extracellular truncation (NEXT) (PubMed:10882063). Plays a role in hemostasis through shedding of GP1BA, the platelet glycoprotein Ib alpha chain (PubMed:12907434). Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 (PubMed:17245433). Mediates the proteolytic cleavage of IL6R, leading to the release of secreted form of IL6R (By similarity). Mediates the proteolytic cleavage and shedding of FCGR3A upon NK cell stimulation, a mechanism that allows for increased NK cell motility and detachment from opsonized target cells., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed]; This gene encodes a member of a disintegrin and metalloprotease (ADAM) family of endoproteases that play important roles in various biological processes including cell signaling, adhesion and migration. The encoded preproprotein undergoes proteolytic processing to generate a mature enzyme that is involved in the proteolytic release of membrane-bound proteins in a process called ectodomain shedding. Mice lacking the encoded protein die in utero or fail to survive beyond one week of age. Alternative splicing results in multiple transcript variants encoding different isoforms, some of which may undergo similar processing. [provided by RefSeq, May 2016]., [RefSeq]; Transmembrane metalloprotease which mediates the ectodomain shedding of a myriad of transmembrane proteins including adhesion proteins, growth factor precursors and cytokines important for inflammation and immunity (PubMed:10799547, PubMed:10882063). Cleaves the membrane-bound precursor of TNF to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein (PubMed:10799547, PubMed:11108241). Acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called Notch extracellular truncation (NEXT) (PubMed:10882063). Plays a role in the proteolytic processing of ACE2 (By similarity). Plays a role in hemostasis through shedding of GP1BA, the platelet glycoprotein Ib alpha chain (PubMed:12907434). Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 (PubMed:17245433). Mediates the proteolytic cleavage of IL6R, leading to the release of secreted form of IL6R. Mediates the proteolytic cleavage and shedding of FCGR3A upon NK cell stimulation, a mechanism that allows for increased NK cell motility and detachment from opsonized target cells (By similarity). Cleaves TREM2, resulting in shedding of the TREM2 ectodomain (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 5,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 5,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 5,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 5,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9641,
        "biomarker_type": "",
        "glycan_count": 6,
        "disease_count": 7,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O88726;Q505A7;Q9R1U4;Q9Z0K3",
        "ec_number_list": "3.4.24.81;3.4.24.-;3.4.24.86",
        "go_molecular_function": "GO:0004175 endopeptidase activity;GO:0004222 metalloendopeptidase activity;GO:0004252 serine-type endopeptidase activity;GO:0005178 integrin binding;GO:0008237 metallopeptidase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0005911 cell-cell junction",
        "go_biological_process": "GO:1905564 positive regulation of vascular endothelial cell proliferation;GO:0048679 regulation of axon regeneration;GO:0006508 proteolysis;GO:0006509 membrane protein ectodomain proteolysis;GO:0007155 cell adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 2.9,
        "record_id": "Q9Z0F8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WVK0-1",
        "uniprot_id": "ATRAP_MOUSE",
        "mass": 17525.0,
        "length": 161,
        "protein_name": "Type-1 angiotensin II receptor-associated protein",
        "gene_name": "Agtrap",
        "organism": "Mouse",
        "refseq_name": "type-1 angiotensin II receptor-associated protein isoform 1",
        "refseq_ac": "NP_033772",
        "gene_names_uniprotkb": "Agtrap; Atrap",
        "gene_names_refseq": "3300002E14Rik; AT1R; Agtrap; Atrap; D4Wsu124e",
        "protein_names_uniprotkb": "Type-1 angiotensin II receptor-associated protein; AT1 receptor-associated protein",
        "protein_names_refseq": "AT1 receptor-associated protein; type-1 angiotensin II receptor-associated protein isoform 1; type-1 angiotensin II receptor-associated protein",
        "tax_id": 10090,
        "disease": "acquired metabolic disease (Disease Ontology:DOID:0060158); hypertension (Disease Ontology:DOID:10763)",
        "pathway": " (mmu:11610)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10358057;11733189;11820795;11910305;15757644;19144319;37856903;37981211;38415902;38484837",
        "class_list": "",
        "function": "Angiotensin II type 1 receptor-associated protein in immune cells: a possible key factor in the pathogenesis of visceral obesity., [RefSeq, PubMed]; Appears to be a negative regulator of type-1 angiotensin II receptor-mediated signaling by regulating receptor internalization as well as mechanism of receptor desensitization such as phosphorylation. Also induces a decrease in angiotensin II-stimulated transcriptional activity. May play a role of negative regulator in cardiomyocyte hypertrophy induced by angiotensin II through an inhibition of p38 mitogen-activated protein kinase pathway., [UniProtKB, PubMed, PubMed]; Enhanced TRPC3 transcription through AT1R/PKA/CREB signaling contributes to mitochondrial dysfunction in renal tubular epithelial cells in D-galactose-induced accelerated aging mice., [RefSeq, PubMed]; In the expressing AT1R, the EGF-induced MAPK pathway was enhanced in the presence of Ang II in a synergistic fashion, [RefSeq, PubMed]; Interact specifically with the carboxyl-terminal cytoplasmic region of the angiotensin II type 1 (AT(1)) receptor to regulate different aspects of AT(1) receptor physiology, [RefSeq, PubMed]; MiR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap., [RefSeq, PubMed]; Microglial AT1R Conditional Knockout Ameliorates Hypoperfusive Cognitive Impairment by Reducing Microglial Inflammatory Responses., [RefSeq, PubMed]; The inhibitory effect of angiotensin II (Ang-II) on macrophage cholesterol efflux is mediated by the Ang-II type 1 (AT1) receptor, as shown by the addition of the AT1 receptor antagonist losartan on peritoneal macrophages prelabeled with [3H] cholesterol., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2KFL8;Q3U7X6;Q9D8Z8;Q9D940",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0004945 angiotensin type II receptor activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005794 Golgi apparatus;GO:0005886 plasma membrane;GO:0005938 cell cortex;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0001666 response to hypoxia;GO:0008217 regulation of blood pressure",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9WVK0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z207-1",
        "uniprot_id": "DIAP3_MOUSE",
        "mass": 133686.0,
        "length": 1171,
        "protein_name": "Protein diaphanous homolog 3",
        "gene_name": "Diaph3",
        "organism": "Mouse",
        "refseq_name": "protein diaphanous homolog 3",
        "refseq_ac": "NP_062644",
        "gene_names_uniprotkb": "Diaph3; Diap3",
        "gene_names_refseq": "4930417P13Rik; Dia2; Diap3; Diaph3; Drf3; p134MDia2",
        "protein_names_uniprotkb": "Protein diaphanous homolog 3; DRF3; Diaphanous-related formin-3; mDIA2; p134mDIA2",
        "protein_names_refseq": "protein diaphanous homolog 3",
        "tax_id": 10090,
        "disease": "autosomal dominant auditory neuropathy 1 (Disease Ontology:DOID:0060690); microcephaly (Disease Ontology:DOID:10907); congenital dyserythropoietic anemia (Disease Ontology:DOID:1338)",
        "pathway": " (mmu:56419);  (R-MMU-5663220);  (R-MMU-8980692);  (R-MMU-9013026);  (R-MMU-9013106);  (R-MMU-9013149);  (R-MMU-9013404);  (R-MMU-9013406);  (R-MMU-9013408);  (R-MMU-9013423);  (R-MMU-9035034)",
        "pathway_count": 11,
        "publication_count": 14,
        "publication_id_list": "10678165;12676083;19117945;19457867;21699497;21750661;23558171;25428506;31219806;34428180;35820727;38613636;39322015;9535835",
        "class_list": "",
        "function": "Actin nucleation and elongation factor required for the assembly of F-actin structures, such as actin cables and stress fibers (PubMed:10678165, PubMed:23558171). Required for cytokinesis, stress fiber formation and transcriptional activation of the serum response factor (PubMed:10678165, PubMed:23558171). Binds to GTP-bound form of Rho and to profilin: acts in a Rho-dependent manner to recruit profilin to the membrane, where it promotes actin polymerization (PubMed:10678165). DFR proteins couple Rho and Src tyrosine kinase during signaling and the regulation of actin dynamics (PubMed:10678165). Also acts as an actin nucleation and elongation factor in the nucleus by promoting nuclear actin polymerization inside the nucleus to drive serum-dependent SRF-MRTFA activity (PubMed:23558171)., [UniProtKB, PubMed, PubMed]; Activated Cdc42 binds to Drf3/mDia2 in cells in regions associated with the generation of filopodia., [RefSeq, PubMed]; CircDiaph3 aggravates H/R-induced cardiomyocyte apoptosis and inflammation through miR-338-3p/SRSF1 axis., [RefSeq, PubMed]; Stub1 promotes degradation of the activated Diaph3: A negative feedback regulatory mechanism of the actin nucleator., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 8,
        "reported_mutagensis": 10,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003779 actin binding;GO:0008017 microtubule binding;GO:0042803 protein homodimerization activity;GO:0031267 small GTPase binding;GO:0008092 cytoskeletal protein binding",
        "go_cellular_component": "GO:0000922 spindle pole;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005884 actin filament;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0046785 microtubule polymerization;GO:0001701 in utero embryonic development;GO:0007015 actin filament organization;GO:0007059 chromosome segregation;GO:0007229 integrin-mediated signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9Z207-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61088-1",
        "uniprot_id": "FZD4_MOUSE",
        "mass": 60143.0,
        "length": 537,
        "protein_name": "Frizzled-4",
        "gene_name": "Fzd4",
        "organism": "Mouse",
        "refseq_name": "frizzled-4 precursor",
        "refseq_ac": "NP_032081",
        "gene_names_uniprotkb": "Fzd4",
        "gene_names_refseq": "Fz4; Fzd4",
        "protein_names_uniprotkb": "Frizzled-4; Fz-4; mFz4",
        "protein_names_refseq": "frizzled homolog 4; frizzled-4 precursor; frizzled-4; fz-4; mFz4",
        "tax_id": 10090,
        "disease": "exudative vitreoretinopathy (Disease Ontology:DOID:0050535); Norrie disease (Disease Ontology:DOID:0060844); exudative vitreoretinopathy 1 (Disease Ontology:DOID:0111412); prostate carcinoma in situ (Disease Ontology:DOID:8634)",
        "pathway": " (mmu:14366);  (R-MMU-4086398);  (R-MMU-4608870);  (R-MMU-4641263);  (R-MMU-5099900);  (R-MMU-8856825);  (R-MMU-8856828)",
        "pathway_count": 7,
        "publication_count": 11,
        "publication_id_list": "10.1101/2023.09.13.557529;10097073;10395542;15035989;15195140;19837033;21856951;26740625;34428180;38589650;8626800",
        "class_list": "",
        "function": "FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4., [RefSeq, PubMed]; Receptor for Wnt proteins (PubMed:10097073). Most frizzled receptors are coupled to the beta-catenin (CTNNB1) canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin (CTNNB1) and activation of Wnt target genes (PubMed:19837033). Plays a critical role in retinal vascularization by acting as a receptor for Wnt proteins and norrin (NDP) (PubMed:19837033). In retina, it can be activated by Wnt protein-binding and also by Wnt-independent signaling via binding of norrin (NDP), promoting in both cases beta-catenin (CTNNB1) accumulation and stimulation of LEF/TCF-mediated transcriptional programs (PubMed:19837033). A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Activation by Wnt5A stimulates PKC activity via a G protein-dependent mechanism., [UniProtKB, PubMed, PubMed, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9545,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 4,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0042803 protein homodimerization activity;GO:0046982 protein heterodimerization activity;GO:0001540 amyloid-beta binding;GO:0031625 ubiquitin protein ligase binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005654 nucleoplasm;GO:0005886 plasma membrane;GO:0005911 cell-cell junction;GO:0005929 cilium",
        "go_biological_process": "GO:0060856 establishment of blood-brain barrier;GO:0001525 angiogenesis;GO:0001570 vasculogenesis;GO:0008283 cell population proliferation;GO:0030335 positive regulation of cell migration",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q61088-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P12367-1",
        "uniprot_id": "KAP2_MOUSE",
        "mass": 45389.0,
        "length": 401,
        "protein_name": "cAMP-dependent protein kinase type II-alpha regulatory subunit",
        "gene_name": "Prkar2a",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Prkar2a",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "cAMP-dependent protein kinase type II-alpha regulatory subunit",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "congestive heart failure (Disease Ontology:DOID:6000)",
        "pathway": " (R-MMU-163615);  (R-MMU-164378);  (R-MMU-180024);  (R-MMU-432040);  (R-MMU-442720);  (R-MMU-5610787);  (R-MMU-9634597);  (R-MMU-983231);  (R-MMU-9856530)",
        "pathway_count": 9,
        "publication_count": 10,
        "publication_id_list": "10074940;16452087;17081989;17242355;17827149;21183079;21750661;3037538;37828378;9852104",
        "class_list": "",
        "function": "Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. Type II regulatory chains mediate membrane association by binding to anchoring proteins, including the MAP2 kinase., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0031698 beta-2 adrenergic receptor binding;GO:0034236 protein kinase A catalytic subunit binding;GO:0019904 protein domain specific binding;GO:0042802 identical protein binding;GO:0004862 cAMP-dependent protein kinase inhibitor activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005737 cytoplasm;GO:0005813 centrosome;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway;GO:0050804 modulation of chemical synaptic transmission;GO:0045859 regulation of protein kinase activity;GO:0141162 negative regulation of cAMP/PKA signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "P12367-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CZW6-1",
        "uniprot_id": "RN146_MOUSE",
        "mass": 38934.0,
        "length": 359,
        "protein_name": "E3 ubiquitin-protein ligase RNF146",
        "gene_name": "Rnf146",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase RNF146",
        "refseq_ac": "NP_001103666",
        "gene_names_uniprotkb": "Rnf146",
        "gene_names_refseq": "2610509H23Rik; Iduna; Rnf146",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase RNF146; 2.3.2.27; Iduna; RING finger protein 146; RING-type E3 ubiquitin transferase RNF146",
        "protein_names_refseq": "E3 ubiquitin-protein ligase RNF146; RING-type E3 ubiquitin transferase RNF146",
        "tax_id": 10090,
        "disease": "osteochondrodysplasia (Disease Ontology:DOID:2256)",
        "pathway": " (mmu:68031);  (R-MMU-201681);  (R-MMU-4641257);  (R-MMU-5689880);  (R-MMU-8948751)",
        "pathway_count": 5,
        "publication_count": 12,
        "publication_id_list": "15813938;21602803;21750661;21825151;23333241;30974833;31472117;32848054;34428180;34856161;37524878;38272024",
        "class_list": "",
        "function": "Dysregulation of the Wnt/beta-catenin signaling pathway via Rnf146 upregulation in a VPA-induced mouse model of autism spectrum disorder., [RefSeq, PubMed]; E3 ubiquitin-protein ligase that specifically binds poly-ADP-ribosylated (PARsylated) proteins and mediates their ubiquitination and subsequent degradation. May regulate many important biological processes, such as cell survival and DNA damage response. Acts as an activator of the Wnt signaling pathway by mediating the ubiquitination of PARsylated AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex. Acts in cooperation with tankyrase proteins (TNKS and TNKS2), which mediate PARsylation of target proteins AXIN1, AXIN2, BLZF1, CASC3, TNKS and TNKS2. Recognizes and binds tankyrase-dependent PARsylated proteins via its WWE domain and mediates their ubiquitination, leading to their degradation. Different ubiquitin linkage types have been observed: TNKS2 undergoes ubiquitination at 'Lys-48' and 'Lys-63', while AXIN1 is only ubiquitinated at 'Lys-48'. May regulate TNKS and TNKS2 subcellular location, preventing aggregation at a centrosomal location. Neuroprotective protein (By similarity). Protects the brain against N-methyl-D-aspartate (NMDA) receptor-mediated glutamate excitotoxicity and ischemia, by interfering with PAR-induced cell death, called parthanatos (PubMed:21602803, PubMed:21825151). Prevents nuclear translocation of AIFM1 in a PAR-binding dependent manner (PubMed:21602803, PubMed:21825151). Does not affect PARP1 activation. Protects against cell death induced by DNA damaging agents, such as N-methyl-N-nitro-N-nitrosoguanidine (MNNG) and rescues cells from G1 arrest (PubMed:21602803, PubMed:21825151). Promotes cell survival after gamma-irradiation. Facilitates DNA repair (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed]; E3 ubiquitin-protein ligase that specifically binds poly-ADP-ribosylated proteins and mediates their ubiquitination and subsequent degradation., [UniProtKB, UniProtKB, UniProtKB]; Iduna acts as a potential antioxidant by improving mitochondrial function and inhibiting oxidative stress-induced parthanatos, and these protective effects are dependent on the involvement of ubiquitin-proteasome system., [RefSeq, PubMed]; Iduna might prevent TBI by specifically inhibiting parthanatos and promoting mitochondrial function, with the p53-MDM2 pathway playing a critical role., [RefSeq, PubMed]; PARP5A and RNF146 phase separation restrains RIPK1-dependent necroptosis., [RefSeq, PubMed]; Rhododendrin is cytoprotective against 6-hydroxydopamine (6-OHDA)-induced cell death, which is largely dependent on ERbeta activity and RNF146 expression. Publication Status: Online-Only, [RefSeq, PubMed]; The RING-domain E3 ubiquitin ligase RNF146 promotes cardiac hypertrophy by suppressing the LKB1/AMPK signaling pathway., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E0CX97;Q3TF93;Q3U6Y7",
        "ec_number_list": "3.1.3.67;3.1.3.-;3.1.3.16;3.1.3.48;3.4.19.12;3.4.25.1;2.4.2.-;2.4.2.30;2.3.2.27",
        "go_molecular_function": "GO:0072572 poly-ADP-D-ribose binding;GO:0008270 zinc ion binding;GO:0019899 enzyme binding;GO:0061630 ubiquitin protein ligase activity;GO:0004842 ubiquitin-protein transferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0070301 cellular response to hydrogen peroxide;GO:0016055 Wnt signaling pathway;GO:0090263 positive regulation of canonical Wnt signaling pathway;GO:0006511 ubiquitin-dependent protein catabolic process;GO:0051865 protein autoubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9CZW6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K4K2-1",
        "uniprot_id": "TRIB3_MOUSE",
        "mass": 39023.0,
        "length": 354,
        "protein_name": "Tribbles homolog 3",
        "gene_name": "Trib3",
        "organism": "Mouse",
        "refseq_name": "tribbles homolog 3",
        "refseq_ac": "NP_780302",
        "gene_names_uniprotkb": "Trib3; Nipk; Trb3",
        "gene_names_refseq": "Ifld2; Nipk; SINK; SKIP3; TRB-3; Trb3; Trib3",
        "protein_names_uniprotkb": "Tribbles homolog 3; Neuronal cell death-inducible putative kinase; TRB-3",
        "protein_names_refseq": "induced in fatty liver dystrophy 2; neuronal cell death-inducible putative kinase; tribbles homolog 3",
        "tax_id": 10090,
        "disease": "glucose metabolism disease (Disease Ontology:DOID:4194)",
        "pathway": " (mmu:228775);  (R-MMU-1257604);  (R-MMU-165158);  (R-MMU-199418);  (R-MMU-389357);  (R-MMU-5218920)",
        "pathway_count": 6,
        "publication_count": 5,
        "publication_id_list": "12749859;12791994;15107844;17369260;22977230",
        "class_list": "",
        "function": "Inactive protein kinase which acts as a regulator of the integrated stress response (ISR), a process for adaptation to various stress (PubMed:17369260). Inhibits the transcriptional activity of DDIT3/CHOP and is involved in DDIT3/CHOP-dependent cell death during ER stress (By similarity). May play a role in programmed neuronal cell death but does not appear to affect non-neuronal cells (By similarity). Acts as a negative feedback regulator of the ATF4-dependent transcription during the ISR: while TRIB3 expression is promoted by ATF4, TRIB3 protein interacts with ATF4 and inhibits ATF4 transcription activity (PubMed:12749859, PubMed:17369260). Disrupts insulin signaling by binding directly to Akt kinases and blocking their activation (PubMed:12791994). May bind directly to and mask the 'Thr-308' phosphorylation site in AKT1 (PubMed:12791994). Interacts with the NF-kappa-B transactivator p65 RELA and inhibits its phosphorylation and thus its transcriptional activation activity (By similarity). Interacts with MAPK kinases and regulates activation of MAP kinases (By similarity). Can inhibit APOBEC3A editing of nuclear DNA (PubMed:22977230)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, PubMed]; Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. Erratum:[Nat Med. 2004 Jul;7(10):755], [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UMQ0;Q921E7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0055106 ubiquitin-protein transferase regulator activity;GO:0005524 ATP binding;GO:0019899 enzyme binding;GO:0019901 protein kinase binding;GO:0003714 transcription corepressor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm",
        "go_biological_process": "GO:0046627 negative regulation of insulin receptor signaling pathway;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0010506 regulation of autophagy;GO:0032869 cellular response to insulin stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q8K4K2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91YL3-1",
        "uniprot_id": "UCKL1_MOUSE",
        "mass": 60842.0,
        "length": 548,
        "protein_name": "Uridine-cytidine kinase-like 1",
        "gene_name": "Uckl1",
        "organism": "Mouse",
        "refseq_name": "uridine-cytidine kinase-like 1 isoform 2",
        "refseq_ac": "NP_081041",
        "gene_names_uniprotkb": "Uckl1; Urkl1",
        "gene_names_refseq": "1110007H10Rik; Uckl1; Urkl1",
        "protein_names_uniprotkb": "Uridine-cytidine kinase-like 1; 2.7.1.48",
        "protein_names_refseq": "uridine kinase-like 1; uridine-cytidine kinase-like 1 isoform 2; uridine-cytidine kinase-like 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68556);  (R-MMU-73614)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "21183079;21750661;31219806;37343364",
        "class_list": "",
        "function": "Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer., [RefSeq, PubMed]; Phosphorylates uridine and cytidine to uridine monophosphate and cytidine monophosphate., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.7.1.48",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0004849 uridine kinase activity;GO:0043771 cytidine kinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0044206 UMP salvage;GO:0044211 CTP salvage;GO:0008655 pyrimidine-containing compound salvage",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q91YL3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JMA1-1",
        "uniprot_id": "UBP14_MOUSE",
        "mass": 56002.0,
        "length": 493,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 14",
        "gene_name": "Usp14",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 14 isoform 1",
        "refseq_ac": "NP_067497",
        "gene_names_uniprotkb": "Usp14",
        "gene_names_refseq": "2610005K12Rik; 2610037B11Rik; Usp14; ax; nmf375",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 14; 3.4.19.12; Deubiquitinating enzyme 14; Ubiquitin thioesterase 14; Ubiquitin-specific-processing protease 14",
        "protein_names_refseq": "ataxia; dUB-type TGT for deubiquitinating enzyme; deubiquitinating enzyme 14; ubiquitin carboxyl-terminal hydrolase 14 isoform 1; ubiquitin carboxyl-terminal hydrolase 14; ubiquitin specific protease 14; ubiquitin thioesterase 14; ubiquitin thiolesterase 14; ubiquitin-specific-processing protease 14",
        "tax_id": 10090,
        "disease": "prion disease (Disease Ontology:DOID:649)",
        "pathway": " (mmu:59025);  (R-MMU-5689880);  (R-MMU-9758274)",
        "pathway_count": 3,
        "publication_count": 21,
        "publication_id_list": "11566882;16190881;17242355;18299400;19726649;21183079;21750661;25605945;26495903;28935714;31219806;33725478;34428180;34887587;35984892;37507081;37828378;38631582;38780644;39252535;39927985",
        "class_list": "",
        "function": "Deubiquitinase USP14 is upregulated in Crohn's disease and inhibits the NOD2 pathway mediated inflammatory response in vitro. Publication Status: Online-Only, [RefSeq, PubMed]; Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes., [UniProtKB, UniProtKB]; Mechanistic insights into the role of USP14 in adipose tissue macrophage recruitment and insulin resistance in obesity., [RefSeq, PubMed]; Proteasome-associated deubiquitinase which releases ubiquitin from the proteasome targeted ubiquitinated proteins (PubMed:16190881). Ensures the regeneration of ubiquitin at the proteasome. Is a reversibly associated subunit of the proteasome and a large fraction of proteasome-free protein exists within the cell. Required for the degradation of the chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis. Also serves as a physiological inhibitor of endoplasmic reticulum-associated degradation (ERAD) under the non-stressed condition by inhibiting the degradation of unfolded endoplasmic reticulum proteins via interaction with ERN1 (By similarity). Indispensable for synaptic development and function at neuromuscular junctions (NMJs) (PubMed:19726649). Plays a role in the innate immune defense against viruses by stabilizing the viral DNA sensor CGAS and thus inhibiting its autophagic degradation (By similarity). Inhibits OPTN-mediated selective autophagic degradation of KDM4D and thereby negatively regulates H3K9me2 and H3K9me3 (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; Usp14 deficiency removes alpha-synuclein by regulating S100A8/A9 in Parkinson's disease. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q543U5;Q923F2;Q9D0L0",
        "ec_number_list": "3.4.19.12;3.4.25.1;2.7.11.10;2.7.11.1",
        "go_molecular_function": "GO:0004866 endopeptidase inhibitor activity;GO:0070628 proteasome binding;GO:0004843 cysteine-type deubiquitinase activity;GO:0061578 K63-linked deubiquitinase activity;GO:0101005 deubiquitinase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0045087 innate immune response;GO:0007268 chemical synaptic transmission;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0050920 regulation of chemotaxis",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "Q9JMA1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5DU02-1",
        "uniprot_id": "UBP22_MOUSE",
        "mass": 59954.0,
        "length": 525,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 22",
        "gene_name": "Usp22",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 22",
        "refseq_ac": "NP_001004143",
        "gene_names_uniprotkb": "Usp22; Kiaa1063",
        "gene_names_refseq": "Usp22",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 22; 3.4.19.12; Deubiquitinating enzyme 22; Ubiquitin thioesterase 22; Ubiquitin-specific-processing protease 22",
        "protein_names_refseq": "deubiquitinating enzyme 22; ubiquitin carboxyl-terminal hydrolase 22; ubiquitin specific protease 22; ubiquitin thioesterase 22; ubiquitin thiolesterase 22; ubiquitin-specific-processing protease 22",
        "tax_id": 10090,
        "disease": "glioblastoma (Disease Ontology:DOID:3068)",
        "pathway": " (mmu:216825);  (R-MMU-5689880)",
        "pathway_count": 2,
        "publication_count": 18,
        "publication_id_list": "16378762;18299400;19224205;20173027;21750661;21952136;22542455;22872234;25428506;27013495;30084848;30779550;32069354;34428180;35244191;35900990;37488049;38347585",
        "class_list": "",
        "function": "Deubiquitinase that plays a role in several cellular processes including transcriptional regulation, cell cycle progression or innate immunity. As part of the transcription regulatory histone acetylation (HAT) complex SAGA, catalyzes the deubiquitination of both histones H2A and H2B, thereby acting as a transcriptional coactivator (PubMed:32069354). Recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Facilitates cell-cycle progression by stabilizing CCNB1 and antagonizing its proteasome-mediated degradation in a cell cycle-specific manner. Modulates cell cycle progression and apoptosis also by antagonizing TP53 transcriptional activation through deacetylase SIRT1 stabilization (PubMed:22542455). Plays multiple roles in immunity and inflammation. Participates in antiviral response by deubiquitinating the importin KPNA2, leading to IRF3 nuclear translocation and subsequent type I interferon production. Acts as a central regulator of type III IFN signaling by negatively regulating STING1 activation and ubiquitination (By similarity). Inhibits NLRP3 inflammasome activation by promoting NLRP3 degradation through ATG5-dependent autophagy (PubMed:35900990). Deubiquitinates CD274 to induce its stabilization and thereby participates in maintenance of immune tolerance to self. Controls necroptotic cell death by regulating RIPK3 phosphorylation and ubiquitination (By similarity). During bacterial infection, promotes pro-inflammatory response by targeting TRAF6 and removing its 'Lys-48'-linked polyubiquitination (PubMed:35244191)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed]; Loss of USP22 alleviates cardiac hypertrophy induced by pressure overload through HiF1-alpha-TAK1 signaling pathway., [RefSeq, PubMed]; USP22 supports the aggressive behavior of basal-like breast cancer by stimulating cellular respiration. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TU34;Q3U2W4;Q5SU81;Q66JV8;Q6PDX3;Q8BJG3",
        "ec_number_list": "3.4.19.12;2.3.1.48;2.3.1.-",
        "go_molecular_function": "GO:0003713 transcription coactivator activity;GO:0008270 zinc ion binding;GO:0019899 enzyme binding;GO:0004843 cysteine-type deubiquitinase activity;GO:0010485 histone H4 acetyltransferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0000124 SAGA complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0016579 protein deubiquitination;GO:0045931 positive regulation of mitotic cell cycle;GO:0000086 G2/M transition of mitotic cell cycle",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "Q5DU02-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5U430-1",
        "uniprot_id": "UBR3_MOUSE",
        "mass": 212757.0,
        "length": 1889,
        "protein_name": "E3 ubiquitin-protein ligase UBR3",
        "gene_name": "Ubr3",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase UBR3 isoform 2",
        "refseq_ac": "NP_808451",
        "gene_names_uniprotkb": "Ubr3; Kiaa2024; Zfp650; Znf650",
        "gene_names_refseq": "1110059H15Rik; 4833421P10Rik; A130030D10Rik; Ubr3; Zfp650; Znf650",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase UBR3; 2.3.2.27; N-recognin-3; RING-type E3 ubiquitin transferase UBR3; Ubiquitin-protein ligase E3-alpha-3; Ubiquitin-protein ligase E3-alpha-III; Zinc finger protein 650",
        "protein_names_refseq": "E3 ubiquitin-protein ligase UBR3 isoform 2; E3 ubiquitin-protein ligase UBR3; N-recognin-3; RING-type E3 ubiquitin transferase UBR3; ubiquitin-protein ligase E3-alpha-3; ubiquitin-protein ligase E3-alpha-III; zinc finger protein 650",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68795)",
        "pathway_count": 1,
        "publication_count": 13,
        "publication_id_list": "10.1101/2023.09.13.557529;17462990;21183079;21750661;21933813;27195754;27331610;31219806;32232464;34203471;34428180;36210013;39927985",
        "class_list": "",
        "function": "E3 ubiquitin-protein ligase which is a component of the N-end rule pathway (PubMed:17462990). Does not bind to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation (PubMed:17462990). May play a role in Shh signaling by mediating the ubiquitination of Kif7 (PubMed:27195754). May be important for MYH9 function in certain tissues, possibly by regulating the ubiquitination of MYH9 and consequently affecting its interaction with MYO7A (PubMed:27331610)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed]; Knockout of the Ubr3 gene in mouse embryonic fibroblasts leads to an up-regulation of the cellular levels of APE1 protein and subsequent genomic instability. Erratum:[Nucleic Acids Res. 2026 Jan 14;54(2):gkag012. doi: 10.1093/nar/gkag012. PMID: 41533598], [RefSeq, PubMed]; Mouse UBR3 poly-ubiquitinates Kif7, the mammalian homologue of Cos2. Finally, loss of UBR3 up-regulates Kif7 protein levels and decreases Hh signaling in cultured cells. Publication Status: Online-Only, [RefSeq, PubMed]; Tex19.1 inhibits the N-end rule pathway and maintains acetylated SMC3 cohesin and sister chromatid cohesion in oocytes., [RefSeq, PubMed]; The UBR box of UBR3 may recognize small compounds that modulate the targeting, by this E3, of its currently unknown substrates, [RefSeq, PubMed]; Ubiquitin ligase protein which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AV04;A6MFP4;Q69Z32",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0061630 ubiquitin protein ligase activity;GO:0004842 ubiquitin-protein transferase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0016020 membrane;GO:0000151 ubiquitin ligase complex",
        "go_biological_process": "GO:0042048 olfactory behavior;GO:0009792 embryo development ending in birth or egg hatching;GO:1904878 negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;GO:0001701 in utero embryonic development;GO:0001967 suckling behavior",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q5U430-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BGG7-1",
        "uniprot_id": "UBS3B_MOUSE",
        "mass": 71443.0,
        "length": 638,
        "protein_name": "Ubiquitin-associated and SH3 domain-containing protein B",
        "gene_name": "Ubash3b",
        "organism": "Mouse",
        "refseq_name": "ubiquitin-associated and SH3 domain-containing protein B isoform 1",
        "refseq_ac": "NP_789830",
        "gene_names_uniprotkb": "Ubash3b; Sts1",
        "gene_names_refseq": "2810457I06Rik; STS-1; TULA-2; Ubash3b; p70",
        "protein_names_uniprotkb": "Ubiquitin-associated and SH3 domain-containing protein B; 3.1.3.48; Cbl-interacting protein p70; STS-1; Suppressor of T-cell receptor signaling 1; T-cell ubiquitin ligand 2; TULA-2; Tyrosine-protein phosphatase STS1/TULA2",
        "protein_names_refseq": "T-cell ubiquitin ligand 2; cbl-interacting protein p70; suppressor of T-cell receptor signaling 1; tyrosine-protein phosphatase STS1/TULA2; ubiquitin-associated and SH3 domain-containing protein B isoform 1; ubiquitin-associated and SH3 domain-containing protein B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72828)",
        "pathway_count": 1,
        "publication_count": 17,
        "publication_id_list": "12370296;14738763;17490611;17679096;19733910;20516590;20585042;20670933;21750661;26903241;27609517;27765766;30018105;30084848;30779550;31219806;34428180",
        "class_list": "",
        "function": "Bone marrow-derived dendritic cells (BMDCs) lacking Protein Tyrosine Phosphatase Sts-1 expression have an enhanced ability to inhibit Candida albicans growth and contribute significantly to the resistance of Sts-/- mice. Within BMDCs, the Sts phosphatases negatively regulate the activation of select pathways downstream of the key fungal pathogen pattern recognition receptor Dectin-1. Publication Status: Online-Only, [RefSeq, PubMed]; Dephosphorylation of Tyr(P)(346) may be considered an important 'checkpoint' in the regulation of Syk activation process. Putative biological functions of TULA-2-mediated dephosphorylation of Tyr(P)(346) may include deactivation of receptor-activated Syk or suppression of Syk activation by suboptimal stimulation. Erratum:[J Biol Chem. 2017 Mar 10;292(10):4360. doi: 10.1074/jbc.A116.743732. PMID: 28283589], [RefSeq, PubMed]; Interferes with CBL-mediated down-regulation and degradation of receptor-type tyrosine kinases. Promotes accumulation of activated target receptors, such as T-cell receptors and EGFR, on the cell surface. Exhibits tyrosine phosphatase activity toward several substrates including EGFR, FAK, SYK, and ZAP70. Down-regulates proteins that are dually modified by both protein tyrosine phosphorylation and ubiquitination., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; Taken together, our data clearly demonstrate the ability of reversine to stimulate adipocyte differentiation, which is independent of the Akt and p70(s6k) signaling pathways., [RefSeq, PubMed]; The absence of TULA-2 and also the relative level of TULA-2 expression modulates FcgammaRIIA-mediated platelet reactivity and heparin-induced thrombocytopenia in vivo., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U8Z2;Q8BMW9",
        "ec_number_list": "3.1.3.48;3.1.3.2;3.1.3.67;3.1.3.-;3.1.3.16;3.1.3.27;3.1.3.5;3.1.3.21;3.1.3.18",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0031625 ubiquitin protein ligase binding;GO:0051219 phosphoprotein binding;GO:0004725 protein tyrosine phosphatase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0035335 peptidyl-tyrosine dephosphorylation;GO:0006469 negative regulation of protein kinase activity;GO:0030168 platelet activation;GO:0070527 platelet aggregation;GO:0009968 negative regulation of signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q8BGG7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BL06-1",
        "uniprot_id": "UBP54_MOUSE",
        "mass": 176664.0,
        "length": 1588,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 54",
        "gene_name": "Usp54",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 54 isoform 1",
        "refseq_ac": "NP_084456",
        "gene_names_uniprotkb": "Usp54",
        "gene_names_refseq": "4930429G18Rik; C030002J06Rik; Usp54",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 54; 3.4.19.12; Ubiquitin-specific peptidase 54",
        "protein_names_refseq": "inactive ubiquitin carboxyl-terminal hydrolase 54; inactive ubiquitin-specific peptidase 54; ubiquitin carboxyl-terminal hydrolase 54 isoform 1; ubiquitin specific protease 54",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:78787)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;21183079;21750661;24129315;32782141;34428180",
        "class_list": "",
        "function": "Deubiquitinase that specifically mediates 'Lys-63'-linked deubiquitination of substrates with a polyubiquitin chain composed of at least 3 ubiquitins. Specifically recognizes ubiquitin chain in position S2 and catalyzes cleavage of polyubiquitin within 'Lys-63'-linked chains. Not able to deubiquitinate substrates with shorter ubiquitin chains. Mediates deubiquitination of PLK4, maintaining PLK4 stability by reducing its ubiquitination-mediated degradation., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q149D8;Q149D9;Q6NZE1;Q8BZ28;Q9D2I9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0004843 cysteine-type deubiquitinase activity;GO:0061578 K63-linked deubiquitinase activity",
        "go_cellular_component": "",
        "go_biological_process": "GO:0006508 proteolysis;GO:0016579 protein deubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8BL06-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QZL6-1",
        "uniprot_id": "UBP21_MOUSE",
        "mass": 62673.0,
        "length": 566,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 21",
        "gene_name": "Usp21",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 21",
        "refseq_ac": "NP_038947",
        "gene_names_uniprotkb": "Usp21; Usp23",
        "gene_names_refseq": "ESTM28; Usp16; Usp21; Usp23",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 21; 3.4.19.12; Deubiquitinating enzyme 21; Ubiquitin thioesterase 21; Ubiquitin-specific-processing protease 21",
        "protein_names_refseq": "deubiquitinating enzyme 21; ubiquitin carboxyl-terminal hydrolase 21; ubiquitin specific protease 21; ubiquitin specific protease 23; ubiquitin thioesterase 21; ubiquitin thiolesterase 21; ubiquitin-specific-processing protease 21",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:30941);  (R-MMU-5357786);  (R-MMU-5357905);  (R-MMU-5357956);  (R-MMU-5689880)",
        "pathway_count": 5,
        "publication_count": 6,
        "publication_id_list": "10786635;18172164;21750661;27886188;34428180;34531315",
        "class_list": "",
        "function": "Deubiquitinates histone H2A, a specific tag for epigenetic transcriptional repression, thereby acting as a coactivator. Deubiquitination of histone H2A releaves the repression of di- and trimethylation of histone H3 at 'Lys-4', resulting in regulation of transcriptional initiation. Regulates gene expression via histone H2A deubiquitination. Deubiquitinates BAZ2A/TIP5 leading to its stabilization. Also capable of removing NEDD8 from NEDD8 conjugates but has no effect on Sentrin-1 conjugates. Also acts as a negative regulator of the ribosome quality control (RQC) by mediating deubiquitination of 40S ribosomal proteins RPS10/eS10 and RPS20/uS10, thereby antagonizing ZNF598-mediated 40S ubiquitination., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, PubMed]; Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes., [UniProtKB, UniProtKB]; USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D0R1",
        "ec_number_list": "3.4.19.12;2.3.2.27;2.7.11.10;2.7.11.1;2.3.2.-;2.7.11.25;3.6.4.13;2.3.2.31",
        "go_molecular_function": "GO:0019784 deNEDDylase activity;GO:0003713 transcription coactivator activity;GO:0046872 metal ion binding;GO:0008234 cysteine-type peptidase activity;GO:0004843 cysteine-type deubiquitinase activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0072344 rescue of stalled ribosome;GO:0032790 ribosome disassembly;GO:0006508 proteolysis;GO:0016579 protein deubiquitination;GO:0031175 neuron projection development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9QZL6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P61079-1",
        "uniprot_id": "UB2D3_MOUSE",
        "mass": 16687.0,
        "length": 147,
        "protein_name": "Ubiquitin-conjugating enzyme E2 D3",
        "gene_name": "Ube2d3",
        "organism": "Mouse",
        "refseq_name": "ubiquitin-conjugating enzyme E2 D3 isoform 1",
        "refseq_ac": "NP_079632",
        "gene_names_uniprotkb": "Ube2d3",
        "gene_names_refseq": "1100001F19Rik; 9430029A22Rik; Ube2d3",
        "protein_names_uniprotkb": "Ubiquitin-conjugating enzyme E2 D3; (E3-independent) E2 ubiquitin-conjugating enzyme D3; 2.3.2.23; 2.3.2.24; E2 ubiquitin-conjugating enzyme D3; Ubiquitin carrier protein D3; Ubiquitin-conjugating enzyme E2(17)KB 3; Ubiquitin-conjugating enzyme E2-17 kDa 3; Ubiquitin-protein ligase D3",
        "protein_names_refseq": "(E3-independent) E2 ubiquitin-conjugating enzyme D3; E2 ubiquitin-conjugating enzyme D3; ubiquitin carrier protein D3; ubiquitin-conjugating enzyme E2 D3 isoform 1; ubiquitin-conjugating enzyme E2(17)KB 3; ubiquitin-conjugating enzyme E2-17 kDa 3; ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-protein ligase D3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66105);  (R-MMU-1234176);  (R-MMU-201451);  (R-MMU-2173795);  (R-MMU-5205685);  (R-MMU-5357905);  (R-MMU-8866654);  (R-MMU-8951664);  (R-MMU-9033241);  (R-MMU-937041);  (R-MMU-9705462);  (R-MMU-983168);  (R-MMU-9954716)",
        "pathway_count": 13,
        "publication_count": 8,
        "publication_id_list": "18515077;21750661;24034696;32145025;34428180;36288343;38440726;39627609",
        "class_list": "",
        "function": "Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'-, as well as 'Lys-48'-linked polyubiquitination. Cooperates with the E2 CDC34 and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Ubiquitin chain elongation is then performed by CDC34, building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. Also acts as an initiator E2, in conjunction with RNF8, for the priming of PCNA. Monoubiquitination of PCNA, and its subsequent polyubiquitination, are essential events in the operation of the DNA damage tolerance (DDT) pathway that is activated after DNA damage caused by UV or chemical agents during S-phase. Associates with the BRCA1/BARD1 E3 ligase complex to perform ubiquitination at DNA damage sites following ionizing radiation leading to DNA repair. Targets DAPK3 for ubiquitination which influences promyelocytic leukemia protein nuclear body (PML-NB) formation in the nucleus. In conjunction with the MDM2 and TOPORS E3 ligases, functions ubiquitination of p53/TP53. In conjunction with the CBL E3 ligase, targets EGFR for polyubiquitination at the plasma membrane as well as during its internalization and transport on endosomes. In conjunction with the STUB1 E3 quality control E3 ligase, ubiquitinates unfolded proteins to catalyze their immediate destruction. Together with RNF135, catalyzes the viral RNA-dependent 'Lys-63'-linked polyubiquitination of RIGI to activate the downstream signaling pathway that leads to interferon beta production. Together with ZNF598, catalyzes ubiquitination of 40S ribosomal proteins in response to ribosome collisions. In cooperation with the GATOR2 complex, catalyzes 'Lys-6'-linked ubiquitination of NPRL2., [UniProtKB, UniProtKB]; Comprehensive bioinformatics analysis reveals the role of cuproptosis-related gene Ube2d3 in myocardial infarction. Publication Status: Online-Only, [RefSeq, PubMed]; Evolution of an Amniote-Specific Mechanism for Modulating Ubiquitin Signaling via Phosphoregulation of the E2 Enzyme UBE2D3., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.3.2.26;2.3.2.31;2.3.2.27;2.3.2.-;3.6.4.-;2.7.10.2;2.3.2.24;2.3.2.23;2.3.2.36;2.3.2.34;2.3.2.32;4.2.99.18;6.2.1.45;2.7.11.1;3.6.5.-;6.2.1.64;2.3.2.25;1.14.11.-;1.14.11.29;6.2.1.-",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0004842 ubiquitin-protein transferase activity;GO:0061631 ubiquitin conjugating enzyme activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005886 plasma membrane;GO:0010008 endosome membrane",
        "go_biological_process": "GO:0006281 DNA repair;GO:0006915 apoptotic process;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination;GO:0070979 protein K11-linked ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "P61079-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UN04-1",
        "uniprot_id": "UBP30_MOUSE",
        "mass": 58221.0,
        "length": 517,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 30",
        "gene_name": "Usp30",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 30 isoform 1",
        "refseq_ac": "NP_001028374",
        "gene_names_uniprotkb": "Usp30",
        "gene_names_refseq": "6330590F17Rik; D5Ertd483e; Usp30",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 30; 3.4.19.12; Deubiquitinating enzyme 30; Ub-specific protease 30; Ubiquitin thioesterase 30; Ubiquitin-specific-processing protease 30",
        "protein_names_refseq": "deubiquitinating enzyme 30; ub-specific protease 30; ubiquitin carboxyl-terminal hydrolase 30 isoform 1; ubiquitin carboxyl-terminal hydrolase 30; ubiquitin specific protease 30; ubiquitin thioesterase 30; ubiquitin thiolesterase 30; ubiquitin-specific-processing protease 30",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100756);  (R-MMU-5689880);  (R-MMU-9664873)",
        "pathway_count": 3,
        "publication_count": 11,
        "publication_id_list": "21750661;24513856;25428506;25428507;27802388;30084848;30700497;30779550;31219806;34428180;38772138",
        "class_list": "",
        "function": "CDK5-USP30 signaling pathway regulates MAVS-mediated inflammation via suppressing mitophagy in MPTP/MPP[+] PD model., [RefSeq, PubMed]; Deubiquitinating enzyme tethered to the mitochondrial outer membrane that acts as a key inhibitor of mitophagy by counteracting the action of parkin (PRKN): hydrolyzes ubiquitin attached by parkin on target proteins, such as RHOT1/MIRO1 and TOMM20, thereby blocking parkin's ability to drive mitophagy. Preferentially cleaves 'Lys-6'- and 'Lys-11'-linked polyubiquitin chains, 2 types of linkage that participate in mitophagic signaling. Does not cleave efficiently polyubiquitin phosphorylated at 'Ser-65' (By similarity). Acts as negative regulator of mitochondrial fusion by mediating deubiquitination of MFN1 and MFN2 (PubMed:24513856)., [UniProtKB, PubMed, UniProtKB]; USP30 can rescue the peroxisome loss observed in some disease-causing peroxisome mutations, pointing to a potential therapeutic target., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TS48;Q3TSB9;Q8BVI3;Q8CHW7",
        "ec_number_list": "5.2.1.8;3.4.19.12;2.7.11.1;3.6.5.-;3.1.1.29;2.3.2.27;3.4.24.56",
        "go_molecular_function": "GO:0004197 cysteine-type endopeptidase activity;GO:0004843 cysteine-type deubiquitinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0005829 cytosol",
        "go_biological_process": "GO:1901525 negative regulation of mitophagy;GO:0006508 proteolysis;GO:0016579 protein deubiquitination;GO:0031647 regulation of protein stability;GO:0008053 mitochondrial fusion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q3UN04-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O54885-1",
        "uniprot_id": "TYOBP_MOUSE",
        "mass": 12367.0,
        "length": 114,
        "protein_name": "TYRO protein tyrosine kinase-binding protein",
        "gene_name": "Tyrobp",
        "organism": "Mouse",
        "refseq_name": "TYRO protein tyrosine kinase-binding protein precursor",
        "refseq_ac": "NP_035792",
        "gene_names_uniprotkb": "Tyrobp; Dap12; Karap",
        "gene_names_refseq": "DAP12; KARAP; Ly83; Tyrobp",
        "protein_names_uniprotkb": "TYRO protein tyrosine kinase-binding protein; DNAX-activation protein 12; KAR-associated protein; Killer-activating receptor-associated protein",
        "protein_names_refseq": "DNAX-activation protein 12; KAR-associated protein; TYRO protein tyrosine kinase-binding protein precursor; killer cell activating receptor associated protein; killer-activating receptor-associated protein",
        "tax_id": 10090,
        "disease": "Nasu-Hakola disease (Disease Ontology:DOID:0090112); rheumatoid arthritis (Disease Ontology:DOID:7148)",
        "pathway": " (mmu:22177);  (R-MMU-2172127);  (R-MMU-2424491);  (R-MMU-391160);  (R-MMU-416700);  (R-MMU-6798695)",
        "pathway_count": 6,
        "publication_count": 31,
        "publication_id_list": "10449773;11754004;12426564;12426565;12569157;12874256;12893283;14969392;15294961;15471863;15728241;16715077;17086186;17202337;17928527;17947660;18685038;18691974;18957693;19144319;21257958;21727189;21750661;24078628;25690660;26740625;29518356;38639190;9490415;9647200;9852069",
        "class_list": "",
        "function": "Adapter protein which non-covalently associates with activating receptors found on the surface of a variety of immune cells to mediate signaling and cell activation following ligand binding by the receptors (PubMed:15471863, PubMed:9647200). TYROBP is tyrosine-phosphorylated in the ITAM domain following ligand binding by the associated receptors which leads to activation of additional tyrosine kinases and subsequent cell activation (PubMed:15728241, PubMed:16715077). Also has an inhibitory role in some cells (PubMed:21727189). Non-covalently associates with activating receptors of the CD300 family to mediate cell activation (By similarity). Also mediates cell activation through association with activating receptors of the CD200R family (PubMed:15471863). Required for neutrophil activation mediated by integrin (PubMed:17086186). Required for the activation of myeloid cells mediated by the CLEC5A/MDL1 receptor (By similarity). Associates with natural killer (NK) cell receptors such as the KLRD1/KLRC2 heterodimer to mediate NK cell activation (By similarity). Also associates non-covalently with the NK cell receptors KLRA4/LY49D and KLRA8/LY49H which leads to NK cell activation (PubMed:9647200). Associates with TREM1 to mediate activation of neutrophils and monocytes (By similarity). Associates with TREM2 on monocyte-derived dendritic cells to mediate up-regulation of chemokine receptor CCR7 and dendritic cell maturation and survival (By similarity). Association with TREM2 mediates cytokine-induced formation of multinucleated giant cells which are formed by the fusion of macrophages (PubMed:18957693). Stabilizes the TREM2 C-terminal fragment (TREM2-CTF) which is produced by TREM2 ectodomain shedding (By similarity). In microglia, required with TREM2 for phagocytosis of apoptotic neurons (PubMed:15728241). Required with ITGAM/CD11B in microglia to control production of microglial superoxide ions which promote the neuronal apoptosis that occurs during brain development (PubMed:18685038). Promotes pro-inflammatory responses in microglia following nerve injury which accelerates degeneration of injured neurons (PubMed:25690660). Positively regulates the expression of the IRAK3/IRAK-M kinase and IL10 production by liver dendritic cells and inhibits their T cell allostimulatory ability (PubMed:21257958). Negatively regulates B cell proliferation (PubMed:21727189). Required for CSF1-mediated osteoclast cytoskeletal organization (PubMed:18691974). Positively regulates multinucleation during osteoclast development (PubMed:12569157, PubMed:14969392)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed]; Deciphering microglial activation and neuronal apoptosis post-traumatic brain injury: The role of TYROBP in inflammation regulation networks., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O88603",
        "ec_number_list": "",
        "go_molecular_function": "GO:0060090 molecular adaptor activity;GO:0005102 signaling receptor binding;GO:0030674 protein-macromolecule adaptor activity;GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009986 cell surface",
        "go_biological_process": "GO:0030316 osteoclast differentiation;GO:2001206 positive regulation of osteoclast development;GO:0032693 negative regulation of interleukin-10 production;GO:0002228 natural killer cell mediated immunity;GO:0002283 neutrophil activation involved in immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 3.2,
        "record_id": "O54885-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99P25-1",
        "uniprot_id": "TXIP1_MOUSE",
        "mass": 81762.0,
        "length": 704,
        "protein_name": "Translin-associated factor X-interacting protein 1",
        "gene_name": "Tsnaxip1",
        "organism": "Mouse",
        "refseq_name": "translin-associated factor X-interacting protein 1",
        "refseq_ac": "NP_077765",
        "gene_names_uniprotkb": "Tsnaxip1; Txi1",
        "gene_names_refseq": "1700016K08Rik; TXI1; Tsnaxip1",
        "protein_names_uniprotkb": "Translin-associated factor X-interacting protein 1; Trax-interacting protein 1",
        "protein_names_refseq": "translin-associated factor X-interacting protein 1; trax-interacting protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72236)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "12036294;17971504;21750661;36598146",
        "class_list": "",
        "function": "Possible role in spermatogenesis., [UniProtKB, PubMed]; Testis-specific proteins, TSNAXIP1 and 1700010I14RIK, are important for sperm motility and male fertility in mice., [RefSeq, PubMed]; Tsnaxip1 is most abundantly expressed in tissues rich in highly ciliated cells, such as olfactory sensory neurons, and is predicted to be important to cilia., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9DA98",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0030154 cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q99P25-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5BLK4-1",
        "uniprot_id": "TUT7_MOUSE",
        "mass": 169103.0,
        "length": 1491,
        "protein_name": "Terminal uridylyltransferase 7",
        "gene_name": "Tut7",
        "organism": "Mouse",
        "refseq_name": "terminal uridylyltransferase 7 isoform 2",
        "refseq_ac": "NP_705766",
        "gene_names_uniprotkb": "Tut7; Kiaa1711; Zcchc6",
        "gene_names_refseq": "6030448M23Rik; Tent3b; Tut7; Zcchc6",
        "protein_names_uniprotkb": "Terminal uridylyltransferase 7; 2.7.7.52; TUTase 7; Zinc finger CCHC domain-containing protein 6",
        "protein_names_refseq": "TUTase 7; terminal uridylyltransferase 7 isoform 2; terminal uridylyltransferase 7; zinc finger CCHC domain-containing protein 6; zinc finger, CCHC domain containing 6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:214290)",
        "pathway_count": 1,
        "publication_count": 13,
        "publication_id_list": "10.1101/2023.09.13.557529;21183079;21750661;21952136;22898984;25428506;25428507;28792939;30084848;30302948;34188032;34428180;37085578",
        "class_list": "",
        "function": "TUT4/7-mediated uridylation of a coronavirus subgenomic RNAs delays viral replication. Publication Status: Online-Only, [RefSeq, PubMed]; Terminal uridyltransferase 7 regulates TLR4-triggered inflammation by controlling Regnase-1 mRNA uridylation and degradation. Publication Status: Online-Only, [RefSeq, PubMed]; Uridylyltransferase that mediates the terminal uridylation of mRNAs with short (less than 25 nucleotides) poly(A) tails, hence facilitating global mRNA decay (PubMed:28792939). Essential for both oocyte maturation and fertility. Through 3' terminal uridylation of mRNA, sculpts, with TUT7, the maternal transcriptome by eliminating transcripts during oocyte growth (PubMed:28792939). Involved in microRNA (miRNA)-induced gene silencing through uridylation of deadenylated miRNA targets. Also acts as a suppressor of miRNA biogenesis by mediating the terminal uridylation of miRNA precursors, including that of let-7 (pre-let-7) (PubMed:22898984). Uridylated pre-let-7 RNA is not processed by Dicer and undergo degradation. Pre-let-7 uridylation is strongly enhanced in the presence of LIN28A. Due to functional redundancy between ZCCHC6 and ZCCHC11, the identification of the specific role of each of these proteins is difficult (By similarity) (PubMed:22898984). Involved in microRNA (miRNA)-induced gene silencing through uridylation of deadenylated miRNA targets (By similarity). Also functions as an integral regulator of microRNA biogenesiS using 3 different uridylation mechanisms (By similarity). Acts as a suppressor of miRNA biogenesis by mediating the terminal uridylation of some miRNA precursors, including that of let-7 (pre-let-7). Uridylated pre-let-7 RNA is not processed by Dicer and undergo degradation. Pre-let-7 oligouridylation is strongly enhanced in the presence of LIN28A (PubMed:22898984). In the absence of LIN28A, TUT7 and TUT4 monouridylate group II pre-miRNAs, which includes most of pre-let7 members, that shapes an optimal 3' end overhang for efficient processing (By similarity). Add oligo-U tails to truncated pre-miRNAS with a 5' overhang which may promote rapid degradation of non-functional pre-miRNA species (By similarity). Does not play a role in replication-dependent histone mRNA degradation (By similarity). Due to functional redundancy between TUT4 and TUT7, the identification of the specific role of each of these proteins is difficult (PubMed:22898984, PubMed:28792939). TUT4 and TUT7 restrict retrotransposition of long interspersed element-1 (LINE-1) in cooperation with MOV10 counteracting the RNA chaperonne activity of L1RE1. TUT7 uridylates LINE-1 mRNAs in the cytoplasm which inhibits initiation of reverse transcription once in the nucleus, whereas uridylation by TUT4 destabilizes mRNAs in cytoplasmic ribonucleoprotein granules (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed]; ZCCHC6 (TUT7) was markedly up-regulated in damaged cartilage from human osteoarthritis (OA) patients and from wild-type mice with surgically induced OA., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A1A4B1;Q3V3V7;Q8CIH3",
        "ec_number_list": "2.7.7.52;2.7.7.19;3.6.4.13",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0035198 miRNA binding;GO:0070569 uridylyltransferase activity;GO:0050265 RNA uridylyltransferase activity;GO:0003676 nucleic acid binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0001556 oocyte maturation;GO:0010586 miRNA metabolic process;GO:0031054 pre-miRNA processing;GO:0031123 RNA 3'-end processing;GO:1990074 polyuridylation-dependent mRNA catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q5BLK4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BJQ2-1",
        "uniprot_id": "UBP1_MOUSE",
        "mass": 87456.0,
        "length": 784,
        "protein_name": "Ubiquitin carboxyl-terminal hydrolase 1",
        "gene_name": "Usp1",
        "organism": "Mouse",
        "refseq_name": "ubiquitin carboxyl-terminal hydrolase 1 isoform 1",
        "refseq_ac": "NP_001288343",
        "gene_names_uniprotkb": "Usp1",
        "gene_names_refseq": "Usp1",
        "protein_names_uniprotkb": "Ubiquitin carboxyl-terminal hydrolase 1; 3.4.19.12; Deubiquitinating enzyme 1; Ubiquitin thioesterase 1; Ubiquitin-specific-processing protease 1",
        "protein_names_refseq": "deubiquitinating enzyme 1; ubiquitin carboxyl-terminal hydrolase 1 isoform 1; ubiquitin carboxyl-terminal hydrolase 1; ubiquitin specific protease 1; ubiquitin thioesterase 1; ubiquitin thiolesterase 1; ubiquitin-specific-processing protease 1",
        "tax_id": 10090,
        "disease": "Fanconi anemia (Disease Ontology:DOID:13636)",
        "pathway": " (mmu:230484);  (R-MMU-110314);  (R-MMU-6783310)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "19217432;20506303;21183079;21750661;23159736;34428180;38012162;38054892;39134949",
        "class_list": "",
        "function": "Autocleaved Usp1 remains a deubiquitylase because its fragments remain associated with Uaf1, an enhancer of Usp1 activity, until the C-terminal fragment is selectively destroyed by the Arg/N-end rule pathway., [RefSeq, PubMed]; Bone marrow from Fancd2-/- mice and Usp1-/- mice exhibited marked hematopoietic defects., [RefSeq, PubMed]; Deubiquitinase USP1 enhances CCAAT/enhancer-binding protein beta (C/EBPbeta) stability and accelerates adipogenesis and lipid accumulation. Publication Status: Online-Only, [RefSeq, PubMed]; Mouse Usp1 functions downstream in the Fanconi anemia pathway, and its deubiquitination is required for Fancd2 nuclear foci assembly, [RefSeq, PubMed]; Multi-regulatory potency of USP1 on inflammasome components promotes pyroptosis in thyroid follicular cells and contributes to the progression of Hashimoto's thyroiditis. Publication Status: Online-Only, [RefSeq, PubMed]; Negative regulator of DNA damage repair which specifically deubiquitinates monoubiquitinated FANCD2. Also involved in PCNA-mediated translesion synthesis (TLS) by deubiquitinating monoubiquitinated PCNA. Has almost no deubiquitinating activity by itself and requires the interaction with WDR48 to have a high activity., [UniProtKB, UniProtKB]; The UAF1-USP1 Deubiquitinase Complex Stabilizes cGAS and Facilitates Antiviral Responses., [RefSeq, PubMed]; This gene encodes a member of the ubiquitin-specific peptidase family. The encoded protein acts as a catalytic subunit in a heterodimeric deubiquitinating enzyme complex that deubiquitinates Fanconi anemia, complementation group D2, and plays a role in homologous recombination-mediated DNA repair. Disruption of this gene is associated with a Fanconi anemia-like phenotype and genomic instability. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene have been defined on chromosomes 3, 12, and 15. [provided by RefSeq, Aug 2014]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8VE17;Q8VEM4",
        "ec_number_list": "3.1.21.-;3.1.4.1;3.6.4.13;3.4.19.12;3.1.-.-;3.5.2.6;3.1.22.-;2.3.2.27",
        "go_molecular_function": "GO:0008233 peptidase activity;GO:0004197 cysteine-type endopeptidase activity;GO:0004843 cysteine-type deubiquitinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:1905368 peptidase complex",
        "go_biological_process": "GO:0006281 DNA repair;GO:0006508 proteolysis;GO:0016579 protein deubiquitination;GO:0001501 skeletal system development;GO:0031647 regulation of protein stability",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q8BJQ2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P61082-1",
        "uniprot_id": "UBC12_MOUSE",
        "mass": 20900.0,
        "length": 183,
        "protein_name": "NEDD8-conjugating enzyme Ubc12",
        "gene_name": "Ube2m",
        "organism": "Mouse",
        "refseq_name": "NEDD8-conjugating enzyme Ubc12 isoform 1",
        "refseq_ac": "NP_663553",
        "gene_names_uniprotkb": "Ube2m; Ubc-rs2; Ubc12",
        "gene_names_refseq": "2510040H03Rik; UBC12; Ubc-rs2; Ube2m",
        "protein_names_uniprotkb": "NEDD8-conjugating enzyme Ubc12; 2.3.2.34; NEDD8 carrier protein; Ubiquitin-conjugating enzyme E2 M",
        "protein_names_refseq": "NEDD8 carrier protein; NEDD8 protein ligase; NEDD8-conjugating enzyme Ubc12 isoform 1; NEDD8-conjugating enzyme Ubc12; UBC12 homolog, yeast; ubiquitin C, related sequence 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22192);  (R-MMU-2173789);  (R-MMU-5607761);  (R-MMU-5676590);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 6,
        "publication_count": 8,
        "publication_id_list": "18826954;21750661;24129315;36210013;36288343;37343564;37507081;40208944",
        "class_list": "",
        "function": "Accepts the ubiquitin-like protein NEDD8 from the UBA3-NAE1 E1 complex and catalyzes its covalent attachment to other proteins. The specific interaction with the E3 ubiquitin ligase RBX1, but not RBX2, suggests that the RBX1-UBE2M complex neddylates specific target proteins, such as CUL1, CUL2, CUL3 and CUL4. Involved in cell proliferation., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Neddylation modification stabilizes LC3B by antagonizing its ubiquitin-mediated degradation and promoting autophagy in skin., [RefSeq, PubMed]; SCCRO recruits Ubc12 approximately NEDD8 to the CAND1-Cul1-ROC1 complex but that this is not sufficient to dissociate or overcome the inhibitory effects of CAND1 on cullin neddylation, [RefSeq, PubMed]; UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O76069;Q8VC50",
        "ec_number_list": "2.3.2.26;2.3.2.31;2.3.2.27;2.3.2.-;3.6.4.-;2.3.2.24;2.3.2.23;2.3.2.34;2.3.2.32;6.2.1.45;2.7.11.10;2.7.11.30;2.7.11.1;6.2.1.64;2.3.2.36;2.3.2.25;6.2.1.-;2.7.11.25",
        "go_molecular_function": "GO:0061654 NEDD8 conjugating enzyme activity;GO:0005524 ATP binding;GO:0004842 ubiquitin-protein transferase activity;GO:0019788 NEDD8 transferase activity;GO:0016740 transferase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005829 cytosol",
        "go_biological_process": "GO:0036211 protein modification process;GO:0043525 positive regulation of neuron apoptotic process;GO:0045116 protein neddylation;GO:0150052 regulation of postsynapse assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "P61082-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P12242-1",
        "uniprot_id": "UCP1_MOUSE",
        "mass": 33248.0,
        "length": 307,
        "protein_name": "Mitochondrial brown fat uncoupling protein 1",
        "gene_name": "Ucp1",
        "organism": "Mouse",
        "refseq_name": "mitochondrial brown fat uncoupling protein 1",
        "refseq_ac": "NP_033489",
        "gene_names_uniprotkb": "Ucp1; Slc25a7; Ucp",
        "gene_names_refseq": "Slc25a7; Ucp1; Ucp",
        "protein_names_uniprotkb": "Mitochondrial brown fat uncoupling protein 1; Solute carrier family 25 member 7; Thermogenin; UCP 1",
        "protein_names_refseq": "UCP 1; mitochondrial brown fat uncoupling protein 1; solute carrier family 25 member 7; thermogenin; uncoupling protein 1, mitochondrial; uncoupling protein, mitochondrial",
        "tax_id": 10090,
        "disease": "Alzheimer's disease (Disease Ontology:DOID:10652); hypertension (Disease Ontology:DOID:10763); prediabetes syndrome (Disease Ontology:DOID:11716); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:22227);  (R-MMU-166187);  (R-MMU-167826)",
        "pathway_count": 3,
        "publication_count": 11,
        "publication_id_list": "19187776;20416274;20466728;23063128;25578880;27027295;32358195;3410843;37507081;8264627;9139827",
        "class_list": "",
        "function": "Mitochondrial transporter that functions as a long-chain fatty acid/LCFA and proton symporter, simultaneously transporting one LCFA and one proton through the inner mitochondrial membrane. However, LCFAs remaining associated with the transporter via their hydrophobic tails, it results in an apparent transport of protons activated by LCFAs. Thereby, dissipates the mitochondrial proton gradient and converts the energy of substrate oxydation into heat instead of ATP (PubMed:23063128). Responsible for thermogenic respiration, a specialized capacity of brown adipose tissue and beige fat that participates in non-shivering adaptive thermogenesis to temperature and diet variations and more generally to the regulation of energy balance (PubMed:19187776, PubMed:23063128, PubMed:27027295, PubMed:9139827). Regulates the production of reactive oxygen species/ROS by mitochondria (PubMed:20416274, PubMed:20466728)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 7,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0036041 long-chain fatty acid binding;GO:0005525 GTP binding;GO:0022857 transmembrane transporter activity;GO:0019003 GDP binding;GO:0015078 proton transmembrane transporter activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005740 mitochondrial envelope;GO:0005743 mitochondrial inner membrane",
        "go_biological_process": "GO:0070417 cellular response to cold;GO:0006357 regulation of transcription by RNA polymerase II;GO:0006839 mitochondrial transport;GO:0009409 response to cold;GO:0050873 brown fat cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "P12242-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3USZ2-1",
        "uniprot_id": "UBFL1_MOUSE",
        "mass": 46131.0,
        "length": 394,
        "protein_name": "Upstream-binding factor 1-like protein 1",
        "gene_name": "Ubtfl1",
        "organism": "Mouse",
        "refseq_name": "upstream-binding factor 1-like protein 1",
        "refseq_ac": "NP_001028965",
        "gene_names_uniprotkb": "Ubtfl1; Hmgpi",
        "gene_names_refseq": "B020006M18Rik; Hmgpi; Ubtfl1",
        "protein_names_uniprotkb": "Upstream-binding factor 1-like protein 1; HMG-box preimplantation embryo-specific protein; HMGPI",
        "protein_names_refseq": "HMG-box preimplantation embryo-specific protein; HMG-box protein, preimplantation-embryo-specific; upstream-binding factor 1-like protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:546118)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "19915186;26092847",
        "class_list": "",
        "function": "Essential for proliferation of the inner cell mass and trophectodermal cells in peri-implantation development., [UniProtKB, PubMed]; Reduction of Hmgpi transcript levels caused developmental loss of preimplantation embryos and implantation failures., [RefSeq, PubMed]; These findings indicate that CHD1 plays important roles in mouse early embryogenesis via activation of Hmgpi at zygotic gene activation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TQX0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001164 RNA polymerase I core promoter sequence-specific DNA binding;GO:0001181 RNA polymerase I general transcription initiation factor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006360 transcription by RNA polymerase I;GO:0010468 regulation of gene expression;GO:0007566 embryo implantation;GO:0045943 positive regulation of transcription by RNA polymerase I;GO:0001832 blastocyst growth",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q3USZ2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q62452-1",
        "uniprot_id": "UD19_MOUSE",
        "mass": 60008.0,
        "length": 528,
        "protein_name": "UDP-glucuronosyltransferase 1A9",
        "gene_name": "Ugt1a9",
        "organism": "Mouse",
        "refseq_name": "UDP-glucuronosyltransferase 1A9 precursor",
        "refseq_ac": "NP_964006",
        "gene_names_uniprotkb": "Ugt1a9; Ugt1a12; Ugt1",
        "gene_names_refseq": "UDPGT 1-9; UDPGT; UGT1-09; UGT1.9; UGTP4; Ugt1a12; Ugt1a9; mUGTBr/P",
        "protein_names_uniprotkb": "UDP-glucuronosyltransferase 1A9; 2.4.1.17; UDP-glucuronosyltransferase 1-7; UDP-glucuronosyltransferase 1-9; UDPGT 1-9; UDPGT; UGT1*9; UGT1-09; UGT1.9; UGT1A12; UGT1A9; UGTP4",
        "protein_names_refseq": "UDP glycosyltransferase 1 family polypeptide A12; UDP-glucuronosyltransferase 1-7; UDP-glucuronosyltransferase 1-9; UDP-glucuronosyltransferase 1A9 precursor; UDP-glucuronosyltransferase 1A9",
        "tax_id": 10090,
        "disease": "pancreatic cancer (Disease Ontology:DOID:1793); cholangiocarcinoma (Disease Ontology:DOID:4947); alcoholic pancreatitis (Disease Ontology:DOID:4988)",
        "pathway": " (mmu:394434);  (R-MMU-156588);  (R-MMU-9749641);  (R-MMU-9753281)",
        "pathway_count": 4,
        "publication_count": 8,
        "publication_id_list": "14672974;23806337;27514509;31219806;32527940;34428180;40997131;8464825",
        "class_list": "glycogene;glycosyltransferase",
        "function": "Circadian Clock Component Rev-erbalpha Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice., [RefSeq, PubMed]; Diabetes mellitus caused a decrease in the activity of Cyp3a11-mediated testosterone-6beta-hydroxylation, but no change in the activity of Cyp3a11-mediated midazolam 1-hydroxylation and an increase in the activity of UGT1a9-mediated propofol O-glucuronidation in db/db mice, [RefSeq, PubMed]; UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile. Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds. Catalyzes the glucuronidation of endogenous estrogen hormones such as estradiol and estrone. Involved in the glucuronidation of arachidonic acid (AA) and AA-derived eicosanoids including 15-HETE, PGB1 and F2-isoprostanes (8-iso-PGF2alpha and 5-epi-5-F2t-IsoP). Glucuronates the phytochemical ferulic acid efficiently at both the phenolic or the carboxylic acid group. Also catalyzes the glucuronidation of the isoflavones genistein, daidzein, glycitein, formononetin, biochanin A and prunetin, which are phytoestrogens with anticancer and cardiovascular properties. Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonist caderastan, a drug which can inhibit the effect of angiotensin II. Involved in the biotransformation of 7-ethyl-10-hydroxycamptothecin (SN-38), the pharmacologically active metabolite of the anticancer drug irinotecan. Also metabolizes mycophenolate, an immunosuppressive agent., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 91,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A6H6W3;E9QN27;Q6XL44",
        "ec_number_list": "2.4.1.17;2.4.1.170;2.4.1.185",
        "go_molecular_function": "GO:0008194 UDP-glycosyltransferase activity;GO:0004857 enzyme inhibitor activity;GO:0005504 fatty acid binding;GO:0019899 enzyme binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane;GO:1902494 catalytic complex",
        "go_biological_process": "GO:0008210 estrogen metabolic process;GO:0001889 liver development;GO:0016125 sterol metabolic process;GO:0071385 cellular response to glucocorticoid stimulus;GO:0051552 flavone metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q62452-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q811S7-1",
        "uniprot_id": "UBIP1_MOUSE",
        "mass": 60212.0,
        "length": 540,
        "protein_name": "Upstream-binding protein 1",
        "gene_name": "Ubp1",
        "organism": "Mouse",
        "refseq_name": "upstream-binding protein 1 isoform a",
        "refseq_ac": "NP_001076788",
        "gene_names_uniprotkb": "Ubp1; Cp2b; Nf2d9",
        "gene_names_refseq": "Cp2b; LBP-1a; LBP-1b; NF2d9; Ubp1",
        "protein_names_uniprotkb": "Upstream-binding protein 1; NF2d9; Nuclear factor 2d9",
        "protein_names_refseq": "nuclear factor 2d9; upstream-binding protein 1 isoform a",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22221)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "15988015;21183079;26740625;28315936;31219806;7623810",
        "class_list": "",
        "function": "Functions as a transcriptional activator in a promoter context-dependent manner. Involved in regulation of the alpha-globin gene in erythroid cells. Activation of the alpha-globin promoter in erythroid cells is via synergistic interaction with TFCP2. Functions as a trans-acting factor that regulates the domestic strain CYP2D9 gene through specific association with the regulatory element SDI-A1. Binding to SDI-A1 depends on the type of nucleotide at position 299; binding is abolished by a nucleotide substitution at this position. Modulates the placental expression of CYP11A1 (By similarity)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A4QPG4;Q3UPR3;Q3US11;Q60786;Q8C514",
        "ec_number_list": "",
        "go_molecular_function": "GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific;GO:1990837 sequence-specific double-stranded DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0032897 negative regulation of viral transcription;GO:0001525 angiogenesis;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q811S7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VBT1-1",
        "uniprot_id": "TXLNB_MOUSE",
        "mass": 77207.0,
        "length": 685,
        "protein_name": "Beta-taxilin",
        "gene_name": "Txlnb",
        "organism": "Mouse",
        "refseq_name": "beta-taxilin",
        "refseq_ac": "NP_619534",
        "gene_names_uniprotkb": "Txlnb; Mdp77",
        "gene_names_refseq": "2310001N14Rik; Mdp77; Txlnb",
        "protein_names_uniprotkb": "Beta-taxilin; Muscle-derived protein 77",
        "protein_names_refseq": "beta-taxilin; muscle specific protein; muscle-derived protein 77",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:378431)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "11805063;21183079;27231216;36288343",
        "class_list": "",
        "function": "Promotes motor nerve regeneration. May be involved in intracellular vesicle traffic (By similarity)., [UniProtKB]; These results demonstrate that beta-taxilin participates in myogenesis through suppressing the function of dysbindin to inhibit the differentiation of C2C12 myoblasts into myotubes., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RU93;Q3UVB8;Q8BUK2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019905 syntaxin binding",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q8VBT1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JIE6-1",
        "uniprot_id": "TSLP_MOUSE",
        "mass": 16152.0,
        "length": 140,
        "protein_name": "Thymic stromal lymphopoietin",
        "gene_name": "Tslp",
        "organism": "Mouse",
        "refseq_name": "thymic stromal lymphopoietin precursor",
        "refseq_ac": "NP_067342",
        "gene_names_uniprotkb": "Tslp",
        "gene_names_refseq": "Tslp",
        "protein_names_uniprotkb": "Thymic stromal lymphopoietin; Thymic stroma-derived lymphopoietin",
        "protein_names_refseq": "thymic stroma-derived lymphopoietin; thymic stromal lymphopoietin precursor",
        "tax_id": 10090,
        "disease": "common cold (Disease Ontology:DOID:10459); respiratory syncytial virus infectious disease (Disease Ontology:DOID:1273); cryoglobulinemia (Disease Ontology:DOID:2917); membranoproliferative glomerulonephritis (Disease Ontology:DOID:2920); atopic dermatitis (Disease Ontology:DOID:3310); allergic rhinitis (Disease Ontology:DOID:4481); autoimmune hemolytic anemia (Disease Ontology:DOID:718)",
        "pathway": " (mmu:53603);  (R-MMU-1266695)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "10974033;14512322;24632570;38145912;38700313",
        "class_list": "",
        "function": "Cytokine that induces the release of T-cell-attracting chemokines from monocytes and, in particular, enhances the maturation of CD11c(+) dendritic cells. Can induce allergic inflammation by directly activating mast cells (By similarity)., [UniProtKB, PubMed]; The arrest in lymphopoiesis and the expansion of myeloid progenitor cells in TSLP transgenic mice suggest that TSLP has negative and positive regulatory effects on lymphoid and myeloid development, respectively., [RefSeq, PubMed]; Thymic Stromal Lymphopoietin Activates Mouse Dendritic Cells Through the JAK/SYK Pathway in Promoting Th17 Response in Psoriasis., [RefSeq, PubMed]; Thymic stromal lymphopoietin contributes to ozone-induced exacerbations of eosinophilic airway inflammation via granulocyte colony-stimulating factor in mice., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 7,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005139 interleukin-7 receptor binding;GO:0005125 cytokine activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space",
        "go_biological_process": "GO:0032736 positive regulation of interleukin-13 production;GO:0032754 positive regulation of interleukin-5 production;GO:0001961 positive regulation of cytokine-mediated signaling pathway;GO:0008284 positive regulation of cell population proliferation;GO:0043066 negative regulation of apoptotic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q9JIE6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91X58-1",
        "uniprot_id": "ZFN2B_MOUSE",
        "mass": 27895.0,
        "length": 257,
        "protein_name": "AN1-type zinc finger protein 2B",
        "gene_name": "Zfand2b",
        "organism": "Mouse",
        "refseq_name": "AN1-type zinc finger protein 2B",
        "refseq_ac": "NP_001153377",
        "gene_names_uniprotkb": "Zfand2b; Airapl",
        "gene_names_refseq": "1110060O18Rik; Zfand2b",
        "protein_names_uniprotkb": "AN1-type zinc finger protein 2B; AIRAP-like protein; Arsenite-inducible RNA-associated protein-like protein",
        "protein_names_refseq": "AIRAP-like protein; AN1-type zinc finger protein 2B; arsenite-inducible RNA-associated protein-like protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68818)",
        "pathway_count": 1,
        "publication_count": 12,
        "publication_id_list": "15345747;18467495;21750661;22517741;22645316;24160817;26192747;26337389;26692333;26876100;32782141;40885482",
        "class_list": "",
        "function": "AIRAPL-deficient mice develop a fully-penetrant myeloproliferative neoplastic process via dysregulation of IGF1/IGF1R., [RefSeq, PubMed]; Plays a role in protein homeostasis by regulating both the translocation and the ubiquitin-mediated proteasomal degradation of nascent proteins at the endoplasmic reticulum (PubMed:24160817, PubMed:26337389, PubMed:26692333). It is involved in the regulation of signal-mediated translocation of proteins into the endoplasmic reticulum (PubMed:24160817). It also plays a role in the ubiquitin-mediated proteasomal degradation of proteins for which signal-mediated translocation to the endoplasmic reticulum has failed (PubMed:18467495, PubMed:26337389). May therefore function in the endoplasmic reticulum stress-induced pre-emptive quality control, a mechanism that selectively attenuates the translocation of newly synthesized proteins into the endoplasmic reticulum and reroutes them to the cytosol for proteasomal degradation (PubMed:24160817, PubMed:26337389). By controlling the steady-state expression of the IGF1R receptor, indirectly regulates the insulin-like growth factor receptor signaling pathway (PubMed:26692333)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; Study demonstrates specificity of AIRAPL for Lys48-linked tri-ubiquitin chains triggered by intrinsic selectivity of its double-sided UIM (UIM2) for Lys48 linkage and a flexible inter-UIM linker that results in an overall conformation which confers simultaneous binding of tUIMs to three consecutive ubiquitin moieties in a Lys48-linked chain., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 7,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 7,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 7,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 25,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D0W4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0036435 K48-linked polyubiquitin modification-dependent protein binding;GO:0008270 zinc ion binding;GO:0031593 polyubiquitin modification-dependent protein binding;GO:0043130 ubiquitin binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0016020 membrane;GO:0005789 endoplasmic reticulum membrane;GO:0000502 proteasome complex",
        "go_biological_process": "GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0045047 protein targeting to ER;GO:0006616 SRP-dependent cotranslational protein targeting to membrane, translocation;GO:0043567 regulation of insulin-like growth factor receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "Q91X58-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5Y5T5-1",
        "uniprot_id": "ZDHC8_MOUSE",
        "mass": 82031.0,
        "length": 762,
        "protein_name": "Palmitoyltransferase ZDHHC8",
        "gene_name": "Zdhhc8",
        "organism": "Mouse",
        "refseq_name": "palmitoyltransferase ZDHHC8 isoform 1",
        "refseq_ac": "NP_742163",
        "gene_names_uniprotkb": "Zdhhc8",
        "gene_names_refseq": "D16H22S1738E; DHHC-8; E330009O14Rik; Op53c05; ZDHHCL1; Zdhhc8",
        "protein_names_uniprotkb": "Palmitoyltransferase ZDHHC8; 2.3.1.225; DHHC-8; Zinc finger DHHC domain-containing protein 8",
        "protein_names_refseq": "DHHC-containing protein 8; palmitoyltransferase ZDHHC8 isoform 1; probable palmitoyltransferase ZDHHC8; zinc finger DHHC domain-containing protein 8",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:27801);  (R-MMU-8963896)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "10.1101/2023.09.13.557529;15184899;15603741;16452087;18775783;21183079;21750661;22645316;24129315;30084848;31219806",
        "class_list": "",
        "function": "Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates and therefore functions in several unrelated biological processes. Through the palmitoylation of ABCA1 regulates the localization of the transporter to the plasma membrane and thereby regulates its function in cholesterol and phospholipid efflux (By similarity). Could also pamitoylate the D(2) dopamine receptor DRD2 and regulate its stability and localization to the plasma membrane (By similarity). Could also play a role in glutamatergic transmission (PubMed:15184899)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TNF7",
        "ec_number_list": "2.3.1.225;6.3.1.2;7.6.2.1;2.3.1.-",
        "go_molecular_function": "GO:0019706 protein-cysteine S-palmitoyltransferase activity;GO:0016409 palmitoyltransferase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0000139 Golgi membrane;GO:0005739 mitochondrion;GO:0005794 Golgi apparatus;GO:0031966 mitochondrial membrane",
        "go_biological_process": "GO:0007626 locomotory behavior;GO:0010875 positive regulation of cholesterol efflux;GO:0044794 host-mediated activation of viral process;GO:0018345 protein palmitoylation;GO:0018230 peptidyl-L-cysteine S-palmitoylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q5Y5T5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60585-1",
        "uniprot_id": "ZFP30_MOUSE",
        "mass": 62769.0,
        "length": 533,
        "protein_name": "Zinc finger protein 30",
        "gene_name": "Zfp30",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 30 isoform c",
        "refseq_ac": "NP_038733",
        "gene_names_uniprotkb": "Zfp30",
        "gene_names_refseq": "2610306P15Rik; Zfp-30; Zfp30",
        "protein_names_uniprotkb": "Zinc finger protein 30; Zfp-30",
        "protein_names_refseq": "zinc finger protein 30 isoform c",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22693);  (R-MMU-212436)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "21750661;24129315;25114278;29242385;31000713;32860515;34428180;35820727;7849402",
        "class_list": "",
        "function": "Baseline and innate immune response characterization of a Zfp30 knockout mouse strain., [RefSeq, PubMed]; Data indicate zinc finger protein 148 (ZFP148) as a transcription factor that differentially binds to the zinc finger protein 30 protein (Zfp30) promoter region harboring rs51434084. Publication Status: Online-Only, [RefSeq, PubMed]; May be involved in transcriptional regulation., [UniProtKB, UniProtKB, UniProtKB]; Using murine and human in vitro and in vivo models, study demonstrated that ZFP30 promotes adipogenesis by directly targeting and activating a retrotransposon-derived Pparg2 enhancer. Through mechanistic studies, study further show that ZFP30 recruits the co-regulator KAP1, which acts as a ZFP30 co-activator in this adipogenic context. Publication Status: Online-Only, [RefSeq, PubMed]; Zfp30 is expressed in airway epithelia in the normal mouse lung and Zfp30 expression in vitro affects CXCL1 responses to an immune stimulus., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CRV9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q60585-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91WU6-1",
        "uniprot_id": "ZDHC7_MOUSE",
        "mass": 35213.0,
        "length": 308,
        "protein_name": "Palmitoyltransferase ZDHHC7",
        "gene_name": "Zdhhc7",
        "organism": "Mouse",
        "refseq_name": "palmitoyltransferase ZDHHC7",
        "refseq_ac": "NP_598728",
        "gene_names_uniprotkb": "Zdhhc7; Gramp2",
        "gene_names_refseq": "Gramp2; Zdhhc7",
        "protein_names_uniprotkb": "Palmitoyltransferase ZDHHC7; 2.3.1.-; 2.3.1.225; Acyltransferase ZDHHC7; DHHC-7; GABA-A receptor-associated membrane protein 2; SERZ-beta; Zinc finger DHHC domain-containing protein 7",
        "protein_names_refseq": "DHHC-7; GABA-A receptor-associated membrane protein 2; SERZ-beta; acyltransferase ZDHHC7; palmitoyltransferase ZDHHC7; zinc finger DHHC domain-containing protein 7",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:102193);  (R-MMU-9009391)",
        "pathway_count": 2,
        "publication_count": 12,
        "publication_id_list": "15229235;15603741;17151279;18596047;19001095;23687301;25253725;25301068;27875292;28057756;28167757;38538834",
        "class_list": "",
        "function": "Golgi-localized palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates and therefore functions in several unrelated biological processes (PubMed:15603741, PubMed:19001095, PubMed:23687301, PubMed:25253725, PubMed:38538834). Has no stringent fatty acid selectivity and in addition to palmitate can also transfer onto target proteins myristate from tetradecanoyl-CoA and stearate from octadecanoyl-CoA (PubMed:28167757). Palmitoylates sex steroid hormone receptors, including ESR1, PGR and AR, thereby regulating their targeting to the plasma membrane and their function in rapid intracellular signaling upon binding of sex hormones. Palmitoylates GNAQ, a heterotrimeric G protein, regulating its dynamic localization at the plasma membrane and is thereby involved in GNAQ-dependent G protein-coupled receptor signaling pathways (PubMed:19001095). Also functions in ligand-induced cell death by regulating the FAS signaling pathway through the palmitoylation and stabilization of the receptor at the plasma membrane. In epithelial cells, palmitoylates SCRIB and regulates its localization to the plasma membrane, regulating indirectly cell polarity and differentiation. Also palmitoylates JAM3 and promotes its expression at tight junctions and regulates its function in cell migration (By similarity). Palmitoylates the glucose transporter GLUT4/SLC2A4 and controls the insulin-dependent translocation of GLUT4 to the plasma membrane (PubMed:28057756). In brain, could also palmitoylate SNAP25 and DLG4/PSD95 (PubMed:15603741, PubMed:25253725). Could also palmitoylate DNAJC5 and regulate its localization to the Golgi membrane (PubMed:18596047). Could also palmitoylate NCDN (PubMed:23687301). May play a role in follicle stimulation hormone (FSH) activation of testicular Sertoli cells (By similarity). Activates pyroptosis by catalyzing palmitoylation of gasdermin-D (GSDMD) (PubMed:38538834)., [UniProtKB, UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TC41;Q6EMK2;Q8K1H6",
        "ec_number_list": "2.3.1.225;6.3.1.2;2.3.1.-",
        "go_molecular_function": "GO:0019706 protein-cysteine S-palmitoyltransferase activity;GO:0016409 palmitoyltransferase activity;GO:0019705 protein-cysteine S-myristoyltransferase activity;GO:0140439 protein-cysteine S-stearoyltransferase activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005654 nucleoplasm;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0072659 protein localization to plasma membrane;GO:0006612 protein targeting to membrane;GO:0043401 steroid hormone receptor signaling pathway;GO:0030521 androgen receptor signaling pathway;GO:1903076 regulation of protein localization to plasma membrane",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q91WU6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D115-1",
        "uniprot_id": "ZN706_MOUSE",
        "mass": 8498.0,
        "length": 76,
        "protein_name": "Transcriptional regulator ZNF706",
        "gene_name": "Znf706",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 706",
        "refseq_ac": "NP_080797",
        "gene_names_uniprotkb": "Znf706; Zfp706",
        "gene_names_refseq": "3110006P09Rik; Zfp706; Znf706",
        "protein_names_uniprotkb": "Transcriptional regulator ZNF706; Zinc finger protein 706",
        "protein_names_refseq": "zinc finger protein 706",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68036);  (R-MMU-212436)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "24412312",
        "class_list": "",
        "function": "Transcription repressor involved in the exit of embryonic stem cells (ESCs) from self-renewal (PubMed:24412312). Acts by repressing expression of KLF4 (PubMed:24412312). Required for Wnt signaling activation (By similarity)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:1902455 negative regulation of stem cell population maintenance;GO:0006417 regulation of translation;GO:0045892 negative regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9D115-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DAH2-1",
        "uniprot_id": "ZNRF4_MOUSE",
        "mass": 35628.0,
        "length": 327,
        "protein_name": "E3 ubiquitin-protein ligase ZNRF4",
        "gene_name": "Znrf4",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase ZNRF4 precursor",
        "refseq_ac": "NP_035613",
        "gene_names_uniprotkb": "Znrf4; Spzn",
        "gene_names_refseq": "1700094M01Rik; Ssrzf1; Znrf4; spzn",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase ZNRF4; 2.3.2.27; RING-type E3 ubiquitin transferase ZNRF4; Sperizin; Zinc/RING finger protein 4",
        "protein_names_refseq": "E3 ubiquitin-protein ligase ZNRF4 precursor; E3 ubiquitin-protein ligase ZNRF4; RING-type E3 ubiquitin transferase ZNRF4; sperizin; spermatid specific RING zinc finger 1; zinc/RING finger protein 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:20834)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "10191088",
        "class_list": "",
        "function": "E3 ubiquitin-protein ligase that acts as a negative regulator of NOD2 signaling by mediating ubiquitination and degradation of RIPK2 (By similarity). Also catalyzes ubiquitination and proteasomal degradation of CANX within the endoplasmic reticulum (By similarity). Could have a role in spermatogenesis (PubMed:10191088)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9WTN2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0061630 ubiquitin protein ligase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0070431 nucleotide-binding oligomerization domain containing 2 signaling pathway;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination;GO:0042742 defense response to bacterium;GO:0006511 ubiquitin-dependent protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9DAH2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z0U1-1",
        "uniprot_id": "ZO2_MOUSE",
        "mass": 131280.0,
        "length": 1167,
        "protein_name": "Tight junction protein 2",
        "gene_name": "Tjp2",
        "organism": "Mouse",
        "refseq_name": "tight junction protein 2 isoform 2",
        "refseq_ac": "NP_035727",
        "gene_names_uniprotkb": "Tjp2; Zo2",
        "gene_names_refseq": "Tjp2; ZO-2",
        "protein_names_uniprotkb": "Tight junction protein 2; Tight junction protein ZO-2; Zona occludens protein 2; Zonula occludens protein 2",
        "protein_names_refseq": "Tight junction protein ZO-2 (Zonula occludens 2 protein) (Zona occludens 2 protein) (Tight junction protein 2); tight junction protein 2 isoform 2; zona occludens protein 2; zonula occludens protein 2",
        "tax_id": 10090,
        "disease": "disease of metabolism (Disease Ontology:DOID:0014667); familial hypercholanemia 1 (Disease Ontology:DOID:0061181); progressive familial intrahepatic cholestasis 4 (Disease Ontology:DOID:0070224); hypertension (Disease Ontology:DOID:10763)",
        "pathway": " (mmu:21873);  (R-MMU-2028269);  (R-MMU-351906);  (R-MMU-8980692);  (R-MMU-9013026);  (R-MMU-9013106)",
        "pathway_count": 6,
        "publication_count": 25,
        "publication_id_list": "10.1101/2023.09.13.557529;10026224;12403786;15592455;16452087;17242355;18630941;19131326;19144319;21183079;21750661;22437732;25428506;26609154;31219806;32848054;34428180;34678516;34887587;35820727;36852467;37507081;37578083;40021952;40885482",
        "class_list": "",
        "function": "Plays a role in tight junctions and adherens junctions (PubMed:10026224). Acts as a positive regulator of RANKL-induced osteoclast differentiation, potentially via mediating downstream transcriptional activity (PubMed:22437732)., [UniProtKB, PubMed, PubMed]; Plays a role in tight junctions and adherens junctions. Acts as a positive regulator of RANKL-induced osteoclast differentiation, potentially via mediating downstream transcriptional activity., [UniProtKB, UniProtKB, UniProtKB]; Silenced LASP1 interacts with DNMT1 to promote TJP2 expression and attenuate articular cartilage injury in mice by suppressing TJP2 methylation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 5,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 5,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 5,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 36,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 4,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8K210",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019904 protein domain specific binding;GO:0030674 protein-macromolecule adaptor activity;GO:0044325 transmembrane transporter binding;GO:0050839 cell adhesion molecule binding;GO:1990782 protein tyrosine kinase binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005886 plasma membrane;GO:0005911 cell-cell junction;GO:0005912 adherens junction;GO:0005923 bicellular tight junction",
        "go_biological_process": "GO:0034109 homotypic cell-cell adhesion;GO:0090559 regulation of membrane permeability;GO:0150105 protein localization to cell-cell junction;GO:0098609 cell-cell adhesion;GO:0050892 intestinal absorption",
        "synthesized_glycan_count": 0,
        "hit_score": 3.8,
        "record_id": "Q9Z0U1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QYR7-1",
        "uniprot_id": "ACOT3_MOUSE",
        "mass": 47490.0,
        "length": 432,
        "protein_name": "Acyl-coenzyme A thioesterase 3",
        "gene_name": "Acot3",
        "organism": "Mouse",
        "refseq_name": "acyl-coenzyme A thioesterase 3 isoform 2",
        "refseq_ac": "NP_001333630",
        "gene_names_uniprotkb": "Acot3; Pte1a; Pte2a; Pte2",
        "gene_names_refseq": "Acot3; PTE-Ia; Pte2a",
        "protein_names_uniprotkb": "Acyl-coenzyme A thioesterase 3; 3.1.2.2; Acyl-CoA thioesterase 3; PTE-Ia; Peroxisomal acyl-coenzyme A thioester hydrolase 2a; Peroxisomal long-chain acyl-CoA thioesterase 2",
        "protein_names_refseq": "acyl-coenzyme A thioesterase 3 isoform 2; acyl-coenzyme A thioesterase 3; peroxisomal acyl-CoA thioesterase 2A; peroxisomal acyl-coenzyme A thioester hydrolase 2a; peroxisomal long-chain acyl-CoA thioesterase 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:171281);  (R-MMU-77289);  (R-MMU-9033241);  (R-MMU-9837999)",
        "pathway_count": 4,
        "publication_count": 4,
        "publication_id_list": "10567408;15007068;16940157;21750661",
        "class_list": "",
        "function": "Catalyzes the hydrolysis of acyl-CoAs into free fatty acids and coenzyme A (CoASH), regulating their respective intracellular levels (PubMed:15007068, PubMed:16940157). Mainly active on long-chain acyl-CoAs (PubMed:15007068, PubMed:16940157). May have a function in termination of beta-oxidation of fatty acids (PubMed:16940157)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6Q2Z7",
        "ec_number_list": "2.3.2.27;3.5.3.1;1.8.1.4;1.1.1.35;1.1.1.62;1.1.1.239;1.1.1.178;1.1.1.53;1.1.1.159;5.1.99.4;2.6.1.51;2.6.1.44;3.1.2.2;5.3.3.21;6.2.1.3;6.2.1.-;6.2.1.7;6.2.1.24;6.2.1.15;3.1.2.-;3.1.2.22;3.4.21.92;1.1.1.42;1.1.1.37;3.6.1.-;3.6.1.77;1.4.3.3;4.98.1.1;1.11.1.6;1.4.1.3;1.14.13.39;2.3.1.176;2.3.1.16;2.3.1.155;1.2.4.1;4.1.3.4;3.6.4.10;5.3.3.8;1.2.1.3;2.3.1.137;2.3.1.7;7.6.2.-;2.3.1.168;2.3.3.10;2.3.2.36;7.1.2.2;3.1.2.27;3.1.2.1;3.1.2.11;3.1.2.3;3.1.2.5;5.6.1.7;4.2.1.2;3.1.1.4;3.1.1.5;2.3.1.42;1.2.4.2;1.1.1.30;2.7.11.2;6.1.1.5;3.5.2.6;2.3.1.9;1.5.3.13;2.7.1.23;3.4.21.53;5.6.2.3;3.1.2.14;2.3.1.37;7.1.1.2;2.3.1.65;1.4.3.1;4.1.1.9;1.1.1.38;4.2.1.3;1.1.1.300;1.1.1.184;6.4.1.3;1.3.1.38;1.2.1.36;1.7.1.-;1.2.1.28;2.3.3.1;2.8.3.5;2.3.1.41;1.1.1.41;1.3.8.5;1.5.3.1;1.5.3.7;3.4.21.-;1.3.8.1;2.5.1.18;1.3.3.6;3.4.24.56;1.1.3.15;4.1.2.63;1.2.3.5;1.3.1.124;6.2.1.4",
        "go_molecular_function": "GO:0047617 fatty acyl-CoA hydrolase activity;GO:0052689 carboxylic ester hydrolase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005777 peroxisome;GO:0005829 cytosol",
        "go_biological_process": "GO:0000038 very long-chain fatty acid metabolic process;GO:0001676 long-chain fatty acid metabolic process;GO:0006631 fatty acid metabolic process;GO:0006637 acyl-CoA metabolic process;GO:0032788 saturated monocarboxylic acid metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9QYR7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6NSR3-1",
        "uniprot_id": "ADCK2_MOUSE",
        "mass": 68677.0,
        "length": 617,
        "protein_name": "Uncharacterized aarF domain-containing protein kinase 2",
        "gene_name": "Adck2",
        "organism": "Mouse",
        "refseq_name": "uncharacterized aarF domain-containing protein kinase 2",
        "refseq_ac": "NP_849204",
        "gene_names_uniprotkb": "Adck2",
        "gene_names_refseq": "Adck2",
        "protein_names_uniprotkb": "Uncharacterized aarF domain-containing protein kinase 2; 2.7.11.-",
        "protein_names_refseq": "uncharacterized aarF domain-containing protein kinase 2",
        "tax_id": 10090,
        "disease": "mitochondrial myopathy (Disease Ontology:DOID:699)",
        "pathway": " (mmu:57869)",
        "pathway_count": 1,
        "publication_count": 15,
        "publication_id_list": "18299400;19892989;20173027;20484733;21750661;21952136;25428506;25605945;27802388;30779550;31480808;31599954;34428180;35820727;35936917",
        "class_list": "",
        "function": "The function of this protein is not yet clear. It is not known if it has protein kinase activity and what type of substrate it would phosphorylate (Ser, Thr or Tyr) (Probable). Involved in the mitochondrial import of CoQ precursors, plays a role in muscle mitochondrial function and fatty acid beta-oxidation (PubMed:31480808, PubMed:35936917)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TTS5;Q8BHC6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0016020 membrane",
        "go_biological_process": "GO:0010795 regulation of ubiquinone biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q6NSR3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80WC9-1",
        "uniprot_id": "ACSF4_MOUSE",
        "mass": 121569.0,
        "length": 1100,
        "protein_name": "Beta-alanine-activating enzyme",
        "gene_name": "Aasdh",
        "organism": "Mouse",
        "refseq_name": "beta-alanine-activating enzyme",
        "refseq_ac": "NP_776126",
        "gene_names_uniprotkb": "Aasdh; Acsf4; U26",
        "gene_names_refseq": "A230062G08Rik; A830035E16; Aasdh; Acsf4; U26",
        "protein_names_uniprotkb": "Beta-alanine-activating enzyme; 6.2.1.-; Acyl-CoA synthetase family member 4; Protein LYS2 homolog",
        "protein_names_refseq": "2-aminoadipic 6-semialdehyde dehydrogenase; acyl-CoA synthetase family member 4; beta-alanine-activating enzyme; protein LYS2 homolog; putative aminoadipate-semialdehyde dehydrogenase",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:231326)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "12712191;15689994;15689995;17029795;21750661;24467666",
        "class_list": "",
        "function": "Covalently binds beta-alanine in an ATP-dependent manner to form a thioester bond with its phosphopantetheine group and transfers it to an as yet unknown acceptor via an amide bond. May be required for a post-translational protein modification or for post-transcriptional modification of an RNA., [UniProtKB, PubMed]; Involved in the lysine degradation pathway, [RefSeq, PubMed]; Recombinant ACSF4-U26 progressively formed a covalent bond with radiolabelled beta-alanine. The bond was not formed in a point mutant lacking the phosphopantetheine attachment site. GeneRIF: ACSF4 (U26) is a beta-alanine activating enzyme homologous to bacterial nonribosomal peptide synthetase. Experiments using the mouse protein suggest this enzyme may be involved in a rare intracellular reaction, possibly an infrequent post-translational or post-transcriptional modification., [RefSeq, PubMed]; The gene product is a cytosolic enzyme involved in the production of alpha-aminoadipic acid from alpha-aminoadipic semialdehyde. It is postulated that this enzyme plays a role in lysine metabolism. There is currently debate regarding this enzyme's putative requirement of pyrroloquinoline quinine as an essential cofactor. A related pseudogene has been identified on chromosome 2. [provided by RefSeq, Jan 2010]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3V3L2;Q505K4;Q8BRP4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0016874 ligase activity",
        "go_cellular_component": "",
        "go_biological_process": "GO:0006631 fatty acid metabolic process;GO:0019482 beta-alanine metabolic process;GO:0043041 amino acid activation for nonribosomal peptide biosynthetic process;GO:0006629 lipid metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q80WC9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P97822-1",
        "uniprot_id": "AN32E_MOUSE",
        "mass": 29622.0,
        "length": 260,
        "protein_name": "Acidic leucine-rich nuclear phosphoprotein 32 family member E",
        "gene_name": "Anp32e",
        "organism": "Mouse",
        "refseq_name": "acidic leucine-rich nuclear phosphoprotein 32 family member E isoform 3",
        "refseq_ac": "NP_001240687",
        "gene_names_uniprotkb": "Anp32e; Cpd1",
        "gene_names_refseq": "2810018A15Rik; Anp32e; CPD1; LANP-L; LANPL; mLANP-L",
        "protein_names_uniprotkb": "Acidic leucine-rich nuclear phosphoprotein 32 family member E; Cerebellar postnatal development protein 1; LANP-L; LANP-like protein",
        "protein_names_refseq": "LANP-like protein; acidic (leucine-rich) nuclear phosphoprotein 32 family, member E; acidic leucine-rich nuclear phosphoprotein 32 family member E isoform 3; cerebellar postnatal development protein 1",
        "tax_id": 10090,
        "disease": "candidiasis (Disease Ontology:DOID:1508)",
        "pathway": " (mmu:66471)",
        "pathway_count": 1,
        "publication_count": 15,
        "publication_id_list": "10692581;11430900;14964690;15895553;16420440;21049064;21750661;23675506;24463511;25605945;30084848;34407406;34428180;35675771;36263179",
        "class_list": "",
        "function": "Anp32e promotes renal interstitial fibrosis by upregulating the expression of fibrosis-related proteins. Publication Status: Online-Only, [RefSeq, PubMed]; Histone chaperone that specifically mediates the genome-wide removal of histone H2A.Z/H2AZ1 from the nucleosome: removes H2A.Z/H2AZ1 from its normal sites of deposition, especially from enhancer and insulator regions. Not involved in deposition of H2A.Z/H2AZ1 in the nucleosome. May stabilize the evicted H2A.Z/H2AZ1-H2B dimer, thus shifting the equilibrium towards dissociation and the off-chromatin state (PubMed:24463511). Inhibits activity of protein phosphatase 2A (PP2A). Does not inhibit protein phosphatase 1. May play a role in cerebellar development and synaptogenesis., [UniProtKB, PubMed, PubMed, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Lockd promotes myoblast proliferation and muscle regeneration via binding with DHX36 to facilitate 5' UTR rG4 unwinding and Anp32e translation., [RefSeq, PubMed]; Multifunctional protein that is involved in the regulation of many processes., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; The histone chaperone Anp32e regulates memory formation, transcription, and dendritic morphology by regulating steady-state H2A.Z binding in neurons., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9Q5H9;Q3TH89;Q3TX26;Q8BPF8;Q8C2L4;Q8C7Q8;Q9CZD2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019212 phosphatase inhibitor activity;GO:0042393 histone binding;GO:0044183 protein folding chaperone;GO:0140713 histone chaperone activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0031410 cytoplasmic vesicle;GO:0030672 synaptic vesicle membrane",
        "go_biological_process": "GO:0006325 chromatin organization;GO:0042981 regulation of apoptotic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "P97822-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5SUE7-1",
        "uniprot_id": "ADAD1_MOUSE",
        "mass": 67840.0,
        "length": 619,
        "protein_name": "Adenosine deaminase domain-containing protein 1",
        "gene_name": "Adad1",
        "organism": "Mouse",
        "refseq_name": "adenosine deaminase domain-containing protein 1",
        "refseq_ac": "NP_033376",
        "gene_names_uniprotkb": "Adad1; Tenr",
        "gene_names_refseq": "Adad1; Tenr",
        "protein_names_uniprotkb": "Adenosine deaminase domain-containing protein 1; Testis nuclear RNA-binding protein",
        "protein_names_refseq": "adenosine deaminase domain containing 1 (testis specific); adenosine deaminase domain-containing protein 1; testis nuclear RNA binding protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:21744)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10779485;12079346;15649457;21750661;32665638;37399121;7543294",
        "class_list": "",
        "function": "2.65 A crystal structure of mouse TB-RBP, [RefSeq, PubMed]; ADAD1 and ADAD2, testis-specific adenosine deaminase domain-containing proteins, are required for male fertility. Publication Status: Online-Only, [RefSeq, PubMed]; ADAD1 is required for normal translation of nuclear pore and transport protein transcripts in spermatids of Mus musculusdagger., [RefSeq, PubMed]; Required for male fertility and normal male germ cell differentiation (PubMed:32665638). Plays a role in spermatogenesis (PubMed:15649457). Binds to RNA but not to DNA (PubMed:15649457)., [UniProtKB, PubMed, PubMed]; Required for male fertility and normal male germ cell differentiation. Plays a role in spermatogenesis. Binds to RNA but not to DNA., [UniProtKB, UniProtKB]; Targeted mutation of the Tenr gene causes male sterility. Tenr mutant males have a reduced sperm count, and Tenr-/- sperm show a decrease in motility and an increase in malformed heads., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AAD7;A2AAD8;A2AAV1;Q08EL2;Q3V0N7;Q62309;Q9JLB6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0008251 tRNA-specific adenosine deaminase activity;GO:0003725 double-stranded RNA binding;GO:0003726 double-stranded RNA adenosine deaminase activity;GO:0004000 adenosine deaminase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005730 nucleolus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006396 RNA processing;GO:0007286 spermatid development;GO:0006382 adenosine to inosine editing;GO:0007283 spermatogenesis;GO:0030154 cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q5SUE7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O08707-1",
        "uniprot_id": "ACKR2_MOUSE",
        "mass": 43207.0,
        "length": 378,
        "protein_name": "Atypical chemokine receptor 2",
        "gene_name": "Ackr2",
        "organism": "Mouse",
        "refseq_name": "atypical chemokine receptor 2",
        "refseq_ac": "NP_001263648",
        "gene_names_uniprotkb": "Ackr2; Ccbp2; D6",
        "gene_names_refseq": "Ackr2; CCR10; CCR9; Ccbp2; Cmkbr9; D6",
        "protein_names_uniprotkb": "Atypical chemokine receptor 2; C-C chemokine receptor D6; Chemokine-binding protein 2; Chemokine-binding protein D6",
        "protein_names_refseq": "C-C chemokine receptor D6; D6 beta-chemokine receptor; atypical chemokine receptor 2; chemokine decoy receptor D6; chemokine-binding protein 2; chemokine-binding protein D6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:59289);  (R-MMU-380108)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "14581607;14744993;15750596;21750661;22651933;23125030;34533865;36518752;38799420;9139699",
        "class_list": "",
        "function": "ACKR2 limits skin fibrosis and hair loss through IFN-beta., [RefSeq, PubMed]; Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Acts as a receptor for chemokines including CCL2, CCL3, CCL3L1, CCL4, CCL5, CCL7, CCL8, CCL11, CCL13, CCL17, CCL22, CCL23, CCL24, SCYA2/MCP-1, SCY3/MIP-1-alpha, SCYA5/RANTES and SCYA7/MCP-3. Upon active ligand stimulation, activates a beta-arrestin 1 (ARRB1)-dependent, G protein-independent signaling pathway that results in the phosphorylation of the actin-binding protein cofilin (CFL1) through a RAC1-PAK1-LIMK1 signaling pathway. Activation of this pathway results in up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. By scavenging chemokines in tissues, on the surfaces of lymphatic vessels, and in placenta, plays an essential role in the resolution (termination) of the inflammatory response and in the regulation of adaptive immune responses. Plays a major role in the immune silencing of macrophages during the resolution of inflammation. Acts as a regulator of inflammatory leukocyte interactions with lymphatic endothelial cells (LECs) and is required for immature/mature dendritic cells discrimination by LECs., [UniProtKB, PubMed]; CCR10 engagement by locally produced CCL27 allows melanoma cells to escape host immune antitumor killing mechanisms (possibly through activation of PI3K/Akt), thereby providing a means for tumor progression, [RefSeq, PubMed]; CCR9-deficient IgA+ plasma cells show reduced migration into the small intestine compared with wild-type controls., [RefSeq, PubMed]; The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice. Publication Status: Online-Only, [RefSeq, PubMed]; The atypical chemokine receptor-2 fine-tunes the immune response in herpes stromal keratitis. Publication Status: Online-Only, [RefSeq, PubMed]; The chemokine receptor D6 limits the inflammatory response in vivo., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CEG1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004950 chemokine receptor activity;GO:0016493 C-C chemokine receptor activity;GO:0019957 C-C chemokine binding;GO:0140319 receptor decoy activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005769 early endosome;GO:0005829 cytosol;GO:0005884 actin filament;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0006955 immune response;GO:0007165 signal transduction;GO:0007204 positive regulation of cytosolic calcium ion concentration;GO:0019722 calcium-mediated signaling",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "O08707-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9PZJ8-1",
        "uniprot_id": "ASCC3_MOUSE",
        "mass": 250557.0,
        "length": 2198,
        "protein_name": "Activating signal cointegrator 1 complex subunit 3",
        "gene_name": "Ascc3",
        "organism": "Mouse",
        "refseq_name": "activating signal cointegrator 1 complex subunit 3",
        "refseq_ac": "NP_932124",
        "gene_names_uniprotkb": "Ascc3",
        "gene_names_refseq": "ASC1p200; Ascc3; B630009I04Rik; D430001L07Rik; D630041L21; Helic1; RNAH",
        "protein_names_uniprotkb": "Activating signal cointegrator 1 complex subunit 3; 5.6.2.4",
        "protein_names_refseq": "activating signal cointegrator 1 complex subunit 3; helicase, ATP binding 1",
        "tax_id": 10090,
        "disease": "autosomal recessive intellectual developmental disorder (Disease Ontology:DOID:0060308)",
        "pathway": " (mmu:77987);  (R-MMU-9954716)",
        "pathway_count": 2,
        "publication_count": 6,
        "publication_id_list": "21750661;23806337;25605945;31219806;34428180;36210013",
        "class_list": "",
        "function": "ATPase involved both in DNA repair and rescue of stalled ribosomes. 3'-5' DNA helicase involved in repair of alkylated DNA: promotes DNA unwinding to generate single-stranded substrate needed for ALKBH3, enabling ALKBH3 to process alkylated N3-methylcytosine (3mC) within double-stranded regions. Also involved in activation of the ribosome quality control (RQC) pathway, a pathway that degrades nascent peptide chains during problematic translation. Drives the splitting of stalled ribosomes that are ubiquitinated in a ZNF598-dependent manner, as part of the ribosome quality control trigger (RQT) complex. Part of the ASC-1 complex that enhances NF-kappa-B, SRF and AP1 transactivation., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6PB36;Q8C1G1;Q8C707;Q8K292",
        "ec_number_list": "3.6.4.13;3.6.4.10;3.6.4.-;5.6.2.3;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;7.6.2.1;3.6.1.5;3.4.24.-;3.6.-.-;3.1.3.1;3.9.1.1;3.6.1.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;3.6.4.6;3.6.5.-;3.6.1.15;3.1.4.-;5.6.2.-;7.2.2.-;7.6.2.16;3.4.21.53;2.7.7.7;2.7.7.49;2.7.11.1;2.7.4.3",
        "go_molecular_function": "GO:0043138 3'-5' DNA helicase activity;GO:0003723 RNA binding;GO:0005524 ATP binding;GO:0016887 ATP hydrolysis activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol;GO:0016607 nuclear speck;GO:0022626 cytosolic ribosome;GO:1990391 DNA repair complex",
        "go_biological_process": "GO:0072344 rescue of stalled ribosome;GO:0032790 ribosome disassembly;GO:0006307 DNA alkylation repair;GO:0071569 protein ufmylation;GO:1990116 ribosome-associated ubiquitin-dependent protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "E9PZJ8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q70FJ1-1",
        "uniprot_id": "AKAP9_MOUSE",
        "mass": 436214.0,
        "length": 3797,
        "protein_name": "A-kinase anchor protein 9",
        "gene_name": "Akap9",
        "organism": "Mouse",
        "refseq_name": "A-kinase anchor protein 9",
        "refseq_ac": "NP_919444",
        "gene_names_uniprotkb": "Akap9; Kiaa0803",
        "gene_names_refseq": "5730481H23Rik; AKAP-9; AKAP450; Akap9; G1-448-15; PRKA9; mKIAA0803; mei2-5; repro12",
        "protein_names_uniprotkb": "A-kinase anchor protein 9; AKAP-9; PRKA9; Protein kinase A-anchoring protein 9",
        "protein_names_refseq": "A kinase (PRKA) anchor protein (yotiao) 9; A-kinase anchor protein 9; protein kinase A-anchoring protein 9",
        "tax_id": 10090,
        "disease": "long QT syndrome 11 (Disease Ontology:DOID:0110652)",
        "pathway": " (mmu:100986);  (R-MMU-2565942);  (R-MMU-380259);  (R-MMU-380270);  (R-MMU-380284);  (R-MMU-380320);  (R-MMU-5576890);  (R-MMU-5576893);  (R-MMU-5620912);  (R-MMU-8854518)",
        "pathway_count": 10,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;31219806;31599954;34428180",
        "class_list": "",
        "function": "Scaffolding protein that assembles several protein kinases and phosphatases on the centrosome and Golgi apparatus. Required to maintain the integrity of the Golgi apparatus. Required for microtubule nucleation at the cis-side of the Golgi apparatus. Required for association of the centrosomes with the poles of the bipolar mitotic spindle during metaphase. In complex with PDE4DIP isoform 2/MMG8/SMYLE, recruits CAMSAP2 to the Golgi apparatus and tethers non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement. In complex with PDE4DIP isoform 2, EB1/MAPRE1 and CDK5RAP2, contributes to microtubules nucleation and extension also from the centrosome to the cell periphery., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TH74;Q80TR6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0060090 molecular adaptor activity;GO:0015459 potassium channel regulator activity;GO:0044325 transmembrane transporter binding;GO:0034237 protein kinase A regulatory subunit binding;GO:0099104 potassium channel activator activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0034705 potassium channel complex;GO:0005737 cytoplasm;GO:0005794 Golgi apparatus;GO:0005813 centrosome",
        "go_biological_process": "GO:0007165 signal transduction;GO:0007194 negative regulation of adenylate cyclase activity;GO:0007283 spermatogenesis;GO:0071320 cellular response to cAMP;GO:0060306 regulation of membrane repolarization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q70FJ1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q4JIM5-1",
        "uniprot_id": "ABL2_MOUSE",
        "mass": 128196.0,
        "length": 1182,
        "protein_name": "Tyrosine-protein kinase ABL2",
        "gene_name": "Abl2",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Abl2; Arg",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Tyrosine-protein kinase ABL2; 2.7.10.2; Abelson murine leukemia viral oncogene homolog 2; Abelson tyrosine-protein kinase 2; Abelson-related gene protein; Tyrosine-protein kinase ARG",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (R-MMU-428890);  (R-MMU-9013149);  (R-MMU-9013423);  (R-MMU-9706369)",
        "pathway_count": 4,
        "publication_count": 23,
        "publication_id_list": "10.1101/2023.09.13.557529;11279004;11752434;12748290;12775773;14729179;14993293;16971514;17892306;18182299;19144319;20173027;20841568;21183079;21750661;22517741;22810897;31219806;32848054;34428180;40021952;40885482;9883720",
        "class_list": "",
        "function": "Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL or DOK1. Required for adhesion-dependent phosphorylation of ARHGAP35 which promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Positively regulates chemokine-mediated T-cell migration, polarization, and homing to lymph nodes and immune-challenged tissues, potentially via activation of NEDD9/HEF1 and RAP1 (PubMed:22810897)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 34,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 0,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.7.12.2;2.7.10.1;2.7.12.1;2.7.1.32;2.7.1.82;2.7.10.2;2.7.11.1;2.7.11.13;2.7.10.4;2.7.1.153;2.7.1.137;3.6.5.2;2.7.1.40;3.1.4.4;1.6.3.-;2.7.11.23",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0001784 phosphotyrosine residue binding;GO:0004713 protein tyrosine kinase activity;GO:0004715 non-membrane spanning protein tyrosine kinase activity;GO:0005524 ATP binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0001891 phagocytic cup;GO:0005886 plasma membrane;GO:0015629 actin cytoskeleton;GO:0030027 lamellipodium",
        "go_biological_process": "GO:0072359 circulatory system development;GO:0031223 auditory behavior;GO:1903905 positive regulation of establishment of T cell polarity;GO:0006468 protein phosphorylation;GO:0007015 actin filament organization",
        "synthesized_glycan_count": 0,
        "hit_score": 3.2,
        "record_id": "Q4JIM5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P29754-1",
        "uniprot_id": "AGTRA_MOUSE",
        "mass": 40856.0,
        "length": 359,
        "protein_name": "Type-1 angiotensin II receptor A",
        "gene_name": "Agtr1a",
        "organism": "Mouse",
        "refseq_name": "type-1 angiotensin II receptor A",
        "refseq_ac": "NP_796296",
        "gene_names_uniprotkb": "Agtr1a; Agtr1",
        "gene_names_refseq": "1810074K20Rik; AG2S; AT1a; AT1; AT2R1A; AT2R1; Agt1ar; Agtr-1a; Agtr1a; Agtr1; Angtr-1a",
        "protein_names_uniprotkb": "Type-1 angiotensin II receptor A; AT1 receptor A; Angiotensin II type-1 receptor A",
        "protein_names_refseq": "AT1 receptor A; angiotensin II type-1 receptor A; angiotensin II type-1A receptor; angiotensin receptor 1a; angiotensin receptor 1; type-1 angiotensin II receptor A; type-1A angiotensin II receptor",
        "tax_id": 10090,
        "disease": "glomerulosclerosis (Disease Ontology:DOID:0050851); atrial fibrillation (Disease Ontology:DOID:0060224); COVID-19 (Disease Ontology:DOID:0080600); Alzheimer's disease (Disease Ontology:DOID:10652); renal hypertension (Disease Ontology:DOID:1073); hypertension (Disease Ontology:DOID:10763); essential hypertension (Disease Ontology:DOID:10825); nephritis (Disease Ontology:DOID:10952); sarcoidosis (Disease Ontology:DOID:11335); Friedreich ataxia (Disease Ontology:DOID:12705); Huntington's disease (Disease Ontology:DOID:12858); dilated cardiomyopathy (Disease Ontology:DOID:12930); focal segmental glomerulosclerosis (Disease Ontology:DOID:1312); Parkinson's disease (Disease Ontology:DOID:14330); renovascular hypertension (Disease Ontology:DOID:1591); breast cancer (Disease Ontology:DOID:1612); hyperinsulinism (Disease Ontology:DOID:2018); asthma (Disease Ontology:DOID:2841); IgA glomerulonephritis (Disease Ontology:DOID:2986); coronary artery disease (Disease Ontology:DOID:3393); carotid artery disease (Disease Ontology:DOID:3407); placental insufficiency (Disease Ontology:DOID:3891); renal cell carcinoma (Disease Ontology:DOID:4450); anti-basement membrane glomerulonephritis (Disease Ontology:DOID:4780); proteinuria (Disease Ontology:DOID:576); myocardial infarction (Disease Ontology:DOID:5844); congestive heart failure (Disease Ontology:DOID:6000); pulmonary hypertension (Disease Ontology:DOID:6432); cerebrovascular disease (Disease Ontology:DOID:6713); chronic kidney disease (Disease Ontology:DOID:784); intermediate coronary syndrome (Disease Ontology:DOID:8805); vesicoureteral reflux (Disease Ontology:DOID:9620)",
        "pathway": " (mmu:11607);  (R-MMU-375276);  (R-MMU-416476);  (R-MMU-8856825);  (R-MMU-8856828)",
        "pathway_count": 5,
        "publication_count": 5,
        "publication_id_list": "1497638;1599461;21750661;34428180;38896605",
        "class_list": "",
        "function": "Inhibiting AGTR1 reduces AML burden and protects the heart from cardiotoxicity in mouse models., [RefSeq, PubMed]; Receptor for angiotensin II, a vasoconstricting peptide, which acts as a key regulator of blood pressure and sodium retention by the kidney. The activated receptor in turn couples to G-alpha proteins G(q) (GNAQ, GNA11, GNA14 or GNA15) and thus activates phospholipase C and increases the cytosolic Ca(2+) concentrations, which in turn triggers cellular responses such as stimulation of protein kinase C., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 32,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019901 protein kinase binding;GO:0046982 protein heterodimerization activity;GO:0031711 bradykinin receptor binding;GO:0001596 angiotensin type I receptor activity;GO:0004945 angiotensin type II receptor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005768 endosome;GO:0005794 Golgi apparatus;GO:0005886 plasma membrane;GO:0016323 basolateral plasma membrane",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007204 positive regulation of cytosolic calcium ion concentration;GO:0007507 heart development;GO:0008284 positive regulation of cell population proliferation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P29754-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P34927-1",
        "uniprot_id": "ASGR1_MOUSE",
        "mass": 32591.0,
        "length": 284,
        "protein_name": "Asialoglycoprotein receptor 1",
        "gene_name": "Asgr1",
        "organism": "Mouse",
        "refseq_name": "asialoglycoprotein receptor 1 isoform a",
        "refseq_ac": "NP_001278060",
        "gene_names_uniprotkb": "Asgr1; Asgr-1",
        "gene_names_refseq": "ASGPR1; Asgr-1; Asgr1; Asgr; HL-1",
        "protein_names_uniprotkb": "Asialoglycoprotein receptor 1; ASGP-R 1; ASGPR 1; HL-1; Hepatic lectin 1; mHL-1",
        "protein_names_refseq": "asialoglycoprotein receptor 1 isoform a; hepatic lectin 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:11889);  (R-MMU-446203)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "10675034;21750661;34428180;34622799;36621538;38281933;38459023;7958950;8439566",
        "class_list": "glycogene",
        "function": "ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity. Publication Status: Online-Only, [RefSeq, PubMed]; ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-kappaB/ATF5 pathway., [RefSeq, PubMed]; Deficiency of ASGR1 promotes liver injury by increasing GP73-mediated hepatic endoplasmic reticulum stress. Publication Status: Online-Only, [RefSeq, PubMed]; Transmembrane protein predominantly expressed on hepatocytes that plays a key role in endocytosis of plasma glycoproteins that lack terminal sialic acid residues. Specifically recognizes terminal galactose and N-acetylgalactosamine residues, facilitating the clearance of desialylated glycoproteins from circulation. Plays thereby a role in a variety of physiological processes, such as removal of desialylated platelets, elimination of activated lymphocytes and maintenance of serum glycoprotein homeostasis. Plays a role in the removal of desialylated platelets by activating a feedback loop regulating thrombopoietin (TPO) expression via the JAK2-STAT3 signaling pathway. Contributes also to recognition and elimination of activated lymphocytes by hepatocytes that can act as cytotoxic effectors (By similarity). May also play a physiological role in the regulatory network of lipid homeostasis (PubMed:34622799). Upon ligand binding, the receptor-ligand complex is internalized and trafficked to a sorting organelle, where dissociation occurs. The receptor is then recycled back to the cell surface (By similarity)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 16,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q64363;Q91Y84",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0046872 metal ion binding;GO:0005537 D-mannose binding;GO:0042806 fucose binding;GO:0004873 asialoglycoprotein receptor activity",
        "go_cellular_component": "GO:0009897 external side of plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0006897 endocytosis;GO:0006955 immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "P34927-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88532-1",
        "uniprot_id": "ZFR_MOUSE",
        "mass": 116859.0,
        "length": 1074,
        "protein_name": "Zinc finger RNA-binding protein",
        "gene_name": "Zfr",
        "organism": "Mouse",
        "refseq_name": "zinc finger RNA-binding protein isoform 1",
        "refseq_ac": "NP_035897",
        "gene_names_uniprotkb": "Zfr",
        "gene_names_refseq": "C920030H05Rik; Zfr",
        "protein_names_uniprotkb": "Zinc finger RNA-binding protein",
        "protein_names_refseq": "zinc finger RNA-binding protein isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22763)",
        "pathway_count": 1,
        "publication_count": 36,
        "publication_id_list": "10.1101/2023.09.13.557529;10.3389/fragi.2021.757801;10072773;11283266;16277607;17242355;21091219;21183079;21606357;21750661;22517741;22645316;22872234;23806337;25605945;26495903;28528544;29237092;31010678;31219806;31616917;32782141;32848054;33300544;34428180;34678516;34887587;35822049;36210013;36757814;36852467;39627609;39927985;40021952;40885482;40997131",
        "class_list": "",
        "function": "Involved in postimplantation and gastrulation stages of development. Binds to DNA and RNA. Involved in the nucleocytoplasmic shuttling of STAU2 (By similarity)., [UniProtKB, PubMed]; Mouse Zfr mRNA was detected in all stages tested during mouse preimplantation, with higher levels at the 1-cell stage that includes the maternal contribution of Zfr mRNA., [RefSeq, PubMed]; ZFR is a native component of Staufen2-containing granules and likely plays its role during early steps of RNA transport and localization, [RefSeq, PubMed]; ZFR overexpression also promoted tumor development of immortalized mouse liver cells., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 19,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 19,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 19,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 21,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TY30;Q8BS85;Q8CGG5;Q91VZ0;Q9CT34",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0008270 zinc ion binding;GO:0003725 double-stranded RNA binding;GO:0003727 single-stranded RNA binding;GO:0003723 RNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005694 chromosome",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 5.9,
        "record_id": "O88532-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "F8VQ03-1",
        "uniprot_id": "ADAM3_MOUSE",
        "mass": 91444.0,
        "length": 822,
        "protein_name": "A disintegrin and metallopeptidase domain 3",
        "gene_name": "Adam3",
        "organism": "Mouse",
        "refseq_name": "A disintegrin and metallopeptidase domain 3 isoform 1 precursor",
        "refseq_ac": "NP_033749",
        "gene_names_uniprotkb": "Adam3; Cyrn1",
        "gene_names_refseq": "Adam3; Cyrn1; Taz83; tMDC",
        "protein_names_uniprotkb": "A disintegrin and metallopeptidase domain 3; Cyritestin",
        "protein_names_refseq": "A disintegrin and metallopeptidase domain 3 isoform 1 precursor; a disintegrin and metallopeptidase domain 3 (cyritestin)",
        "tax_id": 10090,
        "disease": "brain glioma (Disease Ontology:DOID:0060108); conjunctival squamous cell carcinoma (Disease Ontology:DOID:1748)",
        "pathway": " (mmu:11497)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "11439107;15514464;19339711;20945367;21750661;23633567;24501175;32529245;34028541;38217862",
        "class_list": "",
        "function": "Dissecting the PRSS37 interactome and potential mechanisms leading to ADAM3 loss in PRSS37-null sperm., [RefSeq, PubMed]; Involved in fertilization by controlling sperm migration into the oviduct (PubMed:19339711). Promotes the binding of sperm to the oocyte zona pellucida (PubMed:32529245)., [UniProtKB, PubMed, PubMed]; Multiple genes in the Pate5-13 genomic region contribute to ADAM3 processingdagger., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity",
        "go_cellular_component": "GO:0061827 sperm head;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0045121 membrane raft;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006508 proteolysis;GO:0007155 cell adhesion;GO:0007339 binding of sperm to zona pellucida;GO:0009566 fertilization;GO:0010628 positive regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "F8VQ03-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BX37-1",
        "uniprot_id": "ACP7_MOUSE",
        "mass": 50663.0,
        "length": 438,
        "protein_name": "Acid phosphatase type 7",
        "gene_name": "Acp7",
        "organism": "Mouse",
        "refseq_name": "acid phosphatase type 7 precursor",
        "refseq_ac": "NP_780528",
        "gene_names_uniprotkb": "Acp7; Papl1; Papl",
        "gene_names_refseq": "Acp7; C330005M16Rik; Papl",
        "protein_names_uniprotkb": "Acid phosphatase type 7; 3.1.3.2; Purple acid phosphatase long form",
        "protein_names_refseq": "acid phosphatase type 7 precursor; acid phosphatase type 7; iron/zinc purple acid phospatase-like; iron/zinc purple acid phosphatase-like protein; purple acid phosphatase long form",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:101744)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "10.1101/2023.09.13.557529;16793224;21750661;34203471",
        "class_list": "",
        "function": "Putative metallophosphoesterase belonging to the purple acid phosphatase family that catalyzes the hydrolysis of phosphate esters to alcohol and phosphate under acidic conditions., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.1.3.2;3.1.3.48;3.1.3.1;3.9.1.1;3.1.3.5",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0003993 acid phosphatase activity",
        "go_cellular_component": "GO:0005576 extracellular region",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q8BX37-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B2RXR6-1",
        "uniprot_id": "ANR44_MOUSE",
        "mass": 107385.0,
        "length": 993,
        "protein_name": "Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B",
        "gene_name": "Ankrd44",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B",
        "refseq_ac": "NP_001074902",
        "gene_names_uniprotkb": "Ankrd44",
        "gene_names_refseq": "4930444A19Rik; A130096K20; Ankrd44; E130014H08Rik; PP6-ARS-B",
        "protein_names_uniprotkb": "Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B; Ankyrin repeat domain-containing protein 44; PP6-ARS-B; Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B",
        "protein_names_refseq": "ankyrin repeat domain-containing protein 44; serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B; serine/threonine-protein phosphatase 6 regulatory subunit ARS-B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:329154)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "18299400;20484733;21750661;21952136;22872234;25428506;30084848;30779550;34428180;35820727;39627609",
        "class_list": "",
        "function": "Putative regulatory subunit of protein phosphatase 6 (PP6) that may be involved in the recognition of phosphoprotein substrates., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RXN6;B7ZWK8",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "B2RXR6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QUI6-1",
        "uniprot_id": "ACKR1_MOUSE",
        "mass": 36694.0,
        "length": 334,
        "protein_name": "Atypical chemokine receptor 1",
        "gene_name": "Ackr1",
        "organism": "Mouse",
        "refseq_name": "atypical chemokine receptor 1",
        "refseq_ac": "NP_034175",
        "gene_names_uniprotkb": "Ackr1; Darc; Dfy; Fy",
        "gene_names_refseq": "Ackr1; CCBP1; CD234; Darc; Dfy; ESTM35; FY; GPD",
        "protein_names_uniprotkb": "Atypical chemokine receptor 1; Duffy antigen/chemokine receptor",
        "protein_names_refseq": "Duffy antigen receptor for chemokines; Duffy blood group, chemokine receptor; atypical chemokine receptor 1; duffy antigen/chemokine receptor; glycoprotein D",
        "tax_id": 10090,
        "disease": "sickle cell anemia (Disease Ontology:DOID:10923); malaria (Disease Ontology:DOID:12365); Plasmodium vivax malaria (Disease Ontology:DOID:12978)",
        "pathway": " (mmu:13349)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "10520743;11929753;21750661;23386199;31219806;34524684;35803223;9314499",
        "class_list": "",
        "function": "(Microbial infection) Acts as a receptor for the malaria parasite Plasmodium yoelii in mature erythrocytes but not reticulocytes., [UniProtKB, PubMed]; A subset of macrophages and monocytes in the mouse bone marrow express atypical chemokine receptor 1., [RefSeq, PubMed]; ACKR1 favors transcellular over paracellular T-cell diapedesis across the blood-brain barrier in neuroinflammation in vitro., [RefSeq, PubMed]; Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Has a promiscuous chemokine-binding profile, interacting with inflammatory chemokines of both the CXC and the CC subfamilies but not with homeostatic chemokines. Acts as a receptor for chemokines including CCL2, CCL5, CCL7, CCL11, CCL13, CCL14, CCL17, CXCL5, CXCL6, IL8/CXCL8, CXCL11, GRO, RANTES, MCP-1 and TARC. May regulate chemokine bioavailability and, consequently, leukocyte recruitment through two distinct mechanisms: when expressed in endothelial cells, it sustains the abluminal to luminal transcytosis of tissue-derived chemokines and their subsequent presentation to circulating leukocytes; when expressed in erythrocytes, serves as blood reservoir of cognate chemokines but also as a chemokine sink, buffering potential surges in plasma chemokine levels (By similarity)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O35970;Q91VB6;Q920X0;Q920X1;Q920X2;Q920X3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0019957 C-C chemokine binding;GO:0019956 chemokine binding",
        "go_cellular_component": "GO:0005769 early endosome;GO:0055037 recycling endosome;GO:0097648 G protein-coupled receptor complex;GO:0016020 membrane",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0032642 regulation of chemokine production;GO:0070098 chemokine-mediated signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q9QUI6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q924T3-1",
        "uniprot_id": "XRCC4_MOUSE",
        "mass": 37061.0,
        "length": 326,
        "protein_name": "DNA repair protein XRCC4",
        "gene_name": "Xrcc4",
        "organism": "Mouse",
        "refseq_name": "DNA repair protein XRCC4",
        "refseq_ac": "NP_082288",
        "gene_names_uniprotkb": "Xrcc4",
        "gene_names_refseq": "2310057B22Rik; Xrcc4",
        "protein_names_uniprotkb": "DNA repair protein XRCC4; X-ray repair cross-complementing protein 4",
        "protein_names_refseq": "DNA repair protein XRCC4; X-ray repair complementing defective repair in Chinese hamster cells 4; X-ray repair cross-complementing protein 4",
        "tax_id": 10090,
        "disease": "salivary gland carcinoma (Disease Ontology:DOID:0050904); salivary gland adenoid cystic carcinoma (Disease Ontology:DOID:4866); multiple myeloma (Disease Ontology:DOID:9538)",
        "pathway": " (mmu:108138);  (R-MMU-3108214);  (R-MMU-5693571)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;11738935;14599745;21183079;21750661;33725486;9875844",
        "class_list": "",
        "function": "Acts as an activator of the phospholipid scramblase activity of XKR4 (PubMed:33725486). This form, which is generated upon caspase-3 (CASP3) cleavage, translocates into the cytoplasm and interacts with XKR4, thereby promoting phosphatidylserine scramblase activity of XKR4 and leading to phosphatidylserine exposure on apoptotic cell surface (PubMed:33725486)., [UniProtKB, PubMed]; Acts as an activator of the phospholipid scramblase activity of XKR4. This form, which is generated upon caspase-3 (CASP3) cleavage, translocates into the cytoplasm and interacts with XKR4, thereby promoting phosphatidylserine scramblase activity of XKR4 and leading to phosphatidylserine exposure on apoptotic cell surface., [UniProtKB, UniProtKB, UniProtKB]; DNA non-homologous end joining (NHEJ) core factor, required for double-strand break repair and V(D)J recombination (PubMed:9875844). Acts as a scaffold protein that regulates recruitment of other proteins to DNA double-strand breaks (DSBs). Associates with NHEJ1/XLF to form alternating helical filaments that bridge DNA and act like a bandage, holding together the broken DNA until it is repaired. The XRCC4-NHEJ1/XLF subcomplex binds to the DNA fragments of a DSB in a highly diffusive manner and robustly bridges two independent DNA molecules, holding the broken DNA fragments in close proximity to one other. The mobility of the bridges ensures that the ends remain accessible for further processing by other repair factors. Plays a key role in the NHEJ ligation step of the broken DNA during DSB repair via direct interaction with DNA ligase IV (LIG4): the LIG4-XRCC4 subcomplex reseals the DNA breaks after the gap filling is completed. XRCC4 stabilizes LIG4, regulates its subcellular localization and enhances LIG4's joining activity. Binding of the LIG4-XRCC4 subcomplex to DNA ends is dependent on the assembly of the DNA-dependent protein kinase complex DNA-PK to these DNA ends. Promotes displacement of PNKP from processed strand break termini (By similarity)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 16,
        "reported_mutagensis": 9,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9571,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BKC9;Q8BU02;Q9D6U6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0019899 enzyme binding;GO:0030674 protein-macromolecule adaptor activity;GO:0042802 identical protein binding;GO:0070975 FHA domain binding",
        "go_cellular_component": "GO:0070419 nonhomologous end joining complex;GO:0032807 DNA ligase IV complex;GO:0070522 ERCC4-ERCC1 complex;GO:0005634 nucleus;GO:0005654 nucleoplasm",
        "go_biological_process": "GO:1990166 protein localization to site of double-strand break;GO:0002328 pro-B cell differentiation;GO:0061819 telomeric DNA-containing double minutes formation;GO:1905765 negative regulation of protection from non-homologous end joining at telomere;GO:0001701 in utero embryonic development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q924T3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9Q414-1",
        "uniprot_id": "APOB_MOUSE",
        "mass": 509432.0,
        "length": 4505,
        "protein_name": "Apolipoprotein B-100",
        "gene_name": "Apob",
        "organism": "Mouse",
        "refseq_name": "apolipoprotein B-100 precursor",
        "refseq_ac": "NP_033823",
        "gene_names_uniprotkb": "Apob",
        "gene_names_refseq": "Apo B-100; Apob; apob-100; apob-48",
        "protein_names_uniprotkb": "Apolipoprotein B-100; Apo B-100",
        "protein_names_refseq": "apolipoprotein B-100 precursor; apolipoprotein B-100",
        "tax_id": 10090,
        "disease": "familial hypobetalipoproteinemia 2 (Disease Ontology:DOID:0111061); familial hypobetalipoproteinemia 1 (Disease Ontology:DOID:0111062); sickle cell anemia (Disease Ontology:DOID:10923); familial hyperlipidemia (Disease Ontology:DOID:1168); nephrotic syndrome (Disease Ontology:DOID:1184); morbid obesity (Disease Ontology:DOID:11981); beta thalassemia (Disease Ontology:DOID:12241); cardiovascular system disease (Disease Ontology:DOID:1287); familial combined hyperlipidemia (Disease Ontology:DOID:13809); familial hypercholesterolemia (Disease Ontology:DOID:13810); hypobetalipoproteinemia (Disease Ontology:DOID:1390); aortic valve stenosis (Disease Ontology:DOID:1712); arteriosclerosis (Disease Ontology:DOID:2349); ovarian cancer (Disease Ontology:DOID:2394); gallbladder cancer (Disease Ontology:DOID:3121); coronary artery disease (Disease Ontology:DOID:3393); cerebral infarction (Disease Ontology:DOID:3526); bile duct cancer (Disease Ontology:DOID:4606); biliary tract cancer (Disease Ontology:DOID:4607); common bile duct neoplasm (Disease Ontology:DOID:4608); diabetic retinopathy (Disease Ontology:DOID:8947); diabetes mellitus (Disease Ontology:DOID:9351); type 2 diabetes mellitus (Disease Ontology:DOID:9352); steatotic liver disease (Disease Ontology:DOID:9452); type 1 diabetes mellitus (Disease Ontology:DOID:9744); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:238055);  (R-MMU-202733);  (R-MMU-3000471);  (R-MMU-3000480);  (R-MMU-3000497);  (R-MMU-381426);  (R-MMU-432142);  (R-MMU-5686938);  (R-MMU-8856825);  (R-MMU-8856828);  (R-MMU-8866423);  (R-MMU-8957275);  (R-MMU-8963888);  (R-MMU-8963901);  (R-MMU-8964026);  (R-MMU-8964038);  (R-MMU-8964046);  (R-MMU-9707616);  (R-MMU-975634)",
        "pathway_count": 19,
        "publication_count": 23,
        "publication_id_list": "10.1101/2023.09.13.557529;16944957;18250455;19187774;21750661;21913724;23297397;2332175;25428506;26495903;28011936;31616917;32069316;33725478;34428180;35820727;35984892;35990517;36210013;36583994;36684560;37828378;38828596",
        "class_list": "",
        "function": "Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor., [UniProtKB, UniProtKB, UniProtKB]; Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis., [RefSeq, PubMed]; This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-48 and apoB-100. Unlike the apoB-48 and apoB-100 structural equivalents in human, which are synthesized exclusively in the gut and liver, respectively, the mouse apoB-48 isoform is also found in mouse liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2179 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 11,
        "predicted_n_glycosites": 11,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 4,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 5,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 5,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 5,
        "disease_count": 26,
        "glyco_site_count": 18,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UH74;Q497D8;Q61314;Q61318;Q8CGG8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005543 phospholipid binding;GO:0008201 heparin binding;GO:0050750 low-density lipoprotein particle receptor binding;GO:0035473 lipase binding;GO:0048018 receptor ligand activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005811 lipid droplet",
        "go_biological_process": "GO:0001701 in utero embryonic development;GO:0006629 lipid metabolic process;GO:0007283 spermatogenesis;GO:0007399 nervous system development;GO:0008203 cholesterol metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 3.6,
        "record_id": "E9Q414-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VDI9-1",
        "uniprot_id": "ALG9_MOUSE",
        "mass": 69561.0,
        "length": 611,
        "protein_name": "Alpha-1,2-mannosyltransferase ALG9",
        "gene_name": "Alg9",
        "organism": "Mouse",
        "refseq_name": "alpha-1,2-mannosyltransferase ALG9",
        "refseq_ac": "NP_598742",
        "gene_names_uniprotkb": "Alg9",
        "gene_names_refseq": "8230402H15Rik; Alg9; B430313H07Rik; Dibd1",
        "protein_names_uniprotkb": "Alpha-1,2-mannosyltransferase ALG9; 2.4.1.259; 2.4.1.261; Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase; Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase",
        "protein_names_refseq": "alpha-1,2-mannosyltransferase ALG9; asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase); asparagine-linked glycosylation 9 homolog (yeast, alpha 1,2 mannosyltransferase); asparagine-linked glycosylation 9 protein; asparagine-linked glycosylation protein 9 homolog; disrupted in bipolar disorder 1 homolog; disrupted in bipolar disorder protein 1 homolog; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase",
        "tax_id": 10090,
        "disease": "congenital disorder of glycosylation type I (Disease Ontology:DOID:0050570); congenital disorder of glycosylation Il (Disease Ontology:DOID:0080564)",
        "pathway": " (mmu:102580);  (R-MMU-446193)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;30084848;31219806;34428180",
        "class_list": "glycogene;glycosyltransferase",
        "function": "Mannosyltransferase that operates in the biosynthetic pathway of dolichol-linked oligosaccharides, the glycan precursors employed in protein asparagine (N)-glycosylation. The assembly of dolichol-linked oligosaccharides begins on the cytosolic side of the endoplasmic reticulum membrane and finishes in its lumen. The sequential addition of sugars to dolichol pyrophosphate produces dolichol-linked oligosaccharides containing fourteen sugars, including two GlcNAcs, nine mannoses and three glucoses. Once assembled, the oligosaccharide is transferred from the lipid to nascent proteins by oligosaccharyltransferases. In the lumen of the endoplasmic reticulum, catalyzes the addition of the seventh and ninth alpha-1,2-linked mannose residues to Man(6)GlcNAc(2)-PP-dolichol and Man(8)GlcNAc(2)-PP-dolichol respectively., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 27,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BT44;Q8C378;Q8C7G0",
        "ec_number_list": "2.4.1.-;2.4.1.259;2.4.1.261",
        "go_molecular_function": "GO:0000026 alpha-1,2-mannosyltransferase activity;GO:0052918 dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity;GO:0052926 dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity;GO:0016757 glycosyltransferase activity",
        "go_cellular_component": "GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006488 dolichol-linked oligosaccharide biosynthetic process;GO:0006487 protein N-linked glycosylation",
        "synthesized_glycan_count": 505,
        "hit_score": 0.8,
        "record_id": "Q8VDI9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5YD48-1",
        "uniprot_id": "A1CF_MOUSE",
        "mass": 65682.0,
        "length": 595,
        "protein_name": "APOBEC1 complementation factor",
        "gene_name": "A1cf",
        "organism": "Mouse",
        "refseq_name": "APOBEC1 complementation factor isoform 1",
        "refseq_ac": "NP_001074543",
        "gene_names_uniprotkb": "A1cf; Acf; Asp",
        "gene_names_refseq": "1810073H04Rik; 9130016M20Rik; A1cf; ACF64; ACF65; ASP; Acf; MCM; MerCreMer; Tg(Myh6-cre/Esr1*)1Jmk; alpha-MHC-MerCreMer; alphaMHC-Cre-Mer-Cre; mer",
        "protein_names_uniprotkb": "APOBEC1 complementation factor; APOBEC1-stimulating protein",
        "protein_names_refseq": "APOBEC-1 stimulating protein; APOBEC1 complementation factor isoform 1",
        "tax_id": 10090,
        "disease": "gout (Disease Ontology:DOID:13189)",
        "pathway": " (mmu:69865);  (R-MMU-72200);  (R-MMU-75094)",
        "pathway_count": 3,
        "publication_count": 8,
        "publication_id_list": "15451168;16055734;21750661;24916387;34428180;37453647;40021952;40997131",
        "class_list": "",
        "function": "Essential component of the apolipoprotein B mRNA editing enzyme complex which is responsible for the postranscriptional editing of a CAA codon for Gln to a UAA codon for stop in APOB mRNA. Binds to APOB mRNA and is probably responsible for docking the catalytic subunit, APOBEC1, to the mRNA to allow it to deaminate its target cytosine. The complex also seems to protect the edited APOB mRNA from nonsense-mediated decay (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QJS8;Q5FW55;Q5YD47",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0003729 mRNA binding;GO:0003727 single-stranded RNA binding;GO:0140767 enzyme-substrate adaptor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0030895 apolipoprotein B mRNA editing enzyme complex",
        "go_biological_process": "GO:0010609 mRNA localization resulting in post-transcriptional regulation of gene expression;GO:0006397 mRNA processing;GO:0016554 cytidine to uridine editing;GO:0016556 mRNA modification;GO:0050714 positive regulation of protein secretion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q5YD48-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91W96-1",
        "uniprot_id": "APC4_MOUSE",
        "mass": 91708.0,
        "length": 807,
        "protein_name": "Anaphase-promoting complex subunit 4",
        "gene_name": "Anapc4",
        "organism": "Mouse",
        "refseq_name": "anaphase-promoting complex subunit 4",
        "refseq_ac": "NP_077175",
        "gene_names_uniprotkb": "Anapc4; D5Ertd249e",
        "gene_names_refseq": "2610306D21Rik; APC4; Anapc4; D5Ertd249e",
        "protein_names_uniprotkb": "Anaphase-promoting complex subunit 4; APC4; Cyclosome subunit 4",
        "protein_names_refseq": "anaphase-promoting complex subunit 4; cyclosome subunit 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:52206);  (R-MMU-141430);  (R-MMU-174048);  (R-MMU-174084);  (R-MMU-174154);  (R-MMU-174178);  (R-MMU-174184);  (R-MMU-176407);  (R-MMU-176408);  (R-MMU-176409);  (R-MMU-176412);  (R-MMU-179409);  (R-MMU-2467813);  (R-MMU-2559582);  (R-MMU-68867);  (R-MMU-69017);  (R-MMU-983168)",
        "pathway_count": 17,
        "publication_count": 6,
        "publication_id_list": "19144319;21183079;21750661;28315936;31219806;34428180",
        "class_list": "",
        "function": "Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through the cell cycle (By similarity). APC/C acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains (By similarity). APC/C catalyzes assembly of branched 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on target proteins (By similarity). APC/C is activated by CDC20 in the metaphase/anaphase transition of cell cycle, targeting the degradation of cyclin B and securin (By similarity). APC/C is regulated by the mitotic checkpoint complex (MCC), which inhibits APC/C and delays chromosome segregation (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q99LR5;Q9CZZ0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019903 protein phosphatase binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005680 anaphase-promoting complex;GO:0034399 nuclear periphery",
        "go_biological_process": "GO:0051301 cell division;GO:0031145 anaphase-promoting complex-dependent catabolic process;GO:0070979 protein K11-linked ubiquitination;GO:0030071 regulation of mitotic metaphase/anaphase transition;GO:0070936 protein K48-linked ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q91W96-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5EE38-1",
        "uniprot_id": "ACD_MOUSE",
        "mass": 44713.0,
        "length": 416,
        "protein_name": "Adrenocortical dysplasia protein",
        "gene_name": "Acd",
        "organism": "Mouse",
        "refseq_name": "adrenocortical dysplasia protein isoform 1",
        "refseq_ac": "NP_001012656",
        "gene_names_uniprotkb": "Acd",
        "gene_names_refseq": "Acd",
        "protein_names_uniprotkb": "Adrenocortical dysplasia protein",
        "protein_names_refseq": "adrenocortical dysplasia protein isoform 1",
        "tax_id": 10090,
        "disease": "autosomal dominant dyskeratosis congenita 6 (Disease Ontology:DOID:0070023)",
        "pathway": " (mmu:497652);  (R-MMU-110330);  (R-MMU-110331);  (R-MMU-171319);  (R-MMU-174411);  (R-MMU-174414);  (R-MMU-174417);  (R-MMU-174430);  (R-MMU-174437);  (R-MMU-2559586);  (R-MMU-9670095)",
        "pathway_count": 11,
        "publication_count": 8,
        "publication_id_list": "15537664;19648609;21183079;21750661;33822766;34535663;34645668;35805162",
        "class_list": "",
        "function": "Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded TTAGGG repeats added by telomerase and protects chromosome ends. Without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways. Promotes binding of POT1 to single-stranded telomeric DNA. Modulates the inhibitory effects of POT1 on telomere elongation. The ACD-POT1 heterodimer enhances telomere elongation by recruiting telomerase to telomeres and increasing its processivity (By similarity). May play a role in organogenesis (PubMed:15537664)., [UniProtKB, UniProtKB, PubMed, UniProtKB, UniProtKB]; Differential impact of a dyskeratosis congenita mutation in TPP1 on mouse hematopoiesis and germline. Publication Status: Online-Only, [RefSeq, PubMed]; Distinct functions of POT1 proteins contribute to the regulation of telomerase recruitment to telomeres. Publication Status: Online-Only, [RefSeq, PubMed]; Mitoribosomal Deregulation Drives Senescence via TPP1-Mediated Telomere Deprotection. Publication Status: Online-Only, [RefSeq, PubMed]; TPP1 mutagenesis screens unravel shelterin interfaces and functions in hematopoiesis. Publication Status: Online-Only, [RefSeq, PubMed]; Telomeric regulator is required for proper urogenital ridge differentiation, axial skeleton specification and limb patterning in mice., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TBB1;Q3TUR7;Q3UKL6;Q3V3Y1;Q99KF8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042162 telomeric DNA binding;GO:0044877 protein-containing complex binding;GO:0070182 DNA polymerase binding;GO:0010521 telomerase inhibitor activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0016604 nuclear body;GO:0000783 nuclear telomere cap complex;GO:0070187 shelterin complex;GO:0005697 telomerase holoenzyme complex",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0000723 telomere maintenance;GO:0001501 skeletal system development;GO:0001655 urogenital system development;GO:0016233 telomere capping",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q5EE38-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K1E6-1",
        "uniprot_id": "ALKB3_MOUSE",
        "mass": 33061.0,
        "length": 286,
        "protein_name": "Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3",
        "gene_name": "Alkbh3",
        "organism": "Mouse",
        "refseq_name": "alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 isoform a",
        "refseq_ac": "NP_081220",
        "gene_names_uniprotkb": "Alkbh3; Abh3",
        "gene_names_refseq": "1700108H04Rik; 1810020C19Rik; Abh3; Alkbh3; mABH3",
        "protein_names_uniprotkb": "Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3; 1.14.11.33; 1.14.11.54; Alkylated DNA repair protein alkB homolog 3; mAbh3",
        "protein_names_refseq": "alkB, alkylation repair homolog 3; alkylated DNA repair protein alkB homolog 3; alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 isoform a; alpha-ketoglutarate-dependent dioxygenase alkB homolog 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69113)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "16174769;16642038;18519673;21750661;22684101;26930515;30084848;30779550;31219806;34428180",
        "class_list": "",
        "function": "ALKBH2 and ALKBH3 provide cancer protection similar to that of the DNA glycosylase AAG and display apparent epistasis with Aag, [RefSeq, PubMed]; Dioxygenase that mediates demethylation of DNA and RNA containing 1-methyladenosine (m1A) (By similarity). Repairs alkylated DNA containing 1-methyladenosine (m1A) and 3-methylcytosine (m3C) by oxidative demethylation (PubMed:16174769). Has a strong preference for single-stranded DNA (PubMed:16174769). Able to process alkylated m3C within double-stranded regions via its interaction with ASCC3, which promotes DNA unwinding to generate single-stranded substrate needed for ALKBH3. Can repair exocyclic 3,N4-ethenocytosine adducs in single-stranded DNA. Also acts on RNA. Demethylates N(1)-methyladenosine (m1A) RNA, an epigenetic internal modification of messenger RNAs (mRNAs) highly enriched within 5'-untranslated regions (UTRs) and in the vicinity of start codons. Requires molecular oxygen, alpha-ketoglutarate and iron (By similarity)., [UniProtKB, UniProtKB, PubMed]; Dioxygenase that mediates demethylation of DNA and RNA containing 1-methyladenosine (m1A). Repairs alkylated DNA containing 1-methyladenosine (m1A) and 3-methylcytosine (m3C) by oxidative demethylation. Has a strong preference for single-stranded DNA. Able to process alkylated m3C within double-stranded regions via its interaction with ASCC3, which promotes DNA unwinding to generate single-stranded substrate needed for ALKBH3. Can repair exocyclic 3,N4-ethenocytosine adducs in single-stranded DNA. Also acts on RNA. Demethylates N(1)-methyladenosine (m1A) RNA, an epigenetic internal modification of messenger RNAs (mRNAs) highly enriched within 5'-untranslated regions (UTRs) and in the vicinity of start codons. Requires molecular oxygen, alpha-ketoglutarate and iron., [UniProtKB, UniProtKB]; These results revealed that N3-ethylthymidine , but not other DNA lesions, could be repaired by Alkbh2 and Alkbh3 in mammalian cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.14.11.51;4.2.99.18;1.14.11.-;1.14.11.33;1.14.11.54",
        "go_molecular_function": "GO:0008198 ferrous iron binding;GO:0016706 2-oxoglutarate-dependent dioxygenase activity;GO:0051747 cytosine C-5 DNA demethylase activity;GO:1990930 mRNA N1-methyladenosine dioxygenase activity;GO:0035515 oxidative RNA demethylase activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006281 DNA repair;GO:0008283 cell population proliferation;GO:0006307 DNA alkylation repair;GO:2000766 negative regulation of cytoplasmic translation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q8K1E6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R0P4-1",
        "uniprot_id": "AAMDC_MOUSE",
        "mass": 13244.0,
        "length": 122,
        "protein_name": "Mth938 domain-containing protein",
        "gene_name": "Aamdc",
        "organism": "Mouse",
        "refseq_name": "mth938 domain-containing protein isoform 1",
        "refseq_ac": "NP_001171416",
        "gene_names_uniprotkb": "Aamdc; 1810020D17Rik",
        "gene_names_refseq": "1810020D17Rik; 1810037D19Rik; Aamdc; LI2",
        "protein_names_uniprotkb": "Mth938 domain-containing protein; LI2",
        "protein_names_refseq": "UPF0366 protein C11orf67 homolog; mth938 domain-containing protein isoform 1; mth938 domain-containing protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66273)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21622130;21750661;22279136",
        "class_list": "",
        "function": "May play a role in preadipocyte differentiation and adipogenesis., [UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BH71",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0043066 negative regulation of apoptotic process;GO:0045600 positive regulation of fat cell differentiation;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8R0P4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K2A8-1",
        "uniprot_id": "ALG3_MOUSE",
        "mass": 50186.0,
        "length": 438,
        "protein_name": "Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase",
        "gene_name": "Alg3",
        "organism": "Mouse",
        "refseq_name": "dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase isoform 1",
        "refseq_ac": "NP_666051",
        "gene_names_uniprotkb": "Alg3",
        "gene_names_refseq": "Alg3; D16Ertd36e; not",
        "protein_names_uniprotkb": "Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase; 2.4.1.258; Asparagine-linked glycosylation protein 3 homolog; Dol-P-Man-dependent alpha(1-3)-mannosyltransferase; Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase; Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase",
        "protein_names_refseq": "alpha-1,3-mannosyltransferase ALG3; asparagine-linked glycosylation 3 (alpha-1,3-mannosyltransferase); asparagine-linked glycosylation 3 homolog (yeast, alpha-1,3-mannosyltransferase); asparagine-linked glycosylation protein 3 homolog; dol-P-Man-dependent alpha(1-3)-mannosyltransferase; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase isoform 1; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase; dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase; dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase; not56-like protein",
        "tax_id": 10090,
        "disease": "congenital disorder of glycosylation Id (Disease Ontology:DOID:0080556); congenital disorder of glycosylation (Disease Ontology:DOID:5212)",
        "pathway": " (mmu:208624);  (R-MMU-446193)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "21750661;34428180;35676564;40997131",
        "class_list": "glycogene;glycosyltransferase",
        "function": "Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase that operates in the biosynthetic pathway of dolichol-linked oligosaccharides, the glycan precursors employed in protein asparagine (N)-glycosylation. The assembly of dolichol-linked oligosaccharides begins on the cytosolic side of the endoplasmic reticulum membrane and finishes in its lumen. The sequential addition of sugars to dolichol pyrophosphate produces dolichol-linked oligosaccharides containing fourteen sugars, including two GlcNAcs, nine mannoses and three glucoses. Once assembled, the oligosaccharide is transferred from the lipid to nascent proteins by oligosaccharyltransferases. In the lumen of the endoplasmic reticulum, adds the first dolichyl beta-D-mannosyl phosphate derived mannose in an alpha-1,3 linkage to Man(5)GlcNAc(2)-PP-dolichol to produce Man(6)GlcNAc(2)-PP-dolichol. Man(6)GlcNAc(2)-PP-dolichol is a substrate for ALG9, the following enzyme in the biosynthetic pathway., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 34,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QKP9",
        "ec_number_list": "2.4.1.258",
        "go_molecular_function": "GO:0052925 dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006488 dolichol-linked oligosaccharide biosynthetic process;GO:0006487 protein N-linked glycosylation",
        "synthesized_glycan_count": 1389,
        "hit_score": 0.7,
        "record_id": "Q8K2A8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UL36-1",
        "uniprot_id": "ARGL1_MOUSE",
        "mass": 32887.0,
        "length": 271,
        "protein_name": "Arginine and glutamate-rich protein 1",
        "gene_name": "Arglu1",
        "organism": "Mouse",
        "refseq_name": "arginine and glutamate-rich protein 1",
        "refseq_ac": "NP_789819",
        "gene_names_uniprotkb": "Arglu1",
        "gene_names_refseq": "9430010O03Rik; Arglu1; C130008N12",
        "protein_names_uniprotkb": "Arginine and glutamate-rich protein 1",
        "protein_names_refseq": "arginine and glutamate-rich protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:234023)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "19131326;21750661;26495903;30698747;34428180;37612280",
        "class_list": "",
        "function": "Deletion of ARGLU1 causes global defects in alternative splicing in vivo and mouse cortical malformations primarily via apoptosis. Publication Status: Online-Only, [RefSeq, PubMed]; Dual function regulator of gene expression; regulator of transcription and modulator of alternative splicing (PubMed:30698747). General coactivator of nuclear receptor-induced gene expression, including genes activated by the glucocorticoid receptor NR3C1 (PubMed:30698747). Binds to a subset of pre-mRNAs and to components of the spliceosome machinery to directly modulate basal alternative splicing; involved in simple and complex cassette exon splicing events (PubMed:30698747). Binds its own pre-mRNA and regulates its alternative splicing and degradation; one of the alternatively spliced products is a stable intronic sequence RNA (sisRNA) that binds the protein to regulate its ability to affect splicing (By similarity). Binding of the sisRNA stimulates phase separation and localization to nuclear speckles, which may contribute to activation of nuclear receptor-induced gene expression (By similarity). May also indirectly modulate alternative splicing (PubMed:30698747). Regulates transcription of genes involved in heart development, neuronal cell function, protein localization and chromatin localization (PubMed:30698747). Regulates splicing of genes involved in neurogenesis and chromatin organization (PubMed:30698747, PubMed:37612280). Essential for central nervous system development (PubMed:30698747, PubMed:37612280). Required for the estrogen-dependent expression of ESR1 target genes (By similarity). Can act in cooperation with MED1 (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80XJ0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0036002 pre-mRNA binding;GO:0003713 transcription coactivator activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol;GO:0016607 nuclear speck;GO:0005694 chromosome",
        "go_biological_process": "GO:0006397 mRNA processing;GO:0008380 RNA splicing;GO:0000381 regulation of alternative mRNA splicing, via spliceosome",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q3UL36-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99LW0-1",
        "uniprot_id": "ANR10_MOUSE",
        "mass": 43975.0,
        "length": 415,
        "protein_name": "Ankyrin repeat domain-containing protein 10",
        "gene_name": "Ankrd10",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat domain-containing protein 10 isoform 3",
        "refseq_ac": "NP_001268903",
        "gene_names_uniprotkb": "Ankrd10",
        "gene_names_refseq": "4833425P12Rik; Ankrd10",
        "protein_names_uniprotkb": "Ankyrin repeat domain-containing protein 10",
        "protein_names_refseq": "ankyrin repeat domain-containing protein 10 isoform 3; ankyrin repeat domain-containing protein 10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:102334)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21750661;25428506;30084848;34203471",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BGB6",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005654 nucleoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q99LW0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2AIG8-1",
        "uniprot_id": "1A1L1_MOUSE",
        "mass": 56879.0,
        "length": 502,
        "protein_name": "1-aminocyclopropane-1-carboxylate synthase-like protein 1",
        "gene_name": "Accs",
        "organism": "Mouse",
        "refseq_name": "1-aminocyclopropane-1-carboxylate synthase-like protein 1 isoform a",
        "refseq_ac": "NP_001277711",
        "gene_names_uniprotkb": "Accs",
        "gene_names_refseq": "2610203E10Rik; Accs; Phacs",
        "protein_names_uniprotkb": "1-aminocyclopropane-1-carboxylate synthase-like protein 1; ACC synthase-like protein 1",
        "protein_names_refseq": "1-aminocyclopropane-1-carboxylate synthase (non-functional); 1-aminocyclopropane-1-carboxylate synthase homolog; 1-aminocyclopropane-1-carboxylate synthase-like protein 1 isoform a; 1-aminocyclopropane-1-carboxylate synthase-like protein 1; ACC synthase-like protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:329470)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Does not catalyze the synthesis of 1-aminocyclopropane-1-carboxylate but is capable of catalyzing the deamination of L-vinylglycine., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CHS6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030170 pyridoxal phosphate binding;GO:0042802 identical protein binding;GO:0008483 transaminase activity",
        "go_cellular_component": "",
        "go_biological_process": "GO:0006520 amino acid metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A2AIG8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TN79-1",
        "uniprot_id": "AKA7G_MOUSE",
        "mass": 35482.0,
        "length": 314,
        "protein_name": "A-kinase anchor protein 7 isoform gamma",
        "gene_name": "Akap7",
        "organism": "Mouse",
        "refseq_name": "A-kinase anchor protein 7 isoform 1",
        "refseq_ac": "NP_061217",
        "gene_names_uniprotkb": "Akap7; Akap18",
        "gene_names_refseq": "6430401D08; AKAP15; Akap18; Akap7",
        "protein_names_uniprotkb": "A-kinase anchor protein 7 isoform gamma; A-kinase anchor protein 18; AKAP-18; AKAP-7 isoform gamma; PRKA7 isoform gamma; Protein kinase A-anchoring protein 7 isoform gamma",
        "protein_names_refseq": "A kinase (PRKA) anchor protein 7; A-kinase anchor protein 18; A-kinase anchor protein 7 isoform 1; A-kinase anchor protein 9 kDa; AKAP 9; AKAP-18; protein kinase A anchoring protein 7",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:432442)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;12804576;21750661;22645316;25849890;27911261;31219806;33602505;9545239;9620705",
        "class_list": "",
        "function": "AKAP7gamma is the first nuclear AKAP to bind RI and may be responsible for positioning PKA via RI and/or RII to regulate PKA-mediated gene transcription in both somatic cells and oocytes, [RefSeq, PubMed]; Genetic ablation of AKAP7 specifically from dentate granule cells results in disruption of mossy fiber-CA3 pyramidal neuron long-term potentiation directly initiated by cAMP, and the AKAP7 mutant mice are selectively deficient in pattern separation behaviors. The results suggest that the AKAP7/PKA complex in the mossy fiber projections plays an essential role in synaptic plasticity and contextual memory formation. Publication Status: Online-Only, [RefSeq, PubMed]; Probably targets cAMP-dependent protein kinase (PKA) to the cellular membrane or cytoskeletal structures. The membrane-associated form reduces epithelial sodium channel (ENaC) activity, whereas the free cytoplasmic form may negatively regulate ENaC channel feedback inhibition by intracellular sodium (By similarity)., [UniProtKB, UniProtKB]; Requirement of the Ca(2+) channel beta2 subunit for sympathetic PKA phosphorylation., [RefSeq, PubMed]; Targets the cAMP-dependent protein kinase (PKA) to the plasma membrane, and permits functional coupling to the L-type calcium channel. The membrane-associated form reduces epithelial sodium channel (ENaC) activity, whereas the free cytoplasmic form may negatively regulate ENaC channel feedback inhibition by intracellular sodium (By similarity)., [UniProtKB, PubMed]; The results demonstrate that green tea catechins enhance lipolysis in the presence of norepinephrine via a PKA-dependent pathway in 3T3-L1 adipocytes, providing a potential mechanism by which green tea catechins could reduce body fat., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "F8VQ58",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051018 protein kinase A binding;GO:0019901 protein kinase binding;GO:0019904 protein domain specific binding;GO:0016208 AMP binding;GO:0034237 protein kinase A regulatory subunit binding",
        "go_cellular_component": "GO:0016328 lateral plasma membrane;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016324 apical plasma membrane",
        "go_biological_process": "GO:0071320 cellular response to cAMP;GO:0001508 action potential;GO:0060306 regulation of membrane repolarization;GO:0007178 cell surface receptor protein serine/threonine kinase signaling pathway;GO:0050804 modulation of chemical synaptic transmission",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q7TN79-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P63260-1",
        "uniprot_id": "ACTG_MOUSE",
        "mass": 41793.0,
        "length": 375,
        "protein_name": "Actin, cytoplasmic 2",
        "gene_name": "Actg1",
        "organism": "Mouse",
        "refseq_name": "actin, cytoplasmic 2 isoform 1",
        "refseq_ac": "NP_033739",
        "gene_names_uniprotkb": "Actg1; Actg",
        "gene_names_refseq": "Actg1; Actg; Actl; E51",
        "protein_names_uniprotkb": "Actin, cytoplasmic 2; 3.6.4.-; Gamma-actin",
        "protein_names_refseq": "actin, cytoplasmic 2 isoform 1; actin, cytoplasmic 2; beta-actin FE-3; gamma-actin",
        "tax_id": 10090,
        "disease": "Baraitser-Winter syndrome 1 (Disease Ontology:DOID:0081112); Baraitser-Winter syndrome 2 (Disease Ontology:DOID:0081113); hypertrophic cardiomyopathy 11 (Disease Ontology:DOID:0110317); autosomal dominant nonsyndromic deafness 20 (Disease Ontology:DOID:0110550); intestinal atresia (Disease Ontology:DOID:10486); hypertrophic cardiomyopathy (Disease Ontology:DOID:11984); Moyamoya disease (Disease Ontology:DOID:13099); patent ductus arteriosus (Disease Ontology:DOID:13832); thoracic aortic aneurysm (Disease Ontology:DOID:14004)",
        "pathway": " (mmu:11465);  (R-MMU-114608);  (R-MMU-190873);  (R-MMU-196025);  (R-MMU-2029482);  (R-MMU-3928662);  (R-MMU-418990);  (R-MMU-437239);  (R-MMU-4420097);  (R-MMU-445095);  (R-MMU-446353);  (R-MMU-5250924);  (R-MMU-5626467);  (R-MMU-5663213);  (R-MMU-5663220);  (R-MMU-5674135);  (R-MMU-5689603);  (R-MMU-5696394);  (R-MMU-8856828);  (R-MMU-9035034);  (R-MMU-9764561);  (R-MMU-9913351);  (R-MMU-9933937);  (R-MMU-9933939);  (R-MMU-9933946);  (R-MMU-9933947);  (R-MMU-9934037);  (R-MMU-9958825)",
        "pathway_count": 28,
        "publication_count": 22,
        "publication_id_list": "10.1101/2023.09.13.557529;11465105;18250455;213279;21750661;22645316;23911929;25428506;25605945;28011936;30779550;31219806;3210229;32152506;3221869;33300544;33725478;34428180;35820727;36288343;37294664;37828378",
        "class_list": "",
        "function": "Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. Plays a role in the repair of noise-induced stereocilia gaps following recruitment by XIRP2 isoform 3, thereby maintains hearing sensitivity following loud noise damage (PubMed:37294664)., [UniProtKB, UniProtKB, PubMed]; Actins are highly conserved proteins that are involved in various types of cell motility and maintenance of the cytoskeleton. In vertebrates, three main groups of actin isoforms, alpha, beta, and gamma, have been identified. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton, and as mediators of internal cell motility. Actin, gamma 1, encoded by this gene, is a cytoplasmic actin found in non-muscle cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 6,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 6,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 6,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 9,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P02571;P14104;P99022",
        "ec_number_list": "3.6.4.13;3.6.4.10;2.3.2.31;3.6.4.-;5.6.2.3;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;2.7.7.6;7.6.2.1;3.4.-.-;3.6.1.5;2.7.11.1;3.4.24.-;3.6.-.-;2.7.10.2;1.8.-.-;1.15.1.1;3.6.5.2;3.1.3.1;3.9.1.1;3.6.1.-;3.1.27.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;2.7.12.2;3.6.5.5;2.7.10.4;3.6.4.6;1.14.11.-;2.7.10.1;3.4.22.-;3.6.5.-;2.3.2.32;2.7.11.24;3.6.1.15;3.1.4.-;5.6.2.-;7.2.2.-;2.3.2.26;7.6.2.16;3.1.3.86;3.1.3.56;3.1.3.36;3.1.3.-;3.1.30.-;3.4.21.53;2.7.7.7;2.7.7.49;1.16.1.-;2.7.4.3;3.4.19.12;2.7.11.26;3.1.3.95",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0005524 ATP binding;GO:0016787 hydrolase activity;GO:0019901 protein kinase binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0044305 calyx of Held;GO:0098871 postsynaptic actin cytoskeleton;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005884 actin filament",
        "go_biological_process": "GO:0051893 regulation of focal adhesion assembly;GO:0120192 tight junction assembly;GO:0001525 angiogenesis;GO:0007409 axonogenesis;GO:0010628 positive regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 3.2,
        "record_id": "P63260-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P18762-1",
        "uniprot_id": "ADRB2_MOUSE",
        "mass": 46998.0,
        "length": 418,
        "protein_name": "Beta-2 adrenergic receptor",
        "gene_name": "Adrb2",
        "organism": "Mouse",
        "refseq_name": "beta-2 adrenergic receptor",
        "refseq_ac": "NP_031446",
        "gene_names_uniprotkb": "Adrb2; Adrb2r",
        "gene_names_refseq": "Adrb-2; Adrb2; Badm; Gpcr7",
        "protein_names_uniprotkb": "Beta-2 adrenergic receptor; Beta-2 adrenoceptor; Beta-2 adrenoreceptor",
        "protein_names_refseq": "beta 2-AR; beta-2 adrenergic receptor; beta-2 adrenoceptor; beta-2 adrenoreceptor",
        "tax_id": 10090,
        "disease": "disease of metabolism (Disease Ontology:DOID:0014667); childhood-onset asthma (Disease Ontology:DOID:0080815); open-angle glaucoma (Disease Ontology:DOID:1067); primary open angle glaucoma (Disease Ontology:DOID:1070); hypertension (Disease Ontology:DOID:10763); pulmonary edema (Disease Ontology:DOID:11396); polycystic ovary syndrome (Disease Ontology:DOID:11612); Graves' disease (Disease Ontology:DOID:12361); dilated cardiomyopathy (Disease Ontology:DOID:12930); familial hypercholesterolemia (Disease Ontology:DOID:13810); interstitial cystitis (Disease Ontology:DOID:13949); toxic shock syndrome (Disease Ontology:DOID:14115); hypothyroidism (Disease Ontology:DOID:1459); cystic fibrosis (Disease Ontology:DOID:1485); urticaria (Disease Ontology:DOID:1555); dermatitis (Disease Ontology:DOID:2723); asthma (Disease Ontology:DOID:2841); bronchiolitis (Disease Ontology:DOID:2942); acute kidney failure (Disease Ontology:DOID:3021); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); myasthenia gravis (Disease Ontology:DOID:437); cholangiocarcinoma (Disease Ontology:DOID:4947); pneumonia (Disease Ontology:DOID:552); kidney disease (Disease Ontology:DOID:557); myocardial infarction (Disease Ontology:DOID:5844); congestive heart failure (Disease Ontology:DOID:6000); end stage renal disease (Disease Ontology:DOID:783); myocarditis (Disease Ontology:DOID:820); ulcerative colitis (Disease Ontology:DOID:8577); psoriasis (Disease Ontology:DOID:8893); steatotic liver disease (Disease Ontology:DOID:9452); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:11555);  (R-MMU-390696);  (R-MMU-418555);  (R-MMU-5689880);  (R-MMU-8856825);  (R-MMU-8856828)",
        "pathway_count": 6,
        "publication_count": 6,
        "publication_id_list": "11171998;18056263;25460042;2549959;27541735;2834198",
        "class_list": "",
        "function": "G protein-coupled receptor for catecholamines that couples to both G(s) and G(i) proteins, activating bifurcated signaling pathways (PubMed:11171998, PubMed:18056263, PubMed:2834198). ADRB2 binds epinephrine (Epi) with an approximately 30-fold greater affinity than norepinephrine (NE) (PubMed:2834198). In the heart, Epi- and NE-activated ADRB2 induces rapid and slow cardiomyocyte contraction rate, respectively (PubMed:18056263). Both NE and Epi promote coupling to G(s)/PKA pathway to regulate myocyte contraction rate (PubMed:18056263). Epi also promotes ADRB2 coupling to G(i) proteins to exert cardioprotective effects especially in the conditions of hypoxia and oxidative stress through the G(i)/PI3K/Akt signaling pathway (PubMed:11171998, PubMed:18056263). ADRB2-G(s) signaling delivers proapoptotic signals in cardiomyocytes although G(i)-mediated survival effect appears to predominate (PubMed:11171998). ADRB2 also transduces signals independently of PKA to regulate cellular pH by modulating Na(+)/H(+) exchanger SLC9A3 function (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; This intronless gene belongs to the G-protein-coupled receptor superfamily, which includes transmembrane proteins that play a role in signal transduction across biological membranes resulting in a variety of physiological responses. The encoded protein is a beta-2 adrenergic receptor which is activated by catecholamine ligands such as adrenaline and epinephrine. The protein participates in the classical signaling pathway involving G protein, adenylyl cyclase, cAMP (3'-5'-cyclic adenosine monophosphate) and protein kinase A (PKA). In humans, this gene is implicated in susceptibility to nocturnal asthma, obesity and type 2 diabetes. [provided by RefSeq, Apr 2013]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 8,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 32,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BH38",
        "ec_number_list": "",
        "go_molecular_function": "GO:0031713 B2 bradykinin receptor binding;GO:0019899 enzyme binding;GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0001540 amyloid-beta binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0098992 neuronal dense core vesicle;GO:0005634 nucleus;GO:0005768 endosome;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0003059 positive regulation of the force of heart contraction by epinephrine;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway;GO:0008284 positive regulation of cell population proliferation;GO:0008306 associative learning",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "P18762-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91X20-1",
        "uniprot_id": "ASH2L_MOUSE",
        "mass": 68250.0,
        "length": 623,
        "protein_name": "Set1/Ash2 histone methyltransferase complex subunit ASH2",
        "gene_name": "Ash2l",
        "organism": "Mouse",
        "refseq_name": "set1/Ash2 histone methyltransferase complex subunit ASH2 isoform a",
        "refseq_ac": "NP_035921",
        "gene_names_uniprotkb": "Ash2l",
        "gene_names_refseq": "Ash2l",
        "protein_names_uniprotkb": "Set1/Ash2 histone methyltransferase complex subunit ASH2; ASH2-like protein",
        "protein_names_refseq": "ASH2-like protein; ash2 (absent, small, or homeotic)-like; set1/Ash2 histone methyltransferase complex subunit ASH2 isoform a; set1/Ash2 histone methyltransferase complex subunit ASH2",
        "tax_id": 10090,
        "disease": "congenital heart disease (Disease Ontology:DOID:1682); schizophrenia (Disease Ontology:DOID:5419)",
        "pathway": " (mmu:23808);  (R-MMU-201722);  (R-MMU-3214841);  (R-MMU-8936459);  (R-MMU-9772755);  (R-MMU-9818564)",
        "pathway_count": 6,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;10393421;21183079;21335234;21750661;37990471;38280036;38582368",
        "class_list": "",
        "function": "ASH2L Mediates Epidermal Differentiation and Hair Follicle Morphogenesis through H3K4me3 Modification., [RefSeq, PubMed]; ASH2L, Core Subunit of H3K4 Methylation Complex, Regulates Amelogenesis., [RefSeq, PubMed]; Functional role of Ash2l in oxLDL induced endothelial dysfunction and atherosclerosis. Publication Status: Online-Only, [RefSeq, PubMed]; Transcriptional regulator (By similarity). Component or associated component of some histone methyltransferase complexes which regulates transcription through recruitment of those complexes to gene promoters (By similarity). Component of the Set1/Ash2 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3, but not if the neighboring 'Lys-9' residue is already methylated (By similarity). As part of the MLL1/MLL complex it is involved in methylation and dimethylation at 'Lys-4' of histone H3 (By similarity). May play a role in hematopoiesis (By similarity). In association with RBBP5 and WDR5, stimulates the histone methyltransferase activities of KMT2A, KMT2B, KMT2C, KMT2D, SETD1A and SETD1B (By similarity)., [UniProtKB, UniProtKB]; Transcriptional regulator. Component or associated component of some histone methyltransferase complexes which regulates transcription through recruitment of those complexes to gene promoters. Component of the Set1/Ash2 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3, but not if the neighboring 'Lys-9' residue is already methylated. As part of the MLL1/MLL complex it is involved in methylation and dimethylation at 'Lys-4' of histone H3. May play a role in hematopoiesis. In association with RBBP5 and WDR5, stimulates the histone methyltransferase activities of KMT2A, KMT2B, KMT2C, KMT2D, SETD1A and SETD1B., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9671,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UIF9;Q9Z2X4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000976 transcription cis-regulatory region binding;GO:0008013 beta-catenin binding;GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005886 plasma membrane;GO:0035097 histone methyltransferase complex;GO:0000791 euchromatin",
        "go_biological_process": "GO:0008284 positive regulation of cell population proliferation;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0006974 DNA damage response;GO:0045815 transcription initiation-coupled chromatin remodeling;GO:0043627 response to estrogen",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q91X20-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VD66-1",
        "uniprot_id": "ABHD4_MOUSE",
        "mass": 38861.0,
        "length": 342,
        "protein_name": "(Lyso)-N-acylphosphatidylethanolamine lipase",
        "gene_name": "Abhd4",
        "organism": "Mouse",
        "refseq_name": "(Lyso)-N-acylphosphatidylethanolamine lipase isoform 2",
        "refseq_ac": "NP_001192110",
        "gene_names_uniprotkb": "Abhd4",
        "gene_names_refseq": "1110035H23Rik; Abh4; Abhd4",
        "protein_names_uniprotkb": "(Lyso)-N-acylphosphatidylethanolamine lipase; 3.1.1.-; Abhydrolase domain-containing protein 4; Alpha/beta hydrolase domain-containing protein 4; Alpha/beta-hydrolase 4",
        "protein_names_refseq": "(Lyso)-N-acylphosphatidylethanolamine lipase isoform 2; (Lyso)-N-acylphosphatidylethanolamine lipase; abhydrolase domain-containing protein 4; alpha/beta hydrolase domain-containing protein 4; alpha/beta-hydrolase 4; lyso-N-acylphosphatidylethanolamine lipase; protein ABHD4",
        "tax_id": 10090,
        "disease": "Chanarin-Dorfman syndrome (Disease Ontology:DOID:0050729); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:105501);  (R-MMU-1482839)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "16818490;21750661;25853435;37352974",
        "class_list": "",
        "function": "ABHD4 regulates adipocyte differentiation in vitro but does not affect adipose tissue lipid metabolism in mice., [RefSeq, PubMed]; Lysophospholipase selective for N-acyl phosphatidylethanolamine (NAPE). Contributes to the biosynthesis of N-acyl ethanolamines, including the endocannabinoid anandamide by hydrolyzing the sn-1 and sn-2 acyl chains from N-acyl phosphatidylethanolamine (NAPE) generating glycerophospho-N-acyl ethanolamine (GP-NAE), an intermediate for N-acyl ethanolamine biosynthesis (PubMed:16818490, PubMed:25853435). Hydrolyzes substrates bearing saturated, monounsaturated, polyunsaturated N-acyl chains (PubMed:16818490, PubMed:25853435). Shows no significant activity towards other lysophospholipids, including lysophosphatidylcholine, lysophosphatidylethanolamine and lysophosphatidylserine (PubMed:16818490)., [UniProtKB, PubMed, PubMed]; Lysophospholipase/phospholipase B (EC 3.1.1.5) specific for N-acyl phosphatidylethanolamine (NAPE) suggesting a role in the biosynthesis of N-acyl ethanolamines including the endocannabinoid anandamide., [RefSeq, PubMed]; These findings, taken together, designate ABHD4 as a principal regulator of N-acyl phospholipid metabolism in the mammalian nervous system., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.1.1.4;3.1.1.-",
        "go_molecular_function": "GO:0042171 lysophosphatidic acid acyltransferase activity;GO:0004622 phosphatidylcholine lysophospholipase activity",
        "go_cellular_component": "GO:0005811 lipid droplet",
        "go_biological_process": "GO:0070291 N-acylethanolamine metabolic process;GO:0006654 phosphatidic acid biosynthetic process;GO:0055088 lipid homeostasis;GO:0016042 lipid catabolic process;GO:0070292 N-acylphosphatidylethanolamine metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q8VD66-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q62523-1",
        "uniprot_id": "ZYX_MOUSE",
        "mass": 60546.0,
        "length": 564,
        "protein_name": "Zyxin",
        "gene_name": "Zyx",
        "organism": "Mouse",
        "refseq_name": "zyxin isoform a",
        "refseq_ac": "NP_001276546",
        "gene_names_uniprotkb": "Zyx",
        "gene_names_refseq": "9530098H06Rik; Zyx",
        "protein_names_uniprotkb": "Zyxin",
        "protein_names_refseq": "zyxin isoform a",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22793)",
        "pathway_count": 1,
        "publication_count": 29,
        "publication_id_list": "10.1101/2023.09.13.557529;10.3389/fragi.2021.757801;12482962;19144319;21750661;22517741;22645316;23806337;24129315;25153642;26495903;28528544;30016717;30059200;30084848;30779550;32782141;34428180;34657146;35075545;35820727;35822049;36288343;36653484;36852467;38605154;40021952;40885482;8940160",
        "class_list": "",
        "function": "Adhesion plaque protein. Binds alpha-actinin and the CRP protein. Important for targeting TES and ENA/VASP family members to focal adhesions and for the formation of actin-rich structures. May be a component of a signal transduction pathway that mediates adhesion-stimulated changes in gene expression (By similarity)., [UniProtKB]; Essential role of zyxin in platelet biogenesis and glycoprotein Ib-IX surface expression. Publication Status: Online-Only, [RefSeq, PubMed]; Mice that lack zyxin function are viable and fertile and display no obvious histological abnormalities in any of the organs examined.Specifically, we evaluated blood platelet function, nervous system development, and skin architecture, [RefSeq, PubMed]; Zyxin is important for the stability and function of podocytes, especially during mechanical stretch. Publication Status: Online-Only, [RefSeq, PubMed]; Zyxin protects from hypertension-induced cardiac dysfunction. Publication Status: Online-Only, [RefSeq, PubMed]; Zyxin regulates embryonic stem cell fate by modulating mechanical and biochemical signaling interface. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 7,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 7,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 7,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 9,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P70461;Q3UGQ3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0005912 adherens junction",
        "go_biological_process": "GO:0007229 integrin-mediated signaling pathway;GO:0007160 cell-matrix adhesion;GO:0007179 transforming growth factor beta receptor signaling pathway;GO:0071346 cellular response to type II interferon;GO:0043149 stress fiber assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 4.0,
        "record_id": "Q62523-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61247-1",
        "uniprot_id": "A2AP_MOUSE",
        "mass": 54972.0,
        "length": 491,
        "protein_name": "Alpha-2-antiplasmin",
        "gene_name": "Serpinf2",
        "organism": "Mouse",
        "refseq_name": "alpha-2-antiplasmin precursor",
        "refseq_ac": "NP_032904",
        "gene_names_uniprotkb": "Serpinf2; Pli",
        "gene_names_refseq": "Pli; Serpimf2; Serpinf2",
        "protein_names_uniprotkb": "Alpha-2-antiplasmin; Alpha-2-AP; Alpha-2-PI; Alpha-2-plasmin inhibitor; Serpin F2",
        "protein_names_refseq": "alpha-2-AP; alpha-2-PI; alpha-2-antiplasmin precursor; alpha-2-antiplasmin; alpha-2-plasmin inhibitor; pigment epithelium derived factor; plasmin inhibitor alpha 2; serine (or cysteine) proteinase inhibitor, clade F, member 2; serpin F2",
        "tax_id": 10090,
        "disease": "familial encephalopathy with neuroserpin inclusion bodies (Disease Ontology:DOID:0050831); alpha-2-plasmin inhibitor deficiency (Disease Ontology:DOID:0060601); COVID-19 (Disease Ontology:DOID:0080600); acute necrotizing pancreatitis (Disease Ontology:DOID:0080998); pre-eclampsia (Disease Ontology:DOID:10591); hypertension (Disease Ontology:DOID:10763); familial hyperlipidemia (Disease Ontology:DOID:1168); coronary artery disease (Disease Ontology:DOID:3393); systemic scleroderma (Disease Ontology:DOID:418)",
        "pathway": " (mmu:18816);  (R-MMU-114608);  (R-MMU-75205)",
        "pathway_count": 3,
        "publication_count": 13,
        "publication_id_list": "21750661;23386199;26495903;26740625;31219806;33059734;34428180;34709571;34913624;38457368;39627609;7523120;8647939",
        "class_list": "",
        "function": "Alpha2-Antiplasmin as a potential regulator of the spatial memory process and age-related cognitive decline. Publication Status: Online-Only, [RefSeq, PubMed]; Alpha2-Antiplasmin is associated with macrophage activation and fibrin deposition in a macrophage activation syndrome mouse model., [RefSeq, PubMed]; Alpha2-antiplasmin deficiency affects depression and anxiety-like behavior and apoptosis induced by stress in mice. Publication Status: Online-Only, [RefSeq, PubMed]; Alpha2-antiplasmin positively regulates endothelial-to-mesenchymal transition and fibrosis progression in diabetic nephropathy., [RefSeq, PubMed]; Serine protease inhibitor. The major targets of this inhibitor are plasmin and trypsin, but it also inactivates matriptase-3/TMPRSS7 and chymotrypsin (By similarity)., [UniProtKB]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 9,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0002020 protease binding;GO:0004867 serine-type endopeptidase inhibitor activity;GO:0042803 protein homodimerization activity;GO:0004866 endopeptidase inhibitor activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0009986 cell surface;GO:0031012 extracellular matrix;GO:0005577 fibrinogen complex",
        "go_biological_process": "GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0046330 positive regulation of JNK cascade;GO:0070374 positive regulation of ERK1 and ERK2 cascade;GO:0006953 acute-phase response;GO:0002034 maintenance of blood vessel diameter homeostasis by renin-angiotensin",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q61247-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D2V5-1",
        "uniprot_id": "AAR2_MOUSE",
        "mass": 43408.0,
        "length": 384,
        "protein_name": "Protein AAR2 homolog",
        "gene_name": "Aar2",
        "organism": "Mouse",
        "refseq_name": "protein AAR2 homolog",
        "refseq_ac": "NP_001158290",
        "gene_names_uniprotkb": "Aar2; 0610011L14Rik",
        "gene_names_refseq": "0610011L14Rik; Aar2",
        "protein_names_uniprotkb": "Protein AAR2 homolog; AAR2 splicing factor homolog",
        "protein_names_refseq": "novel transcript; protein AAR2 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68295)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "18299400;20484733;21750661;25428506;25605945;30084848;31219806;31599954;34428180;35820727",
        "class_list": "",
        "function": "Component of the U5 snRNP complex that is required for spliceosome assembly and for pre-mRNA splicing., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TEN8;Q3TM16;Q8VBU9",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005681 spliceosomal complex",
        "go_biological_process": "GO:0000244 spliceosomal tri-snRNP complex assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9D2V5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88888-1",
        "uniprot_id": "APBA3_MOUSE",
        "mass": 60718.0,
        "length": 571,
        "protein_name": "Amyloid-beta A4 precursor protein-binding family A member 3",
        "gene_name": "Apba3",
        "organism": "Mouse",
        "refseq_name": "amyloid-beta A4 precursor protein-binding family A member 3 isoform a",
        "refseq_ac": "NP_061228",
        "gene_names_uniprotkb": "Apba3; Mint3",
        "gene_names_refseq": "Apba3; Mint-3; X11gamma; lin-10; mint3",
        "protein_names_uniprotkb": "Amyloid-beta A4 precursor protein-binding family A member 3; Adapter protein X11gamma; Mint-3; Neuron-specific X11L2 protein; Neuronal Munc18-1-interacting protein 3",
        "protein_names_refseq": "Mint 3; adapter protein X11gamma; amyloid beta (A4) precursor protein-binding, family A, member 3; amyloid-beta A4 precursor protein-binding family A member 3 isoform a; neuron-specific X11L2 protein; neuronal munc18-1-interacting protein 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:57267)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "10.1101/2023.09.13.557529;14990567;17167098;17687045;21750661;28507122;28634075;31219806;33854054;34428180;9822620",
        "class_list": "",
        "function": "APBA3-deficient mice show reduced metastasis, with no apparent effect on primary tumor growth. APBA3 deficiency in inflammatory monocytes hampers glycolysis-dependent chemotaxis of cells toward metastatic sites., [RefSeq, PubMed]; Binding of Munc18-1 to closed, target-SNARE syntaxin 1 stimulates vesicle docking and regulates the consecutive priming step during exocytosis of secretory or synaptic vesicles., [RefSeq, PubMed]; May modulate processing of the amyloid-beta precursor protein (APP) and hence formation of APP-beta. May enhance the activity of HIF1A in macrophages by inhibiting the activity of HIF1AN (By similarity)., [UniProtKB]; Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV, [RefSeq, PubMed]; Mint3 depletion attenuated metastasis to the lungs in breast cancer model mice., [RefSeq, PubMed]; Mint3 depletion-mediated glycolytic and oxidative alterations promote pyroptosis and prevent the spread of Listeria monocytogenes infection in macrophages. Publication Status: Online-Only, [RefSeq, PubMed]; Mints are important regulators of presynaptic neurotransmitter release that are essential for mouse survival., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9803,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TDI1;Q8BR09",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004857 enzyme inhibitor activity;GO:0019899 enzyme binding;GO:0001540 amyloid-beta binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0043197 dendritic spine;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0001701 in utero embryonic development;GO:0015031 protein transport;GO:0007268 chemical synaptic transmission;GO:0043086 negative regulation of catalytic activity;GO:0010468 regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "O88888-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6PAM0-1",
        "uniprot_id": "AAKB2_MOUSE",
        "mass": 30209.0,
        "length": 271,
        "protein_name": "5'-AMP-activated protein kinase subunit beta-2",
        "gene_name": "Prkab2",
        "organism": "Mouse",
        "refseq_name": "5'-AMP-activated protein kinase subunit beta-2",
        "refseq_ac": "NP_892042",
        "gene_names_uniprotkb": "Prkab2",
        "gene_names_refseq": "5730553K21Rik; Prkab2",
        "protein_names_uniprotkb": "5'-AMP-activated protein kinase subunit beta-2; AMPK subunit beta-2",
        "protein_names_refseq": "5'-AMP-activated protein kinase subunit beta-2; AMPK subunit beta-2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:108097);  (R-MMU-1632852);  (R-MMU-163680);  (R-MMU-200425);  (R-MMU-380972);  (R-MMU-5628897);  (R-MMU-6804756);  (R-MMU-9931269)",
        "pathway_count": 8,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;17709097;21183079;21460634;21750661;25428506;31189568;32848054;35820727;40885482",
        "class_list": "",
        "function": "Non-catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Beta non-catalytic subunit acts as a scaffold on which the AMPK complex assembles, via its C-terminus that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits (PRKAG1, PRKAG2 or PRKAG3) (By similarity)., [UniProtKB, UniProtKB, UniProtKB]; Results suggest that p38 MAPK is not a downstream component of AMPK-mediated signaling in skeletal muscle., [RefSeq, PubMed]; These data indicate that increased expression of AMPKbeta2 is an important feature of efficient adipogenesis. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019899 enzyme binding;GO:0019901 protein kinase binding;GO:0004679 AMP-activated protein kinase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016324 apical plasma membrane",
        "go_biological_process": "GO:0007165 signal transduction;GO:0006633 fatty acid biosynthetic process;GO:0031669 cellular response to nutrient levels;GO:0120162 positive regulation of cold-induced thermogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q6PAM0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K348-1",
        "uniprot_id": "ACV1C_MOUSE",
        "mass": 54700.0,
        "length": 493,
        "protein_name": "Activin receptor type-1C",
        "gene_name": "Acvr1c",
        "organism": "Mouse",
        "refseq_name": "activin receptor type-1C isoform 1 precursor",
        "refseq_ac": "NP_001104500",
        "gene_names_uniprotkb": "Acvr1c; Alk7",
        "gene_names_refseq": "ACTR-IC; ACVRLK7; ALK7; Acvr1c; Alk-7; C230097P10",
        "protein_names_uniprotkb": "Activin receptor type-1C; 2.7.11.30; ACTR-IC; ALK-7; Activin receptor type IC; Activin receptor-like kinase 7",
        "protein_names_refseq": "activin receptor type IC; activin receptor type-1C isoform 1 precursor; activin receptor type-1C; activin receptor-like kinase 7",
        "tax_id": 10090,
        "disease": "retinal degeneration (Disease Ontology:DOID:8466)",
        "pathway": " (mmu:269275);  (R-MMU-1502540)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;15196700;15485907;18480258;21750661;32641645;34428180;36403856;36626233;38714691",
        "class_list": "",
        "function": "ALK7 is not an essential mediator of Nodal signaling during mesendoderm formation and left-right patterning in the mouse but may instead mediate other activities of Nodal and related ligands in the development or function of particular tissues and organs, [RefSeq, PubMed]; ALK7 is the signaling receptor for activin AB and activin B and is responsible for activin-mediated secretion of insulin from pancreatic beta cell line, MIN6., [RefSeq, PubMed]; Serine/threonine protein kinase which forms a receptor complex on ligand binding. The receptor complex consists of 2 type II and 2 type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators, SMAD2 and SMAD3. Receptor for activin AB, activin B, activin E and NODAL. Upon NODAL binding, activation results in increased apoptosis and reduced proliferation through suppression of AKT signaling and the activation of Smad2-dependent signaling pathway in pancreatic beta-cells, trophoblasts, epithelial or neuronal cells (PubMed:18480258, PubMed:36403856). Acts as a positive regulator for macrophage activation partially through down-regulation of PPARG expression (PubMed:32641645)., [UniProtKB, PubMed, UniProtKB, PubMed, UniProtKB, PubMed, UniProtKB, UniProtKB]; Specific exercise patterns generate an epigenetic molecular memory window that drives long-term memory formation and identifies ACVR1C as a bidirectional regulator of memory in mice. Publication Status: Online-Only, [RefSeq, PubMed]; Targeting activin receptor-like kinase 7 ameliorates adiposity and associated metabolic disorders. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AJR4",
        "ec_number_list": "2.7.11.30",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0019838 growth factor binding;GO:0046872 metal ion binding;GO:0016361 activin receptor activity, type I",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0048179 activin receptor complex;GO:0016020 membrane",
        "go_biological_process": "GO:0007399 nervous system development;GO:0030154 cell differentiation;GO:0043065 positive regulation of apoptotic process;GO:0097190 apoptotic signaling pathway;GO:0046676 negative regulation of insulin secretion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q8K348-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91VJ1-1",
        "uniprot_id": "AIM2_MOUSE",
        "mass": 40155.0,
        "length": 354,
        "protein_name": "Interferon-inducible protein AIM2",
        "gene_name": "Aim2",
        "organism": "Mouse",
        "refseq_name": "interferon-inducible protein AIM2",
        "refseq_ac": "NP_001013801",
        "gene_names_uniprotkb": "Aim2; Gm1313; Ifi210",
        "gene_names_refseq": "Aim2; Gm1313; Ifi210",
        "protein_names_uniprotkb": "Interferon-inducible protein AIM2; Ifi-210; Interferon-inducible protein 210; Interferon-inducible protein p210",
        "protein_names_refseq": "ifi-210; interferon-inducible protein 210; interferon-inducible protein AIM2; interferon-inducible protein p210",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:383619);  (R-MMU-1834949);  (R-MMU-844615)",
        "pathway_count": 3,
        "publication_count": 26,
        "publication_id_list": "15896773;19131592;19158675;19158676;19158679;20351692;20351693;20417169;20457908;21750661;21902795;22555457;23567559;23850291;25888795;26095253;26107252;27462105;27561456;27846608;29033131;32350463;33505023;34006824;34428180;34471287",
        "class_list": "",
        "function": "Also acts as a tumor suppressor independently of its role in inflammatory response (PubMed:26095253). Able to suppress overt cell proliferation in enterocytes: restricts stem cell proliferation in the intestinal mucosa in an inflammasome-independent manner, contributing to a decrease in the likelihood of colorectal cancer development (PubMed:26095253, PubMed:26107252). AIM2 suppresses cell proliferation by inhibiting phosphorylation of AKT1 at 'Ser-473', preventing AKT1 activation and AKT-mTOR signaling pathway (PubMed:26095253, PubMed:26107252). Inhibits AKT1 phosphorylation both by inhibiting the activity of PRKDC/DNA-PK kinase and promoting dephosphorylation by PP2A phosphatase (PubMed:26107252, PubMed:33505023). Also acts as a key regulator of regulatory T-cells (Treg) homeostasis by promoting their stability: acts by preventing AKT1 activation (PubMed:33505023). Its role in Treg homeostasis is important to restain autoimmune diseases (PubMed:33505023)., [UniProtKB, PubMed, PubMed, PubMed]; Identification of AIM2 as an important inflammasome component that senses potentially dangerous cytoplasmic DNA, leading to activation of the ASC pyroptosome and caspase-1, [RefSeq, PubMed]; Observations identify AIM2 as a new receptor for cytoplasmic DNA, which forms an inflammasome with the ligand and ASC to activate caspase-1, [RefSeq, PubMed]; Sensor component of the AIM2 inflammasome, which mediates inflammasome activation in response to the presence of double-stranded DNA (dsDNA) in the cytosol, leading to subsequent pyroptosis (PubMed:19131592, PubMed:19158675, PubMed:19158676, PubMed:19158679, PubMed:20351692, PubMed:20351693, PubMed:20417169, PubMed:20457908, PubMed:21902795, PubMed:23567559, PubMed:32350463, PubMed:34006824). Inflammasomes are supramolecular complexes that assemble in the cytosol in response to pathogens and other damage-associated signals and play critical roles in innate immunity and inflammation (PubMed:19131592, PubMed:19158675, PubMed:19158676, PubMed:20351692, PubMed:20351693, PubMed:20417169, PubMed:20457908, PubMed:21902795, PubMed:23567559, PubMed:32350463). Acts as a recognition receptor (PRR): specifically recognizes and binds dsDNA in the cytosol, and mediates the formation of the inflammasome polymeric complex composed of AIM2, CASP1 and PYCARD/ASC (PubMed:19131592, PubMed:19158675, PubMed:19158676, PubMed:20351692, PubMed:20351693, PubMed:20417169, PubMed:20457908, PubMed:21902795, PubMed:23567559). Recruitment of pro-caspase-1 (proCASP1) to the AIM2 inflammasome promotes caspase-1 (CASP1) activation, which subsequently cleaves and activates inflammatory cytokines IL1B and IL18 and gasdermin-D (GSDMD), promoting cytokine secretion (PubMed:19158676). In some cells, CASP1 activation mediates cleavage and activation of GSDMD, triggering pyroptosis without promoting cytokine secretion (PubMed:27846608, PubMed:32350463). Detects cytosolic dsDNA of viral and bacterial origin in a non-sequence-specific manner (PubMed:19131592, PubMed:19158675, PubMed:20351692, PubMed:23567559). Involved in the DNA damage response caused by acute ionizing radiation by mediating pyroptosis of intestinal epithelial cells and bone marrow cells in response to double-strand DNA breaks (PubMed:27846608). Mechanistically, AIM2 senses DNA damage in the nucleus to mediate inflammasome assembly and inflammatory cell death (PubMed:27846608). Also acts as a regulator of neurodevelopment via its role in the DNA damage response: acts by promoting neural cell death in response to DNA damage in the developing brain, thereby purging genetically compromised cells of the central nervous system (PubMed:32350463). Pyroptosis mediated by the AIM2 inflammasome in response to DNA damage is dependent on GSDMD without involving IL1B and IL18 cytokine secretion (PubMed:27846608, PubMed:32350463). Also acts as a mediator of pyroptosis, necroptosis and apoptosis (PANoptosis), an integral part of host defense against pathogens, in response to bacterial infection (PubMed:34471287). Can also trigger PYCARD/ASC-dependent, caspase-1-independent cell death that involves caspase-8 (CASP8) (PubMed:22555457)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; Study showed p202 is an inhibitor of DNA-induced caspase activation; conversely AIM2 was required for caspase activation by cytoplasmic dsDNA; work indicates HIN-200 proteins can act as pattern recognition receptors mediating response to cytoplasmic dsDNA, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0003690 double-stranded DNA binding;GO:0035591 signaling adaptor activity;GO:0038187 pattern recognition receptor activity;GO:0140608 cysteine-type endopeptidase activator activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol",
        "go_biological_process": "GO:0002221 pattern recognition receptor signaling pathway;GO:0045087 innate immune response;GO:0051607 defense response to virus;GO:0070050 neuron cellular homeostasis;GO:0071466 cellular response to xenobiotic stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "Q91VJ1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q05910-1",
        "uniprot_id": "ADAM8_MOUSE",
        "mass": 90046.0,
        "length": 826,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 8",
        "gene_name": "Adam8",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 8 isoform 1 precursor",
        "refseq_ac": "NP_031429",
        "gene_names_uniprotkb": "Adam8; Ms2",
        "gene_names_refseq": "ADAM 8; Adam8; CD156a; CD156; E430039A18Rik; MS2",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 8; 3.4.24.-; ADAM 8; Cell surface antigen MS2; Macrophage cysteine-rich glycoprotein",
        "protein_names_refseq": "a disintegrin and metalloprotease domain 8; cell surface antigen MS2; disintegrin and metalloproteinase domain-containing protein 8 isoform 1 precursor; disintegrin and metalloproteinase domain-containing protein 8; macrophage cysteine-rich glycoprotein",
        "tax_id": 10090,
        "disease": "asthma (Disease Ontology:DOID:2841); pancreatic ductal carcinoma (Disease Ontology:DOID:3587); pulmonary eosinophilia (Disease Ontology:DOID:9498)",
        "pathway": " (mmu:11501);  (R-MMU-1474228);  (R-MMU-6798695)",
        "pathway_count": 3,
        "publication_count": 16,
        "publication_id_list": "18250455;19144319;1982220;21750661;26495903;26740625;28011936;28935714;31219806;32152506;35984892;37828378;37992987;37995078;39221886;9218457",
        "class_list": "",
        "function": "A Disintegrin and Metalloproteinase-8 Protects Against Erastin-Induced Neuronal Ferroptosis via Activating Nrf2/HO-1/FTH1 Signaling Pathway., [RefSeq, PubMed]; Knockdown of ADAM8 inhibits the proliferation, migration, invasion, and tumorigenesis of renal clear cell carcinoma cells to enhance the immunotherapy efficacy., [RefSeq, PubMed]; METTL14-mediated lncRNA-FAS-AS1 promotes osteoarthritis progression by up-regulating ADAM8., [RefSeq, PubMed]; Possible involvement in extravasation of leukocytes., [UniProtKB]; This gene encodes a member of the Adam family of proteins that contain the disintegrin and metalloprotease domains. The encoded protein is localized to the cell surface, where it is involved in the remodeling of extracellular matrix and cell migration. Mice lacking the encoded protein display persistent inflammation upon treatment with allergens. Alternative splicing of this gene results in multiple variants. [provided by RefSeq, Mar 2015]., [RefSeq]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.3.2.27;7.6.2.1;3.1.3.48;1.14.19.17;5.2.1.-;6.2.1.3;6.2.1.-;6.2.1.7;6.2.1.24;6.2.1.15;3.4.24.81;2.7.11.1;1.14.14.18;3.4.21.73;3.6.5.2;1.1.1.-;3.2.1.20;3.1.3.-;3.4.24.-;2.3.1.78;1.6.3.-;3.2.2.6;3.4.16.2;1.2.1.5;1.2.1.28;1.2.1.7;1.2.1.48;3.6.1.29;2.3.1.51;3.6.1.-;3.1.4.4;2.3.1.20;2.3.1.76",
        "go_molecular_function": "GO:0034987 immunoglobulin receptor binding;GO:0004222 metalloendopeptidase activity;GO:0005178 integrin binding;GO:0008237 metallopeptidase activity;GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0002102 podosome;GO:0032010 phagolysosome",
        "go_biological_process": "GO:0048729 tissue morphogenesis;GO:0001525 angiogenesis;GO:0006508 proteolysis;GO:0006954 inflammatory response;GO:0043410 positive regulation of MAPK cascade",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q05910-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P51908-1",
        "uniprot_id": "ABEC1_MOUSE",
        "mass": 27522.0,
        "length": 229,
        "protein_name": "C->U-editing enzyme APOBEC-1",
        "gene_name": "Apobec1",
        "organism": "Mouse",
        "refseq_name": "C->U-editing enzyme APOBEC-1 isoform a",
        "refseq_ac": "NP_001127863",
        "gene_names_uniprotkb": "Apobec1",
        "gene_names_refseq": "APOBEC-1; Apobec1; Cdar1",
        "protein_names_uniprotkb": "C->U-editing enzyme APOBEC-1; 3.5.4.-; 3.5.4.36; APOBEC-1; Apolipoprotein B mRNA-editing enzyme 1; Apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1; mRNA(cytosine(6666)) deaminase 1",
        "protein_names_refseq": "C->U-editing enzyme APOBEC-1 isoform a; C->U-editing enzyme APOBEC-1; apolipoprotein B editing complex 1; mRNA(cytosine(6666)) deaminase 1",
        "tax_id": 10090,
        "disease": "familial hyperlipidemia (Disease Ontology:DOID:1168); colon cancer (Disease Ontology:DOID:219); liver benign neoplasm (Disease Ontology:DOID:916); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:11810);  (R-MMU-72200);  (R-MMU-75094)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "12859895;21496894;21750661;7768898",
        "class_list": "",
        "function": "Cytidine deaminase catalyzing the cytidine to uridine postranscriptional editing of a variety of mRNAs. Form complexes with cofactors that confer differential editing activity and selectivity. Responsible for the postranscriptional editing of a CAA codon for Gln to a UAA codon for stop in the apolipoprotein B mRNA. Also involved in CGA (Arg) to UGA (Stop) editing in the NF1 mRNA (By similarity). May also play a role in the epigenetic regulation of gene expression by participating in DNA demethylation (PubMed:21496894)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q99L67",
        "ec_number_list": "3.5.4.-;3.5.4.36;3.5.4.38",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0003729 mRNA binding;GO:0004126 cytidine deaminase activity;GO:0008047 enzyme activator activity;GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0030895 apolipoprotein B mRNA editing enzyme complex",
        "go_biological_process": "GO:0044029 positive regulation of gene expression via chromosomal CpG island demethylation;GO:0006397 mRNA processing;GO:0006641 triglyceride metabolic process;GO:0010332 response to gamma radiation;GO:0016554 cytidine to uridine editing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P51908-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O70373-1",
        "uniprot_id": "XIRP1_MOUSE",
        "mass": 196658.0,
        "length": 1813,
        "protein_name": "Xin actin-binding repeat-containing protein 1",
        "gene_name": "Xirp1",
        "organism": "Mouse",
        "refseq_name": "xin actin-binding repeat-containing protein 1 isoform X1",
        "refseq_ac": "XP_030100108",
        "gene_names_uniprotkb": "Xirp1; Cmya1; Xin-alpha; Xin",
        "gene_names_refseq": "Cmya1; Xirp1",
        "protein_names_uniprotkb": "Xin actin-binding repeat-containing protein 1; Cardiomyopathy-associated protein 1",
        "protein_names_refseq": "xin actin-binding repeat-containing protein 1 isoform X1",
        "tax_id": 10090,
        "disease": "hypertrophic cardiomyopathy (Disease Ontology:DOID:11984)",
        "pathway": " (mmu:22437)",
        "pathway_count": 1,
        "publication_count": 13,
        "publication_id_list": "10021346;12203715;17766470;17925400;18682726;21183079;21750661;23296090;23985323;24963132;25582411;34428180;36288343",
        "class_list": "",
        "function": "Protects actin filaments from depolymerization (By similarity). Required for correct cardiac intercalated disk ultrastructure via maintenance of cell-cell adhesion stability, and as a result maintains cardiac organ morphology, conductance and heart beat rhythm (PubMed:17766470). Required for development of normal skeletal muscle morphology and muscle fiber type composition (PubMed:25582411). Plays a role in regulating muscle satellite cell activation and survival, as a result promotes muscle fiber recovery from injury and fatigue (PubMed:25582411)., [UniProtKB, PubMed, PubMed, UniProtKB]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 4,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A571BDS0;E9QQ93",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051015 actin filament binding;GO:0031005 filamin binding;GO:0003779 actin binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005912 adherens junction;GO:0014704 intercalated disc;GO:0005916 fascia adherens;GO:0030057 desmosome",
        "go_biological_process": "GO:0014835 myoblast differentiation involved in skeletal muscle regeneration;GO:0007015 actin filament organization;GO:0007219 Notch signaling pathway;GO:0008285 negative regulation of cell population proliferation;GO:0042391 regulation of membrane potential",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "O70373-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64318-1",
        "uniprot_id": "ZEB1_MOUSE",
        "mass": 122465.0,
        "length": 1117,
        "protein_name": "Zinc finger E-box-binding homeobox 1",
        "gene_name": "Zeb1",
        "organism": "Mouse",
        "refseq_name": "zinc finger E-box-binding homeobox 1 isoform 1",
        "refseq_ac": "NP_035676",
        "gene_names_uniprotkb": "Zeb1; Areb6; Tcf8; Zfhx1a; Zfx1a; Zfx1ha",
        "gene_names_refseq": "3110032K11Rik; AREB6; BZP; MEB1; Nil2; TCF-8; Tcf18; Tcf8; Tw; ZEB; Zeb1; Zfhep; Zfhx1a; Zfx1a; Zfx1ha; [delta]EF1",
        "protein_names_uniprotkb": "Zinc finger E-box-binding homeobox 1; Delta EF1; MEB1; TCF-8; Transcription factor 8; Zinc finger homeobox protein 1a",
        "protein_names_refseq": "transcription factor 8; twirler; zinc finger E-box-binding homeobox 1 isoform 1; zinc finger homeobox protein 1a",
        "tax_id": 10090,
        "disease": "rheumatic heart disease (Disease Ontology:DOID:0050827); posterior polymorphous corneal dystrophy 3 (Disease Ontology:DOID:0110857); hypospadias (Disease Ontology:DOID:10892); Fuchs' endothelial dystrophy (Disease Ontology:DOID:11555); HTLV-1-associated myelopathy/tropical spastic paraparesis (Disease Ontology:DOID:321); acute myocardial infarction (Disease Ontology:DOID:9408)",
        "pathway": " (mmu:21417);  (R-MMU-9764725)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;19935649;20346398;20713358;21183079;21750661;25428506;34428180;8647466;8964504",
        "class_list": "",
        "function": "Acts as a transcriptional repressor. Binds to E-box sequences in the immunoglobulin heavy chain enhancer as well as in the regulatory regions of many other tissue-specific genes. Represses E-cadherin promoter and induces an epithelial-mesenchymal transition (EMT) by recruiting SMARCA4/BRG1. Represses BCL6 transcription in the presence of the corepressor CTBP1 (By similarity). Positively regulates neuronal differentiation. Represses RCOR1 transcription activation during neurogenesis. Represses transcription by binding to the E box (5'-CANNTG-3'). In the absence of TGFB1, acts as a repressor of COL1A2 transcription via binding to the E-box in the upstream enhancer region (PubMed:20713358). Promotes tumorigenicity by repressing stemness-inhibiting microRNAs (PubMed:19935649)., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 6,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A4QPD2;Q62519",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003682 chromatin binding;GO:0008270 zinc ion binding;GO:0003690 double-stranded DNA binding;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005829 cytosol",
        "go_biological_process": "GO:0017015 regulation of transforming growth factor beta receptor signaling pathway;GO:0033081 regulation of T cell differentiation in thymus;GO:0048752 semicircular canal morphogenesis;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q64318-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K4E0-1",
        "uniprot_id": "ALMS1_MOUSE",
        "mass": 360215.0,
        "length": 3251,
        "protein_name": "Centrosome-associated protein ALMS1",
        "gene_name": "Alms1",
        "organism": "Mouse",
        "refseq_name": "centrosome-associated protein ALMS1",
        "refseq_ac": "NP_660258",
        "gene_names_uniprotkb": "Alms1; Kiaa0328",
        "gene_names_refseq": "Alms1; bbb",
        "protein_names_uniprotkb": "Centrosome-associated protein ALMS1; Alstrom syndrome protein 1 homolog",
        "protein_names_refseq": "Alstrom syndrome 1 homolog; alstrom syndrome protein 1 homolog; centrosome-associated protein ALMS1",
        "tax_id": 10090,
        "disease": "Alstrom syndrome (Disease Ontology:DOID:0050473); type 2 diabetes mellitus (Disease Ontology:DOID:9352); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:236266);  (R-MMU-2565942);  (R-MMU-380259);  (R-MMU-380270);  (R-MMU-380284);  (R-MMU-380320);  (R-MMU-5620912);  (R-MMU-8854518)",
        "pathway_count": 8,
        "publication_count": 13,
        "publication_id_list": "11941369;16000322;21183079;21750661;22872234;25428506;31219806;32782141;34203471;34428180;34678516;36852467;38583571",
        "class_list": "",
        "function": "Disruption in ALMS1 manifests human Alstrom syndrome, [RefSeq, PubMed]; Involved in PCM1-dependent intracellular transport. Required, directly or indirectly, for the localization of NCAPD2 to the proximal ends of centrioles. Required for proper formation and/or maintenance of primary cilia (PC), microtubule-based structures that protrude from the surface of epithelial cells (By similarity)., [UniProtKB]; Mesenchymal-specific Alms1 knockout in mice recapitulates metabolic features of Alstrom syndrome., [RefSeq, PubMed]",
        "predicted_glycosites": 5,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 5,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 9,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 9,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 9,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 4,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 13,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QKT8;Q6A084;Q8C9N9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051393 alpha-actinin binding",
        "go_cellular_component": "GO:0097229 sperm end piece;GO:0000922 spindle pole;GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005813 centrosome",
        "go_biological_process": "GO:0006629 lipid metabolic process;GO:0019722 calcium-mediated signaling;GO:0043066 negative regulation of apoptotic process;GO:0007286 spermatid development;GO:0042593 glucose homeostasis",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "Q8K4E0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D385-1",
        "uniprot_id": "AR2BP_MOUSE",
        "mass": 18754.0,
        "length": 163,
        "protein_name": "ADP-ribosylation factor-like protein 2-binding protein",
        "gene_name": "Arl2bp",
        "organism": "Mouse",
        "refseq_name": "ADP-ribosylation factor-like protein 2-binding protein isoform 1",
        "refseq_ac": "NP_077153",
        "gene_names_uniprotkb": "Arl2bp; Bart1; Bart",
        "gene_names_refseq": "1700010P10Rik; 1700027H16Rik; 6330544B05Rik; Arl2bp; BART; Bart1",
        "protein_names_uniprotkb": "ADP-ribosylation factor-like protein 2-binding protein; ARF-like 2-binding protein; Binder of ARF2 protein 1",
        "protein_names_refseq": "ADP-ribosylation factor-like protein 2-binding protein isoform 1; ADP-ribosylation factor-like protein 2-binding protein; ADP-ribosylation-like 2 binding protein; ARF-like 2-binding protein; binder of ARF2 protein 1",
        "tax_id": 10090,
        "disease": "retinitis pigmentosa with or without situs inversus (Disease Ontology:DOID:0110419); male infertility (Disease Ontology:DOID:12336)",
        "pathway": " (mmu:107566);  (R-MMU-83936)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "10488091;11809823;18234692;21750661;23849777;29718757;31425546",
        "class_list": "",
        "function": "ARL2BP is necessary for photoreceptor ciliary doublet formation and axoneme elongation., [RefSeq, PubMed]; BART is essential for the transcriptional activity and nuclear retention of STAT3, [RefSeq, PubMed]; Study identified multiple ciliopathy phenotypes associated with mutations in ARL2BP in human patients and in a mouse knockout model. Spermiogenesis is impaired, resulting in abnormally shaped heads, shortened and mis-assembled sperm tails, and loss of axonemal doublets. ARL2BP is required for the structural maintenance of cilia as well as of the sperm flagellum, and that its deficiency leads to syndromic ciliopathy. Publication Status: Online-Only, [RefSeq, PubMed]; Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. May play a role as an effector of ARL2 (By similarity)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CQW6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003713 transcription coactivator activity;GO:0030695 GTPase regulator activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005758 mitochondrial intermembrane space;GO:0005813 centrosome;GO:0005829 cytosol",
        "go_biological_process": "GO:0042531 positive regulation of tyrosine phosphorylation of STAT protein;GO:0051457 maintenance of protein location in nucleus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9D385-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80SY6-1",
        "uniprot_id": "ADAL_MOUSE",
        "mass": 41001.0,
        "length": 360,
        "protein_name": "N6-Methyl-AMP deaminase",
        "gene_name": "Adal; Mapda",
        "organism": "Mouse",
        "refseq_name": "N6-Methyl-AMP deaminase isoform b",
        "refseq_ac": "NP_001277740",
        "gene_names_uniprotkb": "Adal; Mapda; Adal",
        "gene_names_refseq": "4930578F03Rik; Adal; Mapda",
        "protein_names_uniprotkb": "N6-Methyl-AMP deaminase; 3.5.4.-; Adenosine deaminase-like protein; N6,N6-dimethyl-AMP deaminase; N6-isopentenyl-AMP deaminase",
        "protein_names_refseq": "N6,N6-dimethyl-AMP deaminase; N6-Methyl-AMP deaminase isoform b; N6-isopentenyl-AMP deaminase; adenosine deaminase-like protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:75894);  (R-MMU-2161541);  (R-MMU-74217)",
        "pathway_count": 3,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;28449374;34428180;40840445",
        "class_list": "",
        "function": "Deaminase involved in the detoxification of modified adenosines containing N(6)-methylated adenine (m6A) post-transcriptional modification (PubMed:40840445). Modified nucleosides are derived from the degradation of RNAs (mRNAs, rRNAs and tRNAs) and possess intrinsic cytotoxicity and must be cleared to prevent metabolic dysfunction (PubMed:40840445). Acts downstream of ADK and catalyzes the hydrolysis of the free cytosolic methylated adenosine nucleotides N(6)-methyl-AMP (m6AMP), N(6),N(6)-dimethyl-AMP (m6,6AMP) and N(6)-isopentenyl-AMP (i6AMP) to produce inositol monophosphate (IMP) (PubMed:40840445). Catalyzes the removal of different alkyl groups not only from N6-substituted purine or 2-aminopurine nucleoside monophosphates but also from O6-substituted compounds in vitro (By similarity)., [UniProtKB, UniProtKB, PubMed]; Genetically protective factor against alcohol consumption, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9671,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2ARU3;A2ARU4;Q8BLN3;Q8BX67;Q9D4Q6",
        "ec_number_list": "3.5.4.-",
        "go_molecular_function": "GO:0004000 adenosine deaminase activity;GO:0046872 metal ion binding;GO:0062154 N6-methyl-AMP deaminase activity;GO:0019239 deaminase activity",
        "go_cellular_component": "",
        "go_biological_process": "GO:0006154 adenosine catabolic process;GO:0009117 nucleotide metabolic process;GO:0046103 inosine biosynthetic process;GO:0110052 toxic metabolite repair",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q80SY6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K2X3-1",
        "uniprot_id": "STN1_MOUSE",
        "mass": 43486.0,
        "length": 378,
        "protein_name": "CST complex subunit STN1",
        "gene_name": "Stn1",
        "organism": "Mouse",
        "refseq_name": "CST complex subunit STN1",
        "refseq_ac": "NP_780569",
        "gene_names_uniprotkb": "Stn1; Obfc1",
        "gene_names_refseq": "0610009H20Rik; 2310057J23Rik; AAF-44; AAF44; Obfc1; RPA-32; Stn1",
        "protein_names_uniprotkb": "CST complex subunit STN1; AAF-44; AAF44; Alpha-accessory factor of 44 kDa; Oligonucleotide/oligosaccharide-binding fold-containing protein 1; Suppressor of cdc thirteen homolog",
        "protein_names_refseq": "CST complex subunit STN1; alpha accessory factor 44; alpha-accessory factor of 44 kDa; oligonucleotide/oligosaccharide-binding fold containing 1; oligonucleotide/oligosaccharide-binding fold-containing protein 1; replication protein A 32 kDa subunit; suppressor of cdc thirteen homolog",
        "tax_id": 10090,
        "disease": "telangiectasis (Disease Ontology:DOID:1272); melanoma (Disease Ontology:DOID:1909)",
        "pathway": " (mmu:108689);  (R-MMU-174411);  (R-MMU-174430)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "19119139;19648609;19854130;21750661;22748632;27802388;37163605",
        "class_list": "",
        "function": "Component of the CST complex proposed to act as a specialized replication factor promoting DNA replication under conditions of replication stress or natural replication barriers such as the telomere duplex. The CST complex binds single-stranded DNA with high affinity in a sequence-independent manner, while isolated subunits bind DNA with low affinity by themselves. Initially the CST complex has been proposed to protect telomeres from DNA degradation (PubMed:19854130). However, the CST complex has been shown to be involved in several aspects of telomere replication. The CST complex inhibits telomerase and is involved in telomere length homeostasis; it is proposed to bind to newly telomerase-synthesized 3' overhangs and to terminate telomerase action implicating the association with the ACD:POT1 complex thus interfering with its telomerase stimulation activity. The CST complex is also proposed to be involved in fill-in synthesis of the telomeric C-strand probably implicating recruitment and activation of DNA polymerase alpha (PubMed:22748632). The CST complex facilitates recovery from many forms of exogenous DNA damage; seems to be involved in the re-initiation of DNA replication at repaired forks and/or dormant origins. Required for efficicient replication of the duplex region of the telomere. Promotes efficient replication of lagging-strand telomeres. Promotes general replication start following replication-fork stalling implicating new origin firing. May be in involved in C-strand fill-in during late S/G2 phase independent of its role in telomere duplex replication (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed]; Deficiency in mammalian STN1 promotes colon cancer development via inhibiting DNA repair., [RefSeq, PubMed]; OBFC1 is identical to the previously described 44 kDa subunit of DNA-pol-alpha/primase associated factor (AAF) which increases polymerase-alpha/primase template affinity and stimulate both DNA primase and polymerase-alpha activities in vitro., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TPH0;Q8C6I6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042162 telomeric DNA binding;GO:0003697 single-stranded DNA binding;GO:0043047 single-stranded telomeric DNA binding;GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0001650 fibrillar center;GO:0045111 intermediate filament cytoskeleton;GO:0000781 chromosome, telomeric region",
        "go_biological_process": "GO:0010833 telomere maintenance via telomere lengthening;GO:0000723 telomere maintenance;GO:0016233 telomere capping;GO:0032211 negative regulation of telomere maintenance via telomerase;GO:0045740 positive regulation of DNA replication",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8K2X3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P22725-1",
        "uniprot_id": "WNT5A_MOUSE",
        "mass": 42309.0,
        "length": 380,
        "protein_name": "Protein Wnt-5a",
        "gene_name": "Wnt5a",
        "organism": "Mouse",
        "refseq_name": "protein Wnt-5a isoform 2 precursor",
        "refseq_ac": "NP_001243153",
        "gene_names_uniprotkb": "Wnt5a; Wnt-5a",
        "gene_names_refseq": "8030457G12Rik; Wnt-5a; Wnt5a",
        "protein_names_uniprotkb": "Protein Wnt-5a",
        "protein_names_refseq": "protein Wnt-5a isoform 2 precursor; protein Wnt-5a; wingless-related MMTV integration site 5A",
        "tax_id": 10090,
        "disease": "Robinow syndrome (Disease Ontology:DOID:0060254); autosomal dominant Robinow syndrome 1 (Disease Ontology:DOID:0060766); colon cancer (Disease Ontology:DOID:219); endometrial carcinoma (Disease Ontology:DOID:2871)",
        "pathway": " (mmu:22418);  (R-MMU-201681);  (R-MMU-3238698);  (R-MMU-4086398);  (R-MMU-4086400);  (R-MMU-4608870);  (R-MMU-5099900);  (R-MMU-5140745);  (R-MMU-8856825);  (R-MMU-8856828)",
        "pathway_count": 10,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;10021340;10866835;12952940;16602827;17117926;19841259;22726442;2279700;27214281",
        "class_list": "",
        "function": "Ligand for members of the frizzled family of seven transmembrane receptors (PubMed:17117926). Can activate or inhibit canonical Wnt signaling, depending on receptor context (PubMed:16602827). In the presence of FZD4, activates beta-catenin signaling. In the presence of ROR2, inhibits the canonical Wnt pathway by promoting beta-catenin degradation through a GSK3-independent pathway which involves down-regulation of beta-catenin-induced reporter gene expression (PubMed:16602827). Suppression of the canonical pathway allows chondrogenesis to occur and inhibits tumor formation. Stimulates cell migration (PubMed:17117926). Decreases proliferation, migration, invasiveness and clonogenicity of carcinoma cells and may act as a tumor suppressor. Mediates motility of melanoma cells (By similarity). Required during embryogenesis for extension of the primary anterior-posterior axis and for outgrowth of limbs and the genital tubercle (PubMed:10021340). Inhibits type II collagen expression in chondrocytes (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB, PubMed, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 4,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 4,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 4,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9641,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 4,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BM17;Q8BMF9;Q8VCV6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005102 signaling receptor binding;GO:0005109 frizzled binding;GO:0019904 protein domain specific binding;GO:0005125 cytokine activity;GO:0005115 receptor tyrosine kinase-like orphan receptor binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005788 endoplasmic reticulum lumen;GO:0009986 cell surface",
        "go_biological_process": "GO:0022409 positive regulation of cell-cell adhesion;GO:0060762 regulation of branching involved in mammary gland duct morphogenesis;GO:1903861 positive regulation of dendrite extension;GO:0043032 positive regulation of macrophage activation;GO:0051057 positive regulation of small GTPase mediated signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "P22725-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q4U4S6-1",
        "uniprot_id": "XIRP2_MOUSE",
        "mass": 428259.0,
        "length": 3784,
        "protein_name": "Xin actin-binding repeat-containing protein 2",
        "gene_name": "Xirp2",
        "organism": "Mouse",
        "refseq_name": "xin actin-binding repeat-containing protein 2 isoform 1",
        "refseq_ac": "NP_001019789",
        "gene_names_uniprotkb": "Xirp2; Cmya3; Xin2",
        "gene_names_refseq": "2310003D02Rik; 2310008C07Rik; A530024P18Rik; Cmya3; Gm352; Xin2; Xirp2",
        "protein_names_uniprotkb": "Xin actin-binding repeat-containing protein 2; Beta-xin; Cardiomyopathy-associated protein 3; Myogenic MEF2-activated Xin-related protein; Myomaxin; mXinbeta",
        "protein_names_refseq": "Xin actin-binding repeat containing 2 short splice form; beta-xin; cardiomyopathy associated 3; cardiomyopathy-associated protein 3; mXinbeta; myogenic MEF2-activated Xin-related protein; myomaxin; xeplin; xin actin-binding repeat-containing protein 2 isoform 1; xin actin-binding repeat-containing protein 2; xin-beta",
        "tax_id": 10090,
        "disease": "depressive disorder (Disease Ontology:DOID:1596)",
        "pathway": " (mmu:241431)",
        "pathway_count": 1,
        "publication_count": 13,
        "publication_id_list": "16500513;17046827;17766470;20360251;21183079;21750661;25428506;25772365;29306897;30084848;32938943;34418053;37294664",
        "class_list": "",
        "function": "Facilitates repair of noise-induced stereocilia gaps via interaction and recruitment of ACTG1, thereby maintains hearing sensitivity following loud noise damage., [UniProtKB, PubMed]; Intercalated disc protein Xinbeta is required for Hippo-YAP signaling in the heart. Publication Status: Online-Only, [RefSeq, PubMed]; Myomaxin functions directly downstream of MEF2A at the peripheral Z-disc complex in striated muscle potentially playing a role in regulating cytoarchitectural integrity, [RefSeq, PubMed]; Protects actin filaments from depolymerization (By similarity). Required for correct morphology of cell membranes and maturation of intercalated disks of cardiomyocytes via facilitating localization of XIRP1 and CDH2 to the termini of aligned mature cardiomyocytes (PubMed:20360251). Thereby required for correct postnatal heart development and growth regulation that is crucial for overall heart morphology and diastolic function (PubMed:20360251). Required for normal electrical conduction in the heart including formation of the infranodal ventricular conduction system and normal action potential configuration, as a result of its interaction with the cardiac ion channel components Scn5a/Nav1.5 and Kcna5/Kv1.5 (PubMed:29306897). Required for regular actin filament spacing of the paracrystalline array in both inner and outer hair cells of the cochlea, thereby required for maintenance of stereocilia morphology (PubMed:25772365)., [UniProtKB, PubMed, PubMed, UniProtKB, PubMed]; Repair of noise-induced damage to stereocilia F-actin cores is facilitated by XIRP2 and its novel mechanosensor domain. Publication Status: Online-Only, [RefSeq, PubMed]; Upregulation due to Ang II-induced myocardial damage and not to blood pressure elevation per se, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 8,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A1ECA5;A2AVA2;B2BBR6;Q5S4P6;Q5S4P7;Q5S4P8;Q8BS23",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0051015 actin filament binding;GO:0051393 alpha-actinin binding;GO:0003779 actin binding",
        "go_cellular_component": "GO:0005829 cytosol;GO:0005911 cell-cell junction;GO:0005925 focal adhesion;GO:0001725 stress fiber;GO:0030018 Z disc",
        "go_biological_process": "GO:0007015 actin filament organization;GO:0055008 cardiac muscle tissue morphogenesis;GO:0003281 ventricular septum development;GO:0045216 cell-cell junction organization;GO:1903829 positive regulation of protein localization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "Q4U4S6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80XP9-1",
        "uniprot_id": "WNK3_MOUSE",
        "mass": 193991.0,
        "length": 1757,
        "protein_name": "Serine/threonine-protein kinase WNK3",
        "gene_name": "Wnk3",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein kinase WNK3 isoform 1",
        "refseq_ac": "NP_001258607",
        "gene_names_uniprotkb": "Wnk3",
        "gene_names_refseq": "Prkwnk3; Wnk3-ps; Wnk3",
        "protein_names_uniprotkb": "Serine/threonine-protein kinase WNK3; 2.7.11.1; Protein kinase lysine-deficient 3; Protein kinase with no lysine 3",
        "protein_names_refseq": "WNK lysine deficient protein kinase 3, pseudogene; protein kinase lysine-deficient 3; protein kinase with no lysine 3; serine/threonine-protein kinase WNK3 isoform 1; serine/threonine-protein kinase WNK3",
        "tax_id": 10090,
        "disease": "Prieto syndrome (Disease Ontology:DOID:0060805); pseudohypoaldosteronism (Disease Ontology:DOID:4479)",
        "pathway": " (mmu:279561)",
        "pathway_count": 1,
        "publication_count": 16,
        "publication_id_list": "16275911;16275913;16357011;19470686;21183079;21317537;21750661;22645316;30917032;32782141;34203471;34428180;34887587;35820727;36852467;40885482",
        "class_list": "",
        "function": "Effects of WNK3 on these transporters and their coexpression in renal epithelia implicate WNK3 in NaCl, water, and blood pressure homeostasis, perhaps via signaling downstream of vasopressin, [RefSeq, PubMed]; Serine/threonine-protein kinase component of the WNK3-SPAK/OSR1 kinase cascade, which plays an important role in the regulation of electrolyte homeostasis and regulatory volume increase in response to hyperosmotic stress (By similarity). WNK3 mediates regulatory volume increase in response to hyperosmotic stress by acting as a molecular crowding sensor, which senses cell shrinkage and mediates formation of a membraneless compartment by undergoing liquid-liquid phase separation (By similarity). The membraneless compartment concentrates WNK3 with its substrates, OXSR1/OSR1 and STK39/SPAK, promoting WNK3-dependent phosphorylation and activation of downstream kinases OXSR1/OSR1 and STK39/SPAK (By similarity). Following activation, OXSR1/OSR1 and STK39/SPAK catalyze phosphorylation of ion cotransporters SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A3/NCC, SLC12A4/KCC1, SLC12A5/KCC2 or SLC12A6/KCC3, regulating their activity (PubMed:19470686). Phosphorylation of Na-K-Cl cotransporters SLC12A2/NKCC1 and SLC12A2/NKCC1 promote their activation and ion influx; simultaneously, phosphorylation of K-Cl cotransporters SLC12A4/KCC1, SLC12A5/KCC2 and SLC12A6/KCC3 inhibits its activity, blocking ion efflux (By similarity). Phosphorylates WNK4, possibly regulating the activity of SLC12A3/NCC (By similarity). May also phosphorylate NEDD4L (By similarity). Also acts as a scaffold protein independently of its protein kinase activity: negatively regulates cell membrane localization of various transporters and channels, such as KCNJ1 and SLC26A9 (By similarity). Increases Ca(2+) influx mediated by TRPV5 and TRPV6 by enhancing their membrane expression level via a kinase-dependent pathway (By similarity)., [UniProtKB, UniProtKB, PubMed]; Suggest that WNK3 is part of the Cl(-)/volume-sensing mechanism necessary for the maintenance of cell volume during osmotic stress and the dynamic modulation of GABA neurotransmission, [RefSeq, PubMed]; WNK kinase-dependent pathway can affect both the trafficking as well as intrinsic activity of NKCC2., [RefSeq, PubMed]; WNK3 is likely a component of one of the mechanisms that determines the balance between renal NaCl reabsorption and K+ secretion., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 7,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 7,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 7,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 8,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "H6WJI2;H6WJI3",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0019870 potassium channel inhibitor activity;GO:0004672 protein kinase activity;GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0044325 transmembrane transporter binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005912 adherens junction;GO:0005923 bicellular tight junction",
        "go_biological_process": "GO:0090279 regulation of calcium ion import;GO:0007231 osmosensory signaling pathway;GO:0010800 positive regulation of peptidyl-threonine phosphorylation;GO:0035556 intracellular signal transduction;GO:0043066 negative regulation of apoptotic process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.5,
        "record_id": "Q80XP9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P22227-1",
        "uniprot_id": "ZFP42_MOUSE",
        "mass": 32398.0,
        "length": 288,
        "protein_name": "Zinc finger protein 42",
        "gene_name": "Zfp42",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 42",
        "refseq_ac": "NP_033582",
        "gene_names_uniprotkb": "Zfp42; Rex-1; Rex1",
        "gene_names_refseq": "Rex-1; Rex1; Zfp-42; Zfp42",
        "protein_names_uniprotkb": "Zinc finger protein 42; REX-1; Reduced expression protein 1; Zfp-42; mREX-1",
        "protein_names_refseq": "mREX-1; reduced expression protein 1; zinc finger protein 42",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22702)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "15749260;16714766;16908534;16960129;1821852;21085182;21750661;22596162;2511439;38113263;8474450",
        "class_list": "glycogene",
        "function": "Involved in the reprogramming of X-chromosome inactivation during the acquisition of pluripotency. Required for efficient elongation of TSIX, a non-coding RNA antisense to XIST. Binds DXPas34 enhancer within the TSIX promoter. Involved in ES cell self-renewal., [UniProtKB, PubMed, PubMed]; Roles of the Rlim-Rex1 axis during X chromosome inactivation in mice., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 7,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q4KMN3;Q7TPU3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0043565 sequence-specific DNA binding;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005667 transcription regulator complex;GO:0000785 chromatin;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0001701 in utero embryonic development;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0007286 spermatid development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "P22227-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80U44-1",
        "uniprot_id": "ZFY16_MOUSE",
        "mass": 166670.0,
        "length": 1528,
        "protein_name": "Zinc finger FYVE domain-containing protein 16",
        "gene_name": "Zfyve16",
        "organism": "Mouse",
        "refseq_name": "zinc finger FYVE domain-containing protein 16",
        "refseq_ac": "NP_775568",
        "gene_names_uniprotkb": "Zfyve16; Kiaa0305",
        "gene_names_refseq": "B130024H06Rik; B130031L15; Zfyve16; mKIAA0305",
        "protein_names_uniprotkb": "Zinc finger FYVE domain-containing protein 16; Endofin; Endosomal-associated FYVE domain protein",
        "protein_names_refseq": "endofin; endosomal-associated FYVE domain protein; zinc finger FYVE domain-containing protein 16",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:218441);  (R-MMU-201451)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "19144319;21183079;25428506;29247407;30084848;31219806;34428180;36210013",
        "class_list": "",
        "function": "May be involved in regulating membrane trafficking in the endosomal pathway. Overexpression induces endosome aggregation. Required to target TOM1 to endosomes (By similarity)., [UniProtKB]; The proportion of T cells in the peripheral blood of Zfyve16(KO) mice increases compared with that in wild-type mice. B cell proliferation is inhibited in Zfyve16(KO) mice. The proliferation potential of Zfyve16(KO) B-lymphoid cells also significantly decreases in vitro. Zfyve16 inhibits the proliferation of T cells, possibly through the TGF-beta signaling, but upregulates the proliferation of B-lymphoid cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BRD2;Q8CG97",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005547 phosphatidylinositol-3,4,5-trisphosphate binding;GO:0008270 zinc ion binding;GO:0005545 1-phosphatidylinositol binding",
        "go_cellular_component": "GO:0005769 early endosome;GO:0005829 cytosol;GO:0031901 early endosome membrane",
        "go_biological_process": "GO:0016197 endosomal transport;GO:0006622 protein targeting to lysosome",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q80U44-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BGV5-1",
        "uniprot_id": "ZNF8_MOUSE",
        "mass": 64737.0,
        "length": 572,
        "protein_name": "Zinc finger protein 8",
        "gene_name": "Znf8",
        "organism": "Mouse",
        "refseq_name": "zinc finger protein 8",
        "refseq_ac": "NP_722497",
        "gene_names_uniprotkb": "Znf8; Zfp128",
        "gene_names_refseq": "9630016P15Rik; Zfp128; Znf8; mZnf8",
        "protein_names_uniprotkb": "Zinc finger protein 8; Zinc finger protein 128",
        "protein_names_refseq": "zinc finger protein 8",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:243833)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "12370310;34428180",
        "class_list": "",
        "function": "Transcriptional repressor. May modulate BMP and TGF-beta signal transduction, through its interaction with SMAD proteins., [UniProtKB, PubMed]; Znf8 plays a role in BMP signaling during spermatogenesis in mice, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q52KP6;Q8BJ50",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8BGV5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QXY1-1",
        "uniprot_id": "ZO3_MOUSE",
        "mass": 99324.0,
        "length": 905,
        "protein_name": "Tight junction protein ZO-3",
        "gene_name": "Tjp3",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Tjp3; Zo3",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Tight junction protein ZO-3; Tight junction protein 3; Zona occludens protein 3; Zonula occludens protein 3",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 10,
        "publication_id_list": "10601346;14622136;17000770;17242355;18172007;19538286;21183079;21411630;21750661;34428180",
        "class_list": "",
        "function": "Tjp1, Tjp2, and Tjp3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton (PubMed:17000770). The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Binds and recruits PatJ to tight junctions where it connects and stabilizes apical and lateral components of tight junctions (By similarity). Promotes cell-cycle progression through the sequestration of cyclin D1 (Ccnd1) at tight junctions during mitosis which prevents Ccnd1 degradation during M-phase and enables S-phase transition (PubMed:21411630). With Tjp1 and Tjp2, participates in the junctional retention and stability of the transcription factor DbpA, but is not involved in its shuttling to the nucleus (By similarity). Contrary to Tjp2, Tjp3 is dispensable for individual viability, embryonic development, epithelial differentiation, and the establishment of TJs, at least in the laboratory environment (PubMed:17000770, PubMed:18172007)., [UniProtKB, UniProtKB, PubMed, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 14,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0050839 cell adhesion molecule binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0005911 cell-cell junction",
        "go_biological_process": "GO:0150105 protein localization to cell-cell junction;GO:0098609 cell-cell adhesion;GO:0090557 establishment of endothelial intestinal barrier;GO:2000045 regulation of G1/S transition of mitotic cell cycle;GO:0045216 cell-cell junction organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9QXY1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P30355-1",
        "uniprot_id": "AL5AP_MOUSE",
        "mass": 18136.0,
        "length": 161,
        "protein_name": "Arachidonate 5-lipoxygenase-activating protein",
        "gene_name": "Alox5ap",
        "organism": "Mouse",
        "refseq_name": "arachidonate 5-lipoxygenase-activating protein isoform 1",
        "refseq_ac": "NP_033793",
        "gene_names_uniprotkb": "Alox5ap; Flap",
        "gene_names_refseq": "Alox5ap; Flap",
        "protein_names_uniprotkb": "Arachidonate 5-lipoxygenase-activating protein; FLAP; MK-886-binding protein",
        "protein_names_refseq": "MK-886-binding protein; arachidonate 5-lipoxygenase-activating protein isoform 1",
        "tax_id": 10090,
        "disease": "stroke (Disease Ontology:DOID:0051061); common cold (Disease Ontology:DOID:10459); breast cancer (Disease Ontology:DOID:1612); cerebral palsy (Disease Ontology:DOID:1969); arteriosclerosis (Disease Ontology:DOID:2349); asthma (Disease Ontology:DOID:2841); glomerulonephritis (Disease Ontology:DOID:2921); coronary artery disease (Disease Ontology:DOID:3393); brain infarction (Disease Ontology:DOID:3454); cerebral infarction (Disease Ontology:DOID:3526); kidney disease (Disease Ontology:DOID:557); myocardial infarction (Disease Ontology:DOID:5844); pulmonary hypertension (Disease Ontology:DOID:6432); neuroblastoma (Disease Ontology:DOID:769); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:11690);  (R-MMU-2142688);  (R-MMU-2142691);  (R-MMU-2142700)",
        "pathway_count": 4,
        "publication_count": 7,
        "publication_id_list": "1480129;19075240;21750661;27207555;29311656;30084848;34428180",
        "class_list": "",
        "function": "ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance, [RefSeq, PubMed]; Required for leukotriene biosynthesis by ALOX5 (5-lipoxygenase). Anchors ALOX5 to the membrane. Binds arachidonic acid, and could play an essential role in the transfer of arachidonic acid to ALOX5. Binds to MK-886, a compound that blocks the biosynthesis of leukotrienes (By similarity)., [UniProtKB, PubMed]; Within the endothelial population, cells that transition from haemogenic endothelial to erythro-myeloid progenitors specifically express Alox5 and its co-factor Alox5ap, which control leukotriene production. Functional assays using mouse embryonic stem cells demonstrate that leukotrienes promote haematopoietic progenitor cell generation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 15,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D138",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004364 glutathione transferase activity;GO:0004464 leukotriene-C4 synthase activity;GO:0008047 enzyme activator activity;GO:0019899 enzyme binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005635 nuclear envelope;GO:0005783 endoplasmic reticulum;GO:0031965 nuclear membrane;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0002675 positive regulation of acute inflammatory response;GO:0071277 cellular response to calcium ion;GO:0019370 leukotriene biosynthetic process;GO:0019372 lipoxygenase pathway;GO:0070207 protein homotrimerization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "P30355-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P62743-1",
        "uniprot_id": "AP2S1_MOUSE",
        "mass": 17018.0,
        "length": 142,
        "protein_name": "AP-2 complex subunit sigma",
        "gene_name": "Ap2s1",
        "organism": "Mouse",
        "refseq_name": "AP-2 complex subunit sigma",
        "refseq_ac": "NP_941015",
        "gene_names_uniprotkb": "Ap2s1; Ap17; Claps2",
        "gene_names_refseq": "Ap2s1",
        "protein_names_uniprotkb": "AP-2 complex subunit sigma; Adaptor protein complex AP-2 subunit sigma; Adaptor-related protein complex 2 subunit sigma; Clathrin assembly protein 2 sigma small chain; Clathrin coat assembly protein AP17; Clathrin coat-associated protein AP17; Plasma membrane adaptor AP-2 17 kDa protein; Sigma-adaptin 3b; Sigma2-adaptin",
        "protein_names_refseq": "AP-2 complex subunit sigma; adapter-related protein complex 2 sigma subunit; adapter-related protein complex 2 subunit sigma; adaptor protein complex AP-2 subunit sigma; adaptor-related protein complex 2 subunit sigma; clathrin assembly protein 2 sigma small chain; clathrin assembly protein 2 small chain; clathrin coat assembly protein AP17; clathrin coat-associated protein AP17; plasma membrane adaptor AP-2 17 kDa protein; sigma-adaptin 3b; sigma2-adaptin",
        "tax_id": 10090,
        "disease": "autism spectrum disorder (Disease Ontology:DOID:0060041); familial hypocalciuric hypercalcemia 3 (Disease Ontology:DOID:0060702)",
        "pathway": " (mmu:232910);  (R-MMU-177504);  (R-MMU-2132295);  (R-MMU-416993);  (R-MMU-437239);  (R-MMU-5099900);  (R-MMU-5140745);  (R-MMU-8856825);  (R-MMU-8856828);  (R-MMU-8866427);  (R-MMU-8964038)",
        "pathway_count": 11,
        "publication_count": 9,
        "publication_id_list": "12086608;14745134;15473838;19140243;21750661;33300544;33729479;36412210;37507081",
        "class_list": "",
        "function": "AP2S1 regulates APP degradation through late endosome-lysosome fusion in cells and APP/PS1 mice., [RefSeq, PubMed]; Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2., [RefSeq, PubMed]; Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via Transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. The AP-2 alpha and AP-2 sigma subunits are thought to contribute to the recognition of the [ED]-X-X-X-L-[LI] motif. May also play a role in extracellular calcium homeostasis (By similarity)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 10,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P70626;P97626;Q00380",
        "ec_number_list": "",
        "go_molecular_function": "GO:0035615 clathrin adaptor activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0045202 synapse;GO:0098794 postsynapse;GO:0009898 cytoplasmic side of plasma membrane;GO:0030122 AP-2 adaptor complex",
        "go_biological_process": "GO:0098884 postsynaptic neurotransmitter receptor internalization;GO:0006886 intracellular protein transport;GO:0016192 vesicle-mediated transport;GO:0072583 clathrin-dependent endocytosis;GO:0048488 synaptic vesicle endocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "P62743-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TSV6-1",
        "uniprot_id": "AATC2_MOUSE",
        "mass": 45458.0,
        "length": 404,
        "protein_name": "Aspartate aminotransferase, cytoplasmic 2",
        "gene_name": "Got1l1",
        "organism": "Mouse",
        "refseq_name": "putative aspartate aminotransferase, cytoplasmic 2",
        "refseq_ac": "NP_083950",
        "gene_names_uniprotkb": "Got1l1; DR",
        "gene_names_refseq": "1700083M11Rik; Got1l1",
        "protein_names_uniprotkb": "Aspartate aminotransferase, cytoplasmic 2; 2.6.1.1; Glutamate oxaloacetate transaminase 1-like protein 1; Transaminase A-like protein 1",
        "protein_names_refseq": "glutamate oxaloacetate transaminase 1-like protein 1; putative aspartate aminotransferase, cytoplasmic 2; transaminase A-like protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76615)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "20133766;21750661;25287256;25646960",
        "class_list": "",
        "function": "Catalyzes the conversion of L-aspartate and 2-oxoglutarate to L-glutamate and oxaloacetate (PubMed:25287256). It has been proposed to exhibit aspartate racemase activity, but this function remains debated and lacks strong experimental support (PubMed:20133766, PubMed:25287256)., [UniProtKB, PubMed, PubMed]; Got1l1 is not the major aspartate racemase and is highly expressed in the testis, but it is not detected in the brain and submandibular gland., [RefSeq, PubMed]; The rat and human homologs of mouse GOT1L1 are not involved in D-aspartate biosynthesis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D9F3",
        "ec_number_list": "2.6.1.1;2.6.1.3;2.6.1.7",
        "go_molecular_function": "GO:0030170 pyridoxal phosphate binding;GO:0004069 L-aspartate:2-oxoglutarate aminotransferase activity",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0006532 aspartate biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q7TSV6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80Y20-1",
        "uniprot_id": "ALKB8_MOUSE",
        "mass": 74768.0,
        "length": 664,
        "protein_name": "tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8",
        "gene_name": "Alkbh8",
        "organism": "Mouse",
        "refseq_name": "tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8 isoform 2",
        "refseq_ac": "NP_080579",
        "gene_names_uniprotkb": "Alkbh8",
        "gene_names_refseq": "4930562C03Rik; 8030431D03Rik; 9430088N01Rik; Abh8; Alkbh8",
        "protein_names_uniprotkb": "tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8; 2.1.1.229; Alkylated DNA repair protein alkB homolog 8; Alpha-ketoglutarate-dependent dioxygenase ALKBH8; S-adenosyl-L-methionine-dependent tRNA methyltransferase ALKBH8",
        "protein_names_refseq": "S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8; S-adenosyl-L-methionine-dependent tRNA methyltransferase ALKBH8; alkB, alkylation repair homolog 8; alkylated DNA repair protein alkB homolog 8; alpha-ketoglutarate-dependent dioxygenase ALKBH8; probable alpha-ketoglutarate-dependent dioxygenase ABH8; tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8; tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8 isoform 2; tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8",
        "tax_id": 10090,
        "disease": "autosomal recessive intellectual developmental disorder 71 (Disease Ontology:DOID:0081232)",
        "pathway": " (mmu:67667)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;20123966;20583019;21750661;31219806;32303148;34428180",
        "class_list": "",
        "function": "Catalyzes the methylation of 5-carboxymethyl uridine to 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in tRNA via its methyltransferase domain (PubMed:20123966). Catalyzes the last step in the formation of 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in target tRNA (PubMed:20123966). Has a preference for tRNA(Arg) and tRNA(Glu), and does not bind tRNA(Lys) (By similarity). Binds tRNA and catalyzes the iron and alpha-ketoglutarate dependent hydroxylation of 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in tRNA via its dioxygenase domain, giving rise to 5-(S)-methoxycarbonylhydroxymethyluridine; has a preference for tRNA(Gly) (PubMed:20583019). Required for normal survival after DNA damage (By similarity). May inhibit apoptosis and promote cell survival and angiogenesis (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB]; Data show that ALKBH8 is a tRNA methyltransferase required for the final step in the biogenesis of mcm5U. GeneRIF: The methyltransferase domain of ALKBH8 is demonstrated to be a functional homologue of the Saccharomyces cerevisiae Trm9 protein, mediating the last step in the formation of the wobble uridine modification 5-methoxycarbonylmethyl-uridine in tRNA. This modification is shown to be important for efficient selenoprotein synthesis. ALKBH8 knock-out mice are generated and described., [RefSeq, PubMed]; The epitranscriptomic writer ALKBH8 drives tolerance and protects mouse lungs from the environmental pollutant naphthalene., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9671,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TUG4;Q8BV08;Q9CX44",
        "ec_number_list": "2.1.1.229",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0008270 zinc ion binding;GO:0000049 tRNA binding;GO:0016706 2-oxoglutarate-dependent dioxygenase activity;GO:0008757 S-adenosylmethionine-dependent methyltransferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0043527 tRNA methyltransferase complex",
        "go_biological_process": "GO:0006974 DNA damage response;GO:0002098 tRNA wobble uridine modification;GO:0030488 tRNA methylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q80Y20-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C0I1-1",
        "uniprot_id": "ADAS_MOUSE",
        "mass": 71684.0,
        "length": 645,
        "protein_name": "Alkyldihydroxyacetonephosphate synthase, peroxisomal",
        "gene_name": "Agps",
        "organism": "Mouse",
        "refseq_name": "alkyldihydroxyacetonephosphate synthase, peroxisomal",
        "refseq_ac": "NP_766254",
        "gene_names_uniprotkb": "Agps",
        "gene_names_refseq": "5832437L22; 9930035G10Rik; Adaps; Adas; Adhaps; Adps; Agps; Aldhpsy; bs2",
        "protein_names_uniprotkb": "Alkyldihydroxyacetonephosphate synthase, peroxisomal; 2.5.1.26; Alkyl-DHAP synthase; Alkylglycerone-phosphate synthase",
        "protein_names_refseq": "alkyl-DHAP synthase; alkyldihydroxyacetonephosphate synthase, peroxisomal",
        "tax_id": 10090,
        "disease": "rhizomelic chondrodysplasia punctata type 3 (Disease Ontology:DOID:0110853); rhizomelic chondrodysplasia punctata (Disease Ontology:DOID:2580)",
        "pathway": " (mmu:228061);  (R-MMU-75896);  (R-MMU-9033241)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "15345747;17242355;21183079;21353609;21750661;31219806;6833249",
        "class_list": "",
        "function": "Catalyzes the exchange of an acyl for a long-chain alkyl group and the formation of the ether bond in the biosynthesis of ether phospholipids., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Catalyzes the exchange of the acyl chain in acyl-dihydroxyacetonephosphate (acyl-DHAP) for a long chain fatty alcohol, yielding the first ether linked intermediate, i.e. alkyl-dihydroxyacetonephosphate (alkyl-DHAP), in the pathway of ether lipid biosynthesis., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, PubMed]; Linkage analysis mapped the bs2 locus to mouse chromosome 2, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.3.2.27;1.14.11.18;2.3.2.36;2.3.1.42;2.5.1.26;2.3.1.16;2.3.1.9;2.3.1.155;3.4.21.-",
        "go_molecular_function": "GO:0008609 alkylglycerone-phosphate synthase activity;GO:0071949 FAD binding;GO:0050660 flavin adenine dinucleotide binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005777 peroxisome;GO:0005778 peroxisomal membrane;GO:0005782 peroxisomal matrix",
        "go_biological_process": "GO:0008610 lipid biosynthetic process;GO:0008611 ether lipid biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8C0I1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BS35-1",
        "uniprot_id": "ALKMO_MOUSE",
        "mass": 51778.0,
        "length": 447,
        "protein_name": "Alkylglycerol monooxygenase",
        "gene_name": "Agmo",
        "organism": "Mouse",
        "refseq_name": "alkylglycerol monooxygenase",
        "refseq_ac": "NP_848882",
        "gene_names_uniprotkb": "Agmo; Tmem195",
        "gene_names_refseq": "A530016O06Rik; Agmo; Tmem195",
        "protein_names_uniprotkb": "Alkylglycerol monooxygenase; 1.14.16.5; Transmembrane protein 195",
        "protein_names_refseq": "alkylglycerol monooxygenase; transmembrane protein 195",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:319660);  (R-MMU-75109)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;20643956;21750661;23743196;25675482;30899004;34428180",
        "class_list": "",
        "function": "Glyceryl-ether monooxygenase that cleaves the O-alkyl bond of ether lipids. Ether lipids are essential components of brain membranes (By similarity)., [UniProtKB]; Results suggest a possible mechanism for Alkylglycerol monooxygenase (AGMO) in modulating macrophage platelet-activating factor (PAF) production by regulating cellular lyso-PAF levels., [RefSeq, PubMed]; These results demonstrate a central role of tetrahydrobiopterin and alkylglycerol monooxygenase in ether lipid metabolism of murine macrophages., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TR15;Q8C7H5;Q8CAA6",
        "ec_number_list": "1.14.16.5",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0050479 glyceryl-ether monooxygenase activity;GO:0016491 oxidoreductase activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane;GO:0012505 endomembrane system",
        "go_biological_process": "GO:0006643 membrane lipid metabolic process;GO:0019432 triglyceride biosynthetic process;GO:0046485 ether lipid metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8BS35-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EQX4-1",
        "uniprot_id": "AIF1L_MOUSE",
        "mass": 17024.0,
        "length": 150,
        "protein_name": "Allograft inflammatory factor 1-like",
        "gene_name": "Aif1l",
        "organism": "Mouse",
        "refseq_name": "allograft inflammatory factor 1-like",
        "refseq_ac": "NP_660126",
        "gene_names_uniprotkb": "Aif1l; Iba2",
        "gene_names_refseq": "2810003C17Rik; Aif1l; Iba2",
        "protein_names_uniprotkb": "Allograft inflammatory factor 1-like; Ionized calcium-binding adapter molecule 2",
        "protein_names_refseq": "allograft inflammatory factor 1-like; ionized calcium binding adapter molecule 2",
        "tax_id": 10090,
        "disease": "breast cancer (Disease Ontology:DOID:1612)",
        "pathway": " (mmu:108897)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Actin-binding protein that promotes actin bundling. May neither bind calcium nor depend on calcium for function (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C150",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051015 actin filament binding;GO:0005509 calcium ion binding;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005884 actin filament;GO:0005925 focal adhesion;GO:0015629 actin cytoskeleton;GO:0030027 lamellipodium;GO:0032587 ruffle membrane",
        "go_biological_process": "GO:0051017 actin filament bundle assembly;GO:0097178 ruffle assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9EQX4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K1C0-1",
        "uniprot_id": "ANGE2_MOUSE",
        "mass": 62413.0,
        "length": 544,
        "protein_name": "RNA 2',3'-cyclic phosphatase ANGEL2",
        "gene_name": "Angel2",
        "organism": "Mouse",
        "refseq_name": "RNA 2',3'-cyclic phosphatase ANGEL2 isoform 2",
        "refseq_ac": "NP_001185949",
        "gene_names_uniprotkb": "Angel2; D1Ertd396e; D1Ertd654e; MNCb-4273",
        "gene_names_refseq": "2610307I21Rik; 5730410O10Rik; Angel2; D1Ertd396e; D1Ertd654e",
        "protein_names_uniprotkb": "RNA 2',3'-cyclic phosphatase ANGEL2; 3.-.-.-",
        "protein_names_refseq": "RNA 2',3'-cyclic phosphatase ANGEL2 isoform 2; RNA 2',3'-cyclic phosphatase ANGEL2; protein angel homolog 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:52477)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;28135057;34428180;36180430",
        "class_list": "",
        "function": "ANGEL2 phosphatase activity is required for non-canonical mitochondrial RNA processing. Publication Status: Online-Only, [RefSeq, PubMed]; RNA 2',3'-cyclic phosphatase that catalyzes the hydrolysis of RNA molecules with a 2',3'-cyclic phosphate at the 3' end to produce RNA with a linear 3'-phosphate group (PubMed:36180430). Essential for the maturation and processing of mitochondrial RNAs, particularly those generated via non-canonical pathways (PubMed:36180430). Antagonizes pre-tRNA processing and XBP1 mRNA splicing during the unfolded protein response by limiting the availability of 2',3'-cyclic phosphate substrates for the tRNA ligase complex (By similarity). Promotes tRNA recycling by eliminating 2',3'-cyclic phosphate groups from cleaved tRNAs, thereby enabling the tRNA nucleotidyltransferase TRNT1 to reattach the CCA tail essential for aminoacylation and subsequent translation (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TEH1;Q3TL94;Q8BTT0;Q9JJB0",
        "ec_number_list": "3.-.-.-",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0003730 mRNA 3'-UTR binding;GO:0160273 RNA 2'-phosphatase activity;GO:0160272 RNA 2',3'-cyclic phosphatase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005759 mitochondrial matrix;GO:0015030 Cajal body",
        "go_biological_process": "GO:0008033 tRNA processing;GO:0008380 RNA splicing;GO:0045930 negative regulation of mitotic cell cycle;GO:0070935 3'-UTR-mediated mRNA stabilization;GO:0033119 negative regulation of RNA splicing",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q8K1C0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3U1U7-1",
        "uniprot_id": "AHRR_MOUSE",
        "mass": 77760.0,
        "length": 701,
        "protein_name": "Aryl hydrocarbon receptor repressor",
        "gene_name": "Ahrr",
        "organism": "Mouse",
        "refseq_name": "aryl hydrocarbon receptor repressor isoform 2",
        "refseq_ac": "NP_001304280",
        "gene_names_uniprotkb": "Ahrr; Kiaa1234",
        "gene_names_refseq": "Ahrr; mKIAA1234",
        "protein_names_uniprotkb": "Aryl hydrocarbon receptor repressor; AhR repressor; AhRR",
        "protein_names_refseq": "ahR repressor; aryl hydrocarbon receptor repressor isoform 2",
        "tax_id": 10090,
        "disease": "hypertension (Disease Ontology:DOID:10763)",
        "pathway": " (mmu:11624);  (R-MMU-211945);  (R-MMU-211976);  (R-MMU-211981);  (R-MMU-8937144)",
        "pathway_count": 5,
        "publication_count": 7,
        "publication_id_list": "12520768;17949687;21750661;30084848;32213963;34428180;9887096",
        "class_list": "",
        "function": "AHR Signaling Dampens Inflammatory Signature in Neonatal Skin gammadelta T Cells. Publication Status: Online-Only, [RefSeq, PubMed]; Mediates dioxin toxicity and is involved in regulation of cell growth and differentiation. Represses the transcription activity of AHR by competing with AHR for heterodimer formation with ARNT and subsequently binding to the xenobiotic response element (XRE) sequence present in the promoter regulatory region of a variety of genes. Represses CYP1A1 by binding the XRE sequence and recruiting ANKRA2, HDAC4 and/or HDAC5. Autoregulates its expression by associating with its own XRE site., [UniProtKB, PubMed, PubMed]; This gene encodes a protein that represses aryl hydrocarbon receptor-dependent signaling. The encoded protein competes with the aryl hydrocarbon receptor transcription factor for heterodimerization with the aryl hydrocarbon receptor nuclear translocator protein and binding to xenobiotic response element (XRE) sequence in many genes. This protein is implicated in the regulation of cell growth and differentiation as well as mediating dioxin toxicity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A0R4J020;Q147Z5;Q3U3H6;Q69ZN4;Q9Z312",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046983 protein dimerization activity;GO:0000976 transcription cis-regulatory region binding;GO:0004879 nuclear receptor activity;GO:0003677 DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0034751 aryl hydrocarbon receptor complex",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045892 negative regulation of DNA-templated transcription;GO:0006805 xenobiotic metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q3U1U7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C4Q6-1",
        "uniprot_id": "AIDA_MOUSE",
        "mass": 34888.0,
        "length": 305,
        "protein_name": "Axin interactor, dorsalization-associated protein",
        "gene_name": "Aida",
        "organism": "Mouse",
        "refseq_name": "axin interactor, dorsalization-associated protein",
        "refseq_ac": "NP_859421",
        "gene_names_uniprotkb": "Aida",
        "gene_names_refseq": "2610208M17Rik; Aida",
        "protein_names_uniprotkb": "Axin interactor, dorsalization-associated protein; Axin interaction partner and dorsalization antagonist",
        "protein_names_refseq": "axin interaction partner and dorsalization antagonist; axin interactor, dorsalization-associated protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:108909)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "17681137;21750661;29617643;33664495",
        "class_list": "",
        "function": "AIDA directly connects sympathetic innervation to adaptive thermogenesis by UCP1., [RefSeq, PubMed]; AIDA plays a central role in coordinating the abundance of the enzymes for triacylglycerol synthesis., [RefSeq, PubMed]; Acts as a ventralizing factor during embryogenesis (By similarity). Inhibits axin-mediated JNK activation by binding axin and disrupting axin homodimerization. This in turn antagonizes a Wnt/beta-catenin-independent dorsalization pathway activated by AXIN/JNK-signaling., [UniProtKB, PubMed]; Aida blocks Axin-mediated JNK activation by disrupting Axin homodimerization. In zebrafish embryos, the dorsalization induced by axin could be repressed by aida. This activity of aida is conferred by its ability to block Axin-mediated JNK activity., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U6V0;Q3UP85;Q6NXY2;Q6PG77;Q78W09;Q99K80",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019904 protein domain specific binding;GO:0035091 phosphatidylinositol binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0016020 membrane",
        "go_biological_process": "GO:0031333 negative regulation of protein-containing complex assembly;GO:0009953 dorsal/ventral pattern formation;GO:0043508 negative regulation of JUN kinase activity;GO:0046329 negative regulation of JNK cascade;GO:0048264 determination of ventral identity",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q8C4Q6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O08807-1",
        "uniprot_id": "PRDX4_MOUSE",
        "mass": 31053.0,
        "length": 274,
        "protein_name": "Peroxiredoxin-4",
        "gene_name": "Prdx4",
        "organism": "Mouse",
        "refseq_name": "peroxiredoxin-4 isoform 1 precursor",
        "refseq_ac": "NP_001300640",
        "gene_names_uniprotkb": "Prdx4",
        "gene_names_refseq": "AOE372; Prdx4; Prx-iv; Prx4; TRANK",
        "protein_names_uniprotkb": "Peroxiredoxin-4; 1.11.1.24; Antioxidant enzyme AOE372; Peroxiredoxin IV; Prx-IV; Thioredoxin peroxidase AO372; Thioredoxin-dependent peroxide reductase A0372; Thioredoxin-dependent peroxiredoxin 4",
        "protein_names_refseq": "Prx IV; antioxidant enzyme AOE372; peroxiredoxin IV; peroxiredoxin-4 isoform 1 precursor; thioredoxin peroxidase AO372; thioredoxin-dependent peroxide reductase A0372; thioredoxin-dependent peroxiredoxin 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:53381);  (R-MMU-6798695)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "11229364;21540332;21750661;22645316;23949117;24788674;30042374;31219806;33725478;34428180;37453647;38437534;38641608;38971505",
        "class_list": "",
        "function": "Endothelial peroxiredoxin-4 is indispensable for blood-brain barrier integrity and long-term functional recovery after ischemic stroke., [RefSeq, PubMed]; Peroxiredoxin 4 deficiency induces accelerated ovarian aging through destroyed proteostasis in granulosa cells., [RefSeq, PubMed]; Revealing Prdx4 as a potential diagnostic and therapeutic target for acute pancreatitis based on machine learning analysis. Publication Status: Online-Only, [RefSeq, PubMed]; Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events (PubMed:11229364). Regulates the activation of NF-kappa-B in the cytosol by a modulation of I-kappa-B-alpha phosphorylation (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AZS7;Q3U8E4",
        "ec_number_list": "2.4.1.25;3.2.1.33;3.5.4.6;1.11.1.24;3.4.22.52;3.4.19.12;3.4.22.27;1.1.1.42;3.4.21.46;4.1.2.13;5.3.1.9;5.1.3.-;3.6.4.10;2.4.2.7;1.16.3.1;3.6.5.-;4.2.1.24;3.4.22.1;3.2.1.31;2.7.1.11;2.7.10.2;5.2.1.8;3.4.23.5;2.5.1.18;4.2.99.18;5.6.2.4;2.4.2.1;3.2.1.23;1.11.1.6;3.3.2.6;3.4.11.4;1.1.1.205;5.3.2.1;5.3.3.12;3.4.24.35;3.6.1.-;2.7.11.24;1.13.11.-;1.13.11.34;1.11.1.7;3.1.6.12;2.7.11.1;2.7.1.40;3.5.4.5;3.4.25.1;2.7.11.39;2.7.4.6;2.7.13.3;3.6.4.6;2.7.1.1;2.7.1.-;3.1.1.47;3.6.4.13;2.7.11.22;2.7.11.23;2.3.2.26;5.4.2.2;5.4.2.7;2.3.2.27;3.1.6.14;2.7.1.35;3.4.19.1;3.6.1.6;2.3.3.8;4.1.2.4;2.3.2.5;5.4.2.11;5.4.2.4;2.4.1.1;2.4.1.186;3.4.18.1;3.5.1.23;3.5.1.-",
        "go_molecular_function": "GO:0060090 molecular adaptor activity;GO:0042802 identical protein binding;GO:0008379 thioredoxin peroxidase activity;GO:0140313 molecular sequestering activity;GO:0140824 thioredoxin-dependent peroxiredoxin activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum;GO:0005790 smooth endoplasmic reticulum",
        "go_biological_process": "GO:2000255 negative regulation of male germ cell proliferation;GO:0006979 response to oxidative stress;GO:0007283 spermatogenesis;GO:0030198 extracellular matrix organization;GO:0008584 male gonad development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "O08807-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CPV2-1",
        "uniprot_id": "APC16_MOUSE",
        "mass": 11667.0,
        "length": 110,
        "protein_name": "Anaphase-promoting complex subunit 16",
        "gene_name": "Anapc16",
        "organism": "Mouse",
        "refseq_name": "anaphase-promoting complex subunit 16 isoform 2",
        "refseq_ac": "NP_001334380",
        "gene_names_uniprotkb": "Anapc16; D10Ertd641e",
        "gene_names_refseq": "2310005G07Rik; APC16; Anapc16; D10Ertd641e",
        "protein_names_uniprotkb": "Anaphase-promoting complex subunit 16; APC16; Cyclosome subunit 16",
        "protein_names_refseq": "anaphase-promoting complex subunit 16 isoform 2; cyclosome subunit 16",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:52717);  (R-MMU-141430);  (R-MMU-174048);  (R-MMU-174084);  (R-MMU-174154);  (R-MMU-174178);  (R-MMU-174184);  (R-MMU-176407);  (R-MMU-176408);  (R-MMU-176409);  (R-MMU-176412);  (R-MMU-179409);  (R-MMU-2467813);  (R-MMU-2559582);  (R-MMU-68867);  (R-MMU-69017)",
        "pathway_count": 16,
        "publication_count": 4,
        "publication_id_list": "20360068;21750661;31219806;32782141",
        "class_list": "",
        "function": "Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. The APC/C complex catalyzes assembly of branched 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on target proteins., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005829 cytosol;GO:0000776 kinetochore;GO:0005680 anaphase-promoting complex;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0051301 cell division;GO:0016567 protein ubiquitination;GO:0031145 anaphase-promoting complex-dependent catabolic process;GO:0070979 protein K11-linked ubiquitination;GO:0070936 protein K48-linked ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9CPV2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R159-1",
        "uniprot_id": "ADA25_MOUSE",
        "mass": 86128.0,
        "length": 760,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 25",
        "gene_name": "Adam25",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 25 preproprotein",
        "refseq_ac": "NP_035911",
        "gene_names_uniprotkb": "Adam25",
        "gene_names_refseq": "Adam25",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 25; 3.4.24.-; ADAM 25; Testase-2",
        "protein_names_refseq": "a disintegrin and metallopeptidase domain 25 (testase 2); a disintegrin and metalloprotease domain 25 (testase 2); disintegrin and metalloproteinase domain-containing protein 25 preproprotein; disintegrin and metalloproteinase domain-containing protein 25",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:23793);  (R-MMU-2534343)",
        "pathway_count": 2,
        "publication_count": 2,
        "publication_id_list": "10395895;21750661",
        "class_list": "",
        "function": "Sperm surface membrane protein that may be involved in spermatogenesis and fertilization., [UniProtKB]; This gene encodes a member of a disintegrin and metalloprotease (ADAM) family of endoproteases that play important roles in various biological processes including cell signaling, adhesion and migration. This gene is expressed in a regulated fashion during spermatogenesis. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional metalloprotease enzyme. This gene is located adjacent to other ADAM genes on chromosome 8. [provided by RefSeq, May 2016]., [RefSeq]",
        "predicted_glycosites": 7,
        "predicted_n_glycosites": 7,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 5,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D4E4",
        "ec_number_list": "2.4.1.-;2.4.1.275;2.4.1.22;2.4.1.38;2.4.1.90;3.4.24.-",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0005178 integrin binding;GO:0008237 metallopeptidase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009897 external side of plasma membrane;GO:1990913 sperm head plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0006508 proteolysis;GO:0007283 spermatogenesis;GO:0030154 cell differentiation;GO:0008584 male gonad development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9R159-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2A7Z8-1",
        "uniprot_id": "ADCL3_MOUSE",
        "mass": 46340.0,
        "length": 408,
        "protein_name": "Arylacetamide deacetylase-like 3",
        "gene_name": "Aadacl3",
        "organism": "Mouse",
        "refseq_name": "arylacetamide deacetylase-like 3",
        "refseq_ac": "NP_001078972",
        "gene_names_uniprotkb": "Aadacl3",
        "gene_names_refseq": "Aadacl3; Gm435",
        "protein_names_uniprotkb": "Arylacetamide deacetylase-like 3; 3.1.1.-",
        "protein_names_refseq": "arylacetamide deacetylase-like 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:230883)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "25428506;34428180",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0052689 carboxylic ester hydrolase activity",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "A2A7Z8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A3KFX0-1",
        "uniprot_id": "5NT1A_MOUSE",
        "mass": 40678.0,
        "length": 365,
        "protein_name": "Cytosolic 5'-nucleotidase 1A",
        "gene_name": "Nt5c1a",
        "organism": "Mouse",
        "refseq_name": "cytosolic 5'-nucleotidase 1A",
        "refseq_ac": "NP_001078971",
        "gene_names_uniprotkb": "Nt5c1a",
        "gene_names_refseq": "Cn1a; Gm49; Nt5c1a",
        "protein_names_uniprotkb": "Cytosolic 5'-nucleotidase 1A; 3.1.3.5; 3.1.3.89; 3.1.3.99; 5'-deoxynucleotidase; Cytosolic 5'-nucleotidase IA; cN-IA; cN1A",
        "protein_names_refseq": "5'-deoxynucleotidase; cN-IA; cytosolic 5' nucleotidase, type 1A; cytosolic 5'-nucleotidase 1A; cytosolic 5'-nucleotidase IA",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:230718);  (R-MMU-73621);  (R-MMU-74259)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "21873433;28325731;35820727",
        "class_list": "",
        "function": "Catalyzes the hydrolysis of ribonucleotide and deoxyribonucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside (By similarity). AMP is the major substrate but can also hydrolyze dCMP and IMP (By similarity)., [UniProtKB, UniProtKB]; NT5C1A suppression promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle, [RefSeq, PubMed]; The results on muscles from the NT5C knockout mice contradict previous findings where AMP levels and AMPK activity were shown to be modulated by NT5C enzymes., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RVQ9",
        "ec_number_list": "3.1.3.5;3.1.3.89;3.1.3.99;3.1.3.1;3.9.1.1;3.1.3.91;2.7.1.77;3.1.3.35;3.6.1.-;3.1.4.1;3.6.1.9;3.1.3.2;3.1.3.48;3.1.3.-",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0000166 nucleotide binding;GO:0008253 5'-nucleotidase activity;GO:0002953 5'-deoxynucleotidase activity",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0046085 adenosine metabolic process;GO:0006196 AMP catabolic process;GO:0009128 purine nucleoside monophosphate catabolic process;GO:0000255 allantoin metabolic process;GO:0046059 dAMP catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "A3KFX0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "B5X0E4-1",
        "uniprot_id": "ABCB5_MOUSE",
        "mass": 137397.0,
        "length": 1255,
        "protein_name": "ATP-binding cassette sub-family B member 5",
        "gene_name": "Abcb5",
        "organism": "Mouse",
        "refseq_name": "ATP-binding cassette sub-family B member 5",
        "refseq_ac": "NP_084237",
        "gene_names_uniprotkb": "Abcb5",
        "gene_names_refseq": "9230106F14Rik; Abcb5",
        "protein_names_uniprotkb": "ATP-binding cassette sub-family B member 5; 7.6.2.2; ABCB5 P-gp; P-glycoprotein ABCB5",
        "protein_names_refseq": "ABCB5 P-gp; ATP-binding cassette sub-family B member 5; ATP-binding cassette, sub-family B (MDR/TAP), member 5; P-glycoprotein ABCB5",
        "tax_id": 10090,
        "disease": "cystic fibrosis (Disease Ontology:DOID:1485)",
        "pathway": " (mmu:77706);  (R-MMU-382556)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "19477512;22393060;25030174;25428506;25647612;26666373;34428180;35738589",
        "class_list": "",
        "function": "ABCB5 alleles alter susceptibility to haloperidol-induced toxicity (HIT) in mouse and humans. Publication Status: Online-Only, [RefSeq, PubMed]; ATP-binding cassette, sub-family B, member 5 (ABCB5) marks limbal stem cells (LSCs) and is required for LSC maintenance, corneal development and repair, [RefSeq, PubMed]; Energy-dependent efflux transporter responsible for decreased drug accumulation in multidrug-resistant cells (By similarity). Specifically present in limbal stem cells, where it plays a key role in corneal development and repair (PubMed:25030174)., [UniProtKB, PubMed, UniProtKB]; Expression of Abcb5.ts (testis-specific) (AY766239), a transporter consisting of 1255 amino acids and comprising two transmembrane and nucleotide binding domains, is restricted to testis tissue. In contrast, Abcb5.e (AY766238) is ubiquitously expressed., [RefSeq, PubMed]; Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues., [RefSeq, PubMed]; Results suggest that ATP binding cassette subfamily B member 5 ABCB5/Abcb5 upregulates cellular glutathione levels to protect cells from various poisons. Publication Status: Online-Only, [RefSeq, PubMed]; The helicase HAGE is required for ABCB5+ MMIC-dependent tumor growth through promoting RAS protein expression, [RefSeq, PubMed]",
        "predicted_glycosites": 11,
        "predicted_n_glycosites": 11,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 6,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 11,
        "binding_glycan_count": 0,
        "secondary_ac_list": "W5QLL5",
        "ec_number_list": "7.6.2.2;7.6.2.3;7.6.2.1;7.6.2.-",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0042626 ATPase-coupled transmembrane transporter activity;GO:0008559 ABC-type xenobiotic transporter activity;GO:0016887 ATP hydrolysis activity;GO:0015562 efflux transmembrane transporter activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016324 apical plasma membrane",
        "go_biological_process": "GO:0030154 cell differentiation;GO:0042391 regulation of membrane potential;GO:0055085 transmembrane transport;GO:0001654 eye development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "B5X0E4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9PX95-1",
        "uniprot_id": "ABCAH_MOUSE",
        "mass": 196020.0,
        "length": 1733,
        "protein_name": "ATP-binding cassette sub-family A member 17",
        "gene_name": "Abca17",
        "organism": "Mouse",
        "refseq_name": "ATP-binding cassette sub-family A member 17",
        "refseq_ac": "NP_001026792",
        "gene_names_uniprotkb": "Abca17",
        "gene_names_refseq": "Abca17",
        "protein_names_uniprotkb": "ATP-binding cassette sub-family A member 17",
        "protein_names_refseq": "ATP-binding cassette sub-family A member 17; ATP-binding cassette, sub-family A (ABC1), member 17",
        "tax_id": 10090,
        "disease": "autism spectrum disorder (Disease Ontology:DOID:0060041)",
        "pathway": " (mmu:381072)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "15810880;20485683;21750661;22237709",
        "class_list": "",
        "function": "Promotes cholesterol efflux from sperm which renders sperm capable of fertilization (PubMed:22237709). Has also been shown to decrease levels of intracellular esterified neutral lipids including cholesteryl esters, fatty acid esters and triacylglycerols (PubMed:15810880)., [UniProtKB, PubMed, PubMed]; Results suggest that ABCA17 plays an important role in the process of sterol efflux which renders spermatozoa capable of fertilizing an oocyte., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q4H4D7",
        "ec_number_list": "7.6.2.1;7.6.2.-;7.6.2.2",
        "go_molecular_function": "GO:0005319 lipid transporter activity;GO:0005524 ATP binding;GO:0042626 ATPase-coupled transmembrane transporter activity;GO:0016887 ATP hydrolysis activity;GO:0140359 ABC-type transporter activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006638 neutral lipid metabolic process;GO:0006869 lipid transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "E9PX95-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R2V5-1",
        "uniprot_id": "ADAP2_MOUSE",
        "mass": 43989.0,
        "length": 381,
        "protein_name": "Arf-GAP with dual PH domain-containing protein 2",
        "gene_name": "Adap2",
        "organism": "Mouse",
        "refseq_name": "arf-GAP with dual PH domain-containing protein 2",
        "refseq_ac": "NP_742145",
        "gene_names_uniprotkb": "Adap2; Centa2",
        "gene_names_refseq": "Adap2; Centa2",
        "protein_names_uniprotkb": "Arf-GAP with dual PH domain-containing protein 2; Centaurin-alpha-2; Cnt-a2",
        "protein_names_refseq": "arf-GAP with dual PH domain-containing protein 2; centaurin, alpha 2; cnt-a2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:216991)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;24711647;34428180",
        "class_list": "",
        "function": "ADAP2 has a role in heart development, and might be a reliable candidate gene for the occurrence of cardiovascular malformations in patients with NF1 microdeletion., [RefSeq, PubMed]; GTPase-activating protein for the ADP ribosylation factor family (Potential). Binds phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3) and inositol 1,3,4,5-tetrakisphosphate (InsP4). Possesses a stoichiometry of two binding sites for InsP4 with identical affinity (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0005546 phosphatidylinositol-4,5-bisphosphate binding;GO:0005547 phosphatidylinositol-3,4,5-trisphosphate binding;GO:0008270 zinc ion binding;GO:0043325 phosphatidylinositol-3,4-bisphosphate binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005740 mitochondrial envelope;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0007507 heart development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8R2V5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P05201-1",
        "uniprot_id": "AATC_MOUSE",
        "mass": 46248.0,
        "length": 413,
        "protein_name": "Aspartate aminotransferase, cytoplasmic",
        "gene_name": "Got1",
        "organism": "Mouse",
        "refseq_name": "aspartate aminotransferase, cytoplasmic",
        "refseq_ac": "NP_034454",
        "gene_names_uniprotkb": "Got1",
        "gene_names_refseq": "Got-1; Got1; cAspAT; cCAT",
        "protein_names_uniprotkb": "Aspartate aminotransferase, cytoplasmic; 2.6.1.1; 2.6.1.3; Cysteine aminotransferase, cytoplasmic; Cysteine transaminase, cytoplasmic; Glutamate oxaloacetate transaminase 1; Transaminase A; cAspAT; cCAT",
        "protein_names_refseq": "aspartate aminotransferase, cytoplasmic; cysteine aminotransferase, cytoplasmic; cysteine transaminase, cytoplasmic; cytosolic aspartate aminotransferase; glutamate oxaloacetate transaminase 1, soluble; transaminase A",
        "tax_id": 10090,
        "disease": "cardiomyopathy (Disease Ontology:DOID:0050700); transient cerebral ischemia (Disease Ontology:DOID:224); amyotrophic lateral sclerosis (Disease Ontology:DOID:332); pancreatic ductal adenocarcinoma (Disease Ontology:DOID:3498); amyloidosis (Disease Ontology:DOID:9120)",
        "pathway": " (mmu:14718);  (R-MMU-8963693);  (R-MMU-9856872)",
        "pathway_count": 3,
        "publication_count": 24,
        "publication_id_list": "11465105;16393994;18034455;18250455;21750661;21937432;23806337;26495903;28011936;28935714;31219806;33725478;3379636;34428180;35984892;36288343;37453647;37507081;3782150;37828378;38965342;39927985;40684658;9707606",
        "class_list": "",
        "function": "Biosynthesis of L-glutamate from L-aspartate or L-cysteine. Important regulator of levels of glutamate, the major excitatory neurotransmitter of the vertebrate central nervous system. Acts as a scavenger of glutamate in brain neuroprotection. The aspartate aminotransferase activity is involved in hepatic glucose synthesis during development and in adipocyte glyceroneogenesis. Using L-cysteine as substrate, regulates levels of mercaptopyruvate, an important source of hydrogen sulfide. Mercaptopyruvate is converted into H(2)S via the action of 3-mercaptopyruvate sulfurtransferase (3MST). Hydrogen sulfide is an important synaptic modulator and neuroprotectant in the brain., [UniProtKB, UniProtKB]; Glutamate oxaloacetate transaminase 1 is dispensable in macrophage differentiation and anti-pathogen response. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UJH8",
        "ec_number_list": "2.6.1.1;2.6.1.3;2.6.1.7",
        "go_molecular_function": "GO:0030170 pyridoxal phosphate binding;GO:0004069 L-aspartate:2-oxoglutarate aminotransferase activity;GO:0004609 phosphatidylserine decarboxylase activity;GO:0031406 carboxylic acid binding;GO:0047801 L-cysteine transaminase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0043679 axon terminus",
        "go_biological_process": "GO:1990267 response to transition metal nanoparticle;GO:0006103 2-oxoglutarate metabolic process;GO:0006533 L-aspartate catabolic process;GO:0006536 glutamate metabolic process;GO:0007219 Notch signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "P05201-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z1Q2-1",
        "uniprot_id": "ABHGA_MOUSE",
        "mass": 63086.0,
        "length": 558,
        "protein_name": "Phosphatidylserine lipase ABHD16A",
        "gene_name": "Abhd16a",
        "organism": "Mouse",
        "refseq_name": "phosphatidylserine lipase ABHD16A isoform 1",
        "refseq_ac": "NP_848707",
        "gene_names_uniprotkb": "Abhd16a; Bat5; Ng26",
        "gene_names_refseq": "Abhd16a; Bat-5; Bat5; D17H6S82E; NG26; mBAT5",
        "protein_names_uniprotkb": "Phosphatidylserine lipase ABHD16A; 3.1.-.-; 3.1.1.23; Abhydrolase domain-containing protein 16A; Alpha/beta hydrolase domain-containing protein 16A; HLA-B-associated transcript 5; Monoacylglycerol lipase ABHD16A; mBAT5",
        "protein_names_refseq": "HLA-B associated transcript 5; abhydrolase domain-containing protein 16A; alpha/beta hydrolase domain-containing protein 16A; monoacylglycerol lipase ABHD16A; phosphatidylserine lipase ABHD16A isoform 1; phosphatidylserine lipase ABHD16A; protein ABHD16A; protein BAT5",
        "tax_id": 10090,
        "disease": "hereditary spastic paraplegia 86 (Disease Ontology:DOID:0112342)",
        "pathway": " (mmu:193742)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;14656967;21750661;25290914;25580854;32462874;34428180",
        "class_list": "",
        "function": "Mapping the Neuroanatomy of ABHD16A, ABHD12, and Lysophosphatidylserines Provides New Insights into the Pathophysiology of the Human Neurological Disorder PHARC., [RefSeq, PubMed]; Phosphatidylserine (PS) lipase that mediates the hydrolysis of phosphatidylserine to generate lysophosphatidylserine (LPS) (PubMed:25580854). LPS constitutes a class of signaling lipids that regulates immunological and neurological processes (PubMed:25580854). Has no activity towards diacylglycerol, triacylglycerol or lysophosphatidylserine lipase (By similarity). Also has monoacylglycerol lipase activity, with preference for 1-(9Z,12Z-octadecadienoyl)-glycerol (1-LG) and 2-glyceryl-15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ(2)-G) (PubMed:25290914)., [UniProtKB, PubMed, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9641,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.5.1.99;3.1.1.-;3.1.1.23;3.1.1.4;3.1.1.5;3.1.1.3;3.1.1.26;3.1.1.79;3.1.1.111;3.1.1.13;3.1.1.1;3.1.1.32;2.3.1.-;3.1.-.-;3.3.2.9;3.1.1.6",
        "go_molecular_function": "GO:0004620 phospholipase activity;GO:0047372 monoacylglycerol lipase activity",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "GO:0052651 monoacylglycerol catabolic process;GO:1905344 prostaglandin catabolic process;GO:0006660 phosphatidylserine catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q9Z1Q2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35227-1",
        "uniprot_id": "ADAM7_MOUSE",
        "mass": 89188.0,
        "length": 789,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 7",
        "gene_name": "Adam7",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 7 preproprotein",
        "refseq_ac": "NP_031428",
        "gene_names_uniprotkb": "Adam7",
        "gene_names_refseq": "ADAM 7; Adam7; EAP1; EAPI",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 7; ADAM 7",
        "protein_names_refseq": "a disintegrin and metalloprotease domain (ADAM) 7; disintegrin and metalloproteinase domain-containing protein 7 preproprotein; disintegrin and metalloproteinase domain-containing protein 7; epididymal apical protein I",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:11500)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "19855936;20945367;26246218;30084848;9322939",
        "class_list": "",
        "function": "ADAM7 is required for normal fertility and is important for the maintenance of epididymal integrity and for sperm morphology, [RefSeq, PubMed]; Required for normal male fertility via maintenance of epithelial cell morphology in the caput epididymis and subsequently correct epididymis lumen structure required for sperm development (PubMed:26246218). Plays a role in sperm motility, flagella morphology and tyrosine phosphorylation during sperm capacitance (PubMed:26246218). Plays a role in normal expression levels of HSPA5, ITM2B and ADAM2 in sperm both prior to and post-capacitation (PubMed:26246218). This is a non catalytic metalloprotease-like protein (Probable)., [UniProtKB, PubMed, PubMed]; Suggest that Adam7 functions in fertilization through the formation of a complex with heat shock protein 5, calnexin and Itm2b during capacitation in sperm., [RefSeq, PubMed]; This gene encodes a member of a disintegrin and metalloprotease (ADAM) family of endoproteases that play important roles in various biological processes including cell signaling, adhesion and migration. This gene is specifically expressed in epididymis where the encoded protein is transferred to the sperm surface during epididymal transit. This gene is located adjacent to a related gene from the ADAM family of proteins on chromosome 14. [provided by RefSeq, Oct 2015]., [RefSeq]; This study provides new information regarding the unique mode of secretion and interaction of ADAM7 during the epididymis-to-sperm transfer process., [RefSeq, PubMed]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 6,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "F8VQC6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004175 endopeptidase activity;GO:0004222 metalloendopeptidase activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0045177 apical part of cell",
        "go_biological_process": "GO:0006508 proteolysis;GO:0003382 epithelial cell morphogenesis;GO:1902093 positive regulation of flagellated sperm motility;GO:1905867 epididymis development;GO:1902492 positive regulation of sperm capacitation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "O35227-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35674-1",
        "uniprot_id": "ADA19_MOUSE",
        "mass": 100860.0,
        "length": 920,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 19",
        "gene_name": "Adam19",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 19 isoform 1 preproprotein",
        "refseq_ac": "NP_033746",
        "gene_names_uniprotkb": "Adam19; Mltnb",
        "gene_names_refseq": "Adam19; MADDAM; MTLNB; Mltnb",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 19; 3.4.24.-; ADAM 19; Meltrin-beta",
        "protein_names_refseq": "MDC beta; Mel beta; a disintegrin and metallopeptidase domain 19 (meltrin beta); a disintegrin and metalloproteinase domain 19 (meltrin beta); adamalysin 19; disintegrin and metalloproteinase domain-containing protein 19 isoform 1 preproprotein; disintegrin and metalloproteinase domain-containing protein 19",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:11492);  (R-MMU-8941237);  (R-MMU-9762292)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;11116142;12482604;28011936;30084848;39153120;7566181;9461614;9622634",
        "class_list": "",
        "function": "Adam19 Deficiency Impacts Pulmonary Function: Human GWAS Follow-up in a Mouse Knockout Model., [RefSeq, PubMed]; Meltrin beta-mini is a new isoform that induces neuron outgrowth in neuronal cells, [RefSeq, PubMed]; Participates in the proteolytic processing of beta-type neuregulin isoforms which are involved in neurogenesis and synaptogenesis, suggesting a regulatory role in glial cell. Also cleaves alpha-2 macroglobulin. May be involved in osteoblast differentiation and/or osteoblast activity in bone (By similarity)., [UniProtKB, PubMed]; This gene encodes a cell surface glycoprotein and member of the ADAM (a disintegrin and metalloproteinase) family of endopeptidases. The encoded protein may play a role in the ectodomain shedding of neuregulin proteins. Homozygous knockout mice for this gene exhibit heart development defects and perinatal lethality. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that undergoes proteolytic processing to generate a mature protein product. [provided by RefSeq, Aug 2015]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9641,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.4.24.-",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0017124 SH3 domain binding;GO:0046872 metal ion binding;GO:1902945 metalloendopeptidase activity involved in amyloid precursor protein catabolic process",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005794 Golgi apparatus;GO:0016020 membrane;GO:0031012 extracellular matrix",
        "go_biological_process": "GO:0006509 membrane protein ectodomain proteolysis;GO:0007507 heart development;GO:0010628 positive regulation of gene expression;GO:0016485 protein processing;GO:0001890 placenta development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "O35674-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88839-1",
        "uniprot_id": "ADA15_MOUSE",
        "mass": 92664.0,
        "length": 864,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 15",
        "gene_name": "Adam15",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 15 isoform a preproprotein",
        "refseq_ac": "NP_001032811",
        "gene_names_uniprotkb": "Adam15; Mdc15",
        "gene_names_refseq": "AD56; Adam15; MDC15",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 15; 3.4.24.-; AD56; ADAM 15; MDC-15; Metalloprotease RGD disintegrin protein; Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15; Metargidin",
        "protein_names_refseq": "a disintegrin and metallopeptidase domain 15 (metargidin); a disintegrin and metalloprotease domain 15 (metargidin); disintegrin and metalloproteinase domain-containing protein 15 isoform a preproprotein; disintegrin and metalloproteinase domain-containing protein 15; metalloprotease RGD disintegrin protein; metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15",
        "tax_id": 10090,
        "disease": "pancreatic cancer (Disease Ontology:DOID:1793)",
        "pathway": " (mmu:11490);  (R-MMU-1474228);  (R-MMU-8941237)",
        "pathway_count": 3,
        "publication_count": 21,
        "publication_id_list": "10.1101/2023.09.13.557529;10531379;11882657;12897135;13679040;15818704;16393994;18381816;18390692;26495903;28011936;28935714;31219806;34428180;34995785;35597804;35984892;37828378;38607341;39048163;9748307",
        "class_list": "",
        "function": "ADAM15 in Fibroblasts: Improving the Matrix Remodeling by Blocking the Action of Transforming Growth Factor-beta1., [RefSeq, PubMed]; ADAM15 is required for optimal collagen cross-linking and scar formation following myocardial infarction., [RefSeq, PubMed]; Active metalloproteinase with gelatinolytic and collagenolytic activity. Plays a role in the wound healing process. Mediates both heterotypic intraepithelial cell/T-cell interactions and homotypic T-cell aggregation. Inhibits beta-1 integrin-mediated cell adhesion and migration of airway smooth muscle cells. Suppresses cell motility on or towards fibronectin possibly by driving alpha-v/beta-1 integrin (ITAGV-ITGB1) cell surface expression via ERK1/2 inactivation. Cleaves E-cadherin in response to growth factor deprivation. Plays a role in glomerular cell migration (By similarity). Plays a role in pathological neovascularization. May play a role in cartilage remodeling. May be proteolytically processed, during sperm epididymal maturation and the acrosome reaction. May play a role in sperm-egg binding through its disintegrin domain. Interactions with egg membrane could be mediated via binding between the disintegrin-like domain to one or more integrin receptors on the egg., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; Integrin alpha3/alpha6 and alphaV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression. Publication Status: Online-Only, [RefSeq, PubMed]; Loss of ADAM15 in female mice does not worsen pressure overload cardiomyopathy, independent of ovarian hormones., [RefSeq, PubMed]; This gene encodes a member of a disintegrin and metalloprotease (ADAM) family of endoproteases that play important roles in various biological processes including cell signaling, adhesion and migration. This gene is prominently expressed in vascular cells, the endocardium, hypertrophic cells in developing bone, and specific areas of hippocampus and cerebellum. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional protein. Mice lacking the encoded protein have increased bone mass resulting from osteoblast proliferation, and exhibit reduced neovascularization in a mouse model for retinopathy. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing. [provided by RefSeq, May 2016]., [RefSeq]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 6,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9803,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A4ZYV2;Q3TDN7;Q3U7C2;Q3UE21;Q8C7Z0;Q91VS9;Q9QYL2",
        "ec_number_list": "3.4.24.81;3.4.24.-",
        "go_molecular_function": "GO:0034987 immunoglobulin receptor binding;GO:0004222 metalloendopeptidase activity;GO:0005178 integrin binding;GO:0008237 metallopeptidase activity;GO:0017124 SH3 domain binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005912 adherens junction;GO:0009986 cell surface;GO:0031514 motile cilium;GO:0070062 extracellular exosome",
        "go_biological_process": "GO:1990910 response to hypobaric hypoxia;GO:0002418 immune response to tumor cell;GO:0001525 angiogenesis;GO:0006508 proteolysis;GO:0007155 cell adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 2.6,
        "record_id": "O88839-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P07361-1",
        "uniprot_id": "A1AG2_MOUSE",
        "mass": 23843.0,
        "length": 207,
        "protein_name": "Alpha-1-acid glycoprotein 2",
        "gene_name": "Orm2",
        "organism": "Mouse",
        "refseq_name": "alpha-1-acid glycoprotein 2 precursor",
        "refseq_ac": "NP_035146",
        "gene_names_uniprotkb": "Orm2; Agp-2; Orm-2",
        "gene_names_refseq": "Agp1; Orm-2; Orm2",
        "protein_names_uniprotkb": "Alpha-1-acid glycoprotein 2; AGP 2; OMD 2; Orosomucoid-2",
        "protein_names_refseq": "AGP 2; OMD 2; alpha-1-acid glycoprotein 2 precursor; alpha-1-acid glycoprotein 2; bM340H1.5 (orosomucoid 2)",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:18406);  (R-MMU-114608);  (R-MMU-6798695)",
        "pathway_count": 3,
        "publication_count": 5,
        "publication_id_list": "16944957;2475311;3003086;3676251;37853937",
        "class_list": "",
        "function": "Functions as a transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain (By similarity). Appears to function in modulating the activity of the immune system during the acute-phase reaction., [UniProtKB]; Orm2 Deficiency Aggravates High-Fat Diet-Induced Obesity through Gut Microbial Dysbiosis and Intestinal Inflammation., [RefSeq, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 5,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0036094 small molecule binding",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0006953 acute-phase response;GO:0002682 regulation of immune system process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "P07361-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P09470-1",
        "uniprot_id": "ACE_MOUSE",
        "mass": 150918.0,
        "length": 1312,
        "protein_name": "Angiotensin-converting enzyme",
        "gene_name": "Ace",
        "organism": "Mouse",
        "refseq_name": "angiotensin-converting enzyme isoform 2 precursor",
        "refseq_ac": "NP_033728",
        "gene_names_uniprotkb": "Ace; Dcp1",
        "gene_names_refseq": "Ace; CD143",
        "protein_names_uniprotkb": "Angiotensin-converting enzyme; 3.4.15.1; ACE; Dipeptidyl carboxypeptidase I; Kininase II",
        "protein_names_refseq": "angiotensin I converting enzyme (peptidyl-dipeptidase A) 1; angiotensin-converting enzyme isoform 2 precursor; angiotensin-converting enzyme; dipeptidyl carboxypeptidase I; dipeptidyl peptidase; kininase II",
        "tax_id": 10090,
        "disease": "aspiration pneumonia (Disease Ontology:DOID:0050152); obstructive sleep apnea (Disease Ontology:DOID:0050848); glomerulosclerosis (Disease Ontology:DOID:0050851); renal fibrosis (Disease Ontology:DOID:0050855); non-arteritic anterior ischemic optic neuropathy (Disease Ontology:DOID:0050864); coarctation of the aorta (Disease Ontology:DOID:0051054); stroke (Disease Ontology:DOID:0051061); pre-malignant neoplasm (Disease Ontology:DOID:0060071); atrial fibrillation (Disease Ontology:DOID:0060224); alcohol-associated liver disease (Disease Ontology:DOID:0070658); Coronavirus infectious disease (Disease Ontology:DOID:0080599); COVID-19 (Disease Ontology:DOID:0080600); autosomal recessive polycystic kidney disease (Disease Ontology:DOID:0110861); focal segmental glomerulosclerosis 1 (Disease Ontology:DOID:0111128); stomach cancer (Disease Ontology:DOID:10534); pre-eclampsia (Disease Ontology:DOID:10591); Alzheimer's disease (Disease Ontology:DOID:10652); hypertension (Disease Ontology:DOID:10763); nephritis (Disease Ontology:DOID:10952); IgA vasculitis (Disease Ontology:DOID:11123); sarcoidosis (Disease Ontology:DOID:11335); pyelonephritis (Disease Ontology:DOID:11400); osteoporosis (Disease Ontology:DOID:11476); diabetic angiopathy (Disease Ontology:DOID:11713); nephrotic syndrome (Disease Ontology:DOID:1184); allergic disease (Disease Ontology:DOID:1205); primary biliary cholangitis (Disease Ontology:DOID:12236); leukemia (Disease Ontology:DOID:1240); hepatitis A (Disease Ontology:DOID:12549); endomyocardial fibrosis (Disease Ontology:DOID:12932); leukostasis (Disease Ontology:DOID:12986); uveitis (Disease Ontology:DOID:13141); lung cancer (Disease Ontology:DOID:1324); Behcet's disease (Disease Ontology:DOID:13241); cholestasis (Disease Ontology:DOID:13580); toxic shock syndrome (Disease Ontology:DOID:14115); Fabry disease (Disease Ontology:DOID:14499); renovascular hypertension (Disease Ontology:DOID:1591); breast cancer (Disease Ontology:DOID:1612); anemia (Disease Ontology:DOID:2355); nephrosis (Disease Ontology:DOID:2527); bronchiolitis obliterans (Disease Ontology:DOID:2799); asthma (Disease Ontology:DOID:2841); glomerulonephritis (Disease Ontology:DOID:2921); IgA glomerulonephritis (Disease Ontology:DOID:2986); familial Mediterranean fever (Disease Ontology:DOID:2987); acute kidney failure (Disease Ontology:DOID:3021); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); coronary artery disease (Disease Ontology:DOID:3393); gallbladder adenocarcinoma (Disease Ontology:DOID:3500); middle cerebral artery infarction (Disease Ontology:DOID:3525); cerebral infarction (Disease Ontology:DOID:3526); pancreatic ductal carcinoma (Disease Ontology:DOID:3587); pulmonary fibrosis (Disease Ontology:DOID:3770); congenital diaphragmatic hernia (Disease Ontology:DOID:3827); lung carcinoma (Disease Ontology:DOID:3905); heart valve disease (Disease Ontology:DOID:4079); systemic scleroderma (Disease Ontology:DOID:418); liver cirrhosis (Disease Ontology:DOID:5082); ureteral obstruction (Disease Ontology:DOID:5199); schizophrenia (Disease Ontology:DOID:5419); pneumonia (Disease Ontology:DOID:552); proteinuria (Disease Ontology:DOID:576); myocardial infarction (Disease Ontology:DOID:5844); congestive heart failure (Disease Ontology:DOID:6000); mitral valve disease (Disease Ontology:DOID:61); hepatocellular carcinoma (Disease Ontology:DOID:684); ankylosing spondylitis (Disease Ontology:DOID:7147); abdominal aortic aneurysm (Disease Ontology:DOID:7693); end stage renal disease (Disease Ontology:DOID:783); ocular hypotension (Disease Ontology:DOID:790); myocarditis (Disease Ontology:DOID:820); extrinsic allergic alveolitis (Disease Ontology:DOID:841); polycythemia (Disease Ontology:DOID:8432); lung disease (Disease Ontology:DOID:850); chronic myeloid leukemia (Disease Ontology:DOID:8552); intermediate coronary syndrome (Disease Ontology:DOID:8805); diabetic retinopathy (Disease Ontology:DOID:8947); subacute sclerosing panencephalitis (Disease Ontology:DOID:8970); type 2 diabetes mellitus (Disease Ontology:DOID:9352); multiple myeloma (Disease Ontology:DOID:9538); type 1 diabetes mellitus (Disease Ontology:DOID:9744); diastolic heart failure (Disease Ontology:DOID:9775); mitral valve prolapse (Disease Ontology:DOID:988); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:11421);  (R-MMU-2022377)",
        "pathway_count": 2,
        "publication_count": 33,
        "publication_id_list": "10.1101/2023.09.13.557529;10831599;11303049;11723129;12777443;14757757;15665832;16154999;16270063;1651914;16944957;17114649;17135368;17634445;18443281;21183079;2164636;21750661;23535237;2545691;2835538;2841312;30084848;30899004;33300544;34428180;35201898;37992807;7753170;8642790;9231832;9482924;9664078",
        "class_list": "",
        "function": "Dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus of a variety of circulating hormones, such as angiotensin I, bradykinin or enkephalins, thereby playing a key role in the regulation of blood pressure, electrolyte homeostasis or synaptic plasticity (PubMed:11723129, PubMed:12777443, PubMed:14757757, PubMed:16270063, PubMed:35201898, PubMed:7753170, PubMed:8642790, PubMed:9231832). Composed of two similar catalytic domains, each possessing a functional active site, with different selectivity for substrates (PubMed:11303049). Plays a major role in the angiotensin-renin system that regulates blood pressure and sodium retention by the kidney by converting angiotensin I to angiotensin II, resulting in an increase of the vasoconstrictor activity of angiotensin (PubMed:11303049, PubMed:14757757, PubMed:9231832). Also able to inactivate bradykinin, a potent vasodilator, and therefore enhance the blood pressure response (By similarity). Acts as a regulator of synaptic transmission by mediating cleavage of neuropeptide hormones, such as substance P, neurotensin or enkephalins (By similarity). Catalyzes degradation of different enkephalin neuropeptides (Met-enkephalin, Leu-enkephalin, Met-enkephalin-Arg-Phe and possibly Met-enkephalin-Arg-Gly-Leu) (PubMed:35201898). Acts as a regulator of synaptic plasticity in the nucleus accumbens of the brain by mediating cleavage of Met-enkephalin-Arg-Phe, a strong ligand of Mu-type opioid receptor OPRM1, into Met-enkephalin (PubMed:35201898). Met-enkephalin-Arg-Phe cleavage by ACE decreases activation of OPRM1, leading to long-term synaptic potentiation of glutamate release (PubMed:35201898). Also acts as a regulator of hematopoietic stem cell differentiation by mediating degradation of hemoregulatory peptide N-acetyl-SDKP (AcSDKP) (PubMed:11303049). Acts as a regulator of cannabinoid signaling pathway by mediating degradation of hemopressin, an antagonist peptide of the cannabinoid receptor CNR1 (By similarity). Involved in amyloid-beta metabolism by catalyzing degradation of Amyloid-beta protein 40 and Amyloid-beta protein 42 peptides, thereby preventing plaque formation (By similarity). Catalyzes cleavage of cholecystokinin (maturation of Cholecystokinin-8 and Cholecystokinin-5) and Gonadoliberin-1 (both maturation and degradation) hormones (By similarity). Degradation of hemoregulatory peptide N-acetyl-SDKP (AcSDKP) and amyloid-beta proteins is mediated by the N-terminal catalytic domain, while angiotensin I and cholecystokinin cleavage is mediated by the C-terminal catalytic region (PubMed:11303049)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed]; Isoform produced by alternative promoter usage that is specifically expressed in spermatocytes and adult testis, and which is required for male fertility (PubMed:1651914, PubMed:9482924). In contrast to somatic isoforms, only contains one catalytic domain (PubMed:16270063). Acts as a dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus of substrates (PubMed:16270063). The identity of substrates that are needed for male fertility is unknown (PubMed:16270063). Isoform Testis-specific and isoform Somatic have distinct activities and cannot completely compensate for the loss of the other when expressed in somatic tissues or testis (PubMed:10831599, PubMed:11723129, PubMed:12777443, PubMed:16270063, PubMed:9664078). May also have a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety (PubMed:15665832). The GPIase activity was reported to be essential for the egg-binding ability of the sperm (PubMed:15665832). This activity is however unclear and has been challenged by other groups, suggesting that it may be indirect (PubMed:16270063)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; Soluble form that is released in blood plasma and other body fluids following proteolytic cleavage in the juxtamembrane stalk region., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Testicular ACE regulates sperm metabolism and fertilization through the transcription factor PPARgamma., [RefSeq, PubMed]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 6,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 7,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 8,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 8,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 8,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 17,
        "disease_count": 85,
        "glyco_site_count": 14,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P22967;Q6GTS2",
        "ec_number_list": "3.4.15.1;3.4.-.-;3.4.24.11",
        "go_molecular_function": "GO:0003779 actin binding;GO:0004175 endopeptidase activity;GO:0004222 metalloendopeptidase activity;GO:0005516 calmodulin binding;GO:0008237 metallopeptidase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005737 cytoplasm;GO:0005768 endosome;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0009792 embryo development ending in birth or egg hatching;GO:0090281 negative regulation of calcium ion import;GO:0007283 spermatogenesis;GO:0010629 negative regulation of gene expression;GO:0032496 response to lipopolysaccharide",
        "synthesized_glycan_count": 0,
        "hit_score": 6.0,
        "record_id": "P09470-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P24815-1",
        "uniprot_id": "3BHS1_MOUSE",
        "mass": 42062.0,
        "length": 373,
        "protein_name": "3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1",
        "gene_name": "Hsd3b1",
        "organism": "Mouse",
        "refseq_name": "3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1",
        "refseq_ac": "NP_001291729",
        "gene_names_uniprotkb": "Hsd3b1; Hsd3b",
        "gene_names_refseq": "3-beta-HSD I; D3Ertd383e; Hsd3b1",
        "protein_names_uniprotkb": "3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1; 1.1.1.145; 1.1.1.210; 1.1.1.270; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I; 3-beta-HSD I; 3-beta-hydroxy-5-ene steroid dehydrogenase; 3-beta-hydroxy-Delta(5)-steroid dehydrogenase; 3-beta-hydroxysteroid 3-dehydrogenase; 5.3.3.1; Delta-5-3-ketosteroid isomerase; Dihydrotestosterone oxidoreductase; Steroid Delta-isomerase",
        "protein_names_refseq": "3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1; 3-beta-hydroxy-5-ene steroid dehydrogenase; 3-beta-hydroxy-Delta(5)-steroid dehydrogenase; 3-beta-hydroxysteroid 3-dehydrogenase; delta-5-3-ketosteroid isomerase; dihydrotestosterone oxidoreductase; steroid Delta-isomerase",
        "tax_id": 10090,
        "disease": "Alzheimer's disease (Disease Ontology:DOID:10652); hypertension (Disease Ontology:DOID:10763); hypospadias (Disease Ontology:DOID:10892); sciatic neuropathy (Disease Ontology:DOID:11446); polycystic ovary syndrome (Disease Ontology:DOID:11612); hyperprolactinemia (Disease Ontology:DOID:12700); hypothyroidism (Disease Ontology:DOID:1459); hypogonadism (Disease Ontology:DOID:1924); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:15492);  (R-MMU-193048);  (R-MMU-193993);  (R-MMU-194002)",
        "pathway_count": 4,
        "publication_count": 2,
        "publication_id_list": "1924345;34428180",
        "class_list": "",
        "function": "A bifunctional enzyme responsible for the oxidation and isomerization of 3beta-hydroxy-Delta(5)-steroid precursors to 3-oxo-Delta(4)-steroids, an essential step in steroid hormone biosynthesis. Specifically catalyzes the conversion of pregnenolone to progesterone, 17alpha-hydroxypregnenolone to 17alpha-hydroxyprogesterone, dehydroepiandrosterone (DHEA) to 4-androstenedione, and androstenediol to testosterone. Additionally, catalyzes the interconversion between 3beta-hydroxy and 3-oxo-5alpha-androstane steroids controlling the bioavalability of the active forms. Specifically converts dihydrotestosterone to its inactive form 5alpha-androstanediol, that does not bind androgen receptor/AR. Also converts androstanedione, a precursor of testosterone and estrone, to epiandrosterone. Expected to use NAD(+) as preferred electron donor for the 3-beta-hydroxy-steroid dehydrogenase activity and NADPH for the 3-ketosteroid reductase activity., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 9,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TQ00",
        "ec_number_list": "1.1.1.-;1.1.1.145;5.3.3.1;1.1.1.270;1.1.1.62;1.1.1.210;1.11.1.-;5.3.3.-;2.5.1.18;1.1.1.239;1.1.1.105;1.1.1.209;1.1.1.53",
        "go_molecular_function": "GO:0051287 NAD binding;GO:0003854 3-beta-hydroxy-Delta5-steroid dehydrogenase (NAD+) activity;GO:0004769 steroid Delta-isomerase activity;GO:0005496 steroid binding;GO:0016616 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",
        "go_cellular_component": "GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005758 mitochondrial intermembrane space",
        "go_biological_process": "GO:0006694 steroid biosynthetic process;GO:0006702 androgen biosynthetic process;GO:0006704 glucocorticoid biosynthetic process;GO:0008207 C21-steroid hormone metabolic process;GO:0034651 cortisol biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "P24815-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P28271-1",
        "uniprot_id": "ACOHC_MOUSE",
        "mass": 98126.0,
        "length": 889,
        "protein_name": "Cytoplasmic aconitate hydratase",
        "gene_name": "Aco1",
        "organism": "Mouse",
        "refseq_name": "cytoplasmic aconitate hydratase",
        "refseq_ac": "NP_031412",
        "gene_names_uniprotkb": "Aco1; Ireb1; Irebp",
        "gene_names_refseq": "Aco-1; Aco1; Irebp; Irp1",
        "protein_names_uniprotkb": "Cytoplasmic aconitate hydratase; 4.2.1.3; Aconitase; Citrate hydro-lyase; IRE-BP 1; IRP1; Iron regulatory protein 1; Iron-responsive element-binding protein 1",
        "protein_names_refseq": "IRE-BP 1; citrate hydro-lyase; cytoplasmic aconitase; cytoplasmic aconitate hydratase; iron regulatory protein 1; iron-responsive element-binding protein 1",
        "tax_id": 10090,
        "disease": "metabolic dysfunction-associated steatotic liver disease (Disease Ontology:DOID:0080208); porphyria (Disease Ontology:DOID:13268); duodenal ulcer (Disease Ontology:DOID:1724)",
        "pathway": " (mmu:11428);  (R-MMU-389542);  (R-MMU-917937)",
        "pathway_count": 3,
        "publication_count": 16,
        "publication_id_list": "16424901;18250455;1946430;1956798;22872234;25428506;26495903;30084848;31599954;34428180;37453647;37507081;37828378;38773499;39122013;8041788",
        "class_list": "",
        "function": "Aco1 is a moonlighting protein that has aconitase activity as well as mRNA binding ability., [RefSeq, PubMed]; Bifunctional iron sensor that switches between 2 activities depending on iron availability (By similarity). Iron deprivation, promotes its mRNA binding activity through which it regulates the expression of genes involved in iron uptake, sequestration and utilization. Binds to iron-responsive elements (IRES) in the untranslated region of target mRNAs preventing for instance the translation of ferritin and aminolevulinic acid synthase and stabilizing the transferrin receptor mRNA (PubMed:1956798)., [UniProtKB, PubMed, UniProtKB]; Conversely, when cellular iron levels are high, binds a 4Fe-4S cluster which precludes RNA binding activity and promotes the aconitase activity, the isomerization of citrate to isocitrate via cis-aconitate., [UniProtKB, UniProtKB]; Diurnal control of iron responsive element containing mRNAs through iron regulatory proteins IRP1 and IRP2 is mediated by feeding rhythms. Publication Status: Online-Only, [RefSeq, PubMed]; Human ACO1 is a moonlighting protein that has both aconitase enzyme activity as well as an mRNA binding function., [RefSeq, PubMed]; Iron regulatory protein 1 is required for the propagation of inflammation in inflammatory bowel disease., [RefSeq, PubMed]; This gene encodes a member of the aconitase/IPM isomerase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Depending on iron levels in the cytosol, the encoded protein can function as either an aconitase enzyme or as an mRNA binding protein. When cellular iron levels are high, the encoded protein functions as an aconitase, an essential enzyme in the TCA cycle that catalyzes the conversion of citrate to isocitrate. When cellular iron levels are low, the encoded protein regulates iron uptake and utilization by binding to iron-responsive elements in the untranslated regions of mRNAs for genes involved in iron metabolism. Disruption of this gene is associated with pulmonary hypertension and polycythemia. [provided by RefSeq, Jan 2014]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TQ15;Q99K54",
        "ec_number_list": "4.2.1.3",
        "go_molecular_function": "GO:0000900 mRNA regulatory element binding translation repressor activity;GO:0003723 RNA binding;GO:0003994 aconitate hydratase activity;GO:0046872 metal ion binding;GO:0051538 3 iron, 4 sulfur cluster binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0005829 cytosol",
        "go_biological_process": "GO:0006099 tricarboxylic acid cycle;GO:0006101 citrate metabolic process;GO:0006417 regulation of translation;GO:0006879 intracellular iron ion homeostasis;GO:0050892 intestinal absorption",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "P28271-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P51912-1",
        "uniprot_id": "AAAT_MOUSE",
        "mass": 58483.0,
        "length": 553,
        "protein_name": "Neutral amino acid transporter B(0)",
        "gene_name": "Slc1a5",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Slc1a5; Aaat; Asct2; Slc1a7",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Neutral amino acid transporter B(0); ASC-like Na(+)-dependent neutral amino acid transporter ASCT2; ATB(0); Insulin-activated amino acid transporter; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "tongue squamous cell carcinoma (Disease Ontology:DOID:0050865); episodic ataxia type 6 (Disease Ontology:DOID:0050994); neurodegenerative disease (Disease Ontology:DOID:1289); epilepsy (Disease Ontology:DOID:1826); esophagus squamous cell carcinoma (Disease Ontology:DOID:3748); lung adenocarcinoma (Disease Ontology:DOID:3910); pulmonary hypertension (Disease Ontology:DOID:6432)",
        "pathway": " (R-MMU-352230);  (R-MMU-9013149);  (R-MMU-9013406);  (R-MMU-9013407);  (R-MMU-9013423)",
        "pathway_count": 5,
        "publication_count": 19,
        "publication_id_list": "17094966;19144319;21183079;25428506;25605945;26495903;26740625;29187734;30084848;30779550;31219806;31535081;33725478;34428180;35820727;38650461;39927985;7702599;8662767",
        "class_list": "",
        "function": "Sodium-coupled antiporter of neutral amino acids. In a tri-substrate transport cycle, exchanges neutral amino acids between the extracellular and intracellular compartments, coupled to the inward cotransport of at least one sodium ion (By similarity) (PubMed:7702599, PubMed:8662767). The preferred substrate is the essential amino acid L-glutamine, a precursor for biosynthesis of proteins, nucleotides and amine sugars as well as an alternative fuel for mitochondrial oxidative phosphorylation. Exchanges L-glutamine with other neutral amino acids such as L-serine, L-threonine and L-asparagine in a bidirectional way. Provides L-glutamine to proliferating stem and activated cells driving the metabolic switch toward cell differentiation (By similarity). The transport cycle is usually pH-independent, with the exception of L-glutamate. Transports extracellular L-glutamate coupled to the cotransport of one proton and one sodium ion in exchange for intracellular L-glutamine counter-ion. May provide for L-glutamate uptake in glial cells regulating glutamine/glutamate cycle in the nervous system (By similarity). Part of transport systems for D-amino acids. Mediates D-serine release from the retinal glia potentially affecting NMDA receptor function in retinal neurons (By similarity). May contribute to D-serine reabsorption at the brush border of renal proximal tubules thus modulating the dynamics of urinary versus blood D-serine levels (Probable). Displays sodium- and amino acid-dependent but uncoupled channel-like anion conductance with a preference SCN(-) >> NO3(-) > I(-) > Cl(-) (By similarity). Through binding of the fusogenic protein syncytin-1/ERVW-1 may mediate trophoblasts syncytialization, the spontaneous fusion of their plasma membranes, an essential process in placental development (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, UniProtKB, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 7,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q61326",
        "ec_number_list": "1.8.-.-;1.8.5.1",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0015175 neutral L-amino acid transmembrane transporter activity;GO:0015186 L-glutamine transmembrane transporter activity;GO:0015194 L-serine transmembrane transporter activity;GO:0015293 symporter activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane;GO:0042470 melanosome;GO:0034451 centriolar satellite;GO:0036064 ciliary basal body",
        "go_biological_process": "GO:0015825 L-serine transport;GO:0030218 erythrocyte differentiation;GO:0006868 glutamine transport;GO:0010585 glutamine secretion;GO:0015804 neutral amino acid transport",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "P51912-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P83855-1",
        "uniprot_id": "ACLP_MOUSE",
        "mass": 2502.0,
        "length": 21,
        "protein_name": "Putative sperm adenylate cyclase",
        "gene_name": "",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Putative sperm adenylate cyclase; 4.6.1.1",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 0,
        "publication_id_list": "",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "4.6.1.1;2.7.7.85",
        "go_molecular_function": "GO:0004016 adenylate cyclase activity;GO:0005524 ATP binding",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.1,
        "record_id": "P83855-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P97297-1",
        "uniprot_id": "ADML_MOUSE",
        "mass": 20750.0,
        "length": 184,
        "protein_name": "Pro-adrenomedullin",
        "gene_name": "Adm",
        "organism": "Mouse",
        "refseq_name": "pro-adrenomedullin precursor",
        "refseq_ac": "NP_033757",
        "gene_names_uniprotkb": "Adm",
        "gene_names_refseq": "AM; Adm",
        "protein_names_uniprotkb": "Pro-adrenomedullin; PAMP; ProAM N-terminal 20 peptide; ProAM-N20",
        "protein_names_refseq": "pro-adrenomedullin precursor; pro-adrenomedullin",
        "tax_id": 10090,
        "disease": "stroke (Disease Ontology:DOID:0051061); stomach cancer (Disease Ontology:DOID:10534); hypertension (Disease Ontology:DOID:10763); malignant hypertension (Disease Ontology:DOID:10824); hypertrophic cardiomyopathy (Disease Ontology:DOID:11984); obstructive jaundice (Disease Ontology:DOID:13603); toxic shock syndrome (Disease Ontology:DOID:14115); renovascular hypertension (Disease Ontology:DOID:1591); breast cancer (Disease Ontology:DOID:1612); pancreatic cancer (Disease Ontology:DOID:1793); hyperinsulinism (Disease Ontology:DOID:2018); glomerulonephritis (Disease Ontology:DOID:2921); peripheral vascular disease (Disease Ontology:DOID:341); brain infarction (Disease Ontology:DOID:3454); insulinoma (Disease Ontology:DOID:3892); ureteral obstruction (Disease Ontology:DOID:5199); congestive heart failure (Disease Ontology:DOID:6000); pulmonary hypertension (Disease Ontology:DOID:6432); abdominal aortic aneurysm (Disease Ontology:DOID:7693); diabetic retinopathy (Disease Ontology:DOID:8947); colorectal cancer (Disease Ontology:DOID:9256); type 2 diabetes mellitus (Disease Ontology:DOID:9352); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:11535);  (R-MMU-418555);  (R-MMU-419812);  (R-MMU-9856530)",
        "pathway_count": 4,
        "publication_count": 4,
        "publication_id_list": "37828378;38927741;8938454;9808778",
        "class_list": "",
        "function": "ADM function is mediated by the CALCRL-RAMP2 and CALCRL-RAMP3 receptor complexes with ADM showing the highest potency for the CALCRL-RAMP2 complex., [UniProtKB, UniProtKB]; Adrenomedullin/ADM and proadrenomedullin N-20 terminal peptide/PAMP are peptide hormones that act as potent hypotensive and vasodilatator agents. Numerous actions have been reported most related to the physiologic control of fluid and electrolyte homeostasis., [UniProtKB, UniProtKB]; Leveraging Integrated RNA Sequencing to Decipher Adrenomedullin's Protective Mechanisms in Experimental Bronchopulmonary Dysplasia. Publication Status: Online-Only, [RefSeq, PubMed]; Peptide hormone that act as potent hypotensive and vasodilatator agents by inhibiting catecholamine secretion from sympathetic nerve endings and adrenal chromaffin cells. Acts as a ligand for Mrgprb2 receptor in mast cells., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 23,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P97453;Q6GTK2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005179 hormone activity;GO:0031700 adrenomedullin receptor binding;GO:0048018 receptor ligand activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0001570 vasculogenesis;GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway;GO:0007204 positive regulation of cytosolic calcium ion concentration;GO:0007507 heart development;GO:0008284 positive regulation of cell population proliferation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P97297-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P97718-1",
        "uniprot_id": "ADA1A_MOUSE",
        "mass": 51744.0,
        "length": 466,
        "protein_name": "Alpha-1A adrenergic receptor",
        "gene_name": "Adra1a",
        "organism": "Mouse",
        "refseq_name": "alpha-1A adrenergic receptor isoform 1",
        "refseq_ac": "NP_001258689",
        "gene_names_uniprotkb": "Adra1a; Adra1c",
        "gene_names_refseq": "Adra1a; Adra1c",
        "protein_names_uniprotkb": "Alpha-1A adrenergic receptor; Alpha-1A adrenoceptor; Alpha-1A adrenoreceptor; Alpha-1C adrenergic receptor",
        "protein_names_refseq": "alpha-1A adrenergic receptor isoform 1; alpha-1A adrenergic receptor; alpha-1A adrenoceptor; alpha-1A adrenoreceptor; alpha-1C adrenergic receptor",
        "tax_id": 10090,
        "disease": "Alzheimer's disease (Disease Ontology:DOID:10652); hypertension (Disease Ontology:DOID:10763); polycystic ovary syndrome (Disease Ontology:DOID:11612); bladder neck obstruction (Disease Ontology:DOID:13948); heroin dependence (Disease Ontology:DOID:9976)",
        "pathway": " (mmu:11549);  (R-MMU-390696);  (R-MMU-416476);  (R-MMU-416482)",
        "pathway_count": 4,
        "publication_count": 5,
        "publication_id_list": "12093905;22120526;34428180;7595531;9630362",
        "class_list": "",
        "function": "Alpha-1 adrenergic receptors are G protein-coupled receptors for catecholamines that signal through the G(q) family of G proteins, including G(q) and G(11). Upon activation, they stimulate the phosphatidylinositol-calcium second messenger pathway, leading to calcium release from intracellular stores and activation of protein kinase C. ADRA1A binds the catecholamine ligands norepinephrine and epinephrine (By similarity). Can also couple to G(14) protein (By similarity). Nuclear ADRA1A forms heterooligomers with ADRA1B to regulate phenylephrine(PE)-stimulated ERK signaling in cardiac myocytes. At the plasma membrane, ADRA1A interacts with CAVIN4/MURC to regulates ERK activation in cardiomyocytes, contributing to the regulation of cardiac hypertrophy (By similarity). Additionally, functions as a vasopressor in resistance arteries and plays a role in maintaining normal arterial blood pressure (PubMed:12093905)., [UniProtKB, UniProtKB, PubMed, UniProtKB]; This gene encodes one of several multipass transmembrane proteins that function as G protein-coupled receptors. The encoded protein binds to epinephrine and norepinephrine to mediate signaling in cells of the cardiac, nervous, and other organ systems. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2012]., [RefSeq]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O54913;Q8BV77",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046982 protein heterodimerization activity;GO:0004937 alpha1-adrenergic receptor activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0098982 GABA-ergic synapse;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0007204 positive regulation of cytosolic calcium ion concentration;GO:0007267 cell-cell signaling;GO:0043410 positive regulation of MAPK cascade;GO:0045987 positive regulation of smooth muscle contraction;GO:0070374 positive regulation of ERK1 and ERK2 cascade",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P97718-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q00897-1",
        "uniprot_id": "A1AT4_MOUSE",
        "mass": 45998.0,
        "length": 413,
        "protein_name": "Alpha-1-antitrypsin 1-4",
        "gene_name": "Serpina1d",
        "organism": "Mouse",
        "refseq_name": "alpha-1-antitrypsin 1-4 precursor",
        "refseq_ac": "NP_033272",
        "gene_names_uniprotkb": "Serpina1d; Dom4; Spi1-4",
        "gene_names_refseq": "AAT; DOM-7; Dom1; Dom4; PI4; Serpina1a; Serpina1d; Spi1-1; Spi1-4",
        "protein_names_uniprotkb": "Alpha-1-antitrypsin 1-4; Alpha-1 protease inhibitor 4; Serine protease inhibitor 1-4; Serine protease inhibitor A1d; Serpin A1d",
        "protein_names_refseq": "Alpha-1 protease inhibitor 1; Alpha-1-antiproteinase; Alpha-1-antitrypsin 1-1; Serine protease inhibitor 1-1; Serine protease inhibitor A1a; Serpin A1a; Serpina1 DOM-7; alpha-1 protease inhibitor 4; alpha-1-antitrypsin 1-4 precursor; alpha-1-antitrypsin 1-4; serine (or cysteine) proteinase inhibitor, clade A, member 1d; serine protease inhibitor 1-4; serine protease inhibitor A1d; serpin A1d",
        "tax_id": 10090,
        "disease": "familial encephalopathy with neuroserpin inclusion bodies (Disease Ontology:DOID:0050831); chemical colitis (Disease Ontology:DOID:0060186); ileitis (Disease Ontology:DOID:0060189); pre-eclampsia (Disease Ontology:DOID:10591); hypertension (Disease Ontology:DOID:10763); alpha 1-antitrypsin deficiency (Disease Ontology:DOID:13372); pancreatic cancer (Disease Ontology:DOID:1793); arteriosclerosis (Disease Ontology:DOID:2349); asthma (Disease Ontology:DOID:2841); acute pancreatitis (Disease Ontology:DOID:2913); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); coronary artery disease (Disease Ontology:DOID:3393); pancreatic ductal carcinoma (Disease Ontology:DOID:3587); liver disease (Disease Ontology:DOID:409); primary hyperaldosteronism (Disease Ontology:DOID:446); pancreatitis (Disease Ontology:DOID:4989); liver cirrhosis (Disease Ontology:DOID:5082); human immunodeficiency virus infectious disease (Disease Ontology:DOID:526); proteinuria (Disease Ontology:DOID:576); pulmonary hypertension (Disease Ontology:DOID:6432); osteoarthritis (Disease Ontology:DOID:8398); colorectal cancer (Disease Ontology:DOID:9256); pulmonary emphysema (Disease Ontology:DOID:9675)",
        "pathway": " (mmu:20703)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "11961105;12659817;1946354;30833329;31717526;32723872;34428180;37453647;37625151;39627609;8619829",
        "class_list": "",
        "function": "CHOP and c-JUN up-regulate the mutant Z alpha1-antitrypsin, exacerbating its aggregation and liver proteotoxicity., [RefSeq, PubMed]; Calreticulin modulation may eliminate the toxic gain of function associated with aggregation of ZAAT in lung and liver, thus providing a potential new therapeutic approach to the treatment of AATD-related liver disease., [RefSeq, PubMed]; Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression., [RefSeq, PubMed]; Inhibitor of serine proteases. Can inhibit trypsin and chymotrypsin; relatively ineffective against elastase., [UniProtKB, PubMed, PubMed]; Pi*ZZ individuals display minor alterations in serum iron parameters. Neither mild iron overload seen in these individuals nor the presence of HFE mutations (C282Y and H63D) constitute a major contributor to liver fibrosis development. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 23,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0002020 protease binding;GO:0004867 serine-type endopeptidase inhibitor activity;GO:0042802 identical protein binding;GO:0004866 endopeptidase inhibitor activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0010288 response to lead ion;GO:0034097 response to cytokine;GO:0043434 response to peptide hormone;GO:1900004 negative regulation of serine-type endopeptidase activity;GO:0033986 response to methanol",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q00897-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UKZ7-1",
        "uniprot_id": "A14EL_MOUSE",
        "mass": 17541.0,
        "length": 152,
        "protein_name": "ARL14 effector protein-like",
        "gene_name": "Arl14epl",
        "organism": "Mouse",
        "refseq_name": "ARL14 effector protein-like",
        "refseq_ac": "NP_001028618",
        "gene_names_uniprotkb": "Arl14epl; Gm949",
        "gene_names_refseq": "Arl14epl; Gm949",
        "protein_names_uniprotkb": "ARL14 effector protein-like",
        "protein_names_refseq": "ARL14 effector protein-like",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:381142)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "31599954",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q3UKZ7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60590-1",
        "uniprot_id": "A1AG1_MOUSE",
        "mass": 23895.0,
        "length": 207,
        "protein_name": "Alpha-1-acid glycoprotein 1",
        "gene_name": "Orm1",
        "organism": "Mouse",
        "refseq_name": "alpha-1-acid glycoprotein 1 precursor",
        "refseq_ac": "NP_032794",
        "gene_names_uniprotkb": "Orm1; Agp1; Orm-1",
        "gene_names_refseq": "Agp-1; Agp-2; Orm-1; Orm1",
        "protein_names_uniprotkb": "Alpha-1-acid glycoprotein 1; AGP 1; OMD 1; Orosomucoid-1",
        "protein_names_refseq": "AGP 1; OMD 1; alpha-1-acid glycoprotein 1 precursor; alpha-1-acid glycoprotein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:18405);  (R-MMU-114608);  (R-MMU-6798695)",
        "pathway_count": 3,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;16944957;17330941;20571061;2475311;25428506;33168190;34210751;34428180;37507081;37640741;37949310",
        "class_list": "",
        "function": "Alpha1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages., [RefSeq, PubMed]; Functions as a transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain (By similarity). Appears to function in modulating the activity of the immune system during the acute-phase reaction., [UniProtKB]; Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization. Publication Status: Online-Only, [RefSeq, PubMed]; Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis., [RefSeq, PubMed]; The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation., [RefSeq, PubMed]; This gene encodes a member of the lipocalin family of proteins. The encoded protein is an abundant acute-phase protein that is synthesized by hepatocytes in response to cytokines during the acute phase response. The encoded protein may regulate inflammation and metabolism. This gene is present in a gene cluster on chromosome 4. [provided by RefSeq, Aug 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 5,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 5,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 5,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 4,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 9,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0036094 small molecule binding",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0006953 acute-phase response;GO:0002682 regulation of immune system process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.8,
        "record_id": "Q60590-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61503-1",
        "uniprot_id": "5NTD_MOUSE",
        "mass": 63864.0,
        "length": 576,
        "protein_name": "5'-nucleotidase",
        "gene_name": "Nt5e",
        "organism": "Mouse",
        "refseq_name": "5'-nucleotidase preproprotein",
        "refseq_ac": "NP_035981",
        "gene_names_uniprotkb": "Nt5e; Nt5; Nte",
        "gene_names_refseq": "2210401F01Rik; 5'-NT; CD73; NT; Nt5e; Nt5; eNT",
        "protein_names_uniprotkb": "5'-nucleotidase; 3.1.3.35; 3.1.3.5; 3.1.3.89; 3.1.3.91; 3.1.3.99; 5'-NT; 5'-deoxynucleotidase; Ecto-5'-nucleotidase; IMP-specific 5'-nucleotidase; Thymidylate 5'-phosphatase",
        "protein_names_refseq": "5'-deoxynucleotidase; 5'-nucleotidase preproprotein; 5'-nucleotidase; IMP-specific 5'-nucleotidase; ecto-5'-nucleotidase; thymidylate 5'-phosphatase",
        "tax_id": 10090,
        "disease": "hereditary arterial and articular multiple calcification syndrome (Disease Ontology:DOID:0111582); status epilepticus (Disease Ontology:DOID:1824)",
        "pathway": " (mmu:23959);  (R-MMU-196807);  (R-MMU-73621);  (R-MMU-74259)",
        "pathway_count": 4,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;19349973;30899004;33300544;8224905",
        "class_list": "",
        "function": "Catalyzes the hydrolysis of nucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside (PubMed:8224905). Hydrolyzes IMP (PubMed:8224905). Shows a preference for ribonucleotide monophosphates over their equivalent deoxyribose forms (By similarity). Although AMP is the preferred substrate can also hydrolyze UMP, GMP, CMP, dAMP, dCMP, dTMP, NAD and NMN (By similarity)., [UniProtKB, PubMed, UniProtKB]; This gene encodes a membrane-bound nucleotidase that hydrolyzes extracellular nucleoside monophosphates. The encoded preproprotein undergoes proteolytic processing to generate to a functional, homodimeric enzyme that preferentially uses adenosine monophosphate as a substrate to generate free adenosine. Mice lacking the encoded protein exhibit a significantly reduced fall in stop flow pressure and superficial nephron glomerular filtration rate in response to a saturating increase of tubular perfusion flow. [provided by RefSeq, Sep 2016]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 5,
        "disease_count": 2,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U3S1",
        "ec_number_list": "3.1.3.5;3.1.3.89;3.1.3.99;3.1.3.1;3.9.1.1;3.1.3.91;2.7.1.77;3.1.3.35;3.6.1.-;3.1.4.1;3.6.1.9;3.1.3.2;3.1.3.48;3.1.3.-",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0042802 identical protein binding;GO:0000166 nucleotide binding;GO:0008253 5'-nucleotidase activity;GO:0008198 ferrous iron binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0016020 membrane",
        "go_biological_process": "GO:0046032 ADP catabolic process;GO:0046085 adenosine metabolic process;GO:0050728 negative regulation of inflammatory response;GO:0006196 AMP catabolic process;GO:0007159 leukocyte cell-cell adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q61503-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61618-1",
        "uniprot_id": "AA3R_MOUSE",
        "mass": 36449.0,
        "length": 319,
        "protein_name": "Adenosine receptor A3",
        "gene_name": "Adora3",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Adora3; Gpcr2",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Adenosine receptor A3; A3AR",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (R-MMU-417973);  (R-MMU-418594)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "10191095;10660615;12817016;34428180;8288218",
        "class_list": "",
        "function": "G protein-coupled receptor (GPCR) for adenosine that plays significant roles in various physiological processes including immune regulation, cardioprotection and neuroprotection (PubMed:10660615, PubMed:12817016). Also acts as a receptor for adenosines containing N(6)-methylated adenine (m6A) post-transcriptional modification, which are derived from the degradation of RNAs (mRNAs, rRNAs and tRNAs): activated by N(6)-methyladenosine (m6A), N(6),N(6)-dimethyladenosine (m6,6A) and N(6)-isopentenyladenosine (i6A) (By similarity). Preferentially couples to the inhibitory G protein (Gi), leading to the suppression of adenylate cyclase activity and a reduction in intracellular cyclic AMP levels (PubMed:10660615). Upon adenosine binding, mediates cardioprotection in cardiomyocytes through anti-apoptotic effects primarily via the ERK1/2 pathway as well as the PI3K pathway (By similarity). In the central nervous system, participates in the modulation of synaptic plasticity, including long-term potentiation (LTP) and long-term depression (LTD) in the hippocampus (By similarity). In lung mast cells, receptor activation contributes to the type I allergic response by facilitating mast cell degranulation and histamine release (PubMed:12817016). Highly expressed in inflammatory cells such as neutrophils and mast cells, inhibits neutrophil degranulation and reduces superoxide production, thereby modulating inflammatory responses (By similarity)., [UniProtKB, UniProtKB, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9R202",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001609 G protein-coupled adenosine receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030425 dendrite;GO:0031594 neuromuscular junction;GO:0045202 synapse;GO:0042734 presynaptic membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007193 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;GO:0008285 negative regulation of cell population proliferation;GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;GO:0014061 regulation of norepinephrine secretion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q61618-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64437-1",
        "uniprot_id": "ADH7_MOUSE",
        "mass": 39904.0,
        "length": 374,
        "protein_name": "All-trans-retinol dehydrogenase [NAD(+)] ADH7",
        "gene_name": "Adh7",
        "organism": "Mouse",
        "refseq_name": "all-trans-retinol dehydrogenase [NAD(+)] ADH7",
        "refseq_ac": "NP_033756",
        "gene_names_uniprotkb": "Adh7; Adh-3; Adh3",
        "gene_names_refseq": "Adh-3e; Adh-3t; Adh-3; Adh3-e; Adh3-t; Adh3; Adh4; Adh7; Adt-1",
        "protein_names_uniprotkb": "All-trans-retinol dehydrogenase [NAD(+)] ADH7; 1.1.1.105; 1.1.1.1; 1.1.1.66; ADH-C2; Alcohol dehydrogenase 7; Alcohol dehydrogenase class 4 mu/sigma chain; Alcohol dehydrogenase class IV mu/sigma chain; Gastric alcohol dehydrogenase; Omega-hydroxydecanoate dehydrogenase ADH7; Retinol dehydrogenase",
        "protein_names_refseq": "ADH-C2; IV ADH; alcohol dehydrogenase 3 complex; alcohol dehydrogenase 3 temporal; alcohol dehydrogenase 4; alcohol dehydrogenase class 4 mu/sigma chain; alcohol dehydrogenase class IV mu/sigma chain; all-trans-retinol dehydrogenase [NAD(+)] ADH7; gastric alcohol dehydrogenase; omega-hydroxydecanoate dehydrogenase ADH7; retinol dehydrogenase",
        "tax_id": 10090,
        "disease": "Parkinson's disease (Disease Ontology:DOID:14330)",
        "pathway": " (mmu:11529);  (R-MMU-211935);  (R-MMU-71384)",
        "pathway_count": 3,
        "publication_count": 6,
        "publication_id_list": "24668648;31219806;34428180;37507081;7738026;9126489",
        "class_list": "",
        "function": "ADH3 promotes liver fibrosis by enhancing hepatic stellate cell activation and inhibiting natural killer cell activity, [RefSeq, PubMed]; Catalyzes the NAD-dependent oxidation of all-trans-retinol, alcohol, aldehyde and omega-hydroxy fatty acids and their derivatives. Oxidizes preferentially all trans-retinol, all-trans-4-hydroxyretinol, 9-cis-retinol, 2-hexenol, and long chain omega-hydroxy fatty acids such as juniperic acid. In vitro can also catalyze the NADH-dependent reduction of all-trans-retinal and aldehydes and their derivatives. Reduces preferentially all trans-retinal, all-trans-4-oxoretinal and hexanal. Catalyzes in the oxidative direction with higher efficiency. Therefore may participate in retinoid metabolism, fatty acid omega-oxidation, and elimination of cytotoxic aldehydes produced by lipid peroxidation., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.1.1.105;1.1.1.315;1.1.1.209;1.1.1.53;1.1.1.1;1.1.1.-;1.1.1.284;1.1.1.66;1.1.1.62;1.1.1.239",
        "go_molecular_function": "GO:0004022 alcohol dehydrogenase (NAD+) activity;GO:0008270 zinc ion binding;GO:0042802 identical protein binding;GO:0004031 aldehyde oxidase activity;GO:0004745 all-trans-retinol dehydrogenase (NAD+) activity",
        "go_cellular_component": "GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0001523 retinoid metabolic process;GO:0045471 response to ethanol;GO:0006068 ethanol catabolic process;GO:0009617 response to bacterium;GO:0010430 fatty acid omega-oxidation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q64437-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q67BJ4-1",
        "uniprot_id": "A4GAT_MOUSE",
        "mass": 41366.0,
        "length": 359,
        "protein_name": "Lactosylceramide 4-alpha-galactosyltransferase",
        "gene_name": "A4galt",
        "organism": "Mouse",
        "refseq_name": "lactosylceramide 4-alpha-galactosyltransferase",
        "refseq_ac": "NP_001004150",
        "gene_names_uniprotkb": "A4galt",
        "gene_names_refseq": "A4galt",
        "protein_names_uniprotkb": "Lactosylceramide 4-alpha-galactosyltransferase; 2.4.1.228; Alpha-1,4-N-acetylglucosaminyltransferase; Alpha-1,4-galactosyltransferase; Alpha4Gal-T1; Gb3 synthase; Globotriaosylceramide synthase; UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase",
        "protein_names_refseq": "Gb3 synthase; Gb3/CD77 synthase; UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase; alpha-1,4-N-acetylglucosaminyltransferase; alpha4Gal-T1; globotriaosylceramide synthase; lactosylceramide 4-alpha-galactosyltransferase",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:239559);  (R-MMU-9840309)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;16079416;16476743;18810447;21750661;30084848;31540393;32507026;38359115",
        "class_list": "glycogene;glycosyltransferase",
        "function": "Catalyzes the transfer of galactose from UDP-alpha-D-galactose in an alpha1,4 linkage to lactosylceramide/beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(d18:1(4E)) to produce globotriaosylceramide/globoside Gb3Cer (d18:1(4E)), also known as CD77 (By similarity). Globoside Gb3Cer/CD77 is a root structure in biosynthesis pathway of neutral glycosphingolipids of the globo-series. Broadly expressed in cell membranes of immune cells and other tissues, Gb3Cer/CD77 antigen may participate in mechanisms that regulate cell-cell interactions and cell differentiation. In germinal center B cells, Gb3Cer/CD77 interacts with CD19 to drive centroblast-to-centrocyte transition, B cell receptor complex assembly and T follicular helper cell differentiation. In epithelium, Gb3Cer/CD77 regulates CDH1/E-cadherin-dependent cell-cell adhesion counteracting epithelial-to-mesenchymal transition (By similarity) (PubMed:38359115). Also able to transfer galactose to galactosylceramide/beta-D-Gal-(1<->1')-Cer (By similarity)., [UniProtKB, UniProtKB, PubMed]; Gb3 and Gb4 synthase are responsible for the expression of globo-series glycolipids, [RefSeq, PubMed]; Gb3/CD77 synthase has a role in synthesis of globo-series glycosphingolipids and sensitivity to verotoxins, [RefSeq, PubMed]; The deficiency of Gb3 synthase in mice decreased the number of osteoblasts on the bone surface, and suppressed mRNA levels of osteogenic differentiation markers. Publication Status: Online-Only, [RefSeq, PubMed]; The interaction between flagellin and the glycosphingolipid Gb3 on host cells contributes to Bacillus cereus acute infection., [RefSeq, PubMed]; The protein encoded by this gene catalyzes the transfer of galactose to lactosylceramide to form globotriaosylceramide, which has been identified as the P(k) antigen of the P blood group system. The encoded protein, which is a type II membrane protein found in the Golgi, is also required for the synthesis of the bacterial verotoxins receptor. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2010]., [RefSeq]; Verification of the function of Gb3 in the pathogenesis of hemolytic-uremic syndrome as the cellular receptor responsible for cytotoxicity caused by verotoxin (VT) elaborated by Shigella and certain strains of E.coli., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 9,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.4.1.228",
        "go_molecular_function": "GO:0008378 galactosyltransferase activity;GO:0015643 toxic substance binding;GO:0050512 lactosylceramide 4-alpha-galactosyltransferase activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0001576 globoside biosynthetic process;GO:0006688 glycosphingolipid biosynthetic process;GO:0007009 plasma membrane organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q67BJ4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6P6J0-1",
        "uniprot_id": "ADAT2_MOUSE",
        "mass": 21308.0,
        "length": 191,
        "protein_name": "tRNA-specific adenosine-34 deaminase catalytic subunit ADAT2",
        "gene_name": "Adat2",
        "organism": "Mouse",
        "refseq_name": "tRNA-specific adenosine-34 deaminase catalytic subunit ADAT2",
        "refseq_ac": "NP_080024",
        "gene_names_uniprotkb": "Adat2; Deadc1",
        "gene_names_refseq": "4933426M09Rik; Adat2; Deadc1",
        "protein_names_uniprotkb": "tRNA-specific adenosine-34 deaminase catalytic subunit ADAT2; 3.5.4.33; Deaminase domain-containing protein 1",
        "protein_names_refseq": "adenosine deaminase, tRNA-specific 2, TAD2 homolog; deaminase domain containing 1; deaminase domain-containing protein 1; tRNA-specific adenosine deaminase 2; tRNA-specific adenosine-34 deaminase catalytic subunit ADAT2; tRNA-specific adenosine-34 deaminase subunit ADAT2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66757)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "34057470;40120092",
        "class_list": "",
        "function": "Catalytic subunit of the tRNA-specific adenosine-34 deaminase complex, composed of the ADAT2 catalytic subunit and the ADAT3 regulatory subunit, which deaminates adenosine-34 (the first, also called wobble position of the anticodon) to inosine in many tRNAs (PubMed:34057470). Inosine-34 allows the decoding of 3 different nucleotides at the third position of mRNA codons, as inosine is able to pair with U, C, and A (PubMed:34057470). Binding of the ADAT2-ADAT3 complex to tRNA is mediated by the N-terminus of ADAT3 which rotates with respect to the catalytic domain of the complex, formed by ADAT2 and the ADAT3 C-terminal domain, to position the tRNA anticodon stem-loop correctly in the ADAT2 active site (PubMed:34057470). The ADAT2-ADAT3 complex is required for radial migration of projection neurons in the developing brain cortex, and the catalytic activity of the complex is necessary for this function (PubMed:40120092)., [UniProtKB, PubMed, PubMed]; The structure of the mouse ADAT2/ADAT3 complex reveals the molecular basis for mammalian tRNA wobble adenosine-to-inosine deamination., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CX14",
        "ec_number_list": "3.5.4.33",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0052717 tRNA-specific adenosine-34 deaminase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0002100 tRNA wobble adenosine to inosine editing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q6P6J0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6ZWR4-1",
        "uniprot_id": "2ABB_MOUSE",
        "mass": 51710.0,
        "length": 443,
        "protein_name": "Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform",
        "gene_name": "Ppp2r2b",
        "organism": "Mouse",
        "refseq_name": "serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform 2",
        "refseq_ac": "NP_082668",
        "gene_names_uniprotkb": "Ppp2r2b",
        "gene_names_refseq": "2900026H06Rik; 6330404L05Rik; E130009M08Rik; PP2A-PR55B; PR55-BETA; Ppp2r2b; SCA12",
        "protein_names_uniprotkb": "Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform; PP2A subunit B isoform B55-beta; PP2A subunit B isoform PR55-beta; PP2A subunit B isoform R2-beta; PP2A subunit B isoform beta",
        "protein_names_refseq": "serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform 2",
        "tax_id": 10090,
        "disease": "spinocerebellar ataxia 12 (Disease Ontology:DOID:0050962); Alzheimer's disease (Disease Ontology:DOID:10652); autosomal dominant cerebellar ataxia (Disease Ontology:DOID:1441); breast cancer (Disease Ontology:DOID:1612); systemic lupus erythematosus (Disease Ontology:DOID:9074); brain disease (Disease Ontology:DOID:936)",
        "pathway": " (mmu:72930)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;12473071;18432318;21750661;32750040;33300544;37735923",
        "class_list": "",
        "function": "Bidirectional Transcription at the PPP2R2B Gene Locus in Spinocerebellar Ataxia Type 12., [RefSeq, PubMed]; PP-2A is less abundant than PP-1 in the mouse eye and appear to be highly regulated by various regulatory subunits; the genes encoding PP-1alpha/beta, PP-2Aalpha/beta, PP-2A-Aalpha/beta, and PP-2A-B alpha/beta/gamma are all differentially expressed. Publication Status: Online-Only, [RefSeq, PubMed]; Protein phosphatase 2A B55beta limits CD8+ T cell lifespan following cytokine withdrawal., [RefSeq, PubMed]; The B regulatory subunit might modulate substrate selectivity and catalytic activity, and might also direct the localization of the catalytic enzyme to a particular subcellular compartment. Within the PP2A holoenzyme complex, isoform 2 is required to promote proapoptotic activity. Isoform 2 regulates neuronal survival through the mitochondrial fission and fusion balance., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 6,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UF60;Q8K413;Q9D3B7;Q9D6I1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019888 protein phosphatase regulator activity;GO:0044877 protein-containing complex binding;GO:0140767 enzyme-substrate adaptor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0005829 cytosol;GO:0005856 cytoskeleton",
        "go_biological_process": "GO:0006626 protein targeting to mitochondrion;GO:0043525 positive regulation of neuron apoptotic process;GO:0043653 mitochondrial fragmentation involved in apoptotic process;GO:0000266 mitochondrial fission;GO:0051983 regulation of chromosome segregation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q6ZWR4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TN31-1",
        "uniprot_id": "AGGF1_MOUSE",
        "mass": 79445.0,
        "length": 711,
        "protein_name": "Angiogenic factor with G patch and FHA domains 1",
        "gene_name": "Aggf1",
        "organism": "Mouse",
        "refseq_name": "angiogenic factor with G patch and FHA domains 1",
        "refseq_ac": "NP_079906",
        "gene_names_uniprotkb": "Aggf1; Vg5q",
        "gene_names_refseq": "2010009L17Rik; 2310029P06Rik; Aggf1; Peg3; VG5Q",
        "protein_names_uniprotkb": "Angiogenic factor with G patch and FHA domains 1; Angiogenic factor VG5Q; mVG5Q",
        "protein_names_refseq": "angiogenic factor VG5Q; angiogenic factor with G patch and FHA domains 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66549)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "14961121;21576349;25428506;34339727;34428180;34551592;35202649",
        "class_list": "",
        "function": "Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin alpha7 on vascular smooth muscle cells., [RefSeq, PubMed]; Autophagy is required for the promoting effect of angiogenic factor with G patch domain and forkhead-associated domain 1 (AGGF1) in retinal angiogenesis., [RefSeq, PubMed]; Promotes angiogenesis and the proliferation of endothelial cells. Able to bind to endothelial cells and promote cell proliferation, suggesting that it may act in an autocrine fashion (By similarity)., [UniProtKB]; Receptor and Molecular Mechanism of AGGF1 Signaling in Endothelial Cell Functions and Angiogenesis., [RefSeq, PubMed]; Sphingolipid modulation of angiogenic factor expression in neuroblastoma, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8R2S6;Q9CQR9;Q9CU87;Q9D768",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0003676 nucleic acid binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0001525 angiogenesis;GO:0007155 cell adhesion;GO:0030154 cell differentiation;GO:0045766 positive regulation of angiogenesis;GO:0001938 positive regulation of endothelial cell proliferation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q7TN31-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TNK8-1",
        "uniprot_id": "ADM2_MOUSE",
        "mass": 16188.0,
        "length": 150,
        "protein_name": "Protein ADM2",
        "gene_name": "Adm2",
        "organism": "Mouse",
        "refseq_name": "protein ADM2 preproprotein",
        "refseq_ac": "NP_891558",
        "gene_names_uniprotkb": "Adm2; Am2",
        "gene_names_refseq": "Adm2; Am2; IMD; Imdn",
        "protein_names_uniprotkb": "Protein ADM2; IMDL; Intermedin-long; Intermedin",
        "protein_names_refseq": "intermedin; protein ADM2 preproprotein; protein ADM2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:223780);  (R-MMU-418555);  (R-MMU-419812)",
        "pathway_count": 3,
        "publication_count": 5,
        "publication_id_list": "14615490;14706825;16763098;37352568;37879153",
        "class_list": "",
        "function": "Intermedin (adrenomedullin 2) plays a protective role in sepsis by regulating T- and B-cell proliferation and activity., [RefSeq, PubMed]; Intermedin alleviates diabetic vascular calcification by inhibiting GLUT1 through activation of the cAMP/PKA signaling pathway., [RefSeq, PubMed]; Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes, [RefSeq, PubMed]; Intermedin/ADM2 is a peptide hormone that plays a role as physiological regulator of gastrointestinal and cardiovascular bioactivities mediated by the CALCRL-RAMPs receptor complexes (PubMed:14615490, PubMed:14706825). Activates the cAMP-dependent pathway through interaction with CALCRL-RAMP3 receptor complex (PubMed:14615490)., [UniProtKB, PubMed, PubMed]; Our data suggest that IMD acutely augments cardiomyocyte contractile function through, at least in part, a protein kinase C- and protein kinase A-dependent mechanism., [RefSeq, PubMed]; This gene encodes a member of the calcitonin gene-related peptide (CGRP)/calcitonin family of hormones that play a role in the regulation of cardiovascular homeostasis, prolactin release, anti-diuresis, anti-natriuresis, and regulation of food and water intake. The encoded protein is proteolytically processed to generate one or more biologically active peptides. Intravenous injection of the active peptide was found to protect mouse lungs from ischemia/reperfusion injury. [provided by RefSeq, Aug 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q4VAE1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0044877 protein-containing complex binding;GO:0005179 hormone activity",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0001525 angiogenesis;GO:0006468 protein phosphorylation;GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway;GO:0010628 positive regulation of gene expression;GO:0045766 positive regulation of angiogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q7TNK8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80UX8-1",
        "uniprot_id": "ABHDD_MOUSE",
        "mass": 38525.0,
        "length": 337,
        "protein_name": "Protein ABHD13",
        "gene_name": "Abhd13",
        "organism": "Mouse",
        "refseq_name": "protein ABHD13",
        "refseq_ac": "NP_001074588",
        "gene_names_uniprotkb": "Abhd13",
        "gene_names_refseq": "1110065L07Rik; Abhd13",
        "protein_names_uniprotkb": "Protein ABHD13; 3.-.-.-; Abhydrolase domain-containing protein 13; Alpha/beta hydrolase domain-containing protein 13",
        "protein_names_refseq": "abhydrolase domain-containing protein 13; alpha/beta hydrolase domain-containing protein 13; protein ABHD13",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68904)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "25428506",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BXS1;Q9D0V5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008474 palmitoyl-(protein) hydrolase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0032839 dendrite cytoplasm",
        "go_biological_process": "GO:0002084 protein depalmitoylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q80UX8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80YU0-1",
        "uniprot_id": "ABHGB_MOUSE",
        "mass": 53297.0,
        "length": 474,
        "protein_name": "ABHD16B",
        "gene_name": "Abhd16b",
        "organism": "Mouse",
        "refseq_name": "ABHD16B",
        "refseq_ac": "NP_899004",
        "gene_names_uniprotkb": "Abhd16b",
        "gene_names_refseq": "1700095H12; Abhd16b",
        "protein_names_uniprotkb": "ABHD16B; 3.1.1.111; Abhydrolase domain-containing protein 16B; Alpha/beta hydrolase domain-containing protein 16B",
        "protein_names_refseq": "ABHD16B; abhydrolase domain-containing protein 16B; alpha/beta hydrolase domain-containing protein 16B; protein ABHD16B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:241850)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "23328280",
        "class_list": "",
        "function": "Hydrolyzes the sn-1 position of glycerophospholipids with high specificity towards phosphatidylserine (PS), PS-PLA1 enzyme. Also hydrolyzes the acyl chain of glycerolipids with a preference for the monoacylglycerol (MAG) 1-acylglycerol, MAG lipase. Plays a regulatory role in cellular lipid homeostasis by modulating genes involved in neutral lipid degradation and in phospholipid synthesis and composition., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.1.1.23;3.1.1.3;3.1.1.26;3.1.1.79;3.1.1.5;3.1.1.4;3.1.1.-;3.1.1.32;3.1.1.111;3.1.1.118;3.1.-.-",
        "go_molecular_function": "GO:0004620 phospholipase activity;GO:0047372 monoacylglycerol lipase activity",
        "go_cellular_component": "GO:0005654 nucleoplasm",
        "go_biological_process": "GO:0052651 monoacylglycerol catabolic process;GO:0006660 phosphatidylserine catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q80YU0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q811W1-1",
        "uniprot_id": "AARD_MOUSE",
        "mass": 18923.0,
        "length": 167,
        "protein_name": "Alanine- and arginine-rich domain-containing protein",
        "gene_name": "Aard",
        "organism": "Mouse",
        "refseq_name": "alanine- and arginine-rich domain-containing protein",
        "refseq_ac": "NP_780712",
        "gene_names_uniprotkb": "Aard",
        "gene_names_refseq": "A5D3; Aard",
        "protein_names_uniprotkb": "Alanine- and arginine-rich domain-containing protein",
        "protein_names_refseq": "alanine- and arginine-rich domain-containing protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:239435)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "12617826;17486547;27959439",
        "class_list": "",
        "function": "The results of the present study indicate that Aard is a target of AR action in mouse Sertoli cells and suggest a novel finding by which the loss of AR function in Sertoli cells blocks spermatogenesis and results in male infertility., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BL45",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "GO:0033574 response to testosterone",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q811W1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BM81-1",
        "uniprot_id": "AD4F1_MOUSE",
        "mass": 46220.0,
        "length": 407,
        "protein_name": "Arylacetamide deacetylase-like 4 family member 1",
        "gene_name": "Aadacl4fm1",
        "organism": "Mouse",
        "refseq_name": "arylacetamide deacetylase-like 4 family member 1",
        "refseq_ac": "NP_941064",
        "gene_names_uniprotkb": "Aadacl4fm1",
        "gene_names_refseq": "9430007A20Rik; Aadacl4fm1; Aadacl4; Gm1034",
        "protein_names_uniprotkb": "Arylacetamide deacetylase-like 4 family member 1; 3.1.1.-; AADACL4 family member 1",
        "protein_names_refseq": "arylacetamide deacetylase-like 4 family member 1; arylacetamide deacetylase-like 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:381572)",
        "pathway_count": 1,
        "publication_count": 0,
        "publication_id_list": "",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2A751",
        "ec_number_list": "",
        "go_molecular_function": "GO:0016787 hydrolase activity",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.1,
        "record_id": "Q8BM81-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CHC8-1",
        "uniprot_id": "ADNP2_MOUSE",
        "mass": 126768.0,
        "length": 1165,
        "protein_name": "Activity-dependent neuroprotector homeobox protein 2",
        "gene_name": "Adnp2",
        "organism": "Mouse",
        "refseq_name": "activity-dependent neuroprotector homeobox protein 2",
        "refseq_ac": "NP_778193",
        "gene_names_uniprotkb": "Adnp2; Kiaa0863; Zfp508; Znf508",
        "gene_names_refseq": "8430420L05Rik; Adnp2; Kiaa0863; Zfp508; mKIAA0863",
        "protein_names_uniprotkb": "Activity-dependent neuroprotector homeobox protein 2; ADNP homeobox protein 2; Zinc finger protein 508",
        "protein_names_refseq": "ADNP homeobox protein 2; activity-dependent neuroprotector homeobox protein 2; zinc finger protein 508",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:240442)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "18179478;23071114;30084848;36852467;40997131",
        "class_list": "",
        "function": "May be involved in transcriptional regulation (PubMed:23071114). May play a role in neuronal function; perhaps involved in protection of brain tissues from oxidative stress (PubMed:18179478). May be involved in erythroid differentiation (PubMed:23071114)., [UniProtKB, PubMed, PubMed]; The adnp2 may have an important function in brain by playing a role in cellular survival pathways., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6P294;Q80VS0;Q811H5;Q8R1A2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0007399 nervous system development;GO:0010468 regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8CHC8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R0P8-1",
        "uniprot_id": "ABHD8_MOUSE",
        "mass": 48229.0,
        "length": 439,
        "protein_name": "Protein ABHD8",
        "gene_name": "Abhd8",
        "organism": "Mouse",
        "refseq_name": "protein ABHD8",
        "refseq_ac": "NP_071864",
        "gene_names_uniprotkb": "Abhd8",
        "gene_names_refseq": "0910001L24Rik; Abhd8",
        "protein_names_uniprotkb": "Protein ABHD8; 3.-.-.-; Abhydrolase domain-containing protein 8; Alpha/beta hydrolase domain-containing protein 8",
        "protein_names_refseq": "abhydrolase domain-containing protein 8; alpha/beta hydrolase domain-containing protein 8; protein ABHD8",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:64296)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10679242;20173027;25428506;30084848;30779550;34428180;39225180",
        "class_list": "",
        "function": "Negatively regulates NLRP3-driven inflammation (PubMed:39225180). Promotes NLRP3 degradation through the chaperone-mediated autophagy (CMA) pathway, hence attenuating inflammasome activation and IL1B secretion. Acts by recruiting palmitoyltransferase ZDHHC12 to NLRP3, facilitating NLRP3 palmitoylation and subsequent degradation (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9DC79;Q9JMF5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042171 lysophosphatidic acid acyltransferase activity;GO:0052689 carboxylic ester hydrolase activity;GO:0004620 phospholipase activity",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006654 phosphatidic acid biosynthetic process;GO:0006954 inflammatory response;GO:0055088 lipid homeostasis;GO:1900226 negative regulation of NLRP3 inflammasome complex assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8R0P8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R519-1",
        "uniprot_id": "ACMSD_MOUSE",
        "mass": 38027.0,
        "length": 336,
        "protein_name": "2-amino-3-carboxymuconate-6-semialdehyde decarboxylase",
        "gene_name": "Acmsd",
        "organism": "Mouse",
        "refseq_name": "2-amino-3-carboxymuconate-6-semialdehyde decarboxylase",
        "refseq_ac": "NP_001028213",
        "gene_names_uniprotkb": "Acmsd",
        "gene_names_refseq": "Acmsd",
        "protein_names_uniprotkb": "2-amino-3-carboxymuconate-6-semialdehyde decarboxylase; 4.1.1.45; Picolinate carboxylase",
        "protein_names_refseq": "2-amino-3-carboxymuconate-6-semialdehyde decarboxylase; picolinate carboxylase",
        "tax_id": 10090,
        "disease": "kidney failure (Disease Ontology:DOID:1074)",
        "pathway": " (mmu:266645)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "12140278;16807375;25428506;30084848;30232574;30356218;34428180",
        "class_list": "",
        "function": "Acmsd gene expression was found to be under the control of both hepatocyte nuclear factor 4alpha (HNF4alpha) and peroxisome proliferator-activated receptor alpha (PPARalpha)., [RefSeq, PubMed]; Alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD), the enzyme that limits spontaneous cyclization of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde in the de novo NAD(+) synthesis pathway, controls cellular NAD(+) levels via an evolutionarily conserved mechanism in Caenorhabditis elegans and mouse, [RefSeq, PubMed]; Converts alpha-amino-beta-carboxymuconate-epsilon-semialdehyde (ACMS) to alpha-aminomuconate semialdehyde (AMS). ACMS can be converted non-enzymatically to quinolinate (QA), a key precursor of NAD, and a potent endogenous excitotoxin of neuronal cells which is implicated in the pathogenesis of various neurodegenerative disorders. In the presence of ACMSD, ACMS is converted to AMS, a benign catabolite. ACMSD ultimately controls the metabolic fate of tryptophan catabolism along the kynurenine pathway., [UniProtKB, UniProtKB]; These results indicate that PGC1alpha is involved in Acmsd expression through cooperation with HNF4alpha., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B9EI97;Q3UNW3",
        "ec_number_list": "4.1.1.45",
        "go_molecular_function": "GO:0001760 aminocarboxymuconate-semialdehyde decarboxylase activity;GO:0008270 zinc ion binding;GO:0016787 hydrolase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0006569 L-tryptophan catabolic process;GO:1904985 negative regulation of quinolinate biosynthetic process;GO:0046874 quinolinate metabolic process;GO:0019748 secondary metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8R519-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R534-1",
        "uniprot_id": "ADM1B_MOUSE",
        "mass": 89369.0,
        "length": 806,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 1b",
        "gene_name": "Adam1b",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 1b precursor",
        "refseq_ac": "NP_742123",
        "gene_names_uniprotkb": "Adam1b",
        "gene_names_refseq": "Adam1b; Adam1; Ftna",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 1b; 3.4.24.-; ADAM 1b; Fertilin subunit alpha-b",
        "protein_names_refseq": "PH-30 alpha; a disintegrin and metalloproteinase domain 1b; disintegrin and metalloproteinase domain-containing protein 1b precursor; disintegrin and metalloproteinase domain-containing protein 1b; fertilin alpha; fertilin subunit alpha-b",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:280667)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "10395895;12095680;12711316;16407235;34428180",
        "class_list": "",
        "function": "Localization of ADAM1b in the endoplasmic reticulum of testicular germ cells and on the surface of epididymal sperm., [RefSeq, PubMed]; May play a role in spermatogenesis and sperm maturation., [UniProtKB, PubMed]; These results suggest that mouse ADAM1b/ADAM2 fertilin may play a crucial role not in the sperm/egg fusion but in the appearance of these two ADAMs on the sperm surface., [RefSeq, PubMed]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 6,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RU57;Q9R156",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0008237 metallopeptidase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane;GO:0009897 external side of plasma membrane;GO:1990913 sperm head plasma membrane",
        "go_biological_process": "GO:0006508 proteolysis;GO:0007283 spermatogenesis;GO:0007339 binding of sperm to zona pellucida;GO:0008584 male gonad development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q8R534-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q920H4-1",
        "uniprot_id": "ACM5_MOUSE",
        "mass": 60253.0,
        "length": 532,
        "protein_name": "Muscarinic acetylcholine receptor M5",
        "gene_name": "Chrm5",
        "organism": "Mouse",
        "refseq_name": "muscarinic acetylcholine receptor M5",
        "refseq_ac": "NP_991352",
        "gene_names_uniprotkb": "Chrm5",
        "gene_names_refseq": "AChR-M5; Chrm5; M5R; m5",
        "protein_names_uniprotkb": "Muscarinic acetylcholine receptor M5",
        "protein_names_refseq": "muscarinic acetylcholine receptor 5; muscarinic acetylcholine receptor M5",
        "tax_id": 10090,
        "disease": "nicotine dependence (Disease Ontology:DOID:0050742); alcohol use disorder (Disease Ontology:DOID:1574); cannabis dependence (Disease Ontology:DOID:1849)",
        "pathway": " (mmu:213788);  (R-MMU-390648);  (R-MMU-416476)",
        "pathway_count": 3,
        "publication_count": 1,
        "publication_id_list": "30084848",
        "class_list": "",
        "function": "The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover (By similarity)., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AHU3;Q0VBI9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0016934 extracellularly glycine-gated chloride channel activity;GO:0016907 G protein-coupled acetylcholine receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030425 dendrite;GO:0045202 synapse;GO:0045211 postsynaptic membrane",
        "go_biological_process": "GO:0007197 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway;GO:0007187 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;GO:0007268 chemical synaptic transmission;GO:0001696 gastric acid secretion;GO:0015872 dopamine transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q920H4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D0L4-1",
        "uniprot_id": "ADCK1_MOUSE",
        "mass": 59736.0,
        "length": 525,
        "protein_name": "AarF domain-containing protein kinase 1",
        "gene_name": "Adck1",
        "organism": "Mouse",
        "refseq_name": "aarF domain-containing protein kinase 1 isoform a",
        "refseq_ac": "NP_001264225",
        "gene_names_uniprotkb": "Adck1",
        "gene_names_refseq": "2610005A10Rik; Adck1",
        "protein_names_uniprotkb": "AarF domain-containing protein kinase 1; 2.7.-.-",
        "protein_names_refseq": "aarF domain-containing protein kinase 1 isoform a; aarF domain-containing protein kinase 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72113)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "10.1101/2023.09.13.557529;29237092;34428180",
        "class_list": "",
        "function": "Appears to be essential for maintaining mitochondrial cristae formation and mitochondrial function by acting via YME1L1 in a kinase-independent manner to regulate essential mitochondrial structural proteins OPA1 and IMMT (By similarity). The action of this enzyme is not yet clear. It is not known if it has protein kinase activity and what type of substrate it would phosphorylate (Ser, Thr or Tyr) (Probable)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UKJ2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane",
        "go_biological_process": "GO:0055088 lipid homeostasis;GO:0007005 mitochondrion organization;GO:1903852 positive regulation of cristae formation;GO:0010637 negative regulation of mitochondrial fusion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9D0L4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D2R0-1",
        "uniprot_id": "AACS_MOUSE",
        "mass": 75200.0,
        "length": 672,
        "protein_name": "Acetoacetyl-CoA synthetase",
        "gene_name": "Aacs",
        "organism": "Mouse",
        "refseq_name": "acetoacetyl-CoA synthetase",
        "refseq_ac": "NP_084486",
        "gene_names_uniprotkb": "Aacs",
        "gene_names_refseq": "2210408B16Rik; Aacs; SUR5",
        "protein_names_uniprotkb": "Acetoacetyl-CoA synthetase; 6.2.1.16",
        "protein_names_refseq": "acetoacetyl-CoA synthetase",
        "tax_id": 10090,
        "disease": "obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:78894);  (R-MMU-77111)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "18514076;22985732;23123469;25428506;25605945;27129883;29137983;34428180;35820727",
        "class_list": "",
        "function": "AACS promoter activity was controlled mainly by C/EBPalpha during adipogenesis., [RefSeq, PubMed]; Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels., [RefSeq, PubMed]; Cleavage of AACS by legumain is critical for the regulation of enzymatic activity and results in gain-of-function changes., [RefSeq, PubMed]; Converts acetoacetate to acetoacetyl-CoA in the cytosol (By similarity). Ketone body-utilizing enzyme, responsible for the synthesis of cholesterol and fatty acids (PubMed:22985732)., [UniProtKB, PubMed, UniProtKB]; Knockdown of AACS inhibits differentiation of 3T3-L1 adipocytes and suppresses expression of the adipocyte markers, peroxisome proliferator-activated receptor gama and CCAAT/enhancer binding protein alpha., [RefSeq, PubMed]; These results suggest that Sp1 regulates gene expression of AACS in Neuro-2a cells and ketone body utilization affects the balance of histone acetylation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A1IG47;Q3TCL8;Q3UD39",
        "ec_number_list": "6.2.1.16",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0030729 acetoacetate-CoA ligase activity;GO:0031955 short-chain fatty acid-CoA ligase activity",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0001889 liver development;GO:0006631 fatty acid metabolic process;GO:0007584 response to nutrient;GO:0032024 positive regulation of insulin secretion;GO:0034201 response to oleic acid",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q9D2R0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JI76-1",
        "uniprot_id": "ADA21_MOUSE",
        "mass": 80850.0,
        "length": 729,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 21",
        "gene_name": "Adam21",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 21 preproprotein",
        "refseq_ac": "NP_065063",
        "gene_names_uniprotkb": "Adam21; Adam31",
        "gene_names_refseq": "Adam21; Adam31",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 21; 3.4.24.-; ADAM 21; ADAM 31; Disintegrin and metalloproteinase domain-containing protein 31",
        "protein_names_refseq": "a disintegrin and metalloprotease domain (ADAM) 21; disintegrin and metalloproteinase domain-containing protein 21 preproprotein; disintegrin and metalloproteinase domain-containing protein 21; disintegrin and metalloproteinase domain-containing protein 31",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56622);  (R-MMU-2534343)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "10830287;20117247;25428506",
        "class_list": "",
        "function": "Adam21 gene produces two types of transcripts with different cellular localization in the mouse testis, and the production of these alternate transcripts is due to utilization of cell-type-specific promoters., [RefSeq, PubMed]; May be involved in sperm maturation and/or fertilization. May also be involved in epithelia functions associated with establishing and maintaining gradients of ions or nutrients., [UniProtKB]; This gene encodes a member of a disintegrin and metalloprotease (ADAM) family of endoproteases that play important roles in various biological processes including cell signaling, adhesion and migration. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional metalloprotease enzyme. The encoded protein functions in the regulation of spermatogenesis in the testes and neurogenesis in the central nervous system. [provided by RefSeq, May 2016]., [RefSeq]",
        "predicted_glycosites": 5,
        "predicted_n_glycosites": 5,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2RSL1",
        "ec_number_list": "2.4.1.-;2.4.1.275;2.4.1.22;2.4.1.38;2.4.1.90;3.4.24.-",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030424 axon;GO:0043025 neuronal cell body;GO:0009897 external side of plasma membrane;GO:0043005 neuron projection",
        "go_biological_process": "GO:0006508 proteolysis;GO:0008584 male gonad development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9JI76-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JKX4-1",
        "uniprot_id": "AATF_MOUSE",
        "mass": 59482.0,
        "length": 526,
        "protein_name": "Protein AATF",
        "gene_name": "Aatf",
        "organism": "Mouse",
        "refseq_name": "protein AATF",
        "refseq_ac": "NP_062790",
        "gene_names_uniprotkb": "Aatf; Che1; Trb",
        "gene_names_refseq": "4933415H02Rik; 5830465M17Rik; Aatf; Che-1; Trb",
        "protein_names_uniprotkb": "Protein AATF; Apoptosis-antagonizing transcription factor; Rb-binding protein Che-1; Traube protein",
        "protein_names_refseq": "protein AATF; rb-binding protein Che-1; traube protein",
        "tax_id": 10090,
        "disease": "chromosome 17q12 deletion syndrome (Disease Ontology:DOID:0060404)",
        "pathway": " (mmu:56321)",
        "pathway_count": 1,
        "publication_count": 15,
        "publication_id_list": "11071758;14627703;14636992;17242355;21183079;21952136;30084848;30770218;30779550;31219806;31545418;32923109;34428180;36210013;37435061",
        "class_list": "",
        "function": "AATF is an endogenous antagonist of Par-4 activity and an effective inhibitor of aberrant amyloid beta 1-42 production and secretion under apoptotic conditions., [RefSeq, PubMed]; AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation. Publication Status: Online-Only, [RefSeq, PubMed]; High AATF expression is associated with neuroblastoma., [RefSeq, PubMed]; Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome. May function as a general inhibitor of the histone deacetylase HDAC1. Binding to the pocket region of RB1 may displace HDAC1 from RB1/E2F complexes, leading to activation of E2F target genes and cell cycle progression. Conversely, displacement of HDAC1 from SP1 bound to the CDKN1A promoter leads to increased expression of this CDK inhibitor and blocks cell cycle progression. Also antagonizes PAWR mediated induction of aberrant amyloid peptide production in Alzheimer disease (presenile and senile dementia), although the molecular basis for this phenomenon has not been described to date., [UniProtKB, UniProtKB]; Study in Aatf conditional knockout mice found that Aatf suppressed RNA:DNA hybrid formation and enabled DNA double strand break repair in vitro. Results suggest that Aatf is a regulator of primary cilia and a modulator of the DNA damage response, connecting two pathogenetic mechanisms in nephronophthisis and related ciliopathies., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TQN1;Q8C5Q2;Q99P89",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003713 transcription coactivator activity;GO:0019901 protein kinase binding;GO:0043522 leucine zipper domain binding;GO:0048156 tau protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0043066 negative regulation of apoptotic process;GO:0007346 regulation of mitotic cell cycle;GO:0042254 ribosome biogenesis;GO:0042985 negative regulation of amyloid precursor protein biosynthetic process;GO:0045893 positive regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q9JKX4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QY83-1",
        "uniprot_id": "ACL7B_MOUSE",
        "mass": 45565.0,
        "length": 418,
        "protein_name": "Actin-like protein 7B",
        "gene_name": "Actl7b",
        "organism": "Mouse",
        "refseq_name": "actin-like protein 7B",
        "refseq_ac": "NP_079547",
        "gene_names_uniprotkb": "Actl7b; Tact1",
        "gene_names_refseq": "Actl7b; Gm26657; Tact1",
        "protein_names_uniprotkb": "Actin-like protein 7B; Actin-like-7-beta; T-actin-1; Testis-specific actin-1",
        "protein_names_refseq": "T-actin-1; actin-like protein 7B; actin-like-7-beta; t-actin 1; testis-specific actin-1",
        "tax_id": 10090,
        "disease": "hypertrophic cardiomyopathy 11 (Disease Ontology:DOID:0110317); nemaline myopathy (Disease Ontology:DOID:3191); congenital structural myopathy (Disease Ontology:DOID:422); myopathy (Disease Ontology:DOID:423)",
        "pathway": " (mmu:11471)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "10373328;12672658;12704725;37800308",
        "class_list": "",
        "function": "Actl7b deficiency leads to mislocalization of LC8 type dynein light chains and disruption of murine spermatogenesis., [RefSeq, PubMed]; Results suggest that T-ACTINs play important roles in sperm function and in the specific morphogenesis of spermatozoa during spermiogenesis, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q14AJ4;Q9JMI6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005198 structural molecule activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005856 cytoskeleton",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9QY83-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QZC8-1",
        "uniprot_id": "ABHD1_MOUSE",
        "mass": 45725.0,
        "length": 412,
        "protein_name": "Protein ABHD1",
        "gene_name": "Abhd1",
        "organism": "Mouse",
        "refseq_name": "protein ABHD1",
        "refseq_ac": "NP_067279",
        "gene_names_uniprotkb": "Abhd1; Labh1",
        "gene_names_refseq": "Abhd1; LABH-1; LABH1",
        "protein_names_uniprotkb": "Protein ABHD1; 3.1.1.-; Abhydrolase domain-containing protein 1; Alpha/beta hydrolase domain-containing protein 1; Lung alpha/beta hydrolase 1; MmLABH1",
        "protein_names_refseq": "abhydrolase domain-containing protein 1; alpha/beta hydrolase domain-containing protein 1; alpha/beta hydrolase-1; lung alpha/beta hydrolase 1; mmLABH1; protein ABHD1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:57742)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "11922611;19073140;25428506",
        "class_list": "",
        "function": "LABH-1 protein is a member of a novel family of membrane bound enzymes whose function has yet to be determined; highest expression level in the liver, [RefSeq, PubMed]; The mRNA level of alpha/beta hydrolase 1 (ABHD1) is significantly upregulated in D5-/- mice., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0047372 monoacylglycerol lipase activity;GO:0008126 acetylesterase activity",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "GO:0051793 medium-chain fatty acid catabolic process;GO:0051792 medium-chain fatty acid biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9QZC8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R158-1",
        "uniprot_id": "AD26A_MOUSE",
        "mass": 78747.0,
        "length": 697,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 26A",
        "gene_name": "Adam26a",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 26A preproprotein",
        "refseq_ac": "NP_034215",
        "gene_names_uniprotkb": "Adam26a; Adam26",
        "gene_names_refseq": "Adam26a; Adam26; Dtgn4",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 26A; 3.4.24.-; ADAM 26A; Testase-3",
        "protein_names_refseq": "a disintegrin and metallopeptidase domain 26A (testase 3); a disintegrin and metalloprotease domain 26; disintegrin 4; disintegrin and metalloproteinase domain-containing protein 26A preproprotein; disintegrin and metalloproteinase domain-containing protein 26A; testase 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13525)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "10395895;20945367;31219806;35820727",
        "class_list": "",
        "function": "Sperm surface membrane protein that may be involved in spermatogenesis and fertilization., [UniProtKB]; This gene encodes a member of a disintegrin and metalloprotease (ADAM) family of endoproteases that play important roles in various biological processes including cell signaling, adhesion and migration. This gene is expressed in a regulated fashion during the late stages of spermatogenesis. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional metalloprotease enzyme. This gene is located adjacent to two other ADAM genes on chromosome 8. [provided by RefSeq, May 2016]., [RefSeq]",
        "predicted_glycosites": 9,
        "predicted_n_glycosites": 8,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 6,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "G3X9D0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0005178 integrin binding;GO:0008237 metallopeptidase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009897 external side of plasma membrane;GO:1990913 sperm head plasma membrane",
        "go_biological_process": "GO:0006508 proteolysis;GO:0007283 spermatogenesis;GO:0030154 cell differentiation;GO:0008584 male gonad development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9R158-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R160-1",
        "uniprot_id": "ADA24_MOUSE",
        "mass": 85054.0,
        "length": 761,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 24",
        "gene_name": "Adam24",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 24 preproprotein",
        "refseq_ac": "NP_034216",
        "gene_names_uniprotkb": "Adam24",
        "gene_names_refseq": "Adam24; Dtgn5",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 24; 3.4.24.-; ADAM 24; Testase-1",
        "protein_names_refseq": "a disintegrin and metallopeptidase domain 24 (testase 1); a disintegrin and metalloproteinase domain 24 (testase 1); disintegrin 5; disintegrin and metalloproteinase domain-containing protein 24 preproprotein; disintegrin and metalloproteinase domain-containing protein 24",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13526)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "10395895;11309208;19670298;20945367",
        "class_list": "",
        "function": "Findings suggest that testase 1 is a sperm plasma membrane component which contributes to the prevention of polyspermy at the level of the oocyte plasma membrane., [RefSeq, PubMed]; Plasma membrane protease present on mature sperm that may be involved in sperm function during epididymal maturation and/or fertilization., [UniProtKB, PubMed]; This gene encodes a member of a disintegrin and metalloprotease (ADAM) family of endoproteases that play important roles in various biological processes including cell signaling, adhesion and migration. This gene is expressed in a regulated fashion during spermatogenesis. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional metalloprotease enzyme. Male mice lacking the encoded protein exhibit reduced fertility due to the higher incidence of polyspermic embryos. This gene is located adjacent to other ADAM genes on chromosome 8. [provided by RefSeq, May 2016]., [RefSeq]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 6,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A6H683;E9QL68",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0005178 integrin binding;GO:0008237 metallopeptidase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009897 external side of plasma membrane;GO:1990913 sperm head plasma membrane",
        "go_biological_process": "GO:0006508 proteolysis;GO:0007283 spermatogenesis;GO:0030154 cell differentiation;GO:0008584 male gonad development;GO:0060468 prevention of polyspermy",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9R160-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R1V4-1",
        "uniprot_id": "ADA11_MOUSE",
        "mass": 84134.0,
        "length": 773,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 11",
        "gene_name": "Adam11",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 11 isoform 2 preproprotein",
        "refseq_ac": "NP_033743",
        "gene_names_uniprotkb": "Adam11; Mdc",
        "gene_names_refseq": "Adam11; Mdc",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 11; ADAM 11; MDC; Metalloproteinase-like, disintegrin-like, and cysteine-rich protein",
        "protein_names_refseq": "a disintegrin and metalloprotease domain (ADAM) 11; disintegrin and metalloproteinase domain-containing protein 11 isoform 2 preproprotein; disintegrin and metalloproteinase domain-containing protein 11; metalloproteinase-like, disintegrin-like, and cysteine-rich protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:11488);  (R-MMU-5682910)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;10433968;12088751;16504143;16729981;18974846;26269648;34418053",
        "class_list": "",
        "function": "In the ADAM11 mutant, GABAergic release was not altered, but the ultrarapid electrical signal was absent, demonstrating that the dense presynaptic cluster of Kv1 ion channels at these terminals mediate electrical transmission., [RefSeq, PubMed]; Probable ligand for integrin in the brain. This is a non catalytic metalloprotease-like protein. Required for localization of the potassium channel subunit proteins KCNA1/KV1.1 and KCNA2/KV1.2 at cerebellar cortex basket cell distal terminals, is thereby involved in ephaptic inhibitory synchronization of Purkinje cell firing and response to stress (PubMed:26269648). Plays a role in spatial learning and motor coordination (PubMed:16504143). Involved in the nociceptive pain response to chemical-derived stimulation (PubMed:16729981)., [UniProtKB, PubMed, PubMed, PubMed]; This gene encodes a member of a disintegrin and metalloprotease (ADAM) family of endoproteases that play important roles in various biological processes including cell signaling, adhesion and migration. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional protein. The protein encoded by this gene is believed to lack metalloproteinase activity due to the lack of a critical catalytic motif. Mice lacking the encoded protein exhibit defects in spatial learning, motor coordination and altered perception of pain. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing. [provided by RefSeq, May 2016]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AUA8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity",
        "go_cellular_component": "GO:0030424 axon;GO:0043204 perikaryon;GO:0042734 presynaptic membrane",
        "go_biological_process": "GO:0061368 behavioral response to formalin induced pain;GO:0006508 proteolysis;GO:0045184 establishment of protein localization;GO:0033555 multicellular organismal response to stress;GO:0061367 behavioral response to acetic acid induced pain",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9R1V4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R1V7-1",
        "uniprot_id": "ADA23_MOUSE",
        "mass": 91548.0,
        "length": 829,
        "protein_name": "Disintegrin and metalloproteinase domain-containing protein 23",
        "gene_name": "Adam23",
        "organism": "Mouse",
        "refseq_name": "disintegrin and metalloproteinase domain-containing protein 23 preproprotein",
        "refseq_ac": "NP_035910",
        "gene_names_uniprotkb": "Adam23; Mdc3",
        "gene_names_refseq": "Adam23; MDC3",
        "protein_names_uniprotkb": "Disintegrin and metalloproteinase domain-containing protein 23; ADAM 23; MDC-3; Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3",
        "protein_names_refseq": "a disintegrin and metalloprotease domain 23; disintegrin and metalloproteinase domain-containing protein 23 preproprotein; disintegrin and metalloproteinase domain-containing protein 23; metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:23792);  (R-MMU-5682910)",
        "pathway_count": 2,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;10433968;14697522;18974846;28011936;30899004;33300544;34428180;35984892;36852467;38194969;40021952",
        "class_list": "",
        "function": "May play a role in cell-cell and cell-matrix interactions. This is a non-catalytic metalloprotease-like protein (By similarity)., [UniProtKB]; Oligodendrocyte-derived LGI3 and its receptor ADAM23 organize juxtaparanodal Kv1 channel clustering for short-term synaptic plasticity., [RefSeq, PubMed]; This gene encodes a member of the disintegrin family of membrane-anchored proteins that play a role in diverse biological processes such as brain development, fertilization, tumor development and inflammation. The encoded protein undergoes proteolytic processing to generate a mature polypeptide comprised of an inactive metalloprotease and disintegrin domains. Transgenic disruption of this gene in mice results in postnatal neurological defects including tremor and ataxia resulting in death by 2 weeks of age. [provided by RefSeq, Sep 2015]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 6,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 6,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 6,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 6,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 10,
        "disease_count": 0,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6QDY9;Q6QDZ0;Q8CC33",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005576 extracellular region;GO:0042734 presynaptic membrane",
        "go_biological_process": "GO:0006508 proteolysis;GO:0007155 cell adhesion;GO:1990830 cellular response to leukemia inhibitory factor",
        "synthesized_glycan_count": 0,
        "hit_score": 3.1,
        "record_id": "Q9R1V7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DCJ7-1",
        "uniprot_id": "AKIP_MOUSE",
        "mass": 23300.0,
        "length": 200,
        "protein_name": "Small ribosomal subunit protein bS22, mitochondrial",
        "gene_name": "Aurkaip1",
        "organism": "Mouse",
        "refseq_name": "small ribosomal subunit protein bS22, mitochondrial",
        "refseq_ac": "NP_079614",
        "gene_names_uniprotkb": "Aurkaip1; Aip; Akip; Mrps38",
        "gene_names_refseq": "0610033H09Rik; Aip; Akip; Aurkaip1; MRP-S38",
        "protein_names_uniprotkb": "Small ribosomal subunit protein bS22, mitochondrial; 28S ribosomal protein S38, mitochondrial; AURKA-interacting protein; Aurora kinase A-interacting protein; MRP-S38; Small ribosomal subunit protein mS38",
        "protein_names_refseq": "28S ribosomal protein S38, mitochondrial; AURKA-interacting protein; Aurora-A kinase interacting protein; aurora kinase A-interacting protein; small ribosomal subunit protein bS22, mitochondrial; small ribosomal subunit protein mS38",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66077);  (R-MMU-5389840);  (R-MMU-5419276);  (R-MMU-9937383)",
        "pathway_count": 4,
        "publication_count": 2,
        "publication_id_list": "17125467;21750661",
        "class_list": "",
        "function": "May act as a negative regulator of Aurora-A kinase, by down-regulation through proteasome-dependent degradation., [UniProtKB]; There exists an Ub-independent alternative pathway that promotesAurora-A degradation and AURKAIP1 promotes Aurora-A degradation through this Ub-independent yet proteasome-dependent pathway., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D1J7",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005759 mitochondrial matrix",
        "go_biological_process": "GO:0016567 protein ubiquitination;GO:0045862 positive regulation of proteolysis;GO:0032543 mitochondrial translation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9DCJ7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6P6J4-1",
        "uniprot_id": "ALKB2_MOUSE",
        "mass": 27129.0,
        "length": 239,
        "protein_name": "DNA oxidative demethylase ALKBH2",
        "gene_name": "Alkbh2",
        "organism": "Mouse",
        "refseq_name": "DNA oxidative demethylase ALKBH2 isoform 1",
        "refseq_ac": "NP_778181",
        "gene_names_uniprotkb": "Alkbh2; Abh2",
        "gene_names_refseq": "9530023G02; Abh2; Alkbh2; mABH2",
        "protein_names_uniprotkb": "DNA oxidative demethylase ALKBH2; 1.14.11.33; Alkylated DNA repair protein alkB homolog 2; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2",
        "protein_names_refseq": "DNA oxidative demethylase ALKBH2 isoform 1; DNA oxidative demethylase ALKBH2; alkB, alkylation repair homolog 2; alkylated DNA repair protein alkB homolog 2; alpha-ketoglutarate-dependent dioxygenase alkB homolog 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:231642)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "16174769;16642038;18519673;21750661;22429847;22684101;26930515",
        "class_list": "",
        "function": "ALKBH2 and ALKBH3 provide cancer protection similar to that of the DNA glycosylase AAG and display apparent epistasis with Aag, [RefSeq, PubMed]; Although both Alkbh2 and Alkbh3 can protect against methyl methanesulfonate-induced cell death, only Alkbh2 shows statistically significant protection against mutations following treatment with this exogenous methylating agent., [RefSeq, PubMed]; Dioxygenase that repairs alkylated nucleic acid bases by direct reversal oxidative dealkylation. Can process both double-stranded (ds) and single-stranded (ss) DNA substrates, with a strong preference for dsDNA (PubMed:16174769, PubMed:16642038, PubMed:18519673). Uses molecular oxygen, 2-oxoglutarate and iron as cofactors to oxidize the alkyl groups that are subsequently released as aldehydes, regenerating the undamaged bases. Probes the base pair stability, locates a weakened base pair and flips the damaged base to accommodate the lesion in its active site for efficient catalysis (By similarity) (PubMed:16174769, PubMed:16642038, PubMed:18519673). Repairs monoalkylated bases, specifically N1-methyladenine and N3-methylcytosine, as well as higher order alkyl adducts such as bases modified with exocyclic bridged adducts known as etheno adducts including 1,N6-ethenoadenine, 3,N4-ethenocytosine and 1,N2-ethenoguanine (By similarity). Acts as a gatekeeper of genomic integrity under alkylation stress. Efficiently repairs alkylated lesions in ribosomal DNA (rDNA). These lesions can cause ss- and dsDNA strand breaks that severely impair rDNA transcription (By similarity). In a response mechanism to DNA damage, associates with PCNA at replication forks to repair alkylated adducts prior to replication (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed]; These results revealed that N3-ethylthymidine , but not other DNA lesions, could be repaired by Alkbh2 and Alkbh3 in mammalian cells., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C591",
        "ec_number_list": "1.14.11.51;4.2.99.18;1.14.11.-;1.14.11.33;1.14.11.54",
        "go_molecular_function": "GO:0008198 ferrous iron binding;GO:0016706 2-oxoglutarate-dependent dioxygenase activity;GO:0051747 cytosine C-5 DNA demethylase activity;GO:0000182 rDNA binding;GO:0035516 broad specificity oxidative DNA demethylase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus",
        "go_biological_process": "GO:0006307 DNA alkylation repair",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q6P6J4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P70389-1",
        "uniprot_id": "ALS_MOUSE",
        "mass": 66960.0,
        "length": 603,
        "protein_name": "Insulin-like growth factor-binding protein complex acid labile subunit",
        "gene_name": "Igfals",
        "organism": "Mouse",
        "refseq_name": "insulin-like growth factor-binding protein complex acid labile subunit isoform 1 precursor",
        "refseq_ac": "NP_032366",
        "gene_names_uniprotkb": "Igfals; Albs; Als",
        "gene_names_refseq": "ALS; Albs; Igfals",
        "protein_names_uniprotkb": "Insulin-like growth factor-binding protein complex acid labile subunit; ALS",
        "protein_names_refseq": "insulin-like growth factor-binding protein complex acid labile subunit isoform 1 precursor; insulin-like growth factor-binding protein complex acid labile subunit",
        "tax_id": 10090,
        "disease": "isolated growth hormone deficiency (Disease Ontology:DOID:0060870); congenital disorder of glycosylation Ia (Disease Ontology:DOID:0080552); nephrotic syndrome (Disease Ontology:DOID:1184); Noonan syndrome (Disease Ontology:DOID:3490); anorexia nervosa (Disease Ontology:DOID:8689)",
        "pathway": " (mmu:16005);  (R-MMU-4641263)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "21750661;24424061;35820727;8816745",
        "class_list": "",
        "function": "May have an important role in regulating the access of circulating IGFs to the tissues., [UniProtKB, UniProtKB, UniProtKB]; The Igfals gene has a role in skeletal response of male mice to anabolic hormone therapy, [RefSeq, PubMed]",
        "predicted_glycosites": 7,
        "predicted_n_glycosites": 7,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9DBI7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008201 heparin binding;GO:0005520 insulin-like growth factor binding;GO:0048495 Roundabout binding",
        "go_cellular_component": "GO:0042567 insulin-like growth factor ternary complex",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0050919 negative chemotaxis;GO:0007411 axon guidance",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P70389-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BSZ2-1",
        "uniprot_id": "AP3S2_MOUSE",
        "mass": 22017.0,
        "length": 193,
        "protein_name": "AP-3 complex subunit sigma-2",
        "gene_name": "Ap3s2",
        "organism": "Mouse",
        "refseq_name": "AP-3 complex subunit sigma-2",
        "refseq_ac": "NP_033812",
        "gene_names_uniprotkb": "Ap3s2",
        "gene_names_refseq": "Ap3s2; [s]3B",
        "protein_names_uniprotkb": "AP-3 complex subunit sigma-2; AP-3 complex subunit sigma-3B; Adaptor-related protein complex 3 subunit sigma-2; Sigma-3B-adaptin; Sigma-adaptin 3b; Sigma3B-adaptin",
        "protein_names_refseq": "AP-3 complex sigma-3B subunit; AP-3 complex subunit sigma-2; AP-3 complex subunit sigma-3B; adapter-related protein complex 3 sigma-2 subunit; adapter-related protein complex 3 subunit sigma-2; adaptor-related protein complex 3 subunit sigma-2; adaptor-related protein complex AP-3, sigma 2 subunit; sigma 3B; sigma-3B-adaptin; sigma-adaptin 3b; sigma3B-adaptin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:11778)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "12967569;21750661;21998198;9151686",
        "class_list": "",
        "function": "Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O09077;O09149;Q3UDG7;Q8CAY1;Q99589",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005769 early endosome;GO:0030659 cytoplasmic vesicle membrane;GO:0005802 trans-Golgi network;GO:0030123 AP-3 adaptor complex;GO:1904115 axon cytoplasm",
        "go_biological_process": "GO:1903232 melanosome assembly;GO:0006886 intracellular protein transport;GO:0060155 platelet dense granule organization;GO:0016192 vesicle-mediated transport;GO:0008089 anterograde axonal transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q8BSZ2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P51569-1",
        "uniprot_id": "AGAL_MOUSE",
        "mass": 47643.0,
        "length": 419,
        "protein_name": "Alpha-galactosidase A",
        "gene_name": "Gla",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Gla; Ags",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Alpha-galactosidase A; 3.2.1.22; Alpha-D-galactosidase A; Alpha-D-galactoside galactohydrolase; Galactosylgalactosylglucosylceramidase GLA; Melibiase",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "Fabry disease (Disease Ontology:DOID:14499); lysosomal storage disease (Disease Ontology:DOID:3211)",
        "pathway": " (R-MMU-6798695);  (R-MMU-9840310)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "10.1101/2023.09.13.557529;18034455;20484733;21750661;25428506;25605945;30084848;34428180;7626884;8543175;8733892",
        "class_list": "glycogene;glycosylhydrolase",
        "function": "Catalyzes the hydrolysis of glycosphingolipids and participates in their degradation in the lysosome., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 44,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 2,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "4.6.1.19;1.11.1.27;3.1.1.4;2.3.1.23;3.2.1.24;4.6.1.18;3.2.1.17;1.11.2.2;3.2.1.31;3.4.16.5;3.4.16.-;3.2.1.52;3.2.1.23;3.4.21.20;2.7.10.2;2.7.11.13;3.6.1.-;1.1.1.205;3.1.6.8;3.1.6.12;3.2.1.-;3.2.1.22;2.7.11.24;3.1.27.-;3.4.14.1;3.6.4.6;3.5.3.15;3.4.21.37;3.1.6.4;3.4.21.76;3.5.3.1;1.6.5.5;3.5.1.26;3.1.6.14;3.1.3.16;5.3.99.3;6.3.4.21;2.4.1.1;2.3.3.8;1.8.4.-;5.3.4.1;3.2.1.51;1.6.2.2;3.4.14.2;3.4.21.4;3.4.19.9",
        "go_molecular_function": "GO:0005102 signaling receptor binding;GO:0016787 hydrolase activity;GO:0042803 protein homodimerization activity;GO:0003824 catalytic activity;GO:0004557 alpha-galactosidase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005737 cytoplasm;GO:0005794 Golgi apparatus;GO:0016020 membrane",
        "go_biological_process": "GO:0090325 regulation of locomotion involved in locomotory behavior;GO:0030168 platelet activation;GO:0030431 sleep;GO:0070527 platelet aggregation;GO:0035904 aorta development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "P51569-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3TAE8-1",
        "uniprot_id": "ALG6_MOUSE",
        "mass": 57874.0,
        "length": 507,
        "protein_name": "Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase",
        "gene_name": "Alg6",
        "organism": "Mouse",
        "refseq_name": "dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase precursor",
        "refseq_ac": "NP_001074733",
        "gene_names_uniprotkb": "Alg6",
        "gene_names_refseq": "Alg6; E230028F23Rik",
        "protein_names_uniprotkb": "Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase; 2.4.1.267; Asparagine-linked glycosylation protein 6 homolog; Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase; Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase",
        "protein_names_refseq": "asparagine-linked glycosylation 6 (alpha-1,3,-glucosyltransferase); asparagine-linked glycosylation 6 homolog (yeast, alpha-1,3,-glucosyltransferase); asparagine-linked glycosylation protein 6 homolog; dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase precursor; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase; dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase",
        "tax_id": 10090,
        "disease": "congenital disorder of glycosylation type I (Disease Ontology:DOID:0050570); congenital disorder of glycosylation Ic (Disease Ontology:DOID:0080555)",
        "pathway": " (mmu:320438);  (R-MMU-446193)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "21750661;25428506;31219806",
        "class_list": "glycogene;glycosyltransferase",
        "function": "Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase that operates in the biosynthetic pathway of dolichol-linked oligosaccharides, the glycan precursors employed in protein asparagine (N)-glycosylation. The assembly of dolichol-linked oligosaccharides begins on the cytosolic side of the endoplasmic reticulum membrane and finishes in its lumen. The sequential addition of sugars to dolichol pyrophosphate produces dolichol-linked oligosaccharides containing fourteen sugars, including two GlcNAcs, nine mannoses and three glucoses. Once assembled, the oligosaccharide is transferred from the lipid to nascent proteins by oligosaccharyltransferases. In the lumen of the endoplasmic reticulum, adds the first glucose residue from dolichyl phosphate glucose (Dol-P-Glc) onto the lipid-linked oligosaccharide intermediate Man(9)GlcNAc(2)-PP-Dol to produce Glc(1)Man(9)GlcNAc(2)-PP-Dol. Glc(1)Man(9)GlcNAc(2)-PP-Dol is a substrate for ALG8, the following enzyme in the biosynthetic pathway., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 18,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TZF4",
        "ec_number_list": "2.4.1.-;2.4.1.267",
        "go_molecular_function": "GO:0042281 dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity;GO:0046527 glucosyltransferase activity",
        "go_cellular_component": "GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006488 dolichol-linked oligosaccharide biosynthetic process;GO:0006487 protein N-linked glycosylation",
        "synthesized_glycan_count": 150,
        "hit_score": 0.4,
        "record_id": "Q3TAE8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P45376-1",
        "uniprot_id": "ALDR_MOUSE",
        "mass": 35732.0,
        "length": 316,
        "protein_name": "Aldo-keto reductase family 1 member B1",
        "gene_name": "Akr1b1",
        "organism": "Mouse",
        "refseq_name": "aldo-keto reductase family 1 member B1",
        "refseq_ac": "NP_033788",
        "gene_names_uniprotkb": "Akr1b1; Akr1b3; Aldor1; Aldr1; Alr2",
        "gene_names_refseq": "ALR2; AR; Ahr-1; Ahr1; Akr1b1; Akr1b3; Aldor1; Aldr1",
        "protein_names_uniprotkb": "Aldo-keto reductase family 1 member B1; 1.1.1.21; 1.1.1.300; 1.1.1.372; 1.1.1.54; AR; Aldehyde reductase; Aldo-keto reductase family 1 member B3; Aldose reductase",
        "protein_names_refseq": "aldehyde reductase 1; aldo-keto reductase family 1 member B1; aldo-keto reductase family 1 member B3; aldose reductase",
        "tax_id": 10090,
        "disease": "stomach cancer (Disease Ontology:DOID:10534); allergic disease (Disease Ontology:DOID:1205); arteriosclerosis (Disease Ontology:DOID:2349); hyperglycemia (Disease Ontology:DOID:4195); hypokalemia (Disease Ontology:DOID:4500); hepatocellular carcinoma (Disease Ontology:DOID:684); cataract (Disease Ontology:DOID:83); diabetic retinopathy (Disease Ontology:DOID:8947); type 2 diabetes mellitus (Disease Ontology:DOID:9352); diabetic neuropathy (Disease Ontology:DOID:9743); galactosemia (Disease Ontology:DOID:9870)",
        "pathway": " (mmu:11677);  (R-MMU-196108);  (R-MMU-5652227)",
        "pathway_count": 3,
        "publication_count": 24,
        "publication_id_list": "10049784;10092857;10913167;16479539;17381426;19010934;21750661;22645316;22872234;25153642;25428506;30779550;31219806;34428180;36210013;36288343;36766828;37044030;37507081;38373627;38776924;39927985;7851421;9485485",
        "class_list": "glycogene",
        "function": "Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols (PubMed:17381426, PubMed:19010934, PubMed:7851421). Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosaccharides, bile acids and xenobiotics substrates (PubMed:17381426, PubMed:19010934, PubMed:7851421). It catalyzes the reduction of glucose to sorbitol, the first step of the polyol pathway, an alternative route of glucose metabolism that converts glucose to fructose. This pathway becomes highly active under elevated glucose levels, such as during hyperglycemia (By similarity). Reduces steroids and their derivatives and prostaglandins (PubMed:19010934). Displays low enzymatic activity toward all-trans-retinal, 9-cis-retinal, and 13-cis-retinal. Catalyzes the reduction of diverse phospholipid aldehydes such as 1-palmitoyl-2-(5-oxovaleroyl)-sn -glycero-3-phosphoethanolamin (POVPC) and related phospholipid aldehydes that are generated from the oxydation of phosphotidylcholine and phosphatdyleethanolamides (PubMed:17381426). Plays a role in detoxifying dietary and lipid-derived unsaturated carbonyls, such as crotonaldehyde, 4-hydroxynonenal, trans-2-hexenal, trans-2,4-hexadienal and their glutathione-conjugates carbonyls (GS-carbonyls) (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; High incidence of sebaceous gland inflammation in aldose reductase-deficient mice., [RefSeq, PubMed]; Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis. Publication Status: Online-Only, [RefSeq, PubMed]; Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis., [RefSeq, PubMed]; SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 20,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 11,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O70130;Q99KC9",
        "ec_number_list": "1.1.1.300;1.1.1.21;1.1.1.372;1.1.1.54;1.1.1.184;1.1.1.-;1.1.1.2;1.6.-.-;1.1.1.19;1.1.1.20",
        "go_molecular_function": "GO:0004032 aldose reductase (NADPH) activity;GO:0001758 retinal dehydrogenase (NAD+) activity;GO:0043795 glyceraldehyde oxidoreductase activity;GO:0047939 L-glucuronate reductase activity;GO:0036130 prostaglandin H2 endoperoxidase reductase activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0048471 perinuclear region of cytoplasm;GO:0042629 mast cell granule",
        "go_biological_process": "GO:0006060 sorbitol metabolic process;GO:0001523 retinoid metabolic process;GO:0003091 renal water homeostasis;GO:0043066 negative regulation of apoptotic process;GO:0035809 regulation of urine volume",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "P45376-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JJR5-1",
        "uniprot_id": "AKIP1_MOUSE",
        "mass": 23979.0,
        "length": 212,
        "protein_name": "A-kinase-interacting protein 1",
        "gene_name": "Akip1",
        "organism": "Mouse",
        "refseq_name": "A-kinase-interacting protein 1",
        "refseq_ac": "NP_065641",
        "gene_names_uniprotkb": "Akip1; Bca3; D930014E17Rik",
        "gene_names_refseq": "Akip1; BCA3; C11orf17; D7H11orf17; D930014E17Rik; ICRFP703B1614Q5.6; ORF27",
        "protein_names_uniprotkb": "A-kinase-interacting protein 1; Breast cancer-associated gene 3 protein; PKA-interacting protein; Proline-rich protein BCA3",
        "protein_names_refseq": "A kinase (PRKA) interacting protein 1; A-kinase-interacting protein 1; PKA-interacting protein; breast cancer-associated gene 3 protein; proline-rich protein BCA3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:57373)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "11528127;21750661;23319652;30181740;36899057;37914850",
        "class_list": "",
        "function": "A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling. Publication Status: Online-Only, [RefSeq, PubMed]; A Kinase Interacting Protein 1 regulates mitochondrial protein levels in energy metabolism and promotes mitochondrial turnover after exercise. Publication Status: Online-Only, [RefSeq, PubMed]; Data indicate A-kinase interacting protein 1 (AKIP1) as a critical molecular regulator and a therapeutic control point for stress adaptation in the heart., [RefSeq, PubMed]; Enhances NF-kappa-B transcriptional activity by regulating the nuclear localization of the NF-kappa-B subunit RELA and promoting the phosphorylation of RELA by PRKACA. Regulates the effect of the cAMP-dependent protein kinase signaling pathway on the NF-kappa-B activation cascade (By similarity)., [UniProtKB]; MiR-320 plays an important role in regulating cardiomyocyte apoptosis induced by ischemia-reperfusion injury by targeting AKIP1 and inducing the mitochondrial apoptotic pathway. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TR76",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0034446 substrate adhesion-dependent cell spreading;GO:1901222 regulation of non-canonical NF-kappaB signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9JJR5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JHQ0-1",
        "uniprot_id": "ANXA9_MOUSE",
        "mass": 38110.0,
        "length": 345,
        "protein_name": "Annexin A9",
        "gene_name": "Anxa9",
        "organism": "Mouse",
        "refseq_name": "annexin A9 isoform a",
        "refseq_ac": "NP_001078852",
        "gene_names_uniprotkb": "Anxa9",
        "gene_names_refseq": "1110003P15Rik; 2310069F17Rik; Anxa9",
        "protein_names_uniprotkb": "Annexin A9; Annexin XXXI; Annexin-31; Annexin-9",
        "protein_names_refseq": "annexin A9 isoform a; annexin XXXI; annexin-31; annexin-9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71790)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;22841549",
        "class_list": "glycogene",
        "function": "Plays a role in epidermal differentiation (PubMed:22841549). Can bind acetylcholine (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 28,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CQS1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005543 phospholipid binding;GO:0015464 acetylcholine receptor activity;GO:0005509 calcium ion binding;GO:0005544 calcium-dependent phospholipid binding;GO:0001786 phosphatidylserine binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0009986 cell surface",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0098609 cell-cell adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9JHQ0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BH83-1",
        "uniprot_id": "ANKR9_MOUSE",
        "mass": 35513.0,
        "length": 326,
        "protein_name": "Ankyrin repeat domain-containing protein 9",
        "gene_name": "Ankrd9",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat domain-containing protein 9",
        "refseq_ac": "NP_780416",
        "gene_names_uniprotkb": "Ankrd9",
        "gene_names_refseq": "2500003O20Rik; Ankrd9",
        "protein_names_uniprotkb": "Ankyrin repeat domain-containing protein 9",
        "protein_names_refseq": "ankyrin repeat domain-containing protein 9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74251);  (R-MMU-8951664)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "20485683;21750661;31219806",
        "class_list": "",
        "function": "Substrate receptor subunit of a cullin-RING superfamily E3 ligase complex (CUL5-based E3 ubiquitin ligase complex) which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Depending of the metabolic state of the cell, promotes the proteasomal degradation of IMPDH2, the rate-limiting enzyme in GTP biosynthesis or protects IMPDH2 by stabilizing IMPDH2 filaments assembly. Implicated in different cellular processes, like copper homeostasis and cell proliferation., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TA09;Q8BHR3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0016787 hydrolase activity;GO:1990756 ubiquitin-like ligase-substrate adaptor activity",
        "go_cellular_component": "GO:0005829 cytosol;GO:0031410 cytoplasmic vesicle;GO:0031466 Cul5-RING ubiquitin ligase complex",
        "go_biological_process": "GO:0006878 intracellular copper ion homeostasis;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8BH83-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P00329-1",
        "uniprot_id": "ADH1_MOUSE",
        "mass": 39771.0,
        "length": 375,
        "protein_name": "Alcohol dehydrogenase 1",
        "gene_name": "Adh1",
        "organism": "Mouse",
        "refseq_name": "alcohol dehydrogenase 1",
        "refseq_ac": "NP_031435",
        "gene_names_uniprotkb": "Adh1; Adh-1",
        "gene_names_refseq": "ADH-A2; ADH-AA; Adh-1-t; Adh-1e; Adh-1t; Adh-1; Adh-3e; Adh1-e; Adh1-t; Adh1tl; Adh1; Adh3-e",
        "protein_names_uniprotkb": "Alcohol dehydrogenase 1; 1.1.1.1; ADH-A2; Alcohol dehydrogenase A subunit",
        "protein_names_refseq": "alcohol dehydrogenase 1 temporal, liver; alcohol dehydrogenase 1, complex; alcohol dehydrogenase 1, electrophoretic; alcohol dehydrogenase 1; alcohol dehydrogenase 3, electrophoretic; alcohol dehydrogenase A subunit; class I alcohol dehydrogenase",
        "tax_id": 10090,
        "disease": "alcohol dependence (Disease Ontology:DOID:0050741); late onset Parkinson's disease (Disease Ontology:DOID:0060892); pancreatic cancer (Disease Ontology:DOID:1793)",
        "pathway": " (mmu:11522);  (R-MMU-2161541);  (R-MMU-5365859);  (R-MMU-71384)",
        "pathway_count": 4,
        "publication_count": 19,
        "publication_id_list": "21750661;23806337;26495903;28011936;2893758;30084848;3011597;3157987;33586683;34105348;3428612;34428180;35354963;37453647;37507081;37806378;37828378;7738026;7937138",
        "class_list": "",
        "function": "ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway. Erratum:[Acta Pharmacol Sin. 2024 Nov;45(11):2450-2451. doi: 10.1038/s41401-024-01319-3. PMID: 38918585], [RefSeq, PubMed]; Alcohol dehydrogenase 1 is a tubular mitophagy-dependent apoptosis inhibitor against septic acute kidney injury., [RefSeq, PubMed]; Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.1.1.1;1.1.1.-;1.1.1.284;1.1.1.105;1.1.1.66",
        "go_molecular_function": "GO:0004022 alcohol dehydrogenase (NAD+) activity;GO:0008270 zinc ion binding;GO:0004745 all-trans-retinol dehydrogenase (NAD+) activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0005929 cilium;GO:0036064 ciliary basal body",
        "go_biological_process": "GO:0001523 retinoid metabolic process;GO:0006629 lipid metabolic process;GO:0048149 behavioral response to ethanol;GO:0006068 ethanol catabolic process;GO:0042572 retinol metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "P00329-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QYY9-1",
        "uniprot_id": "ADH4_MOUSE",
        "mass": 40211.0,
        "length": 377,
        "protein_name": "All-trans-retinol dehydrogenase [NAD(+)] ADH4",
        "gene_name": "Adh4",
        "organism": "Mouse",
        "refseq_name": "all-trans-retinol dehydrogenase [NAD(+)] ADH4",
        "refseq_ac": "NP_036126",
        "gene_names_uniprotkb": "Adh4; Adh2",
        "gene_names_refseq": "Adh2; Adh4",
        "protein_names_uniprotkb": "All-trans-retinol dehydrogenase [NAD(+)] ADH4; 1.1.1.105; ADH2; Alcohol dehydrogenase 2; Alcohol dehydrogenase 4; Alcohol dehydrogenase II; Alcohol dehydrogenase class II",
        "protein_names_refseq": "alcohol dehydrogenase 2; alcohol dehydrogenase II; alcohol dehydrogenase class II; all-trans-retinol dehydrogenase [NAD(+)] ADH4; class II type ADH",
        "tax_id": 10090,
        "disease": "alcohol dependence (Disease Ontology:DOID:0050741)",
        "pathway": " (mmu:26876);  (R-MMU-5365859);  (R-MMU-71384)",
        "pathway_count": 3,
        "publication_count": 8,
        "publication_id_list": "10514444;10970744;16081420;17279314;21075145;21750661;22079585;34428180",
        "class_list": "",
        "function": "Catalyzes the NAD-dependent oxidation of either all-trans-retinol or 9-cis-retinol (PubMed:17279314). Also oxidizes long chain omega-hydroxy fatty acids, such as 20-HETE, producing both the intermediate aldehyde, 20-oxoarachidonate and the end product, a dicarboxylic acid, (5Z,8Z,11Z,14Z)-eicosatetraenedioate (PubMed:16081420). Also catalyzes the reduction of benzoquinones (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB]; The metabolism of all-trans- and 9-cis-retinol/ retinaldehyde has been investigated with focus on the activities of human, mouse and rat alcohol dehydrogenase 2 (ADH2), an intriguing enzyme with apparently different functions in human and rodents., [RefSeq, PubMed]; The results suggested that lack of Adh4 gene activity induces changes in the function of the dopamine system, findings which are compatible with a role of loss-of-function mutations in ADH4 as possible risk factors for parkinson disease., [RefSeq, PubMed]; This study demonistrated that adh1/adh4 knockout mice as possible rodent models for presymptomatic Parkinson's disease., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3V0P5",
        "ec_number_list": "1.1.1.105;1.1.1.315;1.1.1.209;1.1.1.53;1.1.1.1;1.1.1.-;1.1.1.284;1.1.1.66;1.1.1.62;1.1.1.239",
        "go_molecular_function": "GO:0004022 alcohol dehydrogenase (NAD+) activity;GO:0008270 zinc ion binding;GO:0051903 S-(hydroxymethyl)glutathione dehydrogenase [NAD(P)+] activity;GO:0003960 quinone reductase (NADPH) activity;GO:0004032 aldose reductase (NADPH) activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0001523 retinoid metabolic process;GO:0046294 formaldehyde catabolic process;GO:0006066 alcohol metabolic process;GO:0006081 aldehyde metabolic process;GO:0010430 fatty acid omega-oxidation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q9QYY9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q2KHK3-1",
        "uniprot_id": "AMPQ_MOUSE",
        "mass": 63338.0,
        "length": 559,
        "protein_name": "Aminopeptidase Q",
        "gene_name": "Lvrn",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Lvrn; Aqpep",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Aminopeptidase Q; 3.4.11.-; AP-Q; APQ; Laeverin",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74574)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Metalloprotease which may be important for placentation by regulating biological activity of key peptides at the embryo-maternal interface. On synthetic substrates it shows a marked preference for Leu-4-methylcoumaryl-7-amide (Leu-MCA) over Met-MCA, Arg-LCA and Lys-LCA. Cleaves the N-terminal amino acid of several peptides such as angiotensin-3, kisspeptin-10 and endokinin C., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 5,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D633",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008237 metallopeptidase activity;GO:0008270 zinc ion binding;GO:0004177 aminopeptidase activity",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "GO:0002003 angiotensin maturation;GO:0006508 proteolysis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q2KHK3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P68033-1",
        "uniprot_id": "ACTC_MOUSE",
        "mass": 42019.0,
        "length": 377,
        "protein_name": "Actin, alpha cardiac muscle 1",
        "gene_name": "Actc1",
        "organism": "Mouse",
        "refseq_name": "actin, alpha cardiac muscle 1",
        "refseq_ac": "NP_033738",
        "gene_names_uniprotkb": "Actc1; Actc",
        "gene_names_refseq": "Actc-1; Actc1",
        "protein_names_uniprotkb": "Actin, alpha cardiac muscle 1; 3.6.4.-; Alpha-cardiac actin",
        "protein_names_refseq": "actin alpha cardiac; actin, alpha cardiac muscle 1; alpha-cardiac actin; alphac-actin",
        "tax_id": 10090,
        "disease": "Baraitser-Winter syndrome 1 (Disease Ontology:DOID:0081112); atrial heart septal defect 5 (Disease Ontology:DOID:0110110); hypertrophic cardiomyopathy 11 (Disease Ontology:DOID:0110317); dilated cardiomyopathy 1R (Disease Ontology:DOID:0110456); autosomal dominant nonsyndromic deafness 20 (Disease Ontology:DOID:0110550); intestinal atresia (Disease Ontology:DOID:10486); hypertension (Disease Ontology:DOID:10763); dilated cardiomyopathy (Disease Ontology:DOID:12930); Moyamoya disease (Disease Ontology:DOID:13099); patent ductus arteriosus (Disease Ontology:DOID:13832); thoracic aortic aneurysm (Disease Ontology:DOID:14004); nemaline myopathy (Disease Ontology:DOID:3191)",
        "pathway": " (mmu:11464);  (R-MMU-390522);  (R-MMU-8980692);  (R-MMU-9013026);  (R-MMU-9764561);  (R-MMU-9913351);  (R-MMU-9958825)",
        "pathway_count": 7,
        "publication_count": 15,
        "publication_id_list": "21750661;23911929;25428506;26495903;26740625;30016717;30084848;3028523;32152506;33300544;34428180;35984892;36173861;36288343;37507081",
        "class_list": "",
        "function": "Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 12,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P04270",
        "ec_number_list": "3.6.4.13;3.6.4.10;2.3.2.31;3.6.4.-;5.6.2.3;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;7.6.2.1;2.7.11.1;3.6.1.5;1.14.14.18;3.4.24.-;3.6.-.-;3.1.3.1;3.9.1.1;3.6.1.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;3.6.4.6;3.1.2.-;7.6.2.-;3.6.5.2;3.6.5.-;3.6.1.15;3.1.4.-;2.7.11.13;2.7.11.39;5.6.2.-;7.2.2.-;2.3.2.26;7.6.2.16;3.4.21.53;2.7.7.7;2.7.7.49;2.7.4.3;3.1.4.4",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0005524 ATP binding;GO:0016787 hydrolase activity;GO:0017022 myosin binding;GO:0000146 microfilament motor activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005737 cytoplasm;GO:0005884 actin filament;GO:0015629 actin cytoskeleton;GO:0030027 lamellipodium",
        "go_biological_process": "GO:0060327 cytoplasmic actin-based contraction involved in cell motility;GO:0007015 actin filament organization;GO:0010628 positive regulation of gene expression;GO:0043066 negative regulation of apoptotic process;GO:0045471 response to ethanol",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "P68033-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q07456-1",
        "uniprot_id": "AMBP_MOUSE",
        "mass": 39029.0,
        "length": 349,
        "protein_name": "Protein AMBP",
        "gene_name": "Ambp",
        "organism": "Mouse",
        "refseq_name": "protein AMBP preproprotein",
        "refseq_ac": "NP_031469",
        "gene_names_uniprotkb": "Ambp; Itil",
        "gene_names_refseq": "ASPI; Ambp; HI-30; Intin4; Itil; UTI",
        "protein_names_uniprotkb": "Protein AMBP; Bikunin; HI-30",
        "protein_names_refseq": "Urinary Trypsin Inhibitor; protein AMBP preproprotein; protein AMBP; ulinastatin",
        "tax_id": 10090,
        "disease": "calcium oxalate nephrolithiasis (Disease Ontology:DOID:0080652); kidney failure (Disease Ontology:DOID:1074); adult respiratory distress syndrome (Disease Ontology:DOID:11394); pyelonephritis (Disease Ontology:DOID:11400); asthma (Disease Ontology:DOID:2841); acute kidney failure (Disease Ontology:DOID:3021)",
        "pathway": " (mmu:11699);  (R-MMU-2168880)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "10395906;11145954;11243855;20571061;21750661;30084848;32092411;32092412;33008134;34428180;37507081;39627609;7533761;7689339",
        "class_list": "",
        "function": "Antioxidant and tissue repair protein with reductase, heme-binding and radical-scavenging activities. Removes and protects against harmful oxidants and repairs macromolecules in intravascular and extravascular spaces and in intracellular compartments. Intravascularly, plays a regulatory role in red cell homeostasis by preventing heme- and reactive oxygen species-induced cell damage. Binds and degrades free heme to protect fetal and adult red blood cells from hemolysis. Reduces extracellular methemoglobin, a Fe3+ (ferric) form of hemoglobin that cannot bind oxygen, back to the Fe2+ (ferrous) form deoxyhemoglobin, which has oxygen-carrying potential. Upon acute inflammation, inhibits oxidation of low-density lipoprotein particles by MPO and limits vascular damage. Extravascularly, protects from oxidation products formed on extracellular matrix structures and cell membranes. Catalyzes the reduction of carbonyl groups on oxidized collagen fibers and preserves cellular and extracellular matrix ultrastructures. Importantly, counteracts the oxidative damage at blood-placenta interface, preventing leakage of free fetal hemoglobin into the maternal circulation. Intracellularly, has a role in maintaining mitochondrial redox homeostasis. Bound to complex I of the respiratory chain of mitochondria, may scavenge free radicals and preserve mitochondrial ATP synthesis. Protects renal tubule epithelial cells from heme-induced oxidative damage to mitochondria. Reduces cytochrome c from Fe3+ (ferric) to the Fe2+ (ferrous) state through formation of superoxide anion radicals in the presence of ascorbate or NADH/NADPH electron donor cofactors, ascorbate being the preferred cofactor (By similarity). Has a chaperone role in facilitating the correct folding of bikunin in the endoplasmic reticulum compartment (PubMed:32092411)., [UniProtKB, PubMed, UniProtKB]; Human radical scavenger alpha1-microglobulin protects against hemolysis in vitro and alpha1-microglobulin knockout mice exhibit a macrocytic anemia phenotype., [RefSeq, PubMed]; Knockout of the radical scavenger alpha1-microglobulin in mice results in defective bikunin synthesis, endoplasmic reticulum stress and increased body weight., [RefSeq, PubMed]; Kunitz-type serine protease inhibitor and structural component of extracellular matrix with a role in extracellular space remodeling and cell adhesion. Among others, has antiprotease activity toward kallikrein, a protease involved in airway inflammation; inhibits GZMK/granzyme, a granule-stored serine protease involved in NK and T cell cytotoxic responses; and inhibits PLG/plasmin, a protease required for activation of matrix metalloproteinases. As part of I-alpha-I complex, provides for the heavy chains to be transferred from I-alpha-I complex to hyaluronan in the presence of TNFAIP6, in a dynamic process that releases free bikunin and remodels extracellular matrix proteoglycan structures. Free bikunin, but not its heavy chain-bound form, acts as a potent protease inhibitor in airway secretions (By similarity). Part of hyaluronan-rich extracellular matrix that surrounds oocyte during cumulus oophorus expansion, an indispensable process for proper ovulation (PubMed:11145954, PubMed:11243855). Also inhibits calcium oxalate crystallization (By similarity)., [UniProtKB, PubMed, PubMed, UniProtKB]; Kunitz-type serine protease inhibitor. Has high catalytic efficiency for F10/blood coagulation factor Xa and may act as an anticoagulant by inhibiting prothrombin activation. Inhibits trypsin and mast cell CMA1/chymase and tryptase proteases., [UniProtKB, UniProtKB]; The Role of alpha1-Microglobulin (A1M) in Erythropoiesis and Erythrocyte Homeostasis-Therapeutic Opportunities in Hemolytic Conditions. Review article Publication Status: Online-Only, [RefSeq, PubMed]; This gene encodes a fusion protein that undergoes proteolytic processing to generate two mature proteins: alpha-1-microglobulin (A1m) is a heme-binding plasma glycoprotein of the lipocalin superfamily of proteins that bind to hydrophobic molecules, whereas bikunin belongs to the superfamily of Kunitz-type protease inhibitors. The transgenic mice specifically lacking bikunin, but not A1m, exhibit female infertility and an increased sensitivity to lung metastasis. [provided by RefSeq, Oct 2015]., [RefSeq]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 6,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q61294;Q925W1;Q9DBJ9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004867 serine-type endopeptidase inhibitor activity;GO:0042803 protein homodimerization activity;GO:0030246 carbohydrate binding;GO:0016209 antioxidant activity;GO:0020037 heme binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0009986 cell surface",
        "go_biological_process": "GO:0020027 hemoglobin metabolic process;GO:0030163 protein catabolic process;GO:0034614 cellular response to reactive oxygen species;GO:0051604 protein maturation;GO:0098869 cellular oxidant detoxification",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "Q07456-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35298-1",
        "uniprot_id": "AOAH_MOUSE",
        "mass": 65155.0,
        "length": 574,
        "protein_name": "Acyloxyacyl hydrolase",
        "gene_name": "Aoah",
        "organism": "Mouse",
        "refseq_name": "acyloxyacyl hydrolase isoform 2 preproprotein",
        "refseq_ac": "NP_001268783",
        "gene_names_uniprotkb": "Aoah",
        "gene_names_refseq": "4930433E13Rik; Aoah",
        "protein_names_uniprotkb": "Acyloxyacyl hydrolase; 3.1.1.77",
        "protein_names_refseq": "acyloxyacyl hydrolase isoform 2 preproprotein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:27052)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "12810692;15155618;17322564;18779055;19860560;28622363;29343645;36112153;37498977;38904010",
        "class_list": "glycogene",
        "function": "Acyloxyacyl Hydrolase Protects against Kidney Injury via Inhibition of Tubular CD74-Macrophage Crosstalk. Publication Status: Online-Only, [RefSeq, PubMed]; Acyloxyacyl hydrolase deficiency induces chronic inflammation and bone loss in male mice., [RefSeq, PubMed]; Acyloxyacyl hydrolase promotes pulmonary defense by preventing alveolar macrophage tolerance. Publication Status: Online-Only, [RefSeq, PubMed]; Produced by renal cortical tubule cells and secreted into urine, where it can deacylate lipopolysaccharides, a mechanism to limit inflammatory response to gram-negative bacteria in urinary tract, [RefSeq, PubMed]; Recovery from the tolerant state induced by Gram-negative bacteria is greatly delayed in in mice that lack AOAH, a lipase that partially deacylates the bacterial cell-wall lipopolysaccharide., [RefSeq, PubMed]; Removes the secondary (acyloxyacyl-linked) fatty acyl chains from the lipid A region of bacterial lipopolysaccharides (LPS) (PubMed:12810692, PubMed:15155618, PubMed:17322564, PubMed:19860560). By breaking down LPS, terminates the host response to bacterial infection and prevents prolonged and damaging inflammatory responses (PubMed:17322564, PubMed:19860560, PubMed:28622363). In peritoneal macrophages, seems to be important for recovery from a state of immune tolerance following infection by Gram-negative bacteria (PubMed:18779055)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; This genes encodes an enzyme that catalyzes the hydrolysis of acyloxylacyl-linked fatty acyl chains from bacterial lipopolysaccharides. The encoded protein modulates host inflammatory response to gram-negative bacteria. The proprotein is further cleaved into a large and small chain that interact in a heterodimer. Alternative splicing results in multiple transcript variants for this gene. [provided by RefSeq, Aug 2013]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 50,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.1.1.77",
        "go_molecular_function": "GO:0005509 calcium ion binding;GO:0050528 acyloxyacyl hydrolase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0031410 cytoplasmic vesicle",
        "go_biological_process": "GO:0009104 lipopolysaccharide catabolic process;GO:0006631 fatty acid metabolic process;GO:0050728 negative regulation of inflammatory response;GO:0008653 lipopolysaccharide metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "O35298-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O54931-6",
        "uniprot_id": "AKAP2_MOUSE",
        "mass": 120791.0,
        "length": 1089,
        "protein_name": "PALM2-AKAP2 fusion protein",
        "gene_name": "Pakap",
        "organism": "Mouse",
        "refseq_name": "paralemmin-2 isoform 5",
        "refseq_ac": "NP_766456",
        "gene_names_uniprotkb": "Pakap; Akap2; Palm2akap2; Palm2",
        "gene_names_refseq": "53-H12; AA959716; AI649048; AKAP-2; AKAP-KL; Akap2; B130066I24; B230340M18Rik; Gm20459; PRKA2; Pakap; Palm2-Akap2; Palm2Akap2; Palm2akap2; Palm2; R75368; pEN70",
        "protein_names_uniprotkb": "PALM2-AKAP2 fusion protein; A-kinase anchor protein 2; AKAP expressed in kidney and lung; AKAP-2; AKAP-KL; PRKA2; Paralemmin A kinase anchor protein; Paralemmin-2; Protein kinase A-anchoring protein 2",
        "protein_names_refseq": "A kinase (PRKA) anchor protein 2; A-kinase anchor protein 2; AKAP expressed in kidney and lung; Palm2-Akap2 readthrough transcript; Protein kinase A-anchoring protein 2; paralemmin 2; paralemmin-2 isoform 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:677884)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "16452087;22095752;26432469;26740625;34831084;9497389",
        "class_list": "",
        "function": "A-Kinase Anchoring Protein 2 Promotes Protection against Myocardial Infarction. Publication Status: Online-Only, [RefSeq, PubMed]; Binds to regulatory subunit (RII) of protein kinase A (PubMed:9497389). May be involved in establishing polarity in signaling systems or in integrating PKA-RII isoforms with downstream effectors to capture, amplify and focus diffuse, trans-cellular signals carried by cAMP (PubMed:9497389). Binds tp and modulates the structure of the actin cytoskeleton (PubMed:9497389)., [UniProtKB, PubMed]; Knocking down akap2 expression remarkably decreased tumorigenicity and metastatic ability of prostate cancer cells. AKAP2 may serve as a critical component of Calcitonin receptor-mediated oncogenic actions., [RefSeq, PubMed]; The AKAP2 protein is direct phosphorylation within a regulatory region of aquaporin-0 to modulate water permeability., [RefSeq, PubMed]; This locus represents naturally occurring readthrough transcription between the neighboring Palm2 (paralemmin 2) and Akap2 (A kinase (PRKA) anchor protein 2) genes on chromosome 4. The readthrough transcript encodes a fusion protein that shares sequence identity with each individual gene product. Similar readthrough transcription has also been observed in human, as described in PMID: 11478809. [provided by RefSeq, Feb 2015]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 12,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2APJ4;O54932;O54933;Q8BR92;Q8C5W1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019904 protein domain specific binding;GO:0044877 protein-containing complex binding;GO:0051018 protein kinase A binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016324 apical plasma membrane;GO:0032991 protein-containing complex;GO:0098552 side of membrane",
        "go_biological_process": "GO:0007015 actin filament organization;GO:0007178 cell surface receptor protein serine/threonine kinase signaling pathway;GO:0008360 regulation of cell shape;GO:0008104 intracellular protein localization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "O54931-6",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O55189-1",
        "uniprot_id": "AMBN_MOUSE",
        "mass": 43664.0,
        "length": 407,
        "protein_name": "Ameloblastin",
        "gene_name": "Ambn",
        "organism": "Mouse",
        "refseq_name": "ameloblastin isoform 2 precursor",
        "refseq_ac": "NP_033794",
        "gene_names_uniprotkb": "Ambn",
        "gene_names_refseq": "Ambn",
        "protein_names_uniprotkb": "Ameloblastin",
        "protein_names_refseq": "ameloblastin isoform 2 precursor",
        "tax_id": 10090,
        "disease": "amelogenesis imperfecta type 1F (Disease Ontology:DOID:0110065)",
        "pathway": " (mmu:11698);  (R-MMU-381426);  (R-MMU-8957275)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "11062984;21285247",
        "class_list": "",
        "function": "Involved in the mineralization and structural organization of enamel., [UniProtKB]; This gene encodes an extracellular matrix glycoprotein that is involved in the formation of dental enamel. Mice lacking the encoded protein fail to undergo normal ameloblast differentiation and develop enamel. Mice overproducing the product of this gene develop thinner and more porous enamel, with disrupted rod patterns and abnormal crystallites. Alternate splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2014]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008083 growth factor activity;GO:0030345 structural constituent of tooth enamel;GO:0030021 extracellular matrix structural constituent conferring compression resistance",
        "go_cellular_component": "GO:0031012 extracellular matrix",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0030198 extracellular matrix organization;GO:0042127 regulation of cell population proliferation;GO:0042475 odontogenesis of dentin-containing tooth;GO:0031214 biomineral tissue development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "O55189-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88312-1",
        "uniprot_id": "AGR2_MOUSE",
        "mass": 19920.0,
        "length": 175,
        "protein_name": "Anterior gradient protein 2 homolog",
        "gene_name": "Agr2",
        "organism": "Mouse",
        "refseq_name": "anterior gradient protein 2 homolog precursor",
        "refseq_ac": "NP_035913",
        "gene_names_uniprotkb": "Agr2; Gob4",
        "gene_names_refseq": "Agr2h; Agr2; Gob-4; HAG-2; XAG-2; mAG-2",
        "protein_names_uniprotkb": "Anterior gradient protein 2 homolog; AG-2; Protein Gob-4; Secreted cement gland protein XAG-2 homolog; mAG-2",
        "protein_names_refseq": "AG-2; anterior gradient 2 homolog; anterior gradient protein 2 homolog precursor; anterior gradient protein 2 homolog; protein Gob-4; secreted cement gland protein XAG-2 homolog",
        "tax_id": 10090,
        "disease": "breast cancer (Disease Ontology:DOID:1612); pancreatic ductal adenocarcinoma (Disease Ontology:DOID:3498); pancreatic ductal carcinoma (Disease Ontology:DOID:3587)",
        "pathway": " (mmu:23795)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "10095068;19359471;36384110;9790916",
        "class_list": "",
        "function": "Agr2-associated ER stress promotes adherent-invasive E. coli dysbiosis and triggers CD103[+] dendritic cell IL-23-dependent ileocolitis., [RefSeq, PubMed]; Required for MUC2 post-transcriptional synthesis and secretion. May play a role in the production of mucus by intestinal cells. Proto-oncogene that may play a role in cell migration, cell differentiation and cell growth (By similarity). Promotes cell adhesion (By similarity)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2CGA2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0002162 dystroglycan binding;GO:0005154 epidermal growth factor receptor binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0010628 positive regulation of gene expression;GO:0010811 positive regulation of cell-substrate adhesion;GO:0045742 positive regulation of epidermal growth factor receptor signaling pathway;GO:0048546 digestive tract morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "O88312-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88845-1",
        "uniprot_id": "AKA10_MOUSE",
        "mass": 73632.0,
        "length": 662,
        "protein_name": "A-kinase anchor protein 10, mitochondrial",
        "gene_name": "Akap10",
        "organism": "Mouse",
        "refseq_name": "A-kinase anchor protein 10, mitochondrial precursor",
        "refseq_ac": "NP_064305",
        "gene_names_uniprotkb": "Akap10",
        "gene_names_refseq": "1500031L16Rik; Akap10; B130049N18Rik; D-AKAP-2; D-AKAP2; PRKA10",
        "protein_names_uniprotkb": "A-kinase anchor protein 10, mitochondrial; AKAP-10; D-AKAP-2; Dual specificity A kinase-anchoring protein 2; PRKA10; Protein kinase A-anchoring protein 10",
        "protein_names_refseq": "A kinase (PRKA) anchor protein 10; A-kinase anchor protein 10, mitochondrial precursor; A-kinase anchor protein 10, mitochondrial; dual specificity A kinase-anchoring protein 2; protein kinase A-anchoring protein 10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56697);  (R-MMU-983231)",
        "pathway_count": 2,
        "publication_count": 15,
        "publication_id_list": "11248059;12206784;14531807;17485678;19144319;20484733;21183079;25428506;30084848;30779550;31219806;32848054;34428180;40885482;9326583",
        "class_list": "",
        "function": "D-AKAP2 may play an important role in the parathyroid hormone (PTH)-mediated regulation of NaPi-IIa by compartmentalization of PKA., [RefSeq, PubMed]; Deuterium exchange-mass spectrometry (DXMS) and limited proteolysis to probe the folded regions of D-AKAP2, providing for the first time insight into the intra-domain dynamics of a scaffold protein, [RefSeq, PubMed]; Differentially targeted protein that binds to type I and II regulatory subunits of protein kinase A and anchors them to the mitochondria or the plasma membrane. Although the physiological relevance between PKA and AKAPS with mitochondria is not fully understood, one idea is that BAD, a proapoptotic member, is phosphorylated and inactivated by mitochondria-anchored PKA. It cannot be excluded too that it may facilitate PKA as well as G protein signal transduction, by acting as an adapter for assembling multiprotein complexes. With its RGS domain, it could lead to the interaction to G-alpha proteins, providing a link between the signaling machinery and the downstream kinase., [UniProtKB]; These studies suggest a role for AKAP10 in heart rhythm control., [RefSeq, PubMed]; This gene encodes a member of A-kinase anchoring proteins (AKAPs), a family of functionally related proteins that target protein kinase A to discrete locations within the cell. The encoded protein is localized to mitochondria and interacts with both the type I and type II regulatory subunits of PKA. It has been reported that this protein is important for maintaining heart rate and myocardial contractility through its targeting of protein kinase A. In mouse, defects of this gene lead to cardiac arrhythmias and premature death. In humans, polymorphisms in this gene may be associated with increased risk of arrhythmias and sudden cardiac death. [provided by RefSeq, May 2013]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SUB5;Q5SUB7;Q7TPE7;Q8BQL6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051018 protein kinase A binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0008104 intracellular protein localization",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "O88845-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O89020-1",
        "uniprot_id": "AFAM_MOUSE",
        "mass": 69379.0,
        "length": 608,
        "protein_name": "Afamin",
        "gene_name": "Afm",
        "organism": "Mouse",
        "refseq_name": "afamin precursor",
        "refseq_ac": "NP_660128",
        "gene_names_uniprotkb": "Afm",
        "gene_names_refseq": "Afm; Alf; alpha-Alb",
        "protein_names_uniprotkb": "Afamin; Alpha-Alb; Alpha-albumin",
        "protein_names_refseq": "afamin precursor; alpha-albumin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:280662)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;16944957;17330941;19046407;19159218;20979532;22749887;34428180;37507081;39627609",
        "class_list": "",
        "function": "Afamin is one of osteoclast-derived chemokines that affect preosteoblasts through the activation of the Akt-signaling pathway., [RefSeq, PubMed]; Data indicate that HNF1alpha is a more potent activator of AFM promoter than is HNF1beta., [RefSeq, PubMed]; Functions as a carrier for hydrophobic molecules in body fluids. Essential for the solubility and activity of lipidated Wnt family members, including WNT1, WNT2B, WNT3, WNT3A, WNT5A, WNT7A, WNT7B, WNT8, WNT9A, WNT9B, WNT10A and WNT10B. Binds vitamin E. May transport vitamin E in body fluids under conditions where the lipoprotein system is not sufficient. May be involved in the transport of vitamin E across the blood-brain barrier., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 4,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 4,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 4,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UNV0;Q497E6;Q8R0J9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008431 vitamin E binding",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0071693 protein transport within extracellular region;GO:0031667 response to nutrient levels;GO:0050821 protein stabilization;GO:0051180 vitamin transport",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "O89020-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P05063-1",
        "uniprot_id": "ALDOC_MOUSE",
        "mass": 39395.0,
        "length": 363,
        "protein_name": "Fructose-bisphosphate aldolase C",
        "gene_name": "Aldoc",
        "organism": "Mouse",
        "refseq_name": "fructose-bisphosphate aldolase C",
        "refseq_ac": "NP_001290352",
        "gene_names_uniprotkb": "Aldoc; Aldo3; Scrg2",
        "gene_names_refseq": "Aldo3; Aldoc; Scrg2",
        "protein_names_uniprotkb": "Fructose-bisphosphate aldolase C; 4.1.2.13; Aldolase 3; Brain-type aldolase; Scrapie-responsive protein 2; Zebrin II",
        "protein_names_refseq": "brain-type aldolase; fructose-bisphosphate aldolase C; scrapie responsive gene 2; scrapie-responsive protein 2; zebrin II",
        "tax_id": 10090,
        "disease": "stroke (Disease Ontology:DOID:0051061); chromosome 16p11.2 deletion syndrome, 593-kb (Disease Ontology:DOID:0070515); autoimmune disease of the nervous system (Disease Ontology:DOID:438); borna disease (Disease Ontology:DOID:5154); hepatocellular carcinoma (Disease Ontology:DOID:684)",
        "pathway": " (mmu:11676);  (R-MMU-6798695);  (R-MMU-70171);  (R-MMU-70263)",
        "pathway_count": 4,
        "publication_count": 5,
        "publication_id_list": "10719228;3009179;34418053;40684658;7925012",
        "class_list": "glycogene",
        "function": "Catalyzes the reversible conversion of beta-D-fructose 1,6-bisphosphate (FBP) into two triose phosphate and plays a key role in glycolysis and gluconeogenesis., [UniProtKB, UniProtKB]; This gene encodes a member of the aldolase family of enzymes that is mainly expressed in neuronal tissues. The encoded protein is an enzyme of the glycolysis pathway, and catalyzes the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Alternate splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2014]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 24,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q64011;Q8CA91;Q99K96;Q9DBA4;Q9JK32",
        "ec_number_list": "2.4.1.25;3.2.1.33;3.5.4.6;1.11.1.24;3.4.22.52;3.4.19.12;3.4.24.34;3.4.22.27;1.1.1.42;3.4.21.46;4.1.2.13;5.3.1.9;5.1.3.-;3.4.21.4;3.6.4.10;2.4.2.7;3.4.21.-;3.2.1.17;1.16.3.1;3.6.5.-;4.2.1.24;3.4.22.1;3.2.1.31;2.7.1.11;2.7.10.2;5.2.1.8;3.4.23.5;2.5.1.18;4.2.99.18;5.6.2.4;2.4.2.1;3.2.1.23;1.11.1.6;3.3.2.6;3.4.11.4;1.1.1.205;3.1.3.48;5.3.2.1;5.3.3.12;3.4.24.35;3.6.1.-;2.7.11.24;1.13.11.-;1.13.11.34;1.11.1.7;3.1.6.12;2.7.11.1;2.7.1.40;3.5.4.5;3.4.25.1;2.7.11.39;2.7.4.6;2.7.13.3;3.6.4.6;2.7.1.1;2.7.1.-;3.1.1.47;3.6.4.13;2.7.11.22;2.7.11.23;2.3.2.26;5.4.2.2;5.4.2.7;2.3.2.27;3.1.6.14;1.8.3.2;2.7.1.35;3.4.19.1;3.6.1.6;2.3.3.8;4.1.2.4;2.3.2.5;3.2.1.14;5.4.2.11;5.4.2.4;2.4.1.1;3.5.1.3;2.4.1.186;3.4.18.1;3.5.1.23;3.5.1.-;3.4.19.9",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0044877 protein-containing complex binding;GO:0008092 cytoskeletal protein binding;GO:0004332 fructose-bisphosphate aldolase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005829 cytosol;GO:0030424 axon;GO:0099524 postsynaptic cytosol",
        "go_biological_process": "GO:0030855 epithelial cell differentiation;GO:0006094 gluconeogenesis;GO:0006096 glycolytic process;GO:0030388 fructose 1,6-bisphosphate metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "P05063-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P34971-1",
        "uniprot_id": "ADRB1_MOUSE",
        "mass": 50494.0,
        "length": 466,
        "protein_name": "Beta-1 adrenergic receptor",
        "gene_name": "Adrb1",
        "organism": "Mouse",
        "refseq_name": "beta-1 adrenergic receptor",
        "refseq_ac": "NP_031445",
        "gene_names_uniprotkb": "Adrb1; Adrb1r",
        "gene_names_refseq": "Adrb-1; Adrb1; beta-AR",
        "protein_names_uniprotkb": "Beta-1 adrenergic receptor; Beta-1 adrenoceptor; Beta-1 adrenoreceptor",
        "protein_names_refseq": "beta 1-AR; beta-1 adrenergic receptor; beta-1 adrenoceptor; beta-1 adrenoreceptor; cardiac beta adrenergic receptor",
        "tax_id": 10090,
        "disease": "obstructive sleep apnea (Disease Ontology:DOID:0050848); hypertension (Disease Ontology:DOID:10763); nephrosclerosis (Disease Ontology:DOID:11664); dilated cardiomyopathy (Disease Ontology:DOID:12930); low tension glaucoma (Disease Ontology:DOID:13544); cystic fibrosis (Disease Ontology:DOID:1485); renovascular hypertension (Disease Ontology:DOID:1591); aortic valve stenosis (Disease Ontology:DOID:1712); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); hyperglycemia (Disease Ontology:DOID:4195); myocardial infarction (Disease Ontology:DOID:5844); congestive heart failure (Disease Ontology:DOID:6000); periodontitis (Disease Ontology:DOID:824); type 1 diabetes mellitus (Disease Ontology:DOID:9744)",
        "pathway": " (mmu:11554);  (R-MMU-390696);  (R-MMU-418555)",
        "pathway_count": 3,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;11171998;28501616;29367546;31473062;8395893",
        "class_list": "",
        "function": "G protein-coupled receptor for catecholamines that couples to G(s) proteins to activate adenylate cyclase and cAMP-dependent pathway. Binds epinephrine and norepinephrine with approximately equal affinity. Mediates the activation of Ras via binding with cAMP-dependent RAPGEF2. As part of the sympathetic nervous system, plays a role in the physiologic regulation of cardiac function such as stimulation of cardiomyocyte contraction (By similarity). Also delivers proapoptotic signals in cardiomyocytes (PubMed:11171998). Involved in the regulation of sleep/wake behaviors (PubMed:31473062)., [UniProtKB, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 1,
        "mined_n_glycosites": 1,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 10,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9737,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 14,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RVY4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046982 protein heterodimerization activity;GO:0031694 alpha-2A adrenergic receptor binding;GO:0030165 PDZ domain binding;GO:0004940 beta1-adrenergic receptor activity;GO:0099579 G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential",
        "go_cellular_component": "GO:0098992 neuronal dense core vesicle;GO:0005769 early endosome;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0098794 postsynapse",
        "go_biological_process": "GO:0045187 regulation of circadian sleep/wake cycle, sleep;GO:0003061 positive regulation of the force of heart contraction by norepinephrine;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway;GO:0007613 memory",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P34971-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P63277-4",
        "uniprot_id": "AMELX_MOUSE",
        "mass": 23483.0,
        "length": 210,
        "protein_name": "Amelogenin, X isoform",
        "gene_name": "Amelx",
        "organism": "Mouse",
        "refseq_name": "amelogenin, X isoform isoform 1 precursor",
        "refseq_ac": "NP_001075447",
        "gene_names_uniprotkb": "Amelx; Amel",
        "gene_names_refseq": "ALGN; AMGL; AMGX; Amelx; Amel; Amg; LRAP; Rgsc888",
        "protein_names_uniprotkb": "Amelogenin, X isoform; LRAP; Leucine-rich amelogenin peptide",
        "protein_names_refseq": "amelogenin X chromosome; amelogenin, X isoform isoform 1 precursor; enamel matrix protein; leucine-rich amelogenin peptide",
        "tax_id": 10090,
        "disease": "autosomal dominant hypocalcemia (Disease Ontology:DOID:0090109); amelogenesis imperfecta type 1E (Disease Ontology:DOID:0110058); amelogenesis imperfecta (Disease Ontology:DOID:2187)",
        "pathway": " (mmu:11704);  (R-MMU-381426);  (R-MMU-8957275)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "12657653;1445358;4015654;8988368",
        "class_list": "",
        "function": "Plays a role in the biomineralization of teeth. Seems to regulate the formation of crystallites during the secretory stage of tooth enamel development. Thought to play a major role in the structural organization and mineralization of developing enamel., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2ALX2;A2ALX3;P45559;P70592;Q61293",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0005509 calcium ion binding;GO:0008083 growth factor activity;GO:0030345 structural constituent of tooth enamel",
        "go_cellular_component": "GO:0009986 cell surface;GO:0031012 extracellular matrix;GO:0030139 endocytic vesicle;GO:0005604 basement membrane;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0007165 signal transduction;GO:0007584 response to nutrient;GO:0042127 regulation of cell population proliferation;GO:0051592 response to calcium ion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P63277-4",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3TAP4-1",
        "uniprot_id": "AP5B1_MOUSE",
        "mass": 94679.0,
        "length": 876,
        "protein_name": "AP-5 complex subunit beta-1",
        "gene_name": "Ap5b1",
        "organism": "Mouse",
        "refseq_name": "AP-5 complex subunit beta-1",
        "refseq_ac": "NP_001028620",
        "gene_names_uniprotkb": "Ap5b1; Gm962",
        "gene_names_refseq": "Ap5b1; Gm962; beta-5",
        "protein_names_uniprotkb": "AP-5 complex subunit beta-1; Adaptor-related protein complex 5 beta subunit; Beta5",
        "protein_names_refseq": "AP-5 complex subunit beta-1; adapter-related protein complex 5 beta subunit",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:381201)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;31219806;34428180",
        "class_list": "",
        "function": "As part of AP-5, a probable fifth adaptor protein complex it may be involved in endosomal transport., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005770 late endosome;GO:0030119 AP-type membrane coat adaptor complex",
        "go_biological_process": "GO:0015031 protein transport;GO:0016197 endosomal transport;GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q3TAP4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61271-1",
        "uniprot_id": "ACV1B_MOUSE",
        "mass": 56700.0,
        "length": 505,
        "protein_name": "Activin receptor type-1B",
        "gene_name": "Acvr1b",
        "organism": "Mouse",
        "refseq_name": "activin receptor type-1B precursor",
        "refseq_ac": "NP_031421",
        "gene_names_uniprotkb": "Acvr1b; Alk4",
        "gene_names_refseq": "6820432J04; ALK-4; ActR-IB; ActRIB; Acvr1b; Acvrlk4; Alk4; SKR2",
        "protein_names_uniprotkb": "Activin receptor type-1B; 2.7.11.30; ACTR-IB; ALK-4; Activin receptor type IB; Activin receptor-like kinase 4; SKR2; Serine/threonine-protein kinase receptor R2",
        "protein_names_refseq": "activin receptor type IB; activin receptor type-1B precursor; activin receptor type-1B; activin receptor-like kinase 4; serine/threonine-protein kinase receptor R2",
        "tax_id": 10090,
        "disease": "stomach cancer (Disease Ontology:DOID:10534); malignant mesothelioma (Disease Ontology:DOID:1790); pancreatic cancer (Disease Ontology:DOID:1793); lung non-small cell carcinoma (Disease Ontology:DOID:3908); lung small cell carcinoma (Disease Ontology:DOID:5409)",
        "pathway": " (mmu:11479);  (R-MMU-1502540)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "10681527;16885157;18039968;18250455;21191412;26495903;39111635;7577669",
        "class_list": "",
        "function": "Acvr1b Loss Increases Formation of Pancreatic Precancerous Lesions From Acinar and Ductal Cells of Origin., [RefSeq, PubMed]; Transmembrane serine/threonine kinase activin type-1 receptor forming an activin receptor complex with activin receptor type-2 (ACVR2A or ACVR2B). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating a many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, type-2 receptors (ACVR2A and/or ACVR2B) act as a primary activin receptors whereas the type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor such as ACVR1B. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor. ACVR1B also phosphorylates TDP2., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.7.11.30",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0019838 growth factor binding;GO:0046872 metal ion binding;GO:0031625 ubiquitin protein ligase binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0043235 receptor complex;GO:0048179 activin receptor complex",
        "go_biological_process": "GO:0001701 in utero embryonic development;GO:0007165 signal transduction;GO:0007166 cell surface receptor signaling pathway;GO:0007399 nervous system development;GO:0010628 positive regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q61271-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64133-1",
        "uniprot_id": "AOFA_MOUSE",
        "mass": 59602.0,
        "length": 526,
        "protein_name": "Amine oxidase [flavin-containing] A",
        "gene_name": "Maoa",
        "organism": "Mouse",
        "refseq_name": "amine oxidase [flavin-containing] A",
        "refseq_ac": "NP_776101",
        "gene_names_uniprotkb": "Maoa",
        "gene_names_refseq": "1110061B18Rik; Maoa",
        "protein_names_uniprotkb": "Amine oxidase [flavin-containing] A; 1.4.3.21; 1.4.3.4; MAO-A; Monoamine oxidase type A",
        "protein_names_refseq": "MAO-A; amine oxidase [flavin-containing] A; monoamine oxidase type A",
        "tax_id": 10090,
        "disease": "autism spectrum disorder (Disease Ontology:DOID:0060041); Brunner Syndrome (Disease Ontology:DOID:0060693); Alzheimer's disease (Disease Ontology:DOID:10652); alcohol use disorder (Disease Ontology:DOID:1574); panic disorder (Disease Ontology:DOID:594)",
        "pathway": " (mmu:17161);  (R-MMU-141333);  (R-MMU-181430);  (R-MMU-379397);  (R-MMU-379398);  (R-MMU-379401);  (R-MMU-380612)",
        "pathway_count": 7,
        "publication_count": 7,
        "publication_id_list": "28011936;33300544;34428180;36242915;37828378;38198753;7792602",
        "class_list": "",
        "function": "Cardiac monoamine oxidase-A inhibition protects against catecholamine-induced ventricular arrhythmias via enhanced diastolic calcium control., [RefSeq, PubMed]; Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues (PubMed:7792602). Preferentially oxidizes serotonin (PubMed:7792602). Also catalyzes the oxidative deamination of kynuramine to 3-(2-aminophenyl)-3-oxopropanal that can spontaneously condense to 4-hydroxyquinoline (By similarity)., [UniProtKB, UniProtKB, PubMed]; Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AX52;Q8K0Z8",
        "ec_number_list": "1.4.3.21;1.4.3.-;1.4.3.4",
        "go_molecular_function": "GO:0097621 monoamine oxidase activity;GO:0050660 flavin adenine dinucleotide binding;GO:0051378 serotonin binding;GO:0008131 primary methylamine oxidase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0005829 cytosol",
        "go_biological_process": "GO:0042443 phenylethylamine metabolic process;GO:0042428 serotonin metabolic process;GO:0042420 dopamine catabolic process;GO:0009967 positive regulation of signal transduction;GO:0019607 phenylethylamine catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q64133-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64438-1",
        "uniprot_id": "ANG2_MOUSE",
        "mass": 16593.0,
        "length": 145,
        "protein_name": "Angiogenin-2",
        "gene_name": "Ang2",
        "organism": "Mouse",
        "refseq_name": "angiogenin-2 precursor",
        "refseq_ac": "NP_031475",
        "gene_names_uniprotkb": "Ang2; Angrp",
        "gene_names_refseq": "Ang2; Angrp; Raa3; Rnase5b",
        "protein_names_uniprotkb": "Angiogenin-2; 3.1.27.-; Angiogenin-related protein",
        "protein_names_refseq": "angiogenin related protein; angiogenin-2 precursor; angiogenin-2; ribonuclease A a3",
        "tax_id": 10090,
        "disease": "inflammatory bowel disease (Disease Ontology:DOID:0050589); ductal carcinoma in situ (Disease Ontology:DOID:0060074); amyotrophic lateral sclerosis type 9 (Disease Ontology:DOID:0060200); prostate cancer (Disease Ontology:DOID:10283); Alzheimer's disease (Disease Ontology:DOID:10652); urinary bladder cancer (Disease Ontology:DOID:11054); endometrial cancer (Disease Ontology:DOID:1380); eosinophilic esophagitis (Disease Ontology:DOID:13922); Parkinson's disease (Disease Ontology:DOID:14330); pancreatic cancer (Disease Ontology:DOID:1793); ovarian cancer (Disease Ontology:DOID:2394); asthma (Disease Ontology:DOID:2841); endometriosis (Disease Ontology:DOID:289); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); amyotrophic lateral sclerosis (Disease Ontology:DOID:332); cerebral infarction (Disease Ontology:DOID:3526); trophoblastic neoplasm (Disease Ontology:DOID:4085); cervical cancer (Disease Ontology:DOID:4362); renal cell carcinoma (Disease Ontology:DOID:4450); rhinitis (Disease Ontology:DOID:4483); myocardial infarction (Disease Ontology:DOID:5844); rheumatoid arthritis (Disease Ontology:DOID:7148); diabetic retinopathy (Disease Ontology:DOID:8947)",
        "pathway": " (mmu:11731)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "11437607;16045902;23170778;32466219;37843277;38015876;8530072;8633065",
        "class_list": "",
        "function": "Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment. Publication Status: Online-Only, [RefSeq, PubMed]; Has ribonuclease activity (in vitro). Seems to lack angiogenic activity., [UniProtKB, PubMed]; Improved methods are presented for substantially increased production of mAngrp in a bacterial expression system and for refolding and purification of the protein from inclusion bodies., [RefSeq, PubMed]; Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis. Publication Status: Online-Only, [RefSeq, PubMed]; Role of the Ang2-Tie2 Axis in Vascular Damage Driven by High Glucose or Nucleoside Diphosphate Kinase B Deficiency. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 23,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "G5E8D0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003779 actin binding;GO:0005102 signaling receptor binding;GO:0008201 heparin binding;GO:0016787 hydrolase activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005634 nucleus;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0015629 actin cytoskeleton",
        "go_biological_process": "GO:0032055 negative regulation of translation in response to stress;GO:0001525 angiogenesis;GO:0001878 response to yeast;GO:0001934 positive regulation of protein phosphorylation;GO:0006468 protein phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q64438-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6P8H8-1",
        "uniprot_id": "ALG8_MOUSE",
        "mass": 59535.0,
        "length": 526,
        "protein_name": "Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase",
        "gene_name": "Alg8",
        "organism": "Mouse",
        "refseq_name": "dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase",
        "refseq_ac": "NP_950200",
        "gene_names_uniprotkb": "Alg8; Gm1089",
        "gene_names_refseq": "Alg8; Gm1089",
        "protein_names_uniprotkb": "Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase; 2.4.1.265; Asparagine-linked glycosylation protein 8 homolog; Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase; Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase",
        "protein_names_refseq": "asparagine-linked glycosylation 8 (alpha-1,3-glucosyltransferase); asparagine-linked glycosylation 8 homolog (yeast, alpha-1,3-glucosyltransferase); asparagine-linked glycosylation protein 8 homolog; dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase; dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase; probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase",
        "tax_id": 10090,
        "disease": "congenital disorder of glycosylation type I (Disease Ontology:DOID:0050570); polycystic liver disease 3 (Disease Ontology:DOID:0060976); congenital disorder of glycosylation Ih (Disease Ontology:DOID:0080560)",
        "pathway": " (mmu:381903);  (R-MMU-446193)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "28375157;30084848;30779550;31219806;31599954;34428180;40997131",
        "class_list": "glycogene;glycosyltransferase",
        "function": "Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase that operates in the biosynthetic pathway of dolichol-linked oligosaccharides, the glycan precursors employed in protein asparagine (N)-glycosylation. The assembly of dolichol-linked oligosaccharides begins on the cytosolic side of the endoplasmic reticulum membrane and finishes in its lumen. The sequential addition of sugars to dolichol pyrophosphate produces dolichol-linked oligosaccharides containing fourteen sugars, including two GlcNAcs, nine mannoses and three glucoses. Once assembled, the oligosaccharide is transferred from the lipid to nascent proteins by oligosaccharyltransferases. In the lumen of the endoplasmic reticulum, adds the second glucose residue from dolichyl phosphate glucose (Dol-P-Glc) onto the lipid-linked oligosaccharide intermediate Glc(1)Man(9)GlcNAc(2)-PP-Dol to produce Glc(2)Man(9)GlcNAc(2)-PP-Dol. Glc(2)Man(9)GlcNAc(2)-PP-Dol is a substrate for ALG10, the following enzyme in the biosynthetic pathway (By similarity). Required for PKD1/Polycystin-1 maturation and localization to the plasma membrane of the primary cilia (PubMed:28375157)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 34,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9Q3H5;Q3TKP5",
        "ec_number_list": "2.4.1.265",
        "go_molecular_function": "GO:0042283 dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity",
        "go_cellular_component": "GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006488 dolichol-linked oligosaccharide biosynthetic process;GO:0006487 protein N-linked glycosylation",
        "synthesized_glycan_count": 81,
        "hit_score": 1.0,
        "record_id": "Q6P8H8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TS75-1",
        "uniprot_id": "AMER1_MOUSE",
        "mass": 124164.0,
        "length": 1132,
        "protein_name": "APC membrane recruitment protein 1",
        "gene_name": "Amer1",
        "organism": "Mouse",
        "refseq_name": "APC membrane recruitment protein 1",
        "refseq_ac": "NP_780388",
        "gene_names_uniprotkb": "Amer1; Fam123b",
        "gene_names_refseq": "2810002O09Rik; Amer1; Fam123b; Wtx",
        "protein_names_uniprotkb": "APC membrane recruitment protein 1; Amer1; Protein FAM123B",
        "protein_names_refseq": "APC membrane recruitment protein 1; family with sequence similarity 123, member B; protein Fam123b",
        "tax_id": 10090,
        "disease": "osteopathia striata with cranial sclerosis (Disease Ontology:DOID:0060886); colorectal cancer (Disease Ontology:DOID:9256)",
        "pathway": " (mmu:72345);  (R-MMU-195253);  (R-MMU-196299);  (R-MMU-4641262)",
        "pathway_count": 4,
        "publication_count": 5,
        "publication_id_list": "17204608;19079258;21571217;25882849;29329488",
        "class_list": "",
        "function": "Analysis provides a novel model for WTX-caused bone diseases and explains on the molecular level how truncation mutations in this gene may retain some of WTX-protein functions., [RefSeq, PubMed]; Regulator of the canonical Wnt signaling pathway. Acts by specifically binding phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), translocating to the cell membrane and interacting with key regulators of the canonical Wnt signaling pathway, such as components of the beta-catenin destruction complex. Acts both as a positive and negative regulator of the Wnt signaling pathway, depending on the context: acts as a positive regulator by promoting LRP6 phosphorylation. Also acts as a negative regulator by acting as a scaffold protein for the beta-catenin destruction complex and promoting stabilization of Axin at the cell membrane. Promotes CTNNB1 ubiquitination and degradation. Involved in kidney development (By similarity)., [UniProtKB]; The constellation of anomalies in Wtx null mice suggests that this tumor suppressor broadly regulates mesenchymal progenitor cells in multiple tissues. Erratum:[Dev Cell. 2012 May 15;22(5):1109-17], [RefSeq, PubMed]; The observed phenotypic discordance dependent upon whether a mutation is germline or occurs somatically suggests the existence of temporal or spatial constraints on the action of WTX during tumorigenesis., [RefSeq, PubMed]; WTX stabilized chromatin binding by TRIM28 and contributed to transcriptional repression of repetitive sequences by TRIM28 in mouse embryonic stem cells., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AUM2;Q8BT92;Q8C7P7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005546 phosphatidylinositol-4,5-bisphosphate binding;GO:0008013 beta-catenin binding;GO:1904713 beta-catenin destruction complex binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0016604 nuclear body",
        "go_biological_process": "GO:0060612 adipose tissue development;GO:0090090 negative regulation of canonical Wnt signaling pathway;GO:0001822 kidney development;GO:0016055 Wnt signaling pathway;GO:0031398 positive regulation of protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q7TS75-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80UG6-1",
        "uniprot_id": "ALKL2_MOUSE",
        "mass": 17496.0,
        "length": 151,
        "protein_name": "ALK and LTK ligand 2",
        "gene_name": "Alkal2",
        "organism": "Mouse",
        "refseq_name": "ALK and LTK ligand 2 isoform 1 precursor",
        "refseq_ac": "NP_001153215",
        "gene_names_uniprotkb": "Alkal2; Fam150b",
        "gene_names_refseq": "6230419C23Rik; Alkal2; Augalpha; Fam150b",
        "protein_names_uniprotkb": "ALK and LTK ligand 2",
        "protein_names_refseq": "ALK and LTK ligand 2 isoform 1 precursor; Augmentor alpha; Protein FAM150B; family with sequence similarity 150, member B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100294583);  (R-MMU-201556);  (R-MMU-9842663)",
        "pathway_count": 3,
        "publication_count": 1,
        "publication_id_list": "35412887",
        "class_list": "",
        "function": "A hypothalamic pathway for Augmentor alpha-controlled body weight regulation. Erratum:[Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2209128119. doi: 10.1073/pnas.2209128119. PMID: 35787061], [RefSeq, PubMed]; Cytokine that acts as a physiological ligand for receptor tyrosine kinases LTK and ALK, leading to their activation. Cytokine-binding is sufficient to activate LTK. In contrast, ALKAL2-driven activation of ALK is coupled with heparin-binding to ALK. Stimulation of ALK signaling is involved in neural development and regulation of energy expenditure., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "G3X9F3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005125 cytokine activity;GO:0030971 receptor tyrosine kinase binding;GO:0030298 receptor signaling protein tyrosine kinase activator activity;GO:0030297 transmembrane receptor protein tyrosine kinase activator activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0097485 neuron projection guidance;GO:0007169 cell surface receptor protein tyrosine kinase signaling pathway;GO:0010976 positive regulation of neuron projection development;GO:0042594 response to starvation;GO:0060612 adipose tissue development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q80UG6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80ZD9-1",
        "uniprot_id": "AMGO2_MOUSE",
        "mass": 57562.0,
        "length": 519,
        "protein_name": "Amphoterin-induced protein 2",
        "gene_name": "Amigo2",
        "organism": "Mouse",
        "refseq_name": "amphoterin-induced protein 2 precursor",
        "refseq_ac": "NP_001158035",
        "gene_names_uniprotkb": "Amigo2; Ali1",
        "gene_names_refseq": "AMIGO-2; Ali1; Amigo2",
        "protein_names_uniprotkb": "Amphoterin-induced protein 2; AMIGO-2; Alivin-1",
        "protein_names_refseq": "alivin 1; amphoterin induced gene and ORF 2; amphoterin-induced protein 2 precursor; amphoterin-induced protein 2",
        "tax_id": 10090,
        "disease": "gastric adenocarcinoma (Disease Ontology:DOID:3717)",
        "pathway": " (mmu:105827);  (R-MMU-9013149);  (R-MMU-9013423)",
        "pathway_count": 3,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;12629050;12843293;22314660;25428506;31219806;34428180;35727300",
        "class_list": "",
        "function": "Adhesion molecule Amigo2 is involved in the fasciculation process of the fasciculus retroflexus., [RefSeq, PubMed]; Expression of ali1 promotes depolarization-dependent survival of cerebellar granule neurons. Mouse ali1 mapped to a chromosome 15 locus syntenic to candidate loci for familial Alzheimer's disease type 5 and Parkinson's disease 8 on human chromosome 12., [RefSeq, PubMed]; Report AMIGO2 mRNA expression in CA2/Ca3a hippocampal region of mouse brain., [RefSeq, PubMed]; Required for depolarization-dependent survival of cultured cerebellar granule neurons. May mediate homophilic as well as heterophilic cell-cell interaction with AMIGO1 or AMIGO3. May contribute to signal transduction through its intracellular domain (By similarity)., [UniProtKB]",
        "predicted_glycosites": 8,
        "predicted_n_glycosites": 7,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 9481,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0043524 negative regulation of neuron apoptotic process;GO:0007420 brain development;GO:0051965 positive regulation of synapse assembly;GO:0007156 homophilic cell adhesion via plasma membrane adhesion molecules",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q80ZD9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BH00-1",
        "uniprot_id": "AL8A1_MOUSE",
        "mass": 53664.0,
        "length": 487,
        "protein_name": "2-aminomuconic semialdehyde dehydrogenase",
        "gene_name": "Aldh8a1",
        "organism": "Mouse",
        "refseq_name": "2-aminomuconic semialdehyde dehydrogenase",
        "refseq_ac": "NP_848828",
        "gene_names_uniprotkb": "Aldh8a1; Raldh4",
        "gene_names_refseq": "Aldh8a1; Raldh4",
        "protein_names_uniprotkb": "2-aminomuconic semialdehyde dehydrogenase; 1.2.1.32; Aldehyde dehydrogenase family 8 member A1; Retinal dehydrogenase 4",
        "protein_names_refseq": "2-aminomuconic semialdehyde dehydrogenase; aldehyde dehydrogenase family 8 member A1; retinal dehydrogenase 4; retinal dehydrogenase type 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:237320);  (R-MMU-5365859)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "12519776;19766701;31209405;34428180;37453647",
        "class_list": "",
        "function": "Catalyzes the NAD-dependent oxidation of 2-aminomuconic semialdehyde of the kynurenine metabolic pathway in L-tryptophan degradation., [UniProtKB, UniProtKB]; Kinetic characterization of RALDH3 and 4, providing their specificities for retinal isomer substrates., [RefSeq, PubMed]; RALDH4 molecular cloning, cellular expression, and activity in 9-cis-retinoic acid biosynthesis in intact cells, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q91WS6",
        "ec_number_list": "1.2.1.32",
        "go_molecular_function": "GO:0001758 retinal dehydrogenase (NAD+) activity;GO:0047102 aminomuconate-semialdehyde dehydrogenase activity",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0097053 L-kynurenine catabolic process;GO:0042573 retinoic acid metabolic process;GO:0042574 retinal metabolic process;GO:0042904 9-cis-retinoic acid biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8BH00-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BIX3-1",
        "uniprot_id": "AL14E_MOUSE",
        "mass": 31011.0,
        "length": 276,
        "protein_name": "ARL14 effector protein",
        "gene_name": "Arl14ep",
        "organism": "Mouse",
        "refseq_name": "ARL14 effector protein",
        "refseq_ac": "NP_001020273",
        "gene_names_uniprotkb": "Arl14ep; Arf7ep",
        "gene_names_refseq": "2700007P21Rik; 4930448O08Rik; ARF7EP; Arl14ep",
        "protein_names_uniprotkb": "ARL14 effector protein; ARF7 effector protein",
        "protein_names_refseq": "ARF7 effector protein; ARL14 effector protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:212772)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "17242355",
        "class_list": "",
        "function": "Through its interaction with ARL14 and MYO1E, may connect MHC class II-containing cytoplasmic vesicles to the actin network and hence controls the movement of these vesicles along the actin cytoskeleton in dendritic cells., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TPE6;Q9CZS0",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0005925 focal adhesion",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8BIX3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BVF7-1",
        "uniprot_id": "APH1A_MOUSE",
        "mass": 28986.0,
        "length": 265,
        "protein_name": "Gamma-secretase subunit APH-1A",
        "gene_name": "Aph1a",
        "organism": "Mouse",
        "refseq_name": "gamma-secretase subunit APH-1A isoform 1",
        "refseq_ac": "NP_666216",
        "gene_names_uniprotkb": "Aph1a",
        "gene_names_refseq": "APH-1a; Aph1a",
        "protein_names_uniprotkb": "Gamma-secretase subunit APH-1A; APH-1a; Aph-1alpha",
        "protein_names_refseq": "anterior pharynx defective 1a homolog; aph-1alpha; gamma-secretase subunit APH-1A isoform 1; gamma-secretase subunit APH-1A",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:226548);  (R-MMU-1251985);  (R-MMU-193692);  (R-MMU-205043);  (R-MMU-3928665);  (R-MMU-9013507);  (R-MMU-9017802);  (R-MMU-9839383)",
        "pathway_count": 8,
        "publication_count": 6,
        "publication_id_list": "15634781;19369254;21750661;25428506;34292306;34879266",
        "class_list": "",
        "function": "Aberrant role of pyruvate kinase M2 in the regulation of gamma-secretase and memory deficits in Alzheimer's disease., [RefSeq, PubMed]; Assembly of gamma-secretase occurs through stable dimers after exit from the endoplasmic reticulum., [RefSeq, PubMed]; Non-catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:15634781, PubMed:19369254). Required for normal gamma-secretase assembly (PubMed:15634781, PubMed:19369254). The gamma-secretase complex plays a role in Notch and Wnt signaling cascades and regulation of downstream processes via its role in processing key regulatory proteins, and by regulating cytosolic CTNNB1 levels (Probable)., [UniProtKB, PubMed, PubMed]; Potential subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral proteins such as Notch receptors., [UniProtKB, UniProtKB]; This gene encodes a subunit of the gamma-secretase complex, which is localized to the endoplasmic reticulum and golgi apparatus. Gamma-secretase is a multi-protein enzyme that catalyzes intramembraneous proteolysis of type I transmembrane proteins and is essential for many signaling pathways, including the Notch signaling pathway. Studies suggest that the protein encoded by this locus binds directly to substrates of the gamma-secretase complex, including the beta-amyloid precursor protein which is associated with Alzheimer disease progression. This gene is required for normal embryonic development and survival, and disruption is associated with defects in the yolk sack angiogenesis, neural tube formation, and somitogenesis. A pseudogene of this gene is located on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8R1T3;Q91VL5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019899 enzyme binding;GO:0030674 protein-macromolecule adaptor activity;GO:0008233 peptidase activity;GO:0061133 endopeptidase activator activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005769 early endosome;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006509 membrane protein ectodomain proteolysis;GO:0007219 Notch signaling pathway;GO:0007220 Notch receptor processing;GO:0016485 protein processing;GO:0042982 amyloid precursor protein metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q8BVF7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C4G9-1",
        "uniprot_id": "AGRA1_MOUSE",
        "mass": 63497.0,
        "length": 578,
        "protein_name": "Adhesion G protein-coupled receptor A1",
        "gene_name": "Adgra1",
        "organism": "Mouse",
        "refseq_name": "adhesion G protein-coupled receptor A1",
        "refseq_ac": "NP_803420",
        "gene_names_uniprotkb": "Adgra1; Gpr123",
        "gene_names_refseq": "2900059M17Rik; Adgra1; D7Ertd680e; Gpr123",
        "protein_names_uniprotkb": "Adhesion G protein-coupled receptor A1; G protein-coupled receptor 123",
        "protein_names_refseq": "G protein coupled receptor Gpr123; G protein-coupled receptor 123; adhesion G protein-coupled receptor A1; probable G-protein coupled receptor 123",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:52389)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "17212699;33824276;36115515",
        "class_list": "",
        "function": "ADGRA1 negatively regulates energy expenditure and thermogenesis through both sympathetic nervous system and hypothalamus-pituitary-thyroid axis in male mice. Publication Status: Online-Only, [RefSeq, PubMed]; Increased Anxiety-like Behaviors in Adgra1(-/-) Male But Not Female Mice are Attributable to Elevated Neuron Dendrite Density, Upregulated PSD95 Expression, and Abnormal Activation of the PI3K/AKT/GSK-3beta and MEK/ERK Pathways., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CC05",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005886 plasma membrane;GO:0014069 postsynaptic density",
        "go_biological_process": "GO:0007166 cell surface receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8C4G9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CJF8-1",
        "uniprot_id": "AGO4_MOUSE",
        "mass": 97037.0,
        "length": 861,
        "protein_name": "Protein argonaute-4",
        "gene_name": "Ago4",
        "organism": "Mouse",
        "refseq_name": "protein argonaute-4",
        "refseq_ac": "NP_694817",
        "gene_names_uniprotkb": "Ago4; Eif2c4; Kiaa1567",
        "gene_names_refseq": "5730550L01Rik; Ago4; Eif2c4",
        "protein_names_uniprotkb": "Protein argonaute-4; Argonaute RISC catalytic component 4; Argonaute4; Eukaryotic translation initiation factor 2C 4; Piwi/argonaute family protein meIF2C4; eIF-2C 4; eIF2C 4; mAgo4",
        "protein_names_refseq": "Piwi/Argonaute family protein meIF2C4; argonaute 4; argonaute RISC catalytic component 4; eukaryotic translation initiation factor 2C, 4; protein argonaute-4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76850);  (R-MMU-203927);  (R-MMU-426486);  (R-MMU-426496)",
        "pathway_count": 4,
        "publication_count": 9,
        "publication_id_list": "12526743;19174539;22863743;24788674;26995025;34203471;34428180;35820727;36210013",
        "class_list": "",
        "function": "Required for RNA-mediated gene silencing (RNAi). Binds to short RNAs such as microRNAs (miRNAs) and represses the translation of mRNAs which are complementary to them. Lacks endonuclease activity and does not appear to cleave target mRNAs., [UniProtKB, HAMAP, PubMed]; Show that Ago4(-/-) spermatogonia initiate meiosis early, resulting from premature induction of retinoic acid-response genes, [RefSeq, PubMed]; Up-regulated in murine macrophage RAW264.7 cells transfected by Echinococcus multilocularis miR-71, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q4VBD7;Q6ZPM6;Q8BTF4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0003725 double-stranded RNA binding;GO:0003727 single-stranded RNA binding;GO:0035198 miRNA binding;GO:0004521 RNA endonuclease activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0000932 P-body;GO:0036464 cytoplasmic ribonucleoprotein granule",
        "go_biological_process": "GO:0070922 RISC complex assembly;GO:0043066 negative regulation of apoptotic process;GO:0008584 male gonad development;GO:0006402 mRNA catabolic process;GO:0007130 synaptonemal complex assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8CJF8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8JZZ6-1",
        "uniprot_id": "AMERL_MOUSE",
        "mass": 34516.0,
        "length": 310,
        "protein_name": "AMMECR1-like protein",
        "gene_name": "Ammecr1l",
        "organism": "Mouse",
        "refseq_name": "AMMECR1-like protein isoform 2",
        "refseq_ac": "NP_705735",
        "gene_names_uniprotkb": "Ammecr1l",
        "gene_names_refseq": "5430429D03Rik; Ammecr1l; E230022H04Rik",
        "protein_names_uniprotkb": "AMMECR1-like protein",
        "protein_names_refseq": "AMMECR1-like protein isoform 2; AMMECR1-like protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:225339)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;28528544",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8JZZ6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K023-1",
        "uniprot_id": "AKC1H_MOUSE",
        "mass": 37177.0,
        "length": 323,
        "protein_name": "Aldo-keto reductase family 1 member C18",
        "gene_name": "Akr1c18",
        "organism": "Mouse",
        "refseq_name": "aldo-keto reductase family 1 member C18 isoform 2",
        "refseq_ac": "NP_001333464",
        "gene_names_uniprotkb": "Akr1c18",
        "gene_names_refseq": "Akr1c18",
        "protein_names_uniprotkb": "Aldo-keto reductase family 1 member C18; 1.1.-.-; 1.1.1.149; 20-alpha-HSD; 20-alpha-hydroxysteroid dehydrogenase",
        "protein_names_refseq": "20-alpha-HSD; 20-alpha-hydroxysteroid dehydrogenase; 20alpha-HSD; 20alpha-hydroxysteroid dehydrogenase; aldo-keto reductase family 1 member C18 isoform 2",
        "tax_id": 10090,
        "disease": "alcohol dependence (Disease Ontology:DOID:0050741); ductal carcinoma in situ (Disease Ontology:DOID:0060074); B-lymphoblastic leukemia/lymphoma (Disease Ontology:DOID:0080630); castration-resistant prostate carcinoma (Disease Ontology:DOID:0080909); 46,XY sex reversal 8 (Disease Ontology:DOID:0111773); prostate cancer (Disease Ontology:DOID:10283); pre-eclampsia (Disease Ontology:DOID:10591); polycystic ovary syndrome (Disease Ontology:DOID:11612); leukemia (Disease Ontology:DOID:1240); T-cell acute lymphoblastic leukemia (Disease Ontology:DOID:5603); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:105349);  (R-MMU-193368);  (R-MMU-193775);  (R-MMU-193807);  (R-MMU-2162123);  (R-MMU-5365859);  (R-MMU-975634);  (R-MMU-9757110)",
        "pathway_count": 8,
        "publication_count": 5,
        "publication_id_list": "14967952;15193432;15222881;15471942;38788959",
        "class_list": "",
        "function": "Catalyzes the conversion of progesterone into 20-alpha-dihydroprogesterone (20 alpha-OHP)., [UniProtKB]; Cloning and chromosome mapping of mouse 20alpha-hydroxysteroid dehydrogenase, [RefSeq, PubMed]; Involvement of Sp1 and Sp3 in the expression of the 20alpha-HSD gene, [RefSeq, PubMed]; Pregnane X receptor (PXR) deficiency promotes hepatocarcinogenesis via induction of Akr1c18 expression and prostaglandin F2alpha (PGF2alpha) levels., [RefSeq, PubMed]; Prolactin activation of Stat5b is important in suppressing 20alpha-HSD gene expression and thereby allowing the maintenance of progesterone levels that are required to sustain pregnancy, [RefSeq, PubMed]; These results suggest that progesterone can be inactivated by 20alpha-hydroxysteroid dehydrogenase in some specific brain areas., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 11,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q99N44",
        "ec_number_list": "1.1.1.21;1.1.1.-;1.1.1.149;1.1.-.-;1.1.1.209",
        "go_molecular_function": "GO:0004032 aldose reductase (NADPH) activity;GO:0004745 all-trans-retinol dehydrogenase (NAD+) activity;GO:0031406 carboxylic acid binding;GO:0001758 retinal dehydrogenase (NAD+) activity;GO:0047787 Delta4-3-oxosteroid 5beta-reductase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol",
        "go_biological_process": "GO:0071394 cellular response to testosterone stimulus;GO:1904322 cellular response to forskolin;GO:0007565 female pregnancy;GO:0006693 prostaglandin metabolic process;GO:0071560 cellular response to transforming growth factor beta stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q8K023-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8QZR5-1",
        "uniprot_id": "ALAT1_MOUSE",
        "mass": 55143.0,
        "length": 496,
        "protein_name": "Alanine aminotransferase 1",
        "gene_name": "Gpt",
        "organism": "Mouse",
        "refseq_name": "alanine aminotransferase 1",
        "refseq_ac": "NP_877957",
        "gene_names_uniprotkb": "Gpt; Gpt1",
        "gene_names_refseq": "1300007J06Rik; 2310022B03Rik; ALT1; ALT; Gpt-1; Gpt1; Gpt",
        "protein_names_uniprotkb": "Alanine aminotransferase 1; 2.6.1.2; ALT1; GPT 1; Glutamate pyruvate transaminase 1; Glutamic--alanine transaminase 1; Glutamic--pyruvic transaminase 1",
        "protein_names_refseq": "GPT 1; alanine aminotransferase 1; glutamate pyruvate transaminase 1; glutamic pyruvic transaminase 1, soluble; glutamic--alanine transaminase 1; glutamic--pyruvic transaminase 1",
        "tax_id": 10090,
        "disease": "metabolic dysfunction-associated steatotic liver disease (Disease Ontology:DOID:0080208); obstructive jaundice (Disease Ontology:DOID:13603); acute kidney failure (Disease Ontology:DOID:3021); liver cancer (Disease Ontology:DOID:3571); liver cirrhosis (Disease Ontology:DOID:5082); myocardial infarction (Disease Ontology:DOID:5844); amino acid metabolic disorder (Disease Ontology:DOID:9252); type 2 diabetes mellitus (Disease Ontology:DOID:9352); steatotic liver disease (Disease Ontology:DOID:9452)",
        "pathway": " (mmu:76282);  (R-MMU-70268);  (R-MMU-8964540)",
        "pathway_count": 3,
        "publication_count": 8,
        "publication_id_list": "15122758;21750661;28011936;29187734;29462428;30084848;34428180;37453647",
        "class_list": "",
        "function": "Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate. Participates in cellular nitrogen metabolism and also in liver gluconeogenesis starting with precursors transported from skeletal muscles (By similarity)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; We used the peripheral blood micronucleus assay to evaluate the chromosomal damage, and Pig-a gene mutation assay and gpt gene mutation assay to examine the mutagenicity of BDE-47., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 9,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.6.1.2",
        "go_molecular_function": "GO:0030170 pyridoxal phosphate binding;GO:0004021 L-alanine:2-oxoglutarate aminotransferase activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0042853 L-alanine catabolic process;GO:0045722 positive regulation of gluconeogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q8QZR5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R0Z6-1",
        "uniprot_id": "ANGL6_MOUSE",
        "mass": 51095.0,
        "length": 457,
        "protein_name": "Angiopoietin-related protein 6",
        "gene_name": "Angptl6",
        "organism": "Mouse",
        "refseq_name": "angiopoietin-related protein 6 precursor",
        "refseq_ac": "NP_660136",
        "gene_names_uniprotkb": "Angptl6; Agf",
        "gene_names_refseq": "6330404E11Rik; AGF; ARP3; Angptl6; Arp5",
        "protein_names_uniprotkb": "Angiopoietin-related protein 6; Angiopoietin-like protein 6; Angiopoietin-related growth factor",
        "protein_names_refseq": "Angiopoietin-related growth factor; angiopoietin-like protein 6; angiopoietin-related protein 5; angiopoietin-related protein 6 precursor; angiopoietin-related protein 6",
        "tax_id": 10090,
        "disease": "gestational diabetes (Disease Ontology:DOID:11714); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:70726)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "12871997;14764539;15778720;16806062;18258819;27698489;28184000;29852166;31219806;33810547;36977368",
        "class_list": "",
        "function": "Activation of an ERK1/2-eNOS-NO pathway is a crucial signaling mechanism by which angiopoietin-related growth factor increases blood flow through induction of angiogenesis and arteriogenesis., [RefSeq, PubMed]; Angiopoietin-Like Growth Factor Involved in Leptin Signaling in the Hypothalamus. Publication Status: Online-Only, [RefSeq, PubMed]; May play a role in the wound healing process. May promote epidermal proliferation, remodeling and regeneration. May promote the chemotactic activity of endothelial cells and induce neovascularization. May counteract high-fat diet-induced obesity and related insulin resistance through increased energy expenditure., [UniProtKB, PubMed, PubMed, PubMed]; Mitochondrial OXPHOS function governs the expression of ANGPTL6, which is an essential factor for FGF21 production in adipose tissue and cultured adipocytes., [RefSeq, PubMed]; Our results strongly suggest that AGF is an integrin ligand as well as a mitogenic growth factor and theoretically participates in cutaneous wound healing in a more complex mechanism., [RefSeq, PubMed]; Regulation of Arp5 expression by alternative splicing coupled to nonsense-mediated RNA decay., [RefSeq, PubMed]; Since upregulation of ANGPTL6 is induced on metabolic stress, we investigated the hepatic expression of ANGPTL6 by leptin, a representative adipokine of obesity. Mice on a high-fat diet showed increased serum leptin levels and hepatic Angptl6 expression., [RefSeq, PubMed]; Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis. Publication Status: Online-Only, [RefSeq, PubMed]; We show that (>80%) of the AGF-deficient mice die at about embryonic day 13, while the surviving AGF-deficient mice develop marked obesity, lipid accumulation in skeletal muscle and liver, and insulin resistance accompanied by reduced energy expenditure, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005102 signaling receptor binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0030141 secretory granule;GO:0031012 extracellular matrix",
        "go_biological_process": "GO:0001525 angiogenesis;GO:0030154 cell differentiation;GO:0007596 blood coagulation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8R0Z6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VCX1-1",
        "uniprot_id": "AK1D1_MOUSE",
        "mass": 37290.0,
        "length": 325,
        "protein_name": "Aldo-keto reductase family 1 member D1",
        "gene_name": "Akr1d1",
        "organism": "Mouse",
        "refseq_name": "aldo-keto reductase family 1 member D1",
        "refseq_ac": "NP_663339",
        "gene_names_uniprotkb": "Akr1d1",
        "gene_names_refseq": "Akr1d1",
        "protein_names_uniprotkb": "Aldo-keto reductase family 1 member D1; 1.3.1.3; 3-oxo-5-beta-steroid 4-dehydrogenase; Delta(4)-3-ketosteroid 5-beta-reductase; Delta(4)-3-oxosteroid 5-beta-reductase",
        "protein_names_refseq": "3-oxo-5-beta-steroid 4-dehydrogenase; aldo-keto reductase family 1 member D1; delta(4)-3-ketosteroid 5-beta-reductase; delta(4)-3-oxosteroid 5-beta-reductase",
        "tax_id": 10090,
        "disease": "congenital bile acid synthesis defect 2 (Disease Ontology:DOID:0111069)",
        "pathway": " (mmu:208665);  (R-MMU-193368);  (R-MMU-193775);  (R-MMU-193807)",
        "pathway_count": 4,
        "publication_count": 4,
        "publication_id_list": "21183079;25428506;30084848;34428180",
        "class_list": "",
        "function": "Catalyzes the stereospecific NADPH-dependent reduction of the C4-C5 double bond of bile acid intermediates and steroid hormones carrying a delta(4)-3-one structure to yield an A/B cis-ring junction. This cis-configuration is crucial for bile acid biosynthesis and plays important roles in steroid metabolism. Capable of reducing a broad range of delta-(4)-3-ketosteroids from C18 (such as, 17beta-hydroxyestr-4-en-3-one) to C27 (such as, 7alpha-hydroxycholest-4-en-3-one)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.1.1.62;1.1.1.64;1.1.1.270;1.3.1.3",
        "go_molecular_function": "GO:0016229 steroid dehydrogenase activity;GO:0004032 aldose reductase (NADPH) activity;GO:0047787 Delta4-3-oxosteroid 5beta-reductase activity;GO:0047086 ketosteroid monooxygenase activity;GO:0047568 3-oxo-5-beta-steroid 4-dehydrogenase activity",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0006699 bile acid biosynthetic process;GO:0007586 digestion;GO:0006707 cholesterol catabolic process;GO:0008207 C21-steroid hormone metabolic process;GO:0008209 androgen metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q8VCX1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91ZB0-1",
        "uniprot_id": "ALPK2_MOUSE",
        "mass": 233298.0,
        "length": 2144,
        "protein_name": "Alpha-protein kinase 2",
        "gene_name": "Alpk2",
        "organism": "Mouse",
        "refseq_name": "alpha-protein kinase 2",
        "refseq_ac": "NP_001032371",
        "gene_names_uniprotkb": "Alpk2; Hak",
        "gene_names_refseq": "Alpk2; Gm549; Hak",
        "protein_names_uniprotkb": "Alpha-protein kinase 2; 2.7.11.1; Heart alpha-protein kinase",
        "protein_names_refseq": "alpha-protein kinase 2; heart alpha-kinase; heart alpha-protein kinase",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:225638)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "10021370;21750661;25428506;32383995",
        "class_list": "",
        "function": "Murine Alpk2-gKO models developed in this work display no overt cardiac phenotype. Our results suggest ALPK2, as a rapidly evolving gene, lost its essential cardiac functions in mammals., [RefSeq, PubMed]; Protein kinase that recognizes phosphorylation sites in which the surrounding peptides have an alpha-helical conformation (PubMed:10021370)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QL35",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;2.7.10.2;2.7.11.-;2.7.11.4;2.7.11.10;2.7.11.11;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.7.11.21;2.7.11.39;2.3.1.-;2.7.11.31;3.6.5.-;2.3.1.48;4.1.1.32;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0016323 basolateral plasma membrane",
        "go_biological_process": "GO:0003007 heart morphogenesis;GO:0042981 regulation of apoptotic process;GO:0055013 cardiac muscle cell development;GO:0010468 regulation of gene expression;GO:0030010 establishment of cell polarity",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q91ZB0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CPX9-1",
        "uniprot_id": "APC11_MOUSE",
        "mass": 9818.0,
        "length": 84,
        "protein_name": "Anaphase-promoting complex subunit 11",
        "gene_name": "Anapc11",
        "organism": "Mouse",
        "refseq_name": "anaphase-promoting complex subunit 11",
        "refseq_ac": "NP_001033319",
        "gene_names_uniprotkb": "Anapc11",
        "gene_names_refseq": "1110011I19Rik; Anapc11",
        "protein_names_uniprotkb": "Anaphase-promoting complex subunit 11; APC11; Cyclosome subunit 11",
        "protein_names_refseq": "APC11; anaphase promoting complex subunit 11 homolog; anaphase-promoting complex subunit 11; cyclosome subunit 11",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66156);  (R-MMU-141430);  (R-MMU-174048);  (R-MMU-174084);  (R-MMU-174154);  (R-MMU-174178);  (R-MMU-174184);  (R-MMU-176407);  (R-MMU-176408);  (R-MMU-176409);  (R-MMU-176412);  (R-MMU-179409);  (R-MMU-2467813);  (R-MMU-2559582);  (R-MMU-68867);  (R-MMU-69017);  (R-MMU-983168)",
        "pathway_count": 17,
        "publication_count": 1,
        "publication_id_list": "34428180",
        "class_list": "",
        "function": "Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through the cell cycle (By similarity). Together with ANAPC2, forms the catalytic component of the E3 ubiquitin ligase complex (By similarity). APC/C acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains (By similarity). APC/C catalyzes assembly of branched 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on target proteins (By similarity). APC/C is activated by CDC20 in the metaphase/anaphase transition of cell cycle, targeting the degradation of cyclin B and securin (By similarity). APC/C is regulated by the mitotic checkpoint complex (MCC), which inhibits APC/C and delays chromosome segregation (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UWH1;Q9CTG0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0001664 G protein-coupled receptor binding;GO:0061630 ubiquitin protein ligase activity;GO:0034450 ubiquitin-ubiquitin ligase activity;GO:0097602 cullin family protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005680 anaphase-promoting complex",
        "go_biological_process": "GO:0051301 cell division;GO:0016567 protein ubiquitination;GO:0031145 anaphase-promoting complex-dependent catabolic process;GO:0070979 protein K11-linked ubiquitination;GO:0045842 positive regulation of mitotic metaphase/anaphase transition",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9CPX9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CY02-1",
        "uniprot_id": "AHSP_MOUSE",
        "mass": 11832.0,
        "length": 102,
        "protein_name": "Alpha-hemoglobin-stabilizing protein",
        "gene_name": "Ahsp",
        "organism": "Mouse",
        "refseq_name": "alpha-hemoglobin-stabilizing protein",
        "refseq_ac": "NP_573508",
        "gene_names_uniprotkb": "Ahsp; Edrf; Eraf",
        "gene_names_refseq": "Ahsp; EDRF; Eraf",
        "protein_names_uniprotkb": "Alpha-hemoglobin-stabilizing protein; Erythroid differentiation-related factor; Erythroid-associated factor",
        "protein_names_refseq": "alpha-hemoglobin-stabilizing protein; erythroid differentiation-related factor; erythroid-associated factor",
        "tax_id": 10090,
        "disease": "HELLP syndrome (Disease Ontology:DOID:13133)",
        "pathway": " (mmu:170812)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "11231637;12066189;12569662;15054113;15545996;30295646;35092867",
        "class_list": "",
        "function": "Activin A does not appear to affect the exocrine or endocrine components of the pancreas, but promotes differentiation of pancreatic tissue into intestine via a Shh-dependent mechanism, [RefSeq, PubMed]; Acts as a chaperone to prevent the harmful aggregation of alpha-hemoglobin during normal erythroid cell development. Specifically protects free alpha-hemoglobin from precipitation., [UniProtKB, PubMed]; An abundant erythroid protein that stabilizes free alpha-haemoglobin., [RefSeq, PubMed]; ENOS reduced AHSP-bound alpha-globin approximately 6-fold faster than did the major erythrocyte hemoglobin reductases (cytochrome B5 reductase plus cytochrome B5). Our data support a model whereby redox-sensitive shuttling of EC alpha-globin between AHSP and eNOS regulates EC NO degradation and vascular tone., [RefSeq, PubMed]; Loss of AHSP impairs erythropoiesis and exacerbates beta-thalassemia., [RefSeq, PubMed]; Nrf2 expands the intracellular pool of the chaperone AHSP in a cellular model of beta-thalassemia., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O70427",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030492 hemoglobin binding",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0030218 erythrocyte differentiation;GO:0050821 protein stabilization;GO:0006457 protein folding",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9CY02-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D3J5-1",
        "uniprot_id": "ANR22_MOUSE",
        "mass": 21910.0,
        "length": 191,
        "protein_name": "Ankyrin repeat domain-containing protein 22",
        "gene_name": "Ankrd22",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat domain-containing protein 22",
        "refseq_ac": "NP_077166",
        "gene_names_uniprotkb": "Ankrd22",
        "gene_names_refseq": "5430429D21Rik; Ankrd22; D19Ertd675e",
        "protein_names_uniprotkb": "Ankyrin repeat domain-containing protein 22",
        "protein_names_refseq": "ankyrin repeat domain-containing protein 22",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:52024)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "34217895;35820727",
        "class_list": "",
        "function": "ANKRD22 Drives Rapid Proliferation of Lgr5(+) Cells and Acts as a Promising Therapeutic Target in Gastric Mucosal Injury., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CZ89;Q9D3I2",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "GO:0006955 immune response;GO:0008283 cell population proliferation;GO:0009611 response to wounding;GO:0050900 leukocyte migration;GO:0070509 calcium ion import",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9D3J5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JHT5-1",
        "uniprot_id": "AMMR1_MOUSE",
        "mass": 36031.0,
        "length": 344,
        "protein_name": "Nuclear protein AMMECR1",
        "gene_name": "Ammecr1",
        "organism": "Mouse",
        "refseq_name": "nuclear protein AMMECR1",
        "refseq_ac": "NP_062369",
        "gene_names_uniprotkb": "Ammecr1",
        "gene_names_refseq": "6230420G18Rik; Ammecr1",
        "protein_names_uniprotkb": "Nuclear protein AMMECR1; AMME syndrome candidate gene 1 protein homolog",
        "protein_names_refseq": "AMME syndrome candidate gene 1 protein homolog; nuclear protein AMMECR1",
        "tax_id": 10090,
        "disease": "midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (Disease Ontology:DOID:0111859)",
        "pathway": " (mmu:56068)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "10828604",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005739 mitochondrion",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9JHT5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R049-1",
        "uniprot_id": "AMFR_MOUSE",
        "mass": 73105.0,
        "length": 643,
        "protein_name": "E3 ubiquitin-protein ligase AMFR",
        "gene_name": "Amfr",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase AMFR isoform 1",
        "refseq_ac": "NP_035917",
        "gene_names_uniprotkb": "Amfr",
        "gene_names_refseq": "Amfr; gp78",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase AMFR; 2.3.2.36; AMF receptor; Autocrine motility factor receptor; RING-type E3 ubiquitin transferase AMFR",
        "protein_names_refseq": "AMF receptor; E3 ubiquitin-protein ligase AMFR isoform 1; E3 ubiquitin-protein ligase AMFR; RING-type E3 ubiquitin transferase AMFR",
        "tax_id": 10090,
        "disease": "hereditary spastic paraplegia 89 (Disease Ontology:DOID:0070458); hereditary spastic paraplegia (Disease Ontology:DOID:2476)",
        "pathway": " (mmu:23802);  (R-MMU-532668)",
        "pathway_count": 2,
        "publication_count": 16,
        "publication_id_list": "10456327;12650607;16709668;16987818;17114649;18216283;19144319;21750661;22863805;25428506;30084848;30779550;31073040;31219806;31599954;34428180",
        "class_list": "",
        "function": "Cytoplasmic protein mouse p97(mp97) participates in the formation of a ternary complex containing mouse autocrine motility factor receptor (mAMFR), mp97, and peptide N-glycanase, [RefSeq, PubMed]; E3 ubiquitin-protein ligase that mediates the polyubiquitination of lysine and cysteine residues on target proteins, such as CD3D, CYP3A4, CFTR, INSIG1, SOAT2/ACAT2 and APOB for proteasomal degradation (PubMed:16987818, PubMed:18216283). Component of a VCP/p97-AMFR/gp78 complex that participates in the final step of endoplasmic reticulum-associated degradation (ERAD) (PubMed:16987818, PubMed:18216283). The VCP/p97-AMFR/gp78 complex is involved in the sterol-accelerated ERAD degradation of HMGCR through binding to the HMGCR-INSIG1 complex at the ER membrane (PubMed:22863805). In addition, interaction of AMFR with AUP1 facilitates interaction of AMFR with ubiquitin-conjugating enzyme UBE2G2 and ubiquitin ligase RNF139, leading to sterol-induced HMGCR ubiquitination (By similarity). The ubiquitinated HMGCR is then released from the ER by the complex into the cytosol for subsequent destruction (By similarity). In addition to ubiquitination on lysine residues, catalyzes ubiquitination on cysteine residues: together with INSIG1, mediates polyubiquitination of SOAT2/ACAT2 at 'Cys-277', leading to its degradation when the lipid levels are low (By similarity). Catalyzes ubiquitination and subsequent degradation of INSIG1 when cells are depleted of sterols (By similarity). Mediates polyubiquitination of INSIG2 at 'Cys-215' in some tissues, leading to its degradation (By similarity). Also regulates ERAD through the ubiquitination of UBL4A a component of the BAG6/BAT3 complex (By similarity). Also acts as a scaffold protein to assemble a complex that couples ubiquitination, retranslocation and deglycosylation (By similarity). Mediates tumor invasion and metastasis as a receptor for the GPI/autocrine motility factor (PubMed:12650607). In association with LMBR1L and UBAC2, negatively regulates the canonical Wnt signaling pathway in the lymphocytes by promoting the ubiquitin-mediated degradation of CTNNB1 and Wnt receptors FZD6 and LRP6 (PubMed:31073040). Regulates NF-kappa-B and MAPK signaling pathways by mediating 'Lys-27'-linked polyubiquitination of TAB3 and promoting subsequent TAK1/MAP3K7 activation (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8K008;Q99LH5",
        "ec_number_list": "1.14.11.-;3.6.4.6;3.5.1.52;2.3.2.36",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0030674 protein-macromolecule adaptor activity;GO:0042802 identical protein binding;GO:0051087 protein-folding chaperone binding;GO:0000166 nucleotide binding",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0030425 dendrite",
        "go_biological_process": "GO:0007611 learning or memory;GO:0090090 negative regulation of canonical Wnt signaling pathway;GO:0016055 Wnt signaling pathway;GO:0000209 protein polyubiquitination;GO:0006511 ubiquitin-dependent protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q9R049-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R0L7-1",
        "uniprot_id": "AKP8L_MOUSE",
        "mass": 71454.0,
        "length": 642,
        "protein_name": "A-kinase anchor protein 8-like",
        "gene_name": "Akap8l",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Akap8l; Nakap95; Nakap",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "A-kinase anchor protein 8-like; AKAP8-like protein; Neighbor of A-kinase-anchoring protein 95; Neighbor of AKAP95",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:54194);  (R-MMU-9772755)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Could play a role in constitutive transport element (CTE)-mediated gene expression by association with DHX9. Increases CTE-dependent nuclear unspliced mRNA export. Proposed to target PRKACA to the nucleus but does not seem to be implicated in the binding of regulatory subunit II of PKA. May be involved in nuclear envelope breakdown and chromatin condensation. May be involved in anchoring nuclear membranes to chromatin in interphase and in releasing membranes from chromating at mitosis. May regulate the initiation phase of DNA replication when associated with TMPO isoform Beta. Required for cell cycle G2/M transition and histone deacetylation during mitosis. In mitotic cells recruits HDAC3 to the vicinity of chromatin leading to deacetylation and subsequent phosphorylation at 'Ser-10' of histone H3; in this function seems to act redundantly with AKAP8. May be involved in regulation of pre-mRNA splicing (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0008270 zinc ion binding;GO:0042826 histone deacetylase binding;GO:0034237 protein kinase A regulatory subunit binding;GO:0005521 lamin binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0016607 nuclear speck;GO:0016363 nuclear matrix;GO:0016605 PML body",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006397 mRNA processing;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0007076 mitotic chromosome condensation;GO:0044839 cell cycle G2/M phase transition",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9R0L7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WV06-1",
        "uniprot_id": "ANKR2_MOUSE",
        "mass": 36707.0,
        "length": 328,
        "protein_name": "Ankyrin repeat domain-containing protein 2",
        "gene_name": "Ankrd2",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat domain-containing protein 2",
        "refseq_ac": "NP_064417",
        "gene_names_uniprotkb": "Ankrd2; Arpp",
        "gene_names_refseq": "Ankrd2; Arpp",
        "protein_names_uniprotkb": "Ankyrin repeat domain-containing protein 2; Skeletal muscle ankyrin repeat protein; mArpp",
        "protein_names_refseq": "ankyrin repeat domain 2 (stretch responsive muscle); ankyrin repeat domain-containing protein 2; skeletal muscle ankyrin repeat protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56642)",
        "pathway_count": 1,
        "publication_count": 14,
        "publication_id_list": "10873377;11444853;12004005;15222314;15677738;17926058;18302940;21183079;21737686;21750661;23824195;24736439;28167675;30084848",
        "class_list": "",
        "function": "Assignment to mouse chromosome 19C3, [RefSeq, PubMed]; CARP, Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to mechanical pressure overload. Erratum:[PLoS One. 2015 Mar 06;10(3):e0118523. doi: 10.1371/journal.pone.0118523. PMID: 25747160] Publication Status: Online-Only, [RefSeq, PubMed]; Functions as a negative regulator of myocyte differentiation. May interact with both sarcoplasmic structural proteins and nuclear proteins to regulate gene expression during muscle development and in response to muscle stress., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB]; We describe a novel mechanism of signal transduction enriched in medium spiny neurons of striatum that likely mediates effects of the neurotransmitter dopamine acting on these cells. We find that the protein ARPP-16, which is highly expressed in striatal medium spiny neurons, acts as a selective inhibitor of certain forms of the serine/threonine protein phosphatase, PP2A, when phosphorylated by the kinase, MAST3., [RefSeq, PubMed]; We suggest that Ankrd2, which is also a titin binding protein, is a stretch-response gene associated with slow muscle function and that it is part of a separate mechanotransduction system to the one that regulates muscle mass., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RS77;Q8QZX4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003682 chromatin binding;GO:0031432 titin binding;GO:0043422 protein kinase B binding;GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0030017 sarcomere;GO:0031674 I band",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006357 regulation of transcription by RNA polymerase II;GO:0001817 regulation of cytokine production;GO:0035994 response to muscle stretch;GO:0035914 skeletal muscle cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9WV06-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "D3KU66-1",
        "uniprot_id": "ASMT_MOUSE",
        "mass": 40925.0,
        "length": 387,
        "protein_name": "Acetylserotonin O-methyltransferase",
        "gene_name": "Asmt",
        "organism": "Mouse",
        "refseq_name": "acetylserotonin O-methyltransferase isoform 1",
        "refseq_ac": "NP_001186141",
        "gene_names_uniprotkb": "Asmt; Hiomt",
        "gene_names_refseq": "Asmt; Hiomt",
        "protein_names_uniprotkb": "Acetylserotonin O-methyltransferase; 2.1.1.4; Hydroxyindole O-methyltransferase",
        "protein_names_refseq": "acetylserotonin O-methyltransferase isoform 1; hydroxyindole O-methyltransfease",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:107626);  (R-MMU-209931)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "20308563;21750661;37935873",
        "class_list": "",
        "function": "ASMT determines gut microbiota and increases neurobehavioral adaptability to exercise in female mice. Publication Status: Online-Only, [RefSeq, PubMed]; Catalyzes the transfer of a methyl group onto N-acetylserotonin, producing melatonin (N-acetyl-5-methoxytryptamine)., [UniProtKB, PubMed, UniProtKB, UniProtKB]; This gene belongs to the methyltransferase superfamily and is located in the pseudoautosomal region (PAR) of the X and Y chromosomes. The encoded enzyme catalyzes the final reaction in the synthesis of melatonin and is abundant in the pineal gland. Two amino acid substitutions (R78G and R242C) are present in the encoded protein derived from the reference strain, C57BL/6J, and this protein shows low enzyme activity relative to the protein derived from other strains. [provided by RefSeq, May 2015]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "D3KU65",
        "ec_number_list": "2.1.1.4",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0008757 S-adenosylmethionine-dependent methyltransferase activity;GO:0017096 acetylserotonin O-methyltransferase activity;GO:0046983 protein dimerization activity",
        "go_cellular_component": "",
        "go_biological_process": "GO:0006629 lipid metabolic process;GO:0032259 methylation;GO:0030187 melatonin biosynthetic process;GO:2000019 negative regulation of male gonad development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "D3KU66-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P50294-1",
        "uniprot_id": "ARY1_MOUSE",
        "mass": 33713.0,
        "length": 290,
        "protein_name": "Arylamine N-acetyltransferase 1",
        "gene_name": "Nat1",
        "organism": "Mouse",
        "refseq_name": "arylamine N-acetyltransferase 1",
        "refseq_ac": "NP_032699",
        "gene_names_uniprotkb": "Nat1; Aac1",
        "gene_names_refseq": "Nat-1; Nat1",
        "protein_names_uniprotkb": "Arylamine N-acetyltransferase 1; 2.3.1.5; Arylamide acetylase 1; N-acetyltransferase type 1; NAT-1",
        "protein_names_refseq": "N(alpha)-acetyltransferase 15, NatA auxiliary subunit; N-acetyl transferase 1, liver, blood; N-acetyltransferase type 1; arylamide acetylase 1; arylamine N-acetyltransferase 1",
        "tax_id": 10090,
        "disease": "prostate cancer (Disease Ontology:DOID:10283); urinary bladder cancer (Disease Ontology:DOID:11054); leukemia (Disease Ontology:DOID:1240); lung cancer (Disease Ontology:DOID:1324); Behcet's disease (Disease Ontology:DOID:13241); Parkinson's disease (Disease Ontology:DOID:14330); malignant mesothelioma (Disease Ontology:DOID:1790); pancreatic cancer (Disease Ontology:DOID:1793); transitional cell carcinoma (Disease Ontology:DOID:2671); asthma (Disease Ontology:DOID:2841); laryngeal squamous cell carcinoma (Disease Ontology:DOID:2876); pulmonary tuberculosis (Disease Ontology:DOID:2957); adenocarcinoma (Disease Ontology:DOID:299); allergic contact dermatitis (Disease Ontology:DOID:3042); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); atopic dermatitis (Disease Ontology:DOID:3310); lung non-small cell carcinoma (Disease Ontology:DOID:3908); systemic scleroderma (Disease Ontology:DOID:418); occupational dermatitis (Disease Ontology:DOID:4404); cholangiocarcinoma (Disease Ontology:DOID:4947); progressive supranuclear palsy (Disease Ontology:DOID:678); lung disease (Disease Ontology:DOID:850); psoriasis (Disease Ontology:DOID:8893); systemic lupus erythematosus (Disease Ontology:DOID:9074); acute myeloid leukemia (Disease Ontology:DOID:9119); diabetes mellitus (Disease Ontology:DOID:9351); oral mucosa leukoplakia (Disease Ontology:DOID:9655); senile cataract (Disease Ontology:DOID:9669); acute lymphoblastic leukemia (Disease Ontology:DOID:9952)",
        "pathway": " (mmu:17960);  (R-MMU-156582);  (R-MMU-9753281)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "1513324;1875909;21750661;25428506;29447909;30883722;33296651;34428180;7545952",
        "class_list": "",
        "function": "Ca(2+)-dependent N-acyltransferase absolutely required Calcium for its activity and the activity was enhanced by phosphatidylserine., [RefSeq, PubMed]; Metabolic efficiency in arylamine N-acetyltransferase-deficient mice, [RefSeq, PubMed]; Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Isoniazid, 2-aminofluorene and anisidine are preferred substrates for NAT-1. No activity with p-aminobenzoic acid (PABA) nor SMZ., [UniProtKB]; Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Abeta Accumulation in Alzheimer's Disease., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 29,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.3.1.5;2.3.1.118",
        "go_molecular_function": "GO:0004060 arylamine N-acetyltransferase activity;GO:0046990 N-hydroxyarylamine O-acetyltransferase activity",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0097068 response to thyroxine;GO:0001889 liver development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "P50294-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "C0HK79-1",
        "uniprot_id": "ARXS1_MOUSE",
        "mass": 20146.0,
        "length": 180,
        "protein_name": "Adipocyte-related X-chromosome expressed sequence 1",
        "gene_name": "Arxes1",
        "organism": "Mouse",
        "refseq_name": "adipocyte-related X-chromosome expressed sequence 1",
        "refseq_ac": "NP_083817",
        "gene_names_uniprotkb": "Arxes1",
        "gene_names_refseq": "6530401D17Rik; Arxes1; Spc22/23; Spcs3",
        "protein_names_uniprotkb": "Adipocyte-related X-chromosome expressed sequence 1",
        "protein_names_refseq": "SPase 22 kDa subunit; SPase 22/23 kDa subunit; adipocyte-related X-chromosome expressed sequence 1; microsomal signal peptidase 22/23 kDa subunit; microsomal signal peptidase 23 kDa subunit",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76219);  (mmu:76976)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21177646",
        "class_list": "",
        "function": "Plays a role in adipogenesis., [UniProtKB, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AUR7;Q8BK31;Q9D365;Q9D6F2",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005787 signal peptidase complex",
        "go_biological_process": "GO:0045444 fat cell differentiation;GO:0045047 protein targeting to ER;GO:0006465 signal peptide processing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "C0HK79-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "C0HK80-1",
        "uniprot_id": "ARXS2_MOUSE",
        "mass": 20146.0,
        "length": 180,
        "protein_name": "Adipocyte-related X-chromosome expressed sequence 2",
        "gene_name": "Arxes2",
        "organism": "Mouse",
        "refseq_name": "adipocyte-related X-chromosome expressed sequence 2",
        "refseq_ac": "NP_084099",
        "gene_names_uniprotkb": "Arxes2",
        "gene_names_refseq": "2900062L11Rik; Arxes2; Spc22/23; Spcs3",
        "protein_names_uniprotkb": "Adipocyte-related X-chromosome expressed sequence 2",
        "protein_names_refseq": "SPase 22 kDa subunit; SPase 22/23 kDa subunit; adipocyte-related X-chromosome expressed sequence 2; microsomal signal peptidase 22/23 kDa subunit",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76219);  (mmu:76976)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21177646",
        "class_list": "",
        "function": "Plays a role in adipogenesis., [UniProtKB, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AUR7;Q8BK31;Q9D365;Q9D6F2",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005787 signal peptidase complex",
        "go_biological_process": "GO:0045444 fat cell differentiation;GO:0045047 protein targeting to ER;GO:0006465 signal peptide processing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "C0HK80-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35885-1",
        "uniprot_id": "ASCL2_MOUSE",
        "mass": 27784.0,
        "length": 263,
        "protein_name": "Achaete-scute homolog 2",
        "gene_name": "Ascl2",
        "organism": "Mouse",
        "refseq_name": "achaete-scute homolog 2",
        "refseq_ac": "NP_032580",
        "gene_names_uniprotkb": "Ascl2; Mash2",
        "gene_names_refseq": "2410083I15Rik; Ascl2; Mash2; bHLHa45",
        "protein_names_uniprotkb": "Achaete-scute homolog 2; ASH-2; mASH-2; mASH2",
        "protein_names_refseq": "ASH-2; achaete-scute complex homolog 2; achaete-scute complex homolog-like 2; achaete-scute homolog 2; long transient receptor potential-related channel 5; mASH-2; mammalian achaete scute homolog 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:17173)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "10495277;10611232;10915772;21750661;24463518;25620640;29500235;7773285;8090202;9175731;9622625",
        "class_list": "",
        "function": "Mash2 gene is preferentially expressed from the paternal allele., [RefSeq, PubMed]; Transcription factor (PubMed:10611232, PubMed:29500235). Binds to E-box motifs 5'-CANNTG-3' in the regulatory elements of target genes, probably as a heterodimer with another basic helix-loop-helix (bHLH) protein such as the transcription factor TCF3 (PubMed:10611232, PubMed:29500235). May bind both open and closed chromatin, acting as a pioneer transcription factor to allow other factors to bind and activate lineage-specific genes (PubMed:29500235). Required during post-implantation development for the generation of some differentiated trophoblast cell types (PubMed:8090202). Transcriptional activity of ASCL2 may be antagonised in a subset of trophoblast cells by bHLH transcription factor HAND1, perhaps by competing for dimerization with other bHLH proteins (PubMed:10611232). Involved in differentiation and function of follicular T-helper (Tfh) cells, thereby playing a role in germinal center responses; probably modulates expression of genes involved in Tfh cell function, such as BCL6 (PubMed:24463518). May also act as a suppressor of Th1-, Th2- and Th17-cell differentiation (PubMed:24463518). Induces the formation of stem cells in intestinal crypts in vitro, synergistically activating transcription of target genes, such as SOX9, together with TCF4/beta-catenin (PubMed:25620640). May form a bistable transcriptional switch, controlling expression of its own gene together with Wnt/R-spondin signaling, and thereby maintaining stem cell characteristics (PubMed:25620640). Modulates expression of target genes, including perhaps down-regulating EGR1/Krox24 and chemokine CXCL10/Mob-1 and up-regulating CXCR4 and CDKN1C/p57kip2, in Schwann cells (By similarity). May play a role in reducing proliferation of Schwann cells, perhaps acting via modulation of expression of CDKN1C (By similarity). May be dispensable for blastocyst formation and later embryonic function (PubMed:8090202, PubMed:9622625). May be involved in the determination of neuronal precursors (By similarity)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9WUJ7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003700 DNA-binding transcription factor activity;GO:0046983 protein dimerization activity;GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0090575 RNA polymerase II transcription regulator complex",
        "go_biological_process": "GO:2000320 negative regulation of T-helper 17 cell differentiation;GO:0045626 negative regulation of T-helper 1 cell differentiation;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0001701 in utero embryonic development;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "O35885-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P59999-1",
        "uniprot_id": "ARPC4_MOUSE",
        "mass": 19667.0,
        "length": 168,
        "protein_name": "Actin-related protein 2/3 complex subunit 4",
        "gene_name": "Arpc4",
        "organism": "Mouse",
        "refseq_name": "actin-related protein 2/3 complex subunit 4 isoform 2",
        "refseq_ac": "NP_001163956",
        "gene_names_uniprotkb": "Arpc4; Arc20",
        "gene_names_refseq": "20kDa; 5330419I20Rik; Arpc4; p20-Arc",
        "protein_names_uniprotkb": "Actin-related protein 2/3 complex subunit 4; Arp2/3 complex 20 kDa subunit; p20-ARC",
        "protein_names_refseq": "actin-related protein 2/3 complex subunit 4 isoform 2; arp2/3 complex 20 kDa subunit",
        "tax_id": 10090,
        "disease": "Down syndrome (Disease Ontology:DOID:14250); cancer (Disease Ontology:DOID:162); psoriasis (Disease Ontology:DOID:8893)",
        "pathway": " (mmu:68089);  (R-MMU-2029482);  (R-MMU-3928662);  (R-MMU-5663213);  (R-MMU-8856828)",
        "pathway_count": 5,
        "publication_count": 6,
        "publication_id_list": "21750661;33300544;34428180;35820727;37453647;39627609",
        "class_list": "",
        "function": "Actin-binding component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility. In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA. The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O15509;Q3UWV4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0019899 enzyme binding;GO:0030674 protein-macromolecule adaptor activity;GO:0051015 actin filament binding;GO:0003779 actin binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0035861 site of double-strand break;GO:0005885 Arp2/3 protein complex;GO:0042995 cell projection",
        "go_biological_process": "GO:0030041 actin filament polymerization;GO:0034314 Arp2/3 complex-mediated actin nucleation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P59999-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "F6VAN0-1",
        "uniprot_id": "ATF6A_MOUSE",
        "mass": 72694.0,
        "length": 656,
        "protein_name": "Cyclic AMP-dependent transcription factor ATF-6 alpha",
        "gene_name": "Atf6",
        "organism": "Mouse",
        "refseq_name": "cyclic AMP-dependent transcription factor ATF-6 alpha",
        "refseq_ac": "NP_001074773",
        "gene_names_uniprotkb": "Atf6",
        "gene_names_refseq": "9130025P16Rik; 9630036G24; Atf6alpha; Atf6; ESTM49",
        "protein_names_uniprotkb": "Cyclic AMP-dependent transcription factor ATF-6 alpha; ATF6-alpha; Activating transcription factor 6 alpha; cAMP-dependent transcription factor ATF-6 alpha",
        "protein_names_refseq": "ATF6-alpha; activating transcription factor 6 alpha; cAMP-dependent transcription factor ATF-6 alpha; cyclic AMP-dependent transcription factor ATF-6 alpha",
        "tax_id": 10090,
        "disease": "achromatopsia 7 (Disease Ontology:DOID:0110009); borna disease (Disease Ontology:DOID:5154)",
        "pathway": " (mmu:226641);  (R-MMU-381033)",
        "pathway_count": 2,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;15598891;22682248;26029869;30899004;34428180",
        "class_list": "",
        "function": "ATF6 and XBP1 have roles in activation of endoplasmic reticulum stress-responsive cis-acting elements, [RefSeq, PubMed]; Precursor of the transcription factor form (Processed cyclic AMP-dependent transcription factor ATF-6 alpha), which is embedded in the endoplasmic reticulum membrane. Endoplasmic reticulum stress promotes processing of this form, releasing the transcription factor form that translocates into the nucleus, where it activates transcription of genes involved in the unfolded protein response (UPR)., [UniProtKB, UniProtKB]; Transcription factor that initiates the unfolded protein response (UPR) during endoplasmic reticulum stress by activating transcription of genes involved in the UPR. Binds DNA on the 5'-CCAC[GA]-3'half of the ER stress response element (ERSE) (5'-CCAAT-N(9)-CCAC[GA]-3') and of ERSE II (5'-ATTGG-N-CCACG-3'). Binding to ERSE requires binding of NF-Y to ERSE. Could also be involved in activation of transcription by the serum response factor. May play a role in foveal development and cone function in the retina., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 5,
        "disease_count": 2,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RU98;Q8BZ84",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003700 DNA-binding transcription factor activity;GO:0019899 enzyme binding;GO:0042802 identical protein binding;GO:0046982 protein heterodimerization activity;GO:0031625 ubiquitin protein ligase binding",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0043065 positive regulation of apoptotic process;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0007601 visual perception",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "F6VAN0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P61213-1",
        "uniprot_id": "ARL4A_MOUSE",
        "mass": 22588.0,
        "length": 200,
        "protein_name": "ADP-ribosylation factor-like protein 4A",
        "gene_name": "Arl4a",
        "organism": "Mouse",
        "refseq_name": "ADP-ribosylation factor-like protein 4A",
        "refseq_ac": "NP_001034604",
        "gene_names_uniprotkb": "Arl4a; Arl4",
        "gene_names_refseq": "Arl4a; Arl4",
        "protein_names_uniprotkb": "ADP-ribosylation factor-like protein 4A",
        "protein_names_refseq": "ADP-ribosylation factor-like 4; ADP-ribosylation factor-like protein 4A; ADP-ribosylation-like 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:11861)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "10980193;11909968;21750661;9761722",
        "class_list": "",
        "function": "Reduced sperm count and normal fertility in male mice with targeted disruption of the ADP-ribosylation factor-like 4 (Arl4) gene., [RefSeq, PubMed]; Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. Recruits CYTH1, CYTH2, CYTH3 and CYTH4 to the plasma membrane in GDP-bound form (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P41275;Q3TGR5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0050873 brown fat cell differentiation;GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P61213-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O70126-1",
        "uniprot_id": "AURKB_MOUSE",
        "mass": 39384.0,
        "length": 345,
        "protein_name": "Aurora kinase B",
        "gene_name": "Aurkb",
        "organism": "Mouse",
        "refseq_name": "aurora kinase B isoform 1",
        "refseq_ac": "NP_035626",
        "gene_names_uniprotkb": "Aurkb; Aik2; Aim1; Airk2; Ark2; Stk12; Stk1; Stk5",
        "gene_names_refseq": "AIM-1; AIRK2; Aik2; Aim1; Ark2; AurB; Aurkb; IPL1; STK-1; Stk12; Stk5",
        "protein_names_uniprotkb": "Aurora kinase B; 2.7.11.1; ARK-2; Aurora 1; Aurora- and IPL1-like midbody-associated protein 1; Aurora-related kinase 2; Aurora/IPL1-related kinase 2; STK-1; Serine/threonine-protein kinase 12; Serine/threonine-protein kinase 5; Serine/threonine-protein kinase aurora-B",
        "protein_names_refseq": "ARK-2; aurora 1; aurora B; aurora kinase B isoform 1; aurora- and IPL1-like midbody-associated protein 1; aurora-related kinase 2; aurora/IPL1-related kinase 2; serine/threonine kinase 12; serine/threonine kinase 5; serine/threonine-protein kinase 12; serine/threonine-protein kinase 5; serine/threonine-protein kinase aurora-B",
        "tax_id": 10090,
        "disease": "brain cancer (Disease Ontology:DOID:1319); endometrial carcinoma (Disease Ontology:DOID:2871); prostate carcinoma in situ (Disease Ontology:DOID:8634)",
        "pathway": " (mmu:20877);  (R-MMU-141430);  (R-MMU-141444);  (R-MMU-174178);  (R-MMU-2467813);  (R-MMU-2500257);  (R-MMU-4615885);  (R-MMU-5663220);  (R-MMU-6804756);  (R-MMU-68877);  (R-MMU-9648025)",
        "pathway_count": 11,
        "publication_count": 10,
        "publication_id_list": "11784863;20173027;24034696;29518391;31219806;32782141;34428180;35820727;8647446;9514916",
        "class_list": "",
        "function": "Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis (By similarity). The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly (By similarity). Involved in the bipolar attachment of spindle microtubules to kinetochores and is a key regulator for the onset of cytokinesis during mitosis (By similarity). Required for central/midzone spindle assembly and cleavage furrow formation (By similarity). Key component of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage: phosphorylates CHMP4C, leading to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis (By similarity). AURKB phosphorylates the CPC complex subunits BIRC5/survivin, CDCA8/borealin and INCENP (By similarity). Phosphorylation of INCENP leads to increased AURKB activity (By similarity). Other known AURKB substrates involved in centromeric functions and mitosis are CENPA, DES/desmin, GPAF, KIF2C, NSUN2, RACGAP1, SEPTIN1, VIM/vimentin, HASPIN, and histone H3 (By similarity). A positive feedback loop involving HASPIN and AURKB contributes to localization of CPC to centromeres (By similarity). Phosphorylation of VIM controls vimentin filament segregation in cytokinetic process, whereas histone H3 is phosphorylated at 'Ser-10' and 'Ser-28' during mitosis (H3S10ph and H3S28ph, respectively) (PubMed:11784863). AURKB is also required for kinetochore localization of BUB1 and SGO1 (By similarity). Phosphorylation of p53/TP53 negatively regulates its transcriptional activity (By similarity). Key regulator of active promoters in resting B- and T-lymphocytes: acts by mediating phosphorylation of H3S28ph at active promoters in resting B-cells, inhibiting RNF2/RING1B-mediated ubiquitination of histone H2A and enhancing binding and activity of the USP16 deubiquitinase at transcribed genes (PubMed:24034696). Acts as an inhibitor of CGAS during mitosis: catalyzes phosphorylation of the N-terminus of CGAS during the G2-M transition, blocking CGAS liquid phase separation and activation, and thereby preventing CGAS-induced autoimmunity (By similarity). Phosphorylates KRT5 during anaphase and telophase (PubMed:29518391). Phosphorylates ATXN10 which promotes phosphorylation of ATXN10 by PLK1 and may play a role in the regulation of cytokinesis and stimulating the proteasomal degradation of ATXN10 (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; This gene encodes a member of the aurora kinase subfamily of serine/threonine kinases. The genes encoding the other two members of this subfamily are located on chromosomes 2 and 7. These kinases participate in the regulation of alignment and segregation of chromosomes during mitosis and meiosis through association with microtubules. [provided by RefSeq, Sep 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q61882;Q8C6C1",
        "ec_number_list": "2.7.11.1;2.7.11.25;2.7.11.24;2.7.12.2;2.7.12.1;2.7.11.22;3.4.19.12;2.3.2.-;2.7.10.2;2.7.11.-;2.7.11.4;3.4.25.1;2.7.11.10;2.7.11.11;3.6.5.-;2.7.11.26;2.7.11.19;2.7.11.17;2.7.2.3;2.7.11.12;2.7.11.23;3.1.11.-;2.7.4.6;2.7.13.3;2.7.4.18;3.1.24.-;2.7.11.13;2.7.1.153;2.7.1.137;2.7.1.40;2.3.2.24;2.3.2.23;2.7.11.21;3.4.22.49;3.6.5.2;3.1.3.16;2.7.11.39;2.3.1.-;2.7.11.31;3.4.21.-;2.3.1.48;4.1.1.32;3.6.4.12;2.7.11.38;3.6.1.-;3.6.-.-;3.1.26.-;2.7.11.34;2.7.1.154;2.7.11.8;2.7.1.150",
        "go_molecular_function": "GO:0004672 protein kinase activity;GO:0004674 protein serine/threonine kinase activity;GO:0005524 ATP binding;GO:0019900 kinase binding;GO:0106310 protein serine kinase activity",
        "go_cellular_component": "GO:0000922 spindle pole;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005813 centrosome;GO:0051233 spindle midzone",
        "go_biological_process": "GO:0051315 attachment of mitotic spindle microtubules to kinetochore;GO:0031117 positive regulation of microtubule depolymerization;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0000278 mitotic cell cycle;GO:0001934 positive regulation of protein phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "O70126-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P00848-1",
        "uniprot_id": "ATP6_MOUSE",
        "mass": 25096.0,
        "length": 226,
        "protein_name": "ATP synthase F(0) complex subunit a",
        "gene_name": "Mtatp6",
        "organism": "Mouse",
        "refseq_name": "ATP synthase F0 subunit 6",
        "refseq_ac": "NP_904333",
        "gene_names_uniprotkb": "Mtatp6; Atp6; Atpase6; mt-Atp6",
        "gene_names_refseq": "ATP6",
        "protein_names_uniprotkb": "ATP synthase F(0) complex subunit a; F-ATPase protein 6; Proton-conducting channel, ATP synthase F(0) complex subunit a",
        "protein_names_refseq": "ATP synthase F0 subunit 6",
        "tax_id": 10090,
        "disease": "left ventricular noncompaction (Disease Ontology:DOID:0060480); NARP syndrome (Disease Ontology:DOID:0111273); Leber hereditary optic neuropathy and dystonia (Disease Ontology:DOID:0111755); prostate cancer (Disease Ontology:DOID:10283); Charcot-Marie-Tooth disease (Disease Ontology:DOID:10595); Parkinson's disease (Disease Ontology:DOID:14330); autosomal dominant cerebellar ataxia (Disease Ontology:DOID:1441); parathyroid carcinoma (Disease Ontology:DOID:1540); breast cancer (Disease Ontology:DOID:1612); thyroid cancer (Disease Ontology:DOID:1781); multiple sclerosis (Disease Ontology:DOID:2377); Leigh disease (Disease Ontology:DOID:3652); schizophrenia (Disease Ontology:DOID:5419); kidney disease (Disease Ontology:DOID:557); mitochondrial metabolism disease (Disease Ontology:DOID:700); Leber hereditary optic neuropathy (Disease Ontology:DOID:705); mitochondrial encephalomyopathy (Disease Ontology:DOID:890); systemic lupus erythematosus (Disease Ontology:DOID:9074)",
        "pathway": " (mmu:17705);  (R-MMU-163210);  (R-MMU-5419276);  (R-MMU-8949613);  (R-MMU-9837999)",
        "pathway_count": 5,
        "publication_count": 5,
        "publication_id_list": "12954771;33300544;34428180;35820727;7332926",
        "class_list": "",
        "function": "Subunit a, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel. These two domains are linked by a central stalk rotating inside the F(1) region and a stationary peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. With the subunit c (ATP5MC1), forms the proton-conducting channel in the F(0) domain, that contains two crucial half-channels (inlet and outlet) that facilitate proton movement from the mitochondrial intermembrane space (IMS) into the matrix. Protons are taken up via the inlet half-channel and released through the outlet half-channel, following a Grotthuss mechanism., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 18,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046933 proton-transporting ATP synthase activity, rotational mechanism;GO:0015252 proton channel activity",
        "go_cellular_component": "GO:0005743 mitochondrial inner membrane;GO:0045259 proton-transporting ATP synthase complex",
        "go_biological_process": "GO:0015986 proton motive force-driven ATP synthesis;GO:0042776 proton motive force-driven mitochondrial ATP synthesis;GO:0055093 response to hyperoxia;GO:1902600 proton transmembrane transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "P00848-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P16460-1",
        "uniprot_id": "ASSY_MOUSE",
        "mass": 46584.0,
        "length": 412,
        "protein_name": "Argininosuccinate synthase",
        "gene_name": "Ass1",
        "organism": "Mouse",
        "refseq_name": "argininosuccinate synthase",
        "refseq_ac": "NP_031520",
        "gene_names_uniprotkb": "Ass1; Ass",
        "gene_names_refseq": "ASS; Ass-1; Ass1; fold",
        "protein_names_uniprotkb": "Argininosuccinate synthase; 6.3.4.5; Citrulline--aspartate ligase",
        "protein_names_refseq": "argininosuccinate synthase; arginosuccinate synthetase 1; citrulline--aspartate ligase",
        "tax_id": 10090,
        "disease": "classic citrullinemia (Disease Ontology:DOID:0070340); Alzheimer's disease (Disease Ontology:DOID:10652); uveitis (Disease Ontology:DOID:13141); melanoma (Disease Ontology:DOID:1909); hepatocellular carcinoma (Disease Ontology:DOID:684); citrullinemia (Disease Ontology:DOID:9273)",
        "pathway": " (mmu:11898);  (R-MMU-70635)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "1708740;21183079;22081021;23576753;26740625;28985504;31219806;33300544;34105348;34428180;34599156;35016033;37453647;37828378",
        "class_list": "",
        "function": "Citrulline depletion by ASS1 is required for proinflammatory macrophage activation and immune responses., [RefSeq, PubMed]; Epithelial argininosuccinate synthetase is dispensable for intestinal regeneration and tumorigenesis. Publication Status: Online-Only, [RefSeq, PubMed]; One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 6,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "6.3.4.5",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0015643 toxic substance binding;GO:0042802 identical protein binding;GO:0016597 amino acid binding;GO:0004055 argininosuccinate synthase activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0005829 cytosol",
        "go_biological_process": "GO:0071400 cellular response to oleic acid;GO:0071242 cellular response to ammonium ion;GO:0001889 liver development;GO:0007584 response to nutrient;GO:0010043 response to zinc ion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "P16460-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P50295-1",
        "uniprot_id": "ARY2_MOUSE",
        "mass": 33701.0,
        "length": 290,
        "protein_name": "Arylamine N-acetyltransferase 2",
        "gene_name": "Nat2",
        "organism": "Mouse",
        "refseq_name": "arylamine N-acetyltransferase 2",
        "refseq_ac": "NP_001162049",
        "gene_names_uniprotkb": "Nat2; Aac2",
        "gene_names_refseq": "Nat2",
        "protein_names_uniprotkb": "Arylamine N-acetyltransferase 2; 2.3.1.118; 2.3.1.5; Arylamide acetylase 2; N-acetyltransferase type 2; N-hydroxyarylamine O-acetyltransferase; NAT-2",
        "protein_names_refseq": "N-acetyl transferase 2; N-acetyltransferase type 2; N-hydroxyarylamine O-acetyltransferase; NAT-2; arylamide acetylase 2; arylamine N-acetyltransferase 2",
        "tax_id": 10090,
        "disease": "prostate cancer (Disease Ontology:DOID:10283); urinary bladder cancer (Disease Ontology:DOID:11054); leukemia (Disease Ontology:DOID:1240); lung cancer (Disease Ontology:DOID:1324); Behcet's disease (Disease Ontology:DOID:13241); Parkinson's disease (Disease Ontology:DOID:14330); malignant mesothelioma (Disease Ontology:DOID:1790); pancreatic cancer (Disease Ontology:DOID:1793); transitional cell carcinoma (Disease Ontology:DOID:2671); asthma (Disease Ontology:DOID:2841); laryngeal squamous cell carcinoma (Disease Ontology:DOID:2876); pulmonary tuberculosis (Disease Ontology:DOID:2957); adenocarcinoma (Disease Ontology:DOID:299); allergic contact dermatitis (Disease Ontology:DOID:3042); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); atopic dermatitis (Disease Ontology:DOID:3310); lung non-small cell carcinoma (Disease Ontology:DOID:3908); systemic scleroderma (Disease Ontology:DOID:418); occupational dermatitis (Disease Ontology:DOID:4404); cholangiocarcinoma (Disease Ontology:DOID:4947); progressive supranuclear palsy (Disease Ontology:DOID:678); end stage renal disease (Disease Ontology:DOID:783); lung disease (Disease Ontology:DOID:850); psoriasis (Disease Ontology:DOID:8893); systemic lupus erythematosus (Disease Ontology:DOID:9074); acute myeloid leukemia (Disease Ontology:DOID:9119); diabetes mellitus (Disease Ontology:DOID:9351); oral mucosa leukoplakia (Disease Ontology:DOID:9655); senile cataract (Disease Ontology:DOID:9669); acute lymphoblastic leukemia (Disease Ontology:DOID:9952)",
        "pathway": " (mmu:17961);  (R-MMU-156582);  (R-MMU-9753281)",
        "pathway_count": 3,
        "publication_count": 10,
        "publication_id_list": "1513324;1875909;24742986;28888949;30417525;30883722;31219806;34428180;36210013;7545952",
        "class_list": "",
        "function": "Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates, and participates in the detoxification of a plethora of hydrazine and arylamine drugs., [UniProtKB, UniProtKB]; It was concluded that an acute colonic inflammation impairs the expression and function of NAT2 enzyme, thereby diminishing the capacity for 5-aminosalisylic acid metabolism by colonic mucosa., [RefSeq, PubMed]; Metabolic efficiency in arylamine N-acetyltransferase-deficient mice, [RefSeq, PubMed]; MiR-217 inhibits proliferation adn promotes apoptosis and autophagy in hepatocytes in CCL4-induced liver injury through targeting NAT2 expression., [RefSeq, PubMed]; This study illustrated that deficiency of NAT1/2 decreases isoniazid (INH) acetylation, but increases the interactions of INH with endobiotics in the liver., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 30,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.3.1.5;2.3.1.118",
        "go_molecular_function": "GO:0004060 arylamine N-acetyltransferase activity;GO:0008080 N-acetyltransferase activity;GO:0046990 N-hydroxyarylamine O-acetyltransferase activity",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "P50295-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P50296-1",
        "uniprot_id": "ARY3_MOUSE",
        "mass": 33686.0,
        "length": 290,
        "protein_name": "Arylamine N-acetyltransferase 3",
        "gene_name": "Nat3",
        "organism": "Mouse",
        "refseq_name": "arylamine N-acetyltransferase 3",
        "refseq_ac": "NP_032700",
        "gene_names_uniprotkb": "Nat3; Aac3",
        "gene_names_refseq": "Nat3",
        "protein_names_uniprotkb": "Arylamine N-acetyltransferase 3; 2.3.1.5; Arylamide acetylase 3; N-acetyltransferase type 3; NAT-3",
        "protein_names_refseq": "N-acetyltransferase type 3; NAT-3; arylamide acetylase 3; arylamine N-acetyltransferase 3",
        "tax_id": 10090,
        "disease": "prostate cancer (Disease Ontology:DOID:10283); urinary bladder cancer (Disease Ontology:DOID:11054); leukemia (Disease Ontology:DOID:1240); lung cancer (Disease Ontology:DOID:1324); Behcet's disease (Disease Ontology:DOID:13241); Parkinson's disease (Disease Ontology:DOID:14330); malignant mesothelioma (Disease Ontology:DOID:1790); pancreatic cancer (Disease Ontology:DOID:1793); transitional cell carcinoma (Disease Ontology:DOID:2671); asthma (Disease Ontology:DOID:2841); laryngeal squamous cell carcinoma (Disease Ontology:DOID:2876); pulmonary tuberculosis (Disease Ontology:DOID:2957); adenocarcinoma (Disease Ontology:DOID:299); allergic contact dermatitis (Disease Ontology:DOID:3042); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); atopic dermatitis (Disease Ontology:DOID:3310); lung non-small cell carcinoma (Disease Ontology:DOID:3908); systemic scleroderma (Disease Ontology:DOID:418); occupational dermatitis (Disease Ontology:DOID:4404); cholangiocarcinoma (Disease Ontology:DOID:4947); progressive supranuclear palsy (Disease Ontology:DOID:678); lung disease (Disease Ontology:DOID:850); psoriasis (Disease Ontology:DOID:8893); systemic lupus erythematosus (Disease Ontology:DOID:9074); acute myeloid leukemia (Disease Ontology:DOID:9119); diabetes mellitus (Disease Ontology:DOID:9351); oral mucosa leukoplakia (Disease Ontology:DOID:9655); senile cataract (Disease Ontology:DOID:9669); acute lymphoblastic leukemia (Disease Ontology:DOID:9952)",
        "pathway": " (mmu:17962);  (R-MMU-156582);  (R-MMU-9753281)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "17403913;7545952",
        "class_list": "",
        "function": "Generated Nat3 knockout mouse, showing that Nat3 is unlikely to play a significant role in the N-acetylation of arylamines either in wild-type mice or in mice lacking Nat1 and Nat2 activities., [RefSeq, PubMed]; Participates in the detoxification of a plethora of hydrazine and arylamine drugs., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 29,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.3.1.5;2.3.1.118",
        "go_molecular_function": "GO:0015179 L-amino acid transmembrane transporter activity;GO:0004060 arylamine N-acetyltransferase activity;GO:0046990 N-hydroxyarylamine O-acetyltransferase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0015807 L-amino acid transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "P50296-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P61208-1",
        "uniprot_id": "ARL4C_MOUSE",
        "mass": 21487.0,
        "length": 192,
        "protein_name": "ADP-ribosylation factor-like protein 4C",
        "gene_name": "Arl4c",
        "organism": "Mouse",
        "refseq_name": "ADP-ribosylation factor-like protein 4C",
        "refseq_ac": "NP_796279",
        "gene_names_uniprotkb": "Arl4c; Arl7",
        "gene_names_refseq": "A630084M22Rik; Arl4c; Arl7; LAK",
        "protein_names_uniprotkb": "ADP-ribosylation factor-like protein 4C; ADP-ribosylation factor-like 7",
        "protein_names_refseq": "ADP-ribosylation factor-like 7; ADP-ribosylation factor-like protein 4C",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:320982)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "10462049;21187453;22673513;32873638;37703759",
        "class_list": "",
        "function": "An important role of LXRs in the coordinated regulation of lipid metabolic and inflammatory gene programs in macrophages, [RefSeq, PubMed]; Arl4c is involved in tooth germ development through osteoblastic/ameloblastic differentiation., [RefSeq, PubMed]; CRL5-dependent regulation of the small GTPases ARL4C and ARF6 controls hippocampal morphogenesis., [RefSeq, PubMed]; Describe that miR-26, an LXR-suppressed miRNA, inhibits the expression of the ATP-binding cassette transporter A1 (ABCA1) and ADP-ribosylation factor-like 7 (ARL7), two LXR target genes which play critical roles in cholesterol efflux, [RefSeq, PubMed]; Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. May be involved in transport between a perinuclear compartment and the plasma membrane, apparently linked to the ABCA1-mediated cholesterol secretion pathway. Recruits CYTH1, CYTH2, CYTH3 and CYTH4 to the plasma membrane in the GDP-bound form. Regulates the microtubule-dependent intracellular vesicular transport from early endosome to recycling endosome process (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0043014 alpha-tubulin binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0030175 filopodium",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0032456 endocytic recycling",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P61208-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P41133-1",
        "uniprot_id": "ID3_MOUSE",
        "mass": 13089.0,
        "length": 119,
        "protein_name": "DNA-binding protein inhibitor ID-3",
        "gene_name": "Id3",
        "organism": "Mouse",
        "refseq_name": "DNA-binding protein inhibitor ID-3",
        "refseq_ac": "NP_032347",
        "gene_names_uniprotkb": "Id3; Hlh462; Id-3; Idb3",
        "gene_names_refseq": "Hlh462; Id3; Idb3; bHLHb25",
        "protein_names_uniprotkb": "DNA-binding protein inhibitor ID-3; ID-like protein inhibitor HLH 462; Inhibitor of DNA binding 3; Inhibitor of differentiation 3",
        "protein_names_refseq": "DNA-binding protein inhibitor ID-3; ID-like protein inhibitor HLH 462; inhibitor of differentiation 3",
        "tax_id": 10090,
        "disease": "Sjogren's syndrome (Disease Ontology:DOID:12894)",
        "pathway": " (mmu:15903)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "11940648;15451666;16556596;19217292;2000388;22862948;23824195;34428180",
        "class_list": "",
        "function": "Transcriptional regulator (lacking a basic DNA binding domain) which negatively regulates the basic helix-loop-helix (bHLH) transcription factors by forming heterodimers and inhibiting their DNA binding and transcriptional activity. Implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation. Involved in myogenesis by inhibiting skeletal muscle and cardiac myocyte differentiation and promoting muscle precursor cells proliferation. Inhibits the binding of E2A-containing protein complexes to muscle creatine kinase E-box enhancer. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:1901707 leptomycin B binding;GO:0019904 protein domain specific binding;GO:0046983 protein dimerization activity;GO:0003714 transcription corepressor activity;GO:0043425 bHLH transcription factor binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0072750 cellular response to leptomycin B;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0007507 heart development;GO:0010628 positive regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P41133-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CGV9-1",
        "uniprot_id": "TSH3_MOUSE",
        "mass": 118626.0,
        "length": 1081,
        "protein_name": "Teashirt homolog 3",
        "gene_name": "Tshz3",
        "organism": "Mouse",
        "refseq_name": "teashirt homolog 3",
        "refseq_ac": "NP_758502",
        "gene_names_uniprotkb": "Tshz3; Kiaa1474; Tsh3; Zfp537; Znf537",
        "gene_names_refseq": "A630038G13Rik; Tsh3; Tshz3; Zfp537; mKIAA1474; teashirt3",
        "protein_names_uniprotkb": "Teashirt homolog 3; Zinc finger protein 537",
        "protein_names_refseq": "teashirt 3; teashirt homolog 3; zinc finger protein 537",
        "tax_id": 10090,
        "disease": "autism spectrum disorder (Disease Ontology:DOID:0060041)",
        "pathway": " (mmu:243931)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "14973285;15834955;18776146;19343227;19745106;20631175;21750661;27668656",
        "class_list": "",
        "function": "Role for mTsh genes in the establishment of regional identity and specification of cell types in the developing and adult forebrain, [RefSeq, PubMed]; Three mouse Tsh genes are functionally equivalent to the Drosophila tsh gene when expressed in developing Drosophila embryos, [RefSeq, PubMed]; Transcriptional regulator involved in developmental processes. Functions in association with APBB1, SET and HDAC factors as a transcriptional repressor, that inhibits the expression of CASP4. TSHZ3-mediated transcription repression involves the recruitment of histone deacetylases HDAC1 and HDAC2. Associates with chromatin in a region surrounding the CASP4 transcriptional start site(s). Regulates the development of neurons involved in both respiratory rhythm and airflow control. Promotes maintenance of nucleus ambiguus (nA) motoneurons, which govern upper airway function, and establishes a respiratory rhythm generator (RRG) activity compatible with survival at birth. Involved in the differentiation of the proximal uretic smooth muscle cells during developmental processes. Involved in the up-regulation of myocardin, that directs the expression of smooth muscle cells in the proximal ureter. Involved in the modulation of glutamatergic synaptic transmission and long-term synaptic potentiation (PubMed:27668656)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5DTX4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003682 chromatin binding;GO:0008270 zinc ion binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005886 plasma membrane;GO:0030426 growth cone",
        "go_biological_process": "GO:0060993 kidney morphogenesis;GO:0050975 sensory perception of touch;GO:0001701 in utero embryonic development;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q8CGV9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P11344-1",
        "uniprot_id": "TYRO_MOUSE",
        "mass": 60606.0,
        "length": 533,
        "protein_name": "Tyrosinase",
        "gene_name": "Tyr",
        "organism": "Mouse",
        "refseq_name": "tyrosinase isoform 1 precursor",
        "refseq_ac": "NP_035791",
        "gene_names_uniprotkb": "Tyr",
        "gene_names_refseq": "Oca1; Tyr; albino; c; skc35",
        "protein_names_uniprotkb": "Tyrosinase; 1.14.18.1; Albino locus protein; Monophenol monooxygenase",
        "protein_names_refseq": "albino locus protein; monophenol monooxygenase; tyrosinase isoform 1 precursor",
        "tax_id": 10090,
        "disease": "oculocutaneous albinism (Disease Ontology:DOID:0050632); ocular albinism 1 (Disease Ontology:DOID:0050633); oculocutaneous albinism type IA (Disease Ontology:DOID:0070094); oculocutaneous albinism type IB (Disease Ontology:DOID:0070095); pigmentation disease (Disease Ontology:DOID:10123); buphthalmos (Disease Ontology:DOID:11211); vitiligo (Disease Ontology:DOID:12306); color blindness (Disease Ontology:DOID:13399); melanoma (Disease Ontology:DOID:1909); retinoschisis (Disease Ontology:DOID:8465); skin melanoma (Disease Ontology:DOID:8923)",
        "pathway": " (mmu:22173);  (R-MMU-5662702)",
        "pathway_count": 2,
        "publication_count": 13,
        "publication_id_list": "1537333;2110899;2118105;21750661;2494997;2507645;2517217;2567165;26620560;3134020;3141148;35469906;35820727",
        "class_list": "",
        "function": "This is a copper-containing oxidase that functions in the formation of pigments such as melanins and other polyphenolic compounds (PubMed:2517217). Catalyzes the initial and rate limiting step in the cascade of reactions leading to melanin production from tyrosine (PubMed:1537333, PubMed:2517217, PubMed:35469906). In addition to hydroxylating tyrosine to DOPA (3,4-dihydroxyphenylalanine), also catalyzes the oxidation of DOPA to DOPA-quinone, and possibly the oxidation of DHI (5,6-dihydroxyindole) to indole-5,6 quinone (PubMed:1537333)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 6,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 11,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.14.18.-;1.14.18.1",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0005507 copper ion binding;GO:0004503 tyrosinase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0016020 membrane;GO:0048471 perinuclear region of cytoplasm;GO:0042470 melanosome;GO:0033162 melanosome membrane",
        "go_biological_process": "GO:0008283 cell population proliferation;GO:0048538 thymus development;GO:0009411 response to UV;GO:0051591 response to cAMP;GO:0033280 response to vitamin D",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "P11344-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BSA9-1",
        "uniprot_id": "TYW3_MOUSE",
        "mass": 28575.0,
        "length": 257,
        "protein_name": "tRNA wybutosine-synthesizing protein 3 homolog",
        "gene_name": "Tyw3",
        "organism": "Mouse",
        "refseq_name": "tRNA wybutosine-synthesizing protein 3 homolog isoform 1",
        "refseq_ac": "NP_766062",
        "gene_names_uniprotkb": "Tyw3",
        "gene_names_refseq": "5230400J09Rik; Tyw3",
        "protein_names_uniprotkb": "tRNA wybutosine-synthesizing protein 3 homolog; 2.1.1.282; tRNA(Phe) 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase; tRNA-yW-synthesizing protein 3",
        "protein_names_refseq": "tRNA wybutosine-synthesizing protein 3 homolog isoform 1; tRNA wybutosine-synthesizing protein 3 homolog; tRNA(Phe) 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))- methyltransferase; tRNA-yW-synthesizing protein 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:209584)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21183079;21750661;34428180",
        "class_list": "",
        "function": "Probable S-adenosyl-L-methionine-dependent methyltransferase that acts as a component of the wybutosine biosynthesis pathway. Wybutosine is a hyper modified guanosine with a tricyclic base found at the 3'-position adjacent to the anticodon of eukaryotic phenylalanine tRNA., [UniProtKB, UniProtKB, UniProtKB]; S-adenosyl-L-methionine-dependent methyltransferase involved in the biosynthesis of wybutosine, a hyper modified guanosine with a tricyclic base located at position 37 of eukaryotic phenylalanine tRNA (tRNA(Phe)) that contributes to maintenance of the translational reading frame. Catalyzes the methylation of 4-demethylwyosine, generating intermediates required for the formation of mature wybutosine., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BSX2",
        "ec_number_list": "2.1.1.282",
        "go_molecular_function": "GO:0008175 tRNA methyltransferase activity;GO:0008168 methyltransferase activity",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0030488 tRNA methylation;GO:0031591 wybutosine biosynthetic process;GO:0008033 tRNA processing;GO:0032259 methylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8BSA9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JLB0-1",
        "uniprot_id": "PALS2_MOUSE",
        "mass": 62631.0,
        "length": 553,
        "protein_name": "Protein PALS2",
        "gene_name": "Pals2",
        "organism": "Mouse",
        "refseq_name": "protein PALS2 isoform a",
        "refseq_ac": "NP_001158205",
        "gene_names_uniprotkb": "Pals2; Dlgh4; Mpp6",
        "gene_names_refseq": "Mpp6; P55t; Pals2",
        "protein_names_uniprotkb": "Protein PALS2; Dlgh4 protein; MAGUK p55 subfamily member 6; P55T protein; Protein associated with Lin-7 2",
        "protein_names_refseq": "MAGUK p55 subfamily member 6; dlgh4 protein; fibroblast growth factor-inducible protein 15; membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 6); membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6); protein PALS2 isoform a; protein PALS2; protein associated with Lin-7 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56524)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "10753959;12826663;21750661;22025680;23306908;26496923;30357511;34428180;37507081",
        "class_list": "",
        "function": "In the mouse sciatic nerve, protein 4.1G colocalized at Schmidt-Lanterman incisures (SLI) and the paranodes with a member of the membrane-associated guanylate kinase (MAGUK) family, membrane protein palmitoylated 6., [RefSeq, PubMed]; The findings indicate that the Src-MPP6-4.1G protein complex in Schmidt-Lanterman incisures(SLIs) has a role in signal transduction in the peripheral nervous system(PNS)., [RefSeq, PubMed]; The results indicate that the MPP6-Lin7 complex regulates myelin formation., [RefSeq, PubMed]; This paper herein showed the immunolocalization and interaction proteins of MPP6 in the mouse small intestine, and also that 4.1B in epithelial cells was not essential for the sorting of MPP6., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9JLB1;Q9WV37",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004385 GMP kinase activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0005911 cell-cell junction;GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q9JLB0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91ZR3-1",
        "uniprot_id": "ZHANG_MOUSE",
        "mass": 37825.0,
        "length": 358,
        "protein_name": "CREB/ATF bZIP transcription factor",
        "gene_name": "Crebzf",
        "organism": "Mouse",
        "refseq_name": "CREB/ATF bZIP transcription factor",
        "refseq_ac": "NP_660133",
        "gene_names_uniprotkb": "Crebzf; Zf",
        "gene_names_refseq": "1110034C16Rik; 6330417B10Rik; Crebzf; LAZipII; LAZip; SMILE; Zf",
        "protein_names_uniprotkb": "CREB/ATF bZIP transcription factor; HCF-binding transcription factor Zhangfei; Host cell factor-binding transcription factor Zhangfei; Tyrosine kinase-associated leucine zipper protein LAZip",
        "protein_names_refseq": "CREB/ATF bZIP transcription factor; HCF-binding transcription factor Zhangfei; host cell factor-binding transcription factor Zhangfei; tyrosine kinase-associated leucine zipper protein LAZipII; tyrosine kinase-associated leucine zipper protein LAZip",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:233490)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "21750661;21956870;21994947;24325733;34203471;36680394;37143079;38286660",
        "class_list": "",
        "function": "CREBZF is involved in implantation and is up-regulated by oestrogen. Publication Status: Online-Only, [RefSeq, PubMed]; Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression., [RefSeq, PubMed]; Macrophage CREBZF Orchestrates Inflammatory Response to Potentiate Insulin Resistance and Type 2 Diabetes., [RefSeq, PubMed]; Small heterodimer partner interacting leucine zipper protein (SMILE) ameliorates autoimmune arthritis via AMPK signaling pathway and the regulation of B cell activation. Publication Status: Online-Only, [RefSeq, PubMed]; Smile is a novel gene specifying both bronchial smooth muscle and lung alveolar myofibroblast lineages, contributing to our understanding of the biological control of the development of these cells., [RefSeq, PubMed]; Strongly activates transcription when bound to HCFC1. Suppresses the expression of HSV proteins in cells infected with the virus in a HCFC1-dependent manner. Also suppresses the HCFC1-dependent transcriptional activation by CREB3 and reduces the amount of CREB3 in the cell. Able to down-regulate expression of some cellular genes in CREBZF-expressing cells (By similarity)., [UniProtKB, UniProtKB]; The curcumin/LKB1/AMPK/SMILE/PGC1alpha pathway differentially regulates ER stress-mediated gene transcription, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q91Y72",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003700 DNA-binding transcription factor activity;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0090575 RNA polymerase II transcription regulator complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0045892 negative regulation of DNA-templated transcription;GO:0009615 response to virus;GO:0045814 negative regulation of gene expression, epigenetic",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q91ZR3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CWR0-1",
        "uniprot_id": "ARHGP_MOUSE",
        "mass": 68262.0,
        "length": 618,
        "protein_name": "Rho guanine nucleotide exchange factor 25",
        "gene_name": "Arhgef25",
        "organism": "Mouse",
        "refseq_name": "rho guanine nucleotide exchange factor 25 isoform 2",
        "refseq_ac": "NP_001159885",
        "gene_names_uniprotkb": "Arhgef25; D10Ertd610e; Geft",
        "gene_names_refseq": "2410008H17Rik; Arhgef25; D10Ertd610e; GEFT",
        "protein_names_uniprotkb": "Rho guanine nucleotide exchange factor 25; Guanine nucleotide exchange factor GEFT; Rac/Cdc42/Rho exchange factor GEFT; RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT; p63RhoGEF",
        "protein_names_refseq": "Rho guanine nucleotide exchange factor (GEF) 25; guanine nucleotide exchange factor GEFT; p63RhoGEF; rac/Cdc42/Rho exchange factor GEFT; rho guanine nucleotide exchange factor 25 isoform 2; rhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT",
        "tax_id": 10090,
        "disease": "epilepsy (Disease Ontology:DOID:1826)",
        "pathway": " (mmu:52666);  (R-MMU-193648);  (R-MMU-416476);  (R-MMU-416482);  (R-MMU-8980692);  (R-MMU-9013026);  (R-MMU-9013106);  (R-MMU-9013148);  (R-MMU-9013149)",
        "pathway_count": 9,
        "publication_count": 11,
        "publication_id_list": "12547822;15322108;16314529;16496360;18541910;21750661;22449701;23696743;25428506;26392029;28528544",
        "class_list": "",
        "function": "Bves directly interacts with GEFT and is a novel regulator of the Rac1 and Cdc42 signaling cascades., [RefSeq, PubMed]; In cultured neonatal cardiac fibroblasts, p63RhoGEF regulated the angiotensin II (Ang II)-dependent RhoA activation, the activation of the serum response factor, and the expression and secretion of CTGF., [RefSeq, PubMed]; May play a role in actin cytoskeleton reorganization in different tissues since its activation induces formation of actin stress fibers. It works as a guanine nucleotide exchange factor for Rho family of small GTPases. Links specifically G alpha q/11-coupled receptors to RHOA activation (By similarity). May be an important regulator of processes involved in axon and dendrite formation. In neurons seems to be an exchange factor primarily for RAC1. Involved in skeletal myogenesis., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Pasteurella multocida toxin prevents osteoblast differentiation by transactivation of the MAP-kinase cascade via the Galpha(q/11)--p63RhoGEF--RhoA axis., [RefSeq, PubMed]; The Geft knockout mice develop normally and exhibit no discernable phenotype, suggesting Geft is dispensable for the development of the second heart field in mouse., [RefSeq, PubMed]; This protein induces cell proliferation, transformation, and migration., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TYF3;Q8R1Q4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005085 guanyl-nucleotide exchange factor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0030017 sarcomere;GO:0030016 myofibril;GO:0019898 extrinsic component of membrane",
        "go_biological_process": "GO:0007411 axon guidance",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q9CWR0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7SIG6-1",
        "uniprot_id": "ASAP2_MOUSE",
        "mass": 106805.0,
        "length": 958,
        "protein_name": "Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2",
        "gene_name": "Asap2",
        "organism": "Mouse",
        "refseq_name": "arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform b",
        "refseq_ac": "NP_001004364",
        "gene_names_uniprotkb": "Asap2; Ddef2; Gm1523; Gm592",
        "gene_names_refseq": "6530401G17Rik; Asap2; Ddef2; Gm1523; Gm592; PAG3; PAP",
        "protein_names_uniprotkb": "Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2; Development and differentiation-enhancing factor 2; PAG3; PAP; Paxillin-associated protein with ARF GAP activity 3; Pyk2 C-terminus-associated protein",
        "protein_names_refseq": "arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform b; arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2; development and differentiation enhancing factor 2; paxillin-associated protein with ARF GAP activity 3; pyk2 C-terminus-associated protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:211914)",
        "pathway_count": 1,
        "publication_count": 15,
        "publication_id_list": "10.1101/2023.09.13.557529;10022920;10601011;11304556;17242355;18630941;21183079;21750661;27601625;28322786;32848054;34428180;34887587;39627609;40885482",
        "class_list": "",
        "function": "Activates the small GTPases ARF1, ARF5 and ARF6. Regulates the formation of post-Golgi vesicles and modulates constitutive secretion. Modulates phagocytosis mediated by Fc gamma receptor and ARF6. Modulates PXN recruitment to focal contacts and cell migration (By similarity)., [UniProtKB, PubMed, PubMed]; In conclusion, we have identified that ARL15 acts as an insulin-sensitizing effector molecule to upregulate the phosphorylation of members of the canonical IR/IRS1/PDPK1/AKT insulin pathway by interacting with its GAP ASAP2 and activating PDPK1. This research may provide new insights into GTPase-mediated insulin signalling regulation and facilitate the development of new pharmacotherapeutic targets for insulin sensitizati, [RefSeq, PubMed]; These findings identify ASAP2 as a new target of Selk-dependent palmitoylation and reveal a new mechanism regulating the efficiency of FcgammaR-mediated phagocytosis., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 10,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 10,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 10,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 6,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q501K1;Q66JN2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0046872 metal ion binding;GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0032580 Golgi cisterna membrane;GO:0005794 Golgi apparatus;GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 2.9,
        "record_id": "Q7SIG6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60936-1",
        "uniprot_id": "COQ8A_MOUSE",
        "mass": 71743.0,
        "length": 645,
        "protein_name": "Atypical kinase COQ8A, mitochondrial",
        "gene_name": "Coq8a",
        "organism": "Mouse",
        "refseq_name": "atypical kinase COQ8A, mitochondrial isoform 1",
        "refseq_ac": "NP_001156762",
        "gene_names_uniprotkb": "Coq8a; Adck3; Cabc1",
        "gene_names_refseq": "4632432J16Rik; Adck3; Cabc1; Coq8a; mKIAA0451",
        "protein_names_uniprotkb": "Atypical kinase COQ8A, mitochondrial; 2.7.-.-; Chaperone activity of bc1 complex-like; Chaperone-ABC1-like; Coenzyme Q protein 8A; aarF domain-containing protein kinase 3",
        "protein_names_refseq": "aarF domain containing kinase 3; aarF domain-containing protein kinase 3; atypical kinase ADCK3, mitochondrial; atypical kinase COQ8A, mitochondrial isoform 1; atypical kinase COQ8A, mitochondrial; chaperone activity of bc1 complex-like, mitochondrial; chaperone, ABC1 activity of bc1 complex like; coenzyme Q protein 8A",
        "tax_id": 10090,
        "disease": "coenzyme Q10 deficiency disease (Disease Ontology:DOID:0050730); primary coenzyme Q10 deficiency 4 (Disease Ontology:DOID:0070241); nephrotic syndrome type 9 (Disease Ontology:DOID:0080391); nephrotic syndrome (Disease Ontology:DOID:1184)",
        "pathway": " (mmu:67426);  (R-MMU-2142789)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "16452087;21750661;27499294;31219806;34428180;36288343;37453647;37507081;39927985",
        "class_list": "",
        "function": "Atypical kinase involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:27499294). Its substrate specificity is still unclear: may act as a protein kinase that mediates phosphorylation of COQ3 (By similarity). According to other reports, acts as a small molecule kinase, possibly a lipid kinase that phosphorylates a prenyl lipid in the ubiquinone biosynthesis pathway, as suggested by its ability to bind coenzyme Q lipid intermediates (By similarity). However, the small molecule kinase activity was not confirmed by another publication (By similarity). Shows an unusual selectivity for binding ADP over ATP (By similarity)., [UniProtKB, UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB]; Loss of COQ8a results in cerebellar ataxia and coenzyme Q deficiency., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8K0M1;Q9D657;Q9DBR5;Q9JHR3",
        "ec_number_list": "1.14.99.60;1.14.13.253;2.7.-.-;4.1.1.130;2.1.1.-;2.1.1.114;2.1.1.64;1.14.15.45;1.14.15.46;2.1.1.201",
        "go_molecular_function": "GO:0004672 protein kinase activity;GO:0005524 ATP binding;GO:0008047 enzyme activator activity;GO:0043531 ADP binding;GO:0016301 kinase activity",
        "go_cellular_component": "GO:0031314 extrinsic component of mitochondrial inner membrane;GO:0005739 mitochondrion;GO:0031966 mitochondrial membrane",
        "go_biological_process": "GO:0016310 phosphorylation;GO:0006744 ubiquinone biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q60936-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60748-1",
        "uniprot_id": "CRHR2_MOUSE",
        "mass": 47623.0,
        "length": 411,
        "protein_name": "Corticotropin-releasing hormone receptor 2",
        "gene_name": "Crhr2",
        "organism": "Mouse",
        "refseq_name": "corticotropin-releasing factor receptor 2 isoform 4",
        "refseq_ac": "NP_001275549",
        "gene_names_uniprotkb": "Crhr2; Crf2r",
        "gene_names_refseq": "CRF-R2; CRFR2alpha; CRFR2beta; Crfr2; Crhr2; HM-CRF",
        "protein_names_uniprotkb": "Corticotropin-releasing hormone receptor 2; CRF-R-2; CRF-R2; CRF-RB; CRFR-2; CRH-R-2; CRH-R2; Corticotropin-releasing factor receptor 2; HM-CRF; Heart and muscle corticotropin-releasing factor receptor",
        "protein_names_refseq": "CRF 2 receptor; CRF-R-2; CRF-RB; CRFR-2; CRH-R-2; CRH-R2; corticotropin releasing factor receptor type 2 beta; corticotropin-releasing factor 2; corticotropin-releasing factor receptor 2 isoform 4; corticotropin-releasing factor receptor 2; heart and muscle corticotropin-releasing factor receptor",
        "tax_id": 10090,
        "disease": "colitis (Disease Ontology:DOID:0060180); depressive disorder (Disease Ontology:DOID:1596); asthma (Disease Ontology:DOID:2841); ischemia (Disease Ontology:DOID:326); functional colonic disease (Disease Ontology:DOID:3877); rhinitis (Disease Ontology:DOID:4483); muscular atrophy (Disease Ontology:DOID:767); irritable bowel syndrome (Disease Ontology:DOID:9778)",
        "pathway": " (mmu:12922);  (R-MMU-373080);  (R-MMU-418555)",
        "pathway_count": 3,
        "publication_count": 13,
        "publication_id_list": "10742107;10742108;10742109;15326300;15514029;16888152;17360332;19246489;21750661;37995804;7565810;7708757;7755719",
        "class_list": "",
        "function": "Basolateral amygdala corticotropin releasing factor receptor 2 interacts with nonmuscle myosin II to destabilize memory in males., [RefSeq, PubMed]; G protein-coupled receptor for CRH, UCN, UCN2 and UCN3 stress hormones, which plays a central role in whole body adaptation to stress (PubMed:10742107, PubMed:10742108, PubMed:10742109). Has highest affinity for UCN, and much lower affinity for CRH, UNC2 and UCN3 (By similarity). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and downstream effectors, such as adenylate cyclase (By similarity). CRHR2 is coupled to G(s) G protein (GNAS), mediating activation of adenylate cyclase activity and production of cAMP (By similarity). CRHR2-dependent signaling is a primary mediator of the neuroendocrine, autonomic (fight-or-flight) and behavioral responses to stress, acting as a key regulator of adaptation by activating the hypothalamus-pituitary-adrenal axis, leading to corticotropin hormone (ACTH) production (PubMed:10742107, PubMed:10742108, PubMed:10742109)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB]; G-protein coupled receptor for CRH (corticotropin-releasing factor), UCN (urocortin), UCN2 and UCN3. Has high affinity for UCN. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and down-stream effectors, such as adenylate cyclase. Promotes the activation of adenylate cyclase, leading to increased intracellular cAMP levels., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 5,
        "predicted_n_glycosites": 5,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 8,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A1D5RLK7;B9EHB5;C0K3M3;Q3UQP0;Q5GL24;Q60783;Q60808",
        "ec_number_list": "",
        "go_molecular_function": "GO:0017046 peptide hormone binding;GO:0005179 hormone activity;GO:0008528 G protein-coupled peptide receptor activity;GO:0015056 corticotrophin-releasing factor receptor activity;GO:0043404 corticotropin-releasing hormone receptor activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0030424 axon",
        "go_biological_process": "GO:0090281 negative regulation of calcium ion import;GO:0046882 negative regulation of follicle-stimulating hormone secretion;GO:2000252 negative regulation of feeding behavior;GO:0035482 gastric motility;GO:2000293 negative regulation of defecation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q60748-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P50285-1",
        "uniprot_id": "FMO1_MOUSE",
        "mass": 59915.0,
        "length": 532,
        "protein_name": "Flavin-containing monooxygenase 1",
        "gene_name": "Fmo1",
        "organism": "Mouse",
        "refseq_name": "flavin-containing monooxygenase 1 isoform 1",
        "refseq_ac": "NP_001317220",
        "gene_names_uniprotkb": "Fmo1; Fmo-1",
        "gene_names_refseq": "Fmo1",
        "protein_names_uniprotkb": "Flavin-containing monooxygenase 1; 1.14.13.148; 1.14.13.8; Dimethylaniline monooxygenase [N-oxide-forming] 1; Dimethylaniline oxidase 1; FMO 1; Hepatic flavin-containing monooxygenase 1; Trimethylamine monooxygenase",
        "protein_names_refseq": "dimethylaniline monooxygenase [N-oxide-forming] 1; dimethylaniline oxidase 1; flavin-containing monooxygenase 1 isoform 1; hepatic flavin-containing monooxygenase 1; trimethylamine monooxygenase",
        "tax_id": 10090,
        "disease": "chromosome 1q21.1 deletion syndrome (Disease Ontology:DOID:0060411)",
        "pathway": " (mmu:14261);  (R-MMU-1614558);  (R-MMU-217271)",
        "pathway_count": 3,
        "publication_count": 6,
        "publication_id_list": "15183119;21750661;32156684;34428180;37507081;9580872",
        "class_list": "",
        "function": "Broad spectrum monooxygenase that catalyzes the oxygenation of a wide variety of nitrogen- and sulfur-containing compounds including xenobiotics (PubMed:32156684, PubMed:9580872). Catalyzes the S-oxygenation of hypotaurine to produce taurine, an organic osmolyte involved in cell volume regulation as well as a variety of cytoprotective and developmental processes (PubMed:32156684). In vitro, catalyzes the N-oxygenation of trimethylamine (TMA) to produce trimethylamine N-oxide (TMAO) and could therefore participate to the detoxification of this compound that is generated by the action of gut microbiota from dietary precursors such as choline, choline containing compounds, betaine or L-carnitine (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB]; Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine., [RefSeq, PubMed]; Fmo1, 2, 3, 4 and 5 exhibit distinct cell-, tissue-, sex- and developmental stage-specific patterns of expression., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.-.-.-;1.14.13.148;1.14.13.8;1.14.13.32;1.6.3.1",
        "go_molecular_function": "GO:0050660 flavin adenine dinucleotide binding;GO:0034899 trimethylamine monooxygenase activity;GO:0050661 NADP binding;GO:0004497 monooxygenase activity;GO:0004499 N,N-dimethylaniline monooxygenase activity",
        "go_cellular_component": "GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0032496 response to lipopolysaccharide;GO:0046322 negative regulation of fatty acid oxidation;GO:0097009 energy homeostasis;GO:0006805 xenobiotic metabolic process;GO:0009404 toxin metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P50285-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3SXB8-1",
        "uniprot_id": "COL11_MOUSE",
        "mass": 28989.0,
        "length": 272,
        "protein_name": "Collectin-11",
        "gene_name": "Colec11",
        "organism": "Mouse",
        "refseq_name": "collectin-11 isoform 2 precursor",
        "refseq_ac": "NP_082142",
        "gene_names_uniprotkb": "Colec11",
        "gene_names_refseq": "CL-K1; Colec11",
        "protein_names_uniprotkb": "Collectin-11; CL-K1; Collectin kidney protein 1",
        "protein_names_refseq": "collectin kidney protein 1; collectin-11 isoform 2 precursor; collectin-11; collectin-L2",
        "tax_id": 10090,
        "disease": "3MC syndrome 2 (Disease Ontology:DOID:0060576); cleft palate (Disease Ontology:DOID:674)",
        "pathway": " (mmu:71693);  (R-MMU-166662);  (R-MMU-3000480)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "18040075;21258343;21750661;36883567",
        "class_list": "glycogene",
        "function": "Collectin-11 promotes cancer cell proliferation and tumor growth. Publication Status: Online-Only, [RefSeq, PubMed]; Lectin that plays a role in innate immunity, apoptosis and embryogenesis. Calcium-dependent lectin that binds self and non-self glycoproteins presenting high mannose oligosaccharides with at least one terminal alpha-1,2-linked mannose epitope. Primarily recognizes the terminal disaccharide of the glycan. Also recognizes a subset of fucosylated glycans and lipopolysaccharides. Plays a role in innate immunity through its ability to bind non-self sugars presented by microorganisms and to activate the complement through the recruitment of MAPS1. Also plays a role in apoptosis through its ability to bind in a calcium-independent manner the DNA present at the surface of apoptotic cells and to activate the complement in response to this binding. Finally, plays a role in development, probably serving as a guidance cue during the migration of neural crest cells and other cell types during embryogenesis., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; This gene encodes a member of the collectin family of C-type lectins that possess collagen-like sequences and carbohydrate recognition domains. Collectins are secreted proteins that play important roles in the innate immune system by binding to carbohydrate antigens on microorganisms, facilitating their recognition and removal. The encoded protein binds to multiple sugars with a preference for fucose and mannose. Mutations in the human gene are a cause of 3MC syndrome-2. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2015]., [RefSeq]; This profile of CL-K1 expression is unique among the collectins. [CL-K1], [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 15,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3SXB7;Q9DC75",
        "ec_number_list": "",
        "go_molecular_function": "GO:0070492 oligosaccharide binding;GO:0003677 DNA binding;GO:0042802 identical protein binding;GO:0005509 calcium ion binding;GO:0005537 D-mannose binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005576 extracellular region",
        "go_biological_process": "GO:0006508 proteolysis;GO:0032502 developmental process;GO:0019730 antimicrobial humoral response;GO:0001867 complement activation, lectin pathway;GO:0006956 complement activation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q3SXB8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60632-1",
        "uniprot_id": "COT1_MOUSE",
        "mass": 46085.0,
        "length": 422,
        "protein_name": "COUP transcription factor 1",
        "gene_name": "Nr2f1",
        "organism": "Mouse",
        "refseq_name": "COUP transcription factor 1 isoform a",
        "refseq_ac": "NP_034281",
        "gene_names_uniprotkb": "Nr2f1; Erbal3; Tfcoup1",
        "gene_names_refseq": "COUP-TF1; COUP-TFI; COUPTFA; EAR-3; EAR3; Erbal3; Nr2f1; SVP44; Tcfcoup1",
        "protein_names_uniprotkb": "COUP transcription factor 1; COUP transcription factor I; COUP-TF I; COUP-TF1; EAR-3; Nuclear receptor subfamily 2 group F member 1; V-erbA-related protein 3",
        "protein_names_refseq": "COUP transcription factor 1 isoform a; COUP transcription factor 1; COUP transcription factor I; V-erbA-related protein 3; avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-like 3",
        "tax_id": 10090,
        "disease": "Bosch-Boonstra-Schaaf optic atrophy syndrome (Disease Ontology:DOID:0112226); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:13865);  (R-MMU-383280)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;7947324;8183930",
        "class_list": "",
        "function": "Coup (chicken ovalbumin upstream promoter) transcription factor binds to the ovalbumin promoter and, in conjunction with another protein (S300-II) stimulates initiation of transcription. Binds to both direct repeats and palindromes of the 5'-AGGTCA-3' motif. Represses transcriptional activity of LHCG (By similarity)., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q61438",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003700 DNA-binding transcription factor activity;GO:0008270 zinc ion binding;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0043565 sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0007399 nervous system development;GO:0030154 cell differentiation;GO:0030900 forebrain development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q60632-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60629-1",
        "uniprot_id": "EPHA5_MOUSE",
        "mass": 97056.0,
        "length": 876,
        "protein_name": "Ephrin type-A receptor 5",
        "gene_name": "Epha5",
        "organism": "Mouse",
        "refseq_name": "ephrin type-A receptor 5 isoform 8 precursor",
        "refseq_ac": "NP_031963",
        "gene_names_uniprotkb": "Epha5; Bsk; Ehk1",
        "gene_names_refseq": "Cek7; Ehk1; Els1; Epha5; Hek7; Rek7; bsk",
        "protein_names_uniprotkb": "Ephrin type-A receptor 5; 2.7.10.1; Brain-specific kinase; CEK-7; EHK-1; EPH homology kinase 1",
        "protein_names_refseq": "EPH homology kinase 1; brain-specific kinase; eck-like sequence 1; ephrin type-A receptor 5 isoform 8 precursor; ephrin type-A receptor 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13839)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;12124402;17448994;21750661;27446912;29749928;30899004;8145300",
        "class_list": "",
        "function": "Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Among GPI-anchored ephrin-A ligands, EFNA5 most probably constitutes the cognate/functional ligand for EPHA5. Functions as an axon guidance molecule during development and may be involved in the development of the retinotectal, entorhino-hippocampal and hippocamposeptal pathways. Together with EFNA5 plays also a role in synaptic plasticity in adult brain through regulation of synaptogenesis. In addition to its function in the nervous system, the interaction of EPHA5 with EFNA5 mediates communication between pancreatic islet cells to regulate glucose-stimulated insulin secretion., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 4,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 4,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 4,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QPV2",
        "ec_number_list": "2.7.12.2;2.7.10.1;2.7.12.1;2.7.1.32;2.7.1.82;2.7.10.2;2.7.11.1;2.7.11.13;2.7.10.4;2.7.1.40;2.7.11.23",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0019838 growth factor binding;GO:0004714 transmembrane receptor protein tyrosine kinase activity;GO:0005003 ephrin receptor activity;GO:0005004 GPI-linked ephrin receptor activity",
        "go_cellular_component": "GO:0005791 rough endoplasmic reticulum;GO:0005886 plasma membrane;GO:0005912 adherens junction;GO:0030424 axon;GO:0030425 dendrite",
        "go_biological_process": "GO:0007162 negative regulation of cell adhesion;GO:0007169 cell surface receptor protein tyrosine kinase signaling pathway;GO:0048013 ephrin receptor signaling pathway;GO:0021766 hippocampus development;GO:1904322 cellular response to forskolin",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q60629-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BH44-1",
        "uniprot_id": "COR2B_MOUSE",
        "mass": 54936.0,
        "length": 480,
        "protein_name": "Coronin-2B",
        "gene_name": "Coro2b",
        "organism": "Mouse",
        "refseq_name": "coronin-2B",
        "refseq_ac": "NP_780693",
        "gene_names_uniprotkb": "Coro2b",
        "gene_names_refseq": "CLIPINC; Coro2b; E130012P22Rik",
        "protein_names_uniprotkb": "Coronin-2B",
        "protein_names_refseq": "E130012P22; coronin-2B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:235431)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;29162887;30084848;30779550;32692409;33300544;34428180;36639906;37828378",
        "class_list": "",
        "function": "CORO2B is a novel podocyte enriched protein influencing cytoskeletal plasticity and stress adaptation. Publication Status: Online-Only, [RefSeq, PubMed]; Coronin 2B Regulates Neuronal Migration via Rac1-Dependent Multipolar-Bipolar Transition., [RefSeq, PubMed]; Coronin 2B regulates dendrite outgrowth by modulating actin dynamics., [RefSeq, PubMed]; May play a role in the reorganization of neuronal actin structure., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6P5U9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051015 actin filament binding;GO:0017166 vinculin binding;GO:1990147 talin binding;GO:0003779 actin binding",
        "go_cellular_component": "GO:0005884 actin filament;GO:0005886 plasma membrane;GO:0005925 focal adhesion;GO:0001725 stress fiber",
        "go_biological_process": "GO:1904951 positive regulation of establishment of protein localization;GO:0007015 actin filament organization;GO:0032956 regulation of actin cytoskeleton organization;GO:0003093 regulation of glomerular filtration;GO:0048041 focal adhesion assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q8BH44-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UPH7-1",
        "uniprot_id": "ARH40_MOUSE",
        "mass": 165132.0,
        "length": 1517,
        "protein_name": "Rho guanine nucleotide exchange factor 40",
        "gene_name": "Arhgef40",
        "organism": "Mouse",
        "refseq_name": "rho guanine nucleotide exchange factor 40 isoform 2",
        "refseq_ac": "NP_001139393",
        "gene_names_uniprotkb": "Arhgef40; Solo",
        "gene_names_refseq": "Arhgef40; E130112L23Rik; Gm669; Solo",
        "protein_names_uniprotkb": "Rho guanine nucleotide exchange factor 40; Protein SOLO; Sabi; Scambio",
        "protein_names_refseq": "Rho guanine nucleotide exchange factor (GEF) 40; protein SOLO; rho guanine nucleotide exchange factor 40 isoform 2; sabi; scambio",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:268739)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "15107133;16143467;21183079;21750661;25428506;28135057;30059200;30084848;31599954;34428180",
        "class_list": "",
        "function": "Acts as a guanine nucleotide exchange factor (GEF) for RHOA and RHOC (By similarity). Promotes actin stress fiber formation, force-induced stress fiber reinforcement and organization of KRT8/KRT18 networks via activation of RHOA/ROCK signaling, which is mediated by N-terminus KRT18 binding (By similarity). Regulates the formation or maintenance of properly elongated morphology of epithelial tubules, via mediation of the organization and orientation of KRT18 filaments (By similarity). Promotes RHOA-dependent, cell-cell contact mediated reorientation of endothelial cells and their actin stress fibers in response to mechanotransduction (By similarity). Positively regulates hemidesmosome formation via acting as a linker protein that anchors keratin filaments to hemidesmosomes (By similarity). Also required for JUP localization at cell-cell adhesion junctions (By similarity)., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U1X1;Q3UGT7;Q3UYX3;Q6KAS1;Q6PD04;Q6PDY3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005085 guanyl-nucleotide exchange factor activity",
        "go_cellular_component": "GO:0005829 cytosol;GO:0005856 cytoskeleton;GO:0005886 plasma membrane;GO:0030056 hemidesmosome",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q3UPH7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BX09-1",
        "uniprot_id": "RBBP5_MOUSE",
        "mass": 59098.0,
        "length": 538,
        "protein_name": "Retinoblastoma-binding protein 5",
        "gene_name": "Rbbp5",
        "organism": "Mouse",
        "refseq_name": "retinoblastoma-binding protein 5 isoform 1",
        "refseq_ac": "NP_766105",
        "gene_names_uniprotkb": "Rbbp5",
        "gene_names_refseq": "4933411J24Rik; C330016J05; Rbbp5",
        "protein_names_uniprotkb": "Retinoblastoma-binding protein 5; RBBP-5",
        "protein_names_refseq": "RBBP-5; retinoblastoma-binding protein 5 isoform 1; retinoblastoma-binding protein 5",
        "tax_id": 10090,
        "disease": "congenital heart disease (Disease Ontology:DOID:1682)",
        "pathway": " (mmu:213464);  (R-MMU-201722);  (R-MMU-3214841);  (R-MMU-8936459);  (R-MMU-8951664);  (R-MMU-9772755);  (R-MMU-9818564)",
        "pathway_count": 7,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;20716525;21335234;21750661;23178126;25593305;29187734;31219806;34428180",
        "class_list": "",
        "function": "A phosphorylation switch on RbBP5 stimulates WRAD complex formation and significantly increases KMT2 (lysine [K] methyltransferase 2) enzyme methylation rates, [RefSeq, PubMed]; Characterization of a novel WDR5-binding site that recruits RbBP5 through a conserved motif to enhance methylation of histone H3 lysine 4 by mixed lineage leukemia protein-1., [RefSeq, PubMed]; In embryonic stem (ES) cells, plays a crucial role in the differentiation potential, particularly along the neural lineage, regulating gene induction and H3 'Lys-4' methylation at key developmental loci, including that mediated by retinoic acid (PubMed:21335234). Does not affect ES cell self-renewal (PubMed:21335234). Component or associated component of some histone methyltransferase complexes which regulates transcription through recruitment of those complexes to gene promoters (By similarity). As part of the MLL1/MLL complex, involved in mono-, di- and trimethylation at 'Lys-4' of histone H3 (By similarity). Histone H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation (By similarity). In association with ASH2L and WDR5, stimulates the histone methyltransferase activities of KMT2A, KMT2B, KMT2C, KMT2D, SETD1A and SETD1B (By similarity)., [UniProtKB, UniProtKB, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TBL4;Q3U3G1;Q6PAP0;Q6PFC2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0000976 transcription cis-regulatory region binding;GO:0042393 histone binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0035097 histone methyltransferase complex;GO:0044666 MLL3/4 complex",
        "go_biological_process": "GO:0006974 DNA damage response;GO:0045815 transcription initiation-coupled chromatin remodeling;GO:0043627 response to estrogen;GO:0010467 gene expression;GO:0006351 DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q8BX09-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C7D2-1",
        "uniprot_id": "CRBN_MOUSE",
        "mass": 50880.0,
        "length": 445,
        "protein_name": "Protein cereblon",
        "gene_name": "Crbn",
        "organism": "Mouse",
        "refseq_name": "protein cereblon isoform 1",
        "refseq_ac": "NP_067424",
        "gene_names_uniprotkb": "Crbn",
        "gene_names_refseq": "2610203G15Rik; 2900045O07Rik; Crbn; piL",
        "protein_names_uniprotkb": "Protein cereblon; Protein PiL",
        "protein_names_refseq": "novel lethal; protein PiL; protein cereblon isoform 1; protein cereblon",
        "tax_id": 10090,
        "disease": "autosomal recessive intellectual developmental disorder (Disease Ontology:DOID:0060308); autosomal recessive intellectual developmental disorder 2 (Disease Ontology:DOID:0081178)",
        "pathway": " (mmu:58799)",
        "pathway_count": 1,
        "publication_count": 13,
        "publication_id_list": "10.1101/2023.09.13.557529;20131966;20691658;21232561;21750661;21995942;25108355;25605945;26495903;29530986;31219806;34428180;38514794",
        "class_list": "",
        "function": "CRBN directly interacts with the alpha1 subunit of AMP-activated protein kinase (AMPK alpha1) and inhibits the activation of AMPK activation., [RefSeq, PubMed]; Findings suggest that crbn-/- mice exhibit selective HPC-dependent deficits in associative learning., [RefSeq, PubMed]; Substrate recognition component of a DCX (DDB1-CUL4-X-box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as MEIS2, ILF2 or GLUL. Normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8 (By similarity). Maintains presynaptic glutamate release and consequently, cognitive functions such as memory and learning, by negatively regulating large-conductance calcium-activated potassium (BK) channels in excitatory neurons (PubMed:29530986). Likely to function by regulating the assembly and neuronal surface expression of BK channels via its interaction with KCNT1 (By similarity). May also be involved in regulating anxiety-like behaviors via a BK channel-independent mechanism (PubMed:29530986). Plays a negative role in TLR4 signaling by interacting with TRAF6 and ECSIT, leading to inhibition of ECSIT ubiquitination, an important step of the signaling (By similarity)., [UniProtKB, UniProtKB, PubMed]; The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls., [RefSeq, PubMed]; These results imply that Nrf2 stimulates CRBN gene transcription under hypoxia-reoxygenation conditions in neuronal cells., [RefSeq, PubMed]; This gene encodes a protein with a Lon protease domain, a 'regulators of G protein-signaling' (RGS)-like domain and a leucine zipper. It has been proposed to regulate the assembly and surface expression of large-conductance calcium-activated potassium channels in brain and to bind thalidomide. In humans mutation in this gene causes autosomal recessive nonsyndromic cognitive disability. In mouse deficiency of this gene serves as a model to study the molecular mechanisms governing learning and memory as they relate to intellectual disability. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jan 2013]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TVC2;Q5RJV6;Q6IS49;Q80XJ1;Q8BP45;Q8C6B7;Q9JKR4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0044325 transmembrane transporter binding",
        "go_cellular_component": "GO:0031464 Cul4A-RING E3 ubiquitin ligase complex;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0016020 membrane;GO:0048471 perinuclear region of cytoplasm",
        "go_biological_process": "GO:0031334 positive regulation of protein-containing complex assembly;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination;GO:0031333 negative regulation of protein-containing complex assembly;GO:0034766 negative regulation of monoatomic ion transmembrane transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q8C7D2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UKU1-1",
        "uniprot_id": "ELL2_MOUSE",
        "mass": 72125.0,
        "length": 639,
        "protein_name": "RNA polymerase II elongation factor ELL2",
        "gene_name": "Ell2",
        "organism": "Mouse",
        "refseq_name": "RNA polymerase II elongation factor ELL2",
        "refseq_ac": "NP_620403",
        "gene_names_uniprotkb": "Ell2",
        "gene_names_refseq": "Ell2",
        "protein_names_uniprotkb": "RNA polymerase II elongation factor ELL2",
        "protein_names_refseq": "ELL-related RNA polymerase II, elongation factor; RNA polymerase II elongation factor ELL2; eleven-nineteen lysine-rich leukemia gene 2; elongation factor RNA polymerase II 2",
        "tax_id": 10090,
        "disease": "cancer (Disease Ontology:DOID:162)",
        "pathway": " (mmu:192657);  (R-MMU-6807505)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "19749764;21183079;21750661;21832080;22991471;25238757;25605945;28870994;34428180",
        "class_list": "",
        "function": "ELL2 enhanced both polyadenylation and exon skipping with the gene encoding the immunoglobulin heavy-chain complex (Igh) and reporter constructs, [RefSeq, PubMed]; ELL2 is important for many aspects of Ab secretion, XBP1 expression, and the unfolded protein response. GeneRIF: Deletion of the Ell2 gene in mice results in loss of Ig secretion from plasma cells and reduced expression of a number of other genes involved in secretion and the unfolded protein response like XBP1, OcaB (BOB1, Pou2af1), cyclin B2 and Ig light chain, [RefSeq, PubMed]; Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (By similarity). Plays a role in immunoglobulin secretion in plasma cells: directs efficient alternative mRNA processing, influencing both proximal poly(A) site choice and exon skipping, as well as immunoglobulin heavy chain (IgH) alternative processing. Probably acts by regulating histone modifications accompanying transition from membrane-specific to secretory IgH mRNA expression., [UniProtKB, PubMed, PubMed]; The splicing factor hnRNPLL and the transcription elongation factor ELL2 modulate the ratio of secred versus membrane-encoding Ighg2b transcripts at the expense of the secreted isoform., [RefSeq, PubMed]; These results suggest that ELL2 and its pathway genes likely play an important role in the development and progression of prostate cancer., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QPE1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0000987 cis-regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0008023 transcription elongation factor complex",
        "go_biological_process": "GO:0006368 transcription elongation by RNA polymerase II;GO:0032968 positive regulation of transcription elongation by RNA polymerase II;GO:0042795 snRNA transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q3UKU1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61210-1",
        "uniprot_id": "ARHG1_MOUSE",
        "mass": 102805.0,
        "length": 920,
        "protein_name": "Rho guanine nucleotide exchange factor 1",
        "gene_name": "Arhgef1",
        "organism": "Mouse",
        "refseq_name": "rho guanine nucleotide exchange factor 1 isoform a",
        "refseq_ac": "NP_001123622",
        "gene_names_uniprotkb": "Arhgef1; Lbcl2; Lsc",
        "gene_names_refseq": "Arhgef1; Lbcl2; Lsc",
        "protein_names_uniprotkb": "Rho guanine nucleotide exchange factor 1; Lbc's second cousin; Lymphoid blast crisis-like 2",
        "protein_names_refseq": "Rho guanine nucleotide exchange factor (GEF) 1; lbc's second cousin; lymphoid blast crisis-like 2; rho guanine nucleotide exchange factor 1 isoform a",
        "tax_id": 10090,
        "disease": "immunodeficiency 62 (Disease Ontology:DOID:0111991)",
        "pathway": " (mmu:16801);  (R-MMU-193648);  (R-MMU-416482);  (R-MMU-8980692);  (R-MMU-9013026);  (R-MMU-9013106)",
        "pathway_count": 6,
        "publication_count": 14,
        "publication_id_list": "10.1101/2023.09.13.557529;12773540;17000758;19144319;20098430;21183079;21750661;25274307;31219806;34428180;39627609;8702517;8910315;9798653",
        "class_list": "",
        "function": "Seems to play a role in the regulation of RhoA GTPase by guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13) subunits. Acts as a GTPase-activating protein (GAP) for GNA12 and GNA13, and as guanine nucleotide exchange factor (GEF) for RhoA GTPase. Activated G alpha 13/GNA13 stimulates the RhoGEF activity through interaction with the RGS-like domain. This GEF activity is inhibited by binding to activated GNA12. Mediates angiotensin-2-induced RhoA activation. Isoform 3 and isoform 4 do not homooligomerize and show an enhanced RhoGEF activity. In lymphoid follicles, may trigger activation of GNA13 as part of S1PR2-dependent signaling pathway that leads to inhibition of germinal center (GC) B cell growth and migration outside the GC niche., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O89074;Q3T9Q7;Q80YE8;Q80YE9;Q91VL3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0001664 G protein-coupled receptor binding;GO:0005085 guanyl-nucleotide exchange factor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007019 microtubule depolymerization;GO:0160221 Rho-activating G protein-coupled receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "Q61210-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q921Q7-1",
        "uniprot_id": "RIN1_MOUSE",
        "mass": 83014.0,
        "length": 763,
        "protein_name": "Ras and Rab interactor 1",
        "gene_name": "Rin1",
        "organism": "Mouse",
        "refseq_name": "ras and Rab interactor 1 isoform 2",
        "refseq_ac": "NP_663470",
        "gene_names_uniprotkb": "Rin1",
        "gene_names_refseq": "Rin1",
        "protein_names_uniprotkb": "Ras and Rab interactor 1; Ras interaction/interference protein 1",
        "protein_names_refseq": "ras and Rab interactor 1 isoform 2; ras interaction/interference protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:225870);  (R-MMU-8876198)",
        "pathway_count": 2,
        "publication_count": 13,
        "publication_id_list": "12574403;15525528;15886098;17114649;18034455;19131326;19837165;21102429;21183079;21750661;25153642;28135057;31219806",
        "class_list": "",
        "function": "BCR-ABL1 kinase activity is regulated by RIN1, [RefSeq, PubMed]; RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration., [RefSeq, PubMed]; Ras effector protein, which may serve as an inhibitory modulator of neuronal plasticity in aversive memory formation. Can affect Ras signaling at different levels. First, by competing with RAF1 protein for binding to activated Ras. Second, by enhancing signaling from ABL1 and ABL2, which regulate cytoskeletal remodeling. Third, by activating RAB5A, possibly by functioning as a guanine nucleotide exchange factor (GEF) for RAB5A, by exchanging bound GDP for free GTP, and facilitating Ras-activated receptor endocytosis (By similarity)., [UniProtKB, PubMed, UniProtKB, UniProtKB]; Rin1 links histone ubiquitylation to gene silencing and X inactivation., [RefSeq, PubMed]; These results provide insight into regulated expression of Rin1, define a promoter useful in telencephalic neuron studies, and describe a novel REST site variant directing expression to mature neurons., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0005085 guanyl-nucleotide exchange factor activity;GO:0031267 small GTPase binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005856 cytoskeleton;GO:0005886 plasma membrane;GO:0030425 dendrite",
        "go_biological_process": "GO:0006897 endocytosis;GO:0007165 signal transduction;GO:0007613 memory;GO:0008306 associative learning;GO:0031914 negative regulation of synaptic plasticity",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q921Q7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61749-1",
        "uniprot_id": "EI2BD_MOUSE",
        "mass": 57624.0,
        "length": 524,
        "protein_name": "Translation initiation factor eIF2B subunit delta",
        "gene_name": "Eif2b4",
        "organism": "Mouse",
        "refseq_name": "translation initiation factor eIF2B subunit delta isoform 1",
        "refseq_ac": "NP_001120827",
        "gene_names_uniprotkb": "Eif2b4; Eif2bd; Eif2b; Jgr1a",
        "gene_names_refseq": "Eif2b4; Eif2b",
        "protein_names_uniprotkb": "Translation initiation factor eIF2B subunit delta; eIF2B GDP-GTP exchange factor subunit delta",
        "protein_names_refseq": "eIF-2B GDP-GTP exchange factor subunit delta; eIF2B GDP-GTP exchange factor subunit delta; translation initiation factor eIF-2B subunit delta; translation initiation factor eIF2B subunit delta isoform 1; translation initiation factor eIF2B subunit delta",
        "tax_id": 10090,
        "disease": "leukoencephalopathy with vanishing white matter (Disease Ontology:DOID:0060868); leukoencephalopathy with vanishing white matter 4 (Disease Ontology:DOID:0070371)",
        "pathway": " (mmu:13667);  (R-MMU-72731)",
        "pathway_count": 2,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;25428506;37507081;39627609;7982969",
        "class_list": "",
        "function": "Acts as a component of the translation initiation factor 2B (eIF2B) complex, which catalyzes the exchange of GDP for GTP on eukaryotic initiation factor 2 (eIF2) gamma subunit. Its guanine nucleotide exchange factor activity is repressed when bound to eIF2 complex phosphorylated on the alpha subunit, thereby limiting the amount of methionyl-initiator methionine tRNA available to the ribosome and consequently global translation is repressed., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TYW7;Q61748;Q8VC35",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005085 guanyl-nucleotide exchange factor activity;GO:0003743 translation initiation factor activity;GO:0031369 translation initiation factor binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005851 eukaryotic translation initiation factor 2B complex",
        "go_biological_process": "GO:0002183 cytoplasmic translational initiation;GO:0042552 myelination;GO:0050852 T cell receptor signaling pathway;GO:0006413 translational initiation;GO:0001541 ovarian follicle development",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q61749-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q69Z28-1",
        "uniprot_id": "ATS16_MOUSE",
        "mass": 136282.0,
        "length": 1222,
        "protein_name": "A disintegrin and metalloproteinase with thrombospondin motifs 16",
        "gene_name": "Adamts16",
        "organism": "Mouse",
        "refseq_name": "A disintegrin and metalloproteinase with thrombospondin motifs 16 preproprotein",
        "refseq_ac": "NP_742050",
        "gene_names_uniprotkb": "Adamts16; Kiaa2029",
        "gene_names_refseq": "Adamts16",
        "protein_names_uniprotkb": "A disintegrin and metalloproteinase with thrombospondin motifs 16; 3.4.24.-; ADAM-TS 16; ADAM-TS16; ADAMTS-16",
        "protein_names_refseq": "A disintegrin and metalloproteinase with thrombospondin motifs 16 preproprotein; a disintegrin and metalloproteinase with thrombospondin motifs 16; a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16; a disintegrin-like and metallopetidase (reprolysin type) with thrombospondin type 1 motif, 16; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 16 preproprotein",
        "tax_id": 10090,
        "disease": "hypertension (Disease Ontology:DOID:10763); cryptorchidism (Disease Ontology:DOID:11383); male infertility (Disease Ontology:DOID:12336)",
        "pathway": " (mmu:271127);  (R-MMU-5173214)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "21750661;29187734;38018454;39147297",
        "class_list": "",
        "function": "A novel role of ADAMTS16 in renal fibrosis through activating TGF-beta/Smad signaling., [RefSeq, PubMed]; Extracellular Matrix Disorganization Caused by ADAMTS16 Deficiency Leads to Bicuspid Aortic Valve With Raphe Formation., [RefSeq, PubMed]; This gene encodes a member of 'a disintegrin and metalloproteinase with thrombospondin motifs' (ADAMTS) family of multi-domain matrix-associated metalloendopeptidases that have diverse roles in tissue morphogenesis and pathophysiological remodeling, in inflammation and in vascular biology. This gene is co-expressed with the Wilms tumor protein, Wt1, in the developing glomeruli of embryonic kidneys. The encoded preproprotein undergoes proteolytic processing to generate an active enzyme. [provided by RefSeq, Jul 2016]., [RefSeq]",
        "predicted_glycosites": 9,
        "predicted_n_glycosites": 9,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 4,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8K206",
        "ec_number_list": "3.4.24.-;3.4.24.87;2.4.1.-;3.4.24.82;3.4.24.14;2.4.1.221",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0031012 extracellular matrix",
        "go_biological_process": "GO:0006508 proteolysis;GO:0030198 extracellular matrix organization;GO:0003073 regulation of systemic arterial blood pressure;GO:0001658 branching involved in ureteric bud morphogenesis;GO:1902017 regulation of cilium assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q69Z28-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VEH8-1",
        "uniprot_id": "ERLEC_MOUSE",
        "mass": 54906.0,
        "length": 483,
        "protein_name": "Endoplasmic reticulum lectin 1",
        "gene_name": "Erlec1",
        "organism": "Mouse",
        "refseq_name": "endoplasmic reticulum lectin 1 precursor",
        "refseq_ac": "NP_080021",
        "gene_names_uniprotkb": "Erlec1",
        "gene_names_refseq": "4933407N01Rik; Erlec1",
        "protein_names_uniprotkb": "Endoplasmic reticulum lectin 1; ER lectin; Erlectin",
        "protein_names_refseq": "ER lectin; endoplasmic reticulum lectin 1 precursor; erlectin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66753);  (R-MMU-382556);  (R-MMU-5358346);  (R-MMU-9931269)",
        "pathway_count": 4,
        "publication_count": 4,
        "publication_id_list": "10.1101/2023.09.13.557529;16531414;21750661;34428180",
        "class_list": "glycogene",
        "function": "Erlectin functions in N-glycan recognition in the endoplasmic reticulum and may regulate glycoprotein traffic, [RefSeq, PubMed]; Lectin involved in the quality control of the secretory pathway. As a member of the endoplasmic reticulum-associated degradation lumenal (ERAD-L) surveillance system, targets misfolded endoplasmic reticulum lumenal glycoproteins for degradation., [UniProtKB, UniProtKB]; Probable lectin that binds selectively to improperly folded lumenal proteins. May function in endoplasmic reticulum quality control and endoplasmic reticulum-associated degradation (ERAD) of both non-glycosylated proteins and glycoproteins (By similarity)., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 14,
        "reported_interactions": 0,
        "missing_score": 9696,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UZF3;Q8BVN6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051082 unfolded protein binding;GO:0030246 carbohydrate binding",
        "go_cellular_component": "GO:0005788 endoplasmic reticulum lumen",
        "go_biological_process": "GO:0030968 endoplasmic reticulum unfolded protein response;GO:0036503 ERAD pathway;GO:0030970 retrograde protein transport, ER to cytosol;GO:1904153 negative regulation of retrograde protein transport, ER to cytosol",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q8VEH8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R4H2-1",
        "uniprot_id": "ARHGC_MOUSE",
        "mass": 172349.0,
        "length": 1543,
        "protein_name": "Rho guanine nucleotide exchange factor 12",
        "gene_name": "Arhgef12",
        "organism": "Mouse",
        "refseq_name": "rho guanine nucleotide exchange factor 12 isoform 2",
        "refseq_ac": "NP_001346161",
        "gene_names_uniprotkb": "Arhgef12; Kiaa0382; Larg",
        "gene_names_refseq": "2310014B11Rik; Arhgef12; Larg; mKIAA0382",
        "protein_names_uniprotkb": "Rho guanine nucleotide exchange factor 12; Leukemia-associated RhoGEF",
        "protein_names_refseq": "Rho guanine nucleotide exchange factor (GEF) 12; leukemia-associated Rho guanine-nucleotide exchange factor; leukemia-associated RhoGEF; rho guanine nucleotide exchange factor 12 isoform 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69632);  (R-MMU-193648);  (R-MMU-416482);  (R-MMU-416572);  (R-MMU-8980692);  (R-MMU-9013026);  (R-MMU-9013106);  (R-MMU-9013148)",
        "pathway_count": 8,
        "publication_count": 12,
        "publication_id_list": "12024019;12492428;15345747;17242355;21183079;21750661;29208526;30059200;31467124;31549965;34428180;35675330",
        "class_list": "",
        "function": "ARHGEF12 regulates erythropoiesis and is involved in erythroid regeneration after chemotherapy in acute lymphoblastic leukemia patients., [RefSeq, PubMed]; Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase and may act as GTPase-activating protein (GAP) for GNA12 and GNA13 (By similarity). May play a role in the regulation of RhoA GTPase by guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13) (By similarity). Promotes endothelial cell and actin stress fiber reorientation in response to mechanotransduction (By similarity)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Here, the authors show that small arteries from mice with smooth muscle-specific loss of G12/G13 or the Rho guanine nucleotide exchange factor ARHGEF12 have lost myogenic vasoconstriction. Publication Status: Online-Only, [RefSeq, PubMed]; Identification of Arhgef12 and Prkci as genetic modifiers of retinal dysplasia in the Crb1rd8 mouse model. Publication Status: Online-Only, [RefSeq, PubMed]; Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA (larg protein), [RefSeq, PubMed]; Mechanical activation of RhoA in mesenchymal progenitors is dependent on LARG, while ARHGAP18 limits RhoA delineated cytoskeletal structure in static cultures, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QPW9;Q80U18",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0001664 G protein-coupled receptor binding;GO:0005085 guanyl-nucleotide exchange factor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0016020 membrane",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0008217 regulation of blood pressure;GO:0007266 Rho protein signal transduction;GO:0160221 Rho-activating G protein-coupled receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q8R4H2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P19070-1",
        "uniprot_id": "CR2_MOUSE",
        "mass": 112995.0,
        "length": 1025,
        "protein_name": "Complement receptor type 2",
        "gene_name": "Cr2",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Cr2",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Complement receptor type 2; Complement C3d receptor; Cr2",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "common variable immunodeficiency 7 (Disease Ontology:DOID:0081150); human immunodeficiency virus infectious disease (Disease Ontology:DOID:526); systemic lupus erythematosus (Disease Ontology:DOID:9074); nasopharynx carcinoma (Disease Ontology:DOID:9261)",
        "pathway": " (mmu:12902);  (R-MMU-977606)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "10671200;12421918;2139457;2145366;21750661;2528587;25428506;26495903;2783485;30084848;34428180",
        "class_list": "",
        "function": "Serves as a receptor for various ligands including complement component CD3d, HNRNPU OR IFNA1. When C3d is bound to antigens, attaches to C3d on B-cell surface and thereby facilitates the recognition and uptake of antigens by B-cells. This interaction enhances B-cell activation and subsequent immune responses. Forms a complex with several partners on the surface of B-cells including CD19, FCRL5 and CD81, to form the B-cell coreceptor complex that plays a crucial role in B-cell activation and signaling. Also induces specific intracellular signaling separately from the BCR and CD19 by activating the tyrosine kinase SRC, which then phosphorylates nucleolin/NCL and triggers AKT and GSK3 kinase activities in a SYK/CD19-independent manner. Acts as a ligand for CD23 (FcepsilonRII), a low-affinity receptor for IgE, which is expressed on B-cells and other immune cells, and thus participates in the regulation of IgE production., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 17,
        "predicted_n_glycosites": 17,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 17,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0034987 immunoglobulin receptor binding;GO:0004875 complement receptor activity;GO:0003677 DNA binding;GO:0004888 transmembrane signaling receptor activity;GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0043235 receptor complex;GO:0009897 external side of plasma membrane",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0042113 B cell activation;GO:0060337 type I interferon-mediated signaling pathway;GO:0071222 cellular response to lipopolysaccharide;GO:0030183 B cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "P19070-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P13346-1",
        "uniprot_id": "FOSB_MOUSE",
        "mass": 35977.0,
        "length": 338,
        "protein_name": "Protein FosB",
        "gene_name": "Fosb",
        "organism": "Mouse",
        "refseq_name": "protein FosB isoform 2",
        "refseq_ac": "NP_001334515",
        "gene_names_uniprotkb": "Fosb",
        "gene_names_refseq": "Fosb",
        "protein_names_uniprotkb": "Protein FosB; FBJ osteosarcoma oncogene B; Transcription factor AP-1 subunit FosB",
        "protein_names_refseq": "FBJ osteosarcoma oncogene B; osteosarcoma oncoprotein B FosB; protein FosB isoform 2; protein fosB; transcription factor AP-1 subunit FosB",
        "tax_id": 10090,
        "disease": "alcohol dependence (Disease Ontology:DOID:0050741); nicotine dependence (Disease Ontology:DOID:0050742); tongue squamous cell carcinoma (Disease Ontology:DOID:0050865); withdrawal disorder (Disease Ontology:DOID:0060001); opioid abuse (Disease Ontology:DOID:11206); alcohol use disorder (Disease Ontology:DOID:1574); depressive disorder (Disease Ontology:DOID:1596); morphine dependence (Disease Ontology:DOID:2560); amphetamine abuse (Disease Ontology:DOID:670); cocaine abuse (Disease Ontology:DOID:809); substance dependence (Disease Ontology:DOID:9973); cocaine dependence (Disease Ontology:DOID:9975); heroin dependence (Disease Ontology:DOID:9976)",
        "pathway": " (mmu:14282)",
        "pathway_count": 1,
        "publication_count": 17,
        "publication_id_list": "16687504;17241283;1741260;18407360;1900040;20473292;21750661;23303048;23319622;2498083;26446228;29272704;30902680;38642602;39413198;8706134;9294222",
        "class_list": "",
        "function": "2'3'-cGAMP interactome identifies 2'3'-cGAMP/Rab18/FosB signaling in cell migration control independent of innate immunity. Erratum:[Sci Adv. 2025 Jan 17;11(3):eadv6581. doi: 10.1126/sciadv.adv6581. PMID: 39823348], [RefSeq, PubMed]; Exhibits lower transactivation activity than isoform 1 in vitro (PubMed:17241283). The heterodimer with JUN does not display any transcriptional activity, and may thereby act as an transcriptional inhibitor (PubMed:1900040). May be involved in the regulation of neurogenesis in the hippocampus (PubMed:23303048). May play a role in synaptic modifications in nucleus accumbens medium spiny neurons and thereby play a role in adaptive and pathological reward-dependent learning, including maladaptive responses involved in drug addiction (PubMed:23319622). Seems to be more stably expressed with a half-life of ~9.5 hours in cell culture as compared to 1.5 hours half-life of isoform 1 (PubMed:18407360)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]; Heterodimerizes with proteins of the JUN family to form an AP-1 transcription factor complex, thereby enhancing their DNA binding activity to gene promoters containing an AP-1 consensus sequence 5'-TGA[GC]TCA-3' and enhancing their transcriptional activity (PubMed:1900040, PubMed:2498083). As part of the AP-1 complex, facilitates enhancer selection together with cell-type-specific transcription factors by collaboratively binding to nucleosomal enhancers and recruiting the SWI/SNF (BAF) chromatin remodeling complex to establish accessible chromatin (PubMed:29272704). Together with JUN, plays a role in activation-induced cell death of T cells by binding to the AP-1 promoter site of FASLG/CD95L, and inducing its transcription in response to activation of the TCR/CD3 signaling pathway (By similarity). Exhibits transactivation activity in vitro (PubMed:17241283). Involved in the display of nurturing behavior towards newborns (PubMed:8706134). May play a role in neurogenesis in the hippocampus and in learning and memory-related tasks by regulating the expression of various genes involved in neurogenesis, depression and epilepsy (PubMed:23303048, PubMed:30902680). Implicated in behavioral responses related to morphine reward and spatial memory (PubMed:18407360, PubMed:9294222)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB]; Persistent FosB expression limits recurrent seizure activity and provides neuroprotection in the dentate gyrus of APP mice., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 13,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A140LIE4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0003690 double-stranded DNA binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0006357 regulation of transcription by RNA polymerase II;GO:0035094 response to nicotine;GO:0045471 response to ethanol;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0001975 response to amphetamine",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "P13346-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P70459-1",
        "uniprot_id": "ERF_MOUSE",
        "mass": 59050.0,
        "length": 551,
        "protein_name": "ETS domain-containing transcription factor ERF",
        "gene_name": "Erf",
        "organism": "Mouse",
        "refseq_name": "ETS domain-containing transcription factor ERF isoform b",
        "refseq_ac": "NP_034285",
        "gene_names_uniprotkb": "Erf",
        "gene_names_refseq": "Erf",
        "protein_names_uniprotkb": "ETS domain-containing transcription factor ERF",
        "protein_names_refseq": "ETS domain-containing transcription factor ERF isoform b; ETS domain-containing transcription factor ERF; Est2 repressor factor",
        "tax_id": 10090,
        "disease": "craniosynostosis 4 (Disease Ontology:DOID:0061012)",
        "pathway": " (mmu:13875);  (R-MMU-2559585)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "17502352;17507653;21750661;23354439;25428506;30084848;34428180;35258130;36852467;37175668;9136988",
        "class_list": "",
        "function": "Development of Erf-Mediated Craniosynostosis and Pharmacological Amelioration. Publication Status: Online-Only, [RefSeq, PubMed]; ETS2 repressor factor (ERF) is involved in T lymphocyte maturation acting as regulator of thymocyte lineage commitment., [RefSeq, PubMed]; Potent transcriptional repressor that binds to the H1 element of the Ets2 promoter. May regulate other genes involved in cellular proliferation (By similarity). Required for extraembryonic ectoderm differentiation, ectoplacental cone cavity closure, and chorioallantoic attachment. May be important for regulating trophoblast stem cell differentiation., [UniProtKB, PubMed]; These data suggest that attenuation of FGF/Erk signaling and consecutive Erf nuclear localization and function is required for extraembryonic ectoderm differentiation, ectoplacental cone cavity closure, and chorioallantoic attachment., [RefSeq, PubMed]; These studies suggest 'repressing repressors' as a potential strategy for achieving utrophin up-regulation in Duchenne's muscular dystrophy, and they provide a model for utrophin-A regulation in muscle., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 15,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TXK4;Q6P544;Q7TSJ1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0043565 sequence-specific DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0001701 in utero embryonic development;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0030154 cell differentiation;GO:0060707 trophoblast giant cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "P70459-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61024-1",
        "uniprot_id": "ASNS_MOUSE",
        "mass": 64283.0,
        "length": 561,
        "protein_name": "Asparagine synthetase [glutamine-hydrolyzing]",
        "gene_name": "Asns",
        "organism": "Mouse",
        "refseq_name": "asparagine synthetase [glutamine-hydrolyzing] isoform a",
        "refseq_ac": "NP_036185",
        "gene_names_uniprotkb": "Asns",
        "gene_names_refseq": "Asns",
        "protein_names_uniprotkb": "Asparagine synthetase [glutamine-hydrolyzing]; 6.3.5.4; Glutamine-dependent asparagine synthetase",
        "protein_names_refseq": "asparagine synthetase [glutamine-hydrolyzing] isoform a; glutamine-dependent asparagine synthetase",
        "tax_id": 10090,
        "disease": "hepatocellular carcinoma (Disease Ontology:DOID:684); retinal degeneration (Disease Ontology:DOID:8466)",
        "pathway": " (mmu:27053);  (R-MMU-8963693)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "21540332;21750661;22645316;23386199;24139043;24292060;24788674;25153642;28528544;34428180;38684863",
        "class_list": "",
        "function": "Asns is involved in the regulation of plasma glucose levels., [RefSeq, PubMed]; Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TJA1;Q8BPC8",
        "ec_number_list": "6.3.5.4",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0042802 identical protein binding;GO:0004066 asparagine synthase (glutamine-hydrolyzing) activity",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0043066 negative regulation of apoptotic process;GO:0045931 positive regulation of mitotic cell cycle;GO:0042149 cellular response to glucose starvation;GO:0070981 L-asparagine biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q61024-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VEA6-1",
        "uniprot_id": "CRDL2_MOUSE",
        "mass": 47765.0,
        "length": 426,
        "protein_name": "Chordin-like protein 2",
        "gene_name": "Chrdl2",
        "organism": "Mouse",
        "refseq_name": "chordin-like protein 2 isoform 1",
        "refseq_ac": "NP_001278249",
        "gene_names_uniprotkb": "Chrdl2; Chl2",
        "gene_names_refseq": "1810022C01Rik; Chl2; Chrdl2",
        "protein_names_uniprotkb": "Chordin-like protein 2",
        "protein_names_refseq": "chordin-like protein 2 isoform 1; chordin-like protein 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69121)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "14660436;15094188;21750661",
        "class_list": "",
        "function": "CHL2 expression is restricted to chondrocytes of various developing joint cartilage surfaces and connective tissues in reproductive organs., [RefSeq, PubMed]; Implicated in tumor angiogenesis (By similarity). May inhibit BMPs activity by blocking their interaction with their receptors. Has a negative regulator effect on the cartilage formation/regeneration from immature mesenchymal cells, by preventing or reducing the rate of matrix accumulation. May play a role during myoblast and osteoblast differentiation, and maturation., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q925I3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0036122 BMP binding",
        "go_cellular_component": "GO:0005576 extracellular region",
        "go_biological_process": "GO:0030154 cell differentiation;GO:0030514 negative regulation of BMP signaling pathway;GO:0001503 ossification;GO:0051216 cartilage development;GO:0048731 system development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8VEA6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6PIX9-1",
        "uniprot_id": "CQ080_MOUSE",
        "mass": 60276.0,
        "length": 558,
        "protein_name": "Mitochondrial nucleoid-associated protein 1",
        "gene_name": "Mtnap1",
        "organism": "Mouse",
        "refseq_name": "mitochondrial nucleoid-associated protein 1",
        "refseq_ac": "NP_808445",
        "gene_names_uniprotkb": "Mtnap1; D11Wsu47e; Gm57859",
        "gene_names_refseq": "D11Wsu47e; Gm57859; Mtnap1",
        "protein_names_uniprotkb": "Mitochondrial nucleoid-associated protein 1",
        "protein_names_refseq": "mitochondrial nucleoid-associated protein 1; uncharacterized protein C17orf80 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:276852)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;37676315",
        "class_list": "",
        "function": "Critical regulator of mitochondrial DNA (mtDNA) abundance (PubMed:37676315). Binds dsDNA throughout the mitochondrial genome without sequence specificity and controls mtDNA copy number by promoting its replication (By similarity). Also plays important roles in mitochondrial metabolism and cell proliferation (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UTJ1;Q80UV5;Q9CYN0",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005743 mitochondrial inner membrane;GO:0042645 mitochondrial nucleoid",
        "go_biological_process": "GO:0090297 positive regulation of mitochondrial DNA replication;GO:0008283 cell population proliferation;GO:0032042 mitochondrial DNA metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q6PIX9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D906-1",
        "uniprot_id": "ATG7_MOUSE",
        "mass": 77520.0,
        "length": 698,
        "protein_name": "Ubiquitin-like modifier-activating enzyme ATG7",
        "gene_name": "Atg7",
        "organism": "Mouse",
        "refseq_name": "ubiquitin-like modifier-activating enzyme ATG7 isoform 1",
        "refseq_ac": "NP_001240646",
        "gene_names_uniprotkb": "Atg7; Apg7l",
        "gene_names_refseq": "1810013K23Rik; Agp7; Apg7l; Atg7l; Atg7; Gm21553",
        "protein_names_uniprotkb": "Ubiquitin-like modifier-activating enzyme ATG7; APG7-like; ATG12-activating enzyme E1 ATG7; Autophagy-related protein 7; Ubiquitin-activating enzyme E1-like protein; mAGP7",
        "protein_names_refseq": "ATG12-activating enzyme E1 ATG7; autophagy-related protein 7; ubiquitin-activating enzyme E1-like protein; ubiquitin-like modifier-activating enzyme ATG7 isoform 1; ubiquitin-like modifier-activating enzyme ATG7",
        "tax_id": 10090,
        "disease": "myelodysplastic syndrome (Disease Ontology:DOID:0050908); cardiac arrest (Disease Ontology:DOID:0060319); autosomal recessive spinocerebellar ataxia 31 (Disease Ontology:DOID:0070412); metabolic dysfunction-associated steatotic liver disease (Disease Ontology:DOID:0080208); metabolic dysfunction-associated steatohepatitis (Disease Ontology:DOID:0080547); hypertension (Disease Ontology:DOID:10763); neurodegenerative disease (Disease Ontology:DOID:1289); Parkinson's disease (Disease Ontology:DOID:14330); high grade glioma (Disease Ontology:DOID:3070); myocardial infarction (Disease Ontology:DOID:5844); paraplegia (Disease Ontology:DOID:607); nervous system disease (Disease Ontology:DOID:863); diabetic retinopathy (Disease Ontology:DOID:8947); degenerative disc disease (Disease Ontology:DOID:90)",
        "pathway": " (mmu:74244);  (R-MMU-1632852);  (R-MMU-6798695);  (R-MMU-983168)",
        "pathway_count": 4,
        "publication_count": 24,
        "publication_id_list": "10.1101/2023.09.13.557529;11890701;12482611;15131264;15866887;16704426;17726112;19417210;19855132;19910529;20723759;21339326;21617129;21750661;22291845;22499945;24089209;25428506;29937374;30084848;30899004;31219806;31361958;34428180",
        "class_list": "",
        "function": "E1-like activating enzyme involved in the 2 ubiquitin-like systems required for cytoplasm to vacuole transport (Cvt) and autophagy. Activates ATG12 for its conjugation with ATG5 as well as the ATG8 family proteins for their conjugation with phosphatidylethanolamine. Both systems are needed for the ATG8 association to Cvt vesicles and autophagosomes membranes. Required for autophagic death induced by caspase-8 inhibition. Required for mitophagy which contributes to regulate mitochondrial quantity and quality by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ROS production. Modulates p53/TP53 activity to regulate cell cycle and survival during metabolic stress., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB]; This gene encodes an E1-like activating enzyme that is essential for autophagy and cytoplasmic to vacuole transport. The encoded protein is also thought to modulate p53-dependent cell cycle pathways during prolonged metabolic stress. It has been associated with multiple functions, including axon membrane trafficking, axonal homeostasis, mitophagy, adipose differentiation, and hematopoietic stem cell maintenance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 14,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TCD9;Q8K4Q5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0019778 Atg12 activating enzyme activity;GO:0019779 Atg8 activating enzyme activity;GO:0008641 ubiquitin-like modifier activating enzyme activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0030424 axon;GO:0048471 perinuclear region of cytoplasm;GO:0005930 axoneme",
        "go_biological_process": "GO:0061684 chaperone-mediated autophagy;GO:0099504 synaptic vesicle cycle;GO:1901526 positive regulation of mitophagy;GO:0000045 autophagosome assembly;GO:0001889 liver development",
        "synthesized_glycan_count": 0,
        "hit_score": 3.2,
        "record_id": "Q9D906-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JIX0-1",
        "uniprot_id": "ENY2_MOUSE",
        "mass": 11529.0,
        "length": 101,
        "protein_name": "Transcription and mRNA export factor ENY2",
        "gene_name": "Eny2",
        "organism": "Mouse",
        "refseq_name": "transcription and mRNA export factor ENY2 isoform 1",
        "refseq_ac": "NP_778174",
        "gene_names_uniprotkb": "Eny2; ENY2",
        "gene_names_refseq": "1810057B09Rik; 6720481I12; DC6; Eny2; Ey2",
        "protein_names_uniprotkb": "Transcription and mRNA export factor ENY2; Enhancer of yellow 2 transcription factor homolog",
        "protein_names_refseq": "e(y)2 homolog; e(y)2 protein; enhancer of yellow 2 homolog; enhancer of yellow 2 transcription factor homolog; enhancer of yellow eye homolog; transcription and mRNA export factor ENY2 isoform 1; transcription and mRNA export factor ENY2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:223527)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "11438676;17643381;21750661;22649445",
        "class_list": "",
        "function": "E(y)2/Sus1, is recruited to the Su(Hw) insulators via binding to the zinc-finger domain of Su(Hw)., [RefSeq, PubMed]; Involved in mRNA export coupled transcription activation by association with both the TREX-2 and the SAGA complexes. The transcription regulatory histone acetylation (HAT) complex SAGA is a multiprotein complex that activates transcription by remodeling chromatin and mediating histone acetylation and deubiquitination. Within the SAGA complex, participates in a subcomplex that specifically deubiquitinates both histones H2A and H2B. The SAGA complex is recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Required for nuclear receptor-mediated transactivation. As a component of the TREX-2 complex, involved in the export of mRNAs to the cytoplasm through the nuclear pores (By similarity)., [UniProtKB, UniProtKB, UniProtKB, HAMAP, UniProtKB]; There is a link between the nuclear protein Eny2 and insulin secretion, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003682 chromatin binding;GO:0003713 transcription coactivator activity",
        "go_cellular_component": "GO:0044615 nuclear pore nuclear basket;GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0071819 DUBm complex;GO:0070390 transcription export complex 2",
        "go_biological_process": "GO:0016973 poly(A)+ mRNA export from nucleus;GO:0006357 regulation of transcription by RNA polymerase II;GO:0015031 protein transport;GO:0045893 positive regulation of DNA-templated transcription;GO:0061179 negative regulation of insulin secretion involved in cellular response to glucose stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9JIX0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P11714-1",
        "uniprot_id": "CP2D9_MOUSE",
        "mass": 56950.0,
        "length": 504,
        "protein_name": "Cytochrome P450 2D9",
        "gene_name": "Cyp2d9",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 2D9",
        "refseq_ac": "NP_034136",
        "gene_names_uniprotkb": "Cyp2d9; Cyp2d-9",
        "gene_names_refseq": "Cyp2d9; Cyp2d; P450-2D",
        "protein_names_uniprotkb": "Cytochrome P450 2D9; 1.14.14.1; CYPIID9; Cytochrome P450-16-alpha; Cytochrome P450CA; Testosterone 16-alpha hydroxylase",
        "protein_names_refseq": "CYPIID9; cytochrome P450 2D9; cytochrome P450, 2d9; cytochrome P450-16-alpha; cytochrome P450CA; testosterone 16-alpha hydroxylase; testosterone 16alpha-hydroxylase",
        "tax_id": 10090,
        "disease": "alcohol dependence (Disease Ontology:DOID:0050741); extrapyramidal and movement disease (Disease Ontology:DOID:13839); major depressive disorder (Disease Ontology:DOID:1470); depressive disorder (Disease Ontology:DOID:1596); autoimmune hepatitis (Disease Ontology:DOID:2048); opiate dependence (Disease Ontology:DOID:2559); asthma (Disease Ontology:DOID:2841); rhinitis (Disease Ontology:DOID:4483); head and neck squamous cell carcinoma (Disease Ontology:DOID:5520); acute myeloid leukemia (Disease Ontology:DOID:9119); acute lymphoblastic leukemia (Disease Ontology:DOID:9952)",
        "pathway": " (mmu:13105)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "21750661;2788458;2831949;2914938;30084848;34428180;37453647",
        "class_list": "",
        "function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 11,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q64489;Q921V1",
        "ec_number_list": "1.14.14.1;1.14.14.-;4.2.1.152;1.14.13.n7;5.3.99.5",
        "go_molecular_function": "GO:0070330 aromatase activity;GO:0005506 iron ion binding;GO:0016491 oxidoreductase activity;GO:0020037 heme binding;GO:0016712 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006805 xenobiotic metabolic process;GO:0019369 arachidonate metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "P11714-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P24456-1",
        "uniprot_id": "CP2DA_MOUSE",
        "mass": 57233.0,
        "length": 504,
        "protein_name": "Cytochrome P450 2D10",
        "gene_name": "Cyp2d10",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 2D10",
        "refseq_ac": "NP_034135",
        "gene_names_uniprotkb": "Cyp2d10; Cyp2d-10",
        "gene_names_refseq": "Cyp2d10; Cyp2d; P450-2D",
        "protein_names_uniprotkb": "Cytochrome P450 2D10; 1.14.14.1; CYPIID10; Cytochrome P450-16-alpha; Cytochrome P450CB; Testosterone 16-alpha hydroxylase",
        "protein_names_refseq": "CYPIID10; cytochrome P450 2D10; cytochrome P450, 2d10; cytochrome P450-16-alpha; cytochrome P450CB; testosterone 16-alpha hydroxylase",
        "tax_id": 10090,
        "disease": "alcohol dependence (Disease Ontology:DOID:0050741); extrapyramidal and movement disease (Disease Ontology:DOID:13839); major depressive disorder (Disease Ontology:DOID:1470); depressive disorder (Disease Ontology:DOID:1596); autoimmune hepatitis (Disease Ontology:DOID:2048); opiate dependence (Disease Ontology:DOID:2559); asthma (Disease Ontology:DOID:2841); rhinitis (Disease Ontology:DOID:4483); head and neck squamous cell carcinoma (Disease Ontology:DOID:5520); acute myeloid leukemia (Disease Ontology:DOID:9119); acute lymphoblastic leukemia (Disease Ontology:DOID:9952)",
        "pathway": " (mmu:13101)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "21750661;2788458;2914938;30084848;34105348;34428180;37453647",
        "class_list": "",
        "function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 11,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q64490",
        "ec_number_list": "1.14.14.1;1.14.14.-;4.2.1.152;1.14.13.n7;5.3.99.5",
        "go_molecular_function": "GO:0070330 aromatase activity;GO:0005506 iron ion binding;GO:0016491 oxidoreductase activity;GO:0020037 heme binding;GO:0016712 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006805 xenobiotic metabolic process;GO:0019369 arachidonate metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "P24456-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88536-1",
        "uniprot_id": "FPR2_MOUSE",
        "mass": 39422.0,
        "length": 351,
        "protein_name": "Formyl peptide receptor 2",
        "gene_name": "Fpr2",
        "organism": "Mouse",
        "refseq_name": "formyl peptide receptor 2",
        "refseq_ac": "NP_032065",
        "gene_names_uniprotkb": "Fpr2; Fpr-rs2",
        "gene_names_refseq": "E330010I07Rik; Fpr-rs2; Fpr2",
        "protein_names_uniprotkb": "Formyl peptide receptor 2; Formylpeptide receptor-related sequence 2; Lipoxin A4 receptor-like protein; N-formylpeptide receptor-like 2",
        "protein_names_refseq": "N-formylpeptide receptor-like 2; formyl peptide receptor 2; formyl peptide receptor, related sequence 2; formylpeptide receptor-related sequence 2; lipoxin A4 receptor-like protein",
        "tax_id": 10090,
        "disease": "dentin caries (Disease Ontology:DOID:10461)",
        "pathway": " (mmu:14289);  (R-MMU-416476);  (R-MMU-418594);  (R-MMU-444473);  (R-MMU-6798695)",
        "pathway_count": 5,
        "publication_count": 14,
        "publication_id_list": "10477558;12218158;12270697;15879124;17237393;19387439;19497865;21750661;25605714;29138422;37056936;37958978;39148732;9722950",
        "class_list": "",
        "function": "By selectively up-regulating FPR2 in microglia, TNF alpha has the capacity to amplify host response in inflammatory diseases in the central nervous system., [RefSeq, PubMed]; Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation. Publication Status: Online-Only, [RefSeq, PubMed]; Pattern recognition G protein-coupled receptor (GPCR) that recognizes peptides with N-terminal formyl methionine, which are derived from invading pathogens or host mitochondria as pathogen or damage-associated molecular patterns (PAMPs and DAMPs) (PubMed:10477558, PubMed:12218158, PubMed:19387439, PubMed:25605714). Preferentially recognizes longer peptides or peptides with specific sequences such as the phenol-soluble modulin (PSM) family of formylated peptide toxins produced by Staphylococcus aureus (By similarity). Ligand binding causes a conformation change that triggers signaling via G(i)/GNAI1 inhibiting adenylate cyclase activity, leading to decreased intracellular cAMP levels. In addition, can recognize a variety of chemically distinct endogenous ligands including proteins and lipids besides formylpeptides and thereby plays multiple roles in inflammation (PubMed:10477558, PubMed:19497865, PubMed:37056936). Acts as a receptor for the chemokine-like protein FAM19A5, mediating FAM19A5-stimulated macrophage chemotaxis and the inhibitory effect on TNFSF11/RANKL-induced osteoclast differentiation (PubMed:29138422). Acts also as a ceramide membrane receptor, and long-chain ceramides (C14 to C20) binding induces conformational changes that inhibits diet-induced adipose thermogenesis (By similarity). May participate in neuroprotection via interaction with MT-RNR2 and Amyloid-beta protein 42, product of APP (By similarity). Differential signaling is also defined by receptor oligomerization state. Binding of ANXA1 to FPR2 homodimer elicits activation of p38 MAPKinase pathway leading to HSPB1/HSP27 phosphorylation and IL10 production in monocytes. Whereas agonistic activation of FPR1:FPR2 heterodimers signals a proapoptotic JNK pathway in neutrophils (By similarity)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed]; Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFkappaB Activity. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004875 complement receptor activity;GO:0005124 scavenger receptor binding;GO:0050786 RAGE receptor binding;GO:0001540 amyloid-beta binding;GO:0004982 N-formyl peptide receptor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0002430 complement receptor mediated signaling pathway;GO:0001774 microglial cell activation;GO:0006954 inflammatory response;GO:0007166 cell surface receptor signaling pathway;GO:0007186 G protein-coupled receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "O88536-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60775-1",
        "uniprot_id": "ELF1_MOUSE",
        "mass": 66221.0,
        "length": 612,
        "protein_name": "ETS-related transcription factor Elf-1",
        "gene_name": "Elf1",
        "organism": "Mouse",
        "refseq_name": "ETS-related transcription factor Elf-1 isoform 1",
        "refseq_ac": "NP_001273340",
        "gene_names_uniprotkb": "Elf1",
        "gene_names_refseq": "Elf-1; Elf1; Sts1; mElf-1; p70",
        "protein_names_uniprotkb": "ETS-related transcription factor Elf-1; E74-like factor 1",
        "protein_names_refseq": "E74-like factor 1; ETS-related transcription factor Elf-1 isoform 1; ETS-related transcription factor Elf-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13709);  (R-MMU-8939247)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "19224205;20173027;21750661;21952136;25428506;28630061;28954885;30084848;30779550;34428180;35507368;36852467;37641376;8666284",
        "class_list": "",
        "function": "E74-like factor 1 contributes to nerve trauma-induced nociceptive hypersensitivity through transcriptionally activating matrix metalloprotein-9 in dorsal root ganglion neurons., [RefSeq, PubMed]; ELF1/PRR11/ARP2/3 promoted trophoblast cells proliferation and motility in early pregnancy., [RefSeq, PubMed]; Green Tea Polyphenol EGCG Upregulates Tollip Expression by Suppressing Elf-1 Expression Erratum:[J Immunol. 2018 Apr 1;200(7):2502-2504. doi: 10.4049/jimmunol.1800143. PMID: 29475984], [RefSeq, PubMed]; Herein, the authors demonstrate that mice lacking Sts expression are significantly resistant to infection by the live vaccine strain of Francisella tularensis. Publication Status: Online-Only, [RefSeq, PubMed]; Transcription factor that activates the LYN and BLK promoters., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003700 DNA-binding transcription factor activity;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific;GO:1990837 sequence-specific double-stranded DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0030154 cell differentiation;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0006355 regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q60775-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8QZY1-1",
        "uniprot_id": "EIF3L_MOUSE",
        "mass": 66613.0,
        "length": 564,
        "protein_name": "Eukaryotic translation initiation factor 3 subunit L",
        "gene_name": "Eif3l",
        "organism": "Mouse",
        "refseq_name": "eukaryotic translation initiation factor 3 subunit L",
        "refseq_ac": "NP_660121",
        "gene_names_uniprotkb": "Eif3l; Eif3eip; Eif3s6ip; Paf67",
        "gene_names_refseq": "0610011H21Rik; D15N1e; Eif3eip; Eif3ip; Eif3l; Eif3s6ip; HSP-66Y; PAF67",
        "protein_names_uniprotkb": "Eukaryotic translation initiation factor 3 subunit L; 66 kDa tyrosine-rich heat shock protein; 67 kDa polymerase-associated factor; Eukaryotic translation initiation factor 3 subunit 6-interacting protein; Eukaryotic translation initiation factor 3 subunit E-interacting protein; HSP-66Y; PAF67; eIF3l",
        "protein_names_refseq": "66 kDa tyrosine-rich heat shock protein; 67 kDa polymerase-associated factor; eukaryotic translation initiation factor 3 subunit 6-interacting protein; eukaryotic translation initiation factor 3 subunit E-interacting protein; eukaryotic translation initiation factor 3 subunit L",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:223691);  (R-MMU-156827);  (R-MMU-72649);  (R-MMU-72689);  (R-MMU-72695);  (R-MMU-72702);  (R-MMU-72706)",
        "pathway_count": 7,
        "publication_count": 17,
        "publication_id_list": "12393749;17581632;18250455;21750661;21952136;22645316;23806337;25428506;30084848;30779550;31219806;33300544;34428180;34887587;36210013;37453647;37828378",
        "class_list": "",
        "function": "Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression., [UniProtKB, PubMed, HAMAP]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3THF8;Q3TJ04;Q91YE4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003743 translation initiation factor activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0045202 synapse;GO:0001650 fibrillar center;GO:0016282 eukaryotic 43S preinitiation complex",
        "go_biological_process": "GO:0006413 translational initiation;GO:0001732 formation of cytoplasmic translation initiation complex;GO:0075525 viral translational termination-reinitiation",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "Q8QZY1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C6B9-1",
        "uniprot_id": "AROS_MOUSE",
        "mass": 15978.0,
        "length": 143,
        "protein_name": "Active regulator of SIRT1",
        "gene_name": "Rps19bp1",
        "organism": "Mouse",
        "refseq_name": "active regulator of SIRT1",
        "refseq_ac": "NP_780318",
        "gene_names_uniprotkb": "Rps19bp1; Aros",
        "gene_names_refseq": "2510038A11Rik; Rps19bp1; S19BP",
        "protein_names_uniprotkb": "Active regulator of SIRT1; 40S ribosomal protein S19-binding protein 1; RPS19-binding protein 1; S19BP",
        "protein_names_refseq": "40S ribosomal protein S19-binding protein 1; RPS19-binding protein 1; S19 binding protein; active regulator of SIRT1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66538);  (R-MMU-3371453)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "16289379;21750661;24463520;24788674;25605945;28528544;30084848;37258580",
        "class_list": "",
        "function": "Identified a novel protein, which was named S19 binding protein (S19BP). No known functional motifs were found in S19BP except a short polylysine tract embedded in a putative nucleolar localization signal., [RefSeq, PubMed]; Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome. Acts as a chaperone that specifically mediates the integration of RPS19 in state post-A1. Direct regulator of SIRT1. Enhances SIRT1-mediated deacetylation of p53/TP53, thereby participating in inhibition of p53/TP53-mediated transcriptional activity., [UniProtKB, UniProtKB]; SIRT1 ubiquitination is regulated by opposing activities of APC/C-Cdh1 and AROS during stress-induced premature senescence., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q2WFQ7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019899 enzyme binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005829 cytosol;GO:0032040 small-subunit processome",
        "go_biological_process": "GO:0042274 ribosomal small subunit biogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q8C6B9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C9R9-1",
        "uniprot_id": "EFCB8_MOUSE",
        "mass": 23313.0,
        "length": 203,
        "protein_name": "EF-hand calcium-binding domain-containing protein 8",
        "gene_name": "Efcab8",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Efcab8",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "EF-hand calcium-binding domain-containing protein 8",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100504221)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005509 calcium ion binding",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8C9R9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P23591-1",
        "uniprot_id": "FCL_MOUSE",
        "mass": 35878.0,
        "length": 321,
        "protein_name": "GDP-L-fucose synthase",
        "gene_name": "Gfus",
        "organism": "Mouse",
        "refseq_name": "GDP-L-fucose synthase isoform 1",
        "refseq_ac": "NP_112478",
        "gene_names_uniprotkb": "Gfus; P35b; Tsta3; Tstap35b",
        "gene_names_refseq": "FX; Gfus; Tsta3; Tstap35b",
        "protein_names_uniprotkb": "GDP-L-fucose synthase; 1.1.1.271; GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase; Protein FX; Red cell NADP(H)-binding protein; Transplantation antigen P35B; Tum-P35B antigen",
        "protein_names_refseq": "GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase; GDP-L-fucose synthase isoform 1; GDP-L-fucose synthetase; GDP-fucose synthase; protein FX; red cell NADP(H)-binding protein; tissue specific transplantation antigen P35B; transplantation antigen P35B; tum-P35B antigen",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:22122);  (R-MMU-6787639)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "20573072;2108859;21750661;25428506;30779550;31219806;34428180;35820727",
        "class_list": "glycogene",
        "function": "Catalyzes the two-step NADP-dependent conversion of GDP-4-dehydro-6-deoxy-D-mannose to GDP-fucose, involving an epimerase and a reductase reaction., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Fucosylation-modified Notch receptor may represent a novel extrinsic regulator for hematopoietic stem cells (HSC) engraftment and HSC niche maintenance., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 5,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.1.1.271",
        "go_molecular_function": "GO:0050577 GDP-L-fucose synthase activity;GO:0047918 GDP-mannose 3,5-epimerase activity;GO:0042802 identical protein binding;GO:0016853 isomerase activity",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0019673 GDP-mannose metabolic process;GO:0042351 'de novo' GDP-L-fucose biosynthetic process;GO:0010595 positive regulation of endothelial cell migration;GO:0001913 T cell mediated cytotoxicity;GO:1904906 positive regulation of endothelial cell-matrix adhesion via fibronectin",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P23591-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WV72-1",
        "uniprot_id": "ASB3_MOUSE",
        "mass": 58283.0,
        "length": 525,
        "protein_name": "Ankyrin repeat and SOCS box protein 3",
        "gene_name": "Asb3",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 3",
        "refseq_ac": "NP_076395",
        "gene_names_uniprotkb": "Asb3",
        "gene_names_refseq": "2400011J03Rik; Asb-3; Asb3",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 3; ASB-3",
        "protein_names_refseq": "ankyrin repeat and SOCS box protein 3; ankyrin repeat and SOCS box-containing protein 3; ankyrin repeat-containing SOCS box protein 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:65257)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "11111040;21750661;34428180;39162488;39266719",
        "class_list": "",
        "function": "ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiota., [RefSeq, PubMed]; Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Recognizes TNFRSF1B. Plays a role in the down-regulation of antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation. Also destabilizes TRAF6 by enhancing its 'Lys-48'-linked polyubiquitination., [UniProtKB, PubMed, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SSV5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006468 protein phosphorylation;GO:0006954 inflammatory response;GO:0035556 intracellular signal transduction;GO:0030111 regulation of Wnt signaling pathway;GO:0009743 response to carbohydrate",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q9WV72-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P29391-1",
        "uniprot_id": "FRIL1_MOUSE",
        "mass": 20802.0,
        "length": 183,
        "protein_name": "Ferritin light chain 1",
        "gene_name": "Ftl1-ps1; Ftl1",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Ftl1-ps1; Ftl1; Ftl-1; Ftl",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Ferritin light chain 1; Ferritin L subunit 1",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "COVID-19 (Disease Ontology:DOID:0080600); neurodegeneration with brain iron accumulation 3 (Disease Ontology:DOID:0110737); hyperferritinemia-cataract syndrome (Disease Ontology:DOID:0111256); neurodegenerative disease (Disease Ontology:DOID:1289); candidiasis (Disease Ontology:DOID:1508); basal ganglia disease (Disease Ontology:DOID:679)",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 10,
        "publication_id_list": "19154717;21750661;25327288;26495903;26740625;2708374;34428180;36288343;37453647;7648356",
        "class_list": "",
        "function": "Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 6,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8WUQ8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0042802 identical protein binding;GO:0008198 ferrous iron binding;GO:0008199 ferric iron binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0005776 autophagosome;GO:0071682 endocytic vesicle lumen;GO:0044754 autolysosome",
        "go_biological_process": "GO:0006879 intracellular iron ion homeostasis;GO:0006826 iron ion transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "P29391-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O89079-1",
        "uniprot_id": "COPE_MOUSE",
        "mass": 34567.0,
        "length": 308,
        "protein_name": "Coatomer subunit epsilon",
        "gene_name": "Cope",
        "organism": "Mouse",
        "refseq_name": "coatomer subunit epsilon",
        "refseq_ac": "NP_067513",
        "gene_names_uniprotkb": "Cope; Cope1",
        "gene_names_refseq": "1110005D17Rik; Cope1; Cope",
        "protein_names_uniprotkb": "Coatomer subunit epsilon; Epsilon-COP; Epsilon-coat protein",
        "protein_names_refseq": "coatomer subunit epsilon; epsilon-coat protein; nonclathrin coat protein epsilon-COP",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:59042);  (R-MMU-6807878);  (R-MMU-6811434)",
        "pathway_count": 3,
        "publication_count": 12,
        "publication_id_list": "16479539;21750661;25428506;30084848;31219806;31599954;33649389;34203471;34428180;36210013;37453647;9798653",
        "class_list": "",
        "function": "The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. The coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated with ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors (By similarity)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9JM65",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005198 structural molecule activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005654 nucleoplasm;GO:0005794 Golgi apparatus;GO:0030137 COPI-coated vesicle;GO:0030126 COPI vesicle coat",
        "go_biological_process": "GO:0099612 protein localization to axon;GO:0015031 protein transport;GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport;GO:0006890 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;GO:0006891 intra-Golgi vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "O89079-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CR89-1",
        "uniprot_id": "ERGI2_MOUSE",
        "mass": 42482.0,
        "length": 377,
        "protein_name": "Endoplasmic reticulum-Golgi intermediate compartment protein 2",
        "gene_name": "Ergic2",
        "organism": "Mouse",
        "refseq_name": "endoplasmic reticulum-Golgi intermediate compartment protein 2 isoform 3",
        "refseq_ac": "NP_001273489",
        "gene_names_uniprotkb": "Ergic2",
        "gene_names_refseq": "1200009B18Rik; 4930572C01Rik; Ergic2; Ptx1",
        "protein_names_uniprotkb": "Endoplasmic reticulum-Golgi intermediate compartment protein 2",
        "protein_names_refseq": "endoplasmic reticulum-Golgi intermediate compartment protein 2 isoform 3; endoplasmic reticulum-Golgi intermediate compartment protein 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:67456)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;19653318;21750661;22613993;34428180;34994051",
        "class_list": "",
        "function": "Co-localization studies revealed an overlap of Ergic2 and Otoferlin signals in IHCs and neurons of cerebral cortical layer I making Ergic2 the promising binding candidate, [RefSeq, PubMed]; ERGIC2 and ERGIC3 regulate the ER-to-Golgi transport of gap junction proteins in metazoans., [RefSeq, PubMed]; Hoxa2 also repressed the expression of its downstream targets Ptx1 within the palate., [RefSeq, PubMed]; Plays a role in transport between endoplasmic reticulum and Golgi., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Possible role in transport between endoplasmic reticulum and Golgi., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9803,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2KFC8;Q3UX13;Q9CWM6;Q9CYA2;Q9D4R1;Q9D8Z9",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport;GO:0006890 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q9CR89-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5DW34-1",
        "uniprot_id": "EHMT1_MOUSE",
        "mass": 141999.0,
        "length": 1296,
        "protein_name": "Histone-lysine N-methyltransferase EHMT1",
        "gene_name": "Ehmt1",
        "organism": "Mouse",
        "refseq_name": "histone-lysine N-methyltransferase EHMT1 isoform 1",
        "refseq_ac": "NP_001012536",
        "gene_names_uniprotkb": "Ehmt1; Euhmtase1; Glp; Kmt1d",
        "gene_names_refseq": "9230102N17Rik; D330003E03; Ehmt1; Eu-HMTase1; GLP1; GLP; KMT1D; mKIAA1876",
        "protein_names_uniprotkb": "Histone-lysine N-methyltransferase EHMT1; 2.1.1.-; 2.1.1.367; Eu-HMTase1; Euchromatic histone-lysine N-methyltransferase 1; G9a-like protein 1; GLP1; GLP; Lysine N-methyltransferase 1D",
        "protein_names_refseq": "G9a-like protein 1; euchromatic histone-lysine N-methyltransferase 1; histone-lysine N-methyltransferase EHMT1 isoform 1; histone-lysine N-methyltransferase EHMT1; lysine N-methyltransferase 1D",
        "tax_id": 10090,
        "disease": "Kleefstra syndrome 1 (Disease Ontology:DOID:0060352); Kleefstra syndrome (Disease Ontology:DOID:0080597); esophagus squamous cell carcinoma (Disease Ontology:DOID:3748); viral infectious disease (Disease Ontology:DOID:934)",
        "pathway": " (mmu:77683);  (R-MMU-2559582);  (R-MMU-3214841);  (R-MMU-6804760);  (R-MMU-8953750)",
        "pathway_count": 5,
        "publication_count": 13,
        "publication_id_list": "15774718;16702210;18818694;21131967;21750661;21913724;22629437;24196706;28528544;32103178;35978186;36690445;39627609",
        "class_list": "",
        "function": "Histone methyltransferase that specifically mono-, di- and trimethylates 'Lys-9' of histone H3 (H3K9me1, H3K9me2 and H3K9me3, respectively) in euchromatin (PubMed:15774718, PubMed:24196706). H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones (PubMed:15774718, PubMed:24196706). Also weakly methylates 'Lys-27' of histone H3 (H3K27me) (PubMed:15774718). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently (PubMed:18818694). Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1 (By similarity). During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in G0/G1 transition in cell cycle (By similarity). Involved in the differentiation of myoblastic precursors into brown adipose cells: following recruitment to chromatin by PRDM16, mediates formation of H3K9me2 and H3K9me3, inhibiting the expression of white adipose-selective genes (PubMed:24196706). Also involved in the differentiation of beige adipocytes from white adipose cells following recruitment by PRDM16 (PubMed:35978186). EHMT1 also promotes protein stabilization of PRDM16, by preventing PRDM16 ubiquitination and degradation (PubMed:24196706). In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53 (By similarity). Represses the expression of mitochondrial function-related genes, perhaps by occupying their promoter regions, working in concert with probable chromatin reader BAZ2B (PubMed:32103178)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]; Multi-omics analyses demonstrate a critical role for EHMT1 methyltransferase in transcriptional repression during oogenesis., [RefSeq, PubMed]; Wiz plays a major role in G9a/GLP heterodimer formation in cultured stem cells., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 4,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AIS3;A2AIS4;Q5EBR1;Q6PGM0",
        "ec_number_list": "2.1.1.367;2.3.2.27;2.1.1.-;2.1.1.366;2.3.2.24;2.3.2.23;2.1.1.359",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0008168 methyltransferase activity;GO:0002039 p53 binding;GO:0016279 protein-lysine N-methyltransferase activity;GO:0046974 histone H3K9 methyltransferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0016604 nuclear body;GO:0000785 chromatin;GO:0005694 chromosome",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0050873 brown fat cell differentiation;GO:0045892 negative regulation of DNA-templated transcription;GO:0050821 protein stabilization;GO:0006325 chromatin organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q5DW34-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CXC9-1",
        "uniprot_id": "ETV5_MOUSE",
        "mass": 57712.0,
        "length": 510,
        "protein_name": "ETS translocation variant 5",
        "gene_name": "Etv5",
        "organism": "Mouse",
        "refseq_name": "ETS translocation variant 5",
        "refseq_ac": "NP_076283",
        "gene_names_uniprotkb": "Etv5",
        "gene_names_refseq": "1110005E01Rik; 8430401F14Rik; ERM; Etv5",
        "protein_names_uniprotkb": "ETS translocation variant 5",
        "protein_names_refseq": "ETS translocation variant 5; ets variant gene 5",
        "tax_id": 10090,
        "disease": "bipolar disorder (Disease Ontology:DOID:3312); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:104156)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "12871699;21750661;27280443;9285689",
        "class_list": "",
        "function": "Binds to DNA sequences containing the consensus nucleotide core sequence 5'-GGAA.-3'., [UniProtKB, UniProtKB]; ERM is a transcription factor in the ets family, within which it forms the PEA3 group., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TG49;Q8C0F3;Q9JHB1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003700 DNA-binding transcription factor activity;GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0000976 transcription cis-regulatory region binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005886 plasma membrane;GO:0045202 synapse",
        "go_biological_process": "GO:0060762 regulation of branching involved in mammary gland duct morphogenesis;GO:0048133 male germ-line stem cell asymmetric division;GO:0060252 positive regulation of glial cell proliferation;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9CXC9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BSY0-1",
        "uniprot_id": "ASPH_MOUSE",
        "mass": 83042.0,
        "length": 741,
        "protein_name": "Aspartyl/asparaginyl beta-hydroxylase",
        "gene_name": "Asph",
        "organism": "Mouse",
        "refseq_name": "aspartyl/asparaginyl beta-hydroxylase isoform 4",
        "refseq_ac": "NP_001171321",
        "gene_names_uniprotkb": "Asph; Bah",
        "gene_names_refseq": "2310005F16Rik; 3110001L23Rik; Asph; BAH; cI-37",
        "protein_names_uniprotkb": "Aspartyl/asparaginyl beta-hydroxylase; 1.14.11.16; ASP beta-hydroxylase; Aspartate beta-hydroxylase; Peptide-aspartate beta-dioxygenase",
        "protein_names_refseq": "ASP beta-hydroxylase; aspartly beta-hydroxylase; aspartyl beta-hydroxylase Humbug; aspartyl/asparaginyl beta-hydroxylase isoform 4; aspartyl/asparaginyl beta-hydroxylase; calsequestrin-binding protein; jumbug; junctate; junctin; peptide-aspartate beta-dioxygenase",
        "tax_id": 10090,
        "disease": "chromosome 16p11.2 deletion syndrome, 593-kb (Disease Ontology:DOID:0070515); cholangiocarcinoma (Disease Ontology:DOID:4947)",
        "pathway": " (mmu:65973);  (R-MMU-2672351);  (R-MMU-5578775)",
        "pathway_count": 3,
        "publication_count": 13,
        "publication_id_list": "10.1101/2023.09.13.557529;10956665;11773073;21750661;22645316;22768324;24768550;30899004;34428180;34996491;37453647;40997131;8530521",
        "class_list": "",
        "function": "INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. Publication Status: Online-Only, [RefSeq, PubMed]; Specifically hydroxylates an Asp or Asn residue in certain epidermal growth factor-like (EGF) domains of a number of proteins., [UniProtKB, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 5,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 5,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 5,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 7,
        "disease_count": 2,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6P8S1;Q9EPA6;Q9EQ64",
        "ec_number_list": "1.14.11.16;5.2.1.8",
        "go_molecular_function": "GO:0005509 calcium ion binding;GO:0062101 peptidyl-aspartic acid 3-dioxygenase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0008285 negative regulation of cell population proliferation;GO:0090316 positive regulation of intracellular protein transport;GO:0051480 regulation of cytosolic calcium ion concentration;GO:0071277 cellular response to calcium ion;GO:0045893 positive regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "Q8BSY0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CR63-1",
        "uniprot_id": "COX16_MOUSE",
        "mass": 12266.0,
        "length": 106,
        "protein_name": "Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial",
        "gene_name": "Cox16",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase assembly protein COX16 homolog, mitochondrial isoform 2",
        "refseq_ac": "NP_001296737",
        "gene_names_uniprotkb": "Cox16",
        "gene_names_refseq": "1810020G14Rik; 1810055I05Rik; Cox16",
        "protein_names_uniprotkb": "Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial",
        "protein_names_refseq": "cytochrome c oxidase assembly protein COX16 homolog, mitochondrial isoform 2; cytochrome c oxidase assembly protein COX16 homolog, mitochondrial",
        "tax_id": 10090,
        "disease": "mitochondrial complex IV deficiency nuclear type 22 (Disease Ontology:DOID:0070507)",
        "pathway": " (mmu:66272);  (R-MMU-9864848)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Required for the assembly of the mitochondrial respiratory chain complex IV (CIV), also known as cytochrome c oxidase. Promotes the insertion of copper into the active site of cytochrome c oxidase subunit II (MT-CO2/COX2). Interacts specifically with newly synthesized MT-CO2/COX and its copper center-forming metallochaperones SCO1, SCO2 and COA6. Probably facilitates MT-CO2/COX2 association with the MITRAC assembly intermediate containing MT-CO1/COX1, thereby participating in merging the MT-CO1/COX1 and MT-CO2/COX2 assembly lines., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BNX4;Q99J15",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane",
        "go_biological_process": "GO:0033617 mitochondrial respiratory chain complex IV assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9CR63-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35075-1",
        "uniprot_id": "VP26C_MOUSE",
        "mass": 32970.0,
        "length": 297,
        "protein_name": "Vacuolar protein sorting-associated protein 26C",
        "gene_name": "Vps26c",
        "organism": "Mouse",
        "refseq_name": "vacuolar protein sorting-associated protein 26C",
        "refseq_ac": "NP_031860",
        "gene_names_uniprotkb": "Vps26c; Dcra; Dscr3; Dscra",
        "gene_names_refseq": "Dcra; Dscr3; Vps26c",
        "protein_names_uniprotkb": "Vacuolar protein sorting-associated protein 26C; Down syndrome critical region protein 3 homolog; Down syndrome critical region protein A homolog",
        "protein_names_refseq": "DSCR3 arrestin fold containing; Down syndrome critical region gene 3; Down syndrome critical region gene A; Down syndrome critical region protein 3 homolog; Down syndrome critical region protein A homolog; vacuolar protein sorting-associated protein 26C",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13185)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;34428180;9399594",
        "class_list": "",
        "function": "Component of the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex (By similarity). Component of the retriever complex, which is a heterotrimeric complex related to retromer cargo-selective complex (CSC) and essential for retromer-independent retrieval and recycling of numerous cargos such as integrin alpha-5/beta-1 (ITGA5:ITGB1) (By similarity). The recruitment of the retriever complex to the endosomal membrane involves CCC and WASH complexes (By similarity). In the endosomes, drives the retriever and recycling of NxxY-motif-containing cargo proteins by coupling to SNX17, a cargo essential for the homeostatic maintenance of numerous cell surface proteins associated with processes that include cell migration, cell adhesion, nutrient supply and cell signaling (By similarity)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9753,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q542V5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005768 endosome;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0032456 endocytic recycling",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "O35075-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99LT0-1",
        "uniprot_id": "DPY30_MOUSE",
        "mass": 11213.0,
        "length": 99,
        "protein_name": "Protein dpy-30 homolog",
        "gene_name": "Dpy30",
        "organism": "Mouse",
        "refseq_name": "protein dpy-30 homolog",
        "refseq_ac": "NP_001139694",
        "gene_names_uniprotkb": "Dpy30",
        "gene_names_refseq": "2810410M20Rik; Dpy30",
        "protein_names_uniprotkb": "Protein dpy-30 homolog; Dpy-30-like protein; Dpy-30L",
        "protein_names_refseq": "dosage compensation-related protein DPY30; dpy-30 homolog; dpy-30-like protein; dpy-30L; protein dpy-30 homolog",
        "tax_id": 10090,
        "disease": "congenital heart disease (Disease Ontology:DOID:1682)",
        "pathway": " (mmu:66310)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "21335234;21750661;26495903;35307321;35563756;35820727",
        "class_list": "",
        "function": "As part of the MLL1/MLL complex, involved in the methylation of histone H3 at 'Lys-4', particularly trimethylation. Histone H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. May play some role in histone H3 acetylation. In embryonic stem (ES) cells, plays a crucial role in the differentiation potential, particularly along the neural lineage, regulating gene induction and histone H3 'Lys-4' methylation at key developmental loci, including that mediated by retinoic acid. Does not affect ES cell self-renewal. May also play an indirect or direct role in endosomal transport., [UniProtKB, PubMed]; Results indicate an essential functional role for Dpy-30 and SET1/MLL complex-mediated H3K4 methylation, as a component of the bivalent mark, at developmental genes during the embryonic stem cells fate transitions. Erratum:[Cell. 2011 Mar 4;144(5):825], [RefSeq, PubMed]; Role of chromatin modulator Dpy30 in osteoclast differentiation and function., [RefSeq, PubMed]; The Ash2l SDI Domain Is Required to Maintain the Stability and Binding of DPY30. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005794 Golgi apparatus;GO:0005802 trans-Golgi network;GO:0035097 histone methyltransferase complex",
        "go_biological_process": "GO:0016197 endosomal transport;GO:0045815 transcription initiation-coupled chromatin remodeling",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q99LT0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CF25-1",
        "uniprot_id": "CS067_MOUSE",
        "mass": 33638.0,
        "length": 301,
        "protein_name": "UPF0575 protein C19orf67 homolog",
        "gene_name": "1700067K01Rik",
        "organism": "Mouse",
        "refseq_name": "UPF0575 protein C19orf67 homolog",
        "refseq_ac": "NP_898920",
        "gene_names_uniprotkb": "1700067K01Rik",
        "gene_names_refseq": "1700067K01Rik",
        "protein_names_uniprotkb": "UPF0575 protein C19orf67 homolog",
        "protein_names_refseq": "UPF0575 protein C19orf67 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:73453)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "F6UZF9",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "GO:0001701 in utero embryonic development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8CF25-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P01901-1",
        "uniprot_id": "HA1B_MOUSE",
        "mass": 41302.0,
        "length": 369,
        "protein_name": "H-2 class I histocompatibility antigen, K-B alpha chain",
        "gene_name": "H2-K1",
        "organism": "Mouse",
        "refseq_name": "H-2 class I histocompatibility antigen, K-W28 alpha chain isoform 1 precursor",
        "refseq_ac": "NP_001001892",
        "gene_names_uniprotkb": "H2-K1; H2-K",
        "gene_names_refseq": "H-2K(d); H-2K; H2-D1; H2-K1; H2-K; K-f",
        "protein_names_uniprotkb": "H-2 class I histocompatibility antigen, K-B alpha chain; H-2K(B)",
        "protein_names_refseq": "H-2 class I histocompatibility antigen, K-B alpha chain; H-2 class I histocompatibility antigen, K-D alpha chain; H-2 class I histocompatibility antigen, K-K alpha chain; H-2 class I histocompatibility antigen, K-Q alpha chain; H-2 class I histocompatibility antigen, K-W28 alpha chain isoform 1 precursor; H-2 class I histocompatibility antigen, K-W28 alpha chain; H-2K(B); H-2K(K); H-2K(Q); MHC H2-K transplantation antigen; MHC class I H2-K-b-alpha-2 cell surface glycoprotein; MHC class I antigen; MHC class I heavy chain H2-K; MHC class I heavy chain heavy chain; MHC class I heavy chain maturation peptide; MHC class II antigen D; MHC class II antigen K; class I major histocompatibility antigen H-2Kd; histocompatibility 2, K region, promoter 1",
        "tax_id": 10090,
        "disease": "Stevens-Johnson syndrome (Disease Ontology:DOID:0050426); colitis (Disease Ontology:DOID:0060180); Cytomegalovirus retinitis (Disease Ontology:DOID:0080160); COVID-19 (Disease Ontology:DOID:0080600); ankylosing spondylitis 1 (Disease Ontology:DOID:0080603); erythema nodosum (Disease Ontology:DOID:0080750); occupational asthma (Disease Ontology:DOID:0080820); birdshot chorioretinopathy (Disease Ontology:DOID:0111079); psoriasis 1 (Disease Ontology:DOID:0111286); sensorineural hearing loss (Disease Ontology:DOID:10003); pre-eclampsia (Disease Ontology:DOID:10591); spondyloarthropathy (Disease Ontology:DOID:1123); trachoma (Disease Ontology:DOID:11265); sarcoidosis (Disease Ontology:DOID:11335); retinal vasculitis (Disease Ontology:DOID:11563); otosclerosis (Disease Ontology:DOID:12185); Graves' disease (Disease Ontology:DOID:12361); vulva cancer (Disease Ontology:DOID:1245); respiratory syncytial virus infectious disease (Disease Ontology:DOID:1273); thromboangiitis obliterans (Disease Ontology:DOID:12918); retinopathy of prematurity (Disease Ontology:DOID:13025); Moyamoya disease (Disease Ontology:DOID:13099); uveitis (Disease Ontology:DOID:13141); Behcet's disease (Disease Ontology:DOID:13241); anterior uveitis (Disease Ontology:DOID:1407); cystic fibrosis (Disease Ontology:DOID:1485); Melkersson-Rosenthal syndrome (Disease Ontology:DOID:1761); hepatitis C (Disease Ontology:DOID:1883); Takayasu's arteritis (Disease Ontology:DOID:2508); synovitis (Disease Ontology:DOID:2703); dermatitis (Disease Ontology:DOID:2723); asthma (Disease Ontology:DOID:2841); severe acute respiratory syndrome (Disease Ontology:DOID:2945); cerebral infarction (Disease Ontology:DOID:3526); acute retinal necrosis syndrome (Disease Ontology:DOID:3611); thrombophlebitis (Disease Ontology:DOID:3875); tuberculosis (Disease Ontology:DOID:399); scleroderma (Disease Ontology:DOID:419); cervical cancer (Disease Ontology:DOID:4362); allergic rhinitis (Disease Ontology:DOID:4481); central nervous system vasculitis (Disease Ontology:DOID:525); human immunodeficiency virus infectious disease (Disease Ontology:DOID:526); uveal melanoma (Disease Ontology:DOID:6039); reactive arthritis (Disease Ontology:DOID:6196); myositis (Disease Ontology:DOID:633); acquired immunodeficiency syndrome (Disease Ontology:DOID:635); ankylosing spondylitis (Disease Ontology:DOID:7147); diabetic retinopathy (Disease Ontology:DOID:8947); allergic asthma (Disease Ontology:DOID:9415); Meniere's disease (Disease Ontology:DOID:9849); alopecia (Disease Ontology:DOID:987); mitral valve prolapse (Disease Ontology:DOID:988)",
        "pathway": " (mmu:14972)",
        "pathway_count": 1,
        "publication_count": 44,
        "publication_id_list": "10.1101/2023.09.13.557529;10023770;11894934;11894963;1323877;1622899;17242355;18250455;19144319;19349973;19656770;21183079;21750661;21952136;22645316;2428867;24788674;25428506;25428507;25605945;26495903;26740625;28011936;30084848;31219806;31599954;3335396;3374494;34428180;3680952;37453647;37828378;3838967;3840763;3980466;6096831;6298749;6689056;6954478;7018573;7306483;7490121;9806638;9869916",
        "class_list": "",
        "function": "Involved in the presentation of foreign antigens to the immune system., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 5,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 52,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046703 natural killer cell lectin-like receptor binding;GO:0046978 TAP1 binding;GO:0046979 TAP2 binding;GO:0005102 signaling receptor binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0030670 phagocytic vesicle membrane;GO:0042612 MHC class I protein complex;GO:0098553 lumenal side of endoplasmic reticulum membrane;GO:0032398 MHC class Ib protein complex;GO:0000139 Golgi membrane",
        "go_biological_process": "GO:0006955 immune response;GO:0002474 antigen processing and presentation of peptide antigen via MHC class I;GO:0002476 antigen processing and presentation of endogenous peptide antigen via MHC class Ib;GO:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I;GO:0002486 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",
        "synthesized_glycan_count": 0,
        "hit_score": 5.1,
        "record_id": "P01901-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60778-1",
        "uniprot_id": "IKBB_MOUSE",
        "mass": 37965.0,
        "length": 359,
        "protein_name": "NF-kappa-B inhibitor beta",
        "gene_name": "Nfkbib",
        "organism": "Mouse",
        "refseq_name": "NF-kappa-B inhibitor beta",
        "refseq_ac": "NP_001293151",
        "gene_names_uniprotkb": "Nfkbib; Ikbb",
        "gene_names_refseq": "I(Kappa)B(beta); I-kappa-B-beta; IKB-beta; IKappaBbeta; IkBb; IkB; NF-kappa-BIB; Nfkbib; ikB-B",
        "protein_names_uniprotkb": "NF-kappa-B inhibitor beta; I-kappa-B-beta; IkB-B; IkB-beta; IkappaBbeta; NF-kappa-BIB",
        "protein_names_refseq": "NF-kappa-B inhibitor beta; nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, beta",
        "tax_id": 10090,
        "disease": "collagen disease (Disease Ontology:DOID:854)",
        "pathway": " (mmu:18036);  (R-MMU-1169091);  (R-MMU-1810476);  (R-MMU-445989);  (R-MMU-933542)",
        "pathway_count": 5,
        "publication_count": 7,
        "publication_id_list": "10657303;21750661;26342031;27508931;32064589;7867065;8816457",
        "class_list": "",
        "function": "CpG-ODN-mediated TLR9 innate immune signalling and calcium dyshomeostasis converge on the NFkappaB inhibitory protein IkappaBbeta to drive IL1alpha and IL1beta expression., [RefSeq, PubMed]; Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. However, the unphosphorylated form resynthesized after cell stimulation is able to bind NF-kappa-B allowing its transport to the nucleus and protecting it to further NFKBIA-dependent inactivation. Association with inhibitor kappa B-interacting NKIRAS1 and NKIRAS2 prevent its phosphorylation rendering it more resistant to degradation, explaining its slower degradation., [UniProtKB]; These results mechanistically link the innate immune response mediated by IkappaBbeta/NF-kappaB to ET-1 expression and potentially reveal therapeutic targets for patients with Gram-negative septic shock., [RefSeq, PubMed]; This gene encodes an inhibitor of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB). The encoded protein prevents NF-kappaB-mediated transcription activation by sequestering it in the cytosol. In response to signals that induce NF-kappaB, such as cytokines and growth factors, the encoded protein undergoes phosphorylation, triggering its rapid ubiquitination and proteasomal degradation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q564F1;Q9D6L5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0071222 cellular response to lipopolysaccharide;GO:0043122 regulation of canonical NF-kappaB signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q60778-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R000-1",
        "uniprot_id": "ITBP2_MOUSE",
        "mass": 38768.0,
        "length": 350,
        "protein_name": "Integrin beta-1-binding protein 2",
        "gene_name": "Itgb1bp2",
        "organism": "Mouse",
        "refseq_name": "integrin beta-1-binding protein 2 isoform 1",
        "refseq_ac": "NP_038740",
        "gene_names_uniprotkb": "Itgb1bp2",
        "gene_names_refseq": "Chordc3; Itgb1bp2",
        "protein_names_uniprotkb": "Integrin beta-1-binding protein 2; Melusin",
        "protein_names_refseq": "integrin beta-1-binding protein 2 isoform 1; melusin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:26549)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10506186;12496958;23198998;24130190;24859929;25428506;35271535",
        "class_list": "",
        "function": "Data show that melusin prevents cardiac dilation during chronic pressure overload by specifically sensing mechanical stress., [RefSeq, PubMed]; Findings implicate melusin as an enhancer of AKT and ERK pathways and as a novel player in cardioprotection from ischemia-reperfusion injury., [RefSeq, PubMed]; May play a role during maturation and/or organization of muscles cells., [UniProtKB]; Modulation of LTCC Pathways by a Melusin Mimetic Increases Ventricular Contractility During LPS-Induced Cardiomyopathy., [RefSeq, PubMed]; Multiple hypertrophic stimuli regulate melusin expression predominately in the atria, which may represent a necessary initial step in early adaptive remodelling processes in left ventricular hypertrophy., [RefSeq, PubMed]; Reduces maladaptive remodelling after myocardial infarction Erratum:[Cardiovasc Res. 2020 Apr 1;116(5):1005. doi: 10.1093/cvr/cvaa038. PMID: 32087012], [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D161",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005178 integrin binding;GO:0008270 zinc ion binding;GO:0017124 SH3 domain binding;GO:0005509 calcium ion binding",
        "go_cellular_component": "GO:0030018 Z disc",
        "go_biological_process": "GO:0051298 centrosome duplication",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9R000-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CJH3-1",
        "uniprot_id": "PLXB1_MOUSE",
        "mass": 231376.0,
        "length": 2119,
        "protein_name": "Plexin-B1",
        "gene_name": "Plxnb1",
        "organism": "Mouse",
        "refseq_name": "plexin-B1 precursor",
        "refseq_ac": "NP_766363",
        "gene_names_uniprotkb": "Plxnb1; Kiaa0407",
        "gene_names_refseq": "2900002G15Rik; Plxnb1; mKIAA0407",
        "protein_names_uniprotkb": "Plexin-B1",
        "protein_names_refseq": "plexin-B1 precursor",
        "tax_id": 10090,
        "disease": "developmental disorder of mental health (Disease Ontology:DOID:0060037); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:235611);  (R-MMU-416482);  (R-MMU-416550);  (R-MMU-416572)",
        "pathway_count": 4,
        "publication_count": 16,
        "publication_id_list": "10.1101/2023.09.13.557529;12196628;12198496;12559962;19349973;19788569;21750661;23699507;29981480;30899004;33300544;34428180;36210013;37828378;38802590;40885482",
        "class_list": "",
        "function": "Binding of Sema 4D to Plexin B1 stimulates the tyrosine kinase activity of Met, [RefSeq, PubMed]; LARG plays a critical role in plexin-B1 signaling to stimulate Rho activation and cytoskeletal reorganization., [RefSeq, PubMed]; Receptor for SEMA4D (PubMed:19788569). Plays a role in GABAergic synapse development (PubMed:23699507, PubMed:29981480). Mediates SEMA4A- and SEMA4D-dependent inhibitory synapse development (PubMed:23699507, PubMed:29981480). Plays a role in RHOA activation and subsequent changes of the actin cytoskeleton (By similarity). Plays a role in axon guidance, invasive growth and cell migration (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed]; Regulation of cell distancing in peri-plaque glial nets by Plexin-B1 affects glial activation and amyloid compaction in Alzheimer's disease., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 7,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 4,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 7,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 7,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 23,
        "disease_count": 2,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QKS4;Q6ZQC3;Q80ZZ1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0032794 GTPase activating protein binding;GO:0017154 semaphorin receptor activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0002116 semaphorin receptor complex;GO:0005886 plasma membrane;GO:0045211 postsynaptic membrane",
        "go_biological_process": "GO:0043931 ossification involved in bone maturation;GO:0007162 negative regulation of cell adhesion;GO:0043547 positive regulation of GTPase activity;GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;GO:0071526 semaphorin-plexin signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 4.8,
        "record_id": "Q8CJH3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BT88-1",
        "uniprot_id": "CP090_MOUSE",
        "mass": 18157.0,
        "length": 171,
        "protein_name": "Uncharacterized protein C16orf90 homolog",
        "gene_name": "1700037C18Rik",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein C16orf90 homolog",
        "refseq_ac": "NP_082760",
        "gene_names_uniprotkb": "1700037C18Rik",
        "gene_names_refseq": "1700037C18Rik; 2810022L20Rik",
        "protein_names_uniprotkb": "Uncharacterized protein C16orf90 homolog",
        "protein_names_refseq": "uncharacterized protein C16orf90 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:73261)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;25428506",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B9EJK2;Q9D9P5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8BT88-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99LD9-1",
        "uniprot_id": "EI2BB_MOUSE",
        "mass": 38898.0,
        "length": 351,
        "protein_name": "Translation initiation factor eIF2B subunit beta",
        "gene_name": "Eif2b2",
        "organism": "Mouse",
        "refseq_name": "translation initiation factor eIF2B subunit beta",
        "refseq_ac": "NP_663420",
        "gene_names_uniprotkb": "Eif2b2",
        "gene_names_refseq": "EIF-2Bbeta; EIF2B; Eif2b2",
        "protein_names_uniprotkb": "Translation initiation factor eIF2B subunit beta; eIF2B GDP-GTP exchange factor subunit beta",
        "protein_names_refseq": "eIF-2B GDP-GTP exchange factor subunit beta; eIF2B GDP-GTP exchange factor subunit beta; translation initiation factor eIF-2B subunit beta; translation initiation factor eIF2B subunit beta",
        "tax_id": 10090,
        "disease": "leukoencephalopathy with vanishing white matter (Disease Ontology:DOID:0060868); leukoencephalopathy with vanishing white matter 2 (Disease Ontology:DOID:0070373)",
        "pathway": " (mmu:217715);  (R-MMU-72731)",
        "pathway_count": 2,
        "publication_count": 2,
        "publication_id_list": "21750661;34428180",
        "class_list": "",
        "function": "Acts as a component of the translation initiation factor 2B (eIF2B) complex, which catalyzes the exchange of GDP for GTP on eukaryotic initiation factor 2 (eIF2) gamma subunit. Its guanine nucleotide exchange factor activity is repressed when bound to eIF2 complex phosphorylated on the alpha subunit, thereby limiting the amount of methionyl-initiator methionine tRNA available to the ribosome and consequently global translation is repressed., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; This gene encodes the beta subunit of eukaryotic initiation factor-2B (EIF2B). EIF2B is involved in protein synthesis and exchanges GDP and GTP for its activation and deactivation. Mutations in the human gene are associated with ovarioleukodystrophy and leukoencephalopathy with vanishing white matter. [provided by RefSeq, Sep 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0005525 GTP binding;GO:0005085 guanyl-nucleotide exchange factor activity;GO:0003743 translation initiation factor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol;GO:0030424 axon;GO:0098794 postsynapse",
        "go_biological_process": "GO:0002183 cytoplasmic translational initiation;GO:0042552 myelination;GO:0050852 T cell receptor signaling pathway;GO:0007417 central nervous system development;GO:0006413 translational initiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q99LD9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61245-1",
        "uniprot_id": "COBA1_MOUSE",
        "mass": 181032.0,
        "length": 1804,
        "protein_name": "Collagen alpha-1(XI) chain",
        "gene_name": "Col11a1",
        "organism": "Mouse",
        "refseq_name": "collagen alpha-1(XI) chain preproprotein",
        "refseq_ac": "NP_031755",
        "gene_names_uniprotkb": "Col11a1",
        "gene_names_refseq": "C530001D20Rik; Col11a1; cho",
        "protein_names_uniprotkb": "Collagen alpha-1(XI) chain",
        "protein_names_refseq": "a1(XI) collagen; collagen alpha-1(XI) chain preproprotein; collagen alpha-1(XI) chain; pro-alpha1(XI) collagen; procollagen, type XI, alpha 1",
        "tax_id": 10090,
        "disease": "autosomal dominant nonsyndromic deafness 37 (Disease Ontology:DOID:0070601); Stickler syndrome (Disease Ontology:DOID:0080046); fibrochondrogenesis 1 (Disease Ontology:DOID:0080672); Stickler syndrome 2 (Disease Ontology:DOID:0080675); Marshall syndrome (Disease Ontology:DOID:0111510); osteoarthritis (Disease Ontology:DOID:8398)",
        "pathway": " (mmu:12814);  (R-MMU-1442490);  (R-MMU-1650814);  (R-MMU-2022090);  (R-MMU-3000171);  (R-MMU-8874081);  (R-MMU-8948216)",
        "pathway_count": 7,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;20485683;21750661;31219806;34203471;7859283;8530046",
        "class_list": "",
        "function": "May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils., [UniProtKB]; This gene encodes the alpha-1 subunit of type XI collagen, one of the low abundance fibrillar collagens that is essential for normal embryonic skeletal development and the cohesive properties of cartilage. The encoded protein, in association with the alpha-1 subunit of type II collagen, forms a heterotrimeric type XI procollagen that undergoes proteolytic processing. Mice lacking the encoded protein develop severe chondrodysplasia and die at birth. [provided by RefSeq, Dec 2015]., [RefSeq]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 6,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q64047;Q80WR4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008201 heparin binding;GO:0046872 metal ion binding;GO:1904399 heparan sulfate binding;GO:0030020 extracellular matrix structural constituent conferring tensile strength;GO:0005201 extracellular matrix structural constituent",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005783 endoplasmic reticulum;GO:0031012 extracellular matrix;GO:0005581 collagen trimer;GO:0005592 collagen type XI trimer",
        "go_biological_process": "GO:0042472 inner ear morphogenesis;GO:0050910 detection of mechanical stimulus involved in sensory perception of sound;GO:0007601 visual perception;GO:0030199 collagen fibril organization;GO:0003007 heart morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q61245-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P16879-1",
        "uniprot_id": "FES_MOUSE",
        "mass": 93779.0,
        "length": 822,
        "protein_name": "Tyrosine-protein kinase Fes/Fps",
        "gene_name": "Fes",
        "organism": "Mouse",
        "refseq_name": "tyrosine-protein kinase Fes/Fps",
        "refseq_ac": "NP_034324",
        "gene_names_uniprotkb": "Fes; Fps",
        "gene_names_refseq": "FPS; Fes; c-fes",
        "protein_names_uniprotkb": "Tyrosine-protein kinase Fes/Fps; 2.7.10.2; Proto-oncogene c-Fes",
        "protein_names_refseq": "feline sarcoma oncogene; proto-oncogene c-Fes; proto-oncogene tyrosine-protein kinase Fes/Fps; tyrosine kinase Fps/Fes; tyrosine-protein kinase Fes/Fps",
        "tax_id": 10090,
        "disease": "esophagus squamous cell carcinoma (Disease Ontology:DOID:3748); lung adenocarcinoma (Disease Ontology:DOID:3910); hepatocellular carcinoma (Disease Ontology:DOID:684)",
        "pathway": " (mmu:14159);  (R-MMU-1433557);  (R-MMU-399954);  (R-MMU-399956)",
        "pathway_count": 4,
        "publication_count": 17,
        "publication_id_list": "11909942;12901971;16731527;17595334;17947660;19892014;21750661;2482828;28463229;29237092;30084848;3060793;30779550;34428180;35820727;36321446;37122758",
        "class_list": "",
        "function": "Establishing the role of the FES tyrosine kinase in the pathogenesis, pathophysiology, and severity of sepsis and its outcomes. Publication Status: Online-Only, [RefSeq, PubMed]; FES is a driver of melanoma progression in a mouse model., [RefSeq, PubMed]; The FES Gene at the 15q26 Coronary-Artery-Disease Locus Inhibits Atherosclerosis., [RefSeq, PubMed]; Tyrosine-protein kinase that acts downstream of cell surface receptors and plays a role in the regulation of the actin cytoskeleton, microtubule assembly, cell attachment and cell spreading. Plays a role in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Acts down-stream of the activated FCER1 receptor and the mast/stem cell growth factor receptor KIT. Plays a role in the regulation of mast cell degranulation. Plays a role in the regulation of cell differentiation and promotes neurite outgrowth in response to NGF signaling. Plays a role in cell scattering and cell migration in response to HGF-induced activation of EZR. Phosphorylates BCR and down-regulates BCR kinase activity. Phosphorylates HCLS1/HS1, PECAM1, STAT3 and TRIM28., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 8,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TD20;Q62122;Q8CG02",
        "ec_number_list": "2.7.12.2;2.7.10.1;2.7.11.1;2.7.12.1;2.7.1.32;2.7.1.82;2.7.10.2;3.6.5.2;2.7.11.13;2.7.10.4;2.7.1.40;2.7.11.23",
        "go_molecular_function": "GO:0034987 immunoglobulin receptor binding;GO:0004672 protein kinase activity;GO:0004713 protein tyrosine kinase activity;GO:0004715 non-membrane spanning protein tyrosine kinase activity;GO:0005524 ATP binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005794 Golgi apparatus;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0005925 focal adhesion",
        "go_biological_process": "GO:0006935 chemotaxis;GO:0007155 cell adhesion;GO:0010976 positive regulation of neuron projection development;GO:0018108 peptidyl-tyrosine phosphorylation;GO:0030155 regulation of cell adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "P16879-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EQH2-1",
        "uniprot_id": "ERAP1_MOUSE",
        "mass": 106599.0,
        "length": 930,
        "protein_name": "Endoplasmic reticulum aminopeptidase 1",
        "gene_name": "Erap1",
        "organism": "Mouse",
        "refseq_name": "endoplasmic reticulum aminopeptidase 1 isoform 1 precursor",
        "refseq_ac": "NP_109636",
        "gene_names_uniprotkb": "Erap1; Appils; Arts1",
        "gene_names_refseq": "A-LAP; ARTS-1; Arts1; ERAAP; Erap1; PILSAP; PILSA",
        "protein_names_uniprotkb": "Endoplasmic reticulum aminopeptidase 1; 3.4.11.-; A-LAP; ARTS-1; Adipocyte-derived leucine aminopeptidase; Aminopeptidase PILS; PILS-AP; Puromycin-insensitive leucyl-specific aminopeptidase; VEGF-induced aminopeptidase",
        "protein_names_refseq": "VEGF-induced aminopeptidase; adipocyte-derived leucine aminopeptidase; aminopeptidase PILS; endoplasmic reticulum aminopeptidase 1 isoform 1 precursor; puromycin-insensitive leucyl-specific aminopeptidase; type 1 tumor necrosis factor receptor shedding aminopeptidase regulator",
        "tax_id": 10090,
        "disease": "severe pre-eclampsia (Disease Ontology:DOID:13129); endometrial carcinoma (Disease Ontology:DOID:2871); cervix carcinoma (Disease Ontology:DOID:2893)",
        "pathway": " (mmu:80898);  (R-MMU-983170)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "10.1101/2023.09.13.557529;11964289;12368856;16075062;21750661;26740625;30899004;31219806;34203471;37003592;37453647;37507081;39627609;40997131",
        "class_list": "",
        "function": "Aminopeptidase that plays a central role in peptide trimming, a step required for the generation of most HLA class I-binding peptides. Peptide trimming is essential to customize longer precursor peptides to fit them to the correct length required for presentation on MHC class I molecules. Strongly prefers substrates 9-16 residues long. Rapidly degrades 13-mer to a 9-mer and then stops. Preferentially hydrolyzes the residue Leu and peptides with a hydrophobic C-terminus, while it has weak activity toward peptides with charged C-terminus. May play a role in the inactivation of peptide hormones. May be involved in the regulation of blood pressure through the inactivation of angiotensin II and/or the generation of bradykinin in the kidney (By similarity)., [UniProtKB]; Characterization of immune responses associated with ERAP-1 expression in HSV-induced Behcet's disease mouse model., [RefSeq, PubMed]; Identification of ERAAP, the aminopeptidase associated with antigen processing in the endoplasmic reticulum (ERAAP), [RefSeq, PubMed]",
        "predicted_glycosites": 5,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 5,
        "disease_count": 3,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6GTP5;Q9ET63",
        "ec_number_list": "3.4.11.-",
        "go_molecular_function": "GO:0004175 endopeptidase activity;GO:0008270 zinc ion binding;GO:0004177 aminopeptidase activity;GO:0008235 metalloexopeptidase activity;GO:0070006 metalloaminopeptidase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005788 endoplasmic reticulum lumen;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006508 proteolysis;GO:0006509 membrane protein ectodomain proteolysis;GO:0043171 peptide catabolic process;GO:0045766 positive regulation of angiogenesis;GO:0002474 antigen processing and presentation of peptide antigen via MHC class I",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q9EQH2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BJW6-1",
        "uniprot_id": "EIF2A_MOUSE",
        "mass": 64403.0,
        "length": 581,
        "protein_name": "Eukaryotic translation initiation factor 2A",
        "gene_name": "Eif2a",
        "organism": "Mouse",
        "refseq_name": "eukaryotic translation initiation factor 2A isoform 1",
        "refseq_ac": "NP_001005509",
        "gene_names_uniprotkb": "Eif2a; D3Ertd194e",
        "gene_names_refseq": "D030048D22; D3Ertd194e; Eif2a",
        "protein_names_uniprotkb": "Eukaryotic translation initiation factor 2A; eIF-2A",
        "protein_names_refseq": "eIF-2A; eukaryotic translation initiation factor 2A isoform 1",
        "tax_id": 10090,
        "disease": "borna disease (Disease Ontology:DOID:5154)",
        "pathway": " (mmu:229317)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "16717090;21750661;25605945;25937070;34428180;36288343;37828378;39927985",
        "class_list": "",
        "function": "Double-stranded RNA-dependent protein kinase phosphorylation of the alpha-subunit of eukaryotic translation initiation factor 2 mediates apoptosis, [RefSeq, PubMed]; Functions in the early steps of protein synthesis of a small number of specific mRNAs. Acts by directing the binding of methionyl-tRNAi to 40S ribosomal subunits. In contrast to the eIF-2 complex, it binds methionyl-tRNAi to 40S subunits in a codon-dependent manner, whereas the eIF-2 complex binds methionyl-tRNAi to 40S subunits in a GTP-dependent manner., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 1,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 1,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q05C11;Q640P8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003729 mRNA binding;GO:0000049 tRNA binding;GO:0043022 ribosome binding;GO:0003743 translation initiation factor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005850 eukaryotic translation initiation factor 2 complex",
        "go_biological_process": "GO:0006417 regulation of translation;GO:0006468 protein phosphorylation;GO:0006413 translational initiation;GO:0006412 translation;GO:1990928 response to amino acid starvation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q8BJW6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6DYE8-1",
        "uniprot_id": "ENPP3_MOUSE",
        "mass": 98662.0,
        "length": 874,
        "protein_name": "Ectonucleotide pyrophosphatase/phosphodiesterase family member 3",
        "gene_name": "Enpp3",
        "organism": "Mouse",
        "refseq_name": "ectonucleotide pyrophosphatase/phosphodiesterase family member 3",
        "refseq_ac": "NP_598766",
        "gene_names_uniprotkb": "Enpp3",
        "gene_names_refseq": "CD203c; Enpp3",
        "protein_names_uniprotkb": "Ectonucleotide pyrophosphatase/phosphodiesterase family member 3; 3.1.4.1; 3.6.1.-; 3.6.1.9; Alkaline phosphodiesterase I; Dinucleoside polyphosphatase; E-NPP 3; NPPase; Nucleotide diphosphatase; Nucleotide pyrophosphatase; PD-Ibeta; Phosphodiesterase I beta; Phosphodiesterase I/nucleotide pyrophosphatase 3",
        "protein_names_refseq": "E-NPP 3; NPPase; PD-Ibeta; alkaline phosphodiesterase I; dinucleoside polyphosphatase; ectonucleotide pyrophosphatase/phosphodiesterase family member 3; nucleotide diphosphatase; phosphodiesterase I beta; phosphodiesterase I/nucleotide pyrophosphatase 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:209558)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;19349973;21750661;23960081;25692702;28225814;34428180;38749434",
        "class_list": "",
        "function": "E-NPP3 decreases ATP concentration and suppresses basophil and mast cell activity., [RefSeq, PubMed]; Hydrolase that metabolizes extracellular nucleotides, including ATP, GTP, UTP and CTP (By similarity). Also hydrolyzes extracellular 2',3'-cGAMP (cyclic GMP-AMP), a second messenger that activates TMEM173/STING and triggers type-I interferon production, and is therefore involved in the regulation of innate immune response (PubMed:38749434). 2',3'-cGAMP appears to be further processed to GMP, AMP and inorganic phosphate (PubMed:38749434). Limits mast cells and basophils response during inflammation and during the chronic phases of allergic responses by eliminating extracellular ATP, a signaling molecule activating these cells in an autocrine manner (PubMed:25692702). Metabolizes extracellular ATP in the lumen of the small intestine, and thereby prevents ATP-induced apoptosis of intestinal plasmacytoid dendritic cells (PubMed:28225814). Has a broad specificity and can also hydrolyze UDP-GlcNAc into UMP and GlcNAc-1-phosphate and potentially several other intracellular nucleotide sugars, including UDP-GalNAc, CMP-NeuAc, GDP-Fuc, and UDP-GlcA. Thereby, could modulate glycan biosynthesis and protein glycosylation (PubMed:23960081). Can hydrolyze extracellular dinucleoside polyphosphates, including the vasoactive adenosine polyphosphates as well. In addition, displays an alkaline phosphodiesterase activity in vitro (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed]; Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint., [RefSeq, PubMed]; In Enpp3-/- mice, ATP concentrations were increased in the intestinal lumen. Plasmacytoid dendritic cell (pDC) numbers were remarkably decreased in the small intestinal lamina propria and Peyer's patches. Intestinal pDCs of Enpp3-/- mice showed enhanced cell death. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 5,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 5,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 5,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 5,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9781,
        "biomarker_type": "",
        "glycan_count": 5,
        "disease_count": 0,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QMU8",
        "ec_number_list": "3.1.3.5;3.1.3.89;3.1.3.99;3.6.1.29;3.9.1.-;2.7.7.51;3.6.2.1;3.1.4.1;3.6.1.9;3.1.3.1;3.9.1.1;3.6.1.52;3.6.1.60;3.6.1.17;2.7.1.77;3.1.3.91;3.1.3.35;3.6.1.-;3.6.1.68;3.6.1.76;3.6.1.59;3.6.1.62;3.6.1.10;3.6.1.61",
        "go_molecular_function": "GO:0034432 bis(5'-adenosyl)-pentaphosphatase activity;GO:0005524 ATP binding;GO:0008270 zinc ion binding;GO:0005509 calcium ion binding;GO:0036219 GTP diphosphatase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005886 plasma membrane;GO:0048471 perinuclear region of cytoplasm;GO:0009897 external side of plasma membrane;GO:0016324 apical plasma membrane",
        "go_biological_process": "GO:0050728 negative regulation of inflammatory response;GO:0006796 phosphate-containing compound metabolic process;GO:0055062 phosphate ion homeostasis;GO:0046034 ATP metabolic process;GO:0009143 nucleoside triphosphate catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "Q6DYE8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99M71-1",
        "uniprot_id": "EPDR1_MOUSE",
        "mass": 25485.0,
        "length": 224,
        "protein_name": "Mammalian ependymin-related protein 1",
        "gene_name": "Epdr1",
        "organism": "Mouse",
        "refseq_name": "mammalian ependymin-related protein 1 precursor",
        "refseq_ac": "NP_598826",
        "gene_names_uniprotkb": "Epdr1; Epdr2; Merp1; Merp2",
        "gene_names_refseq": "Epdm2; Epdr1; Epdr2; MERP-1; MERP-2; MERP2; Ucc1",
        "protein_names_uniprotkb": "Mammalian ependymin-related protein 1; MERP-1",
        "protein_names_refseq": "ependymin 2; ependymin related protein 1; ependymin related protein 2; mammalian ependymin-related protein 1 precursor; mammalian ependymin-related protein 1; upregulated in colorectal cancer gene 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:105298)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;11749721;16954209;21750661;30899004;35872017",
        "class_list": "",
        "function": "A novel density shift method was used to demonstrate that EPDR resides in the lysosome., [RefSeq, PubMed]; Binds anionic lipids and gangliosides at acidic pH., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; EPDR1 is a noncanonical effector of insulin-mediated angiogenesis regulated by an endothelial-specific TGF-beta receptor complex., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 9,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q06BK9;Q8BQY1;Q8CAI2",
        "ec_number_list": "",
        "go_molecular_function": "GO:1905573 ganglioside GM1 binding;GO:0005543 phospholipid binding;GO:0042802 identical protein binding;GO:0005509 calcium ion binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005764 lysosome;GO:0043202 lysosomal lumen",
        "go_biological_process": "GO:0007160 cell-matrix adhesion;GO:1990764 myofibroblast contraction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q99M71-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P55850-1",
        "uniprot_id": "DSC3_MOUSE",
        "mass": 100203.0,
        "length": 896,
        "protein_name": "Desmocollin-3",
        "gene_name": "Dsc3",
        "organism": "Mouse",
        "refseq_name": "desmocollin-3 isoform 2 precursor",
        "refseq_ac": "NP_001278738",
        "gene_names_uniprotkb": "Dsc3",
        "gene_names_refseq": "5430426I24Rik; Dsc3",
        "protein_names_uniprotkb": "Desmocollin-3",
        "protein_names_refseq": "desmocollin-3 isoform 2 precursor",
        "tax_id": 10090,
        "disease": "arrhythmogenic right ventricular cardiomyopathy (Disease Ontology:DOID:0050431)",
        "pathway": " (mmu:13507);  (R-MMU-6805567);  (R-MMU-6809371)",
        "pathway_count": 3,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;16170054;16418220;18682494;21750661;28011936;34428180;38395410;9389456;9404003",
        "class_list": "",
        "function": "A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:38395410). Required for cell-cell adhesion in the epidermis, as a result required for the maintenance of the dermal cohesion and the dermal barrier function (PubMed:18682494). Required for cell-cell adhesion of epithelial cell layers surrounding the telogen hair club, as a result plays an important role in telogen hair shaft anchorage (PubMed:18682494). Essential for successful completion of embryo compaction and development beyond the 8-cell stage (PubMed:16418220)., [UniProtKB, PubMed, PubMed, PubMed]; This gene encodes a member of the cadherin family of proteins that mediates adhesion in desmosomes. Together with desmogleins, the encoded protein forms the transmembrane core of desmosomes, a multiprotein complex involved in cell adhesion, organization of the cytoskeleton, cell sorting and cell signaling. Mice lacking the encoded protein exhibit a pre-implantation lethal phenotype. This gene is located in a cluster of desmosomal cadherin genes on chromosome 18. This gene encodes distinct isoforms, some or all of which may undergo similar processing to generate the mature protein. [provided by RefSeq, Jul 2016]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "G5E8S6;O55110;O55122",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005509 calcium ion binding;GO:0045295 gamma-catenin binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0030054 cell junction;GO:0030057 desmosome",
        "go_biological_process": "GO:0001701 in utero embryonic development;GO:0098609 cell-cell adhesion;GO:0050821 protein stabilization;GO:0007156 homophilic cell adhesion via plasma membrane adhesion molecules;GO:0007155 cell adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "P55850-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CQ02-1",
        "uniprot_id": "COMD4_MOUSE",
        "mass": 21860.0,
        "length": 199,
        "protein_name": "COMM domain-containing protein 4",
        "gene_name": "Commd4",
        "organism": "Mouse",
        "refseq_name": "COMM domain-containing protein 4",
        "refseq_ac": "NP_079693",
        "gene_names_uniprotkb": "Commd4",
        "gene_names_refseq": "1110039H05Rik; Commd4",
        "protein_names_uniprotkb": "COMM domain-containing protein 4",
        "protein_names_refseq": "COMM domain-containing protein 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66199);  (R-MMU-8951664)",
        "pathway_count": 2,
        "publication_count": 2,
        "publication_id_list": "21750661;34428180",
        "class_list": "",
        "function": "Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex (By similarity). May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (By similarity). Down-regulates activation of NF-kappa-B (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0007165 signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9CQ02-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O08696-1",
        "uniprot_id": "FOXM1_MOUSE",
        "mass": 83694.0,
        "length": 760,
        "protein_name": "Forkhead box protein M1",
        "gene_name": "Foxm1",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Foxm1; Fkh16",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Forkhead box protein M1; Forkhead homolog 16; Winged-helix transcription factor Trident",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "stomach cancer (Disease Ontology:DOID:10534); lung cancer (Disease Ontology:DOID:1324); pancreatic ductal adenocarcinoma (Disease Ontology:DOID:3498); hepatocellular carcinoma (Disease Ontology:DOID:684); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (R-MMU-156711);  (R-MMU-69273)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "17101782;21750661;25428506;30084848;31219806;34418053;9108152",
        "class_list": "",
        "function": "Transcription factor regulating the expression of cell cycle genes essential for DNA replication and mitosis (By similarity). Plays a role in the control of cell proliferation (By similarity). Also plays a role in DNA break repair, participating in the DNA damage checkpoint response (PubMed:17101782). Promotes transcription of PHB2 (By similarity)., [UniProtKB, UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0019901 protein kinase binding;GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0000976 transcription cis-regulatory region binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0001570 vasculogenesis;GO:0001889 liver development;GO:0006281 DNA repair;GO:0006351 DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "O08696-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D2I5-1",
        "uniprot_id": "ARMC9_MOUSE",
        "mass": 91922.0,
        "length": 817,
        "protein_name": "LisH domain-containing protein ARMC9",
        "gene_name": "Armc9",
        "organism": "Mouse",
        "refseq_name": "lisH domain-containing protein ARMC9 isoform 3",
        "refseq_ac": "NP_001297631",
        "gene_names_uniprotkb": "Armc9",
        "gene_names_refseq": "3830422A13Rik; 4831423D23Rik; 4930438O05Rik; 5730415N24Rik; Armc9",
        "protein_names_uniprotkb": "LisH domain-containing protein ARMC9",
        "protein_names_refseq": "lisH domain-containing protein ARMC9 isoform 3; lisH domain-containing protein ARMC9",
        "tax_id": 10090,
        "disease": "Joubert syndrome 30 (Disease Ontology:DOID:0080275)",
        "pathway": " (mmu:78795)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21750661;25428506;29459677;34203471;34428180",
        "class_list": "",
        "function": "Involved in ciliogenesis (By similarity). It is required for appropriate acetylation and polyglutamylation of ciliary microtubules, and regulation of cilium length (By similarity). Acts as a positive regulator of hedgehog (Hh) signaling (PubMed:29459677). May participate in the trafficking and/or retention of GLI2 and GLI3 proteins at the ciliary tip (PubMed:29459677)., [UniProtKB, UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BQQ3;Q8BR45;Q8BSX7;Q8C6A6;Q8C889;Q8CA23;Q8CBG2;Q8K112;Q9CYL1;Q9D2L3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005929 cilium;GO:0005814 centriole;GO:0036064 ciliary basal body;GO:0097542 ciliary tip",
        "go_biological_process": "GO:0045880 positive regulation of smoothened signaling pathway;GO:0060271 cilium assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q9D2I5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P57759-1",
        "uniprot_id": "ERP29_MOUSE",
        "mass": 28823.0,
        "length": 262,
        "protein_name": "Endoplasmic reticulum resident protein 29",
        "gene_name": "Erp29",
        "organism": "Mouse",
        "refseq_name": "endoplasmic reticulum resident protein 29 precursor",
        "refseq_ac": "NP_080405",
        "gene_names_uniprotkb": "Erp29",
        "gene_names_refseq": "1200015M03Rik; 2810446M09Rik; Erp28; Erp29; Erp31; PDI-Db",
        "protein_names_uniprotkb": "Endoplasmic reticulum resident protein 29; ERp29",
        "protein_names_refseq": "endoplasmic reticulum resident protein 29 precursor; endoplasmic reticulum resident protein 29",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:67397)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "12475965;21750661;26495903;26548430;26740625;28534505;32152506;34428180;36572185;37507081",
        "class_list": "",
        "function": "Does not seem to be a disulfide isomerase. Plays an important role in the processing of secretory proteins within the endoplasmic reticulum (ER), possibly by participating in the folding of proteins in the ER., [UniProtKB]; Erp29 may have an important role in Endoplasmic reticulum stress in islet beta cells., [RefSeq, PubMed]; Regulatory role of endoplasmic reticulum resident chaperone protein ERp29 in anti-murine beta-coronavirus host cell response., [RefSeq, PubMed]; The anti-aggregation peptide ReACp53 significantly decreased ERP29 expression and suppressed the chemoresistant effect. These findings highlight a role of ERP29 in the acquired chemoresistance of cancer cells expressing the aggregating p53 mutant Arg282Trp., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3THW3;Q9CQ42",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0051087 protein-folding chaperone binding",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005788 endoplasmic reticulum lumen;GO:0005790 smooth endoplasmic reticulum;GO:0009986 cell surface;GO:0042470 melanosome",
        "go_biological_process": "GO:0050709 negative regulation of protein secretion;GO:0010628 positive regulation of gene expression;GO:0010629 negative regulation of gene expression;GO:0043410 positive regulation of MAPK cascade;GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "P57759-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BQZ5-1",
        "uniprot_id": "CPSF4_MOUSE",
        "mass": 23653.0,
        "length": 211,
        "protein_name": "Cleavage and polyadenylation specificity factor subunit 4",
        "gene_name": "Cpsf4",
        "organism": "Mouse",
        "refseq_name": "cleavage and polyadenylation specificity factor subunit 4 isoform a",
        "refseq_ac": "NP_001278177",
        "gene_names_uniprotkb": "Cpsf4; Cpsf30",
        "gene_names_refseq": "30kDa; Cpsf4",
        "protein_names_uniprotkb": "Cleavage and polyadenylation specificity factor subunit 4; CPSF 30 kDa subunit; Cleavage and polyadenylation specificity factor 30 kDa subunit; Clipper homolog; Clipper/CPSF 30K",
        "protein_names_refseq": "CPSF 30 kDa subunit; cleavage and polyadenylation specific factor 4, 30kD subunit; cleavage and polyadenylation specificity factor subunit 4 isoform a; cleavage and polyadenylation specificity factor subunit 4; clipper homolog; clipper/CPSF 30K; musculus clipper/cleavage and polyadenylation specificity factor 30 kDa subunit",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:54188);  (R-MMU-159231);  (R-MMU-72187);  (R-MMU-73856);  (R-MMU-77595);  (R-MMU-9770562)",
        "pathway_count": 6,
        "publication_count": 2,
        "publication_id_list": "21750661;9512528",
        "class_list": "",
        "function": "Component of the cleavage and polyadenylation specificity factor (CPSF) complex that play a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. CPSF4 binds RNA polymers with a preference for poly(U) (By similarity)., [UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O54930",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0008270 zinc ion binding;GO:1990837 sequence-specific double-stranded DNA binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005847 mRNA cleavage and polyadenylation specificity factor complex",
        "go_biological_process": "GO:0031124 mRNA 3'-end processing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8BQZ5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CDG5-1",
        "uniprot_id": "CRERF_MOUSE",
        "mass": 72598.0,
        "length": 640,
        "protein_name": "CREB3 regulatory factor",
        "gene_name": "Crebrf",
        "organism": "Mouse",
        "refseq_name": "CREB3 regulatory factor",
        "refseq_ac": "NP_084146",
        "gene_names_uniprotkb": "Crebrf; A930001N09Rik",
        "gene_names_refseq": "A930001N09Rik; Crebrf; LRF",
        "protein_names_uniprotkb": "CREB3 regulatory factor; LRF; Luman recruitment factor",
        "protein_names_refseq": "CREB3 regulatory factor; UPF0474 protein C5orf41 homolog; luman recruitment factor",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:77128);  (R-MMU-8874211)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "18391022;21750661;23071095;23400243;31219806;32901804;34275032;34520472;35159305",
        "class_list": "",
        "function": "A murine model of the human CREBRFR457Q obesity-risk variant does not influence energy or glucose homeostasis in response to nutritional stress. Publication Status: Online-Only, [RefSeq, PubMed]; Acts as a negative regulator of the endoplasmic reticulum stress response or unfolded protein response (UPR). Represses the transcriptional activity of CREB3 during the UPR. Recruits CREB3 into nuclear foci (By similarity)., [UniProtKB]; LRF has a role in the process of implantation in uteri and development of preimplantation embryos in mice, [RefSeq, PubMed]; Limited Metabolic Effect of the CREBRF(R457Q) Obesity Variant in Mice. Publication Status: Online-Only, [RefSeq, PubMed]; Loss of CREBRF Reduces Anxiety-like Behaviors and Circulating Glucocorticoids in Male and Female Mice., [RefSeq, PubMed]; Molecular characterization of mouse CREB3 regulatory factor in Neuro2a cells., [RefSeq, PubMed]; Postulate that LRF plays a critical role in the attenuation of the HPA axis through repression of glucocorticoid stress signaling during parturition and the postpartum period, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B8JJI1;Q14DI2;Q8C8N7;Q9CTQ7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific;GO:0003700 DNA-binding transcription factor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0016604 nuclear body",
        "go_biological_process": "GO:1900102 negative regulation of endoplasmic reticulum unfolded protein response;GO:1902213 positive regulation of prolactin signaling pathway;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q8CDG5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QXT5-1",
        "uniprot_id": "EGFL7_MOUSE",
        "mass": 29765.0,
        "length": 275,
        "protein_name": "Epidermal growth factor-like protein 7",
        "gene_name": "Egfl7",
        "organism": "Mouse",
        "refseq_name": "epidermal growth factor-like protein 7 isoform 1 precursor",
        "refseq_ac": "NP_001158036",
        "gene_names_uniprotkb": "Egfl7; Megf7",
        "gene_names_refseq": "Egfl7; VE-statin; Zneu1",
        "protein_names_uniprotkb": "Epidermal growth factor-like protein 7; EGF-like protein 7; Multiple EGF-like domains protein 7; Multiple epidermal growth factor-like domains protein 7; NOTCH4-like protein; VE-statin; Vascular endothelial statin; Zneu1",
        "protein_names_refseq": "EGF-like protein 7; NEU1 protein; NOTCH4-like protein; epidermal growth factor-like protein 7 isoform 1 precursor; epidermal growth factor-like protein 7; multiple EGF-like domains protein 7; multiple epidermal growth factor-like domains protein 7; vascular endothelial statin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:353156)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "14592969;15085134;15162510;21750661;36530156;36715759;37480091",
        "class_list": "",
        "function": "EGFL7 affects the migration of epidermal stem cells in refractory diabetic wounds by regulating Notch signaling pathway., [RefSeq, PubMed]; EGFL7 loss correlates with increased VEGF-D expression, upregulating hippocampal adult neurogenesis and improving spatial learning and memory. Erratum:[Cell Mol Life Sci. 2023 Jul 13;80(8):201. doi: 10.1007/s00018-023-04835-3. PMID: 37439854] Publication Status: Online-Only, [RefSeq, PubMed]; EGFL7 protein is localized to the endoplasmic reticulum and Golgi apparatus, suggesting that the protein is targeted for secretion, [RefSeq, PubMed]; Hepatocellular carcinoma cells remodel the pro-metastatic tumour microenvironment through recruitment and activation of fibroblasts via paracrine Egfl7 signaling. Publication Status: Online-Only, [RefSeq, PubMed]; Is the first identified inhibitor of mural cell migration specifically produced by endothelial cells., [RefSeq, PubMed]; Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cell adhesion to the extracellular matrix and angiogenesis., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB]; Regulator that controls a specific and important step in vasculogenesis, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6XD35;Q9DCP5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005102 signaling receptor binding;GO:0005509 calcium ion binding;GO:0005112 Notch binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0009986 cell surface;GO:0031012 extracellular matrix",
        "go_biological_process": "GO:0001525 angiogenesis;GO:0001570 vasculogenesis;GO:0007155 cell adhesion;GO:0030336 negative regulation of cell migration;GO:0001568 blood vessel development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9QXT5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80VP9-1",
        "uniprot_id": "ASPH2_MOUSE",
        "mass": 38731.0,
        "length": 343,
        "protein_name": "Aspartate beta-hydroxylase domain-containing protein 2",
        "gene_name": "Asphd2",
        "organism": "Mouse",
        "refseq_name": "aspartate beta-hydroxylase domain-containing protein 2",
        "refseq_ac": "NP_082662",
        "gene_names_uniprotkb": "Asphd2",
        "gene_names_refseq": "2900006N09Rik; 9230106G13Rik; Asphd2",
        "protein_names_uniprotkb": "Aspartate beta-hydroxylase domain-containing protein 2; 1.14.11.-",
        "protein_names_refseq": "aspartate beta-hydroxylase domain-containing protein 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72898)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "May function as 2-oxoglutarate-dependent dioxygenase., [UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CUZ2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0051213 dioxygenase activity",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q80VP9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BLI0-1",
        "uniprot_id": "ATL1_MOUSE",
        "mass": 192008.0,
        "length": 1745,
        "protein_name": "ADAMTS-like protein 1",
        "gene_name": "Adamtsl1",
        "organism": "Mouse",
        "refseq_name": "ADAMTS-like protein 1 isoform 1 precursor",
        "refseq_ac": "NP_084243",
        "gene_names_uniprotkb": "Adamtsl1",
        "gene_names_refseq": "5930437A14Rik; 6720426B09Rik; ADAMTSL-1; Adamtsl1",
        "protein_names_uniprotkb": "ADAMTS-like protein 1; ADAMTSL-1; Punctin-1",
        "protein_names_refseq": "ADAMTS-like protein 1 isoform 1 precursor; ADAMTS-like protein 1; punctin-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:77739);  (R-MMU-5173214)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;32152506;34203471",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 5,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 5,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 5,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 5,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 5,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9835,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AM52",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0031012 extracellular matrix;GO:0005576 extracellular region",
        "go_biological_process": "GO:0030198 extracellular matrix organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q8BLI0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88587-1",
        "uniprot_id": "COMT_MOUSE",
        "mass": 29486.0,
        "length": 265,
        "protein_name": "Catechol O-methyltransferase",
        "gene_name": "Comt",
        "organism": "Mouse",
        "refseq_name": "catechol O-methyltransferase",
        "refseq_ac": "NP_001104532",
        "gene_names_uniprotkb": "Comt; Comt1",
        "gene_names_refseq": "Comt1; Comt; D16Wsu103e; D330014B15Rik",
        "protein_names_uniprotkb": "Catechol O-methyltransferase; 2.1.1.6",
        "protein_names_refseq": "catechol O-methyltransferase; catechol-O-methyltransferase 1",
        "tax_id": 10090,
        "disease": "alcohol dependence (Disease Ontology:DOID:0050741); nicotine dependence (Disease Ontology:DOID:0050742); withdrawal disorder (Disease Ontology:DOID:0060001); autism spectrum disorder (Disease Ontology:DOID:0060041); Parkinsonism (Disease Ontology:DOID:0080855); prostate cancer (Disease Ontology:DOID:10283); pre-eclampsia (Disease Ontology:DOID:10591); hypertension (Disease Ontology:DOID:10763); obsessive-compulsive disorder (Disease Ontology:DOID:10933); attention deficit hyperactivity disorder (Disease Ontology:DOID:1094); urinary bladder cancer (Disease Ontology:DOID:11054); polycystic ovary syndrome (Disease Ontology:DOID:11612); bulimia nervosa (Disease Ontology:DOID:12129); vitiligo (Disease Ontology:DOID:12306); pathological gambling (Disease Ontology:DOID:12399); intermittent explosive disorder (Disease Ontology:DOID:12401); leiomyoma (Disease Ontology:DOID:127); eumycotic mycetoma (Disease Ontology:DOID:13078); lung cancer (Disease Ontology:DOID:1324); endometrial cancer (Disease Ontology:DOID:1380); cognitive disorder (Disease Ontology:DOID:1561); alcohol use disorder (Disease Ontology:DOID:1574); breast cancer (Disease Ontology:DOID:1612); cannabis dependence (Disease Ontology:DOID:1849); ovarian cancer (Disease Ontology:DOID:2394); opiate dependence (Disease Ontology:DOID:2559); morphine dependence (Disease Ontology:DOID:2560); bipolar disorder (Disease Ontology:DOID:3312); renal cell carcinoma (Disease Ontology:DOID:4450); uremia (Disease Ontology:DOID:4676); schizophrenia (Disease Ontology:DOID:5419); fibromyalgia (Disease Ontology:DOID:631); amphetamine abuse (Disease Ontology:DOID:670); psoriasis (Disease Ontology:DOID:8893); cannabis abuse (Disease Ontology:DOID:9505); neonatal abstinence syndrome (Disease Ontology:DOID:9828); obesity (Disease Ontology:DOID:9970); drug dependence (Disease Ontology:DOID:9974); cocaine dependence (Disease Ontology:DOID:9975); heroin dependence (Disease Ontology:DOID:9976)",
        "pathway": " (mmu:12846);  (R-MMU-156581);  (R-MMU-379397);  (R-MMU-379398)",
        "pathway_count": 4,
        "publication_count": 13,
        "publication_id_list": "17242355;18794526;19131326;19144319;21183079;21750661;26495903;34428180;36623778;37453647;37507081;37684514;9707588",
        "class_list": "",
        "function": "Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol., [UniProtKB, PubMed]; Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric Catechol-O-Methyltransferase/microRNA-155/Tumor Necrosis Factor alpha Axis., [RefSeq, PubMed]; Dysregulated COMT Expression in Fragile X Syndrome., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 40,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q91XH4",
        "ec_number_list": "2.1.1.6",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0016206 catechol O-methyltransferase activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol;GO:0016020 membrane",
        "go_biological_process": "GO:0008210 estrogen metabolic process;GO:0046959 habituation;GO:0071626 mastication;GO:0021696 cerebellar cortex morphogenesis;GO:0001964 startle response",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "O88587-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VHA6-1",
        "uniprot_id": "ASB18_MOUSE",
        "mass": 50700.0,
        "length": 467,
        "protein_name": "Ankyrin repeat and SOCS box protein 18",
        "gene_name": "Asb18",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 18 isoform 1",
        "refseq_ac": "NP_631891",
        "gene_names_uniprotkb": "Asb18",
        "gene_names_refseq": "Asb-18; Asb18",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 18; ASB-18",
        "protein_names_refseq": "SOCS box protein ASB-18; ankyrin repeat and SOCS box protein 18 isoform 1; ankyrin repeat and SOCS box protein 18",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:208372);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "21750661;37828378",
        "class_list": "",
        "function": "May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3B7Y5;Q3KNB0",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8VHA6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60899-1",
        "uniprot_id": "ELAV2_MOUSE",
        "mass": 39577.0,
        "length": 360,
        "protein_name": "ELAV-like protein 2",
        "gene_name": "Elavl2",
        "organism": "Mouse",
        "refseq_name": "ELAV-like protein 2 isoform 2",
        "refseq_ac": "NP_034616",
        "gene_names_uniprotkb": "Elavl2; Hub",
        "gene_names_refseq": "Elavl2; Hub; mel-N1",
        "protein_names_uniprotkb": "ELAV-like protein 2; ELAV-like neuronal protein 1; Hu-antigen B; HuB; Nervous system-specific RNA-binding protein Mel-N1",
        "protein_names_refseq": "ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B); ELAV like RNA binding protein 1; ELAV-like neuronal protein 1; ELAV-like protein 2 isoform 2; ELAV-like protein 2; HU-antigen B; nervous system-specific RNA-binding protein Mel-N1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:15569)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;11573004;21288476;21750661;34428180;8668530",
        "class_list": "",
        "function": "RNA-binding protein that binds to the 3' untranslated region (3'UTR) of target mRNAs (PubMed:8668530). Seems to recognize a GAAA motif (PubMed:8668530). Can bind to its own 3'UTR, the FOS 3'UTR and the ID 3'UTR (PubMed:8668530)., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0140517 protein-RNA adaptor activity",
        "go_cellular_component": "GO:0045202 synapse;GO:1990904 ribonucleoprotein complex;GO:0150048 cerebellar granule cell to Purkinje cell synapse",
        "go_biological_process": "GO:1990830 cellular response to leukemia inhibitory factor;GO:0051963 regulation of synapse assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q60899-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K0V4-1",
        "uniprot_id": "CNOT3_MOUSE",
        "mass": 81946.0,
        "length": 751,
        "protein_name": "CCR4-NOT transcription complex subunit 3",
        "gene_name": "Cnot3",
        "organism": "Mouse",
        "refseq_name": "CCR4-NOT transcription complex subunit 3",
        "refseq_ac": "NP_666288",
        "gene_names_uniprotkb": "Cnot3; Not3",
        "gene_names_refseq": "A930039N10Rik; Cnot3",
        "protein_names_uniprotkb": "CCR4-NOT transcription complex subunit 3; CCR4-associated factor 3",
        "protein_names_refseq": "CCR4-NOT transcription complex subunit 3; CCR4-associated factor 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:232791);  (R-MMU-429947);  (R-MMU-6804115)",
        "pathway_count": 3,
        "publication_count": 15,
        "publication_id_list": "10.1101/2023.09.13.557529;18250455;20133598;21183079;21750661;21897366;22367759;25605945;26495903;33725478;34210974;34428180;34613789;35984892;37828378",
        "class_list": "",
        "function": "CNOT3 interacts with the Aurora B and MAPK/ERK kinases to promote survival of differentiating mesendodermal progenitor cells., [RefSeq, PubMed]; Component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation (PubMed:34210974). Additional complex functions may be a consequence of its influence on mRNA expression. May be involved in metabolic regulation; may be involved in recruitment of the CCR4-NOT complex to deadenylation target mRNAs involved in energy metabolism. Involved in mitotic progression and regulation of the spindle assembly checkpoint by regulating the stability of MAD1L1 mRNA. Can repress transcription and may link the CCR4-NOT complex to transcriptional regulation; the repressive function may involve histone deacetylases. Involved in the maintenance of embryonic stem (ES) cell identity; prevents their differentiation towards extraembryonic trophectoderm lineages., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 6,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9671,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RUA7",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol;GO:0000932 P-body;GO:0030014 CCR4-NOT complex;GO:0030015 CCR4-NOT core complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006417 regulation of translation;GO:0006355 regulation of DNA-templated transcription;GO:0001829 trophectodermal cell differentiation;GO:0007368 determination of left/right symmetry",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q8K0V4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P48024-1",
        "uniprot_id": "EIF1_MOUSE",
        "mass": 12747.0,
        "length": 113,
        "protein_name": "Eukaryotic translation initiation factor 1",
        "gene_name": "Eif1",
        "organism": "Mouse",
        "refseq_name": "eukaryotic translation initiation factor 1",
        "refseq_ac": "NP_035638",
        "gene_names_uniprotkb": "Eif1; Sui1-rs1; Sui1",
        "gene_names_refseq": "Eif1; Sui1-rs1",
        "protein_names_uniprotkb": "Eukaryotic translation initiation factor 1; Protein translation factor SUI1 homolog; eIF1",
        "protein_names_refseq": "eukaryotic translation initiation factor 1; protein translation factor SUI1 homolog; suppressor of initiator codon mutations, related sequence 1; suppressor of initiator codon mutations-Yeast homolog related sequence 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:20918)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "21750661;25428506;30084848;30779550;34428180;8903738",
        "class_list": "",
        "function": "Component of the 43S pre-initiation complex (43S PIC), which binds to the mRNA cap-proximal region, scans mRNA 5'-untranslated region, and locates the initiation codon. Together with eIF1A (EIF1AX), EIF1 facilitates scanning and is essential for start codon recognition on the basis of AUG nucleotide context and location relative to the 5'-cap. Participates to initiation codon selection by influencing the conformation of the 40S ribosomal subunit and the positions of bound mRNA and initiator tRNA; this is possible after its binding to the interface surface of the platform of the 40S ribosomal subunit close to the P-site. Together with eIF1A (EIF1AX), also regulates the opening and closing of the mRNA binding channel, which ensures mRNA recruitment, scanning and the fidelity of initiation codon selection. Continuously monitors and protects against premature and partial base-pairing of codons in the 5'-UTR with the anticodon of initiator tRNA. Together with eIF1A (EIF1AX), acts for ribosomal scanning, promotion of the assembly of 48S complex at the initiation codon (43S PIC becomes 48S PIC after the start codon is reached), and dissociation of aberrant complexes. Interacts with EIF4G1, which in a mutual exclusive interaction associates either with EIF1 or with EIF4E on a common binding site. EIF4G1-EIF1 complex promotes ribosome scanning (on both short and long 5'UTR), leaky scanning (on short 5'UTR) which is the bypass of the initial start codon, and discrimination against cap-proximal AUG. Is probably maintained within the 43S PIC in open conformation thanks to eIF1A-EIF5 interaction. Once the correct start codon is reached, EIF1 is physically excluded from the decoding site, shifting the PIC into the closed conformation and arresting it at the start codon., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9WUD5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0043024 ribosomal small subunit binding;GO:0003743 translation initiation factor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0016282 eukaryotic 43S preinitiation complex;GO:0033290 eukaryotic 48S preinitiation complex;GO:0043614 multi-eIF complex",
        "go_biological_process": "GO:0006413 translational initiation;GO:0006446 regulation of translational initiation;GO:1905746 positive regulation of mRNA cis splicing, via spliceosome;GO:0010468 regulation of gene expression;GO:0080090 regulation of primary metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "P48024-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q920L5-1",
        "uniprot_id": "ELOV6_MOUSE",
        "mass": 31610.0,
        "length": 267,
        "protein_name": "Very long chain fatty acid elongase 6",
        "gene_name": "Elovl6",
        "organism": "Mouse",
        "refseq_name": "very long chain fatty acid elongase 6",
        "refseq_ac": "NP_569717",
        "gene_names_uniprotkb": "Elovl6; Face; Lce; Masr",
        "gene_names_refseq": "Elovl6; FAE; LCE",
        "protein_names_uniprotkb": "Very long chain fatty acid elongase 6; 2.3.1.199; 3-keto acyl-CoA synthase Elovl6; ELOVL FA elongase 6; ELOVL fatty acid elongase 6; Elongation of very long chain fatty acids protein 6; Fatty acyl-CoA elongase; Long chain fatty acid elongase; Myelin-associated SUR4 protein; Very long chain 3-ketoacyl-CoA synthase 6; Very long chain 3-oxoacyl-CoA synthase 6",
        "protein_names_refseq": "3-keto acyl-CoA synthase Elovl6; ELOVL FA elongase 6; ELOVL family member 6, elongation of long chain fatty acids; elongation of very long chain fatty acids protein 6; fatty acyl-CoA elongase; long chain fatty acid elongase; long chain fatty acyl elongase; myelin-associated SUR4 protein; very long chain 3-ketoacyl-CoA synthase 6; very long chain 3-oxoacyl-CoA synthase 6; very long chain fatty acid elongase 6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:170439);  (R-MMU-75876)",
        "pathway_count": 2,
        "publication_count": 18,
        "publication_id_list": "10.1101/2023.09.13.557529;11567032;12032166;12084938;17906635;18299400;20484733;21750661;21952136;22645316;25428506;25605945;30084848;30779550;31219806;34428180;37669365;38760797",
        "class_list": "glycogene",
        "function": "Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that elongates fatty acids with 12, 14 and 16 carbons with higher activity toward C16:0 acyl-CoAs. Catalyzes the synthesis of unsaturated C16 long chain fatty acids and, to a lesser extent, C18:0 and those with low desaturation degree. May participate in the production of saturated and monounsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators., [UniProtKB, HAMAP, PubMed, PubMed, PubMed]; Data indicate this elongase is a lipogenic enzyme regulated by SREBP-1, playing an important role in de novo synthesis of long-chain saturated and monosaturated fatty acids in conjunction with fatty acid synthase and stearoyl-CoA desaturase., [RefSeq, PubMed]; Fatty acid elongation by ELOVL6 hampers remyelination by promoting inflammatory foam cell formation during demyelination., [RefSeq, PubMed]; Low expression of ELOVL6 may be involved in fat loss in white adipose tissue of cancer-associated cachexia. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 18,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CE45",
        "ec_number_list": "2.3.1.199",
        "go_molecular_function": "GO:0016747 acyltransferase activity, transferring groups other than amino-acyl groups;GO:0009922 fatty acid elongase activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane;GO:0009923 fatty acid elongase complex;GO:0016020 membrane",
        "go_biological_process": "GO:0030148 sphingolipid biosynthetic process;GO:0035338 long-chain fatty-acyl-CoA biosynthetic process;GO:0006636 unsaturated fatty acid biosynthetic process;GO:0030497 fatty acid elongation;GO:0034625 fatty acid elongation, monounsaturated fatty acid",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q920L5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80US4-1",
        "uniprot_id": "ARP5_MOUSE",
        "mass": 67845.0,
        "length": 605,
        "protein_name": "Actin-related protein 5",
        "gene_name": "Actr5",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Actr5",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Actin-related protein 5",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:109275);  (R-MMU-5689603);  (R-MMU-5696394)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "21750661;31219806;34428180",
        "class_list": "",
        "function": "Proposed core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair. Involved in DNA double-strand break repair and UV-damage excision repair (By similarity)., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2ACC9;Q8BL26",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030234 enzyme regulator activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0031011 Ino80 complex",
        "go_biological_process": "GO:0060382 regulation of DNA strand elongation;GO:0033044 regulation of chromosome organization;GO:0006310 DNA recombination;GO:0006338 chromatin remodeling;GO:0006351 DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q80US4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q566J8-1",
        "uniprot_id": "COQ8B_MOUSE",
        "mass": 59232.0,
        "length": 533,
        "protein_name": "Atypical kinase COQ8B, mitochondrial",
        "gene_name": "Coq8b",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Coq8b; Adck4",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Atypical kinase COQ8B, mitochondrial; 2.7.-.-; AarF domain-containing protein kinase 4; Coenzyme Q protein 8B",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "coenzyme Q10 deficiency disease (Disease Ontology:DOID:0050730); primary coenzyme Q10 deficiency 4 (Disease Ontology:DOID:0070241); nephrotic syndrome type 9 (Disease Ontology:DOID:0080391); nephrotic syndrome (Disease Ontology:DOID:1184)",
        "pathway": " (mmu:76889);  (R-MMU-2142789)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Atypical kinase involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration. Its substrate specificity is still unclear: may act as a protein kinase that mediates phosphorylation of COQ3 (By similarity). According to other reports, acts as a small molecule kinase, possibly a lipid kinase that phosphorylates a prenyl lipid in the ubiquinone biosynthesis pathway, as suggested by its ability to bind coenzyme Q lipid intermediates (By similarity). However, the small molecule kinase activity was not confirmed by another publication. Required for podocyte migration (By similarity)., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5XJH7;Q91WT5",
        "ec_number_list": "1.14.99.60;1.14.13.253;2.7.-.-;4.1.1.130;2.1.1.-;2.1.1.114;2.1.1.64;1.14.15.45;1.14.15.46;2.1.1.201",
        "go_molecular_function": "GO:0004672 protein kinase activity;GO:0005524 ATP binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0031966 mitochondrial membrane",
        "go_biological_process": "GO:0006744 ubiquinone biosynthetic process;GO:0021692 cerebellar Purkinje cell layer morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q566J8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BGN3-1",
        "uniprot_id": "ENPP6_MOUSE",
        "mass": 50618.0,
        "length": 440,
        "protein_name": "Glycerophosphocholine cholinephosphodiesterase ENPP6",
        "gene_name": "Enpp6",
        "organism": "Mouse",
        "refseq_name": "glycerophosphocholine cholinephosphodiesterase ENPP6 preproprotein",
        "refseq_ac": "NP_796278",
        "gene_names_uniprotkb": "Enpp6",
        "gene_names_refseq": "4833421B01Rik; B830047L21Rik; D8Ertd514e; E-NPP 6; Enpp6; GPC-Cpde; Npp6",
        "protein_names_uniprotkb": "Glycerophosphocholine cholinephosphodiesterase ENPP6; 3.1.4.-; 3.1.4.38; Choline-specific glycerophosphodiester phosphodiesterase; E-NPP 6; Ectonucleotide pyrophosphatase/phosphodiesterase family member 6; GPC-Cpde; NPP-6",
        "protein_names_refseq": "choline-specific glycerophosphodiester phosphodiesterase; ectonucleotide pyrophosphatase/phosphodiesterase family member 6; glycerophosphocholine cholinephosphodiesterase ENPP6 preproprotein; glycerophosphocholine cholinephosphodiesterase ENPP6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:320981);  (R-MMU-6814848)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;15788404;21750661;26888014;30084848;30899004;33300544;34428180",
        "class_list": "",
        "function": "Choline-specific glycerophosphodiesterase that hydrolyzes glycerophosphocholine (GPC) and lysophosphatidylcholine (LPC) and contributes to supplying choline to the cells (PubMed:15788404, PubMed:26888014). Has a preference for LPC with short (12:0 and 14:0) or polyunsaturated (18:2 and 20:4) fatty acids (PubMed:15788404). In vitro, hydrolyzes only choline-containing lysophospholipids, such as sphingosylphosphorylcholine (SPC), platelet-activating factor (PAF) and lysoPAF, but not other lysophospholipids (PubMed:15788404)., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; NPP6 has a specific role through the hydrolysis of polyunsaturated LPC, glycerophosphorylcholine, or sphingosylphosphorylcholine in kidney, brain and heart, [RefSeq, PubMed]; The crystal structure of ENPP6 in complex with phosphocholine revealed that the choline moiety of the phosphocholine is recognized by a choline-binding pocket formed by conserved aromatic and acidic residues. The present study provides the molecular basis for ENPP6-mediated choline metabolism at atomic, cellular and tissue levels. Publication Status: Online-Only, [RefSeq, PubMed]; This gene encodes a member of the nucleotide pyrophosphatase/phosphodiesterase family of enzymes that play an important role in regulating extracellular nucleotide metabolism. The encoded preproprotein undergoes proteolytic processing to generate a glycosylphosphatidylinositol (GPI)-anchored membrane protein that hydrolyzes choline-containing lysophospholipids such as glycerophosphocholine. Mice lacking the encoded protein develop fatty liver and myelin sheath abnormalities. [provided by RefSeq, Jul 2016]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 4,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 4,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 4,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 4,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 9,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 8,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q4VAH5",
        "ec_number_list": "3.1.4.12;3.1.4.38;3.1.4.-;3.1.1.-;3.1.1.23;3.1.-.-",
        "go_molecular_function": "GO:0047390 glycerophosphocholine cholinephosphodiesterase activity;GO:0046872 metal ion binding;GO:0008081 phosphoric diester hydrolase activity;GO:0008889 glycerophosphodiester phosphodiesterase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005886 plasma membrane;GO:0098552 side of membrane",
        "go_biological_process": "GO:0019695 choline metabolic process;GO:0006629 lipid metabolic process;GO:0016042 lipid catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "Q8BGN3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BYG9-1",
        "uniprot_id": "EPHAA_MOUSE",
        "mass": 109100.0,
        "length": 1007,
        "protein_name": "Ephrin type-A receptor 10",
        "gene_name": "Epha10",
        "organism": "Mouse",
        "refseq_name": "ephrin type-A receptor 10 isoform 2 precursor",
        "refseq_ac": "NP_808339",
        "gene_names_uniprotkb": "Epha10",
        "gene_names_refseq": "A330090H18; Epha10",
        "protein_names_uniprotkb": "Ephrin type-A receptor 10; Inactive tyrosine-protein kinase EPHA10",
        "protein_names_refseq": "ephrin type-A receptor 10 isoform 2 precursor; ephrin type-A receptor 10",
        "tax_id": 10090,
        "disease": "autosomal dominant nonsyndromic deafness 88 (Disease Ontology:DOID:0070611)",
        "pathway": " (mmu:230735);  (R-MMU-2682334);  (R-MMU-3928663);  (R-MMU-3928665)",
        "pathway_count": 4,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;23352741;31219806;36048850",
        "class_list": "",
        "function": "Ephrin A10 is significantly increased in hippocampus following epileptogenesis., [RefSeq, PubMed]; Receptor for members of the ephrin-A family. Binds to EFNA3, EFNA4 and EFNA5 (By similarity)., [UniProtKB, UniProtKB]; Receptor for members of the ephrin-A family. Binds to EFNA3, EFNA4 and EFNA5., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2A7J5;Q3UPV5",
        "ec_number_list": "2.7.12.2;2.7.10.1;2.7.12.1;2.7.1.32;2.7.1.82;2.7.10.2;2.7.11.1;2.7.11.13;2.7.10.4;2.7.1.40;2.7.11.23",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0005005 transmembrane-ephrin receptor activity;GO:0005003 ephrin receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030425 dendrite",
        "go_biological_process": "GO:0048013 ephrin receptor signaling pathway;GO:0007411 axon guidance",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8BYG9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JKC8-1",
        "uniprot_id": "AP3M1_MOUSE",
        "mass": 46936.0,
        "length": 418,
        "protein_name": "AP-3 complex subunit mu-1",
        "gene_name": "Ap3m1",
        "organism": "Mouse",
        "refseq_name": "AP-3 complex subunit mu-1",
        "refseq_ac": "NP_061299",
        "gene_names_uniprotkb": "Ap3m1",
        "gene_names_refseq": "1200013D09Rik; Ap3m1",
        "protein_names_uniprotkb": "AP-3 complex subunit mu-1; AP-3 adaptor complex mu3A subunit; Adaptor-related protein complex 3 subunit mu-1; Mu-adaptin 3A; Mu3A-adaptin",
        "protein_names_refseq": "AP-3 adapter complex mu3A subunit; AP-3 adaptor complex mu3A subunit; AP-3 complex subunit mu-1; adapter-related protein complex 3 mu-1 subunit; adapter-related protein complex 3 subunit mu-1; adaptor-related protein complex 3 subunit mu-1; adaptor-related protein complex AP-3, mu 1 subunit; clathrin adaptor protein mu3A; mu-adaptin 3A; mu3A-adaptin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:55946)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;12967569;21750661;21998198;23404500;25428506;27568566;34428180",
        "class_list": "",
        "function": "Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals., [UniProtKB, PubMed, UniProtKB, UniProtKB]; Structural basis for the recognition of tyrosine-based sorting signals by the mu3A subunit of the AP-3 adaptor complex, [RefSeq, PubMed]; These data suggest that excess mu3A acts independently of the AP-3A complex to reroute AMPAR to recycling endosomes., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9803,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5BKQ6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0031267 small GTPase binding;GO:0035615 clathrin adaptor activity",
        "go_cellular_component": "GO:0098837 postsynaptic recycling endosome;GO:0005769 early endosome;GO:0005802 trans-Golgi network;GO:1904115 axon cytoplasm;GO:0030121 AP-1 adaptor complex",
        "go_biological_process": "GO:1903232 melanosome assembly;GO:0098884 postsynaptic neurotransmitter receptor internalization;GO:0006886 intracellular protein transport;GO:0006897 endocytosis;GO:0060155 platelet dense granule organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q9JKC8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O70378-1",
        "uniprot_id": "EMC8_MOUSE",
        "mass": 23348.0,
        "length": 207,
        "protein_name": "ER membrane protein complex subunit 8",
        "gene_name": "Emc8",
        "organism": "Mouse",
        "refseq_name": "ER membrane protein complex subunit 8",
        "refseq_ac": "NP_035056",
        "gene_names_uniprotkb": "Emc8; Cox4al; Cox4nb; Noc4",
        "gene_names_refseq": "Cox4nb; Emc8; Fam158b; Noc4",
        "protein_names_uniprotkb": "ER membrane protein complex subunit 8; Neighbor of COX4",
        "protein_names_refseq": "COX4 neighbor; ER membrane protein complex subunit 8; neighbor of Cox4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:18117)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10337626;16452087;21750661;22645316;26495903;28011936;31219806;34428180;36210013;37828378",
        "class_list": "",
        "function": "Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0032977 membrane insertase activity",
        "go_cellular_component": "GO:0072546 EMC complex;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0071816 tail-anchored membrane protein insertion into ER membrane;GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "O70378-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q924H9-1",
        "uniprot_id": "DQX1_MOUSE",
        "mass": 78799.0,
        "length": 718,
        "protein_name": "ATP-dependent RNA helicase homolog DQX1",
        "gene_name": "Dqx1",
        "organism": "Mouse",
        "refseq_name": "ATP-dependent RNA helicase homolog DQX1",
        "refseq_ac": "NP_291084",
        "gene_names_uniprotkb": "Dqx1",
        "gene_names_refseq": "2310066E11Rik; Dqx1",
        "protein_names_uniprotkb": "ATP-dependent RNA helicase homolog DQX1; DEAQ box polypeptide 1",
        "protein_names_refseq": "ATP-dependent RNA helicase DQX1; ATP-dependent RNA helicase homolog DQX1; DEAQ box polypeptide 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:93838)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "11353393;21750661;30084848;34428180",
        "class_list": "",
        "function": "Might be involved in RNA metabolism; it is missing helicase motif III and may not have helicase activity (PubMed:11353393)., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80ZJ5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0005524 ATP binding;GO:0016887 ATP hydrolysis activity;GO:0004386 helicase activity",
        "go_cellular_component": "GO:0005681 spliceosomal complex",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q924H9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C7G5-1",
        "uniprot_id": "APOA5_MOUSE",
        "mass": 41262.0,
        "length": 368,
        "protein_name": "Apolipoprotein A-V",
        "gene_name": "Apoa5",
        "organism": "Mouse",
        "refseq_name": "apolipoprotein A-V precursor",
        "refseq_ac": "NP_001335024",
        "gene_names_uniprotkb": "Apoa5; Rap3",
        "gene_names_refseq": "1300007O05Rik; Apoa5; Apoav; RAP3",
        "protein_names_uniprotkb": "Apolipoprotein A-V; Apo-AV; ApoA-V; Apolipoprotein A5; Regeneration-associated protein 3",
        "protein_names_refseq": "apolipoprotein A-V precursor; apolipoprotein A5; regeneration-associated protein 3",
        "tax_id": 10090,
        "disease": "hyperlipoproteinemia type V (Disease Ontology:DOID:1171); hyperlipoproteinemia type IV (Disease Ontology:DOID:1172); hypothyroidism (Disease Ontology:DOID:1459); coronary artery disease (Disease Ontology:DOID:3393); cerebral infarction (Disease Ontology:DOID:3526); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:66113);  (R-MMU-381426);  (R-MMU-8957275);  (R-MMU-8963901)",
        "pathway_count": 4,
        "publication_count": 13,
        "publication_id_list": "11577099;11588264;12135615;12615678;15090553;17242355;21183079;21750661;26495903;33549451;34428180;35984892;37824203",
        "class_list": "",
        "function": "A role of ApoA-V in regulating levels of circulating triglycerides and cholesterol., [RefSeq, PubMed]; Apolipoprotein A5 controls fructose-induced metabolic dysregulation in mice., [RefSeq, PubMed]; Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen. Publication Status: Online-Only, [RefSeq, PubMed]; Minor apolipoprotein mainly associated with HDL and to a lesser extent with VLDL. May also be associated with chylomicrons. Important determinant of plasma triglyceride (TG) levels by both being a potent stimulator of apo-CII lipoprotein lipase (LPL) TG hydrolysis and an inhibitor of the hepatic VLDL-TG production rate (without affecting the VLDL-apoB production rate). Activates poorly lecithin:cholesterol acyltransferase (LCAT) and does not enhance efflux of cholesterol from macrophages (By similarity). Binds heparin (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; Review. APOA5 represents a newly discovered gene involved in triglyceride metabolism in both humans and mice whose mechanism of action remains to be deciphered. Review article, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 6,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q91X90;Q99P64",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005543 phospholipid binding;GO:0008201 heparin binding;GO:0019899 enzyme binding;GO:0050750 low-density lipoprotein particle receptor binding;GO:0008289 lipid binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005769 early endosome;GO:0005794 Golgi apparatus;GO:0005829 cytosol",
        "go_biological_process": "GO:0006641 triglyceride metabolic process;GO:0006869 lipid transport;GO:0008203 cholesterol metabolic process;GO:0010898 positive regulation of triglyceride catabolic process;GO:0033700 phospholipid efflux",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q8C7G5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BWQ6-1",
        "uniprot_id": "VP35L_MOUSE",
        "mass": 109077.0,
        "length": 963,
        "protein_name": "VPS35 endosomal protein-sorting factor-like",
        "gene_name": "Vps35l",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Vps35l; 9030624J02Rik; Vsp35l",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "VPS35 endosomal protein-sorting factor-like",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "Ritscher-Schinzel syndrome (Disease Ontology:DOID:0060565)",
        "pathway": " (mmu:71517);  (R-MMU-6798695)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;22872234;25428506;25605945;31219806;31712251;34428180;36210013;37507081",
        "class_list": "",
        "function": "Acts as a component of the retriever complex. The retriever complex is a heterotrimeric complex related to retromer cargo-selective complex (CSC) and essential for retromer-independent retrieval and recycling of numerous cargos such as integrin alpha-5/beta-1 (ITGA5:ITGB1). The recruitment of the retriever complex to the endosomal membrane involves CCC and WASH complexes. In the endosomes, drives the retrieval and recycling of NxxY-motif-containing cargo proteins by coupling to SNX17, a cargo essential for the homeostatic maintenance of numerous cell surface proteins associated with processes that include cell migration, cell adhesion, nutrient supply and cell signaling. Involved in copper-dependent ATP7A trafficking between the trans-Golgi network and vesicles in the cell periphery; the function is proposed to depend on its association with the CCC complex and cooperation with the WASH complex on early endosomes. Does not seem to be required for CCC complex stability., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UWS3;Q3UXM0;Q7TQF5;Q80XN3;Q8R3A8;Q91VY3;Q9D307",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005768 endosome;GO:0016020 membrane;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0015031 protein transport;GO:0032456 endocytic recycling;GO:0006893 Golgi to plasma membrane transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q8BWQ6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z1K6-1",
        "uniprot_id": "ARI2_MOUSE",
        "mass": 57697.0,
        "length": 492,
        "protein_name": "E3 ubiquitin-protein ligase ARIH2",
        "gene_name": "Arih2",
        "organism": "Mouse",
        "refseq_name": "E3 ubiquitin-protein ligase ARIH2 isoform a",
        "refseq_ac": "NP_035920",
        "gene_names_uniprotkb": "Arih2; Ari2; Triad1; Uip48",
        "gene_names_refseq": "ARI2; Arih2; TRIAD1; UIP48",
        "protein_names_uniprotkb": "E3 ubiquitin-protein ligase ARIH2; 2.3.2.31; ARI-2; Protein ariadne-2 homolog; Triad1 protein; UbcM4-interacting protein 48",
        "protein_names_refseq": "ARI-2; E3 ubiquitin-protein ligase ARIH2 isoform a; E3 ubiquitin-protein ligase ARIH2; RING-type E3 ubiquitin transferase ARIH2; ariadne 2; ariadne homolog 2; protein ariadne-2 homolog; ubcM4-interacting protein 48",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:23807);  (R-MMU-983168)",
        "pathway_count": 2,
        "publication_count": 10,
        "publication_id_list": "10431818;10880484;16118314;21183079;21750661;25895533;31219806;34428180;35899529;36210013",
        "class_list": "",
        "function": "Arih2 regulates Hedgehog signaling through smoothened ubiquitylation and ER-associated degradation., [RefSeq, PubMed]; E3 ubiquitin-protein ligase, which catalyzes ubiquitination of target proteins together with ubiquitin-conjugating enzyme E2 UBE2L3 (By similarity). Acts as an atypical E3 ubiquitin-protein ligase by working together with cullin-5-RING ubiquitin ligase complex (ECS complex, also named CRL5 complex) and initiating ubiquitination of ECS substrates: associates with ECS complex and specifically mediates addition of the first ubiquitin on ECS targets (By similarity). The initial ubiquitin is then elongated (By similarity). E3 ubiquitin-protein ligase activity is activated upon binding to neddylated form of the ECS complex. Mediates 'Lys-6', 'Lys-48'- and 'Lys-63'-linked polyubiquitination. May play a role in myelopoiesis (By similarity)., [UniProtKB, UniProtKB, UniProtKB]; HOXA10 gene disruption exhibited an overwhelming and fatal emergency granulopoiesis response that was characterized by tissue infiltration with granulocytes, but reversed by re-expression of Triad1 in the bone marrow., [RefSeq, PubMed]; Proteasomal degradation of proteins that are ubiquitinated by Triad1 affects the clonogenic growth of primary myeloid progenitor cells, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.3.2.26;2.3.2.31;2.3.2.27;2.3.2.-;3.6.4.-;2.3.2.24;2.3.2.23;2.3.2.34;2.3.2.32;2.7.11.1;2.3.2.36;2.3.2.25;6.2.1.-",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0061630 ubiquitin protein ligase activity;GO:0031624 ubiquitin conjugating enzyme binding;GO:0004842 ubiquitin-protein transferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0000151 ubiquitin ligase complex;GO:0031466 Cul5-RING ubiquitin ligase complex",
        "go_biological_process": "GO:0045087 innate immune response;GO:0051607 defense response to virus;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination;GO:0000209 protein polyubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9Z1K6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80ZM8-1",
        "uniprot_id": "CRLS1_MOUSE",
        "mass": 32502.0,
        "length": 303,
        "protein_name": "Cardiolipin synthase (CMP-forming)",
        "gene_name": "Crls1",
        "organism": "Mouse",
        "refseq_name": "cardiolipin synthase (CMP-forming) isoform 1",
        "refseq_ac": "NP_001019556",
        "gene_names_uniprotkb": "Crls1",
        "gene_names_refseq": "0610009I22Rik; 4930557M15Rik; 5730490M08Rik; Crls1",
        "protein_names_uniprotkb": "Cardiolipin synthase (CMP-forming); 2.7.8.41; CLS",
        "protein_names_refseq": "CLS; cardiolipin synthase (CMP-forming) isoform 1; cardiolipin synthase (CMP-forming)",
        "tax_id": 10090,
        "disease": "combined oxidative phosphorylation deficiency 57 (Disease Ontology:DOID:0070430)",
        "pathway": " (mmu:66586);  (R-MMU-1482925);  (R-MMU-1483076)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "18454555;20652826;21750661;22584571;25428506;31219806;34428180;35147173;38556544",
        "class_list": "",
        "function": "Age-dependent loss of Crls1 causes myopathy and skeletal muscle regeneration failure. Erratum:[Exp Mol Med. 2024 Apr;56(4):1031. doi: 10.1038/s12276-024-01238-7. PMID: 38658706], [RefSeq, PubMed]; CL has roles in in neuronal signaling, mitochondrial bioenergetics, and apoptosis, [RefSeq, PubMed]; CLS mRNA levels cannot be correlated with CLS enzyme activity nor CL content in the LPS model of inflammation., [RefSeq, PubMed]; Catalyzes the synthesis of cardiolipin (CL) (diphosphatidylglycerol) by specifically transferring a phosphatidyl group from CDP-diacylglycerol to phosphatidylglycerol (PG). CL is a key phospholipid in mitochondrial membranes and plays important roles in maintaining the functional integrity and dynamics of mitochondria under both optimal and stress conditions., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Transgenic expression of cardiolipin synthase attenuated maladaptive cardiolipin remodeling and bioenergetic inefficiency in myocardium rendered diabetic by streptozotocin treatment., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D4U1",
        "ec_number_list": "2.7.8.41",
        "go_molecular_function": "GO:0043337 cardiolipin synthase (CMP-forming);GO:0008444 CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity;GO:0016780 phosphotransferase activity, for other substituted phosphate groups",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0031966 mitochondrial membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0097068 response to thyroxine;GO:1905711 response to phosphatidylethanolamine;GO:0032049 cardiolipin biosynthetic process;GO:0008654 phospholipid biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q80ZM8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q05421-1",
        "uniprot_id": "CP2E1_MOUSE",
        "mass": 56805.0,
        "length": 493,
        "protein_name": "Cytochrome P450 2E1",
        "gene_name": "Cyp2e1",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 2E1",
        "refseq_ac": "NP_067257",
        "gene_names_uniprotkb": "Cyp2e1; Cyp2e-1; Cyp2e",
        "gene_names_refseq": "CYPIIE1; Cyp2e1; Cyp2e",
        "protein_names_uniprotkb": "Cytochrome P450 2E1; 1.14.13.n7; 1.14.14.1; 4-nitrophenol 2-hydroxylase; CYPIIE1; Cytochrome P450-ALC; Cytochrome P450-J",
        "protein_names_refseq": "4-nitrophenol 2-hydroxylase; cytochrome P450 2E1; cytochrome P450, 2e1, ethanol inducible; cytochrome P450-ALC; cytochrome P450-J",
        "tax_id": 10090,
        "disease": "alcohol dependence (Disease Ontology:DOID:0050741); oral squamous cell carcinoma (Disease Ontology:DOID:0050866); hepatocellular adenoma (Disease Ontology:DOID:0050868); alcohol-associated liver disease (Disease Ontology:DOID:0070658); metabolic dysfunction-associated steatotic liver disease (Disease Ontology:DOID:0080208); asbestosis (Disease Ontology:DOID:10320); stomach cancer (Disease Ontology:DOID:10534); familial hyperlipidemia (Disease Ontology:DOID:1168); morbid obesity (Disease Ontology:DOID:11981); hypertrophic cardiomyopathy (Disease Ontology:DOID:11984); acoustic neuroma (Disease Ontology:DOID:12689); alcoholic liver cirrhosis (Disease Ontology:DOID:14018); alcohol use disorder (Disease Ontology:DOID:1574); depressive disorder (Disease Ontology:DOID:1596); drug-induced hepatitis (Disease Ontology:DOID:2044); colon cancer (Disease Ontology:DOID:219); asthma (Disease Ontology:DOID:2841); acute kidney failure (Disease Ontology:DOID:3021); high grade glioma (Disease Ontology:DOID:3070); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); middle cerebral artery infarction (Disease Ontology:DOID:3525); liver disease (Disease Ontology:DOID:409); pneumonia (Disease Ontology:DOID:552); hepatocellular carcinoma (Disease Ontology:DOID:684); extrinsic allergic alveolitis (Disease Ontology:DOID:841); oral cavity cancer (Disease Ontology:DOID:8618); colorectal cancer (Disease Ontology:DOID:9256); nasopharynx carcinoma (Disease Ontology:DOID:9261); type 2 diabetes mellitus (Disease Ontology:DOID:9352); steatotic liver disease (Disease Ontology:DOID:9452); type 1 diabetes mellitus (Disease Ontology:DOID:9744); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:13106);  (R-MMU-211981);  (R-MMU-211999);  (R-MMU-9027307);  (R-MMU-9749641);  (R-MMU-9753281)",
        "pathway_count": 6,
        "publication_count": 10,
        "publication_id_list": "1536649;21750661;30084848;34428180;37453647;38603858;6194512;6851839;7947804;8344939",
        "class_list": "",
        "function": "A cytochrome P450 monooxygenase involved in the metabolism of fatty acids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Hydroxylates fatty acids specifically at the omega-1 position displaying the highest catalytic activity for saturated fatty acids. May be involved in the oxidative metabolism of xenobiotics., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Cyp2e1 protects against OVA-induced allergic rhinitis through the inhibition of Th2 cell activation and differentiation: Mediated by MAFB., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 32,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9Z198",
        "ec_number_list": "1.14.14.1;1.14.14.-;1.14.14.80;4.2.1.152;1.14.13.n7;5.3.99.5",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0019899 enzyme binding;GO:0016491 oxidoreductase activity;GO:0020037 heme binding;GO:0051879 Hsp90 protein binding",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005737 cytoplasm;GO:0005743 mitochondrial inner membrane;GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0002933 lipid hydroxylation;GO:0016098 monoterpenoid metabolic process;GO:0001676 long-chain fatty acid metabolic process;GO:0006641 triglyceride metabolic process;GO:0009617 response to bacterium",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q05421-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WV54-1",
        "uniprot_id": "ASAH1_MOUSE",
        "mass": 44670.0,
        "length": 394,
        "protein_name": "Acid ceramidase",
        "gene_name": "Asah1",
        "organism": "Mouse",
        "refseq_name": "acid ceramidase preproprotein",
        "refseq_ac": "NP_062708",
        "gene_names_uniprotkb": "Asah1; Asah",
        "gene_names_refseq": "2310081N20Rik; AC; Asah1; Asah",
        "protein_names_uniprotkb": "Acid ceramidase; 3.5.1.-; 3.5.1.23; ACDase; AC; Acid CDase; Acylsphingosine deacylase; N-acylethanolamine hydrolase ASAH1; N-acylsphingosine amidohydrolase",
        "protein_names_refseq": "ACDase; N-acylethanolamine hydrolase ASAH1; acid CDase; acid ceramidase preproprotein; acid ceramidase; acylsphingosine deacylase",
        "tax_id": 10090,
        "disease": "Farber lipogranulomatosis (Disease Ontology:DOID:0050464); spinal muscular atrophy with progressive myoclonic epilepsy (Disease Ontology:DOID:0111527); sphingolipidosis (Disease Ontology:DOID:1927)",
        "pathway": " (mmu:11886);  (R-MMU-6798695);  (R-MMU-9840310)",
        "pathway_count": 3,
        "publication_count": 21,
        "publication_id_list": "10.1101/2023.09.13.557529;10974027;11829492;12815059;17322886;19349973;21750661;23770692;26192747;26495903;26740625;28011936;28935714;29187734;30899004;31219806;34428180;35984892;37828378;40885482;9653654",
        "class_list": "glycogene",
        "function": "Biochemistry of acid ceramidase reaction with acid sphingomyelinase, [RefSeq, PubMed]; Lysosomal ceramidase that hydrolyzes sphingolipid ceramides into sphingosine and free fatty acids at acidic pH (PubMed:11829492, PubMed:9653654). Ceramides, sphingosine, and its phosphorylated form sphingosine-1-phosphate are bioactive lipids that mediate cellular signaling pathways regulating several biological processes including cell proliferation, apoptosis and differentiation (PubMed:9653654). Has a higher catalytic efficiency towards C12-ceramides versus other ceramides (By similarity). Also catalyzes the reverse reaction allowing the synthesis of ceramides from fatty acids and sphingosine (By similarity). For the reverse synthetic reaction, the natural sphingosine D-erythro isomer is more efficiently utilized as a substrate compared to D-erythro-dihydrosphingosine and D-erythro-phytosphingosine, while the fatty acids with chain lengths of 12 or 14 carbons are the most efficiently used (By similarity). Also has an N-acylethanolamine hydrolase activity (By similarity). By regulating the levels of ceramides, sphingosine and sphingosine-1-phosphate in the epidermis, mediates the calcium-induced differentiation of epidermal keratinocytes (By similarity). Also indirectly regulates tumor necrosis factor/TNF-induced apoptosis (PubMed:10974027). By regulating the intracellular balance between ceramides and sphingosine, in adrenocortical cells, probably also acts as a regulator of steroidogenesis (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; Mutagenesis leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Erratum:[Genomics 2002 Jun;79(6):890. Hepbiloikler Stefan [corrected to Hepbildikler Stefan]], [RefSeq, PubMed]; This gene encodes acid ceramidase, an enzyme that plays a central role in ceramide metabolism. The encoded protein undergoes proteolytic processing to generate a heterodimeric enzyme comprised of alpha and beta subunits that catalyzes the hydrolysis of sphingolipid ceramide into sphingosine and free fatty acid. The homozygous disruption of this gene leads to embryonic lethality in mice whereas the heterozygous animals exhibit a progressive lipid storage disease phenotype. [provided by RefSeq, Oct 2015]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 4,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 4,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 4,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 4,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 20,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 13,
        "disease_count": 3,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.4.1.25;3.2.1.33;3.5.4.6;1.11.1.24;3.4.22.52;3.4.19.12;3.4.24.34;3.4.22.27;1.1.1.42;3.4.21.46;4.1.2.13;5.3.1.9;5.1.3.-;3.4.21.4;3.6.4.10;3.4.21.-;3.2.1.17;1.16.3.1;3.6.5.-;4.2.1.24;3.4.22.1;3.2.1.31;2.7.1.11;5.2.1.8;3.4.23.5;2.5.1.18;4.2.99.18;5.6.2.4;2.4.2.1;3.2.1.23;1.11.1.6;3.3.2.6;3.4.11.4;1.1.1.205;3.1.3.48;5.3.2.1;5.3.3.12;3.4.24.35;3.6.1.-;2.7.11.24;1.13.11.-;1.13.11.34;3.1.6.12;2.7.10.2;2.7.11.1;2.7.1.40;3.5.4.5;3.4.25.1;2.7.4.6;2.7.13.3;3.6.4.6;2.7.1.1;2.7.1.-;3.1.1.47;3.6.4.13;2.7.11.22;2.7.11.23;2.3.2.26;5.4.2.2;5.4.2.7;2.3.2.27;3.1.6.14;1.8.3.2;3.4.19.1;3.5.1.23;3.5.1.-;3.6.1.6;2.3.3.8;4.1.2.4;2.3.2.5;3.2.1.14;3.5.1.60;5.4.2.11;5.4.2.4;2.4.1.1;3.5.1.3;2.4.1.186;3.4.18.1;3.4.19.9",
        "go_molecular_function": "GO:0017064 fatty acid amide hydrolase activity;GO:0003714 transcription corepressor activity;GO:0017040 N-acylsphingosine amidohydrolase activity;GO:0016922 nuclear receptor binding;GO:0016811 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005634 nucleus;GO:0016020 membrane;GO:0005764 lysosome",
        "go_biological_process": "GO:0006631 fatty acid metabolic process;GO:0046513 ceramide biosynthetic process;GO:0030324 lung development;GO:0046512 sphingosine biosynthetic process;GO:0046514 ceramide catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 4.1,
        "record_id": "Q9WV54-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P48760-1",
        "uniprot_id": "FOLC_MOUSE",
        "mass": 64955.0,
        "length": 587,
        "protein_name": "Folylpolyglutamate synthase, mitochondrial",
        "gene_name": "Fpgs",
        "organism": "Mouse",
        "refseq_name": "folylpolyglutamate synthase, mitochondrial isoform 1 precursor",
        "refseq_ac": "NP_034366",
        "gene_names_uniprotkb": "Fpgs",
        "gene_names_refseq": "Fpgs",
        "protein_names_uniprotkb": "Folylpolyglutamate synthase, mitochondrial; 6.3.2.17; FPGS; Folylpoly-gamma-glutamate synthetase; Tetrahydrofolate synthase; Tetrahydrofolylpolyglutamate synthase",
        "protein_names_refseq": "folylpoly-gamma-glutamate synthetase; folylpolyglutamate synthase, mitochondrial isoform 1 precursor; folylpolyglutamate synthase, mitochondrial; tetrahydrofolate synthase; tetrahydrofolylpolyglutamate synthase",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:14287);  (R-MMU-196757)",
        "pathway_count": 2,
        "publication_count": 12,
        "publication_id_list": "10626793;11772020;17998333;18035049;21750661;31219806;34428180;6548641;7592937;8605241;8798611;9038166",
        "class_list": "",
        "function": "Catalyzes conversion of folates to polyglutamate derivatives allowing concentration of folate compounds in the cell and the intracellular retention of these cofactors, which are important substrates for most of the folate-dependent enzymes that are involved in one-carbon transfer reactions involved in purine, pyrimidine and amino acid synthesis. Dihydrofolate, tetrahydrofolate, 5,10-methylenetetrahydrofolate, 10-formyltetrahydrofolate and 5-formyltetrahydrofolate are the best substrates. Folic acid and 5-methyltetrahydrofolate can also act as substrates., [UniProtKB, PubMed, PubMed]; These results suggest that FPGS and GGH expression levels in tumors are determinants of the efficacy of LV in enhancing the antitumor activity of 5-FU., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AK69;Q3U0B4;Q99K38",
        "ec_number_list": "6.3.2.17",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0046872 metal ion binding;GO:0004326 tetrahydrofolylpolyglutamate synthase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005759 mitochondrial matrix;GO:0005829 cytosol",
        "go_biological_process": "GO:0006536 glutamate metabolic process;GO:0008283 cell population proliferation;GO:0006730 one-carbon metabolic process;GO:0046901 tetrahydrofolylpolyglutamate biosynthetic process;GO:0006760 folic acid-containing compound metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "P48760-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P02664-1",
        "uniprot_id": "CS2LB_MOUSE",
        "mass": 16911.0,
        "length": 143,
        "protein_name": "Alpha-S2-casein-like B",
        "gene_name": "Csn1s2b",
        "organism": "Mouse",
        "refseq_name": "alpha-S2-casein-like B isoform 2 precursor",
        "refseq_ac": "NP_001288263",
        "gene_names_uniprotkb": "Csn1s2b; Csnd; Csne",
        "gene_names_refseq": "Csn1s2b; Csnd; Csne",
        "protein_names_uniprotkb": "Alpha-S2-casein-like B; Casein alpha S2-like B; Epsilon-casein",
        "protein_names_refseq": "alpha-S2-casein-like B isoform 2 precursor; alpha-S2-casein-like B; casein delta; epsilon-casein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:12992)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21750661;31044023;33854063;6897225",
        "class_list": "",
        "function": "Important role in the capacity of milk to transport calcium phosphate., [UniProtKB, UniProtKB, UniProtKB]; Redundant and non-redundant cytokine-activated enhancers control Csn1s2b expression in the lactating mouse mammary gland. Publication Status: Online-Only, [RefSeq, PubMed]; This gene is a member of the alpha-s2-like casein gene family, and this gene product is a calcium-sensitive casein. Members of this gene family are organized as a gene cluster that is conserved in its order, but with greater conservation amongst orthologs than paralogs. The protein encoded by this gene interacts with other casein proteins to form a micelle structure, and is a major source of protein in milk. This structure is important for the transport of calcium, phosphate, and protein. Alternative splicing results in multiple transcript variants encoding different protein isoforms. [provided by RefSeq, Aug 2014]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TP28;Q3TP29;Q542L5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0035375 zymogen binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005576 extracellular region",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P02664-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BVM4-1",
        "uniprot_id": "AZIN2_MOUSE",
        "mass": 49503.0,
        "length": 459,
        "protein_name": "Antizyme inhibitor 2",
        "gene_name": "Azin2",
        "organism": "Mouse",
        "refseq_name": "antizyme inhibitor 2 isoform 1",
        "refseq_ac": "NP_766463",
        "gene_names_uniprotkb": "Azin2; Adc; Odcp",
        "gene_names_refseq": "4933429I20Rik; Adc; Azi2; Azin2; B930082O19; ODC-p; Odcp",
        "protein_names_uniprotkb": "Antizyme inhibitor 2; ADC; ARGDC; Arginine decarboxylase-like protein; AzI2; ODC-like protein; ODC-p; Ornithine decarboxylase-like protein; ornithine decarboxylase paralog",
        "protein_names_refseq": "ODC antizyme inhibitor-2; ODC-like protein; antizyme inhibitor 2 isoform 1; arginine decarboxylase; ornithine decarboxylase paralog; ornithine decarboxylase-like protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:242669);  (R-MMU-351143)",
        "pathway_count": 2,
        "publication_count": 13,
        "publication_id_list": "16916800;18062773;18508777;18973822;19449338;19956990;21750661;22562773;23874910;24967154;34428180;36671399;38797332",
        "class_list": "",
        "function": "AZIN2 affects polyamine homeostasis not only by increasing ornithine decarboxylase activity but also by stimulating polyamine uptake, through negating the inhibitory effect of the antizymes, [RefSeq, PubMed]; AZIN2 expression appears to be restricted to brain and testis and it is a labile protein degraded by a ubiquitin-dependent mechanism. Review article, [RefSeq, PubMed]; AZIN2 is associated with apoptosis of germ cells in undescended testis., [RefSeq, PubMed]; Antizyme Inhibitor 2-Deficient Mice Exhibit Altered Brain Polyamine Levels and Reduced Locomotor Activity. Publication Status: Online-Only, [RefSeq, PubMed]; Antizyme inhibitor (AZI) protein that positively regulates ornithine decarboxylase (ODC) activity and polyamine uptake. AZI is an enzymatically inactive ODC homolog that counteracts the negative effect of ODC antizymes (AZs) OAZ1, OAZ2 and OAZ3 on ODC activity by competing with ODC for antizyme-binding (PubMed:18062773, PubMed:18508777, PubMed:18973822). Inhibits antizyme-dependent ODC degradation and releases ODC monomers from their inactive complex with antizymes, leading to formation of the catalytically active ODC homodimer and restoring polyamine production (PubMed:16916800, PubMed:24967154). Participates in the morphological integrity of the trans-Golgi network (TGN) and functions as a regulator of intracellular secretory vesicle trafficking (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, UniProtKB]; Catalyzes the first and rate-limiting step of polyamine biosynthesis that converts ornithine into putrescine, which is the precursor for the polyamines, spermidine and spermine. Polyamines are essential for cell proliferation and are implicated in cellular processes, ranging from DNA replication to apoptosis., [UniProtKB, UniProtKB, UniProtKB]; In contrast to human ODCp, mouse ornithine decarboxylase-like gene encodes an antizyme inhibitor devoid of ornithine and arginine decarboxylating activity, [RefSeq, PubMed]; The protein encoded by this gene belongs to the antizyme inhibitor family, which plays a role in cell growth and proliferation by maintaining polyamine homeostasis within the cell. Antizyme inhibitors are homologs of ornithine decarboxylase (ODC, the key enzyme in polyamine biosynthesis) that have lost the ability to decarboxylase ornithine; however, retain the ability to bind to antizymes. Antizymes negatively regulate intracellular polyamine levels by binding to ODC and targeting it for degradation, as well as by inhibiting polyamine uptake. Antizyme inhibitors function as positive regulators of polyamine levels by sequestering antizymes and neutralizing their effect. This gene encodes antizyme inhibitor 2, the second member of this gene family. Like antizyme inhibitor 1, antizyme inhibitor 2 interacts with all 3 antizymes and stimulates ODC activity and polyamine uptake. However, unlike antizyme inhibitor 1, which is ubiquitously expressed and localized in the nucleus and cytoplasm, antizyme inhibitor 2 is predominantly expressed in the brain and testis and localized in the endoplasmic reticulum-golgi intermediate compartment. Recent studies indicate that antizyme inhibitor 2 is also expressed in specific cell types in ovaries, adrenal glands and pancreas, and in mast cells. The exact function of this gene is not known, however, available data suggest its role in cell growth, spermiogenesis, vesicular trafficking and secretion. There has been confusion in literature and databases over the nomenclature of this gene, stemming from an earlier report that a human cDNA clone (identical to ODCp/AZIN2) had arginine decarboxylase (ADC) activity (PMID:14738999). Subsequent studies in human and mouse showed that antizyme inhibitor 2 was devoid of arginine decarboxylase activity (PMID:19956990). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2A823",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003824 catalytic activity;GO:0042978 ornithine decarboxylase activator activity;GO:0016829 lyase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol;GO:0030424 axon",
        "go_biological_process": "GO:0006591 ornithine metabolic process;GO:0043085 positive regulation of catalytic activity;GO:0042177 negative regulation of protein catabolic process;GO:0033387 putrescine biosynthetic process from arginine, via ornithine;GO:1902269 positive regulation of polyamine transmembrane transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q8BVM4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JM76-1",
        "uniprot_id": "ARPC3_MOUSE",
        "mass": 20525.0,
        "length": 178,
        "protein_name": "Actin-related protein 2/3 complex subunit 3",
        "gene_name": "Arpc3",
        "organism": "Mouse",
        "refseq_name": "actin-related protein 2/3 complex subunit 3",
        "refseq_ac": "NP_062798",
        "gene_names_uniprotkb": "Arpc3",
        "gene_names_refseq": "1110006A04Rik; Arpc3; p21-ARC; p21-Ar; p21Arc",
        "protein_names_uniprotkb": "Actin-related protein 2/3 complex subunit 3; Arp2/3 complex 21 kDa subunit; p21-ARC",
        "protein_names_refseq": "Arp2/3 complex subunit p21-Arc; actin-related protein 2/3 complex subunit 3; arp2/3 complex 21 kDa subunit",
        "tax_id": 10090,
        "disease": "Parkinson's disease (Disease Ontology:DOID:14330); diabetes mellitus (Disease Ontology:DOID:9351)",
        "pathway": " (mmu:56378);  (R-MMU-2029482);  (R-MMU-3928662);  (R-MMU-5663213);  (R-MMU-8856828)",
        "pathway_count": 5,
        "publication_count": 12,
        "publication_id_list": "17947660;21750661;25428506;25605945;26495903;28935714;30084848;30779550;32726629;34428180;35820727;37507081",
        "class_list": "",
        "function": "Component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility. In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA. The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Dysregulation of the Synaptic Cytoskeleton in the PFC Drives Neural Circuit Pathology, Leading to Social Dysfunction., [RefSeq, PubMed]; Functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TAT0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005200 structural constituent of cytoskeleton;GO:0051015 actin filament binding;GO:0003779 actin binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0030027 lamellipodium;GO:0031252 cell leading edge;GO:0035861 site of double-strand break;GO:0005885 Arp2/3 protein complex",
        "go_biological_process": "GO:0034314 Arp2/3 complex-mediated actin nucleation;GO:0030833 regulation of actin filament polymerization;GO:1900242 regulation of synaptic vesicle endocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9JM76-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QXJ4-1",
        "uniprot_id": "ARL10_MOUSE",
        "mass": 27303.0,
        "length": 243,
        "protein_name": "ADP-ribosylation factor-like protein 10",
        "gene_name": "Arl10",
        "organism": "Mouse",
        "refseq_name": "ADP-ribosylation factor-like protein 10 isoform 1",
        "refseq_ac": "NP_064352",
        "gene_names_uniprotkb": "Arl10; Arl10a; Arm1",
        "gene_names_refseq": "Arl10a; Arl10; Arm1",
        "protein_names_uniprotkb": "ADP-ribosylation factor-like protein 10; ADP-ribosylation factor-like membrane-associated protein",
        "protein_names_refseq": "ADP-ribosylation factor-like 10A; ADP-ribosylation factor-like membrane-associated protein; ADP-ribosylation factor-like protein 10 isoform 1; ADP-ribosylation factor-like protein 10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56795)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "15033445;21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q14C12",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0046872 metal ion binding",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9QXJ4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WV74-1",
        "uniprot_id": "ASB1_MOUSE",
        "mass": 37232.0,
        "length": 336,
        "protein_name": "Ankyrin repeat and SOCS box protein 1",
        "gene_name": "Asb1",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 1 isoform a",
        "refseq_ac": "NP_001034215",
        "gene_names_uniprotkb": "Asb1",
        "gene_names_refseq": "1700029O08Rik; 1700054C17Rik; Asb1; mKIAA1146",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 1; ASB-1",
        "protein_names_refseq": "ASB-1; ankyrin repeat and SOCS box protein 1 isoform a; ankyrin repeat and SOCS box protein 1; ankyrin repeat and SOCS box-containing protein 1; ankyrin repeat-containing SOCS box protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:65247);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 6,
        "publication_id_list": "11111040;11509662;21750661;28540928;31219806;33431678",
        "class_list": "",
        "function": "An unconventional role of an ASB family protein in NF-kappaB activation and inflammatory response during microbial infection and colitis., [RefSeq, PubMed]; In murine acute social defeat stress, Asb1 gene expression is significantly upregulated in a tissue-specific manner (p=0.006), which correlates with upregulation of the neuroimmunomodulating cytokine interleukin 1 beta., [RefSeq, PubMed]; Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). Mediates Notch-induced ubiquitination and degradation of TCF3/E2A and JAK2 (By similarity). May play a role in testis development (PubMed:11509662)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0061630 ubiquitin protein ligase activity;GO:1990756 ubiquitin-like ligase-substrate adaptor activity",
        "go_cellular_component": "GO:0000151 ubiquitin ligase complex",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination;GO:0030539 male genitalia development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9WV74-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R3I3-1",
        "uniprot_id": "COG6_MOUSE",
        "mass": 73040.0,
        "length": 657,
        "protein_name": "Conserved oligomeric Golgi complex subunit 6",
        "gene_name": "Cog6",
        "organism": "Mouse",
        "refseq_name": "conserved oligomeric Golgi complex subunit 6",
        "refseq_ac": "NP_080501",
        "gene_names_uniprotkb": "Cog6; Kiaa1134",
        "gene_names_refseq": "4933405E16Rik; Cog6; mKIAA1134",
        "protein_names_uniprotkb": "Conserved oligomeric Golgi complex subunit 6; COG complex subunit 6; Component of oligomeric Golgi complex 6",
        "protein_names_refseq": "COG complex subunit 6; conserved oligomeric Golgi complex protein 6; conserved oligomeric Golgi complex subunit 6",
        "tax_id": 10090,
        "disease": "congenital disorder of glycosylation type IIl (Disease Ontology:DOID:0070264)",
        "pathway": " (mmu:67542);  (R-MMU-6807878);  (R-MMU-6811438);  (R-MMU-6811440)",
        "pathway_count": 4,
        "publication_count": 6,
        "publication_id_list": "21750661;31219806;34203471;34428180;36210013;37507081",
        "class_list": "",
        "function": "Required for normal Golgi function., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BSN7;Q8CHB1;Q9CTA8",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0017119 Golgi transport complex",
        "go_biological_process": "GO:0015031 protein transport;GO:0007030 Golgi organization;GO:0000301 retrograde transport, vesicle recycling within Golgi;GO:0006891 intra-Golgi vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q8R3I3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5BKS4-1",
        "uniprot_id": "ERI2_MOUSE",
        "mass": 76524.0,
        "length": 688,
        "protein_name": "ERI1 exoribonuclease 2",
        "gene_name": "Eri2",
        "organism": "Mouse",
        "refseq_name": "ERI1 exoribonuclease 2 isoform 1",
        "refseq_ac": "NP_081974",
        "gene_names_uniprotkb": "Eri2; Exod1; Kiaa1504",
        "gene_names_refseq": "4933424N09Rik; Eri2; Exod1; mKIAA1504",
        "protein_names_uniprotkb": "ERI1 exoribonuclease 2; 3.1.-.-; Exonuclease domain-containing protein 1",
        "protein_names_refseq": "ERI1 exoribonuclease 2 isoform 1; ERI1 exoribonuclease 2; exonuclease domain containing 1; exonuclease domain-containing protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71151)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TUK9;Q8C133",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0003676 nucleic acid binding;GO:0000175 3'-5'-RNA exonuclease activity",
        "go_cellular_component": "",
        "go_biological_process": "GO:0000467 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);GO:0060906 negative regulation of regulatory ncRNA-mediated heterochromatin formation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q5BKS4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99NG0-1",
        "uniprot_id": "ARIP4_MOUSE",
        "mass": 162642.0,
        "length": 1467,
        "protein_name": "Helicase ARIP4",
        "gene_name": "Rad54l2",
        "organism": "Mouse",
        "refseq_name": "helicase ARIP4",
        "refseq_ac": "NP_109655",
        "gene_names_uniprotkb": "Rad54l2; Arip4; Srisnf2l",
        "gene_names_refseq": "Arip4; D130058C05; G630026H09Rik; Rad54l2; Srisnf2l",
        "protein_names_uniprotkb": "Helicase ARIP4; 5.6.2.-; Androgen receptor-interacting protein 4; RAD54-like protein 2; Steroid receptor-interacting SNF2 domain-containing protein-like",
        "protein_names_refseq": "HCMV-interacting protein; RAD54-like protein 2; androgen receptor-interacting protein 4; helicase ARIP4; steroid receptor-interacting SNF2 domain protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:81000)",
        "pathway_count": 1,
        "publication_count": 11,
        "publication_id_list": "12058073;15199138;16212558;17003240;17374848;21183079;21750661;26412716;32782141;32848054;36852467",
        "class_list": "",
        "function": "ARIP4 is an AR coregulator in Sertoli cells in vivo, but the expression in the germ cells implies that it has also AR-independent functions in spermatogenesis., [RefSeq, PubMed]; ARIP4 plays an essential role in mouse embryonic development and cell proliferation, and it appears to coordinate multiple essential biological processes, possibly through a complex chromatin remodeling system., [RefSeq, PubMed]; DNA helicase that modulates androgen receptor (AR)-dependent transactivation in a promoter-dependent manner (PubMed:12058073). May stimulate the release of RNA polymerase II, that has paused near the transcription start sites of AR-targeted genes and unwind R-loops formed at these sites; R-loops result from the hybridization of the short RNA strand nascently synthesized by the paused RNA polymerase II molecule and the DNA template (By similarity). May also stimulate double-strand break formation by TOP2B, which appears important for transcriptional output (By similarity). Not able to remodel mononucleosomes in vitro (PubMed:16212558)., [UniProtKB, UniProtKB, PubMed, PubMed]; P62 is a novel binding partner for ARIP4, and that its binding regulates the cellular protein level of ARIP4 under conditions of metabolic stress. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 8,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QKL0;Q3UPJ1",
        "ec_number_list": "3.6.4.13;3.6.4.10;3.6.4.-;5.6.2.3;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;7.6.2.1;3.6.1.5;3.4.24.-;3.6.-.-;3.1.3.1;3.9.1.1;3.6.1.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;3.6.4.6;3.6.5.-;3.6.1.15;3.1.4.-;5.6.2.-;7.2.2.-;7.6.2.16;3.4.21.53;2.7.7.7;2.7.7.49;2.7.11.1;2.7.4.3",
        "go_molecular_function": "GO:0033677 DNA/RNA helicase activity;GO:0003677 DNA binding;GO:0005524 ATP binding;GO:0019901 protein kinase binding;GO:0016887 ATP hydrolysis activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0016607 nuclear speck;GO:0000785 chromatin",
        "go_biological_process": "GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0006325 chromatin organization;GO:0006368 transcription elongation by RNA polymerase II;GO:0062176 R-loop processing",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q99NG0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CPQ1-1",
        "uniprot_id": "COX6C_MOUSE",
        "mass": 8469.0,
        "length": 76,
        "protein_name": "Cytochrome c oxidase subunit 6C",
        "gene_name": "Cox6c",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase subunit 6C",
        "refseq_ac": "NP_444301",
        "gene_names_uniprotkb": "Cox6c",
        "gene_names_refseq": "Cox6c",
        "protein_names_uniprotkb": "Cytochrome c oxidase subunit 6C; Cytochrome c oxidase polypeptide VIc",
        "protein_names_refseq": "cytochrome c oxidase polypeptide VIc; cytochrome c oxidase subunit 6C; cytochrome c oxidase subunit VIc",
        "tax_id": 10090,
        "disease": "cytochrome-c oxidase deficiency disease (Disease Ontology:DOID:3762)",
        "pathway": " (mmu:12864);  (R-MMU-5628897);  (R-MMU-611105);  (R-MMU-9707564);  (R-MMU-9864848)",
        "pathway_count": 5,
        "publication_count": 12,
        "publication_id_list": "1645653;21750661;25428506;25605945;30779550;31599954;33300544;34428180;34616041;36288343;37507081;38575788",
        "class_list": "",
        "function": "Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q52KC6",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0031966 mitochondrial membrane;GO:0045277 respiratory chain complex IV",
        "go_biological_process": "GO:0006119 oxidative phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9CPQ1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q32M00-1",
        "uniprot_id": "CRBL2_MOUSE",
        "mass": 14002.0,
        "length": 123,
        "protein_name": "cAMP-responsive element-binding protein-like 2",
        "gene_name": "Crebl2",
        "organism": "Mouse",
        "refseq_name": "cAMP-responsive element-binding protein-like 2",
        "refseq_ac": "NP_808355",
        "gene_names_uniprotkb": "Crebl2",
        "gene_names_refseq": "B230205M03; Crebl2",
        "protein_names_uniprotkb": "cAMP-responsive element-binding protein-like 2",
        "protein_names_refseq": "cAMP-responsive element-binding protein-like 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:232430)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21728997;21750661;35820727;36939197",
        "class_list": "",
        "function": "Parathyroid hormone receptor-1 signaling aggravates hepatic fibrosis through upregulating cAMP response element-binding protein-like 2., [RefSeq, PubMed]; Probable regulator of CREB1 transcriptional activity which is involved in adipose cells differentiation. May also play a regulatory role in the cell cycle., [UniProtKB, PubMed, UniProtKB, UniProtKB]; Results of the present study indicate that CREBL2 plays a critical role in adipogenesis and lipogenesis via interaction with CREB., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BR67",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0030154 cell differentiation;GO:0033138 positive regulation of peptidyl-serine phosphorylation;GO:0045600 positive regulation of fat cell differentiation;GO:0006355 regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q32M00-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C6Y6-1",
        "uniprot_id": "ASB14_MOUSE",
        "mass": 64883.0,
        "length": 587,
        "protein_name": "Ankyrin repeat and SOCS box protein 14",
        "gene_name": "Asb14",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 14 isoform 1",
        "refseq_ac": "NP_001164219",
        "gene_names_uniprotkb": "Asb14",
        "gene_names_refseq": "Asb-14; Asb14",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 14",
        "protein_names_refseq": "ankyrin repeat and SOCS box protein 14 isoform 1; ankyrin repeat and SOCS box protein 14; ankyrin repeat and SOCS box-containing protein 14; ankyrin repeat domain-containing SOCS box protein 14",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:142687);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "21750661;38319584",
        "class_list": "",
        "function": "E3 Ubiquitin Ligase ASB14 Inhibits Cardiomyocyte Proliferation by Regulating MAPRE2 Ubiquitination., [RefSeq, PubMed]; May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Plays a role in the inhibition of cardiomyocyte nuclear proliferation by mediating the ubiquitination and degradation of MAPRE2 (PubMed:38319584)., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B7ZN45;Q8VHS7",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8C6Y6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q924X2-1",
        "uniprot_id": "CPT1B_MOUSE",
        "mass": 88217.0,
        "length": 772,
        "protein_name": "Carnitine O-palmitoyltransferase 1, muscle isoform",
        "gene_name": "Cpt1b",
        "organism": "Mouse",
        "refseq_name": "carnitine O-palmitoyltransferase 1, muscle isoform",
        "refseq_ac": "NP_034078",
        "gene_names_uniprotkb": "Cpt1b",
        "gene_names_refseq": "Cpt1-m; Cpt1b; Cpt1; Cpti-m; Cpti; M-cpti",
        "protein_names_uniprotkb": "Carnitine O-palmitoyltransferase 1, muscle isoform; 2.3.1.21; CPT I; CPT1-M; CPTI-M; Carnitine O-palmitoyltransferase I, muscle isoform; Carnitine palmitoyltransferase 1B",
        "protein_names_refseq": "carnitine O-palmitoyltransferase 1, muscle isoform; muscle-type carnitine palmitoyltransferase I",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:12895);  (R-MMU-200425)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "12015320;21750661;25428506;27802388;36288343;37507081;39927985",
        "class_list": "",
        "function": "Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O35287;Q9QYP4",
        "ec_number_list": "2.3.1.21;2.3.1.-",
        "go_molecular_function": "GO:0004095 carnitine O-palmitoyltransferase activity;GO:0016746 acyltransferase activity;GO:0003824 catalytic activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0005758 mitochondrial intermembrane space",
        "go_biological_process": "GO:0006631 fatty acid metabolic process;GO:0006635 fatty acid beta-oxidation;GO:0006853 carnitine shuttle;GO:0015909 long-chain fatty acid transport;GO:0009437 carnitine metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q924X2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q66JT7-1",
        "uniprot_id": "COQ2_MOUSE",
        "mass": 40504.0,
        "length": 374,
        "protein_name": "4-hydroxybenzoate polyprenyltransferase, mitochondrial",
        "gene_name": "Coq2",
        "organism": "Mouse",
        "refseq_name": "4-hydroxybenzoate polyprenyltransferase, mitochondrial precursor",
        "refseq_ac": "NP_082254",
        "gene_names_uniprotkb": "Coq2",
        "gene_names_refseq": "2310002F18Rik; Coq2; PHB:PPT",
        "protein_names_uniprotkb": "4-hydroxybenzoate polyprenyltransferase, mitochondrial; 2.5.1.39; 4-HB polyprenyltransferase; PHB:PPT; PHB:polyprenyltransferase; Para-hydroxybenzoate--polyprenyltransferase",
        "protein_names_refseq": "4-HB polyprenyltransferase; 4-hydroxybenzoate polyprenyltransferase, mitochondrial precursor; 4-hydroxybenzoate polyprenyltransferase, mitochondrial; PHB:polyprenyltransferase; coenzyme Q2 homolog, prenyltransferase; para-hydroxybenzoate--polyprenyltransferase, mitochondrial",
        "tax_id": 10090,
        "disease": "coenzyme Q10 deficiency disease (Disease Ontology:DOID:0050730); primary coenzyme Q10 deficiency 1 (Disease Ontology:DOID:0070238); glucose intolerance (Disease Ontology:DOID:10603); nephrotic syndrome (Disease Ontology:DOID:1184); multiple system atrophy (Disease Ontology:DOID:4752)",
        "pathway": " (mmu:71883);  (R-MMU-1268020);  (R-MMU-2142789)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "20526342;21447381;21750661;31219806",
        "class_list": "",
        "function": "Calorie restriction modifies ubiquinone and COQ transcript levels in mouse tissues, [RefSeq, PubMed]; Mediates the second step in the final reaction sequence of coenzyme Q (CoQ) biosynthesis (PubMed:20526342). Catalyzes the prenylation of para-hydroxybenzoate (PHB) with an all-trans polyprenyl donor (such as all-trans-nonaprenyl diphosphate) (PubMed:20526342). The length of the polyprenyl side chain varies depending on the species, in humans, the side chain is comprised of 10 isoprenyls producing CoQ10 (also known as ubiquinone), whereas rodents predominantly generate CoQ9 (PubMed:20526342). However, this specificity is not complete, human tissues have low amounts of CoQ9 and rodent organs contain some CoQ10 (By similarity). Plays a central role in the biosynthesis of CoQ9 (PubMed:20526342). CoQ9 is a vital molecule that transports electrons from mitochondrial respiratory chain complexes (PubMed:20526342). CoQs also function as cofactors for uncoupling protein and play a role as regulators of the extracellularly-induced ceramide-dependent apoptotic pathway (By similarity). Regulates mitochondrial permeability transition pore (mPTP) opening and ROS production (pivotal events in cell death) in a tissue specific manner (By similarity)., [UniProtKB, UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QPH1;Q9D7M9",
        "ec_number_list": "1.16.3.1;2.1.3.3;7.1.2.2;5.6.1.7;2.5.1.39;1.1.98.-;3.4.24.-;2.5.1.-",
        "go_molecular_function": "GO:0004659 prenyltransferase activity;GO:0008412 4-hydroxybenzoate polyprenyltransferase activity",
        "go_cellular_component": "GO:0031314 extrinsic component of mitochondrial inner membrane;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0006744 ubiquinone biosynthetic process;GO:0006071 glycerol metabolic process;GO:0008299 isoprenoid biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q66JT7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JMB8-1",
        "uniprot_id": "CNTN6_MOUSE",
        "mass": 113761.0,
        "length": 1028,
        "protein_name": "Contactin-6",
        "gene_name": "Cntn6",
        "organism": "Mouse",
        "refseq_name": "contactin-6 isoform a precursor",
        "refseq_ac": "NP_059079",
        "gene_names_uniprotkb": "Cntn6",
        "gene_names_refseq": "Cntn6; NB-3",
        "protein_names_uniprotkb": "Contactin-6; Neural recognition molecule NB-3; mNB-3",
        "protein_names_refseq": "contactin-6 isoform a precursor; mNB-3; neural recognition molecule NB-3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:53870)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;10717476;12884264;15082708;20133774;21750661;30899004;36860170;38183624",
        "class_list": "",
        "function": "Contactin 6, A Novel Causative Gene for Congenital Hypothyroidism, Mediates Thyroid Hormone Biosynthesis Through Notch Signaling., [RefSeq, PubMed]; Contactin-6-deficient male mice exhibit the abnormal function of the accessory olfactory system and impaired reproductive behavior., [RefSeq, PubMed]; Contactins mediate cell surface interactions during nervous system development. Participates in oligodendrocytes generation by acting as a ligand of NOTCH1. Its association with NOTCH1 promotes NOTCH1 activation through the released notch intracellular domain (NICD) and subsequent translocation to the nucleus (By similarity). Involved in motor coordination., [UniProtKB, PubMed]; Mice deficient for NB-3 are slow to learn to stay on the rotating rod in the rotorod test during repeated trials and display dysfunction of equilibrium and vestibular senses in the wire hang and horizontal rod-walking tests., [RefSeq, PubMed]; NB-3/Notch1 pathway promotes neural progenitor cell differentiation into oligodendrocytes via Deltex1., [RefSeq, PubMed]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 6,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 7,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 7,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 7,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 7,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 6,
        "disease_count": 0,
        "glyco_site_count": 13,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C6X1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0098632 cell-cell adhesion mediator activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030424 axon;GO:0045202 synapse;GO:0042734 presynaptic membrane;GO:0098793 presynapse",
        "go_biological_process": "GO:0007219 Notch signaling pathway;GO:0050808 synapse organization;GO:0045747 positive regulation of Notch signaling pathway;GO:0007156 homophilic cell adhesion via plasma membrane adhesion molecules;GO:0007411 axon guidance",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q9JMB8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P29387-1",
        "uniprot_id": "GBB4_MOUSE",
        "mass": 37379.0,
        "length": 340,
        "protein_name": "Guanine nucleotide-binding protein subunit beta-4",
        "gene_name": "Gnb4",
        "organism": "Mouse",
        "refseq_name": "guanine nucleotide-binding protein subunit beta-4 isoform 1",
        "refseq_ac": "NP_001334991",
        "gene_names_uniprotkb": "Gnb4",
        "gene_names_refseq": "6720453A21Rik; G(beta)4; Gnb4; Hg2b",
        "protein_names_uniprotkb": "Guanine nucleotide-binding protein subunit beta-4; Transducin beta chain 4",
        "protein_names_refseq": "guanine nucleotide-binding protein subunit beta-4 isoform 1; guanine nucleotide-binding protein subunit beta-4; heterotrimeric guanine nucleotide-binding protein 2b; transducin beta chain 4",
        "tax_id": 10090,
        "disease": "Charcot-Marie-Tooth disease dominant intermediate F (Disease Ontology:DOID:0110206)",
        "pathway": " (mmu:14696);  (R-MMU-1296041);  (R-MMU-202040);  (R-MMU-381676);  (R-MMU-392170);  (R-MMU-392451);  (R-MMU-392851);  (R-MMU-400042);  (R-MMU-4086398);  (R-MMU-416476);  (R-MMU-416482);  (R-MMU-418217);  (R-MMU-418555);  (R-MMU-418592);  (R-MMU-418594);  (R-MMU-418597);  (R-MMU-420092);  (R-MMU-428930);  (R-MMU-432040);  (R-MMU-456926);  (R-MMU-500657);  (R-MMU-6814122);  (R-MMU-8964315);  (R-MMU-8964616);  (R-MMU-9009391);  (R-MMU-9634597);  (R-MMU-9856530);  (R-MMU-997272)",
        "pathway_count": 28,
        "publication_count": 8,
        "publication_id_list": "10970423;11842130;1543505;21750661;31219806;33300544;34428180;36210013",
        "class_list": "",
        "function": "Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TJJ1;Q8R475;Q9JHX8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0044877 protein-containing complex binding;GO:0030159 signaling receptor complex adaptor activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0043209 myelin sheath;GO:0045202 synapse;GO:0044297 cell body;GO:0005834 heterotrimeric G-protein complex",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0007165 signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "P29387-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q2UY11-1",
        "uniprot_id": "COSA1_MOUSE",
        "mass": 118749.0,
        "length": 1141,
        "protein_name": "Collagen alpha-1(XXVIII) chain",
        "gene_name": "Col28a1",
        "organism": "Mouse",
        "refseq_name": "collagen alpha-1(XXVIII) chain precursor",
        "refseq_ac": "NP_001032954",
        "gene_names_uniprotkb": "Col28a1; Col28",
        "gene_names_refseq": "Col28a1; Col28; Gm466",
        "protein_names_uniprotkb": "Collagen alpha-1(XXVIII) chain",
        "protein_names_refseq": "collagen 28; collagen alpha-1(XXVIII) chain precursor; collagen alpha-1(XXVIII) chain",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:213945);  (R-MMU-1650814);  (R-MMU-8948216)",
        "pathway_count": 3,
        "publication_count": 7,
        "publication_id_list": "16330543;20830809;21750661;25428506;30084848;36518326;36883360",
        "class_list": "",
        "function": "COL28 promotes proliferation, migration, and EMT of renal tubular epithelial cells., [RefSeq, PubMed]; Collagen XXVIII is a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain, [RefSeq, PubMed]; May act as a cell-binding protein., [UniProtKB]; The correlation between the absence of myelin and the presence of collagen XXVIII is confirmed in a mouse model of Charcot-Marie-Tooth characterized by dysmyelinated nerve fibers, in which enhancement of collagen XXVIII labeling is observed, [RefSeq, PubMed]; Type XXVIII Collagen Regulates Renal Interstitial Fibrosis and Epithelial-Mesenchymal Transition by SREBP1-Mediated HKDC1 Expression. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q2UY10",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004867 serine-type endopeptidase inhibitor activity;GO:0030020 extracellular matrix structural constituent conferring tensile strength",
        "go_cellular_component": "GO:0031012 extracellular matrix;GO:0005604 basement membrane",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0030199 collagen fibril organization;GO:0048705 skeletal system morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q2UY11-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3TAS6-1",
        "uniprot_id": "EMC10_MOUSE",
        "mass": 27053.0,
        "length": 258,
        "protein_name": "ER membrane protein complex subunit 10",
        "gene_name": "Emc10",
        "organism": "Mouse",
        "refseq_name": "ER membrane protein complex subunit 10 isoform 1 precursor",
        "refseq_ac": "NP_932108",
        "gene_names_uniprotkb": "Emc10; 2310044H10Rik; Hsm1; Inm02",
        "gene_names_refseq": "2310044H10Rik; 5430410O10Rik; Emc10; Inm02; Mirta22",
        "protein_names_uniprotkb": "ER membrane protein complex subunit 10; Hematopoietic signal peptide-containing membrane domain-containing protein 1",
        "protein_names_refseq": "ER membrane protein complex subunit 10 isoform 1 precursor; UPF0510 protein INM02; hematopoietic signal peptide-containing membrane domain-containing protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69683)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;20680400;21750661;28931551;29659949;30899004;36077468;36443308",
        "class_list": "",
        "function": "Male mice lacking Emc10 gene are completely sterile. Emc10-null spermatozoa exhibit multiple defects including abnormal morphology, decreased motility, impaired capacitation, and impotency of acrosome reaction, thereby which are incapable of fertilizing intact or ZP-free oocytes., [RefSeq, PubMed]; Membrane-Bound EMC10 Is Required for Sperm Motility via Maintaining the Homeostasis of Cytoplasm Sodium in Sperm. Publication Status: Online-Only, [RefSeq, PubMed]; Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors (By similarity). By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes. Promotes angiogenesis and tissue repair in the heart after myocardial infarction. Stimulates cardiac endothelial cell migration and outgrowth via the activation of p38 MAPK, PAK and MAPK2 signaling pathways (PubMed:28931551)., [UniProtKB, UniProtKB, PubMed]; Secreted EMC10 is upregulated in human obesity and its neutralizing antibody prevents diet-induced obesity in mice. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 7,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TFU1;Q5UCC3;Q5UCC5;Q8VCD8;Q99JJ8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0032977 membrane insertase activity",
        "go_cellular_component": "GO:0072546 EMC complex;GO:0005576 extracellular region;GO:0016020 membrane;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0001525 angiogenesis;GO:0010595 positive regulation of endothelial cell migration;GO:0045766 positive regulation of angiogenesis;GO:0001938 positive regulation of endothelial cell proliferation;GO:0071816 tail-anchored membrane protein insertion into ER membrane",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q3TAS6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6GQV0-1",
        "uniprot_id": "TEDC2_MOUSE",
        "mass": 47848.0,
        "length": 436,
        "protein_name": "Tubulin epsilon and delta complex protein 2",
        "gene_name": "Tedc2",
        "organism": "Mouse",
        "refseq_name": "tubulin epsilon and delta complex protein 2",
        "refseq_ac": "NP_082332",
        "gene_names_uniprotkb": "Tedc2; 1600002H07Rik",
        "gene_names_refseq": "1600002H07Rik; Tedc2",
        "protein_names_uniprotkb": "Tubulin epsilon and delta complex protein 2",
        "protein_names_refseq": "tubulin epsilon and delta complex protein 2; uncharacterized protein C16orf59 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72016)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21750661;29187734;29459677;31219806",
        "class_list": "",
        "function": "Acts as a positive regulator of ciliary hedgehog signaling. Required for centriole stability., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9DAZ6",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005813 centrosome;GO:0005929 cilium;GO:0005814 centriole",
        "go_biological_process": "GO:0045880 positive regulation of smoothened signaling pathway;GO:0007010 cytoskeleton organization;GO:0000226 microtubule cytoskeleton organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q6GQV0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q02862-1",
        "uniprot_id": "CS2LA_MOUSE",
        "mass": 21101.0,
        "length": 184,
        "protein_name": "Alpha-S2-casein-like A",
        "gene_name": "Csn1s2a",
        "organism": "Mouse",
        "refseq_name": "alpha-S2-casein-like A isoform 1 precursor",
        "refseq_ac": "NP_031811",
        "gene_names_uniprotkb": "Csn1s2a; Csng",
        "gene_names_refseq": "Csn1s2a; Csng; PP22",
        "protein_names_uniprotkb": "Alpha-S2-casein-like A; Casein alpha S2-like A; Gamma-casein; PP22",
        "protein_names_refseq": "alpha-S2-casein-like A isoform 1 precursor; alpha-S2-casein-like A; gamma casein; milk protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:12993)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "12427545;21750661;7763793",
        "class_list": "",
        "function": "Important role in the capacity of milk to transport calcium phosphate., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Promoter is active in lactating mammary tissue; can be induced synergistically by glucocorticoids and prolactin; regulation of the promoter was analysed in cell culture models and compared to the regulaton of the beta casein promoter, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity;GO:0035375 zymogen binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q02862-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35348-1",
        "uniprot_id": "COLQ_MOUSE",
        "mass": 47684.0,
        "length": 457,
        "protein_name": "Acetylcholinesterase collagenic tail peptide",
        "gene_name": "Colq",
        "organism": "Mouse",
        "refseq_name": "acetylcholinesterase collagenic tail peptide precursor",
        "refseq_ac": "NP_034067",
        "gene_names_uniprotkb": "Colq",
        "gene_names_refseq": "A130034K24Rik; Colq",
        "protein_names_uniprotkb": "Acetylcholinesterase collagenic tail peptide; AChE Q subunit; Acetylcholinesterase-associated collagen",
        "protein_names_refseq": "AChE Q subunit; acetylcholinesterase collagenic tail peptide precursor; acetylcholinesterase collagenic tail peptide; acetylcholinesterase-associated collagen; collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase",
        "tax_id": 10090,
        "disease": "congenital myasthenic syndrome 5 (Disease Ontology:DOID:0110667)",
        "pathway": " (mmu:382864)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;38003406;9278446",
        "class_list": "",
        "function": "Anchors the catalytic subunits of asymmetric AChE to the synaptic basal membrane, and is therefore involved in the down-regulation of colinergic synaptic transmission., [UniProtKB, UniProtKB]; Molecular Analysis of a Congenital Myasthenic Syndrome Due to a Pathogenic Variant Affecting the C-Terminus of ColQ. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q08EK8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0060090 molecular adaptor activity;GO:0008201 heparin binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030054 cell junction;GO:0031012 extracellular matrix;GO:0031594 neuromuscular junction",
        "go_biological_process": "GO:0030198 extracellular matrix organization;GO:0032223 negative regulation of synaptic transmission, cholinergic;GO:0035418 protein localization to synapse;GO:0090150 establishment of protein localization to membrane;GO:0008582 regulation of synaptic assembly at neuromuscular junction",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "O35348-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q08AU9-1",
        "uniprot_id": "CQ058_MOUSE",
        "mass": 33674.0,
        "length": 305,
        "protein_name": "UPF0450 protein C17orf58 homolog",
        "gene_name": "1810010H24Rik",
        "organism": "Mouse",
        "refseq_name": "UPF0450 protein C17orf58 homolog isoform 2 precursor",
        "refseq_ac": "NP_001359431",
        "gene_names_uniprotkb": "1810010H24Rik",
        "gene_names_refseq": "1810010H24Rik",
        "protein_names_uniprotkb": "UPF0450 protein C17orf58 homolog",
        "protein_names_refseq": "UPF0450 protein C17orf58 homolog isoform 2 precursor; UPF0450 protein C17orf58 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69066)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A1B0GR98",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q08AU9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6B8I0-1",
        "uniprot_id": "DS13A_MOUSE",
        "mass": 20646.0,
        "length": 188,
        "protein_name": "Dual specificity protein phosphatase 13A",
        "gene_name": "Dusp13a",
        "organism": "Mouse",
        "refseq_name": "dual specificity protein phosphatase 13A",
        "refseq_ac": "NP_001007269",
        "gene_names_uniprotkb": "Dusp13a; Dusp13; Mdsp",
        "gene_names_refseq": "Dusp13a; Dusp13",
        "protein_names_uniprotkb": "Dual specificity protein phosphatase 13A; 3.1.3.16; 3.1.3.48; DUSP13A; Muscle-restricted DSP",
        "protein_names_refseq": "dual specificity protein phosphatase 13A; dual specificity protein phosphatase 13; muscle-restricted DSP",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:128932648)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "15252030;21750661",
        "class_list": "",
        "function": "Probable protein tyrosine phosphatase. Has phosphatase activity with synthetic substrates. Has a phosphatase activity-independent regulatory role in MAP3K5/ASK1-mediated apoptosis, preventing MAP3K5/ASK1 inhibition by AKT1. Shows no phosphatase activity on MAPK1/ERK2, MAPK8/JNK, MAPK14/p38 and MAP3K5/ASK1., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.1.3.48;3.1.3.2;3.1.3.67;3.1.3.-;3.1.3.16;3.1.3.74;3.1.3.53;3.1.3.27;3.1.3.52;3.1.3.5;3.1.3.21;3.1.3.18;3.1.3.86;3.1.3.36",
        "go_molecular_function": "GO:0004722 protein serine/threonine phosphatase activity;GO:0008138 protein tyrosine/serine/threonine phosphatase activity;GO:0004725 protein tyrosine phosphatase activity",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q6B8I0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A0JP43-1",
        "uniprot_id": "EFCB5_MOUSE",
        "mass": 159935.0,
        "length": 1406,
        "protein_name": "EF-hand calcium-binding domain-containing protein 5",
        "gene_name": "Efcab5",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Efcab5",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "EF-hand calcium-binding domain-containing protein 5",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:319634)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "16183747;21750661;35820727",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B0QZJ9;Q5NC53;Q8CBN1;Q8CDP1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005509 calcium ion binding",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "A0JP43-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CS74-1",
        "uniprot_id": "ECD_MOUSE",
        "mass": 71710.0,
        "length": 641,
        "protein_name": "Protein ecdysoneless homolog",
        "gene_name": "Ecd",
        "organism": "Mouse",
        "refseq_name": "protein ecdysoneless homolog",
        "refseq_ac": "NP_081751",
        "gene_names_uniprotkb": "Ecd",
        "gene_names_refseq": "5730461K03Rik; Ecd; Hsgt1",
        "protein_names_uniprotkb": "Protein ecdysoneless homolog",
        "protein_names_refseq": "ecdysoneless homolog; protein SGT1 homolog; protein ecdysoneless homolog; suppressor of S. cerevisiae gcr2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:70601)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "19640839;21750661;26711270;28652267;32782141;32848054;34428180;36852467",
        "class_list": "",
        "function": "Regulator of p53/TP53 stability and function. Inhibits MDM2-mediated degradation of p53/TP53 possibly by cooperating in part with TXNIP. May be involved transcriptional regulation. In vitro has intrinsic transactivation activity enhanced by EP300. May be a transcriptional activator required for the expression of glycolytic genes (By similarity). Involved in regulation of cell cycle progression (PubMed:26711270). Proposed to disrupt Rb-E2F binding leading to transcriptional activation of E2F proteins (PubMed:19640839). The cell cycle -regulating function may depend on its RUVBL1-mediated association with the R2TP complex. May play a role in regulation of pre-mRNA splicing (By similarity). Participates together with DDX39A in mRNA nuclear export (By similarity)., [UniProtKB, UniProtKB]; Results demonstrate that mammalian Ecd plays a role in cell cycle progression via the Rb-E2F pathway., [RefSeq, PubMed]; The data demonstrate that ECD promotes survival upon endoplasmic reticulum stress by increasing GRP78 protein levels to enhance the adaptive folding protein in the endoplasmic reticulum to attenuate PERK signaling. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0035035 histone acetyltransferase binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006397 mRNA processing;GO:0008283 cell population proliferation;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0008380 RNA splicing",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9CS74-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61817-1",
        "uniprot_id": "CREB3_MOUSE",
        "mass": 45112.0,
        "length": 404,
        "protein_name": "Cyclic AMP-responsive element-binding protein 3",
        "gene_name": "Creb3",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Creb3; Lzip",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Cyclic AMP-responsive element-binding protein 3; CREB-3; Transcription factor LZIP; cAMP-responsive element-binding protein 3",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (R-MMU-8874211)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21750661;31219806;34428180;37828378;8112612",
        "class_list": "",
        "function": "Endoplasmic reticulum (ER)-bound sequence-specific transcription factor that directly binds DNA and activates transcription. Plays a role in the unfolded protein response (UPR), promoting cell survival versus ER stress-induced apoptotic cell death. Also involved in cell proliferation, migration and differentiation, tumor suppression and inflammatory gene expression. Acts as a positive regulator of LKN-1/CCL15-induced chemotaxis signaling of leukocyte cell migration. Associates with chromatin to the HERPUD1 promoter. Also induces transcriptional activation of chemokine receptors. Functions as a negative transcriptional regulator in ligand-induced transcriptional activation of the glucocorticoid receptor NR3C1 by recruiting and activating histone deacetylases (HDAC1, HDAC2 and HDAC6). Also decreases the acetylation level of histone H4. Does not promote the chemotactic activity of leukocyte cells., [UniProtKB, UniProtKB]; This is the transcriptionally active form that translocates to the nucleus and activates unfolded protein response (UPR) target genes during endoplasmic reticulum (ER) stress response. Binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AG][AG]-3') and C/EBP sequences present in many promoters to activate transcription of the genes. Binds to the unfolded protein response element (UPRE) consensus sequences sites. Binds DNA to the 5'-CCAC[GA]-3'half of ERSE II (5'-ATTGG-N-CCACG-3')., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q99M21;Q9CVK9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003682 chromatin binding;GO:0003700 DNA-binding transcription factor activity;GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0090045 positive regulation of deacetylase activity;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0006935 chemotaxis;GO:0030335 positive regulation of cell migration",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q61817-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91X46-1",
        "uniprot_id": "ARHG3_MOUSE",
        "mass": 59526.0,
        "length": 524,
        "protein_name": "Rho guanine nucleotide exchange factor 3",
        "gene_name": "Arhgef3",
        "organism": "Mouse",
        "refseq_name": "rho guanine nucleotide exchange factor 3 isoform 1",
        "refseq_ac": "NP_001276615",
        "gene_names_uniprotkb": "Arhgef3",
        "gene_names_refseq": "1200004I24Rik; 9830169H03Rik; Arhgef3; Xpln",
        "protein_names_uniprotkb": "Rho guanine nucleotide exchange factor 3",
        "protein_names_refseq": "Rho guanine nucleotide exchange factor (GEF) 3; rho guanine nucleotide exchange factor 3 isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71704);  (R-MMU-193648);  (R-MMU-416482);  (R-MMU-8980692);  (R-MMU-9013026)",
        "pathway_count": 5,
        "publication_count": 8,
        "publication_id_list": "11839749;21750661;23192023;25428506;33406419;34390950;34428180;37311604",
        "class_list": "",
        "function": "ARHGEF3 Regulates Skeletal Muscle Regeneration and Strength through Autophagy. Erratum:[Cell Rep. 2021 Feb 9;34(6):108731. doi: 10.1016/j.celrep.2021.108731. PMID: 33567278], [RefSeq, PubMed]; Acts as a guanine nucleotide exchange factor (GEF) for RhoA and RhoB GTPases., [UniProtKB, PubMed, UniProtKB, UniProtKB]; Disrupting RhoA activity by blocking Arhgef3 expression mitigates microglia-induced neuroinflammation post spinal cord contusion., [RefSeq, PubMed]; RhoA/ROCK signalling activated by ARHGEF3 promotes muscle weakness via autophagy in dystrophic mdx mice., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CDM0;Q91VY4;Q99K14;Q9DC31",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005085 guanyl-nucleotide exchange factor activity",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0035025 positive regulation of Rho protein signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q91X46-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91ZT7-1",
        "uniprot_id": "ASB10_MOUSE",
        "mass": 51583.0,
        "length": 467,
        "protein_name": "Ankyrin repeat and SOCS box protein 10",
        "gene_name": "Asb10",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 10 isoform 2",
        "refseq_ac": "NP_001297405",
        "gene_names_uniprotkb": "Asb10",
        "gene_names_refseq": "Asb-10; Asb10",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 10; ASB-10",
        "protein_names_refseq": "ankyrin repeat and SOCS box protein 10 isoform 2; ankyrin repeat and SOCS box protein 10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:117590);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "11509662;21750661",
        "class_list": "",
        "function": "May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RUP6",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q91ZT7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UK37-1",
        "uniprot_id": "TEDC1_MOUSE",
        "mass": 46797.0,
        "length": 420,
        "protein_name": "Tubulin epsilon and delta complex protein 1",
        "gene_name": "Tedc1",
        "organism": "Mouse",
        "refseq_name": "tubulin epsilon and delta complex protein 1",
        "refseq_ac": "NP_598802",
        "gene_names_uniprotkb": "Tedc1; 4930427A07Rik",
        "gene_names_refseq": "4930427A07Rik; Tedc1; mFLJ00116",
        "protein_names_uniprotkb": "Tubulin epsilon and delta complex protein 1; Uncharacterized protein C14orf80 homolog",
        "protein_names_refseq": "tubulin epsilon and delta complex protein 1; uncharacterized protein C14orf80 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:104732)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21750661;29459677;31219806;35820727",
        "class_list": "",
        "function": "Acts as a positive regulator of ciliary hedgehog signaling. Required for centriole stability (PubMed:29459677). May play a role in counteracting perturbation of actin filaments, such as after treatment with the actin depolymerizing microbial metabolite Chivosazole F (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9Q930;Q3TK97",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005813 centrosome;GO:0005929 cilium;GO:0005814 centriole",
        "go_biological_process": "GO:0045880 positive regulation of smoothened signaling pathway;GO:0007010 cytoskeleton organization;GO:0000226 microtubule cytoskeleton organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q3UK37-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BK75-1",
        "uniprot_id": "ELP6_MOUSE",
        "mass": 29327.0,
        "length": 266,
        "protein_name": "Elongator complex protein 6",
        "gene_name": "Elp6",
        "organism": "Mouse",
        "refseq_name": "elongator complex protein 6",
        "refseq_ac": "NP_001074850",
        "gene_names_uniprotkb": "Elp6; Tmem103",
        "gene_names_refseq": "2610001P13Rik; 2610002I17Rik; Elp6; Tmem103",
        "protein_names_uniprotkb": "Elongator complex protein 6; Protein TMEM103",
        "protein_names_refseq": "UPF0405 protein C3orf75 homolog; elongator complex protein 6 homolog; elongator complex protein 6; transmembrane protein 103",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72341)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;22854966;30097576",
        "class_list": "",
        "function": "A single point mutation in the gene encoding Elongator complex subunit 6 causing Purkinje neuron degeneration and an ataxia-like phenotype in the mutant wobbly mouse, is reported. Publication Status: Online-Only, [RefSeq, PubMed]; Component of the elongator complex which is required for multiple tRNA modifications, including mcm5U (5-methoxycarbonylmethyl uridine), mcm5s2U (5-methoxycarbonylmethyl-2-thiouridine), and ncm5U (5-carbamoylmethyl uridine) (By similarity). The elongator complex catalyzes formation of carboxymethyluridine in the wobble base at position 34 in tRNAs (By similarity). Involved in cell migration (PubMed:22854966)., [UniProtKB, UniProtKB, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D0M9",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol;GO:0033588 elongator holoenzyme complex;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0097352 autophagosome maturation;GO:0010992 ubiquitin recycling;GO:0048877 homeostasis of number of retina cells;GO:0007626 locomotory behavior;GO:0030335 positive regulation of cell migration",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8BK75-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64191-1",
        "uniprot_id": "ASPG_MOUSE",
        "mass": 37022.0,
        "length": 346,
        "protein_name": "N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase",
        "gene_name": "Aga",
        "organism": "Mouse",
        "refseq_name": "N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase isoform 1 preproprotein",
        "refseq_ac": "NP_001005847",
        "gene_names_uniprotkb": "Aga",
        "gene_names_refseq": "Aga",
        "protein_names_uniprotkb": "N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase; 3.5.1.26; AGA; Aspartylglucosaminidase; Glycosylasparaginase; N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase",
        "protein_names_refseq": "N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase isoform 1 preproprotein; N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase; glycosylasparaginase; n(4)-(beta-N-acetylglucosaminyl)-L-asparaginase",
        "tax_id": 10090,
        "disease": "aspartylglucosaminuria (Disease Ontology:DOID:0050461); lysosomal storage disease (Disease Ontology:DOID:3211)",
        "pathway": " (mmu:11593);  (R-MMU-6798695)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "15342551;21750661;8586423",
        "class_list": "glycogene",
        "function": "Cleaves the GlcNAc-Asn bond which joins oligosaccharides to the peptide of asparagine-linked glycoproteins., [UniProtKB, PubMed]; There is evidence for a role for storage of glycoasparagines other than aspartylglucosamine in the pathogenesis of aspartylglycosaminuria, [RefSeq, PubMed]; This gene encodes an amidase enzyme that participates in the breakdown of glycoproteins in the cell. The encoded protein undergoes proteolytic processing to generate a mature enzyme. Mice lacking the encoded protein exhibit accumulation of aspartylglucosamine along with lysosomal vacuolization, axonal swelling in the gracile nucleus and impaired neuromotor coordination. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate mature protein. [provided by RefSeq, Oct 2015]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 20,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "4.6.1.19;1.11.1.27;3.1.1.4;2.3.1.23;3.2.1.24;4.6.1.18;3.2.1.17;1.11.2.2;3.2.1.31;3.4.16.5;3.4.16.-;3.2.1.52;3.2.1.23;3.4.21.20;2.7.10.2;2.7.11.13;3.6.1.-;1.1.1.205;3.1.6.8;3.1.6.12;3.2.1.-;3.2.1.22;2.7.11.24;3.1.27.-;3.4.14.1;3.6.4.6;3.5.3.15;3.4.21.37;3.1.6.4;3.4.21.76;3.5.3.1;1.6.5.5;3.5.1.26;3.1.6.14;3.1.3.16;5.3.99.3;6.3.4.21;2.4.1.1;2.3.3.8;1.8.4.-;5.3.4.1;3.2.1.51;1.6.2.2;3.4.14.2;3.4.21.4;3.4.19.9",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0008233 peptidase activity;GO:0003948 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005764 lysosome",
        "go_biological_process": "GO:0006508 proteolysis;GO:0006517 protein deglycosylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q64191-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BNU0-1",
        "uniprot_id": "ARMC6_MOUSE",
        "mass": 50683.0,
        "length": 468,
        "protein_name": "Armadillo repeat-containing protein 6",
        "gene_name": "Armc6",
        "organism": "Mouse",
        "refseq_name": "armadillo repeat-containing protein 6",
        "refseq_ac": "NP_598733",
        "gene_names_uniprotkb": "Armc6",
        "gene_names_refseq": "2410153K17Rik; Armc6",
        "protein_names_uniprotkb": "Armadillo repeat-containing protein 6",
        "protein_names_refseq": "armadillo repeat-containing protein 6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76813)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C4P5;Q8C7S1;Q8K2S7;Q99JQ2;Q9CWE4",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0002244 hematopoietic progenitor cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8BNU0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A3KGK3-1",
        "uniprot_id": "FR1L4_MOUSE",
        "mass": 223891.0,
        "length": 1992,
        "protein_name": "Fer-1-like protein 4",
        "gene_name": "Fer1l4",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Fer1l4",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Fer-1-like protein 4",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "limb-girdle muscular dystrophy (Disease Ontology:DOID:11724)",
        "pathway": " (mmu:74562)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;35820727",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B7ZCP2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "GO:0007009 plasma membrane organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "A3KGK3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6X1Y6-1",
        "uniprot_id": "ASIC3_MOUSE",
        "mass": 58704.0,
        "length": 530,
        "protein_name": "Acid-sensing ion channel 3",
        "gene_name": "Asic3",
        "organism": "Mouse",
        "refseq_name": "acid-sensing ion channel 3 isoform 2",
        "refseq_ac": "NP_001297403",
        "gene_names_uniprotkb": "Asic3; Accn3; Drasic",
        "gene_names_refseq": "Accn3; Asic3; DRASIC; SLNAC1; TNAC1",
        "protein_names_uniprotkb": "Acid-sensing ion channel 3; ASIC3; Amiloride-sensitive cation channel 3; DRASIC; Dorsal root ASIC",
        "protein_names_refseq": "acid-sensing (proton-gated) ion channel 3; acid-sensing ion channel 3 isoform 2; amiloride-sensitive cation channel 3; dorsal root ASIC",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:171209);  (R-MMU-2672351)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "10798398;11754838;12037186;12060708;14659506;15051137;15317815;15471860;21750661;22850675;38902277",
        "class_list": "",
        "function": "DRASIC contributes to pH-gated currents in large dorsal root ganglion sensory neurons by forming heteromultimeric channels., [RefSeq, PubMed]; Forms voltage-independent, pH-gated heterotrimeric sodium channels that act as postsynaptic excitatory receptors in the nervous system (PubMed:11754838, PubMed:14659506). Upon extracellular acidification, these channels generate a biphasic current with a fast inactivating and a slow sustained phase (PubMed:11754838). ASIC3 is more sensitive to protons and gates between closed, open, and desensitized states faster than other ASICs (PubMed:11754838). Displays high selectivity for sodium ions but can also permit the permeation of other cations (By similarity). As a neuronal acid sensor, probably contributes to mechanoreception, acid nociception, and heat nociception (PubMed:11754838, PubMed:12060708). By forming heterotrimeric channels with ASIC2, generates a biphasic current with a fast inactivating and a slow sustained phase, which in sensory neurons is proposed to mediate the pain induced by acidosis that occurs in ischemic, damaged or inflamed tissues (By similarity)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB]; Sensory ASIC3 channel exacerbates psoriatic inflammation via a neurogenic pathway in female mice. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TQH4",
        "ec_number_list": "1.8.-.-;2.7.11.1",
        "go_molecular_function": "GO:0015280 ligand-gated sodium channel activity;GO:0022839 monoatomic ion-gated channel activity;GO:0005261 monoatomic cation channel activity;GO:0160128 pH-gated monoatomic ion channel activity;GO:0160125 pH-gated sodium channel activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0048471 perinuclear region of cytoplasm;GO:0016020 membrane",
        "go_biological_process": "GO:0050907 detection of chemical stimulus involved in sensory perception;GO:0034220 monoatomic ion transmembrane transport;GO:0050965 detection of temperature stimulus involved in sensory perception of pain;GO:0051899 membrane depolarization;GO:0009612 response to mechanical stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q6X1Y6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D853-1",
        "uniprot_id": "EFMT2_MOUSE",
        "mass": 26864.0,
        "length": 244,
        "protein_name": "EEF1A lysine methyltransferase 2",
        "gene_name": "Eef1akmt2",
        "organism": "Mouse",
        "refseq_name": "EEF1A lysine methyltransferase 2 isoform 1",
        "refseq_ac": "NP_082371",
        "gene_names_uniprotkb": "Eef1akmt2; Mettl10",
        "gene_names_refseq": "2010208K18Rik; Eef1akmt2; Mettl10",
        "protein_names_uniprotkb": "EEF1A lysine methyltransferase 2; 2.1.1.-; Methyltransferase-like protein 10; Protein-lysine N-methyltransferase Mettl10",
        "protein_names_refseq": "EEF1A lysine methyltransferase 2 isoform 1; methyltransferase like 10; methyltransferase-like protein 10; protein-lysine N-methyltransferase Mettl10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72096);  (R-MMU-8876725)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Protein-lysine methyltransferase that selectively catalyzes the trimethylation of EEF1A at 'Lys-318'., [UniProtKB, HAMAP]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q4V9Y9",
        "ec_number_list": "2.1.1.-;2.1.1.359;3.6.5.-;2.1.1.372",
        "go_molecular_function": "GO:0008168 methyltransferase activity;GO:0016279 protein-lysine N-methyltransferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol",
        "go_biological_process": "GO:0018022 peptidyl-lysine methylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9D853-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q62431-1",
        "uniprot_id": "ARI3A_MOUSE",
        "mass": 64173.0,
        "length": 601,
        "protein_name": "AT-rich interactive domain-containing protein 3A",
        "gene_name": "Arid3a",
        "organism": "Mouse",
        "refseq_name": "AT-rich interactive domain-containing protein 3A isoform a",
        "refseq_ac": "NP_001275554",
        "gene_names_uniprotkb": "Arid3a; Dri1; Dril1",
        "gene_names_refseq": "Arid3a; Bright; Dri1; Dril1",
        "protein_names_uniprotkb": "AT-rich interactive domain-containing protein 3A; ARID domain-containing protein 3A; B-cell regulator of IgH transcription; Bright; Dead ringer-like protein 1",
        "protein_names_refseq": "ARID domain-containing protein 3A; AT rich interactive domain 3A (BRIGHT-like); AT rich interactive domain 3A (Bright like); AT-rich interactive domain-containing protein 3A isoform a; AT-rich interactive domain-containing protein 3A; B-cell regulator of IgH transcription; dead ringer homolog 1; dead ringer-like protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13496)",
        "pathway_count": 1,
        "publication_count": 17,
        "publication_id_list": "11120822;11294836;12193717;15456761;15743806;16507996;16738337;17312145;19144319;21183079;21750661;29237092;34678516;36852467;37659731;8543152;9590220",
        "class_list": "",
        "function": "A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis., [RefSeq, PubMed]; Identify regions within Bright that are required for the DNA binding activity of Bright and for its function as a transcription factor, [RefSeq, PubMed]; The ability of Bright to enhance immunoglobulin transcription critically requires functional Bruton's tyrosine kinase ., [RefSeq, PubMed]; Transcription factor involved in B-cell differentiation. Binds a VH promoter proximal site necessary for induced mu-heavy-chain transcription. Binds the minor groove of a restricted ATC sequence that is sufficient for nuclear matrix association. This sequence motif is present in matrix-associating regions (MARS) proximal to the promoter and flanking E mu. Activates E mu-driven transcription by binding these sites. May be involved in the control of cell cycle progression by the RB1/E2F1 pathway., [UniProtKB, PubMed, PubMed, PubMed]; Transcription factor., [UniProtKB, UniProtKB]; Variations in Bright binding and matrix attachment region activity contribute to localized control of accessibility and therefore nonrandom gene use during V(D)J recombination., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 8,
        "reported_mutagensis": 13,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U338;Q80YP8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003682 chromatin binding;GO:0042802 identical protein binding;GO:0003712 transcription coregulator activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0045121 membrane raft;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0006355 regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q62431-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6IE26-1",
        "uniprot_id": "EPHX4_MOUSE",
        "mass": 41477.0,
        "length": 359,
        "protein_name": "Epoxide hydrolase 4",
        "gene_name": "Ephx4",
        "organism": "Mouse",
        "refseq_name": "epoxide hydrolase 4 isoform 1",
        "refseq_ac": "NP_001001804",
        "gene_names_uniprotkb": "Ephx4; Abhd7; Ephxrp",
        "gene_names_refseq": "Abhd7; Ephx4; Ephxrp; Gm1382",
        "protein_names_uniprotkb": "Epoxide hydrolase 4; 3.3.-.-; Abhydrolase domain-containing protein 7; Epoxide hydrolase-related protein",
        "protein_names_refseq": "abhydrolase domain containing 7; abhydrolase domain-containing protein 7; epoxide hydrolase 4 isoform 1; epoxide hydrolase-related protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:384214)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "15060002;21750661;38308845",
        "class_list": "",
        "function": "ABHD7-mediated depalmitoylation of lamin A promotes myoblast differentiation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "F8VQ47",
        "ec_number_list": "",
        "go_molecular_function": "GO:0016787 hydrolase activity;GO:0004301 epoxide hydrolase activity",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q6IE26-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6GQV7-1",
        "uniprot_id": "EDRF1_MOUSE",
        "mass": 138834.0,
        "length": 1239,
        "protein_name": "Erythroid differentiation-related factor 1",
        "gene_name": "Edrf1",
        "organism": "Mouse",
        "refseq_name": "erythroid differentiation-related factor 1 isoform 1",
        "refseq_ac": "NP_835216",
        "gene_names_uniprotkb": "Edrf1; 2700050L05Rik",
        "gene_names_refseq": "2700050L05Rik; Edrf1",
        "protein_names_uniprotkb": "Erythroid differentiation-related factor 1",
        "protein_names_refseq": "erythroid differentiation-related factor 1 isoform 1; erythroid differentiation-related factor 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:214764)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21750661;30084848;30779550;31219806;34428180",
        "class_list": "",
        "function": "Transcription factor involved in erythroid differentiation. Involved in transcriptional activation of the globin gene (By similarity)., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80ZY3;Q8R3P5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0045893 positive regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q6GQV7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P37237-1",
        "uniprot_id": "FGF8_MOUSE",
        "mass": 30420.0,
        "length": 268,
        "protein_name": "Fibroblast growth factor 8",
        "gene_name": "Fgf8",
        "organism": "Mouse",
        "refseq_name": "fibroblast growth factor 8 isoform 3 precursor",
        "refseq_ac": "NP_001159834",
        "gene_names_uniprotkb": "Fgf8; Aigf",
        "gene_names_refseq": "Aigf; Fgf-8; Fgf6c; Fgf8; HBGF-8",
        "protein_names_uniprotkb": "Fibroblast growth factor 8; AIGF; Androgen-induced growth factor; FGF-8; HBGF-8; Heparin-binding growth factor 8",
        "protein_names_refseq": "androgen-induced growth factor; fibroblast growth factor 6c; fibroblast growth factor 8 isoform 3 precursor; heparin-binding growth factor 8",
        "tax_id": 10090,
        "disease": "hypogonadotropic hypogonadism 6 with or without anosmia (Disease Ontology:DOID:0090086); hypospadias (Disease Ontology:DOID:10892); prostatic hypertrophy (Disease Ontology:DOID:11132); DiGeorge syndrome (Disease Ontology:DOID:11198); breast cancer (Disease Ontology:DOID:1612); endodermal sinus tumor (Disease Ontology:DOID:1911); embryonal carcinoma (Disease Ontology:DOID:3308); choriocarcinoma (Disease Ontology:DOID:3594); tetralogy of Fallot (Disease Ontology:DOID:6419); prostate carcinoma in situ (Disease Ontology:DOID:8634)",
        "pathway": " (mmu:14179);  (R-MMU-109704);  (R-MMU-1257604);  (R-MMU-190322);  (R-MMU-190371);  (R-MMU-190372);  (R-MMU-190373);  (R-MMU-190375);  (R-MMU-5654219);  (R-MMU-5654221);  (R-MMU-5654227);  (R-MMU-5654228);  (R-MMU-5654687);  (R-MMU-5654688);  (R-MMU-5654689);  (R-MMU-5654693);  (R-MMU-5654695);  (R-MMU-5654699);  (R-MMU-5654700);  (R-MMU-5654704);  (R-MMU-5654706);  (R-MMU-5654710);  (R-MMU-5654712);  (R-MMU-5654719);  (R-MMU-5654720);  (R-MMU-5654726);  (R-MMU-5654727);  (R-MMU-5654732);  (R-MMU-5654733);  (R-MMU-5658623);  (R-MMU-5673001);  (R-MMU-6811558)",
        "pathway_count": 32,
        "publication_count": 5,
        "publication_id_list": "1409588;21750661;24447999;7583127;7884899",
        "class_list": "glycogene",
        "function": "Plays an important role in the regulation of embryonic development, cell proliferation, cell differentiation and cell migration. Required for normal brain, eye, ear and limb development during embryogenesis. Required for normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Plays a role in neurite outgrowth in hippocampal cells (By similarity). Cooperates with Wnt-1 in mouse mammary tumor virus-induced murine mammary tumorigenesis (PubMed:7884899)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 4,
        "reported_interactions": 1,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 10,
        "glyco_site_count": 2,
        "binding_glycan_count": 1,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005105 type 1 fibroblast growth factor receptor binding;GO:0042056 chemoattractant activity;GO:0008083 growth factor activity;GO:0005111 type 2 fibroblast growth factor receptor binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005737 cytoplasm;GO:0009897 external side of plasma membrane;GO:0005576 extracellular region",
        "go_biological_process": "GO:0030878 thyroid gland development;GO:0001759 organ induction;GO:0021544 subpallium development;GO:0009792 embryo development ending in birth or egg hatching;GO:0006979 response to oxidative stress",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P37237-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P49772-1",
        "uniprot_id": "FLT3L_MOUSE",
        "mass": 26141.0,
        "length": 232,
        "protein_name": "Fms-related tyrosine kinase 3 ligand",
        "gene_name": "Flt3lg; Flt3l",
        "organism": "Mouse",
        "refseq_name": "fms-related tyrosine kinase 3 ligand isoform b precursor",
        "refseq_ac": "NP_038548",
        "gene_names_uniprotkb": "Flt3lg; Flt3l; Flt3l",
        "gene_names_refseq": "Flt3lg; Flt3l; Ly72L",
        "protein_names_uniprotkb": "Fms-related tyrosine kinase 3 ligand; Flt3 ligand; Flt3L; SL cytokine",
        "protein_names_refseq": "flt3 ligand; fms-related tyrosine kinase 3 ligand isoform b precursor; fms-related tyrosine kinase 3 ligand",
        "tax_id": 10090,
        "disease": "immunodeficiency 125 (Disease Ontology:DOID:0061091); aplastic anemia (Disease Ontology:DOID:12449); Fanconi anemia (Disease Ontology:DOID:13636); colon carcinoma (Disease Ontology:DOID:1520); glioblastoma (Disease Ontology:DOID:3068); high grade glioma (Disease Ontology:DOID:3070); myelofibrosis (Disease Ontology:DOID:4971); multiple myeloma (Disease Ontology:DOID:9538)",
        "pathway": " (mmu:14256);  (R-MMU-109704);  (R-MMU-1257604);  (R-MMU-5673001);  (R-MMU-6811558);  (R-MMU-9607240);  (R-MMU-9706369);  (R-MMU-9706374)",
        "pathway_count": 8,
        "publication_count": 8,
        "publication_id_list": "21750661;30779550;34428180;38701783;7505204;7566977;7824267;8145851",
        "class_list": "",
        "function": "Stimulates the proliferation of early hematopoietic cells by activating FLT3. Synergizes well with a number of other colony stimulating factors and interleukins. Essential for the development of natural killer (NK) cells, B cells, and dendritic cells (DCs)., [UniProtKB, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 8,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q64085",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0005125 cytokine activity;GO:0030971 receptor tyrosine kinase binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0009897 external side of plasma membrane",
        "go_biological_process": "GO:0001779 natural killer cell differentiation;GO:0008284 positive regulation of cell population proliferation;GO:0030183 B cell differentiation;GO:0097028 dendritic cell differentiation;GO:0035162 embryonic hemopoiesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P49772-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R1P4-1",
        "uniprot_id": "ATG10_MOUSE",
        "mass": 24577.0,
        "length": 215,
        "protein_name": "Ubiquitin-like-conjugating enzyme ATG10",
        "gene_name": "Atg10",
        "organism": "Mouse",
        "refseq_name": "ubiquitin-like-conjugating enzyme ATG10 isoform 1",
        "refseq_ac": "NP_080046",
        "gene_names_uniprotkb": "Atg10; Apg10l",
        "gene_names_refseq": "5330424L23Rik; 5430428K15Rik; APG10; Agp10; Apg10l; Apg10p; Atg10l; Atg10; mAPG10",
        "protein_names_uniprotkb": "Ubiquitin-like-conjugating enzyme ATG10; 2.3.2.-; APG10-like; Autophagy-related protein 10; mAPG10",
        "protein_names_refseq": "autophagy-related protein 10; ubiquitin-like-conjugating enzyme ATG10 isoform 1; ubiquitin-like-conjugating enzyme ATG10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66795);  (R-MMU-1632852)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "12482611;12890687;20723759;21367888;21750661;25428506;25605945;31219806;34428180",
        "class_list": "",
        "function": "APG10 has a role in mediating the conjugation of APG12 with APG5, [RefSeq, PubMed]; E2-like enzyme involved in autophagy. Acts as an E2-like enzyme that catalyzes the conjugation of ATG12 to ATG5. ATG12 conjugation to ATG5 is required for autophagy. Likely serves as an ATG5-recognition molecule. Not involved in ATG12 conjugation to ATG3. Plays a role in adenovirus-mediated cell lysis., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, UniProtKB]; The isolated mouse APG10 gene product interacts with mammalian Apg12p dependent on mammalian Apg7p (E1-like enzyme), and facilitates Apg12p conjugation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BPA9;Q9D3J7",
        "ec_number_list": "2.3.2.-",
        "go_molecular_function": "GO:0019777 Atg12 transferase activity;GO:0061651 Atg12 conjugating enzyme activity",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0000045 autophagosome assembly;GO:0015031 protein transport;GO:0006914 autophagy;GO:0006497 protein lipidation;GO:0031401 positive regulation of protein modification process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q8R1P4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DBR3-1",
        "uniprot_id": "ARMC8_MOUSE",
        "mass": 75364.0,
        "length": 673,
        "protein_name": "Armadillo repeat-containing protein 8",
        "gene_name": "Armc8",
        "organism": "Mouse",
        "refseq_name": "armadillo repeat-containing protein 8 isoform 2",
        "refseq_ac": "NP_001159610",
        "gene_names_uniprotkb": "Armc8",
        "gene_names_refseq": "1200015K23Rik; Armc8; Gid5; HSPC056",
        "protein_names_uniprotkb": "Armadillo repeat-containing protein 8",
        "protein_names_refseq": "armadillo repeat-containing protein 8 isoform 2; armadillo repeat-containing protein 8",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74125);  (R-MMU-6798695);  (R-MMU-9861718)",
        "pathway_count": 3,
        "publication_count": 13,
        "publication_id_list": "20173027;20484733;21750661;22872234;25428506;25605945;30084848;30779550;31219806;32152506;34428180;35820727;36210013",
        "class_list": "",
        "function": "Component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BGV2;Q8BUP3",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0000151 ubiquitin ligase complex",
        "go_biological_process": "GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q9DBR3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R0S1-1",
        "uniprot_id": "ATF7_MOUSE",
        "mass": 44608.0,
        "length": 413,
        "protein_name": "Cyclic AMP-dependent transcription factor ATF-7",
        "gene_name": "Atf7",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Atf7",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Cyclic AMP-dependent transcription factor ATF-7; Activating transcription factor 7; Transcription factor ATF-A; cAMP-dependent transcription factor ATF-7",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "colorectal cancer (Disease Ontology:DOID:9256)",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 9,
        "publication_id_list": "19893493;21750661;29490055;30826729;31219806;31294895;31958521;34428180;36852467",
        "class_list": "",
        "function": "Stress-responsive chromatin regulator that plays a role in various biological processes including innate immunological memory, adipocyte differentiation or telomerase regulation (PubMed:29490055). In absence of stress, contributes to the formation of heterochromatin and heterochromatin-like structure by recruiting histone H3K9 tri- and di-methyltransferases thus silencing the transcription of target genes such as Htr5b, STAT1 in adipocytes, or genes involved in innate immunity in macrophages and adipocytes (PubMed:19893493, PubMed:30826729, PubMed:31294895). Phosphorylation of ATF7 disrupts interactions with histone methyltransferase and enhances the association with coactivators containing histone acetyltransferase and/or histone demethylase, leading to disruption of the heterochromatin-like structure and subsequently transcriptional activation (PubMed:19893493). In response to TNF, which is induced by various stresses, phosphorylated ATF7 and telomerase are released from telomeres leading to telomere shortening (PubMed:29490055). Also plays a role in maintaining epithelial regenerative capacity and protecting against cell death during intestinal epithelial damage and repair (PubMed:31958521)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0019899 enzyme binding;GO:0051019 mitogen-activated protein kinase binding;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0000976 transcription cis-regulatory region binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0090575 RNA polymerase II transcription regulator complex;GO:0000781 chromosome, telomeric region",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0001701 in utero embryonic development;GO:0001889 liver development;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8R0S1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2AFR3-1",
        "uniprot_id": "FRPD4_MOUSE",
        "mass": 144978.0,
        "length": 1320,
        "protein_name": "FERM and PDZ domain-containing protein 4",
        "gene_name": "Frmpd4",
        "organism": "Mouse",
        "refseq_name": "FERM and PDZ domain-containing protein 4 isoform a",
        "refseq_ac": "NP_001028502",
        "gene_names_uniprotkb": "Frmpd4; Gm196; Kiaa0316; Pdzd10; Pdzk10",
        "gene_names_refseq": "Frmpd4; Gm196; PKAP1; Pdzd10; Pdzk10; Preso1; preso",
        "protein_names_uniprotkb": "FERM and PDZ domain-containing protein 4; PDZ domain-containing protein 10; PSD-95-interacting regulator of spine morphogenesis; Preso",
        "protein_names_refseq": "FERM and PDZ domain-containing protein 4 isoform a; FERM and PDZ domain-containing protein 4; PDZ domain-containing protein 10; PSD-95-interacting regulator of spine morphogenesis",
        "tax_id": 10090,
        "disease": "non-syndromic X-linked intellectual disability 104 (Disease Ontology:DOID:0112018); schizophrenia (Disease Ontology:DOID:5419)",
        "pathway": " (mmu:333605)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "19118189;21750661;29267967;31235685",
        "class_list": "",
        "function": "Positive regulator of dendritic spine morphogenesis and density. Required for the maintenance of excitatory synaptic transmission. Binds phosphatidylinositol 4,5-bisphosphate., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; The findings point to an important role of FRMPD4 in normal cognitive development and function in humans and mice, and support the hypothesis that FRMPD4 mutations cause ID by disrupting dendritic spine morphogenesis in glutamatergic neurons., [RefSeq, PubMed]; Uncoupling the linkage between Preso and PSD-95 attenuated the stability of this complex and suppressed the regulatory effect of Preso on the NO response. In addition, phosphorylation of NMDAR by cyclin-dependent kinase 5 (CDK5) was shown to be responsible for the Preso-mediated Ca(2+) response, which was dependent on the interaction between Preso and CDK5. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B9EIG4;Q3UHE4;Q3UHI9;Q80U41",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005546 phosphatidylinositol-4,5-bisphosphate binding;GO:0008289 lipid binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0014069 postsynaptic density;GO:0043197 dendritic spine;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0098974 postsynaptic actin cytoskeleton organization;GO:0051835 positive regulation of synapse structural plasticity",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "A2AFR3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91ZU1-1",
        "uniprot_id": "ASB6_MOUSE",
        "mass": 46276.0,
        "length": 418,
        "protein_name": "Ankyrin repeat and SOCS box protein 6",
        "gene_name": "Asb6",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 6",
        "refseq_ac": "NP_579924",
        "gene_names_uniprotkb": "Asb6",
        "gene_names_refseq": "2510004M11Rik; Asb6",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 6; ASB-6",
        "protein_names_refseq": "ASB-6; ankyrin repeat and SOCS box protein 6; ankyrin repeat and SOCS box-containing protein 6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72323);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "11509662;15231829;20173027;21750661;25428506;30084848;30779550;31219806;34428180",
        "class_list": "",
        "function": "Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. May play a role in the regulation of cell proliferation and autophagy by promoting the ubiquitination and degradation of SQSTM1., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8VEC6",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q91ZU1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VHP9-1",
        "uniprot_id": "ASB17_MOUSE",
        "mass": 34471.0,
        "length": 295,
        "protein_name": "Ankyrin repeat and SOCS box protein 17",
        "gene_name": "Asb17",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 17",
        "refseq_ac": "NP_080034",
        "gene_names_uniprotkb": "Asb17",
        "gene_names_refseq": "4933436O18Rik; Asb17",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 17; ASB-17",
        "protein_names_refseq": "ASB-17; ankyrin repeat and SOCS box protein 17; ankyrin repeat and SOCS box-containing protein 17",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66772);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "15204681;15460110;21750661",
        "class_list": "",
        "function": "Expressed from the fourth week after birth to adult, with the highest expression in round spermatids, [RefSeq, PubMed]; Expressed from the third week post birth to adult; expressed in spermatogenic cells in adult mouse, but not in Leydig cells and epididymis, [RefSeq, PubMed]; May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CUF9",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0031461 cullin-RING ubiquitin ligase complex;GO:0061831 apical ectoplasmic specialization",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0000209 protein polyubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8VHP9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CQW2-1",
        "uniprot_id": "ARL8B_MOUSE",
        "mass": 21539.0,
        "length": 186,
        "protein_name": "ADP-ribosylation factor-like protein 8B",
        "gene_name": "Arl8b",
        "organism": "Mouse",
        "refseq_name": "ADP-ribosylation factor-like protein 8B",
        "refseq_ac": "NP_080287",
        "gene_names_uniprotkb": "Arl8b; Arl10c; Gie1",
        "gene_names_refseq": "2610313E07Rik; 3100002J04Rik; Arl10c; Arl8b; gie1",
        "protein_names_uniprotkb": "ADP-ribosylation factor-like protein 8B; 3.6.5.2; ADP-ribosylation factor-like protein 10C; Novel small G protein indispensable for equal chromosome segregation 1",
        "protein_names_refseq": "ADP-ribosylation factor-like 10C; ADP-ribosylation factor-like protein 10C; ADP-ribosylation factor-like protein 8B; novel small G protein indispensable for equal chromosome segregation 1; small G protein indispensable for equal chromosome segregation 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:67166)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;15331635;16861820;21750661;21802320;22909026;25637027;30174114;33157038;37507081",
        "class_list": "",
        "function": "(Microbial infection) During infection, murine coronavirus (MHV) and the chaperone HSPA5/GRP78 are co-released through ARL8B-dependent lysosomal exocytic pathway for unconventional egress., [UniProtKB, PubMed]; Arl8B is required for LPS-stimulated lysosome tubulation in macrophages., [RefSeq, PubMed]; Arl8B plays an important role of Arl8B in neurite formation., [RefSeq, PubMed]; Small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins playing a key role in the regulation of lysosomal positioning which is important for nutrient sensing, natural killer cell-mediated cytotoxicity and antigen presentation (PubMed:30174114, PubMed:33157038). Along with its effectors, orchestrates lysosomal transport and fusion. Localizes specifically to lysosomal membranes and mediates anterograde lysosomal motility by recruiting PLEKHM2, which in turn recruits the motor protein kinesin-1 on lysosomes. Required for lysosomal and cytolytic granule exocytosis. Critical factor involved in NK cell-mediated cytotoxicity. Drives the polarization of cytolytic granules and microtubule-organizing centers (MTOCs) toward the immune synapse between effector NK lymphocytes and target cells (By similarity). In neurons, mediates the anterograde axonal long-range transport of presynaptic lysosome-related vesicles required for presynaptic biogenesis and synaptic function (PubMed:30174114). Also acts as a regulator of endosome to lysosome trafficking pathways of special significance for host defense. Recruits RUFY1 onto early endosomes regulating endosomes to trans-Golgi network proteins retrieval (By similarity). Regulates cargo trafficking to lysosomes by binding to PLEKHM1 and recruiting the HOPS subunit VPS41, resulting in functional assembly of the HOPS complex on lysosomal membranes. Plays an important role in cargo delivery to lysosomes for antigen presentation and microbial killing. Directs the intersection of CD1d with lipid antigens in lysosomes, and plays a role in intersecting phagosomes with lysosomes to generate phagolysosomes that kill microbes (PubMed:21802320). Involved in the process of MHC II presentation. Regulates the delivery of antigens to lysosomes and the formation of MHC II-peptide complexes through the recruitment of the HOPS complex to lysosomes allowing the fusion of late endosomes to lysosomes (PubMed:25637027). May play a role in chromosome segregation (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TXD7;Q3U769;Q3UBB1;Q3UJU2",
        "ec_number_list": "3.6.5.-;3.6.5.2;3.6.5.3;3.6.1.5;3.6.5.4;3.6.5.5;3.6.1.-;3.6.1.15;2.7.11.1;3.6.-.-",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0048487 beta-tubulin binding;GO:0019003 GDP binding;GO:0043014 alpha-tubulin binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0030424 axon;GO:0045202 synapse;GO:0051233 spindle midzone",
        "go_biological_process": "GO:0001778 plasma membrane repair;GO:0007059 chromosome segregation;GO:0015031 protein transport;GO:0051301 cell division;GO:0016197 endosomal transport",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9CQW2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91ZT9-1",
        "uniprot_id": "ASB8_MOUSE",
        "mass": 31735.0,
        "length": 288,
        "protein_name": "Ankyrin repeat and SOCS box protein 8",
        "gene_name": "Asb8",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 8",
        "refseq_ac": "NP_001164181",
        "gene_names_uniprotkb": "Asb8",
        "gene_names_refseq": "4930539L19Rik; Asb8; C430011H06Rik",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 8; ASB-8",
        "protein_names_refseq": "ASB-8; ankyrin repeat and SOCS box protein 8; ankyrin repeat and SOCS box-containing protein 8",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:78541);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "11509662;21750661;34428180",
        "class_list": "",
        "function": "May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Inhibits IFN-beta production through the IRF3 signaling pathway by targeting TBK1 via 'Lys-48'-linked ubiquitination, leading to its proteasomal degradation., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8R178",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q91ZT9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D738-1",
        "uniprot_id": "ASB12_MOUSE",
        "mass": 33912.0,
        "length": 308,
        "protein_name": "Ankyrin repeat and SOCS box protein 12",
        "gene_name": "Asb12",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 12",
        "refseq_ac": "NP_001300672",
        "gene_names_uniprotkb": "Asb12",
        "gene_names_refseq": "2310036C05Rik; Asb-12; Asb12",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 12; ASB-12",
        "protein_names_refseq": "ankyrin repeat and SOCS box protein 12; ankyrin repeat and SOCS box-containing protein 12; ankyrin repeat domain-containing SOCS box protein 12",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:70392);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0061630 ubiquitin protein ligase activity",
        "go_cellular_component": "GO:0000151 ubiquitin ligase complex",
        "go_biological_process": "GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9D738-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64446-1",
        "uniprot_id": "ATP7B_MOUSE",
        "mass": 157190.0,
        "length": 1462,
        "protein_name": "Copper-transporting ATPase 2",
        "gene_name": "Atp7b",
        "organism": "Mouse",
        "refseq_name": "copper-transporting ATPase 2 isoform 2",
        "refseq_ac": "NP_031537",
        "gene_names_uniprotkb": "Atp7b; Wnd",
        "gene_names_refseq": "Atp7a; Atp7b; WND; tx",
        "protein_names_uniprotkb": "Copper-transporting ATPase 2; 7.2.2.8; Copper pump 2; Wilson disease-associated protein homolog",
        "protein_names_refseq": "ATPase, Cu++ transporting, beta polypeptide; Wilson protein; copper pump 2; copper-transporting ATPase 2 isoform 2; copper-transporting ATPase 2; toxic milk; wilson disease-associated protein homolog",
        "tax_id": 10090,
        "disease": "occipital horn syndrome (Disease Ontology:DOID:0111272); spinal muscular atrophy (Disease Ontology:DOID:12377); Menkes disease (Disease Ontology:DOID:1838); renal adenoma (Disease Ontology:DOID:2697); breast carcinoma (Disease Ontology:DOID:3459); liver carcinoma (Disease Ontology:DOID:686); Wilson disease (Disease Ontology:DOID:893); metal metabolism disorder (Disease Ontology:DOID:896)",
        "pathway": " (mmu:11979);  (R-MMU-936837)",
        "pathway_count": 2,
        "publication_count": 6,
        "publication_id_list": "21750661;30084848;34203471;34428180;36210013;8894697",
        "class_list": "",
        "function": "Copper ion transmembrane transporter involved in the export of copper out of the cells, such as the efflux of hepatic copper into the bile., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 8,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1AQ56",
        "ec_number_list": "7.2.2.8",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0008270 zinc ion binding;GO:0016887 ATP hydrolysis activity;GO:0005507 copper ion binding;GO:0005375 copper ion transmembrane transporter activity",
        "go_cellular_component": "GO:0005794 Golgi apparatus;GO:0005886 plasma membrane;GO:0005923 bicellular tight junction;GO:0016020 membrane;GO:0016323 basolateral plasma membrane",
        "go_biological_process": "GO:0006878 intracellular copper ion homeostasis;GO:0007595 lactation;GO:0046688 response to copper ion;GO:0071280 cellular response to copper ion;GO:0006825 copper ion transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q64446-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q04519-1",
        "uniprot_id": "ASM_MOUSE",
        "mass": 69927.0,
        "length": 627,
        "protein_name": "Sphingomyelin phosphodiesterase",
        "gene_name": "Smpd1",
        "organism": "Mouse",
        "refseq_name": "sphingomyelin phosphodiesterase precursor",
        "refseq_ac": "NP_035551",
        "gene_names_uniprotkb": "Smpd1; Asm",
        "gene_names_refseq": "A-SMase; ASM; Smpd1; Zn-SMase; aSMase",
        "protein_names_uniprotkb": "Sphingomyelin phosphodiesterase; 3.1.4.12; 3.1.4.3; ASMase; Acid sphingomyelinase",
        "protein_names_refseq": "acid sphingomyelinase; sphingomyelin phosphodiesterase precursor",
        "tax_id": 10090,
        "disease": "Niemann-Pick disease type A (Disease Ontology:DOID:0070111); Niemann-Pick disease type B (Disease Ontology:DOID:0070112); Niemann-Pick disease (Disease Ontology:DOID:14504); Wilson disease (Disease Ontology:DOID:893)",
        "pathway": " (mmu:20597);  (R-MMU-9769739);  (R-MMU-9840310)",
        "pathway_count": 3,
        "publication_count": 14,
        "publication_id_list": "10.1101/2023.09.13.557529;12563314;1292508;26495903;27435900;35705808;37828378;37956788;38634138;39026344;8702487;8706124;8943261;9660788",
        "class_list": "glycogene",
        "function": "(Microbial infection) Secretion is activated by bacteria such as P.aeruginosa, this activation results in the release of ceramide in the outer leaflet of the plasma membrane which facilitates the infection., [UniProtKB, PubMed]; ASM is a therapeutic target in dermatomyositis by regulating the differentiation of naive CD4 + T cells into Th17 and Treg subsets. Publication Status: Online-Only, [RefSeq, PubMed]; Converts sphingomyelin to ceramide (PubMed:8706124, PubMed:9660788). Exists as two enzymatic forms that arise from alternative trafficking of a single protein precursor, one that is targeted to the endolysosomal compartment, whereas the other is released extracellularly. However, in response to various forms of stress, lysosomal exocytosis may represent a major source of the secretory form (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; In the lysosomes, converts sphingomyelin to ceramide. Plays an important role in the export of cholesterol from the intraendolysosomal membranes. Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol (PubMed:27435900). Modulates stress-induced apoptosis through the production of ceramide (PubMed:8706124)., [UniProtKB, PubMed, PubMed]; Neurons regulate the esterification of bioactive lipid mediators in the brain of acid sphingomyelinase deficient mice., [RefSeq, PubMed]; Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation., [RefSeq, PubMed]; This form is generated following cleavage by CASP7 in the extracellular milieu in response to bacterial infection (PubMed:35705808). It shows increased ability to convert sphingomyelin to ceramide and promotes plasma membrane repair. Plasma membrane repair by ceramide counteracts the action of gasdermin-D (GSDMD) perforin (PRF1) pores that are formed in response to bacterial infection (PubMed:35705808)., [UniProtKB, PubMed]; When secreted, modulates cell signaling with its ability to reorganize the plasma membrane by converting sphingomyelin to ceramide. Secreted form is increased in response to stress and inflammatory mediators such as IL1B, IFNG or TNF as well as upon infection with bacteria and viruses. Produces the release of ceramide in the outer leaflet of the plasma membrane playing a central role in host defense. Ceramide reorganizes these rafts into larger signaling platforms that are required to internalize P.aeruginosa, induce apoptosis and regulate the cytokine response in infected cells. In wounded cells, the lysosomal form is released extracellularly in the presence of Ca(2+) and promotes endocytosis and plasma membrane repair., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 6,
        "mined_n_glycosites": 6,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 6,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 5,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 6,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 6,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 4,
        "reported_phosphosites": 1,
        "reported_mutagensis": 9,
        "reported_glycation": 0,
        "reported_snv": 35,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 6,
        "disease_count": 4,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UL52",
        "ec_number_list": "3.1.4.12;3.1.4.3",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0004767 sphingomyelin phosphodiesterase activity;GO:0016798 hydrolase activity, acting on glycosyl bonds;GO:0061750 acid sphingomyelin phosphodiesterase activity;GO:0034480 phosphatidylcholine phospholipase C activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005768 endosome;GO:0005811 lipid droplet;GO:0005886 plasma membrane;GO:0005764 lysosome",
        "go_biological_process": "GO:0001778 plasma membrane repair;GO:0008203 cholesterol metabolic process;GO:0034612 response to tumor necrosis factor;GO:0043065 positive regulation of apoptotic process;GO:0046513 ceramide biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.7,
        "record_id": "Q04519-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3SXC5-1",
        "uniprot_id": "ARL14_MOUSE",
        "mass": 21835.0,
        "length": 192,
        "protein_name": "ADP-ribosylation factor-like protein 14",
        "gene_name": "Arl14",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Arl14; Arf7",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "ADP-ribosylation factor-like protein 14; ADP-ribosylation factor 7",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71619)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "GTPase that recruits MYO1E to MHC class II-containing vesicles via the effector protein ARL14EP and hence controls the movement of these vesicles along the actin cytoskeleton in dendritic cells., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0031410 cytoplasmic vesicle",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0016192 vesicle-mediated transport;GO:0030010 establishment of cell polarity",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q3SXC5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UJZ3-1",
        "uniprot_id": "ARMC7_MOUSE",
        "mass": 21639.0,
        "length": 198,
        "protein_name": "Armadillo repeat-containing protein 7",
        "gene_name": "Armc7",
        "organism": "Mouse",
        "refseq_name": "armadillo repeat-containing protein 7 isoform 1",
        "refseq_ac": "NP_808446",
        "gene_names_uniprotkb": "Armc7",
        "gene_names_refseq": "A630084C13; Armc7",
        "protein_names_uniprotkb": "Armadillo repeat-containing protein 7",
        "protein_names_refseq": "armadillo repeat-containing protein 7 isoform 1; armadillo repeat-containing protein 7",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:276905)",
        "pathway_count": 1,
        "publication_count": 0,
        "publication_id_list": "",
        "class_list": "",
        "function": "As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8R599",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005829 cytosol;GO:0071018 U12-type catalytic step 2 spliceosome",
        "go_biological_process": "GO:0006397 mRNA processing;GO:0008380 RNA splicing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.1,
        "record_id": "Q3UJZ3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UZB0-1",
        "uniprot_id": "ARMX5_MOUSE",
        "mass": 67895.0,
        "length": 606,
        "protein_name": "Armadillo repeat-containing X-linked protein 5",
        "gene_name": "Armcx5",
        "organism": "Mouse",
        "refseq_name": "armadillo repeat-containing X-linked protein 5",
        "refseq_ac": "NP_001009575",
        "gene_names_uniprotkb": "Armcx5",
        "gene_names_refseq": "Armcx5",
        "protein_names_uniprotkb": "Armadillo repeat-containing X-linked protein 5",
        "protein_names_refseq": "armadillo repeat-containing X-linked protein 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:494468)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "22569362;22645316;32782141;36852467;40021952;40885482",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AGB5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q3UZB0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5U464-1",
        "uniprot_id": "ASAP3_MOUSE",
        "mass": 99276.0,
        "length": 904,
        "protein_name": "Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3",
        "gene_name": "Asap3",
        "organism": "Mouse",
        "refseq_name": "arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 isoform 1",
        "refseq_ac": "NP_001008233",
        "gene_names_uniprotkb": "Asap3; Ddefl1",
        "gene_names_refseq": "9430088F20Rik; Asap3; Ddefl1; Gm140; UPLC1",
        "protein_names_uniprotkb": "Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3; Development and differentiation-enhancing factor-like 1",
        "protein_names_refseq": "arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 isoform 1; arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3; development and differentiation enhancing factor-like 1",
        "tax_id": 10090,
        "disease": "colorectal cancer (Disease Ontology:DOID:9256)",
        "pathway": " (mmu:230837)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "18400762;30084848;31219806;31599954;34428180",
        "class_list": "",
        "function": "ASAP3 functions nonredundantly with ASAP1 to control cell movement and may have a role in cancer cell invasion., [RefSeq, PubMed]; Promotes cell proliferation., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity;GO:0008270 zinc ion binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0005925 focal adhesion;GO:0001726 ruffle",
        "go_biological_process": "GO:0016477 cell migration;GO:0043547 positive regulation of GTPase activity;GO:0051492 regulation of stress fiber assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q5U464-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6EBV9-1",
        "uniprot_id": "ATG9B_MOUSE",
        "mass": 101913.0,
        "length": 922,
        "protein_name": "Autophagy-related protein 9B",
        "gene_name": "Atg9b",
        "organism": "Mouse",
        "refseq_name": "autophagy-related protein 9B",
        "refseq_ac": "NP_001002897",
        "gene_names_uniprotkb": "Atg9b; Apg9l2; Nos3as",
        "gene_names_refseq": "Apg912; Apg9l2; Apgdc2; Atg9b; Gm574; Nos3as; eONE; sONE",
        "protein_names_uniprotkb": "Autophagy-related protein 9B; APG9-like 2; Nitric oxide synthase 3-overlapping antisense gene protein",
        "protein_names_refseq": "APG9-like 2; ATG9 autophagy related 9 homolog B; autophagy 9-like 2 protein; autophagy-related protein 9B; nitric oxide synthase 3 antisense; nitric oxide synthase 3-overlapping antisense gene protein",
        "tax_id": 10090,
        "disease": "Parkinson's disease (Disease Ontology:DOID:14330)",
        "pathway": " (mmu:213948);  (R-MMU-1632852)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "15234981;15755735;20173027;29031735;32627317;34131310;34428180;35971776",
        "class_list": "",
        "function": "Aging is associated with a decline in Atg9b-mediated autophagosome formation and appearance of enlarged mitochondria in the heart., [RefSeq, PubMed]; Exosomal miR-7002-5p derived from highglucose-induced macrophages suppresses autophagy in tubular epithelial cells by targeting Atg9b., [RefSeq, PubMed]; MYH9-dependent polarization of ATG9B promotes colorectal cancer metastasis by accelerating focal adhesion assembly., [RefSeq, PubMed]; Nos3as undergoes differential expression during embryonic and post-embryonic stages of development of the brain. Low levels of Nos3as NAT coincide with active neurogenesis., [RefSeq, PubMed]; Phospholipid scramblase involved in autophagy by mediating autophagosomal membrane expansion (PubMed:15755735). Cycles between the preautophagosomal structure/phagophore assembly site (PAS) and the cytoplasmic vesicle pool and supplies membrane for the growing autophagosome. Lipid scramblase activity plays a key role in preautophagosomal structure/phagophore assembly by distributing the phospholipids that arrive through ATG2 (ATG2A or ATG2B) from the cytoplasmic to the luminal leaflet of the bilayer, thereby driving autophagosomal membrane expansion (By similarity). In addition to autophagy, also plays a role in necrotic cell death (By similarity)., [UniProtKB, UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "F8VQL8;Q674R6",
        "ec_number_list": "1.6.5.5;3.1.-.-",
        "go_molecular_function": "GO:0017128 phospholipid scramblase activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005737 cytoplasm;GO:0005789 endoplasmic reticulum membrane;GO:0055038 recycling endosome membrane;GO:0005776 autophagosome",
        "go_biological_process": "GO:0000045 autophagosome assembly;GO:0006914 autophagy;GO:0034497 protein localization to phagophore assembly site;GO:0060349 bone morphogenesis;GO:0000423 mitophagy",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q6EBV9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q811B3-1",
        "uniprot_id": "ATS12_MOUSE",
        "mass": 177769.0,
        "length": 1600,
        "protein_name": "A disintegrin and metalloproteinase with thrombospondin motifs 12",
        "gene_name": "Adamts12",
        "organism": "Mouse",
        "refseq_name": "A disintegrin and metalloproteinase with thrombospondin motifs 12 preproprotein",
        "refseq_ac": "NP_780710",
        "gene_names_uniprotkb": "Adamts12",
        "gene_names_refseq": "ADAMTS-12; Adamts12",
        "protein_names_uniprotkb": "A disintegrin and metalloproteinase with thrombospondin motifs 12; 3.4.24.-; ADAM-TS 12; ADAM-TS12; ADAMTS-12",
        "protein_names_refseq": "A disintegrin and metalloproteinase with thrombospondin motifs 12 preproprotein; a disintegrin and metalloproteinase with thrombospondin motifs 12; a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 12; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 12",
        "tax_id": 10090,
        "disease": "stroke (Disease Ontology:DOID:0051061)",
        "pathway": " (mmu:239337);  (R-MMU-5173214)",
        "pathway_count": 2,
        "publication_count": 6,
        "publication_id_list": "20208563;20412686;22962682;37819632;38396702;39286973",
        "class_list": "",
        "function": "ADAMTS-12 plays protective roles acting against the development of asthma phenotype upon experimental allergen exposure, interfering with immunological processes leading to inflammation and airway hyperresponsiveness. Erratum:[J Immunol. 2021 Nov 1;207(9):2388-2389. doi: 10.4049/jimmunol.2100809. PMID: 34561231], [RefSeq, PubMed]; ADAMTS12 is a stromal modulator in chronic liver disease., [RefSeq, PubMed]; ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts. Publication Status: Online-Only, [RefSeq, PubMed]; Absence of Adamts-12 is associated with the increase in angiogenic response and tumor invasion into host tissue., [RefSeq, PubMed]; Lung Inflammatory Phenotype in Mice Deficient in Fibulin-2 and ADAMTS-12. Publication Status: Online-Only, [RefSeq, PubMed]; Metalloprotease that plays a role in the degradation of COMP (By similarity). Also cleaves alpha-2 macroglobulin and aggregan. Has anti-tumorigenic properties (By similarity)., [UniProtKB]; Results define a break point in mouse chromosome 15qA1 to a 27-kb region containing ADAMTS12, and show that the break is likely between exons 2 and 3 of ADAMTS12., [RefSeq, PubMed]; This gene encodes a member of 'a disintegrin and metalloproteinase with thrombospondin motifs' (ADAMTS) family of multi-domain matrix-associated metalloendopeptidases that have diverse roles in tissue morphogenesis and pathophysiological remodeling, in inflammation and in vascular biology. The encoded preproprotein undergoes proteolytic processing to generate an active protease. Mice lacking the encoded protein exhibit increased angiogenic response and tumor invasion in different models of angiogenesis and, severe inflammation and delayed recovery when subjected to experimental conditions that induce colitis, endotoxic sepsis and pancreatitis. [provided by RefSeq, Jul 2016]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QKD6;Q8BK92;Q8BKY1",
        "ec_number_list": "3.4.24.-;3.4.24.87;2.4.1.-;3.4.24.82;3.4.24.14;2.4.1.221",
        "go_molecular_function": "GO:0004222 metalloendopeptidase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0031012 extracellular matrix",
        "go_biological_process": "GO:0043931 ossification involved in bone maturation;GO:0006508 proteolysis;GO:0016477 cell migration;GO:0030198 extracellular matrix organization;GO:0007160 cell-matrix adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q811B3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CG72-1",
        "uniprot_id": "ADPRS_MOUSE",
        "mass": 39414.0,
        "length": 370,
        "protein_name": "ADP-ribosylhydrolase ARH3",
        "gene_name": "Adprs",
        "organism": "Mouse",
        "refseq_name": "ADP-ribosylhydrolase ARH3",
        "refseq_ac": "NP_598644",
        "gene_names_uniprotkb": "Adprs; Adprhl2; Arh3",
        "gene_names_refseq": "Adprhl2; Adprs; Arh3",
        "protein_names_uniprotkb": "ADP-ribosylhydrolase ARH3; 3.2.1.143; 3.2.2.-; 3.5.1.-; ADP-ribose glycohydrolase ARH3; ADP-ribosylhydrolase 3; O-acetyl-ADP-ribose deacetylase ARH3; Poly(ADP-ribose) glycohydrolase ARH3; [Protein ADP-ribosylarginine] hydrolase-like protein 2; [Protein ADP-ribosylserine] hydrolase",
        "protein_names_refseq": "ADP-ribose glycohydrolase ARH3; ADP-ribosylhydrolase 2; ADP-ribosylhydrolase 3; ADP-ribosylhydrolase ARH3; ADP-ribosylhydrolase like 2; O-acetyl-ADP-ribose deacetylase ARH3; [Protein ADP-ribosylarginine] hydrolase-like protein 2; [Protein ADP-ribosylserine] hydrolase; ecto ADP-ribosylhydrolase; poly(ADP-ribose) glycohydrolase ARH3",
        "tax_id": 10090,
        "disease": "stress-induced childhood-onset neurodegeneration with variable ataxia and seizures (Disease Ontology:DOID:0070352)",
        "pathway": " (mmu:100206);  (R-MMU-110362)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "12070318;16278211;18323597;22433848;24191052;25428506;30830864;31219806",
        "class_list": "",
        "function": "ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose)., [RefSeq, PubMed]; ADP-ribosylhydrolase that preferentially hydrolyzes the scissile alpha-O-linkage attached to the anomeric C1'' position of ADP-ribose and acts on different substrates, such as proteins ADP-ribosylated on serine and threonine, free poly(ADP-ribose) and O-acetyl-ADP-D-ribose (By similarity). Specifically acts as a serine mono-ADP-ribosylhydrolase by mediating the removal of mono-ADP-ribose attached to serine residues on proteins, thereby playing a key role in DNA damage response (By similarity). Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage (By similarity). Does not hydrolyze ADP-ribosyl-arginine, -cysteine, -diphthamide, or -asparagine bonds (By similarity). Also able to degrade protein free poly(ADP-ribose), which is synthesized in response to DNA damage: free poly(ADP-ribose) acts as a potent cell death signal and its degradation by ADPRHL2 protects cells from poly(ADP-ribose)-dependent cell death, a process named parthanatos (PubMed:24191052, PubMed:30830864). Also hydrolyzes free poly(ADP-ribose) in mitochondria (By similarity). Specifically digests O-acetyl-ADP-D-ribose, a product of deacetylation reactions catalyzed by sirtuins (By similarity). Specifically degrades 1''-O-acetyl-ADP-D-ribose isomer, rather than 2''-O-acetyl-ADP-D-ribose or 3''-O-acetyl-ADP-D-ribose isomers (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; ARH3 has poly(ADP-ribose) glycohydrolase activity but is structurally unrelated to poly(ADP-ribose) glycohydrolase, [RefSeq, PubMed]; Arh3-deficient mouse showed vulnerability to parthanatos. Arh3-/- fibroblasts demonstrated the failure of normal poly(ADP-ribose) (PAR) degradation in the nucleus and cytoplasm resulted in apoptosis-inducing factor-mediated DNA fragmentation. Data indicate that Arh3 is a PAR-degrading enzyme responsible for the regulation of PAR metabolism under conditions of oxidative stress both in vivo and in vitro. Publication Status: Online-Only, [RefSeq, PubMed]; Structural comparison of mouse ADP-ribosylhydrolase 3 with its human orthologue shows a high degree of structural similarity, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A3KFY3;Q80UW9;Q8R575;Q921U6",
        "ec_number_list": "3.2.1.143;3.2.2.19;3.5.1.-;3.2.2.-;3.1.1.106",
        "go_molecular_function": "GO:0000287 magnesium ion binding;GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds;GO:0004649 poly(ADP-ribose) glycohydrolase activity;GO:0061463 O-acetyl-ADP-ribose deacetylase activity;GO:0140292 ADP-ribosylserine hydrolase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005759 mitochondrial matrix",
        "go_biological_process": "GO:0006281 DNA repair;GO:0060546 negative regulation of necroptotic process;GO:0071451 cellular response to superoxide;GO:0140290 peptidyl-serine ADP-deribosylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q8CG72-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K0L0-1",
        "uniprot_id": "ASB2_MOUSE",
        "mass": 70221.0,
        "length": 634,
        "protein_name": "Ankyrin repeat and SOCS box protein 2",
        "gene_name": "Asb2",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 2 isoform 1",
        "refseq_ac": "NP_075536",
        "gene_names_uniprotkb": "Asb2",
        "gene_names_refseq": "1110008E15Rik; Asb2",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 2; ASB-2",
        "protein_names_refseq": "ASB-2; ankyrin repeat and SOCS box protein 2 isoform 1; ankyrin repeat and SOCS box protein 2; ankyrin repeat and SOCS box-containing protein 2; ankyrin repeat-containing SOCS box protein 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:65256)",
        "pathway_count": 1,
        "publication_count": 13,
        "publication_id_list": "11111040;19300455;23632887;25428506;26343497;27182554;29374072;31175139;32179481;33717133;33993984;34428180;34845242",
        "class_list": "",
        "function": "ASB2 is a novel E3 ligase of SMAD9 required for cardiogenesis. Publication Status: Online-Only, [RefSeq, PubMed]; Heart defects and embryonic lethality in Asb2 knock out mice correlate with placental defects., [RefSeq, PubMed]; Involved in myogenic differentiation and targets filamin FLNB for proteasomal degradation but not filamin FLNA (PubMed:26343497). Also targets DES for proteasomal degradation (PubMed:26343497). Acts as a negative regulator of skeletal muscle mass (PubMed:27182554)., [UniProtKB, PubMed, PubMed]; Substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). Mediates Notch-induced ubiquitination and degradation of substrates including TCF3/E2A and JAK2 (By similarity). Required during embryonic heart development for complete heart looping (PubMed:32179481). Required for cardiomyocyte differentiation (By similarity). Specifically promotes the ubiquitination of SMAD9 and targets it for proteasomal degradation, leading to avoid excessive accumulation of SMAD9 (By similarity). Plays a role in the regulation of NK-cell migration by modulating protein levels of filamin A/FLNA via regulation of its ubiquitination and proteasome degradation (PubMed:33717133)., [UniProtKB, UniProtKB, PubMed, PubMed]; Targets filamins FLNA and FLNB for proteasomal degradation (PubMed:23632887). This leads to enhanced adhesion of hematopoietic cells to fibronectin (By similarity). Required for FLNA degradation in immature cardiomyocytes which is necessary for actin cytoskeleton remodeling, leading to proper organization of myofibrils and function of mature cardiomyocytes (PubMed:29374072). Required for degradation of FLNA and FLNB in immature dendritic cells (DC) which enhances immature DC migration by promoting DC podosome formation and DC-mediated degradation of the extracellular matrix (PubMed:23632887). Does not promote proteasomal degradation of tyrosine-protein kinases JAK1 or JAK2 in hematopoietic cells (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CTH4;Q9WV73",
        "ec_number_list": "",
        "go_molecular_function": "GO:0061630 ubiquitin protein ligase activity;GO:0097602 cullin family protein binding",
        "go_cellular_component": "GO:0001725 stress fiber;GO:0030018 Z disc;GO:0000151 ubiquitin ligase complex;GO:0031466 Cul5-RING ubiquitin ligase complex",
        "go_biological_process": "GO:0007507 heart development;GO:0035556 intracellular signal transduction;GO:0030036 actin cytoskeleton organization;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q8K0L0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VBX0-1",
        "uniprot_id": "ASB13_MOUSE",
        "mass": 29896.0,
        "length": 278,
        "protein_name": "Ankyrin repeat and SOCS box protein 13",
        "gene_name": "Asb13",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 13 isoform 1",
        "refseq_ac": "NP_840068",
        "gene_names_uniprotkb": "Asb13",
        "gene_names_refseq": "2210015B19Rik; 6430573K02Rik; Asb-13; Asb13",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 13; ASB-13",
        "protein_names_refseq": "ankyrin repeat and SOCS box protein 13 isoform 1; ankyrin repeat and SOCS box protein 13; ankyrin repeat and SOCS box-containing protein 13; ankyrin repeat domain-containing SOCS box protein 13",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:142688);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "30084848;30779550",
        "class_list": "",
        "function": "May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8VBX0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VHS5-1",
        "uniprot_id": "ASB16_MOUSE",
        "mass": 49097.0,
        "length": 453,
        "protein_name": "Ankyrin repeat and SOCS box protein 16",
        "gene_name": "Asb16",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 16",
        "refseq_ac": "NP_683755",
        "gene_names_uniprotkb": "Asb16",
        "gene_names_refseq": "Asb16",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 16; ASB-16",
        "protein_names_refseq": "ASB-16; ankyrin repeat and SOCS box protein 16; ankyrin repeat domain-containing SOCS box protein Asb-16",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:217217);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 0,
        "publication_id_list": "",
        "class_list": "",
        "function": "May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BYT0",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.1,
        "record_id": "Q8VHS5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VHS6-1",
        "uniprot_id": "ASB15_MOUSE",
        "mass": 65512.0,
        "length": 583,
        "protein_name": "Ankyrin repeat and SOCS box protein 15",
        "gene_name": "Asb15",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 15",
        "refseq_ac": "NP_543123",
        "gene_names_uniprotkb": "Asb15",
        "gene_names_refseq": "4930400E23Rik; Asb-15; Asb15",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 15; ASB-15",
        "protein_names_refseq": "ankyrin repeat and SOCS box protein 15; ankyrin repeat and SOCS box-containing protein 15",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:78910)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "16424087;18641171",
        "class_list": "",
        "function": "ASB15 has a role in early myoblast differentiation and that its effects may be mediated in part by the PI3K/Akt signal transduction pathway, [RefSeq, PubMed]; May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins., [UniProtKB]; Results suggest ASB15 participates in the regulation of protein turnover and muscle cell development by stimulating protein synthesis and regulating differentiation of muscle cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CDP8",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0016567 protein ubiquitination;GO:0030111 regulation of Wnt signaling pathway;GO:0007163 establishment or maintenance of cell polarity",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8VHS6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91WR3-1",
        "uniprot_id": "ASCC2_MOUSE",
        "mass": 85653.0,
        "length": 749,
        "protein_name": "Activating signal cointegrator 1 complex subunit 2",
        "gene_name": "Ascc2",
        "organism": "Mouse",
        "refseq_name": "activating signal cointegrator 1 complex subunit 2 isoform 1",
        "refseq_ac": "NP_083567",
        "gene_names_uniprotkb": "Ascc2; Asc1p100",
        "gene_names_refseq": "1700011I11Rik; 2610034L15Rik; ASC1p100; Ascc2",
        "protein_names_uniprotkb": "Activating signal cointegrator 1 complex subunit 2; ASC-1 complex subunit p100; Trip4 complex subunit p100",
        "protein_names_refseq": "ASC-1 complex subunit P100; activating signal cointegrator 1 complex subunit 2 isoform 1; trip4 complex subunit p100",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:75452);  (R-MMU-9954716)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "19047629;25428506;34428180",
        "class_list": "",
        "function": "ASC-2, MLL3, and MLL4 are recruited to the PPARgamma-activated aP2 gene during adipogenesis, [RefSeq, PubMed]; Ubiquitin-binding protein involved in DNA repair and rescue of stalled ribosomes. Plays a role in DNA damage repair as component of the ASCC complex. Recruits ASCC3 and ALKBH3 to sites of DNA damage by binding to polyubiquitinated proteins that have 'Lys-63'-linked polyubiquitin chains. Part of the ASC-1 complex that enhances NF-kappa-B, SRF and AP1 transactivation. Involved in activation of the ribosome quality control (RQC) pathway, a pathway that degrades nascent peptide chains during problematic translation. Specifically recognizes and binds RPS20/uS10 ubiquitinated by ZNF598, promoting recruitment of the RQT (ribosome quality control trigger) complex on stalled ribosomes, followed by disassembly of stalled ribosomes., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5NCK1;Q8BKM9;Q8BX60;Q8R1B9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0043130 ubiquitin binding;GO:0070530 K63-linked polyubiquitin modification-dependent protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0016607 nuclear speck;GO:0022626 cytosolic ribosome;GO:1990391 DNA repair complex;GO:0180022 RQC-trigger complex",
        "go_biological_process": "GO:0072344 rescue of stalled ribosome;GO:0032790 ribosome disassembly;GO:0006281 DNA repair;GO:0006351 DNA-templated transcription;GO:0006355 regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q91WR3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91WU5-1",
        "uniprot_id": "AS3MT_MOUSE",
        "mass": 41794.0,
        "length": 376,
        "protein_name": "Arsenite methyltransferase",
        "gene_name": "As3mt",
        "organism": "Mouse",
        "refseq_name": "arsenite methyltransferase",
        "refseq_ac": "NP_065602",
        "gene_names_uniprotkb": "As3mt; Cyt19",
        "gene_names_refseq": "2310045H08Rik; As3mt; Cyt19",
        "protein_names_uniprotkb": "Arsenite methyltransferase; 2.1.1.137; Methylarsonite methyltransferase; S-adenosyl-L-methionine:arsenic(III) methyltransferase",
        "protein_names_refseq": "S-adenosyl-L-methionine:arsenic(III) methyltransferase; S-adenosylmethionine:arsenic (III) methyltransferase; arsenic (+3 oxidation state) methyltransferase; arsenite methyltransferase; methylarsonite methyltransferase; methyltransferase Cyt19",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:57344);  (R-MMU-156581)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "15808521;21750661;26210637;26883664;27847981;30084848;33141059;37507081",
        "class_list": "",
        "function": "As3mt role in obesity and insulin resistance, [RefSeq, PubMed]; Catalyzes the transfer of a methyl group from AdoMet to trivalent arsenicals producing methylated and dimethylated arsenicals. It methylates arsenite to form methylarsonate, Me-AsO(3)H(2), which is reduced by methylarsonate reductase to methylarsonite, Me-As(OH)2. Methylarsonite is also a substrate and it is converted into the much less toxic compound dimethylarsinate (cacodylate), Me(2)As(O)-OH., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Data, including date from studies in knockout mice, suggest that As3mt is involved in energy metabolism in a sex-specific manner, independent of inorganic arsenic poisoning; thus, As3mt may be involved in cellular processes beyond methylation of inorganic arsenic., [RefSeq, PubMed]; Oxidative damage and Ogg1 deficient background exacerbate repair deficiencies..  Overexpression of the arsenic metabolizing enzyme As3mt acts as adaptive mechanism., [RefSeq, PubMed]; Rat, mouse and human are efficient methylators of inorganic arsenic. Findings suggest a role for AS3MT in the methylation of inorganic arsenic., [RefSeq, PubMed]; Role of As3mt and Mth1 in the genotoxic and carcinogenic effects induced by long-term exposures to arsenic in MEF cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A6H5W4;E9QLU6;Q9QZT1",
        "ec_number_list": "2.1.1.137",
        "go_molecular_function": "GO:0030791 arsenite methyltransferase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005829 cytosol",
        "go_biological_process": "GO:0046685 response to arsenic-containing substance;GO:0009404 toxin metabolic process;GO:0018872 arsonoacetate metabolic process;GO:0032259 methylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q91WU5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91ZT8-1",
        "uniprot_id": "ASB9_MOUSE",
        "mass": 31656.0,
        "length": 290,
        "protein_name": "Ankyrin repeat and SOCS box protein 9",
        "gene_name": "Asb9",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 9",
        "refseq_ac": "NP_081303",
        "gene_names_uniprotkb": "Asb9",
        "gene_names_refseq": "1700011M07Rik; Asb9",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 9; ASB-9",
        "protein_names_refseq": "ASB-9; ankyrin repeat and SOCS box protein 9; ankyrin repeat and SOCS box-containing protein 9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69299);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "11509662;17148442;18776735",
        "class_list": "",
        "function": "Creatine kinase B (CKB) interacts with Asb-9 in a specific, SOCS box-independent manner, [RefSeq, PubMed]; MAsb-9 could be a specific marker of active spermatogenesis and would be useful for studies of male germ cell development., [RefSeq, PubMed]; Substrate-recognition component of a cullin-5-RING E3 ubiquitin-protein ligase complex (ECS complex, also named CRL5 complex), which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:17148442). The ECS(ASB9) complex catalyzes ubiquitination of creatine kinases CKB and CKMT1A (PubMed:17148442)., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6GT43;Q9DAF7",
        "ec_number_list": "",
        "go_molecular_function": "GO:1990756 ubiquitin-like ligase-substrate adaptor activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0031466 Cul5-RING ubiquitin ligase complex",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination;GO:0045732 positive regulation of protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q91ZT8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91ZU0-1",
        "uniprot_id": "ASB7_MOUSE",
        "mass": 35984.0,
        "length": 318,
        "protein_name": "Ankyrin repeat and SOCS box protein 7",
        "gene_name": "Asb7",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 7",
        "refseq_ac": "NP_536691",
        "gene_names_uniprotkb": "Asb7",
        "gene_names_refseq": "Asb-7; Asb7; D030055C23Rik",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 7; ASB-7",
        "protein_names_refseq": "ankyrin repeat and SOCS box protein 7; ankyrin repeat and SOCS box-containing protein 7",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:117589);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "11509662;30059200;33251222;34428180",
        "class_list": "",
        "function": "Substrate-recognition component of a cullin-5-RING E3 ubiquitin-protein ligase complex (ECS complex, also named CRL5 complex), which mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as LZTS1, PSRC1 and SUV39H1 (By similarity). The ECS(ASB7) complex acts as a negative regulator of H3K9me3 histone mark by mediating ubiquitination and degradation of SUV39H1: ASB7 is recruited to heterochromatin by CBX5 (HP1 alpha), where it associates with SUV39H1, promoting the ubiquitin-proteasome-mediated degradation of SUV39H1 (By similarity). During mitosis, ASB7 is phosphorylated and inactivated, allowing SUV39H1 activity (By similarity). The ECS(ASB7) complex also plays a role in spindle dynamics and genome integrity by targeting the mitotic progression protein PSRC1 for proteasomal degradation in a cell cycle-dependent manner (By similarity). Also participates in meiosis by mediating the proper attachment between kinetochores and microtubules (PubMed:33251222)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "G3UVX4",
        "ec_number_list": "",
        "go_molecular_function": "GO:1990756 ubiquitin-like ligase-substrate adaptor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0031466 Cul5-RING ubiquitin ligase complex;GO:0000792 heterochromatin",
        "go_biological_process": "GO:0051310 metaphase chromosome alignment;GO:0008608 attachment of spindle microtubules to kinetochore;GO:0035556 intracellular signal transduction;GO:0007010 cytoskeleton organization;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q91ZU0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q925H0-1",
        "uniprot_id": "ASIC2_MOUSE",
        "mass": 57739.0,
        "length": 512,
        "protein_name": "Acid-sensing ion channel 2",
        "gene_name": "Asic2",
        "organism": "Mouse",
        "refseq_name": "acid-sensing ion channel 2 isoform MDEG1",
        "refseq_ac": "NP_001029185",
        "gene_names_uniprotkb": "Asic2; Accn1; Bnac1",
        "gene_names_refseq": "ACIC2; Accn1; Asic2; BNC1; BNaC1a; BNaC1; Mdeg",
        "protein_names_uniprotkb": "Acid-sensing ion channel 2; ASIC2; Amiloride-sensitive cation channel 1, neuronal; BNC1; BNaC1; Brain sodium channel 1",
        "protein_names_refseq": "acid-sensing (proton-gated) ion channel 2; acid-sensing ion channel 2 isoform MDEG1; amiloride-sensitive brain sodium channel; amiloride-sensitive cation channel 1, neuronal (degenerin); brain sodium channel 1; degenerin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:11418);  (R-MMU-2672351)",
        "pathway_count": 2,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;11069180;11306621;14762118;14960591;15471860;15537887;15708491;20064394;22850675;39453995;9368048",
        "class_list": "",
        "function": "Forms pH-gated trimeric sodium channels that act as postsynaptic excitatory sensors in the nervous system (PubMed:14960591, PubMed:9368048). Upon extracellular acidification, these channels generate rapid, transient inward currents that fully desensitize (PubMed:11306621, PubMed:14960591, PubMed:9368048). Highly selective for sodium, they are permeable to other cations (PubMed:9368048). By forming heterotrimeric channels with ASIC1, could contribute to synaptic plasticity, learning, and memory (PubMed:14960591). Additionally, as acid sensors at nerve terminals, plays a role in mechanosensation and phototransduction (PubMed:11069180, PubMed:14762118, PubMed:15537887, PubMed:20064394)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; Has no pH-gated sodium channel activity per se but can associate with other ASICs to produce functional channels with specific properties., [UniProtKB, PubMed]; Mice lacking acid-sensing ion channel 2 in the medial prefrontal cortex exhibit social dominance., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SUU2;Q61203",
        "ec_number_list": "1.8.-.-",
        "go_molecular_function": "GO:0005216 monoatomic ion channel activity;GO:0015280 ligand-gated sodium channel activity;GO:0022839 monoatomic ion-gated channel activity;GO:0005261 monoatomic cation channel activity;GO:0160125 pH-gated sodium channel activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane;GO:0043025 neuronal cell body;GO:0043197 dendritic spine;GO:0045202 synapse",
        "go_biological_process": "GO:0042391 regulation of membrane potential;GO:0043066 negative regulation of apoptotic process;GO:0019229 regulation of vasoconstriction;GO:0034220 monoatomic ion transmembrane transport;GO:0071466 cellular response to xenobiotic stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q925H0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99MQ4-1",
        "uniprot_id": "ASPN_MOUSE",
        "mass": 42573.0,
        "length": 373,
        "protein_name": "Asporin",
        "gene_name": "Aspn",
        "organism": "Mouse",
        "refseq_name": "asporin preproprotein",
        "refseq_ac": "NP_001165952",
        "gene_names_uniprotkb": "Aspn",
        "gene_names_refseq": "4631401G09Rik; Aspn; Plap1; Slrr1c",
        "protein_names_uniprotkb": "Asporin; PLAP-1; Periodontal ligament-associated protein 1",
        "protein_names_refseq": "asporin preproprotein; periodontal ligament-associated protein 1",
        "tax_id": 10090,
        "disease": "ankylosing spondylitis (Disease Ontology:DOID:7147); osteoarthritis (Disease Ontology:DOID:8398); degenerative disc disease (Disease Ontology:DOID:90)",
        "pathway": " (mmu:66695)",
        "pathway_count": 1,
        "publication_count": 13,
        "publication_id_list": "10.1101/2023.09.13.557529;11152692;11152695;17522060;17804408;17827158;18407830;20052601;34428180;37507081;37828378;38796094;39927985",
        "class_list": "glycogene",
        "function": "Asporin and CD109, expressed in the injured neonatal spinal cord, attenuate axonal re-growth in vitro., [RefSeq, PubMed]; Binds calcium and plays a role in osteoblast-driven collagen biomineralization activity (By similarity). Critical regulator of TGF-beta in articular cartilage and plays an essential role in cartilage homeostasis and osteoarthritis (OA) pathogenesis. Negatively regulates chondrogenesis in the articular cartilage by blocking the TGF-beta/receptor interaction on the cell surface and inhibiting the canonical TGF-beta/Smad signal. Negatively regulates periodontal ligament (PDL) differentiation and mineralization to ensure that the PDL is not ossified and to maintain homeostasis of the tooth-supporting system. Inhibits BMP2-induced cytodifferentiation of PDL cells by preventing its binding to BMPR1B/BMP type-1B receptor, resulting in inhibition of BMP-dependent activation of SMAD proteins. Inhibits the interaction between TGFB1 and TGF-beta receptor type II in the presence of heparin/heparan sulfate in vitro., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; PLAP-1/asporin plays a specific role in the periodontal ligament as a negative regulator of cytodifferentiation and mineralization by regulating BMP-2 activity to prevent the periodontal ligament from developing non-physiological mineralization, [RefSeq, PubMed]; The findings indicate that TGF-beta1 induces ASPN through Smad3 but that this induction is indirect., [RefSeq, PubMed]; This gene encodes a member of the small leucine-rich proteoglycan family. The encoded protein is an extracellular matrix protein that modulates the transforming growth factor-beta signaling pathway, regulating cartilage matrix gene expression and cartilage formation. The protein plays a role in the pathology of osteoarthritis. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2010]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 10,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 3,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D6A2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005509 calcium ion binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0031012 extracellular matrix;GO:0042995 cell projection;GO:0140150 gel phase of interstitial matrix",
        "go_biological_process": "GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway;GO:0030282 bone mineralization;GO:0070171 negative regulation of tooth mineralization;GO:1902617 response to fluoride",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "Q99MQ4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99PE9-1",
        "uniprot_id": "ARL4D_MOUSE",
        "mass": 22270.0,
        "length": 201,
        "protein_name": "ADP-ribosylation factor-like protein 4D",
        "gene_name": "Arl4d",
        "organism": "Mouse",
        "refseq_name": "ADP-ribosylation factor-like protein 4D",
        "refseq_ac": "NP_079680",
        "gene_names_uniprotkb": "Arl4d; Arf4l; Arl5",
        "gene_names_refseq": "1110036H21Rik; ARL6; Arf4l; Arfl4; Arl4d; Arl5",
        "protein_names_uniprotkb": "ADP-ribosylation factor-like protein 4D; ADP-ribosylation factor-like protein 4L; ADP-ribosylation factor-like protein 5",
        "protein_names_refseq": "ADP-ribosylation factor-like 5; ADP-ribosylation factor-like protein 4D; ADP-ribosylation factor-like protein 4L; ADP-ribosylation factor-like protein 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:80981)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "12414990;19327349;20858711;21769420;31219806;36078047",
        "class_list": "",
        "function": "Analysis identified an epistatic interaction that plays a role in the buffering of HDL levels in C57BL/6J mice, and we have identified Arl4d as a candidate gene that mediates this effect., [RefSeq, PubMed]; Arl4D is a previously unknown regulator of neurite formation through cytohesin-2 and Arf6, providing another example that the functional interaction of two different small GTPases controls an important cellular function., [RefSeq, PubMed]; Developmentally regulated ARL5, with its distinctive nuclear/nucleolar localization and interaction with HP1alpha, may play a role(s) in nuclear dynamics and/or signaling cascades during embryonic development, [RefSeq, PubMed]; Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. Recruits CYTH1, CYTH2, CYTH3 and CYTH4 to the plasma membrane in GDP-bound form (By similarity)., [UniProtKB]; The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability. Publication Status: Online-Only, [RefSeq, PubMed]; The results suggest that rapid reduction of Arl4D is required for adipogenesis to proceed., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CQB1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q99PE9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CPX6-1",
        "uniprot_id": "ATG3_MOUSE",
        "mass": 35796.0,
        "length": 314,
        "protein_name": "Ubiquitin-like-conjugating enzyme ATG3",
        "gene_name": "Atg3",
        "organism": "Mouse",
        "refseq_name": "ubiquitin-like-conjugating enzyme ATG3 isoform 1",
        "refseq_ac": "NP_080678",
        "gene_names_uniprotkb": "Atg3; Apg3l",
        "gene_names_refseq": "2610016C12Rik; APG3; Apg3l; Atg3l; Atg3; PC3-96",
        "protein_names_uniprotkb": "Ubiquitin-like-conjugating enzyme ATG3; 2.3.2.-; APG3-like; Autophagy-related protein 3",
        "protein_names_refseq": "autophagy-related protein 3; ubiquitin-like-conjugating enzyme ATG3 isoform 1; ubiquitin-like-conjugating enzyme ATG3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:67841);  (R-MMU-1632852)",
        "pathway_count": 2,
        "publication_count": 13,
        "publication_id_list": "16479539;18321988;18768753;20723759;22024753;24089205;24747438;25605945;25686249;29712776;31219806;34428180;36210013",
        "class_list": "",
        "function": "E2 conjugating enzyme that catalyzes the covalent conjugation of the C-terminal Gly of ATG8-like proteins (GABARAP, GABARAPL1, GABARAPL2 or MAP1LC3A) to the amino group of phosphatidylethanolamine (PE)-containing lipids in the membrane resulting in membrane-bound ATG8-like proteins which is one of the key steps in the development of autophagic isolation membranes during autophagosome formation (PubMed:18768753). Cycles back and forth between binding to ATG7 for loading with the ATG8-like proteins and binding to E3 enzyme, composed of ATG12, ATG5 and ATG16L1 to promote ATG8-like proteins lipidation (By similarity). Also play a role as a membrane curvature sensor that facilitates LC3/GABARAP lipidation by sensing local membrane stress associated with lipid-packing defects as occurs with high molar proportions of conical lipids or strident membrane curvature (PubMed:24747438). Interacts with negatively-charged membranes promoting membrane tethering and enhancing LC3/GABARAP lipidation (By similarity). Also acts as an autocatalytic E2-like enzyme by catalyzing the conjugation of ATG12 to itself in an ATG7-dependent manner, this complex thus formed, plays a role in mitochondrial homeostasis but not in autophagy (PubMed:20723759). ATG12-ATG3 conjugation promotes late endosome to lysosome trafficking and basal autophagosome maturation via its interaction with PDCD6IP (PubMed:25686249). ATG12-ATG3 conjugate is also formed upon viccina virus infection, leading to the disruption the cellular autophagy which is not necessary for vaccinia survival and proliferation (PubMed:22024753). Promotes primary ciliogenesis by removing OFD1 from centriolar satellites via the autophagic pathway (PubMed:24089205)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 16,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TXJ9",
        "ec_number_list": "2.3.2.-",
        "go_molecular_function": "GO:0019899 enzyme binding;GO:0019787 ubiquitin-like protein transferase activity;GO:0019776 Atg8-family ligase activity;GO:0019777 Atg12 transferase activity;GO:0141046 Atg8-family conjugating enzyme activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0000407 phagophore assembly site;GO:0034274 Atg12-Atg5-Atg16 complex",
        "go_biological_process": "GO:0000045 autophagosome assembly;GO:0015031 protein transport;GO:0016236 macroautophagy;GO:0006914 autophagy;GO:0016567 protein ubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q9CPX6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CQ31-1",
        "uniprot_id": "ASB11_MOUSE",
        "mass": 35331.0,
        "length": 323,
        "protein_name": "Ankyrin repeat and SOCS box protein 11",
        "gene_name": "Asb11",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 11 isoform 1",
        "refseq_ac": "NP_001300666",
        "gene_names_uniprotkb": "Asb11",
        "gene_names_refseq": "1110067L12Rik; 1600009D24Rik; Asb11",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 11; ASB-11",
        "protein_names_refseq": "ASB-11; ankyrin repeat and SOCS box protein 11 isoform 1; ankyrin repeat and SOCS box protein 11; ankyrin repeat and SOCS box-containing protein 11",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68854);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "11509662;25428506;30084848",
        "class_list": "",
        "function": "Substrate-recognition component of a cullin-5-RING E3 ubiquitin-protein ligase complex (ECS complex, also named CRL5 complex), which mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as BIK, DIRAS2 and RPN1. The ECS(ASB11) complex acts as a regulator of the endoplasmic reticulum unfolded protein response by mediating ubiquitination and degradation of BIK., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AIH7;Q3UJ13;Q9D0V1",
        "ec_number_list": "",
        "go_molecular_function": "GO:1990756 ubiquitin-like ligase-substrate adaptor activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0031466 Cul5-RING ubiquitin ligase complex",
        "go_biological_process": "GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0016567 protein ubiquitination;GO:0045732 positive regulation of protein catabolic process;GO:0070979 protein K11-linked ubiquitination;GO:0030968 endoplasmic reticulum unfolded protein response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9CQ31-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D1A4-1",
        "uniprot_id": "ASB5_MOUSE",
        "mass": 36282.0,
        "length": 329,
        "protein_name": "Ankyrin repeat and SOCS box protein 5",
        "gene_name": "Asb5",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 5 isoform 1",
        "refseq_ac": "NP_083845",
        "gene_names_uniprotkb": "Asb5",
        "gene_names_refseq": "1110018D09Rik; Asb5",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 5; ASB-5",
        "protein_names_refseq": "ASB-5; ankyrin repeat and SOCS box protein 5 isoform 1; ankyrin repeat and SOCS box protein 5; ankyrin repeat and SOCs box-containing protein 5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76294);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "11509662;21750661;25428506",
        "class_list": "",
        "function": "May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. May play a role in the initiation of arteriogenesis (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:0016567 protein ubiquitination;GO:0045732 positive regulation of protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9D1A4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D8Z1-1",
        "uniprot_id": "ASCC1_MOUSE",
        "mass": 41280.0,
        "length": 356,
        "protein_name": "Activating signal cointegrator 1 complex subunit 1",
        "gene_name": "Ascc1",
        "organism": "Mouse",
        "refseq_name": "activating signal cointegrator 1 complex subunit 1",
        "refseq_ac": "NP_001186116",
        "gene_names_uniprotkb": "Ascc1",
        "gene_names_refseq": "1810015P09Rik; ASC1p50; Ascc1; CGI-18",
        "protein_names_uniprotkb": "Activating signal cointegrator 1 complex subunit 1; ASC-1 complex subunit p50; Trip4 complex subunit p50",
        "protein_names_refseq": "ASC-1 complex subunit p50; activating signal cointegrator 1 complex subunit 1; trip4 complex subunit p50",
        "tax_id": 10090,
        "disease": "Barrett's esophagus (Disease Ontology:DOID:9206)",
        "pathway": " (mmu:69090)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "26924529;34428180",
        "class_list": "",
        "function": "Homozygous and compound-heterozygous nonsense and frameshift TRIP4 and ASCC1 mutations that cosegregated with the Prenatal Spinal Muscular Atrophy and Congenital Bone Fracture phenotype, [RefSeq, PubMed]; Plays a role in DNA damage repair as component of the ASCC complex. Part of the ASC-1 complex that enhances NF-kappa-B, SRF and AP1 transactivation. In cells responding to gastrin-activated paracrine signals, it is involved in the induction of SERPINB2 expression by gastrin. May also play a role in the development of neuromuscular junction., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TAC2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0016607 nuclear speck;GO:0005667 transcription regulator complex;GO:1990391 DNA repair complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006307 DNA alkylation repair;GO:0006355 regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9D8Z1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DCZ9-1",
        "uniprot_id": "APH1C_MOUSE",
        "mass": 29045.0,
        "length": 258,
        "protein_name": "Putative gamma-secretase subunit APH-1C",
        "gene_name": "Aph1c",
        "organism": "Mouse",
        "refseq_name": "putative gamma-secretase subunit APH-1C isoform 1",
        "refseq_ac": "NP_080950",
        "gene_names_uniprotkb": "Aph1c",
        "gene_names_refseq": "Aph1c",
        "protein_names_uniprotkb": "Putative gamma-secretase subunit APH-1C",
        "protein_names_refseq": "anterior pharynx defective 1b; anterior pharynx defective 1c homolog; putative gamma-secretase subunit APH-1C isoform 1; putative gamma-secretase subunit APH-1C",
        "tax_id": 10090,
        "disease": "coronary artery disease (Disease Ontology:DOID:3393)",
        "pathway": " (mmu:68318)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "30084848;34428180",
        "class_list": "",
        "function": "Potential subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral proteins such as Notch receptors and APP (amyloid-beta precursor protein)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U2R3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030674 protein-macromolecule adaptor activity;GO:0061133 endopeptidase activator activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane;GO:0045202 synapse;GO:0030133 transport vesicle;GO:0070765 gamma-secretase complex",
        "go_biological_process": "GO:0006509 membrane protein ectodomain proteolysis;GO:0007219 Notch signaling pathway;GO:0007220 Notch receptor processing;GO:0016485 protein processing;GO:0001963 synaptic transmission, dopaminergic",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9DCZ9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JHE3-1",
        "uniprot_id": "ASAH2_MOUSE",
        "mass": 83509.0,
        "length": 756,
        "protein_name": "Neutral ceramidase",
        "gene_name": "Asah2",
        "organism": "Mouse",
        "refseq_name": "neutral ceramidase",
        "refseq_ac": "NP_061300",
        "gene_names_uniprotkb": "Asah2",
        "gene_names_refseq": "Asah2",
        "protein_names_uniprotkb": "Neutral ceramidase; 3.5.1.-; 3.5.1.23; Acylsphingosine deacylase 2; N-CDase; N-acylsphingosine amidohydrolase 2; NCDase",
        "protein_names_refseq": "N-CDase; NCDase; acylsphingosine deacylase 2; neutral ceramidase; neutral/alkaline ceramidase",
        "tax_id": 10090,
        "disease": "cardiomyopathy (Disease Ontology:DOID:0050700)",
        "pathway": " (mmu:54447);  (R-MMU-9840310)",
        "pathway_count": 2,
        "publication_count": 13,
        "publication_id_list": "10.1101/2023.09.13.557529;10652340;10753931;11591392;12435403;12921776;14557071;16126722;16380386;21613224;21750661;35354041;38302493",
        "class_list": "glycogene",
        "function": "Molecular cloning of the mouse neutral ceramidase gene and its promoter analysis, [RefSeq, PubMed]; Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages. Publication Status: Online-Only, [RefSeq, PubMed]; Neutral ceramidase-dependent regulation of macrophage metabolism directs intestinal immune homeostasis and controls enteric infection., [RefSeq, PubMed]; Plasma membrane ceramidase that hydrolyzes sphingolipid ceramides into sphingosine and free fatty acids at neutral pH (PubMed:10652340, PubMed:10753931, PubMed:16380386). Ceramides, sphingosine, and its phosphorylated form sphingosine-1-phosphate are bioactive lipids that mediate cellular signaling pathways regulating several biological processes including cell proliferation, apoptosis and differentiation (PubMed:14557071). Also catalyzes the reverse reaction allowing the synthesis of ceramides from fatty acids and sphingosine (PubMed:10652340, PubMed:21613224). Together with sphingomyelinase, participates in the production of sphingosine and sphingosine-1-phosphate from the degradation of sphingomyelin, a sphingolipid enriched in the plasma membrane of cells (PubMed:16126722). Also participates in the hydrolysis of ceramides from the extracellular milieu allowing the production of sphingosine-1-phosphate inside and outside cells (PubMed:16126722). This is the case for instance with the digestion of dietary sphingolipids in the intestinal tract (PubMed:16380386)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 7,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 4,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 5,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 5,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 5,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 33,
        "reported_interactions": 0,
        "missing_score": 9820,
        "biomarker_type": "",
        "glycan_count": 5,
        "disease_count": 1,
        "glyco_site_count": 12,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UWP9;Q8BNP0;Q8BQN7;Q8R236",
        "ec_number_list": "3.5.1.23;3.5.1.-;3.5.1.60",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0017040 N-acylsphingosine amidohydrolase activity;GO:0005509 calcium ion binding;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005739 mitochondrion;GO:0005794 Golgi apparatus",
        "go_biological_process": "GO:0006670 sphingosine metabolic process;GO:0046513 ceramide biosynthetic process;GO:0006915 apoptotic process;GO:0046512 sphingosine biosynthetic process;GO:0046514 ceramide catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 2.4,
        "record_id": "Q9JHE3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JJR7-1",
        "uniprot_id": "ASCL3_MOUSE",
        "mass": 20245.0,
        "length": 174,
        "protein_name": "Achaete-scute homolog 3",
        "gene_name": "Ascl3",
        "organism": "Mouse",
        "refseq_name": "achaete-scute homolog 3",
        "refseq_ac": "NP_064435",
        "gene_names_uniprotkb": "Ascl3; Mash3; Sgn1",
        "gene_names_refseq": "Ascl3; Sgn1; bHLHa42",
        "protein_names_uniprotkb": "Achaete-scute homolog 3; ASH-3; bHLH transcriptional regulator Sgn-1; mASH-3; mASH3",
        "protein_names_refseq": "ASH-3; ICRFP703B1614Q5.4; ICRFP703N2430Q5.4; achaete-scute complex homolog 3; achaete-scute complex homolog-like 3; achaete-scute homolog 3; bHLH transcriptional regulator Sgn-1; mASH-3; mASH3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56787)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "11528127;11784080;18572159;21377457;27910949;34428180",
        "class_list": "",
        "function": "Ascl3 knockouts develop smaller salivary glands than wild types, but secrete saliva normally. They display a lower level of cell proliferation, consistent with their smaller size. In the absence of Ascl3, the cells maintain their progenitor function., [RefSeq, PubMed]; These results demonstrate that Ascl3 marks progenitors that are lineage-committed strictly to microvillar cells and Bowman's glands, and highlight the requirement for these cell types to support OE homeostasis. Publication Status: Online-Only, [RefSeq, PubMed]; Transcriptional repressor (PubMed:11784080). Inhibits myogenesis (PubMed:11784080). Plays a role in progenitor cells which differentiate into ductal and acinar, but not myoepithelial, cell lineages in the salivary glands (PubMed:18572159, PubMed:21377457). Involved in the functions of the microvillar cells and Bowman's glands and probably, in a non-cell-autonomous manner, in the development or regeneration of a complete olfactory epithelium (OE) (PubMed:27910949)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3SXE3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0046983 protein dimerization activity;GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005667 transcription regulator complex;GO:0090575 RNA polymerase II transcription regulator complex",
        "go_biological_process": "GO:0060429 epithelium development;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9JJR7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WU60-1",
        "uniprot_id": "ATRN_MOUSE",
        "mass": 158058.0,
        "length": 1428,
        "protein_name": "Attractin",
        "gene_name": "Atrn",
        "organism": "Mouse",
        "refseq_name": "attractin preproprotein",
        "refseq_ac": "NP_033860",
        "gene_names_uniprotkb": "Atrn; Mgca; Mg",
        "gene_names_refseq": "Atrn; Mgca; mg",
        "protein_names_uniprotkb": "Attractin; Protein mahogany",
        "protein_names_refseq": "attractin preproprotein; protein mahogany",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:11990)",
        "pathway_count": 1,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;10086355;10086356;11137996;16075062;25318887;30899004;32580758;33300544;35820727;35822049;40885482",
        "class_list": "glycogene",
        "function": "Data indicate that Attractin was involved in male reproduction in both human and BALB/c mice, but it exerted a different expression profile in different species., [RefSeq, PubMed]; Involved in the initial immune cell clustering during inflammatory response and may regulate chemotactic activity of chemokines (By similarity). May play a role in melanocortin signaling pathways that regulate energy homeostasis and hair color. Low-affinity receptor for agouti. Has a critical role in normal myelination in the central nervous system (By similarity)., [UniProtKB, PubMed]; Post-developmental extracellular proteoglycan maintenance in attractin-deficient mice. Publication Status: Online-Only, [RefSeq, PubMed]; This gene encodes a widely expressed transmembrane glycoprotein that plays important roles in diverse physiological processes such as regulation of hair pigmentation, monocyte-T cell interaction and control of energy homeostasis. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional protein. Certain mutations in this gene are responsible for the mahogany mouse phenotype of dark brown or black coat on a normally agouti background. Mice with loss-of-function mutations in this gene exhibit black coat color, tremor, adiposity, higher basal metabolic rate, juvenile-onset hypomyelination and age-dependent spongiform neurodegeneration of the central nervous system. [provided by RefSeq, Jul 2016]., [RefSeq]",
        "predicted_glycosites": 13,
        "predicted_n_glycosites": 13,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 12,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 12,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 12,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 12,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 50,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 18,
        "disease_count": 0,
        "glyco_site_count": 26,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AP43;Q9R263;Q9WU77",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003682 chromatin binding;GO:0030246 carbohydrate binding;GO:0038023 signaling receptor activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005737 cytoplasm;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0006979 response to oxidative stress;GO:0040014 regulation of multicellular organism growth;GO:0042552 myelination;GO:0043473 pigmentation",
        "synthesized_glycan_count": 0,
        "hit_score": 4.4,
        "record_id": "Q9WU60-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WV71-1",
        "uniprot_id": "ASB4_MOUSE",
        "mass": 48098.0,
        "length": 426,
        "protein_name": "Ankyrin repeat and SOCS box protein 4",
        "gene_name": "Asb4",
        "organism": "Mouse",
        "refseq_name": "ankyrin repeat and SOCS box protein 4",
        "refseq_ac": "NP_075535",
        "gene_names_uniprotkb": "Asb4",
        "gene_names_refseq": "8430401O13Rik; Asb4",
        "protein_names_uniprotkb": "Ankyrin repeat and SOCS box protein 4; ASB-4",
        "protein_names_refseq": "ASB-4; ankyrin repeat and SOCS box protein 4; ankyrin repeat and SOCS box-containing protein 4",
        "tax_id": 10090,
        "disease": "pre-eclampsia (Disease Ontology:DOID:10591)",
        "pathway": " (mmu:65255);  (R-MMU-8951664);  (R-MMU-983168)",
        "pathway_count": 3,
        "publication_count": 6,
        "publication_id_list": "11111040;11820791;17276034;17636018;24586788;35536884",
        "class_list": "",
        "function": "Asb4 has been identified as an imprinted gene by high-throughput screening using RIKEN cDNA microarray., [RefSeq, PubMed]; Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Promotes differentiation and maturation of the vascular lineage by an oxygen-dependent mechanism. Regulates IRS4 levels by directing its degradation via ubiquitination and thereby decreases the downstream signal of IRS4 (By similarity). Also acts as a negative regulator of GPS1, a component of the COP9 signalosome (CSN) multiprotein complex, thereby inhibiting the serine phosphorylation of IRS1 (PubMed:17276034). Plays a critical role during early vascular development and proper placentation (PubMed:24586788, PubMed:35536884). Mechanistically, negatively regulates the transcriptional regulator inhibitor of DNA binding 2/ID2 expression through polyubiquitination and proteasome dependent degradation (PubMed:24586788)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 7,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UZE1;Q3V070",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019899 enzyme binding;GO:0031625 ubiquitin protein ligase binding;GO:0061630 ubiquitin protein ligase activity;GO:0004842 ubiquitin-protein transferase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0031462 Cul2-RING ubiquitin ligase complex;GO:0031466 Cul5-RING ubiquitin ligase complex",
        "go_biological_process": "GO:0035556 intracellular signal transduction;GO:2001214 positive regulation of vasculogenesis;GO:0051865 protein autoubiquitination",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9WV71-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z0F3-1",
        "uniprot_id": "B2L10_MOUSE",
        "mass": 22302.0,
        "length": 191,
        "protein_name": "Bcl-2-like protein 10",
        "gene_name": "Bcl2l10",
        "organism": "Mouse",
        "refseq_name": "bcl-2-like protein 10",
        "refseq_ac": "NP_038507",
        "gene_names_uniprotkb": "Bcl2l10; Bcl-b; Boo; Diva",
        "gene_names_refseq": "Bcl2l10; Boo; Diva",
        "protein_names_uniprotkb": "Bcl-2-like protein 10; Anti-apoptotic protein Boo; Apoptosis regulator Bcl-B; Bcl-2 homolog Diva; Bcl2-L-10",
        "protein_names_refseq": "anti-apoptotic protein Boo; apoptosis regulator Bcl-B; bcl-2 homolog Diva; bcl-2-like protein 10; bcl2-L-10",
        "tax_id": 10090,
        "disease": "myelodysplastic syndrome (Disease Ontology:DOID:0050908); breast carcinoma (Disease Ontology:DOID:3459); stomach carcinoma (Disease Ontology:DOID:5517); multiple myeloma (Disease Ontology:DOID:9538)",
        "pathway": " (mmu:12049)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "17532299;20455273;27455953;27753540;30635551;9829980;9878060",
        "class_list": "",
        "function": "Bcl2l10, Tpx2, and Aurka co-localized on the meiotic spindles, and Bcl2l10 was present in the same complex with Tpx2., [RefSeq, PubMed]; Promotes cell survival by suppressing apoptosis induced by BAX but not BAK (By similarity). Increases binding of AHCYL1/IRBIT to ITPR1 (By similarity). Reduces ITPR1-mediated calcium release from the endoplasmic reticulum cooperatively with AHCYL1/IRBIT under normal cellular conditions (By similarity). Under apoptotic stress conditions, dissociates from ITPR1 and is displaced from mitochondria-associated endoplasmic reticulum membranes, leading to increased Ca(2+) transfer to mitochondria which promotes apoptosis (By similarity). Required for the correct formation of the microtubule organizing center during oocyte cell division, potentially via regulation of protein abundance and localization of other microtubule organizing center components such as AURKA and TPX2 (PubMed:27753540)., [UniProtKB, UniProtKB, PubMed]; Role for Bcl-B in B cell proliferation and plasmocyte differentiation through its ability to impair B cell death and drive multiple myeloma progression., [RefSeq, PubMed]; The knockdown of BCL-B resulted in increased apoptosis and mitophagy in hepatic stellate cells, while the overexpression of BCL-B caused the opposite effects. Erratum:[Exp Mol Med. 2025 Jul;57(7):1615-1617. doi: 10.1038/s12276-025-01515-z. PMID: 40715461] Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3ULP5;Q7TPY8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0005509 calcium ion binding;GO:0015267 channel activity;GO:0089720 caspase binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0005783 endoplasmic reticulum;GO:0005819 spindle;GO:0005829 cytosol",
        "go_biological_process": "GO:0043065 positive regulation of apoptotic process;GO:0043066 negative regulation of apoptotic process;GO:0006915 apoptotic process;GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage;GO:0001836 release of cytochrome c from mitochondria",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9Z0F3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JJV1-1",
        "uniprot_id": "CRBA2_MOUSE",
        "mass": 22237.0,
        "length": 197,
        "protein_name": "Beta-crystallin A2",
        "gene_name": "Cryba2",
        "organism": "Mouse",
        "refseq_name": "beta-crystallin A2",
        "refseq_ac": "NP_067516",
        "gene_names_uniprotkb": "Cryba2",
        "gene_names_refseq": "Cryba2; E130107M19Rik",
        "protein_names_uniprotkb": "Beta-crystallin A2; Beta-A2 crystallin",
        "protein_names_refseq": "beta-A2 crystallin; beta-crystallin A2; betaA2-crystallin; lens structural protein",
        "tax_id": 10090,
        "disease": "cataract 42 (Disease Ontology:DOID:0110237)",
        "pathway": " (mmu:12958)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "Crystallins are the dominant structural components of the vertebrate eye lens., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q540J7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0005212 structural constituent of eye lens",
        "go_cellular_component": "",
        "go_biological_process": "GO:0007601 visual perception;GO:0002088 lens development in camera-type eye;GO:0001654 eye development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9JJV1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QZ82-1",
        "uniprot_id": "CP11A_MOUSE",
        "mass": 60315.0,
        "length": 526,
        "protein_name": "Cholesterol side-chain cleavage enzyme, mitochondrial",
        "gene_name": "Cyp11a1",
        "organism": "Mouse",
        "refseq_name": "cholesterol side-chain cleavage enzyme, mitochondrial isoform 1 precursor",
        "refseq_ac": "NP_062753",
        "gene_names_uniprotkb": "Cyp11a1; Cyp11a",
        "gene_names_refseq": "Cyp11a1; Cyp11a; Cypxia1; D9Ertd411e; P450scc; Scc; cscc",
        "protein_names_uniprotkb": "Cholesterol side-chain cleavage enzyme, mitochondrial; 1.14.15.6; CYPXIA1; Cholesterol desmolase; Cytochrome P450 11A1; Cytochrome P450(scc)",
        "protein_names_refseq": "cholesterol desmolase; cholesterol side-chain cleavage enzyme, mitochondrial isoform 1 precursor; cholesterol side-chain cleavage enzyme, mitochondrial; cytochrome P450 11A1; cytochrome P450 side-chain cleavage enzyme; cytochrome P450(scc); cytochrome P450, 11a, cholesterol side-chain cleavage",
        "tax_id": 10090,
        "disease": "congenital adrenal insufficiency (Disease Ontology:DOID:0050546); congenital adrenal hyperplasia (Disease Ontology:DOID:0050811); hypertension (Disease Ontology:DOID:10763); sciatic neuropathy (Disease Ontology:DOID:11446); status epilepticus (Disease Ontology:DOID:1824); hypogonadism (Disease Ontology:DOID:1924); nephrosis (Disease Ontology:DOID:2527); hyperglycemia (Disease Ontology:DOID:4195); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:13070);  (R-MMU-196108);  (R-MMU-211976)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "21750661;34428180",
        "class_list": "",
        "function": "A cytochrome P450 monooxygenase that catalyzes the side-chain hydroxylation and cleavage of cholesterol to pregnenolone, the precursor of most steroid hormones. Catalyzes three sequential oxidation reactions of cholesterol, namely the hydroxylation at C22 followed with the hydroxylation at C20 to yield 20R,22R-hydroxycholesterol that is further cleaved between C20 and C22 to yield the C21-steroid pregnenolone and 4-methylpentanal. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate and reducing the second into a water molecule. Two electrons are provided by NADPH via a two-protein mitochondrial transfer system comprising flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron-sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin)., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 9,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.18.1.6;1.14.15.6",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0020037 heme binding;GO:0008386 cholesterol monooxygenase (side-chain-cleaving) activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005759 mitochondrial matrix;GO:0043204 perikaryon;GO:0030061 mitochondrial crista",
        "go_biological_process": "GO:0007617 mating behavior;GO:0008203 cholesterol metabolic process;GO:0042542 response to hydrogen peroxide;GO:0006700 C21-steroid hormone biosynthetic process;GO:0006694 steroid biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9QZ82-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C1R3-1",
        "uniprot_id": "CQ050_MOUSE",
        "mass": 21117.0,
        "length": 189,
        "protein_name": "Uncharacterized protein C17orf50 homolog",
        "gene_name": "1700020L24Rik",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein C17orf50 homolog",
        "refseq_ac": "NP_079768",
        "gene_names_uniprotkb": "1700020L24Rik",
        "gene_names_refseq": "1700020L24Rik",
        "protein_names_uniprotkb": "Uncharacterized protein C17orf50 homolog",
        "protein_names_refseq": "uncharacterized protein C17orf50 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66330)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A7MCU3;Q9DAI8",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005654 nucleoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8C1R3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O55127-1",
        "uniprot_id": "CP26A_MOUSE",
        "mass": 56178.0,
        "length": 497,
        "protein_name": "Cytochrome P450 26A1",
        "gene_name": "Cyp26a1",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 26A1",
        "refseq_ac": "NP_031837",
        "gene_names_uniprotkb": "Cyp26a1; Cyp26; P450ra",
        "gene_names_refseq": "Cyp26a1; Cyp26; P450RAI; P450RA; RAH",
        "protein_names_uniprotkb": "Cytochrome P450 26A1; 1.14.13.-; CYP26A1; Cytochrome P450RAI; Retinoic acid 4-hydroxylase; Retinoic acid-metabolizing cytochrome",
        "protein_names_refseq": "cytochrome P450 26A1; cytochrome P450, 26, retinoic acid A1; cytochrome P450RAI; retinoic acid 4-hydroxylase; retinoic acid hydrolase; retinoic acid-metabolizing cytochrome",
        "tax_id": 10090,
        "disease": "holoprosencephaly (Disease Ontology:DOID:4621); Barrett's adenocarcinoma (Disease Ontology:DOID:7941); actinic keratosis (Disease Ontology:DOID:8866)",
        "pathway": " (mmu:13082);  (R-MMU-211916);  (R-MMU-5365859)",
        "pathway_count": 3,
        "publication_count": 5,
        "publication_id_list": "11063033;15911617;21750661;9250660;9442090",
        "class_list": "",
        "function": "A cytochrome P450 monooxygenase involved in the metabolism of retinoates (RAs), the active metabolites of vitamin A, and critical signaling molecules in animals (PubMed:15911617, PubMed:9250660, PubMed:9442090). RAs exist as at least four different isomers: all-trans-RA (atRA), 9-cis-RA, 13-cis-RA, and 9,13-dicis-RA, where atRA is considered to be the biologically active isomer, although 9-cis-RA and 13-cis-RA also have activity (By similarity). Catalyzes the hydroxylation of atRA primarily at C-4 and C-18, thereby contributing to the regulation of atRA homeostasis and signaling (PubMed:15911617, PubMed:9250660, PubMed:9442090). Hydroxylation of atRA limits its biological activity and initiates a degradative process leading to its eventual elimination (By similarity). Involved in the convertion of atRA to all-trans-4-oxo-RA (PubMed:15911617). Able to metabolize other RAs such as 9-cis, 13-cis and 9,13-di-cis RA (PubMed:9250660). Can oxidize all-trans-13,14-dihydroretinoate (DRA) to metabolites which could include all-trans-4-oxo-DRA, all-trans-4-hydroxy-DRA, all-trans-5,8-epoxy-DRA, and all-trans-18-hydroxy-DRA (Probable). May play a role in the oxidative metabolism of xenobiotics such as tazarotenic acid (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9R1F4",
        "ec_number_list": "1.14.14.1;1.14.13.-",
        "go_molecular_function": "GO:0008401 retinoic acid 4-hydroxylase activity;GO:0016709 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;GO:0005506 iron ion binding;GO:0020037 heme binding;GO:0001972 retinoic acid binding",
        "go_cellular_component": "GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0071300 cellular response to retinoic acid;GO:0007417 central nervous system development;GO:0042573 retinoic acid metabolic process;GO:0006805 xenobiotic metabolic process;GO:0009952 anterior/posterior pattern specification",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "O55127-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UM29-1",
        "uniprot_id": "COG7_MOUSE",
        "mass": 86073.0,
        "length": 770,
        "protein_name": "Conserved oligomeric Golgi complex subunit 7",
        "gene_name": "Cog7",
        "organism": "Mouse",
        "refseq_name": "conserved oligomeric Golgi complex subunit 7",
        "refseq_ac": "NP_001028490",
        "gene_names_uniprotkb": "Cog7",
        "gene_names_refseq": "5630400E24Rik; Cog7; Gm167",
        "protein_names_uniprotkb": "Conserved oligomeric Golgi complex subunit 7; COG complex subunit 7; Component of oligomeric Golgi complex 7",
        "protein_names_refseq": "COG complex subunit 7; conserved oligomeric Golgi complex subunit 7",
        "tax_id": 10090,
        "disease": "congenital disorder of glycosylation type IIe (Disease Ontology:DOID:0070257); genetic disease (Disease Ontology:DOID:630)",
        "pathway": " (mmu:233824);  (R-MMU-6807878);  (R-MMU-6811438);  (R-MMU-6811440)",
        "pathway_count": 4,
        "publication_count": 5,
        "publication_id_list": "21750661;26740625;30084848;31219806;34428180",
        "class_list": "",
        "function": "Required for normal Golgi function., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U3L7",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005730 nucleolus;GO:0005794 Golgi apparatus;GO:0017119 Golgi transport complex",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0009101 glycoprotein biosynthetic process;GO:0050821 protein stabilization;GO:0006890 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;GO:0007030 Golgi organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q3UM29-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D2L5-1",
        "uniprot_id": "CPXM2_MOUSE",
        "mass": 86963.0,
        "length": 764,
        "protein_name": "Inactive carboxypeptidase-like protein X2",
        "gene_name": "Cpxm2",
        "organism": "Mouse",
        "refseq_name": "inactive carboxypeptidase-like protein X2 precursor",
        "refseq_ac": "NP_061355",
        "gene_names_uniprotkb": "Cpxm2; Cpx2",
        "gene_names_refseq": "4632435C11Rik; CPX-2; Cpx2; Cpxm2",
        "protein_names_uniprotkb": "Inactive carboxypeptidase-like protein X2",
        "protein_names_refseq": "carboxypeptidase X 2 (M14 family); carboxypeptidase X2; inactive carboxypeptidase-like protein X2 precursor; inactive carboxypeptidase-like protein X2; metallocarboxypeptidase 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:55987)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;34916661;9809751",
        "class_list": "",
        "function": "Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension., [RefSeq, PubMed]; May be involved in cell-cell interactions., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O54860;Q8VDQ4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0004181 metallocarboxypeptidase activity",
        "go_cellular_component": "GO:0005576 extracellular region",
        "go_biological_process": "GO:0006508 proteolysis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q9D2L5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P97478-1",
        "uniprot_id": "COQ7_MOUSE",
        "mass": 24042.0,
        "length": 217,
        "protein_name": "NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial",
        "gene_name": "Coq7",
        "organism": "Mouse",
        "refseq_name": "NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial isoform 1",
        "refseq_ac": "NP_034070",
        "gene_names_uniprotkb": "Coq7; COQ7",
        "gene_names_refseq": "Coq7; clk-1",
        "protein_names_uniprotkb": "NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial; 1.14.13.253; 3-demethoxyubiquinone 3-hydroxylase (NADH); Timing protein clk-1 homolog; Ubiquinone biosynthesis monooxygenase COQ7",
        "protein_names_refseq": "3-demethoxyubiquinone 3-hydroxylase (NADH); 5-demethoxyubiquinone hydroxylase, mitochondrial; DMQ hydroxylase; NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial isoform 1; NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial; coenzyme Q biosynthesis protein 7 homolog; timing protein clk-1 homolog; ubiquinone biosynthesis monooxygenase COQ7; ubiquinone biosynthesis protein COQ7 homolog",
        "tax_id": 10090,
        "disease": "primary coenzyme Q10 deficiency 8 (Disease Ontology:DOID:0070245); autosomal recessive distal hereditary motor neuronopathy 9 (Disease Ontology:DOID:0081428)",
        "pathway": " (mmu:12850);  (R-MMU-2142789)",
        "pathway_count": 2,
        "publication_count": 15,
        "publication_id_list": "10373327;10501970;11387338;11511092;19478076;20923139;21750661;28409910;29025968;30084848;31219806;34203471;34428180;36288343;9020081",
        "class_list": "",
        "function": "Catalyzes the hydroxylation of 2-polyprenyl-3-methyl-6-methoxy-1,4-benzoquinol (DMQH2) during ubiquinone biosynthesis. Has also a structural role in the COQ enzyme complex, stabilizing other COQ polypeptides. Involved in lifespan determination in a ubiquinone-independent manner., [UniProtKB, HAMAP]; Catalyzes the hydroxylation of the 5-methoxy-2-methyl-3-(all-trans-polyprenyl)benzoquinone at the C6 position and participates in the biosynthesis of ubiquinone. Catalyzes the reaction through a substrate-mediated reduction pathway, whereby NADH shuttles electrons to 5-methoxy-2-methyl-3-(all-trans-decaprenyl)benzoquinone, which then transfers the electrons to the two Fe(3+) centers. The binding of 5-methoxy-2-methyl-3-(all-trans-polyprenyl)benzoquinone (DMQn) mediates reduction of the diiron center by nicotinamide adenine dinucleotide (NADH) and initiates oxygen activation for subsequent DMQ hydroxylation. The physiological substrates are 5-methoxy-2-methyl-3-(all-trans-nonaprenyl)benzoquinone (DMQ(9)) and 5-methoxy-2-methyl-3-(all-trans-decaprenyl)benzoquinone (DMQ(10)), however in vitro the enzyme does not have any specificity concerning the length of the polyprenyl tail, and accepts tails of various lengths with similar efficiency (By similarity). Also has a structural role in the COQ enzyme complex, stabilizing other COQ polypeptides (By similarity). Involved in lifespan determination in a ubiquinone-independent manner (PubMed:19478076). Plays a role in modulating mitochondrial stress responses, acting in the nucleus, perhaps via regulating gene expression, independent of its characterized mitochondrial function in ubiquinone biosynthesis (By similarity)., [UniProtKB, HAMAP, PubMed, UniProtKB]; Clk1 plays a direct role in dopaminergic neuronal survival via regulating the autophagy-lysosome pathway that may contribute to the pathologic development of Parkinson disease., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9R0D7",
        "ec_number_list": "1.14.99.60;1.14.13.253;2.7.-.-;4.1.1.130;2.1.1.-;2.1.1.114;2.1.1.64;1.14.15.45;1.14.15.46;2.1.1.201",
        "go_molecular_function": "GO:0016709 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;GO:0003682 chromatin binding;GO:0046872 metal ion binding;GO:0160224 3-demethoxyubiquinone 3-hydroxylase (NADH) activity;GO:0008682 3-demethoxyubiquinol 3-hydroxylase activity",
        "go_cellular_component": "GO:0031314 extrinsic component of mitochondrial inner membrane;GO:0005634 nucleus;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0110142 ubiquinone biosynthesis complex",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0001701 in utero embryonic development;GO:0006979 response to oxidative stress;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0034599 cellular response to oxidative stress",
        "synthesized_glycan_count": 0,
        "hit_score": 1.8,
        "record_id": "P97478-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CPZ8-1",
        "uniprot_id": "COXM1_MOUSE",
        "mass": 12553.0,
        "length": 106,
        "protein_name": "COX assembly mitochondrial protein homolog",
        "gene_name": "Cmc1",
        "organism": "Mouse",
        "refseq_name": "COX assembly mitochondrial protein homolog",
        "refseq_ac": "NP_080718",
        "gene_names_uniprotkb": "Cmc1",
        "gene_names_refseq": "2010110K16Rik; 2010312P05Rik; Cmc1",
        "protein_names_uniprotkb": "COX assembly mitochondrial protein homolog; Cmc1p",
        "protein_names_refseq": "COX assembly mitochondrial protein 1; COX assembly mitochondrial protein homolog; cmc1p",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:67899);  (R-MMU-9864848)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "21750661;26495903;34428180;36288343",
        "class_list": "",
        "function": "Component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6PH95;Q80ZR0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0044183 protein folding chaperone",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005758 mitochondrial intermembrane space",
        "go_biological_process": "GO:0033617 mitochondrial respiratory chain complex IV assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9CPZ8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9WVK8-1",
        "uniprot_id": "CP46A_MOUSE",
        "mass": 56814.0,
        "length": 500,
        "protein_name": "Cholesterol 24-hydroxylase",
        "gene_name": "Cyp46a1",
        "organism": "Mouse",
        "refseq_name": "cholesterol 24-hydroxylase",
        "refseq_ac": "NP_034140",
        "gene_names_uniprotkb": "Cyp46a1; Cyp46",
        "gene_names_refseq": "CH24H; Cyp46a1; Cyp46",
        "protein_names_uniprotkb": "Cholesterol 24-hydroxylase; 1.14.14.25; CH24H; Cholesterol 24-monooxygenase; Cholesterol 24S-hydroxylase; Cytochrome P450 46A1",
        "protein_names_refseq": "cholesterol 24-hydroxylase; cholesterol 24-monooxygenase; cholesterol 24S-hydroxylase; cholestrol 24-hydroxylase; cytochrome P450, 46a1 (cholesterol 24-hydroxylase)",
        "tax_id": 10090,
        "disease": "Alzheimer's disease (Disease Ontology:DOID:10652); alcohol use disorder (Disease Ontology:DOID:1574)",
        "pathway": " (mmu:13116);  (R-MMU-193775);  (R-MMU-211976)",
        "pathway_count": 3,
        "publication_count": 12,
        "publication_id_list": "10377398;12232784;12686551;16505352;18241055;21750661;25428506;28190002;33300544;36453552;37944529;38266095",
        "class_list": "",
        "function": "CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized mice., [RefSeq, PubMed]; Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis., [RefSeq, PubMed]; Cholesterol-24-hydroxylase (CYP46) in the old brain: Analysis of positive populations and factors triggering its expression in astrocytes., [RefSeq, PubMed]; Constitutes a major tissue-specific pathway for cholesterol turnover in the brain, [RefSeq, PubMed]; P450 monooxygenase that plays a major role in cholesterol homeostasis in the brain. Primarily catalyzes the hydroxylation (with S stereochemistry) at C-24 of cholesterol side chain, triggering cholesterol diffusion out of neurons and its further degradation (PubMed:10377398, PubMed:16505352, PubMed:28190002). By promoting constant cholesterol elimination in neurons, may activate the mevalonate pathway and coordinate the synthesis of new cholesterol and nonsterol isoprenoids involved in synaptic activity and learning (PubMed:16505352). Further hydroxylates cholesterol derivatives and hormone steroids on both the ring and side chain of these molecules, converting them into active oxysterols involved in lipid signaling and biosynthesis (By similarity). Acts as an epoxidase converting cholesta-5,24-dien-3beta-ol/desmosterol into (24S),25-epoxycholesterol, an abundant lipid ligand of nuclear NR1H2 and NR1H3 receptors shown to promote neurogenesis in developing brain (By similarity). May also catalyze the oxidative metabolism of xenobiotics, such as clotrimazole (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]; The CYP46 gene locus may predispose to Alzheimer's disease by increasing the 24S-hydroxycholesterol/cholesterol ratio in the brain., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.14.14.19;1.14.14.32;1.14.14.1;4.2.1.152;1.14.14.25",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0020037 heme binding;GO:0008395 steroid hydroxylase activity;GO:0033781 cholesterol 24-hydroxylase activity;GO:0050649 testosterone 6-beta-hydroxylase activity",
        "go_cellular_component": "GO:0030425 dendrite;GO:0005789 endoplasmic reticulum membrane;GO:0098794 postsynapse;GO:0098793 presynapse",
        "go_biological_process": "GO:0006805 xenobiotic metabolic process;GO:0006707 cholesterol catabolic process;GO:1900271 regulation of long-term synaptic potentiation;GO:0042448 progesterone metabolic process;GO:1903044 protein localization to membrane raft",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "Q9WVK8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2A5I3-1",
        "uniprot_id": "CRSPL_MOUSE",
        "mass": 28269.0,
        "length": 253,
        "protein_name": "Peptidase inhibitor R3HDML",
        "gene_name": "R3hdml",
        "organism": "Mouse",
        "refseq_name": "peptidase inhibitor R3HDML precursor",
        "refseq_ac": "NP_001092801",
        "gene_names_uniprotkb": "R3hdml",
        "gene_names_refseq": "R3hdml",
        "protein_names_uniprotkb": "Peptidase inhibitor R3HDML; Cysteine-rich secretory protein R3HDML",
        "protein_names_refseq": "cysteine-rich secretory protein R3HDML; novel SCP-like extracellular protein domain containing protein; peptidase inhibitor R3HDML precursor; peptidase inhibitor R3HDML",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100043899)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "31524320",
        "class_list": "",
        "function": "Our results indicate that R3hdml is required for skeletal muscle development, regeneration, and, in particular, satellite cell proliferation and differentiation., [RefSeq, PubMed]; Putative serine protease inhibitor., [UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030414 peptidase inhibitor activity",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "A2A5I3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6A152-1",
        "uniprot_id": "CP4X1_MOUSE",
        "mass": 58557.0,
        "length": 507,
        "protein_name": "Cytochrome P450 4X1",
        "gene_name": "Cyp4x1",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 4X1",
        "refseq_ac": "NP_001003947",
        "gene_names_uniprotkb": "Cyp4x1",
        "gene_names_refseq": "A230025G20; CYPIVX1; CYP_a; Cyp4a28-ps; Cyp4x1",
        "protein_names_uniprotkb": "Cytochrome P450 4X1; 1.14.14.-; CYPIVX1",
        "protein_names_refseq": "cytochrome P450 4X1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:81906)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "16478468;21750661",
        "class_list": "",
        "function": "A cytochrome P450 monooxygenase that selectively catalyzes the epoxidation of the last double bond of the arachidonoyl moiety of anandamide, potentially modulating endocannabinoid signaling. Has no hydroxylase activity toward various fatty acids, steroids and prostaglandins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase)., [UniProtKB, UniProtKB]; Cyp4x RNA was expressed principally in brain, and at much lower levels in liver, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q2HJC6;Q8BYS0",
        "ec_number_list": "1.14.14.-",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0020037 heme binding;GO:0062189 anandamide 14,15 epoxidase activity;GO:0004497 monooxygenase activity;GO:0016705 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",
        "go_cellular_component": "GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006631 fatty acid metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q6A152-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D8X5-1",
        "uniprot_id": "CNOT8_MOUSE",
        "mass": 33574.0,
        "length": 292,
        "protein_name": "CCR4-NOT transcription complex subunit 8",
        "gene_name": "Cnot8",
        "organism": "Mouse",
        "refseq_name": "CCR4-NOT transcription complex subunit 8",
        "refseq_ac": "NP_081225",
        "gene_names_uniprotkb": "Cnot8",
        "gene_names_refseq": "1500015I04Rik; 1810022F04Rik; Cnot8",
        "protein_names_uniprotkb": "CCR4-NOT transcription complex subunit 8; 3.1.13.4; CCR4-associated factor 8",
        "protein_names_refseq": "CCR4-NOT transcription complex subunit 8; CCR4-associated factor 8",
        "tax_id": 10090,
        "disease": "heart disease (Disease Ontology:DOID:114)",
        "pathway": " (mmu:69125);  (R-MMU-429947);  (R-MMU-6804115)",
        "pathway_count": 3,
        "publication_count": 10,
        "publication_id_list": "21750661;22367759;25428506;27065194;30084848;30779550;31924127;34428180;35248544;35390160",
        "class_list": "",
        "function": "CNOT7 Outcompetes Its Paralog CNOT8 for Integration into The CCR4-NOT Complex., [RefSeq, PubMed]; Cnot8 eliminates naive regulation networks and is essential for naive-to-formative pluripotency transition., [RefSeq, PubMed]; Essential functions of the CNOT7/8 catalytic subunits of the CCR4-NOT complex in mRNA regulation and cell viability., [RefSeq, PubMed]; Has 3'-5' poly(A) exoribonuclease activity for synthetic poly(A) RNA substrate. Its function seems to be partially redundant with that of CNOT7. Catalytic component of the CCR4-NOT complex which is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. During miRNA-mediated repression the complex also seems to act as translational repressor during translational initiation. Additional complex functions may be a consequence of its influence on mRNA expression. Associates with members of the BTG family such as TOB1 and BTG2 and is required for their anti-proliferative activity., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U532",
        "ec_number_list": "3.6.4.13;3.1.13.4;2.3.2.27",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0046872 metal ion binding;GO:0000175 3'-5'-RNA exonuclease activity;GO:0004535 poly(A)-specific ribonuclease activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol;GO:0000932 P-body;GO:0030014 CCR4-NOT complex;GO:0030015 CCR4-NOT core complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006417 regulation of translation;GO:0008284 positive regulation of cell population proliferation;GO:0035279 miRNA-mediated gene silencing by mRNA destabilization;GO:0061014 positive regulation of mRNA catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9D8X5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BG94-1",
        "uniprot_id": "COMD7_MOUSE",
        "mass": 22652.0,
        "length": 200,
        "protein_name": "COMM domain-containing protein 7",
        "gene_name": "Commd7",
        "organism": "Mouse",
        "refseq_name": "COMM domain-containing protein 7 isoform 2",
        "refseq_ac": "NP_001182319",
        "gene_names_uniprotkb": "Commd7",
        "gene_names_refseq": "2310010I22Rik; Commd7; mU3",
        "protein_names_uniprotkb": "COMM domain-containing protein 7",
        "protein_names_refseq": "COMM domain-containing protein 7 isoform 2; COMM domain-containing protein 7",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:99311);  (R-MMU-8951664)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "21750661;25428506;30084848;30779550;34428180",
        "class_list": "",
        "function": "Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex (By similarity). May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (By similarity). Associates with the NF-kappa-B complex and suppresses its transcriptional activity (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q99J75",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051059 NF-kappaB binding",
        "go_cellular_component": "GO:0031410 cytoplasmic vesicle;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0045892 negative regulation of DNA-templated transcription;GO:0033209 tumor necrosis factor-mediated signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q8BG94-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88207-1",
        "uniprot_id": "CO5A1_MOUSE",
        "mass": 183677.0,
        "length": 1838,
        "protein_name": "Collagen alpha-1(V) chain",
        "gene_name": "Col5a1",
        "organism": "Mouse",
        "refseq_name": "collagen alpha-1(V) chain precursor",
        "refseq_ac": "NP_056549",
        "gene_names_uniprotkb": "Col5a1",
        "gene_names_refseq": "Col5a1",
        "protein_names_uniprotkb": "Collagen alpha-1(V) chain",
        "protein_names_refseq": "alpha1(V) collagen; collagen alpha-1(V) chain precursor; collagen alpha-1(V) chain; pro-alpha1(V) collagen; procollagen type V alpha 1",
        "tax_id": 10090,
        "disease": "Ehlers-Danlos syndrome (Disease Ontology:DOID:13359); Ehlers-Danlos syndrome classic type 1 (Disease Ontology:DOID:14720)",
        "pathway": " (mmu:12831);  (R-MMU-1442490);  (R-MMU-1566977);  (R-MMU-1650814);  (R-MMU-186797);  (R-MMU-2022090);  (R-MMU-216083);  (R-MMU-3000171);  (R-MMU-3000178);  (R-MMU-419037);  (R-MMU-8874081);  (R-MMU-8948216)",
        "pathway_count": 12,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;15246108;21750661;22149965;25428506;28011936;31787984;34203471;9582436",
        "class_list": "",
        "function": "Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin (By similarity). Transcriptionally activated by CEBPZ, which recognizes a CCAAT-like motif, CAAAT in the COL5A1 promoter., [UniProtKB, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 4,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9343,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 2,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A3KGE3;Q3UG94;Q6F6B0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008201 heparin binding;GO:0043394 proteoglycan binding;GO:0005201 extracellular matrix structural constituent;GO:0030020 extracellular matrix structural constituent conferring tensile strength;GO:0048407 platelet-derived growth factor binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0031012 extracellular matrix;GO:0005604 basement membrane;GO:0005581 collagen trimer;GO:0005588 collagen type V trimer",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0016477 cell migration;GO:0030199 collagen fibril organization;GO:0001568 blood vessel development;GO:0003007 heart morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "O88207-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3V3I5-1",
        "uniprot_id": "CQ067_MOUSE",
        "mass": 10620.0,
        "length": 90,
        "protein_name": "Uncharacterized protein C17orf67 homolog",
        "gene_name": "Gm525",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein C17orf67 homolog precursor",
        "refseq_ac": "NP_001028438",
        "gene_names_uniprotkb": "Gm525",
        "gene_names_refseq": "Gm525",
        "protein_names_uniprotkb": "Uncharacterized protein C17orf67 homolog",
        "protein_names_refseq": "novel transcript; uncharacterized protein C17orf67 homolog precursor; uncharacterized protein C17orf67 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:217071)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2KGT0",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005576 extracellular region",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q3V3I5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K211-1",
        "uniprot_id": "COPT1_MOUSE",
        "mass": 21961.0,
        "length": 196,
        "protein_name": "High affinity copper uptake protein 1",
        "gene_name": "Slc31a1",
        "organism": "Mouse",
        "refseq_name": "high affinity copper uptake protein 1",
        "refseq_ac": "NP_780299",
        "gene_names_uniprotkb": "Slc31a1; Ctr1",
        "gene_names_refseq": "4930445G01Rik; Ctr1; Slc31a1",
        "protein_names_uniprotkb": "High affinity copper uptake protein 1; CTR1; Copper transporter 1; Solute carrier family 31 member 1",
        "protein_names_refseq": "copper transporter 1; high affinity copper uptake protein 1; solute carrier family 13 (sodium/sulphate symporters), member 1",
        "tax_id": 10090,
        "disease": "cardiomyopathy (Disease Ontology:DOID:0050700)",
        "pathway": " (mmu:20529);  (R-MMU-425410)",
        "pathway_count": 2,
        "publication_count": 22,
        "publication_id_list": "11391004;11391005;12177073;12370430;16847145;16950140;19144690;20569931;20699218;21750661;24167251;25428506;25605945;27143361;30084848;31002737;34428180;35027734;36675183;37254056;38376274;38956325",
        "class_list": "",
        "function": "ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury. Publication Status: Online-Only, [RefSeq, PubMed]; Matrigel-based organoid culture of malignant mesothelioma reproduces cisplatin sensitivity through CTR1. Publication Status: Online-Only, [RefSeq, PubMed]; Mobilizes copper(1+) out of the endosomal compartment, making copper(1+) available for export out of the cells., [UniProtKB, PubMed, UniProtKB, UniProtKB]; Protective effect of rosmarinic acid on the transmembrane transporter Ctr1 expression in cisplatin-treated mice., [RefSeq, PubMed]; Uniporter that mediates the transport of copper(1+) from the extracellular space to the cytoplasm, across the plasma membrane (PubMed:11391005, PubMed:12177073, PubMed:16847145, PubMed:24167251). Then, delivers directly copper(1+) to specific chaperone such as ATOX1, via a copper(1+)- mediated transient interaction between the C-terminal domain and a copper(1+) chaperone, thus controlling intracellular copper(1+) levels (By similarity). May function in copper(1+) import from the apical membrane thus may drive intestinal copper absorption (PubMed:16950140). The copper(1+) transport mechanism is sodium-independent, saturable and of high-affinity (By similarity). Also mediates the uptake of silver(1+) (PubMed:20569931). May function in the influx of the platinum-containing chemotherapeutic agents (PubMed:12370430, PubMed:16847145, PubMed:19144690). The platinum-containing chemotherapeutic agents uptake is saturable (By similarity). Also participates in the first step of copper(2+) acquisition by cells through a direct transfer of copper(2+) from copper(2+) carriers in blood, such as ALB to the N-terminal domain of SLC31A1, leading to copper(2+) reduction and probably followed by copper(1+) stabilization (By similarity). In addition, functions as a redox sensor to promote angiogenesis in endothelial cells, in a copper(1+) transport independent manner, by transmitting the VEGF-induced ROS signal through a sulfenylation at Cys-195 leading to a subsequent disulfide bond formation between SLC31A1 and KDR (PubMed:35027734). The SLC31A1-KDR complex is then co-internalized to early endosomes, driving a sustained VEGFR2 signaling (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UAJ9;Q8BXJ1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042910 xenobiotic transmembrane transporter activity;GO:0042802 identical protein binding;GO:0005507 copper ion binding;GO:0005375 copper ion transmembrane transporter activity;GO:0015080 silver ion transmembrane transporter activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016323 basolateral plasma membrane;GO:0043025 neuronal cell body;GO:0055037 recycling endosome;GO:0014704 intercalated disc",
        "go_biological_process": "GO:0035434 copper ion transmembrane transport;GO:0001525 angiogenesis;GO:0006878 intracellular copper ion homeostasis;GO:0051259 protein complex oligomerization;GO:0055085 transmembrane transport",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "Q8K211-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K4G2-1",
        "uniprot_id": "CONA1_MOUSE",
        "mass": 51476.0,
        "length": 532,
        "protein_name": "Collagen alpha-1(XXIII) chain",
        "gene_name": "Col23a1",
        "organism": "Mouse",
        "refseq_name": "collagen alpha-1(XXIII) chain",
        "refseq_ac": "NP_700442",
        "gene_names_uniprotkb": "Col23a1",
        "gene_names_refseq": "2810458L13Rik; Col23a1",
        "protein_names_uniprotkb": "Collagen alpha-1(XXIII) chain",
        "protein_names_refseq": "collagen alpha-1(XXIII) chain; procollagen, type XXIII, alpha 1",
        "tax_id": 10090,
        "disease": "dilated cardiomyopathy (Disease Ontology:DOID:12930)",
        "pathway": " (mmu:237759);  (R-MMU-1650814);  (R-MMU-8948216)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "16728390;21750661",
        "class_list": "",
        "function": "Analysis of collagen XXIII mRNA and protein, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SUQ0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008201 heparin binding;GO:0042802 identical protein binding;GO:0030020 extracellular matrix structural constituent conferring tensile strength",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0031012 extracellular matrix",
        "go_biological_process": "GO:0030198 extracellular matrix organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8K4G2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C0P5-1",
        "uniprot_id": "COR2A_MOUSE",
        "mass": 59573.0,
        "length": 524,
        "protein_name": "Coronin-2A",
        "gene_name": "Coro2a",
        "organism": "Mouse",
        "refseq_name": "coronin-2A isoform 2",
        "refseq_ac": "NP_001158276",
        "gene_names_uniprotkb": "Coro2a",
        "gene_names_refseq": "9030208C03Rik; Coro2a; IR10",
        "protein_names_uniprotkb": "Coronin-2A",
        "protein_names_refseq": "coronin 4; coronin-2A isoform 2; coronin-2A",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:107684)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "21331046;21750661;22872234;27802388;29187734;30084848;30779550",
        "class_list": "",
        "function": "Findings uncover a CORO2A-actin-dependent mechanism for the de-repression of inflammatory response genes that can be differentially regulated by phosphorylation and by nuclear receptor signalling pathways that control immunity and homeostasis, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U6H8;Q8BW42",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003779 actin binding;GO:0051015 actin filament binding",
        "go_cellular_component": "GO:0005884 actin filament;GO:0005886 plasma membrane;GO:0005903 brush border;GO:0017053 transcription repressor complex",
        "go_biological_process": "GO:0007015 actin filament organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q8C0P5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CQC2-1",
        "uniprot_id": "COL_MOUSE",
        "mass": 12445.0,
        "length": 113,
        "protein_name": "Colipase",
        "gene_name": "Clps",
        "organism": "Mouse",
        "refseq_name": "colipase isoform 2 precursor",
        "refseq_ac": "NP_001303994",
        "gene_names_uniprotkb": "Clps",
        "gene_names_refseq": "2200003J09Rik; Clps",
        "protein_names_uniprotkb": "Colipase",
        "protein_names_refseq": "colipase isoform 2 precursor",
        "tax_id": 10090,
        "disease": "type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:109791);  (R-MMU-192456);  (R-MMU-975634)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "10769148;21339507;21750661",
        "class_list": "",
        "function": "Colipase is a cofactor of pancreatic lipase. It allows the lipase to anchor itself to the lipid-water interface. Without colipase the enzyme is washed off by bile salts, which have an inhibitory effect on the lipase., [UniProtKB, PubMed]; Data suggest that the conditional expression of mPlrp2 and mClps is involved in the hydrolysis of retinyl esters in the mouse liver., [RefSeq, PubMed]; Enterostatin has a biological activity as a satiety signal., [UniProtKB]; This gene encodes a member of the colipase family of coenzymes that is required for the optimal activity of pancreatic lipase. The encoded protein undergoes proteolytic processing to generate a mature polypeptide that binds to the lipase and prevents inhibition by bile acids. Over half of the mice lacking the encoded protein die within two weeks of birth while the remaining ones exhibit fat malabsorption and altered body weight regulation. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Nov 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8VHR2;Q8VHR3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008047 enzyme activator activity;GO:0035473 lipase binding",
        "go_cellular_component": "GO:0005576 extracellular region",
        "go_biological_process": "GO:0001523 retinoid metabolic process;GO:0016042 lipid catabolic process;GO:0043085 positive regulation of catalytic activity;GO:0009617 response to bacterium;GO:0007586 digestion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9CQC2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99P47-1",
        "uniprot_id": "CNTP4_MOUSE",
        "mass": 144730.0,
        "length": 1310,
        "protein_name": "Contactin-associated protein-like 4",
        "gene_name": "Cntnap4",
        "organism": "Mouse",
        "refseq_name": "contactin-associated protein-like 4 precursor",
        "refseq_ac": "NP_569724",
        "gene_names_uniprotkb": "Cntnap4; Caspr4",
        "gene_names_refseq": "Caspr4; Cntnap4; E130114F09Rik",
        "protein_names_uniprotkb": "Contactin-associated protein-like 4; Cell recognition molecule Caspr4",
        "protein_names_refseq": "cell recognition molecule Caspr4; cell recognition protein CASPR4; contactin associated protein 4; contactin-associated protein-like 4 precursor",
        "tax_id": 10090,
        "disease": "autism spectrum disorder (Disease Ontology:DOID:0060041); autosomal recessive intellectual developmental disorder (Disease Ontology:DOID:0060308)",
        "pathway": " (mmu:170571)",
        "pathway_count": 1,
        "publication_count": 12,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;24870235;25428506;29905970;30899004;32194851;33300544;35820727;36395738;37087484;38479556",
        "class_list": "",
        "function": "A novel biological functional axis for Nell-1 and Cntnap4 in osteogenesis and, potentially, in neural development and function, is reported., [RefSeq, PubMed]; CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. Publication Status: Online-Only, [RefSeq, PubMed]; Cntnap4 partial deficiency exacerbates alpha-synuclein pathology through astrocyte-microglia C3-C3aR pathway. Publication Status: Online-Only, [RefSeq, PubMed]; Early B Cell Factor 3 (EBF3) attenuates Parkinson's disease through directly regulating contactin-associated protein-like 4 (CNTNAP4) transcription: An experimental study., [RefSeq, PubMed]; Lactobacillus reuteri normalizes altered fear memory in male Cntnap4 knockout mice., [RefSeq, PubMed]; Presynaptic protein involved in both dopaminergic synaptic transmission and GABAergic system, thereby participating in the structural maturation of inhibitory interneuron synapses. Involved in the dopaminergic synaptic transmission by attenuating dopamine release through a presynaptic mechanism. Also participates in the GABAergic system., [UniProtKB, PubMed]",
        "predicted_glycosites": 7,
        "predicted_n_glycosites": 6,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 7,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 7,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 7,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 7,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 13,
        "disease_count": 2,
        "glyco_site_count": 14,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8K002",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030165 PDZ domain binding",
        "go_cellular_component": "GO:0098982 GABA-ergic synapse;GO:0005886 plasma membrane;GO:0030425 dendrite;GO:0045202 synapse;GO:0042734 presynaptic membrane",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0007165 signal transduction;GO:0007399 nervous system development;GO:0032225 regulation of synaptic transmission, dopaminergic;GO:0030182 neuron differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 3.4,
        "record_id": "Q99P47-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CYZ6-1",
        "uniprot_id": "REX1B_MOUSE",
        "mass": 18706.0,
        "length": 169,
        "protein_name": "Required for excision 1-B domain-containing protein",
        "gene_name": "Rex1bd",
        "organism": "Mouse",
        "refseq_name": "required for excision 1-B domain-containing protein isoform 1",
        "refseq_ac": "NP_079853",
        "gene_names_uniprotkb": "Rex1bd; 2810428I15Rik",
        "gene_names_refseq": "2810428I15Rik; Rex1bd",
        "protein_names_uniprotkb": "Required for excision 1-B domain-containing protein",
        "protein_names_refseq": "required for excision 1-B domain-containing protein isoform 1; required for excision 1-B domain-containing protein; uncharacterized protein C19orf60 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66462)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TUY7;Q9CRH2",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9CYZ6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CGD2-1",
        "uniprot_id": "CRLD1_MOUSE",
        "mass": 56918.0,
        "length": 500,
        "protein_name": "Cysteine-rich secretory protein LCCL domain-containing 1",
        "gene_name": "Crispld1",
        "organism": "Mouse",
        "refseq_name": "cysteine-rich secretory protein LCCL domain-containing 1 precursor",
        "refseq_ac": "NP_113579",
        "gene_names_uniprotkb": "Crispld1",
        "gene_names_refseq": "Cocoacrisp; Crispld1; Lcrisp1",
        "protein_names_uniprotkb": "Cysteine-rich secretory protein LCCL domain-containing 1; CocoaCrisp",
        "protein_names_refseq": "LCCL domain containing cysteine-rich secretory protein 1; cysteine-rich secretory protein LCCL domain-containing 1 precursor",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:83691)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;30084848;35820727",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8K018;Q99MM6",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0060325 face morphogenesis;GO:0061484 hematopoietic stem cell homeostasis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8CGD2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CXV3-1",
        "uniprot_id": "CRGF_MOUSE",
        "mass": 21249.0,
        "length": 174,
        "protein_name": "Gamma-crystallin F",
        "gene_name": "Crygf",
        "organism": "Mouse",
        "refseq_name": "gamma-crystallin F isoform 1",
        "refseq_ac": "NP_081286",
        "gene_names_uniprotkb": "Crygf",
        "gene_names_refseq": "3110001K11Rik; Cryg-2; Crygf; DGcry-2; Len-2",
        "protein_names_uniprotkb": "Gamma-crystallin F; Gamma-F-crystallin",
        "protein_names_refseq": "gamma-F-crystallin; gamma-crystallin F isoform 1; gamma-crystallin F",
        "tax_id": 10090,
        "disease": "cataract 4 multiple types (Disease Ontology:DOID:0110234); cataract 7 (Disease Ontology:DOID:0110260)",
        "pathway": " (mmu:12969)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "1623964;21750661;3837188;9782080",
        "class_list": "",
        "function": "Crystallins are the dominant structural components of the vertebrate eye lens., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005212 structural constituent of eye lens",
        "go_cellular_component": "",
        "go_biological_process": "GO:0007601 visual perception;GO:0034614 cellular response to reactive oxygen species;GO:0001654 eye development;GO:0002088 lens development in camera-type eye",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9CXV3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q922C1-1",
        "uniprot_id": "CS044_MOUSE",
        "mass": 69273.0,
        "length": 641,
        "protein_name": "Uncharacterized protein C19orf44 homolog",
        "gene_name": "1700030K09Rik",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein C19orf44 homolog",
        "refseq_ac": "NP_082446",
        "gene_names_uniprotkb": "1700030K09Rik",
        "gene_names_refseq": "1700030K09Rik",
        "protein_names_uniprotkb": "Uncharacterized protein C19orf44 homolog",
        "protein_names_refseq": "uncharacterized protein C19orf44 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72254)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "19144319;21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UZJ9",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q922C1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JHH9-1",
        "uniprot_id": "COPZ2_MOUSE",
        "mass": 22934.0,
        "length": 205,
        "protein_name": "Coatomer subunit zeta-2",
        "gene_name": "Copz2",
        "organism": "Mouse",
        "refseq_name": "coatomer subunit zeta-2",
        "refseq_ac": "NP_063930",
        "gene_names_uniprotkb": "Copz2",
        "gene_names_refseq": "1110012D12Rik; Copz2; zeta2-COP",
        "protein_names_uniprotkb": "Coatomer subunit zeta-2; Zeta-2 COP; Zeta-2-coat protein",
        "protein_names_refseq": "coatomer subunit zeta-2; nonclathrin coat protein zeta2-COP; zeta-2 COP; zeta-2-coat protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56358);  (R-MMU-6807878);  (R-MMU-6811434)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "11056392;17360540;21750661",
        "class_list": "",
        "function": "The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. The zeta subunit may be involved in regulating the coat assembly and, hence, the rate of biosynthetic protein transport due to its association-dissociation properties with the coatomer complex., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2A6D6",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005829 cytosol;GO:0033116 endoplasmic reticulum-Golgi intermediate compartment membrane;GO:0030137 COPI-coated vesicle;GO:0030126 COPI vesicle coat",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0006890 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;GO:0006891 intra-Golgi vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9JHH9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CXI0-1",
        "uniprot_id": "COQ5_MOUSE",
        "mass": 37336.0,
        "length": 327,
        "protein_name": "2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial",
        "gene_name": "Coq5",
        "organism": "Mouse",
        "refseq_name": "2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial precursor",
        "refseq_ac": "NP_080780",
        "gene_names_uniprotkb": "Coq5; D5Ertd33e",
        "gene_names_refseq": "1810014G04Rik; Coq5; D5Ertd33e",
        "protein_names_uniprotkb": "2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial; 2.1.1.201; Ubiquinone biosynthesis methyltransferase COQ5",
        "protein_names_refseq": "2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial precursor; 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial; coenzyme Q5 homolog, methyltransferase; ubiquinone biosynthesis methyltransferase COQ5, mitochondrial",
        "tax_id": 10090,
        "disease": "coenzyme Q10 deficiency disease (Disease Ontology:DOID:0050730); primary coenzyme Q10 deficiency 9 (Disease Ontology:DOID:0112138)",
        "pathway": " (mmu:52064);  (R-MMU-2142789)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "21750661;30084848;34428180;37507081",
        "class_list": "",
        "function": "Methyltransferase required for the conversion of 2-decaprenyl-6-methoxy-1,4-benzoquinol (DDMQH2) to 2-decaprenyl-3-methyl-6-methoxy-1,4-benzoquinol (DMQH2)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D6Y6;Q9D900",
        "ec_number_list": "1.14.99.60;1.14.13.253;2.7.-.-;4.1.1.130;2.1.1.-;2.1.1.114;2.1.1.64;1.14.15.45;1.14.15.46;2.1.1.201",
        "go_molecular_function": "GO:0008425 2-methoxy-6-polyprenyl-1,4-benzoquinol methyltransferase activity;GO:0008168 methyltransferase activity",
        "go_cellular_component": "GO:0031314 extrinsic component of mitochondrial inner membrane;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005759 mitochondrial matrix;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006744 ubiquinone biosynthetic process;GO:0032259 methylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9CXI0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P04342-1",
        "uniprot_id": "CRGD_MOUSE",
        "mass": 21118.0,
        "length": 174,
        "protein_name": "Gamma-crystallin D",
        "gene_name": "Crygd",
        "organism": "Mouse",
        "refseq_name": "gamma-crystallin D",
        "refseq_ac": "NP_031802",
        "gene_names_uniprotkb": "Crygd",
        "gene_names_refseq": "Aey4; Cryg-1; Crygd; DGcry-1; Lop12",
        "protein_names_uniprotkb": "Gamma-crystallin D; Gamma-D-crystallin; Gamma-crystallin 1",
        "protein_names_refseq": "gamma-D-crystallin; gamma-crystallin 1; gamma-crystallin D; lens opacity 12",
        "tax_id": 10090,
        "disease": "cataract 4 multiple types (Disease Ontology:DOID:0110234); cataract 2 multiple types (Disease Ontology:DOID:0110235); cataract 7 (Disease Ontology:DOID:0110260)",
        "pathway": " (mmu:12967)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21750661;27517863;35820727;6096855;9782080",
        "class_list": "",
        "function": "Crystallins are the dominant structural components of the vertebrate eye lens., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O89027;Q6PGI0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005212 structural constituent of eye lens",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0007601 visual perception;GO:0034614 cellular response to reactive oxygen species;GO:0001654 eye development;GO:0002088 lens development in camera-type eye;GO:0070306 lens fiber cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P04342-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P01029-1",
        "uniprot_id": "CO4B_MOUSE",
        "mass": 192915.0,
        "length": 1738,
        "protein_name": "Complement C4-B",
        "gene_name": "C4b",
        "organism": "Mouse",
        "refseq_name": "complement C4-B precursor",
        "refseq_ac": "NP_033910",
        "gene_names_uniprotkb": "C4b; C4",
        "gene_names_refseq": "C4b; C4; Ss",
        "protein_names_uniprotkb": "Complement C4-B",
        "protein_names_refseq": "complement C4-B precursor; complement C4-B; complement component 4 (within H-2S); complement component 4B (Chido blood group); complement component 4B (Childo blood group)",
        "tax_id": 10090,
        "disease": "complement component 4a deficiency (Disease Ontology:DOID:0060297); complement component 4b deficiency (Disease Ontology:DOID:0060298); vitiligo (Disease Ontology:DOID:12306); Graves' disease (Disease Ontology:DOID:12361); autistic disorder (Disease Ontology:DOID:12849); renal cell carcinoma (Disease Ontology:DOID:4450); rheumatoid arthritis (Disease Ontology:DOID:7148); systemic lupus erythematosus (Disease Ontology:DOID:9074)",
        "pathway": " (mmu:12268);  (R-MMU-166663);  (R-MMU-174577);  (R-MMU-381426);  (R-MMU-8957275);  (R-MMU-977606)",
        "pathway_count": 6,
        "publication_count": 30,
        "publication_id_list": "10.1101/2023.09.13.557529;14656967;17330941;20571061;21750661;2387317;2459207;25428506;26495903;26740625;2777798;29187734;2993295;2997024;3008092;30084848;31219806;32152506;34428180;3464002;36210013;37507081;37828378;3856857;3862104;39627609;40021952;6149581;6192448;6208559",
        "class_list": "",
        "function": "Non-enzymatic component of C3 and C5 convertases. Generated following cleavage by complement proteases (C1S, MASP2 or GZMK, depending on the complement pathway), it covalently attaches to the surface of pathogens, where it acts as an opsonin that marks the surface of antigens for removal. It then recruits the serine protease complement C2b to form the C3 and C5 convertases, which cleave and activate C3 and C5, respectively, the next components of the complement pathways. Complement C4b-A isotype is responsible for effective binding to form amide bonds with immune aggregates or protein antigens, while complement C4b-B isotype catalyzes the transacylation of the thioester carbonyl group to form ester bonds with carbohydrate antigens., [UniProtKB, UniProtKB]; Precursor of non-enzymatic components of the classical, lectin and GZMK complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system., [UniProtKB, UniProtKB]; Putative humoral mediator released following cleavage by complement proteases (C1S, MASP2 or GZMK, depending on the complement pathway). While it is strongly similar to anaphylatoxins, its role is unclear. Was reported to act as a mediator of local inflammatory process; however these effects were probably due to contamination with C3a and/C5a anaphylatoxins in biological assays., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 7,
        "disease_count": 8,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QKK7;O70346;Q31201;Q3TYY1;Q3TZC9;Q61372;Q61859;Q62353;Q6NWV8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004866 endopeptidase inhibitor activity;GO:0030246 carbohydrate binding;GO:0003823 antigen binding;GO:0001849 complement component C1q complex binding;GO:0001848 complement binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space;GO:0009986 cell surface;GO:0030424 axon;GO:0030425 dendrite",
        "go_biological_process": "GO:0006954 inflammatory response;GO:0001867 complement activation, lectin pathway;GO:0016064 immunoglobulin mediated immune response;GO:0006958 complement activation, classical pathway;GO:0006956 complement activation",
        "synthesized_glycan_count": 0,
        "hit_score": 4.2,
        "record_id": "P01029-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BXC6-1",
        "uniprot_id": "COMD2_MOUSE",
        "mass": 22848.0,
        "length": 199,
        "protein_name": "COMM domain-containing protein 2",
        "gene_name": "Commd2",
        "organism": "Mouse",
        "refseq_name": "COMM domain-containing protein 2",
        "refseq_ac": "NP_780304",
        "gene_names_uniprotkb": "Commd2",
        "gene_names_refseq": "1190017G07Rik; Commd2; D3Ertd176e; HSPC042",
        "protein_names_uniprotkb": "COMM domain-containing protein 2",
        "protein_names_refseq": "COMM domain-containing protein 2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:52245);  (R-MMU-8951664)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "21750661;30084848;30779550;31219806;34428180;35820727;37507081",
        "class_list": "",
        "function": "Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex (By similarity). May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (By similarity). May down-regulate activation of NF-kappa-B (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BJI3",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q8BXC6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BKE6-1",
        "uniprot_id": "CP20A_MOUSE",
        "mass": 52149.0,
        "length": 462,
        "protein_name": "Cytochrome P450 20A1",
        "gene_name": "Cyp20a1",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 20A1 isoform 1",
        "refseq_ac": "NP_084289",
        "gene_names_uniprotkb": "Cyp20a1",
        "gene_names_refseq": "A930011N14Rik; Cyp20a1; Cypm",
        "protein_names_uniprotkb": "Cytochrome P450 20A1; 1.14.-.-",
        "protein_names_refseq": "cytochrome P450 20A1 isoform 1; cytochrome P450 monooxygenase; cytochrome P450, 20a1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:77951)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;34428180",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0020037 heme binding;GO:0004497 monooxygenase activity;GO:0016705 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q8BKE6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JJA2-1",
        "uniprot_id": "COG8_MOUSE",
        "mass": 71602.0,
        "length": 640,
        "protein_name": "Conserved oligomeric Golgi complex subunit 8",
        "gene_name": "Cog8",
        "organism": "Mouse",
        "refseq_name": "conserved oligomeric Golgi complex subunit 8",
        "refseq_ac": "NP_631975",
        "gene_names_uniprotkb": "Cog8; MNCb-5704",
        "gene_names_refseq": "Cog8",
        "protein_names_uniprotkb": "Conserved oligomeric Golgi complex subunit 8; COG complex subunit 8; Component of oligomeric Golgi complex 8",
        "protein_names_refseq": "COG complex subunit 8; conserved oligomeric Golgi complex protein 8; conserved oligomeric Golgi complex subunit 8",
        "tax_id": 10090,
        "disease": "congenital disorder of glycosylation type IIh (Disease Ontology:DOID:0070260)",
        "pathway": " (mmu:97484);  (R-MMU-6807878);  (R-MMU-6811438);  (R-MMU-6811440)",
        "pathway_count": 4,
        "publication_count": 5,
        "publication_id_list": "21750661;25428506;30084848;31219806;34428180",
        "class_list": "",
        "function": "Required for normal Golgi function., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BFW5",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005794 Golgi apparatus;GO:0017119 Golgi transport complex",
        "go_biological_process": "GO:0015031 protein transport;GO:0007030 Golgi organization;GO:0000301 retrograde transport, vesicle recycling within Golgi;GO:0006891 intra-Golgi vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q9JJA2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35486-1",
        "uniprot_id": "CRYGS_MOUSE",
        "mass": 20850.0,
        "length": 178,
        "protein_name": "Gamma-crystallin S",
        "gene_name": "Crygs",
        "organism": "Mouse",
        "refseq_name": "gamma-crystallin S",
        "refseq_ac": "NP_034097",
        "gene_names_uniprotkb": "Crygs",
        "gene_names_refseq": "Crygs; Opj; rncat",
        "protein_names_uniprotkb": "Gamma-crystallin S; Beta-crystallin S; Gamma-S-crystallin",
        "protein_names_refseq": "beta-crystallin S; gamma-crystallin S; opacity due to poor secondary fiber cell junction; recessive nuclear cataract",
        "tax_id": 10090,
        "disease": "cataract 20 multiple types (Disease Ontology:DOID:0110240)",
        "pathway": " (mmu:12970)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "22715935;9565648",
        "class_list": "",
        "function": "Crystallins are the dominant structural components of the vertebrate eye lens., [UniProtKB]; GammaS may have a functional role related to actin, perhaps in 'shepherding' filaments to maintain the optical properties of the lens cytoplasm and normal fiber cell maturation, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005212 structural constituent of eye lens",
        "go_cellular_component": "",
        "go_biological_process": "GO:0007601 visual perception;GO:0002009 morphogenesis of an epithelium;GO:0002088 lens development in camera-type eye",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "O35486-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O54749-1",
        "uniprot_id": "CP2J5_MOUSE",
        "mass": 57784.0,
        "length": 501,
        "protein_name": "Cytochrome P450 2J5",
        "gene_name": "Cyp2j5",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 2J5 isoform 1",
        "refseq_ac": "NP_034137",
        "gene_names_uniprotkb": "Cyp2j5",
        "gene_names_refseq": "Cyp2j5",
        "protein_names_uniprotkb": "Cytochrome P450 2J5; 1.14.14.1; Arachidonic acid epoxygenase; CYPIIJ5",
        "protein_names_refseq": "CYPIIJ5; arachidonic acid epoxygenase; cytochrome P450 2J5 isoform 1; cytochrome P450 2J5; cytochrome P450, 2j5",
        "tax_id": 10090,
        "disease": "renal fibrosis (Disease Ontology:DOID:0050855); pre-eclampsia (Disease Ontology:DOID:10591); renal hypertension (Disease Ontology:DOID:1073); hypertension (Disease Ontology:DOID:10763); myocardial infarction (Disease Ontology:DOID:5844); pulmonary hypertension (Disease Ontology:DOID:6432)",
        "pathway": " (mmu:13109)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "18716027;23041291;23696562;29030652;34428180;9570962",
        "class_list": "",
        "function": "Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice., [RefSeq, PubMed]; Data indicate that cardiac-specific overexpression of arachidonate epoxygenase (CYP2J5) significantly protects against diabetic cardiomyopathy, which may be due to improved cardiac insulin resistance, glucose uptake, and reversal of cardiac hypertrophy., [RefSeq, PubMed]; Microsomal epoxide hydrolase forms complex with CYP2J5 in the endoplasmic reticulum., [RefSeq, PubMed]; Our findings illustrate a sex-specific role for CYP2J5 in regulation of blood pressure, proximal tubular transport, and afferent arteriolar responsiveness via an estrogen-dependent mechanism., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 6,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.14.14.1;1.14.14.-;4.2.1.152;1.14.13.n7;5.3.99.5",
        "go_molecular_function": "GO:0008404 arachidonate 14,15-epoxygenase activity;GO:0008405 arachidonate 11,12-epoxygenase activity;GO:0071614 linoleic acid epoxygenase activity;GO:0005506 iron ion binding;GO:0020037 heme binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006690 icosanoid metabolic process;GO:0043651 linoleic acid metabolic process;GO:0006805 xenobiotic metabolic process;GO:0019373 epoxygenase P450 pathway;GO:0097254 renal tubular secretion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "O54749-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O54750-1",
        "uniprot_id": "CP2J6_MOUSE",
        "mass": 57792.0,
        "length": 501,
        "protein_name": "Cytochrome P450 2J6",
        "gene_name": "Cyp2j6",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 2J6 isoform 1",
        "refseq_ac": "NP_034138",
        "gene_names_uniprotkb": "Cyp2j6",
        "gene_names_refseq": "Cyp2j6",
        "protein_names_uniprotkb": "Cytochrome P450 2J6; 1.14.14.1; Arachidonic acid epoxygenase; CYPIIJ6",
        "protein_names_refseq": "CYPIIJ6; arachidonic acid epoxygenase; cytochrome P450 2J6 isoform 1; cytochrome P450 2J6; cytochrome P450, 2j6",
        "tax_id": 10090,
        "disease": "renal fibrosis (Disease Ontology:DOID:0050855); pre-eclampsia (Disease Ontology:DOID:10591); renal hypertension (Disease Ontology:DOID:1073); hypertension (Disease Ontology:DOID:10763); myocardial infarction (Disease Ontology:DOID:5844); pulmonary hypertension (Disease Ontology:DOID:6432)",
        "pathway": " (mmu:13110);  (R-MMU-211935);  (R-MMU-211981);  (R-MMU-2142670)",
        "pathway_count": 4,
        "publication_count": 4,
        "publication_id_list": "27791151;34203471;34428180;9570962",
        "class_list": "",
        "function": "Data suggest inhibition of cytochrome P-450 CYP2J6 (CYP2J) isoforms as a treatment option for paclitaxel-induced neuropathic pain., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 6,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BR78",
        "ec_number_list": "1.14.14.1;1.14.14.-;4.2.1.152;1.14.13.n7;5.3.99.5",
        "go_molecular_function": "GO:0008404 arachidonate 14,15-epoxygenase activity;GO:0008405 arachidonate 11,12-epoxygenase activity;GO:0071614 linoleic acid epoxygenase activity;GO:0005506 iron ion binding;GO:0020037 heme binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006690 icosanoid metabolic process;GO:0043651 linoleic acid metabolic process;GO:0006805 xenobiotic metabolic process;GO:0019373 epoxygenase P450 pathway;GO:0006082 organic acid metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "O54750-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88843-1",
        "uniprot_id": "CRADD_MOUSE",
        "mass": 22656.0,
        "length": 199,
        "protein_name": "Death domain-containing protein CRADD",
        "gene_name": "Cradd",
        "organism": "Mouse",
        "refseq_name": "death domain-containing protein CRADD isoform 1",
        "refseq_ac": "NP_001317067",
        "gene_names_uniprotkb": "Cradd; Raidd",
        "gene_names_refseq": "Cradd; RAIDD",
        "protein_names_uniprotkb": "Death domain-containing protein CRADD; Caspase and RIP adapter with death domain; RIP-associated protein with a death domain",
        "protein_names_refseq": "RIP-associated protein with a death domain; caspase and RIP adapter with death domain; death domain-containing protein CRADD isoform 1; death domain-containing protein CRADD",
        "tax_id": 10090,
        "disease": "autosomal recessive intellectual developmental disorder 34 (Disease Ontology:DOID:0081200)",
        "pathway": " (mmu:12905);  (R-MMU-6803207)",
        "pathway_count": 2,
        "publication_count": 6,
        "publication_id_list": "12558660;22279524;25857265;31219806;34428180;9806843",
        "class_list": "",
        "function": "Adapter protein that associates with PIDD1 and the caspase CASP2 to form the PIDDosome, a complex that activates CASP2 and triggers apoptosis. Also recruits CASP2 to the TNFR-1 signaling complex through its interaction with RIPK1 and TRADD and may play a role in the tumor necrosis factor-mediated signaling pathway., [UniProtKB, UniProtKB]; Overexpression of Raidd cDNA in 3T3L1 cells inhibited differentiation of the preadipocytes., [RefSeq, PubMed]; The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9QUN0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0070513 death domain binding;GO:0002020 protease binding;GO:0030674 protein-macromolecule adaptor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:1905369 endopeptidase complex",
        "go_biological_process": "GO:0043065 positive regulation of apoptotic process;GO:0097190 apoptotic signaling pathway;GO:2001235 positive regulation of apoptotic signaling pathway;GO:0006974 DNA damage response;GO:0071260 cellular response to mechanical stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "O88843-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P00184-1",
        "uniprot_id": "CP1A1_MOUSE",
        "mass": 59230.0,
        "length": 524,
        "protein_name": "Cytochrome P450 1A1",
        "gene_name": "Cyp1a1",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 1A1",
        "refseq_ac": "NP_001129531",
        "gene_names_uniprotkb": "Cyp1a1; Cyp1a-1",
        "gene_names_refseq": "AHH; AHRR; CP11; CYPIA1; Cyp1a1; P450-1",
        "protein_names_uniprotkb": "Cytochrome P450 1A1; 1.14.14.1; 4.2.1.152; CYPIA1; Cytochrome P450 form 6; Cytochrome P450-C; Cytochrome P450-P1; Hydroperoxy icosatetraenoate dehydratase",
        "protein_names_refseq": "cytochrome P450 1A1; cytochrome P450 form 6; cytochrome P450 subfamily I, polypeptide 1; cytochrome P450, 1a1, aromatic compound inducible; cytochrome P450-C; cytochrome P450-P1; hydroperoxy icosatetraenoate dehydratase",
        "tax_id": 10090,
        "disease": "Keshan disease (Disease Ontology:DOID:0050083); oral squamous cell carcinoma (Disease Ontology:DOID:0050866); prostate cancer (Disease Ontology:DOID:10283); stomach cancer (Disease Ontology:DOID:10534); hypertension (Disease Ontology:DOID:10763); hypospadias (Disease Ontology:DOID:10892); urinary bladder cancer (Disease Ontology:DOID:11054); heart disease (Disease Ontology:DOID:114); polycystic ovary syndrome (Disease Ontology:DOID:11612); clubfoot (Disease Ontology:DOID:11836); head and neck cancer (Disease Ontology:DOID:11934); hypertrophic cardiomyopathy (Disease Ontology:DOID:11984); Graves' disease (Disease Ontology:DOID:12361); Sjogren's syndrome (Disease Ontology:DOID:12894); dilated cardiomyopathy (Disease Ontology:DOID:12930); lung cancer (Disease Ontology:DOID:1324); Behcet's disease (Disease Ontology:DOID:13241); endometrial cancer (Disease Ontology:DOID:1380); Parkinson's disease (Disease Ontology:DOID:14330); cystic fibrosis (Disease Ontology:DOID:1485); breast cancer (Disease Ontology:DOID:1612); endometriosis (Disease Ontology:DOID:289); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); gallbladder cancer (Disease Ontology:DOID:3121); porphyria cutanea tarda (Disease Ontology:DOID:3132); esophagus squamous cell carcinoma (Disease Ontology:DOID:3748); renal cell carcinoma (Disease Ontology:DOID:4450); biliary tract cancer (Disease Ontology:DOID:4607); esophageal cancer (Disease Ontology:DOID:5041); pneumonia (Disease Ontology:DOID:552); bronchitis (Disease Ontology:DOID:6132); reactive arthritis (Disease Ontology:DOID:6196); pulmonary hypertension (Disease Ontology:DOID:6432); ankylosing spondylitis (Disease Ontology:DOID:7147); end stage renal disease (Disease Ontology:DOID:783); periodontitis (Disease Ontology:DOID:824); chronic myeloid leukemia (Disease Ontology:DOID:8552); oral cavity cancer (Disease Ontology:DOID:8618); psoriasis (Disease Ontology:DOID:8893); psoriatic arthritis (Disease Ontology:DOID:9008); systemic lupus erythematosus (Disease Ontology:DOID:9074); acute myeloid leukemia (Disease Ontology:DOID:9119); diabetes mellitus (Disease Ontology:DOID:9351); type 2 diabetes mellitus (Disease Ontology:DOID:9352); multiple myeloma (Disease Ontology:DOID:9538); acute lymphoblastic leukemia (Disease Ontology:DOID:9952)",
        "pathway": " (mmu:13076);  (R-MMU-211981);  (R-MMU-2142670);  (R-MMU-2142816);  (R-MMU-9018681)",
        "pathway_count": 5,
        "publication_count": 11,
        "publication_id_list": "2425809;30084848;3308449;34428180;3718958;37453647;38251251;38821243;3988744;6547952;6548461",
        "class_list": "",
        "function": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C15alpha and C16alpha positions. Displays different regioselectivities for polyunsaturated fatty acids (PUFA) hydroxylation. Catalyzes the epoxidation of double bonds of certain PUFA. Converts arachidonic acid toward epoxyeicosatrienoic acid (EET) regioisomers, 8,9-, 11,12-, and 14,15-EET, that function as lipid mediators in the vascular system. Displays an absolute stereoselectivity in the epoxidation of eicosapentaenoic acid (EPA) producing the 17(R),18(S) enantiomer. May play an important role in all-trans retinoic acid biosynthesis in extrahepatic tissues. Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid. May also participate in eicosanoids metabolism by converting hydroperoxide species into oxo metabolites (lipoxygenase-like reaction, NADPH-independent)., [UniProtKB, UniProtKB]; Inhibition of CYP1A1 Alleviates Colchicine-Induced Hepatotoxicity. Publication Status: Online-Only, [RefSeq, PubMed]; Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 46,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q61455",
        "ec_number_list": "1.14.14.1;1.14.14.-;5.3.99.4;4.2.1.152;1.14.14.14;5.3.99.5;1.14.13.n7;1.14.14.80;1.14.14.94;5.4.4.7",
        "go_molecular_function": "GO:0101020 estrogen 16-alpha-hydroxylase activity;GO:0005506 iron ion binding;GO:0019899 enzyme binding;GO:0016491 oxidoreductase activity;GO:0020037 heme binding",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0002933 lipid hydroxylation;GO:0008210 estrogen metabolic process;GO:0042359 vitamin D metabolic process;GO:0046209 nitric oxide metabolic process;GO:1904010 response to Aroclor 1254",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "P00184-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P00397-1",
        "uniprot_id": "COX1_MOUSE",
        "mass": 56910.0,
        "length": 514,
        "protein_name": "Cytochrome c oxidase subunit 1",
        "gene_name": "Mtco1",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Mtco1; COI; mt-Co1",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Cytochrome c oxidase subunit 1; 7.1.1.9; Cytochrome c oxidase polypeptide I",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "Parkinsonism (Disease Ontology:DOID:0080855); cytochrome-c oxidase deficiency disease (Disease Ontology:DOID:3762); hepatocellular carcinoma (Disease Ontology:DOID:684)",
        "pathway": " (mmu:17708);  (R-MMU-5419276);  (R-MMU-5628897);  (R-MMU-611105);  (R-MMU-9707564);  (R-MMU-9837999);  (R-MMU-9864848)",
        "pathway_count": 7,
        "publication_count": 12,
        "publication_id_list": "12954771;22645316;31616917;33300544;34428180;34616041;36288343;37453647;37507081;38575788;7332926;8617953",
        "class_list": "",
        "function": "Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "7.1.1.9;7.1.1.2;1.17.99.9;3.4.24.-;3.6.-.-;3.1.1.29;3.6.5.-",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0020037 heme binding;GO:0004129 cytochrome-c oxidase activity",
        "go_cellular_component": "GO:0005743 mitochondrial inner membrane;GO:0045277 respiratory chain complex IV",
        "go_biological_process": "GO:0006979 response to oxidative stress;GO:0001666 response to hypoxia;GO:0046688 response to copper ion;GO:0051602 response to electrical stimulus;GO:0006119 oxidative phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "P00397-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P00405-1",
        "uniprot_id": "COX2_MOUSE",
        "mass": 25976.0,
        "length": 227,
        "protein_name": "Cytochrome c oxidase subunit 2",
        "gene_name": "Mt-co2",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase subunit II",
        "refseq_ac": "NP_904331",
        "gene_names_uniprotkb": "Mt-co2; COII; COX2",
        "gene_names_refseq": "COX2",
        "protein_names_uniprotkb": "Cytochrome c oxidase subunit 2; 7.1.1.9; Cytochrome c oxidase polypeptide II",
        "protein_names_refseq": "cytochrome c oxidase subunit II",
        "tax_id": 10090,
        "disease": "colorectal carcinoma (Disease Ontology:DOID:0080199); stomach cancer (Disease Ontology:DOID:10534); Huntington's disease (Disease Ontology:DOID:12858); type 2 diabetes mellitus (Disease Ontology:DOID:9352); acute myocardial infarction (Disease Ontology:DOID:9408)",
        "pathway": " (mmu:17709);  (R-MMU-5419276);  (R-MMU-5628897);  (R-MMU-611105);  (R-MMU-9707564);  (R-MMU-9864848)",
        "pathway_count": 6,
        "publication_count": 16,
        "publication_id_list": "12954771;22872234;25428506;30084848;31219806;33300544;34203471;34428180;34616041;36210013;36288343;37453647;38575788;39627609;7332926;8281018",
        "class_list": "",
        "function": "Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q85K21",
        "ec_number_list": "7.1.1.9;7.1.1.2;1.17.99.9;3.1.1.29;3.6.5.-",
        "go_molecular_function": "GO:0016491 oxidoreductase activity;GO:0005507 copper ion binding;GO:0004129 cytochrome-c oxidase activity",
        "go_cellular_component": "GO:0005743 mitochondrial inner membrane;GO:0031966 mitochondrial membrane;GO:0045277 respiratory chain complex IV",
        "go_biological_process": "GO:0042773 ATP synthesis coupled electron transport;GO:0045471 response to ethanol;GO:0001666 response to hypoxia;GO:0007595 lactation;GO:0017004 cytochrome complex assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "P00405-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P01587-1",
        "uniprot_id": "CSF2_MOUSE",
        "mass": 16091.0,
        "length": 141,
        "protein_name": "Granulocyte-macrophage colony-stimulating factor",
        "gene_name": "Csf2",
        "organism": "Mouse",
        "refseq_name": "granulocyte-macrophage colony-stimulating factor precursor",
        "refseq_ac": "NP_034099",
        "gene_names_uniprotkb": "Csf2; Csfgm",
        "gene_names_refseq": "CSF; Csf2; Csfgm; GMCSF; Gm-CSf; MGI-IGM",
        "protein_names_uniprotkb": "Granulocyte-macrophage colony-stimulating factor; CSF; Colony-stimulating factor; GM-CSF",
        "protein_names_refseq": "granulocyte-macrophage colony stimulating factor 2; granulocyte-macrophage colony-stimulating factor precursor; granulocyte-macrophage colony-stimulating factor; put. GM-CSF",
        "tax_id": 10090,
        "disease": "juvenile myelomonocytic leukemia (Disease Ontology:DOID:0050458); COVID-19 (Disease Ontology:DOID:0080600); Parkinsonism (Disease Ontology:DOID:0080855); silicosis (Disease Ontology:DOID:10325); pneumocystosis (Disease Ontology:DOID:11339); pulmonary alveolar proteinosis (Disease Ontology:DOID:12120); neutropenia (Disease Ontology:DOID:1227); temporal arteritis (Disease Ontology:DOID:13375); interstitial cystitis (Disease Ontology:DOID:13949); bronchiolitis obliterans (Disease Ontology:DOID:2799); asthma (Disease Ontology:DOID:2841); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); pulmonary fibrosis (Disease Ontology:DOID:3770); myocardial infarction (Disease Ontology:DOID:5844); abdominal aortic aneurysm (Disease Ontology:DOID:7693); acute myeloid leukemia (Disease Ontology:DOID:9119); visceral leishmaniasis (Disease Ontology:DOID:9146)",
        "pathway": " (mmu:12981);  (R-MMU-512988);  (R-MMU-5673001);  (R-MMU-912526)",
        "pathway_count": 4,
        "publication_count": 11,
        "publication_id_list": "16027123;2002066;3318813;3871523;3874057;3876930;3876931;3898082;3902470;6610831;8515057",
        "class_list": "",
        "function": "Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes., [UniProtKB]",
        "predicted_glycosites": 5,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 17,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005129 granulocyte macrophage colony-stimulating factor receptor binding;GO:0005125 cytokine activity;GO:0008083 growth factor activity",
        "go_cellular_component": "GO:0030526 granulocyte macrophage colony-stimulating factor receptor complex;GO:0005576 extracellular region;GO:0005615 extracellular space",
        "go_biological_process": "GO:0030223 neutrophil differentiation;GO:0032747 positive regulation of interleukin-23 production;GO:0042045 epithelial fluid transport;GO:0045187 regulation of circadian sleep/wake cycle, sleep;GO:0006955 immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "P01587-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P04344-1",
        "uniprot_id": "CRGB_MOUSE",
        "mass": 21086.0,
        "length": 175,
        "protein_name": "Gamma-crystallin B",
        "gene_name": "Crygb",
        "organism": "Mouse",
        "refseq_name": "gamma-crystallin B",
        "refseq_ac": "NP_658906",
        "gene_names_uniprotkb": "Crygb",
        "gene_names_refseq": "Cryg-3; Crygb; DGcry-3; Nop",
        "protein_names_uniprotkb": "Gamma-crystallin B; Gamma-B-crystallin; Gamma-crystallin 3",
        "protein_names_refseq": "gamma-B-crystallin; gamma-crystallin 3; gamma-crystallin B; gammaB-crystallin; nuclear opacity",
        "tax_id": 10090,
        "disease": "cataract 39 multiple types (Disease Ontology:DOID:0110236)",
        "pathway": " (mmu:12965)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "35726360;6096855;8293998",
        "class_list": "",
        "function": "Crystallins are the dominant structural components of the vertebrate eye lens., [UniProtKB]; Oxidation of active cysteines mediates protein aggregation of S10R, the cataract-associated mutant of mouse GammaB-crystallin., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q61593;Q6PHP7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005212 structural constituent of eye lens",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0007601 visual perception;GO:0070307 lens fiber cell development;GO:0001654 eye development;GO:0002088 lens development in camera-type eye;GO:0070309 lens fiber cell morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "P04344-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P27786-1",
        "uniprot_id": "CP17A_MOUSE",
        "mass": 57638.0,
        "length": 507,
        "protein_name": "Steroid 17-alpha-hydroxylase/17,20 lyase",
        "gene_name": "Cyp17a1",
        "organism": "Mouse",
        "refseq_name": "steroid 17-alpha-hydroxylase/17,20 lyase",
        "refseq_ac": "NP_031835",
        "gene_names_uniprotkb": "Cyp17a1; Cyp17",
        "gene_names_refseq": "Cyp17a1; Cyp17; p450c17",
        "protein_names_uniprotkb": "Steroid 17-alpha-hydroxylase/17,20 lyase; 1.14.14.19; 1.14.14.32; 17-alpha-hydroxyprogesterone aldolase; CYPXVII; Cytochrome P450 17A1; Cytochrome P450-C17; Cytochrome P450c17; Steroid 17-alpha-monooxygenase",
        "protein_names_refseq": "17-alpha-hydroxyprogesterone aldolase; CYPXVII; cytochrome P450 17A1; cytochrome P450, 17a1; cytochrome P450-C17; cytochrome P450c17; steroid 17-alpha hydroxylase; steroid 17-alpha-hydroxylase/17,20 lyase; steroid 17-alpha-monooxygenase",
        "tax_id": 10090,
        "disease": "congenital adrenal hyperplasia (Disease Ontology:DOID:0050811); cholelithiasis (Disease Ontology:DOID:10211); prostate cancer (Disease Ontology:DOID:10283); sciatic neuropathy (Disease Ontology:DOID:11446); osteoporosis (Disease Ontology:DOID:11476); polycystic ovary syndrome (Disease Ontology:DOID:11612); breast cancer (Disease Ontology:DOID:1612); pancreatic cancer (Disease Ontology:DOID:1793); gallbladder cancer (Disease Ontology:DOID:3121)",
        "pathway": " (mmu:13074);  (R-MMU-193048);  (R-MMU-194002)",
        "pathway_count": 3,
        "publication_count": 3,
        "publication_id_list": "1840559;21750661;36640554",
        "class_list": "",
        "function": "A cytochrome P450 monooxygenase involved in corticoid and androgen biosynthesis. Catalyzes 17-alpha hydroxylation of C21 steroids, which is common for both pathways. A second oxidative step, required only for androgen synthesis, involves an acyl-carbon cleavage. The 17-alpha hydroxy intermediates, as part of adrenal glucocorticoids biosynthesis pathway, are precursors of cortisol. Hydroxylates steroid hormones, pregnenolone and progesterone to form 17-alpha hydroxy metabolites, followed by the cleavage of the C17-C20 bond to form C19 steroids, dehydroepiandrosterone (DHEA) and androstenedione (PubMed:36640554). Has 16-alpha hydroxylase activity. Catalyzes 16-alpha hydroxylation of 17-alpha hydroxy pregnenolone, followed by the cleavage of the C17-C20 bond to form 16-alpha-hydroxy DHEA. Also 16-alpha hydroxylates androgens, relevant for estriol synthesis. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (By similarity)., [UniProtKB, UniProtKB, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 9,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.14.14.19;1.14.14.32;1.14.14.25",
        "go_molecular_function": "GO:0005506 iron ion binding;GO:0020037 heme binding;GO:0016829 lyase activity;GO:0004508 steroid 17-alpha-monooxygenase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum;GO:0030424 axon;GO:0043025 neuronal cell body;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0042446 hormone biosynthetic process;GO:0006694 steroid biosynthetic process;GO:0006702 androgen biosynthetic process;GO:0006704 glucocorticoid biosynthetic process;GO:0008202 steroid metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "P27786-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P35347-1",
        "uniprot_id": "CRHR1_MOUSE",
        "mass": 47769.0,
        "length": 415,
        "protein_name": "Corticotropin-releasing hormone receptor 1",
        "gene_name": "Crhr1",
        "organism": "Mouse",
        "refseq_name": "corticotropin-releasing factor receptor 1 isoform 1 precursor",
        "refseq_ac": "NP_031788",
        "gene_names_uniprotkb": "Crhr1; Crhr",
        "gene_names_refseq": "CRF-R1alpha; CRF1R; CRFR1; Crhr1; Crhr",
        "protein_names_uniprotkb": "Corticotropin-releasing hormone receptor 1; CRF-R-1; CRF-R1; CRFR-1; CRH-R-1; CRH-R1; Corticotropin-releasing factor receptor 1",
        "protein_names_refseq": "CRF 1 receptor; corticotropin-releasing factor receptor 1 isoform 1 precursor; corticotropin-releasing factor receptor 1",
        "tax_id": 10090,
        "disease": "fetal alcohol spectrum disorder (Disease Ontology:DOID:0050696); hypertension (Disease Ontology:DOID:10763); thromboangiitis obliterans (Disease Ontology:DOID:12918); alcohol use disorder (Disease Ontology:DOID:1574); depressive disorder (Disease Ontology:DOID:1596); asthma (Disease Ontology:DOID:2841); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); functional colonic disease (Disease Ontology:DOID:3877); rhinitis (Disease Ontology:DOID:4483); type 2 diabetes mellitus (Disease Ontology:DOID:9352); irritable bowel syndrome (Disease Ontology:DOID:9778); obesity (Disease Ontology:DOID:9970); heroin dependence (Disease Ontology:DOID:9976)",
        "pathway": " (mmu:12921);  (R-MMU-373080);  (R-MMU-418555)",
        "pathway_count": 3,
        "publication_count": 13,
        "publication_id_list": "10.1101/2023.09.13.557529;11471062;11988580;12973355;15001778;16339307;17296558;21885734;23576434;37669667;8243652;9620773;9655498",
        "class_list": "",
        "function": "G protein-coupled receptor for CRH and UCN stress hormones, which plays a central role in whole body adaptation to stress (PubMed:11988580, PubMed:12973355, PubMed:15001778, PubMed:16339307, PubMed:17296558, PubMed:21885734, PubMed:8243652, PubMed:9620773, PubMed:9655498). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and downstream effectors, such as adenylate cyclase (PubMed:9620773). CRHR1 is mainly coupled to G(s) G protein (GNAS), mediating activation of adenylate cyclase activity and production of cAMP (PubMed:9620773). In some conditions, can also couple to G(q) G protein (GNAQ) and mediate production of diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) second messengers (By similarity). CRHR1-dependent signaling is a primary mediator of the neuroendocrine, autonomic (fight-or-flight) and behavioral responses to stress, acting as a key regulator of adaptation by activating the hypothalamus-pituitary-adrenal axis, leading to corticotropin hormone (ACTH) production (PubMed:15001778, PubMed:17296558, PubMed:21885734, PubMed:8243652, PubMed:9620773, PubMed:9655498). Mediates both anxiogenic and anxiolytic response to stress in glutamatergic and dopaminergic neurons, respectively (PubMed:21885734). CRHR1 also plays a critical role in addiction by mediating the brain's stress response, particularly during withdrawal and relapse: it drives the transition to compulsive drug seeking by increasing anxiety and negative emotional states (PubMed:11988580, PubMed:12973355, PubMed:15001778, PubMed:16339307, PubMed:17296558). Also involved in social behavior by triggering a signaling in the prefrontal cortex that favor social interactions with novel conspecifics over familiar ones (PubMed:37669667)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; The protein encoded by this gene is a G-protein coupled receptor that binds corticotropin-releasing factor (CRH) and urocortin (UCN) with high affinity. The encoded protein upregulates adenylate cyclase activity and intracellular cAMP levels. This protein is essential for the activation of signal transduction pathways that regulate diverse physiological processes including stress, reproduction, immune response, and obesity. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]., [RefSeq]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 3,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9507,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 13,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0044877 protein-containing complex binding;GO:0001965 G-protein alpha-subunit binding;GO:0008528 G protein-coupled peptide receptor activity;GO:0042277 peptide binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0030425 dendrite;GO:0043025 neuronal cell body",
        "go_biological_process": "GO:2000252 negative regulation of feeding behavior;GO:0007166 cell surface receptor signaling pathway;GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway;GO:0007204 positive regulation of cytosolic calcium ion concentration;GO:0007218 neuropeptide signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "P35347-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P56393-1",
        "uniprot_id": "COX7B_MOUSE",
        "mass": 9011.0,
        "length": 80,
        "protein_name": "Cytochrome c oxidase subunit 7B, mitochondrial",
        "gene_name": "Cox7b",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase subunit 7B, mitochondrial precursor",
        "refseq_ac": "NP_079655",
        "gene_names_uniprotkb": "Cox7b",
        "gene_names_refseq": "1110004F07Rik; Cox7b",
        "protein_names_uniprotkb": "Cytochrome c oxidase subunit 7B, mitochondrial; Cytochrome c oxidase polypeptide VIIb",
        "protein_names_refseq": "cytochrome c oxidase polypeptide VIIb; cytochrome c oxidase subunit 7B, mitochondrial precursor; cytochrome c oxidase subunit 7B, mitochondrial; cytochrome c oxidase subunit VIIb",
        "tax_id": 10090,
        "disease": "linear skin defects with multiple congenital anomalies 2 (Disease Ontology:DOID:0111877)",
        "pathway": " (mmu:66142);  (R-MMU-5628897);  (R-MMU-611105);  (R-MMU-9707564);  (R-MMU-9864848)",
        "pathway_count": 5,
        "publication_count": 4,
        "publication_id_list": "31219806;34616041;36288343;38575788",
        "class_list": "",
        "function": "Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation (PubMed:34616041, PubMed:38575788). The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase (PubMed:34616041, PubMed:38575788). Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix (By similarity). Plays a role in proper central nervous system (CNS) development in vertebrates (By similarity)., [UniProtKB, UniProtKB, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0031966 mitochondrial membrane;GO:0045277 respiratory chain complex IV",
        "go_biological_process": "GO:0007417 central nervous system development;GO:0006123 mitochondrial electron transport, cytochrome c to oxygen",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "P56393-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P56394-1",
        "uniprot_id": "COX17_MOUSE",
        "mass": 6784.0,
        "length": 63,
        "protein_name": "Cytochrome c oxidase copper chaperone",
        "gene_name": "Cox17",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase copper chaperone",
        "refseq_ac": "NP_001017429",
        "gene_names_uniprotkb": "Cox17; Cox17a",
        "gene_names_refseq": "Cox17",
        "protein_names_uniprotkb": "Cytochrome c oxidase copper chaperone",
        "protein_names_refseq": "cytochrome c oxidase copper chaperone; cytochrome c oxidase, subunit XVII assembly protein homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:12856);  (R-MMU-9864848)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "11997103;12370308;28528544;37217601;37813994",
        "class_list": "",
        "function": "COX17 restricts renal fibrosis development by maintaining mitochondrial copper homeostasis and restoring complex IV activity., [RefSeq, PubMed]; Copper metallochaperone involved in the assembly of cytochrome c oxidase (respiratory chain complex IV, CIV) (PubMed:12370308, PubMed:37813994). Binds two copper ions and delivers them to metallochaperones SCO1 and SCO2, which co-chaperone the copper ions to the Cu(A) site on the cytochrome c oxidase subunit II (MT-CO2/COX2), and to metallochaperone COX11 which relays the copper to the Cu(B) site on the cytochrome c oxidase subunit I (MT-CO1/COX1) (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; Cox17 has a role in activating cytochrome c oxidase in mice, [RefSeq, PubMed]; Sp1, NRF-1 and NRF-2 are involved in basal transcription, similar to the transcription mechanism of other CCO-related genes, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 8,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008047 enzyme activator activity;GO:0005507 copper ion binding;GO:1903136 cuprous ion binding;GO:0016531 copper chaperone activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005758 mitochondrial intermembrane space",
        "go_biological_process": "GO:0008284 positive regulation of cell population proliferation;GO:0033617 mitochondrial respiratory chain complex IV assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "P56394-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P56469-1",
        "uniprot_id": "CORT_MOUSE",
        "mass": 11613.0,
        "length": 109,
        "protein_name": "Cortistatin",
        "gene_name": "Cort",
        "organism": "Mouse",
        "refseq_name": "cortistatin isoform 1 preproprotein",
        "refseq_ac": "NP_031771",
        "gene_names_uniprotkb": "Cort",
        "gene_names_refseq": "CST; Cort; PCST",
        "protein_names_uniprotkb": "Cortistatin",
        "protein_names_refseq": "cortistatin isoform 1 preproprotein",
        "tax_id": 10090,
        "disease": "brain infarction (Disease Ontology:DOID:3454)",
        "pathway": " (mmu:12854);  (R-MMU-375276);  (R-MMU-418594)",
        "pathway_count": 3,
        "publication_count": 5,
        "publication_id_list": "10521599;15364032;32811643;37794493;9205124",
        "class_list": "",
        "function": "Cortistatin deficiency reveals a dysfunctional brain endothelium with impaired gene pathways, exacerbated immune activation, and disrupted barrier integrity. Publication Status: Online-Only, [RefSeq, PubMed]; Cortistatin mRNA concentration in the hippocampus and dentate gyrus is significantly increased in aged non-transgenic (Tg) mice compared with young non-Tg mice., [RefSeq, PubMed]; Cortistatin protects against inflammatory airway diseases through curbing CCL2 and antagonizing NF-kappaB signaling pathway. Erratum:[Biochem Biophys Res Commun. 2020 Nov 19;532(4):683-684. doi: 10.1016/j.bbrc.2020.09.069. PMID: 33012512], [RefSeq, PubMed]; Neuropeptide with neuronal depressant and sleep-modulating properties (By similarity). Acts as a ligand for Mrgprb2 receptor in mast cells (By similarity)., [UniProtKB, UniProtKB, UniProtKB]; Precursor of neuropeptides that bind to all somatostatin receptor (SSTR) subtypes. Inhibits cAMP production induced by forskolin through SSTRs., [UniProtKB, UniProtKB]; This gene encodes a member of the somatostatin family of multifunctional peptides attributed with neurohormone, neurotransmitter/modulator and autocrine/paracrine actions. The encoded preproprotein undergoes proteolytic processing to generate a mature functional peptide that can bind to somatostatin receptors. Mice lacking the encoded protein exhibit elevated levels of growth hormone in the plasma without major changes in somatic growth and have exacerbated nociceptive responses to neuropathic and inflammatory pain sensitization. Transgenic mice overexpressing the encoded protein in neurons do not express long-term potentiation in the dentate gyrus and exhibit deficits in synaptic plasticity and learning. [provided by RefSeq, Nov 2015]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AH76;Q9R1P8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001664 G protein-coupled receptor binding;GO:0005184 neuropeptide hormone activity",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0045187 regulation of circadian sleep/wake cycle, sleep;GO:0007193 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;GO:0007218 neuropeptide signaling pathway;GO:0030334 regulation of cell migration",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P56469-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P97742-1",
        "uniprot_id": "CPT1A_MOUSE",
        "mass": 88251.0,
        "length": 773,
        "protein_name": "Carnitine O-palmitoyltransferase 1, liver isoform",
        "gene_name": "Cpt1a",
        "organism": "Mouse",
        "refseq_name": "carnitine O-palmitoyltransferase 1, liver isoform",
        "refseq_ac": "NP_038523",
        "gene_names_uniprotkb": "Cpt1a; Cpt-1; Cpt1",
        "gene_names_refseq": "C730027G07; CPTI; Cpt1a; Cpt1",
        "protein_names_uniprotkb": "Carnitine O-palmitoyltransferase 1, liver isoform; 2.3.1.-; 2.3.1.21; CPT I; CPT1-L; CPTI-L; Carnitine O-palmitoyltransferase I, liver isoform; Carnitine palmitoyltransferase 1A; Succinyltransferase CPT1A",
        "protein_names_refseq": "CPT I; CPT1-L; CPTI-L; L-CPT I; carnitine O-palmitoyltransferase 1, liver isoform; carnitine palmitoyltransferase 1, liver; succinyltransferase CPT1A",
        "tax_id": 10090,
        "disease": "metabolic dysfunction and alcohol associated liver disease (Disease Ontology:DOID:0070508); metabolic dysfunction-associated steatohepatitis (Disease Ontology:DOID:0080547); carnitine palmitoyltransferase I deficiency (Disease Ontology:DOID:0090129); alcoholic hepatitis (Disease Ontology:DOID:12351); lipid metabolism disorder (Disease Ontology:DOID:3146); lymphangioleiomyomatosis (Disease Ontology:DOID:3319); end stage renal disease (Disease Ontology:DOID:783); type 2 diabetes mellitus (Disease Ontology:DOID:9352); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:12894);  (R-MMU-200425)",
        "pathway_count": 2,
        "publication_count": 14,
        "publication_id_list": "16169268;17030509;21750661;22229081;22872234;31219806;32893669;34035164;34428180;36210013;37453647;37507081;8830050;9680378",
        "class_list": "",
        "function": "Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion (PubMed:16169268, PubMed:17030509). Plays an important role in hepatic triglyceride metabolism (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 9,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O35288;Q80SW3;Q8BP98;Q8C7H8",
        "ec_number_list": "2.3.1.48;2.3.1.-;2.3.1.137;2.3.1.7;2.3.1.21;3.1.2.22",
        "go_molecular_function": "GO:0004095 carnitine O-palmitoyltransferase activity;GO:0030674 protein-macromolecule adaptor activity;GO:0042802 identical protein binding;GO:0016747 acyltransferase activity, transferring groups other than amino-acyl groups;GO:0016746 acyltransferase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane;GO:0005743 mitochondrial inner membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0043279 response to alkaloid;GO:0001676 long-chain fatty acid metabolic process;GO:0006631 fatty acid metabolic process;GO:0006635 fatty acid beta-oxidation;GO:0006641 triglyceride metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "P97742-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q0VE82-1",
        "uniprot_id": "CPNE7_MOUSE",
        "mass": 61891.0,
        "length": 557,
        "protein_name": "Copine-7",
        "gene_name": "Cpne7",
        "organism": "Mouse",
        "refseq_name": "copine-7",
        "refseq_ac": "NP_733785",
        "gene_names_uniprotkb": "Cpne7",
        "gene_names_refseq": "Cpne7",
        "protein_names_uniprotkb": "Copine-7; Copine VII",
        "protein_names_refseq": "copine 7 protein; copine-7",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:102278);  (R-MMU-1483206)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "30734591;30863901;32283105;32848054;38105557",
        "class_list": "",
        "function": "Calcium-dependent membrane-binding proteins may regulate molecular events at the interface of the cell membrane and cytoplasm. This gene is one of several genes that encodes a calcium-dependent protein containing two N-terminal type II C2 domains and an integrin A domain-like sequence in the C-terminus. [provided by RefSeq, Jul 2008]., [RefSeq]; Calcium-dependent phospholipid-binding protein that may play a role in calcium-mediated intracellular processes., [UniProtKB, UniProtKB]; Copine-7 is required for REM sleep regulation following cage change or water immersion and restraint stress in mice., [RefSeq, PubMed]; Cpne7 deficiency induces cellular senescence and premature aging of dental pulp., [RefSeq, PubMed]; The effect of CPNE7 on periodontal regeneration., [RefSeq, PubMed]; These results illustrate the dynamic expression of CPNE7 during tooth development and suggest its important function in entire stages of tooth development, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0005544 calcium-dependent phospholipid binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0045202 synapse",
        "go_biological_process": "GO:0071277 cellular response to calcium ion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q0VE82-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3U962-1",
        "uniprot_id": "CO5A2_MOUSE",
        "mass": 145018.0,
        "length": 1497,
        "protein_name": "Collagen alpha-2(V) chain",
        "gene_name": "Col5a2",
        "organism": "Mouse",
        "refseq_name": "collagen alpha-2(V) chain preproprotein",
        "refseq_ac": "NP_031763",
        "gene_names_uniprotkb": "Col5a2",
        "gene_names_refseq": "1110014L14Rik; Col5a2",
        "protein_names_uniprotkb": "Collagen alpha-2(V) chain",
        "protein_names_refseq": "collagen alpha-2(V) chain preproprotein; collagen alpha-2(V) chain; procollagen, type V, alpha 2",
        "tax_id": 10090,
        "disease": "Ehlers-Danlos syndrome classic type 2 (Disease Ontology:DOID:0080726); proliferative diabetic retinopathy (Disease Ontology:DOID:13207); Ehlers-Danlos syndrome (Disease Ontology:DOID:13359); Ehlers-Danlos syndrome classic type 1 (Disease Ontology:DOID:14720); lung disease (Disease Ontology:DOID:850)",
        "pathway": " (mmu:12832);  (R-MMU-1442490);  (R-MMU-1566977);  (R-MMU-1650814);  (R-MMU-186797);  (R-MMU-2022090);  (R-MMU-216083);  (R-MMU-3000171);  (R-MMU-3000178);  (R-MMU-419037);  (R-MMU-8874081);  (R-MMU-8948216)",
        "pathway_count": 12,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;1297453;15199158;20485683;37828378;7704020;9642685",
        "class_list": "",
        "function": "This gene encodes the alpha-2 subunit of type V collagen, one of the low abundance fibrillar collagens that gets incorporated into growing fibrils with type I collagen. The encoded protein, in association with alpha-1 and/or alpha-3 subunits, forms homo- or heterotrimeric type V procollagen that undergoes proteolytic processing. Mice lacking the encoded protein die in utero. Transgenic mice that produce a structurally abnormal form of the encoded protein survive poorly and exhibit skin fragility, skeletal abnormalities and alterations in the collagen fiber organization. [provided by RefSeq, Dec 2015]., [RefSeq]; Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin. Type V collagen is a key determinant in the assembly of tissue-specific matrices., [UniProtKB, PubMed, PubMed, UniProtKB, PubMed]",
        "predicted_glycosites": 14,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 13,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 15,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TVR2;Q3UHK7;Q3UTT4;Q3V1J6;Q61431;Q7TMS0;Q80VS8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0046332 SMAD binding;GO:0030020 extracellular matrix structural constituent conferring tensile strength",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0031012 extracellular matrix;GO:0005581 collagen trimer;GO:0005588 collagen type V trimer",
        "go_biological_process": "GO:0001501 skeletal system development;GO:0030199 collagen fibril organization;GO:0043588 skin development;GO:0071230 cellular response to amino acid stimulus;GO:0048592 eye morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q3U962-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UW21-1",
        "uniprot_id": "COLL2_MOUSE",
        "mass": 11027.0,
        "length": 102,
        "protein_name": "Colipase-like protein 2",
        "gene_name": "Clpsl2",
        "organism": "Mouse",
        "refseq_name": "colipase-like protein 2 precursor",
        "refseq_ac": "NP_001030043",
        "gene_names_uniprotkb": "Clpsl2; Gm749",
        "gene_names_refseq": "Clpsl2; Gm749",
        "protein_names_uniprotkb": "Colipase-like protein 2",
        "protein_names_refseq": "colipase-like protein 2 precursor; colipase-like protein 2; colipase-like protein C6orf126 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:328788)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "29323738",
        "class_list": "",
        "function": "This study identified a novel and conserved molecule, Clpsl2, was specifically expressed in epididymis and involved in the regulation of spermatozoa motility, acrosomal integrity, and male fertility., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008047 enzyme activator activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0001669 acrosomal vesicle;GO:0036126 sperm flagellum",
        "go_biological_process": "GO:0016042 lipid catabolic process;GO:0007338 single fertilization;GO:0007340 acrosome reaction;GO:0007586 digestion;GO:0048872 homeostasis of number of cells",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q3UW21-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5QNQ9-1",
        "uniprot_id": "CORA1_MOUSE",
        "mass": 186319.0,
        "length": 1845,
        "protein_name": "Collagen alpha-1(XXVII) chain",
        "gene_name": "Col27a1",
        "organism": "Mouse",
        "refseq_name": "collagen alpha-1(XXVII) chain preproprotein",
        "refseq_ac": "NP_079961",
        "gene_names_uniprotkb": "Col27a1; Kiaa1870",
        "gene_names_refseq": "5730512J02Rik; Col27a1",
        "protein_names_uniprotkb": "Collagen alpha-1(XXVII) chain",
        "protein_names_refseq": "collagen alpha-1(XXVII) chain preproprotein; collagen alpha-1(XXVII) chain; procollagen, type XXVII, alpha 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:373864);  (R-MMU-1650814);  (R-MMU-2022090);  (R-MMU-8874081);  (R-MMU-8948216)",
        "pathway_count": 5,
        "publication_count": 7,
        "publication_id_list": "12714037;12766169;17331945;17693149;19414009;21750661;34203471",
        "class_list": "",
        "function": "Molecular cloning, [RefSeq, PubMed]; Plays a role during the calcification of cartilage and the transition of cartilage to bone., [UniProtKB]; Results suggest that Lc-Maf may affect the process of endochondral ossification by participating in the regulation of Col27a1 expression., [RefSeq, PubMed]; This gene encodes the alpha-1 subunit of type XXVII collagen, one of the low abundance fibril-forming collagens found in cartilage. The encoded protein forms a homotrimeric triple helical procollagen that undergoes proteolytic processing during fibril formation. Transgenic mice lacking a portion of the collagenous domain in the encoded protein exhibit skeletal abnormalities, chondrodysplasia and die at birth because of a lung defect. [provided by RefSeq, Dec 2015]., [RefSeq]; Type XXVII collagen has unusual molecular features such as no minor helical domain, a major helical domain that is short and interrupted, and a short chain selection sequence within the NC1 domain (COLLAGEN TYPE XXVII), [RefSeq, PubMed]",
        "predicted_glycosites": 7,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 4,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 7,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q69Z83;Q80UA8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0005201 extracellular matrix structural constituent;GO:0030020 extracellular matrix structural constituent conferring tensile strength",
        "go_cellular_component": "GO:0031012 extracellular matrix;GO:0005583 fibrillar collagen trimer;GO:0030937 collagen type XVII trimer",
        "go_biological_process": "GO:0030198 extracellular matrix organization;GO:0001501 skeletal system development;GO:0003431 growth plate cartilage chondrocyte development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q5QNQ9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5QR91-1",
        "uniprot_id": "CQ078_MOUSE",
        "mass": 32583.0,
        "length": 290,
        "protein_name": "Uncharacterized protein C17orf78 homolog",
        "gene_name": "Gm11437",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein C17orf78 homolog",
        "refseq_ac": "NP_001033021",
        "gene_names_uniprotkb": "Gm11437",
        "gene_names_refseq": "Gm11437",
        "protein_names_uniprotkb": "Uncharacterized protein C17orf78 homolog",
        "protein_names_refseq": "uncharacterized protein C17orf78 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:628813)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "34428180",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B0QZI9;B9EK11;Q5SWU4",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q5QR91-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6P8I6-1",
        "uniprot_id": "COX11_MOUSE",
        "mass": 30849.0,
        "length": 275,
        "protein_name": "Cytochrome c oxidase assembly protein COX11, mitochondrial",
        "gene_name": "Cox11",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase assembly protein COX11, mitochondrial",
        "refseq_ac": "NP_950173",
        "gene_names_uniprotkb": "Cox11",
        "gene_names_refseq": "2010004I09Rik; Cox11",
        "protein_names_uniprotkb": "Cytochrome c oxidase assembly protein COX11, mitochondrial",
        "protein_names_refseq": "COX11 homolog, cytochrome c oxidase assembly protein; cytochrome c oxidase assembly protein COX11, mitochondrial",
        "tax_id": 10090,
        "disease": "mitochondrial complex IV deficiency nuclear type 23 (Disease Ontology:DOID:0070485)",
        "pathway": " (mmu:69802);  (R-MMU-9864848)",
        "pathway_count": 2,
        "publication_count": 2,
        "publication_id_list": "17069463;21750661",
        "class_list": "",
        "function": "Assembly factor for cytochrome c oxidase (respiratory chain complex IV, CIV). Probably acts as a metallochaperone that delivers copper to the copper B site of COX1., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; RanBP2 associates in vitro and in vivo and colocalizes with the mitochondrial metallochaperone, Cox11, and the pacemaker of glycolysis, hexokinase type I (HKI) via its leucine-rich domain., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UNX9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005507 copper ion binding;GO:0016531 copper chaperone activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006754 ATP biosynthetic process;GO:0030003 intracellular monoatomic cation homeostasis;GO:0033617 mitochondrial respiratory chain complex IV assembly;GO:0033132 negative regulation of glucokinase activity",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q6P8I6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q5XFZ0-1",
        "uniprot_id": "RMP24_MOUSE",
        "mass": 24123.0,
        "length": 217,
        "protein_name": "Ribonuclease MRP protein subunit p24",
        "gene_name": "2700062C07Rik; Rmp24",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "2700062C07Rik; Rmp24",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Ribonuclease MRP protein subunit p24",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68046)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;31219806",
        "class_list": "",
        "function": "Specific component of the MRP ribonucleoprotein endoribonuclease, Rnase/Mrp complex, a ribonucleoprotein complex involved in pre-rRNA processing., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CXC1;Q9CZ41",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0000172 ribonuclease MRP complex",
        "go_biological_process": "GO:0006396 RNA processing;GO:0006364 rRNA processing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q5XFZ0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61597-1",
        "uniprot_id": "CRGC_MOUSE",
        "mass": 20917.0,
        "length": 174,
        "protein_name": "Gamma-crystallin C",
        "gene_name": "Crygc",
        "organism": "Mouse",
        "refseq_name": "gamma-crystallin C isoform 1",
        "refseq_ac": "NP_031801",
        "gene_names_uniprotkb": "Crygc; Gammab-cry",
        "gene_names_refseq": "Cryg-5; Crygc",
        "protein_names_uniprotkb": "Gamma-crystallin C; Gamma-C-crystallin",
        "protein_names_refseq": "gamma-C-crystallin; gamma-crystallin C isoform 1; gamma-crystallin C; gammaC-crystallin",
        "tax_id": 10090,
        "disease": "cataract 2 multiple types (Disease Ontology:DOID:0110235); cataract (Disease Ontology:DOID:83); retinal degeneration (Disease Ontology:DOID:8466)",
        "pathway": " (mmu:12966)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "1623964;8293998",
        "class_list": "",
        "function": "Crystallins are the dominant structural components of the vertebrate eye lens., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q03739",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005212 structural constituent of eye lens",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0007601 visual perception;GO:0001654 eye development;GO:0043010 camera-type eye development;GO:0002088 lens development in camera-type eye",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q61597-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64429-1",
        "uniprot_id": "CP1B1_MOUSE",
        "mass": 60537.0,
        "length": 543,
        "protein_name": "Cytochrome P450 1B1",
        "gene_name": "Cyp1b1",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 1B1 isoform 1",
        "refseq_ac": "NP_034124",
        "gene_names_uniprotkb": "Cyp1b1; Cyp1-b1",
        "gene_names_refseq": "CP1B; CYPIB1; Cyp1b1; P4501b1",
        "protein_names_uniprotkb": "Cytochrome P450 1B1; 1.14.14.1; 4.2.1.152; CYPIB1; Cytochrome P450CMEF; Cytochrome P450EF; Hydroperoxy icosatetraenoate dehydratase",
        "protein_names_refseq": "cytochrome P450 1B1 isoform 1; cytochrome P450 1B1; cytochrome P450, 1b1, benz[a]anthracene inducible; cytochrome P450CMEF; cytochrome P450EF; hydroperoxy icosatetraenoate dehydratase",
        "tax_id": 10090,
        "disease": "Peters anomaly (Disease Ontology:DOID:0060673); anterior segment dysgenesis 6 (Disease Ontology:DOID:0080611); primary open angle glaucoma (Disease Ontology:DOID:1070); hypertension (Disease Ontology:DOID:10763); urinary bladder cancer (Disease Ontology:DOID:11054); buphthalmos (Disease Ontology:DOID:11211); hydrophthalmos (Disease Ontology:DOID:11212); hypertrophic cardiomyopathy (Disease Ontology:DOID:11984); breast cancer (Disease Ontology:DOID:1612); breast adenocarcinoma (Disease Ontology:DOID:3458); esophagus squamous cell carcinoma (Disease Ontology:DOID:3748); lung squamous cell carcinoma (Disease Ontology:DOID:3907); myocardial infarction (Disease Ontology:DOID:5844)",
        "pathway": " (mmu:13078);  (R-MMU-211976);  (R-MMU-2142670);  (R-MMU-2142816)",
        "pathway_count": 4,
        "publication_count": 15,
        "publication_id_list": "15258110;19005183;20032512;21750661;23568032;23692925;23821647;23979599;31599954;34428180;38429921;39321267;7505439;7772257;8195121",
        "class_list": "",
        "function": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins (By similarity). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (By similarity). Exhibits catalytic activity for the formation of hydroxyestrogens from 17beta-estradiol (E2), namely 2- and 4-hydroxy E2 (PubMed:23821647). Metabolizes testosterone and progesterone to B or D ring hydroxylated metabolites (By similarity). May act as a major enzyme for all-trans retinoic acid biosynthesis in extrahepatic tissues. Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid (PubMed:15258110). Catalyzes the epoxidation of double bonds of certain PUFA. Converts arachidonic acid toward epoxyeicosatrienoic acid (EpETrE) regioisomers, 8,9-, 11,12-, and 14,15- EpETrE, that function as lipid mediators in the vascular system (PubMed:15258110). Additionally, displays dehydratase activity toward oxygenated eicosanoids hydroperoxyeicosatetraenoates (HpETEs). This activity is independent of cytochrome P450 reductase, NADPH, and O2 (By similarity). Also involved in the oxidative metabolism of xenobiotics, particularly converting polycyclic aromatic hydrocarbons and heterocyclic aryl amines procarcinogens to DNA-damaging products (By similarity). Plays an important role in retinal vascular development. Under ambient/hyperoxic O2 conditions, promotes angiogenesis and capillary morphogenesis of retinal endothelial cells and pericytes, likely by metabolizing the oxygenated products symptomatic of oxidative stress (PubMed:19005183, PubMed:20032512, PubMed:23568032). Also, contributes to oxidative homeostasis and ultrastructural organization and function of trabecular meshwork tissue through modulation of POSTN expression (PubMed:23979599)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB, PubMed]; CYP1B1 affects the integrity of the blood-brain barrier and oxidative stress in the striatum: An investigation of manganese-induced neurotoxicity., [RefSeq, PubMed]; Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 13,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UVA8;Q60593;Q64461",
        "ec_number_list": "1.14.14.1;1.14.14.-;5.3.99.4;4.2.1.152;1.14.14.14;5.3.99.5;1.14.13.n7;1.14.14.80;1.14.14.94;5.4.4.7;1.14.14.25",
        "go_molecular_function": "GO:0101020 estrogen 16-alpha-hydroxylase activity;GO:0005506 iron ion binding;GO:0016491 oxidoreductase activity;GO:0020037 heme binding;GO:0016712 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0002930 trabecular meshwork development;GO:0008210 estrogen metabolic process;GO:0071603 endothelial cell-cell adhesion;GO:0001525 angiogenesis;GO:0007155 cell adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q64429-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64445-1",
        "uniprot_id": "COX8A_MOUSE",
        "mass": 7648.0,
        "length": 69,
        "protein_name": "Cytochrome c oxidase subunit 8A, mitochondrial",
        "gene_name": "Cox8a",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase subunit 8A, mitochondrial precursor",
        "refseq_ac": "NP_031776",
        "gene_names_uniprotkb": "Cox8a; Cox8l; Cox8",
        "gene_names_refseq": "COX8L; Cox8a",
        "protein_names_uniprotkb": "Cytochrome c oxidase subunit 8A, mitochondrial; Cytochrome c oxidase polypeptide VIII-liver; Cytochrome c oxidase subunit 8-2",
        "protein_names_refseq": "COX VIII-L; cytochrome c oxidase polypeptide VIII-liver; cytochrome c oxidase subunit 8-2; cytochrome c oxidase subunit 8A, mitochondrial precursor; cytochrome c oxidase subunit 8A, mitochondrial; cytochrome c oxidase subunit VIIIa",
        "tax_id": 10090,
        "disease": "mitochondrial complex IV deficiency nuclear type 15 (Disease Ontology:DOID:0070500)",
        "pathway": " (mmu:12868);  (R-MMU-5628897);  (R-MMU-611105);  (R-MMU-9707564);  (R-MMU-9864848)",
        "pathway_count": 5,
        "publication_count": 4,
        "publication_id_list": "21750661;31219806;34428180;9166597",
        "class_list": "",
        "function": "Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q0VBB1;Q545I2",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0031966 mitochondrial membrane;GO:0045277 respiratory chain complex IV",
        "go_biological_process": "GO:0006123 mitochondrial electron transport, cytochrome c to oxygen;GO:0006119 oxidative phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q64445-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64464-1",
        "uniprot_id": "CP3AD_MOUSE",
        "mass": 57492.0,
        "length": 503,
        "protein_name": "Cytochrome P450 3A13",
        "gene_name": "Cyp3a13",
        "organism": "Mouse",
        "refseq_name": "cytochrome P450 3A13",
        "refseq_ac": "NP_031845",
        "gene_names_uniprotkb": "Cyp3a13; Cyp3a-13",
        "gene_names_refseq": "Cyp3a13; IIIAm2",
        "protein_names_uniprotkb": "Cytochrome P450 3A13; 1.14.14.1; CYPIIIA13",
        "protein_names_refseq": "CYPIIIA13; cytochrome P450 3A13; cytochrome P450, steroid inducible 3a13",
        "tax_id": 10090,
        "disease": "alcohol-associated liver disease (Disease Ontology:DOID:0070658); B-lymphoblastic leukemia/lymphoma (Disease Ontology:DOID:0080630); essential hypertension (Disease Ontology:DOID:10825); familial Mediterranean fever (Disease Ontology:DOID:2987); liver cirrhosis (Disease Ontology:DOID:5082); oral submucous fibrosis (Disease Ontology:DOID:5773); chronic myeloid leukemia (Disease Ontology:DOID:8552); acute lymphoblastic leukemia (Disease Ontology:DOID:9952)",
        "pathway": " (mmu:13113);  (R-MMU-211945);  (R-MMU-211958);  (R-MMU-211981);  (R-MMU-5423646);  (R-MMU-9027307);  (R-MMU-9749641);  (R-MMU-9754706);  (R-MMU-9757110)",
        "pathway_count": 9,
        "publication_count": 5,
        "publication_id_list": "29125184;30084848;33300544;34428180;7803471",
        "class_list": "",
        "function": "A significant increase of Cyp3a13 transcript level and protein expression was found in the liver and hippocampi during spontaneous recurrent seizures in mice., [RefSeq, PubMed]; Can activate aflatoxin B1 to a genotoxic product., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 8,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.14.14.1;1.14.14.-;4.2.1.152;1.14.13.n7;5.3.99.5",
        "go_molecular_function": "GO:0008401 retinoic acid 4-hydroxylase activity;GO:0101020 estrogen 16-alpha-hydroxylase activity;GO:0005506 iron ion binding;GO:0019899 enzyme binding;GO:0016491 oxidoreductase activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0010628 positive regulation of gene expression;GO:0070989 oxidative demethylation;GO:0008202 steroid metabolic process;GO:0042908 xenobiotic transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q64464-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q64739-2",
        "uniprot_id": "COBA2_MOUSE",
        "mass": 171535.0,
        "length": 1736,
        "protein_name": "Collagen alpha-2(XI) chain",
        "gene_name": "Col11a2",
        "organism": "Mouse",
        "refseq_name": "collagen alpha-2(XI) chain isoform 1 precursor",
        "refseq_ac": "NP_001304651",
        "gene_names_uniprotkb": "Col11a2",
        "gene_names_refseq": "Col11a2",
        "protein_names_uniprotkb": "Collagen alpha-2(XI) chain",
        "protein_names_refseq": "collagen alpha-2(XI) chain isoform 1 precursor; collagen alpha-2(XI) chain; procollagen, type XI, alpha 2",
        "tax_id": 10090,
        "disease": "otospondylomegaepiphyseal dysplasia, autosomal recessive (Disease Ontology:DOID:0080026); Stickler syndrome (Disease Ontology:DOID:0080046); fibrochondrogenesis 2 (Disease Ontology:DOID:0080673); otospondylomegaepiphyseal dysplasia, autosomal dominant (Disease Ontology:DOID:0080677); autosomal recessive nonsyndromic deafness 53 (Disease Ontology:DOID:0110509); autosomal dominant nonsyndromic deafness 13 (Disease Ontology:DOID:0110545); osteochondrodysplasia (Disease Ontology:DOID:2256); cleft palate (Disease Ontology:DOID:674)",
        "pathway": " (mmu:12815);  (R-MMU-1442490);  (R-MMU-1650814);  (R-MMU-2022090);  (R-MMU-3000171);  (R-MMU-8874081);  (R-MMU-8948216)",
        "pathway_count": 7,
        "publication_count": 5,
        "publication_id_list": "33725478;34418053;7836472;8830784;8981332",
        "class_list": "",
        "function": "May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils., [UniProtKB]; This gene encodes the alpha-2 subunit of type XI collagen, one of the low abundance fibrillar collagens found in cartilage. The encoded protein, in association with other collagen subunits, forms a heterotrimeric type XI procollagen that may undergo proteolytic processing similar to the alpha-1 subunit. Mice lacking the encoded protein exhibit a mild phenotype similar to nonocular Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED) as well as a nonsyndromic form of deafness called DFNA13. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]., [RefSeq]",
        "predicted_glycosites": 9,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 8,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 8,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q61432;Q9Z1W0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0005201 extracellular matrix structural constituent;GO:0030020 extracellular matrix structural constituent conferring tensile strength",
        "go_cellular_component": "GO:0031012 extracellular matrix;GO:0005581 collagen trimer",
        "go_biological_process": "GO:0001894 tissue homeostasis;GO:0001501 skeletal system development;GO:0030199 collagen fibril organization;GO:0007605 sensory perception of sound;GO:0048705 skeletal system morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q64739-2",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80WM3-1",
        "uniprot_id": "CPLX4_MOUSE",
        "mass": 18351.0,
        "length": 160,
        "protein_name": "Complexin-4",
        "gene_name": "Cplx4",
        "organism": "Mouse",
        "refseq_name": "complexin-4",
        "refseq_ac": "NP_663468",
        "gene_names_uniprotkb": "Cplx4",
        "gene_names_refseq": "A930004D23Rik; CPXIV; Cplx4; Gm957",
        "protein_names_uniprotkb": "Complexin-4; CPX IV; Complexin IV",
        "protein_names_refseq": "CPX IV; complexin IV; complexin-4",
        "tax_id": 10090,
        "disease": "depressive disorder (Disease Ontology:DOID:1596)",
        "pathway": " (mmu:225644)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "15911881;16000319;19386896;22694764;27335398",
        "class_list": "",
        "function": "Complexin that regulates SNARE protein complex-mediated synaptic vesicle fusion (PubMed:19386896). Required for the maintenance of synaptic ultrastructure in the adult retina (PubMed:19386896). Positively regulates synaptic transmission through synaptic vesicle availability and exocytosis of neurotransmitters at photoreceptor ribbon synapses in the retina (PubMed:15911881, PubMed:19386896, PubMed:27335398). Suppresses tonic photoreceptor activity and baseline 'noise' by suppression of Ca(2+) vesicle tonic release and the facilitation of evoked synchronous and asynchronous Ca(2+) vesicle release (PubMed:22694764, PubMed:27335398)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; Disruption in complexin I is associated with profound ataxia with a complex phenotype that includes exploratory and habituation deficits, [RefSeq, PubMed]; Results show that complexin 3 and complexin 4 are essential regulators of transmitter release at retinal ribbon synapses., [RefSeq, PubMed]; The findings of this study reveal a suppressing action of Cplx3/4 on tonic neurotransmitter release, a facilitating action on evoked release, and a regulatory role of Cplx3/4 in the adaptation-dependent availability of synaptic vesicles at mouse photoreceptor ribbon synapses. Erratum:[J Neurosci. 2017 Aug 9;37(32):7796. doi: 10.1523/JNEUROSCI.1954-17.2017. PMID: 31305591], [RefSeq, PubMed]; The lack of Cplx 3 and Cplx 4 differentially impacts the ON and OFF pathways in the retina is corroborated by localization studies of Cplx 3 and Cplx 4 in the retina., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C8Y0;Q91WE5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0019905 syntaxin binding;GO:0000149 SNARE binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0043195 terminal bouton;GO:0045202 synapse;GO:0031201 SNARE complex",
        "go_biological_process": "GO:0007601 visual perception;GO:0046928 regulation of neurotransmitter secretion;GO:0050804 modulation of chemical synaptic transmission;GO:0031630 regulation of synaptic vesicle fusion to presynaptic active zone membrane;GO:0016079 synaptic vesicle exocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q80WM3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BGJ3-1",
        "uniprot_id": "CQ100_MOUSE",
        "mass": 14539.0,
        "length": 129,
        "protein_name": "Uncharacterized protein C17orf100 homolog",
        "gene_name": "",
        "organism": "Mouse",
        "refseq_name": "uncharacterized protein C17orf100 homolog",
        "refseq_ac": "NP_001157200",
        "gene_names_uniprotkb": "",
        "gene_names_refseq": "4930563E22Rik",
        "protein_names_uniprotkb": "Uncharacterized protein C17orf100 homolog",
        "protein_names_refseq": "uncharacterized protein C17orf100 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:75304)",
        "pathway_count": 1,
        "publication_count": 0,
        "publication_id_list": "",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3V1L1",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.1,
        "record_id": "Q8BGJ3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BH51-1",
        "uniprot_id": "COX14_MOUSE",
        "mass": 6380.0,
        "length": 57,
        "protein_name": "Cytochrome c oxidase assembly protein COX14",
        "gene_name": "Cox14",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase assembly protein COX14",
        "refseq_ac": "NP_899079",
        "gene_names_uniprotkb": "Cox14",
        "gene_names_refseq": "2310016M24Rik; Cox14",
        "protein_names_uniprotkb": "Cytochrome c oxidase assembly protein COX14",
        "protein_names_refseq": "cytochrome c oxidase assembly protein COX14",
        "tax_id": 10090,
        "disease": "mitochondrial complex IV deficiency nuclear type 10 (Disease Ontology:DOID:0070496)",
        "pathway": " (mmu:66379);  (R-MMU-9864848)",
        "pathway_count": 2,
        "publication_count": 6,
        "publication_id_list": "25428506;30084848;31219806;34428180;35820727;39134548",
        "class_list": "",
        "function": "Core component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. Requires for coordination of the early steps of cytochrome c oxidase assembly with the synthesis of MT-CO1., [UniProtKB, UniProtKB]; Defective mitochondrial COX1 translation due to loss of COX14 function triggers ROS-induced inflammation in mouse liver. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0044183 protein folding chaperone",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005741 mitochondrial outer membrane",
        "go_biological_process": "GO:0033617 mitochondrial respiratory chain complex IV assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q8BH51-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BJ03-1",
        "uniprot_id": "COX15_MOUSE",
        "mass": 45853.0,
        "length": 413,
        "protein_name": "Heme A synthase COX15",
        "gene_name": "Cox15",
        "organism": "Mouse",
        "refseq_name": "heme A synthase COX15",
        "refseq_ac": "NP_659123",
        "gene_names_uniprotkb": "Cox15",
        "gene_names_refseq": "2900026G05Rik; Cox15; HAS",
        "protein_names_uniprotkb": "Heme A synthase COX15; 1.17.99.9; Cytochrome c oxidase assembly protein COX15 homolog; HAS",
        "protein_names_refseq": "COX15 homolog, cytochrome c oxidase assembly protein; cytochrome c oxidase assembly protein COX15 homolog; heme A synthase COX15",
        "tax_id": 10090,
        "disease": "mitochondrial complex IV deficiency nuclear type 6 (Disease Ontology:DOID:0080358); hypertrophic cardiomyopathy (Disease Ontology:DOID:11984); ovarian dysfunction (Disease Ontology:DOID:1414); Leigh disease (Disease Ontology:DOID:3652)",
        "pathway": " (mmu:226139);  (R-MMU-189451);  (R-MMU-9864848)",
        "pathway_count": 3,
        "publication_count": 1,
        "publication_id_list": "34428180",
        "class_list": "",
        "function": "Catalyzes the second reaction in the biosynthesis of heme A, a prosthetic group of mitochondrial cytochrome c oxidase (CcO). Heme A is synthesized from heme B by two sequential enzymatic reactions catalyzed by heme O synthase (HOS) and heme A synthase (HAS). HAS catalyzes the conversion of heme O to heme A by two successive hydroxylations of the methyl group at C8, in a reaction that involves matrix ferredoxin and ferredoxin reductase. The first hydroxylation forms heme I, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme A., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3URB2;Q8VDN0;Q921K5",
        "ec_number_list": "7.1.1.9;1.17.99.9",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors;GO:0120547 heme A synthase activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005759 mitochondrial matrix;GO:0070069 cytochrome complex",
        "go_biological_process": "GO:0017004 cytochrome complex assembly;GO:0006784 heme A biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8BJ03-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BW22-1",
        "uniprot_id": "CREST_MOUSE",
        "mass": 43729.0,
        "length": 402,
        "protein_name": "Calcium-responsive transactivator",
        "gene_name": "Ss18l1",
        "organism": "Mouse",
        "refseq_name": "calcium-responsive transactivator",
        "refseq_ac": "NP_848865",
        "gene_names_uniprotkb": "Ss18l1; Crest; Kiaa0693",
        "gene_names_refseq": "A230053O16Rik; CREST; Ss18l1",
        "protein_names_uniprotkb": "Calcium-responsive transactivator; SS18-like protein 1",
        "protein_names_refseq": "SS18-like protein 1; calcium-responsive transactivator; synovial sarcoma translocation gene on chromosome 18-like 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:269397);  (R-MMU-9933937);  (R-MMU-9933947)",
        "pathway_count": 3,
        "publication_count": 8,
        "publication_id_list": "14716005;17920018;19081374;22517741;22645316;34678516;40885482;40997131",
        "class_list": "",
        "function": "Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6A014;Q7TQF3;Q8BYQ7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0003713 transcription coactivator activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0016604 nuclear body;GO:0000775 chromosome, centromeric region",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0016358 dendrite development;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0006355 regulation of DNA-templated transcription;GO:0045893 positive regulation of DNA-templated transcription",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8BW22-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C6K9-1",
        "uniprot_id": "CO6A6_MOUSE",
        "mass": 246323.0,
        "length": 2265,
        "protein_name": "Collagen alpha-6(VI) chain",
        "gene_name": "Col6a6",
        "organism": "Mouse",
        "refseq_name": "collagen alpha-6(VI) chain isoform 1 precursor",
        "refseq_ac": "NP_001096077",
        "gene_names_uniprotkb": "Col6a6",
        "gene_names_refseq": "Col6a6; E330019B14; E330026B02Rik",
        "protein_names_uniprotkb": "Collagen alpha-6(VI) chain",
        "protein_names_refseq": "collagen alpha-6(VI) chain isoform 1 precursor; collagen alpha-6(VI) chain",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:245026);  (R-MMU-1442490);  (R-MMU-1650814);  (R-MMU-186797);  (R-MMU-2022090);  (R-MMU-216083);  (R-MMU-3000178);  (R-MMU-419037);  (R-MMU-8948216)",
        "pathway_count": 9,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;18276594;18400749;21477648;21750661;25428506;34203471",
        "class_list": "",
        "function": "Analysis of collagen VI chains alpha4, alpha5, and alpha6with high homology to the alpha3 chain, [RefSeq, PubMed]; Collagen VI acts as a cell-binding protein., [UniProtKB, UniProtKB, UniProtKB]; Discovery of three additional collagen VI chains doubles the collagen VI family and adds a layer of complexity to collagen VI assembly and function in the extracellular matrix, [RefSeq, PubMed]; Immunoelectron microscopy of skeletal muscle localized the collagen VI alpha 6 chain to the reticular lamina of muscle fibers, [RefSeq, PubMed]",
        "predicted_glycosites": 6,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 3,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9753,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A6H587;A6H588;A6H589;A6H590",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0031012 extracellular matrix;GO:0005589 collagen type VI trimer",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0030198 extracellular matrix organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q8C6K9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C784-1",
        "uniprot_id": "MOSMO_MOUSE",
        "mass": 18250.0,
        "length": 167,
        "protein_name": "Modulator of smoothened protein",
        "gene_name": "Mosmo",
        "organism": "Mouse",
        "refseq_name": "modulator of smoothened protein isoform 1 precursor",
        "refseq_ac": "NP_001158052",
        "gene_names_uniprotkb": "Mosmo; Atthog; BC030336",
        "gene_names_refseq": "Atthog; Mosmo",
        "protein_names_uniprotkb": "Modulator of smoothened protein; Attenuator of hedgehog",
        "protein_names_refseq": "Attenuator of Hedgehog; modulator of smoothened protein isoform 1 precursor; modulator of smoothened protein; uncharacterized protein C16orf52 homolog",
        "tax_id": 10090,
        "disease": "chromosome 16p12.1 deletion syndrome (Disease Ontology:DOID:0060399)",
        "pathway": " (mmu:233812)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;29290584;34486668",
        "class_list": "",
        "function": "Acts as a negative regulator of hedgehog signaling probably by promoting internalization and subsequent degradation of smoothened protein (SMO) present in the ciliary membrane (PubMed:29290584). Plays a role in sonic hedgehog (SHH)-induced spinal neural progenitor cells differentiation (PubMed:29290584)., [UniProtKB, PubMed]; Gene-teratogen interactions influence the penetrance of birth defects by altering Hedgehog signaling strength., [RefSeq, PubMed]; This gene encodes a four-pass transmembrane protein that dampens signaling through the Hedgehog pathway by reducing the levels of the Smoothened oncoprotein at the cell surface and the primary cilium. Erratum:[Dev Cell. 2018 Jan 22;44(2):271. doi: 10.1016/j.devcel.2018.01.002. PMID: 29401421], [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TS22;Q8K0V1",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005794 Golgi apparatus;GO:0005886 plasma membrane;GO:0060170 ciliary membrane",
        "go_biological_process": "GO:0060972 left/right pattern formation;GO:0001701 in utero embryonic development;GO:0007507 heart development;GO:0030154 cell differentiation;GO:0030324 lung development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8C784-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CD60-1",
        "uniprot_id": "INSY1_MOUSE",
        "mass": 31813.0,
        "length": 292,
        "protein_name": "Inhibitory synaptic factor 1",
        "gene_name": "Insyn1",
        "organism": "Mouse",
        "refseq_name": "inhibitory synaptic factor 1",
        "refseq_ac": "NP_795895",
        "gene_names_uniprotkb": "Insyn1",
        "gene_names_refseq": "6030419C18Rik; Insyn1",
        "protein_names_uniprotkb": "Inhibitory synaptic factor 1; InSyn1",
        "protein_names_refseq": "UPF0583 protein C15orf59 homolog; inhibitory synaptic factor 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:319477)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "27609886",
        "class_list": "",
        "function": "Component of the protein machinery at the inhibitory synapses, probably acting as a scaffold. Inhibitory synapses dampen neuronal activity through postsynaptic hyperpolarization. This synaptic inhibition is fundamental for the functioning of the central nervous system, shaping and orchestrating the flow of information through neuronal networks to generate a precise neural code., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0098982 GABA-ergic synapse;GO:0014069 postsynaptic density;GO:0099572 postsynaptic specialization",
        "go_biological_process": "GO:0060080 inhibitory postsynaptic potential;GO:0099565 chemical synaptic transmission, postsynaptic;GO:0099084 postsynaptic specialization organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q8CD60-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8CFY5-1",
        "uniprot_id": "COX10_MOUSE",
        "mass": 48884.0,
        "length": 443,
        "protein_name": "Protoheme IX farnesyltransferase, mitochondrial",
        "gene_name": "Cox10",
        "organism": "Mouse",
        "refseq_name": "protoheme IX farnesyltransferase, mitochondrial",
        "refseq_ac": "NP_848466",
        "gene_names_uniprotkb": "Cox10",
        "gene_names_refseq": "2410004F01Rik; Cox10",
        "protein_names_uniprotkb": "Protoheme IX farnesyltransferase, mitochondrial; 2.5.1.141; Heme O synthase",
        "protein_names_refseq": "COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase; cytochrome c oxidase assembly protein 10; heme O synthase; protoheme IX farnesyltransferase, mitochondrial",
        "tax_id": 10090,
        "disease": "mitochondrial complex IV deficiency nuclear type 3 (Disease Ontology:DOID:0070492); Parkinson's disease (Disease Ontology:DOID:14330); Leigh disease (Disease Ontology:DOID:3652); cytochrome-c oxidase deficiency disease (Disease Ontology:DOID:3762); mitochondrial myopathy (Disease Ontology:DOID:699)",
        "pathway": " (mmu:70383);  (R-MMU-189451)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "16103131;16782876;31219806",
        "class_list": "",
        "function": "Converts protoheme IX and farnesyl diphosphate to heme O., [UniProtKB]; Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency., [RefSeq, PubMed]; The levels of respiratory complex I were markedly reduced in COX10 knockout clones., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.5.1.141",
        "go_molecular_function": "GO:0004311 geranylgeranyl diphosphate synthase activity;GO:0008495 protoheme IX farnesyltransferase activity",
        "go_cellular_component": "GO:0005730 nucleolus;GO:0005739 mitochondrion;GO:0005759 mitochondrial matrix;GO:0005829 cytosol;GO:0031966 mitochondrial membrane",
        "go_biological_process": "GO:0006629 lipid metabolic process;GO:0035264 multicellular organism growth;GO:0018343 protein farnesylation;GO:0007005 mitochondrion organization;GO:0055070 copper ion homeostasis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8CFY5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K2Q0-1",
        "uniprot_id": "COMD9_MOUSE",
        "mass": 21850.0,
        "length": 198,
        "protein_name": "COMM domain-containing protein 9",
        "gene_name": "Commd9",
        "organism": "Mouse",
        "refseq_name": "COMM domain-containing protein 9",
        "refseq_ac": "NP_083911",
        "gene_names_uniprotkb": "Commd9",
        "gene_names_refseq": "1810029F08Rik; Commd9",
        "protein_names_uniprotkb": "COMM domain-containing protein 9",
        "protein_names_refseq": "COMM domain-containing protein 9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:76501);  (R-MMU-6798695);  (R-MMU-8951664)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "26965651;34428180",
        "class_list": "",
        "function": "Increased total plasma cholesterol levels are seen in hepatic COMMD9-deficient mice. Publication Status: Online-Only, [RefSeq, PubMed]; Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex (By similarity). May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (By similarity). May down-regulate activation of NF-kappa-B (By similarity). Modulates Na(+) transport in epithelial cells by regulation of apical cell surface expression of amiloride-sensitive sodium channel (ENaC) subunits (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U3J2;Q7TNP5;Q811K2;Q9D8V8",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005794 Golgi apparatus;GO:0005829 cytosol;GO:0031410 cytoplasmic vesicle;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0042632 cholesterol homeostasis;GO:0006814 sodium ion transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8K2Q0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K4Q8-1",
        "uniprot_id": "COL12_MOUSE",
        "mass": 81304.0,
        "length": 742,
        "protein_name": "Collectin-12",
        "gene_name": "Colec12",
        "organism": "Mouse",
        "refseq_name": "collectin-12",
        "refseq_ac": "NP_569716",
        "gene_names_uniprotkb": "Colec12; Clp1; Srcl",
        "gene_names_refseq": "CL-P1; Colec12; SRCL; Scara4",
        "protein_names_uniprotkb": "Collectin-12; CL-P1; Collectin placenta protein 1; Scavenger receptor with C-type lectin",
        "protein_names_refseq": "collectin placenta protein 1; collectin-12; scavenger receptor with C-type lectin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:140792)",
        "pathway_count": 1,
        "publication_count": 15,
        "publication_id_list": "10.1101/2023.09.13.557529;11564734;11718900;16868960;17420244;19073604;19656770;21750661;28317919;29187734;30084848;30779550;30899004;33300544;34428180",
        "class_list": "glycogene",
        "function": "CL-P1 is a novel receptor involved in myelin uptake by phagocytes and likely plays a role in multiple sclerosis lesion development. Erratum:[Sci Rep. 2017 Dec 22;7:46925. doi: 10.1038/srep46925. PMID: 29271403] Publication Status: Online-Only, [RefSeq, PubMed]; CL-P1 predominantly mediated phagocytosis for fungi in vascular endothelia., [RefSeq, PubMed]; Scavenger receptor that displays several functions associated with host defense. Promotes binding and phagocytosis of Gram-positive, Gram-negative bacteria and yeast. Also binds to sialyl Lewis X or a trisaccharide and asialo-orosomucoid (ASOR). Mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells (By similarity). Binds to several carbohydrates including Gal-type ligands, D-galactose, L- and D-fucose, GalNAc, T and Tn antigens in a calcium-dependent manner and internalizes specifically GalNAc in nurse-like cells (By similarity)., [UniProtKB, PubMed]; Structural analysis of carbohydrate-recognition domain of SRCL in complex with Lewis(x) and mutagenesis show the basis for this specificity, which is analogous to how selectins and DC-SIGN bind to related fucosylated glycans [scavenger receptor C], [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 4,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 7,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 8,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 8,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 36,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 8,
        "disease_count": 0,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TYT8;Q8C979;Q8VIF6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005044 scavenger receptor activity;GO:0046872 metal ion binding;GO:0030246 carbohydrate binding;GO:0030169 low-density lipoprotein particle binding;GO:0038187 pattern recognition receptor activity",
        "go_cellular_component": "GO:0016020 membrane;GO:0031012 extracellular matrix",
        "go_biological_process": "GO:0006955 immune response;GO:0042742 defense response to bacterium;GO:0006910 phagocytosis, recognition",
        "synthesized_glycan_count": 0,
        "hit_score": 3.3,
        "record_id": "Q8K4Q8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R555-1",
        "uniprot_id": "CRAC1_MOUSE",
        "mass": 70325.0,
        "length": 646,
        "protein_name": "Cartilage acidic protein 1",
        "gene_name": "Crtac1",
        "organism": "Mouse",
        "refseq_name": "cartilage acidic protein 1 isoform 1 precursor",
        "refseq_ac": "NP_660105",
        "gene_names_uniprotkb": "Crtac1; Aspic1; Cep68",
        "gene_names_refseq": "2810454P21Rik; Crtac1B; Crtac1; Lotus",
        "protein_names_uniprotkb": "Cartilage acidic protein 1; 68 kDa chondrocyte-expressed protein; ASPIC; CEP-68; Protein CRTAC1-B",
        "protein_names_refseq": "68 kDa chondrocyte-expressed protein; ASPIC; CEP-68; cartilage acidic protein 1 isoform 1 precursor; protein CRTAC1-B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72832)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "21750661;21817055;22281491;36510132",
        "class_list": "",
        "function": "Found CRTAC1-B(LOTUS)is key molecule for lateral olfactory tract(LOT)formation; NgR1 is LOTUS-binding protein;LOTUS suppressed Nogo-NgR1 binding and Nogo-induced growth cone collapse;suggest endogenous antagonism of NgR1 by LOTUS crucial for LOT formation, [RefSeq, PubMed]; LOTUS suppresses amyloid beta-induced dendritic spine elimination through the blockade of amyloid beta binding to PirB. Publication Status: Online-Only, [RefSeq, PubMed]; These findings suggest that the UA/EC region is a functional domain of LOTUS serving for an antagonistic action to NgR1., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UF32;Q3UF40;Q8BMF1;Q8R3V8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005509 calcium ion binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0014069 postsynaptic density;GO:0030426 growth cone",
        "go_biological_process": "GO:0051963 regulation of synapse assembly;GO:0007413 axonal fasciculation;GO:0021772 olfactory bulb development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q8R555-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91VF6-1",
        "uniprot_id": "COQA1_MOUSE",
        "mass": 45810.0,
        "length": 440,
        "protein_name": "Collagen alpha-1(XXVI) chain",
        "gene_name": "Col26a1",
        "organism": "Mouse",
        "refseq_name": "collagen alpha-1(XXVI) chain isoform 2 precursor",
        "refseq_ac": "NP_001333628",
        "gene_names_uniprotkb": "Col26a1; Col26a; Emid2; Emu2",
        "gene_names_refseq": "9430032K24Rik; Col26a1; Col26a; Emid2; Emu2",
        "protein_names_uniprotkb": "Collagen alpha-1(XXVI) chain; Alpha-1 type XXVI collagen; EMI domain-containing protein 2; Emilin and multimerin domain-containing protein 2; Emu2",
        "protein_names_refseq": "Collagen XXVI; EMI domain containing 2; EMI domain-containing protein 2; alpha-1 type XXVI collagen; collagen alpha-1(XXVI) chain isoform 2 precursor; collagen alpha-1(XXVI) chain; emilin and multimerin domain-containing protein 2; procollagen, type XXVI, alpha 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:140709);  (R-MMU-1442490);  (R-MMU-1650814);  (R-MMU-8948216)",
        "pathway_count": 4,
        "publication_count": 3,
        "publication_id_list": "10.1101/2023.09.13.557529;12145293;12221002",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9803,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8K4P3",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0031012 extracellular matrix",
        "go_biological_process": "GO:0010811 positive regulation of cell-substrate adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q91VF6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91W29-1",
        "uniprot_id": "COX42_MOUSE",
        "mass": 20206.0,
        "length": 172,
        "protein_name": "Cytochrome c oxidase subunit 4 isoform 2, mitochondrial",
        "gene_name": "Cox4i2",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase subunit 4 isoform 2, mitochondrial isoform 2 precursor",
        "refseq_ac": "NP_444321",
        "gene_names_uniprotkb": "Cox4i2; Cox4b",
        "gene_names_refseq": "Cox4b; Cox4i2; CoxIV-2",
        "protein_names_uniprotkb": "Cytochrome c oxidase subunit 4 isoform 2, mitochondrial; COX IV-2; Cytochrome c oxidase subunit IV isoform 2",
        "protein_names_refseq": "cytochrome c oxidase subunit 4 isoform 2, mitochondrial isoform 2 precursor; cytochrome c oxidase, subunit IVb",
        "tax_id": 10090,
        "disease": "cytochrome-c oxidase deficiency disease (Disease Ontology:DOID:3762)",
        "pathway": " (mmu:84682);  (R-MMU-5628897);  (R-MMU-611105);  (R-MMU-9707564);  (R-MMU-9864848)",
        "pathway_count": 5,
        "publication_count": 3,
        "publication_id_list": "11311561;16981895;31848220",
        "class_list": "",
        "function": "Acute O2 sensing through HIF2alpha-dependent expression of atypical cytochrome oxidase subunits in arterial chemoreceptors. Publication Status: Online-Only, [RefSeq, PubMed]; Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix., [UniProtKB, UniProtKB]; The presence of the COX isoform IV-2 suppresses the sensitivity of COX to its allosteric regulator ATP and overrules the regulation of COX by the cellular energy level, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004129 cytochrome-c oxidase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0031966 mitochondrial membrane;GO:0045277 respiratory chain complex IV",
        "go_biological_process": "GO:0006123 mitochondrial electron transport, cytochrome c to oxygen",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q91W29-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91XE9-1",
        "uniprot_id": "CR3L3_MOUSE",
        "mass": 52145.0,
        "length": 479,
        "protein_name": "Cyclic AMP-responsive element-binding protein 3-like protein 3",
        "gene_name": "Creb3l3",
        "organism": "Mouse",
        "refseq_name": "cyclic AMP-responsive element-binding protein 3-like protein 3",
        "refseq_ac": "NP_663340",
        "gene_names_uniprotkb": "Creb3l3; Crebh",
        "gene_names_refseq": "CREB-H; Creb3l3; D10Bur1e",
        "protein_names_uniprotkb": "Cyclic AMP-responsive element-binding protein 3-like protein 3; Transcription factor CREB-H; cAMP-responsive element-binding protein 3-like protein 3",
        "protein_names_refseq": "cAMP-responsive element-binding protein 3-like protein 3; cyclic AMP-responsive element-binding protein 3-like protein 3; transcription factor CREB-H",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:208677);  (R-MMU-8874211)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "15800215;16469704;18704925;21666694;27507854;30389664;37493829",
        "class_list": "",
        "function": "CREB-H is a liver-enriched bZIP transcription factor that may be involved in hepatic physiology and hepatocarcinogenesis. Publication Status: Online-Only, [RefSeq, PubMed]; CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development., [RefSeq, PubMed]; HNF4alpha has a role in controlling the acute phase response of the liver induced by ER stress by regulating expression of CrebH., [RefSeq, PubMed]; Molecular mechanism for activation of an ER-localized transcription factor, CREBH, [RefSeq, PubMed]; Transcription factor that may act during endoplasmic reticulum (ER) stress by activating unfolded protein response target genes. Activated in response to cAMP stimulation. Binds to the cAMP response element (CRE). Activates transcription through box-B element (By similarity). Activates transcription through CRE. May function synergistically with ATF6. In acute inflammatory response, may activate expression of acute phase response (APR) genes. May be involved in growth suppression. Regulates FGF21 transcription (PubMed:30389664). Plays a crucial role in the regulation of triglyceride metabolism and is required for the maintenance of normal plasma triglyceride concentrations (PubMed:21666694)., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BWS0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity;GO:0046982 protein heterodimerization activity;GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0000976 transcription cis-regulatory region binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005783 endoplasmic reticulum;GO:0005829 cytosol;GO:0016020 membrane",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0034976 response to endoplasmic reticulum stress;GO:0006986 response to unfolded protein",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q91XE9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q920M5-1",
        "uniprot_id": "CORO6_MOUSE",
        "mass": 52599.0,
        "length": 471,
        "protein_name": "Coronin-6",
        "gene_name": "Coro6",
        "organism": "Mouse",
        "refseq_name": "coronin-6 isoform A",
        "refseq_ac": "NP_624354",
        "gene_names_uniprotkb": "Coro6",
        "gene_names_refseq": "Coro6",
        "protein_names_uniprotkb": "Coronin-6; Clipin-E; Coronin-like protein E",
        "protein_names_refseq": "clipin E; coronin 6/clipin E type D; coronin, actin binding protein 6; coronin-6 isoform A; coronin-like protein E",
        "tax_id": 10090,
        "disease": "chromosome 16p11.2 deletion syndrome, 593-kb (Disease Ontology:DOID:0070515)",
        "pathway": " (mmu:216961)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;24523531",
        "class_list": "",
        "function": "These findings demonstrate that Coronin 6 is a critical regulator of AChR clustering at the postsynaptic region of the neuromuscular junction, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TZ14;Q5F262;Q5F263;Q5F264;Q5F265;Q920M3;Q920M4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0051015 actin filament binding",
        "go_cellular_component": "GO:0005884 actin filament;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0007015 actin filament organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q920M5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99KP3-1",
        "uniprot_id": "CRYL1_MOUSE",
        "mass": 35209.0,
        "length": 319,
        "protein_name": "Lambda-crystallin homolog",
        "gene_name": "Cryl1",
        "organism": "Mouse",
        "refseq_name": "lambda-crystallin homolog",
        "refseq_ac": "NP_084280",
        "gene_names_uniprotkb": "Cryl1; Cry",
        "gene_names_refseq": "1110025H08Rik; A230106J09Rik; Cryl1; gul3dh",
        "protein_names_uniprotkb": "Lambda-crystallin homolog; 1.1.1.45; Gul3DH; L-gulonate 3-dehydrogenase",
        "protein_names_refseq": "L-gulonate 3-dehydrogenase; crystallin, lamda 1; lambda-crystallin homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68631);  (R-MMU-5661270)",
        "pathway_count": 2,
        "publication_count": 2,
        "publication_id_list": "12527201;18250455",
        "class_list": "",
        "function": "Catalyzes the conversion of L-gulonate to 3-dehydro-L-gulonate (By similarity). It also exhibits low dehydrogenase activity toward L-3-hydroxybutyrate (HBA) and L-threonate (By similarity). Utilizes NAD as the sole cosubstrate and shows no activity with NADP (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q542R9;Q8R4W7",
        "ec_number_list": "1.1.1.45",
        "go_molecular_function": "GO:0050104 L-gulonate 3-dehydrogenase activity;GO:0042803 protein homodimerization activity;GO:0070403 NAD+ binding",
        "go_cellular_component": "GO:0005829 cytosol",
        "go_biological_process": "GO:0006631 fatty acid metabolic process;GO:0019640 D-glucuronate catabolic process to D-xylulose 5-phosphate",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q99KP3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q99M07-1",
        "uniprot_id": "COA5_MOUSE",
        "mass": 8359.0,
        "length": 74,
        "protein_name": "Cytochrome c oxidase assembly factor 5",
        "gene_name": "Coa5",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase assembly factor 5",
        "refseq_ac": "NP_932123",
        "gene_names_uniprotkb": "Coa5",
        "gene_names_refseq": "1700001A24Rik; 6330578E17Rik; Coa5; Pet191",
        "protein_names_uniprotkb": "Cytochrome c oxidase assembly factor 5",
        "protein_names_refseq": "cytochrome c oxidase assembly factor 5",
        "tax_id": 10090,
        "disease": "mitochondrial complex IV deficiency nuclear type 9 (Disease Ontology:DOID:0080359)",
        "pathway": " (mmu:76178);  (R-MMU-9864848)",
        "pathway_count": 2,
        "publication_count": 0,
        "publication_id_list": "",
        "class_list": "",
        "function": "Assembly factor for cytochrome c oxidase (respiratory chain complex IV). Stabilizes an early formation of cytochrome c oxidase assembly factors, until it is displaced by the metallochaperone copper-delivery protein COX17., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005758 mitochondrial intermembrane space",
        "go_biological_process": "GO:0035264 multicellular organism growth;GO:0048536 spleen development;GO:0048538 thymus development;GO:0002521 leukocyte differentiation;GO:0033617 mitochondrial respiratory chain complex IV assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.1,
        "record_id": "Q99M07-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CX63-1",
        "uniprot_id": "IL40_MOUSE",
        "mass": 26851.0,
        "length": 252,
        "protein_name": "Protein IL-40",
        "gene_name": "",
        "organism": "Mouse",
        "refseq_name": "protein IL-40 precursor",
        "refseq_ac": "NP_084240",
        "gene_names_uniprotkb": "",
        "gene_names_refseq": "6030468B19Rik; Il-40",
        "protein_names_uniprotkb": "Protein IL-40; IL-40; Interleukin-40",
        "protein_names_refseq": "interleukin-40; protein IL-40 precursor; protein IL-40; uncharacterized protein C17orf99 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:77727)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "28978694",
        "class_list": "",
        "function": "Probable B cell-associated cytokine that plays a role in the regulation of humoral immune responses (PubMed:28978694). Involved in lymphocyte B cell development and immunoglobulin/IgA production (PubMed:28978694)., [UniProtKB, PubMed]; These observations indicate that C17orf99 encodes a novel B cell-associated cytokine, which we have called IL-40, that plays an important role in humoral immune responses and may also play a role in B cell development., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B1ATC1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004888 transmembrane signaling receptor activity;GO:0005125 cytokine activity",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0009897 external side of plasma membrane",
        "go_biological_process": "GO:0006955 immune response;GO:0007166 cell surface receptor signaling pathway;GO:0002250 adaptive immune response;GO:2000558 positive regulation of immunoglobulin production in mucosal tissue;GO:0002313 mature B cell differentiation involved in immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9CX63-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CZT6-1",
        "uniprot_id": "CMS1_MOUSE",
        "mass": 31594.0,
        "length": 276,
        "protein_name": "Protein CMSS1",
        "gene_name": "Cmss1",
        "organism": "Mouse",
        "refseq_name": "protein CMSS1",
        "refseq_ac": "NP_079875",
        "gene_names_uniprotkb": "Cmss1",
        "gene_names_refseq": "1110001A06Rik; 2610528E23Rik; 4930572F24Rik; Cmss1",
        "protein_names_uniprotkb": "Protein CMSS1; Cms1 ribosomal small subunit homolog",
        "protein_names_refseq": "cms1 ribosomal small subunit homolog; protein CMSS1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66497)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;31219806",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CY77",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9CZT6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D2A5-1",
        "uniprot_id": "CR3L4_MOUSE",
        "mass": 41025.0,
        "length": 370,
        "protein_name": "Cyclic AMP-responsive element-binding protein 3-like protein 4",
        "gene_name": "Creb3l4",
        "organism": "Mouse",
        "refseq_name": "cyclic AMP-responsive element-binding protein 3-like protein 4 isoform 1",
        "refseq_ac": "NP_001294863",
        "gene_names_uniprotkb": "Creb3l4; Atce1; Jal; Tisp40",
        "gene_names_refseq": "1700012K17Rik; 5330432F22Rik; AIBZIP; CREB4; Creb3l4; JAL; TISP40; acre1",
        "protein_names_uniprotkb": "Cyclic AMP-responsive element-binding protein 3-like protein 4; ATCE1; Acre1; Attaching to CRE-like 1; Tisp40; Transcript induced in spermiogenesis protein 40; cAMP-responsive element-binding protein 3-like protein 4; mJAL",
        "protein_names_refseq": "androgen-induced basic leucine zipper; attaching to CRE-like 1; cAMP-responsive element-binding protein 3-like protein 4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform 1; cyclic AMP-responsive element-binding protein 3-like protein 4; transcript induced in spermiogenesis protein 40",
        "tax_id": 10090,
        "disease": "prostate adenocarcinoma (Disease Ontology:DOID:2526); prostate carcinoma in situ (Disease Ontology:DOID:8634)",
        "pathway": " (mmu:78284)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "11943763;11956138;15938716;16107712;16595651;16728718;16925989;16999736;25412305;37291168",
        "class_list": "",
        "function": "Creb3l4 is an essential negative regulator of adipogenesis. Publication Status: Online-Only, [RefSeq, PubMed]; Creb3l4 plays a role in male germ cell development, [RefSeq, PubMed]; Expression of full-length ATCE1 in various cell lines revealed ER and Golgi localization whereas truncation of the C-terminus allowed entrance into the nucleus. A speculation that ATCE1 might be paternally delivered to newly formed zygote is discussed., [RefSeq, PubMed]; TISP40 functions by binding to the unfolded protein response element via the Rip pathway., [RefSeq, PubMed]; This gene encodes a CREB (cyclic AMP-responsive element-binding) protein with a transmembrane domain which localizes it to the ER membrane. The encoded protein may play a role in adiposity and male germ cell development. Homozygous knockout mice for this gene show increased adipogenesis, elevated testicular germ cell apoptosis and defects in spermatogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]., [RefSeq]; Tisp40 and CREM bind to the Tisp40 promoter in vivo, [RefSeq, PubMed]; Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Publication Status: Online-Only, [RefSeq, PubMed]; Transcriptional activator that may play a role in the unfolded protein response of the testis. Proposed to be involved in spermiogenesis. May be involved in regulating the maturation of sperm head nuclei. Alternatively proposed to be a paternally delivered transcription factor that may function in early zygotic gene activation. Increases the binding of CREM isoform Tau with CRE. The CREM isoform Tau-CREB3L4 heterodimer functions through CRE but not through UPRE and may recruit HIRA to CRE to regulate histone exchange., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; We show that Atce1/Tisp40alpha is the major form of CREB3L4 in mouse testis. These findings suggest that testis-specific isoforms of Creb3l4 could play an important role in spermatid differentiation., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9DAE0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0007283 spermatogenesis;GO:0030154 cell differentiation;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9D2A5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D7J4-1",
        "uniprot_id": "COX20_MOUSE",
        "mass": 13163.0,
        "length": 117,
        "protein_name": "Cytochrome c oxidase assembly protein COX20, mitochondrial",
        "gene_name": "Cox20",
        "organism": "Mouse",
        "refseq_name": "cytochrome c oxidase assembly protein COX20, mitochondrial",
        "refseq_ac": "NP_079787",
        "gene_names_uniprotkb": "Cox20; Fam36a",
        "gene_names_refseq": "2310005N03Rik; Cox20; Fam36a",
        "protein_names_uniprotkb": "Cytochrome c oxidase assembly protein COX20, mitochondrial",
        "protein_names_refseq": "COX20 Cox2 chaperone; cytochrome c oxidase assembly protein COX20, mitochondrial; cytochrome c oxidase protein 20 homolog; family with sequence similarity 36, member A; protein FAM36A",
        "tax_id": 10090,
        "disease": "mitochondrial complex IV deficiency nuclear type 11 (Disease Ontology:DOID:0070497)",
        "pathway": " (mmu:66359);  (R-MMU-9864848)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "34428180",
        "class_list": "",
        "function": "Essential for the assembly of the mitochondrial respiratory chain complex IV (CIV), also known as cytochrome c oxidase. Acts as a chaperone in the early steps of cytochrome c oxidase subunit II (MT-CO2/COX2) maturation, stabilizing the newly synthesized protein and presenting it to metallochaperones SCO1/2 which in turn facilitates the incorporation of the mature MT-CO2/COX2 into the assembling CIV holoenzyme., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BT52",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane",
        "go_biological_process": "GO:0033617 mitochondrial respiratory chain complex IV assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9D7J4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D979-1",
        "uniprot_id": "CHCT1_MOUSE",
        "mass": 27118.0,
        "length": 236,
        "protein_name": "CHD1 helical C-terminal domain containing protein 1",
        "gene_name": "Chct1",
        "organism": "Mouse",
        "refseq_name": "CHD1 helical C-terminal domain containing protein 1",
        "refseq_ac": "NP_082865",
        "gene_names_uniprotkb": "Chct1",
        "gene_names_refseq": "1700125H20Rik; Chct1",
        "protein_names_uniprotkb": "CHD1 helical C-terminal domain containing protein 1; Uncharacterized protein C17orf64 homolog",
        "protein_names_refseq": "CHD1 helical C-terminal domain containing protein 1; uncharacterized protein C17orf64 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:73634)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "27591891;33566224",
        "class_list": "",
        "function": "Expression profile analysis of a new testis-specifically expressed gene C17ORF64 and its association with cell apoptosis in MCF-7 cells., [RefSeq, PubMed]; May play a role in regulation of apoptosis., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SX10;Q80ZN8",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9D979-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DAZ5-1",
        "uniprot_id": "F174C_MOUSE",
        "mass": 12374.0,
        "length": 108,
        "protein_name": "Protein FAM174C",
        "gene_name": "Fam174c",
        "organism": "Mouse",
        "refseq_name": "protein FAM174C precursor",
        "refseq_ac": "NP_081483",
        "gene_names_uniprotkb": "Fam174c",
        "gene_names_refseq": "1600002K03Rik; Fam174c",
        "protein_names_uniprotkb": "Protein FAM174C",
        "protein_names_refseq": "protein FAM174C precursor; protein FAM174C",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69770)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21183079",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3THR0",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0016020 membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9DAZ5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DBB9-1",
        "uniprot_id": "CPN2_MOUSE",
        "mass": 60479.0,
        "length": 547,
        "protein_name": "Carboxypeptidase N subunit 2",
        "gene_name": "Cpn2",
        "organism": "Mouse",
        "refseq_name": "carboxypeptidase N subunit 2 precursor",
        "refseq_ac": "NP_082180",
        "gene_names_uniprotkb": "Cpn2",
        "gene_names_refseq": "1300018K11Rik; Cpn2",
        "protein_names_uniprotkb": "Carboxypeptidase N subunit 2; Carboxypeptidase N 83 kDa chain; Carboxypeptidase N large subunit; Carboxypeptidase N polypeptide 2; Carboxypeptidase N regulatory subunit",
        "protein_names_refseq": "carboxypeptidase N 83 kDa chain; carboxypeptidase N large subunit; carboxypeptidase N regulatory subunit; carboxypeptidase N subunit 2 precursor; carboxypeptidase N subunit 2; carboxypeptidase N, polypeptide 2 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71756);  (R-MMU-977606)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;16944957;17330941;25428506;30084848;32152506;34428180",
        "class_list": "",
        "function": "The 83 kDa subunit binds and stabilizes the catalytic subunit at 37 degrees Celsius and keeps it in circulation. Under some circumstances it may be an allosteric modifier of the catalytic subunit (By similarity)., [UniProtKB]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 6,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 4,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 6,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 6,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9803,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 9,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RR89;Q8R113",
        "ec_number_list": "",
        "go_molecular_function": "GO:0038023 signaling receptor activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005886 plasma membrane;GO:0031012 extracellular matrix",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q9DBB9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DC53-1",
        "uniprot_id": "CPNE8_MOUSE",
        "mass": 64667.0,
        "length": 577,
        "protein_name": "Copine-8",
        "gene_name": "Cpne8",
        "organism": "Mouse",
        "refseq_name": "copine-8 isoform 1",
        "refseq_ac": "NP_080091",
        "gene_names_uniprotkb": "Cpne8",
        "gene_names_refseq": "1200003E11Rik; 1500031E20Rik; Cpne8",
        "protein_names_uniprotkb": "Copine-8; Copine VIII",
        "protein_names_refseq": "copine-8 isoform 1; copine-8",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66871);  (R-MMU-9013406)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "12670487;19795140;25605945",
        "class_list": "",
        "function": "Characterization of the human ortholog, CPNE8., [RefSeq, PubMed]; Probable calcium-dependent phospholipid-binding protein that may play a role in calcium-mediated intracellular processes., [UniProtKB, UniProtKB]; Results identify Cpne8, a member of the copine family, as the most promising candidate gene for prion disease incubation time., [RefSeq, PubMed]; This gene encodes a member of the copine family of highly conserved, calcium-dependent phospholipid binding proteins. The encoded protein has two characteristic C2 domains and a VWFA domain and may play a role in membrane trafficking. A related pseudogene is found on chromosome 8. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RS65;Q9CUZ8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0005544 calcium-dependent phospholipid binding",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0071277 cellular response to calcium ion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9DC53-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EP75-1",
        "uniprot_id": "CP4FE_MOUSE",
        "mass": 59800.0,
        "length": 524,
        "protein_name": "Leukotriene-B4 omega-hydroxylase 3",
        "gene_name": "Cyp4f14",
        "organism": "Mouse",
        "refseq_name": "leukotriene-B4 omega-hydroxylase 3",
        "refseq_ac": "NP_001191262",
        "gene_names_uniprotkb": "Cyp4f14",
        "gene_names_refseq": "1300014O15Rik; Cyp4f14; cyp4f-14",
        "protein_names_uniprotkb": "Leukotriene-B4 omega-hydroxylase 3; 1.14.14.94; Cyp4f-14; Cytochrome P450 4F14; Cytochrome P450-LTB-omega; Leukotriene-B4 20-monooxygenase 3",
        "protein_names_refseq": "cytochrome P450 4F14; cytochrome P450, subfamily IVF, polypeptide 14 (leukotriene B4 omega hydroxylase); cytochrome P450-LTB-omega; leukotriene-B4 20-monooxygenase 3; leukotriene-B4 omega-hydroxylase 3",
        "tax_id": 10090,
        "disease": "colorectal adenocarcinoma (Disease Ontology:DOID:0050861); hypertension (Disease Ontology:DOID:10763)",
        "pathway": " (mmu:64385);  (R-MMU-211935);  (R-MMU-211958);  (R-MMU-211979);  (R-MMU-2142691);  (R-MMU-2142816)",
        "pathway_count": 6,
        "publication_count": 7,
        "publication_id_list": "21466787;21750661;22160543;22665481;22969154;30084848;34428180",
        "class_list": "",
        "function": "CYP4F14 is the major but not the only vitamin E-omega-hydroxylase in mice, [RefSeq, PubMed]; Catalytic activity of Cyp4fs is a novel target for modulating neuroinflammation through hydroxylation of LTB(4)., [RefSeq, PubMed]; Cytochromes P450 are a group of heme-thiolate monooxygenases. Catalyzes the omega-hydroxylation of LTB4 (By similarity)., [UniProtKB]; THE TOH-omega-hydroxylase activity was exhibited by microsomes from mouse and human small intestine; murine activity was entirely due to CYP4F14., [RefSeq, PubMed]; The data suggested that, in the absence of A2A adenosine receptor, omega-hydroxylase induces vasoconstriction through mitogen-activated protein kinases via upregulation of adenosine A1 receptor and protein kinase C-alpha., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q52L93",
        "ec_number_list": "1.14.14.1;1.14.14.80;4.2.1.152;1.14.14.94",
        "go_molecular_function": "GO:0016709 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;GO:0005504 fatty acid binding;GO:0005506 iron ion binding;GO:0020037 heme binding;GO:0050544 arachidonate binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005789 endoplasmic reticulum membrane;GO:0016324 apical plasma membrane",
        "go_biological_process": "GO:0006690 icosanoid metabolic process;GO:0097267 omega-hydroxylase P450 pathway;GO:0019369 arachidonate metabolic process;GO:0036101 leukotriene B4 catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9EP75-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QZE5-1",
        "uniprot_id": "COPG1_MOUSE",
        "mass": 97513.0,
        "length": 874,
        "protein_name": "Coatomer subunit gamma-1",
        "gene_name": "Copg1",
        "organism": "Mouse",
        "refseq_name": "coatomer subunit gamma-1 isoform 1",
        "refseq_ac": "NP_059505",
        "gene_names_uniprotkb": "Copg1; Copg",
        "gene_names_refseq": "Copg1; Copg; D6Ertd71e; D6Wsu16e",
        "protein_names_uniprotkb": "Coatomer subunit gamma-1; Gamma-1-COP; Gamma-1-coat protein",
        "protein_names_refseq": "coatomer subunit gamma-1 isoform 1; coatomer subunit gamma-1; coatomer subunit gamma; gamma-1-COP; gamma-1-coat protein; gamma-COP; gamma-coat protein",
        "tax_id": 10090,
        "disease": "immunodeficiency 128 (Disease Ontology:DOID:0061093); combined immunodeficiency (Disease Ontology:DOID:0111962); polyclonal hypergammaglobulinemia (Disease Ontology:DOID:2344)",
        "pathway": " (mmu:54161);  (R-MMU-6807878);  (R-MMU-6811434)",
        "pathway_count": 3,
        "publication_count": 16,
        "publication_id_list": "11018518;17360540;19067489;22872234;25428506;28315936;28528544;30084848;31219806;33300544;33529166;34203471;34428180;36210013;37453647;39627609",
        "class_list": "",
        "function": "Analysis of differential localization of coatomer complex isoforms within the Golgi apparatus, [RefSeq, PubMed]; Combined immunodeficiency due to a mutation in the gamma1 subunit of the coat protein I complex., [RefSeq, PubMed]; The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors (By similarity). Required for limiting lipid storage in lipid droplets. Involved in lipid homeostasis by regulating the presence of perilipin family members PLIN2 and PLIN3 at the lipid droplet surface and promoting the association of adipocyte triglyceride lipase (PNPLA2) with the lipid droplet surface to mediate lipolysis., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3U9F4;Q8BP96;Q8R1A7;Q922C6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005198 structural molecule activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005783 endoplasmic reticulum;GO:0005794 Golgi apparatus;GO:0005829 cytosol;GO:0005793 endoplasmic reticulum-Golgi intermediate compartment",
        "go_biological_process": "GO:0006886 intracellular protein transport;GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport;GO:0051683 establishment of Golgi localization;GO:0009306 protein secretion;GO:0072384 organelle transport along microtubule",
        "synthesized_glycan_count": 0,
        "hit_score": 1.9,
        "record_id": "Q9QZE5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z100-1",
        "uniprot_id": "CPXM1_MOUSE",
        "mass": 80907.0,
        "length": 722,
        "protein_name": "Probable carboxypeptidase X1",
        "gene_name": "Cpxm1",
        "organism": "Mouse",
        "refseq_name": "probable carboxypeptidase X1 precursor",
        "refseq_ac": "NP_062670",
        "gene_names_uniprotkb": "Cpxm1; Cpx1; Cpxm",
        "gene_names_refseq": "Cpx-1; Cpx1; Cpxm1; Cpxm",
        "protein_names_uniprotkb": "Probable carboxypeptidase X1; 3.4.17.-; Metallocarboxypeptidase CPX-1",
        "protein_names_refseq": "carboxypeptidase X (M14 family); carboxypeptidase X 1 (M14 family); metallocarboxypeptidase 1; metallocarboxypeptidase CPX-1; probable carboxypeptidase X1 precursor; probable carboxypeptidase X1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56264)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;10073577;15094061;27006448;34428180",
        "class_list": "",
        "function": "May be involved in cell-cell interactions. No carboxypeptidase activity was found yet., [UniProtKB]; These findings establish CPX-1 as a positive regulator of adipogenesis situated downstream of FGF-1/BAMBI that may contribute to hyperplastic adipose tissue expansion via affecting extracellular matrix remodeling., [RefSeq, PubMed]; Transient up-regulation pattern of CPX-1 expression may be important for the successful progression from pre-osteoclasts to mature osteoclasts., [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9641,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2BI86;Q99LA3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0004181 metallocarboxypeptidase activity",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0006508 proteolysis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q9Z100-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9Z2L7-1",
        "uniprot_id": "CRLF3_MOUSE",
        "mass": 49559.0,
        "length": 442,
        "protein_name": "Cytokine receptor-like factor 3",
        "gene_name": "Crlf3",
        "organism": "Mouse",
        "refseq_name": "cytokine receptor-like factor 3 isoform 2",
        "refseq_ac": "NP_001264035",
        "gene_names_uniprotkb": "Crlf3; Creme9; Cytor4",
        "gene_names_refseq": "Creme9; Crlf3; Cytor4",
        "protein_names_uniprotkb": "Cytokine receptor-like factor 3; CREME-9; Cytokine receptor-like molecule 9; Cytokine receptor-related factor 4",
        "protein_names_refseq": "cytokine receptor-like factor 3 isoform 2; cytokine receptor-like molecule 9; cytokine receptor-related factor 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:54394)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;37712888",
        "class_list": "",
        "function": "A common single nucleotide variant in the cytokine receptor-like factor-3 (CRLF3) gene causes neuronal deficits in human and mouse cells., [RefSeq, PubMed]; May play a role in the negative regulation of cell cycle progression., [UniProtKB]; This gene encodes a cytokine receptor-like factor that contains a fibronectin type 3 domain. The encoded protein may act as a negative regulator of the cell cycle. There is a pseudogene for this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SYK6;Q91W21;Q9R262",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0042802 identical protein binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane",
        "go_biological_process": "GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0045893 positive regulation of DNA-templated transcription;GO:0030308 negative regulation of cell growth;GO:0046427 positive regulation of receptor signaling pathway via JAK-STAT;GO:2000134 negative regulation of G1/S transition of mitotic cell cycle",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9Z2L7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q60750-1",
        "uniprot_id": "EPHA1_MOUSE",
        "mass": 108578.0,
        "length": 977,
        "protein_name": "Ephrin type-A receptor 1",
        "gene_name": "Epha1",
        "organism": "Mouse",
        "refseq_name": "ephrin type-A receptor 1 precursor",
        "refseq_ac": "NP_076069",
        "gene_names_uniprotkb": "Epha1; Esk",
        "gene_names_refseq": "5730453L17Rik; Epha1; Eph; Esk",
        "protein_names_uniprotkb": "Ephrin type-A receptor 1; 2.7.10.1; Embryonic stem cell kinase; Tyrosine-protein kinase receptor ESK; mEpha1",
        "protein_names_refseq": "embryonic stem cell kinase; ephrin type-A receptor 1 precursor; ephrin type-A receptor 1; mEpha1; tyrosine-protein kinase receptor ESK",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13835);  (R-MMU-2682334);  (R-MMU-3928663);  (R-MMU-3928665)",
        "pathway_count": 4,
        "publication_count": 9,
        "publication_id_list": "11519828;18802966;21750661;25428506;27446912;33057926;36214254;37162645;8552593",
        "class_list": "",
        "function": "EphA1 Activation Induces Neuropathological Changes in a Mouse Model of Parkinson's Disease Through the CXCL12/CXCR4 Signaling Pathway., [RefSeq, PubMed]; EphA1 aggravates neuropathic pain by activating CXCR4/RhoA/ROCK2 pathway in mice., [RefSeq, PubMed]; EphA1 receptor tyrosine kinase is localized to the nucleus in rhabdomyosarcoma from multiple species., [RefSeq, PubMed]; Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Binds with a low affinity EFNA3 and EFNA4 and with a high affinity to EFNA1 which most probably constitutes its cognate/functional ligand. Upon activation by EFNA1 induces cell attachment to the extracellular matrix inhibiting cell spreading and motility through regulation of ILK and downstream RHOA and RAC. Also plays a role in angiogenesis and regulates cell proliferation. May play a role in apoptosis., [UniProtKB, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 5,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CED9;Q9ESJ2",
        "ec_number_list": "2.7.12.2;2.7.10.1;2.7.12.1;2.7.1.32;2.7.1.82;2.7.10.2;2.7.11.1;2.7.11.13;2.7.10.4;2.7.1.40;3.6.5.2;2.7.11.23",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0019901 protein kinase binding;GO:0004714 transmembrane receptor protein tyrosine kinase activity;GO:0001968 fibronectin binding;GO:0005005 transmembrane-ephrin receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0043235 receptor complex",
        "go_biological_process": "GO:0001525 angiogenesis;GO:0007169 cell surface receptor protein tyrosine kinase signaling pathway;GO:0030335 positive regulation of cell migration;GO:0030336 negative regulation of cell migration;GO:0045766 positive regulation of angiogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q60750-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q7TSV9-1",
        "uniprot_id": "ENKD1_MOUSE",
        "mass": 38967.0,
        "length": 346,
        "protein_name": "Enkurin domain-containing protein 1",
        "gene_name": "Enkd1",
        "organism": "Mouse",
        "refseq_name": "enkurin domain-containing protein 1",
        "refseq_ac": "NP_938041",
        "gene_names_uniprotkb": "Enkd1",
        "gene_names_refseq": "E130303B06Rik; Enkd1",
        "protein_names_uniprotkb": "Enkurin domain-containing protein 1",
        "protein_names_refseq": "enkurin domain-containing protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:102124)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "17971504;21183079;21750661;31219806;35072334;35197565;35301795",
        "class_list": "",
        "function": "E130303B06Rik is most abundantly expressed in tissues rich in highly ciliated cells, such as olfactory sensory neurons, and is predicted to be important to cilia., [RefSeq, PubMed]; ENKD1 promotes CP110 removal through competing with CEP97 to initiate ciliogenesis., [RefSeq, PubMed]; ENKD1 promotes epidermal stratification by regulating spindle orientation in basal keratinocytes., [RefSeq, PubMed]; Microtubule-binding protein which regulates microtubule organization and stability (By similarity). Promotes the stability of astral microtubules and facilitates the proper orientation of the mitotic spindle (By similarity). This allows the oriented division of basal keratinocytes and contributes to epidermal stratification (PubMed:35197565). Required for the assembly of both primary and motile cilia (PubMed:35072334, PubMed:35301795). Destabilizes the interaction between CCP110 and CEP97 by competing with CEP97 for binding to CCP110 which promotes the removal of CCP110 and CEP97 from the mother centriole and allows the initiation of ciliogenesis (PubMed:35301795)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008017 microtubule binding;GO:0043014 alpha-tubulin binding",
        "go_cellular_component": "GO:0000922 spindle pole;GO:0005813 centrosome;GO:0005886 plasma membrane;GO:0005929 cilium;GO:0015630 microtubule cytoskeleton",
        "go_biological_process": "GO:0044458 motile cilium assembly;GO:1905515 non-motile cilium assembly;GO:0000132 establishment of mitotic spindle orientation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q7TSV9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CXU9-1",
        "uniprot_id": "EIF1B_MOUSE",
        "mass": 12824.0,
        "length": 113,
        "protein_name": "Eukaryotic translation initiation factor 1b",
        "gene_name": "Eif1b",
        "organism": "Mouse",
        "refseq_name": "eukaryotic translation initiation factor 1b",
        "refseq_ac": "NP_081168",
        "gene_names_uniprotkb": "Eif1b",
        "gene_names_refseq": "1500010M16Rik; 3110001N14Rik; Eif1b; Gc20",
        "protein_names_uniprotkb": "Eukaryotic translation initiation factor 1b; eIF1b",
        "protein_names_refseq": "eukaryotic translation initiation factor 1b; translation factor sui1 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68969)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "21750661;30680919;31219806",
        "class_list": "",
        "function": "Deficiency of TPPP2 might affect the translation of specific proteins, such as eEf1b, altering the structure and function of sperm mitochondria, and resulting in decreased sperm count, motility and fertility., [RefSeq, PubMed]; Probably involved in translation., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0043024 ribosomal small subunit binding;GO:0003743 translation initiation factor activity",
        "go_cellular_component": "GO:0016282 eukaryotic 43S preinitiation complex",
        "go_biological_process": "GO:0010468 regulation of gene expression;GO:0080090 regulation of primary metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9CXU9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9ER73-1",
        "uniprot_id": "ELP4_MOUSE",
        "mass": 46325.0,
        "length": 422,
        "protein_name": "Elongator complex protein 4",
        "gene_name": "Elp4",
        "organism": "Mouse",
        "refseq_name": "elongator complex protein 4",
        "refseq_ac": "NP_076365",
        "gene_names_uniprotkb": "Elp4; Paxneb",
        "gene_names_refseq": "A330107A17Rik; Elp4; Paxneb",
        "protein_names_uniprotkb": "Elongator complex protein 4; PAX6 neighbor gene protein",
        "protein_names_refseq": "PAX6 neighbor gene protein; elongation protein 4 homolog; elongator complex protein 4",
        "tax_id": 10090,
        "disease": "aniridia (Disease Ontology:DOID:12271)",
        "pathway": " (mmu:77766)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "11889558;21750661;28528544;30097576;31219806;34203471;34428180",
        "class_list": "",
        "function": "Component of the elongator complex which is required for multiple tRNA modifications, including mcm5U (5-methoxycarbonylmethyl uridine), mcm5s2U (5-methoxycarbonylmethyl-2-thiouridine), and ncm5U (5-carbamoylmethyl uridine). The elongator complex catalyzes the formation of carboxymethyluridine in the wobble base at position 34 in tRNAs., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BGM1;Q8BVB1;Q8BZN8;Q9CTR2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008607 phosphorylase kinase regulator activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0008023 transcription elongation factor complex;GO:0033588 elongator holoenzyme complex;GO:0005634 nucleus",
        "go_biological_process": "GO:0006357 regulation of transcription by RNA polymerase II;GO:0002098 tRNA wobble uridine modification",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q9ER73-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P70245-1",
        "uniprot_id": "EBP_MOUSE",
        "mass": 26215.0,
        "length": 230,
        "protein_name": "3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",
        "gene_name": "Ebp",
        "organism": "Mouse",
        "refseq_name": "3-beta-hydroxysteroid-Delta(8), Delta(7)-isomerase",
        "refseq_ac": "NP_031924",
        "gene_names_uniprotkb": "Ebp; Msi",
        "gene_names_refseq": "Ebp; Pabp; SI; Td; mSI",
        "protein_names_uniprotkb": "3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase; 3.3.2.11; 5.3.3.5; Cholestenol Delta-isomerase; Cholesterol-5,6-epoxide hydrolase subunit EBP; D8-D7 sterol isomerase; Delta(8)-Delta(7) sterol isomerase; Emopamil-binding protein",
        "protein_names_refseq": "3-beta-hydroxysteroid-Delta(8), Delta(7)-isomerase; D8-D7 sterol isomerase; cholestenol Delta-isomerase; cholesterol-5,6-epoxide hydrolase subunit EBP; delta(8)-Delta(7) sterol isomerase; phenylalkylamine Ca2+ antagonist (emopamil) binding protein; tattered",
        "tax_id": 10090,
        "disease": "X-linked chondrodysplasia punctata 1 (Disease Ontology:DOID:0060292); X-linked chondrodysplasia punctata 2 (Disease Ontology:DOID:0080352); MEND syndrome (Disease Ontology:DOID:0111865); chondrodysplasia punctata (Disease Ontology:DOID:2581)",
        "pathway": " (mmu:13595);  (R-MMU-6807047);  (R-MMU-9969901)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "10391218;21606357;21750661;22645316;25605945;28487965;34428180;37453647;8798407",
        "class_list": "",
        "function": "Component of the microsomal antiestrogen binding site (AEBS), a multiproteic complex at the ER membrane that consists of an association between EBP and 7-dehydrocholesterol reductase/DHCR7. This complex is responsible for cholesterol-5,6-epoxide hydrolase (ChEH) activity, which consists in the hydration of cholesterol-5,6-epoxides (5,6-EC) into cholestane-3beta,5alpha,6beta-triol (CT). The precise role of each component of this complex has not been described yet., [UniProtKB, UniProtKB]; Isomerase that catalyzes the conversion of Delta(8)-sterols to their corresponding Delta(7)-isomers., [UniProtKB, PubMed]; These findings indicate that the HO-1/EBP interaction plays a protective role in alleviating the dysfunction of oxidative stress and cardiac systolic function induced by cholesterol stimulation., [RefSeq, PubMed]; This gene encodes a transmembrane protein that localizes to the endoplasmic reticulum. This protein catalyses the conversion of delta8 to delta7 sterols, an important step in sterol biosynthesis. Mutations in this gene are responsible for the mouse tattered mutant phenotype. Tattered males are embryonic lethal, while heterozygous females have developmental defects. Deficiency of the related gene in human causes X-linked dominant chondrodysplasia punctata. [provided by RefSeq, May 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 4,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9CSP4",
        "ec_number_list": "1.3.1.21;3.3.2.11;1.3.1.70;5.3.3.5",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0004769 steroid Delta-isomerase activity;GO:0047750 cholestenol delta-isomerase activity;GO:0000247 C-8 sterol isomerase activity;GO:0016863 intramolecular oxidoreductase activity, transposing C=C bonds",
        "go_cellular_component": "GO:0005635 nuclear envelope;GO:0005783 endoplasmic reticulum;GO:0031965 nuclear membrane;GO:0005789 endoplasmic reticulum membrane;GO:0031410 cytoplasmic vesicle",
        "go_biological_process": "GO:0043931 ossification involved in bone maturation;GO:0016126 sterol biosynthetic process;GO:0006695 cholesterol biosynthetic process;GO:0030097 hemopoiesis;GO:0033489 cholesterol biosynthetic process via desmosterol",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "P70245-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80X60-1",
        "uniprot_id": "EFCB3_MOUSE",
        "mass": 49710.0,
        "length": 432,
        "protein_name": "EF-hand calcium-binding domain-containing protein 3",
        "gene_name": "Efcab3",
        "organism": "Mouse",
        "refseq_name": "EF-hand calcium-binding domain-containing protein 3 isoform 2",
        "refseq_ac": "NP_001074515",
        "gene_names_uniprotkb": "Efcab3",
        "gene_names_refseq": "4921510J17Rik; Efcab13; Efcab15; Efcab3; Gm11639; Gm19",
        "protein_names_uniprotkb": "EF-hand calcium-binding domain-containing protein 3",
        "protein_names_refseq": "EF-hand calcium binding domain 13; EF-hand calcium-binding domain-containing protein 3 isoform 2; EF-hand calcium-binding domain-containing protein 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:70894)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005509 calcium ion binding",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q80X60-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DAM2-1",
        "uniprot_id": "EFCB9_MOUSE",
        "mass": 26125.0,
        "length": 216,
        "protein_name": "EF-hand calcium-binding domain-containing protein 9",
        "gene_name": "Efcab9",
        "organism": "Mouse",
        "refseq_name": "EF-hand calcium-binding domain-containing protein 9",
        "refseq_ac": "NP_081307",
        "gene_names_uniprotkb": "Efcab9",
        "gene_names_refseq": "1700007I06Rik; 4930403C08Rik; Efcab9",
        "protein_names_uniprotkb": "EF-hand calcium-binding domain-containing protein 9",
        "protein_names_refseq": "EF-hand calcium-binding domain-containing protein 9",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69306)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "15489334;21750661;31056283;34225353;35820727",
        "class_list": "",
        "function": "Auxiliary component of the CatSper complex, a complex involved in sperm cell hyperactivation (PubMed:31056283, PubMed:34225353). pH-dependent Ca(2+) sensor required to activate the CatSper channel (PubMed:31056283). Sperm cell hyperactivation is needed for sperm motility which is essential late in the preparation of sperm for fertilization (PubMed:31056283). Associates with the CatSper complex via direct interaction with CATSPERZ, and senses intracellular Ca(2+) (PubMed:31056283). Together with CATSPERZ, associates with the CatSper channel pore and is required for the two-row structure of each single CatSper channel (PubMed:31056283)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D5P6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005516 calmodulin binding;GO:0005509 calcium ion binding;GO:0061891 calcium ion sensor activity",
        "go_cellular_component": "GO:0036128 CatSper complex;GO:0005737 cytoplasm;GO:0097228 sperm principal piece",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0030317 flagellated sperm motility;GO:0048240 sperm capacitation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q9DAM2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "D3YWP0-1",
        "uniprot_id": "EFMT3_MOUSE",
        "mass": 25675.0,
        "length": 232,
        "protein_name": "EEF1A lysine methyltransferase 3",
        "gene_name": "Eef1akmt3",
        "organism": "Mouse",
        "refseq_name": "EEF1A lysine methyltransferase 3",
        "refseq_ac": "NP_001191965",
        "gene_names_uniprotkb": "Eef1akmt3; Fam119b; Mettl21b; mCG_5197",
        "gene_names_refseq": "EG546486; Eef1akmt3; Fam119b; Gm16109; Mettl21b",
        "protein_names_uniprotkb": "EEF1A lysine methyltransferase 3; 2.1.1.-; Methyltransferase-like protein 21B; Protein-lysine methyltransferase METTL21B",
        "protein_names_refseq": "EEF1A lysine methyltransferase 3; Methyltransferase-like protein 21B; Protein-lysine methyltransferase METTL21B; family with sequence similarity 119, member B; methyltransferase like 21B",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100504608)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "28108655",
        "class_list": "",
        "function": "Protein-lysine methyltransferase that selectively mono-, di- and trimethylates 'Lys-165' of the translation elongation factors EEF1A1 and EEF1A2 in an aminoacyl-tRNA and GTP-dependent manner (By similarity). EEF1A1 methylation by EEF1AKMT3 is dynamic as well as inducible by stress conditions, such as ER-stress, and plays a regulatory role on mRNA translation (PubMed:28108655)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.1.1.-;2.1.1.359;2.1.1.364;2.1.1.361;2.1.1.372;2.1.1.354;2.1.1.355;2.1.1.362",
        "go_molecular_function": "GO:0031072 heat shock protein binding;GO:0008168 methyltransferase activity;GO:0016279 protein-lysine N-methyltransferase activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005813 centrosome;GO:0005829 cytosol;GO:0005694 chromosome",
        "go_biological_process": "GO:0018022 peptidyl-lysine methylation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "D3YWP0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80TA1-1",
        "uniprot_id": "EPT1_MOUSE",
        "mass": 45346.0,
        "length": 398,
        "protein_name": "Ethanolaminephosphotransferase 1",
        "gene_name": "Selenoi",
        "organism": "Mouse",
        "refseq_name": "ethanolaminephosphotransferase 1",
        "refseq_ac": "NP_081928",
        "gene_names_uniprotkb": "Selenoi; D5Wsu178e; Ept1; Kiaa1724",
        "gene_names_refseq": "4933402G07Rik; D5Wsu178e; Ept1; SELI; Selenoi; mKIAA1724",
        "protein_names_uniprotkb": "Ethanolaminephosphotransferase 1; 2.7.8.1; SelI; Selenoprotein I",
        "protein_names_refseq": "ethanolaminephosphotransferase 1 (CDP-ethanolamine-specific); ethanolaminephosphotransferase 1",
        "tax_id": 10090,
        "disease": "hereditary spastic paraplegia 81 (Disease Ontology:DOID:0112349)",
        "pathway": " (mmu:28042);  (R-MMU-1483213)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "21750661;32502470;33300544;35916034;36007576;38582453;38837270",
        "class_list": "",
        "function": "Ethanolaminephosphotransferase that catalyzes the transfer of phosphoethanolamine (PE) from CDP-ethanolamine to lipid acceptors, the final step in the synthesis of PE via the 'Kennedy' pathway (By similarity). PE is the second most abundant phospholipid of membranes in mammals and is involved in various membrane-related cellular processes (By similarity). The enzyme is critical for the synthesis of several PE species and also catalyzes the synthesis of plasmanyl-PE, a lipid required for proper myelination and neurodevelopment, from 1-alkyl-2-acylglycerol (PubMed:38582453)., [UniProtKB, UniProtKB, PubMed]; Hepatocyte-specific Selenoi deficiency predisposes mice to hepatic steatosis and obesity., [RefSeq, PubMed]; Selenoprotein I (selenoi) as a critical enzyme in the central nervous system., [RefSeq, PubMed]; Selenoprotein I deficiency in T cells promotes differentiation into tolerant phenotypes while decreasing Th17 pathology., [RefSeq, PubMed]; Selenoprotein I is essential for murine embryogenesis., [RefSeq, PubMed]; Selenoprotein I is indispensable for ether lipid homeostasis and proper myelination., [RefSeq, PubMed]; The multi-pass transmembrane protein encoded by this gene belongs to the CDP-alcohol phosphatidyltransferase class-I family. It catalyzes the transfer of phosphoethanolamine from CDP-ethanolamine to diacylglycerol to produce phosphatidylethanolamine, which is involved in the formation and maintenance of vesicular membranes, regulation of lipid metabolism, and protein folding. This protein is a selenoprotein, containing the rare selenocysteine (Sec) amino acid at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2016]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3KQQ5;Q8BG08",
        "ec_number_list": "2.7.8.1;2.7.8.2;2.7.8.22",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0004307 ethanolaminephosphotransferase activity",
        "go_cellular_component": "GO:0005794 Golgi apparatus;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0008611 ether lipid biosynthetic process;GO:0042552 myelination;GO:0006646 phosphatidylethanolamine biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q80TA1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DC16-1",
        "uniprot_id": "ERGI1_MOUSE",
        "mass": 32562.0,
        "length": 290,
        "protein_name": "Endoplasmic reticulum-Golgi intermediate compartment protein 1",
        "gene_name": "Ergic1",
        "organism": "Mouse",
        "refseq_name": "endoplasmic reticulum-Golgi intermediate compartment protein 1",
        "refseq_ac": "NP_080446",
        "gene_names_uniprotkb": "Ergic1; Ergic32",
        "gene_names_refseq": "1200007D18Rik; Ergic1; maa-136",
        "protein_names_uniprotkb": "Endoplasmic reticulum-Golgi intermediate compartment protein 1; ER-Golgi intermediate compartment 32 kDa protein; ERGIC-32",
        "protein_names_refseq": "ER-Golgi intermediate compartment 32 kDa protein; ERGIC-32; endoplasmic reticulum-Golgi intermediate compartment protein 1; endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1",
        "tax_id": 10090,
        "disease": "neurogenic-type arthrogryposis multiplex congenita-2 (Disease Ontology:DOID:0090124)",
        "pathway": " (mmu:67458)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;21952136;34203471;34428180",
        "class_list": "",
        "function": "Plays a role in transport between endoplasmic reticulum and Golgi., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Possible role in transport between endoplasmic reticulum and Golgi., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005654 nucleoplasm;GO:0005783 endoplasmic reticulum;GO:0030134 COPII-coated ER to Golgi transport vesicle;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport;GO:0006890 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9DC16-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BLN5-1",
        "uniprot_id": "LSS_MOUSE",
        "mass": 83141.0,
        "length": 733,
        "protein_name": "Lanosterol synthase",
        "gene_name": "Lss",
        "organism": "Mouse",
        "refseq_name": "lanosterol synthase isoform 1",
        "refseq_ac": "NP_666118",
        "gene_names_uniprotkb": "Lss",
        "gene_names_refseq": "2810025N20Rik; D10Ertd116e; Lss; Osc",
        "protein_names_uniprotkb": "Lanosterol synthase; 2,3-epoxysqualene--lanosterol cyclase; 5.4.99.7; OSC; Oxidosqualene--lanosterol cyclase",
        "protein_names_refseq": "2,3-epoxysqualene--lanosterol cyclase; lanosterol synthase isoform 1; oxidosqualene--lanosterol cyclase",
        "tax_id": 10090,
        "disease": "hypotrichosis 14 (Disease Ontology:DOID:0080582); alopecia-mental retardation syndrome 4 (Disease Ontology:DOID:0080950); cataract 44 (Disease Ontology:DOID:0110267); cataract (Disease Ontology:DOID:83)",
        "pathway": " (mmu:16987);  (R-MMU-9969896)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "19119143;21750661;22645316;24788674;25428506;28135057;31219806;32101538;34428180",
        "class_list": "",
        "function": "Key enzyme in the cholesterol biosynthesis pathway. Catalyzes the cyclization of (S)-2,3 oxidosqualene to lanosterol, a reaction that forms the sterol nucleus. Through the production of lanosterol may regulate lens protein aggregation and increase transparency., [UniProtKB, UniProtKB]; Study identified two patients with novel biallelic LSS mutations who exhibited congenital hypotrichosis and midline anomalies but did not have cataracts. Epidermis-specific Lss knockout mice showed neonatal lethality due to dehydration, indicating that LSS could be involved in skin barrier integrity. Knockout of Lss in the epidermis caused hypotrichosis in adult mice. Lens-specific Lss knockout mice had cataracts. Publication Status: Online-Only, [RefSeq, PubMed]; Suppression of 2,3-oxidosqualene cyclase by high fat diet contributes to liver X receptor-alpha-mediated improvement of hepatic lipid profile., [RefSeq, PubMed]; This gene encodes an enzyme that catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. The encoded protein is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. [provided by RefSeq, Feb 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BVJ4;Q8K307",
        "ec_number_list": "5.4.99.7",
        "go_molecular_function": "GO:0000250 lanosterol synthase activity",
        "go_cellular_component": "GO:0098554 cytoplasmic side of endoplasmic reticulum membrane;GO:0005811 lipid droplet;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006695 cholesterol biosynthetic process;GO:0031647 regulation of protein stability;GO:0016125 sterol metabolic process;GO:0006694 steroid biosynthetic process;GO:0033489 cholesterol biosynthetic process via desmosterol",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "Q8BLN5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q62413-1",
        "uniprot_id": "EPHA6_MOUSE",
        "mass": 116185.0,
        "length": 1035,
        "protein_name": "Ephrin type-A receptor 6",
        "gene_name": "Epha6",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Epha6; Ehk-2; Ehk2",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Ephrin type-A receptor 6; 2.7.10.1; EHK-2; EPH homology kinase 2",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13840);  (R-MMU-2682334);  (R-MMU-3928663);  (R-MMU-3928665)",
        "pathway_count": 4,
        "publication_count": 3,
        "publication_id_list": "20485683;21750661;8892754",
        "class_list": "",
        "function": "Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling (By similarity)., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B9EIV2;Q8CCN2",
        "ec_number_list": "2.7.12.2;2.7.10.1;2.7.12.1;2.7.1.32;2.7.1.82;2.7.10.2;2.7.11.1;2.7.11.13;2.7.10.4;2.7.1.40;3.6.5.2;2.7.11.23",
        "go_molecular_function": "GO:0005524 ATP binding;GO:0005005 transmembrane-ephrin receptor activity;GO:0005004 GPI-linked ephrin receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030425 dendrite;GO:0016020 membrane",
        "go_biological_process": "GO:0050793 regulation of developmental process;GO:0048013 ephrin receptor signaling pathway;GO:0007417 central nervous system development;GO:0007411 axon guidance;GO:0048513 animal organ development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q62413-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DB76-1",
        "uniprot_id": "EMC9_MOUSE",
        "mass": 22787.0,
        "length": 206,
        "protein_name": "ER membrane protein complex subunit 9",
        "gene_name": "Emc9",
        "organism": "Mouse",
        "refseq_name": "ER membrane protein complex subunit 9 isoform 1",
        "refseq_ac": "NP_149158",
        "gene_names_uniprotkb": "Emc9; Cgi112; Fam158a",
        "gene_names_refseq": "1500005A01Rik; Cgi112; Emc9; Fam158a",
        "protein_names_uniprotkb": "ER membrane protein complex subunit 9; Protein FAM158A",
        "protein_names_refseq": "ER membrane protein complex subunit 9 isoform 1; UPF0172 protein FAM158A; family with sequence similarity 158, member A",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:85308)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;31219806",
        "class_list": "",
        "function": "Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0032977 membrane insertase activity",
        "go_cellular_component": "GO:0072546 EMC complex;GO:0005737 cytoplasm;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0071816 tail-anchored membrane protein insertion into ER membrane;GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9DB76-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UNU4-1",
        "uniprot_id": "ERIC4_MOUSE",
        "mass": 15244.0,
        "length": 136,
        "protein_name": "Glutamate-rich protein 4",
        "gene_name": "Erich4",
        "organism": "Mouse",
        "refseq_name": "glutamate-rich protein 4",
        "refseq_ac": "NP_001034332",
        "gene_names_uniprotkb": "Erich4; Gm7092",
        "gene_names_refseq": "EG632778; Erich4; Gm7092; Kseg1",
        "protein_names_uniprotkb": "Glutamate-rich protein 4",
        "protein_names_refseq": "glutamate-rich protein 4; kidney specific expressed protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:632778)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "21750661",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q3UNU4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O08542-1",
        "uniprot_id": "EFNA4_MOUSE",
        "mass": 22861.0,
        "length": 206,
        "protein_name": "Ephrin-A4",
        "gene_name": "Efna4",
        "organism": "Mouse",
        "refseq_name": "ephrin-A4 precursor",
        "refseq_ac": "NP_031936",
        "gene_names_uniprotkb": "Efna4; Epl4; Eplg4; Lerk4",
        "gene_names_refseq": "EFL-4; Efna4; Epl4; LERK-4",
        "protein_names_uniprotkb": "Ephrin-A4; EPH-related receptor tyrosine kinase ligand 4; LERK-4",
        "protein_names_refseq": "EPH-related receptor tyrosine kinase ligand 4; ephrin-A4 precursor",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13639);  (R-MMU-2682334);  (R-MMU-3928663);  (R-MMU-3928665)",
        "pathway_count": 4,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;27446912;30899004;8903354;9465306",
        "class_list": "",
        "function": "Cell surface GPI-bound ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. May play a role in the interaction between activated B-lymphocytes and dendritic cells in tonsils (By similarity)., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O55218",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046875 ephrin receptor binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0098552 side of membrane",
        "go_biological_process": "GO:0048013 ephrin receptor signaling pathway;GO:0007411 axon guidance",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "O08542-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35709-1",
        "uniprot_id": "ENC1_MOUSE",
        "mass": 66113.0,
        "length": 589,
        "protein_name": "Ectoderm-neural cortex protein 1",
        "gene_name": "Enc1",
        "organism": "Mouse",
        "refseq_name": "ectoderm-neural cortex protein 1",
        "refseq_ac": "NP_031956",
        "gene_names_uniprotkb": "Enc1; Enc-1",
        "gene_names_refseq": "Enc1; Nrpb; PIG10",
        "protein_names_uniprotkb": "Ectoderm-neural cortex protein 1; ENC-1",
        "protein_names_refseq": "ENC-1; ectoderm-neural cortex protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13803)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "25428506;9096139",
        "class_list": "",
        "function": "Actin-binding protein involved in the regulation of neuronal process formation and in differentiation of neural crest cells. Down-regulates transcription factor NF2L2/NRF2 by decreasing the rate of protein synthesis and not via a ubiquitin-mediated proteasomal degradation mechanism (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8C7V2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003779 actin binding;GO:1990756 ubiquitin-like ligase-substrate adaptor activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005856 cytoskeleton;GO:0043025 neuronal cell body;GO:0016363 nuclear matrix",
        "go_biological_process": "GO:0010976 positive regulation of neuron projection development;GO:0016567 protein ubiquitination;GO:0017148 negative regulation of translation;GO:0006511 ubiquitin-dependent protein catabolic process;GO:0010499 proteasomal ubiquitin-independent protein catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "O35709-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35902-1",
        "uniprot_id": "DSG3_MOUSE",
        "mass": 107889.0,
        "length": 993,
        "protein_name": "Desmoglein-3",
        "gene_name": "Dsg3",
        "organism": "Mouse",
        "refseq_name": "desmoglein-3 preproprotein",
        "refseq_ac": "NP_085099",
        "gene_names_uniprotkb": "Dsg3",
        "gene_names_refseq": "Dsg3; bal",
        "protein_names_uniprotkb": "Desmoglein-3; 130 kDa pemphigus vulgaris antigen homolog",
        "protein_names_refseq": "130 kDa pemphigus vulgaris antigen homolog; desmoglein-3 preproprotein",
        "tax_id": 10090,
        "disease": "pemphigus vulgaris (Disease Ontology:DOID:0060851)",
        "pathway": " (mmu:13512);  (R-MMU-351906);  (R-MMU-6805567);  (R-MMU-6809371)",
        "pathway_count": 4,
        "publication_count": 14,
        "publication_id_list": "12787123;18343367;21750661;26763450;30084848;30660666;30949721;34203471;34428180;34996836;36539957;7894164;9166409;9701552",
        "class_list": "",
        "function": "A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:9166409). Required for adherens and desmosome junction assembly in response to mechanical force in keratinocytes (By similarity). Required for desmosome-mediated cell-cell adhesion of cells surrounding the telogen hair club and the basal layer of the outer root sheath epithelium, consequently is essential for the anchoring of telogen hairs in the hair follicle (PubMed:9166409, PubMed:9701552). Required for the maintenance of the epithelial barrier via promoting desmosome-mediated intercellular attachment of suprabasal epithelium to basal cells (PubMed:9166409). May play a role in the protein stability of the desmosome plaque components DSP, JUP, PKP1, PKP2 and PKP3 (By similarity). Required for YAP1 localization at the plasma membrane in keratinocytes in response to mechanical strain, via the formation of an interaction complex composed of DSG3, PKP1 and YWHAG (By similarity). May also be involved in the positive regulation of YAP1 target gene transcription and as a result cell proliferation (By similarity). Positively regulates cellular contractility and cell junction formation via organization of cortical F-actin bundles and anchoring of actin to tight junctions, in conjunction with RAC1 (By similarity). The cytoplasmic pool of DSG3 is required for the localization of CDH1 and CTNNB1 at developing adherens junctions, potentially via modulation of SRC activity (By similarity). Inhibits keratinocyte migration via suppression of p38MAPK signaling, may therefore play a role in moderating wound healing (PubMed:26763450)., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, UniProtKB]; IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse., [RefSeq, PubMed]; T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen. Review article, [RefSeq, PubMed]; This gene encodes a member of the cadherin family of proteins that forms an integral transmembrane component of desmosomes, the multiprotein complexes involved in cell adhesion, organization of the cytoskeleton, cell sorting and cell signaling. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional protein. Mice lacking the encoded protein exhibit loss of keratinocyte cell adhesion resulting in a phenotype that resembles that of patients with pemphigus vulgaris. This gene is located in a cluster of desmosomal cadherin genes on chromosome 18. [provided by RefSeq, Feb 2016]., [RefSeq]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8CB02;Q8CE48",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046983 protein dimerization activity;GO:0005509 calcium ion binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0005911 cell-cell junction;GO:0005912 adherens junction;GO:0005923 bicellular tight junction",
        "go_biological_process": "GO:0120192 tight junction assembly;GO:0007015 actin filament organization;GO:0007155 cell adhesion;GO:0030336 negative regulation of cell migration;GO:0098609 cell-cell adhesion",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "O35902-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P0DMC4-1",
        "uniprot_id": "ELA_MOUSE",
        "mass": 6828.0,
        "length": 54,
        "protein_name": "Apelin receptor early endogenous ligand",
        "gene_name": "Apela",
        "organism": "Mouse",
        "refseq_name": "apelin receptor early endogenous ligand precursor",
        "refseq_ac": "NP_001284483",
        "gene_names_uniprotkb": "Apela; Ela; Ende; Gm10664; Tdl",
        "gene_names_refseq": "Apela; Elabela; Ela; Ende; Gm10664",
        "protein_names_uniprotkb": "Apelin receptor early endogenous ligand; ELA; Protein Elabela; Protein Toddler",
        "protein_names_refseq": "Protein Elabela; apelin receptor early endogenous ligand precursor; protein Toddler",
        "tax_id": 10090,
        "disease": "pre-eclampsia (Disease Ontology:DOID:10591)",
        "pathway": " (mmu:100038489)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "20153842;26611206;28371822;28663440;28854362;28890073;36813109;37540330",
        "class_list": "",
        "function": "ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway., [RefSeq, PubMed]; Elabela-APJ axis mediates angiogenesis via YAP/TAZ pathway in cerebral ischemia/reperfusion injury., [RefSeq, PubMed]; Ende was expressed dynamically and in specific populations of the definitive endoderm from E7.0 to E8.5., [RefSeq, PubMed]; Peptide hormone that functions as endogenous ligand for the G protein-coupled apelin receptor (APLNR/APJ), that plays a role in the regulation of normal cardiovascular function and fluid homeostasis. Functions as a balanced agonist activating both G(i) protein pathway and beta-arrestin pathway of APLNR. Downstream G proteins activation, apelin can inhibit cAMP production and activate key intracellular effectors such as ERKs. On the other hand, APLNR activation induces beta-arrestin recruitment to the membrane leading to desensitization and internalization of the receptor (By similarity). Required for mesendodermal differentiation, blood vessels formation and heart morphogenesis during early development and for adult cardiovascular homeostasis (PubMed:28371822, PubMed:28663440, PubMed:28854362, PubMed:28890073). Acts as a motogen by promoting mesendodermal cell migration during gastrulation by binding and activating APLNR (By similarity). Acts as an early embryonic regulator of cellular movement with a role in migration and development of cardiac progenitor cells (PubMed:28854362). May act as a chemoattractant for the activation of angioblast migration toward the embryonic midline, i.e. the position of the future vessel formation, during vasculogenesis (By similarity). Positively regulates sinus venosus (SV)-derived endothelial cells migration into the developing heart to promote coronary blood vessel sprouting (PubMed:28890073). Plays a role in placental vascular development; promotes placental trophoblast invasion and spiral artery remodeling in the uterus (PubMed:28663440). Involved in the regulation of maternal cardiovascular homeostasis to prevent gestational hypertension and for potent cardioprotective functions during heart failure (PubMed:28371822, PubMed:28663440). Mediates myocardial contractility in an ERK1/2-dependent manner (By similarity)., [UniProtKB, UniProtKB, UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005179 hormone activity;GO:0031704 apelin receptor binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005615 extracellular space",
        "go_biological_process": "GO:0001525 angiogenesis;GO:0001570 vasculogenesis;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007193 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;GO:0007507 heart development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P0DMC4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P10404-1",
        "uniprot_id": "ENV1_MOUSE",
        "mass": 69613.0,
        "length": 641,
        "protein_name": "MLV-related proviral Env polyprotein",
        "gene_name": "",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "MLV-related proviral Env polyprotein",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 8,
        "publication_id_list": "10.1101/2023.09.13.557529;12970417;2415714;25605945;28011936;29187734;34428180;37828378",
        "class_list": "",
        "function": "The surface protein (SU) attaches the virus to the host cell by binding to its receptor. This interaction triggers the refolding of the transmembrane protein (TM) and is thought to activate its fusogenic potential by unmasking its fusion peptide. Fusion occurs at the host cell plasma membrane (By similarity)., [UniProtKB]; The transmembrane protein (TM) acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Membranes fusion leads to delivery of the nucleocapsid into the cytoplasm (By similarity)., [UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 4,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 5,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 5,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 5,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 6,
        "disease_count": 0,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q78N71;Q78N73;Q78N94;Q80SW7;Q80SW8;Q80SY0;Q80SY1;Q811M9;Q811N4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "P10404-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P23116-1",
        "uniprot_id": "EIF3A_MOUSE",
        "mass": 161936.0,
        "length": 1344,
        "protein_name": "Eukaryotic translation initiation factor 3 subunit A",
        "gene_name": "Eif3a",
        "organism": "Mouse",
        "refseq_name": "eukaryotic translation initiation factor 3 subunit A",
        "refseq_ac": "NP_034253",
        "gene_names_uniprotkb": "Eif3a; Csma; Eif3s10; Eif3",
        "gene_names_refseq": "A830012B05Rik; Csma; Eif3a; Eif3s10; Eif3; mKIAA0139",
        "protein_names_uniprotkb": "Eukaryotic translation initiation factor 3 subunit A; Centrosomin; Eukaryotic translation initiation factor 3 subunit 10; eIF-3-theta; eIF3 p167; eIF3 p180; eIF3 p185; eIF3a; p162",
        "protein_names_refseq": "EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 10 (EIF-3 THETA) (EIF3 P167) (EIF3 P180) (EIF3 P185) (P162 PROTEIN) (CENTROSOMIN); centrosomin; eIF-3-theta; eIF3 p167; eIF3 p180; eIF3 p185; eukaryotic translation initiation factor 3 subunit A; eukaryotic translation initiation factor 3, subunit 10 (theta); p162",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13669);  (R-MMU-156827);  (R-MMU-72649);  (R-MMU-72689);  (R-MMU-72695);  (R-MMU-72702);  (R-MMU-72706)",
        "pathway_count": 7,
        "publication_count": 32,
        "publication_id_list": "10.1101/2023.09.13.557529;11904180;16541103;17581632;18250455;1829085;18299400;19114715;19224205;20173027;21183079;21750661;21952136;22645316;25428506;25428507;25605945;26495903;26740625;31219806;33300544;34428180;34678516;34887587;35820727;36288343;37453647;37507081;37515335;37828378;39627609;9372446",
        "class_list": "",
        "function": "RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression., [UniProtKB, HAMAP, PubMed]; Stable expression of a truncated eIF3e in NIH 3T3 cells causes malignant transformation, [RefSeq, PubMed]; [IL-33 up-regulates eIF3a expression by activating NF-kappaB signaling pathway to mediate the proliferation and differentiation of mouse pulmonary myofibroblasts and aggravate pulmonary fibrosis]., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 3,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 3,
        "total_reported_o_glycosites": 3,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 3,
        "total_o_glycosites": 3,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 10,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 0,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QQ50;Q60697;Q62162",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0003729 mRNA binding;GO:0030971 receptor tyrosine kinase binding;GO:0003743 translation initiation factor activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005813 centrosome;GO:0005829 cytosol;GO:0005874 microtubule",
        "go_biological_process": "GO:0002188 translation reinitiation;GO:0075522 IRES-dependent viral translational initiation;GO:0070373 negative regulation of ERK1 and ERK2 cascade;GO:0001732 formation of cytoplasmic translation initiation complex;GO:0075525 viral translational termination-reinitiation",
        "synthesized_glycan_count": 0,
        "hit_score": 4.2,
        "record_id": "P23116-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P49135-1",
        "uniprot_id": "ERCC3_MOUSE",
        "mass": 89126.0,
        "length": 783,
        "protein_name": "General transcription and DNA repair factor IIH helicase/translocase subunit XPB",
        "gene_name": "Ercc3",
        "organism": "Mouse",
        "refseq_name": "general transcription and DNA repair factor IIH helicase/translocase subunit XPB",
        "refseq_ac": "NP_598419",
        "gene_names_uniprotkb": "Ercc3; Xpbc; Xpb",
        "gene_names_refseq": "BTF2 p89; Ercc-3; Ercc3; XPB",
        "protein_names_uniprotkb": "General transcription and DNA repair factor IIH helicase/translocase subunit XPB; 5.6.2.4; BTF2 p89; Basic transcription factor 2 89 kDa subunit; DNA 3'-5' helicase/translocase XPB; DNA excision repair protein ERCC-3; DNA repair protein complementing XP-B cells; TFIIH 89 kDa subunit; TFIIH subunit XPB; Xeroderma pigmentosum group B-complementing protein",
        "protein_names_refseq": "DNA 3'-5' helicase/translocase XPB; DNA excision repair protein ERCC-3; DNA repair protein complementing XP-B cells; TFIIH 89 kDa subunit; TFIIH basal transcription factor complex helicase XPB subunit; basic transcription factor 2 89 kDa subunit; general transcription and DNA repair factor IIH helicase subunit XPB; general transcription and DNA repair factor IIH helicase/translocase subunit XPB; xeroderma pigmentosum group B-complementing protein",
        "tax_id": 10090,
        "disease": "xeroderma pigmentosum (Disease Ontology:DOID:0050427); xeroderma pigmentosum group B (Disease Ontology:DOID:0110850); trichothiodystrophy (Disease Ontology:DOID:0111866); photosensitive trichothiodystrophy 2 (Disease Ontology:DOID:0111869); Alzheimer's disease (Disease Ontology:DOID:10652); asphyxia neonatorum (Disease Ontology:DOID:11088); Down syndrome (Disease Ontology:DOID:14250); Cockayne syndrome (Disease Ontology:DOID:2962); lung non-small cell carcinoma (Disease Ontology:DOID:3908); colorectal cancer (Disease Ontology:DOID:9256)",
        "pathway": " (mmu:13872);  (R-MMU-112382);  (R-MMU-113418);  (R-MMU-5696395);  (R-MMU-5696400);  (R-MMU-674695);  (R-MMU-6781823);  (R-MMU-6782135);  (R-MMU-6782210);  (R-MMU-6796648);  (R-MMU-72086);  (R-MMU-73762);  (R-MMU-73772);  (R-MMU-73776);  (R-MMU-73779);  (R-MMU-73863);  (R-MMU-75953);  (R-MMU-75955);  (R-MMU-76042);  (R-MMU-77075)",
        "pathway_count": 20,
        "publication_count": 3,
        "publication_id_list": "1747940;31219806;34428180",
        "class_list": "",
        "function": "ATP-dependent 3'-5' DNA helicase/translocase; binds dsDNA rather than ssDNA, unzipping it in a translocase rather than classical helicase activity. Component of the general transcription and DNA repair factor IIH (TFIIH) core complex. When complexed to CDK-activating kinase (CAK), involved in RNA transcription by RNA polymerase II. The ATPase activity of XPB/ERCC3, but not its helicase activity, is required for DNA opening; it may wrap around the damaged DNA wedging it open, causing localized melting and twisting that allows XPD/ERCC2 helicase to anchor. The ATP-dependent helicase activity of XPB/ERCC3 may be required for promoter escape. Also involved in transcription-coupled nucleotide excision repair (NER) of damaged DNA. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. The structure of the TFIIH transcription complex differs from the NER-TFIIH complex; large movements by XPD/ERCC2 and XPB/ERCC3 are stabilized by XPA., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 10,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.6.4.13;3.6.4.10;3.6.4.-;5.6.2.3;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;2.7.7.6;7.6.2.1;3.4.-.-;3.6.1.5;2.4.2.-;2.4.2.30;3.4.24.-;3.6.-.-;3.1.13.-;2.7.7.48;3.1.3.1;3.9.1.1;3.6.1.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;6.5.1.1;3.6.4.6;2.7.7.7;3.1.11.-;1.14.11.-;2.3.2.23;3.6.5.-;2.3.2.32;2.3.1.48;3.6.1.15;3.1.4.-;2.7.11.22;2.7.11.23;2.7.11.24;5.6.2.-;7.2.2.-;7.6.2.16;3.4.19.12;3.1.3.16;2.7.11.1;3.4.21.53;2.7.7.49;2.7.4.3;2.1.1.56;5.2.1.8",
        "go_molecular_function": "GO:0043138 3'-5' DNA helicase activity;GO:0003677 DNA binding;GO:0005524 ATP binding;GO:0016887 ATP hydrolysis activity;GO:1990841 promoter-specific chromatin binding",
        "go_cellular_component": "GO:0097550 transcription preinitiation complex;GO:0005654 nucleoplasm;GO:0005675 transcription factor TFIIH holo complex;GO:0005669 transcription factor TFIID complex;GO:0000112 nucleotide-excision repair factor 3 complex",
        "go_biological_process": "GO:0006281 DNA repair;GO:0006979 response to oxidative stress;GO:0043065 positive regulation of apoptotic process;GO:0006915 apoptotic process;GO:0009411 response to UV",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "P49135-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P52801-1",
        "uniprot_id": "EFNA2_MOUSE",
        "mass": 23586.0,
        "length": 209,
        "protein_name": "Ephrin-A2",
        "gene_name": "Efna2",
        "organism": "Mouse",
        "refseq_name": "ephrin-A2 precursor",
        "refseq_ac": "NP_031935",
        "gene_names_uniprotkb": "Efna2; Elf1; Epl6; Eplg6; Lerk6",
        "gene_names_refseq": "CEK7L; Efna2; Elf1; Epl6; Eplg6; Lerk6",
        "protein_names_uniprotkb": "Ephrin-A2; CEK7-L; CEK7-ligand; ELF-1; EPH-related receptor tyrosine kinase ligand 6; LERK-6",
        "protein_names_refseq": "CEK7-ligand; EPH related receptor tyrosine kinase ligand 6; ephrin A6; ephrin-A2 precursor",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13637);  (R-MMU-2682334);  (R-MMU-3928663);  (R-MMU-3928665)",
        "pathway_count": 4,
        "publication_count": 6,
        "publication_id_list": "10.1101/2023.09.13.557529;19299512;27446912;7522971;7876076;9053851",
        "class_list": "",
        "function": "Cell surface GPI-bound ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. With the EPHA2 receptor may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046875 ephrin receptor binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0031594 neuromuscular junction;GO:0043204 perikaryon;GO:0098552 side of membrane",
        "go_biological_process": "GO:0030316 osteoclast differentiation;GO:0048013 ephrin receptor signaling pathway;GO:0046849 bone remodeling;GO:0007411 axon guidance;GO:0021772 olfactory bulb development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P52801-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P52963-1",
        "uniprot_id": "E41LA_MOUSE",
        "mass": 78533.0,
        "length": 686,
        "protein_name": "Band 4.1-like protein 4A",
        "gene_name": "Epb41l4a",
        "organism": "Mouse",
        "refseq_name": "band 4.1-like protein 4A",
        "refseq_ac": "NP_038540",
        "gene_names_uniprotkb": "Epb41l4a; Epb4.1l4a; Epb4.1l4; Epb41l4",
        "gene_names_refseq": "Epb4.1l4a; Epb4.1l4; Epb41l4a; NBL4",
        "protein_names_uniprotkb": "Band 4.1-like protein 4A; Erythrocyte membrane protein band 4.1-like 4A; Protein NBL4",
        "protein_names_refseq": "band 4.1-like protein 4A; erythrocyte protein band 4.1-like 4a; erythrocyte protein band 4.1-like 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13824)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "31599954;40885482;7983158",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q91VX6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008092 cytoskeletal protein binding",
        "go_cellular_component": "GO:0005856 cytoskeleton;GO:0016020 membrane",
        "go_biological_process": "GO:0031032 actomyosin structure organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P52963-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P97425-1",
        "uniprot_id": "ECP2_MOUSE",
        "mass": 17620.0,
        "length": 156,
        "protein_name": "Eosinophil cationic protein 2",
        "gene_name": "Ear2",
        "organism": "Mouse",
        "refseq_name": "eosinophil cationic protein 2 precursor",
        "refseq_ac": "NP_031921",
        "gene_names_uniprotkb": "Ear2; Rnase2",
        "gene_names_refseq": "EAR-13; EAR-2; ECP 2; ECP; Ear2; Raf3; Rnase2",
        "protein_names_uniprotkb": "Eosinophil cationic protein 2; 3.1.27.-; EAR-2; ECP 2; Eosinophil secondary granule ribonuclease 2; RNase 3-2; Ribonuclease 3-2",
        "protein_names_refseq": "RNase 3-2; eosinophil cationic protein 2 precursor; eosinophil cationic protein 2; eosinophil secondary granule ribonuclease 2; eosinophil-associated ribonuclease 13; eosinophil-associated ribonuclease 2; eosinophil-derived neurotoxin, liver; ribonuclease 3-2; ribonuclease A f3",
        "tax_id": 10090,
        "disease": "idiopathic pulmonary fibrosis (Disease Ontology:DOID:0050156)",
        "pathway": " (mmu:13587);  (R-MMU-6798695)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "11311552;12855582;12927308;23271121;24966384;27765572;8901588",
        "class_list": "",
        "function": "Cytotoxin and helminthotoxin with ribonuclease activity. Selectively chemotactic for dendritic cells. Possesses a wide variety of biological activities., [UniProtKB]; Decreased expression of total mEar2 mRNA and protein in lung tissue and a corresponding fivefold drop in ribonuclease activity in BALF in pneumovirus infection of mice, [RefSeq, PubMed]; Functional activity of four mouse eosinophil associated ribonucleases, mEAR2, mEAR5, mEAR7 and mEAR11., [RefSeq, PubMed]; Testing spatial memory and hippocampal long-term potentiation revealed an impairment in APP/PS1 Ear2(-/-) mice, whereas APP/PS1 or Ear2(-/-) mice showed only minor changes. Erratum:[J Neurosci. 2015 Feb 4;35(5):2321. Urban, Inga [Added]], [RefSeq, PubMed]; This suggests that ECP can activate a canonical Wnt/b-catenin signaling pathway by enhancing the stabilization of b-catenin during cardiomyocyte differentiation., [RefSeq, PubMed]; Was selectively chemotactic for dendritic cells; induced the activation of p42/44 MAPK in DCs, [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q505C0",
        "ec_number_list": "4.6.1.19;1.11.1.27;3.1.1.4;2.3.1.23;3.2.1.24;4.6.1.18;3.2.1.17;1.11.2.2;3.2.1.31;3.4.16.5;3.4.16.-;3.2.1.52;3.2.1.23;3.4.21.20;2.7.10.2;2.7.11.13;3.6.1.-;1.1.1.205;3.1.6.8;3.1.6.12;3.2.1.-;3.2.1.22;2.7.11.24;3.1.27.-;3.4.14.1;3.6.4.6;3.5.3.15;3.4.21.37;3.1.6.4;3.4.21.76;3.5.3.1;1.6.5.5;3.5.1.26;3.1.6.14;3.1.3.16;5.3.99.3;6.3.4.21;2.4.1.1;2.3.3.8;1.8.4.-;5.3.4.1;3.2.1.51;1.6.2.2;3.4.14.2;3.4.21.4;3.4.19.9",
        "go_molecular_function": "GO:0016787 hydrolase activity;GO:0003676 nucleic acid binding;GO:0004519 endonuclease activity;GO:0004540 RNA nuclease activity;GO:0001530 lipopolysaccharide binding",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0006935 chemotaxis;GO:0050830 defense response to Gram-positive bacterium;GO:0002227 innate immune response in mucosa",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "P97425-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P97426-1",
        "uniprot_id": "ECP1_MOUSE",
        "mass": 17296.0,
        "length": 155,
        "protein_name": "Eosinophil cationic protein 1",
        "gene_name": "Ear1",
        "organism": "Mouse",
        "refseq_name": "eosinophil cationic protein 1 precursor",
        "refseq_ac": "NP_031920",
        "gene_names_uniprotkb": "Ear1",
        "gene_names_refseq": "EAR-1; ECP 1; Ear1; Raf1",
        "protein_names_uniprotkb": "Eosinophil cationic protein 1; 3.1.27.-; EAR-1; ECP 1; Eosinophil secondary granule ribonuclease 1; RNase 3-1; Ribonuclease 3-1",
        "protein_names_refseq": "RNase 3-1; eosinophil cationic protein 1 precursor; eosinophil cationic protein 1; eosinophil secondary granule ribonuclease 1; eosinophil-associated ribonuclease 1; ribonuclease 3-1; ribonuclease A f1",
        "tax_id": 10090,
        "disease": "idiopathic pulmonary fibrosis (Disease Ontology:DOID:0050156)",
        "pathway": " (mmu:13586);  (R-MMU-6798695)",
        "pathway_count": 2,
        "publication_count": 4,
        "publication_id_list": "22677423;28011936;34428180;8901588",
        "class_list": "",
        "function": "Cytotoxin and helminthotoxin with ribonuclease activity. Possesses a wide variety of biological activities (By similarity)., [UniProtKB]; These findings demonstrate that novel epithelial expression of Ear1 functions to limit influenza A virus infection., [RefSeq, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 4,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "4.6.1.19;1.11.1.27;3.1.1.4;2.3.1.23;3.2.1.24;4.6.1.18;3.2.1.17;1.11.2.2;3.2.1.31;3.4.16.5;3.4.16.-;3.2.1.52;3.2.1.23;3.4.21.20;2.7.10.2;2.7.11.13;3.6.1.-;1.1.1.205;3.1.6.8;3.1.6.12;3.2.1.-;3.2.1.22;2.7.11.24;3.1.27.-;3.4.14.1;3.6.4.6;3.5.3.15;3.4.21.37;3.1.6.4;3.4.21.76;3.5.3.1;1.6.5.5;3.5.1.26;3.1.6.14;3.1.3.16;5.3.99.3;6.3.4.21;2.4.1.1;2.3.3.8;1.8.4.-;5.3.4.1;3.2.1.51;1.6.2.2;3.4.14.2;3.4.21.4;3.4.19.9",
        "go_molecular_function": "GO:0016787 hydrolase activity;GO:0003676 nucleic acid binding;GO:0004519 endonuclease activity;GO:0004540 RNA nuclease activity;GO:0001530 lipopolysaccharide binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006935 chemotaxis;GO:0050830 defense response to Gram-positive bacterium;GO:0002227 innate immune response in mucosa",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P97426-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q04742-1",
        "uniprot_id": "EMX1_MOUSE",
        "mass": 28173.0,
        "length": 257,
        "protein_name": "Homeobox protein EMX1",
        "gene_name": "Emx1",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Emx1; Emx-1",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Homeobox protein EMX1; Empty spiracles homolog 1; Empty spiracles-like protein 1",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13796)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "1352754;1353865;15147765;20887964;29263200",
        "class_list": "",
        "function": "Transcription factor, which in cooperation with EMX2, acts to generate the boundary between the roof and archipallium in the developing brain. May function in combinations with OTX1/2 to specify cell fates in the developing central nervous system., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3SXG0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:1990837 sequence-specific double-stranded DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005730 nucleolus;GO:0005694 chromosome",
        "go_biological_process": "GO:0001701 in utero embryonic development;GO:0006357 regulation of transcription by RNA polymerase II;GO:0021987 cerebral cortex development;GO:0007417 central nervous system development;GO:0007420 brain development",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q04742-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UGC7-1",
        "uniprot_id": "EI3JA_MOUSE",
        "mass": 29344.0,
        "length": 261,
        "protein_name": "Eukaryotic translation initiation factor 3 subunit J-A",
        "gene_name": "Eif3j1",
        "organism": "Mouse",
        "refseq_name": "eukaryotic translation initiation factor 3 subunit J",
        "refseq_ac": "NP_653128",
        "gene_names_uniprotkb": "Eif3j1; Eif3s1-1",
        "gene_names_refseq": "1810016I04Rik; 2700079K05Rik; Eif3j-1; Eif3j-2; Eif3j1; Eif3j2; Eif3j; Eif3s1; eIF-3-alpha-A; eIF-3-alpha-B; eIF3-alpha; eIF3-p35; eIF3j-A; eIF3j-B",
        "protein_names_uniprotkb": "Eukaryotic translation initiation factor 3 subunit J-A; Eukaryotic translation initiation factor 3 subunit 1-A; eIF-3-alpha-A; eIF3 p35; eIF3j-A",
        "protein_names_refseq": "eukaryotic translation initiation factor 3 subunit 1-A; eukaryotic translation initiation factor 3 subunit 1-B; eukaryotic translation initiation factor 3 subunit J; eukaryotic translation initiation factor 3, subunit 1 alpha; eukaryotic translation initiation factor 3, subunit J",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:78655);  (R-MMU-156827);  (R-MMU-72649);  (R-MMU-72689);  (R-MMU-72695);  (R-MMU-72702);  (R-MMU-72706)",
        "pathway_count": 7,
        "publication_count": 3,
        "publication_id_list": "10.1101/2023.09.13.557529;22025682;36288343",
        "class_list": "",
        "function": "Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. This subunit binds directly within the mRNA entry channel of the 40S ribosome to the aminoacyl (A) site. It may regulate the interaction between the 43S PIC and mRNA., [UniProtKB, HAMAP]; EIF-3-alpha interferes with Ras-induced focus formation in NIH 3T3 cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0003743 translation initiation factor activity",
        "go_cellular_component": "GO:0005829 cytosol;GO:0016282 eukaryotic 43S preinitiation complex;GO:0033290 eukaryotic 48S preinitiation complex;GO:0005852 eukaryotic translation initiation factor 3 complex",
        "go_biological_process": "GO:0001732 formation of cytoplasmic translation initiation complex",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q3UGC7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UP38-2",
        "uniprot_id": "EFC4B_MOUSE",
        "mass": 82667.0,
        "length": 726,
        "protein_name": "EF-hand calcium-binding domain-containing protein 4B",
        "gene_name": "Cracr2a",
        "organism": "Mouse",
        "refseq_name": "EF-hand calcium-binding domain-containing protein 4B isoform 2",
        "refseq_ac": "NP_001028636",
        "gene_names_uniprotkb": "Cracr2a; Efcab4b; Gm1073; Rab46",
        "gene_names_refseq": "Cracr2a; Efcab4b; Gm1073; Gm462",
        "protein_names_uniprotkb": "EF-hand calcium-binding domain-containing protein 4B; 3.6.5.2; Calcium release-activated channel regulator 2A; Ras-related protein Rab-46",
        "protein_names_refseq": "EF-hand calcium binding domain 4B; EF-hand calcium-binding domain-containing protein 4B isoform 2; EF-hand calcium-binding domain-containing protein 4B; ras-related protein Rab-46",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:381812);  (R-MMU-6798695)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "25428506;27016526;29987160",
        "class_list": "",
        "function": "Ca(2+)-binding protein that plays a key role in store-operated Ca(2+) entry (SOCE) in T-cells by regulating CRAC channel activation. Acts as a cytoplasmic calcium-sensor that facilitates the clustering of ORAI1 and STIM1 at the junctional regions between the plasma membrane and the endoplasmic reticulum upon low Ca(2+) concentration. It thereby regulates CRAC channel activation, including translocation and clustering of ORAI1 and STIM1. Upon increase of cytoplasmic Ca(2+) resulting from opening of CRAC channels, dissociates from ORAI1 and STIM1, thereby destabilizing the ORAI1-STIM1 complex (By similarity)., [UniProtKB, UniProtKB]; GTP binding and prenylation of CRACR2A were associated with its localization near the Golgi and its stability Publication Status: Online-Only, [RefSeq, PubMed]; Rab GTPase that mediates the trafficking of Weibel-Palade bodies (WPBs) to microtubule organizing center (MTOC) in endothelial cells in response to acute inflammatory stimuli (By similarity). During histamine (but not thrombin) stimulation of endothelial cells, the dynein-bound form induces retrograde transport of a subset of WPBs along microtubules to the MTOC in a Ca(2+)-independent manner and its GTPase activity is essential for this function (By similarity). Ca(2+)-regulated dynein adapter protein that activates dynein-mediated transport and dynein-dynactin motility on microtubules and regulates endosomal trafficking of CD47 (By similarity). Acts as an intracellular signaling module bridging two important T-cell receptor (TCR) signaling pathways, Ca(2+)-NFAT and JNK, to affect T-cell activation (PubMed:27016526). In resting T-cells, is predominantly localized near TGN network in a GTP-bound form, upon TCR stimulation, localizes at the immunological synapse via interaction with VAV1 to activate downstream Ca(2+)-NFAT and JNK signaling pathways (By similarity). Plays a role in T-helper 1 (Th1) cell differentiation and T-helper 17 (Th17) cell effector function (PubMed:29987160). Plays a role in store-operated Ca(2+) entry (SOCE) in T-cells by regulating CRAC channel activation (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; This study demonstrates the requirement of CRACR2A-mediated TCR signaling in Th1 responses as well as pathogenic conversion of Th17 cells, which occurs at the site of inflammation Erratum:[J Immunol. 2019 Jul 1;203(1):293. doi: 10.4049/jimmunol.1900492. PMID: 31127031], [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A0A1D5RLZ8;B9EKF2",
        "ec_number_list": "3.6.5.-;3.6.5.2;3.6.5.3;3.2.1.18;3.6.1.5;3.4.24.34;3.4.21.-;3.2.1.17;3.6.5.4;3.4.23.5;3.1.3.48;3.6.5.5;3.6.1.-;3.6.1.15;3.4.21.37;2.7.11.1;3.5.3.1;3.2.1.166;1.8.3.2;3.6.-.-;1.4.3.22;1.4.3.-;2.7.1.35;3.6.1.6;2.3.1.16;2.3.1.9;2.3.1.155;2.7.10.2;2.3.2.5;3.1.21.-;3.2.1.14;3.5.1.3;3.4.18.1;3.4.19.9",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0005509 calcium ion binding;GO:0003925 G protein activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0032588 trans-Golgi network membrane;GO:0005815 microtubule organizing center",
        "go_biological_process": "GO:0045063 T-helper 1 cell differentiation;GO:0034776 response to histamine;GO:0046330 positive regulation of JNK cascade;GO:0016197 endosomal transport;GO:0016192 vesicle-mediated transport",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q3UP38-2",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3UPW2-1",
        "uniprot_id": "ELF3_MOUSE",
        "mass": 44273.0,
        "length": 391,
        "protein_name": "ETS-related transcription factor Elf-3",
        "gene_name": "Elf3",
        "organism": "Mouse",
        "refseq_name": "ETS-related transcription factor Elf-3 isoform 1",
        "refseq_ac": "NP_001156603",
        "gene_names_uniprotkb": "Elf3; Ert; Esx; Jen",
        "gene_names_refseq": "ESE-1; ESX; Elf3; jen",
        "protein_names_uniprotkb": "ETS-related transcription factor Elf-3; E74-like factor 3; ESE-1; Epithelial-restricted with serine box; Epithelium-restricted Ets protein ESX; Epithelium-specific Ets transcription factor 1",
        "protein_names_refseq": "ETS-related transcription factor Elf-3 isoform 1; ETS-related transcription factor Elf-3; epithelial-restricted with serine box; epithelium-restricted Ets protein ESX; epithelium-specific Ets transcription factor 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13710);  (R-MMU-1912408)",
        "pathway_count": 2,
        "publication_count": 12,
        "publication_id_list": "11025204;11893733;11984530;16516205;16630543;25428506;30084848;34428180;37946371;38975675;9395241;9806763",
        "class_list": "",
        "function": "ESE-1 mediates lipopolysaccharide-induced BV2 cell inflammation via upregulation of HMGB1 expression., [RefSeq, PubMed]; Evidence that mElf-3, a member of the Ets family, plays a key role in the activation of the mTbetaR-II promoter., [RefSeq, PubMed]; Expression of Interferon Epsilon in Mucosal Epithelium is Regulated by Elf3., [RefSeq, PubMed]; Transcriptional activator that binds and transactivates ETS sequences containing the consensus nucleotide core sequence GGA[AT]. Acts synergistically with POU2F3 to transactivate the SPRR2A promoter and with RUNX1 to transactivate the ANGPT1 promoter (By similarity). Also transactivates collagenase, CCL20, CLND7, FLG, KRT8, NOS2, PTGS2, SPRR2B, TGFBR2 and TGM3 promoters. Represses KRT4 promoter activity (By similarity). Involved in mediating vascular inflammation. May play an important role in epithelial cell differentiation and tumorigenesis. May be a critical downstream effector of the ERBB2 signaling pathway (By similarity). May be associated with mammary gland development and involution. Plays an important role in the regulation of transcription with TATA-less promoters in preimplantation embryos, which is essential in preimplantation development., [UniProtKB, UniProtKB, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 5,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B7ZNQ9;B9EI01;O35275",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005794 Golgi apparatus;GO:0005829 cytosol",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0006954 inflammatory response;GO:0030154 cell differentiation;GO:0030198 extracellular matrix organization",
        "synthesized_glycan_count": 0,
        "hit_score": 1.3,
        "record_id": "Q3UPW2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3V1U8-1",
        "uniprot_id": "ELMD1_MOUSE",
        "mass": 38034.0,
        "length": 326,
        "protein_name": "ELMO domain-containing protein 1",
        "gene_name": "Elmod1",
        "organism": "Mouse",
        "refseq_name": "ELMO domain-containing protein 1 isoform 2",
        "refseq_ac": "NP_808437",
        "gene_names_uniprotkb": "Elmod1",
        "gene_names_refseq": "4831417L10; Elmod1",
        "protein_names_uniprotkb": "ELMO domain-containing protein 1",
        "protein_names_refseq": "ELMO domain containing 1; ELMO domain-containing protein 1 isoform 2; ELMO domain-containing protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:270162)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "22558334;24523945;34818063",
        "class_list": "",
        "function": "Acts as a GTPase-activating protein (GAP) toward guanine nucleotide exchange factors like ARL2, ARL3, ARF1 and ARF6, but not for GTPases outside the Arf family., [UniProtKB]; Elmod1 has relatively high and selective expression in the brain but as of 2014 has not been well-studied with respect to CNS function or disease associations. It is part of the core brain ignorome. Elmod1 has a high cis-eQTL in hippocampus, hypothalamus, striatum. Hearing sensitivity trait in GeneNetwork.org also maps to the region containing Elmod1. Publication Status: Online-Only, [RefSeq, PubMed]; The ARF GAPs ELMOD1 and ELMOD3 act at the Golgi and cilia to regulate ciliogenesis and ciliary protein traffic. Erratum:[Mol Biol Cell. 2022 Jun 1;33(7):cor1. doi: 10.1091/mbc.E21-09-0443_corr. PMID: 35612986], [RefSeq, PubMed]; This finding connecting ELMOD1 deficiencies with stereocilia dysmorphologies establishes a link between the Ras superfamily of small regulatory GTPases and the actin cytoskeleton dynamics of hair cell stereocilia., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005096 GTPase activator activity",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005794 Golgi apparatus;GO:0005929 cilium;GO:0045202 synapse",
        "go_biological_process": "GO:0015031 protein transport;GO:0060271 cilium assembly;GO:0008104 intracellular protein localization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q3V1U8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61495-1",
        "uniprot_id": "DSG1A_MOUSE",
        "mass": 114597.0,
        "length": 1057,
        "protein_name": "Desmoglein-1-alpha",
        "gene_name": "Dsg1a",
        "organism": "Mouse",
        "refseq_name": "desmoglein-1-alpha preproprotein",
        "refseq_ac": "NP_034209",
        "gene_names_uniprotkb": "Dsg1a; Dsg1",
        "gene_names_refseq": "DG1; DGI; Dsg1a; Dsg1; dsg1-alpha",
        "protein_names_uniprotkb": "Desmoglein-1-alpha; DG1; DGI; Desmoglein-1; Desmosomal glycoprotein I; Dsg1-alpha",
        "protein_names_refseq": "desmoglein-1-alpha preproprotein; desmosomal glycoprotein I",
        "tax_id": 10090,
        "disease": "keratosis palmoplantaris striata 1 (Disease Ontology:DOID:0081108)",
        "pathway": " (mmu:13510);  (R-MMU-351906);  (R-MMU-6798695);  (R-MMU-6805567);  (R-MMU-6809371);  (R-MMU-9696264);  (R-MMU-9696270)",
        "pathway_count": 7,
        "publication_count": 16,
        "publication_id_list": "10.1101/2023.09.13.557529;11994138;12093888;12631242;24220297;25428506;28011936;30660666;30779550;31302121;34905516;35820727;36064721;39627609;40684658;7959727",
        "class_list": "",
        "function": "A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (By similarity). Mediates the interaction between the desmosome and COP9 signalosome complex (CSN) protein complex (By similarity). As a result of this interaction, promotes keratinocyte differentiation via deneddylation of EGFR resulting in a reduction in EGFR protein stabilization and translocation away from the cell membrane (By similarity). Critical for epidermal integrity and barrier function of the skin (PubMed:30660666). Required for esophageal epithelial barrier integrity and correct intercellular spacing in differentiated esophageal epithelium (By similarity). Required for recovery of epidermal architecture and correct expression of differentiation markers following UVB exposure (By similarity). May also be required for OCLN involvement in tight junctions (PubMed:30660666)., [UniProtKB, UniProtKB, UniProtKB, PubMed]; Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion., [RefSeq, PubMed]; This gene encodes a member of the cadherin family of proteins that forms an integral transmembrane component of desmosomes, the multiprotein complexes involved in cell adhesion, organization of the cytoskeleton, cell sorting and cell signaling. The encoded preproprotein undergoes proteolytic processing to generate a mature, functional protein. This gene is located in a cluster of desmosomal cadherin genes on chromosome 18. [provided by RefSeq, Jan 2016]., [RefSeq]; Translational implications of Th17-skewed inflammation due to genetic deficiency of a cadherin stress sensor., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A8WFQ4;Q8CE03",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005509 calcium ion binding;GO:0045295 gamma-catenin binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0016324 apical plasma membrane;GO:0009898 cytoplasmic side of plasma membrane",
        "go_biological_process": "GO:0098609 cell-cell adhesion;GO:0050821 protein stabilization;GO:0007156 homophilic cell adhesion via plasma membrane adhesion molecules",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "Q61495-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q61502-1",
        "uniprot_id": "E2F5_MOUSE",
        "mass": 36555.0,
        "length": 335,
        "protein_name": "Transcription factor E2F5",
        "gene_name": "E2f5",
        "organism": "Mouse",
        "refseq_name": "transcription factor E2F5",
        "refseq_ac": "NP_031918",
        "gene_names_uniprotkb": "E2f5",
        "gene_names_refseq": "E2F-5; E2f5",
        "protein_names_uniprotkb": "Transcription factor E2F5; E2F-5",
        "protein_names_refseq": "transcription factor E2F5",
        "tax_id": 10090,
        "disease": "prostate cancer (Disease Ontology:DOID:10283); prostate carcinoma (Disease Ontology:DOID:10286); hydrocephalus (Disease Ontology:DOID:10908)",
        "pathway": " (mmu:13559);  (R-MMU-1538133);  (R-MMU-2173796);  (R-MMU-69231)",
        "pathway_count": 4,
        "publication_count": 6,
        "publication_id_list": "25428506;31219806;34428180;7542760;9149906;9376316",
        "class_list": "",
        "function": "Transcriptional activator that binds to E2F sites, these sites are present in the promoter of many genes whose products are involved in cell proliferation. May mediate growth factor-initiated signal transduction. It is likely involved in the early responses of resting cells to growth factor stimulation. Specifically required for multiciliate cell differentiation: together with MCIDAS and E2F5, binds and activate genes required for centriole biogenesis., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q99LK0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003700 DNA-binding transcription factor activity;GO:0046983 protein dimerization activity;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0043565 sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005635 nuclear envelope;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0006355 regulation of DNA-templated transcription;GO:0009887 animal organ morphogenesis;GO:0000082 G1/S transition of mitotic cell cycle",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q61502-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q66JS6-1",
        "uniprot_id": "EI3JB_MOUSE",
        "mass": 29486.0,
        "length": 263,
        "protein_name": "Eukaryotic translation initiation factor 3 subunit J-B",
        "gene_name": "Eif3j2",
        "organism": "Mouse",
        "refseq_name": "eukaryotic translation initiation factor 3 subunit J-B",
        "refseq_ac": "NP_001242984",
        "gene_names_uniprotkb": "Eif3j2; Eif3s1-2; Gm9781",
        "gene_names_refseq": "Eif3j-2; Eif3j2; Gm9781; eIF3 p35; eIF3j-B",
        "protein_names_uniprotkb": "Eukaryotic translation initiation factor 3 subunit J-B; Eukaryotic translation initiation factor 3 subunit 1-B; eIF-3-alpha-B; eIF3 p35; eIF3j-B",
        "protein_names_refseq": "eIF-3-alpha-B; eIF-3-alpha; eukaryotic translation initiation factor 3 subunit 1-B; eukaryotic translation initiation factor 3 subunit 1; eukaryotic translation initiation factor 3 subunit J-B; eukaryotic translation initiation factor 3 subunit J",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:100042807);  (R-MMU-156827);  (R-MMU-72649);  (R-MMU-72689);  (R-MMU-72695);  (R-MMU-72702);  (R-MMU-72706)",
        "pathway_count": 7,
        "publication_count": 2,
        "publication_id_list": "34428180;36288343",
        "class_list": "",
        "function": "Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. This subunit binds directly within the mRNA entry channel of the 40S ribosome to the aminoacyl (A) site. It may regulate the interaction between the 43S PIC and mRNA., [UniProtKB, HAMAP]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 6,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8BUW6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0003743 translation initiation factor activity",
        "go_cellular_component": "GO:0005829 cytosol;GO:0016282 eukaryotic 43S preinitiation complex;GO:0033290 eukaryotic 48S preinitiation complex;GO:0005852 eukaryotic translation initiation factor 3 complex",
        "go_biological_process": "GO:0001732 formation of cytoplasmic translation initiation complex",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q66JS6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6PDI5-2",
        "uniprot_id": "ECM29_MOUSE",
        "mass": 203915.0,
        "length": 1840,
        "protein_name": "Proteasome adapter and scaffold protein ECM29",
        "gene_name": "Ecpas",
        "organism": "Mouse",
        "refseq_name": "proteasome adapter and scaffold protein ECM29 isoform 2",
        "refseq_ac": "NP_759013",
        "gene_names_uniprotkb": "Ecpas; Ecm29; Kiaa0368",
        "gene_names_refseq": "Ecpas; mKIAA0368",
        "protein_names_uniprotkb": "Proteasome adapter and scaffold protein ECM29; Proteasome-associated protein ECM29 homolog",
        "protein_names_refseq": "ecm29; proteasome adapter and scaffold protein ECM29 isoform 2; proteasome adapter and scaffold protein ECM29; proteasome-associated protein ECM29 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:230249)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;15496406;22872234;25428506;26802743;30084848;30779550;30899004;31910261;39627609",
        "class_list": "",
        "function": "Adapter/scaffolding protein that binds to the 26S proteasome, motor proteins and other compartment specific proteins. May couple the proteasome to different compartments including endosome, endoplasmic reticulum and centrosome. May play a role in ERAD and other enhanced proteolysis (By similarity). Promotes proteasome dissociation under oxidative stress (PubMed:26802743)., [UniProtKB, UniProtKB, PubMed]; Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2ALW0;Q6ZQC9;Q8BSW7;Q8CAH0;Q8R3M6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0060090 molecular adaptor activity;GO:0070628 proteasome binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005769 early endosome;GO:0005783 endoplasmic reticulum",
        "go_biological_process": "GO:0036503 ERAD pathway;GO:0043248 proteasome assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 1.7,
        "record_id": "Q6PDI5-2",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8C9X6-1",
        "uniprot_id": "EPC1_MOUSE",
        "mass": 90411.0,
        "length": 813,
        "protein_name": "Enhancer of polycomb homolog 1",
        "gene_name": "Epc1",
        "organism": "Mouse",
        "refseq_name": "enhancer of polycomb homolog 1 isoform 3",
        "refseq_ac": "NP_001263279",
        "gene_names_uniprotkb": "Epc1",
        "gene_names_refseq": "2400007E14Rik; 5730566F07Rik; A930032N02Rik; Epc1; mir-1893",
        "protein_names_uniprotkb": "Enhancer of polycomb homolog 1",
        "protein_names_refseq": "enhancer of polycomb homolog 1 isoform 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13831);  (R-MMU-8953750)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "28694333;31219806;34428180;40997131;9735366",
        "class_list": "",
        "function": "Component of the NuA4 histone acetyltransferase (HAT) complex, a multiprotein complex involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A (PubMed:28694333). The NuA4 complex plays a direct role in repair of DNA double-strand breaks (DSBs) by promoting homologous recombination (HR) (By similarity). The NuA4 complex is also required for spermatid development by promoting acetylation of histones: histone acetylation is required for histone replacement during the transition from round to elongating spermatids (PubMed:28694333). In the NuA4 complex, EPC1 is required to recruit MBTD1 into the complex (By similarity)., [UniProtKB, UniProtKB, PubMed]; Results report that EPC1 and TIP60 are co-expressed in male germ cells. Genetic ablation of either Epc1 or Tip60 disrupts hyperacetylation and impairs histone replacement, in turn causing aberrant spermatid development. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RRY2;Q9Z299",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030674 protein-macromolecule adaptor activity;GO:0140463 chromatin-protein adaptor activity;GO:0140767 enzyme-substrate adaptor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005730 nucleolus;GO:0005737 cytoplasm;GO:0031965 nuclear membrane",
        "go_biological_process": "GO:0035886 vascular associated smooth muscle cell differentiation;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q8C9X6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8K3P0-1",
        "uniprot_id": "DR9C7_MOUSE",
        "mass": 35149.0,
        "length": 313,
        "protein_name": "Short-chain dehydrogenase/reductase family 9C member 7",
        "gene_name": "Sdr9c7",
        "organism": "Mouse",
        "refseq_name": "short-chain dehydrogenase/reductase family 9C member 7",
        "refseq_ac": "NP_081577",
        "gene_names_uniprotkb": "Sdr9c7; Rdhs; Sdro",
        "gene_names_refseq": "1810054F20Rik; Rdh20; Rdhs; SDR-O; Sdr9c7; Sdro",
        "protein_names_uniprotkb": "Short-chain dehydrogenase/reductase family 9C member 7; 1.1.1.-; O-acylceramide dehydrogenase; Orphan short-chain dehydrogenase/reductase; RDH-S; SDR-O; SDR9C7",
        "protein_names_refseq": "O-acylceramide dehydrogenase; RDH-S; orphan short chain dehydrogenase/reductase; retinol dehydrogenase 20; short-chain dehydrogenase/reductase family 9C member 7",
        "tax_id": 10090,
        "disease": "chromosome 3q29 microdeletion syndrome (Disease Ontology:DOID:0060419); autosomal recessive congenital ichthyosis 13 (Disease Ontology:DOID:0080257)",
        "pathway": " (mmu:70061);  (R-MMU-2453902)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "12234675;12855677;31671075",
        "class_list": "",
        "function": "Plays a crucial role in the formation of the epidermal permeability barrier. Catalyzes the NAD+-dependent dehydrogenation of the linoleate 9,10-trans-epoxy-11E-13-alcohol esterified in omega-O-acylceramides (such as in N-[omega-(9R,10R)-epoxy-(13R)-hydroxy-(11E)-octadecenoyloxy]-acylsphing-4E-enine) to the corresponding 13-ketone, the reactive moiety required for binding of epidermal ceramides to proteins. Displays weak conversion of all-trans-retinal to all-trans-retinol in the presence of NADH. Has apparently no steroid dehydrogenase activity., [UniProtKB, UniProtKB]; SDR9C7 catalyzes critical dehydrogenation of acylceramides for skin barrier formation., [RefSeq, PubMed]; Short-chain dehydrogenase/reductase (SDR), retinol dehydrogenase-similar (RDH-S), with intense mRNA expression in liver and kidney, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.1.1.315;1.1.1.209;1.1.1.53;1.1.1.105;1.1.1.-;1.1.1.62;1.1.1.239",
        "go_molecular_function": "GO:0004745 all-trans-retinol dehydrogenase (NAD+) activity",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0042572 retinol metabolic process;GO:0008202 steroid metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q8K3P0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8R050-1",
        "uniprot_id": "ERF3A_MOUSE",
        "mass": 68625.0,
        "length": 636,
        "protein_name": "Eukaryotic peptide chain release factor GTP-binding subunit ERF3A",
        "gene_name": "Gspt1",
        "organism": "Mouse",
        "refseq_name": "eukaryotic peptide chain release factor GTP-binding subunit ERF3A isoform 2",
        "refseq_ac": "NP_001123480",
        "gene_names_uniprotkb": "Gspt1; Erf3a",
        "gene_names_refseq": "G1st; Gspt1; Gst-1",
        "protein_names_uniprotkb": "Eukaryotic peptide chain release factor GTP-binding subunit ERF3A; 3.6.5.-; Eukaryotic peptide chain release factor subunit 3a; G1 to S phase transition protein 1 homolog; eRF3a",
        "protein_names_refseq": "G1 to S phase transition protein 1 homolog; G1 to phase transition 1; G1-to-S transition GTP binding protein; eRF3a; eukaryotic peptide chain release factor GTP-binding subunit ERF3A isoform 2; eukaryotic peptide chain release factor GTP-binding subunit ERF3A; eukaryotic peptide chain release factor subunit 3a; eukaryotic polypeptide chain release factor 3; guanine nucleotide regulatory protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:14852);  (R-MMU-72764);  (R-MMU-975956);  (R-MMU-975957)",
        "pathway_count": 4,
        "publication_count": 18,
        "publication_id_list": "21540332;21750661;22645316;25153642;25428506;26495903;27941025;28135057;28528544;30084848;30779550;31599954;34428180;36210013;37507081;37828378;39117611;9712840",
        "class_list": "",
        "function": "GTPase component of the eRF1-eRF3-GTP ternary complex, a ternary complex that mediates translation termination in response to the termination codons UAA, UAG and UGA. GSPT1/ERF3A mediates ETF1/ERF1 delivery to stop codons: The eRF1-eRF3-GTP complex binds to a stop codon in the ribosomal A-site. GTP hydrolysis by GSPT1/ERF3A induces a conformational change that leads to its dissociation, permitting ETF1/ERF1 to accommodate fully in the A-site. Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons. Required for SHFL-mediated translation termination which inhibits programmed ribosomal frameshifting (-1PRF) of mRNA from viruses and cellular genes., [UniProtKB, UniProtKB]; Potential of GSPT1 as a novel target for glioblastoma therapy. Publication Status: Online-Only, [RefSeq, PubMed]; Rac1-GSPT1 represents a novel signaling axis in astrocytes that accelerates proliferation in response to inflammation, which is one important factor in the development of astrogliosis/glial scar following CNS injury, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QK49;G3UWC0;O88179;Q8K2E1",
        "ec_number_list": "3.6.5.-;3.6.5.2;3.6.5.3;3.6.1.5;3.6.5.4;3.6.5.5;3.1.-.-;4.2.99.18;3.1.3.16;3.6.1.-;3.6.1.15;2.7.11.1;2.1.1.-;3.6.-.-;3.6.4.13;3.6.1.62;5.6.2.3;5.6.2.5",
        "go_molecular_function": "GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0003747 translation release factor activity",
        "go_cellular_component": "GO:0018444 translation release factor complex;GO:0005737 cytoplasm;GO:0022626 cytosolic ribosome",
        "go_biological_process": "GO:0006449 regulation of translational termination;GO:0032790 ribosome disassembly;GO:0006415 translational termination;GO:0000184 nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;GO:0006412 translation",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "Q8R050-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VHX2-1",
        "uniprot_id": "EDAD_MOUSE",
        "mass": 23753.0,
        "length": 208,
        "protein_name": "Ectodysplasin-A receptor-associated adapter protein",
        "gene_name": "Edaradd",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Edaradd; Cr",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Ectodysplasin-A receptor-associated adapter protein; EDAR-associated death domain protein; Protein crinkled",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "ectodermal dysplasia 11A (Disease Ontology:DOID:0111653); ectodermal dysplasia 11B (Disease Ontology:DOID:0111654); otitis media (Disease Ontology:DOID:10754); hypohidrotic ectodermal dysplasia (Disease Ontology:DOID:14793)",
        "pathway": " (R-MMU-5669034)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "11780064;11882293",
        "class_list": "",
        "function": "Adapter protein that interacts with EDAR DEATH domain and couples the receptor to EDA signaling pathway during morphogenesis of ectodermal organs. Mediates the activation of NF-kappa-B (By similarity)., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005123 death receptor binding",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0030154 cell differentiation;GO:1901224 positive regulation of non-canonical NF-kappaB signal transduction;GO:0001942 hair follicle development;GO:0042475 odontogenesis of dentin-containing tooth;GO:0007249 canonical NF-kappaB signal transduction",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q8VHX2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q91YE3-1",
        "uniprot_id": "EGLN1_MOUSE",
        "mass": 43111.0,
        "length": 400,
        "protein_name": "Egl nine homolog 1",
        "gene_name": "Egln1",
        "organism": "Mouse",
        "refseq_name": "egl nine homolog 1 isoform 1",
        "refseq_ac": "NP_444437",
        "gene_names_uniprotkb": "Egln1",
        "gene_names_refseq": "C1orf12; Egln1; HIF-PH2; HPH-2; Hif-p4h-2; ORF13; Phd2; SM-20",
        "protein_names_uniprotkb": "Egl nine homolog 1; 1.14.11.29; HIF-PH2; HIF-prolyl hydroxylase 2; HPH-2; Hypoxia-inducible factor prolyl hydroxylase 2; PHD2; Prolyl hydroxylase domain-containing protein 2; SM-20",
        "protein_names_refseq": "HIF-prolyl hydroxylase 2; egl nine homolog 1 isoform 1; hypoxia-inducible factor prolyl hydroxylase 2; prolyl hydroxylase domain-containing protein 2",
        "tax_id": 10090,
        "disease": "familial erythrocytosis 3 (Disease Ontology:DOID:0080338); hypertension (Disease Ontology:DOID:10763); acute kidney failure (Disease Ontology:DOID:3021); renal cell carcinoma (Disease Ontology:DOID:4450); myocardial infarction (Disease Ontology:DOID:5844); polycythemia (Disease Ontology:DOID:8432)",
        "pathway": " (mmu:112405);  (R-MMU-1234176)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "10.1101/2023.09.13.557529;10543731;11574160;12234095;18096761;18500250;21435465;35820727;36288343",
        "class_list": "",
        "function": "Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A. Has a preference for the CODD site for both HIF1A and HIF1B. Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes. EGLN1 is the most important isozyme under normoxia and, through regulating the stability of HIF1, involved in various hypoxia-influenced processes such as angiogenesis in retinal and cardiac functionality. Target proteins are preferentially recognized via a LXXLAP motif., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 6,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8VHJ2;Q922P3",
        "ec_number_list": "3.4.19.12;3.4.25.1;2.3.2.24;2.3.2.23;2.3.2.27;2.3.2.32;1.14.11.29;1.14.11.-",
        "go_molecular_function": "GO:0004857 enzyme inhibitor activity;GO:0008270 zinc ion binding;GO:0019899 enzyme binding;GO:0008198 ferrous iron binding;GO:0031418 L-ascorbic acid binding",
        "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0014069 postsynaptic density",
        "go_biological_process": "GO:1902072 negative regulation of hypoxia-inducible factor-1alpha signaling pathway;GO:1905290 negative regulation of CAMKK-AMPK signaling cascade;GO:0043065 positive regulation of apoptotic process;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0001666 response to hypoxia",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q91YE3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CRD2-1",
        "uniprot_id": "EMC2_MOUSE",
        "mass": 34935.0,
        "length": 297,
        "protein_name": "ER membrane protein complex subunit 2",
        "gene_name": "Emc2",
        "organism": "Mouse",
        "refseq_name": "ER membrane protein complex subunit 2 isoform 1",
        "refseq_ac": "NP_080012",
        "gene_names_uniprotkb": "Emc2; Kiaa0103; Ttc35",
        "gene_names_refseq": "4921531G14Rik; Emc2; Ttc35",
        "protein_names_uniprotkb": "ER membrane protein complex subunit 2; TPR repeat protein 35; Tetratricopeptide repeat protein 35",
        "protein_names_refseq": "ER membrane protein complex subunit 2 isoform 1; TPR repeat protein 35; tetratricopeptide repeat domain 35; tetratricopeptide repeat protein 35",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66736)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "11471062;11593002",
        "class_list": "",
        "function": "Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q925K1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0032977 membrane insertase activity",
        "go_cellular_component": "GO:0072546 EMC complex;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0071816 tail-anchored membrane protein insertion into ER membrane;GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9CRD2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CZU4-1",
        "uniprot_id": "ERAL1_MOUSE",
        "mass": 48187.0,
        "length": 437,
        "protein_name": "GTPase Era, mitochondrial",
        "gene_name": "Eral1",
        "organism": "Mouse",
        "refseq_name": "GTPase Era, mitochondrial",
        "refseq_ac": "NP_071708",
        "gene_names_uniprotkb": "Eral1; Mera",
        "gene_names_refseq": "2610524P08Rik; 9130407C09Rik; Eral1; Era; M-ERA; MERA-S; MERA-W",
        "protein_names_uniprotkb": "GTPase Era, mitochondrial; CEGA; Conserved ERA-like GTPase; ERA-W; ERA-like protein 1; M-ERA",
        "protein_names_refseq": "CEGA; ERA-W; ERA-like GTPase; ERA-like protein 1; GTP-binding protein era homolog; GTPase Era, mitochondrial; conserved ERA-like GTPase",
        "tax_id": 10090,
        "disease": "Perrault syndrome 6 (Disease Ontology:DOID:0080256)",
        "pathway": " (mmu:57837);  (R-MMU-5389840);  (R-MMU-5419276);  (R-MMU-9937383)",
        "pathway_count": 4,
        "publication_count": 8,
        "publication_id_list": "11733036;25428506;27797820;31219806;31547314;31599954;33472079;37806316",
        "class_list": "",
        "function": "LonP1(+/-) mouse embryonal fibroblasts also showed Eral1 accumulation, but no systematic effect on mitoribosomal subunits. Publication Status: Online-Only, [RefSeq, PubMed]; Probable GTPase that plays a role in the mitochondrial ribosomal small subunit assembly. Specifically binds the 12S mitochondrial rRNA (12S mt-rRNA) to a 33 nucleotide section delineating the 3' terminal stem-loop region. May act as a chaperone that protects the 12S mt-rRNA on the 28S mitoribosomal subunit during ribosomal small subunit assembly (By similarity)., [UniProtKB, UniProtKB]; Role of membrane estrogen receptor alpha (ERalpha) in the rapid regulation of male sexual behavior., [RefSeq, PubMed]; The authors show that the defect in mitoribosomal assembly is a consequence of the accumulation of ERAL1, a putative 12S rRNA chaperone, and novel ClpXP substrate., [RefSeq, PubMed]; The mitochondrial protein ERAL1 suppresses RNA virus infection by facilitating RIG-I-like receptor signaling., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6NV78;Q8VE60;Q925U1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005525 GTP binding;GO:0043024 ribosomal small subunit binding;GO:0019843 rRNA binding;GO:0140691 RNA folding chaperone",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005743 mitochondrial inner membrane;GO:0005759 mitochondrial matrix;GO:0005829 cytosol",
        "go_biological_process": "GO:0000028 ribosomal small subunit assembly;GO:0180026 mitochondrial small ribosomal subunit assembly",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q9CZU4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CZX9-1",
        "uniprot_id": "EMC4_MOUSE",
        "mass": 20117.0,
        "length": 183,
        "protein_name": "ER membrane protein complex subunit 4",
        "gene_name": "Emc4",
        "organism": "Mouse",
        "refseq_name": "ER membrane protein complex subunit 4 isoform a",
        "refseq_ac": "NP_080795",
        "gene_names_uniprotkb": "Emc4; Tmem85",
        "gene_names_refseq": "2610318K02Rik; Emc4; Tmem85",
        "protein_names_uniprotkb": "ER membrane protein complex subunit 4; Transmembrane protein 85",
        "protein_names_refseq": "ER membrane protein complex subunit 4 isoform a; transmembrane protein 85",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68032)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "18250455;21183079;25428506;25605945;30084848;34428180",
        "class_list": "",
        "function": "Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AGJ7;Q9D1D9",
        "ec_number_list": "",
        "go_molecular_function": "GO:0032977 membrane insertase activity",
        "go_cellular_component": "GO:0072546 EMC complex;GO:0016020 membrane;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0006915 apoptotic process;GO:0071816 tail-anchored membrane protein insertion into ER membrane;GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9CZX9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D0P0-1",
        "uniprot_id": "EBPL_MOUSE",
        "mass": 23307.0,
        "length": 206,
        "protein_name": "Emopamil-binding protein-like",
        "gene_name": "Ebpl",
        "organism": "Mouse",
        "refseq_name": "emopamil-binding protein-like",
        "refseq_ac": "NP_080874",
        "gene_names_uniprotkb": "Ebpl; Ebrp; Erp",
        "gene_names_refseq": "5730442K12Rik; EBRP; Ebpl",
        "protein_names_uniprotkb": "Emopamil-binding protein-like; Emopamil-binding-related protein",
        "protein_names_refseq": "emopamil binding related protein, delta8-delta7 sterol isomerase related protein; emopamil-binding protein-like; emopamil-binding-related protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:68177)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "12760743",
        "class_list": "",
        "function": "Does not possess sterol isomerase activity and does not bind sigma ligands., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TQR1;Q9CRQ2;Q9CY81",
        "ec_number_list": "",
        "go_molecular_function": "GO:0047750 cholestenol delta-isomerase activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0016125 sterol metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9D0P0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D485-1",
        "uniprot_id": "EFHC2_MOUSE",
        "mass": 87646.0,
        "length": 750,
        "protein_name": "EF-hand domain-containing family member C2",
        "gene_name": "Efhc2",
        "organism": "Mouse",
        "refseq_name": "EF-hand domain-containing family member C2",
        "refseq_ac": "NP_083192",
        "gene_names_uniprotkb": "Efhc2",
        "gene_names_refseq": "4933407D04Rik; Efhc2; mRib72-2",
        "protein_names_uniprotkb": "EF-hand domain-containing family member C2",
        "protein_names_refseq": "EF-hand domain-containing family member C2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74405)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "35820727;37295417;37865089;37989994",
        "class_list": "",
        "function": "Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q0VBF5;Q8CDV9",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0036126 sperm flagellum;GO:0036064 ciliary basal body;GO:0005879 axonemal microtubule;GO:0160111 axonemal A tubule inner sheath",
        "go_biological_process": "GO:0048814 regulation of dendrite morphogenesis;GO:0030317 flagellated sperm motility;GO:1990830 cellular response to leukemia inhibitory factor",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9D485-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D8U3-1",
        "uniprot_id": "ERP27_MOUSE",
        "mass": 30693.0,
        "length": 272,
        "protein_name": "Endoplasmic reticulum resident protein 27",
        "gene_name": "Erp27",
        "organism": "Mouse",
        "refseq_name": "endoplasmic reticulum resident protein 27 isoform 1 precursor",
        "refseq_ac": "NP_081259",
        "gene_names_uniprotkb": "Erp27",
        "gene_names_refseq": "1810033M07Rik; 1810047B09Rik; Erp27",
        "protein_names_uniprotkb": "Endoplasmic reticulum resident protein 27; ER protein 27; ERp27; Inactive protein disulfide-isomerase 27",
        "protein_names_refseq": "ER protein 27; endoplasmic reticulum resident protein 27 isoform 1 precursor; endoplasmic reticulum resident protein 27; endoplasmic reticulum resident protein ERp27; inactive protein disulfide-isomerase 27",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69187)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "25605945",
        "class_list": "",
        "function": "Specifically binds unfolded proteins and may recruit protein disulfide isomerase PDIA3 to unfolded substrates. Binds protein substrates via a hydrophobic pocket in the C-terminal domain. May play a role in the unfolded stress response., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3SX97",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0005788 endoplasmic reticulum lumen",
        "go_biological_process": "GO:0006457 protein folding;GO:0034976 response to endoplasmic reticulum stress;GO:0006986 response to unfolded protein",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9D8U3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D9T8-1",
        "uniprot_id": "EFHC1_MOUSE",
        "mass": 75142.0,
        "length": 648,
        "protein_name": "EF-hand domain-containing protein 1",
        "gene_name": "Efhc1",
        "organism": "Mouse",
        "refseq_name": "EF-hand domain-containing protein 1",
        "refseq_ac": "NP_082250",
        "gene_names_uniprotkb": "Efhc1",
        "gene_names_refseq": "1700029F22Rik; Efhc1; mRib72-1; myoclonin1",
        "protein_names_uniprotkb": "EF-hand domain-containing protein 1; Myoclonin-1",
        "protein_names_refseq": "EF-hand domain-containing protein 1; myoclonin-1",
        "tax_id": 10090,
        "disease": "juvenile absence epilepsy 1 (Disease Ontology:DOID:0111324); juvenile myoclonic epilepsy (Disease Ontology:DOID:4890)",
        "pathway": " (mmu:71877)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "15258581;15670853;17971504;25428506;33328576;37295417;37865089;37989994",
        "class_list": "",
        "function": "Abundantly present in sperm flagella and tracheal cilia but only in a small amount in the brain, [RefSeq, PubMed]; Efhc1 is most abundantly expressed in tissues rich in highly ciliated cells, such as olfactory sensory neurons, and is predicted to be important to cilia., [RefSeq, PubMed]; Epilepsy protein Efhc1/myoclonin1 is expressed in cells with motile cilia but not in neurons or mitotic apparatuses in brain. Publication Status: Online-Only, [RefSeq, PubMed]; Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating (PubMed:37295417, PubMed:37865089, PubMed:37989994). Microtubule-associated protein which regulates cell division and neuronal migration during cortical development (By similarity). Necessary for radial and tangential cell migration during brain development, possibly acting as a regulator of cell morphology and process formation during migration (By similarity). May enhance calcium influx through CACNA1E and stimulate programmed cell death (By similarity). Overexpression of EFHC1 in hippocampal primary culture neurons induced apoptosis (PubMed:15258581)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005509 calcium ion binding;GO:0043014 alpha-tubulin binding",
        "go_cellular_component": "GO:0000922 spindle pole;GO:0005813 centrosome;GO:0005929 cilium;GO:0043025 neuronal cell body;GO:0036126 sperm flagellum",
        "go_biological_process": "GO:0043065 positive regulation of apoptotic process;GO:0006874 intracellular calcium ion homeostasis;GO:0030317 flagellated sperm motility;GO:0021795 cerebral cortex cell migration;GO:0000281 mitotic cytokinesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q9D9T8-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DBT4-1",
        "uniprot_id": "ENTP4_MOUSE",
        "mass": 69746.0,
        "length": 613,
        "protein_name": "Ectonucleoside triphosphate diphosphohydrolase 4",
        "gene_name": "Entpd4",
        "organism": "Mouse",
        "refseq_name": "ectonucleoside triphosphate diphosphohydrolase 4 isoform 1",
        "refseq_ac": "NP_080450",
        "gene_names_uniprotkb": "Entpd4; Lalp70; Lysal1",
        "gene_names_refseq": "1200014F22Rik; 4930513O14Rik; A430102M06Rik; Entpd4; Lysal1; mKIAA0392",
        "protein_names_uniprotkb": "Ectonucleoside triphosphate diphosphohydrolase 4; 3.6.1.15; 3.6.1.42; 3.6.1.6; Lysosomal apyrase-like protein of 70 kDa; NTPDase 4; UDPase; Uridine-diphosphatase",
        "protein_names_refseq": "NTPDase 4; UDPase; ectonucleoside triphosphate diphosphohydrolase 4 isoform 1; lysosomal apyrase-like 1; lysosomal apyrase-like protein of 70 kDa; uridine-diphosphatase",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:67464);  (R-MMU-8850843)",
        "pathway_count": 2,
        "publication_count": 1,
        "publication_id_list": "10858452",
        "class_list": "",
        "function": "Catalyzes the hydrolysis of nucleoside triphosphates and diphosphates in a calcium- or magnesium-dependent manner, with a preference for pyrimidines. Preferentially hydrolyzes UTP and TTP on UTP and TTP. AMP, ADP, ATP and UMP are not substrates. Preferentially activated by Ca(2+) over Mg(2+)., [UniProtKB, UniProtKB]; Has a broad substrate specificity with the ability of cleaving all nucleotide di- and triphosphates with the exception of adenosine di- and triphosphate (ADP and ATP). Preferentially hydrolyzes CTP, UDP, CDP, GTP and GDP. Can use either Ca(2+) or Mg(2+) equally., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.6.1.5;3.6.5.-;3.6.1.15;3.1.4.-;3.6.1.-;3.6.1.6;3.6.1.42;3.6.4.13",
        "go_molecular_function": "GO:0005525 GTP binding;GO:0004382 GDP phosphatase activity;GO:0045134 UDP phosphatase activity;GO:0017110 nucleoside diphosphate phosphatase activity;GO:0017111 ribonucleoside triphosphate phosphatase activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0000421 autophagosome membrane;GO:0005794 Golgi apparatus;GO:0016020 membrane;GO:0005765 lysosomal membrane",
        "go_biological_process": "GO:0046712 GDP catabolic process;GO:0006256 UDP catabolic process;GO:0034656 nucleobase-containing small molecule catabolic process;GO:0046036 CTP metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "Q9DBT4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EP72-1",
        "uniprot_id": "EMC7_MOUSE",
        "mass": 26310.0,
        "length": 241,
        "protein_name": "Endoplasmic reticulum membrane protein complex subunit 7",
        "gene_name": "Emc7",
        "organism": "Mouse",
        "refseq_name": "endoplasmic reticulum membrane protein complex subunit 7 precursor",
        "refseq_ac": "NP_598510",
        "gene_names_uniprotkb": "Emc7; Orf3",
        "gene_names_refseq": "2900064A13Rik; Emc7; ORF3; c11orf3",
        "protein_names_uniprotkb": "Endoplasmic reticulum membrane protein complex subunit 7; ER membrane protein complex subunit 7",
        "protein_names_refseq": "UPF0480 protein C15orf24 homolog; endoplasmic reticulum membrane protein complex subunit 7 precursor; endoplasmic reticulum membrane protein complex subunit 7",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:73024)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "10.1101/2023.09.13.557529;10873569;25428506;25605945;34428180",
        "class_list": "",
        "function": "Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030246 carbohydrate binding;GO:0032977 membrane insertase activity",
        "go_cellular_component": "GO:0072546 EMC complex;GO:0016020 membrane;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0071816 tail-anchored membrane protein insertion into ER membrane;GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9EP72-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QXB9-1",
        "uniprot_id": "DRG2_MOUSE",
        "mass": 40718.0,
        "length": 364,
        "protein_name": "Developmentally-regulated GTP-binding protein 2",
        "gene_name": "Drg2",
        "organism": "Mouse",
        "refseq_name": "developmentally-regulated GTP-binding protein 2",
        "refseq_ac": "NP_067329",
        "gene_names_uniprotkb": "Drg2",
        "gene_names_refseq": "DRG-2; Drg2",
        "protein_names_uniprotkb": "Developmentally-regulated GTP-binding protein 2; 3.6.5.-; DRG-2; TRAFAC GTPase DRG2; Translation factor GTPase DRG2",
        "protein_names_refseq": "TRAFAC GTPase DRG2; developmentally-regulated GTP-binding protein 2; translation factor GTPase DRG2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13495);  (R-MMU-9629569)",
        "pathway_count": 2,
        "publication_count": 17,
        "publication_id_list": "10760581;15676025;19224205;19892989;20173027;25428506;27802388;28865956;30084848;30779550;31219806;31861806;34428180;36210013;37507081;37828378;37918467",
        "class_list": "",
        "function": "Catalyzes the conversion of GTP to GDP through hydrolysis of the gamma-phosphate bond in GTP. When hydroxylated at C-3 of 'Lys-21' by JMJD7, may bind to RNA and play a role in translation., [UniProtKB, UniProtKB]; DRG2 in macrophages is crucial for initial inflammatory response and protection against Listeria monocytogenes infection., [RefSeq, PubMed]; DRG2 knockout (KO) mice displayed defects in motor function in motor coordination and rotarod tests and increased anxiety. Publication Status: Online-Only, [RefSeq, PubMed]; Our results reveal a novel mechanism for regulation of membrane tubule stability mediated by DRG2., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q5SX94",
        "ec_number_list": "3.6.5.-;3.6.5.2;3.6.5.3;3.6.1.5;3.4.-.-;1.14.11.63;3.6.5.4;3.6.5.5;3.6.1.-;3.6.1.15;2.7.11.1;3.6.-.-",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0003924 GTPase activity;GO:0005525 GTP binding;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005829 cytosol",
        "go_biological_process": "GO:0002181 cytoplasmic translation",
        "synthesized_glycan_count": 0,
        "hit_score": 2.0,
        "record_id": "Q9QXB9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9QYY7-1",
        "uniprot_id": "ESM1_MOUSE",
        "mass": 20043.0,
        "length": 184,
        "protein_name": "Endothelial cell-specific molecule 1",
        "gene_name": "Esm1",
        "organism": "Mouse",
        "refseq_name": "endothelial cell-specific molecule 1 precursor",
        "refseq_ac": "NP_076101",
        "gene_names_uniprotkb": "Esm1",
        "gene_names_refseq": "0610042H23Rik; ESM-1; Esm1",
        "protein_names_uniprotkb": "Endothelial cell-specific molecule 1; ESM-1",
        "protein_names_refseq": "endothelial cell-specific molecule 1 precursor",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71690)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "16956626;20516397;22370430;24055127;30084848;30779550",
        "class_list": "glycogene",
        "function": "A paracrine vasoregulatory pathway mediated by endothelial cell-derived ET-1 acting on the vascular smooth muscle ET(A) receptor., [RefSeq, PubMed]; Endocan is normally present in the mouse brain and prior vascular perfusion with FITC may provide a useful tool for identify newly forming blood vessels., [RefSeq, PubMed]; Involved in angiogenesis; promotes angiogenic sprouting. May have potent implications in lung endothelial cell-leukocyte interactions (By similarity)., [UniProtKB]; Mouse endocan serum level was measured at a median of 0.96 ng/mL and 1.08 ng/mL in 129Sv mice and C57bl6, respectively., [RefSeq, PubMed]; Results suggest that endocan (ESM-1)is preferentially expressed in tumor endothelium in vivo and that its expression is regulated by tumor-derived factors., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005171 hepatocyte growth factor receptor binding;GO:0005178 integrin binding",
        "go_cellular_component": "GO:0005576 extracellular region",
        "go_biological_process": "GO:1902204 positive regulation of hepatocyte growth factor receptor signaling pathway;GO:0001525 angiogenesis;GO:0008284 positive regulation of cell population proliferation;GO:0002040 sprouting angiogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "Q9QYY7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P08508-1",
        "uniprot_id": "FCGR3_MOUSE",
        "mass": 30036.0,
        "length": 261,
        "protein_name": "Low affinity immunoglobulin gamma Fc region receptor III",
        "gene_name": "Fcgr3",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Fcgr3",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Low affinity immunoglobulin gamma Fc region receptor III; Fc-gamma RIII; FcRIII; IgG Fc receptor III",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "diffuse large B-cell lymphoma (Disease Ontology:DOID:0050745); stroke (Disease Ontology:DOID:0051061); non-Hodgkin lymphoma (Disease Ontology:DOID:0060060); thrombosis (Disease Ontology:DOID:0060903); lupus nephritis (Disease Ontology:DOID:0080162); haemophilus meningitis (Disease Ontology:DOID:0080179); lymphoid leukemia (Disease Ontology:DOID:1037); hemolytic disease of the fetus (Disease Ontology:DOID:1098); factor VIII deficiency (Disease Ontology:DOID:12134); common variable immunodeficiency (Disease Ontology:DOID:12177); dengue disease (Disease Ontology:DOID:12205); dengue hemorrhagic fever (Disease Ontology:DOID:12206); neutropenia (Disease Ontology:DOID:1227); malaria (Disease Ontology:DOID:12365); crescentic glomerulonephritis (Disease Ontology:DOID:13139); temporal arteritis (Disease Ontology:DOID:13375); Plasmodium falciparum malaria (Disease Ontology:DOID:14067); cystic fibrosis (Disease Ontology:DOID:1485); arthus reaction (Disease Ontology:DOID:1556); respiratory system disease (Disease Ontology:DOID:1579); diffuse scleroderma (Disease Ontology:DOID:1580); thrombocytopenia (Disease Ontology:DOID:1588); epilepsy (Disease Ontology:DOID:1826); atherosclerosis (Disease Ontology:DOID:1936); asthma (Disease Ontology:DOID:2841); atopic dermatitis (Disease Ontology:DOID:3310); coronary artery disease (Disease Ontology:DOID:3393); hemolytic anemia (Disease Ontology:DOID:583); lymphopenia (Disease Ontology:DOID:614); rheumatoid arthritis (Disease Ontology:DOID:7148); osteoarthritis (Disease Ontology:DOID:8398); chronic myeloid leukemia (Disease Ontology:DOID:8552); ulcerative colitis (Disease Ontology:DOID:8577); Crohn's disease (Disease Ontology:DOID:8778); psoriasis (Disease Ontology:DOID:8893); autoimmune thrombocytopenic purpura (Disease Ontology:DOID:8924); systemic lupus erythematosus (Disease Ontology:DOID:9074); multiple myeloma (Disease Ontology:DOID:9538)",
        "pathway": " (mmu:14131)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "12393695;17558411;18097064;21750661;29237092;2946078;34428180;8070412",
        "class_list": "",
        "function": "Receptor for the Fc region of complexed immunoglobulins gamma. Low affinity receptor which binds to IgG1, IgG2a and IgG2b (PubMed:17558411). Mediates neutrophil activation by IgG complexes redundantly with Fcgr4 (PubMed:18097064)., [UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 4,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 4,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 4,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 4,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 38,
        "glyco_site_count": 8,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0034987 immunoglobulin receptor binding;GO:0019864 IgG binding;GO:0019770 IgG receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0009897 external side of plasma membrane",
        "go_biological_process": "GO:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I;GO:0006911 phagocytosis, engulfment;GO:0007166 cell surface receptor signaling pathway;GO:0050776 regulation of immune response;GO:0050766 positive regulation of phagocytosis",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "P08508-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P0DM40-1",
        "uniprot_id": "FR1L5_MOUSE",
        "mass": 235837.0,
        "length": 2038,
        "protein_name": "Fer-1-like protein 5",
        "gene_name": "Fer1l5",
        "organism": "Mouse",
        "refseq_name": "fer-1-like protein 5",
        "refseq_ac": "NP_001264005",
        "gene_names_uniprotkb": "Fer1l5",
        "gene_names_refseq": "4930533C12Rik; Fer1l5",
        "protein_names_uniprotkb": "Fer-1-like protein 5",
        "protein_names_refseq": "fer-1-like 5 protein; fer-1-like protein 5",
        "tax_id": 10090,
        "disease": "limb-girdle muscular dystrophy (Disease Ontology:DOID:11724)",
        "pathway": " (mmu:100534273)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "21177873;21750661;33182221;35820727;36696506",
        "class_list": "",
        "function": "Plays a crucial role in male fertility, primarily through its involvement in the acrosome reaction of spermatozoa. Required for the Ca(2+)-activated fusion of the acrosomal membrane with the plasma membrane during the acrosome reaction (PubMed:36696506). May play a role in skeletal muscle cell development by ensuring effective myoblast fusion and facilitating membrane repair (PubMed:21177873, PubMed:33182221)., [UniProtKB, PubMed, PubMed, PubMed]; Testis-enriched ferlin, FER1L5, is required for Ca[2+]-activated acrosome reaction and male fertility., [RefSeq, PubMed]; The characterization of Fer1L5 and its interaction with EHD1 and EHD2 underscores the complex requirement of ferlin proteins and mediators of endocytic recycling for membrane trafficking events during myotube formation, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "M1J7P7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0030659 cytoplasmic vesicle membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0001778 plasma membrane repair;GO:0007339 binding of sperm to zona pellucida;GO:0007520 myoblast fusion;GO:0061025 membrane fusion;GO:0033292 T-tubule organization",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P0DM40-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A1YIY0-1",
        "uniprot_id": "FCRL6_MOUSE",
        "mass": 30237.0,
        "length": 268,
        "protein_name": "Fc receptor-like protein 6",
        "gene_name": "Fcrl6",
        "organism": "Mouse",
        "refseq_name": "Fc receptor-like protein 6 precursor",
        "refseq_ac": "NP_001158197",
        "gene_names_uniprotkb": "Fcrl6",
        "gene_names_refseq": "FcRH6; Fcrl6; mIFGP6; moFcRH6",
        "protein_names_uniprotkb": "Fc receptor-like protein 6; FcR-like protein 6; FcRL6",
        "protein_names_refseq": "Fc receptor-like protein 6 precursor; cell surface glycoprotein gp42; fc receptor-like protein 6; fcR-like protein 6",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:677296)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "17213291;32117244",
        "class_list": "",
        "function": "Acts as a MHC class II receptor. When stimulated on its own, does not play a role in cytokine production or the release of cytotoxic granules by NK cells and cytotoxic CD8(+) T cells. Does not act as an Fc receptor., [UniProtKB, UniProtKB]; Fc Receptor-Like 6 (FCRL6) Discloses Progenitor B Cell Heterogeneity That Correlates With Pre-BCR Dependent and Independent Pathways of Natural Antibody Selection. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QM04",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004888 transmembrane signaling receptor activity;GO:0019903 protein phosphatase binding;GO:0019902 phosphatase binding;GO:0042289 MHC class II protein binding",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0009897 external side of plasma membrane",
        "go_biological_process": "GO:0006955 immune response;GO:0007166 cell surface receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "A1YIY0-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2A995-1",
        "uniprot_id": "FYB2_MOUSE",
        "mass": 82296.0,
        "length": 729,
        "protein_name": "FYN-binding protein 2",
        "gene_name": "Fyb2",
        "organism": "Mouse",
        "refseq_name": "FYN-binding protein 2 isoform b",
        "refseq_ac": "NP_001156452",
        "gene_names_uniprotkb": "Fyb2; 1700024P16Rik; ARAP",
        "gene_names_refseq": "1700024P16Rik; ARAP; C1orf168; Fyb2; Gm620",
        "protein_names_uniprotkb": "FYN-binding protein 2; Activation-dependent, raft-recruited ADAP-like phosphoprotein",
        "protein_names_refseq": "FYN-binding protein 2 isoform b; activation-dependent, raft-recruited ADAP-like phosphoprotein; uncharacterized protein C1orf168 homolog",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:242594)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "17242355;21750661;34428180",
        "class_list": "",
        "function": "Adapter protein that plays a role in T-cell receptor (TCR)-mediated activation of signaling pathways. Required for T-cell activation and integrin-mediated T-cell adhesion in response to TCR stimulation., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0045121 membrane raft;GO:0001772 immunological synapse",
        "go_biological_process": "GO:0007229 integrin-mediated signaling pathway;GO:0072659 protein localization to plasma membrane;GO:0050852 T cell receptor signaling pathway;GO:0033627 cell adhesion mediated by integrin",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "A2A995-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2ACJ2-1",
        "uniprot_id": "FP100_MOUSE",
        "mass": 94281.0,
        "length": 879,
        "protein_name": "Fanconi anemia core complex-associated protein 100",
        "gene_name": "Faap100",
        "organism": "Mouse",
        "refseq_name": "Fanconi anemia core complex-associated protein 100",
        "refseq_ac": "NP_082256",
        "gene_names_uniprotkb": "Faap100",
        "gene_names_refseq": "2310003H01Rik; Faap100",
        "protein_names_uniprotkb": "Fanconi anemia core complex-associated protein 100; Fanconi anemia-associated protein of 100 kDa",
        "protein_names_refseq": "Fanconi anemia core complex-associated protein 100; fanconi anemia-associated protein of 100 kDa",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71885);  (R-MMU-6783310);  (R-MMU-9833482)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "25428506;30084848;34428180;37580696",
        "class_list": "",
        "function": "FAAP100 is required for the resolution of transcription-replication conflicts in primordial germ cells. Publication Status: Online-Only, [RefSeq, PubMed]; Plays a role in Fanconi anemia-associated DNA damage response network. Regulates FANCD2 monoubiquitination and the stability of the FA core complex. Induces chromosomal instability as well as hypersensitivity to DNA cross-linking agents, when repressed (By similarity)., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q0P653;Q810W2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding",
        "go_cellular_component": "GO:0043240 Fanconi anaemia nuclear complex;GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0000785 chromatin",
        "go_biological_process": "GO:0036297 interstrand cross-link repair",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "A2ACJ2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A2AKB4-1",
        "uniprot_id": "FRPD1_MOUSE",
        "mass": 169208.0,
        "length": 1549,
        "protein_name": "FERM and PDZ domain-containing protein 1",
        "gene_name": "Frmpd1",
        "organism": "Mouse",
        "refseq_name": "FERM and PDZ domain-containing protein 1",
        "refseq_ac": "NP_001074641",
        "gene_names_uniprotkb": "Frmpd1; Kiaa0967",
        "gene_names_refseq": "Frmpd1; mKIAA0967",
        "protein_names_uniprotkb": "FERM and PDZ domain-containing protein 1",
        "protein_names_refseq": "FERM and PDZ domain-containing protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:666060)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "21750661;22517741;23318951;36180221;39627609;40885482",
        "class_list": "",
        "function": "Frmpd1 Facilitates Trafficking of G-Protein Transducin and Modulates Synaptic Function in Rod Photoreceptors of Mammalian Retina. Publication Status: Online-Only, [RefSeq, PubMed]; Stabilizes membrane-bound GPSM1, and thereby promotes its interaction with GNAI1., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 4,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 4,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 2,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 6,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80TN2;Q80XK5;Q8K0C0",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0005938 cell cortex;GO:0032991 protein-containing complex",
        "go_biological_process": "GO:0007165 signal transduction;GO:0015031 protein transport;GO:0009642 response to light intensity;GO:0090150 establishment of protein localization to membrane;GO:0008277 regulation of G protein-coupled receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "A2AKB4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A4FUQ5-1",
        "uniprot_id": "FPRS4_MOUSE",
        "mass": 36294.0,
        "length": 323,
        "protein_name": "Formyl peptide receptor-related sequence 4",
        "gene_name": "Fpr-rs4",
        "organism": "Mouse",
        "refseq_name": "formyl peptide receptor-related sequence 4",
        "refseq_ac": "NP_032067",
        "gene_names_uniprotkb": "Fpr-rs4",
        "gene_names_refseq": "Fpr-rs4",
        "protein_names_uniprotkb": "Formyl peptide receptor-related sequence 4; N-formylpeptide receptor-like 4",
        "protein_names_refseq": "N-formylpeptide receptor-like 4; formyl peptide receptor-related sequence 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:14291);  (R-MMU-418594);  (R-MMU-444473)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "19387439;19497865;34428180;9722950",
        "class_list": "",
        "function": "May have an olfactory function associated with the identification of pathogens or of pathogenic states., [UniProtKB, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A4QMY2;E9QPJ4;O88538",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004875 complement receptor activity;GO:0004982 N-formyl peptide receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0002430 complement receptor mediated signaling pathway;GO:0006954 inflammatory response;GO:0007204 positive regulation of cytosolic calcium ion concentration;GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "A4FUQ5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "A6PWD2-1",
        "uniprot_id": "FHAD1_MOUSE",
        "mass": 163728.0,
        "length": 1420,
        "protein_name": "Forkhead-associated domain-containing protein 1",
        "gene_name": "Fhad1",
        "organism": "Mouse",
        "refseq_name": "forkhead-associated domain-containing protein 1",
        "refseq_ac": "NP_808536",
        "gene_names_uniprotkb": "Fhad1",
        "gene_names_refseq": "2900090M10Rik; B230311F11; Fhad1",
        "protein_names_uniprotkb": "Forkhead-associated domain-containing protein 1; FHA domain-containing protein 1",
        "protein_names_refseq": "FHA domain-containing protein 1; forkhead-associated (FHA) phosphopeptide binding domain 1; forkhead-associated domain-containing protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:329977)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "26495903;35820727;38563001",
        "class_list": "",
        "function": "Forkhead-associated phosphopeptide binding domain 1 (FHAD1) deficiency impaired murine sperm motility. Publication Status: Online-Only, [RefSeq, PubMed]; Regulator of sperm motility and spermatocyte meiosis., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2AAC3;Q3UFH8;Q8BLA4;Q8CHV8;Q9CUV2",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0036126 sperm flagellum",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0030154 cell differentiation;GO:0006915 apoptotic process;GO:0051321 meiotic cell cycle",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "A6PWD2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35943-1",
        "uniprot_id": "FRDA_MOUSE",
        "mass": 22924.0,
        "length": 207,
        "protein_name": "Frataxin, mitochondrial",
        "gene_name": "Fxn",
        "organism": "Mouse",
        "refseq_name": "frataxin, mitochondrial precursor",
        "refseq_ac": "NP_032070",
        "gene_names_uniprotkb": "Fxn; Frda",
        "gene_names_refseq": "FARR; FA; Frda; Fxn; X25",
        "protein_names_uniprotkb": "Frataxin, mitochondrial; 1.16.3.1; Fxn",
        "protein_names_refseq": "Friedreich ataxia; frataxin, mitochondrial precursor; frataxin, mitochondrial",
        "tax_id": 10090,
        "disease": "Friedreich ataxia 1 (Disease Ontology:DOID:0111218); Friedreich ataxia (Disease Ontology:DOID:12705); cancer (Disease Ontology:DOID:162); iron metabolism disease (Disease Ontology:DOID:2351); glioblastoma (Disease Ontology:DOID:3068); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
        "pathway": " (mmu:14297);  (R-MMU-1268020);  (R-MMU-1362409);  (R-MMU-9854311);  (R-MMU-9865881)",
        "pathway_count": 5,
        "publication_count": 11,
        "publication_id_list": "11823441;17597094;18725397;19629184;19805308;21298097;21750661;25597503;30084848;34428180;9241270",
        "class_list": "",
        "function": "Functions as an activator of persulfide transfer to the scaffoding protein ISCU as component of the core iron-sulfur cluster (ISC) assembly complex and participates to the [2Fe-2S] cluster assembly (PubMed:19805308, PubMed:25597503). Accelerates sulfur transfer from NFS1 persulfide intermediate to ISCU and to small thiols such as L-cysteine and glutathione leading to persulfuration of these thiols and ultimately sulfide release (PubMed:25597503). Binds ferrous ion and is released from FXN upon the addition of both L-cysteine and reduced FDX2 during [2Fe-2S] cluster assembly (By similarity). The core iron-sulfur cluster (ISC) assembly complex is involved in the de novo synthesis of a [2Fe-2S] cluster, the first step of the mitochondrial iron-sulfur protein biogenesis. This process is initiated by the cysteine desulfurase complex (NFS1:LYRM4:NDUFAB1) that produces persulfide which is delivered on the scaffold protein ISCU in a FXN-dependent manner. Then this complex is stabilized by FDX2 which provides reducing equivalents to accomplish the [2Fe-2S] cluster assembly. Finally, the [2Fe-2S] cluster is transferred from ISCU to chaperone proteins, including HSCB, HSPA9 and GLRX5 (By similarity). May play a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe(2+) to Fe(3+); the oligomeric form but not the monomeric form has in vitro ferroxidase activity. May be able to store large amounts of iron in the form of a ferrihydrite mineral by oligomerization; however, the physiological relevance is unsure as reports are conflicting and the function has only been shown using heterologous overexpression systems. May function as an iron chaperone protein that protects the aconitase [4Fe-4S]2+ cluster from disassembly and promotes enzyme reactivation. May play a role as a high affinity iron binding partner for FECH that is capable of both delivering iron to ferrochelatase and mediating the terminal step in mitochondrial heme biosynthesis (By similarity)., [UniProtKB, PubMed, UniProtKB, UniProtKB, PubMed]; Modulates the RNA-binding activity of ACO1. May be involved in the cytoplasmic iron-sulfur protein biogenesis. May contribute to oxidative stress resistance and overall cell survival., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 6,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.16.3.1;2.1.3.3;3.6.4.10;7.1.2.2;5.6.1.7;1.11.1.27;1.11.1.9;1.16.3.4;2.5.1.39;1.1.98.-;3.4.24.-;4.2.1.3;1.3.5.1;1.1.5.-;7.1.1.8;2.8.1.7",
        "go_molecular_function": "GO:0008047 enzyme activator activity;GO:0019899 enzyme binding;GO:0051537 2 iron, 2 sulfur cluster binding;GO:0008198 ferrous iron binding;GO:0004322 ferroxidase activity",
        "go_cellular_component": "GO:0005739 mitochondrion;GO:0005829 cytosol;GO:0099128 mitochondrial [2Fe-2S] assembly complex;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0016226 iron-sulfur cluster assembly;GO:0046621 negative regulation of organ growth;GO:0009792 embryo development ending in birth or egg hatching;GO:0010888 negative regulation of lipid storage;GO:0043066 negative regulation of apoptotic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "O35943-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O08790-1",
        "uniprot_id": "FPRS1_MOUSE",
        "mass": 39523.0,
        "length": 351,
        "protein_name": "Formyl peptide receptor-related sequence 1",
        "gene_name": "Fpr-s1",
        "organism": "Mouse",
        "refseq_name": "formyl peptide receptor-related sequence 1",
        "refseq_ac": "NP_032068",
        "gene_names_uniprotkb": "Fpr-s1; Fpr2; Fpr3; Fprl1; Lxa4r",
        "gene_names_refseq": "ALX; Fpr-rs1; Fpr-s1; Fpr3; Fprl1; LXA4-R; Lxa4r",
        "protein_names_uniprotkb": "Formyl peptide receptor-related sequence 1; FMLP-R-I; FMLP-related receptor I; Formyl peptide receptor related sequence 1; Formyl peptide receptor-like 1; LXA4 receptor; Lipoxin A4 receptor; N-formyl peptide receptor 2; N-formyl peptide receptor 3",
        "protein_names_refseq": "FMLP-R-I; FMLP-related receptor I; LXA4 receptor; N-formyl peptide receptor 2; N-formyl peptide receptor 3; N-formylpeptide receptor-like 1; formyl peptide receptor-like 1; formyl peptide receptor-related sequence 1; lipoxin A4 receptor",
        "tax_id": 10090,
        "disease": "dentin caries (Disease Ontology:DOID:10461)",
        "pathway": " (mmu:14294);  (R-MMU-418594);  (R-MMU-444473)",
        "pathway_count": 3,
        "publication_count": 9,
        "publication_id_list": "12218158;19387439;19497865;25428506;32617132;36834844;37422776;9151906;9722950",
        "class_list": "",
        "function": "Deletion of Annexin A1 in Mice Upregulates the Expression of Its Receptor, Fpr2/3, and Reactivity to the AnxA1 Mimetic Peptide in Platelets. Publication Status: Online-Only, [RefSeq, PubMed]; FoxO4 mediates macrophage M2 polarization by promoting LXA4R expression in an ovalbumin-induced allergic asthma model in mice. Publication Status: Online-Only, [RefSeq, PubMed]; Low affinity receptor for N-formyl-methionyl peptides. Receptor for lipoxin A4. May have an olfactory function associated with the identification of pathogens or of pathogenic states., [UniProtKB, PubMed]; Reversal of beta-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3. Publication Status: Online-Only, [RefSeq, PubMed]; This homologue receptor shows 89% sequence identity with murine lipoxin A4 receptor cDNA and functionally responds to LXA4 as a ligand., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O88535",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004875 complement receptor activity;GO:0004982 N-formyl peptide receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0002430 complement receptor mediated signaling pathway;GO:0006935 chemotaxis;GO:0006954 inflammatory response;GO:0007204 positive regulation of cytosolic calcium ion concentration;GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "O08790-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35565-1",
        "uniprot_id": "FGF10_MOUSE",
        "mass": 23597.0,
        "length": 209,
        "protein_name": "Fibroblast growth factor 10",
        "gene_name": "Fgf10",
        "organism": "Mouse",
        "refseq_name": "fibroblast growth factor 10 precursor",
        "refseq_ac": "NP_032028",
        "gene_names_uniprotkb": "Fgf10",
        "gene_names_refseq": "AEY17; Fgf-10; Fgf10; Fgf5a; Gsfaey17",
        "protein_names_uniprotkb": "Fibroblast growth factor 10; FGF-10; Keratinocyte growth factor 2",
        "protein_names_refseq": "fibroblast growth factor 10 precursor; fibroblast growth factor 5a; keratinocyte growth factor 2",
        "tax_id": 10090,
        "disease": "lacrimoauriculodentodigital syndrome 1 (Disease Ontology:DOID:0050331); developmental and epileptic encephalopathy 47 (Disease Ontology:DOID:0080425); lacrimoauriculodentodigital syndrome 3 (Disease Ontology:DOID:0081372); aplasia of lacrimal and salivary glands (Disease Ontology:DOID:0111549); intestinal atresia (Disease Ontology:DOID:10486); hypospadias (Disease Ontology:DOID:10892)",
        "pathway": " (mmu:14165);  (R-MMU-109704);  (R-MMU-1257604);  (R-MMU-190370);  (R-MMU-190377);  (R-MMU-5654219);  (R-MMU-5654221);  (R-MMU-5654687);  (R-MMU-5654688);  (R-MMU-5654689);  (R-MMU-5654693);  (R-MMU-5654695);  (R-MMU-5654699);  (R-MMU-5654700);  (R-MMU-5654726);  (R-MMU-5654727);  (R-MMU-5658623);  (R-MMU-5673001);  (R-MMU-6811558)",
        "pathway_count": 19,
        "publication_count": 2,
        "publication_id_list": "35820727;9332392",
        "class_list": "glycogene",
        "function": "Plays an important role in the regulation of embryonic development, cell proliferation and cell differentiation. Required for normal branching morphogenesis. May play a role in wound healing., [UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 11,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 6,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q543V5",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008201 heparin binding;GO:0042056 chemoattractant activity;GO:0008083 growth factor activity;GO:0005111 type 2 fibroblast growth factor receptor binding;GO:0005104 fibroblast growth factor receptor binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0009986 cell surface",
        "go_biological_process": "GO:0030878 thyroid gland development;GO:0046579 positive regulation of Ras protein signal transduction;GO:0001759 organ induction;GO:0048752 semicircular canal morphogenesis;GO:0060594 mammary gland specification",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "O35565-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35969-1",
        "uniprot_id": "GAMT_MOUSE",
        "mass": 26336.0,
        "length": 236,
        "protein_name": "Guanidinoacetate N-methyltransferase",
        "gene_name": "Gamt",
        "organism": "Mouse",
        "refseq_name": "guanidinoacetate N-methyltransferase isoform 2",
        "refseq_ac": "NP_001334048",
        "gene_names_uniprotkb": "Gamt",
        "gene_names_refseq": "Gamt; Spintz1",
        "protein_names_uniprotkb": "Guanidinoacetate N-methyltransferase; 2.1.1.2",
        "protein_names_refseq": "guanidinoacetate N-methyltransferase isoform 2; guanidinoacetate N-methyltransferase",
        "tax_id": 10090,
        "disease": "guanidinoacetate methyltransferase deficiency (Disease Ontology:DOID:0050799); pre-eclampsia (Disease Ontology:DOID:10591); amino acid metabolic disorder (Disease Ontology:DOID:9252)",
        "pathway": " (mmu:14431);  (R-MMU-71288)",
        "pathway_count": 2,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;15245487;30084848;34428180;34440375;8312439;9325156",
        "class_list": "",
        "function": "Converts guanidinoacetate to creatine, using S-adenosylmethionine as the methyl donor. Important in nervous system development., [UniProtKB, UniProtKB]; Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency. Review article Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 9781,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 3,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TZ58;Q3US90",
        "ec_number_list": "2.1.1.2",
        "go_molecular_function": "GO:0030731 guanidinoacetate N-methyltransferase activity;GO:0042802 identical protein binding;GO:0008757 S-adenosylmethionine-dependent methyltransferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0005902 microvillus",
        "go_biological_process": "GO:0007283 spermatogenesis;GO:0040014 regulation of multicellular organism growth;GO:0009887 animal organ morphogenesis;GO:0032259 methylation;GO:0046498 S-adenosylhomocysteine metabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "O35969-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O54743-1",
        "uniprot_id": "FOXF2_MOUSE",
        "mass": 46383.0,
        "length": 446,
        "protein_name": "Forkhead box protein F2",
        "gene_name": "Foxf2",
        "organism": "Mouse",
        "refseq_name": "forkhead box protein F2",
        "refseq_ac": "NP_034355",
        "gene_names_uniprotkb": "Foxf2; Lun",
        "gene_names_refseq": "FREAC2; Fkh20; Foxf2; LUN",
        "protein_names_uniprotkb": "Forkhead box protein F2; Protein LUN",
        "protein_names_refseq": "forkhead box protein F2; forkhead homolog 20",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:14238)",
        "pathway_count": 1,
        "publication_count": 1,
        "publication_id_list": "9676429",
        "class_list": "",
        "function": "Probable transcription activator for a number of lung-specific genes (PubMed:9676429). Mediates up-regulation of the E3 ligase IRF2BPL and drives ubiquitination and degradation of CTNNB1 (By similarity)., [UniProtKB, PubMed, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RQI5;Q3V1L3;Q78DW1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001093 TFIIB-class transcription factor binding;GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0016604 nuclear body;GO:0005667 transcription regulator complex",
        "go_biological_process": "GO:0048806 genitalia development;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0030198 extracellular matrix organization;GO:0045944 positive regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "O54743-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O70220-1",
        "uniprot_id": "FOXQ1_MOUSE",
        "mass": 41368.0,
        "length": 400,
        "protein_name": "Forkhead box protein Q1",
        "gene_name": "Foxq1",
        "organism": "Mouse",
        "refseq_name": "forkhead box protein Q1",
        "refseq_ac": "NP_032265",
        "gene_names_uniprotkb": "Foxq1; Hfh1l; Hfh1",
        "gene_names_refseq": "Foxq1; HFH-1; Hfh1l; Hfh1; sa",
        "protein_names_uniprotkb": "Forkhead box protein Q1; HFH-1l; HFH-1; HNF-3/forkhead-like protein 1; Hepatocyte nuclear factor 3 forkhead homolog 1",
        "protein_names_refseq": "HFH-1l; HNF-3/forkhead homolog 1 like; HNF-3/forkhead-like protein 1; forkhead box protein Q1; hepatocyte nuclear factor 3 forkhead homolog 1; satin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:15220)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "11309849;16835220;36575252;37591453;38503493;9726250",
        "class_list": "",
        "function": "FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643/miR-153/SLC7A11 axis., [RefSeq, PubMed]; FOXQ1 inhibits the progression of osteoarthritis by regulating pyroptosis., [RefSeq, PubMed]; Plays a role in hair follicle differentiation., [UniProtKB, PubMed]; STUB1 directs FOXQ1-mediated transactivation of Ldha gene and facilitates lactate production in mouse Sertoli cells., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9JJ18",
        "ec_number_list": "",
        "go_molecular_function": "GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:1990837 sequence-specific double-stranded DNA binding",
        "go_cellular_component": "GO:0005634 nucleus",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0030154 cell differentiation;GO:0031069 hair follicle morphogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "O70220-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88537-1",
        "uniprot_id": "FPRS3_MOUSE",
        "mass": 38064.0,
        "length": 343,
        "protein_name": "Formyl peptide receptor-related sequence 3",
        "gene_name": "Fpr-rs3",
        "organism": "Mouse",
        "refseq_name": "formyl peptide receptor-related sequence 3",
        "refseq_ac": "NP_032066",
        "gene_names_uniprotkb": "Fpr-rs3",
        "gene_names_refseq": "Fpr-rs3",
        "protein_names_uniprotkb": "Formyl peptide receptor-related sequence 3",
        "protein_names_refseq": "N-formylpeptide receptor-like 3; formyl peptide receptor-related sequence 3",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:14290);  (R-MMU-418594);  (R-MMU-444473)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "19387439;19497865;31599954;9722950",
        "class_list": "",
        "function": "May have an olfactory function associated with the identification of pathogens or of pathogenic states., [UniProtKB, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A4IF56;E9QL30",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004875 complement receptor activity;GO:0004982 N-formyl peptide receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0002430 complement receptor mediated signaling pathway;GO:0006935 chemotaxis;GO:0006954 inflammatory response;GO:0007204 positive regulation of cytosolic calcium ion concentration;GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "O88537-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O89101-1",
        "uniprot_id": "FGF18_MOUSE",
        "mass": 23921.0,
        "length": 207,
        "protein_name": "Fibroblast growth factor 18",
        "gene_name": "Fgf18",
        "organism": "Mouse",
        "refseq_name": "fibroblast growth factor 18 precursor",
        "refseq_ac": "NP_032031",
        "gene_names_uniprotkb": "Fgf18",
        "gene_names_refseq": "D130055P09Rik; FGF-18; Fgf18; Fgf6a",
        "protein_names_uniprotkb": "Fibroblast growth factor 18; FGF-18; zFGF5",
        "protein_names_refseq": "fibroblast growth factor 18 precursor; fibroblast growth factor 6a; zFGF5",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:14172);  (R-MMU-109704);  (R-MMU-1257604);  (R-MMU-190322);  (R-MMU-190371);  (R-MMU-190372);  (R-MMU-190375);  (R-MMU-5654221);  (R-MMU-5654227);  (R-MMU-5654228);  (R-MMU-5654695);  (R-MMU-5654699);  (R-MMU-5654700);  (R-MMU-5654704);  (R-MMU-5654706);  (R-MMU-5654710);  (R-MMU-5654712);  (R-MMU-5654719);  (R-MMU-5654720);  (R-MMU-5654727);  (R-MMU-5654732);  (R-MMU-5654733);  (R-MMU-5658623);  (R-MMU-5673001);  (R-MMU-6811558)",
        "pathway_count": 25,
        "publication_count": 4,
        "publication_id_list": "21750661;9651520;9660775;9742123",
        "class_list": "glycogene",
        "function": "Plays an important role in the regulation of cell proliferation, cell differentiation and cell migration. Required for normal ossification and bone development. Stimulates hepatic and intestinal proliferation (By similarity)., [UniProtKB]; The expression from early streak stage to midgestation of Fgf18 is measured. It is, closely related to Fgf8 (56.8% identical at the amino acid level). Fgf18 RNA is not expressed until later, in paraxial mesoderm., [RefSeq, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 14,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005105 type 1 fibroblast growth factor receptor binding;GO:0008083 growth factor activity;GO:0005111 type 2 fibroblast growth factor receptor binding;GO:0005104 fibroblast growth factor receptor binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005634 nucleus;GO:0005730 nucleolus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:2000347 positive regulation of hepatocyte proliferation;GO:0001525 angiogenesis;GO:0007165 signal transduction;GO:0007399 nervous system development;GO:0008284 positive regulation of cell population proliferation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "O89101-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P01863-1",
        "uniprot_id": "GCAA_MOUSE",
        "mass": 36389.0,
        "length": 330,
        "protein_name": "Ig gamma-2A chain C region, A allele",
        "gene_name": "Ighg",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Ighg",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Ig gamma-2A chain C region, A allele; Immunoglobulin heavy chain gamma polypeptide",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 11,
        "publication_id_list": "17330941;31219806;33725478;34428180;35820727;36583994;4565406;4831970;6262729;6777755;6787604",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 2,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0034987 immunoglobulin receptor binding;GO:0034988 Fc-gamma receptor I complex binding;GO:0003823 antigen binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0042571 immunoglobulin complex, circulating;GO:0071735 IgG immunoglobulin complex",
        "go_biological_process": "GO:0019731 antibacterial humoral response;GO:0006958 complement activation, classical pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.5,
        "record_id": "P01863-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P0DJI6-1",
        "uniprot_id": "FCOR_MOUSE",
        "mass": 11233.0,
        "length": 106,
        "protein_name": "Foxo1-corepressor",
        "gene_name": "Fcor",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Fcor",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Foxo1-corepressor; 2.3.1.-; FCoR; Foxo1 CoRepressor",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "",
        "pathway": "",
        "pathway_count": 0,
        "publication_count": 1,
        "publication_id_list": "22510882",
        "class_list": "",
        "function": "Regulator of adipocytes that acts by repressing FOXO1 transcriptional activity. Acts by promoting acetylation of FOXO1, both by preventing the interaction between FOXO1 and SIRT1 deacetylase, and by mediating acetyltransferase activity in vitro. Regulates insulin sensitivity and energy metabolism., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 8,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A5S7P8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003682 chromatin binding;GO:0016407 acetyltransferase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005739 mitochondrion;GO:0005829 cytosol",
        "go_biological_process": "GO:0070417 cellular response to cold;GO:0001659 temperature homeostasis;GO:0006351 DNA-templated transcription;GO:0045892 negative regulation of DNA-templated transcription;GO:0097009 energy homeostasis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.2,
        "record_id": "P0DJI6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P15656-1",
        "uniprot_id": "FGF5_MOUSE",
        "mass": 29103.0,
        "length": 264,
        "protein_name": "Fibroblast growth factor 5",
        "gene_name": "Fgf5",
        "organism": "Mouse",
        "refseq_name": "fibroblast growth factor 5 isoform 2 precursor",
        "refseq_ac": "NP_001264197",
        "gene_names_uniprotkb": "Fgf5; Fgf-5",
        "gene_names_refseq": "Fgf-5; Fgf3a; Fgf5; HBGF-5; angora; go",
        "protein_names_uniprotkb": "Fibroblast growth factor 5; FGF-5; HBGF-5; Heparin-binding growth factor 5",
        "protein_names_refseq": "fibroblast growth factor 3a; fibroblast growth factor 5 isoform 2 precursor; heparin-binding growth factor 5",
        "tax_id": 10090,
        "disease": "developmental and epileptic encephalopathy 47 (Disease Ontology:DOID:0080425); familial isolated trichomegaly (Disease Ontology:DOID:0111566)",
        "pathway": " (mmu:14176);  (R-MMU-109704);  (R-MMU-1257604);  (R-MMU-190372);  (R-MMU-190373);  (R-MMU-190375);  (R-MMU-5654219);  (R-MMU-5654221);  (R-MMU-5654227);  (R-MMU-5654687);  (R-MMU-5654688);  (R-MMU-5654689);  (R-MMU-5654693);  (R-MMU-5654695);  (R-MMU-5654699);  (R-MMU-5654700);  (R-MMU-5654704);  (R-MMU-5654706);  (R-MMU-5654710);  (R-MMU-5654726);  (R-MMU-5654727);  (R-MMU-5654732);  (R-MMU-5658623);  (R-MMU-5673001);  (R-MMU-6811558)",
        "pathway_count": 25,
        "publication_count": 5,
        "publication_id_list": "1700424;2318343;25428506;36244113;9786939",
        "class_list": "glycogene",
        "function": "FGF5 alleviated acute lung injury via AKT signal pathway in endothelial cells., [RefSeq, PubMed]; Plays an important role in the regulation of cell proliferation and cell differentiation. Required for normal regulation of the hair growth cycle. Functions as an inhibitor of hair elongation by promoting progression from anagen, the growth phase of the hair follicle, into catagen the apoptosis-induced regression phase (By similarity)., [UniProtKB, UniProtKB]; This gene encodes a secreted protein that is a member of a family of heparin-binding growth factors. The encoded protein regulates cell proliferation, particularly the growth of hair follicles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 2,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "O88825",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008083 growth factor activity;GO:0005104 fibroblast growth factor receptor binding",
        "go_cellular_component": "GO:0005615 extracellular space;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0008284 positive regulation of cell population proliferation;GO:0043410 positive regulation of MAPK cascade;GO:0051781 positive regulation of cell division;GO:0030334 regulation of cell migration;GO:0022008 neurogenesis",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "P15656-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P35378-1",
        "uniprot_id": "FSHR_MOUSE",
        "mass": 77769.0,
        "length": 692,
        "protein_name": "Follicle-stimulating hormone receptor",
        "gene_name": "Fshr",
        "organism": "Mouse",
        "refseq_name": "follicle-stimulating hormone receptor precursor",
        "refseq_ac": "NP_038551",
        "gene_names_uniprotkb": "Fshr",
        "gene_names_refseq": "Fshr",
        "protein_names_uniprotkb": "Follicle-stimulating hormone receptor; FSH-R; Follitropin receptor",
        "protein_names_refseq": "follicle-stimulating hormone receptor precursor; follitropin receptor",
        "tax_id": 10090,
        "disease": "ovarian dysgenesis 1 (Disease Ontology:DOID:0080493); 46 XX gonadal dysgenesis (Disease Ontology:DOID:14450); granulosa cell tumor (Disease Ontology:DOID:2999); ovarian hyperstimulation syndrome (Disease Ontology:DOID:5425)",
        "pathway": " (mmu:14309);  (R-MMU-375281);  (R-MMU-418555)",
        "pathway_count": 3,
        "publication_count": 2,
        "publication_id_list": "10330114;1459341",
        "class_list": "",
        "function": "G protein-coupled receptor for follitropin, the follicle-stimulating hormone. Through cAMP production activates the downstream PI3K-AKT and ERK1/ERK2 signaling pathways., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 4,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D4C2;Q9QWV8",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004963 follicle-stimulating hormone receptor activity;GO:0017046 peptide hormone binding;GO:0008528 G protein-coupled peptide receptor activity",
        "go_cellular_component": "GO:0005768 endosome;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0016020 membrane;GO:0043235 receptor complex",
        "go_biological_process": "GO:0033044 regulation of chromosome organization;GO:0001545 primary ovarian follicle growth;GO:0010640 regulation of platelet-derived growth factor receptor signaling pathway;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "P35378-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P35582-1",
        "uniprot_id": "FOXA1_MOUSE",
        "mass": 48854.0,
        "length": 468,
        "protein_name": "Hepatocyte nuclear factor 3-alpha",
        "gene_name": "Foxa1",
        "organism": "Mouse",
        "refseq_name": "hepatocyte nuclear factor 3-alpha",
        "refseq_ac": "NP_032285",
        "gene_names_uniprotkb": "Foxa1; Hnf3a; Tcf-3a; Tcf3a",
        "gene_names_refseq": "Foxa1; Hnf-3a; Hnf3a; Tcf-3a; Tcf3a",
        "protein_names_uniprotkb": "Hepatocyte nuclear factor 3-alpha; Forkhead box protein A1; HNF-3-alpha; HNF-3A",
        "protein_names_refseq": "HNF-3-alpha; fork head domain; forkhead box protein A1; hepatocyte nuclear factor 3 alpha (winged helix transcription factor); hepatocyte nuclear factor 3-alpha",
        "tax_id": 10090,
        "disease": "brain glioma (Disease Ontology:DOID:0060108); stomach cancer (Disease Ontology:DOID:10534); lung cancer (Disease Ontology:DOID:1324); colon carcinoma (Disease Ontology:DOID:1520); breast cancer (Disease Ontology:DOID:1612); colon adenocarcinoma (Disease Ontology:DOID:234); esophagus squamous cell carcinoma (Disease Ontology:DOID:3748); lung carcinoma (Disease Ontology:DOID:3905); lung non-small cell carcinoma (Disease Ontology:DOID:3908); lung adenocarcinoma (Disease Ontology:DOID:3910); esophagus adenocarcinoma (Disease Ontology:DOID:4914); lung small cell carcinoma (Disease Ontology:DOID:5409); hepatocellular carcinoma (Disease Ontology:DOID:684); colorectal cancer (Disease Ontology:DOID:9256)",
        "pathway": " (mmu:15375);  (R-MMU-9018519)",
        "pathway_count": 2,
        "publication_count": 17,
        "publication_id_list": "10049364;11571307;11864602;15252040;15668254;15748903;15959514;15987773;17220277;17596284;19141476;19436110;22872234;34428180;38861834;40997131;8034310",
        "class_list": "",
        "function": "Transcription factor that is involved in embryonic development, establishment of tissue-specific gene expression and regulation of gene expression in differentiated tissues. Is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites. Binds DNA with the consensus sequence 5'-[AC]A[AT]T[AG]TT[GT][AG][CT]T[CT]-3' (By similarity). Proposed to play a role in translating the epigenetic signatures into cell type-specific enhancer-driven transcriptional programs. Involved in the development of multiple endoderm-derived organ systems such as the liver, pancreas, lungs and prostate; FOXA1 and FOXA2 seem to have at least in part redundant roles. Plays a role in prostate morphogenesis and epithelial cell differentiation. FOXA1 and FOXA2 are essential for hepatic specification. FOXA1 and FOXA2 are required for morphogenesis and cell differentiation during formation of the lung. FOXA1 and FOXA2 are involved in bile duct formation; they positively regulate the binding of glucocorticoid receptor/NR3C1 to the IL6 promoter. FOXA1 and FOXA2 regulate multiple phases of midbrain dopaminergic neuron development; they regulate expression of NEUROG2 at the beginning of mDA neurogenesis and of NR4A2 and EN1 in immature mDA neurons. Modulates the transcriptional activity of nuclear hormone receptors. Is involved in ESR1-mediated transcription. Inhibits NKX2-1-mediated transcription from the SFTPC promoter in lung epithel independently from DNA-binding. Involved in regulation of apoptosis. Involved in cell cycle regulation. Originally described as a transcription activator for a number of liver genes such as AFP, albumin, tyrosine aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory regions of these genes. Involved in glucose homeostasis; activates the GCG promoter., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 2,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 14,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q4VA63;Q61108",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003682 chromatin binding;GO:0003700 DNA-binding transcription factor activity;GO:0019904 protein domain specific binding;GO:0003690 double-stranded DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0001650 fibrillar center;GO:0005902 microvillus",
        "go_biological_process": "GO:0045880 positive regulation of smoothened signaling pathway;GO:0060743 epithelial cell maturation involved in prostate gland development;GO:0060638 mesenchymal-epithelial cell signaling;GO:0060741 prostate gland stromal morphogenesis;GO:0060528 secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development",
        "synthesized_glycan_count": 0,
        "hit_score": 2.1,
        "record_id": "P35582-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P35584-1",
        "uniprot_id": "FOXA3_MOUSE",
        "mass": 37601.0,
        "length": 353,
        "protein_name": "Hepatocyte nuclear factor 3-gamma",
        "gene_name": "Foxa3",
        "organism": "Mouse",
        "refseq_name": "hepatocyte nuclear factor 3-gamma",
        "refseq_ac": "NP_032286",
        "gene_names_uniprotkb": "Foxa3; Hnf3g; Tcf-3g; Tcf3g",
        "gene_names_refseq": "Foxa3; Hnf-3g; Hnf3g; Tcf-3g; Tcf3g",
        "protein_names_uniprotkb": "Hepatocyte nuclear factor 3-gamma; Forkhead box protein A3; HNF-3-gamma; HNF-3G",
        "protein_names_refseq": "HNF-3-gamma; forkhead box protein A3; hepatocyte nuclear factor 3 gamma (winged helix transcription factor); hepatocyte nuclear factor 3-gamma",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:15377)",
        "pathway_count": 1,
        "publication_count": 8,
        "publication_id_list": "11546810;17488644;27802388;30084848;34428180;38721807;8034310;9632808",
        "class_list": "",
        "function": "Direct reprogramming of fibroblasts into functional hepatocytes via CRISPRa activation of endogenous Gata4 and Foxa3., [RefSeq, PubMed]; Transcription factor that is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites (By similarity). Originally described as a transcription activator for a number of liver genes such as AFP, albumin, tyrosine aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory regions of these genes. Involved in glucose homeostasis; activates GLUT2 transcription. Involved in regulation of neuronal-specific transcription. Involved in regulation of spermatogenesis; required for the maintenance of the testicular germ cell population and male fertility., [UniProtKB, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 2,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0019904 protein domain specific binding;GO:0000976 transcription cis-regulatory region binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0015629 actin cytoskeleton",
        "go_biological_process": "GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II;GO:0007283 spermatogenesis;GO:0008285 negative regulation of cell population proliferation;GO:0030154 cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "P35584-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P48031-1",
        "uniprot_id": "GBX2_MOUSE",
        "mass": 37359.0,
        "length": 348,
        "protein_name": "Homeobox protein GBX-2",
        "gene_name": "Gbx2",
        "organism": "Mouse",
        "refseq_name": "homeobox protein GBX-2",
        "refseq_ac": "NP_034392",
        "gene_names_uniprotkb": "Gbx2; Mmoxa; Stra7",
        "gene_names_refseq": "D130058E05Rik; Gbx-2; Gbx2; MMoxA; Stra7",
        "protein_names_uniprotkb": "Homeobox protein GBX-2; Gastrulation and brain-specific homeobox protein 2; Stimulated by retinoic acid gene 7 protein",
        "protein_names_refseq": "gastrulation and brain-specific homeobox protein 2; homeobox protein GBX-2; stimulated by retinoic acid gene 7 protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:14472)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "1720547;7758585;8601031;9417909",
        "class_list": "glycogene",
        "function": "May act as a transcription factor for cell pluripotency and differentiation in the embryo., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 10,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q14A66",
        "ec_number_list": "",
        "go_molecular_function": "GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding;GO:0000979 RNA polymerase II core promoter sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific;GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm",
        "go_biological_process": "GO:0021555 midbrain-hindbrain boundary morphogenesis;GO:0021568 rhombomere 2 development;GO:0048483 autonomic nervous system development;GO:0006351 DNA-templated transcription;GO:0006357 regulation of transcription by RNA polymerase II",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P48031-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P48757-1",
        "uniprot_id": "GAST_MOUSE",
        "mass": 11590.0,
        "length": 101,
        "protein_name": "Gastrin",
        "gene_name": "Gast",
        "organism": "Mouse",
        "refseq_name": "gastrin preproprotein",
        "refseq_ac": "NP_034387",
        "gene_names_uniprotkb": "Gast; Gas",
        "gene_names_refseq": "GAS; Gast",
        "protein_names_uniprotkb": "Gastrin; G34; Gastrin-34",
        "protein_names_refseq": "gastrin preproprotein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:14459);  (R-MMU-416476);  (R-MMU-881907)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "34412590;7488110;7492958;8647266",
        "class_list": "",
        "function": "Gastrin exerts a protective effect against myocardial infarction via promoting angiogenesis. Erratum:[Mol Med. 2025 May 29;31(1):212. doi: 10.1186/s10020-025-01256-9. PMID: 40442610] Publication Status: Online-Only, [RefSeq, PubMed]; Gastrin stimulates the stomach mucosa to produce and secrete hydrochloric acid and the pancreas to secrete its digestive enzymes. It also stimulates smooth muscle contraction and increases blood circulation and water secretion in the stomach and intestine., [UniProtKB]; This gene encodes the peptide hormone gastrin, which stimulates gastric acid secretion, proliferation, cell migration and angiogenesis, as well as inhibits apoptosis. The encoded preproprotein undergoes proteolytic processing to generate multiple gastrin peptides differing in size. Mice lacking the encoded protein exhibit a decrease in the number of parietal cells, achlorohydria and a decrease in the colonic proliferation. [provided by RefSeq, Nov 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P70334;Q64295;Q9CPR2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005179 hormone activity",
        "go_cellular_component": "GO:0005615 extracellular space",
        "go_biological_process": "GO:0007186 G protein-coupled receptor signaling pathway;GO:0032094 response to food",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "P48757-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O88939-1",
        "uniprot_id": "ZBT7A_MOUSE",
        "mass": 60281.0,
        "length": 569,
        "protein_name": "Zinc finger and BTB domain-containing protein 7A",
        "gene_name": "Zbtb7a",
        "organism": "Mouse",
        "refseq_name": "zinc finger and BTB domain-containing protein 7A",
        "refseq_ac": "NP_034861",
        "gene_names_uniprotkb": "Zbtb7a; Lrf; Zbtb7",
        "gene_names_refseq": "9030619K07Rik; 9130006G12Rik; FBI-1; Lrf; Pokemon; Zbtb7a; Zbtb7",
        "protein_names_uniprotkb": "Zinc finger and BTB domain-containing protein 7A; Leukemia/lymphoma-related factor; POK erythroid myeloid ontogenic factor; POZ and Krueppel erythroid myeloid ontogenic factor; Pokemon",
        "protein_names_refseq": "POK erythroid myeloid ontogenic factor; POZ and Krueppel erythroid myeloid ontogenic factor; leukemia/lymphoma related factor; zinc finger and BTB domain-containing protein 7A",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:16969)",
        "pathway_count": 1,
        "publication_count": 15,
        "publication_id_list": "14701838;15337766;15662416;17495164;19144319;20485683;21183079;21750661;26446488;26816381;29813070;31209250;31998789;35474350;9927193",
        "class_list": "",
        "function": "Intragenic antagonistic roles of protein and circRNA in tumorigenesis. Erratum:[Cell Res. 2020 Feb;30(2):188. doi: 10.1038/s41422-019-0262-4. PMID: 31911670], [RefSeq, PubMed]; LRF is the first transcription factor found to bind directly to the COMP gene promoter, to recruit HDAC1, and to regulate both COMP gene expression and chondrogenic differentiation, [RefSeq, PubMed]; Leukemia/lymphoma-related factor (LRF) or osteoclast zinc finger protein (OCZF) overexpression promotes osteoclast survival by increasing Bcl-xl mRNA: A novel regulatory mechanism mediated by the RNA binding protein SAM68., [RefSeq, PubMed]; May contribute to adipogenesis through influencing the switch from cellular proliferation to terminal differentiation, [RefSeq, PubMed]; Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1. Publication Status: Online-Only, [RefSeq, PubMed]; Pokemon can specifically repress the transcription of the tumour suppressor gene ARF through direct binding, [RefSeq, PubMed]; Transcription factor that represses the transcription of a wide range of genes involved in cell proliferation and differentiation (PubMed:15337766, PubMed:15662416, PubMed:17495164, PubMed:26816381, PubMed:29813070). Directly and specifically binds to the consensus sequence 5'-[GA][CA]GACCCCCCCCC-3' and represses transcription both by regulating the organization of chromatin and through the direct recruitment of transcription factors to gene regulatory regions (PubMed:15337766, PubMed:15662416, PubMed:26816381, PubMed:29813070). Negatively regulates SMAD4 transcriptional activity in the TGF-beta signaling pathway through these two mechanisms (By similarity). That is, recruits the chromatin regulator HDAC1 to the SMAD4-DNA complex and in parallel prevents the recruitment of the transcriptional activators CREBBP and EP300 (By similarity). Collaborates with transcription factors like RELA to modify the accessibility of gene transcription regulatory regions to secondary transcription factors (PubMed:29813070). Also directly interacts with transcription factors like SP1 to prevent their binding to DNA (By similarity). Functions as an androgen receptor/AR transcriptional corepressor by recruiting NCOR1 and NCOR2 to the androgen response elements/ARE on target genes (By similarity). Thereby, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (By similarity). Involved in the switch between fetal and adult globin expression during erythroid cells maturation (PubMed:26816381). Through its interaction with the NuRD complex regulates chromatin at the fetal globin genes to repress their transcription (PubMed:26816381). Specifically represses the transcription of the tumor suppressor ARF isoform from the CDKN2A gene (PubMed:15662416). Efficiently abrogates E2F1-dependent CDKN2A transactivation (PubMed:15662416). Regulates chondrogenesis through the transcriptional repression of specific genes via a mechanism that also requires histone deacetylation (PubMed:15337766). Regulates cell proliferation through the transcriptional regulation of genes involved in glycolysis (By similarity). Involved in adipogenesis through the regulation of genes involved in adipocyte differentiation (By similarity). Plays a key role in the differentiation of lymphoid progenitors into B and T lineages (PubMed:17495164). Promotes differentiation towards the B lineage by inhibiting the T-cell instructive Notch signaling pathway through the specific transcriptional repression of Notch downstream target genes (PubMed:17495164). Also regulates osteoclast differentiation (By similarity). May also play a role, independently of its transcriptional activity, in double-strand break repair via classical non-homologous end joining/cNHEJ (PubMed:26446488). Recruited to double-strand break sites on damage DNA, interacts with the DNA-dependent protein kinase complex and directly regulates its stability and activity in DNA repair (PubMed:26446488). May also modulate the splicing activity of KHDRBS1 toward BCL2L1 in a mechanism which is histone deacetylase-dependent and thereby negatively regulates the pro-apoptotic effect of KHDRBS1 (By similarity)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed, PubMed, UniProtKB, PubMed, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RRP7;B7ZNL6;Q3U372;Q9CRJ0",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0008270 zinc ion binding;GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0046332 SMAD binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0097680 double-strand break repair via classical nonhomologous end joining;GO:2000677 regulation of transcription regulatory region DNA binding;GO:0043249 erythrocyte maturation;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006110 regulation of glycolytic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "O88939-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q920E5-1",
        "uniprot_id": "FPPS_MOUSE",
        "mass": 40582.0,
        "length": 353,
        "protein_name": "Farnesyl pyrophosphate synthase",
        "gene_name": "Fdps",
        "organism": "Mouse",
        "refseq_name": "farnesyl pyrophosphate synthase isoform 1",
        "refseq_ac": "NP_001240680",
        "gene_names_uniprotkb": "Fdps",
        "gene_names_refseq": "6030492I17Rik; Fdpsl1; Fdps; mKIAA1293",
        "protein_names_uniprotkb": "Farnesyl pyrophosphate synthase; (2E,6E)-farnesyl diphosphate synthase; 2.5.1.10; 2.5.1.1; CR 39; Cholesterol-regulated 39 kDa protein; Dimethylallyltranstransferase; FPP synthase; FPS; Farnesyl diphosphate synthase; Geranyltranstransferase",
        "protein_names_refseq": "(2E,6E)-farnesyl diphosphate synthase; CR 39; FPP synthase; FPP synthetase; FPS; cholesterol-regulated 39 kDa protein; dimethylallyltranstransferase; farnesyl diphosphate synthase; farnesyl pyrophosphate synthase isoform 1; farnesyl pyrophosphate synthase; farnesyl pyrophosphate synthetase; geranyltranstransferase",
        "tax_id": 10090,
        "disease": "alcohol use disorder (Disease Ontology:DOID:1574); porokeratosis (Disease Ontology:DOID:3805)",
        "pathway": " (mmu:110196);  (R-MMU-9969896)",
        "pathway_count": 2,
        "publication_count": 11,
        "publication_id_list": "12020352;21750661;22872234;25428506;31219806;31599954;34203471;34428180;36210013;37310396;37453647",
        "class_list": "",
        "function": "Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR-CD36 axis., [RefSeq, PubMed]; Key enzyme in isoprenoid biosynthesis which catalyzes the formation of farnesyl diphosphate (FPP), a precursor for several classes of essential metabolites including sterols, dolichols, carotenoids, and ubiquinones. FPP also serves as substrate for protein farnesylation and geranylgeranylation. Catalyzes the sequential condensation of isopentenyl pyrophosphate with the allylic pyrophosphates, dimethylallyl pyrophosphate, and then with the resultant geranylpyrophosphate to the ultimate product farnesyl pyrophosphate (By similarity)., [UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 2,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "2.5.1.1;2.5.1.10;2.5.1.29;2.5.1.-",
        "go_molecular_function": "GO:0004161 dimethylallyltranstransferase activity;GO:0004337 (2E,6E)-farnesyl diphosphate synthase activity;GO:0046872 metal ion binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005739 mitochondrion;GO:0005759 mitochondrial matrix;GO:0005777 peroxisome",
        "go_biological_process": "GO:0033384 geranyl diphosphate biosynthetic process;GO:0045337 farnesyl diphosphate biosynthetic process;GO:0045542 positive regulation of cholesterol biosynthetic process;GO:0061051 positive regulation of cell growth involved in cardiac muscle cell development;GO:0033386 geranylgeranyl diphosphate biosynthetic process",
        "synthesized_glycan_count": 0,
        "hit_score": 1.4,
        "record_id": "Q920E5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9EQ15-1",
        "uniprot_id": "GNB1L_MOUSE",
        "mass": 35663.0,
        "length": 326,
        "protein_name": "Guanine nucleotide-binding protein subunit beta-like protein 1",
        "gene_name": "Gnb1l",
        "organism": "Mouse",
        "refseq_name": "guanine nucleotide-binding protein subunit beta-like protein 1 isoform 1",
        "refseq_ac": "NP_001075151",
        "gene_names_uniprotkb": "Gnb1l; Estm55; Wdr14",
        "gene_names_refseq": "ESTM55; Gm16314; Gnb1l; Me49f07; Rtl10; Wdr14; Wdvcf",
        "protein_names_uniprotkb": "Guanine nucleotide-binding protein subunit beta-like protein 1; G protein subunit beta-like protein 1; WD repeat-containing protein 14; WD40 repeat-containing protein deleted in VCFS; WDVCF",
        "protein_names_refseq": "WD repeat-containing protein 14; WD40 repeat-containing protein deleted in VCFS; g protein subunit beta-like protein 1; guanine nucleotide-binding protein subunit beta-like protein 1 isoform 1; guanine nucleotide-binding protein subunit beta-like protein 1; retrotransposon Gag like 10",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13972)",
        "pathway_count": 1,
        "publication_count": 4,
        "publication_id_list": "11350118;16684884;18775783;21750661",
        "class_list": "",
        "function": "Acts as a critical regulator of DNA damage response (DDR) signaling via specifically regulating phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8R1F3;Q9CWP2;Q9D3Y1",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006974 DNA damage response;GO:0035176 social behavior;GO:0000077 DNA damage checkpoint signaling",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q9EQ15-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BTM9-1",
        "uniprot_id": "GRP4_MOUSE",
        "mass": 74907.0,
        "length": 673,
        "protein_name": "RAS guanyl-releasing protein 4",
        "gene_name": "Rasgrp4",
        "organism": "Mouse",
        "refseq_name": "RAS guanyl-releasing protein 4 isoform 1",
        "refseq_ac": "NP_001167626",
        "gene_names_uniprotkb": "Rasgrp4",
        "gene_names_refseq": "Rasgrp4",
        "protein_names_uniprotkb": "RAS guanyl-releasing protein 4",
        "protein_names_refseq": "RAS guanyl-releasing protein 4 isoform 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:233046);  (R-MMU-5673001)",
        "pathway_count": 2,
        "publication_count": 8,
        "publication_id_list": "11956218;12817022;17523924;21750661;22728827;26982501;30084848;34428180",
        "class_list": "",
        "function": "Binds diacylglycerol (DAG)., [UniProtKB, PubMed]; Functions as a cation- and diacylglycerol (DAG)-regulated nucleotide exchange factor activating Ras through the exchange of bound GDP for GTP (PubMed:12817022, PubMed:22728827). In neutrophils, participates in a phospholipase C-activating N-formyl peptide-activated GPCR (G protein-coupled receptor) signaling pathway by promoting Ras-mediated activation of PIK3CG/PI3Kgamma to promote neutrophil functional responses (PubMed:22728827). In CD117(+) dendritic cells and mast cells, participates in an lipopolysaccharide (LPS)-activated signaling pathway that stimulates the production of interferon-gamma and other pro-inflammatory cytokines by natural killer (NK) cells (PubMed:26982501). May function in mast cell differentiation (PubMed:12817022). Does not appear to be required for the development of B-cells, DC-cells, T-cells, or NK-cells (PubMed:26982501)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB]; Unable to bind diacylglycerol (DAG)., [UniProtKB, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TNQ1;Q3TRL5;Q3U3I4;Q811P7;Q8BKV7;Q91ZC8;Q920A2",
        "ec_number_list": "",
        "go_molecular_function": "GO:0008270 zinc ion binding;GO:0005085 guanyl-nucleotide exchange factor activity;GO:0019992 diacylglycerol binding;GO:0008289 lipid binding",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0005886 plasma membrane;GO:0016020 membrane;GO:0009898 cytoplasmic side of plasma membrane",
        "go_biological_process": "GO:0002717 positive regulation of natural killer cell mediated immunity;GO:0030154 cell differentiation;GO:0007265 Ras protein signal transduction;GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway;GO:0140367 antibacterial innate immune response",
        "synthesized_glycan_count": 0,
        "hit_score": 0.9,
        "record_id": "Q8BTM9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P98154-1",
        "uniprot_id": "IDD_MOUSE",
        "mass": 60697.0,
        "length": 548,
        "protein_name": "Integral membrane protein DGCR2/IDD",
        "gene_name": "Dgcr2",
        "organism": "Mouse",
        "refseq_name": "integral membrane protein DGCR2/IDD isoform 2 precursor",
        "refseq_ac": "NP_001103220",
        "gene_names_uniprotkb": "Dgcr2; Dgsc; Idd; Sez-12; Sez12",
        "gene_names_refseq": "9930034O06Rik; DGS-C; Dgcr2; Dgsc; Idd; Lan; Sez12; mKIAA0163",
        "protein_names_uniprotkb": "Integral membrane protein DGCR2/IDD; Seizure-related membrane-bound adhesion protein",
        "protein_names_refseq": "DiGeorge syndrome gene c; DiGeorge syndrome protein C; integral membrane protein DGCR2/IDD isoform 2 precursor; integral membrane protein DGCR2/IDD; seizure-related membrane-bound adhesion protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:13356)",
        "pathway_count": 1,
        "publication_count": 7,
        "publication_id_list": "10.1101/2023.09.13.557529;21750661;29305086;31219806;35212007;8630060;9107688",
        "class_list": "glycogene",
        "function": "Downregulation of the schizophrenia risk-gene Dgcr2 alters early microcircuit development in the mouse medial prefrontal cortex., [RefSeq, PubMed]; Probably plays a role in neural crest cell migration. May play a role in delivery of extracellular signals., [UniProtKB]; SZ-risk gene DGCR2 regulates critical steps of early corticogenesis possibly through a Reelin-dependent mechanism., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 26,
        "reported_interactions": 0,
        "missing_score": 9696,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q61844",
        "ec_number_list": "",
        "go_molecular_function": "GO:0030246 carbohydrate binding",
        "go_cellular_component": "GO:0016020 membrane",
        "go_biological_process": "GO:0007155 cell adhesion;GO:0050890 cognition;GO:0009410 response to xenobiotic stimulus",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "P98154-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "O35453-1",
        "uniprot_id": "HEPS_MOUSE",
        "mass": 46821.0,
        "length": 436,
        "protein_name": "Serine protease hepsin",
        "gene_name": "Hpn",
        "organism": "Mouse",
        "refseq_name": "serine protease hepsin isoform 1 precursor",
        "refseq_ac": "NP_001103722",
        "gene_names_uniprotkb": "Hpn",
        "gene_names_refseq": "Hlb320; Hpn",
        "protein_names_uniprotkb": "Serine protease hepsin; 3.4.21.106",
        "protein_names_refseq": "serine protease hepsin isoform 1 precursor; serine protease hepsin",
        "tax_id": 10090,
        "disease": "intellectual disability (Disease Ontology:DOID:1059)",
        "pathway": " (mmu:15451);  (R-MMU-6806942);  (R-MMU-8852405)",
        "pathway_count": 3,
        "publication_count": 10,
        "publication_id_list": "10411637;11127869;12962630;17620368;21750661;26673890;32404422;34428180;9395459;9435303",
        "class_list": "",
        "function": "Crystal structure of human hepsin, confirming cleavage and association of the two chains, [RefSeq, PubMed]; Hepsin enhances liver metabolism and inhibits adipocyte browning in mice., [RefSeq, PubMed]; Serine protease that cleaves extracellular substrates, and contributes to the proteolytic processing of growth factors, such as HGF and MST1/HGFL. Plays a role in cell growth and maintenance of cell morphology. Plays a role in the proteolytic processing of ACE2 (By similarity). Mediates the proteolytic cleavage of urinary UMOD that is required for UMOD polymerization (PubMed:26673890)., [UniProtKB, UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB]; This gene encodes a type II transmembrane serine protease that may function in diverse processes, including regulation of cell growth. Deficiency in this gene results in hearing loss. The protein is cleaved into a catalytic serine protease chain and a non-catalytic scavenger receptor cysteine-rich chain, which associate via a single disulfide bond. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2013]., [RefSeq]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B2RSC4;Q9CW97",
        "ec_number_list": "3.4.21.106",
        "go_molecular_function": "GO:0004252 serine-type endopeptidase activity;GO:0008233 peptidase activity;GO:0008236 serine-type peptidase activity;GO:0070008 serine-type exopeptidase activity",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0005911 cell-cell junction;GO:0009986 cell surface",
        "go_biological_process": "GO:2000347 positive regulation of hepatocyte proliferation;GO:0060429 epithelium development;GO:0010756 positive regulation of plasminogen activation;GO:0006508 proteolysis;GO:0010628 positive regulation of gene expression",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "O35453-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9D1G3-1",
        "uniprot_id": "HHATL_MOUSE",
        "mass": 56431.0,
        "length": 503,
        "protein_name": "Protein-cysteine N-palmitoyltransferase HHAT-like protein",
        "gene_name": "Hhatl",
        "organism": "Mouse",
        "refseq_name": "protein-cysteine N-palmitoyltransferase HHAT-like protein",
        "refseq_ac": "NP_083371",
        "gene_names_uniprotkb": "Hhatl; Gup1; Kiaa1173",
        "gene_names_refseq": "1110011D13Rik; Gup1; Hhatl; Mg56",
        "protein_names_uniprotkb": "Protein-cysteine N-palmitoyltransferase HHAT-like protein; Glycerol uptake/transporter homolog; Hedgehog acyltransferase-like protein",
        "protein_names_refseq": "Mitsugumin 56; glycerol uptake/transporter homolog; hedgehog acyltransferase-like protein; protein-cysteine N-palmitoyltransferase HHAT-like protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:74770)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "18081866;21750661;25841338;31219806;37507081",
        "class_list": "",
        "function": "MG56 seems essential for postnatal skeletal muscle maturation, [RefSeq, PubMed]; Negatively regulates N-terminal palmitoylation of SHH by HHAT/SKN., [UniProtKB, PubMed]; Results suggest that Gup1 is a negative regulator of N-terminal palmitoylation of Shh and may contribute to the variety of biological actions of Shh, [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TZE3;Q8R1K3",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0048471 perinuclear region of cytoplasm;GO:0005789 endoplasmic reticulum membrane",
        "go_biological_process": "GO:0060262 negative regulation of N-terminal protein palmitoylation;GO:0031399 regulation of protein modification process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9D1G3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q923X4-1",
        "uniprot_id": "GLRX2_MOUSE",
        "mass": 17307.0,
        "length": 156,
        "protein_name": "Glutaredoxin-2, mitochondrial",
        "gene_name": "Glrx2",
        "organism": "Mouse",
        "refseq_name": "glutaredoxin-2, mitochondrial isoform a",
        "refseq_ac": "NP_001033681",
        "gene_names_uniprotkb": "Glrx2; Grx2",
        "gene_names_refseq": "1700010P22Rik; Glrx2; Grx2",
        "protein_names_uniprotkb": "Glutaredoxin-2, mitochondrial",
        "protein_names_refseq": "glutaredoxin-2, mitochondrial isoform a; glutaredoxin-2, mitochondrial; thioltransferase",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:69367)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "11397793;12954614;15347644;21750661;25428506;35290904;37277068;37541331;39117135",
        "class_list": "",
        "function": "Glutaredoxin 2 protects lens epithelial cells from epithelial-mesenchymal transition by suppressing mitochondrial oxidative stress-related upregulation of integrin-linked kinase., [RefSeq, PubMed]; Glutathione-dependent oxidoreductase that facilitates the maintenance of mitochondrial redox homeostasis upon induction of apoptosis by oxidative stress. Involved in response to hydrogen peroxide and regulation of apoptosis caused by oxidative stress. Acts as a very efficient catalyst of monothiol reactions because of its high affinity for protein glutathione-mixed disulfides. Can receive electrons not only from glutathione (GSH), but also from thioredoxin reductase supporting both monothiol and dithiol reactions. Efficiently catalyzes both glutathionylation and deglutathionylation of mitochondrial complex I, which in turn regulates the superoxide production by the complex. Overexpression decreases the susceptibility to apoptosis and prevents loss of cardiolipin and cytochrome c release., [UniProtKB, PubMed, PubMed]; Mitochondrial depletion of glutaredoxin 2 induces metabolic dysfunction-associated fatty liver disease in mice., [RefSeq, PubMed]; Pericyte loss via glutaredoxin2 downregulation aggravates diabetes-induced microvascular dysfunction., [RefSeq, PubMed]; The impact of glutaredoxin 1 and glutaredoxin 2 double knockout on lens epithelial cell function., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9DAG8;Q9JHY6",
        "ec_number_list": "",
        "go_molecular_function": "GO:0046872 metal ion binding;GO:0051537 2 iron, 2 sulfur cluster binding;GO:0015035 protein-disulfide reductase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005739 mitochondrion;GO:0005759 mitochondrial matrix;GO:0030425 dendrite",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q923X4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DB70-1",
        "uniprot_id": "FUND1_MOUSE",
        "mass": 17159.0,
        "length": 155,
        "protein_name": "FUN14 domain-containing protein 1",
        "gene_name": "Fundc1",
        "organism": "Mouse",
        "refseq_name": "FUN14 domain-containing protein 1 isoform 2",
        "refseq_ac": "NP_001300674",
        "gene_names_uniprotkb": "Fundc1",
        "gene_names_refseq": "1500005J14Rik; 1810033P05Rik; Fundc1",
        "protein_names_uniprotkb": "FUN14 domain-containing protein 1",
        "protein_names_refseq": "FUN14 domain-containing protein 1 isoform 2; FUN14 domain-containing protein 1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:72018);  (R-MMU-8934903)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "21183079;21750661;24573672;27995894;34428180;36828120;38305334;38759931;39247823",
        "class_list": "",
        "function": "FUDNC1-dependent mitophagy ameliorate motor neuron death in an amyotrophic lateral sclerosis mouse model., [RefSeq, PubMed]; Integral mitochondrial outer-membrane protein that mediates the formation of mitochondria-associated endoplasmic reticulum membranes (MAMs). In turn, mediates angiogenesis and neoangiogenesis through interference with intracellular Ca(2+) communication and regulation of the vascular endothelial growth factor receptor KDR/VEGFR2 expression at both mRNA and protein levels. Also acts as an activator of hypoxia-induced mitophagy, an important mechanism for mitochondrial quality and homeostasis, by interacting with and recruiting LC3 protein family to mitochondria. Mechanistically, recruits DRP1 at ER-mitochondria contact sites leading to DRP1 oligomerization and GTPase activity to facilitate mitochondrial fission during hypoxia (By similarity). Additionally, plays a role in hepatic ferroptosis by interacting directly with glutathione peroxidase/GPX4 to facilitate its recruitment into mitochondria through TOM/TIM complex where it is degraded by mitophagy (PubMed:36828120)., [UniProtKB, UniProtKB, PubMed]; MicroRNA-137 has a role in inhibiting mitophagy via regulation of two mitophagy receptors FUNDC1 and NIX, [RefSeq, PubMed]; Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy. Publication Status: Online-Only, [RefSeq, PubMed]; Silencing of FUN14 Domain Containing 1 Inhibits Platelet Activation in Diabetes Mellitus through Blocking Mitophagy., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "A2BEA3",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005741 mitochondrial outer membrane",
        "go_biological_process": "GO:0001666 response to hypoxia;GO:0008053 mitochondrial fusion;GO:0000422 autophagy of mitochondrion;GO:0000423 mitophagy;GO:0006914 autophagy",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q9DB70-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P48774-1",
        "uniprot_id": "GSTM5_MOUSE",
        "mass": 26635.0,
        "length": 224,
        "protein_name": "Glutathione S-transferase Mu 5",
        "gene_name": "Gstm5",
        "organism": "Mouse",
        "refseq_name": "glutathione S-transferase Mu 5",
        "refseq_ac": "NP_034490",
        "gene_names_uniprotkb": "Gstm5; Fsc2; Gstm3",
        "gene_names_refseq": "Fsc2; Gstm5",
        "protein_names_uniprotkb": "Glutathione S-transferase Mu 5; 2.5.1.18; Fibrous sheath component 2; Fsc2; GST class-mu 5",
        "protein_names_refseq": "GST class-mu 5; fibrous sheath component 2; glutathione S-transferase Mu 5",
        "tax_id": 10090,
        "disease": "Alzheimer's disease (Disease Ontology:DOID:10652); cystic fibrosis (Disease Ontology:DOID:1485); multiple sclerosis (Disease Ontology:DOID:2377); larynx cancer (Disease Ontology:DOID:2596); asthma (Disease Ontology:DOID:2841); high grade glioma (Disease Ontology:DOID:3070); osteosarcoma (Disease Ontology:DOID:3347); meningioma (Disease Ontology:DOID:3565); macular degeneration (Disease Ontology:DOID:4448); pulmonary emphysema (Disease Ontology:DOID:9675); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:14866);  (R-MMU-156590)",
        "pathway_count": 2,
        "publication_count": 9,
        "publication_id_list": "19889946;21750661;22872234;28135057;28528544;33300544;37507081;37828378;8607970",
        "class_list": "",
        "function": "Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles., [UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 11,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q545W5",
        "ec_number_list": "1.11.1.-;4.4.1.20;2.5.1.18;1.20.4.2;1.8.5.1;5.3.3.-;5.3.99.2;5.2.1.2",
        "go_molecular_function": "GO:0004364 glutathione transferase activity;GO:0043295 glutathione binding;GO:0019899 enzyme binding;GO:0042802 identical protein binding;GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0035686 sperm fibrous sheath",
        "go_biological_process": "GO:0042178 xenobiotic catabolic process;GO:0043627 response to estrogen;GO:0006749 glutathione metabolic process;GO:0018916 nitrobenzene metabolic process;GO:0070458 cellular detoxification of nitrogen compound",
        "synthesized_glycan_count": 0,
        "hit_score": 1.2,
        "record_id": "P48774-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P06876-1",
        "uniprot_id": "MYB_MOUSE",
        "mass": 71422.0,
        "length": 636,
        "protein_name": "Transcriptional activator Myb",
        "gene_name": "Myb",
        "organism": "Mouse",
        "refseq_name": "transcriptional activator Myb isoform 1",
        "refseq_ac": "NP_001185843",
        "gene_names_uniprotkb": "Myb",
        "gene_names_refseq": "Myb; c-myb",
        "protein_names_uniprotkb": "Transcriptional activator Myb; Proto-oncogene c-Myb",
        "protein_names_refseq": "gag-myb protein; myb proto-oncogene protein; myeloblastosis oncogene; myeloblastosis proto-oncogene product; proto-oncogene c-Myb; transcriptional activator Myb isoform 1; transcriptional activator Myb; tumor-specific myb protein",
        "tax_id": 10090,
        "disease": "adult T-cell leukemia/lymphoma (Disease Ontology:DOID:0050523); B-lymphoblastic leukemia/lymphoma (Disease Ontology:DOID:0080630); essential thrombocythemia (Disease Ontology:DOID:2224); transient cerebral ischemia (Disease Ontology:DOID:224); myelofibrosis (Disease Ontology:DOID:4971)",
        "pathway": " (mmu:17863)",
        "pathway_count": 1,
        "publication_count": 28,
        "publication_id_list": "11792321;15082531;16162816;1631139;17823980;1923521;21606357;21750661;21952136;2481264;25428506;2670562;2998780;30084848;3010282;3014527;3016644;3023843;3033638;32873855;3608990;36210013;7796266;8365401;8408047;8942977;9447996;9566892",
        "class_list": "",
        "function": "Transcriptional activator; DNA-binding protein that specifically recognize the sequence 5'-YAAC[GT]G-3'. Plays an important role in the control of proliferation and differentiation of hematopoietic progenitor cells., [UniProtKB, PubMed, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 3,
        "reported_mutagensis": 2,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 5,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "E9QMG8;Q61929",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005654 nucleoplasm;GO:0005829 cytosol;GO:0090575 RNA polymerase II transcription regulator complex",
        "go_biological_process": "GO:0060252 positive regulation of glial cell proliferation;GO:2000491 positive regulation of hepatic stellate cell activation;GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0000278 mitotic cell cycle;GO:0001701 in utero embryonic development",
        "synthesized_glycan_count": 0,
        "hit_score": 3.1,
        "record_id": "P06876-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CRC9-1",
        "uniprot_id": "GNPI2_MOUSE",
        "mass": 31084.0,
        "length": 276,
        "protein_name": "Glucosamine-6-phosphate deaminase 2",
        "gene_name": "Gnpda2",
        "organism": "Mouse",
        "refseq_name": "glucosamine-6-phosphate deaminase 2 isoform 1",
        "refseq_ac": "NP_001033104",
        "gene_names_uniprotkb": "Gnpda2; Kiaa4008",
        "gene_names_refseq": "4921523I18Rik; 4933412A11Rik; GNPDA; Gnp2; Gnpda2; Sb52; mKIAA4008",
        "protein_names_uniprotkb": "Glucosamine-6-phosphate deaminase 2; 3.5.99.6; GlcN6P deaminase 2; Glucosamine-6-phosphate isomerase 2",
        "protein_names_refseq": "GNPDA 2; glcN6P deaminase 2; glucosamine-6-phosphate deaminase 2 isoform 1; glucosamine-6-phosphate isomerase 2; oscillin",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:67980);  (R-MMU-70171)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "21750661;22872234;31219806;34428180;36210013",
        "class_list": "glycogene",
        "function": "Catalyzes the reversible conversion of alpha-D-glucosamine 6-phosphate (GlcN-6P) into beta-D-fructose 6-phosphate (Fru-6P) and ammonium ion, a regulatory reaction step in de novo uridine diphosphate-N-acetyl-alpha-D-glucosamine (UDP-GlcNAc) biosynthesis via hexosamine pathway. Deamination is coupled to aldo-keto isomerization mediating the metabolic flux from UDP-GlcNAc toward Fru-6P. At high ammonium level can drive amination and isomerization of Fru-6P toward hexosamines and UDP-GlcNAc synthesis. Has a role in fine tuning the metabolic fluctuations of cytosolic UDP-GlcNAc and their effects on hyaluronan synthesis that occur during tissue remodeling., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 16,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TH02;Q9D457",
        "ec_number_list": "3.5.99.6",
        "go_molecular_function": "GO:0004342 glucosamine-6-phosphate deaminase activity;GO:0042802 identical protein binding;GO:0016853 isomerase activity",
        "go_cellular_component": "GO:0005737 cytoplasm",
        "go_biological_process": "GO:0006043 glucosamine catabolic process;GO:0006046 N-acetylglucosamine catabolic process;GO:0005975 carbohydrate metabolic process;GO:0006048 UDP-N-acetylglucosamine biosynthetic process;GO:0019262 N-acetylneuraminate catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q9CRC9-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JHJ3-1",
        "uniprot_id": "GLMP_MOUSE",
        "mass": 43804.0,
        "length": 404,
        "protein_name": "Glycosylated lysosomal membrane protein",
        "gene_name": "Glmp",
        "organism": "Mouse",
        "refseq_name": "glycosylated lysosomal membrane protein precursor",
        "refseq_ac": "NP_064387",
        "gene_names_uniprotkb": "Glmp; 0610031J06Rik",
        "gene_names_refseq": "0610031J06Rik; Glmp; NCU-G1",
        "protein_names_uniprotkb": "Glycosylated lysosomal membrane protein; Lysosomal protein NCU-G1",
        "protein_names_refseq": "glycosylated lysosomal membrane protein precursor; lysosomal protein NCU-G1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:56700)",
        "pathway_count": 1,
        "publication_count": 26,
        "publication_id_list": "10.1101/2023.09.13.557529;11444019;18250455;19224205;19349973;19489740;20173027;20484733;21750661;21952136;24487409;25428506;25428507;25605945;26047317;26495903;26707125;27141234;27802388;30084848;30779550;30899004;31661432;32959924;34428180;35820727",
        "class_list": "",
        "function": "Characterization of the complex of the lysosomal membrane transporter MFSD1 and its accessory subunit GLMP., [RefSeq, PubMed]; Data indicate that increased flux of glucose, increased de novo lipogenesis and lipid accumulation were detected in lysosomal protein NCU-G1 (Glmp) gt/gt primary hepatocytes. Publication Status: Online-Only, [RefSeq, PubMed]; Mfsd1 knockout mice develop splenomegaly and severe liver disease. Proteomics of isolated lysosomes from Mfsd1 knockout mice revealed GLMP as a critical accessory subunit for MFSD1. MFSD1 and GLMP physically interact. GLMP is essential for the maintenance of normal levels of MFSD1 in lysosomes and vice versa. Publication Status: Online-Only, [RefSeq, PubMed]; Microscopic examination of liver sections revealed accumulation of autofluorescent lipofuscin and iron in Ncu-g1(gt/gt) Kupffer cells., [RefSeq, PubMed]; Required to protect lysosomal transporter MFSD1 from lysosomal proteolysis and for MFSD1 lysosomal localization., [UniProtKB, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; The importance of GLMP in skeletal muscle, [RefSeq, PubMed]; The lysosomal localization of the mouse orthologue of the human C1orf85 protein, which has been termed kidney-predominant protein NCU-G1, is demonstrated. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 7,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 3,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 7,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 7,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 9,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 4,
        "disease_count": 0,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TUF5;Q3UBV7;Q8C6H7",
        "ec_number_list": "",
        "go_molecular_function": "",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005829 cytosol;GO:0016020 membrane;GO:0005764 lysosome;GO:0005765 lysosomal membrane",
        "go_biological_process": "GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0050821 protein stabilization;GO:0061462 protein localization to lysosome",
        "synthesized_glycan_count": 0,
        "hit_score": 3.8,
        "record_id": "Q9JHJ3-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P08505-1",
        "uniprot_id": "IL6_MOUSE",
        "mass": 24384.0,
        "length": 211,
        "protein_name": "Interleukin-6",
        "gene_name": "Il6",
        "organism": "Mouse",
        "refseq_name": "interleukin-6 isoform 2 precursor",
        "refseq_ac": "NP_001300983",
        "gene_names_uniprotkb": "Il6; Il-6",
        "gene_names_refseq": "Il-6; Il6",
        "protein_names_uniprotkb": "Interleukin-6; B-cell hybridoma growth factor; IL-6; Interleukin HP-1",
        "protein_names_refseq": "B-cell hybridoma growth factor; interleukin HP-1; interleukin-6 isoform 2 precursor",
        "tax_id": 10090,
        "disease": "adult T-cell leukemia/lymphoma (Disease Ontology:DOID:0050523); biliary tract benign neoplasm (Disease Ontology:DOID:0050625); small cell carcinoma (Disease Ontology:DOID:0050685); chorioamnionitis (Disease Ontology:DOID:0050697); obstructive sleep apnea (Disease Ontology:DOID:0050848); oral squamous cell carcinoma (Disease Ontology:DOID:0050866); stroke (Disease Ontology:DOID:0051061); arteriovenous malformations of the brain (Disease Ontology:DOID:0060688); lymphoplasmacytic lymphoma (Disease Ontology:DOID:0060901); alcohol-associated liver disease (Disease Ontology:DOID:0070658); colorectal carcinoma (Disease Ontology:DOID:0080199); metabolic dysfunction-associated steatotic liver disease (Disease Ontology:DOID:0080208); aortic valve disease 1 (Disease Ontology:DOID:0080333); metabolic dysfunction-associated steatohepatitis (Disease Ontology:DOID:0080547); COVID-19 (Disease Ontology:DOID:0080600); transverse myelitis (Disease Ontology:DOID:0080743); acute necrotizing pancreatitis (Disease Ontology:DOID:0080998); dry eye syndrome (Disease Ontology:DOID:10140); stomach cancer (Disease Ontology:DOID:10534); pre-eclampsia (Disease Ontology:DOID:10591); celiac disease (Disease Ontology:DOID:10608); Alzheimer's disease (Disease Ontology:DOID:10652); renal hypertension (Disease Ontology:DOID:1073); otitis media (Disease Ontology:DOID:10754); hypertension (Disease Ontology:DOID:10763); Kuhnt-Junius degeneration (Disease Ontology:DOID:10873); intracranial aneurysm (Disease Ontology:DOID:10941); cholesteatoma of middle ear (Disease Ontology:DOID:10964); anogenital venereal wart (Disease Ontology:DOID:11168); spondyloarthropathy (Disease Ontology:DOID:1123); disseminated intravascular coagulation (Disease Ontology:DOID:11247); sciatic neuropathy (Disease Ontology:DOID:11446); gestational diabetes (Disease Ontology:DOID:11714); prediabetes syndrome (Disease Ontology:DOID:11716); iron deficiency anemia (Disease Ontology:DOID:11758); primary biliary cholangitis (Disease Ontology:DOID:12236); beta thalassemia (Disease Ontology:DOID:12241); alcoholic hepatitis (Disease Ontology:DOID:12351); Graves' disease (Disease Ontology:DOID:12361); ataxia telangiectasia (Disease Ontology:DOID:12704); respiratory syncytial virus infectious disease (Disease Ontology:DOID:1273); quadriplegia (Disease Ontology:DOID:12835); autistic disorder (Disease Ontology:DOID:12849); Huntington's disease (Disease Ontology:DOID:12858); Sjogren's syndrome (Disease Ontology:DOID:12894); keratoconjunctivitis sicca (Disease Ontology:DOID:12895); uveitis (Disease Ontology:DOID:13141); Behcet's disease (Disease Ontology:DOID:13241); eclampsia (Disease Ontology:DOID:13593); polyneuropathy (Disease Ontology:DOID:1389); alcoholic liver cirrhosis (Disease Ontology:DOID:14018); major depressive disorder (Disease Ontology:DOID:1470); aggressive periodontitis (Disease Ontology:DOID:1474); cystic fibrosis (Disease Ontology:DOID:1485); alcohol use disorder (Disease Ontology:DOID:1574); diffuse scleroderma (Disease Ontology:DOID:1580); thrombocytopenia (Disease Ontology:DOID:1588); depressive disorder (Disease Ontology:DOID:1596); breast cancer (Disease Ontology:DOID:1612); neovascular glaucoma (Disease Ontology:DOID:1687); retinal vein occlusion (Disease Ontology:DOID:1727); pancreatic cancer (Disease Ontology:DOID:1793); epilepsy (Disease Ontology:DOID:1826); impotence (Disease Ontology:DOID:1875); hepatitis C (Disease Ontology:DOID:1883); hypogonadism (Disease Ontology:DOID:1924); rectum cancer (Disease Ontology:DOID:1993); hyperinsulinism (Disease Ontology:DOID:2018); hepatitis B (Disease Ontology:DOID:2043); multiple sclerosis (Disease Ontology:DOID:2377); idiopathic interstitial pneumonia (Disease Ontology:DOID:2797); asthma (Disease Ontology:DOID:2841); glucosephosphate dehydrogenase deficiency (Disease Ontology:DOID:2862); severe acute respiratory syndrome (Disease Ontology:DOID:2945); pulmonary tuberculosis (Disease Ontology:DOID:2957); familial Mediterranean fever (Disease Ontology:DOID:2987); acute kidney failure (Disease Ontology:DOID:3021); chronic obstructive pulmonary disease (Disease Ontology:DOID:3083); gingivitis (Disease Ontology:DOID:3087); spinal cord disease (Disease Ontology:DOID:319); central nervous system disease (Disease Ontology:DOID:331); periodontal disease (Disease Ontology:DOID:3388); coronary artery disease (Disease Ontology:DOID:3393); peripheral vascular disease (Disease Ontology:DOID:341); middle cerebral artery infarction (Disease Ontology:DOID:3525); gastric adenocarcinoma (Disease Ontology:DOID:3717); systemic scleroderma (Disease Ontology:DOID:418); hyperglycemia (Disease Ontology:DOID:4195); conjunctival disease (Disease Ontology:DOID:4251); macular retinal edema (Disease Ontology:DOID:4449); keratitis (Disease Ontology:DOID:4677); cholangiocarcinoma (Disease Ontology:DOID:4947); human immunodeficiency virus infectious disease (Disease Ontology:DOID:526); retinal detachment (Disease Ontology:DOID:5327); ovarian hyperstimulation syndrome (Disease Ontology:DOID:5425); cochlear disease (Disease Ontology:DOID:5463); pneumonia (Disease Ontology:DOID:552); proteinuria (Disease Ontology:DOID:576); myocardial infarction (Disease Ontology:DOID:5844); congestive heart failure (Disease Ontology:DOID:6000); pulmonary hypertension (Disease Ontology:DOID:6432); amphetamine abuse (Disease Ontology:DOID:670); systemic juvenile rheumatoid arthritis (Disease Ontology:DOID:676); hepatocellular carcinoma (Disease Ontology:DOID:684); ankylosing spondylitis (Disease Ontology:DOID:7147); periodontitis (Disease Ontology:DOID:824); peritonitis (Disease Ontology:DOID:8283); corneal ulcer (Disease Ontology:DOID:8463); retinal artery occlusion (Disease Ontology:DOID:8483); lung disease (Disease Ontology:DOID:850); Hodgkin's lymphoma (Disease Ontology:DOID:8567); Kaposi's sarcoma (Disease Ontology:DOID:8632); perinatal necrotizing enterocolitis (Disease Ontology:DOID:8677); alcoholic gastritis (Disease Ontology:DOID:8680); Crohn's disease (Disease Ontology:DOID:8778); neuromyelitis optica (Disease Ontology:DOID:8869); diabetic retinopathy (Disease Ontology:DOID:8947); acute myeloid leukemia (Disease Ontology:DOID:9119); colorectal cancer (Disease Ontology:DOID:9256); diabetes mellitus (Disease Ontology:DOID:9351); type 2 diabetes mellitus (Disease Ontology:DOID:9352); epididymitis (Disease Ontology:DOID:9402); acute myocardial infarction (Disease Ontology:DOID:9408); allergic asthma (Disease Ontology:DOID:9415); steatotic liver disease (Disease Ontology:DOID:9452); neovascular inflammatory vitreoretinopathy (Disease Ontology:DOID:9719); type 1 diabetes mellitus (Disease Ontology:DOID:9744); obesity (Disease Ontology:DOID:9970); heroin dependence (Disease Ontology:DOID:9976)",
        "pathway": " (mmu:16193);  (R-MMU-1059683);  (R-MMU-110056);  (R-MMU-112411);  (R-MMU-381426);  (R-MMU-8957275);  (R-MMU-9958825)",
        "pathway_count": 7,
        "publication_count": 22,
        "publication_id_list": "11113088;11786910;15124018;16990136;17075861;2106569;21750661;22037645;2243807;2302197;23045607;2563387;27893700;28402851;2948184;2965020;30995492;3262059;3262872;3263439;3264160;8910279",
        "class_list": "",
        "function": "Acts as an essential factor in bone homeostasis and on vessels directly or indirectly by induction of VEGF, resulting in increased angiogenesis activity and vascular permeability. Induces, through 'trans-signaling' and synergistically with IL1B and TNF, the production of VEGF (PubMed:17075861). Involved in metabolic controls, is discharged into the bloodstream after muscle contraction increasing lipolysis and improving insulin resistance (PubMed:11786910). 'Trans-signaling' in central nervous system regulates energy and glucose homeostasis (PubMed:28402851). Mediates, through GLP-1, crosstalk between insulin-sensitive tissues, intestinal L cells and pancreatic islets to adapt to changes in insulin demand (PubMed:11113088). Also acts as a myokine (By similarity). Plays a protective role during liver injury, being required for maintenance of tissue regeneration (PubMed:11113088, PubMed:8910279). Also has a pivotal role in iron metabolism by regulating HAMP/hepcidin expression upon inflammation or bacterial infection (PubMed:15124018). Through activation of IL6ST-YAP-NOTCH pathway, induces inflammation-induced epithelial regeneration (By similarity)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed, UniProtKB]; Cytokine with a wide variety of biological functions in immunity, tissue regeneration, and metabolism (Probable). Binds to IL6R, then the complex associates to the signaling subunit IL6ST/gp130 to trigger the intracellular IL6-signaling pathway (PubMed:8910279). The interaction with the membrane-bound IL6R and IL6ST stimulates 'classic signaling', whereas the binding of IL6 and soluble IL6R to IL6ST stimulates 'trans-signaling'. Alternatively, 'cluster signaling' occurs when membrane-bound IL6:IL6R complexes on transmitter cells activate IL6ST receptors on neighboring receiver cells (PubMed:27893700)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; IL6 is a potent inducer of the acute phase response. Rapid production of IL6 contributes to host defense during infection and tissue injury, but excessive IL6 synthesis is involved in disease pathology. In the innate immune response, is synthesized by myeloid cells, such as macrophages and dendritic cells, upon recognition of pathogens through toll-like receptors (TLRs) at the site of infection or tissue injury. In the adaptive immune response, is required for the differentiation of B-cells into immunoglolin-secreting cells (Probable). Plays a major role in the differentiation of CD4(+) T cell subsets. Essential factor for the development of T follicular helper (Tfh) cells that are required for the induction of germinal-center formation. Together with IL21, controls the early generation of Tfh cells and are critical for an effective antibody response to acute viral infection (PubMed:23045607). Required to drive naive CD4(+) T cells to the Th17 lineage, through 'cluster signaling' by dendritic cells (PubMed:16990136, PubMed:27893700). Also required for proliferation of myeloma cells and the survival of plasmablast cells (Probable)., [UniProtKB, PubMed, PubMed, PubMed, PubMed]; This gene encodes a member of the interleukin family of cytokines that have important functions in immune response, hematopoiesis, inflammation and the acute phase response. The ectopic overexpression of the encoded protein in mice results in excessive plasma cells in circulation, leading to death. Mice lacking the encoded protein exhibit abnormalities in hepatic acute phase response, some immune mechanisms, bone resorption in response to estrogen, liver regeneration and wound healing. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2015]., [RefSeq]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 129,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3UCQ0;Q8BN26",
        "ec_number_list": "",
        "go_molecular_function": "GO:0005102 signaling receptor binding;GO:0042802 identical protein binding;GO:0005125 cytokine activity;GO:0008083 growth factor activity;GO:0005138 interleukin-6 receptor binding",
        "go_cellular_component": "GO:0005896 interleukin-6 receptor complex;GO:0005615 extracellular space;GO:0009897 external side of plasma membrane",
        "go_biological_process": "GO:0042307 positive regulation of protein import into nucleus;GO:0002384 hepatic immune response;GO:0048635 negative regulation of muscle organ development;GO:0070091 glucagon secretion;GO:0072574 hepatocyte proliferation",
        "synthesized_glycan_count": 0,
        "hit_score": 2.3,
        "record_id": "P08505-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q0P543-1",
        "uniprot_id": "GIPR_MOUSE",
        "mass": 52992.0,
        "length": 460,
        "protein_name": "Gastric inhibitory polypeptide receptor",
        "gene_name": "Gipr",
        "organism": "Mouse",
        "refseq_name": "gastric inhibitory polypeptide receptor precursor",
        "refseq_ac": "NP_001074284",
        "gene_names_uniprotkb": "Gipr",
        "gene_names_refseq": "GIP-R; Gipr; Gm1081; Gm160",
        "protein_names_uniprotkb": "Gastric inhibitory polypeptide receptor; GIP-R; Glucose-dependent insulinotropic polypeptide receptor",
        "protein_names_refseq": "gastric inhibitory polypeptide receptor precursor; glucose-dependent insulinotropic polypeptide receptor",
        "tax_id": 10090,
        "disease": "cardiovascular system disease (Disease Ontology:DOID:1287); hyperglycemia (Disease Ontology:DOID:4195); diabetes mellitus (Disease Ontology:DOID:9351); type 2 diabetes mellitus (Disease Ontology:DOID:9352); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:381853);  (R-MMU-418555);  (R-MMU-420092)",
        "pathway_count": 3,
        "publication_count": 4,
        "publication_id_list": "12540373;12679517;21750661;31905038",
        "class_list": "",
        "function": "GIPR(-/-) mice exhibit altered islet structure and topography and increased islet sensitivity to glucagon-like peptide-1 despite a decrease in pancreatic insulin content and gene expression, [RefSeq, PubMed]; This is a receptor for GIP. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 3,
        "predicted_n_glycosites": 3,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 5,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q80UB4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0017046 peptide hormone binding;GO:0008528 G protein-coupled peptide receptor activity;GO:0016519 gastric inhibitory peptide receptor activity;GO:0038023 signaling receptor activity;GO:0120022 glucagon family peptide binding",
        "go_cellular_component": "GO:0005886 plasma membrane",
        "go_biological_process": "GO:0007166 cell surface receptor signaling pathway;GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway;GO:0007204 positive regulation of cytosolic calcium ion concentration;GO:0007218 neuropeptide signaling pathway;GO:0032024 positive regulation of insulin secretion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q0P543-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9JJK5-1",
        "uniprot_id": "HERP1_MOUSE",
        "mass": 43907.0,
        "length": 391,
        "protein_name": "Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein",
        "gene_name": "Herpud1",
        "organism": "Mouse",
        "refseq_name": "homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform 1",
        "refseq_ac": "NP_071726",
        "gene_names_uniprotkb": "Herpud1",
        "gene_names_refseq": "Herpud1; Herp; Mifl; SUP",
        "protein_names_uniprotkb": "Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein",
        "protein_names_refseq": "homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform 1; homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:64209)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10922362;12153396;14742429;18042451;21750661;25428506;30084848;34057287;34428180;36746840",
        "class_list": "",
        "function": "Component of the endoplasmic reticulum quality control (ERQC) system also called ER-associated degradation (ERAD) involved in ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins. Binds to ubiquilins and this interaction is required for efficient degradation of CD3D via the ERAD pathway., [UniProtKB, UniProtKB]; Herp is in a complex with ubiquitinated proteins and with the 26S proteasome, suggesting that it plays a role in linking substrates with the proteasome., [RefSeq, PubMed]; Herp represents a second target, in addition to CHOP, that is dually regulated by both the shared and the ER stress-specific branches during unfolded protein activation, [RefSeq, PubMed]; Herpud1 deficiency alleviates homocysteine-induced aortic valve calcification., [RefSeq, PubMed]; The P300/XBP1s/Herpud1 axis promotes macrophage M2 polarization and the development of choroidal neovascularization., [RefSeq, PubMed]; Upregulation by Wnt-1, [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 1,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0044325 transmembrane transporter binding;GO:1990756 ubiquitin-like ligase-substrate adaptor activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0016020 membrane;GO:0005789 endoplasmic reticulum membrane;GO:0044322 endoplasmic reticulum quality control compartment;GO:1990037 Lewy body core",
        "go_biological_process": "GO:1904292 regulation of ERAD pathway;GO:0006874 intracellular calcium ion homeostasis;GO:0006511 ubiquitin-dependent protein catabolic process;GO:0030968 endoplasmic reticulum unfolded protein response;GO:0036503 ERAD pathway",
        "synthesized_glycan_count": 0,
        "hit_score": 1.1,
        "record_id": "Q9JJK5-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P26952-1",
        "uniprot_id": "IL3RA_MOUSE",
        "mass": 43195.0,
        "length": 396,
        "protein_name": "Interleukin-3 receptor subunit alpha",
        "gene_name": "Il3ra",
        "organism": "Mouse",
        "refseq_name": "interleukin-3 receptor subunit alpha isoform 3 precursor",
        "refseq_ac": "NP_032395",
        "gene_names_uniprotkb": "Il3ra; Sut-1",
        "gene_names_refseq": "CD123; CDw123; Il3ra; SUT-1",
        "protein_names_uniprotkb": "Interleukin-3 receptor subunit alpha; IL-3 receptor subunit alpha; IL-3R subunit alpha; IL-3R-alpha; IL-3RA; Interleukin-3 receptor class II alpha chain",
        "protein_names_refseq": "IL-3 receptor alpha chain; IL-3 receptor subunit alpha; IL-3R subunit alpha; IL-3R-alpha; IL-3RA; Il-3 alpha subunit; interleukin-3 receptor class II alpha chain; interleukin-3 receptor subunit alpha isoform 3 precursor; interleukin-3 receptor subunit alpha",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:16188)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "10376805;10477686;1582416;19109256;21750661;31990690;35075102;38566191;7889941",
        "class_list": "",
        "function": "Cell surface receptor for IL3 expressed on hematopoietic progenitor cells, monocytes and B-lymphocytes that controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells (By similarity). Ligand stimulation rapidly induces hetrodimerization with IL3RB, phosphorylation and enzyme activity of effector proteins such as JAK2 and PI3K that play a role in signaling cell proliferation and differentiation (PubMed:10477686, PubMed:31990690). Activation of JAK2 leads to STAT5-mediated transcriptional program (PubMed:10376805)., [UniProtKB, PubMed, UniProtKB, PubMed, PubMed]; EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia. Publication Status: Online-Only, [RefSeq, PubMed]; MARCH3 negatively regulates IL-3-triggered inflammatory response by mediating K48-linked polyubiquitination and degradation of IL-3Ralpha. Publication Status: Online-Only, [RefSeq, PubMed]",
        "predicted_glycosites": 5,
        "predicted_n_glycosites": 5,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 5,
        "binding_glycan_count": 0,
        "secondary_ac_list": "B9VI80",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004912 interleukin-3 receptor activity;GO:0019978 interleukin-3 binding;GO:0004896 cytokine receptor activity",
        "go_cellular_component": "GO:0005886 plasma membrane;GO:0016020 membrane;GO:0012505 endomembrane system",
        "go_biological_process": "GO:0038156 interleukin-3-mediated signaling pathway;GO:0001558 regulation of cell growth;GO:0019221 cytokine-mediated signaling pathway;GO:0030224 monocyte differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "P26952-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8BGW1-1",
        "uniprot_id": "FTO_MOUSE",
        "mass": 58007.0,
        "length": 502,
        "protein_name": "Alpha-ketoglutarate-dependent dioxygenase FTO",
        "gene_name": "Fto",
        "organism": "Mouse",
        "refseq_name": "alpha-ketoglutarate-dependent dioxygenase FTO",
        "refseq_ac": "NP_036066",
        "gene_names_uniprotkb": "Fto; Kiaa1752",
        "gene_names_refseq": "Fto; mKIAA1752",
        "protein_names_uniprotkb": "Alpha-ketoglutarate-dependent dioxygenase FTO; 1.14.11.-; 1.14.11.53; Fat mass and obesity-associated protein; Protein fatso; U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO; U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO; m6A(m)-demethylase FTO; mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO; mRNA N(6)-methyladenosine demethylase FTO; tRNA N1-methyl adenine demethylase FTO",
        "protein_names_refseq": "U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO; U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO; alpha-ketoglutarate-dependent dioxygenase FTO; fat mass and obesity associated; fat mass and obesity-associated protein; m6A(m)-demethylase FTO; mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO; mRNA N(6)-methyladenosine demethylase FTO; protein fatso; tRNA N1-methyl adenine demethylase FTO",
        "tax_id": 10090,
        "disease": "metabolic dysfunction-associated steatotic liver disease (Disease Ontology:DOID:0080208); aortic valve disease 2 (Disease Ontology:DOID:0080334); traumatic brain injury (Disease Ontology:DOID:0081292); hypertension (Disease Ontology:DOID:10763); essential hypertension (Disease Ontology:DOID:10825); sciatic neuropathy (Disease Ontology:DOID:11446); cardiovascular system disease (Disease Ontology:DOID:1287); nuclear senile cataract (Disease Ontology:DOID:13963); transient cerebral ischemia (Disease Ontology:DOID:224); coronary artery disease (Disease Ontology:DOID:3393); renal cell carcinoma (Disease Ontology:DOID:4450); clear cell renal cell carcinoma (Disease Ontology:DOID:4467); myocardial infarction (Disease Ontology:DOID:5844); congestive heart failure (Disease Ontology:DOID:6000); abdominal aortic aneurysm (Disease Ontology:DOID:7693); type 2 diabetes mellitus (Disease Ontology:DOID:9352); pulmonary embolism (Disease Ontology:DOID:9477); multiple myeloma (Disease Ontology:DOID:9538); diabetic neuropathy (Disease Ontology:DOID:9743); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:26383);  (R-MMU-73943)",
        "pathway_count": 2,
        "publication_count": 17,
        "publication_id_list": "10.1101/2023.09.13.557529;10501967;17991826;18775698;19234441;19680540;21076408;21750661;23300482;23817550;24646999;24807221;28002401;28135057;28528544;30084848;39390397",
        "class_list": "",
        "function": "FTO mediates the diabetic kidney disease progression through regulating the m[6]A modification of NLRP3. Publication Status: Online-Only, [RefSeq, PubMed]; RNA demethylase that mediates oxidative demethylation of different RNA species, such as mRNAs, tRNAs and snRNAs, and acts as a regulator of fat mass, adipogenesis and energy homeostasis (PubMed:17991826, PubMed:18775698, PubMed:28002401). Specifically demethylates N(6)-methyladenosine (m6A) RNA, the most prevalent internal modification of messenger RNA (mRNA) in higher eukaryotes (PubMed:28002401). M6A demethylation by FTO affects mRNA expression and stability (By similarity). Also able to demethylate m6A in U6 small nuclear RNA (snRNA) (By similarity). Mediates demethylation of N(6),2'-O-dimethyladenosine cap (m6A(m)), by demethylating the N(6)-methyladenosine at the second transcribed position of mRNAs and U6 snRNA (PubMed:28002401). Demethylation of m6A(m) in the 5'-cap by FTO affects mRNA stability by promoting susceptibility to decapping (By similarity). Also acts as a tRNA demethylase by removing N(1)-methyladenine from various tRNAs (By similarity). Has no activity towards 1-methylguanine (By similarity). Has no detectable activity towards double-stranded DNA (By similarity). Also able to repair alkylated DNA and RNA by oxidative demethylation: demethylates single-stranded RNA containing 3-methyluracil, single-stranded DNA containing 3-methylthymine and has low demethylase activity towards single-stranded DNA containing 1-methyladenine or 3-methylcytosine (PubMed:17991826, PubMed:18775698). Ability to repair alkylated DNA and RNA is however unsure in vivo (PubMed:17991826, PubMed:18775698). Involved in the regulation of fat mass, adipogenesis and body weight, thereby contributing to the regulation of body size and body fat accumulation (PubMed:19234441, PubMed:19680540, PubMed:21076408, PubMed:23300482, PubMed:23817550). Involved in the regulation of thermogenesis and the control of adipocyte differentiation into brown or white fat cells (PubMed:19234441, PubMed:19680540). Regulates activity of the dopaminergic midbrain circuitry via its ability to demethylate m6A in mRNAs (PubMed:23817550)., [UniProtKB, PubMed, PubMed, PubMed, UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 4,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 2,
        "disease_count": 20,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TTZ5;Q6ZPI7;Q8BR68;Q8CB66;Q8R250;Q9QZ13",
        "ec_number_list": "1.14.11.51;4.2.99.18;1.14.11.-;1.14.11.33;1.14.11.53",
        "go_molecular_function": "GO:0008198 ferrous iron binding;GO:0016706 2-oxoglutarate-dependent dioxygenase activity;GO:1990984 tRNA demethylase activity;GO:0035515 oxidative RNA demethylase activity;GO:1990931 mRNA N6-methyladenosine dioxygenase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016607 nuclear speck",
        "go_biological_process": "GO:1903999 negative regulation of eating behavior;GO:0001659 temperature homeostasis;GO:0040014 regulation of multicellular organism growth;GO:0043065 positive regulation of apoptotic process;GO:0060612 adipose tissue development",
        "synthesized_glycan_count": 0,
        "hit_score": 2.2,
        "record_id": "Q8BGW1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "E9Q5G7-1",
        "uniprot_id": "OOG1_MOUSE",
        "mass": 56633.0,
        "length": 496,
        "protein_name": "Oogenesin-1",
        "gene_name": "Gm2042; Oog1",
        "organism": "Mouse",
        "refseq_name": "oogenesin-1",
        "refseq_ac": "NP_848772",
        "gene_names_uniprotkb": "Gm2042; Oog1; Oog1; Oog",
        "gene_names_refseq": "Oog1; Oog; c-1",
        "protein_names_uniprotkb": "Oogenesin-1",
        "protein_names_refseq": "oogenesin-1",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:193322)",
        "pathway_count": 1,
        "publication_count": 6,
        "publication_id_list": "12890732;16580637;19480014;21750661;23894331;29731491",
        "class_list": "",
        "function": "Aberrant demethylation of the proximal promoter region induced ectopic expression in male germ cells under the control of 3.9 kb Oog1 promoter Publication Status: Online-Only, [RefSeq, PubMed]; May down-regulate the expression of spermatogenesis-associated genes in female germ cells allowing their normal differentiation into oocytes (PubMed:29731491). May act as a Ras-mediated signaling protein in early embryogenesis., [UniProtKB, PubMed, PubMed]; RT-PCR data shows an increase in oogenesis specific gene transcripts (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) between the primordial until the preantral stages, with the exception of the Oogenesin1 transcripts under gonadotropin-induction., [RefSeq, PubMed]; These results indicate that Oog1 down-regulates the expression of spermatogenesis-associated genes in female germ cells, allowing them to develop normally into oocytes., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q810D9",
        "ec_number_list": "",
        "go_molecular_function": "GO:1990756 ubiquitin-like ligase-substrate adaptor activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0031462 Cul2-RING ubiquitin ligase complex",
        "go_biological_process": "GO:0008284 positive regulation of cell population proliferation;GO:0043066 negative regulation of apoptotic process;GO:0045892 negative regulation of DNA-templated transcription;GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process;GO:0045596 negative regulation of cell differentiation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "E9Q5G7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q62448-1",
        "uniprot_id": "IF4G2_MOUSE",
        "mass": 102106.0,
        "length": 906,
        "protein_name": "Eukaryotic translation initiation factor 4 gamma 2",
        "gene_name": "Eif4g2",
        "organism": "Mouse",
        "refseq_name": "eukaryotic translation initiation factor 4 gamma 2 isoform 2",
        "refseq_ac": "NP_001035221",
        "gene_names_uniprotkb": "Eif4g2; Nat1",
        "gene_names_refseq": "DAP-5; E130105L11Rik; Eif4g2; Nat1; Natm1; p97",
        "protein_names_uniprotkb": "Eukaryotic translation initiation factor 4 gamma 2; Novel APOBEC-1 target 1; Translation repressor NAT1; eIF-4-gamma 2; eIF-4G 2; eIF4G 2; p97",
        "protein_names_refseq": "eIF-4-gamma 2; eIF-4G 2; eIF4G 2; eukaryotic translation initiation factor 4 gamma 2 isoform 2; novel APOBEC-1 target 1; translation repressor Nat1",
        "tax_id": 10090,
        "disease": "hypertension (Disease Ontology:DOID:10763); Parkinson's disease (Disease Ontology:DOID:14330); renovascular hypertension (Disease Ontology:DOID:1591)",
        "pathway": " (mmu:13690);  (R-MMU-1169408)",
        "pathway_count": 2,
        "publication_count": 25,
        "publication_id_list": "10.1101/2023.09.13.557529;15345747;17242355;19144319;21750661;22645316;25428506;30084848;30779550;31219806;32782141;32848054;34428180;34887587;35822049;36288343;36852467;37646610;38589584;39627609;40021952;40885482;9027506;9030685;9049310",
        "class_list": "",
        "function": "Appears to play a role in the switch from cap-dependent to IRES-mediated translation during mitosis, apoptosis and viral infection. Cleaved by some caspases and viral proteases., [UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB, UniProtKB]; In vitro and in vivo studies in human show that translation starts at a non-AUG (GUG) codon. Suggest the same in mouse based on sequence conservation., [RefSeq, PubMed]; MiR-379-5P INHIBITION ENHANCES INTESTINAL EPITHELIAL PROLIFERATION AND BARRIER FUNCTION RECOVERY AFTER ISCHEMIA/REPERFUSION BY TARGETING EIF4G2., [RefSeq, PubMed]; Neuronal activity rapidly reprograms dendritic translation via eIF4G2:uORF binding., [RefSeq, PubMed]; Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. The protein encoded by this gene shares similarity with the C-terminal region of eIF4G, that contains the binding sites for eIF4A and eIF3; eIF4G in addition, contains a binding site for eIF4E at the N-terminus. Unlike eIF4G which supports cap-dependent and independent translation, this gene product functions as a general repressor of translation by forming translationally inactive complexes. Transgene expression of the apolipoprotein B mRNA-editing enzyme (APOBEC-1) causes extensive editing of this mRNA, which could contribute to the potent oncogenesis induced by overexpression of APOBEC-1. In vitro and in vivo studies in human indicate that translation of this mRNA initiates exclusively at a non-AUG (GUG) codon. This also appears to be true for mouse. Two alternatively spliced transcript variants that encode different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]., [RefSeq]; Translation starts at a non-AUG translation initiation codon (GUG)., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 2,
        "reported_o_glycosites_with_glycan": 2,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 2,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 2,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 7,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 3,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "P97867;Q0VGZ3;Q3UNC1;Q5XKD8;Q6P1Z0;Q921U3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003729 mRNA binding;GO:0008135 translation factor activity, RNA binding;GO:0003743 translation initiation factor activity;GO:0003723 RNA binding",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0014069 postsynaptic density;GO:0030424 axon;GO:0016281 eukaryotic translation initiation factor 4F complex",
        "go_biological_process": "GO:0030307 positive regulation of cell growth;GO:0006413 translational initiation;GO:0010507 negative regulation of autophagy;GO:0045727 positive regulation of translation;GO:0045773 positive regulation of axon extension",
        "synthesized_glycan_count": 0,
        "hit_score": 3.3,
        "record_id": "Q62448-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9CPS6-1",
        "uniprot_id": "HINT3_MOUSE",
        "mass": 18788.0,
        "length": 165,
        "protein_name": "Adenosine 5'-monophosphoramidase HINT3",
        "gene_name": "Hint3",
        "organism": "Mouse",
        "refseq_name": "adenosine 5'-monophosphoramidase HINT3",
        "refseq_ac": "NP_080074",
        "gene_names_uniprotkb": "Hint3; Hint4",
        "gene_names_refseq": "0610010I17Rik; HINT-3; HINT-4; HINT4; Hint3",
        "protein_names_uniprotkb": "Adenosine 5'-monophosphoramidase HINT3; 3.9.1.-; HINT-3; HINT-4; Histidine triad nucleotide-binding protein 3",
        "protein_names_refseq": "adenosine 5'-monophosphoramidase HINT3; histidine triad protein 4",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:66847)",
        "pathway_count": 1,
        "publication_count": 2,
        "publication_id_list": "21750661;31088288",
        "class_list": "",
        "function": "Exhibits adenosine 5'-monophosphoramidase activity, hydrolyzing purine nucleotide phosphoramidates with a single phosphate group such as adenosine 5'monophosphoramidate (AMP-NH2) to yield AMP and NH2 (By similarity). Hydrolyzes lysyl-AMP (AMP-N-epsilon-(N-alpha-acetyl lysine methyl ester)) generated by lysine tRNA ligase (By similarity)., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 0,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "3.6.1.29;3.9.1.-;2.7.7.51;3.6.2.1;3.4.22.-",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0000166 nucleotide binding;GO:0043530 adenosine 5'-monophosphoramidase activity;GO:0016787 hydrolase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm",
        "go_biological_process": "",
        "synthesized_glycan_count": 0,
        "hit_score": 0.3,
        "record_id": "Q9CPS6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P26954-1",
        "uniprot_id": "IL3B2_MOUSE",
        "mass": 97195.0,
        "length": 878,
        "protein_name": "Interleukin-3 receptor class 2 subunit beta",
        "gene_name": "Csf2rb2",
        "organism": "Mouse",
        "refseq_name": "interleukin-3 receptor class 2 subunit beta isoform 1 precursor",
        "refseq_ac": "NP_031807",
        "gene_names_uniprotkb": "Csf2rb2; Ai2ca; Il3rb2; Il3r",
        "gene_names_refseq": "AIC2A; BetaIl3; Bil3; Csf2rb2; Csfgmrb; Il3rb2; Il3rb; Il3r",
        "protein_names_uniprotkb": "Interleukin-3 receptor class 2 subunit beta; Colony-stimulating factor 2 receptor subunit beta-2; IL-3 receptor class 2 subunit beta; IL-3R class 2 subunit beta; Interleukin-3 receptor class II beta chain",
        "protein_names_refseq": "IL-3 receptor class 2 subunit beta; IL-3R class 2 subunit beta; colony-stimulating factor 2 receptor subunit beta-2; interleukin-3 receptor class 2 subunit beta isoform 1 precursor; interleukin-3 receptor class 2 subunit beta; interleukin-3 receptor class II beta chain",
        "tax_id": 10090,
        "disease": "pulmonary alveolar proteinosis (Disease Ontology:DOID:12120); brain ischemia (Disease Ontology:DOID:2316); asthma (Disease Ontology:DOID:2841)",
        "pathway": " (mmu:12984)",
        "pathway_count": 1,
        "publication_count": 5,
        "publication_id_list": "18250455;21750661;2404337;28011936;34428180",
        "class_list": "",
        "function": "In mouse, there are two classes of high-affinity IL3 receptors. One contains this IL3-specific beta subunit and the other contains the beta subunit also shared by high-affinity IL5 and GM-CSF receptors., [UniProtKB]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 1,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 1,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 3,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 3,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 3,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "",
        "go_molecular_function": "GO:0015026 coreceptor activity;GO:0004896 cytokine receptor activity",
        "go_cellular_component": "GO:0030526 granulocyte macrophage colony-stimulating factor receptor complex;GO:0005886 plasma membrane;GO:0009897 external side of plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0038043 interleukin-5-mediated signaling pathway;GO:0038156 interleukin-3-mediated signaling pathway;GO:0016064 immunoglobulin mediated immune response;GO:0007259 cell surface receptor signaling pathway via JAK-STAT;GO:0070665 positive regulation of leukocyte proliferation",
        "synthesized_glycan_count": 0,
        "hit_score": 0.7,
        "record_id": "P26954-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "P15208-1",
        "uniprot_id": "INSR_MOUSE",
        "mass": 155610.0,
        "length": 1372,
        "protein_name": "Insulin receptor",
        "gene_name": "Insr",
        "organism": "Mouse",
        "refseq_name": "insulin receptor isoform A preproprotein",
        "refseq_ac": "NP_034698",
        "gene_names_uniprotkb": "Insr",
        "gene_names_refseq": "4932439J01Rik; CD220; D630014A15Rik; IR-A; IR-B; IR; Insr",
        "protein_names_uniprotkb": "Insulin receptor; 2.7.10.1; IR",
        "protein_names_refseq": "insulin receptor isoform A preproprotein",
        "tax_id": 10090,
        "disease": "Donohue syndrome (Disease Ontology:DOID:0050470); alcohol dependence (Disease Ontology:DOID:0050741); pre-malignant neoplasm (Disease Ontology:DOID:0060071); familial hyperinsulinemic hypoglycemia 5 (Disease Ontology:DOID:0070220); metabolic dysfunction-associated steatotic liver disease (Disease Ontology:DOID:0080208); short bowel syndrome (Disease Ontology:DOID:10605); Alzheimer's disease (Disease Ontology:DOID:10652); gestational diabetes (Disease Ontology:DOID:11714); hepatic encephalopathy (Disease Ontology:DOID:13413); Parkinson's disease (Disease Ontology:DOID:14330); breast cancer (Disease Ontology:DOID:1612); cancer (Disease Ontology:DOID:162); prostate adenocarcinoma (Disease Ontology:DOID:2526); high grade glioma (Disease Ontology:DOID:3070); choriocarcinoma (Disease Ontology:DOID:3594); glucose metabolism disease (Disease Ontology:DOID:4194); seminoma (Disease Ontology:DOID:4440); renal cell carcinoma (Disease Ontology:DOID:4450); sleep disorder (Disease Ontology:DOID:535); hepatocellular carcinoma (Disease Ontology:DOID:684); chronic kidney disease (Disease Ontology:DOID:784); diabetic retinopathy (Disease Ontology:DOID:8947); diabetes mellitus (Disease Ontology:DOID:9351); type 2 diabetes mellitus (Disease Ontology:DOID:9352); steatotic liver disease (Disease Ontology:DOID:9452); diabetic neuropathy (Disease Ontology:DOID:9743); obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:16337);  (R-MMU-6811558);  (R-MMU-74713);  (R-MMU-74749);  (R-MMU-74751);  (R-MMU-74752);  (R-MMU-77387)",
        "pathway_count": 7,
        "publication_count": 25,
        "publication_id_list": "10.1101/2023.09.13.557529;10207032;10821852;12612081;15169905;18288188;19122674;19349973;19656770;20655470;21750661;24078630;2557333;2602374;27322061;30084848;30899004;31219806;32258946;33300544;34271222;34428180;38061240;8626379;9447983",
        "class_list": "",
        "function": "Receptor tyrosine kinase which mediates the pleiotropic actions of insulin (PubMed:38061240). Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). When present in a hybrid receptor with IGF1R, binds IGF1 (By similarity). In adipocytes, inhibits lipolysis (PubMed:27322061)., [UniProtKB, PubMed, PubMed]; This gene encodes a member of the receptor tyrosine kinase family of transmembrane signaling proteins that play important roles in cell differentiation, growth and metabolism. The encoded preproprotein undergoes proteolytic processing to generate alpha and beta chains that form a disulfide-linked heterodimer which, in turn homodimerizes to form a mature, functional receptor. Mice lacking the encoded protein develop severe hyperglycemia and hyperketonemia, and die within a couple of days after birth as a result of diabetic ketoacidosis. [provided by RefSeq, Aug 2016]., [RefSeq]",
        "predicted_glycosites": 5,
        "predicted_n_glycosites": 5,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 13,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 14,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 14,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 14,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 12,
        "reported_mutagensis": 1,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 18,
        "disease_count": 27,
        "glyco_site_count": 19,
        "binding_glycan_count": 0,
        "secondary_ac_list": "F8VPU4",
        "ec_number_list": "3.1.3.48;2.7.12.2;2.7.10.1;2.7.12.1;2.7.1.32;2.7.1.82;2.7.10.2;2.7.11.1;2.7.11.13;2.7.10.4;2.7.1.40;3.1.3.16;2.7.11.23",
        "go_molecular_function": "GO:0005009 insulin receptor activity;GO:0004672 protein kinase activity;GO:0004713 protein tyrosine kinase activity;GO:0005524 ATP binding;GO:0005525 GTP binding",
        "go_cellular_component": "GO:0031981 nuclear lumen;GO:0005635 nuclear envelope;GO:0005768 endosome;GO:0005886 plasma membrane;GO:0016020 membrane",
        "go_biological_process": "GO:0032410 negative regulation of transporter activity;GO:0051446 positive regulation of meiotic cell cycle;GO:2000194 regulation of female gonad development;GO:2000252 negative regulation of feeding behavior;GO:0006468 protein phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 5.9,
        "record_id": "P15208-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q6S5C2-1",
        "uniprot_id": "GNPTG_MOUSE",
        "mass": 34169.0,
        "length": 307,
        "protein_name": "N-acetylglucosamine-1-phosphotransferase subunit gamma",
        "gene_name": "Gnptg",
        "organism": "Mouse",
        "refseq_name": "N-acetylglucosamine-1-phosphotransferase subunit gamma isoform 2 precursor",
        "refseq_ac": "NP_001333666",
        "gene_names_uniprotkb": "Gnptg; Mdcp1",
        "gene_names_refseq": "6430527N14Rik; A830081F19; Gnptg; Mdcp1; Tce7",
        "protein_names_uniprotkb": "N-acetylglucosamine-1-phosphotransferase subunit gamma; GlcNAc-1-phosphotransferase subunit gamma; M6PR domain-containing protein 1; UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma",
        "protein_names_refseq": "M6PR domain-containing protein 1; N-acetylglucosamine-1-phosphotransferase subunit gamma isoform 2 precursor; N-acetylglucosamine-1-phosphotransferase subunit gamma; T-complex expressed 7; UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma; glcNAc-1-phosphotransferase subunit gamma; mannose-6-phosphate receptor domain",
        "tax_id": 10090,
        "disease": "mucolipidosis III gamma (Disease Ontology:DOID:0080678); glycoproteinosis (Disease Ontology:DOID:3343)",
        "pathway": " (mmu:214505)",
        "pathway_count": 1,
        "publication_count": 10,
        "publication_id_list": "10.1101/2023.09.13.557529;15716021;19955174;21173149;21750661;25428506;25605945;30899004;31219806;34116066",
        "class_list": "glycogene",
        "function": "Analysis of functional differences in alpha, beta, and gamma subunits of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase, [RefSeq, PubMed]; Non-catalytic subunit of the N-acetylglucosamine-1-phosphotransferase complex, an enzyme that catalyzes the formation of mannose 6-phosphate (M6P) markers on high mannose type oligosaccharides in the Golgi apparatus. Binds and presents the high mannose glycans of the acceptor to the catalytic alpha and beta subunits (GNPTAB). Enhances the rate of N-acetylglucosamine-1-phosphate transfer to the oligosaccharides of acid hydrolase acceptors., [UniProtKB, PubMed, UniProtKB, UniProtKB, UniProtKB]; UDP-GlcNAc-1-Phosphotransferase Is a Clinically Important Regulator of Human and Mouse Hair Pigmentation., [RefSeq, PubMed]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 2,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 2,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 2,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 7,
        "reported_glycation": 0,
        "reported_snv": 25,
        "reported_interactions": 0,
        "missing_score": 9015,
        "biomarker_type": "",
        "glycan_count": 3,
        "disease_count": 2,
        "glyco_site_count": 2,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q7TNE0;Q8C5J3",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0000139 Golgi membrane;GO:0005576 extracellular region;GO:0005794 Golgi apparatus;GO:0070622 UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase complex",
        "go_biological_process": "GO:0046835 carbohydrate phosphorylation",
        "synthesized_glycan_count": 0,
        "hit_score": 1.6,
        "record_id": "Q6S5C2-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9R092-1",
        "uniprot_id": "H17B6_MOUSE",
        "mass": 36103.0,
        "length": 317,
        "protein_name": "17-beta-hydroxysteroid dehydrogenase type 6",
        "gene_name": "Hsd17b6",
        "organism": "Mouse",
        "refseq_name": "17-beta-hydroxysteroid dehydrogenase type 6 isoform a precursor",
        "refseq_ac": "NP_038814",
        "gene_names_uniprotkb": "Hsd17b6; Gm182; Hsd17b9; Rdh8",
        "gene_names_refseq": "17betaHSD9; Hsd17b6; Hsd17b9; Rdh8",
        "protein_names_uniprotkb": "17-beta-hydroxysteroid dehydrogenase type 6; 1.1.1.105; 1.1.1.209; 1.1.1.239; 1.1.1.53; 1.1.1.62; 17-beta-HSD 6; 17-beta-HSD6; 17-beta-HSD9; 3-alpha->beta-HSE; 3-alpha->beta-hydroxysteroid epimerase; Oxidative 3-alpha hydroxysteroid dehydrogenase",
        "protein_names_refseq": "17-beta-HSD 6; 17-beta-HSD6; 17-beta-HSD9; 17-beta-hydroxysteroid dehydrogenase type 6 isoform a precursor; 17-beta-hydroxysteroid dehydrogenase type 6; 3-alpha->beta-HSE; 3-alpha->beta-hydroxysteroid epimerase; hydroxysteroid (17-beta) dehydrogenase 9; oxidative 3-alpha hydroxysteroid dehydrogenase",
        "tax_id": 10090,
        "disease": "chromosome 3q29 microdeletion syndrome (Disease Ontology:DOID:0060419)",
        "pathway": " (mmu:27400);  (R-MMU-2453902)",
        "pathway_count": 2,
        "publication_count": 5,
        "publication_id_list": "10537158;21750661;34418053;34428180;37330135",
        "class_list": "",
        "function": "HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation., [RefSeq, PubMed]; NAD-dependent oxidoreductase with broad substrate specificity that shows both oxidative and reductive activity (in vitro). Has 17-beta-hydroxysteroid dehydrogenase activity towards various steroids (in vitro). Converts 5-alpha-androstan-3-alpha,17-beta-diol to androsterone and estradiol to estrone (in vitro). Has 3-alpha-hydroxysteroid dehydrogenase activity towards androsterone (in vitro). Has retinol dehydrogenase activity towards all-trans-retinol (in vitro)., [UniProtKB, PubMed]",
        "predicted_glycosites": 2,
        "predicted_n_glycosites": 2,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 3,
        "binding_glycan_count": 0,
        "secondary_ac_list": "",
        "ec_number_list": "1.1.1.300;1.1.1.35;1.1.1.62;1.1.1.239;1.1.1.178;1.1.1.53;1.1.1.159;1.1.1.105;1.1.1.315;1.1.1.209;1.1.1.330;1.1.1.270;1.1.1.210;1.1.1.145;5.3.3.1;1.1.1.n12;1.1.1.51;1.1.1.64;1.1.1.1;1.1.1.66;1.1.1.-",
        "go_molecular_function": "GO:0004745 all-trans-retinol dehydrogenase (NAD+) activity;GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity;GO:0047023 androsterone dehydrogenase [NAD(P)+] activity;GO:0047035 testosterone dehydrogenase (NAD+) activity;GO:0047045 testosterone dehydrogenase (NADP+) activity",
        "go_cellular_component": "GO:0005783 endoplasmic reticulum;GO:0031901 early endosome membrane",
        "go_biological_process": "GO:0042572 retinol metabolic process;GO:0006703 estrogen biosynthetic process;GO:0008202 steroid metabolic process;GO:0062175 brexanolone catabolic process",
        "synthesized_glycan_count": 0,
        "hit_score": 0.8,
        "record_id": "Q9R092-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q3TVI4-1",
        "uniprot_id": "HEXI2_MOUSE",
        "mass": 35397.0,
        "length": 313,
        "protein_name": "Protein HEXIM2",
        "gene_name": "Hexim2",
        "organism": "Mouse",
        "refseq_name": "protein HEXIM2",
        "refseq_ac": "NP_001123987",
        "gene_names_uniprotkb": "Hexim2",
        "gene_names_refseq": "4933402L21Rik; Hexim2",
        "protein_names_uniprotkb": "Protein HEXIM2",
        "protein_names_refseq": "hexamthylene bis-acetamide inducible 2; protein HEXIM2",
        "tax_id": 10090,
        "disease": "",
        "pathway": " (mmu:71059)",
        "pathway_count": 1,
        "publication_count": 3,
        "publication_id_list": "10.1101/2023.09.13.557529;21183079;21750661",
        "class_list": "",
        "function": "Transcriptional regulator which functions as a general RNA polymerase II transcription inhibitor. Core component of the 7SK RNP complex: in cooperation with 7SK snRNA sequesters P-TEFb in a large inactive 7SK snRNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 1,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 1,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 1,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 9688,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 0,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q9D4C7",
        "ec_number_list": "",
        "go_molecular_function": "GO:0042802 identical protein binding;GO:0017069 snRNA binding;GO:0097322 7SK snRNA binding;GO:0004861 cyclin-dependent protein serine/threonine kinase inhibitor activity",
        "go_cellular_component": "GO:0005654 nucleoplasm;GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016607 nuclear speck;GO:0005634 nucleus",
        "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0006351 DNA-templated transcription;GO:0045892 negative regulation of DNA-templated transcription;GO:0010972 negative regulation of G2/M transition of mitotic cell cycle",
        "synthesized_glycan_count": 0,
        "hit_score": 0.6,
        "record_id": "Q3TVI4-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q9DBM1-1",
        "uniprot_id": "GPTC1_MOUSE",
        "mass": 103008.0,
        "length": 930,
        "protein_name": "G patch domain-containing protein 1",
        "gene_name": "Gpatch1",
        "organism": "Mouse",
        "refseq_name": "G patch domain-containing protein 1",
        "refseq_ac": "NP_080457",
        "gene_names_uniprotkb": "Gpatch1; Gpatc1",
        "gene_names_refseq": "1300003A17Rik; ECGP; Gpatc1; Gpatch1",
        "protein_names_uniprotkb": "G patch domain-containing protein 1",
        "protein_names_refseq": "G patch domain-containing protein 1; evolutionarily conserved G-patch domain containing",
        "tax_id": 10090,
        "disease": "progressive myoclonus epilepsy 3 (Disease Ontology:DOID:0111446)",
        "pathway": " (mmu:67471);  (R-MMU-72163)",
        "pathway_count": 2,
        "publication_count": 3,
        "publication_id_list": "21750661;31219806;34428180",
        "class_list": "",
        "function": "",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 4,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q8R0V4",
        "ec_number_list": "",
        "go_molecular_function": "GO:0003723 RNA binding;GO:0003676 nucleic acid binding",
        "go_cellular_component": "GO:0005634 nucleus;GO:0071013 catalytic step 2 spliceosome",
        "go_biological_process": "GO:0006397 mRNA processing",
        "synthesized_glycan_count": 0,
        "hit_score": 0.4,
        "record_id": "Q9DBM1-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q8VHN7-1",
        "uniprot_id": "AGRV1_MOUSE",
        "mass": 687458.0,
        "length": 6298,
        "protein_name": "Adhesion G protein-coupled receptor V1",
        "gene_name": "Adgrv1",
        "organism": "Mouse",
        "refseq_name": "",
        "refseq_ac": "",
        "gene_names_uniprotkb": "Adgrv1; Gpr98; Kiaa0686; Mass1; Vlgr1",
        "gene_names_refseq": "",
        "protein_names_uniprotkb": "Adhesion G protein-coupled receptor V1; 3.4.-.-; ADGRV1; G protein-coupled receptor 98; MASS1; Monogenic audiogenic seizure susceptibility protein 1; Neurepin; Protein rueda; VLGR1 subunit beta; VLGR1; Vbeta; Very large G protein-coupled receptor 1",
        "protein_names_refseq": "",
        "tax_id": 10090,
        "disease": "Usher syndrome type 2C (Disease Ontology:DOID:0110839); familial febrile seizures 4 (Disease Ontology:DOID:0111305); retinitis pigmentosa (Disease Ontology:DOID:10584)",
        "pathway": " (mmu:110789)",
        "pathway_count": 1,
        "publication_count": 19,
        "publication_id_list": "10.1101/2023.09.13.557529;11545713;11606593;15606908;16775142;17329413;17567809;20173027;20502675;21750661;22419726;23055499;24191038;24334608;24962568;25406310;25428506;34203471;34418053",
        "class_list": "",
        "function": "Cleaved ADGRV1 beta-subunit couples with G-alpha(i)-proteins, GNAI1/2/3, and constitutively inhibits adenylate cyclase (AC) activity with a stronger effect than full ADGRV1., [UniProtKB, PubMed, UniProtKB, UniProtKB]; G protein-coupled receptor which has an essential role in the development of hearing and vision (PubMed:16775142, PubMed:17567809, PubMed:20502675, PubMed:24191038). Couples to G-alpha(i)-proteins, GNAI1/2/3, G-alpha(q)-proteins, GNAQ, as well as G-alpha(s)-proteins, GNAS, inhibiting adenylate cyclase (AC) activity and cAMP production (PubMed:24191038, PubMed:24962568). Required for the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells of the inner ear (PubMed:16775142, PubMed:17567809). In response to extracellular calcium, activates kinases PKA and PKC to regulate myelination by inhibiting the ubiquitination of MAG, thus enhancing the stability of this protein in myelin-forming cells of the auditory pathway (PubMed:24191038). In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport (PubMed:20502675). Involved in the regulation of bone metabolism (PubMed:22419726)., [UniProtKB, PubMed, PubMed, PubMed, PubMed, PubMed, PubMed]; G-protein coupled receptor which has an essential role in the development of hearing and vision. Couples to G-alpha(i)-proteins, GNAI1/2/3, G-alpha(q)-proteins, GNAQ, as well as G-alpha(s)-proteins, GNAS, inhibiting adenylate cyclase (AC) activity and cAMP production. Required for the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells of the inner ear. In response to extracellular calcium, activates kinases PKA and PKC to regulate myelination by inhibiting the ubiquitination of MAG, thus enhancing the stability of this protein in myelin-forming cells of the auditory pathway. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport. Involved in the regulation of bone metabolism., [UniProtKB, UniProtKB]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 8,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 8,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 8,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 3,
        "reported_glycation": 0,
        "reported_snv": 6,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 9,
        "disease_count": 3,
        "glyco_site_count": 10,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q6ZQ69;Q810D2;Q810D3;Q91ZS0;Q91ZS1",
        "ec_number_list": "",
        "go_molecular_function": "GO:0004930 G protein-coupled receptor activity;GO:0016787 hydrolase activity;GO:0005509 calcium ion binding;GO:0017022 myosin binding;GO:0001965 G-protein alpha-subunit binding",
        "go_cellular_component": "GO:0005576 extracellular region;GO:0005737 cytoplasm;GO:0005886 plasma membrane;GO:0009986 cell surface;GO:0016020 membrane",
        "go_biological_process": "GO:0048496 maintenance of animal organ identity;GO:0007166 cell surface receptor signaling pathway;GO:0007186 G protein-coupled receptor signaling pathway;GO:0007194 negative regulation of adenylate cyclase activity;GO:0007399 nervous system development",
        "synthesized_glycan_count": 0,
        "hit_score": 3.8,
        "record_id": "Q8VHN7-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q2VPA6-1",
        "uniprot_id": "HELQ_MOUSE",
        "mass": 119098.0,
        "length": 1069,
        "protein_name": "Helicase POLQ-like",
        "gene_name": "Helq",
        "organism": "Mouse",
        "refseq_name": "helicase POLQ-like isoform 1",
        "refseq_ac": "NP_001074576",
        "gene_names_uniprotkb": "Helq; Hel308",
        "gene_names_refseq": "D430018E21Rik; Hel308; Helq",
        "protein_names_uniprotkb": "Helicase POLQ-like; 5.6.2.4; Mus308-like helicase; POLQ-like helicase",
        "protein_names_refseq": "DNA helicase Hel308; POLQ-like helicase; helicase POLQ-like isoform 1; helicase, mus308-like; mus308-like helicase",
        "tax_id": 10090,
        "disease": "primary ovarian insufficiency (Disease Ontology:DOID:5426)",
        "pathway": " (mmu:191578)",
        "pathway_count": 1,
        "publication_count": 9,
        "publication_id_list": "11751861;12794064;21750661;24005041;24005329;31219806;35820727;38540391;38720471",
        "class_list": "",
        "function": "A Human Homozygous HELQ Missense Variant Does Not Cause Premature Ovarian Insufficiency in a Mouse Model. Publication Status: Online-Only, [RefSeq, PubMed]; HELQ deficiency impairs the induction of primordial germ cell-like cells. Erratum:[FEBS Open Bio. 2025 May;15(5):885. doi: 10.1002/2211-5463.70029. PMID: 40176377], [RefSeq, PubMed]; Identification of homolog to POLN, [RefSeq, PubMed]; Results reveal a critical role for HELQ in replication-coupled DNA repair, germ cell maintenance and tumour suppression in mammals, [RefSeq, PubMed]; Single-stranded 3'-5' DNA helicase that plays a key role in homology-driven double-strand break (DSB) repair (PubMed:24005041, PubMed:24005329). Involved in different DSB repair mechanisms that are guided by annealing of extensive stretches of complementary bases at break ends, such as microhomology-mediated end-joining (MMEJ), single-strand annealing (SSA) or synthesis-dependent strand annealing (SDSA) (By similarity). Possesses both DNA unwinding and annealing activities (By similarity). Forms a complex with RAD51, stimulating HELQ DNA helicase activity and ability to unwing DNA (By similarity). Efficiently unwinds substrates containing 3' overhangs or a D-loop (By similarity). In contrast, interaction with the replication protein A (RPA/RP-A) complex inhibits DNA unwinding by HELQ but strongly stimulates DNA strand annealing (By similarity). Triggers displacement of RPA from single-stranded DNA to facilitate annealing of complementary sequences (By similarity)., [UniProtKB, UniProtKB, PubMed, PubMed]; The findings suggest that HELQ contributes to genome stability in unchallenged conditions through a mechanism distinct from the function of FANCC., [RefSeq, PubMed]",
        "predicted_glycosites": 1,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 1,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 0,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 0,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 0,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 0,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 1,
        "reported_interactions": 0,
        "missing_score": 10000,
        "biomarker_type": "",
        "glycan_count": 0,
        "disease_count": 1,
        "glyco_site_count": 1,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q2VPA7;Q640L4;Q8BWI5;Q8R4K9",
        "ec_number_list": "3.6.4.13;3.6.4.10;3.6.4.-;5.6.2.3;5.6.2.4;2.3.2.-;2.3.2.27;3.1.13.1;5.6.2.6;3.1.-.-;7.6.2.1;3.6.1.5;3.4.24.-;3.6.-.-;3.1.3.1;3.9.1.1;3.6.1.-;5.6.2.5;4.2.99.18;3.6.4.12;5.6.1.6;3.6.4.6;3.6.5.-;3.6.1.15;3.1.4.-;5.6.2.-;7.2.2.-;7.6.2.16;3.4.21.53;2.7.7.7;2.7.7.49;2.7.11.1;2.7.4.3",
        "go_molecular_function": "GO:1990518 single-stranded 3'-5' DNA helicase activity;GO:0003677 DNA binding;GO:0005524 ATP binding;GO:0016887 ATP hydrolysis activity;GO:0017116 single-stranded DNA helicase activity",
        "go_cellular_component": "GO:0005634 nucleus;GO:0090734 site of DNA damage;GO:0017117 single-stranded DNA-dependent ATP-dependent DNA helicase complex",
        "go_biological_process": "GO:0097681 double-strand break repair via alternative nonhomologous end joining;GO:0006259 DNA metabolic process;GO:0000724 double-strand break repair via homologous recombination;GO:0010792 DNA double-strand break processing involved in repair via single-strand annealing;GO:1905168 positive regulation of double-strand break repair via homologous recombination",
        "synthesized_glycan_count": 0,
        "hit_score": 1.0,
        "record_id": "Q2VPA6-1",
        "record_type": "protein"
    },
    {
        "uniprot_canonical_ac": "Q80W21-1",
        "uniprot_id": "GSTM7_MOUSE",
        "mass": 25710.0,
        "length": 218,
        "protein_name": "Glutathione S-transferase Mu 7",
        "gene_name": "Gstm7",
        "organism": "Mouse",
        "refseq_name": "glutathione S-transferase Mu 7 isoform 1",
        "refseq_ac": "NP_080948",
        "gene_names_uniprotkb": "Gstm7",
        "gene_names_refseq": "0610005A07Rik; Cd203c; Gstm7",
        "protein_names_uniprotkb": "Glutathione S-transferase Mu 7; 2.5.1.18; GST class-mu 7; GSTM-7",
        "protein_names_refseq": "GST class-mu 7; glutathione S-transferase Mu 7 isoform 1",
        "tax_id": 10090,
        "disease": "obesity (Disease Ontology:DOID:9970)",
        "pathway": " (mmu:68312);  (R-MMU-156590)",
        "pathway_count": 2,
        "publication_count": 2,
        "publication_id_list": "21750661;33300544",
        "class_list": "",
        "function": "Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles., [UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB, UniProtKB]",
        "predicted_glycosites": 0,
        "predicted_n_glycosites": 0,
        "predicted_o_glycosites": 0,
        "predicted_c_glycosites": 0,
        "predicted_s_glycosites": 0,
        "mined_glycosites": 0,
        "mined_n_glycosites": 0,
        "mined_o_glycosites": 0,
        "mined_c_glycosites": 0,
        "mined_s_glycosites": 0,
        "reported_n_glycosites": 0,
        "reported_o_glycosites": 0,
        "reported_c_glycosites": 0,
        "reported_s_glycosites": 0,
        "reported_n_glycosites_with_glycan": 0,
        "reported_o_glycosites_with_glycan": 1,
        "reported_c_glycosites_with_glycan": 0,
        "reported_s_glycosites_with_glycan": 0,
        "total_reported_n_glycosites": 0,
        "total_reported_o_glycosites": 1,
        "total_reported_c_glycosites": 0,
        "total_reported_s_glycosites": 0,
        "total_n_glycosites": 0,
        "total_o_glycosites": 1,
        "total_c_glycosites": 0,
        "total_s_glycosites": 0,
        "reported_fully_resolved_glycans": 1,
        "reported_phosphosites": 0,
        "reported_mutagensis": 0,
        "reported_glycation": 0,
        "reported_snv": 0,
        "reported_interactions": 0,
        "missing_score": 0,
        "biomarker_type": "",
        "glycan_count": 1,
        "disease_count": 1,
        "glyco_site_count": 0,
        "binding_glycan_count": 0,
        "secondary_ac_list": "Q3TRV7;Q3V4E2",
        "ec_number_list": "1.11.1.-;4.4.1.20;2.5.1.18;1.20.4.2;1.8.5.1;5.3.3.-;2.5.1.-;5.3.99.2;5.3.99.3;5.2.1.2",
        "go_molecular_function": "GO:0004364 glutathione transferase activity;GO:0043295 glutathione binding;GO:0005504 fatty acid binding;GO:0019899 enzyme binding;GO:0042803 protein homodimerization activity",
        "go_cellular_component": "GO:0005737 cytoplasm;GO:0005829 cytosol;GO:0016529 sarcoplasmic reticulum",
        "go_biological_process": "GO:0043651 linoleic acid metabolic process;GO:0042178 xenobiotic catabolic process;GO:0010880 regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;GO:0010881 regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;GO:0014809 regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion",
        "synthesized_glycan_count": 0,
        "hit_score": 0.5,
        "record_id": "Q80W21-1",
        "record_type": "protein"
    }
]